data_1fm1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1fm1 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.1 mt . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 121.417 0.627 . . . . 1.0 109.529 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.05 162.25 34.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.335 -0.853 . . . . 1.0 108.815 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -71.99 149.21 45.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.999 -1.063 . . . . 1.0 109.071 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.0 t -79.41 -4.8 52.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.402 -0.811 . . . . 1.0 110.382 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.2 pttt -150.08 159.15 44.63 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.954 -1.091 . . . . 1.0 109.705 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.536 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.03 0.41 57.13 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.459 -0.776 . . . . 1.0 109.416 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -95.27 126.51 40.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.329 -0.857 . . . . 1.0 108.753 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.3 mt -140.14 152.11 45.82 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.279 -0.888 . . . . 1.0 109.069 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.8 p -130.27 155.29 46.54 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.893 -0.78 . . . . 1.0 108.893 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -145.62 158.72 43.81 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.039 -1.038 . . . . 1.0 109.89 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.556 HH12 ' H ' ' A' ' 56' ' ' GLY . 70.7 ttt180 -144.14 133.73 23.52 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.513 -0.742 . . . . 1.0 109.533 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.4 mt -89.43 117.59 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.091 -1.006 . . . . 1.0 109.125 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 56.6 t -69.94 -41.44 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.171 -0.956 . . . . 1.0 109.414 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.3 p-10 -163.2 162.99 25.71 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.775 -1.203 . . . . 1.0 110.125 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -102.12 -167.39 1.4 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.203 -1.406 . . . . 1.0 107.203 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.469 ' HG1' ' H ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -120.72 143.08 35.63 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.374 -0.829 . . . . 1.0 109.817 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -66.07 -15.58 49.12 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 120.854 1.036 . . . . 1.0 110.822 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.469 ' H ' ' HG1' ' A' ' 23' ' ' THR . 98.7 m-20 -59.17 -39.6 83.01 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.288 -0.869 . . . . 1.0 109.995 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.5 mtm -136.27 166.06 24.3 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.252 -0.905 . . . . 1.0 109.428 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.7 p -71.77 161.2 31.33 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.515 -0.74 . . . . 1.0 109.648 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 49.3 m170 -61.77 -39.91 93.32 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.553 -0.717 . . . . 1.0 109.741 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.7 m -59.9 -40.05 87.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.983 -1.073 . . . . 1.0 110.08 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -64.67 -40.08 94.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.924 -1.11 . . . . 1.0 109.975 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 63.2 t -70.02 -40.4 78.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 120.935 -1.103 . . . . 1.0 110.278 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.98 -52.87 63.56 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.235 -0.916 . . . . 1.0 110.899 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.5 ptmt -64.5 -28.82 69.92 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.196 -0.94 . . . . 1.0 109.992 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.12 -49.67 76.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.874 -1.141 . . . . 1.0 109.413 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -67.77 -38.53 83.53 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.994 -1.067 . . . . 1.0 110.083 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -59.88 -43.08 94.95 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.903 -1.123 . . . . 1.0 109.37 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -61.59 -40.09 93.55 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.058 -1.026 . . . . 1.0 108.781 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.08 -47.17 87.01 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.528 -0.733 . . . . 1.0 109.825 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -63.31 -39.85 95.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.992 -1.068 . . . . 1.0 109.57 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -59.8 -48.96 79.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.087 -1.008 . . . . 1.0 109.859 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.5 t -60.05 -40.41 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.255 -0.903 . . . . 1.0 110.602 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.436 ' CE3' ' CD1' ' A' ' 125' ' ' LEU . 73.5 m95 -79.4 -37.1 38.03 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.949 -1.094 . . . . 1.0 109.424 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.7 p -71.22 -20.0 62.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.104 -0.998 . . . . 1.0 110.029 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -60.65 -39.91 90.1 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.954 -1.091 . . . . 1.0 110.899 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.2 m -111.31 22.78 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.195 -0.941 . . . . 1.0 111.071 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.6 p -146.94 135.36 10.92 Favored Pre-proline 0 N--CA 1.501 2.11 0 O-C-N 120.843 -1.161 . . . . 1.0 109.361 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -74.28 17.57 0.51 Allowed 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 120.733 0.955 . . . . 1.0 111.967 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 78.2 mt -69.33 139.53 54.27 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.253 -0.904 . . . . 1.0 109.915 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -110.79 120.78 43.52 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.865 -0.791 . . . . 1.0 108.865 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -107.6 122.43 46.68 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.413 -0.804 . . . . 1.0 109.647 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -120.18 130.11 54.43 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.663 -0.648 . . . . 1.0 110.068 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -81.83 135.7 35.43 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.27 -0.894 . . . . 1.0 109.348 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.3 mt -104.27 126.23 51.2 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.364 -0.835 . . . . 1.0 109.181 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.41 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 45.8 m-70 -61.61 -40.16 93.83 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.329 -0.857 . . . . 1.0 109.737 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 77.3 m-20 -146.45 167.48 23.53 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.242 -0.911 . . . . 1.0 109.857 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.556 ' H ' HH12 ' A' ' 18' ' ' ARG . . . 98.22 175.73 33.09 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.136 -1.585 . . . . 1.0 109.136 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -93.55 136.81 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.228 -1.16 . . . . 1.0 108.579 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.66 161.08 15.74 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.423 -0.798 . . . . 1.0 109.281 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.02 -49.8 76.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.303 -0.873 . . . . 1.0 109.144 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.407 HG21 HD12 ' A' ' 60' ' ' ILE . 88.6 mt -106.64 102.59 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.377 -0.827 . . . . 1.0 109.702 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.1 ptm -102.47 131.49 49.13 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.348 -0.845 . . . . 1.0 109.148 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 88.3 mt -105.92 135.11 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.539 -0.725 . . . . 1.0 109.808 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 64.4 p -152.32 158.88 43.37 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.192 -0.942 . . . . 1.0 109.851 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -104.46 121.23 43.0 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.24 -170.01 23.97 Favored Glycine 0 N--CA 1.501 2.984 0 O-C-N 121.156 -0.965 . . . . 1.0 111.121 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 78.0 mt . . . . . 0 N--CA 1.498 1.937 0 N-CA-C 107.995 -1.113 . . . . 1.0 107.995 179.521 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.53 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 72.2 m-85 . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 109.207 -0.664 . . . . 1.0 109.207 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -100.11 8.04 44.19 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.236 -0.915 . . . . 1.0 110.102 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 127.99 -156.4 20.69 Favored Glycine 0 N--CA 1.504 3.193 0 N-CA-C 108.608 -1.797 . . . . 1.0 108.608 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -60.7 -65.66 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.462 0 CA-C-N 118.855 1.328 . . . . 1.0 111.422 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 87.4 p -76.53 160.03 29.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.059 -1.026 . . . . 1.0 109.436 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.26 -126.87 7.24 Favored Glycine 0 N--CA 1.504 3.203 0 N-CA-C 110.016 -1.234 . . . . 1.0 110.016 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.427 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 28.4 mt -68.71 107.69 3.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.228 -1.16 . . . . 1.0 109.483 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 38.0 mt -79.67 -16.54 55.55 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.017 -1.052 . . . . 1.0 108.209 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.32 175.26 0.94 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.203 -1.036 . . . . 1.0 108.203 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.468 ' CE1' ' ND1' ' A' ' 97' ' ' HIS . 7.5 p80 -161.2 159.99 29.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.994 -1.066 . . . . 1.0 109.479 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.07 160.16 44.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.371 -0.831 . . . . 1.0 108.866 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -106.25 151.45 40.21 Favored Pre-proline 0 N--CA 1.499 1.984 0 N-CA-C 108.766 -0.827 . . . . 1.0 108.766 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -44.81 161.92 0.08 OUTLIER 'Trans proline' 0 N--CA 1.488 1.152 0 C-N-CA 120.694 0.93 . . . . 1.0 111.656 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo . . . . . 0 N--CA 1.494 1.543 0 C-N-CA 121.158 1.239 . . . . 1.0 112.529 -179.477 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.6 p-10 . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 121.191 0.52 . . . . 1.0 109.733 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.49 122.57 8.26 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.289 -0.882 . . . . 1.0 109.533 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.468 ' ND1' ' CE1' ' A' ' 84' ' ' HIS . 60.8 m170 -110.74 148.25 32.7 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.652 -0.655 . . . . 1.0 109.692 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -123.05 156.46 34.82 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.571 -0.706 . . . . 1.0 109.19 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.53 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 1.1 m-20 -81.2 121.35 26.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 1.0 109.633 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -84.67 -12.95 52.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.068 -1.02 . . . . 1.0 109.422 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -82.96 -11.54 58.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.311 -0.868 . . . . 1.0 109.879 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -87.82 173.01 9.21 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.36 -0.838 . . . . 1.0 110.075 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.0 m -99.88 104.85 16.53 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.411 -0.806 . . . . 1.0 108.871 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.494 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 95.9 m95 -88.71 125.28 34.78 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.633 -0.877 . . . . 1.0 108.633 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.8 t -140.35 150.46 43.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.492 -0.755 . . . . 1.0 109.308 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 75.7 m -92.17 -8.26 46.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.104 -0.998 . . . . 1.0 108.383 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.8 m -91.19 174.84 7.18 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.57 -0.9 . . . . 1.0 108.57 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.49 ' OG ' ' CZ ' ' A' ' 143' ' ' TYR . 4.2 m -78.06 77.59 4.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.835 -1.166 . . . . 1.0 109.429 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -146.98 149.58 33.44 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.707 -0.849 . . . . 1.0 108.707 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.81 -135.66 6.64 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.793 -1.323 . . . . 1.0 109.793 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -100.6 114.3 27.85 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.323 -1.104 . . . . 1.0 109.136 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -63.94 132.43 50.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.135 -0.978 . . . . 1.0 109.248 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.3 tp -59.8 -41.38 91.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.32 -0.862 . . . . 1.0 110.255 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -59.97 -43.8 94.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.311 -0.868 . . . . 1.0 111.095 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -59.42 -50.49 73.74 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.671 -1.268 . . . . 1.0 109.814 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.1 t -66.24 -40.8 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.933 -1.104 . . . . 1.0 109.407 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.32 -51.5 69.67 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.282 -0.887 . . . . 1.0 110.067 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.27 -36.44 73.26 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.383 -1.448 . . . . 1.0 110.181 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.533 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 56.7 t60 -66.77 -47.75 71.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.113 -0.992 . . . . 1.0 111.746 -178.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -59.54 -39.86 85.34 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.624 -1.298 . . . . 1.0 109.515 -178.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -59.87 -39.37 85.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.11 -0.994 . . . . 1.0 108.513 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.95 -43.48 87.78 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.581 -1.408 . . . . 1.0 109.581 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.533 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 78.0 m-70 -64.5 -39.83 94.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.015 -1.286 . . . . 1.0 109.289 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 90.5 p -66.72 -24.12 66.2 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.137 -0.977 . . . . 1.0 110.025 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.436 ' CD1' ' CE3' ' A' ' 42' ' ' TRP . 80.9 mt -81.71 -1.64 47.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.11 -0.994 . . . . 1.0 109.689 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 91.33 9.62 63.1 Favored Glycine 0 N--CA 1.499 2.835 0 C-N-CA 120.243 -0.979 . . . . 1.0 111.01 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.8 mt -86.92 146.18 26.26 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.903 -1.351 . . . . 1.0 109.903 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 36.9 t0 -103.62 172.02 7.04 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.694 -0.854 . . . . 1.0 108.694 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.545 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 35.5 m170 -59.94 134.67 57.26 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.001 -1.062 . . . . 1.0 109.612 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 37.4 t -97.4 164.83 12.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.283 -0.886 . . . . 1.0 109.513 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -99.16 1.88 45.37 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.294 -0.879 . . . . 1.0 109.237 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 17.3 t0 -85.67 125.11 70.11 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.299 -0.875 . . . . 1.0 108.971 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -68.82 -20.53 39.39 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 CA-C-N 120.146 1.088 . . . . 1.0 111.822 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.451 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -86.26 -7.2 80.27 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.739 -1.344 . . . . 1.0 109.739 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.11 148.52 26.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.128 -1.219 . . . . 1.0 109.913 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.8 mt -69.83 -29.03 66.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.348 -0.845 . . . . 1.0 109.461 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.6 mmm -73.93 8.74 1.84 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.572 -0.705 . . . . 1.0 110.81 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -67.37 132.78 93.14 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 120.795 -1.191 . . . . 1.0 108.38 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -60.32 -24.73 78.38 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 120.861 1.041 . . . . 1.0 113.477 -178.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.3 mt -93.49 139.18 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 120.909 -1.119 . . . . 1.0 110.369 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -73.94 131.59 41.59 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.495 0.664 . . . . 1.0 110.05 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.8 t -141.19 140.45 34.02 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.719 -0.613 . . . . 1.0 109.441 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.49 ' CZ ' ' OG ' ' A' ' 108' ' ' SER . 79.3 t80 -80.94 145.07 31.43 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.241 -0.912 . . . . 1.0 109.033 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.8 t -141.01 155.32 46.22 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.342 -0.849 . . . . 1.0 108.918 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -77.8 112.66 3.54 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.258 -1.537 . . . . 1.0 109.258 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -77.79 3.34 14.47 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.239 -1.154 . . . . 1.0 110.034 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.5 ' O ' ' ND1' ' A' ' 148' ' ' HIS . 86.5 p -59.9 -38.38 82.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.077 -1.014 . . . . 1.0 109.679 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . 0.5 ' ND1' ' O ' ' A' ' 147' ' ' SER . 89.3 m-70 -154.08 33.05 0.43 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.09 -1.006 . . . . 1.0 110.078 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -70.85 138.69 50.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.996 -1.065 . . . . 1.0 109.67 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 58.4 mtt -140.02 149.53 43.31 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.225 -1.028 . . . . 1.0 108.225 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.8 mp -52.25 127.38 38.59 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.87 -1.144 . . . . 1.0 108.833 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -65.1 -179.05 0.92 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 CA-C-N 120.088 1.067 . . . . 1.0 111.875 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -62.59 -40.14 95.96 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.456 -0.777 . . . . 1.0 110.175 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.407 ' C ' ' OD1' ' A' ' 154' ' ' ASP . 52.7 t0 -57.22 -49.71 75.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.964 -1.085 . . . . 1.0 110.138 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -70.44 -40.04 74.0 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.155 -0.966 . . . . 1.0 109.92 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 51.5 t -61.3 -44.74 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.051 -1.031 . . . . 1.0 109.591 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -61.61 -39.05 89.89 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.98 -1.075 . . . . 1.0 109.97 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -69.97 -53.27 15.52 Favored Glycine 0 N--CA 1.494 2.545 0 O-C-N 121.051 -1.03 . . . . 1.0 111.262 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 6.3 tp -62.04 -40.54 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.722 -1.457 . . . . 1.0 109.837 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 164' ' ' GLY . 97.6 mt-30 -64.48 -39.79 94.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.01 -1.056 . . . . 1.0 109.757 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 93.2 p -64.75 -26.61 68.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.139 -0.976 . . . . 1.0 110.271 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 92.2 mt -86.39 -54.02 4.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.164 -0.96 . . . . 1.0 110.174 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -91.0 -11.27 39.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.229 -0.919 . . . . 1.0 110.27 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.626 0 N-CA-C 109.386 -1.486 . . . . 1.0 109.386 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.5 mt . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.5 pttt -161.26 162.05 30.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.372 -0.83 . . . . 1.0 109.499 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -70.65 146.53 49.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.205 -0.934 . . . . 1.0 109.419 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.3 m -99.57 17.82 19.49 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.36 -0.837 . . . . 1.0 110.043 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -147.82 147.63 30.03 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.001 -1.062 . . . . 1.0 109.438 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.538 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -91.82 -0.68 57.54 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.347 -0.845 . . . . 1.0 110.087 -179.707 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -99.28 119.9 38.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.264 -0.898 . . . . 1.0 108.589 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.7 mt -140.04 150.38 44.32 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.262 -0.899 . . . . 1.0 109.059 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.1 p -132.11 158.36 41.83 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.566 -0.709 . . . . 1.0 109.27 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -143.43 158.23 43.81 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.266 -0.896 . . . . 1.0 109.759 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.0 ttt-85 -143.14 132.65 23.58 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.483 -0.76 . . . . 1.0 109.796 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.8 mt -88.46 117.31 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.251 -0.906 . . . . 1.0 109.259 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.89 -40.05 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.079 -1.013 . . . . 1.0 108.937 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.689 HD22 ' H ' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -163.01 160.77 24.99 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.099 -1.001 . . . . 1.0 110.065 -179.656 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.639 ' CD1' ' CD2' ' A' ' 28' ' ' HIS . 46.9 m-85 -102.71 -160.39 0.78 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.086 -1.449 . . . . 1.0 107.086 178.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.798 ' HG1' ' H ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -127.62 153.76 77.66 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.053 -1.029 . . . . 1.0 110.704 -179.287 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -74.16 -16.9 22.28 Favored 'Trans proline' 0 N--CA 1.486 1.068 0 C-N-CA 121.089 1.193 . . . . 1.0 110.124 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.798 ' H ' ' HG1' ' A' ' 23' ' ' THR . 96.0 m-20 -59.46 -39.97 85.37 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.382 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 73.9 mtm -135.86 163.76 29.49 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.305 -0.872 . . . . 1.0 109.519 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.8 p -72.42 159.71 33.54 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.34 -0.85 . . . . 1.0 109.422 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.639 ' CD2' ' CD1' ' A' ' 22' ' ' TYR . 1.1 m80 -61.41 -40.03 92.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.434 -0.791 . . . . 1.0 110.399 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.5 m -60.08 -39.94 87.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.128 -0.982 . . . . 1.0 110.235 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -67.0 -39.98 87.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.136 -0.977 . . . . 1.0 109.871 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.4 t -68.21 -41.46 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.935 . . . . 1.0 110.457 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -60.05 -48.74 80.47 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.978 -1.076 . . . . 1.0 110.582 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -62.61 -32.46 73.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.979 -1.075 . . . . 1.0 109.948 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.07 -47.83 84.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.086 -1.009 . . . . 1.0 109.68 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -66.04 -39.73 90.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.074 -1.016 . . . . 1.0 109.868 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -60.02 -41.97 93.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.95 -1.094 . . . . 1.0 109.771 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -60.81 -41.93 96.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.966 -1.084 . . . . 1.0 109.201 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.39 -45.4 93.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.458 -0.776 . . . . 1.0 110.276 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -68.13 -38.37 82.12 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.986 -1.071 . . . . 1.0 110.162 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -59.93 -46.65 88.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.032 -1.043 . . . . 1.0 109.404 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.2 t -59.94 -41.0 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.943 . . . . 1.0 109.759 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 71.9 m95 -79.48 -36.56 38.52 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.983 -1.073 . . . . 1.0 110.293 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.8 p -71.23 -18.74 62.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.974 -1.078 . . . . 1.0 109.843 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.88 -39.66 90.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.188 -0.945 . . . . 1.0 110.847 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.9 m -110.05 23.25 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.28 -0.887 . . . . 1.0 110.836 -178.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.0 p -149.05 137.7 12.01 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 120.861 -1.149 . . . . 1.0 109.377 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -75.25 18.03 0.59 Allowed 'Trans proline' 0 N--CA 1.495 1.598 0 CA-C-N 119.68 0.921 . . . . 1.0 112.102 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.9 mt -68.19 138.39 55.58 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.048 -1.032 . . . . 1.0 109.991 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -110.15 120.35 42.17 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.665 -0.865 . . . . 1.0 108.665 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -108.12 121.32 44.59 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.42 -0.8 . . . . 1.0 109.589 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -120.01 130.03 54.54 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.598 -0.688 . . . . 1.0 109.333 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -82.53 134.7 35.2 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.198 -0.939 . . . . 1.0 109.441 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.4 mt -104.03 131.94 50.78 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.35 -0.844 . . . . 1.0 109.448 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.438 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 91.6 m-70 -65.03 -40.01 94.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.483 -0.761 . . . . 1.0 110.405 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 80.5 m-20 -146.74 170.02 17.86 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.106 -0.996 . . . . 1.0 109.985 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.26 177.51 40.35 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.483 -1.447 . . . . 1.0 109.483 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.5 mt -93.81 136.45 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.212 -1.17 . . . . 1.0 109.105 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -107.83 173.16 6.44 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.404 -0.81 . . . . 1.0 109.415 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -60.04 -49.18 78.66 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.193 -0.942 . . . . 1.0 109.216 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.0 mt -119.99 117.52 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.471 -0.768 . . . . 1.0 109.179 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.8 ptp -100.97 140.0 35.88 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.209 -0.932 . . . . 1.0 109.293 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 86.4 mt -110.01 130.09 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.622 -0.674 . . . . 1.0 109.802 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 31.0 p -150.51 156.21 40.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.217 -0.927 . . . . 1.0 109.826 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.689 ' H ' HD22 ' A' ' 21' ' ' ASN . 91.5 m-85 -102.76 122.79 45.2 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.292 -1.003 . . . . 1.0 108.292 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.7 -177.28 23.93 Favored Glycine 0 N--CA 1.499 2.891 0 N-CA-C 110.709 -0.956 . . . . 1.0 110.709 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 66' ' ' ILE . 87.6 mt . . . . . 0 N--CA 1.493 1.708 0 O-C-N 121.71 -0.877 . . . . 1.0 108.813 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.517 ' CD2' ' OD2' ' A' ' 99' ' ' ASP . 34.0 m-85 . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -99.94 0.04 40.41 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.217 -0.927 . . . . 1.0 110.478 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 128.05 -139.46 11.1 Favored Glycine 0 N--CA 1.502 3.056 0 N-CA-C 108.344 -1.902 . . . . 1.0 108.344 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.448 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 24.9 Cg_endo -79.02 -52.9 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.314 0 CA-C-N 119.917 1.859 . . . . 1.0 112.09 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 91.6 p -79.6 170.49 16.48 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.205 -0.934 . . . . 1.0 110.086 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.82 -122.5 7.6 Favored Glycine 0 N--CA 1.498 2.817 0 N-CA-C 110.488 -1.045 . . . . 1.0 110.488 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.465 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 9.8 mt -67.26 100.48 0.81 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.454 -1.027 . . . . 1.0 109.111 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 64.2 mt -79.06 -20.03 49.87 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.014 -1.054 . . . . 1.0 110.03 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.01 171.99 1.32 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 1.0 109.035 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -162.28 159.14 25.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.012 -1.055 . . . . 1.0 109.896 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.08 156.18 42.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.49 -0.756 . . . . 1.0 109.322 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -103.5 150.94 38.55 Favored Pre-proline 0 N--CA 1.496 1.863 0 N-CA-C 108.39 -0.967 . . . . 1.0 108.39 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.73 166.47 11.85 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 120.924 1.083 . . . . 1.0 111.42 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo . . . . . 0 C--N 1.313 -1.34 0 C-N-CA 120.661 0.907 . . . . 1.0 111.361 -179.897 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 109.602 -0.518 . . . . 1.0 109.602 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.04 122.43 9.05 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.209 -0.932 . . . . 1.0 109.526 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -109.72 155.98 20.86 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.596 -0.69 . . . . 1.0 109.392 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.524 ' CE2' ' OE2' ' A' ' 120' ' ' GLU . 29.1 m-85 -130.23 143.66 50.91 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.197 -1.038 . . . . 1.0 108.197 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.517 ' OD2' ' CD2' ' A' ' 75' ' ' PHE . 93.6 m-20 -80.01 117.06 20.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.725 -1.234 . . . . 1.0 109.576 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 39.1 t0 -81.59 2.74 27.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.386 -0.821 . . . . 1.0 109.559 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -81.2 -17.34 49.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 1.0 110.101 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.512 ' N ' ' OE1' ' A' ' 102' ' ' GLU . 58.0 mp0 -92.86 174.87 7.02 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.018 -1.051 . . . . 1.0 109.605 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 23.3 m -99.14 105.12 17.17 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.529 -0.915 . . . . 1.0 108.529 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -85.21 128.12 34.55 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.347 -0.845 . . . . 1.0 108.73 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.449 ' HG1' ' H ' ' A' ' 107' ' ' SER . 8.9 t -142.77 158.33 43.74 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.416 -0.803 . . . . 1.0 109.781 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.6 t -95.56 -9.09 33.28 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.253 -1.017 . . . . 1.0 108.253 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.644 ' HG ' ' H ' ' A' ' 108' ' ' SER . 11.4 t -92.1 -171.6 2.88 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.888 -0.782 . . . . 1.0 108.888 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.644 ' H ' ' HG ' ' A' ' 107' ' ' SER . 2.5 t -88.38 77.77 8.07 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.077 -1.014 . . . . 1.0 109.619 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -149.31 151.39 34.07 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.324 -0.86 . . . . 1.0 108.761 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.48 -137.7 5.29 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.949 -1.26 . . . . 1.0 109.949 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -100.06 118.97 37.55 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.376 -1.073 . . . . 1.0 109.316 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.694 HD22 ' HZ2' ' A' ' 146' ' ' LYS . 23.8 t-20 -65.52 130.11 42.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 1.0 110.059 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 58.6 tp -60.06 -47.11 87.24 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.368 -0.832 . . . . 1.0 111.295 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -59.79 -42.9 94.4 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.083 -1.01 . . . . 1.0 111.843 -177.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.403 ' N ' HD21 ' A' ' 115' ' ' LEU . 4.0 mm? -60.01 -49.99 75.5 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.532 -1.355 . . . . 1.0 109.21 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 65.3 t -66.66 -42.36 89.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.244 -0.91 . . . . 1.0 110.866 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.97 -48.74 79.06 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.081 -1.012 . . . . 1.0 110.325 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.35 -39.17 82.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.947 -1.096 . . . . 1.0 110.294 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.599 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 56.4 t60 -65.27 -52.42 54.41 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.137 -0.977 . . . . 1.0 111.411 -178.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.524 ' OE2' ' CE2' ' A' ' 98' ' ' PHE . 10.1 pt-20 -60.03 -42.3 94.1 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.772 -1.205 . . . . 1.0 110.609 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.435 ' O ' ' OG ' ' A' ' 124' ' ' SER . 26.8 m-85 -60.09 -39.86 87.59 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.729 -1.232 . . . . 1.0 108.814 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -54.82 -42.74 80.1 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.366 -1.494 . . . . 1.0 109.366 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.599 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 90.1 m-70 -65.68 -39.1 90.94 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.125 -1.221 . . . . 1.0 109.134 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 121' ' ' PHE . 79.1 p -62.14 -24.97 67.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -0.903 . . . . 1.0 109.892 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 88.8 mt -81.19 -0.08 38.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.057 -1.027 . . . . 1.0 109.792 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 91.89 10.36 61.49 Favored Glycine 0 N--CA 1.498 2.784 0 O-C-N 121.058 -1.026 . . . . 1.0 110.668 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.3 mt -84.71 150.01 25.4 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.931 -1.334 . . . . 1.0 109.462 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 37.1 t0 -100.65 169.99 8.66 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.435 -0.79 . . . . 1.0 109.06 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.526 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 74.8 m80 -59.99 139.74 57.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.153 -0.967 . . . . 1.0 109.545 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 41.2 t -96.25 156.16 16.46 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.27 -0.894 . . . . 1.0 108.913 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -99.13 3.95 46.75 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.127 -0.983 . . . . 1.0 109.574 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -87.07 129.49 51.73 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.089 -1.007 . . . . 1.0 108.726 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -67.9 -27.82 36.61 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 CA-C-N 120.086 1.066 . . . . 1.0 113.022 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -84.86 -2.31 88.58 Favored Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.824 -1.179 . . . . 1.0 110.454 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.83 146.81 26.07 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.022 -1.281 . . . . 1.0 110.015 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 86.5 mt -70.06 -29.96 67.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.221 -0.924 . . . . 1.0 109.677 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.2 mmm -73.6 8.3 1.94 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.183 -0.948 . . . . 1.0 110.171 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -69.41 132.64 89.48 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.096 -1.002 . . . . 1.0 108.595 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -63.41 14.19 0.07 OUTLIER 'Trans proline' 0 N--CA 1.505 2.182 0 C-N-CA 121.152 1.235 . . . . 1.0 115.167 -177.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 76.0 mt -130.78 138.02 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.382 0 O-C-N 120.785 -1.197 . . . . 1.0 109.495 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.464 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 21.5 t80 -73.37 128.3 35.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.444 -0.785 . . . . 1.0 109.957 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 10.0 t -136.56 137.0 39.76 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.579 -0.701 . . . . 1.0 109.197 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -85.11 143.18 29.0 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.17 -0.956 . . . . 1.0 109.265 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.7 t -140.38 151.19 44.77 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.3 -0.875 . . . . 1.0 109.52 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -68.89 109.39 2.87 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.734 -1.746 . . . . 1.0 108.734 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.694 ' HZ2' HD22 ' A' ' 112' ' ' ASN . 85.0 mttt -73.35 126.03 29.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.133 -1.216 . . . . 1.0 109.298 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 10.6 p -176.86 -93.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.307 -0.871 . . . . 1.0 109.111 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -98.81 18.83 16.09 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.664 -0.865 . . . . 1.0 108.664 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -60.15 134.62 57.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.592 -0.693 . . . . 1.0 109.829 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 95.0 mtp -136.96 150.14 47.98 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.732 -0.84 . . . . 1.0 108.732 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 20.8 mt -48.23 125.87 11.85 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.069 -1.02 . . . . 1.0 108.949 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -62.83 175.62 2.25 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 CA-C-N 120.118 1.078 . . . . 1.0 112.201 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.02 -39.95 87.62 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.311 -0.868 . . . . 1.0 109.553 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.403 ' OD1' ' C ' ' A' ' 154' ' ' ASP . 52.7 t0 -55.89 -50.02 71.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.911 . . . . 1.0 109.739 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -70.07 -39.94 75.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.143 -0.973 . . . . 1.0 110.427 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.3 t -59.97 -46.41 94.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.903 -1.123 . . . . 1.0 109.018 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -60.3 -40.04 89.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.977 -1.077 . . . . 1.0 110.278 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -67.93 -55.89 12.5 Favored Glycine 0 N--CA 1.494 2.526 0 O-C-N 121.12 -0.988 . . . . 1.0 111.152 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.3 tp -60.44 -39.98 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.909 -1.347 . . . . 1.0 109.523 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.492 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.5 mt-30 -65.28 -39.93 93.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.076 -1.015 . . . . 1.0 109.812 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 85.6 p -60.05 -33.92 72.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.064 -1.023 . . . . 1.0 110.488 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.4 mt -84.83 -56.71 3.44 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.004 -1.06 . . . . 1.0 111.167 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -89.66 -9.0 51.21 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.989 -1.07 . . . . 1.0 110.647 -178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.497 2.748 0 N-CA-C 109.538 -1.425 . . . . 1.0 109.538 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.2 mt . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.422 0.63 . . . . 1.0 109.343 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.5 pttm -165.12 167.04 18.61 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.37 -0.831 . . . . 1.0 109.442 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -71.88 142.32 49.54 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.182 -0.949 . . . . 1.0 109.188 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.3 t -89.86 4.47 49.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.253 -0.905 . . . . 1.0 109.924 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -145.07 154.1 42.13 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.182 -0.949 . . . . 1.0 109.452 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.1 mmt -90.47 0.51 57.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.287 -0.883 . . . . 1.0 109.684 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -95.73 126.9 41.31 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.218 -0.927 . . . . 1.0 109.554 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.8 mt -143.26 149.16 37.49 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.366 -0.834 . . . . 1.0 108.816 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.0 p -132.78 155.18 49.37 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.424 -0.798 . . . . 1.0 108.851 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.499 ' CD2' ' NH1' ' A' ' 52' ' ' ARG . 34.7 p90 -148.4 160.12 43.34 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.821 -1.174 . . . . 1.0 110.752 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.0 ttt-85 -145.72 134.77 22.68 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.387 -0.598 . . . . 1.0 109.387 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.679 ' H ' ' NH2' ' A' ' 52' ' ' ARG . 93.5 mt -89.9 119.1 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 120.792 -1.193 . . . . 1.0 108.684 178.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 56.1 t -69.0 -40.78 81.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.964 -1.085 . . . . 1.0 109.027 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.4 p-10 -162.95 164.12 25.9 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.032 -1.067 . . . . 1.0 110.203 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.516 ' CD2' ' CG ' ' A' ' 28' ' ' HIS . 36.7 m-85 -103.42 -161.08 0.81 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.646 -1.613 . . . . 1.0 106.646 178.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.12 151.84 74.95 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.614 -0.679 . . . . 1.0 110.668 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -70.19 -14.28 34.55 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.056 1.171 . . . . 1.0 110.062 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -59.45 -40.02 85.5 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 115.307 -0.86 . . . . 1.0 110.027 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.6 mtm -140.47 168.07 20.68 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.343 -0.848 . . . . 1.0 109.236 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.4 p -72.79 159.98 32.92 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.401 -0.812 . . . . 1.0 109.207 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.516 ' CG ' ' CD2' ' A' ' 22' ' ' TYR . 51.2 m170 -59.97 -40.0 87.56 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.442 -0.787 . . . . 1.0 110.007 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 61.9 m -60.01 -40.06 87.98 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.165 -0.959 . . . . 1.0 110.488 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.65 -39.96 91.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.96 -1.088 . . . . 1.0 109.838 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.4 t -69.51 -41.38 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.135 -0.978 . . . . 1.0 110.485 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.0 -49.05 79.18 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.989 -1.069 . . . . 1.0 110.495 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -62.17 -32.91 73.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.987 -1.071 . . . . 1.0 109.825 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.98 -50.43 73.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.184 -0.948 . . . . 1.0 110.042 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -65.82 -38.94 90.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.054 -1.029 . . . . 1.0 109.672 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.97 -42.36 93.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.06 -1.025 . . . . 1.0 109.808 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -60.56 -40.59 92.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.942 -1.098 . . . . 1.0 109.234 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.26 -43.1 96.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -0.89 . . . . 1.0 109.99 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -66.07 -40.01 90.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.03 -1.043 . . . . 1.0 109.705 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -59.94 -47.87 84.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -0.934 . . . . 1.0 110.139 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 70.5 t -59.95 -40.04 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.058 -1.026 . . . . 1.0 109.965 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -81.66 -35.31 30.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.895 -1.128 . . . . 1.0 110.182 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.7 p -70.46 -22.82 62.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.92 -1.113 . . . . 1.0 109.414 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -59.96 -40.01 87.58 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.433 -0.792 . . . . 1.0 110.606 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.5 m -112.14 25.35 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.372 -0.83 . . . . 1.0 110.729 -178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.422 ' C ' ' H ' ' A' ' 48' ' ' LEU . 59.9 p -148.91 131.62 7.95 Favored Pre-proline 0 N--CA 1.501 2.09 0 O-C-N 120.88 -1.137 . . . . 1.0 109.796 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -72.93 20.54 0.33 Allowed 'Trans proline' 0 N--CA 1.495 1.577 0 CA-C-N 119.668 0.917 . . . . 1.0 112.032 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.422 ' H ' ' C ' ' A' ' 46' ' ' THR . 83.9 mt -67.97 139.1 56.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.175 -0.953 . . . . 1.0 109.614 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -107.92 120.58 42.7 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.851 -0.796 . . . . 1.0 108.851 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -107.21 127.1 53.22 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.304 -0.873 . . . . 1.0 110.023 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.3 m -120.05 129.98 54.48 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.648 -0.657 . . . . 1.0 109.404 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.679 ' NH2' ' H ' ' A' ' 19' ' ' ILE . 28.9 tpt180 -84.03 136.5 34.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.247 -0.908 . . . . 1.0 109.833 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.0 mt -110.61 128.71 55.79 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.438 -0.789 . . . . 1.0 109.26 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.44 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 56.6 m170 -69.43 -39.78 77.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.396 -0.815 . . . . 1.0 109.708 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 76.7 m-20 -148.77 168.66 22.33 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.231 -0.918 . . . . 1.0 110.084 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.27 -175.48 29.52 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 109.868 -1.293 . . . . 1.0 109.868 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.7 mt -94.46 133.98 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.313 -1.11 . . . . 1.0 109.021 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.79 163.0 14.66 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.493 -0.754 . . . . 1.0 109.511 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -59.94 -49.25 78.41 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.279 -0.888 . . . . 1.0 109.045 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 95.8 mt -113.64 108.36 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.465 -0.772 . . . . 1.0 109.516 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.6 ptm -103.47 132.44 49.72 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.207 -0.933 . . . . 1.0 109.435 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 90.1 mt -102.34 138.25 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.506 -0.746 . . . . 1.0 109.777 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.8 p -153.63 157.34 39.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.249 -0.907 . . . . 1.0 109.49 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -102.08 125.28 48.73 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.8 -0.815 . . . . 1.0 108.8 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.14 158.04 16.21 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.424 -1.071 . . . . 1.0 110.424 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 9.8 tt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 108.758 -0.83 . . . . 1.0 108.758 179.985 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.537 ' CE2' ' OD1' ' A' ' 99' ' ' ASP . 27.2 m-85 . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 108.366 -0.976 . . . . 1.0 108.366 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 79' ' ' SER . 23.7 p-10 -99.95 10.25 41.61 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.046 -1.034 . . . . 1.0 110.948 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 110.73 -150.5 17.72 Favored Glycine 0 N--CA 1.507 3.395 0 N-CA-C 109.557 -1.417 . . . . 1.0 109.557 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -58.77 -65.81 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.577 0 CA-C-N 118.913 1.357 . . . . 1.0 112.846 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.433 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 78.9 p -75.24 159.16 31.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.095 -1.003 . . . . 1.0 109.693 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.22 -128.59 8.04 Favored Glycine 0 N--CA 1.5 2.944 0 N-CA-C 109.773 -1.331 . . . . 1.0 109.773 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.464 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 14.8 mt -69.4 105.84 2.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.326 -1.102 . . . . 1.0 109.41 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 72.2 mt -78.73 -24.4 44.88 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.127 -0.983 . . . . 1.0 108.738 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.65 169.99 1.31 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.053 -1.091 . . . . 1.0 108.053 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -163.0 161.39 25.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.855 -1.153 . . . . 1.0 110.209 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -145.5 162.31 37.68 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.502 -0.749 . . . . 1.0 109.193 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -103.06 151.92 38.5 Favored Pre-proline 0 N--CA 1.501 2.113 0 O-C-N 121.114 -0.991 . . . . 1.0 109.227 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -49.67 167.15 0.19 Allowed 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 120.784 0.99 . . . . 1.0 112.518 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo . . . . . 0 N--CA 1.494 1.545 0 C-N-CA 121.249 1.299 . . . . 1.0 111.845 179.131 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.2 p-10 . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.139 0.495 . . . . 1.0 109.716 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.87 123.17 10.26 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.279 -0.888 . . . . 1.0 109.27 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 57.5 m170 -112.31 154.8 25.12 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.571 -0.705 . . . . 1.0 109.973 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.519 ' CZ ' ' OE2' ' A' ' 120' ' ' GLU . 38.9 m-85 -133.12 149.79 52.09 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.625 -0.88 . . . . 1.0 108.625 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.537 ' OD1' ' CE2' ' A' ' 75' ' ' PHE . 64.4 m-20 -79.93 123.23 27.59 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.964 -1.085 . . . . 1.0 110.058 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -84.8 -9.72 57.89 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.297 -0.877 . . . . 1.0 109.621 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -84.73 -11.55 55.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.261 -0.899 . . . . 1.0 109.848 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -90.02 169.94 10.77 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.37 -0.831 . . . . 1.0 110.026 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 16.7 m -100.14 105.19 16.78 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.435 -0.79 . . . . 1.0 109.101 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -89.32 124.29 34.28 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.084 -0.71 . . . . 1.0 109.084 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.8 t -140.7 154.55 46.4 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.279 -0.888 . . . . 1.0 110.151 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 70.2 m -92.88 -8.01 44.59 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.427 -0.953 . . . . 1.0 108.427 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.4 m -92.63 176.78 6.32 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.9 m -79.72 76.64 6.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.998 -1.064 . . . . 1.0 109.428 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -147.26 148.66 31.67 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.392 -0.817 . . . . 1.0 108.866 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 46.11 -139.39 6.66 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.747 -1.341 . . . . 1.0 109.747 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -99.7 114.41 27.5 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.251 -1.146 . . . . 1.0 109.21 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.503 ' H ' ' HH ' ' A' ' 141' ' ' TYR . 18.9 t-20 -63.69 133.76 54.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.137 -0.977 . . . . 1.0 109.538 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.3 tp -59.99 -44.76 94.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.506 -0.747 . . . . 1.0 110.825 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -59.97 -42.75 94.84 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.005 -1.06 . . . . 1.0 110.561 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -59.61 -50.01 75.54 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.878 -1.139 . . . . 1.0 109.363 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.7 t -69.07 -41.46 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.15 -0.969 . . . . 1.0 109.691 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.63 -50.16 74.85 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.369 -0.832 . . . . 1.0 110.274 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.44 -38.71 81.41 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.865 -1.147 . . . . 1.0 110.218 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.595 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 57.3 t60 -64.02 -50.01 70.17 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.093 -1.004 . . . . 1.0 111.031 -178.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.519 ' OE2' ' CZ ' ' A' ' 98' ' ' PHE . 7.4 pt-20 -59.99 -44.64 94.38 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.698 -1.251 . . . . 1.0 110.048 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.405 ' O ' ' OG ' ' A' ' 124' ' ' SER . 33.0 m-85 -59.99 -40.03 87.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.785 -1.197 . . . . 1.0 108.895 179.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.29 -43.75 64.85 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.241 -1.543 . . . . 1.0 109.241 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.595 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 87.8 m-70 -66.29 -39.93 89.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.217 -1.166 . . . . 1.0 109.112 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 121' ' ' PHE . 77.4 p -62.39 -21.41 65.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.898 . . . . 1.0 109.561 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.5 mt -83.0 -3.55 57.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 1.0 109.391 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 92.4 8.14 62.92 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.524 -1.03 . . . . 1.0 110.524 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.3 mt -86.58 146.34 26.39 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.95 -1.324 . . . . 1.0 109.208 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 27.7 t0 -99.47 175.29 5.9 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.476 -0.765 . . . . 1.0 109.576 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.461 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 75.2 m80 -61.15 135.66 57.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 1.0 109.72 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.446 ' HG ' ' N ' ' A' ' 131' ' ' LYS . 41.5 t -97.37 156.7 16.34 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.21 -0.931 . . . . 1.0 109.358 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.446 ' N ' ' HG ' ' A' ' 130' ' ' SER . 63.2 mttp -97.33 0.39 47.9 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.155 -0.965 . . . . 1.0 109.632 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -83.7 130.23 56.46 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.171 -0.955 . . . . 1.0 108.476 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -70.58 -20.69 30.67 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 CA-C-N 120.022 1.044 . . . . 1.0 112.384 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -87.58 -5.05 79.2 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.823 -1.311 . . . . 1.0 109.823 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.73 145.72 26.55 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.173 -1.192 . . . . 1.0 109.267 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.502 ' C ' ' H ' ' A' ' 138' ' ' PHE . 95.5 mt -70.67 -30.98 67.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.078 -1.014 . . . . 1.0 109.477 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 98.2 mmm -70.23 14.14 0.13 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.364 -0.835 . . . . 1.0 109.766 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.502 ' H ' ' C ' ' A' ' 136' ' ' LEU . 13.5 t80 -68.89 134.03 90.07 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.071 -1.018 . . . . 1.0 108.297 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -62.67 -18.36 63.6 Favored 'Trans proline' 0 N--CA 1.501 1.957 0 C-N-CA 121.04 1.16 . . . . 1.0 113.985 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.422 HD13 HG22 ' A' ' 140' ' ' ILE . 96.8 mt -102.79 141.43 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 120.834 -1.166 . . . . 1.0 109.691 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.503 ' HH ' ' H ' ' A' ' 112' ' ' ASN . 46.3 t80 -75.58 126.01 30.16 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.331 -0.856 . . . . 1.0 110.221 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 11.0 t -134.73 137.46 43.5 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.426 -0.796 . . . . 1.0 109.268 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -80.1 143.56 33.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.966 -1.084 . . . . 1.0 108.6 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.9 t -139.83 151.73 45.94 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.313 -0.867 . . . . 1.0 109.615 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.55 104.75 1.51 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.374 -1.49 . . . . 1.0 109.374 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -77.9 1.72 19.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.26 -1.141 . . . . 1.0 109.95 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 73.3 m -60.05 -40.1 88.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.193 -0.942 . . . . 1.0 109.652 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -143.41 29.45 1.43 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.246 -0.909 . . . . 1.0 109.468 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -69.7 138.87 53.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.173 -0.955 . . . . 1.0 110.11 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 93.9 mtp -138.79 146.67 41.62 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.544 -0.91 . . . . 1.0 108.544 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 58.1 mt -51.74 129.03 36.29 Favored Pre-proline 0 C--N 1.302 -1.483 0 O-C-N 121.111 -0.993 . . . . 1.0 108.728 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -69.2 178.56 4.11 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 CA-C-N 119.985 1.03 . . . . 1.0 112.266 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -63.11 -39.89 96.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.476 -0.765 . . . . 1.0 110.12 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -55.64 -48.56 74.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.337 -0.852 . . . . 1.0 109.764 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -69.93 -40.03 75.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.97 . . . . 1.0 109.847 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.04 -48.13 89.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.075 -1.016 . . . . 1.0 108.995 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -60.11 -40.02 88.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.191 -0.943 . . . . 1.0 110.261 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.43 -55.0 7.11 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 120.199 -1.001 . . . . 1.0 111.477 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.408 ' CG2' ' N ' ' A' ' 160' ' ' GLN . 5.3 tp -60.0 -40.14 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.967 -1.313 . . . . 1.0 109.732 -178.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.55 ' O ' ' N ' ' A' ' 164' ' ' GLY . 12.4 mm100 -64.43 -39.34 93.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.209 -0.932 . . . . 1.0 109.316 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 79.9 p -60.95 -34.13 74.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.139 -0.976 . . . . 1.0 110.484 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.2 mt -84.43 -52.79 5.9 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.877 -1.139 . . . . 1.0 110.671 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -90.67 -8.01 51.1 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.046 -1.034 . . . . 1.0 110.541 -178.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.536 0 N-CA-C 109.288 -1.525 . . . . 1.0 109.288 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.3 mt . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.328 -0.619 . . . . 1.0 109.328 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -160.34 159.97 31.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.24 -0.913 . . . . 1.0 109.384 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -76.37 127.24 32.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.148 -0.97 . . . . 1.0 109.259 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.43 ' HG ' ' N ' ' A' ' 12' ' ' LYS . 78.4 p -69.24 -38.48 78.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.038 -1.039 . . . . 1.0 108.933 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.43 ' N ' ' HG ' ' A' ' 11' ' ' SER . 49.1 pttt -89.47 136.43 33.03 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.932 -1.136 . . . . 1.0 107.932 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.611 ' N ' ' SD ' ' A' ' 13' ' ' MET . 4.8 mmm -90.7 -0.27 57.64 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.065 -1.022 . . . . 1.0 109.872 -178.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -97.98 132.72 43.3 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.997 -1.112 . . . . 1.0 107.997 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.6 mt -139.57 149.92 44.43 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.202 -0.936 . . . . 1.0 109.376 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.7 p -135.67 156.43 48.85 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.661 -0.866 . . . . 1.0 108.661 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -145.86 160.04 42.35 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.137 -0.977 . . . . 1.0 109.958 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 37.0 ttt-85 -144.31 134.94 24.84 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.49 -0.756 . . . . 1.0 109.272 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.8 mt -87.54 119.68 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.244 -0.91 . . . . 1.0 108.748 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.5 t -69.17 -39.93 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.239 -0.913 . . . . 1.0 109.345 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -165.01 153.08 11.67 Favored 'General case' 0 C--N 1.29 -1.991 0 O-C-N 120.163 -1.586 . . . . 1.0 110.802 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -100.81 106.52 17.92 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 105.87 -1.9 . . . . 1.0 105.87 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.663 ' HG1' ' H ' ' A' ' 25' ' ' ASP . 0.4 OUTLIER -45.45 140.04 4.32 Favored Pre-proline 0 C--N 1.299 -1.612 0 O-C-N 121.487 -0.758 . . . . 1.0 109.591 -177.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -59.22 -3.05 1.51 Allowed 'Trans proline' 0 N--CA 1.487 1.111 0 CA-C-N 119.358 0.807 . . . . 1.0 110.75 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.663 ' H ' ' HG1' ' A' ' 23' ' ' THR . 94.3 m-20 -59.73 -36.04 75.79 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.585 -0.524 . . . . 1.0 109.585 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 78.0 mtm -140.0 166.75 23.8 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.219 -0.925 . . . . 1.0 109.801 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.6 p -71.63 160.15 33.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.417 -0.802 . . . . 1.0 109.335 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -60.09 -40.93 91.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.307 -0.871 . . . . 1.0 110.32 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.5 m -60.03 -40.34 88.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.935 -1.103 . . . . 1.0 110.875 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.01 -42.96 89.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.109 -0.994 . . . . 1.0 110.767 -178.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.7 t -65.37 -39.87 86.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 121.248 -0.907 . . . . 1.0 109.598 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -58.1 -54.97 41.0 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.371 -0.831 . . . . 1.0 111.708 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.9 pttt -63.47 -33.68 76.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.607 -1.308 . . . . 1.0 110.723 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.37 -50.78 70.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.637 -1.289 . . . . 1.0 109.666 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -67.69 -38.81 84.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.842 -1.161 . . . . 1.0 110.401 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -59.89 -40.69 89.58 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.724 -1.235 . . . . 1.0 109.438 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -60.72 -39.94 90.48 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.158 -0.964 . . . . 1.0 108.988 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.09 -47.12 87.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.432 -0.792 . . . . 1.0 109.834 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -65.21 -38.9 91.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.081 -1.012 . . . . 1.0 109.656 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 44.0 tptt -59.95 -47.83 84.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.079 -1.013 . . . . 1.0 109.893 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.5 t -60.07 -40.77 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.28 -0.887 . . . . 1.0 110.79 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.423 ' O ' ' OG1' ' A' ' 46' ' ' THR . 83.8 m95 -82.32 -35.38 27.96 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.86 -1.15 . . . . 1.0 110.483 -178.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.6 p -70.03 -17.3 63.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.13 -0.981 . . . . 1.0 109.606 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -59.82 -39.98 86.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.261 -0.9 . . . . 1.0 110.868 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.4 m -110.85 -19.46 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 O-C-N 121.147 -0.971 . . . . 1.0 110.487 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 42' ' ' TRP . 67.3 p -94.46 129.79 35.66 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 120.843 -1.161 . . . . 1.0 109.709 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -73.01 10.18 1.18 Allowed 'Trans proline' 0 N--CA 1.494 1.553 0 CA-C-N 119.831 0.975 . . . . 1.0 111.953 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.7 mt -67.95 140.61 56.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.215 -0.928 . . . . 1.0 109.822 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -104.47 121.97 44.55 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.933 -0.765 . . . . 1.0 108.933 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -107.69 122.42 46.69 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.293 -0.879 . . . . 1.0 109.699 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.0 m -119.88 129.98 54.64 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.483 -0.76 . . . . 1.0 109.615 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.475 ' NH1' ' CB ' ' A' ' 52' ' ' ARG . 11.1 ttp-105 -85.03 133.66 34.24 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.288 -0.883 . . . . 1.0 109.725 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 86.2 mt -102.52 126.72 49.67 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.269 -0.894 . . . . 1.0 109.353 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.425 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 54.8 m170 -61.41 -39.87 92.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.447 -0.783 . . . . 1.0 109.874 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 80.8 m-20 -146.19 171.4 14.99 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.225 -0.922 . . . . 1.0 109.563 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.24 179.87 38.12 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.758 -1.337 . . . . 1.0 109.758 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.5 mt -95.56 136.39 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.313 -1.11 . . . . 1.0 109.262 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.72 163.58 14.39 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.483 -0.761 . . . . 1.0 109.244 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -59.99 -49.77 76.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -0.895 . . . . 1.0 109.472 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.9 mt -108.48 104.17 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.488 -0.757 . . . . 1.0 109.753 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.8 ptp -100.83 135.06 42.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.218 -0.926 . . . . 1.0 109.181 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.5 mt -109.99 131.09 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.624 -0.673 . . . . 1.0 109.711 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.3 p -150.55 156.59 41.7 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.205 -0.935 . . . . 1.0 109.898 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -102.37 120.02 39.79 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.207 -1.035 . . . . 1.0 108.207 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.0 -169.48 23.25 Favored Glycine 0 N--CA 1.499 2.878 0 N-CA-C 110.629 -0.988 . . . . 1.0 110.629 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 93.2 mt . . . . . 0 N--CA 1.495 1.784 0 N-CA-C 108.139 -1.06 . . . . 1.0 108.139 179.613 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.585 ' CD1' ' OD1' ' A' ' 99' ' ' ASP . 90.6 m-85 . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -101.27 0.03 36.58 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.31 -0.869 . . . . 1.0 110.848 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 134.18 -150.27 19.97 Favored Glycine 0 N--CA 1.504 3.18 0 N-CA-C 108.767 -1.733 . . . . 1.0 108.767 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.424 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 2.8 Cg_exo -64.07 -64.1 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.339 0 CA-C-N 119.013 1.406 . . . . 1.0 111.473 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 94.3 p -77.83 160.85 28.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.118 -0.989 . . . . 1.0 109.331 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.98 -129.83 8.71 Favored Glycine 0 N--CA 1.501 3.007 0 N-CA-C 109.101 -1.6 . . . . 1.0 109.101 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.413 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 10.1 mt -69.41 107.5 3.35 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.132 -1.216 . . . . 1.0 108.735 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 55.6 mt -75.16 -25.77 58.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.942 -1.098 . . . . 1.0 109.31 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.92 172.94 1.25 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -164.61 160.01 19.65 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.999 -1.063 . . . . 1.0 109.648 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -142.86 153.77 43.49 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.412 -0.805 . . . . 1.0 108.867 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -89.18 151.92 47.31 Favored Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.047 -1.033 . . . . 1.0 108.683 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -58.64 165.37 8.01 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 120.951 1.101 . . . . 1.0 111.788 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo . . . . . 0 C--N 1.316 -1.175 0 C-N-CA 121.215 1.277 . . . . 1.0 112.384 179.758 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.204 0.526 . . . . 1.0 109.589 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.0 124.1 11.43 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.266 -0.896 . . . . 1.0 109.4 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -112.99 133.81 54.78 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.549 -0.72 . . . . 1.0 110.098 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.499 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 25.5 m-85 -116.15 149.41 39.08 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 109.005 -0.739 . . . . 1.0 109.005 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.585 ' OD1' ' CD1' ' A' ' 75' ' ' PHE . 82.0 m-20 -77.75 123.67 26.99 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.878 -1.138 . . . . 1.0 109.845 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 42.0 t0 -84.29 -11.56 56.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.447 -0.783 . . . . 1.0 109.184 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -82.19 -11.69 58.56 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.35 -0.844 . . . . 1.0 108.951 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.424 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 97.5 mt-10 -90.53 168.54 11.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.466 -0.771 . . . . 1.0 109.3 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 19.5 m -100.34 105.24 16.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.326 -0.859 . . . . 1.0 108.723 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.462 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 94.5 m95 -87.33 120.58 28.77 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.481 -0.762 . . . . 1.0 109.103 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.484 ' HG1' ' H ' ' A' ' 107' ' ' SER . 7.3 t -139.95 150.02 44.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.461 -0.774 . . . . 1.0 109.779 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 52.7 m -92.85 -6.14 49.43 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.214 -0.929 . . . . 1.0 108.534 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.484 ' H ' ' HG1' ' A' ' 105' ' ' THR . 16.6 t -92.03 175.69 6.78 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.871 -0.789 . . . . 1.0 108.871 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.1 t -75.59 75.29 2.61 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.028 -1.045 . . . . 1.0 109.222 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 110' ' ' GLY . 98.6 mttt -149.4 149.75 31.33 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.574 -0.898 . . . . 1.0 108.574 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 109' ' ' LYS . . . 42.98 -139.17 2.9 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 110.033 -1.227 . . . . 1.0 110.033 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -100.19 118.85 37.37 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.348 -1.089 . . . . 1.0 109.265 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.613 ' H ' ' HH ' ' A' ' 141' ' ' TYR . 62.0 t-20 -63.31 129.39 40.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.359 -0.838 . . . . 1.0 109.877 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.5 tp -60.01 -43.27 95.36 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.49 -0.756 . . . . 1.0 110.552 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -59.99 -41.63 92.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.214 -0.929 . . . . 1.0 111.177 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.61 -49.62 76.81 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.769 -1.207 . . . . 1.0 109.226 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 67.7 t -69.94 -41.32 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.301 -0.874 . . . . 1.0 110.712 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.34 -53.25 60.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.998 -1.064 . . . . 1.0 109.778 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.97 -34.43 73.27 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.186 -0.946 . . . . 1.0 109.785 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.635 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 60.0 t60 -63.12 -50.73 69.33 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.228 -0.92 . . . . 1.0 110.783 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.499 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 6.9 pt-20 -60.0 -39.42 85.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.792 -1.192 . . . . 1.0 110.111 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -59.94 -40.01 87.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.904 -1.123 . . . . 1.0 108.798 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.67 -41.92 94.0 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.332 -1.507 . . . . 1.0 109.332 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.635 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 83.9 m-70 -67.32 -39.96 85.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.139 -1.212 . . . . 1.0 109.577 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 95.4 p -68.97 -21.93 64.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.397 -0.814 . . . . 1.0 109.513 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 49.7 mt -82.99 -0.96 51.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 1.0 109.902 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 92.5 6.43 64.25 Favored Glycine 0 N--CA 1.498 2.77 0 C-N-CA 120.221 -0.99 . . . . 1.0 110.852 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.3 mt -85.1 144.86 27.95 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.745 -1.444 . . . . 1.0 109.916 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 44.6 t0 -99.01 172.43 7.41 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.167 -1.049 . . . . 1.0 108.167 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.485 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 74.6 m80 -61.76 132.17 52.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.757 -1.214 . . . . 1.0 109.281 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.7 t -97.35 158.39 15.49 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.253 -0.905 . . . . 1.0 109.135 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -99.92 8.45 44.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.322 -0.861 . . . . 1.0 109.279 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -85.14 125.35 70.46 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.188 -0.945 . . . . 1.0 108.895 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -66.91 -20.94 50.93 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 CA-C-N 120.195 1.105 . . . . 1.0 112.541 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -87.3 -7.14 77.06 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.078 -1.209 . . . . 1.0 110.078 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.87 139.58 31.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.117 -1.225 . . . . 1.0 109.458 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.493 ' C ' ' H ' ' A' ' 138' ' ' PHE . 91.6 mt -62.18 -40.05 94.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.142 -0.974 . . . . 1.0 109.88 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 85.8 mtp -70.5 24.72 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.245 -0.909 . . . . 1.0 111.04 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.493 ' H ' ' C ' ' A' ' 136' ' ' LEU . 23.5 t80 -69.94 129.99 90.41 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 120.766 -1.209 . . . . 1.0 108.331 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -49.55 -19.8 3.6 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 120.954 1.103 . . . . 1.0 114.505 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.4 HG23 HD11 ' A' ' 140' ' ' ILE . 90.6 mt -107.78 137.39 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 O-C-N 120.879 -1.138 . . . . 1.0 110.37 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.613 ' HH ' ' H ' ' A' ' 112' ' ' ASN . 28.8 t80 -74.13 128.27 35.1 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.554 -0.716 . . . . 1.0 109.519 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.9 t -139.55 143.4 37.36 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.915 -0.772 . . . . 1.0 108.915 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -81.53 142.85 32.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.108 -0.995 . . . . 1.0 108.885 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.2 t -139.7 150.96 45.49 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.172 -0.955 . . . . 1.0 110.151 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.64 105.13 1.66 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.218 -1.553 . . . . 1.0 109.218 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 21.8 mtmm -75.74 1.9 13.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.379 -1.071 . . . . 1.0 109.834 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 67.9 m -59.92 -40.02 87.44 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.171 -0.955 . . . . 1.0 109.712 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -144.18 27.7 1.41 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.096 -1.003 . . . . 1.0 110.1 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -68.78 137.4 53.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.919 -1.113 . . . . 1.0 109.768 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 67.1 mtt -138.86 147.94 43.06 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.38 -0.825 . . . . 1.0 108.955 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 74.2 mt -51.57 124.84 26.55 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.0 -1.062 . . . . 1.0 108.631 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -67.81 -179.42 2.06 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 CA-C-N 120.102 1.072 . . . . 1.0 112.329 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -61.77 -39.58 92.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.333 -0.854 . . . . 1.0 109.868 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -56.98 -49.55 75.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -0.945 . . . . 1.0 110.01 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -70.09 -39.97 75.23 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.99 -1.069 . . . . 1.0 110.31 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 76.4 t -60.84 -48.36 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.958 -1.089 . . . . 1.0 108.927 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -60.36 -39.98 89.13 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.16 -0.962 . . . . 1.0 110.856 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.77 -53.79 7.91 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 120.06 -1.067 . . . . 1.0 111.121 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 9.4 tp -60.56 -40.53 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.016 -1.284 . . . . 1.0 109.837 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.527 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.9 mt-30 -65.81 -38.69 89.63 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.136 -0.977 . . . . 1.0 109.54 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 83.9 p -65.72 -24.98 67.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.119 -0.988 . . . . 1.0 110.666 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 87.8 mt -87.34 -50.72 6.38 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.747 -1.22 . . . . 1.0 110.0 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -93.01 -9.11 41.01 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.04 -1.038 . . . . 1.0 110.048 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.607 0 N-CA-C 109.548 -1.421 . . . . 1.0 109.548 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.6 mt . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 109.173 -0.677 . . . . 1.0 109.173 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -161.24 163.37 31.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.065 -1.022 . . . . 1.0 109.647 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -71.16 146.2 49.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.881 . . . . 1.0 109.543 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 87.8 p -90.06 3.44 53.27 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.4 -0.812 . . . . 1.0 110.148 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -144.7 154.01 42.31 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.065 -1.022 . . . . 1.0 109.51 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.5 mmt -90.46 -0.04 57.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.229 -0.919 . . . . 1.0 109.748 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -96.65 125.49 41.16 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.126 -0.983 . . . . 1.0 109.182 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.0 mt -140.01 152.34 46.19 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.293 -0.88 . . . . 1.0 109.187 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.5 p -133.61 154.29 51.0 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.494 -0.754 . . . . 1.0 109.312 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -145.1 160.0 42.09 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.186 -0.946 . . . . 1.0 109.811 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 44.9 ttt-85 -144.61 131.5 20.27 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.427 -0.796 . . . . 1.0 109.503 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 86.0 mt -86.94 119.98 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.278 -0.889 . . . . 1.0 108.818 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.6 t -69.47 -41.53 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.089 -1.007 . . . . 1.0 109.282 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -165.09 155.02 13.31 Favored 'General case' 0 C--N 1.289 -2.06 0 O-C-N 119.967 -1.708 . . . . 1.0 110.412 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.411 ' O ' ' C ' ' A' ' 23' ' ' THR . 23.9 m-85 -99.4 95.94 7.37 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 105.907 -1.886 . . . . 1.0 105.907 178.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.411 ' C ' ' O ' ' A' ' 22' ' ' TYR . 1.5 t -39.86 142.53 0.66 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.963 -0.461 . . . . 1.0 110.619 -177.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -59.68 -21.48 63.11 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 120.436 0.757 . . . . 1.0 110.994 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -58.4 -14.86 8.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.73 -0.606 . . . . 1.0 109.865 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 78.0 mtp -142.7 150.78 40.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.291 -0.881 . . . . 1.0 109.816 -178.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.1 p -75.52 160.05 30.61 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.476 -0.935 . . . . 1.0 108.476 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 27.9 m170 -60.64 -40.1 90.72 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.12 -0.988 . . . . 1.0 109.948 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.9 m -64.82 -42.35 95.04 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.065 -1.022 . . . . 1.0 110.922 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -66.4 -40.11 89.42 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.153 -0.967 . . . . 1.0 111.321 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.4 t -67.91 -42.07 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.969 -1.082 . . . . 1.0 110.535 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -59.94 -49.49 77.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.127 -0.983 . . . . 1.0 110.715 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -64.15 -32.66 74.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.823 -1.173 . . . . 1.0 110.377 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.35 -50.62 73.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.794 -1.191 . . . . 1.0 110.01 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -69.35 -37.51 77.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.043 -1.036 . . . . 1.0 110.218 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -59.95 -42.72 94.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.981 -1.074 . . . . 1.0 109.484 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -61.78 -40.18 94.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.091 -1.006 . . . . 1.0 108.849 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.82 -50.83 71.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.444 -0.785 . . . . 1.0 110.135 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -63.26 -39.95 96.03 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.952 -1.092 . . . . 1.0 109.947 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -60.05 -48.65 80.84 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.062 -1.024 . . . . 1.0 109.841 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 72.0 t -60.03 -41.84 87.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.34 -0.85 . . . . 1.0 110.435 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -78.43 -34.81 47.63 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.958 -1.089 . . . . 1.0 110.23 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 52.4 p -72.33 -20.0 61.55 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.95 -1.094 . . . . 1.0 109.814 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -60.07 -40.02 88.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.496 -0.752 . . . . 1.0 111.417 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.5 m -111.87 22.48 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.241 -0.912 . . . . 1.0 111.131 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.452 ' C ' ' H ' ' A' ' 48' ' ' LEU . 18.8 p -146.57 139.45 14.32 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 120.872 -1.142 . . . . 1.0 109.274 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -72.93 17.55 0.39 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 120.675 0.917 . . . . 1.0 111.178 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.452 ' H ' ' C ' ' A' ' 46' ' ' THR . 90.4 mt -67.65 134.12 50.58 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.361 -0.837 . . . . 1.0 110.374 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -108.78 120.53 42.77 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.531 -0.914 . . . . 1.0 108.531 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -108.4 130.34 55.23 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.309 -0.869 . . . . 1.0 109.418 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.5 m -120.03 130.01 54.51 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.571 -0.705 . . . . 1.0 110.147 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -82.83 129.54 35.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.397 -0.814 . . . . 1.0 109.277 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 89.4 mt -108.89 118.62 37.28 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 108.74 -0.837 . . . . 1.0 108.74 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.445 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 72.2 m-70 -70.18 -24.08 63.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.22 -0.925 . . . . 1.0 110.063 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 77.8 m-20 -148.33 162.88 38.63 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.216 -0.928 . . . . 1.0 109.876 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.21 174.9 39.14 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.746 -1.342 . . . . 1.0 109.746 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 87.5 mt -94.25 134.1 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.331 -1.1 . . . . 1.0 109.019 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.98 160.94 15.98 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.446 -0.784 . . . . 1.0 109.122 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.04 -49.34 78.06 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.178 -0.951 . . . . 1.0 109.113 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.9 mt -105.02 99.06 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.427 -0.796 . . . . 1.0 109.818 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.3 ptm -99.28 133.89 42.91 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.115 -0.99 . . . . 1.0 109.084 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 62' ' ' ILE . 85.5 mt -106.09 137.4 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.536 -0.728 . . . . 1.0 109.749 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 81.8 p -153.13 155.82 37.46 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.129 -0.982 . . . . 1.0 109.565 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -104.88 123.96 48.63 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.573 -0.704 . . . . 1.0 109.127 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -103.82 -169.9 25.36 Favored Glycine 0 N--CA 1.5 2.949 0 N-CA-C 110.48 -1.048 . . . . 1.0 110.48 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.4 HD13 HG23 ' A' ' 66' ' ' ILE . 70.9 mt . . . . . 0 N--CA 1.498 1.934 0 O-C-N 121.57 -0.959 . . . . 1.0 109.037 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.549 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 96.7 m-85 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 108.622 -0.881 . . . . 1.0 108.622 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 79' ' ' SER . 22.8 p-10 -96.75 -0.27 48.41 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.992 -1.067 . . . . 1.0 110.829 -178.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.459 ' O ' ' OE2' ' A' ' 102' ' ' GLU . . . 117.44 -120.03 4.64 Favored Glycine 0 N--CA 1.506 3.325 0 N-CA-C 110.338 -1.105 . . . . 1.0 110.338 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.461 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 28.1 Cg_endo -74.29 -73.19 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.803 0 CA-C-N 120.26 2.03 . . . . 1.0 113.04 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.457 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 82.2 p -78.28 -178.9 5.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.925 -1.109 . . . . 1.0 109.806 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.34 -135.43 12.16 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.305 -1.118 . . . . 1.0 110.305 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.7 mt -71.17 111.11 6.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.552 -0.97 . . . . 1.0 110.033 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 55.2 mt -83.63 -17.3 42.02 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.128 -0.982 . . . . 1.0 108.927 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.86 176.0 0.97 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.023 -0.732 . . . . 1.0 109.023 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -161.84 163.37 29.37 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.103 -0.998 . . . . 1.0 109.444 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.34 170.01 19.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.289 -0.882 . . . . 1.0 109.404 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -107.2 154.06 40.71 Favored Pre-proline 0 N--CA 1.498 1.972 0 N-CA-C 108.849 -0.797 . . . . 1.0 108.849 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -60.3 165.6 10.68 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 120.588 0.859 . . . . 1.0 111.558 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo . . . . . 0 N--CA 1.491 1.354 0 C-N-CA 121.149 1.233 . . . . 1.0 112.108 -179.654 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 40.4 p-10 . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 121.387 0.613 . . . . 1.0 109.835 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.24 129.93 15.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.258 -0.901 . . . . 1.0 109.641 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 58.5 m170 -124.9 147.07 49.02 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.614 -0.679 . . . . 1.0 109.252 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -129.72 151.95 49.76 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.528 -0.732 . . . . 1.0 109.469 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.549 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 96.4 m-20 -79.6 120.55 24.09 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.045 -1.035 . . . . 1.0 109.104 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 43.0 t0 -83.54 -4.97 59.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.235 -0.916 . . . . 1.0 109.04 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -82.01 -10.81 59.12 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.412 -0.805 . . . . 1.0 109.075 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.461 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 49.2 mm-40 -90.68 179.1 5.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.385 -0.822 . . . . 1.0 108.991 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 39.0 m -104.93 104.55 14.32 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.445 -0.946 . . . . 1.0 108.445 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.419 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 88.6 m95 -87.95 120.0 28.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.929 . . . . 1.0 109.08 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.3 t -140.97 151.2 43.97 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.525 -0.734 . . . . 1.0 109.708 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 61.2 m -92.71 -5.64 50.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.104 -0.998 . . . . 1.0 108.546 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 34.0 t -92.93 174.78 7.06 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.6 -0.889 . . . . 1.0 108.6 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.515 ' OG ' ' CZ ' ' A' ' 143' ' ' TYR . 10.6 m -75.85 75.29 2.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.881 -1.137 . . . . 1.0 109.526 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 110' ' ' GLY . 61.3 mttp -147.5 148.84 31.63 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.58 -0.896 . . . . 1.0 108.58 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 109' ' ' LYS . . . 44.53 -139.18 4.65 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.644 -1.382 . . . . 1.0 109.644 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -98.91 118.97 36.88 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.284 -1.127 . . . . 1.0 109.025 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -64.65 130.24 42.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.459 -0.775 . . . . 1.0 110.044 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.3 tp -59.93 -40.45 88.98 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.256 -0.902 . . . . 1.0 110.056 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -59.92 -40.65 89.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 1.0 110.328 -178.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -60.04 -55.4 34.39 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.819 -1.176 . . . . 1.0 109.625 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.0 t -67.44 -42.49 87.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.278 -0.889 . . . . 1.0 109.318 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.94 -52.69 64.32 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.173 -0.954 . . . . 1.0 109.101 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.36 82.38 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.816 -1.177 . . . . 1.0 109.801 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.635 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 73.0 t60 -64.01 -49.85 70.82 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.452 -0.78 . . . . 1.0 111.644 -178.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -59.95 -39.5 85.82 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.602 -1.311 . . . . 1.0 109.664 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -59.81 -40.07 87.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.893 -1.129 . . . . 1.0 108.237 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.38 -43.9 84.88 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.808 -1.717 . . . . 1.0 108.808 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.635 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 87.0 m-70 -67.42 -40.05 85.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.224 -1.162 . . . . 1.0 109.546 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 84.2 p -64.71 -24.03 67.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.206 -0.934 . . . . 1.0 109.731 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 84.5 mt -81.15 0.87 34.42 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.182 -0.949 . . . . 1.0 110.005 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 89.76 4.17 73.09 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 120.056 -1.068 . . . . 1.0 110.738 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.8 mt -84.47 149.74 25.75 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.865 -1.374 . . . . 1.0 109.592 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 37.2 t0 -99.78 174.52 6.18 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.615 -0.883 . . . . 1.0 108.615 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.485 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 74.5 m80 -59.33 139.48 56.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.99 -1.069 . . . . 1.0 109.395 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 38.2 t -98.42 152.73 19.19 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.297 -0.877 . . . . 1.0 109.248 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -99.99 5.49 45.14 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.225 -0.922 . . . . 1.0 109.37 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -88.39 126.82 59.09 Favored Pre-proline 0 N--CA 1.493 1.714 0 N-CA-C 108.179 -1.045 . . . . 1.0 108.179 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -67.56 -15.02 44.06 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 CA-C-N 120.273 1.133 . . . . 1.0 111.94 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -90.72 -5.55 68.63 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.357 -1.497 . . . . 1.0 109.357 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.42 142.51 27.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -1.174 . . . . 1.0 108.901 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.521 ' C ' ' H ' ' A' ' 138' ' ' PHE . 74.5 mt -68.5 -36.9 79.55 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.08 -1.013 . . . . 1.0 109.902 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 76.2 mtp -69.92 20.88 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.133 -0.979 . . . . 1.0 110.405 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.521 ' H ' ' C ' ' A' ' 136' ' ' LEU . 14.6 t80 -66.26 135.5 94.95 Favored Pre-proline 0 N--CA 1.493 1.699 0 N-CA-C 107.853 -1.165 . . . . 1.0 107.853 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -62.92 -10.46 20.38 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 120.826 1.018 . . . . 1.0 114.052 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.403 HG21 HD12 ' A' ' 140' ' ' ILE . 91.5 mt -111.81 138.28 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.39 0 O-C-N 120.875 -1.14 . . . . 1.0 110.012 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -74.95 125.1 28.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.505 -0.747 . . . . 1.0 110.484 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 10.2 t -138.98 140.14 38.13 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.441 -0.787 . . . . 1.0 109.043 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.515 ' CZ ' ' OG ' ' A' ' 108' ' ' SER . 89.3 t80 -81.79 141.96 33.02 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.889 -1.132 . . . . 1.0 109.949 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.5 m -130.28 138.33 50.43 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.039 -0.726 . . . . 1.0 109.039 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -66.4 101.38 0.62 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.62 -1.792 . . . . 1.0 108.62 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 58.1 mmtt -75.96 129.33 36.74 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.288 -1.125 . . . . 1.0 109.302 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.5 t -179.78 -51.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.592 -0.892 . . . . 1.0 108.592 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -135.99 19.85 3.24 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.557 -0.905 . . . . 1.0 108.557 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -65.17 139.41 58.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.406 -0.808 . . . . 1.0 110.602 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 96.5 mtp -137.62 149.91 47.0 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.324 -0.991 . . . . 1.0 108.324 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.5 mt -51.83 131.44 38.32 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 120.902 -1.124 . . . . 1.0 109.03 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -71.41 177.96 6.12 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 CA-C-N 119.919 1.007 . . . . 1.0 112.083 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -62.12 -39.97 94.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.418 -0.801 . . . . 1.0 110.285 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -55.06 -48.68 73.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.035 -1.041 . . . . 1.0 109.778 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -69.96 -40.0 75.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.119 -0.988 . . . . 1.0 110.186 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.5 t -60.45 -47.78 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.968 -1.083 . . . . 1.0 109.302 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -60.61 -40.02 90.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.05 -1.031 . . . . 1.0 110.076 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.416 ' O ' ' OG ' ' A' ' 161' ' ' SER . . . -72.17 -52.39 11.25 Favored Glycine 0 N--CA 1.495 2.631 0 O-C-N 121.246 -0.909 . . . . 1.0 111.874 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 8.4 tp -59.94 -39.97 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.744 -1.445 . . . . 1.0 109.917 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.547 ' O ' ' N ' ' A' ' 164' ' ' GLY . 32.3 mt-30 -68.36 -35.21 77.38 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.059 -1.026 . . . . 1.0 109.425 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 158' ' ' GLY . 77.2 p -60.23 -35.06 74.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.131 -0.981 . . . . 1.0 110.344 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 94.5 mt -86.13 -49.61 7.63 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.958 -1.089 . . . . 1.0 110.671 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -90.04 -9.12 49.74 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.137 -0.977 . . . . 1.0 110.328 -178.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.513 0 N-CA-C 109.411 -1.476 . . . . 1.0 109.411 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.8 mt . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.322 0.582 . . . . 1.0 109.439 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -160.09 160.3 32.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.383 -0.823 . . . . 1.0 109.36 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -71.75 148.94 45.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.211 -0.93 . . . . 1.0 109.573 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 90.7 p -90.03 2.26 55.38 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.42 -0.8 . . . . 1.0 109.798 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.516 ' NZ ' ' O ' ' A' ' 14' ' ' ASN . 20.0 pttp -141.74 153.12 44.4 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.179 -0.95 . . . . 1.0 109.501 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.8 mmt -90.11 -0.04 57.4 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.323 -0.861 . . . . 1.0 109.814 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.516 ' O ' ' NZ ' ' A' ' 12' ' ' LYS . 28.1 m120 -96.97 129.25 44.45 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.197 -0.939 . . . . 1.0 109.286 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.7 mt -141.13 152.0 44.36 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.233 -0.917 . . . . 1.0 109.104 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 63.1 p -133.88 152.81 51.99 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.422 -0.799 . . . . 1.0 109.285 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -145.85 157.46 43.91 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.094 -1.004 . . . . 1.0 109.864 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.4 ' HG2' HH11 ' A' ' 18' ' ' ARG . 38.0 ttt-85 -144.54 135.26 24.81 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.376 -0.827 . . . . 1.0 109.356 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 86.3 mt -87.67 119.71 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.274 -0.891 . . . . 1.0 108.793 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 63.4 t -69.12 -40.22 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.315 -0.865 . . . . 1.0 109.409 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -162.86 156.63 20.32 Favored 'General case' 0 C--N 1.287 -2.146 0 O-C-N 119.38 -2.075 . . . . 1.0 111.369 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.438 ' CB ' ' CD2' ' A' ' 28' ' ' HIS . 64.4 m-85 -100.72 109.03 21.02 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 106.248 -1.76 . . . . 1.0 106.248 178.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.41 ' C ' ' H ' ' A' ' 25' ' ' ASP . 1.1 t -54.62 139.13 60.4 Favored Pre-proline 0 C--N 1.294 -1.842 0 O-C-N 121.38 -0.825 . . . . 1.0 109.309 -178.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -57.8 -6.94 2.84 Favored 'Trans proline' 0 N--CA 1.486 1.085 0 CA-C-N 119.443 0.837 . . . . 1.0 111.145 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 23' ' ' THR . 92.9 m-20 -60.07 -39.58 86.54 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 119.78 -0.768 . . . . 1.0 110.013 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.5 mtm -137.27 159.58 41.52 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.265 -0.897 . . . . 1.0 109.086 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.488 ' OG1' ' OE1' ' A' ' 30' ' ' GLU . 36.3 p -75.3 167.88 21.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.166 -0.959 . . . . 1.0 109.714 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.438 ' CD2' ' CB ' ' A' ' 22' ' ' TYR . 29.6 m170 -60.05 -40.43 89.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.434 -0.791 . . . . 1.0 111.057 -178.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.3 m -60.1 -46.09 90.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.886 -1.134 . . . . 1.0 110.733 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.576 ' N ' ' OE1' ' A' ' 30' ' ' GLU . 8.9 mp0 -66.75 -41.51 87.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.222 -0.924 . . . . 1.0 110.259 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 72.2 t -67.49 -44.77 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.995 -1.066 . . . . 1.0 110.134 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -60.0 -49.67 76.74 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.236 -0.915 . . . . 1.0 111.178 -178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -60.94 -33.81 73.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.692 -1.255 . . . . 1.0 109.852 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.03 -50.93 71.79 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.916 -1.115 . . . . 1.0 110.398 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -65.58 -38.43 89.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.925 -1.11 . . . . 1.0 110.387 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.01 -42.17 93.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.898 -1.127 . . . . 1.0 109.543 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.14 -40.06 88.53 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.219 -0.926 . . . . 1.0 109.291 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.94 -46.45 89.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 1.0 110.075 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -66.84 -38.13 85.81 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.091 -1.006 . . . . 1.0 109.791 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -59.68 -48.26 82.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.13 -0.981 . . . . 1.0 109.577 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.1 t -60.01 -43.08 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.136 -0.977 . . . . 1.0 110.122 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -78.14 -35.69 48.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.99 -1.069 . . . . 1.0 110.18 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.0 p -70.38 -22.43 62.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.096 -1.003 . . . . 1.0 109.741 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.03 -40.01 87.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.31 -0.869 . . . . 1.0 110.8 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.2 m -111.96 25.37 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.335 -0.853 . . . . 1.0 110.621 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.407 ' C ' ' H ' ' A' ' 48' ' ' LEU . 58.5 p -150.01 130.09 6.75 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.144 -0.973 . . . . 1.0 109.083 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -73.54 19.63 0.38 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 CA-C-N 119.974 1.026 . . . . 1.0 112.047 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.407 ' H ' ' C ' ' A' ' 46' ' ' THR . 81.6 mt -69.41 138.74 53.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.177 -0.952 . . . . 1.0 109.616 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -107.28 120.8 43.13 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.798 -0.816 . . . . 1.0 108.798 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -107.01 127.92 53.89 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.32 -0.862 . . . . 1.0 109.162 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -119.98 129.95 54.53 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.63 -0.669 . . . . 1.0 109.444 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.412 HH11 ' HG2' ' A' ' 52' ' ' ARG . 34.1 ttt-85 -82.74 130.0 35.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.398 -0.814 . . . . 1.0 109.424 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.4 mt -103.98 119.87 39.86 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.367 -0.833 . . . . 1.0 109.168 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.434 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 59.0 m-70 -62.28 -39.96 94.67 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.427 -0.796 . . . . 1.0 110.005 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 87.4 m-20 -143.4 164.0 31.52 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.259 -0.9 . . . . 1.0 109.86 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.76 177.81 33.72 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.726 -1.35 . . . . 1.0 109.726 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.8 mt -93.24 134.77 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.292 -1.122 . . . . 1.0 109.29 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.28 167.46 10.1 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.515 -0.74 . . . . 1.0 109.422 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -59.96 -48.94 79.64 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.31 -0.869 . . . . 1.0 109.031 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.7 mt -115.59 108.66 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.535 -0.728 . . . . 1.0 109.897 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.5 ptp -98.68 138.53 35.72 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.199 -0.938 . . . . 1.0 109.108 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.9 mt -109.96 133.57 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.499 -0.75 . . . . 1.0 109.747 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 77.6 p -150.98 159.29 44.67 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.059 -1.026 . . . . 1.0 110.022 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -110.47 126.55 54.46 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.564 -0.71 . . . . 1.0 109.248 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 100' ' ' ASP . . . -102.38 -170.74 26.96 Favored Glycine 0 N--CA 1.502 3.059 0 N-CA-C 110.786 -0.925 . . . . 1.0 110.786 -179.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 62.1 mt . . . . . 0 N--CA 1.498 1.97 0 O-C-N 121.532 -0.981 . . . . 1.0 109.303 -179.941 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.545 ' CD1' ' OD1' ' A' ' 99' ' ' ASP . 94.3 m-85 . . . . . 0 N--CA 1.494 1.725 0 N-CA-C 108.799 -0.815 . . . . 1.0 108.799 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 79' ' ' SER . 27.2 p-10 -99.58 -4.12 31.79 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.084 -1.01 . . . . 1.0 110.709 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.441 ' O ' ' OE2' ' A' ' 102' ' ' GLU . . . 119.14 -115.32 3.03 Favored Glycine 0 N--CA 1.505 3.287 0 N-CA-C 110.267 -1.133 . . . . 1.0 110.267 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.468 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 29.1 Cg_endo -73.91 -75.11 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.956 0 CA-C-N 120.158 1.979 . . . . 1.0 113.402 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.459 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 88.5 p -76.61 177.88 7.14 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.915 -1.115 . . . . 1.0 110.151 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.11 -136.53 12.73 Favored Glycine 0 N--CA 1.498 2.819 0 N-CA-C 110.683 -0.967 . . . . 1.0 110.683 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.0 mt -71.81 110.41 6.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.375 -1.073 . . . . 1.0 109.763 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 55.4 mt -83.76 -18.3 38.27 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.73 173.96 1.22 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.502 -0.925 . . . . 1.0 108.502 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.497 ' CE1' ' ND1' ' A' ' 97' ' ' HIS . 9.4 p80 -162.29 164.33 27.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.971 -1.081 . . . . 1.0 109.985 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -157.17 160.52 38.84 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.823 -0.806 . . . . 1.0 108.823 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -106.75 151.36 40.48 Favored Pre-proline 0 N--CA 1.501 2.102 0 O-C-N 121.365 -0.834 . . . . 1.0 109.131 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -62.51 165.56 15.26 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 120.987 1.124 . . . . 1.0 112.328 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo . . . . . 0 N--CA 1.489 1.263 0 C-N-CA 121.161 1.241 . . . . 1.0 112.356 179.898 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.386 -0.598 . . . . 1.0 109.386 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.89 119.83 6.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 1.0 109.191 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.497 ' ND1' ' CE1' ' A' ' 84' ' ' HIS . 52.4 m170 -103.85 145.78 29.61 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.539 -0.725 . . . . 1.0 109.994 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -129.68 147.03 51.43 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.447 -0.946 . . . . 1.0 108.447 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.545 ' OD1' ' CD1' ' A' ' 75' ' ' PHE . 98.3 m-20 -80.81 124.28 28.94 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.92 -1.113 . . . . 1.0 109.579 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 65' ' ' GLY . 39.2 t0 -84.24 -6.81 59.45 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.144 -0.973 . . . . 1.0 109.214 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -80.33 -9.91 59.75 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.633 -0.877 . . . . 1.0 108.633 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.468 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 57.5 mm-40 -89.57 173.3 8.4 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.985 -0.746 . . . . 1.0 108.985 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 54.2 m -105.29 107.62 18.7 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -88.58 119.98 29.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.304 -0.872 . . . . 1.0 108.739 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.0 t -140.24 157.85 44.94 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.365 -0.835 . . . . 1.0 109.79 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.4 t -95.76 -9.83 30.72 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.223 -0.923 . . . . 1.0 109.053 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 71.3 m -92.46 179.22 5.59 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.368 -0.833 . . . . 1.0 108.975 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.1 t -78.64 77.78 5.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.032 -1.043 . . . . 1.0 109.56 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -148.76 148.12 29.62 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.266 -0.896 . . . . 1.0 108.821 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.53 -141.3 4.72 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.746 -1.342 . . . . 1.0 109.746 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -100.33 117.02 33.66 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.352 -1.087 . . . . 1.0 108.925 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.693 ' H ' ' HH ' ' A' ' 141' ' ' TYR . 16.6 t-20 -62.74 133.85 55.42 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.076 -1.015 . . . . 1.0 109.219 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.9 tp -59.99 -42.82 95.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 1.0 109.823 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -59.86 -40.8 89.87 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.234 -0.916 . . . . 1.0 110.968 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -59.76 -52.12 66.85 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.604 -1.31 . . . . 1.0 109.722 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.3 t -69.91 -40.79 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.059 -1.026 . . . . 1.0 110.049 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.45 -50.15 74.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.153 -0.967 . . . . 1.0 109.547 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.0 -37.3 79.3 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.71 -1.244 . . . . 1.0 110.16 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.598 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 56.9 t60 -63.5 -50.1 70.96 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.219 -0.926 . . . . 1.0 111.315 -178.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.99 -39.03 84.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.748 -1.22 . . . . 1.0 109.858 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -59.99 -40.05 87.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.821 -1.174 . . . . 1.0 108.519 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.45 -46.8 79.51 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.807 -1.317 . . . . 1.0 109.807 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.598 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 86.0 m-70 -65.85 -39.98 91.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.06 -1.259 . . . . 1.0 109.462 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.1 p -64.58 -25.1 67.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.228 -0.92 . . . . 1.0 109.8 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 72.8 mt -80.95 1.98 28.77 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.138 -0.976 . . . . 1.0 109.371 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 87.19 9.51 73.12 Favored Glycine 0 N--CA 1.495 2.629 0 O-C-N 121.2 -0.938 . . . . 1.0 110.834 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.4 mt -84.95 150.02 25.22 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.836 -1.39 . . . . 1.0 109.759 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 39.6 t0 -99.53 171.33 8.0 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.869 -0.789 . . . . 1.0 108.869 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.537 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 71.9 m80 -59.96 139.96 57.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.12 -0.987 . . . . 1.0 109.53 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 44.4 t -97.1 152.4 18.82 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.428 -0.795 . . . . 1.0 109.554 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -99.01 2.22 46.1 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.311 -0.868 . . . . 1.0 109.354 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 9.5 t70 -87.26 130.0 49.44 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.294 -0.879 . . . . 1.0 108.708 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -67.15 -22.22 47.4 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 CA-C-N 120.078 1.064 . . . . 1.0 112.437 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.444 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -86.89 -2.39 84.14 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.817 -1.313 . . . . 1.0 109.817 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.57 143.48 28.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.183 -1.186 . . . . 1.0 109.219 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.452 ' C ' ' H ' ' A' ' 138' ' ' PHE . 84.3 mt -69.26 -38.31 78.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.098 -1.001 . . . . 1.0 109.698 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 81.4 mtp -72.09 20.92 0.06 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 1.0 110.735 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.452 ' H ' ' C ' ' A' ' 136' ' ' LEU . 16.3 t80 -68.11 134.48 91.58 Favored Pre-proline 0 N--CA 1.496 1.857 0 N-CA-C 107.885 -1.154 . . . . 1.0 107.885 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -61.47 -9.46 13.31 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 120.836 1.024 . . . . 1.0 114.227 -177.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.415 HG21 HD11 ' A' ' 140' ' ' ILE . 86.4 mt -113.05 134.08 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 O-C-N 120.955 -1.091 . . . . 1.0 109.705 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.693 ' HH ' ' H ' ' A' ' 112' ' ' ASN . 36.1 t80 -72.34 127.24 31.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.467 -0.77 . . . . 1.0 110.402 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 14.1 t -141.29 141.14 33.95 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.582 -0.895 . . . . 1.0 108.582 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -78.95 143.83 35.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.09 -1.007 . . . . 1.0 109.199 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.6 t -138.8 150.78 46.45 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.292 -0.88 . . . . 1.0 109.71 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -66.15 101.59 0.63 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.465 -1.454 . . . . 1.0 109.465 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 20.9 mtmm -76.71 0.34 20.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.423 -1.046 . . . . 1.0 109.768 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 73.6 p -60.06 -39.97 87.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -0.901 . . . . 1.0 109.965 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -147.62 30.69 0.9 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.079 -1.013 . . . . 1.0 109.526 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -65.28 139.61 58.63 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.132 -0.98 . . . . 1.0 109.586 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 68.2 mtt -136.55 145.24 44.8 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.702 -0.851 . . . . 1.0 108.702 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 20.9 mt -52.86 128.86 46.7 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.091 -1.006 . . . . 1.0 108.719 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -70.13 178.69 4.54 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 CA-C-N 120.081 1.065 . . . . 1.0 112.286 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -60.36 -39.95 89.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.432 -0.792 . . . . 1.0 110.096 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -56.14 -49.12 74.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.199 -0.938 . . . . 1.0 109.969 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -70.08 -39.93 75.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.996 -1.065 . . . . 1.0 110.064 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 58.1 t -61.28 -47.43 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.012 -1.055 . . . . 1.0 109.498 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -60.43 -40.09 89.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.048 -1.032 . . . . 1.0 110.45 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.416 ' O ' ' OG ' ' A' ' 161' ' ' SER . . . -72.26 -53.72 8.67 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 120.374 -0.917 . . . . 1.0 111.477 -178.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 6.8 tp -59.97 -40.06 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.817 -1.402 . . . . 1.0 109.569 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.7 mt-30 -66.06 -39.94 90.5 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.101 -1.0 . . . . 1.0 109.202 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 158' ' ' GLY . 95.1 p -60.53 -28.75 68.66 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.01 -1.056 . . . . 1.0 109.853 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 86.5 mt -89.8 -51.64 5.4 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.047 -1.033 . . . . 1.0 110.643 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -98.04 -22.08 16.45 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.945 -1.097 . . . . 1.0 110.829 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.626 0 N-CA-C 109.692 -1.363 . . . . 1.0 109.692 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.0 mt . . . . . 0 N--CA 1.496 1.841 0 N-CA-C 109.049 -0.723 . . . . 1.0 109.049 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -160.0 160.04 32.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 1.0 109.69 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -72.88 150.0 43.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.304 -0.873 . . . . 1.0 109.304 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.1 t -85.48 1.61 48.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.303 -0.873 . . . . 1.0 110.093 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.528 ' NZ ' ' O ' ' A' ' 14' ' ' ASN . 20.1 pttp -149.14 154.24 38.9 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.162 -0.961 . . . . 1.0 109.635 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.54 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.01 0.39 57.14 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.289 -0.882 . . . . 1.0 109.666 -179.549 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.528 ' O ' ' NZ ' ' A' ' 12' ' ' LYS . 98.5 m-20 -95.51 128.76 42.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.219 -0.926 . . . . 1.0 108.884 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.5 mt -141.31 149.93 41.85 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.186 -0.946 . . . . 1.0 109.253 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 74.3 p -130.9 155.46 46.71 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.03 -0.73 . . . . 1.0 109.03 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -145.86 160.16 42.18 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.146 -0.972 . . . . 1.0 109.835 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.511 ' NH1' ' N ' ' A' ' 56' ' ' GLY . 73.4 ttt180 -143.36 133.45 24.32 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.537 -0.727 . . . . 1.0 109.583 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 91.8 mt -88.36 117.09 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.189 -0.944 . . . . 1.0 108.663 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.54 -40.12 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.06 -1.025 . . . . 1.0 109.391 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -163.85 160.94 22.82 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.431 -1.418 . . . . 1.0 110.631 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -97.21 -173.33 2.64 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.56 -1.274 . . . . 1.0 107.56 178.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.598 ' HG1' ' H ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -117.7 148.4 43.01 Favored Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 121.377 -0.827 . . . . 1.0 110.029 -179.451 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -67.68 -20.64 46.35 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 120.833 1.022 . . . . 1.0 110.335 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.598 ' H ' ' HG1' ' A' ' 23' ' ' THR . 94.8 m-20 -59.4 -40.12 85.6 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.15 -0.932 . . . . 1.0 110.168 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 78.0 mtm -138.95 159.93 40.95 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.257 -0.902 . . . . 1.0 109.853 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 82.6 p -74.21 160.86 30.58 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.497 0.665 . . . . 1.0 109.417 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.634 ' CD2' ' H ' ' A' ' 28' ' ' HIS . 2.7 p80 -62.47 -35.88 80.72 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.552 -0.718 . . . . 1.0 110.148 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.9 m -60.04 -40.28 88.82 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.845 -1.16 . . . . 1.0 109.61 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -69.94 -40.04 75.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.114 -0.991 . . . . 1.0 109.035 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.0 t -69.13 -41.47 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.314 -0.866 . . . . 1.0 110.258 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.95 -48.13 82.95 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.931 -1.105 . . . . 1.0 110.346 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -63.75 -31.82 73.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.87 -1.144 . . . . 1.0 109.834 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.97 -49.96 75.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.07 -1.019 . . . . 1.0 110.031 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -65.55 -37.89 88.01 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.018 -1.051 . . . . 1.0 109.661 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.07 -41.24 92.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.096 -1.003 . . . . 1.0 109.878 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -60.07 -45.32 93.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.12 -0.987 . . . . 1.0 109.475 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.12 -48.06 83.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.44 -0.787 . . . . 1.0 110.717 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.42 ' CZ ' ' CZ ' ' A' ' 121' ' ' PHE . 49.7 m-85 -64.04 -40.05 95.44 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.956 -1.09 . . . . 1.0 109.529 -179.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.6 tptt -59.99 -47.33 86.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.029 -1.045 . . . . 1.0 109.543 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.02 -41.52 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.143 -0.973 . . . . 1.0 110.128 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -78.49 -36.71 44.74 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.012 -1.055 . . . . 1.0 110.376 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 96.1 p -70.91 -20.76 62.46 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.982 -1.074 . . . . 1.0 109.936 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.93 -39.89 87.04 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.252 -0.905 . . . . 1.0 110.558 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.1 m -110.01 23.84 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.201 -0.937 . . . . 1.0 110.944 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.4 p -150.27 139.8 13.42 Favored Pre-proline 0 N--CA 1.502 2.129 0 O-C-N 120.76 -1.213 . . . . 1.0 109.658 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -75.37 15.7 0.79 Allowed 'Trans proline' 0 N--CA 1.497 1.693 0 CA-C-N 119.743 0.944 . . . . 1.0 112.088 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 88.2 mt -67.1 139.92 57.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.079 -1.013 . . . . 1.0 109.71 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -111.81 121.38 44.91 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 109.045 -0.724 . . . . 1.0 109.045 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -107.8 119.01 38.24 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.33 -0.856 . . . . 1.0 109.251 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.1 m -119.95 129.98 54.57 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.64 -0.663 . . . . 1.0 109.946 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.404 ' HG2' HH11 ' A' ' 52' ' ' ARG . 33.6 ttt-85 -82.0 135.13 35.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 1.0 109.241 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.5 mt -102.1 132.0 48.25 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.343 -0.848 . . . . 1.0 109.188 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.447 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 42.0 m170 -63.95 -40.01 95.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -0.84 . . . . 1.0 109.733 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 76.7 m-20 -148.89 169.95 19.39 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.328 -0.857 . . . . 1.0 109.869 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.511 ' N ' ' NH1' ' A' ' 18' ' ' ARG . . . 95.06 178.52 37.5 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.7 -1.36 . . . . 1.0 109.7 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.4 mt -92.58 139.52 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.292 -1.122 . . . . 1.0 108.961 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.05 170.55 8.08 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.473 -0.767 . . . . 1.0 109.702 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.03 -49.05 79.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.242 -0.911 . . . . 1.0 108.935 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 90.2 mt -119.95 112.97 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.616 -0.678 . . . . 1.0 109.251 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.0 ptm -100.93 135.0 43.07 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.397 -0.814 . . . . 1.0 108.952 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 95.8 mt -104.43 135.17 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.505 -0.747 . . . . 1.0 110.365 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 79.4 p -152.9 159.03 42.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.345 -0.847 . . . . 1.0 109.278 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -102.81 127.71 49.87 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.413 -0.804 . . . . 1.0 109.564 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.89 157.95 17.86 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 109.436 -1.466 . . . . 1.0 109.436 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.9 tt . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.465 -1.021 . . . . 1.0 108.719 179.995 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.538 ' CD1' ' OD2' ' A' ' 99' ' ' ASP . 90.8 m-85 . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 108.604 -0.887 . . . . 1.0 108.604 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.6 p-10 -97.4 0.0 47.06 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.082 -1.011 . . . . 1.0 110.099 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.21 -157.89 22.9 Favored Glycine 0 N--CA 1.5 2.944 0 N-CA-C 108.722 -1.751 . . . . 1.0 108.722 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -59.68 -63.68 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.354 0 CA-C-N 118.655 1.228 . . . . 1.0 111.612 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 88.1 p -77.62 162.34 27.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.428 -0.795 . . . . 1.0 109.485 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.15 -129.95 9.03 Favored Glycine 0 N--CA 1.499 2.894 0 N-CA-C 109.709 -1.356 . . . . 1.0 109.709 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.449 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 10.2 mt -64.99 101.13 0.47 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.222 -1.164 . . . . 1.0 108.66 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 53.5 mt -75.66 -28.36 58.69 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.468 -0.938 . . . . 1.0 108.468 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -177.92 163.94 1.84 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.385 -0.969 . . . . 1.0 108.385 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -160.78 160.41 31.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.907 -1.121 . . . . 1.0 109.97 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -144.11 156.21 44.25 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.705 -0.85 . . . . 1.0 108.705 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -95.51 150.99 38.26 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.149 -0.969 . . . . 1.0 108.807 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -65.5 165.01 24.04 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 120.771 0.981 . . . . 1.0 111.556 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo . . . . . 0 C--N 1.314 -1.238 0 C-N-CA 121.164 1.243 . . . . 1.0 111.792 179.865 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.016 -0.735 . . . . 1.0 109.016 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.65 123.67 10.73 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.083 -1.011 . . . . 1.0 109.61 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -110.08 154.76 22.8 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.589 0.709 . . . . 1.0 110.015 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.486 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 44.9 m-85 -130.58 150.22 51.88 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.538 ' OD2' ' CD1' ' A' ' 75' ' ' PHE . 1.2 m-20 -78.96 122.86 26.68 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.991 -1.068 . . . . 1.0 109.591 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -84.44 -6.84 59.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.142 -0.974 . . . . 1.0 109.379 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -85.98 -14.74 43.7 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.336 -0.853 . . . . 1.0 110.067 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.574 ' N ' ' OE1' ' A' ' 102' ' ' GLU . 0.9 OUTLIER -88.66 169.91 11.27 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.176 -0.953 . . . . 1.0 109.687 -179.113 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.7 m -99.05 102.57 14.32 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.75 -0.833 . . . . 1.0 108.75 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.446 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 93.4 m95 -85.16 121.99 28.7 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.48 -0.762 . . . . 1.0 109.33 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.2 t -140.63 150.4 43.52 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.476 -0.765 . . . . 1.0 109.761 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 74.8 m -93.04 -6.2 48.77 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.193 -0.942 . . . . 1.0 108.52 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.1 p -91.3 178.63 5.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.571 -0.706 . . . . 1.0 109.208 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 89.7 p -77.0 70.0 3.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 1.0 109.376 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -146.22 150.81 36.52 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.192 -0.942 . . . . 1.0 109.484 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 43.56 -137.73 4.18 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.046 -1.221 . . . . 1.0 110.046 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -99.99 115.32 29.42 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.394 -1.063 . . . . 1.0 109.22 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.441 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 19.3 t-20 -63.18 130.63 45.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.212 -0.93 . . . . 1.0 109.873 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.7 tp -59.92 -43.54 94.83 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.402 -0.811 . . . . 1.0 110.832 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -60.07 -42.14 93.9 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.989 -1.07 . . . . 1.0 111.096 -178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -60.01 -50.05 75.26 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.672 -1.267 . . . . 1.0 109.509 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.5 t -70.03 -41.4 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.078 -1.014 . . . . 1.0 110.006 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.56 -50.52 72.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.227 -0.921 . . . . 1.0 109.891 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.96 -39.78 86.78 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.255 -0.903 . . . . 1.0 110.627 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.639 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 67.9 t60 -63.03 -48.4 78.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.115 -0.991 . . . . 1.0 111.156 -178.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.486 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 7.0 pt-20 -59.89 -39.6 85.91 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.589 -1.319 . . . . 1.0 110.011 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.42 ' CZ ' ' CZ ' ' A' ' 39' ' ' PHE . 32.3 m-85 -60.02 -40.11 88.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.912 -1.117 . . . . 1.0 108.479 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -56.42 -42.55 89.63 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.365 -1.494 . . . . 1.0 109.365 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.639 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 81.9 m-70 -65.53 -40.02 92.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.073 -1.251 . . . . 1.0 109.592 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 80.0 p -67.15 -23.69 65.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.18 -0.95 . . . . 1.0 109.317 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.7 mt -81.96 -0.97 46.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.183 -0.948 . . . . 1.0 109.59 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 92.68 7.94 62.63 Favored Glycine 0 N--CA 1.497 2.735 0 O-C-N 121.149 -0.969 . . . . 1.0 110.933 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.4 mt -86.98 141.98 28.29 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.854 -1.38 . . . . 1.0 109.858 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 10.8 t70 -98.72 174.94 6.16 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.555 -0.715 . . . . 1.0 109.089 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.491 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 76.8 m80 -59.86 139.74 57.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.026 -1.046 . . . . 1.0 109.9 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 30.4 t -98.98 156.46 16.9 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.405 -0.809 . . . . 1.0 109.182 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -97.05 -1.43 45.4 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.229 -0.919 . . . . 1.0 109.016 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -85.43 129.32 55.76 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.079 -1.013 . . . . 1.0 108.976 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -68.69 -20.16 40.72 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 CA-C-N 120.027 1.045 . . . . 1.0 112.372 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -87.3 -7.14 77.05 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.895 -1.282 . . . . 1.0 109.895 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.58 145.7 26.65 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.086 -1.243 . . . . 1.0 109.427 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.455 ' C ' ' H ' ' A' ' 138' ' ' PHE . 96.1 mt -69.97 -29.13 66.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.047 -1.033 . . . . 1.0 109.696 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.1 mmm -72.2 13.49 0.31 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.332 -0.855 . . . . 1.0 110.262 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.455 ' H ' ' C ' ' A' ' 136' ' ' LEU . 12.2 t80 -70.0 131.83 88.83 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.071 -1.018 . . . . 1.0 108.768 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -63.56 -8.56 15.45 Favored 'Trans proline' 0 N--CA 1.501 1.93 0 C-N-CA 120.924 1.083 . . . . 1.0 114.37 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 84.2 mt -109.72 138.6 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 O-C-N 120.936 -1.103 . . . . 1.0 109.317 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.441 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 45.7 t80 -74.38 128.2 34.94 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.357 -0.839 . . . . 1.0 110.7 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.1 t -139.22 138.29 36.73 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.578 -0.702 . . . . 1.0 109.211 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.467 ' CE1' ' NZ ' ' A' ' 146' ' ' LYS . 70.6 t80 -80.83 150.12 29.28 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.975 -1.078 . . . . 1.0 109.352 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.6 t -142.4 158.56 43.57 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.116 -0.99 . . . . 1.0 109.992 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.07 113.91 4.75 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.423 -1.471 . . . . 1.0 109.423 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.467 ' NZ ' ' CE1' ' A' ' 143' ' ' TYR . 62.2 mttp -80.85 3.28 23.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.382 -1.069 . . . . 1.0 110.203 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 27.6 t -58.07 -41.29 83.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.845 -1.159 . . . . 1.0 109.532 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -160.96 68.66 0.34 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.32 -0.862 . . . . 1.0 109.18 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -94.36 120.54 34.75 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.249 -0.907 . . . . 1.0 109.812 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 75.0 mtm -116.62 142.5 46.81 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 22.3 mt -50.4 132.78 25.53 Favored Pre-proline 0 C--N 1.302 -1.498 0 O-C-N 121.043 -1.036 . . . . 1.0 108.914 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -68.87 179.42 3.23 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 CA-C-N 119.865 0.987 . . . . 1.0 112.355 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -62.43 -39.95 94.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.457 -0.777 . . . . 1.0 110.126 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -56.82 -48.62 77.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 1.0 110.071 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -70.11 -39.96 75.18 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.078 -1.014 . . . . 1.0 109.803 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 54.6 t -61.25 -48.08 90.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.18 -0.95 . . . . 1.0 109.162 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -61.05 -40.08 92.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.115 -0.991 . . . . 1.0 110.413 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.25 -53.66 13.24 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 120.243 -0.98 . . . . 1.0 111.253 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.2 tp -60.36 -40.0 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.889 -1.36 . . . . 1.0 109.749 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.4 mt-30 -64.71 -39.9 94.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.04 -1.038 . . . . 1.0 109.636 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 84.4 p -65.96 -24.4 66.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -0.949 . . . . 1.0 110.2 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 85.6 mt -88.42 -51.5 5.69 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.931 -1.106 . . . . 1.0 110.232 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -90.89 -8.78 48.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.939 -1.1 . . . . 1.0 109.539 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.493 2.448 0 N-CA-C 109.664 -1.375 . . . . 1.0 109.664 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.9 mt . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.526 -0.546 . . . . 1.0 109.526 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -159.86 160.0 33.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 1.0 109.377 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -73.78 150.06 41.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.224 -0.922 . . . . 1.0 109.047 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.3 t -85.62 -0.07 54.06 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.159 -0.963 . . . . 1.0 110.249 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -150.22 159.57 44.34 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.98 -1.075 . . . . 1.0 109.878 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.557 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -91.8 -0.03 57.51 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.385 -0.822 . . . . 1.0 109.689 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -96.22 123.38 39.82 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.215 -0.928 . . . . 1.0 108.995 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.3 mt -140.0 152.29 46.16 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.368 -0.832 . . . . 1.0 108.997 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.6 p -132.89 155.48 48.96 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.492 -0.755 . . . . 1.0 109.103 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -144.69 158.71 43.67 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.231 -0.918 . . . . 1.0 109.648 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 37.2 ttt-85 -142.44 132.28 24.23 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.467 -0.77 . . . . 1.0 109.47 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 93.1 mt -87.05 119.62 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.331 -0.856 . . . . 1.0 109.113 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.4 t -69.84 -40.3 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.175 -0.953 . . . . 1.0 109.495 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.414 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 18.6 p-10 -162.53 154.99 19.19 Favored 'General case' 0 C--N 1.288 -2.076 0 O-C-N 119.718 -1.864 . . . . 1.0 111.028 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.408 ' OH ' ' NH2' ' A' ' 52' ' ' ARG . 44.0 m-85 -99.87 108.85 21.22 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 105.582 -2.007 . . . . 1.0 105.582 177.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.1 t -57.55 139.58 80.97 Favored Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.055 -1.028 . . . . 1.0 109.727 -177.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -59.16 -10.15 9.77 Favored 'Trans proline' 0 N--CA 1.487 1.093 0 CA-C-N 119.246 0.766 . . . . 1.0 110.96 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -57.57 -28.21 63.37 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.848 -0.741 . . . . 1.0 110.078 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 77.4 mtm -143.44 162.48 35.68 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.085 -1.009 . . . . 1.0 109.862 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.2 p -71.81 160.83 31.91 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.309 -0.869 . . . . 1.0 109.205 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -61.41 -40.21 93.58 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.426 -0.796 . . . . 1.0 110.487 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.5 m -61.08 -41.23 96.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.968 -1.083 . . . . 1.0 110.705 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.89 -40.01 91.15 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.15 -0.969 . . . . 1.0 110.623 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 69.5 t -69.73 -42.22 80.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 120.936 -1.102 . . . . 1.0 110.275 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -59.97 -53.87 52.76 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.212 -0.93 . . . . 1.0 110.83 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.3 ptmm? -65.92 -29.83 70.32 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.586 -0.696 . . . . 1.0 110.821 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.04 -49.93 75.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.785 -1.197 . . . . 1.0 109.463 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -66.96 -38.26 85.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.018 -1.051 . . . . 1.0 110.211 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.06 -40.58 89.96 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.913 -1.117 . . . . 1.0 109.559 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.04 -41.41 96.54 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.889 -1.132 . . . . 1.0 108.964 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.99 -46.44 89.45 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.516 -0.74 . . . . 1.0 109.957 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.432 ' CE1' ' CD1' ' A' ' 50' ' ' PHE . 53.3 m-85 -65.15 -39.98 93.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.968 -1.083 . . . . 1.0 109.499 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -60.05 -48.46 81.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.052 -1.03 . . . . 1.0 109.852 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.7 t -60.0 -41.06 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.092 -1.005 . . . . 1.0 110.083 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -78.4 -36.42 45.78 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.92 -1.113 . . . . 1.0 110.135 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 81.7 p -71.78 -18.02 62.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.071 -1.018 . . . . 1.0 109.845 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -60.01 -39.69 86.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.239 -0.913 . . . . 1.0 110.285 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.478 ' O ' ' NE2' ' A' ' 160' ' ' GLN . 21.9 m -111.41 20.97 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.38 -0.825 . . . . 1.0 110.788 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 22.5 p -148.42 138.22 12.62 Favored Pre-proline 0 N--CA 1.504 2.255 0 O-C-N 120.77 -1.207 . . . . 1.0 109.914 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -73.95 21.23 0.38 Allowed 'Trans proline' 0 N--CA 1.498 1.793 0 C-N-CA 120.962 1.108 . . . . 1.0 112.495 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.3 mt -69.5 136.46 51.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.893 -1.13 . . . . 1.0 110.018 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -107.91 120.0 41.06 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.614 -0.884 . . . . 1.0 108.614 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.432 ' CD1' ' CE1' ' A' ' 39' ' ' PHE . 95.1 m-85 -108.5 125.29 51.63 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.311 -0.868 . . . . 1.0 109.723 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -120.05 130.03 54.5 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.67 -0.644 . . . . 1.0 109.792 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.408 ' NH2' ' OH ' ' A' ' 22' ' ' TYR . 68.6 ttt180 -82.38 130.73 35.17 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.365 -0.835 . . . . 1.0 109.892 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.0 mt -109.64 124.33 50.99 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.421 -0.799 . . . . 1.0 109.083 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.439 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 48.4 m170 -79.27 -19.08 51.44 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.197 -0.94 . . . . 1.0 110.111 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 79.9 m-20 -146.6 160.42 42.19 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.067 -1.02 . . . . 1.0 109.901 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.97 175.3 44.0 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.555 -1.418 . . . . 1.0 109.555 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.2 mt -96.43 136.46 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.212 -1.17 . . . . 1.0 108.965 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.98 160.86 16.43 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.388 -0.82 . . . . 1.0 109.449 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.04 -49.11 78.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.223 -0.923 . . . . 1.0 109.293 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.9 mt -104.32 98.52 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.416 -0.802 . . . . 1.0 109.839 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.4 ptm -100.11 131.69 45.91 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.191 -0.943 . . . . 1.0 109.399 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.414 HG22 HD12 ' A' ' 62' ' ' ILE . 92.1 mt -103.02 138.92 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.541 -0.724 . . . . 1.0 110.208 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 82.5 p -153.07 157.74 40.89 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.371 -0.83 . . . . 1.0 109.249 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -106.5 125.68 51.31 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.83 -0.804 . . . . 1.0 108.83 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 98' ' ' PHE . . . -98.11 178.78 32.11 Favored Glycine 0 N--CA 1.499 2.873 0 O-C-N 121.108 -0.995 . . . . 1.0 110.761 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 41.1 mt . . . . . 0 N--CA 1.497 1.917 0 O-C-N 121.672 -0.899 . . . . 1.0 109.018 179.717 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.54 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 99.0 m-85 . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 108.657 -0.868 . . . . 1.0 108.657 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -100.15 5.51 44.82 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.181 -0.949 . . . . 1.0 110.82 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 126.1 -156.23 19.58 Favored Glycine 0 N--CA 1.504 3.169 0 N-CA-C 109.085 -1.606 . . . . 1.0 109.085 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -59.83 -66.48 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 0 CA-C-N 118.697 1.249 . . . . 1.0 112.372 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 80.3 p -75.56 160.06 30.56 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.12 -0.987 . . . . 1.0 109.529 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.37 -130.02 8.9 Favored Glycine 0 N--CA 1.502 3.04 0 N-CA-C 109.67 -1.372 . . . . 1.0 109.67 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.423 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 10.9 mt -68.6 105.37 2.23 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.252 -1.146 . . . . 1.0 109.065 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 39.2 mt -78.7 -16.29 57.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.98 -1.075 . . . . 1.0 108.951 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.83 176.1 0.97 Allowed 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.435 ' ND1' ' C ' ' A' ' 84' ' ' HIS . 7.0 p80 -161.08 162.25 31.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.015 -1.053 . . . . 1.0 109.557 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.63 165.73 31.42 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.223 -0.923 . . . . 1.0 109.651 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -113.66 153.39 45.88 Favored Pre-proline 0 N--CA 1.5 2.033 0 N-CA-C 108.873 -0.788 . . . . 1.0 108.873 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -55.56 169.08 1.28 Allowed 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.023 1.149 . . . . 1.0 112.363 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo . . . . . 0 N--CA 1.494 1.545 0 C-N-CA 121.278 1.318 . . . . 1.0 112.451 -179.754 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.497 -0.557 . . . . 1.0 109.497 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.01 117.02 5.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.299 -0.876 . . . . 1.0 109.421 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -105.64 152.23 23.38 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.491 -0.755 . . . . 1.0 109.821 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.482 ' O ' ' N ' ' A' ' 65' ' ' GLY . 38.2 m-85 -131.81 148.82 52.58 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.774 -0.824 . . . . 1.0 108.774 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.54 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 89.5 m-20 -79.03 122.83 26.68 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.915 -1.116 . . . . 1.0 109.689 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -84.04 -11.78 56.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.355 -0.841 . . . . 1.0 109.077 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -81.6 -12.56 58.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.408 -0.807 . . . . 1.0 109.278 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -89.23 169.1 11.74 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.868 -0.79 . . . . 1.0 108.868 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 39.2 m -99.81 104.41 16.1 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.201 -0.937 . . . . 1.0 109.266 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.47 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 91.3 m95 -87.46 127.11 35.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.336 -0.852 . . . . 1.0 108.915 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.486 ' HG1' ' N ' ' A' ' 106' ' ' SER . 8.0 t -143.14 158.15 43.87 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.356 -0.84 . . . . 1.0 109.755 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.486 ' N ' ' HG1' ' A' ' 105' ' ' THR . 5.2 t -96.98 -10.41 26.31 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.453 -0.943 . . . . 1.0 108.453 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 81.1 p -90.41 -176.4 4.77 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.007 -0.738 . . . . 1.0 109.007 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 m -82.82 76.57 9.65 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.135 -0.978 . . . . 1.0 109.58 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -149.6 151.12 33.28 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.19 -0.944 . . . . 1.0 108.992 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 43.73 -139.44 3.63 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.992 -1.243 . . . . 1.0 109.992 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -100.08 116.46 32.17 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.359 -1.083 . . . . 1.0 109.161 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -64.56 132.13 48.97 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.899 -1.125 . . . . 1.0 109.785 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.6 tp -59.99 -42.97 95.38 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.352 -0.842 . . . . 1.0 110.552 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -60.01 -40.65 89.96 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.098 -1.001 . . . . 1.0 110.836 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -59.93 -50.77 72.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.765 -1.209 . . . . 1.0 109.25 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.9 t -70.03 -40.15 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.202 -0.936 . . . . 1.0 110.224 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.58 -52.15 66.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.112 -0.993 . . . . 1.0 109.552 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.98 -34.34 73.18 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.246 -0.909 . . . . 1.0 110.078 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -64.3 -50.04 69.41 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.224 -0.922 . . . . 1.0 111.051 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.451 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 7.1 pt-20 -60.01 -39.31 85.36 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.801 -1.187 . . . . 1.0 110.025 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -59.98 -40.0 87.62 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.934 -1.104 . . . . 1.0 108.851 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.32 -46.05 81.12 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.753 -1.739 . . . . 1.0 108.753 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -64.5 -40.0 94.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.335 -1.097 . . . . 1.0 109.413 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.0 p -67.42 -23.57 65.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.361 -0.837 . . . . 1.0 109.67 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 69.9 mt -82.81 -0.3 47.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.227 -0.921 . . . . 1.0 109.927 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 89.12 9.83 67.02 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 110.447 -1.061 . . . . 1.0 110.447 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.9 mt -85.79 150.05 24.84 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.067 -1.255 . . . . 1.0 110.251 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 12.0 t70 -101.0 169.98 8.59 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.833 -0.803 . . . . 1.0 108.833 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.529 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 23.9 m170 -59.34 136.39 57.95 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.997 -1.065 . . . . 1.0 108.961 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 35.8 t -97.93 155.0 17.28 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.312 -0.868 . . . . 1.0 109.63 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -99.87 4.84 45.33 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.275 -0.891 . . . . 1.0 109.621 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -86.11 128.54 57.4 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 108.323 -0.991 . . . . 1.0 108.323 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -67.78 -18.63 47.54 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 CA-C-N 120.208 1.11 . . . . 1.0 111.864 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -88.9 -5.52 73.67 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.574 -1.41 . . . . 1.0 109.574 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.76 135.95 33.9 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.247 -1.149 . . . . 1.0 109.056 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.459 ' C ' ' H ' ' A' ' 138' ' ' PHE . 94.9 mt -60.5 -39.99 89.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.073 -1.017 . . . . 1.0 109.894 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 92.4 mtp -71.16 24.35 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.337 -0.852 . . . . 1.0 111.558 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.459 ' H ' ' C ' ' A' ' 136' ' ' LEU . 15.5 t80 -68.78 132.8 90.6 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 120.811 -1.181 . . . . 1.0 108.013 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -57.98 -8.78 5.04 Favored 'Trans proline' 0 N--CA 1.5 1.892 0 C-N-CA 120.859 1.039 . . . . 1.0 114.353 -177.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.409 HD13 HG23 ' A' ' 140' ' ' ILE . 96.9 mt -114.83 137.34 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 120.971 -1.08 . . . . 1.0 109.155 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -71.64 129.72 39.4 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.26 -0.9 . . . . 1.0 109.943 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 10.1 t -140.12 135.87 32.96 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.423 -0.798 . . . . 1.0 109.011 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -79.52 144.47 33.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.105 -0.997 . . . . 1.0 109.098 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.7 t -140.97 153.25 45.51 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.203 -0.936 . . . . 1.0 109.465 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.17 112.08 3.88 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.445 -1.462 . . . . 1.0 109.445 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -78.55 7.92 6.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -1.135 . . . . 1.0 109.598 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 73.4 m -59.99 -40.04 87.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 1.0 109.34 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -158.82 68.2 0.45 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 1.0 109.265 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -100.51 124.62 46.28 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.379 -0.826 . . . . 1.0 109.741 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 76.0 mtm -120.61 141.65 50.14 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.487 -0.931 . . . . 1.0 108.487 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.6 mt -48.89 129.36 14.7 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.015 -1.053 . . . . 1.0 108.924 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -68.23 176.69 5.24 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 CA-C-N 119.939 1.014 . . . . 1.0 112.646 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.23 -40.02 88.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.481 -0.762 . . . . 1.0 109.793 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -56.38 -49.41 74.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -0.944 . . . . 1.0 109.691 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -70.03 -40.01 75.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.204 -0.935 . . . . 1.0 110.141 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 62.4 t -59.97 -46.56 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.936 -1.102 . . . . 1.0 109.099 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -60.73 -40.01 90.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.144 -0.973 . . . . 1.0 110.321 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.34 -54.7 10.17 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 120.199 -1.0 . . . . 1.0 111.188 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.403 ' CG2' ' N ' ' A' ' 160' ' ' GLN . 7.2 tp -61.7 -40.47 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.975 -1.309 . . . . 1.0 109.957 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.527 ' O ' ' N ' ' A' ' 164' ' ' GLY . 92.3 mm-40 -65.28 -39.61 92.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.182 -0.949 . . . . 1.0 109.539 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 78.0 p -64.7 -27.74 69.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.921 . . . . 1.0 110.273 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 94.0 mt -87.0 -53.18 5.02 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.978 -1.077 . . . . 1.0 110.322 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -92.04 -9.25 43.44 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.215 -0.928 . . . . 1.0 110.119 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.496 2.64 0 N-CA-C 109.401 -1.48 . . . . 1.0 109.401 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.0 mt . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.326 -0.62 . . . . 1.0 109.326 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -165.63 163.66 19.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.216 -0.928 . . . . 1.0 110.126 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -70.45 147.01 49.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 1.0 109.443 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.2 t -89.41 2.2 54.8 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.301 -0.874 . . . . 1.0 109.987 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -147.94 155.39 41.52 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.064 -1.023 . . . . 1.0 109.688 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.535 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.55 1.92 56.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.352 -0.843 . . . . 1.0 109.842 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -95.41 120.95 36.53 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.1 -1.0 . . . . 1.0 109.205 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.9 mt -140.28 150.54 44.18 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.372 -0.83 . . . . 1.0 108.9 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 69.1 p -134.26 156.14 48.94 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.885 -0.783 . . . . 1.0 108.885 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -145.12 162.07 37.93 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.063 -1.023 . . . . 1.0 110.142 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.404 HH21 ' HA ' ' A' ' 57' ' ' ILE . 6.8 ttm180 -141.74 131.05 23.58 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.46 -0.775 . . . . 1.0 109.933 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 86.5 mt -86.76 111.16 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.938 -1.134 . . . . 1.0 107.938 178.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 79.6 t -66.56 -40.71 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.088 -1.008 . . . . 1.0 109.371 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' A' ' 21' ' ' ASN . 18.2 p-10 -161.11 150.55 16.84 Favored 'General case' 0 C--N 1.286 -2.178 0 C-N-CA 117.452 -1.699 . . . . 1.0 111.005 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -97.01 107.81 20.42 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 104.676 -2.342 . . . . 1.0 104.676 177.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.421 ' OG1' ' OD2' ' A' ' 25' ' ' ASP . 0.6 OUTLIER -55.75 141.51 65.42 Favored Pre-proline 0 C--N 1.299 -1.595 0 O-C-N 121.143 -0.973 . . . . 1.0 110.168 -176.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -61.19 -11.79 20.45 Favored 'Trans proline' 0 N--CA 1.485 1.028 0 CA-C-N 119.061 0.7 . . . . 1.0 110.869 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.421 ' OD2' ' OG1' ' A' ' 23' ' ' THR . 70.8 m-20 -56.77 -26.21 56.99 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.774 -0.77 . . . . 1.0 110.092 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 73.1 mtm -144.32 163.11 34.69 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.965 -1.085 . . . . 1.0 109.27 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.1 p -72.69 158.82 34.89 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.377 -0.827 . . . . 1.0 109.138 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -60.21 -41.48 93.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -0.917 . . . . 1.0 110.401 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.1 m -59.84 -40.38 88.33 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.967 -1.083 . . . . 1.0 110.569 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.93 -41.59 86.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.885 -1.134 . . . . 1.0 110.413 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.3 t -67.9 -40.09 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.86 -1.15 . . . . 1.0 109.818 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -57.48 -58.87 6.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.332 -0.855 . . . . 1.0 111.286 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -27.55 69.4 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.248 -0.908 . . . . 1.0 110.203 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.02 -51.47 69.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.961 -1.087 . . . . 1.0 110.223 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -68.79 -37.02 78.98 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.876 -1.14 . . . . 1.0 110.158 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -60.02 -44.95 94.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.945 -1.097 . . . . 1.0 109.398 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.4 mtpm? -59.96 -40.07 87.78 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.157 -0.964 . . . . 1.0 109.207 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.03 -46.86 88.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.341 -0.849 . . . . 1.0 110.049 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.418 ' CZ ' ' CZ ' ' A' ' 121' ' ' PHE . 62.5 m-85 -67.51 -38.64 84.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.926 -1.109 . . . . 1.0 109.747 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -60.02 -47.85 84.15 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.269 -0.895 . . . . 1.0 109.644 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.4 t -59.98 -40.61 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.142 -0.974 . . . . 1.0 109.972 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -79.49 -35.16 40.6 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.864 -1.147 . . . . 1.0 109.789 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.3 p -72.49 -20.26 61.4 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.908 -1.12 . . . . 1.0 109.865 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.88 -40.02 87.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.253 -0.905 . . . . 1.0 110.561 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.7 m -111.13 22.25 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.336 -0.852 . . . . 1.0 110.404 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.415 ' C ' ' H ' ' A' ' 48' ' ' LEU . 29.6 p -149.0 135.85 10.57 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 120.81 -1.181 . . . . 1.0 109.439 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -73.13 20.72 0.34 Allowed 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 120.682 0.921 . . . . 1.0 112.01 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.415 ' H ' ' C ' ' A' ' 46' ' ' THR . 95.0 mt -67.76 136.39 54.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 1.0 109.563 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -108.82 120.59 42.94 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.668 -0.864 . . . . 1.0 108.668 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -110.45 124.93 52.68 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.458 -0.776 . . . . 1.0 109.946 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.5 m -119.97 130.01 54.57 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.558 -0.713 . . . . 1.0 109.275 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.9 ttt-85 -81.28 130.5 35.06 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.201 -0.937 . . . . 1.0 110.003 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 89.8 mt -104.07 130.02 51.75 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.315 -0.866 . . . . 1.0 109.094 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.436 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 50.9 m170 -63.94 -40.1 95.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.307 -0.871 . . . . 1.0 109.823 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 70.7 m-20 -153.46 179.99 8.29 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.063 -1.023 . . . . 1.0 109.769 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.56 -173.05 32.07 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.839 -1.304 . . . . 1.0 109.839 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.404 ' HA ' HH21 ' A' ' 18' ' ' ARG . 90.2 mt -95.02 126.38 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.341 -1.093 . . . . 1.0 109.109 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.16 158.61 19.45 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.391 -0.818 . . . . 1.0 109.264 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -59.96 -49.94 75.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.232 -0.918 . . . . 1.0 109.87 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 92.7 mt -109.11 97.19 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.504 -0.748 . . . . 1.0 109.882 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.6 ptm -96.5 130.06 43.74 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.913 -1.117 . . . . 1.0 109.061 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.3 mt -108.71 133.38 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.609 -0.682 . . . . 1.0 109.788 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 79.3 p -152.31 158.44 42.76 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.144 -0.972 . . . . 1.0 109.854 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -100.18 135.0 42.28 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.464 -0.939 . . . . 1.0 108.464 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -121.83 167.82 14.54 Favored Glycine 0 N--CA 1.498 2.818 0 N-CA-C 110.243 -1.143 . . . . 1.0 110.243 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 108.514 -0.921 . . . . 1.0 108.514 179.378 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.543 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 89.3 m-85 . . . . . 0 N--CA 1.495 1.797 0 N-CA-C 108.908 -0.775 . . . . 1.0 108.908 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -100.05 12.55 36.64 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.156 -0.965 . . . . 1.0 111.03 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 119.79 -146.8 18.06 Favored Glycine 0 N--CA 1.506 3.352 0 N-CA-C 109.03 -1.628 . . . . 1.0 109.03 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.43 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 13.2 Cg_endo -77.91 -51.94 0.07 OUTLIER 'Trans proline' 0 N--CA 1.49 1.31 0 CA-C-N 119.281 1.54 . . . . 1.0 111.762 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 81.3 p -80.4 161.9 24.74 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.243 -0.911 . . . . 1.0 109.69 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 105.52 -126.53 8.65 Favored Glycine 0 N--CA 1.501 2.972 0 N-CA-C 110.189 -1.165 . . . . 1.0 110.189 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.424 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 13.6 mt -67.12 100.13 0.74 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.414 -1.051 . . . . 1.0 109.344 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 31.0 mt -79.2 -19.15 51.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.083 -1.011 . . . . 1.0 108.765 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.99 171.02 1.42 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.684 -0.858 . . . . 1.0 108.684 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.455 ' ND1' ' C ' ' A' ' 84' ' ' HIS . 8.5 p80 -162.32 167.44 23.82 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.238 -0.914 . . . . 1.0 108.797 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.29 159.55 44.36 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.189 -0.944 . . . . 1.0 109.188 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -95.64 151.83 38.76 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 108.016 -1.105 . . . . 1.0 108.016 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -62.49 166.49 13.22 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 120.47 0.78 . . . . 1.0 111.088 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo . . . . . 0 N--CA 1.491 1.337 0 C-N-CA 121.03 1.153 . . . . 1.0 111.792 -179.748 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 121.197 0.522 . . . . 1.0 110.053 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.7 122.93 9.56 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.294 -0.879 . . . . 1.0 109.524 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.448 ' ND1' ' CE1' ' A' ' 84' ' ' HIS . 41.4 m170 -106.7 142.54 36.18 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.534 -0.729 . . . . 1.0 110.179 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.499 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 40.3 m-85 -124.11 138.24 54.46 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 108.801 -0.814 . . . . 1.0 108.801 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.543 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 93.4 m-20 -80.33 123.59 28.13 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.092 -1.005 . . . . 1.0 109.985 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 9.8 t70 -84.31 2.92 38.01 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.194 -0.941 . . . . 1.0 109.667 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -79.8 -18.8 50.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.227 -0.921 . . . . 1.0 109.42 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.516 ' N ' ' OE1' ' A' ' 102' ' ' GLU . 57.3 mp0 -91.83 169.96 10.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.366 -0.833 . . . . 1.0 109.166 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 11.9 m -98.59 108.16 20.78 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.433 -0.951 . . . . 1.0 108.433 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -85.63 128.32 34.74 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.248 -0.908 . . . . 1.0 108.565 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.6 t -143.87 155.96 44.29 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.265 -0.897 . . . . 1.0 110.071 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 83.6 p -94.91 -7.26 40.54 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.323 -0.991 . . . . 1.0 108.323 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 57.9 m -92.65 179.01 5.62 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.645 -0.872 . . . . 1.0 108.645 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.4 m -80.7 76.08 7.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.983 -1.073 . . . . 1.0 109.34 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -147.85 152.24 37.28 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.735 -0.839 . . . . 1.0 108.735 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 43.27 -140.0 2.89 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.111 -1.195 . . . . 1.0 110.111 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -100.02 114.46 27.78 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.386 -1.067 . . . . 1.0 109.321 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -62.27 132.11 51.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.093 -1.005 . . . . 1.0 109.26 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.06 -41.45 92.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.28 -0.888 . . . . 1.0 110.289 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -60.02 -43.91 94.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.214 -0.929 . . . . 1.0 111.344 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -57.81 -51.21 70.51 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.845 -1.159 . . . . 1.0 109.65 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 64.3 t -69.72 -40.02 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.108 -0.995 . . . . 1.0 109.691 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.54 -49.96 74.63 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.237 -0.914 . . . . 1.0 109.55 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.8 -38.99 83.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.321 -0.862 . . . . 1.0 110.47 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.591 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 77.9 t60 -62.46 -49.86 73.74 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.044 -1.035 . . . . 1.0 111.059 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.499 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 7.7 pt-20 -60.03 -39.48 86.03 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.719 -1.238 . . . . 1.0 110.302 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.418 ' CZ ' ' CZ ' ' A' ' 39' ' ' PHE . 30.4 m-85 -60.07 -40.12 88.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.882 -1.136 . . . . 1.0 108.732 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.11 -45.23 94.2 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.276 -1.53 . . . . 1.0 109.276 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.591 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 84.8 m-70 -65.75 -39.94 91.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.107 -1.231 . . . . 1.0 109.405 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.3 p -62.02 -26.23 68.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.923 . . . . 1.0 109.195 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 84.5 mt -80.61 -4.27 53.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.186 -0.946 . . . . 1.0 109.718 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 92.41 10.09 61.03 Favored Glycine 0 N--CA 1.496 2.684 0 C-N-CA 120.178 -1.01 . . . . 1.0 110.907 178.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.7 mt -82.74 149.9 27.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.83 -1.394 . . . . 1.0 109.165 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 42.6 t0 -101.19 171.65 7.48 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.542 -0.724 . . . . 1.0 109.339 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.493 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 65.7 m80 -59.91 137.18 58.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.13 -0.982 . . . . 1.0 109.71 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 40.3 t -97.35 156.0 16.64 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.405 -0.81 . . . . 1.0 109.171 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -97.45 2.03 49.84 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.172 -0.955 . . . . 1.0 110.006 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 7.5 t70 -85.84 129.98 52.39 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.097 -1.002 . . . . 1.0 108.665 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -68.23 -28.02 34.31 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 CA-C-N 120.106 1.073 . . . . 1.0 112.377 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.475 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -81.97 -1.81 90.39 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.753 -1.339 . . . . 1.0 109.753 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.17 146.16 25.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.304 -1.115 . . . . 1.0 109.754 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.447 ' C ' ' H ' ' A' ' 138' ' ' PHE . 84.2 mt -69.98 -32.97 71.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.333 -0.855 . . . . 1.0 109.428 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 98.1 mmm -71.78 13.33 0.28 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.504 -0.747 . . . . 1.0 110.328 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.447 ' H ' ' C ' ' A' ' 136' ' ' LEU . 13.5 t80 -69.24 135.6 89.06 Favored Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 107.811 -1.181 . . . . 1.0 107.811 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -64.22 -0.42 2.81 Favored 'Trans proline' 0 N--CA 1.5 1.855 0 CA-C-N 119.96 1.021 . . . . 1.0 114.564 -177.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.412 HG21 HD11 ' A' ' 140' ' ' ILE . 96.7 mt -119.69 138.1 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.368 0 O-C-N 120.835 -1.166 . . . . 1.0 109.979 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.422 ' C ' ' CD1' ' A' ' 141' ' ' TYR . 24.3 t80 -72.75 130.22 40.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.692 -0.63 . . . . 1.0 110.012 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.7 t -140.53 139.98 35.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.429 -0.794 . . . . 1.0 109.198 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -82.72 140.72 32.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.972 -1.08 . . . . 1.0 109.52 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.5 t -138.64 155.46 48.28 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.296 -0.878 . . . . 1.0 109.927 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -75.48 109.64 2.84 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.096 -1.602 . . . . 1.0 109.096 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -78.23 0.29 25.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.284 -1.127 . . . . 1.0 110.033 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 22.9 t -60.01 -40.49 89.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.075 -1.016 . . . . 1.0 109.856 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -139.94 32.21 1.99 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.212 -0.93 . . . . 1.0 109.825 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -79.23 130.15 35.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.001 -1.062 . . . . 1.0 110.151 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 77.8 mtm -133.87 149.35 51.34 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.39 -0.967 . . . . 1.0 108.39 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 62.0 mt -51.58 128.71 34.39 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 120.957 -1.09 . . . . 1.0 108.898 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -69.63 177.47 5.46 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 CA-C-N 120.051 1.054 . . . . 1.0 112.175 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -62.24 -39.97 94.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.46 -0.775 . . . . 1.0 109.878 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -55.9 -48.46 75.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.15 -0.968 . . . . 1.0 109.87 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.04 -39.87 75.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.078 -1.013 . . . . 1.0 110.027 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.23 -47.15 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.123 -0.986 . . . . 1.0 109.341 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -60.34 -40.07 89.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.845 -1.159 . . . . 1.0 110.503 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.431 ' O ' ' OG ' ' A' ' 161' ' ' SER . . . -69.9 -54.65 11.21 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 120.176 -1.011 . . . . 1.0 111.129 -178.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.7 tp -60.05 -39.93 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.857 -1.378 . . . . 1.0 109.572 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -64.01 -39.99 95.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.932 -1.105 . . . . 1.0 109.473 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 158' ' ' GLY . 88.6 p -58.46 -30.16 66.75 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.747 -1.221 . . . . 1.0 108.871 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 92.5 mt -88.87 -69.62 0.7 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.245 -0.909 . . . . 1.0 111.079 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -89.17 -11.59 43.37 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.998 -1.064 . . . . 1.0 111.185 -177.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.72 0 N-CA-C 109.766 -1.334 . . . . 1.0 109.766 179.967 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.9 mt . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.328 -0.619 . . . . 1.0 109.328 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -163.05 162.34 25.8 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 1.0 109.304 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -71.02 147.26 48.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.181 -0.949 . . . . 1.0 109.594 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.2 t -89.98 2.05 55.57 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.402 -0.811 . . . . 1.0 110.35 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -144.83 154.31 42.53 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.001 -1.062 . . . . 1.0 109.99 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.55 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.28 0.21 57.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.305 -0.872 . . . . 1.0 109.72 -179.734 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -94.0 121.99 36.05 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.148 -0.97 . . . . 1.0 109.007 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.2 mt -140.18 151.47 45.27 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.365 -0.834 . . . . 1.0 109.213 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.0 p -133.72 157.33 46.1 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.455 -0.778 . . . . 1.0 109.193 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -145.32 160.24 41.82 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.142 -0.974 . . . . 1.0 109.916 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -140.99 134.01 29.25 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.369 -0.832 . . . . 1.0 110.068 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.7 mm -89.04 111.21 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.011 -1.107 . . . . 1.0 108.011 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.6 t -67.84 -39.74 82.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.126 -0.984 . . . . 1.0 109.121 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.621 ' N ' HD21 ' A' ' 21' ' ' ASN . 0.0 OUTLIER -161.23 150.5 16.56 Favored 'General case' 0 C--N 1.29 -1.992 0 O-C-N 119.294 -2.129 . . . . 1.0 111.466 -179.628 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.63 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 52.4 m-85 -99.94 99.03 9.74 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 106.097 -1.816 . . . . 1.0 106.097 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.686 ' HG1' ' H ' ' A' ' 25' ' ' ASP . 1.1 t -47.67 141.15 7.58 Favored Pre-proline 0 C--N 1.299 -1.615 0 O-C-N 121.515 -0.74 . . . . 1.0 110.769 -177.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.86 -8.12 7.18 Favored 'Trans proline' 0 N--CA 1.488 1.166 0 C-N-CA 120.649 0.899 . . . . 1.0 111.223 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.686 ' H ' ' HG1' ' A' ' 23' ' ' THR . 96.6 m-20 -59.02 -35.5 73.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.461 -0.775 . . . . 1.0 109.821 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 74.0 mtm -139.59 160.99 38.58 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.192 -0.942 . . . . 1.0 109.657 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 55.1 p -70.71 160.37 32.76 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.401 -0.812 . . . . 1.0 109.397 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.63 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 3.8 m80 -60.1 -40.54 89.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.318 -0.864 . . . . 1.0 110.263 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.7 m -59.97 -42.36 93.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.085 -1.009 . . . . 1.0 110.526 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -67.87 -40.36 83.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.242 -0.911 . . . . 1.0 110.393 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 70.9 t -68.97 -43.01 82.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.166 -0.959 . . . . 1.0 110.242 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -60.04 -49.16 78.75 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.138 -0.976 . . . . 1.0 110.824 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -61.35 -33.12 73.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.908 -1.12 . . . . 1.0 110.068 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.0 -49.77 76.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.893 -1.129 . . . . 1.0 109.979 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -67.36 -39.98 85.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.022 -1.049 . . . . 1.0 110.185 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -60.01 -43.22 95.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.951 -1.093 . . . . 1.0 110.089 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.45 -40.18 95.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.06 -1.025 . . . . 1.0 109.676 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.18 -44.45 95.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.263 -0.898 . . . . 1.0 110.196 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -69.58 -38.2 77.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.04 -1.038 . . . . 1.0 109.697 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.415 ' O ' ' CG ' ' A' ' 44' ' ' ASP . 50.4 tptt -60.0 -48.05 83.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.063 -1.023 . . . . 1.0 109.594 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.3 t -59.97 -41.15 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.119 -0.988 . . . . 1.0 109.869 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -78.46 -37.96 42.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.854 -1.154 . . . . 1.0 109.903 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.3 p -71.18 -19.22 62.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.054 -1.029 . . . . 1.0 109.643 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.415 ' CG ' ' O ' ' A' ' 40' ' ' LYS . 95.0 m-20 -60.04 -40.02 87.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.911 . . . . 1.0 110.603 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.9 m -108.63 22.04 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 121.126 -0.984 . . . . 1.0 111.304 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.2 p -149.79 144.82 18.11 Favored Pre-proline 0 N--CA 1.502 2.129 0 O-C-N 120.678 -1.264 . . . . 1.0 109.418 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -75.27 19.56 0.51 Allowed 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 120.615 0.877 . . . . 1.0 111.502 178.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.7 mt -68.99 130.31 42.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.12 -0.988 . . . . 1.0 109.719 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -107.02 120.61 42.55 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.591 -0.892 . . . . 1.0 108.591 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -108.39 125.98 52.35 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.285 -0.884 . . . . 1.0 109.713 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -120.01 129.95 54.5 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.643 -0.661 . . . . 1.0 109.846 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -82.01 130.92 35.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.325 -0.859 . . . . 1.0 109.028 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 89.4 mt -102.84 135.19 44.95 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.284 -0.885 . . . . 1.0 109.021 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.447 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 91.9 m-70 -64.26 -40.4 95.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.243 -0.911 . . . . 1.0 109.905 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 69.3 m-20 -155.69 -173.76 4.67 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.191 -0.943 . . . . 1.0 109.706 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.59 -169.51 35.77 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.05 -1.22 . . . . 1.0 110.05 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 87.6 mt -93.75 129.42 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.414 -1.051 . . . . 1.0 108.978 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.79 164.31 12.69 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.395 -0.816 . . . . 1.0 109.156 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -59.95 -49.64 76.9 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.124 -0.985 . . . . 1.0 109.032 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.2 mt -122.34 112.81 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.916 -0.772 . . . . 1.0 108.916 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.7 ptp -97.96 137.06 37.34 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.996 -1.065 . . . . 1.0 109.238 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 97.5 mt -105.29 133.07 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.279 -0.888 . . . . 1.0 109.687 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 84.2 p -151.84 152.4 32.56 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.235 -0.916 . . . . 1.0 109.761 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.451 ' H ' HD22 ' A' ' 21' ' ' ASN . 55.3 m-85 -106.68 122.67 46.81 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.461 -0.774 . . . . 1.0 109.045 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 100' ' ' ASP . . . -97.31 -178.97 34.18 Favored Glycine 0 N--CA 1.497 2.756 0 O-C-N 121.187 -0.946 . . . . 1.0 111.187 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.422 HG23 HD12 ' A' ' 66' ' ' ILE . 67.5 mt . . . . . 0 N--CA 1.497 1.922 0 O-C-N 121.793 -0.827 . . . . 1.0 108.843 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.556 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 99.8 m-85 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 108.946 -0.761 . . . . 1.0 108.946 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 28.2 p-10 -96.53 -0.04 49.44 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.126 -0.984 . . . . 1.0 110.532 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.426 ' O ' ' OE2' ' A' ' 102' ' ' GLU . . . 117.4 -119.45 4.44 Favored Glycine 0 N--CA 1.504 3.225 0 N-CA-C 110.249 -1.141 . . . . 1.0 110.249 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.459 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 28.8 Cg_endo -74.69 -72.45 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.797 0 CA-C-N 120.179 1.989 . . . . 1.0 113.012 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.425 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 81.3 p -74.76 171.49 13.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.034 -1.041 . . . . 1.0 109.839 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 104.02 -135.19 12.29 Favored Glycine 0 N--CA 1.498 2.8 0 N-CA-C 110.231 -1.148 . . . . 1.0 110.231 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.6 mt -68.86 107.32 3.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.388 -1.066 . . . . 1.0 109.692 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 84.2 mt -79.65 -25.54 41.33 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.158 -0.964 . . . . 1.0 108.892 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.54 172.82 1.4 Allowed 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.733 -0.84 . . . . 1.0 108.733 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -162.78 166.23 24.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.79 -1.194 . . . . 1.0 109.982 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -153.34 159.73 42.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.439 -0.788 . . . . 1.0 109.21 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -106.77 151.63 40.58 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.366 -0.834 . . . . 1.0 109.128 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -64.38 165.51 19.79 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 121.045 1.164 . . . . 1.0 111.614 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo . . . . . 0 C--N 1.316 -1.162 0 C-N-CA 120.906 1.071 . . . . 1.0 112.003 -179.847 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.5 p-10 . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 109.235 -0.654 . . . . 1.0 109.235 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -146.31 123.76 11.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.021 -1.05 . . . . 1.0 109.654 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -114.73 153.17 30.78 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.375 -0.602 . . . . 1.0 109.375 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.529 ' CE2' ' OE2' ' A' ' 120' ' ' GLU . 39.5 m-85 -137.69 149.78 46.8 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.609 -0.886 . . . . 1.0 108.609 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.556 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 88.1 m-20 -81.39 121.14 25.86 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.684 -1.26 . . . . 1.0 109.009 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 65' ' ' GLY . 28.6 t0 -82.65 -5.45 58.84 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.121 -0.987 . . . . 1.0 109.35 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -81.39 -9.33 59.75 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.347 -0.846 . . . . 1.0 109.209 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.459 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 52.7 mm-40 -89.03 176.05 7.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.334 -0.854 . . . . 1.0 109.422 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 26.0 m -106.96 107.01 17.82 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.475 -0.935 . . . . 1.0 108.475 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -86.88 122.9 31.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.365 -0.834 . . . . 1.0 109.127 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.8 t -141.54 150.76 42.54 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.363 -0.835 . . . . 1.0 109.925 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 59.8 p -93.01 -6.91 47.26 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.232 -1.025 . . . . 1.0 108.232 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 81.9 p -92.83 176.67 6.35 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.005 -0.739 . . . . 1.0 109.005 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.6 t -77.68 76.95 4.21 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.198 -0.939 . . . . 1.0 109.484 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -148.13 146.92 28.98 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.74 -139.92 5.81 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.881 -1.287 . . . . 1.0 109.881 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -100.11 115.19 29.21 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.304 -1.115 . . . . 1.0 109.365 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.655 ' H ' ' HH ' ' A' ' 141' ' ' TYR . 9.7 t-20 -61.76 133.04 55.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.117 -0.989 . . . . 1.0 109.469 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.5 tp -59.99 -42.95 95.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.32 -0.862 . . . . 1.0 110.482 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -59.93 -40.99 90.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.087 -1.008 . . . . 1.0 110.436 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -59.91 -50.69 72.78 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.872 -1.143 . . . . 1.0 110.014 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.5 t -68.36 -45.11 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.172 -0.955 . . . . 1.0 110.448 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.63 -47.43 82.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.308 -0.87 . . . . 1.0 110.018 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.98 -41.0 91.07 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.929 -1.107 . . . . 1.0 110.77 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.612 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 60.8 t60 -65.91 -49.02 69.5 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.055 -1.028 . . . . 1.0 111.78 -178.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.529 ' OE2' ' CE2' ' A' ' 98' ' ' PHE . 9.0 pt-20 -60.02 -42.34 94.12 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.495 -1.378 . . . . 1.0 110.368 -178.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.421 ' O ' ' OG ' ' A' ' 124' ' ' SER . 27.8 m-85 -60.05 -40.04 88.08 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.682 -1.261 . . . . 1.0 108.655 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.32 -42.71 64.42 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.161 -1.576 . . . . 1.0 109.161 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.612 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 83.3 m-70 -66.27 -40.0 89.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -1.13 . . . . 1.0 109.136 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 121' ' ' PHE . 86.2 p -64.58 -21.96 66.84 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.42 -0.8 . . . . 1.0 109.577 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.9 mt -83.51 1.51 41.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.298 -0.877 . . . . 1.0 109.972 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.93 4.88 68.8 Favored Glycine 0 N--CA 1.497 2.705 0 O-C-N 121.068 -1.02 . . . . 1.0 110.701 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.9 mt -85.52 146.14 27.06 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.887 -1.361 . . . . 1.0 109.387 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -102.56 174.84 5.72 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.47 -0.769 . . . . 1.0 109.373 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 66.9 m80 -59.97 137.93 57.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.142 -0.974 . . . . 1.0 109.374 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 34.2 t -98.25 158.07 15.79 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.361 -0.837 . . . . 1.0 109.48 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.433 ' HZ3' ' CB ' ' A' ' 131' ' ' LYS . 9.7 mtpm? -95.97 -0.42 50.71 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.225 -0.922 . . . . 1.0 109.663 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -86.08 128.47 57.73 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.108 -0.995 . . . . 1.0 108.935 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -68.41 -19.84 42.83 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 CA-C-N 120.065 1.059 . . . . 1.0 112.5 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -88.38 -5.0 76.38 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.772 -1.331 . . . . 1.0 109.772 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.79 145.62 27.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.33 -1.1 . . . . 1.0 109.664 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.43 ' C ' ' H ' ' A' ' 138' ' ' PHE . 84.5 mt -70.0 -30.98 68.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.876 . . . . 1.0 109.406 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.7 mmm -71.89 10.67 0.66 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.361 -0.837 . . . . 1.0 110.053 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.43 ' H ' ' C ' ' A' ' 136' ' ' LEU . 12.8 t80 -70.05 134.14 87.65 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 107.907 -1.146 . . . . 1.0 107.907 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -60.81 -20.36 65.86 Favored 'Trans proline' 0 N--CA 1.502 1.983 0 C-N-CA 120.968 1.112 . . . . 1.0 114.308 -177.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.419 HD13 HG23 ' A' ' 140' ' ' ILE . 96.6 mt -98.22 139.84 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 O-C-N 120.696 -1.253 . . . . 1.0 110.293 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.655 ' HH ' ' H ' ' A' ' 112' ' ' ASN . 28.3 t80 -75.97 132.28 40.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.482 -0.761 . . . . 1.0 109.901 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.4 t -141.5 142.25 33.6 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.26 -0.9 . . . . 1.0 109.412 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -79.41 143.35 35.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.092 -1.005 . . . . 1.0 108.681 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.3 t -139.99 150.01 43.93 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.172 -0.955 . . . . 1.0 109.684 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.19 108.03 2.32 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.617 -1.393 . . . . 1.0 109.617 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.446 ' CB ' ' NZ ' ' A' ' 146' ' ' LYS . 7.8 mtpm? -76.81 0.12 21.86 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.422 -1.046 . . . . 1.0 109.778 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.3 t -60.01 -44.81 94.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.192 -0.943 . . . . 1.0 110.148 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -142.34 29.61 1.6 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.17 -0.956 . . . . 1.0 110.11 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -66.44 138.03 57.27 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.836 -1.165 . . . . 1.0 109.34 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 76.9 mtm -139.54 142.74 37.2 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.356 -0.84 . . . . 1.0 109.124 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 46.9 mt -49.16 110.92 1.69 Allowed Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.151 -0.968 . . . . 1.0 109.164 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -56.01 177.09 0.15 Allowed 'Trans proline' 0 N--CA 1.494 1.555 0 CA-C-N 120.119 1.078 . . . . 1.0 112.887 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -60.02 -39.88 87.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.466 -0.771 . . . . 1.0 109.997 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -56.1 -48.63 75.79 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.174 -0.953 . . . . 1.0 110.029 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -70.05 -40.01 75.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.908 . . . . 1.0 109.904 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.64 -45.66 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.178 -0.951 . . . . 1.0 109.641 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -61.6 -40.12 93.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.993 -1.067 . . . . 1.0 110.448 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.16 -52.32 14.19 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 120.35 -0.928 . . . . 1.0 111.524 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.0 tp -60.59 -40.04 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.886 -1.361 . . . . 1.0 109.587 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 164' ' ' GLY . 97.4 mt-30 -65.33 -40.01 93.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.099 -1.001 . . . . 1.0 109.725 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 79.3 p -60.86 -32.25 71.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.112 -0.992 . . . . 1.0 110.483 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 89.5 mt -86.23 -51.83 6.03 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.874 -1.141 . . . . 1.0 110.921 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -92.0 -9.38 43.11 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.851 -1.156 . . . . 1.0 110.458 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.632 0 N-CA-C 109.676 -1.37 . . . . 1.0 109.676 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.3 mt . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.217 -0.66 . . . . 1.0 109.217 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -161.69 166.96 25.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 1.0 109.508 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -70.46 140.6 51.99 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.24 -0.912 . . . . 1.0 109.794 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.4 t -88.0 1.79 53.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.407 -0.808 . . . . 1.0 110.249 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -143.01 153.5 43.04 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.075 -1.016 . . . . 1.0 109.59 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.519 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.95 0.89 57.41 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.479 -0.763 . . . . 1.0 109.597 -179.609 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -96.56 121.14 38.06 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.174 -0.954 . . . . 1.0 109.183 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.8 mt -139.97 148.0 41.29 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.3 -0.875 . . . . 1.0 109.169 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.9 p -130.6 153.77 48.56 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -143.4 157.5 44.41 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.184 -0.948 . . . . 1.0 110.074 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.488 ' NH1' ' N ' ' A' ' 56' ' ' GLY . 71.7 ttt180 -143.18 132.74 23.64 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.555 -0.715 . . . . 1.0 109.333 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 84.7 mt -87.66 118.31 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.063 -1.023 . . . . 1.0 108.581 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.0 t -69.91 -40.02 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.991 -1.068 . . . . 1.0 109.002 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.2 p-10 -160.4 157.0 27.02 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.733 -1.23 . . . . 1.0 110.169 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.592 ' CD1' ' CD2' ' A' ' 28' ' ' HIS . 47.6 m-85 -100.44 -163.01 0.99 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.38 -1.341 . . . . 1.0 107.38 178.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.405 ' HG1' ' H ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -123.73 148.26 55.82 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.371 -0.831 . . . . 1.0 110.336 -179.372 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -70.83 -21.64 28.27 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 120.661 0.907 . . . . 1.0 110.105 177.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.405 ' H ' ' HG1' ' A' ' 23' ' ' THR . 83.9 m-20 -56.67 -36.05 69.13 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 115.725 -0.671 . . . . 1.0 110.707 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.7 mtm -135.04 163.85 28.96 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.299 -0.876 . . . . 1.0 109.469 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.4 p -73.36 159.68 32.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.484 -0.76 . . . . 1.0 109.291 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.592 ' CD2' ' CD1' ' A' ' 22' ' ' TYR . 2.9 m80 -60.79 -40.03 91.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.465 -0.772 . . . . 1.0 110.031 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.3 m -60.09 -40.46 89.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.147 -0.97 . . . . 1.0 110.185 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -67.29 -40.53 86.12 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.146 -0.971 . . . . 1.0 110.395 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.7 t -68.12 -40.41 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.121 -0.987 . . . . 1.0 109.988 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -60.05 -49.64 76.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.05 -1.031 . . . . 1.0 110.534 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -61.98 -31.55 71.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.984 -1.073 . . . . 1.0 109.68 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.07 -50.29 74.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.089 -1.007 . . . . 1.0 109.802 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -67.41 -39.67 85.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.161 -0.962 . . . . 1.0 110.215 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -59.97 -42.88 95.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.978 -1.077 . . . . 1.0 109.494 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -60.34 -39.84 88.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 1.0 109.065 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.86 -46.2 90.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.51 -0.744 . . . . 1.0 110.024 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.4 ' CZ ' ' CZ ' ' A' ' 121' ' ' PHE . 59.1 m-85 -67.04 -39.4 86.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.051 -1.03 . . . . 1.0 109.196 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.404 ' O ' ' CG ' ' A' ' 44' ' ' ASP . 47.3 tptt -60.09 -47.77 84.52 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.372 -0.83 . . . . 1.0 109.737 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.2 t -60.0 -40.03 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.011 -1.055 . . . . 1.0 109.591 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 70.0 m95 -79.61 -37.16 36.79 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.049 -1.032 . . . . 1.0 110.022 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 62.3 p -70.44 -19.78 62.95 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.034 -1.042 . . . . 1.0 109.557 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.404 ' CG ' ' O ' ' A' ' 40' ' ' LYS . 96.1 m-20 -60.09 -38.55 83.26 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.402 -0.811 . . . . 1.0 110.749 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.3 m -112.33 22.57 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.302 -0.873 . . . . 1.0 110.641 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.7 p -149.81 139.77 13.51 Favored Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 120.928 -1.108 . . . . 1.0 109.655 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -76.97 22.17 0.56 Allowed 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 120.829 1.019 . . . . 1.0 112.378 178.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 77.5 mt -69.71 139.96 53.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.919 -1.113 . . . . 1.0 109.75 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -109.71 120.07 41.36 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -109.09 125.64 52.34 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.351 -0.843 . . . . 1.0 109.481 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 93.8 m -120.07 129.93 54.43 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.542 -0.724 . . . . 1.0 109.476 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.426 ' NH2' ' HH ' ' A' ' 22' ' ' TYR . 69.2 ttt180 -82.72 128.24 34.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.332 -0.855 . . . . 1.0 109.496 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.9 mt -105.37 119.27 38.65 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.363 -0.835 . . . . 1.0 108.844 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.448 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 85.6 m-70 -70.03 -25.17 63.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.419 -0.801 . . . . 1.0 109.993 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 78.3 m-20 -147.76 160.18 43.01 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.271 -0.893 . . . . 1.0 109.806 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.488 ' N ' ' NH1' ' A' ' 18' ' ' ARG . . . 98.54 174.12 32.41 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 109.624 -1.39 . . . . 1.0 109.624 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.431 HG22 HD11 ' A' ' 57' ' ' ILE . 85.4 mt -94.42 133.49 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.349 -1.089 . . . . 1.0 108.977 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.28 159.35 17.5 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.367 -0.833 . . . . 1.0 109.61 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -59.85 -49.8 76.27 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.238 -0.914 . . . . 1.0 109.196 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.3 mt -105.13 100.43 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.539 -0.726 . . . . 1.0 109.666 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.2 ptm -102.79 127.89 49.77 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.323 -0.861 . . . . 1.0 108.993 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.5 mt -102.65 139.45 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.441 -0.787 . . . . 1.0 109.313 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.0 p -151.38 154.94 37.64 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.169 -0.957 . . . . 1.0 109.522 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -104.44 122.67 45.98 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.767 -0.827 . . . . 1.0 108.767 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.27 -169.5 20.5 Favored Glycine 0 N--CA 1.5 2.956 0 N-CA-C 110.197 -1.161 . . . . 1.0 110.197 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.4 mt . . . . . 0 N--CA 1.495 1.804 0 O-C-N 121.501 -1.0 . . . . 1.0 108.824 -179.855 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.534 ' CE2' ' OD1' ' A' ' 99' ' ' ASP . 22.2 m-85 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 108.782 -0.822 . . . . 1.0 108.782 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.5 p-10 -101.08 6.93 43.52 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.234 -0.916 . . . . 1.0 110.841 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 125.4 -145.71 15.83 Favored Glycine 0 N--CA 1.506 3.321 0 N-CA-C 108.938 -1.665 . . . . 1.0 108.938 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.472 ' O ' ' CG ' ' A' ' 102' ' ' GLU . 12.9 Cg_endo -77.43 -56.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.3 0 CA-C-N 119.41 1.605 . . . . 1.0 111.936 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 83.4 p -78.92 170.63 16.38 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.2 -0.938 . . . . 1.0 110.571 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.79 -120.19 6.78 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 110.571 -1.012 . . . . 1.0 110.571 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.418 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 11.0 mt -66.39 100.66 0.66 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.422 -1.046 . . . . 1.0 109.113 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 66.9 mt -81.15 -19.97 42.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.074 -1.016 . . . . 1.0 109.538 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.78 172.27 1.11 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -162.1 159.52 26.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 1.0 109.241 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.03 163.84 35.64 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.322 -0.861 . . . . 1.0 109.358 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -99.72 153.25 37.87 Favored Pre-proline 0 N--CA 1.495 1.794 0 N-CA-C 108.678 -0.86 . . . . 1.0 108.678 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -59.06 167.22 5.95 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 CA-C-N 118.801 0.607 . . . . 1.0 111.338 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo . . . . . 0 C--N 1.312 -1.379 0 C-N-CA 121.031 1.154 . . . . 1.0 111.759 179.915 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.556 -0.535 . . . . 1.0 109.556 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.75 124.69 10.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.245 -0.91 . . . . 1.0 109.184 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 46.3 m170 -112.33 146.22 38.67 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.484 -0.76 . . . . 1.0 110.141 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -125.44 141.49 52.03 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.819 -0.808 . . . . 1.0 108.819 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.534 ' OD1' ' CE2' ' A' ' 75' ' ' PHE . 95.8 m-20 -79.81 121.43 25.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.079 -1.013 . . . . 1.0 109.42 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 47.0 t0 -84.16 1.55 43.81 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.122 -0.986 . . . . 1.0 109.844 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -81.78 -15.18 55.06 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.004 -1.06 . . . . 1.0 110.312 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.567 ' N ' ' OE1' ' A' ' 102' ' ' GLU . 57.4 mp0 -93.15 177.3 6.1 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.114 -0.991 . . . . 1.0 109.911 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 16.6 m -100.17 108.11 20.14 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.724 -0.843 . . . . 1.0 108.724 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -90.18 121.8 32.54 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.796 -0.816 . . . . 1.0 108.796 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.448 ' CG2' ' O ' ' A' ' 109' ' ' LYS . 7.5 t -143.2 158.04 43.97 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.178 -0.951 . . . . 1.0 110.285 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.3 t -95.01 -6.99 41.02 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.459 -0.941 . . . . 1.0 108.459 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 45.0 t -90.81 170.03 10.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.577 -0.702 . . . . 1.0 109.216 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.6 m -70.67 63.37 0.28 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.145 -0.972 . . . . 1.0 109.152 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.448 ' O ' ' CG2' ' A' ' 105' ' ' THR . 67.9 mmtt -140.92 149.88 42.46 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.399 -0.813 . . . . 1.0 109.234 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 46.67 -146.16 3.57 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.477 -1.449 . . . . 1.0 109.477 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -98.61 115.27 28.28 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.33 -1.1 . . . . 1.0 108.836 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.431 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 61.4 t-20 -62.24 133.49 55.24 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.129 -0.982 . . . . 1.0 109.302 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.1 tp -59.95 -43.45 95.01 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.547 -0.721 . . . . 1.0 110.127 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -60.14 -42.41 94.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.345 -0.847 . . . . 1.0 111.274 -179.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -58.15 -52.83 63.93 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.749 -1.22 . . . . 1.0 109.585 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 71.1 t -66.85 -41.09 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.153 -0.967 . . . . 1.0 109.779 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.11 -49.51 76.7 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.253 -0.905 . . . . 1.0 109.71 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.31 -37.91 78.94 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 120.757 -1.214 . . . . 1.0 110.229 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.636 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 68.3 t60 -65.8 -49.24 69.02 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.157 -0.965 . . . . 1.0 111.884 -178.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -59.92 -39.34 85.13 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.534 -1.354 . . . . 1.0 109.609 -178.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.4 ' CZ ' ' CZ ' ' A' ' 39' ' ' PHE . 29.8 m-85 -59.92 -40.09 87.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.877 -1.14 . . . . 1.0 108.894 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.65 -41.28 93.63 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.761 -1.336 . . . . 1.0 109.761 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.636 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 87.4 m-70 -66.52 -38.98 88.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.951 -1.323 . . . . 1.0 108.866 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 87.5 p -67.8 -22.51 65.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 1.0 109.639 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 84.3 mt -83.35 -1.87 54.39 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.122 -0.986 . . . . 1.0 110.09 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.07 5.4 62.44 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.382 -1.087 . . . . 1.0 110.382 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.6 mt -86.86 144.03 27.18 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.899 -1.353 . . . . 1.0 109.491 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 34.6 t0 -102.54 178.2 4.65 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.563 -0.711 . . . . 1.0 109.176 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.421 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 65.0 m80 -59.89 136.96 58.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.078 -1.014 . . . . 1.0 109.497 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 17.5 t -98.88 158.48 15.61 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.344 -0.848 . . . . 1.0 109.381 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -99.49 2.56 45.03 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.258 -0.902 . . . . 1.0 109.054 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -85.66 122.34 73.21 Favored Pre-proline 0 N--CA 1.488 1.452 0 N-CA-C 108.179 -1.045 . . . . 1.0 108.179 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -67.44 -15.01 44.4 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 CA-C-N 120.117 1.078 . . . . 1.0 111.903 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -90.26 -5.98 69.34 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.354 -1.498 . . . . 1.0 109.354 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -87.62 148.84 24.64 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.246 -1.149 . . . . 1.0 109.829 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.526 ' C ' ' H ' ' A' ' 138' ' ' PHE . 86.0 mt -70.08 -36.34 74.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.169 -0.957 . . . . 1.0 109.298 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.0 mmm -68.91 17.24 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.397 -0.814 . . . . 1.0 110.433 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.526 ' H ' ' C ' ' A' ' 136' ' ' LEU . 14.0 t80 -69.99 134.69 87.57 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 107.711 -1.218 . . . . 1.0 107.711 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -60.53 -6.89 6.17 Favored 'Trans proline' 0 N--CA 1.501 1.952 0 CA-C-N 119.833 0.976 . . . . 1.0 114.609 -177.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.85 137.77 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.43 0 O-C-N 121.054 -1.029 . . . . 1.0 109.656 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.431 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 29.4 t80 -73.14 130.72 40.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.611 -0.681 . . . . 1.0 110.014 -178.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.3 t -139.69 139.94 36.72 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.361 -0.837 . . . . 1.0 109.068 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -81.55 141.75 33.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 1.0 109.256 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.9 t -139.96 152.46 46.34 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.27 -0.894 . . . . 1.0 109.977 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.15 108.66 2.56 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.551 -1.42 . . . . 1.0 109.551 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -77.21 1.19 19.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -1.147 . . . . 1.0 109.659 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 33.9 p -59.97 -40.1 87.96 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.32 -0.862 . . . . 1.0 110.011 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -144.02 22.9 1.73 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.063 -1.023 . . . . 1.0 110.41 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -64.97 135.48 55.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.078 -1.014 . . . . 1.0 110.016 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 78.0 mtm -136.4 146.13 46.09 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.086 -1.079 . . . . 1.0 108.086 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 54.5 mt -51.25 129.63 31.94 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 120.862 -1.149 . . . . 1.0 108.595 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -69.16 177.87 4.75 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 CA-C-N 119.994 1.033 . . . . 1.0 112.19 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -61.75 -40.02 93.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.569 -0.707 . . . . 1.0 110.214 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -54.69 -46.13 74.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.166 -0.959 . . . . 1.0 110.189 -178.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -69.0 -39.43 79.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.056 -1.027 . . . . 1.0 109.913 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 58.2 t -60.11 -47.68 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.087 -1.008 . . . . 1.0 108.792 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -61.1 -40.21 92.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.118 -0.989 . . . . 1.0 110.428 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.03 -51.77 13.41 Favored Glycine 0 N--CA 1.495 2.586 0 O-C-N 121.16 -0.962 . . . . 1.0 111.261 -178.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' A' ' 160' ' ' GLN . 5.1 tp -62.19 -41.29 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.897 -1.355 . . . . 1.0 110.163 -178.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.536 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.2 mt-30 -63.42 -38.97 93.2 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.0 -1.062 . . . . 1.0 109.597 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 79.5 p -60.91 -34.52 74.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.906 . . . . 1.0 110.507 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 95.6 mt -84.13 -48.81 9.47 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.872 -1.142 . . . . 1.0 110.845 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -91.57 -9.81 42.86 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.824 -1.173 . . . . 1.0 110.322 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.493 2.446 0 N-CA-C 109.615 -1.394 . . . . 1.0 109.615 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.0 mt . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 108.859 -0.793 . . . . 1.0 108.859 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.465 ' NZ ' ' O ' ' A' ' 162' ' ' LEU . 0.8 OUTLIER -159.97 160.04 32.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.175 -0.953 . . . . 1.0 109.601 -179.827 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -72.88 134.66 44.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.906 . . . . 1.0 109.436 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.6 t -69.63 -42.06 74.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 1.0 109.515 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -95.09 149.97 20.69 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.245 -0.91 . . . . 1.0 109.661 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.3 mmt -90.7 -0.0 57.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.28 -0.887 . . . . 1.0 109.598 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -96.72 132.28 42.55 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.227 -0.921 . . . . 1.0 109.313 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.5 mt -140.22 149.99 43.57 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.283 -0.885 . . . . 1.0 109.226 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 70.5 p -133.38 157.24 46.04 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.559 -0.904 . . . . 1.0 108.559 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -143.88 162.93 34.83 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.002 -1.061 . . . . 1.0 110.464 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -141.66 127.45 19.24 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 91.1 mt -87.74 118.65 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.273 -0.892 . . . . 1.0 108.935 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.9 t -69.5 -39.97 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.392 -0.818 . . . . 1.0 109.613 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -164.83 152.94 11.93 Favored 'General case' 0 C--N 1.289 -2.023 0 O-C-N 119.927 -1.733 . . . . 1.0 110.964 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.608 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 27.3 m-85 -98.39 109.46 22.21 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 104.436 -2.431 . . . . 1.0 104.436 177.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.529 ' OG1' ' OD2' ' A' ' 25' ' ' ASP . 3.0 t -57.42 143.07 75.3 Favored Pre-proline 0 C--N 1.294 -1.824 0 C-N-CA 119.355 -0.938 . . . . 1.0 110.21 -176.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -60.16 -8.49 8.36 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 C-N-CA 120.436 0.757 . . . . 1.0 111.015 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.529 ' OD2' ' OG1' ' A' ' 23' ' ' THR . 66.1 m-20 -57.47 -32.56 67.09 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 120.054 -0.658 . . . . 1.0 109.597 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 73.5 mtm -140.06 160.88 38.94 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.208 -0.932 . . . . 1.0 109.317 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 76.4 p -71.41 161.06 31.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.315 -0.866 . . . . 1.0 109.244 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.608 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 9.2 m80 -61.1 -41.17 96.18 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.297 -0.877 . . . . 1.0 110.296 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.4 m -60.71 -40.59 92.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.989 -1.069 . . . . 1.0 110.204 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -68.9 -39.99 79.39 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.419 -0.801 . . . . 1.0 110.563 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 79.3 t -69.25 -42.8 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.1 -1.0 . . . . 1.0 110.399 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -59.98 -49.19 78.65 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.095 -1.003 . . . . 1.0 110.47 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -61.4 -33.35 73.54 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.054 -1.029 . . . . 1.0 109.915 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.96 -48.83 80.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.007 -1.058 . . . . 1.0 109.976 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -68.16 -39.96 82.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.892 -1.13 . . . . 1.0 110.217 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -60.05 -43.76 95.16 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.858 -1.151 . . . . 1.0 109.775 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -60.07 -39.98 87.9 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.087 -1.008 . . . . 1.0 110.107 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.01 -46.83 88.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.223 -0.923 . . . . 1.0 109.906 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -67.36 -36.21 80.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.067 -1.021 . . . . 1.0 109.531 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -60.0 -49.67 76.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.072 -1.018 . . . . 1.0 109.875 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.7 t -60.25 -40.35 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.086 -1.009 . . . . 1.0 110.357 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -81.36 -34.9 31.44 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.957 -1.089 . . . . 1.0 110.118 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.5 p -71.06 -16.91 62.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.04 -1.038 . . . . 1.0 109.645 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.96 -40.03 87.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.326 -0.858 . . . . 1.0 110.062 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.5 m -110.05 -22.02 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.369 -0.832 . . . . 1.0 110.562 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.1 p -94.84 127.73 42.12 Favored Pre-proline 0 N--CA 1.499 2.009 0 O-C-N 120.794 -1.191 . . . . 1.0 109.536 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -74.12 15.66 0.6 Allowed 'Trans proline' 0 N--CA 1.492 1.441 0 CA-C-N 120.067 1.06 . . . . 1.0 111.609 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 78.7 mt -68.06 139.99 56.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 1.0 109.555 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -105.28 121.0 42.95 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.773 -0.825 . . . . 1.0 108.773 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -107.0 120.88 43.26 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.383 -0.823 . . . . 1.0 109.748 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.2 m -120.0 130.03 54.55 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.613 -0.679 . . . . 1.0 109.827 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.472 ' NH1' ' CB ' ' A' ' 52' ' ' ARG . 11.6 ttp-105 -83.05 138.01 33.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.309 -0.869 . . . . 1.0 109.711 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.4 mt -103.6 132.58 49.73 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.289 -0.882 . . . . 1.0 109.025 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.446 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 61.2 m170 -60.12 -39.99 88.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.875 . . . . 1.0 109.857 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 71.9 m-20 -153.43 179.8 8.46 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.234 -0.916 . . . . 1.0 109.464 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.73 -178.47 42.52 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.961 -1.256 . . . . 1.0 109.961 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.419 HD13 HG22 ' A' ' 57' ' ' ILE . 85.7 mt -95.58 132.95 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.387 -1.067 . . . . 1.0 109.454 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.41 165.9 11.41 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.006 -0.738 . . . . 1.0 109.006 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -59.99 -49.64 76.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.012 -1.055 . . . . 1.0 109.396 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 92.9 mt -110.13 105.56 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.429 -0.795 . . . . 1.0 109.826 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.9 ptm -102.07 132.75 47.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.231 -0.918 . . . . 1.0 108.893 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.9 mt -109.39 133.11 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.61 -0.681 . . . . 1.0 109.63 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 43.6 p -149.99 160.74 43.39 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.222 -0.924 . . . . 1.0 109.926 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -106.71 123.12 47.66 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.557 -0.714 . . . . 1.0 109.15 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.48 -171.58 26.92 Favored Glycine 0 N--CA 1.499 2.879 0 N-CA-C 110.655 -0.978 . . . . 1.0 110.655 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 60.9 mt . . . . . 0 N--CA 1.496 1.87 0 O-C-N 121.656 -0.908 . . . . 1.0 108.669 179.802 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.543 ' CD1' ' OD2' ' A' ' 99' ' ' ASP . 94.0 m-85 . . . . . 0 N--CA 1.494 1.769 0 N-CA-C 108.828 -0.805 . . . . 1.0 108.828 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -99.77 0.89 42.57 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.197 -0.94 . . . . 1.0 110.944 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.51 -148.38 19.36 Favored Glycine 0 N--CA 1.504 3.185 0 N-CA-C 108.876 -1.69 . . . . 1.0 108.876 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.456 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 2.5 Cg_endo -68.65 -63.15 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.302 0 CA-C-N 119.124 1.462 . . . . 1.0 111.273 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 87.7 p -79.14 166.68 21.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.123 -0.986 . . . . 1.0 109.161 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 112.86 -128.62 8.51 Favored Glycine 0 N--CA 1.501 2.976 0 N-CA-C 109.517 -1.433 . . . . 1.0 109.517 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.418 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 20.2 mt -70.43 112.47 6.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.334 -1.098 . . . . 1.0 109.367 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 46.0 mt -83.95 -15.18 48.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.943 -1.098 . . . . 1.0 109.037 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 179.06 172.52 0.82 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.033 -0.728 . . . . 1.0 109.033 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -162.71 158.26 22.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 1.0 109.196 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.33 158.86 44.53 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.178 -0.952 . . . . 1.0 109.437 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -96.48 153.54 38.84 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.173 -0.955 . . . . 1.0 108.849 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -64.84 166.04 19.38 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 120.719 0.946 . . . . 1.0 111.952 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo . . . . . 0 C--N 1.314 -1.286 0 C-N-CA 120.958 1.105 . . . . 1.0 111.691 179.533 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.279 0.562 . . . . 1.0 109.746 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.83 120.83 7.69 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.304 -0.873 . . . . 1.0 109.174 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -108.59 147.9 31.13 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.534 -0.728 . . . . 1.0 110.374 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -124.15 146.37 48.7 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.999 -0.741 . . . . 1.0 108.999 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.543 ' OD2' ' CD1' ' A' ' 75' ' ' PHE . 1.3 m-20 -79.6 123.73 27.88 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.057 -1.027 . . . . 1.0 109.347 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -89.22 -0.02 57.13 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.106 -0.996 . . . . 1.0 110.226 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -81.85 -16.1 51.88 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.074 -1.016 . . . . 1.0 110.08 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.604 ' N ' ' OE1' ' A' ' 102' ' ' GLU . 40.1 mp0 -93.97 173.89 7.43 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.307 -0.87 . . . . 1.0 109.202 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.8 m -99.69 105.42 17.24 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.216 -0.927 . . . . 1.0 108.862 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.496 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 90.2 m95 -85.87 126.06 33.77 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.761 -0.829 . . . . 1.0 108.761 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.8 t -141.07 153.61 45.56 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.467 -0.77 . . . . 1.0 109.635 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 52.5 m -90.94 -5.17 55.82 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.198 -1.038 . . . . 1.0 108.198 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.7 t -92.73 177.93 5.95 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.752 -0.833 . . . . 1.0 108.752 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.5 m -80.25 64.29 5.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.027 -1.046 . . . . 1.0 109.998 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -139.01 152.38 47.59 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.267 -0.896 . . . . 1.0 108.788 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.8 -139.42 6.2 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.759 -1.336 . . . . 1.0 109.759 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -99.72 113.8 26.5 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.338 -1.095 . . . . 1.0 109.057 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.574 HD21 ' N ' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -62.77 130.68 45.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.148 -0.97 . . . . 1.0 109.76 -179.822 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.574 ' N ' HD21 ' A' ' 112' ' ' ASN . 61.7 tp -60.01 -43.29 95.33 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.48 -0.763 . . . . 1.0 111.022 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -60.01 -39.99 87.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.165 -0.959 . . . . 1.0 110.645 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -59.95 -50.86 72.09 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.811 -1.181 . . . . 1.0 109.874 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 71.0 t -69.98 -40.06 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.931 -1.106 . . . . 1.0 110.196 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.19 -51.97 67.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -0.939 . . . . 1.0 110.089 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.84 -37.97 80.73 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.271 -0.893 . . . . 1.0 110.259 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.627 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 67.8 t60 -64.24 -50.2 68.92 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.182 -0.949 . . . . 1.0 111.267 -178.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -60.07 -37.83 81.07 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.552 -1.342 . . . . 1.0 110.329 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -59.98 -40.05 87.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.766 -1.208 . . . . 1.0 108.255 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.39 -41.83 93.4 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.382 -1.487 . . . . 1.0 109.382 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.627 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 90.0 m-70 -68.74 -39.93 80.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.022 -1.281 . . . . 1.0 109.467 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.4 p -67.2 -33.08 74.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.318 -0.864 . . . . 1.0 109.618 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 81.6 mt -70.22 -39.68 74.96 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.23 -0.919 . . . . 1.0 109.84 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 135.31 7.59 1.92 Allowed Glycine 0 N--CA 1.5 2.959 0 N-CA-C 110.045 -1.222 . . . . 1.0 110.045 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.1 mt -87.65 141.21 28.78 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.08 -1.247 . . . . 1.0 110.042 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 34.5 t0 -99.15 175.34 5.93 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.88 -0.785 . . . . 1.0 108.88 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.517 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 63.2 m80 -60.05 133.49 56.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.033 -1.042 . . . . 1.0 109.606 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 47.8 t -98.76 158.1 15.85 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.359 -0.838 . . . . 1.0 109.1 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -98.35 3.05 48.58 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.265 -0.897 . . . . 1.0 109.369 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -85.64 129.55 54.47 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.205 -0.934 . . . . 1.0 108.62 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -69.54 -25.45 29.6 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 CA-C-N 120.012 1.04 . . . . 1.0 112.34 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -82.23 -3.86 90.41 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.413 -1.475 . . . . 1.0 109.413 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.15 143.93 26.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.421 -1.047 . . . . 1.0 109.467 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.534 ' C ' ' H ' ' A' ' 138' ' ' PHE . 89.0 mt -70.0 -34.1 72.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.076 -1.015 . . . . 1.0 109.6 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.3 mmm -70.02 18.19 0.05 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.394 -0.817 . . . . 1.0 109.997 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.534 ' H ' ' C ' ' A' ' 136' ' ' LEU . 13.7 t80 -69.5 133.62 88.94 Favored Pre-proline 0 N--CA 1.488 1.446 0 N-CA-C 107.552 -1.277 . . . . 1.0 107.552 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -60.51 -15.91 39.1 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 CA-C-N 119.805 0.966 . . . . 1.0 114.005 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 95.7 mt -106.59 138.82 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 120.988 -1.07 . . . . 1.0 110.083 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.464 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 35.0 t80 -73.75 129.98 39.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.579 -0.701 . . . . 1.0 109.967 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.1 t -141.31 141.96 33.87 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.43 -0.794 . . . . 1.0 109.246 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -79.98 144.5 33.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.013 -1.054 . . . . 1.0 109.381 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.5 t -140.01 150.64 44.68 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.437 -0.789 . . . . 1.0 109.266 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.61 105.11 1.44 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.422 -1.471 . . . . 1.0 109.422 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -73.61 -6.24 45.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.432 -1.04 . . . . 1.0 109.788 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 61.1 m -60.04 -40.09 88.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.257 -0.902 . . . . 1.0 110.819 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -141.75 19.87 2.16 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.036 -1.04 . . . . 1.0 110.4 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -61.03 140.0 57.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.843 -1.16 . . . . 1.0 109.953 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 67.8 mtt -138.47 145.44 40.85 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.661 -0.866 . . . . 1.0 108.661 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 45.5 mt -54.48 129.04 61.63 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.921 -1.112 . . . . 1.0 108.914 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -68.14 177.9 4.04 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 CA-C-N 119.996 1.034 . . . . 1.0 112.166 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -61.13 -39.96 92.02 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.315 -0.866 . . . . 1.0 110.141 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -56.32 -49.94 72.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.162 -0.961 . . . . 1.0 110.091 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -70.62 -40.03 73.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.137 -0.977 . . . . 1.0 110.252 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.452 ' O ' ' OE1' ' A' ' 160' ' ' GLN . 68.1 t -63.85 -50.06 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.963 . . . . 1.0 109.618 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.54 -40.01 89.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.844 -1.16 . . . . 1.0 110.063 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.411 ' O ' ' OG ' ' A' ' 161' ' ' SER . . . -71.42 -48.45 30.19 Favored Glycine 0 N--CA 1.493 2.473 0 O-C-N 121.352 -0.842 . . . . 1.0 112.227 -178.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.564 ' CG2' ' NE2' ' A' ' 160' ' ' GLN . 4.7 tp -60.9 -43.29 95.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.609 -1.524 . . . . 1.0 110.464 -177.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.564 ' NE2' ' CG2' ' A' ' 159' ' ' ILE . 5.9 mp0 -67.64 -36.38 80.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.579 -1.325 . . . . 1.0 108.903 179.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 158' ' ' GLY . 79.4 p -60.75 -27.99 68.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.131 -0.981 . . . . 1.0 109.878 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.465 ' O ' ' NZ ' ' A' ' 9' ' ' LYS . 88.1 mt -85.28 -45.93 11.5 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.02 -1.05 . . . . 1.0 110.381 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -91.36 -9.29 45.39 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.017 -1.052 . . . . 1.0 109.821 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.553 -1.419 . . . . 1.0 109.553 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.0 mt . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.427 0.632 . . . . 1.0 109.54 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -160.76 160.68 31.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.499 -0.75 . . . . 1.0 109.499 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -71.47 148.74 46.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.185 -0.947 . . . . 1.0 109.61 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 91.6 p -88.44 3.39 50.21 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.333 -0.854 . . . . 1.0 109.98 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -145.07 153.24 41.24 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.067 -1.021 . . . . 1.0 109.609 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.6 mmt -90.38 -0.01 57.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.392 -0.818 . . . . 1.0 109.606 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -96.58 131.41 43.24 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.179 -0.951 . . . . 1.0 109.283 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.8 mt -143.95 151.03 39.23 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.117 -0.989 . . . . 1.0 109.399 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.436 ' HG1' ' H ' ' A' ' 59' ' ' ASP . 54.5 p -135.71 155.73 49.93 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.475 -0.765 . . . . 1.0 108.937 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -144.27 161.19 39.54 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.146 -0.971 . . . . 1.0 110.383 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.461 ' HG2' HH11 ' A' ' 18' ' ' ARG . 0.8 OUTLIER -139.17 131.08 27.72 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 109.084 -0.709 . . . . 1.0 109.084 -179.384 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.9 mt -89.79 116.49 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.161 -0.962 . . . . 1.0 108.765 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.5 t -68.67 -39.93 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.193 -0.942 . . . . 1.0 109.226 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.403 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 23.8 p-10 -164.7 152.98 12.24 Favored 'General case' 0 C--N 1.288 -2.081 0 O-C-N 120.051 -1.656 . . . . 1.0 110.873 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.624 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 36.7 m-85 -99.94 109.11 21.48 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 104.781 -2.303 . . . . 1.0 104.781 177.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 t -55.87 140.55 68.43 Favored Pre-proline 0 C--N 1.297 -1.712 0 O-C-N 121.124 -0.985 . . . . 1.0 110.111 -176.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.27 -11.04 9.61 Favored 'Trans proline' 0 N--CA 1.485 1.008 0 CA-C-N 119.194 0.748 . . . . 1.0 110.901 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -55.61 -29.88 59.92 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.898 -0.721 . . . . 1.0 110.007 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 73.9 mtm -144.42 162.2 37.09 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.035 -1.041 . . . . 1.0 109.587 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.9 p -72.95 159.89 32.98 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.395 -0.815 . . . . 1.0 109.391 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.624 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 1.9 m80 -60.16 -40.75 90.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.306 -0.871 . . . . 1.0 110.07 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.5 m -60.12 -41.39 92.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.151 -0.968 . . . . 1.0 110.336 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.82 -40.0 79.71 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.205 -0.934 . . . . 1.0 110.321 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 70.9 t -67.59 -43.96 86.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.24 -0.913 . . . . 1.0 110.23 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -59.98 -49.92 75.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.137 -0.977 . . . . 1.0 110.837 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -61.44 -32.73 72.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.928 -1.108 . . . . 1.0 110.22 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.98 -50.07 75.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.984 -1.072 . . . . 1.0 110.006 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -68.11 -37.25 80.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.0 -1.062 . . . . 1.0 110.034 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -60.05 -44.41 94.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.973 -1.08 . . . . 1.0 109.428 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -60.44 -40.03 89.64 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.165 -0.959 . . . . 1.0 109.204 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.1 -45.96 91.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.355 -0.841 . . . . 1.0 110.212 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -69.88 -39.82 76.07 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.009 -1.057 . . . . 1.0 109.746 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -59.89 -47.88 83.98 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.194 -0.941 . . . . 1.0 109.91 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.0 t -60.0 -41.9 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.095 -1.003 . . . . 1.0 109.8 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 63.1 m95 -79.0 -35.6 42.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.038 -1.039 . . . . 1.0 109.874 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.7 p -70.14 -20.35 63.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.808 -1.183 . . . . 1.0 109.217 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -59.97 -40.13 88.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.506 -0.746 . . . . 1.0 110.667 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.7 m -110.8 23.0 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.333 -0.855 . . . . 1.0 110.633 -178.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.403 ' C ' ' H ' ' A' ' 48' ' ' LEU . 28.6 p -149.95 139.63 13.35 Favored Pre-proline 0 N--CA 1.5 2.052 0 O-C-N 120.909 -1.119 . . . . 1.0 109.23 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -75.17 19.35 0.51 Allowed 'Trans proline' 0 N--CA 1.496 1.638 0 CA-C-N 119.664 0.916 . . . . 1.0 111.605 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.403 ' H ' ' C ' ' A' ' 46' ' ' THR . 84.0 mt -67.49 138.92 56.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -0.86 . . . . 1.0 109.933 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -112.91 120.8 42.68 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.947 -0.76 . . . . 1.0 108.947 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -109.14 122.24 46.88 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.325 -0.86 . . . . 1.0 109.354 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -119.99 130.07 54.58 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.572 0.701 . . . . 1.0 109.974 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -83.14 132.7 35.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.35 -0.844 . . . . 1.0 109.64 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.2 mt -101.76 132.68 47.36 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.198 -0.939 . . . . 1.0 108.894 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.446 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 43.1 m170 -61.27 -40.05 92.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.088 -1.007 . . . . 1.0 110.061 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 73.8 m-20 -152.31 178.01 9.97 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.19 -0.944 . . . . 1.0 109.546 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.07 -178.58 42.08 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.71 -1.356 . . . . 1.0 109.71 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.3 mt -94.45 134.82 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.393 -1.063 . . . . 1.0 109.115 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.92 174.09 6.03 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.505 -0.747 . . . . 1.0 109.154 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.436 ' H ' ' HG1' ' A' ' 16' ' ' THR . 97.8 m-20 -60.05 -49.09 79.02 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.081 -1.012 . . . . 1.0 108.513 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.8 mt -120.03 118.07 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.544 -0.723 . . . . 1.0 109.42 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.1 ptp -101.63 139.26 37.52 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.164 -0.96 . . . . 1.0 109.153 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.412 HD12 HG23 ' A' ' 62' ' ' ILE . 97.0 mt -107.46 133.56 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.393 -0.817 . . . . 1.0 109.927 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 79.7 p -152.45 156.75 40.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.292 -0.88 . . . . 1.0 109.368 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -100.77 125.58 47.26 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.288 -0.883 . . . . 1.0 109.161 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 100' ' ' ASP . . . -93.14 155.31 22.28 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.946 -1.261 . . . . 1.0 109.946 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 9.6 tt . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.444 -1.033 . . . . 1.0 108.77 179.931 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.523 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 77.0 m-85 . . . . . 0 N--CA 1.495 1.791 0 N-CA-C 108.438 -0.949 . . . . 1.0 108.438 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -100.62 9.19 42.82 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.277 -0.889 . . . . 1.0 111.168 -178.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 121.15 -159.94 15.59 Favored Glycine 0 N--CA 1.508 3.459 0 N-CA-C 109.161 -1.575 . . . . 1.0 109.161 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -56.36 -63.97 0.15 Allowed 'Trans proline' 0 N--CA 1.49 1.268 0 CA-C-N 118.771 1.285 . . . . 1.0 111.955 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 96.3 p -76.54 160.45 29.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.496 -0.752 . . . . 1.0 109.578 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.71 -130.8 9.29 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 110.177 -1.169 . . . . 1.0 110.177 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.1 mt -69.49 105.33 2.59 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.424 -1.045 . . . . 1.0 109.242 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 32.2 mt -79.82 -14.76 58.44 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.124 -0.985 . . . . 1.0 109.057 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.57 175.54 0.88 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.056 -0.72 . . . . 1.0 109.056 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.523 ' CE1' ' ND1' ' A' ' 97' ' ' HIS . 21.2 p80 -163.22 160.91 24.57 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.231 -0.918 . . . . 1.0 109.787 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -153.2 167.74 28.31 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.858 -0.793 . . . . 1.0 108.858 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -114.51 153.98 46.61 Favored Pre-proline 0 N--CA 1.499 2.006 0 N-CA-C 108.494 -0.928 . . . . 1.0 108.494 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -69.71 161.42 46.0 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 120.57 0.847 . . . . 1.0 111.503 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo . . . . . 0 C--N 1.313 -1.331 0 C-N-CA 121.068 1.179 . . . . 1.0 112.104 -179.902 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 45.5 p-10 . . . . . 0 N--CA 1.494 1.761 0 N-CA-C 109.236 -0.653 . . . . 1.0 109.236 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.88 123.24 9.01 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.101 -0.999 . . . . 1.0 109.18 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.523 ' ND1' ' CE1' ' A' ' 84' ' ' HIS . 64.9 m170 -117.78 159.98 22.12 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.625 0.726 . . . . 1.0 109.933 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.536 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 47.1 m-85 -137.88 153.46 49.56 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.702 -0.851 . . . . 1.0 108.702 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.523 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 1.5 m-20 -79.39 124.0 28.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.844 -1.16 . . . . 1.0 109.662 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 65' ' ' GLY . 36.5 t0 -84.81 -12.67 53.13 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.473 -0.767 . . . . 1.0 109.416 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -82.26 -11.51 58.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.265 -0.897 . . . . 1.0 109.574 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -91.63 166.79 12.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.294 -0.879 . . . . 1.0 109.153 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.3 m -98.78 107.42 19.86 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.177 -0.952 . . . . 1.0 109.086 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.454 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 94.1 m95 -88.74 123.65 33.36 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.846 -0.798 . . . . 1.0 108.846 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.491 ' HG1' ' HG ' ' A' ' 107' ' ' SER . 8.7 t -140.36 153.16 46.3 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.378 -0.826 . . . . 1.0 109.439 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.8 t -92.06 -6.09 51.64 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.205 -1.035 . . . . 1.0 108.205 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.491 ' HG ' ' HG1' ' A' ' 105' ' ' THR . 65.1 p -93.16 179.44 5.43 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.713 -0.847 . . . . 1.0 108.713 179.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.2 m -82.04 77.06 8.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.016 -1.052 . . . . 1.0 109.467 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -149.31 150.03 31.86 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.74 -139.85 5.86 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.567 -1.413 . . . . 1.0 109.567 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -100.09 113.77 26.63 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.312 -1.111 . . . . 1.0 108.751 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -62.94 134.11 55.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.113 -0.992 . . . . 1.0 109.34 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.6 tp -59.98 -43.94 94.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.39 -0.819 . . . . 1.0 110.587 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -59.88 -43.22 94.87 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.965 -1.085 . . . . 1.0 110.603 -178.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -58.6 -51.91 67.9 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.74 -1.225 . . . . 1.0 109.644 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.6 t -68.47 -43.97 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.174 -0.954 . . . . 1.0 110.319 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.25 -52.79 63.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.304 -0.873 . . . . 1.0 110.014 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.95 -32.65 71.0 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.937 -1.102 . . . . 1.0 109.882 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.473 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 45.7 t60 -65.68 -52.95 47.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.969 -1.082 . . . . 1.0 110.654 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.536 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 7.7 pt-20 -60.13 -40.97 91.63 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.902 -1.124 . . . . 1.0 110.453 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -60.03 -39.91 87.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.861 -1.149 . . . . 1.0 109.001 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -56.45 -42.8 90.13 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.128 -1.589 . . . . 1.0 109.128 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.473 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 90.6 m-70 -67.44 -39.98 85.43 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.213 -1.169 . . . . 1.0 109.221 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 59.7 p -64.45 -25.01 67.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -0.895 . . . . 1.0 109.923 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.2 mt -80.19 -0.53 36.59 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.13 -0.981 . . . . 1.0 110.049 -179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 91.93 6.8 64.95 Favored Glycine 0 N--CA 1.497 2.744 0 O-C-N 120.997 -1.065 . . . . 1.0 110.562 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.4 mt -84.79 149.46 25.72 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.907 -1.349 . . . . 1.0 109.554 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 42.0 t0 -98.67 171.32 8.19 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.674 -0.861 . . . . 1.0 108.674 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.535 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 62.8 m80 -58.92 136.98 58.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.026 -1.046 . . . . 1.0 109.724 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.0 t -97.36 151.16 20.2 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.542 -0.724 . . . . 1.0 109.246 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -99.86 6.83 45.28 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.255 -0.903 . . . . 1.0 108.907 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -87.31 123.76 69.31 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.057 -1.027 . . . . 1.0 108.396 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -64.2 -17.1 58.47 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 CA-C-N 120.189 1.103 . . . . 1.0 112.168 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -89.98 -6.35 69.58 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.553 -1.419 . . . . 1.0 109.553 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.56 141.49 30.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.221 -1.164 . . . . 1.0 109.25 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.499 ' C ' ' H ' ' A' ' 138' ' ' PHE . 97.0 mt -65.78 -39.74 91.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.15 -0.969 . . . . 1.0 109.6 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 91.1 mtp -70.36 23.35 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.32 -0.862 . . . . 1.0 111.117 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.499 ' H ' ' C ' ' A' ' 136' ' ' LEU . 11.5 t80 -67.26 133.11 93.33 Favored Pre-proline 0 N--CA 1.493 1.692 0 N-CA-C 107.522 -1.288 . . . . 1.0 107.522 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -61.7 -9.79 14.87 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 CA-C-N 119.958 1.021 . . . . 1.0 113.644 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.433 HD13 HG23 ' A' ' 140' ' ' ILE . 88.4 mt -113.45 133.28 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.162 -0.961 . . . . 1.0 109.14 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -71.36 128.51 36.1 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.168 -0.957 . . . . 1.0 110.102 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.8 t -141.84 143.59 33.46 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.637 -0.875 . . . . 1.0 108.637 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -81.24 146.03 30.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.079 -1.013 . . . . 1.0 109.766 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.0 t -140.8 157.49 45.32 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.371 -0.831 . . . . 1.0 109.662 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.95 106.47 1.97 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.534 -1.426 . . . . 1.0 109.534 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.458 ' CB ' ' NZ ' ' A' ' 146' ' ' LYS . 8.4 mtpm? -77.43 2.9 14.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -1.15 . . . . 1.0 109.597 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.471 ' O ' ' ND1' ' A' ' 148' ' ' HIS . 34.7 t -59.44 -46.06 89.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 1.0 110.067 -179.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . 0.471 ' ND1' ' O ' ' A' ' 147' ' ' SER . 50.0 m-70 -146.58 30.77 0.99 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.014 -1.054 . . . . 1.0 109.472 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -61.0 136.0 57.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.145 -0.972 . . . . 1.0 109.7 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 65.9 mtt -133.47 144.56 49.53 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.476 -0.765 . . . . 1.0 108.939 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 36.4 mt -51.48 125.77 28.06 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.177 -0.952 . . . . 1.0 108.767 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -67.63 177.52 4.0 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 CA-C-N 120.04 1.05 . . . . 1.0 112.253 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.21 -39.98 88.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.395 -0.816 . . . . 1.0 109.955 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -55.11 -48.34 73.74 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.183 -0.948 . . . . 1.0 109.998 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -69.98 -39.96 75.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.042 -1.037 . . . . 1.0 110.115 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 56.3 t -59.95 -49.13 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.158 -0.964 . . . . 1.0 109.478 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -60.34 -40.11 89.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.878 -1.138 . . . . 1.0 110.468 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.63 -53.28 12.66 Favored Glycine 0 N--CA 1.496 2.638 0 O-C-N 121.046 -1.034 . . . . 1.0 111.512 -178.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 6.3 tp -61.19 -40.0 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.97 -1.312 . . . . 1.0 109.617 -178.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 164' ' ' GLY . 97.1 mt-30 -65.49 -39.69 92.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 1.0 109.566 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 83.3 p -60.0 -34.65 73.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 1.0 110.625 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 83.7 mt -87.47 -50.47 6.52 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.843 -1.161 . . . . 1.0 110.884 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -90.62 -9.12 48.16 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.969 -1.082 . . . . 1.0 110.226 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.568 0 N-CA-C 109.512 -1.435 . . . . 1.0 109.512 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.3 mt . . . . . 0 N--CA 1.488 1.436 0 N-CA-C 109.075 -0.713 . . . . 1.0 109.075 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -159.84 159.88 33.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.198 -0.939 . . . . 1.0 109.525 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -71.76 145.54 48.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -0.868 . . . . 1.0 109.193 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.1 t -80.83 -0.86 40.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.413 -0.805 . . . . 1.0 110.369 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -149.27 154.8 39.58 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.067 -1.02 . . . . 1.0 109.574 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.551 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.07 0.03 57.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.34 -0.85 . . . . 1.0 109.723 -179.644 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -97.65 124.76 42.08 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.279 -0.888 . . . . 1.0 108.954 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.4 mt -140.03 150.07 43.96 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.263 -0.898 . . . . 1.0 109.713 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.0 p -130.7 157.3 43.16 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.61 -0.885 . . . . 1.0 108.61 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -144.18 160.05 41.61 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.082 -1.011 . . . . 1.0 110.251 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.462 ' CZ ' ' O ' ' A' ' 54' ' ' HIS . 26.1 tpt180 -143.61 129.4 19.36 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.652 -0.655 . . . . 1.0 109.566 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.41 HG21 HD11 ' A' ' 19' ' ' ILE . 86.8 mt -88.11 119.68 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.149 -0.969 . . . . 1.0 109.132 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.6 t -69.48 -40.53 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.169 -0.957 . . . . 1.0 109.259 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.632 ' N ' HD21 ' A' ' 21' ' ' ASN . 0.0 OUTLIER -163.8 165.21 23.2 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.496 -1.378 . . . . 1.0 110.948 -179.126 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -104.22 -172.98 2.2 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.78 -1.193 . . . . 1.0 107.78 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.69 ' HG1' ' H ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -119.85 148.81 47.28 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.445 -0.784 . . . . 1.0 109.901 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -64.93 -16.11 53.8 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 120.926 1.084 . . . . 1.0 110.156 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.69 ' H ' ' HG1' ' A' ' 23' ' ' THR . 95.9 m-20 -59.94 -39.99 87.41 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.348 -0.842 . . . . 1.0 110.471 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.6 mtm -144.21 160.16 41.43 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.128 -0.982 . . . . 1.0 109.663 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 69.3 p -73.48 159.98 32.39 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.393 -0.817 . . . . 1.0 109.373 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.634 ' CD2' ' H ' ' A' ' 28' ' ' HIS . 2.8 p80 -60.95 -31.82 71.36 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.337 -0.852 . . . . 1.0 109.972 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 56.0 m -60.02 -42.11 93.63 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.855 -1.153 . . . . 1.0 109.446 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -69.92 -40.06 75.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.09 -1.006 . . . . 1.0 109.544 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 56.2 t -69.58 -40.07 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.232 -0.917 . . . . 1.0 110.001 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -59.73 -49.92 75.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.088 -1.008 . . . . 1.0 110.107 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -63.25 -31.54 72.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.976 -1.078 . . . . 1.0 109.958 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.01 -49.96 75.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.017 -1.052 . . . . 1.0 110.197 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -67.66 -36.94 81.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.98 -1.075 . . . . 1.0 109.978 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -59.93 -41.07 90.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.987 -1.071 . . . . 1.0 109.721 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -62.2 -40.18 95.21 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.071 -1.018 . . . . 1.0 108.868 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.97 -45.89 91.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.511 -0.743 . . . . 1.0 110.139 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.508 ' CD1' ' CD1' ' A' ' 50' ' ' PHE . 63.4 m-85 -68.4 -40.06 81.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.963 -1.085 . . . . 1.0 110.02 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.402 ' O ' ' CG ' ' A' ' 44' ' ' ASP . 27.4 tptp -60.01 -47.54 85.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.122 -0.987 . . . . 1.0 109.665 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.5 t -60.01 -40.09 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.184 -0.948 . . . . 1.0 110.119 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -81.54 -35.46 30.27 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.876 -1.14 . . . . 1.0 109.985 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.5 p -71.64 -20.1 62.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.905 -1.122 . . . . 1.0 109.725 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.402 ' CG ' ' O ' ' A' ' 40' ' ' LYS . 95.3 m-20 -59.95 -39.89 87.12 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.246 -0.909 . . . . 1.0 111.048 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 m -109.52 20.25 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 O-C-N 121.191 -0.943 . . . . 1.0 110.797 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.408 ' C ' ' H ' ' A' ' 48' ' ' LEU . 19.3 p -147.93 140.38 14.6 Favored Pre-proline 0 N--CA 1.502 2.128 0 O-C-N 120.83 -1.169 . . . . 1.0 109.221 179.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -72.83 18.37 0.36 Allowed 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 120.716 0.944 . . . . 1.0 111.999 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.408 ' H ' ' C ' ' A' ' 46' ' ' THR . 79.0 mt -68.1 137.12 54.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.122 -0.986 . . . . 1.0 109.916 -179.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -111.46 120.75 43.19 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.885 -0.783 . . . . 1.0 108.885 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.508 ' CD1' ' CD1' ' A' ' 39' ' ' PHE . 92.4 m-85 -109.16 123.3 48.99 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.367 -0.833 . . . . 1.0 109.335 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.1 m -119.95 130.02 54.6 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.55 -0.718 . . . . 1.0 109.679 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -82.32 132.35 35.22 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.467 -0.77 . . . . 1.0 109.566 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.4 mt -104.96 131.16 52.83 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.326 -0.859 . . . . 1.0 108.819 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.462 ' O ' ' CZ ' ' A' ' 18' ' ' ARG . 42.2 m170 -61.73 -40.24 94.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.177 -0.952 . . . . 1.0 110.005 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 74.9 m-20 -151.74 176.33 11.5 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.112 -0.992 . . . . 1.0 109.924 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.87 -179.76 35.63 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.858 -1.297 . . . . 1.0 109.858 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 91.3 mt -93.51 130.44 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.366 -1.079 . . . . 1.0 109.583 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.46 164.52 12.62 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.971 -0.752 . . . . 1.0 108.971 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.87 -49.52 77.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.067 -1.021 . . . . 1.0 109.332 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.7 mt -111.81 109.63 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.506 -0.746 . . . . 1.0 109.534 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.5 ptm -106.46 132.0 53.0 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.328 -0.858 . . . . 1.0 109.481 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.41 HG21 HD12 ' A' ' 62' ' ' ILE . 86.1 mt -103.22 137.72 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.619 -0.675 . . . . 1.0 109.383 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.2 p -152.08 152.96 33.03 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.07 -1.019 . . . . 1.0 109.755 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.612 ' H ' HD22 ' A' ' 21' ' ' ASN . 93.4 m-85 -100.42 120.27 39.73 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.891 -0.781 . . . . 1.0 108.891 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -103.85 -170.6 25.37 Favored Glycine 0 N--CA 1.5 2.966 0 N-CA-C 110.773 -0.931 . . . . 1.0 110.773 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 74.4 mt . . . . . 0 N--CA 1.497 1.889 0 O-C-N 121.569 -0.959 . . . . 1.0 109.111 179.838 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 . . . . . 0 N--CA 1.495 1.824 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.5 p-10 -101.81 -0.07 34.85 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.331 -0.855 . . . . 1.0 111.127 -178.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 128.04 -149.16 18.04 Favored Glycine 0 N--CA 1.505 3.261 0 N-CA-C 109.381 -1.488 . . . . 1.0 109.381 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.425 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 3.5 Cg_exo -64.39 -64.36 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.501 0 CA-C-N 118.953 1.376 . . . . 1.0 112.114 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 77.0 p -75.9 158.67 31.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.12 -0.987 . . . . 1.0 109.039 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.26 -128.34 8.04 Favored Glycine 0 N--CA 1.501 3.012 0 N-CA-C 109.594 -1.402 . . . . 1.0 109.594 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.425 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 18.4 mt -67.28 106.35 2.02 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.389 -1.065 . . . . 1.0 109.555 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 46.3 mt -75.81 -23.63 55.83 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.919 -1.113 . . . . 1.0 109.063 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -177.68 173.89 1.56 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.635 -0.876 . . . . 1.0 108.635 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.559 ' NE2' ' ND1' ' A' ' 97' ' ' HIS . 0.3 OUTLIER -161.08 165.75 29.18 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.175 -0.953 . . . . 1.0 109.177 179.521 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -155.3 159.15 39.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.388 -0.82 . . . . 1.0 109.162 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -99.05 153.9 37.57 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 121.097 -1.002 . . . . 1.0 108.499 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -62.75 160.39 33.11 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 120.847 1.031 . . . . 1.0 112.396 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo . . . . . 0 N--CA 1.492 1.419 0 C-N-CA 121.806 1.67 . . . . 1.0 113.212 -179.716 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 43.0 p-10 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.218 -0.66 . . . . 1.0 109.218 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.87 121.39 8.53 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.086 -1.009 . . . . 1.0 109.423 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.559 ' ND1' ' NE2' ' A' ' 84' ' ' HIS . 3.4 m170 -109.63 147.25 33.4 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.7 -0.625 . . . . 1.0 109.575 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -121.21 151.73 39.63 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.66 -0.867 . . . . 1.0 108.66 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.425 ' OD2' ' O ' ' A' ' 81' ' ' LEU . 88.7 m-20 -78.67 120.63 23.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.973 -1.079 . . . . 1.0 109.386 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -83.11 -10.44 58.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.318 -0.864 . . . . 1.0 109.334 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -83.08 -10.07 58.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.892 . . . . 1.0 109.471 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 97.8 mt-10 -91.63 168.19 11.67 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.308 -0.87 . . . . 1.0 109.618 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 8.2 m -97.73 106.48 18.79 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.335 -0.853 . . . . 1.0 109.007 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -89.13 121.17 31.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.429 -0.794 . . . . 1.0 108.887 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.655 ' HG1' ' H ' ' A' ' 107' ' ' SER . 6.1 t -140.31 152.55 45.94 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.325 -0.86 . . . . 1.0 110.103 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 69.8 m -95.03 -8.42 36.81 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.774 -0.824 . . . . 1.0 108.774 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.655 ' H ' ' HG1' ' A' ' 105' ' ' THR . 90.3 p -91.89 175.33 6.92 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.467 -0.771 . . . . 1.0 108.957 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.1 t -72.82 71.85 1.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.04 -1.038 . . . . 1.0 109.485 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.474 ' O ' ' CG2' ' A' ' 105' ' ' THR . 43.7 mtpt -148.47 154.76 40.3 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.287 -0.883 . . . . 1.0 108.836 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 109' ' ' LYS . . . 40.83 -141.89 0.88 Allowed Glycine 0 N--CA 1.499 2.864 0 N-CA-C 110.473 -1.051 . . . . 1.0 110.473 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -99.53 119.55 38.22 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.336 -1.096 . . . . 1.0 108.962 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.416 ' H ' ' HH ' ' A' ' 141' ' ' TYR . 1.6 t-20 -64.08 130.39 43.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.157 -0.965 . . . . 1.0 109.623 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.9 tp -60.0 -43.45 95.17 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.436 -0.79 . . . . 1.0 110.814 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -59.84 -40.22 87.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.103 -0.998 . . . . 1.0 110.774 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -59.28 -51.35 70.32 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.845 -1.16 . . . . 1.0 109.197 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.6 t -69.99 -41.78 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.161 -0.962 . . . . 1.0 109.728 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.1 -51.76 68.36 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.032 -1.043 . . . . 1.0 109.264 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.59 -40.63 88.11 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.428 -0.795 . . . . 1.0 110.662 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.654 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 63.4 t60 -62.54 -49.17 76.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.204 -0.935 . . . . 1.0 111.022 -178.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -59.83 -38.8 83.05 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.619 -1.301 . . . . 1.0 109.701 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -59.85 -40.02 87.16 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.818 -1.176 . . . . 1.0 108.46 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -56.99 -40.44 91.16 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.576 -1.41 . . . . 1.0 109.576 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.654 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 86.7 m-70 -67.36 -40.06 85.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.957 -1.319 . . . . 1.0 109.311 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 86.1 p -66.03 -26.09 67.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.131 -0.981 . . . . 1.0 109.056 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 83.2 mt -80.51 2.55 24.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.365 -0.834 . . . . 1.0 109.552 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 85.14 9.77 79.49 Favored Glycine 0 N--CA 1.494 2.562 0 C-N-CA 120.2 -1.0 . . . . 1.0 110.921 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 77.5 mt -87.05 141.06 28.94 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.712 -1.464 . . . . 1.0 109.673 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 30.8 t0 -98.98 173.01 7.04 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.432 -0.792 . . . . 1.0 109.263 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.507 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 66.9 m80 -60.08 132.69 54.71 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.272 -0.892 . . . . 1.0 109.821 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.6 t -100.26 156.03 17.45 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.812 -0.81 . . . . 1.0 108.812 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -98.28 6.29 47.52 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.1 -1.0 . . . . 1.0 109.514 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -86.16 125.27 68.67 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.15 -0.969 . . . . 1.0 108.476 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -67.26 -19.34 50.33 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 CA-C-N 120.226 1.116 . . . . 1.0 112.57 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -87.21 -8.03 75.78 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.88 -1.288 . . . . 1.0 109.88 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.6 145.65 25.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.04 -1.271 . . . . 1.0 109.443 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.482 ' C ' ' H ' ' A' ' 138' ' ' PHE . 95.0 mt -68.38 -31.19 70.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.23 -0.919 . . . . 1.0 109.39 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 96.4 mmm -71.22 17.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.427 -0.796 . . . . 1.0 110.743 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.482 ' H ' ' C ' ' A' ' 136' ' ' LEU . 12.5 t80 -70.01 130.17 90.12 Favored Pre-proline 0 N--CA 1.494 1.764 0 N-CA-C 107.901 -1.148 . . . . 1.0 107.901 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -68.13 4.96 1.29 Allowed 'Trans proline' 0 N--CA 1.505 2.173 0 C-N-CA 121.041 1.16 . . . . 1.0 114.623 -177.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.418 HG23 HD12 ' A' ' 140' ' ' ILE . 96.6 mt -119.63 134.37 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 O-C-N 120.984 -1.072 . . . . 1.0 108.446 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.416 ' HH ' ' H ' ' A' ' 112' ' ' ASN . 60.3 t80 -71.74 130.8 42.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.022 -1.049 . . . . 1.0 109.666 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 15.0 t -145.11 144.98 31.22 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.56 -0.904 . . . . 1.0 108.56 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -80.8 147.68 30.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.99 -1.069 . . . . 1.0 109.912 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 19.3 m -137.77 145.14 42.04 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.481 -0.762 . . . . 1.0 110.008 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.17 97.16 0.57 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 107.646 -2.181 . . . . 1.0 107.646 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -73.97 5.1 4.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.379 -1.071 . . . . 1.0 109.805 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 70.0 m -60.05 -40.09 88.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.132 -0.98 . . . . 1.0 110.052 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -147.5 39.95 0.99 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.021 -1.05 . . . . 1.0 109.911 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -78.87 130.59 35.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.099 -1.001 . . . . 1.0 110.915 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 97.9 mmm -128.67 145.02 51.27 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.108 -1.071 . . . . 1.0 108.108 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 26.8 mt -50.26 129.43 24.11 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 120.841 -1.162 . . . . 1.0 108.981 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -71.97 179.44 4.85 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 CA-C-N 119.939 1.014 . . . . 1.0 112.084 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -61.42 -40.02 92.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.431 -0.793 . . . . 1.0 110.171 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -57.46 -45.11 85.13 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.185 -0.947 . . . . 1.0 110.353 -178.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -70.0 -39.9 75.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.804 -1.185 . . . . 1.0 109.49 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.5 t -59.75 -45.61 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.094 -1.004 . . . . 1.0 109.379 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -62.09 -40.07 94.59 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.945 -1.097 . . . . 1.0 110.016 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.4 -54.49 8.77 Favored Glycine 0 N--CA 1.494 2.523 0 C-N-CA 120.253 -0.975 . . . . 1.0 111.197 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.42 ' CG2' ' N ' ' A' ' 160' ' ' GLN . 8.8 tp -60.18 -40.33 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.934 -1.333 . . . . 1.0 109.644 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.553 ' O ' ' N ' ' A' ' 164' ' ' GLY . 92.1 mm-40 -65.15 -39.87 93.6 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.191 -0.943 . . . . 1.0 109.416 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 78.7 p -61.56 -28.62 69.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.085 -1.009 . . . . 1.0 110.279 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.4 mt -87.27 -52.58 5.31 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.94 -1.1 . . . . 1.0 110.477 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -90.81 -10.04 44.24 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.088 -1.007 . . . . 1.0 110.103 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.523 0 N-CA-C 109.348 -1.501 . . . . 1.0 109.348 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.1 mt . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.032 -0.729 . . . . 1.0 109.032 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -159.69 160.05 33.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.214 -0.929 . . . . 1.0 109.339 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -73.41 151.09 41.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.115 -0.991 . . . . 1.0 109.683 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.0 t -87.54 0.5 55.5 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.456 -0.777 . . . . 1.0 109.478 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -144.82 150.91 37.96 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.262 -0.899 . . . . 1.0 109.217 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.9 mmt -90.01 -0.1 57.4 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.357 -0.839 . . . . 1.0 109.952 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -98.2 131.02 44.91 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.266 -0.897 . . . . 1.0 108.896 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.9 mt -139.84 150.51 44.75 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.288 -0.882 . . . . 1.0 109.088 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 48.8 p -133.09 157.65 44.76 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.414 -0.804 . . . . 1.0 109.32 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -146.47 160.23 42.37 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.062 -1.024 . . . . 1.0 110.049 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.6 ttt-85 -144.32 133.29 22.68 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.381 -0.824 . . . . 1.0 109.429 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 84.9 mt -87.69 117.62 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.198 -0.939 . . . . 1.0 108.961 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.4 t -69.99 -39.97 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.16 -0.963 . . . . 1.0 109.767 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.436 HD22 ' H ' ' A' ' 64' ' ' PHE . 15.7 p30 -162.06 152.13 16.74 Favored 'General case' 0 C--N 1.292 -1.895 0 O-C-N 119.798 -1.814 . . . . 1.0 111.656 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -99.04 105.64 17.79 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 103.924 -2.621 . . . . 1.0 103.924 176.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.64 145.34 50.93 Favored Pre-proline 0 C--N 1.295 -1.8 0 O-C-N 121.127 -0.983 . . . . 1.0 110.532 -175.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -56.1 -14.14 10.95 Favored 'Trans proline' 0 N--CA 1.486 1.078 0 C-N-CA 120.668 0.912 . . . . 1.0 110.865 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -59.79 -39.2 84.16 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.523 -0.871 . . . . 1.0 109.708 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.7 mtm -139.66 156.18 46.98 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.211 -0.931 . . . . 1.0 109.496 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 82.5 p -75.6 163.88 26.88 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.423 -0.798 . . . . 1.0 109.681 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.504 ' CD2' ' H ' ' A' ' 28' ' ' HIS . 6.9 p80 -59.97 -39.03 84.27 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.542 -0.724 . . . . 1.0 110.079 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.4 m -60.02 -45.27 93.34 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.854 -1.154 . . . . 1.0 109.696 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -69.99 -40.2 75.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.136 -0.978 . . . . 1.0 109.846 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 77.6 t -68.48 -44.59 83.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.275 -0.891 . . . . 1.0 109.989 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -59.87 -48.54 81.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.052 -1.03 . . . . 1.0 111.033 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -61.11 -34.65 75.3 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.632 -1.292 . . . . 1.0 110.223 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.2 -48.66 80.81 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.868 -1.145 . . . . 1.0 109.619 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -66.47 -37.81 85.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.074 -1.016 . . . . 1.0 109.523 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.06 -40.82 90.8 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.899 -1.126 . . . . 1.0 109.307 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -60.11 -42.74 95.36 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.941 -1.099 . . . . 1.0 108.27 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.0 -48.47 81.56 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.427 -0.796 . . . . 1.0 109.599 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -65.62 -39.01 91.04 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.01 -1.056 . . . . 1.0 109.852 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -59.4 -47.19 86.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.1 -1.0 . . . . 1.0 109.728 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.4 t -61.37 -41.34 89.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.216 -0.928 . . . . 1.0 110.303 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -77.99 -36.89 48.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.067 -1.021 . . . . 1.0 109.809 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 86.7 p -71.22 -15.5 62.46 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.506 -0.746 . . . . 1.0 109.634 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -59.19 -40.07 84.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.3 -0.875 . . . . 1.0 109.909 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.9 m -112.94 -21.79 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.301 -0.874 . . . . 1.0 110.874 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.1 p -91.4 128.32 47.38 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 120.697 -1.252 . . . . 1.0 110.268 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -75.81 15.67 0.87 Allowed 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 120.855 1.037 . . . . 1.0 111.471 179.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 79.1 mt -69.16 140.62 54.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.335 -0.853 . . . . 1.0 109.55 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -106.11 121.04 43.34 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -106.93 123.18 47.81 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.303 -0.873 . . . . 1.0 109.194 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -120.0 130.24 54.64 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.589 -0.694 . . . . 1.0 109.728 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -82.09 135.85 35.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.185 -0.947 . . . . 1.0 109.073 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 84.7 mt -103.67 129.68 51.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.317 -0.864 . . . . 1.0 108.837 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.43 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 18.5 m170 -61.3 -40.01 92.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 1.0 109.869 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 75.1 m-20 -149.11 169.86 19.73 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.188 -0.945 . . . . 1.0 109.809 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.0 -178.03 34.42 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.726 -1.35 . . . . 1.0 109.726 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.2 mt -93.87 139.13 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.269 -1.136 . . . . 1.0 109.3 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.35 169.23 9.1 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.517 -0.739 . . . . 1.0 109.439 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -59.99 -48.42 81.78 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.27 -0.894 . . . . 1.0 109.147 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.0 mt -119.92 112.34 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.503 -0.748 . . . . 1.0 109.401 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.7 ptm -103.58 133.81 47.98 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.306 -0.871 . . . . 1.0 108.9 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.416 HD12 HG22 ' A' ' 62' ' ' ILE . 84.6 mt -107.54 133.83 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.568 -0.707 . . . . 1.0 109.394 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 76.6 p -151.74 157.57 42.19 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.072 -1.017 . . . . 1.0 109.988 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.436 ' H ' HD22 ' A' ' 21' ' ' ASN . 73.7 m-85 -110.02 121.72 45.91 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.823 -0.806 . . . . 1.0 108.823 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -114.24 -167.23 15.93 Favored Glycine 0 N--CA 1.501 2.977 0 N-CA-C 110.289 -1.124 . . . . 1.0 110.289 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 96.9 mt . . . . . 0 N--CA 1.496 1.83 0 O-C-N 121.653 -0.91 . . . . 1.0 108.594 179.271 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.544 ' CD1' ' OD1' ' A' ' 99' ' ' ASP . 96.3 m-85 . . . . . 0 N--CA 1.495 1.782 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.1 p-10 -100.26 0.56 40.51 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.911 -1.118 . . . . 1.0 110.81 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 129.85 -146.15 17.11 Favored Glycine 0 N--CA 1.502 3.091 0 N-CA-C 108.663 -1.775 . . . . 1.0 108.663 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.426 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 5.7 Cg_exo -65.54 -63.4 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.331 0 CA-C-N 119.314 1.557 . . . . 1.0 111.63 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 84.4 p -78.58 161.1 27.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.206 -0.934 . . . . 1.0 110.001 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.47 -133.06 10.85 Favored Glycine 0 N--CA 1.502 3.047 0 N-CA-C 109.916 -1.273 . . . . 1.0 109.916 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.7 mt -65.56 107.92 1.86 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.345 -1.091 . . . . 1.0 108.287 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 50.9 mt -75.65 -29.95 59.28 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.113 -0.992 . . . . 1.0 109.123 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -177.07 168.6 2.4 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -160.63 162.39 32.73 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.18 -0.95 . . . . 1.0 109.6 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -146.25 158.67 43.9 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.256 -0.903 . . . . 1.0 109.511 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -101.78 151.98 38.03 Favored Pre-proline 0 N--CA 1.498 1.963 0 N-CA-C 108.469 -0.937 . . . . 1.0 108.469 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -63.68 165.36 18.46 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 120.535 0.823 . . . . 1.0 111.93 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo . . . . . 0 N--CA 1.489 1.233 0 C-N-CA 121.035 1.157 . . . . 1.0 111.753 179.609 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 48.7 p-10 . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 109.282 -0.636 . . . . 1.0 109.282 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.15 118.84 7.0 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.225 -0.922 . . . . 1.0 110.126 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -104.12 136.02 44.52 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.505 -0.747 . . . . 1.0 109.845 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.44 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 19.4 m-85 -116.15 142.51 46.72 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.745 -0.835 . . . . 1.0 108.745 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.544 ' OD1' ' CD1' ' A' ' 75' ' ' PHE . 93.4 m-20 -79.22 124.09 28.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.935 -1.103 . . . . 1.0 109.523 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 48.3 t0 -84.32 -0.02 50.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.323 -0.861 . . . . 1.0 109.662 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -79.62 -16.39 55.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.022 -1.049 . . . . 1.0 110.157 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.509 ' N ' ' OE1' ' A' ' 102' ' ' GLU . 56.1 mp0 -93.53 171.17 9.06 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.177 -0.952 . . . . 1.0 109.128 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 13.7 m -99.48 108.57 21.05 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.352 -0.981 . . . . 1.0 108.352 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -85.84 127.57 34.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 1.0 109.368 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.451 ' CG2' ' O ' ' A' ' 109' ' ' LYS . 1.8 t -139.86 153.11 46.95 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.428 -0.795 . . . . 1.0 109.638 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.5 t -98.69 -4.28 34.03 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.418 -0.801 . . . . 1.0 108.972 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 53.1 m -89.65 -116.47 0.06 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.327 -0.858 . . . . 1.0 109.626 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.8 p -141.84 64.58 1.39 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.134 -0.979 . . . . 1.0 110.147 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.451 ' O ' ' CG2' ' A' ' 105' ' ' THR . 98.7 mttt -144.87 155.29 43.38 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.09 -1.006 . . . . 1.0 108.848 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 49.97 -138.62 20.3 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.485 -1.446 . . . . 1.0 109.485 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -99.55 118.96 37.25 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.241 -1.152 . . . . 1.0 109.337 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.425 HD21 ' HZ3' ' A' ' 146' ' ' LYS . 49.2 t-20 -62.24 127.48 31.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.296 -0.878 . . . . 1.0 109.927 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.7 tp -59.98 -40.29 88.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.3 -0.875 . . . . 1.0 110.237 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -59.89 -40.96 90.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.237 -0.915 . . . . 1.0 110.233 -178.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -60.76 -51.31 69.88 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.511 -1.368 . . . . 1.0 110.173 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.1 t -68.96 -43.77 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -0.889 . . . . 1.0 110.296 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.5 -52.24 66.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.074 -1.016 . . . . 1.0 109.739 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.23 -39.62 87.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.875 . . . . 1.0 110.374 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.634 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 68.2 t60 -62.04 -50.01 73.73 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.366 -0.834 . . . . 1.0 111.481 -178.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.44 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 9.5 pt-20 -59.6 -39.77 85.26 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.842 -1.161 . . . . 1.0 109.943 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -60.39 -39.8 88.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.955 -1.091 . . . . 1.0 108.738 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.76 -43.29 86.79 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.162 -1.575 . . . . 1.0 109.162 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.634 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 89.2 m-70 -67.53 -39.91 85.04 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.221 -1.164 . . . . 1.0 109.864 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 72.3 p -66.72 -21.61 66.07 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.134 -0.979 . . . . 1.0 109.463 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 77.1 mt -81.67 -0.73 44.01 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.457 -0.777 . . . . 1.0 109.484 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.82 6.96 66.85 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 110.902 -0.879 . . . . 1.0 110.902 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.5 mt -86.84 149.51 24.78 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.815 -1.403 . . . . 1.0 109.733 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 36.3 t0 -100.78 173.9 6.3 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.546 -0.721 . . . . 1.0 109.056 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.482 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 76.3 m80 -58.06 137.78 56.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.079 -1.013 . . . . 1.0 109.069 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 41.1 t -98.35 151.12 20.87 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.383 -0.823 . . . . 1.0 109.719 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -97.65 1.54 48.81 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.329 -0.857 . . . . 1.0 109.487 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -87.04 128.88 54.12 Favored Pre-proline 0 N--CA 1.489 1.487 0 N-CA-C 108.217 -1.031 . . . . 1.0 108.217 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -69.08 -11.04 30.76 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 CA-C-N 120.128 1.081 . . . . 1.0 112.059 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -93.43 -8.87 60.79 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.425 -1.47 . . . . 1.0 109.425 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.54 136.28 33.87 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.4 -1.059 . . . . 1.0 109.195 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.478 ' C ' ' H ' ' A' ' 138' ' ' PHE . 89.8 mt -60.84 -37.15 81.07 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.027 -1.046 . . . . 1.0 109.638 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 72.8 mtp -70.06 21.42 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.473 -0.767 . . . . 1.0 111.361 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.478 ' H ' ' C ' ' A' ' 136' ' ' LEU . 12.1 t80 -67.69 132.68 92.58 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 120.941 -1.099 . . . . 1.0 108.089 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -62.2 -2.07 2.82 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 CA-C-N 119.851 0.982 . . . . 1.0 114.56 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 95.7 mt -118.46 140.61 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.683 0 O-C-N 120.831 -1.168 . . . . 1.0 110.081 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -75.84 126.49 31.11 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.544 -0.723 . . . . 1.0 110.528 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 14.3 t -144.43 141.88 29.93 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.327 -0.858 . . . . 1.0 109.502 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -80.68 149.63 29.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.094 -1.004 . . . . 1.0 109.571 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.635 ' H ' ' HZ2' ' A' ' 146' ' ' LYS . 3.9 m -146.19 162.49 37.9 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.232 -0.918 . . . . 1.0 109.761 -178.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.439 ' N ' ' CG2' ' A' ' 144' ' ' THR . . . -84.88 103.17 2.64 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.134 -1.586 . . . . 1.0 109.134 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.635 ' HZ2' ' H ' ' A' ' 144' ' ' THR . 9.8 mptt -77.7 3.42 14.05 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.206 -1.173 . . . . 1.0 109.74 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 18.5 t -59.97 -47.56 85.3 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.464 -0.772 . . . . 1.0 109.793 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -133.65 19.12 3.89 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.267 -0.896 . . . . 1.0 110.097 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -65.35 139.84 58.61 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.901 -1.124 . . . . 1.0 110.416 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 76.6 mtm -138.04 149.69 46.26 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.284 -1.006 . . . . 1.0 108.284 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.1 mt -53.07 128.63 48.22 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.819 -1.176 . . . . 1.0 108.882 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.37 175.55 5.79 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 CA-C-N 120.201 1.107 . . . . 1.0 112.334 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -60.06 -39.69 86.89 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.529 -0.732 . . . . 1.0 109.968 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -56.65 -48.43 77.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.264 -0.897 . . . . 1.0 110.107 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -70.15 -40.03 75.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.137 -0.977 . . . . 1.0 109.677 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 76.7 t -63.09 -48.47 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.097 -1.002 . . . . 1.0 109.661 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -60.32 -40.24 89.91 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.904 -1.123 . . . . 1.0 110.298 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.67 -54.55 8.38 Favored Glycine 0 N--CA 1.496 2.659 0 O-C-N 121.168 -0.958 . . . . 1.0 111.41 -178.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.401 ' CG2' ' N ' ' A' ' 160' ' ' GLN . 6.3 tp -60.94 -40.22 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.813 -1.404 . . . . 1.0 109.59 -179.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.2 mm-40 -65.27 -39.71 92.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.16 -0.963 . . . . 1.0 109.434 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 83.9 p -66.68 -26.62 67.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.231 -0.918 . . . . 1.0 110.265 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 84.9 mt -87.0 -50.85 6.38 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.954 -1.091 . . . . 1.0 110.202 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -91.47 -9.19 45.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.104 -0.998 . . . . 1.0 110.286 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.492 2.429 0 N-CA-C 109.549 -1.42 . . . . 1.0 109.549 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.2 mt . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.233 -0.655 . . . . 1.0 109.233 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -160.6 160.4 31.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 1.0 109.016 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -72.25 151.67 42.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.101 -0.999 . . . . 1.0 109.214 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 82.8 p -86.51 1.92 49.82 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.243 -0.91 . . . . 1.0 110.487 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -149.63 154.59 38.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.082 -1.011 . . . . 1.0 109.342 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.504 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.02 0.96 56.83 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.219 -0.925 . . . . 1.0 109.88 -179.529 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -95.85 127.69 42.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.107 -0.996 . . . . 1.0 108.687 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.6 mt -141.36 151.0 43.18 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.154 -0.966 . . . . 1.0 109.256 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.3 p -132.11 155.58 47.87 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.439 -0.788 . . . . 1.0 109.088 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -144.02 159.98 41.66 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.163 -0.96 . . . . 1.0 109.934 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.535 ' NE ' ' O ' ' A' ' 56' ' ' GLY . 25.2 ttm-85 -145.87 136.09 23.83 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.533 -0.729 . . . . 1.0 109.906 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.405 HG21 HD11 ' A' ' 19' ' ' ILE . 87.4 mt -88.81 113.93 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 108.339 -0.985 . . . . 1.0 108.339 178.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.66 -40.27 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.104 -0.997 . . . . 1.0 109.094 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -161.9 160.98 28.6 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.856 -1.152 . . . . 1.0 110.473 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.557 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 62.8 m-85 -101.95 -168.05 1.49 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.607 -1.257 . . . . 1.0 107.607 179.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.22 149.02 50.83 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.165 -0.959 . . . . 1.0 110.131 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -70.63 -12.03 30.62 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 120.827 1.018 . . . . 1.0 110.148 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -59.62 -39.96 85.99 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 115.334 -0.848 . . . . 1.0 110.531 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.9 mtm -139.99 169.93 16.8 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.163 -0.96 . . . . 1.0 109.634 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 78.8 p -73.15 160.05 32.57 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.137 -0.977 . . . . 1.0 109.472 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.557 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 1.8 m80 -60.16 -39.79 87.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.52 -0.738 . . . . 1.0 110.344 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.1 m -59.97 -39.9 87.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.08 -1.012 . . . . 1.0 109.549 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -62.47 -46.57 87.88 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.099 -1.001 . . . . 1.0 110.31 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.2 t -66.32 -39.92 85.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.401 -0.812 . . . . 1.0 109.804 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -54.44 -57.08 12.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.276 -0.89 . . . . 1.0 111.221 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.8 pttt -62.32 -32.17 72.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.683 -1.261 . . . . 1.0 110.439 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.34 -49.95 70.9 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.887 -1.133 . . . . 1.0 109.687 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -65.17 -39.67 93.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.027 -1.046 . . . . 1.0 109.759 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.15 -40.22 89.12 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.062 -1.024 . . . . 1.0 109.485 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -60.06 -43.45 95.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.979 -1.076 . . . . 1.0 108.845 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.21 -47.33 84.91 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.471 -0.768 . . . . 1.0 110.39 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.429 ' CZ ' ' CZ ' ' A' ' 121' ' ' PHE . 43.0 m-85 -63.32 -40.25 96.79 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.816 -1.178 . . . . 1.0 109.767 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -60.01 -44.43 94.57 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.163 -0.961 . . . . 1.0 110.043 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.8 t -60.11 -41.88 88.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.292 -0.88 . . . . 1.0 110.26 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -79.68 -37.49 35.72 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.157 -0.964 . . . . 1.0 111.162 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.3 p -69.85 -17.58 63.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.889 -1.132 . . . . 1.0 109.664 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.77 -40.14 91.41 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.546 -0.721 . . . . 1.0 110.833 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.8 m -118.65 35.3 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.257 -0.902 . . . . 1.0 110.69 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.6 p -151.12 134.62 9.08 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 120.917 -1.114 . . . . 1.0 109.925 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -73.39 10.64 1.17 Allowed 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 120.809 1.006 . . . . 1.0 111.908 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.0 mt -68.93 136.85 53.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.001 -1.062 . . . . 1.0 110.02 -179.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -107.21 120.76 42.99 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.501 -0.926 . . . . 1.0 108.501 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -108.25 124.57 50.51 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.309 -0.869 . . . . 1.0 109.599 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -120.37 130.02 54.21 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.56 -0.712 . . . . 1.0 110.088 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -81.37 130.03 34.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.235 -0.916 . . . . 1.0 109.288 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.521 ' C ' HH12 ' A' ' 18' ' ' ARG . 85.1 mt -106.04 139.94 39.8 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.391 -0.818 . . . . 1.0 108.942 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.444 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 41.3 m170 -95.33 -14.35 23.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.254 -0.904 . . . . 1.0 109.704 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 77.2 m-20 -149.66 160.28 43.64 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.309 -0.869 . . . . 1.0 109.865 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.535 ' O ' ' NE ' ' A' ' 18' ' ' ARG . . . 88.12 179.6 47.06 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.751 -1.34 . . . . 1.0 109.751 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.6 mt -97.36 139.77 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.322 -1.105 . . . . 1.0 109.514 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.04 155.75 22.3 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.478 -0.763 . . . . 1.0 109.16 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -59.92 -49.83 76.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.113 -0.992 . . . . 1.0 109.257 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.7 mt -103.91 99.85 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.405 -0.809 . . . . 1.0 109.786 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.5 ptp -99.8 138.94 36.18 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.161 -0.962 . . . . 1.0 109.166 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.2 mt -110.19 132.15 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.999 -0.741 . . . . 1.0 108.999 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 71.5 p -149.3 149.91 31.68 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.896 -1.127 . . . . 1.0 109.879 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -101.98 123.45 45.91 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.727 -0.842 . . . . 1.0 108.727 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.73 -165.96 22.51 Favored Glycine 0 N--CA 1.499 2.838 0 N-CA-C 110.107 -1.197 . . . . 1.0 110.107 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.426 HD11 HG22 ' A' ' 66' ' ' ILE . 71.8 mt . . . . . 0 N--CA 1.495 1.811 0 O-C-N 121.671 -0.899 . . . . 1.0 108.822 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.551 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 89.2 m-85 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 108.609 -0.886 . . . . 1.0 108.609 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -105.18 20.01 19.61 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.319 -0.863 . . . . 1.0 110.811 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 112.37 -156.71 15.41 Favored Glycine 0 N--CA 1.504 3.222 0 N-CA-C 109.149 -1.58 . . . . 1.0 109.149 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -57.41 -68.25 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.49 0 CA-C-N 118.657 1.228 . . . . 1.0 112.423 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 84.9 p -76.36 162.86 27.53 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.326 -0.859 . . . . 1.0 109.982 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.78 -129.16 8.37 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 109.734 -1.346 . . . . 1.0 109.734 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.0 mt -69.12 107.71 3.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.44 -1.035 . . . . 1.0 109.123 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 60.1 mt -78.92 -22.4 45.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.894 -1.129 . . . . 1.0 109.016 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -177.49 173.03 1.73 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.755 -0.831 . . . . 1.0 108.755 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.572 ' CE1' ' ND1' ' A' ' 97' ' ' HIS . 19.8 p80 -161.56 162.2 30.11 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.047 -1.033 . . . . 1.0 109.652 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.4 155.13 40.85 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.745 -0.835 . . . . 1.0 108.745 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -93.44 151.67 40.4 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.176 -0.952 . . . . 1.0 108.559 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -50.0 169.38 0.14 Allowed 'Trans proline' 0 N--CA 1.488 1.176 0 CA-C-N 119.189 0.746 . . . . 1.0 111.295 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo . . . . . 0 C--N 1.314 -1.274 0 C-N-CA 120.661 0.908 . . . . 1.0 111.849 179.903 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.244 0.545 . . . . 1.0 109.895 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.08 122.75 10.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.267 -0.896 . . . . 1.0 109.428 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.572 ' ND1' ' CE1' ' A' ' 84' ' ' HIS . 46.1 m170 -105.31 136.36 44.99 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.652 -0.655 . . . . 1.0 109.853 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -120.23 145.0 47.44 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.896 -0.779 . . . . 1.0 108.896 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.551 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 82.9 m-20 -78.56 121.75 25.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.034 -1.041 . . . . 1.0 109.856 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.402 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 37.8 t0 -85.63 -7.36 58.88 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.905 -0.776 . . . . 1.0 108.905 179.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -82.39 -12.56 57.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.432 -0.793 . . . . 1.0 109.197 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -91.1 170.56 9.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.378 -0.826 . . . . 1.0 109.291 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.9 m -101.29 105.37 16.45 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.382 -0.824 . . . . 1.0 109.097 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -88.41 123.77 33.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.342 -0.849 . . . . 1.0 109.057 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.1 t -140.52 157.67 45.14 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.331 -0.856 . . . . 1.0 110.198 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 53.4 m -96.1 -9.18 31.4 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.181 -1.044 . . . . 1.0 108.181 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 72.4 m -92.35 171.58 8.96 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.58 -0.896 . . . . 1.0 108.58 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.6 t -72.09 76.19 0.95 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.07 -1.018 . . . . 1.0 109.928 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -149.53 150.29 32.06 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.204 -0.935 . . . . 1.0 108.982 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.07 -137.46 4.91 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.702 -1.359 . . . . 1.0 109.702 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -102.68 117.57 34.95 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.436 -1.038 . . . . 1.0 109.405 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.569 HD21 ' NZ ' ' A' ' 146' ' ' LYS . 55.3 t-20 -64.2 130.09 42.52 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.22 -0.925 . . . . 1.0 109.583 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.2 tp -60.13 -40.56 90.19 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.41 -0.806 . . . . 1.0 110.94 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -58.71 -40.13 82.79 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.793 -1.192 . . . . 1.0 110.346 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -58.68 -59.92 4.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.944 -1.097 . . . . 1.0 109.749 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 86.9 t -62.99 -42.13 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.53 -0.732 . . . . 1.0 110.216 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.69 -49.99 75.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.119 -0.988 . . . . 1.0 109.403 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.99 -39.69 86.59 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.918 -1.114 . . . . 1.0 109.803 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.632 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 68.4 t60 -65.08 -48.55 73.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.347 -0.846 . . . . 1.0 111.946 -178.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.506 ' OE2' ' CD1' ' A' ' 121' ' ' PHE . 1.1 pp20? -59.13 -40.05 84.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.535 -1.353 . . . . 1.0 109.281 -178.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.506 ' CD1' ' OE2' ' A' ' 120' ' ' GLU . 28.4 m-85 -60.04 -39.87 87.42 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.857 -1.152 . . . . 1.0 109.175 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.76 -45.36 85.81 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.843 -1.303 . . . . 1.0 109.843 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.632 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 87.6 m-70 -64.89 -40.06 94.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.004 -1.292 . . . . 1.0 109.645 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 82.2 p -63.78 -23.48 67.38 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.251 -0.906 . . . . 1.0 109.421 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.6 mt -84.16 -1.09 54.42 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.046 -1.034 . . . . 1.0 109.876 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.48 10.83 63.18 Favored Glycine 0 N--CA 1.496 2.698 0 C-N-CA 120.025 -1.084 . . . . 1.0 110.747 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 77.9 mt -84.65 144.0 28.87 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.888 -1.36 . . . . 1.0 109.944 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 11.6 t70 -99.15 170.1 8.93 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.302 -0.874 . . . . 1.0 109.029 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.493 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 65.7 m80 -60.0 137.35 58.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.153 -0.967 . . . . 1.0 110.154 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 28.6 t -100.62 154.15 18.82 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -97.98 5.72 48.5 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.096 -1.003 . . . . 1.0 109.911 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -86.98 129.48 51.93 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.066 -1.021 . . . . 1.0 108.66 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -66.4 -24.0 50.38 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 CA-C-N 120.188 1.103 . . . . 1.0 112.406 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -86.15 -5.09 83.47 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.012 -1.235 . . . . 1.0 110.012 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.59 144.48 27.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.933 -1.334 . . . . 1.0 108.731 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.475 ' C ' ' H ' ' A' ' 138' ' ' PHE . 88.4 mt -68.99 -33.22 73.33 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.307 -0.871 . . . . 1.0 109.181 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 96.3 mmm -71.58 19.87 0.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.462 -0.774 . . . . 1.0 110.771 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.475 ' H ' ' C ' ' A' ' 136' ' ' LEU . 12.0 t80 -69.16 132.34 90.1 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 120.826 -1.171 . . . . 1.0 108.532 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -64.53 -3.65 6.92 Favored 'Trans proline' 0 N--CA 1.501 1.926 0 CA-C-N 119.888 0.996 . . . . 1.0 113.936 -178.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.0 mt -118.67 141.11 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 O-C-N 121.012 -1.055 . . . . 1.0 109.104 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.497 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 38.3 t80 -74.73 130.63 39.82 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.489 -0.757 . . . . 1.0 110.252 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.8 t -140.63 142.48 35.0 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.431 -0.951 . . . . 1.0 108.431 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -79.8 144.17 33.77 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.918 -1.114 . . . . 1.0 110.074 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.4 m -130.42 140.03 50.58 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.04 -0.726 . . . . 1.0 109.04 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.41 113.92 3.98 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 107.655 -2.178 . . . . 1.0 107.655 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.569 ' NZ ' HD21 ' A' ' 112' ' ' ASN . 33.0 mmtm -73.25 98.77 2.72 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.063 -1.257 . . . . 1.0 109.297 -178.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.462 ' HG ' ' C ' ' A' ' 146' ' ' LYS . 6.9 m -159.72 104.75 1.58 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.301 -0.875 . . . . 1.0 108.846 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 72.9 m80 50.1 40.57 21.97 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.408 -0.807 . . . . 1.0 109.399 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -85.19 129.96 34.7 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.16 -0.963 . . . . 1.0 109.393 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 66.9 mtt -124.28 149.06 46.93 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.981 -0.748 . . . . 1.0 108.981 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 29.1 mt -51.84 131.54 38.42 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.099 -1.001 . . . . 1.0 108.408 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -66.14 174.41 6.0 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 CA-C-N 119.992 1.033 . . . . 1.0 112.32 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -60.08 -39.65 86.81 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.429 -0.794 . . . . 1.0 110.152 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -57.16 -49.67 75.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.135 -0.978 . . . . 1.0 109.809 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.01 -40.19 75.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.088 -1.008 . . . . 1.0 110.516 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 67.5 t -60.74 -45.72 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.949 -1.094 . . . . 1.0 108.989 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -60.17 -39.92 88.13 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.137 -0.977 . . . . 1.0 110.398 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -69.54 -52.45 21.09 Favored Glycine 0 N--CA 1.494 2.546 0 O-C-N 121.145 -0.972 . . . . 1.0 111.504 -178.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.3 tp -62.25 -40.01 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.754 -1.439 . . . . 1.0 109.661 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.8 mt-30 -65.01 -38.99 92.74 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.246 -0.909 . . . . 1.0 109.628 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 79.5 p -69.26 -22.25 63.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.174 -0.953 . . . . 1.0 110.174 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 88.8 mt -88.24 -50.68 6.2 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.888 -1.132 . . . . 1.0 110.065 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -93.53 -9.32 38.67 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.034 -1.041 . . . . 1.0 109.67 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.509 0 N-CA-C 109.473 -1.451 . . . . 1.0 109.473 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.4 mt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.582 -0.525 . . . . 1.0 109.582 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.544 ' CB ' ' NZ ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -161.41 159.82 28.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.149 -0.969 . . . . 1.0 109.56 179.502 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -76.23 152.6 36.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 1.0 109.407 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 99.0 p -87.51 0.03 56.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.361 -0.837 . . . . 1.0 109.809 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -148.57 154.59 39.96 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.154 -0.966 . . . . 1.0 109.686 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.567 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.49 -0.03 57.5 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.377 -0.827 . . . . 1.0 110.222 -179.577 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -96.6 122.38 39.46 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.181 -0.949 . . . . 1.0 108.863 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 71.8 mt -138.85 149.08 44.49 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.471 -0.768 . . . . 1.0 108.98 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.3 p -131.67 160.01 36.68 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.703 -0.851 . . . . 1.0 108.703 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -142.89 161.19 38.77 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.13 -0.981 . . . . 1.0 110.435 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -142.63 129.75 20.85 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.137 -0.69 . . . . 1.0 109.137 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.7 mt -88.13 118.25 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.182 -0.949 . . . . 1.0 108.908 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.67 -39.53 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.218 -0.926 . . . . 1.0 109.505 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.46 ' OD1' ' N ' ' A' ' 21' ' ' ASN . 21.4 p-10 -162.47 155.5 19.94 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.212 -1.555 . . . . 1.0 111.366 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.482 ' O ' ' O ' ' A' ' 23' ' ' THR . 19.3 m-85 -104.96 75.73 1.2 Allowed 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 106.358 -1.719 . . . . 1.0 106.358 176.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.482 ' O ' ' O ' ' A' ' 22' ' ' TYR . 3.0 t -23.45 144.71 0.02 OUTLIER Pre-proline 0 N--CA 1.512 2.636 0 C-N-CA 122.83 0.452 . . . . 1.0 111.744 -177.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -63.94 -4.74 7.92 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 121.631 1.554 . . . . 1.0 112.915 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -59.09 -36.84 75.82 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.442 -0.786 . . . . 1.0 109.557 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 76.8 mtm -138.47 164.17 30.08 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.298 -0.876 . . . . 1.0 109.582 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.416 ' HG1' ' H ' ' A' ' 30' ' ' GLU . 76.0 p -70.58 160.03 33.25 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.378 -0.826 . . . . 1.0 109.154 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.452 ' CD2' ' HB2' ' A' ' 22' ' ' TYR . 26.2 m170 -60.03 -42.45 94.4 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.291 -0.881 . . . . 1.0 110.206 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.2 m -60.41 -40.6 91.58 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.166 -0.959 . . . . 1.0 110.735 -179.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.416 ' H ' ' HG1' ' A' ' 27' ' ' THR . 47.1 mt-10 -65.78 -41.04 92.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.973 -1.079 . . . . 1.0 110.144 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 69.5 t -66.6 -40.0 85.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 121.422 -0.799 . . . . 1.0 109.978 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -59.78 -52.54 65.03 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.404 -0.81 . . . . 1.0 112.144 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.2 pttt -65.13 -32.63 74.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.558 -1.339 . . . . 1.0 110.277 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.57 -51.31 70.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.941 -1.1 . . . . 1.0 110.181 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -65.87 -37.39 86.03 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.825 -1.172 . . . . 1.0 110.099 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -59.99 -40.55 89.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.942 -1.098 . . . . 1.0 109.67 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -61.55 -40.31 94.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.067 -1.021 . . . . 1.0 109.529 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.08 -46.12 90.64 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.422 -0.799 . . . . 1.0 110.44 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -68.07 -39.67 82.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.01 -1.056 . . . . 1.0 109.86 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.408 ' O ' ' CG ' ' A' ' 44' ' ' ASP . 49.9 tptt -60.02 -47.17 86.94 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.186 -0.946 . . . . 1.0 109.878 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.2 t -60.08 -42.07 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.145 -0.972 . . . . 1.0 110.846 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.412 ' O ' ' OG1' ' A' ' 46' ' ' THR . 76.9 m95 -79.31 -35.36 41.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.85 -1.156 . . . . 1.0 110.148 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 38.8 p -71.5 -16.26 62.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.098 -1.001 . . . . 1.0 109.62 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.408 ' CG ' ' O ' ' A' ' 40' ' ' LYS . 96.0 m-20 -59.98 -39.59 86.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.339 -0.851 . . . . 1.0 110.314 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.4 m -112.18 -21.85 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.306 -0.871 . . . . 1.0 110.65 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' A' ' 42' ' ' TRP . 69.6 p -93.78 133.05 28.49 Favored Pre-proline 0 N--CA 1.501 2.109 0 O-C-N 120.759 -1.213 . . . . 1.0 109.611 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -75.43 15.95 0.77 Allowed 'Trans proline' 0 N--CA 1.496 1.622 0 CA-C-N 120.204 1.109 . . . . 1.0 112.039 178.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 78.8 mt -68.31 140.02 55.93 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.195 -0.941 . . . . 1.0 109.912 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -108.19 121.73 45.46 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 108.993 -0.743 . . . . 1.0 108.993 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -108.95 124.52 50.81 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.249 -0.907 . . . . 1.0 109.958 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.0 m -119.96 129.95 54.55 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.418 0.628 . . . . 1.0 109.306 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -83.82 137.9 33.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.307 -0.871 . . . . 1.0 110.042 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 77.3 mt -102.79 129.29 49.4 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.703 -0.851 . . . . 1.0 108.703 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.448 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 61.0 m170 -61.67 -40.04 93.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.914 . . . . 1.0 109.428 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 75.0 m-20 -151.0 168.02 25.85 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.379 -0.825 . . . . 1.0 109.249 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.03 -178.64 29.57 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.543 -1.423 . . . . 1.0 109.543 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.0 mt -96.3 132.82 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.353 -1.087 . . . . 1.0 109.76 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.96 164.71 12.34 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.367 -0.833 . . . . 1.0 109.071 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.04 -49.48 77.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.189 -0.944 . . . . 1.0 109.527 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 95.2 mt -107.28 101.85 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.51 -0.743 . . . . 1.0 109.691 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.2 ptp -100.21 135.97 40.82 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.248 -0.908 . . . . 1.0 109.469 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.411 HD11 HG22 ' A' ' 62' ' ' ILE . 85.4 mt -110.0 133.92 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.726 -0.609 . . . . 1.0 109.945 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.2 p -152.47 155.18 37.0 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.017 -1.052 . . . . 1.0 110.274 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -102.68 121.86 43.28 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.499 -0.926 . . . . 1.0 108.499 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.78 -173.45 22.86 Favored Glycine 0 N--CA 1.499 2.894 0 N-CA-C 110.761 -0.935 . . . . 1.0 110.761 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 96.7 mt . . . . . 0 N--CA 1.497 1.91 0 N-CA-C 107.755 -1.202 . . . . 1.0 107.755 179.413 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.561 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 94.4 m-85 . . . . . 0 N--CA 1.494 1.739 0 N-CA-C 109.106 -0.701 . . . . 1.0 109.106 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 79' ' ' SER . 23.2 p-10 -99.72 18.61 17.7 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.132 -0.98 . . . . 1.0 110.61 -178.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 110.21 -151.87 17.4 Favored Glycine 0 N--CA 1.503 3.16 0 N-CA-C 109.337 -1.505 . . . . 1.0 109.337 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.439 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 6.3 Cg_exo -62.16 -63.67 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.563 0 CA-C-N 118.919 1.359 . . . . 1.0 112.408 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.434 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 95.9 p -77.36 162.77 27.0 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.934 -1.104 . . . . 1.0 109.882 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.68 -130.05 9.01 Favored Glycine 0 N--CA 1.502 3.081 0 N-CA-C 110.341 -1.104 . . . . 1.0 110.341 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.429 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 8.9 mt -68.54 108.32 3.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.607 -0.937 . . . . 1.0 108.589 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 74.4 mt -80.67 -17.98 49.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.969 -1.082 . . . . 1.0 109.818 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.64 174.13 1.23 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.427 -0.796 . . . . 1.0 109.194 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.434 ' CE1' ' ND1' ' A' ' 97' ' ' HIS . 11.5 p80 -161.99 159.35 26.36 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.357 -0.84 . . . . 1.0 109.236 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.22 154.6 40.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.154 -0.966 . . . . 1.0 109.368 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -92.15 152.11 42.32 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.096 -1.002 . . . . 1.0 108.418 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -50.01 171.08 0.1 OUTLIER 'Trans proline' 0 N--CA 1.49 1.265 0 CA-C-N 119.139 0.728 . . . . 1.0 111.191 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo . . . . . 0 C--N 1.315 -1.21 0 CA-C-O 121.932 0.722 . . . . 1.0 111.402 -179.693 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.2 p-10 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.446 0.641 . . . . 1.0 109.856 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.0 120.48 7.42 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.434 -0.792 . . . . 1.0 109.02 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.434 ' ND1' ' CE1' ' A' ' 84' ' ' HIS . 48.7 m170 -105.61 139.51 40.1 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.561 -0.712 . . . . 1.0 110.265 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.528 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 29.2 m-85 -120.78 140.97 50.95 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.733 -0.84 . . . . 1.0 108.733 179.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.561 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 93.9 m-20 -78.92 122.94 26.75 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.834 -1.166 . . . . 1.0 109.65 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.401 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 34.4 t0 -84.39 1.61 44.42 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.281 -0.887 . . . . 1.0 109.722 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -80.74 -17.95 49.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.124 -0.985 . . . . 1.0 109.57 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.534 ' N ' ' OE1' ' A' ' 102' ' ' GLU . 56.9 mp0 -91.27 172.13 8.75 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.315 -0.865 . . . . 1.0 109.012 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 15.5 m -100.93 107.02 18.41 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.292 -1.003 . . . . 1.0 108.292 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -85.2 127.29 34.23 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.533 -0.914 . . . . 1.0 108.533 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.9 t -141.8 153.63 44.67 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.343 -0.848 . . . . 1.0 109.979 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 96.6 p -91.88 -5.66 52.88 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.911 -1.144 . . . . 1.0 107.911 178.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 65.2 m -93.1 -176.94 4.32 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.899 -0.778 . . . . 1.0 108.899 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.8 t -85.08 75.51 10.35 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.017 -1.052 . . . . 1.0 109.454 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -148.67 152.82 37.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.321 -0.862 . . . . 1.0 108.889 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 43.37 -138.72 3.54 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 110.169 -1.172 . . . . 1.0 110.169 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -99.99 117.4 34.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.35 -1.088 . . . . 1.0 109.277 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.577 ' ND2' ' HZ1' ' A' ' 146' ' ' LYS . 17.2 t-20 -64.24 132.6 50.76 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.105 -0.997 . . . . 1.0 109.426 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.3 tp -59.97 -44.1 94.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 1.0 110.309 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -59.98 -40.9 90.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.167 -0.958 . . . . 1.0 111.585 -178.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -59.38 -49.98 75.71 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.443 -1.41 . . . . 1.0 109.415 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 66.0 t -69.97 -40.01 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.136 -0.977 . . . . 1.0 110.047 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.21 -52.8 63.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.089 -1.007 . . . . 1.0 109.807 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.0 -39.54 86.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.824 . . . . 1.0 110.695 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.624 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 69.0 t60 -61.94 -50.03 73.77 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.047 -1.033 . . . . 1.0 111.387 -178.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.528 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 8.2 pt-20 -60.04 -38.57 83.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.608 -1.308 . . . . 1.0 110.113 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -60.03 -40.03 87.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.82 -1.175 . . . . 1.0 108.588 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.79 -43.18 94.74 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.449 -1.46 . . . . 1.0 109.449 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.624 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 90.5 m-70 -65.62 -40.01 92.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.05 -1.265 . . . . 1.0 109.291 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 93.3 p -67.19 -25.39 66.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.179 -0.951 . . . . 1.0 109.438 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 83.2 mt -82.53 -3.0 55.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.22 -0.925 . . . . 1.0 109.791 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 96.94 7.53 57.45 Favored Glycine 0 N--CA 1.5 2.906 0 O-C-N 121.101 -1.0 . . . . 1.0 111.108 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.3 mt -85.25 148.0 26.29 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.698 -1.472 . . . . 1.0 109.693 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 39.7 t0 -102.75 171.49 7.39 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.993 -0.743 . . . . 1.0 108.993 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.488 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 76.9 m80 -59.22 136.26 57.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.012 -1.055 . . . . 1.0 109.106 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.451 ' HG ' ' N ' ' A' ' 131' ' ' LYS . 40.3 t -97.38 155.28 16.98 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.237 -0.915 . . . . 1.0 109.541 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.451 ' N ' ' HG ' ' A' ' 130' ' ' SER . 92.7 mttt -98.61 1.3 46.24 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.351 -0.843 . . . . 1.0 109.75 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -85.4 130.18 52.53 Favored Pre-proline 0 N--CA 1.495 1.79 0 N-CA-C 107.843 -1.169 . . . . 1.0 107.843 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -67.44 -26.18 41.01 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 CA-C-N 120.212 1.111 . . . . 1.0 113.285 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -85.92 -2.75 86.09 Favored Glycine 0 N--CA 1.497 2.709 0 C-N-CA 119.799 -1.191 . . . . 1.0 110.342 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.63 144.42 27.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.047 -1.266 . . . . 1.0 109.146 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.451 ' C ' ' H ' ' A' ' 138' ' ' PHE . 91.5 mt -67.05 -33.46 75.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.177 -0.952 . . . . 1.0 109.813 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 94.8 mmm -69.17 9.61 0.41 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.164 -0.96 . . . . 1.0 110.2 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.451 ' H ' ' C ' ' A' ' 136' ' ' LEU . 13.2 t80 -67.43 135.9 93.18 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 107.738 -1.208 . . . . 1.0 107.738 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -65.13 -31.83 53.79 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 CA-C-N 119.898 0.999 . . . . 1.0 113.818 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 90.6 mt -83.42 140.41 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.481 -1.387 . . . . 1.0 110.119 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -76.07 128.92 36.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.491 -0.756 . . . . 1.0 109.591 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 10.2 t -140.16 142.41 35.95 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.221 -0.924 . . . . 1.0 109.55 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -82.5 144.93 30.08 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.359 -0.838 . . . . 1.0 109.643 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.8 t -140.79 156.09 46.24 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.259 -0.9 . . . . 1.0 110.076 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.0 110.36 3.17 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.92 -1.672 . . . . 1.0 108.92 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.577 ' HZ1' ' ND2' ' A' ' 112' ' ' ASN . 57.7 mttp -78.63 -3.38 43.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.328 -1.101 . . . . 1.0 109.708 -179.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.0 t -60.04 -41.14 91.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.234 -0.916 . . . . 1.0 110.635 -178.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -143.01 28.89 1.52 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.939 -1.101 . . . . 1.0 110.513 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -68.32 135.65 52.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.754 -1.216 . . . . 1.0 109.071 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 98.7 mtp -138.39 148.2 44.23 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.502 -0.925 . . . . 1.0 108.502 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 88.0 mt -50.83 121.25 14.76 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 120.959 -1.088 . . . . 1.0 108.682 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -66.57 178.55 2.61 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 CA-C-N 120.275 1.134 . . . . 1.0 112.153 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.16 -39.97 88.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.474 -0.766 . . . . 1.0 109.669 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -56.94 -49.2 76.38 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.238 -0.914 . . . . 1.0 109.678 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.68 -40.01 73.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.961 -1.087 . . . . 1.0 110.299 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 72.9 t -62.15 -46.67 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.915 -1.116 . . . . 1.0 109.159 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -60.28 -40.05 89.02 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 1.0 110.212 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.13 -53.77 8.8 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 120.219 -0.991 . . . . 1.0 111.436 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.414 ' CG2' ' N ' ' A' ' 160' ' ' GLN . 9.9 tp -60.45 -40.31 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.74 -1.447 . . . . 1.0 109.971 -178.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.536 ' O ' ' N ' ' A' ' 164' ' ' GLY . 25.8 mm100 -65.68 -39.6 91.49 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.323 -0.861 . . . . 1.0 109.352 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 79.2 p -63.46 -25.82 68.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.197 -0.94 . . . . 1.0 110.14 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 84.5 mt -86.95 -52.56 5.39 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.959 -1.088 . . . . 1.0 110.456 -179.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -92.7 -9.01 42.31 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.035 -1.041 . . . . 1.0 110.135 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.522 0 N-CA-C 109.502 -1.439 . . . . 1.0 109.502 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.1 mt . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 121.27 0.557 . . . . 1.0 109.575 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.9 pttt -161.96 160.05 27.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 1.0 109.85 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -73.56 147.25 44.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.403 -0.81 . . . . 1.0 109.411 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 99.4 p -89.33 3.1 53.26 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.192 -0.942 . . . . 1.0 110.091 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -143.21 153.61 43.0 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.118 -0.989 . . . . 1.0 109.435 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.1 mmt -90.17 -0.1 57.44 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.399 -0.813 . . . . 1.0 110.219 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -97.27 127.98 43.72 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.111 -0.993 . . . . 1.0 109.632 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.7 mt -142.28 148.65 38.4 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.101 -1.0 . . . . 1.0 109.123 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.4 p -135.28 158.57 44.03 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -145.1 160.99 40.54 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.038 -1.039 . . . . 1.0 110.615 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.477 ' HG2' HH11 ' A' ' 18' ' ' ARG . 0.5 OUTLIER -141.81 131.14 23.59 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 -179.141 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.7 mt -88.14 115.24 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.127 -0.983 . . . . 1.0 108.694 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.08 -41.7 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.122 -0.986 . . . . 1.0 109.537 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.499 HD22 ' H ' ' A' ' 64' ' ' PHE . 1.8 p30 -164.36 160.94 21.36 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.271 -1.518 . . . . 1.0 110.114 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.587 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 51.1 m-85 -102.06 -169.92 1.74 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.157 -1.053 . . . . 1.0 108.157 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.25 147.02 42.1 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.343 -0.848 . . . . 1.0 110.154 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -68.61 -14.42 39.47 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 120.876 1.05 . . . . 1.0 110.912 178.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -59.86 -39.59 85.74 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.601 -0.727 . . . . 1.0 110.186 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 74.3 mtm -137.23 165.26 26.54 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.283 -0.886 . . . . 1.0 109.425 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.7 p -72.51 159.63 33.62 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.289 -0.882 . . . . 1.0 109.406 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.628 ' N ' ' HD1' ' A' ' 28' ' ' HIS . 0.9 OUTLIER -60.16 -39.98 88.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.422 -0.799 . . . . 1.0 110.346 -179.25 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.1 m -59.91 -40.11 87.7 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.151 -0.968 . . . . 1.0 110.266 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -66.0 -40.0 90.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.126 -0.984 . . . . 1.0 110.087 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.6 t -68.8 -40.38 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.209 -0.932 . . . . 1.0 110.272 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.94 -49.91 75.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.031 -1.043 . . . . 1.0 110.197 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -61.7 -32.52 72.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.039 -1.038 . . . . 1.0 110.015 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.89 -48.51 81.4 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.888 -1.133 . . . . 1.0 110.007 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -66.89 -39.04 87.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.94 -1.1 . . . . 1.0 109.815 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -60.04 -42.5 94.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.111 -0.993 . . . . 1.0 109.516 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -60.14 -41.21 92.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.09 -1.006 . . . . 1.0 109.203 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.71 -45.3 94.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.503 -0.748 . . . . 1.0 110.224 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -65.64 -38.55 89.68 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.065 -1.022 . . . . 1.0 109.95 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -59.59 -48.82 80.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.102 -0.999 . . . . 1.0 109.782 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 76.1 t -60.0 -40.36 82.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.163 -0.961 . . . . 1.0 110.556 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.413 ' O ' ' OG1' ' A' ' 46' ' ' THR . 82.6 m95 -81.18 -36.54 30.03 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.842 -1.161 . . . . 1.0 109.823 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.6 p -70.22 -17.08 63.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.179 -0.951 . . . . 1.0 109.666 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -60.03 -40.04 87.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.938 . . . . 1.0 110.3 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -112.16 -17.61 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.338 -0.851 . . . . 1.0 110.782 -179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.414 ' C ' ' H ' ' A' ' 48' ' ' LEU . 67.9 p -94.93 125.5 50.63 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 120.744 -1.223 . . . . 1.0 109.48 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -72.37 16.14 0.39 Allowed 'Trans proline' 0 N--CA 1.495 1.578 0 CA-C-N 120.177 1.099 . . . . 1.0 111.8 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.414 ' H ' ' C ' ' A' ' 46' ' ' THR . 66.3 mt -69.17 140.01 54.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.297 -0.877 . . . . 1.0 109.934 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -106.32 120.56 42.19 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.79 -0.819 . . . . 1.0 108.79 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -106.75 127.22 53.2 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.273 -0.892 . . . . 1.0 109.42 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.9 m -119.99 129.69 54.4 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -84.04 132.57 34.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.517 -0.739 . . . . 1.0 109.116 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.9 mt -105.4 131.7 52.51 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.175 -0.953 . . . . 1.0 109.171 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.44 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 43.0 m170 -61.02 -40.01 91.94 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.146 -0.971 . . . . 1.0 109.284 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 71.9 m-20 -151.95 180.0 7.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.365 -0.834 . . . . 1.0 109.624 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.67 178.71 39.43 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.364 -1.494 . . . . 1.0 109.364 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.5 mt -96.9 130.28 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.284 -1.127 . . . . 1.0 109.673 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.54 162.67 14.48 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.581 -0.699 . . . . 1.0 109.163 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -59.92 -49.83 76.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.187 -0.945 . . . . 1.0 109.499 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.405 HD11 HG23 ' A' ' 60' ' ' ILE . 94.8 mt -104.81 101.24 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.412 -0.805 . . . . 1.0 109.898 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.2 ptp -100.93 132.13 46.48 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.319 -0.863 . . . . 1.0 109.161 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.6 mt -102.5 138.09 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.454 -0.779 . . . . 1.0 109.724 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 81.4 p -151.34 160.02 43.99 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.312 -0.867 . . . . 1.0 109.716 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.499 ' H ' HD22 ' A' ' 21' ' ' ASN . 86.1 m-85 -109.61 125.87 53.02 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.516 -0.74 . . . . 1.0 109.515 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -101.78 -178.26 28.15 Favored Glycine 0 N--CA 1.5 2.921 0 N-CA-C 110.839 -0.904 . . . . 1.0 110.839 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.5 mt . . . . . 0 N--CA 1.498 1.964 0 O-C-N 121.613 -0.933 . . . . 1.0 109.721 179.786 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.536 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 67.8 m-85 . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 109.48 -0.563 . . . . 1.0 109.48 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.6 p-10 -101.0 0.29 37.87 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.454 -0.779 . . . . 1.0 109.994 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 135.19 -155.29 22.01 Favored Glycine 0 N--CA 1.501 2.976 0 N-CA-C 108.707 -1.757 . . . . 1.0 108.707 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.425 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 12.3 Cg_exo -59.41 -68.2 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.39 0 CA-C-N 118.843 1.322 . . . . 1.0 111.776 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 88.1 p -76.0 160.69 29.59 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.311 -0.868 . . . . 1.0 109.203 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.75 -131.09 8.95 Favored Glycine 0 N--CA 1.501 3.031 0 N-CA-C 109.369 -1.493 . . . . 1.0 109.369 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.425 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 24.1 mt -69.81 111.81 5.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.069 -1.254 . . . . 1.0 109.06 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 30.8 mt -82.17 -13.8 56.6 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.237 -0.915 . . . . 1.0 108.625 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 179.39 169.43 1.05 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.999 -0.741 . . . . 1.0 108.999 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.479 ' NE2' ' ND1' ' A' ' 97' ' ' HIS . 3.4 p-80 -162.54 160.88 26.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.077 -1.015 . . . . 1.0 109.572 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -147.48 164.53 33.09 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.193 -0.942 . . . . 1.0 109.577 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -100.8 152.81 37.94 Favored Pre-proline 0 N--CA 1.498 1.966 0 N-CA-C 108.713 -0.847 . . . . 1.0 108.713 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -56.42 169.07 1.78 Allowed 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 120.582 0.855 . . . . 1.0 111.774 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo . . . . . 0 N--CA 1.49 1.314 0 C-N-CA 120.745 0.963 . . . . 1.0 111.608 179.729 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.508 -0.553 . . . . 1.0 109.508 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.87 139.2 23.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.232 -0.917 . . . . 1.0 109.38 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.479 ' ND1' ' NE2' ' A' ' 84' ' ' HIS . 18.0 m170 -130.13 157.71 41.68 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.56 -0.713 . . . . 1.0 109.884 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -136.72 153.81 50.76 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.011 -0.737 . . . . 1.0 109.011 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.536 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 0.6 OUTLIER -79.99 122.09 26.29 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.062 -1.024 . . . . 1.0 109.495 179.842 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -85.28 -11.62 54.32 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.095 -1.003 . . . . 1.0 109.347 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -81.33 -10.68 59.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.873 . . . . 1.0 109.47 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 98.3 mt-10 -90.81 169.98 10.49 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.311 -0.868 . . . . 1.0 109.466 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 22.3 m -98.43 106.23 18.48 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.103 -0.998 . . . . 1.0 109.728 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.427 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 93.5 m95 -89.82 127.48 35.99 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.704 -0.85 . . . . 1.0 108.704 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.2 t -143.19 155.65 44.58 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.237 -0.915 . . . . 1.0 109.583 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 60.0 p -94.82 -5.7 44.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.111 -0.993 . . . . 1.0 108.431 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 70.3 m -93.48 179.17 5.47 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.955 -0.757 . . . . 1.0 108.955 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.416 ' OG ' ' CZ ' ' A' ' 143' ' ' TYR . 19.6 m -81.04 77.02 7.98 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.008 -1.058 . . . . 1.0 108.988 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -149.06 150.19 32.35 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.739 -0.838 . . . . 1.0 108.739 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.21 -138.77 4.48 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.203 -1.159 . . . . 1.0 110.203 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -99.5 116.68 32.21 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.303 -1.116 . . . . 1.0 109.487 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.66 131.42 47.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.156 -0.965 . . . . 1.0 109.246 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.7 tp -59.86 -41.66 91.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 1.0 110.12 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -59.98 -43.0 95.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.133 -0.979 . . . . 1.0 111.106 -178.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -59.38 -50.17 74.98 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.661 -1.274 . . . . 1.0 109.319 -178.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 95.7 t -70.54 -42.2 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.059 -1.025 . . . . 1.0 109.974 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.13 -50.66 73.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.004 -1.06 . . . . 1.0 110.12 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.09 -36.44 77.4 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.581 -1.325 . . . . 1.0 109.577 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.599 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 72.3 t60 -65.5 -48.71 71.65 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.29 -0.881 . . . . 1.0 111.353 -178.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.67 -39.95 82.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.642 -1.286 . . . . 1.0 109.419 -178.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -60.04 -39.99 87.82 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.945 -1.097 . . . . 1.0 109.077 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.4 -46.51 80.07 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.795 -1.322 . . . . 1.0 109.795 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.599 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 85.9 m-70 -65.37 -39.93 92.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.135 -1.215 . . . . 1.0 109.3 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.8 p -64.64 -23.61 67.31 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.291 -0.88 . . . . 1.0 108.998 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 50.6 mt -82.49 -4.97 58.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 1.0 109.59 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 95.27 5.83 60.36 Favored Glycine 0 N--CA 1.499 2.869 0 O-C-N 121.154 -0.966 . . . . 1.0 111.075 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.2 mt -84.21 150.27 25.58 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.811 -1.405 . . . . 1.0 109.94 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 11.0 t70 -103.16 173.19 6.42 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.558 -0.714 . . . . 1.0 109.477 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.483 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 69.2 m80 -59.97 136.35 57.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.132 -0.98 . . . . 1.0 109.221 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 47.7 t -99.45 156.02 17.25 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.324 -0.86 . . . . 1.0 109.516 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -98.72 2.37 47.0 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.165 -0.959 . . . . 1.0 109.358 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -85.66 128.46 58.75 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 120.955 -1.091 . . . . 1.0 108.409 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -68.44 -17.04 43.95 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 CA-C-N 120.14 1.086 . . . . 1.0 112.094 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -89.32 -7.48 69.65 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.091 -1.203 . . . . 1.0 110.091 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.09 144.99 26.18 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.159 -1.201 . . . . 1.0 109.125 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.516 ' C ' ' H ' ' A' ' 138' ' ' PHE . 96.2 mt -69.71 -31.51 69.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.035 -1.04 . . . . 1.0 109.599 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 94.1 mmm -70.88 19.82 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.178 -0.951 . . . . 1.0 110.372 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.516 ' H ' ' C ' ' A' ' 136' ' ' LEU . 13.5 t80 -69.2 131.86 90.28 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.104 -0.997 . . . . 1.0 108.367 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -62.95 -2.22 3.45 Favored 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 120.831 1.021 . . . . 1.0 114.149 -178.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.426 HD11 HG23 ' A' ' 140' ' ' ILE . 97.0 mt -120.43 136.77 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 O-C-N 120.987 -1.071 . . . . 1.0 109.944 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -71.97 127.73 33.49 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.278 -0.889 . . . . 1.0 110.437 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.7 t -139.83 133.61 30.57 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.436 -0.79 . . . . 1.0 109.346 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.416 ' CZ ' ' OG ' ' A' ' 108' ' ' SER . 79.0 t80 -82.16 144.89 30.41 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.065 -1.022 . . . . 1.0 108.749 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 2.5 t -141.86 159.98 41.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.101 -0.999 . . . . 1.0 109.473 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.27 105.66 1.7 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.928 -1.669 . . . . 1.0 108.928 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -78.06 9.8 3.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.342 -1.093 . . . . 1.0 109.37 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 59.2 m -59.91 -40.09 87.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.908 . . . . 1.0 109.826 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -150.25 29.92 0.7 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.006 -1.059 . . . . 1.0 109.575 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -61.59 138.78 58.31 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.154 -0.966 . . . . 1.0 109.59 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 66.9 mtt -137.83 145.86 42.78 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.689 -0.856 . . . . 1.0 108.689 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 45.4 mt -52.31 129.32 41.92 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.043 -1.036 . . . . 1.0 108.883 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -70.19 175.74 8.05 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 CA-C-N 119.985 1.03 . . . . 1.0 112.33 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.44 -39.9 89.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.54 -0.725 . . . . 1.0 110.097 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -56.73 -47.55 79.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.081 -1.012 . . . . 1.0 109.593 -179.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -70.33 -39.98 74.42 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.101 -1.0 . . . . 1.0 110.121 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 74.2 t -60.81 -47.74 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.028 -1.045 . . . . 1.0 109.098 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -60.26 -39.93 88.53 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.136 -0.977 . . . . 1.0 110.389 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.75 -54.55 7.24 Favored Glycine 0 N--CA 1.495 2.577 0 O-C-N 121.029 -1.044 . . . . 1.0 111.276 -178.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 7.1 tp -60.1 -40.02 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.996 -1.297 . . . . 1.0 109.672 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.554 ' O ' ' N ' ' A' ' 164' ' ' GLY . 26.4 mt-30 -65.51 -39.56 91.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.106 -0.996 . . . . 1.0 109.492 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.459 ' HG ' ' N ' ' A' ' 162' ' ' LEU . 83.3 p -60.61 -32.0 71.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.214 -0.929 . . . . 1.0 110.688 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.459 ' N ' ' HG ' ' A' ' 161' ' ' SER . 97.4 mt -85.13 -49.97 7.81 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.772 -1.205 . . . . 1.0 110.606 -178.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -91.39 -8.92 46.6 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.023 -1.048 . . . . 1.0 110.173 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.492 2.41 0 N-CA-C 109.563 -1.415 . . . . 1.0 109.563 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.6 mt . . . . . 0 N--CA 1.494 1.74 0 N-CA-C 109.357 -0.608 . . . . 1.0 109.357 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.543 ' CB ' ' HZ3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -159.96 162.17 34.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.898 . . . . 1.0 109.547 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -73.05 150.45 42.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.196 -0.94 . . . . 1.0 109.666 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.0 t -80.21 -2.63 45.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.332 -0.855 . . . . 1.0 109.749 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -145.88 152.38 39.38 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.235 -0.915 . . . . 1.0 109.284 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.1 mmt -89.99 -0.68 57.71 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.211 -0.931 . . . . 1.0 109.771 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -96.9 131.17 43.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.205 -0.934 . . . . 1.0 109.059 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.8 mt -139.97 149.94 43.87 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.204 -0.935 . . . . 1.0 109.173 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 54.6 p -131.36 155.35 47.4 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.573 -0.899 . . . . 1.0 108.573 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -146.15 159.59 43.1 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.04 -1.038 . . . . 1.0 110.067 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.404 ' HG2' HH11 ' A' ' 18' ' ' ARG . 36.9 ttt-85 -145.26 133.98 22.24 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.48 -0.763 . . . . 1.0 109.296 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.9 mt -86.59 119.63 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 1.0 108.915 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 69.7 t -69.62 -41.11 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.353 -0.842 . . . . 1.0 109.207 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -164.56 157.87 17.51 Favored 'General case' 0 C--N 1.286 -2.175 0 O-C-N 119.686 -1.884 . . . . 1.0 110.819 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -100.41 113.0 25.41 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 106.475 -1.676 . . . . 1.0 106.475 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.458 ' C ' ' H ' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -56.87 136.54 79.25 Favored Pre-proline 0 C--N 1.299 -1.588 0 C-N-CA 119.103 -1.039 . . . . 1.0 109.199 -177.938 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -57.48 -7.87 3.4 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 CA-C-N 119.606 0.895 . . . . 1.0 110.31 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' A' ' 23' ' ' THR . 68.2 m-20 -58.27 -31.55 67.55 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 120.036 -0.666 . . . . 1.0 109.656 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 78.0 mtm -142.55 163.25 33.35 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.228 -0.92 . . . . 1.0 109.895 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 42.3 p -72.56 161.23 31.05 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.454 -0.778 . . . . 1.0 109.648 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -61.22 -40.06 92.58 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.274 -0.891 . . . . 1.0 110.045 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.3 m -61.1 -42.52 98.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.997 -1.065 . . . . 1.0 110.545 -179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.0 -40.03 87.25 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.077 -1.014 . . . . 1.0 110.297 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 79.7 t -68.12 -43.35 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.122 -0.986 . . . . 1.0 110.555 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.04 -49.31 78.18 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.044 -1.035 . . . . 1.0 110.676 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -61.87 -33.81 74.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.946 -1.097 . . . . 1.0 110.176 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.02 -49.74 76.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.833 -1.167 . . . . 1.0 110.31 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -67.2 -39.94 86.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.915 -1.116 . . . . 1.0 110.449 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -60.02 -40.54 89.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.873 -1.142 . . . . 1.0 109.793 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -60.09 -40.73 90.61 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.918 -1.114 . . . . 1.0 108.763 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.94 -46.99 87.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.49 -0.756 . . . . 1.0 110.254 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -66.57 -39.04 88.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.032 -1.043 . . . . 1.0 109.98 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -60.03 -46.62 88.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.08 -1.012 . . . . 1.0 109.882 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 67.8 t -60.01 -41.46 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.148 -0.97 . . . . 1.0 110.36 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -79.39 -36.8 38.62 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.875 -1.14 . . . . 1.0 110.587 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.1 p -70.0 -18.86 63.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.024 -1.047 . . . . 1.0 109.995 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.04 -39.96 87.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.166 -0.959 . . . . 1.0 110.549 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.4 m -117.96 33.84 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.276 -0.89 . . . . 1.0 110.756 -178.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.7 p -151.4 134.48 8.91 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 120.769 -1.207 . . . . 1.0 109.604 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -73.5 13.14 0.75 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 CA-C-N 119.677 0.92 . . . . 1.0 112.004 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 79.9 mt -68.36 139.78 55.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.061 -1.024 . . . . 1.0 109.865 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -110.5 120.98 44.18 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.83 -0.804 . . . . 1.0 108.83 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -106.28 125.27 50.79 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.334 -0.854 . . . . 1.0 109.509 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.1 m -119.92 129.97 54.59 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.648 -0.658 . . . . 1.0 109.929 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -83.29 130.25 35.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.366 -0.834 . . . . 1.0 109.149 179.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 98.4 mt -101.33 123.21 45.06 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.246 -0.909 . . . . 1.0 109.199 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.439 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 48.8 m170 -60.85 -40.0 91.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.313 -0.867 . . . . 1.0 109.792 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 83.0 m-20 -146.67 169.99 17.89 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.21 -0.931 . . . . 1.0 109.827 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.04 179.1 35.93 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.451 -1.46 . . . . 1.0 109.451 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.5 mt -95.8 134.6 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.234 -1.156 . . . . 1.0 109.377 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.52 159.79 17.21 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.429 -0.794 . . . . 1.0 109.337 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.02 -49.11 78.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.156 -0.965 . . . . 1.0 109.436 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.6 mt -104.84 99.18 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.387 -0.821 . . . . 1.0 109.939 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.1 ptp -100.16 132.83 45.3 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.141 -0.975 . . . . 1.0 109.047 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.5 mt -110.03 130.48 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.588 -0.695 . . . . 1.0 109.534 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.3 p -151.2 158.53 44.06 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.128 -0.983 . . . . 1.0 110.245 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -102.84 127.64 49.94 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.212 -1.033 . . . . 1.0 108.212 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -117.73 -166.83 14.04 Favored Glycine 0 N--CA 1.499 2.863 0 N-CA-C 110.018 -1.233 . . . . 1.0 110.018 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.411 HG23 HD13 ' A' ' 66' ' ' ILE . 83.0 mt . . . . . 0 N--CA 1.494 1.767 0 O-C-N 121.669 -0.901 . . . . 1.0 108.702 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.475 ' CE2' ' OD1' ' A' ' 99' ' ' ASP . 37.4 m-85 . . . . . 0 N--CA 1.493 1.72 0 N-CA-C 107.94 -1.133 . . . . 1.0 107.94 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 79' ' ' SER . 24.2 p-10 -103.27 13.34 34.08 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.054 -1.029 . . . . 1.0 110.569 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 108.89 -151.54 17.09 Favored Glycine 0 N--CA 1.503 3.103 0 N-CA-C 109.223 -1.551 . . . . 1.0 109.223 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.404 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 13.6 Cg_exo -58.58 -64.13 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.552 0 CA-C-N 118.892 1.346 . . . . 1.0 112.737 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.447 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 79.2 p -75.04 159.83 31.25 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.976 -1.078 . . . . 1.0 109.828 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.97 -129.8 8.83 Favored Glycine 0 N--CA 1.502 3.068 0 N-CA-C 109.992 -1.243 . . . . 1.0 109.992 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.441 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 23.0 mt -66.17 104.38 1.16 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.358 -1.084 . . . . 1.0 108.889 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 33.8 mt -80.04 -15.73 56.57 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.991 -1.068 . . . . 1.0 108.727 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 179.61 170.8 1.05 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.07 -0.715 . . . . 1.0 109.07 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -160.03 153.46 22.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.184 -0.947 . . . . 1.0 109.423 178.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -142.2 158.58 43.58 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.409 -0.807 . . . . 1.0 109.297 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -96.18 153.32 39.1 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 108.287 -1.005 . . . . 1.0 108.287 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -49.38 170.02 0.1 OUTLIER 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 120.529 0.819 . . . . 1.0 111.549 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo . . . . . 0 N--CA 1.493 1.493 0 C-N-CA 121.021 1.147 . . . . 1.0 112.08 -179.296 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.7 p-10 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.542 -0.54 . . . . 1.0 109.542 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.24 124.43 11.49 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.229 -0.919 . . . . 1.0 109.468 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -111.84 146.35 37.83 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.486 0.66 . . . . 1.0 109.963 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -126.64 148.98 49.76 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.343 -0.984 . . . . 1.0 108.343 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.475 ' OD1' ' CE2' ' A' ' 75' ' ' PHE . 87.8 m-20 -78.57 123.52 27.18 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.862 -1.149 . . . . 1.0 109.367 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -83.08 -9.38 59.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.893 . . . . 1.0 109.257 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -83.08 -13.5 55.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.335 -0.853 . . . . 1.0 108.897 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.404 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 99.1 mt-10 -89.09 166.19 14.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.508 -0.745 . . . . 1.0 109.168 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.7 m -99.12 105.82 17.95 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.225 -0.922 . . . . 1.0 109.342 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -88.04 124.11 33.42 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.557 -0.905 . . . . 1.0 108.557 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.0 t -140.2 160.03 40.87 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.232 -0.917 . . . . 1.0 110.115 -178.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 32.2 t -96.63 -10.02 28.0 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.415 -0.958 . . . . 1.0 108.415 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.3 t -91.06 -176.34 4.58 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.681 -0.859 . . . . 1.0 108.681 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.4 t -85.59 77.81 9.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.995 -1.066 . . . . 1.0 109.373 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -148.44 149.93 32.59 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.372 -0.973 . . . . 1.0 108.372 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.13 -139.71 5.08 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.764 -1.335 . . . . 1.0 109.764 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -101.01 115.58 30.83 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.451 -1.029 . . . . 1.0 108.923 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.444 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 17.4 t-20 -62.69 134.52 56.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.115 -0.99 . . . . 1.0 109.945 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.7 tp -60.03 -46.19 90.34 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.513 -0.742 . . . . 1.0 110.867 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -59.51 -40.04 85.78 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.261 -0.899 . . . . 1.0 110.743 -178.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -58.41 -51.09 71.31 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.686 -1.259 . . . . 1.0 109.337 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 64.6 t -70.04 -40.77 78.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.097 -1.002 . . . . 1.0 110.235 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.93 -49.42 76.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.172 -0.955 . . . . 1.0 109.738 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.97 -39.68 86.5 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.197 -0.939 . . . . 1.0 110.366 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.635 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 71.0 t60 -63.52 -49.85 71.9 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.14 -0.975 . . . . 1.0 111.416 -178.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -60.03 -38.81 83.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.602 -1.311 . . . . 1.0 110.276 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -60.06 -39.95 87.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.698 -1.251 . . . . 1.0 108.493 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.23 -40.27 91.44 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.571 -1.411 . . . . 1.0 109.571 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.635 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 78.4 m-70 -66.53 -39.99 88.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.037 -1.272 . . . . 1.0 109.132 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 84.3 p -66.38 -24.44 66.49 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.278 -0.889 . . . . 1.0 109.566 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 92.9 mt -81.78 -1.69 48.15 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.152 -0.967 . . . . 1.0 109.607 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 89.69 9.64 66.14 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 110.645 -0.982 . . . . 1.0 110.645 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 82.6 mt -84.82 147.13 26.98 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.924 -1.339 . . . . 1.0 109.302 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 41.3 t0 -102.2 172.9 6.63 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.462 -0.774 . . . . 1.0 109.49 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.505 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 61.3 m80 -59.05 136.93 58.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.878 . . . . 1.0 109.612 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 47.3 t -98.57 157.01 16.51 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.369 -0.832 . . . . 1.0 109.293 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -99.71 0.01 40.97 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.383 -0.823 . . . . 1.0 109.582 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 9.6 t70 -85.46 129.45 55.2 Favored Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 108.225 -1.028 . . . . 1.0 108.225 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -68.47 -21.07 40.9 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 CA-C-N 120.126 1.081 . . . . 1.0 112.004 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.459 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -87.5 -4.61 80.0 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.443 -1.463 . . . . 1.0 109.443 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.09 145.71 26.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.241 -1.152 . . . . 1.0 109.496 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.495 ' C ' ' H ' ' A' ' 138' ' ' PHE . 84.5 mt -69.95 -34.9 74.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.249 -0.907 . . . . 1.0 109.493 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 96.8 mmm -70.98 18.84 0.06 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.341 -0.85 . . . . 1.0 110.533 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.495 ' H ' ' C ' ' A' ' 136' ' ' LEU . 11.9 t80 -68.73 133.29 90.53 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.902 -1.124 . . . . 1.0 108.096 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -63.43 -13.15 34.43 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 120.782 0.988 . . . . 1.0 113.843 -178.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.7 mt -108.36 139.96 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.036 -1.04 . . . . 1.0 109.884 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.444 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 56.0 t80 -73.63 129.37 37.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.511 -0.743 . . . . 1.0 110.127 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.6 t -138.49 140.12 39.06 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.589 -0.893 . . . . 1.0 108.589 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -79.88 130.0 34.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.036 -1.04 . . . . 1.0 109.537 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 20.6 m -115.81 125.51 52.81 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.705 -0.622 . . . . 1.0 109.639 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.9 100.06 0.22 Allowed Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.068 -2.013 . . . . 1.0 108.068 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.445 ' O ' ' OG ' ' A' ' 147' ' ' SER . 8.3 mtpm? -70.14 138.24 51.73 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.292 -1.122 . . . . 1.0 109.955 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 146' ' ' LYS . 3.1 m 176.26 -81.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.51 -0.922 . . . . 1.0 108.51 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -112.93 19.87 16.91 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -61.16 137.48 58.23 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 1.0 110.492 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 96.6 mmm -137.53 146.99 44.81 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.336 -0.986 . . . . 1.0 108.336 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.9 mt -47.84 111.38 1.7 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.183 -0.948 . . . . 1.0 109.377 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -54.9 178.24 0.09 OUTLIER 'Trans proline' 0 N--CA 1.494 1.516 0 CA-C-N 120.051 1.054 . . . . 1.0 112.379 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -60.39 -39.96 89.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.4 -0.813 . . . . 1.0 110.065 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -57.27 -47.87 80.34 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.142 -0.974 . . . . 1.0 109.597 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.04 -39.98 75.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.237 -0.914 . . . . 1.0 110.231 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 55.9 t -63.41 -46.95 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.989 -1.07 . . . . 1.0 109.261 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -60.01 -40.04 87.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.16 -0.962 . . . . 1.0 110.208 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -68.8 -56.63 9.05 Favored Glycine 0 N--CA 1.493 2.463 0 O-C-N 121.142 -0.974 . . . . 1.0 111.131 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.4 tp -61.27 -40.02 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.941 -1.329 . . . . 1.0 109.711 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 164' ' ' GLY . 93.1 mm-40 -64.99 -39.94 94.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 1.0 109.613 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 87.5 p -65.25 -26.76 68.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.185 -0.947 . . . . 1.0 110.051 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 89.5 mt -88.38 -50.59 6.23 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.993 -1.067 . . . . 1.0 110.263 -179.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -94.47 -9.53 35.2 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.027 -1.046 . . . . 1.0 110.422 -179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.496 2.678 0 N-CA-C 109.509 -1.437 . . . . 1.0 109.509 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.6 mt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.212 -0.662 . . . . 1.0 109.212 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -160.77 159.99 30.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.342 -0.849 . . . . 1.0 109.476 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -71.29 148.77 46.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.007 -1.058 . . . . 1.0 109.278 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.9 t -81.93 0.87 37.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.905 . . . . 1.0 109.766 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -149.97 155.68 40.39 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.017 -1.052 . . . . 1.0 110.054 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.544 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.93 0.01 57.62 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.405 -0.809 . . . . 1.0 109.731 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -95.89 126.95 41.49 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.234 -0.916 . . . . 1.0 108.696 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.8 mt -140.48 151.35 44.76 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.276 -0.89 . . . . 1.0 109.377 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.9 p -130.42 152.1 50.19 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.825 -0.806 . . . . 1.0 108.825 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -145.4 160.04 42.15 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.116 -0.99 . . . . 1.0 109.911 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.722 HH12 ' H ' ' A' ' 58' ' ' ALA . 13.9 ttp-105 -143.4 137.6 28.78 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.294 -0.879 . . . . 1.0 109.793 -179.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 92.0 mt -88.53 119.08 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.219 -0.925 . . . . 1.0 108.837 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.0 t -69.92 -39.98 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 1.0 109.722 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.616 HD22 ' H ' ' A' ' 64' ' ' PHE . 9.7 p30 -163.0 150.99 13.67 Favored 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 117.243 -1.783 . . . . 1.0 111.744 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -99.79 105.13 16.88 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 104.313 -2.477 . . . . 1.0 104.313 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.1 t -58.32 145.74 73.79 Favored Pre-proline 0 C--N 1.294 -1.807 0 O-C-N 121.027 -1.046 . . . . 1.0 110.419 -176.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -60.86 -11.65 18.82 Favored 'Trans proline' 0 N--CA 1.488 1.16 0 C-N-CA 120.961 1.108 . . . . 1.0 111.57 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -56.7 -32.43 65.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.326 -0.859 . . . . 1.0 110.002 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.6 mtm -140.13 160.52 39.75 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.185 -0.947 . . . . 1.0 109.415 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 66.3 p -73.59 162.34 29.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.255 -0.903 . . . . 1.0 109.781 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 30.3 m170 -60.87 -41.75 96.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.213 -0.929 . . . . 1.0 109.98 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.6 m -60.44 -41.88 94.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.083 -1.011 . . . . 1.0 110.183 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.59 -40.03 80.64 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.187 -0.946 . . . . 1.0 110.277 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 69.3 t -68.73 -43.67 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.117 -0.989 . . . . 1.0 110.205 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -59.93 -48.6 81.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.127 -0.983 . . . . 1.0 110.754 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.412 ' HA ' ' HZ3' ' A' ' 36' ' ' LYS . 16.7 ptpt -62.01 -33.45 74.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.765 -1.209 . . . . 1.0 110.118 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.99 -50.84 72.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.919 -1.113 . . . . 1.0 110.215 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -69.15 -39.78 78.61 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.85 -1.156 . . . . 1.0 110.609 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.485 ' CB ' ' HZ2' ' A' ' 36' ' ' LYS . 9.6 mtmp? -59.93 -41.85 92.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.913 -1.117 . . . . 1.0 109.715 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -60.6 -40.04 90.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.79 -1.194 . . . . 1.0 108.725 178.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.99 -44.06 94.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -0.871 . . . . 1.0 110.059 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -65.58 -40.15 92.43 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.867 -1.146 . . . . 1.0 109.106 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.4 ' O ' ' CG ' ' A' ' 44' ' ' ASP . 48.1 tptt -60.12 -49.65 76.8 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.496 -0.752 . . . . 1.0 110.718 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.8 t -60.18 -43.03 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 120.799 -1.188 . . . . 1.0 110.487 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -76.98 -36.83 56.15 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.801 -1.187 . . . . 1.0 109.996 -178.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.1 p -71.0 -20.73 62.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.058 -1.026 . . . . 1.0 109.882 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.4 ' CG ' ' O ' ' A' ' 40' ' ' LYS . 81.7 m-20 -59.95 -40.12 87.93 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.354 -0.841 . . . . 1.0 110.6 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.446 ' O ' ' NE2' ' A' ' 160' ' ' GLN . 12.5 m -110.04 24.13 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 121.187 -0.945 . . . . 1.0 110.73 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.4 p -150.15 134.09 9.02 Favored Pre-proline 0 N--CA 1.501 2.094 0 O-C-N 120.973 -1.079 . . . . 1.0 109.588 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -74.49 21.91 0.4 Allowed 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 120.794 0.996 . . . . 1.0 112.166 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 79.6 mt -69.74 138.71 53.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.132 -0.98 . . . . 1.0 109.954 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -106.86 120.78 42.95 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -109.9 125.59 52.98 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.44 -0.787 . . . . 1.0 109.547 -179.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 93.8 m -120.05 130.1 54.54 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.641 -0.662 . . . . 1.0 109.735 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.407 ' NH1' ' HG3' ' A' ' 52' ' ' ARG . 39.0 ttm-85 -81.32 130.27 34.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.368 -0.832 . . . . 1.0 109.226 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.1 mt -102.38 126.92 49.55 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.189 -0.944 . . . . 1.0 109.37 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.447 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 43.6 m170 -62.86 -40.12 96.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.368 -0.833 . . . . 1.0 109.666 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 78.7 m-20 -148.52 173.32 13.26 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.354 -0.841 . . . . 1.0 109.799 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.519 ' O ' ' NH1' ' A' ' 18' ' ' ARG . . . 95.85 178.51 36.36 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.411 -1.476 . . . . 1.0 109.411 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.5 mt -95.5 133.79 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.114 -1.227 . . . . 1.0 109.245 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.722 ' H ' HH12 ' A' ' 18' ' ' ARG . . . -110.15 159.04 17.7 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.401 -0.812 . . . . 1.0 109.232 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.06 -49.41 77.75 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.227 -0.921 . . . . 1.0 109.249 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.43 HD12 HG21 ' A' ' 60' ' ' ILE . 93.9 mt -106.4 102.13 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.428 -0.795 . . . . 1.0 109.83 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.8 ptp -101.87 134.27 45.32 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.213 -0.93 . . . . 1.0 109.102 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.5 mt -109.94 130.53 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 109.091 -0.707 . . . . 1.0 109.091 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.6 p -151.15 157.03 42.19 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.929 -1.107 . . . . 1.0 110.577 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.616 ' H ' HD22 ' A' ' 21' ' ' ASN . 90.8 m-85 -105.68 120.08 40.78 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.769 -1.197 . . . . 1.0 107.769 178.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -111.68 -171.06 18.88 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 110.739 -0.944 . . . . 1.0 110.739 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 66' ' ' ILE . 96.6 mt . . . . . 0 N--CA 1.493 1.675 0 N-CA-C 107.892 -1.151 . . . . 1.0 107.892 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.552 ' CE2' ' OD1' ' A' ' 99' ' ' ASP . 88.7 m-85 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 108.239 -1.023 . . . . 1.0 108.239 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.0 p-10 -100.72 9.71 42.08 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.218 -0.926 . . . . 1.0 111.119 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 118.01 -149.68 18.4 Favored Glycine 0 N--CA 1.506 3.304 0 N-CA-C 109.012 -1.635 . . . . 1.0 109.012 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.439 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 9.6 Cg_exo -60.11 -65.72 0.07 OUTLIER 'Trans proline' 0 N--CA 1.492 1.395 0 CA-C-N 119.157 1.479 . . . . 1.0 112.392 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 90.0 p -76.54 164.74 25.66 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.966 -1.084 . . . . 1.0 110.079 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.38 -130.87 9.67 Favored Glycine 0 N--CA 1.502 3.057 0 N-CA-C 109.998 -1.241 . . . . 1.0 109.998 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.435 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 5.0 mt -68.62 105.43 2.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.509 -0.995 . . . . 1.0 108.624 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 82.1 mt -75.87 -32.6 59.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.091 -1.006 . . . . 1.0 109.535 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -176.44 161.95 2.27 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.929 -0.767 . . . . 1.0 108.929 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -160.24 162.41 33.71 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.154 -0.966 . . . . 1.0 110.084 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -139.65 157.97 44.9 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.168 -1.049 . . . . 1.0 108.168 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -90.92 152.23 44.22 Favored Pre-proline 0 N--CA 1.497 1.918 0 N-CA-C 108.186 -1.042 . . . . 1.0 108.186 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -54.97 167.95 1.4 Allowed 'Trans proline' 0 N--CA 1.492 1.401 0 CA-C-N 119.437 0.835 . . . . 1.0 111.44 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo . . . . . 0 C--N 1.307 -1.654 0 C-N-CA 120.558 0.839 . . . . 1.0 111.84 -179.861 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 42.5 p-10 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.31 0.576 . . . . 1.0 109.78 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.31 116.4 6.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.088 -1.008 . . . . 1.0 109.13 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -105.54 130.52 53.58 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.515 -0.74 . . . . 1.0 109.824 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -112.59 142.6 44.98 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.522 -0.918 . . . . 1.0 108.522 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.552 ' OD1' ' CE2' ' A' ' 75' ' ' PHE . 94.1 m-20 -79.32 124.6 28.55 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.082 -1.011 . . . . 1.0 109.938 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 44.7 t0 -84.08 2.34 39.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.362 -0.836 . . . . 1.0 109.189 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -81.31 -16.06 53.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.345 -0.847 . . . . 1.0 109.952 -179.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.549 ' N ' ' OE1' ' A' ' 102' ' ' GLU . 58.1 mp0 -93.43 170.14 9.83 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.174 -0.954 . . . . 1.0 109.49 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 47.7 m -98.96 105.42 17.56 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.462 -0.94 . . . . 1.0 108.462 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -84.29 127.93 34.27 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.319 -0.863 . . . . 1.0 108.941 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.2 t -139.95 159.93 41.05 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.391 -0.818 . . . . 1.0 110.066 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.1 t -93.64 -10.46 34.46 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.923 -1.14 . . . . 1.0 107.923 178.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 81.7 p -92.13 179.08 5.68 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.577 -0.897 . . . . 1.0 108.577 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.3 t -85.34 75.95 10.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.94 -1.1 . . . . 1.0 109.564 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.0 mmmm -140.02 144.86 37.13 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 107.987 -1.116 . . . . 1.0 107.987 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 49.89 -129.97 27.15 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.119 -1.592 . . . . 1.0 109.119 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -104.97 115.44 30.28 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.318 -1.107 . . . . 1.0 109.309 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.694 HD22 ' NZ ' ' A' ' 146' ' ' LYS . 62.2 t-20 -65.3 131.77 47.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.905 . . . . 1.0 109.581 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.1 tp -59.96 -45.09 93.8 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.445 -0.784 . . . . 1.0 111.215 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -59.93 -40.02 87.46 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.046 -1.033 . . . . 1.0 110.69 -178.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -59.34 -52.68 64.59 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.849 -1.157 . . . . 1.0 109.835 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.4 t -69.93 -40.06 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.924 -1.11 . . . . 1.0 109.409 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.74 -52.3 65.52 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.138 -0.976 . . . . 1.0 108.839 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.78 -32.59 67.67 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 120.64 -1.288 . . . . 1.0 109.686 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.548 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 76.4 t60 -66.48 -55.82 13.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.031 -1.043 . . . . 1.0 111.666 -178.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.29 -31.88 70.67 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.487 -1.383 . . . . 1.0 110.131 -179.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -59.8 -41.52 91.41 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.752 -1.218 . . . . 1.0 108.396 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.0 -43.46 98.15 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.364 -1.494 . . . . 1.0 109.364 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.548 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 84.4 m-70 -64.5 -39.86 94.57 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.047 -1.267 . . . . 1.0 109.248 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.0 p -67.82 -25.85 65.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.354 -0.841 . . . . 1.0 109.525 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 75.2 mt -81.57 -3.1 52.37 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.234 -0.916 . . . . 1.0 109.94 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.67 9.3 58.83 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 110.534 -1.027 . . . . 1.0 110.534 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.1 mt -85.88 144.59 27.59 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.917 -1.343 . . . . 1.0 109.559 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 28.6 t0 -101.63 173.41 6.44 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.97 -0.752 . . . . 1.0 108.97 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.501 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 75.7 m80 -60.01 134.61 57.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.203 -0.936 . . . . 1.0 109.236 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 47.6 t -96.77 160.24 14.48 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.023 -1.048 . . . . 1.0 109.376 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -99.67 2.17 44.15 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.353 -0.842 . . . . 1.0 109.655 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 9.6 t70 -85.18 129.48 55.67 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.901 . . . . 1.0 108.713 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -68.13 -25.48 37.38 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 CA-C-N 119.984 1.03 . . . . 1.0 112.389 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.437 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -84.9 -3.82 87.62 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.837 -1.305 . . . . 1.0 109.837 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.03 144.84 27.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.35 -1.088 . . . . 1.0 109.663 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.419 ' C ' ' H ' ' A' ' 138' ' ' PHE . 93.8 mt -70.03 -30.68 68.02 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.316 -0.865 . . . . 1.0 109.187 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 98.1 mmm -72.67 15.47 0.19 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.385 -0.822 . . . . 1.0 110.603 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.419 ' H ' ' C ' ' A' ' 136' ' ' LEU . 11.5 t80 -72.13 137.59 81.77 Favored Pre-proline 0 N--CA 1.5 2.061 0 O-C-N 121.02 -1.05 . . . . 1.0 108.421 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -61.8 -11.92 23.07 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 120.862 1.041 . . . . 1.0 114.29 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 95.9 mt -109.97 139.08 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.443 0 O-C-N 120.655 -1.278 . . . . 1.0 109.744 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.565 ' HH ' ' H ' ' A' ' 112' ' ' ASN . 33.6 t80 -73.55 129.87 38.88 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.582 -0.699 . . . . 1.0 110.08 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 15.2 t -140.1 143.33 36.2 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.482 -0.762 . . . . 1.0 109.139 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -81.21 149.44 29.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.957 -1.089 . . . . 1.0 109.532 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.9 t -140.23 155.5 46.87 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.906 -0.776 . . . . 1.0 108.906 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.45 111.43 3.57 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.465 -1.454 . . . . 1.0 109.465 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.694 ' NZ ' HD22 ' A' ' 112' ' ' ASN . 49.7 mtmt -76.78 -1.48 28.36 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.297 -1.119 . . . . 1.0 109.391 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.2 m -60.0 -40.13 88.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.372 -0.83 . . . . 1.0 109.762 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -160.36 67.48 0.35 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.238 -0.914 . . . . 1.0 109.336 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' A' ' 149' ' ' PHE . 39.0 t80 -99.16 125.04 44.63 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.333 -0.855 . . . . 1.0 109.36 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 75.2 mtm -120.24 141.3 50.07 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.843 -0.799 . . . . 1.0 108.843 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 49.0 mt -49.17 129.06 16.22 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.041 -1.037 . . . . 1.0 108.654 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -66.08 176.93 3.4 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 CA-C-N 119.944 1.016 . . . . 1.0 112.798 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.28 -39.78 88.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.623 -0.673 . . . . 1.0 109.588 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -58.06 -49.28 77.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.315 -0.866 . . . . 1.0 109.86 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -70.03 -40.01 75.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.014 -1.054 . . . . 1.0 109.774 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.3 t -60.1 -46.35 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.129 -0.982 . . . . 1.0 109.335 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -60.23 -39.99 88.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.904 -1.123 . . . . 1.0 110.131 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -68.63 -55.28 12.1 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.154 -1.022 . . . . 1.0 111.113 -178.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.409 ' CG2' ' N ' ' A' ' 160' ' ' GLN . 5.7 tp -61.93 -40.39 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.941 -1.329 . . . . 1.0 109.74 -179.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.446 ' NE2' ' O ' ' A' ' 45' ' ' VAL . 94.2 mm-40 -66.39 -39.93 89.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 1.0 109.648 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 91.9 p -70.17 -22.59 62.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 1.0 110.044 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 86.9 mt -88.1 -50.39 6.42 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.957 -1.089 . . . . 1.0 110.188 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -93.0 -9.78 38.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.96 -1.087 . . . . 1.0 109.697 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.524 0 N-CA-C 109.621 -1.392 . . . . 1.0 109.621 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.4 mt . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.346 -0.612 . . . . 1.0 109.346 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -160.92 163.03 32.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 1.0 109.242 179.72 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 62.7 m95 -72.42 145.35 47.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -0.923 . . . . 1.0 109.806 -179.435 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 61.1 m -88.84 4.24 48.4 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.33 -0.856 . . . . 1.0 110.235 -179.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.483 ' NZ ' ' O ' ' A' ' 14' ' ' ASN . 21.5 pttp -140.76 150.78 43.82 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.123 -0.986 . . . . 1.0 109.394 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.1 mmt -90.03 0.23 57.23 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.394 -0.816 . . . . 1.0 109.798 -179.043 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.483 ' O ' ' NZ ' ' A' ' 12' ' ' LYS . 33.2 m120 -94.89 128.59 41.78 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.2 -0.938 . . . . 1.0 109.349 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.7 mt -141.43 150.01 41.76 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.156 -0.965 . . . . 1.0 108.974 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.8 p -132.66 155.39 48.85 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.565 -0.71 . . . . 1.0 109.145 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -145.69 162.7 36.96 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.045 -1.034 . . . . 1.0 110.119 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.552 ' NE ' ' O ' ' A' ' 56' ' ' GLY . 36.8 ttm-85 -144.25 131.43 20.66 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.629 -0.669 . . . . 1.0 109.44 -179.378 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.5 mt -88.92 114.55 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.074 -1.016 . . . . 1.0 108.624 178.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.7 -40.55 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 1.0 109.906 -179.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.6 p-10 -165.56 154.46 11.89 Favored 'General case' 0 C--N 1.285 -2.2 0 O-C-N 119.675 -1.89 . . . . 1.0 111.168 -179.154 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -99.95 113.0 25.27 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 105.814 -1.921 . . . . 1.0 105.814 178.081 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.442 ' C ' ' H ' ' A' ' 25' ' ' ASP . 0.4 OUTLIER -56.45 137.79 75.94 Favored Pre-proline 0 C--N 1.297 -1.707 0 O-C-N 120.957 -1.09 . . . . 1.0 109.201 -177.805 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -56.76 -9.29 3.86 Favored 'Trans proline' 0 N--CA 1.483 0.872 0 CA-C-N 119.503 0.858 . . . . 1.0 110.352 179.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.442 ' H ' ' C ' ' A' ' 23' ' ' THR . 98.0 m-20 -57.1 -32.08 65.93 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 120.13 -0.628 . . . . 1.0 110.086 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.8 mtm -140.94 164.36 30.48 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.117 -0.99 . . . . 1.0 109.441 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 75.6 p -71.96 160.69 32.1 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.373 -0.829 . . . . 1.0 109.131 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 24.1 m170 -60.12 -42.34 94.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.173 -0.954 . . . . 1.0 110.2 -179.105 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.546 ' O ' ' NZ ' ' A' ' 33' ' ' LYS . 73.2 m -60.23 -43.18 96.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.103 -0.998 . . . . 1.0 111.006 -179.163 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.25 -40.89 96.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.083 -1.011 . . . . 1.0 110.802 -178.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 63.2 t -67.18 -40.21 84.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.101 -0.999 . . . . 1.0 109.746 -179.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -60.02 -50.13 74.94 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.261 -0.899 . . . . 1.0 110.929 -179.259 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.546 ' NZ ' ' O ' ' A' ' 29' ' ' SER . 1.7 ptpp? -63.9 -31.03 72.08 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.04 -1.037 . . . . 1.0 110.015 -179.517 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.9 -49.55 77.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.046 -1.034 . . . . 1.0 109.566 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -67.54 -38.97 84.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.118 -0.989 . . . . 1.0 109.797 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.0 -41.91 93.15 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.982 -1.074 . . . . 1.0 109.429 -179.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -60.96 -40.87 95.03 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.911 -1.118 . . . . 1.0 108.693 178.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.55 -47.08 85.43 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.369 -0.832 . . . . 1.0 109.743 179.447 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.428 ' CZ ' ' CZ ' ' A' ' 121' ' ' PHE . 48.7 m-85 -67.68 -39.98 84.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.063 -1.023 . . . . 1.0 109.742 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -59.95 -45.58 92.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.163 -0.96 . . . . 1.0 109.618 -179.085 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.5 t -60.01 -45.53 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.328 -0.858 . . . . 1.0 109.913 -179.42 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.445 ' O ' ' OG1' ' A' ' 46' ' ' THR . 76.8 m95 -76.71 -35.23 57.97 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.075 -1.015 . . . . 1.0 109.995 -179.54 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 62.9 p -71.62 -19.6 62.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.075 -1.016 . . . . 1.0 109.873 -179.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -60.0 -39.22 85.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.252 -0.905 . . . . 1.0 110.562 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.9 m -110.5 -22.96 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.249 -0.907 . . . . 1.0 110.62 -178.592 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.454 ' C ' ' H ' ' A' ' 48' ' ' LEU . 56.1 p -95.73 130.4 31.84 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 120.888 -1.132 . . . . 1.0 110.108 -179.623 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -72.32 18.48 0.33 Allowed 'Trans proline' 0 N--CA 1.492 1.4 0 CA-C-N 119.873 0.99 . . . . 1.0 111.463 178.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.454 ' H ' ' C ' ' A' ' 46' ' ' THR . 77.4 mt -69.3 138.7 54.04 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.207 -0.933 . . . . 1.0 109.602 -179.47 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -109.26 121.88 46.12 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 179.532 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -107.13 128.93 54.83 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.369 -0.832 . . . . 1.0 109.359 -179.269 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 90.2 m -121.88 130.26 53.22 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.524 -0.735 . . . . 1.0 109.961 -179.526 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -80.14 130.05 34.95 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.236 -0.915 . . . . 1.0 109.163 179.656 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.499 ' O ' ' NH1' ' A' ' 18' ' ' ARG . 94.3 mt -102.53 132.42 48.6 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.165 -0.959 . . . . 1.0 109.415 179.331 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.475 ' C ' HH12 ' A' ' 18' ' ' ARG . 23.9 m-70 -68.83 -39.91 79.74 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.662 -0.649 . . . . 1.0 110.206 -179.702 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.484 ' C ' ' NH2' ' A' ' 18' ' ' ARG . 74.1 m-20 -150.09 166.75 28.84 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.115 -0.99 . . . . 1.0 109.992 -179.565 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.552 ' O ' ' NE ' ' A' ' 18' ' ' ARG . . . 99.95 -176.42 28.27 Favored Glycine 0 N--CA 1.498 2.825 0 N-CA-C 109.53 -1.428 . . . . 1.0 109.53 -179.696 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.4 mt -95.5 135.25 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.192 -1.181 . . . . 1.0 109.261 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.04 158.94 18.25 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.436 -0.79 . . . . 1.0 109.284 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -59.99 -49.57 77.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.2 -0.937 . . . . 1.0 109.51 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 92.5 mt -108.35 98.47 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.434 -0.791 . . . . 1.0 109.698 179.634 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.5 ptm -97.96 126.07 43.19 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.487 -0.931 . . . . 1.0 108.487 179.134 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.8 mt -104.84 136.84 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.455 -0.778 . . . . 1.0 110.58 -178.509 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.1 p -153.68 160.03 42.22 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.398 -0.814 . . . . 1.0 109.548 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -102.13 122.28 43.84 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.605 -0.887 . . . . 1.0 108.605 179.486 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 98' ' ' PHE . . . -99.76 -172.76 30.51 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 110.822 -0.911 . . . . 1.0 110.822 -178.677 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 73.4 mt . . . . . 0 N--CA 1.497 1.883 0 O-C-N 121.784 -0.833 . . . . 1.0 109.043 179.935 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.533 ' CE2' ' OD1' ' A' ' 99' ' ' ASP . 40.6 m-85 . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 109.305 -0.628 . . . . 1.0 109.305 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 79' ' ' SER . 34.5 p-10 -101.05 10.65 40.79 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.352 -0.842 . . . . 1.0 110.474 -179.288 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 114.96 -155.61 16.22 Favored Glycine 0 N--CA 1.504 3.188 0 N-CA-C 109.092 -1.603 . . . . 1.0 109.092 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.424 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 15.8 Cg_exo -56.64 -64.12 0.14 Allowed 'Trans proline' 0 N--CA 1.492 1.403 0 CA-C-N 118.827 1.314 . . . . 1.0 112.308 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.43 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 83.9 p -75.0 159.03 32.26 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.896 -1.128 . . . . 1.0 109.384 179.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.03 -129.67 8.22 Favored Glycine 0 N--CA 1.502 3.045 0 N-CA-C 110.218 -1.153 . . . . 1.0 110.218 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.401 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 19.0 mt -70.19 112.72 6.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.351 -1.087 . . . . 1.0 109.406 -179.584 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 38.1 mt -79.22 -24.54 43.02 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.155 -0.966 . . . . 1.0 108.703 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -177.07 170.68 2.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.531 -0.731 . . . . 1.0 109.412 -179.733 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -162.41 163.33 27.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.104 -0.997 . . . . 1.0 109.968 179.676 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -147.2 153.48 39.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.385 -0.822 . . . . 1.0 109.071 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -88.44 152.67 50.07 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.151 -0.968 . . . . 1.0 109.23 -179.607 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -53.5 162.58 3.2 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 CA-C-N 119.214 0.755 . . . . 1.0 111.716 179.583 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo . . . . . 0 N--CA 1.49 1.28 0 C-N-CA 121.12 1.213 . . . . 1.0 111.942 179.68 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.2 p-10 . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 109.409 -0.589 . . . . 1.0 109.409 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.08 120.72 7.49 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.019 -1.051 . . . . 1.0 110.014 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -106.06 154.03 21.22 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.58 -0.7 . . . . 1.0 109.633 179.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' A' ' 65' ' ' GLY . 28.0 m-85 -129.94 152.01 49.87 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.289 -1.004 . . . . 1.0 108.289 179.177 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.533 ' OD1' ' CE2' ' A' ' 75' ' ' PHE . 86.5 m-20 -78.5 120.81 23.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.913 -1.117 . . . . 1.0 109.987 -179.63 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -84.06 -7.85 59.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.311 -0.868 . . . . 1.0 109.056 179.286 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -82.63 -15.93 50.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.3 -0.875 . . . . 1.0 109.178 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.424 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 97.2 mt-10 -89.88 169.92 10.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.502 -0.749 . . . . 1.0 109.07 -179.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 16.9 m -99.23 108.5 21.09 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.26 -0.9 . . . . 1.0 109.286 -179.555 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.491 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 93.7 m95 -91.08 125.14 35.78 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.705 -0.85 . . . . 1.0 108.705 179.505 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.3 t -140.16 151.17 45.04 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.376 -0.828 . . . . 1.0 109.885 -179.156 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 55.7 m -90.25 -8.23 51.51 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.074 -1.084 . . . . 1.0 108.074 178.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.1 p -90.65 177.27 6.39 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.625 -0.879 . . . . 1.0 108.625 178.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 m -81.09 76.53 8.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.981 -1.074 . . . . 1.0 109.628 -179.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -147.03 149.67 33.57 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.367 -0.833 . . . . 1.0 108.884 179.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.31 -135.88 7.38 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.935 -1.266 . . . . 1.0 109.935 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -100.11 118.22 36.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.413 -1.051 . . . . 1.0 109.143 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -66.58 129.09 38.69 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.365 -0.835 . . . . 1.0 110.294 -179.567 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.6 tp -60.02 -40.66 90.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.357 -0.84 . . . . 1.0 109.875 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -59.96 -47.76 84.47 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.416 -0.802 . . . . 1.0 110.587 -178.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -58.66 -50.63 73.16 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.854 -1.154 . . . . 1.0 109.761 -179.612 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 77.9 t -69.1 -40.11 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.918 -1.114 . . . . 1.0 109.668 -179.22 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.99 -50.26 74.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.098 -1.001 . . . . 1.0 109.976 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.78 -37.84 80.2 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.564 -1.335 . . . . 1.0 109.521 -179.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.494 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 67.1 t60 -63.8 -49.98 70.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.316 -0.865 . . . . 1.0 111.624 -178.594 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.84 -38.55 78.97 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.512 -1.367 . . . . 1.0 109.723 -178.735 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.428 ' CZ ' ' CZ ' ' A' ' 39' ' ' PHE . 29.9 m-85 -60.02 -39.86 87.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.92 -1.112 . . . . 1.0 108.535 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.55 -46.83 91.6 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.69 -1.364 . . . . 1.0 109.69 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.494 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 81.8 m-70 -63.94 -40.08 95.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.13 -1.217 . . . . 1.0 109.449 179.66 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 91.9 p -68.49 -22.73 64.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.277 -0.89 . . . . 1.0 109.571 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 35.7 mt -81.68 -7.03 59.55 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.103 -0.998 . . . . 1.0 109.472 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 99.54 2.74 56.47 Favored Glycine 0 N--CA 1.499 2.887 0 N-CA-C 110.674 -0.971 . . . . 1.0 110.674 178.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 75.2 mt -85.11 147.23 26.74 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.947 -1.325 . . . . 1.0 109.775 179.653 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 35.5 t0 -102.96 -178.73 3.75 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.86 -0.792 . . . . 1.0 108.86 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.482 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 75.9 m80 -60.1 139.99 57.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.088 -1.008 . . . . 1.0 109.764 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 27.2 t -96.21 162.05 13.69 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.242 -0.912 . . . . 1.0 109.244 179.513 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -101.11 1.92 39.77 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.344 -0.848 . . . . 1.0 109.857 -179.692 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -90.52 114.14 60.14 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.212 -0.93 . . . . 1.0 109.206 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -53.77 -22.75 24.29 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 CA-C-N 120.27 1.132 . . . . 1.0 112.216 -179.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -86.8 -7.68 77.78 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.49 -1.044 . . . . 1.0 110.49 -179.306 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.44 149.42 26.67 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.985 -1.303 . . . . 1.0 109.576 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.415 ' C ' ' H ' ' A' ' 138' ' ' PHE . 92.9 mt -70.07 -30.97 68.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.142 -0.974 . . . . 1.0 109.473 179.69 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 98.0 mmm -73.42 13.56 0.44 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.368 -0.833 . . . . 1.0 110.396 -178.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.415 ' H ' ' C ' ' A' ' 136' ' ' LEU . 11.6 t80 -70.37 134.61 86.8 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.964 -1.085 . . . . 1.0 108.114 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -65.35 15.42 0.09 OUTLIER 'Trans proline' 0 N--CA 1.506 2.229 0 C-N-CA 121.065 1.177 . . . . 1.0 115.048 -177.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.403 HD12 HG21 ' A' ' 140' ' ' ILE . 90.0 mt -133.69 140.49 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 O-C-N 120.73 -1.231 . . . . 1.0 109.609 179.453 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -72.87 130.67 40.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.517 -0.739 . . . . 1.0 110.046 -179.25 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.2 t -143.15 137.63 29.2 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.322 -0.861 . . . . 1.0 109.479 179.777 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -81.41 143.98 31.75 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.081 -1.012 . . . . 1.0 109.18 179.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.7 t -139.11 156.53 47.09 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.208 -0.932 . . . . 1.0 110.117 -179.362 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.38 108.87 2.63 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.409 -1.476 . . . . 1.0 109.409 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -77.11 2.8 14.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.325 -1.103 . . . . 1.0 109.44 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 44.2 t -59.97 -45.01 94.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.228 -0.92 . . . . 1.0 110.149 -179.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -150.01 29.97 0.72 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.965 -1.084 . . . . 1.0 110.134 -179.536 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -60.44 139.17 57.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.054 -1.029 . . . . 1.0 109.647 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 73.7 mtm -138.55 148.5 44.28 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.353 -0.842 . . . . 1.0 108.762 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.7 mt -53.84 129.68 56.34 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 120.987 -1.071 . . . . 1.0 108.612 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -68.94 175.36 7.52 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 CA-C-N 120.112 1.076 . . . . 1.0 111.715 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.04 -38.78 83.76 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.344 -0.848 . . . . 1.0 109.48 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -55.07 -50.21 69.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.879 . . . . 1.0 110.057 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -70.2 -39.97 74.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.184 -0.947 . . . . 1.0 110.28 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 66.5 t -59.87 -47.02 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.006 -1.059 . . . . 1.0 109.035 -179.467 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -60.53 -40.07 90.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.055 -1.028 . . . . 1.0 110.463 179.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.409 ' O ' ' OG ' ' A' ' 161' ' ' SER . . . -73.82 -52.42 8.16 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.328 -0.939 . . . . 1.0 111.49 -178.465 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 8.4 tp -60.49 -39.93 82.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.637 -1.508 . . . . 1.0 109.705 -178.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.8 mt-30 -66.37 -38.81 88.42 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.198 -0.939 . . . . 1.0 109.58 179.503 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 158' ' ' GLY . 96.6 p -60.06 -34.94 74.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.394 -0.816 . . . . 1.0 110.686 -179.021 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 93.3 mt -85.17 -47.59 9.97 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.857 -1.152 . . . . 1.0 111.027 -178.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -91.68 -8.46 47.0 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.894 -1.129 . . . . 1.0 110.176 -179.007 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.404 -1.479 . . . . 1.0 109.404 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.6 mt . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -160.09 163.24 34.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.255 -0.903 . . . . 1.0 109.628 -179.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -70.9 144.43 50.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -0.907 . . . . 1.0 109.439 -179.828 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.8 t -95.91 14.25 24.12 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.289 -0.882 . . . . 1.0 109.434 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.51 149.62 37.75 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.236 -0.915 . . . . 1.0 109.438 -179.764 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.3 mmt -91.71 -2.95 56.79 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.33 -0.856 . . . . 1.0 109.731 -179.634 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -101.59 125.63 48.27 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.295 -0.878 . . . . 1.0 109.362 179.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.7 mt -140.48 149.35 42.41 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.246 -0.909 . . . . 1.0 109.16 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.1 p -131.77 153.86 49.67 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.875 -0.787 . . . . 1.0 108.875 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -143.11 158.46 43.59 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.145 -0.972 . . . . 1.0 110.385 179.877 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.545 ' NH1' ' N ' ' A' ' 56' ' ' GLY . 72.1 ttt180 -146.55 134.97 21.94 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.469 -0.769 . . . . 1.0 109.59 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.429 HG23 HD11 ' A' ' 19' ' ' ILE . 85.9 mt -89.89 118.92 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.112 -0.992 . . . . 1.0 108.963 179.008 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.67 -40.58 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.091 -1.006 . . . . 1.0 109.107 -179.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -162.11 162.22 28.5 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.667 -1.27 . . . . 1.0 110.26 -179.184 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -103.25 -162.92 0.95 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.521 -1.288 . . . . 1.0 107.521 178.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.74 152.04 61.54 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.459 -0.775 . . . . 1.0 109.744 -179.708 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -68.1 -35.99 18.33 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 120.923 1.082 . . . . 1.0 111.512 179.271 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -59.01 -48.6 81.01 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.359 0.599 . . . . 1.0 110.756 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 56.2 mtp -96.29 145.99 25.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.373 -0.829 . . . . 1.0 110.47 -178.435 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.1 p -74.93 160.85 30.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.889 . . . . 1.0 108.783 179.361 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -61.23 -46.2 91.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.219 -0.925 . . . . 1.0 110.777 -179.146 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.8 m -62.2 -40.03 94.74 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.024 -1.047 . . . . 1.0 110.89 -178.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.55 -40.08 88.86 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.106 -0.996 . . . . 1.0 110.947 -179.156 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 71.3 t -68.49 -40.53 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.834 -1.166 . . . . 1.0 110.318 -179.173 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.97 -49.8 76.25 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.042 -1.036 . . . . 1.0 110.564 -179.134 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.19 -32.72 72.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.058 -1.026 . . . . 1.0 110.089 -179.502 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.03 -49.94 75.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.114 -0.991 . . . . 1.0 110.045 -179.447 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -66.4 -37.32 84.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.021 -1.05 . . . . 1.0 110.062 -179.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -59.97 -40.56 89.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.974 -1.079 . . . . 1.0 109.533 -179.68 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -61.95 -40.65 96.28 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.949 -1.094 . . . . 1.0 108.88 179.227 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.44 -49.75 76.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.377 -0.827 . . . . 1.0 110.528 -179.285 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.414 ' CZ ' ' CZ ' ' A' ' 121' ' ' PHE . 53.8 m-85 -65.27 -40.53 94.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.985 -1.072 . . . . 1.0 109.962 -179.262 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -59.99 -47.42 85.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.107 -0.995 . . . . 1.0 109.7 -179.579 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 70.8 t -59.99 -40.51 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.339 -0.851 . . . . 1.0 110.426 -179.394 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -79.87 -34.57 39.12 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.911 -1.118 . . . . 1.0 110.202 -179.236 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 94.8 p -72.82 -20.62 61.11 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.966 -1.083 . . . . 1.0 109.916 -179.761 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -59.99 -39.74 86.79 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 1.0 110.342 -179.36 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.4 m -111.81 30.72 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 O-C-N 121.264 -0.897 . . . . 1.0 110.69 -179.474 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.7 p -152.21 137.95 11.4 Favored Pre-proline 0 N--CA 1.502 2.14 0 O-C-N 120.607 -1.308 . . . . 1.0 109.756 179.015 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -74.72 11.83 1.28 Allowed 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 120.746 0.964 . . . . 1.0 112.285 178.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 77.9 mt -67.95 137.69 55.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.031 -1.043 . . . . 1.0 109.655 -179.095 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -106.93 120.7 42.74 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.028 -0.73 . . . . 1.0 109.028 179.664 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -108.25 123.33 48.61 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.446 -0.784 . . . . 1.0 109.238 -179.545 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.9 m -120.01 130.03 54.54 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.579 -0.701 . . . . 1.0 109.492 -179.795 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -82.12 132.55 35.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.438 -0.789 . . . . 1.0 109.406 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.3 mt -105.13 128.45 53.38 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.413 -0.804 . . . . 1.0 109.488 179.813 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.417 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 61.7 m170 -68.56 -39.74 80.9 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.481 -0.762 . . . . 1.0 109.347 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 89.4 m-20 -142.84 166.92 23.33 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.294 -0.879 . . . . 1.0 109.328 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.545 ' N ' ' NH1' ' A' ' 18' ' ' ARG . . . 97.24 172.4 33.91 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.646 -1.381 . . . . 1.0 109.646 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 93.5 mt -95.09 139.23 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.284 -1.127 . . . . 1.0 109.242 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -114.2 164.3 14.07 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.441 -0.787 . . . . 1.0 109.598 -179.634 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -59.94 -47.85 84.09 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.475 -0.935 . . . . 1.0 108.475 179.413 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.3 mt -105.27 133.84 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.697 -0.853 . . . . 1.0 108.697 179.697 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.2 ptm -139.31 129.79 25.71 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.63 -1.294 . . . . 1.0 109.491 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 93.5 mt -102.5 140.2 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.351 0.596 . . . . 1.0 109.958 -179.067 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 81.6 p -151.46 154.75 37.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.318 -0.864 . . . . 1.0 109.623 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -109.18 144.09 37.73 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.048 -0.723 . . . . 1.0 109.048 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.81 -162.82 9.73 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.457 -1.457 . . . . 1.0 109.457 -179.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 92.6 mt . . . . . 0 N--CA 1.497 1.902 0 O-C-N 121.583 -0.951 . . . . 1.0 109.247 -179.933 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.554 ' CD2' ' OD2' ' A' ' 99' ' ' ASP . 94.6 m-85 . . . . . 0 N--CA 1.495 1.787 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.405 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 33.4 p-10 -99.56 -1.01 39.33 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.203 -0.935 . . . . 1.0 110.758 -178.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.55 -138.04 9.8 Favored Glycine 0 N--CA 1.503 3.114 0 N-CA-C 108.816 -1.714 . . . . 1.0 108.816 -179.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.427 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 18.6 Cg_endo -77.67 -58.42 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.376 0 CA-C-N 119.872 1.836 . . . . 1.0 111.932 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 92.2 p -79.42 167.45 20.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.341 -0.849 . . . . 1.0 109.566 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 105.76 -129.33 9.74 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 109.882 -1.287 . . . . 1.0 109.882 179.715 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.43 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 8.3 mt -67.06 105.91 1.8 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.391 -1.064 . . . . 1.0 108.939 -179.781 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 71.9 mt -80.66 -14.25 58.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.114 -0.992 . . . . 1.0 109.027 -179.672 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.93 177.51 0.66 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.468 ' ND1' ' C ' ' A' ' 84' ' ' HIS . 3.2 p80 -161.89 160.61 28.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.101 -1.0 . . . . 1.0 109.508 179.341 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.31 165.02 34.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.884 . . . . 1.0 109.423 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -108.04 151.96 41.54 Favored Pre-proline 0 N--CA 1.498 1.962 0 N-CA-C 108.494 -0.928 . . . . 1.0 108.494 179.576 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -62.52 165.76 14.85 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 120.643 0.895 . . . . 1.0 111.675 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo . . . . . 0 C--N 1.314 -1.263 0 C-N-CA 120.85 1.033 . . . . 1.0 111.371 179.967 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 31.6 p-10 . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 108.982 -0.747 . . . . 1.0 108.982 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.95 120.96 8.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.151 -0.968 . . . . 1.0 109.78 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -104.29 139.83 38.73 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.566 -0.709 . . . . 1.0 110.069 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.476 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 25.8 m-85 -119.95 139.93 51.7 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.483 -0.761 . . . . 1.0 108.976 179.081 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.554 ' OD2' ' CD2' ' A' ' 75' ' ' PHE . 99.0 m-20 -79.98 126.19 30.72 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.915 -1.116 . . . . 1.0 109.787 179.907 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 49.1 t0 -87.75 0.94 55.07 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.306 -0.871 . . . . 1.0 109.844 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -81.34 -16.52 52.13 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.934 -1.104 . . . . 1.0 110.246 -179.428 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.545 ' N ' ' OE1' ' A' ' 102' ' ' GLU . 56.6 mp0 -93.02 174.99 6.95 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.183 -0.948 . . . . 1.0 109.445 -179.769 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 27.6 m -99.43 107.49 19.73 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.341 -0.849 . . . . 1.0 109.051 179.921 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -87.32 123.08 31.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 1.0 108.987 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.593 ' HG1' ' HG ' ' A' ' 107' ' ' SER . 8.1 t -141.75 159.09 42.93 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.335 -0.853 . . . . 1.0 109.931 -179.192 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 44.3 t -96.03 -9.76 30.17 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.288 -1.005 . . . . 1.0 108.288 178.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.593 ' HG ' ' HG1' ' A' ' 105' ' ' THR . 94.6 p -90.64 178.04 6.18 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.007 -0.738 . . . . 1.0 109.007 179.542 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.2 t -78.81 74.01 5.35 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.137 -0.977 . . . . 1.0 109.678 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -146.66 148.69 32.31 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.463 -0.94 . . . . 1.0 108.463 179.093 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 46.28 -139.91 6.57 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.89 -1.284 . . . . 1.0 109.89 179.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -100.0 116.35 31.84 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.323 -1.104 . . . . 1.0 109.173 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.43 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 2.2 t-20 -63.54 133.91 54.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.11 -0.994 . . . . 1.0 109.842 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.3 tp -59.98 -44.03 94.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.464 -0.772 . . . . 1.0 110.436 -179.744 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -60.04 -40.02 87.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.108 -0.995 . . . . 1.0 110.357 -178.733 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -59.48 -51.43 69.93 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.711 -1.243 . . . . 1.0 109.543 -179.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.6 t -69.95 -42.63 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.961 -1.087 . . . . 1.0 110.087 -179.174 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.43 -52.15 66.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.933 . . . . 1.0 109.764 -179.331 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.69 -38.09 80.58 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.414 -0.804 . . . . 1.0 110.343 -179.613 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.621 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 66.7 t60 -63.41 -50.1 71.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -0.927 . . . . 1.0 111.2 -178.401 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.476 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 8.2 pt-20 -59.97 -39.79 86.86 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.691 -1.256 . . . . 1.0 110.298 -179.233 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.414 ' CZ ' ' CZ ' ' A' ' 39' ' ' PHE . 30.9 m-85 -60.03 -39.96 87.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.78 -1.2 . . . . 1.0 108.95 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.81 -42.35 94.49 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.648 -1.381 . . . . 1.0 109.648 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.621 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 88.0 m-70 -66.01 -39.78 90.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.99 -1.3 . . . . 1.0 109.033 179.394 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 80.6 p -64.56 -23.98 67.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.345 -0.847 . . . . 1.0 109.462 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.2 mt -82.56 -1.84 51.87 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.132 -0.98 . . . . 1.0 109.577 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.05 10.21 64.73 Favored Glycine 0 N--CA 1.497 2.728 0 C-N-CA 120.304 -0.951 . . . . 1.0 110.812 179.191 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.5 mt -85.38 146.97 26.74 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.899 -1.354 . . . . 1.0 109.682 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 12.3 t70 -99.69 172.47 7.25 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.479 -0.763 . . . . 1.0 109.22 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.46 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 66.2 m80 -59.99 139.48 57.4 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.182 -0.949 . . . . 1.0 109.66 -179.534 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 34.1 t -98.76 152.97 19.11 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.346 -0.846 . . . . 1.0 109.407 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -96.67 -0.02 49.05 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.208 -0.933 . . . . 1.0 109.683 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -85.24 130.49 51.64 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.057 -1.027 . . . . 1.0 108.237 179.227 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -68.48 -21.37 40.38 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 CA-C-N 120.121 1.079 . . . . 1.0 112.147 -179.457 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -86.1 -4.83 83.86 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.942 -1.263 . . . . 1.0 109.942 -179.704 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -87.33 145.1 26.47 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.127 -1.219 . . . . 1.0 109.534 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.467 ' C ' ' H ' ' A' ' 138' ' ' PHE . 91.6 mt -70.0 -31.06 68.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.087 -1.008 . . . . 1.0 108.975 179.643 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.3 mmm -73.0 19.14 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.441 -0.787 . . . . 1.0 110.201 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.467 ' H ' ' C ' ' A' ' 136' ' ' LEU . 16.0 t80 -70.0 131.7 88.9 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 120.914 -1.116 . . . . 1.0 108.087 179.866 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -63.9 0.48 2.02 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 121.012 1.142 . . . . 1.0 114.536 -177.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.426 HG21 HD11 ' A' ' 140' ' ' ILE . 95.7 mt -123.19 139.45 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 120.935 -1.103 . . . . 1.0 109.321 179.677 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.43 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 58.8 t80 -73.1 125.03 26.72 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.288 -0.882 . . . . 1.0 109.896 -179.396 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.9 t -138.2 140.05 39.58 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.719 -0.845 . . . . 1.0 108.719 179.388 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -81.25 130.5 35.05 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.081 -1.012 . . . . 1.0 109.921 -179.763 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.7 m -118.91 137.07 53.71 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.97 -0.752 . . . . 1.0 108.97 179.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -62.12 103.04 0.53 Allowed Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.121 -1.992 . . . . 1.0 108.121 178.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -72.64 114.62 10.97 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.19 -1.182 . . . . 1.0 108.728 -179.241 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.4 p -178.37 109.18 0.05 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.377 -0.972 . . . . 1.0 108.377 -179.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 49.99 39.88 19.87 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.046 -1.034 . . . . 1.0 108.752 -179.249 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -88.39 119.18 28.57 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.363 -0.836 . . . . 1.0 109.398 -179.699 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 97.3 mtp -110.17 148.29 32.08 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.343 -0.984 . . . . 1.0 108.343 179.368 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.7 mt -52.46 136.86 41.84 Favored Pre-proline 0 C--N 1.3 -1.552 0 O-C-N 121.158 -0.964 . . . . 1.0 109.214 -179.514 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -68.78 174.23 8.93 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 CA-C-N 119.569 0.882 . . . . 1.0 112.177 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -60.36 -39.99 89.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.498 -0.752 . . . . 1.0 109.951 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -55.09 -49.35 71.91 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.123 -0.986 . . . . 1.0 109.852 -179.347 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.12 -40.01 75.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.244 -0.91 . . . . 1.0 110.214 -179.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.8 t -59.99 -46.47 94.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.163 -0.961 . . . . 1.0 109.067 -179.661 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -61.58 -40.01 93.25 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.083 -1.01 . . . . 1.0 110.075 179.71 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.39 -53.38 13.45 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 120.312 -0.947 . . . . 1.0 111.468 -178.483 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 6.0 tp -60.73 -39.98 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.835 -1.391 . . . . 1.0 109.778 -178.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.544 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.3 mt-30 -66.07 -39.98 90.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.115 -0.991 . . . . 1.0 109.51 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 86.2 p -61.24 -30.37 70.41 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.175 -0.953 . . . . 1.0 110.263 -179.642 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 85.5 mt -86.69 -51.8 5.91 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.001 -1.062 . . . . 1.0 110.656 -179.025 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -91.85 -9.23 44.11 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.067 -1.02 . . . . 1.0 110.312 -178.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.511 0 N-CA-C 109.457 -1.457 . . . . 1.0 109.457 -179.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.0 mt . . . . . 0 N--CA 1.494 1.726 0 N-CA-C 109.412 -0.588 . . . . 1.0 109.412 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.9 pttt -162.7 163.35 26.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.284 -0.885 . . . . 1.0 109.301 179.671 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -70.21 149.56 47.36 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.113 -0.992 . . . . 1.0 109.566 -179.51 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 98.3 p -90.03 1.19 56.6 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.29 -0.881 . . . . 1.0 109.757 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -146.92 154.86 41.78 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.074 -1.016 . . . . 1.0 110.039 -179.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.549 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.5 0.37 57.35 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.382 -0.824 . . . . 1.0 109.713 -179.81 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -93.93 125.09 38.35 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.152 -0.968 . . . . 1.0 109.203 -179.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.5 mt -142.27 150.23 40.6 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.355 -0.841 . . . . 1.0 108.982 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.9 p -130.75 153.12 49.36 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.411 -0.959 . . . . 1.0 108.411 179.643 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -145.11 159.99 42.12 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.059 -1.026 . . . . 1.0 109.902 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.494 ' NH1' ' O ' ' A' ' 56' ' ' GLY . 43.3 ttp180 -144.75 139.18 27.69 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.604 -0.685 . . . . 1.0 109.316 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.8 mm -88.15 118.45 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.266 -1.013 . . . . 1.0 108.266 179.212 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.3 t -69.79 -39.95 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.131 -0.981 . . . . 1.0 108.985 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.587 HD22 ' H ' ' A' ' 64' ' ' PHE . 15.2 p30 -160.71 153.8 21.51 Favored 'General case' 0 C--N 1.287 -2.124 0 O-C-N 120.028 -1.67 . . . . 1.0 110.697 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -97.02 101.28 12.82 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 104.895 -2.261 . . . . 1.0 104.895 177.091 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.632 ' HG1' ' H ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -55.33 116.55 11.96 Favored Pre-proline 0 C--N 1.299 -1.598 0 C-N-CA 118.849 -1.141 . . . . 1.0 108.408 -177.588 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -50.23 -1.17 0.04 OUTLIER 'Trans proline' 0 N--CA 1.486 1.055 0 CA-C-N 119.804 0.966 . . . . 1.0 112.447 -179.592 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.632 ' H ' ' HG1' ' A' ' 23' ' ' THR . 87.0 m-20 -60.1 -18.5 47.6 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 118.826 -1.149 . . . . 1.0 108.065 178.455 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 76.2 mtm -147.99 163.84 35.61 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.617 -0.883 . . . . 1.0 108.617 179.281 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.0 p -73.23 157.36 37.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.17 -0.956 . . . . 1.0 109.123 179.735 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -60.68 -40.09 90.87 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.293 -0.879 . . . . 1.0 109.964 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 63.6 m -60.29 -41.96 94.46 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.206 -0.934 . . . . 1.0 109.616 -179.405 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.32 -40.15 85.92 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.446 -0.784 . . . . 1.0 110.397 179.737 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 70.7 t -67.4 -44.98 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 1.0 110.708 -179.02 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.87 -48.12 82.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.134 -0.979 . . . . 1.0 110.388 -178.362 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -62.47 -32.86 73.81 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.884 -1.135 . . . . 1.0 110.285 -179.783 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.01 -49.72 76.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.015 -1.053 . . . . 1.0 110.072 -179.274 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -68.63 -40.01 80.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.968 -1.083 . . . . 1.0 109.805 -179.648 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.3 mmtt -60.04 -44.87 94.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.019 -1.051 . . . . 1.0 109.642 -179.468 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -60.12 -40.26 89.11 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.149 -0.97 . . . . 1.0 109.219 179.726 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.17 -45.36 93.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.528 -0.732 . . . . 1.0 109.642 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -66.15 -34.66 78.54 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.884 -1.135 . . . . 1.0 109.605 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.7 tptt -59.82 -52.59 64.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.168 -0.957 . . . . 1.0 110.166 -179.665 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.0 m -60.91 -39.86 83.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 O-C-N 120.895 -1.128 . . . . 1.0 110.556 -179.678 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -79.35 -38.34 35.33 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.99 -1.069 . . . . 1.0 110.161 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.3 p -71.68 -22.96 61.58 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.709 -1.244 . . . . 1.0 110.123 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -60.09 -40.02 88.14 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.193 -0.942 . . . . 1.0 111.104 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.6 m -111.42 25.12 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 O-C-N 121.211 -0.931 . . . . 1.0 111.122 -178.309 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.42 ' C ' ' H ' ' A' ' 48' ' ' LEU . 34.3 p -148.79 133.84 9.27 Favored Pre-proline 0 N--CA 1.501 2.122 0 O-C-N 120.701 -1.249 . . . . 1.0 109.617 179.495 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -72.37 17.49 0.35 Allowed 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 120.696 0.931 . . . . 1.0 111.902 179.335 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.42 ' H ' ' C ' ' A' ' 46' ' ' THR . 75.3 mt -67.23 137.92 56.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.195 -0.941 . . . . 1.0 109.829 -179.273 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -108.29 121.42 44.87 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.095 -0.706 . . . . 1.0 109.095 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -109.57 127.65 54.64 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.488 -0.758 . . . . 1.0 109.264 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.7 m -119.99 129.95 54.52 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.482 0.658 . . . . 1.0 109.559 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -82.45 131.25 35.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.359 -0.838 . . . . 1.0 109.529 179.85 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.9 mt -105.94 128.85 54.07 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.274 -0.891 . . . . 1.0 109.514 179.639 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.41 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 17.5 m-70 -66.44 -40.08 89.26 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.436 -0.79 . . . . 1.0 109.839 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 68.0 m-20 -150.07 173.12 14.22 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.222 -0.924 . . . . 1.0 109.468 -179.709 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.494 ' O ' ' NH1' ' A' ' 18' ' ' ARG . . . 95.37 178.68 37.03 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.071 -1.612 . . . . 1.0 109.071 -179.723 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.5 mt -93.7 133.62 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.139 -1.213 . . . . 1.0 109.439 -179.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.68 158.26 18.26 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.483 -0.76 . . . . 1.0 109.167 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -59.72 -49.41 77.84 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.21 -0.931 . . . . 1.0 109.238 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 90.4 mt -105.77 99.74 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.335 -0.853 . . . . 1.0 109.875 179.562 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.7 ptp -99.21 134.77 41.59 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.146 -0.971 . . . . 1.0 109.145 179.048 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.5 mt -109.93 132.33 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.655 -0.653 . . . . 1.0 109.462 -179.014 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.0 p -151.67 157.74 42.5 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.875 -1.141 . . . . 1.0 110.562 -179.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.587 ' H ' HD22 ' A' ' 21' ' ' ASN . 62.0 m-85 -109.62 120.79 43.58 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.55 -0.907 . . . . 1.0 108.55 179.28 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.28 -169.78 23.01 Favored Glycine 0 N--CA 1.499 2.87 0 N-CA-C 110.24 -1.144 . . . . 1.0 110.24 -179.515 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 87.4 mt . . . . . 0 N--CA 1.498 1.951 0 O-C-N 121.644 -0.915 . . . . 1.0 108.836 179.809 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.55 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 83.0 m-85 . . . . . 0 N--CA 1.493 1.675 0 N-CA-C 109.33 -0.619 . . . . 1.0 109.33 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.3 p-10 -101.01 3.96 41.97 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.35 -0.844 . . . . 1.0 110.961 -178.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 126.32 -151.61 18.03 Favored Glycine 0 N--CA 1.507 3.383 0 N-CA-C 108.911 -1.676 . . . . 1.0 108.911 -179.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -60.0 -66.21 0.07 OUTLIER 'Trans proline' 0 N--CA 1.492 1.438 0 CA-C-N 119.116 1.458 . . . . 1.0 112.02 179.617 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 91.7 p -76.82 161.89 28.09 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.183 -0.948 . . . . 1.0 109.525 179.811 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 117.48 -133.21 10.4 Favored Glycine 0 N--CA 1.501 3.002 0 N-CA-C 109.307 -1.517 . . . . 1.0 109.307 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.8 mt -70.16 111.55 5.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.088 -1.242 . . . . 1.0 108.456 179.541 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 38.3 mt -79.33 -17.48 54.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.963 -1.085 . . . . 1.0 108.806 -179.431 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 179.97 175.45 0.8 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.719 -0.845 . . . . 1.0 108.719 179.762 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -166.0 157.7 13.99 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.188 -0.945 . . . . 1.0 109.298 178.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -144.93 157.9 43.99 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -96.89 151.29 37.7 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 107.881 -1.155 . . . . 1.0 107.881 179.478 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -61.54 163.52 17.89 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 CA-C-N 119.324 0.794 . . . . 1.0 111.751 -179.32 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo . . . . . 0 C--N 1.314 -1.267 0 C-N-CA 121.113 1.208 . . . . 1.0 112.253 179.917 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.4 p-10 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.272 0.558 . . . . 1.0 109.707 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.61 124.42 9.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.234 -0.916 . . . . 1.0 109.529 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -112.91 147.59 36.74 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.592 -0.693 . . . . 1.0 109.937 -179.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -125.57 149.44 48.34 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 -179.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.55 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 84.7 m-20 -78.92 123.23 27.06 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.078 -1.014 . . . . 1.0 109.627 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -84.93 -7.73 59.04 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.233 -0.917 . . . . 1.0 109.275 179.577 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -83.5 -14.01 53.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.401 -0.812 . . . . 1.0 109.186 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -88.73 168.67 12.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.503 -0.748 . . . . 1.0 109.166 -179.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 30.9 m -99.94 106.08 17.85 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.209 -0.932 . . . . 1.0 109.214 -179.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -87.11 123.38 32.11 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.577 -0.897 . . . . 1.0 108.577 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.606 ' HG1' ' H ' ' A' ' 107' ' ' SER . 8.7 t -141.99 156.57 45.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.38 -0.825 . . . . 1.0 109.901 -178.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.408 ' N ' ' HG1' ' A' ' 105' ' ' THR . 5.7 t -96.8 -7.69 33.03 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.594 -0.891 . . . . 1.0 108.594 179.21 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.606 ' H ' ' HG1' ' A' ' 105' ' ' THR . 79.4 p -93.62 173.43 7.69 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.524 -0.735 . . . . 1.0 109.428 179.522 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.0 t -70.72 70.34 0.46 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 1.0 109.617 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 110' ' ' GLY . 44.6 mtpt -146.55 153.8 40.79 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.213 -0.93 . . . . 1.0 109.22 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 109' ' ' LYS . . . 41.89 -139.78 1.95 Allowed Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.037 -1.225 . . . . 1.0 110.037 179.494 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -101.0 119.12 38.28 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.33 -1.1 . . . . 1.0 108.943 179.524 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -63.88 132.19 50.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.177 -0.952 . . . . 1.0 109.796 -179.585 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 58.7 tp -59.88 -39.97 87.08 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.351 -0.843 . . . . 1.0 109.923 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -59.91 -41.05 90.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.218 -0.926 . . . . 1.0 110.261 -179.218 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -58.85 -57.92 10.89 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.829 -1.169 . . . . 1.0 110.294 -179.482 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.7 t -66.3 -41.12 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.402 -0.811 . . . . 1.0 109.964 -178.431 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.84 -51.66 68.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.966 -1.084 . . . . 1.0 109.192 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.06 -39.49 86.19 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.336 -0.852 . . . . 1.0 110.246 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.643 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 76.7 t60 -63.8 -49.86 71.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.894 . . . . 1.0 111.443 -178.194 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -59.95 -37.7 80.3 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.671 -1.268 . . . . 1.0 110.086 -179.046 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -60.15 -39.81 87.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.645 -1.284 . . . . 1.0 108.453 179.302 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -59.06 -40.38 95.51 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.246 -1.542 . . . . 1.0 109.246 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.643 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 80.7 m-70 -68.48 -39.99 81.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.043 -1.269 . . . . 1.0 108.832 179.192 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.1 p -65.76 -24.75 67.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.411 -0.806 . . . . 1.0 109.12 179.703 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 65.9 mt -81.86 -4.91 57.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.361 -0.837 . . . . 1.0 109.47 179.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 92.22 10.03 61.36 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.659 -0.976 . . . . 1.0 110.659 179.105 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.8 mt -85.21 147.91 26.36 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.871 -1.37 . . . . 1.0 109.671 179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 44.1 t0 -100.63 175.46 5.65 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.476 -0.765 . . . . 1.0 108.97 -179.884 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.515 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 74.0 m80 -59.93 138.89 57.72 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.973 . . . . 1.0 109.72 -179.597 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 46.7 t -97.34 155.66 16.79 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.32 -0.863 . . . . 1.0 109.226 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -99.26 0.21 42.66 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.144 -0.973 . . . . 1.0 109.754 -179.893 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -85.32 130.4 51.82 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.306 -0.871 . . . . 1.0 108.695 179.85 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -68.1 -19.88 44.67 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 CA-C-N 120.136 1.084 . . . . 1.0 112.456 -179.668 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -91.2 -4.63 68.47 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 110.243 -1.143 . . . . 1.0 110.243 -179.558 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.86 145.63 27.1 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.014 -1.286 . . . . 1.0 109.31 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.521 ' C ' ' H ' ' A' ' 138' ' ' PHE . 70.3 mt -66.34 -38.63 88.08 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.911 -1.118 . . . . 1.0 110.01 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 94.5 mmm -69.97 19.84 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.315 -0.866 . . . . 1.0 110.585 -178.529 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.521 ' H ' ' C ' ' A' ' 136' ' ' LEU . 17.3 t80 -70.15 129.59 90.5 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 108.094 -1.076 . . . . 1.0 108.094 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -54.68 -10.98 2.85 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 CA-C-N 119.996 1.034 . . . . 1.0 114.079 -179.061 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.9 mt -113.93 140.63 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.512 0 O-C-N 120.891 -1.13 . . . . 1.0 110.664 -178.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.433 ' CD1' ' C ' ' A' ' 141' ' ' TYR . 20.7 t80 -74.7 129.58 37.97 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.513 -0.742 . . . . 1.0 110.069 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.0 t -139.0 142.4 38.32 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.434 -0.792 . . . . 1.0 109.402 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -83.05 152.18 25.48 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.994 -1.066 . . . . 1.0 109.721 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.526 ' O ' ' NZ ' ' A' ' 146' ' ' LYS . 2.7 m -145.66 154.45 42.12 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.399 -0.813 . . . . 1.0 109.863 -179.771 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.92 103.93 1.55 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.312 -1.915 . . . . 1.0 108.312 178.633 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.526 ' NZ ' ' O ' ' A' ' 144' ' ' THR . 37.3 mmtm -77.3 12.49 1.49 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.212 -1.169 . . . . 1.0 110.095 -178.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 48.5 t -60.0 -39.96 87.58 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.032 -1.043 . . . . 1.0 108.633 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -160.01 69.81 0.42 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.355 -0.841 . . . . 1.0 109.071 179.053 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -97.7 139.74 33.13 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.308 -0.87 . . . . 1.0 110.498 -179.547 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 97.4 mmm -136.9 149.72 47.8 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.983 -1.118 . . . . 1.0 107.983 178.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.9 mt -53.57 131.13 54.84 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.058 -1.026 . . . . 1.0 109.566 -179.134 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -68.49 175.47 6.95 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 CA-C-N 119.835 0.977 . . . . 1.0 112.136 179.638 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -60.08 -39.9 87.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.514 -0.741 . . . . 1.0 110.027 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -57.19 -47.31 81.56 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.221 -0.925 . . . . 1.0 110.067 -179.146 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -69.86 -39.83 76.12 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.188 -0.945 . . . . 1.0 109.435 -179.751 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.28 -45.02 96.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.198 -0.939 . . . . 1.0 109.196 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -60.23 -39.72 87.66 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.926 -1.109 . . . . 1.0 109.748 179.519 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.425 ' O ' ' OG ' ' A' ' 161' ' ' SER . . . -70.71 -54.41 10.02 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 120.501 -0.857 . . . . 1.0 111.669 -178.471 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 8.4 tp -60.03 -40.18 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.666 -1.491 . . . . 1.0 109.621 -178.728 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.546 ' O ' ' N ' ' A' ' 164' ' ' GLY . 26.5 mt-30 -65.54 -39.39 91.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.089 -1.007 . . . . 1.0 109.466 179.217 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.468 ' HG ' ' N ' ' A' ' 162' ' ' LEU . 84.7 p -59.13 -30.91 68.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.055 -1.028 . . . . 1.0 110.032 -179.553 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.468 ' N ' ' HG ' ' A' ' 161' ' ' SER . 88.7 mt -86.92 -53.61 4.8 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.938 -1.101 . . . . 1.0 110.725 -179.147 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -91.92 -9.98 41.19 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.91 -1.119 . . . . 1.0 110.933 -178.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.597 0 N-CA-C 109.292 -1.523 . . . . 1.0 109.292 -179.633 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.0 mt . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 108.934 -0.765 . . . . 1.0 108.934 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -162.48 166.52 24.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 1.0 109.867 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -72.19 140.75 48.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.185 -0.947 . . . . 1.0 110.043 -179.398 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.3 t -89.99 0.02 57.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.406 -0.809 . . . . 1.0 109.722 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.538 ' NZ ' ' O ' ' A' ' 14' ' ' ASN . 20.7 pttp -141.98 154.21 44.86 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.185 -0.947 . . . . 1.0 109.622 -179.651 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.4 mmt -90.47 -0.13 57.54 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.363 -0.835 . . . . 1.0 110.203 -178.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.538 ' O ' ' NZ ' ' A' ' 12' ' ' LYS . 30.1 m120 -97.02 128.61 44.15 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.224 -0.922 . . . . 1.0 109.151 -179.844 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.4 mt -141.66 149.54 40.76 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.265 -0.897 . . . . 1.0 109.307 -179.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.5 p -132.11 154.11 49.8 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.004 -0.739 . . . . 1.0 109.004 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -144.58 159.1 43.35 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.11 -0.994 . . . . 1.0 110.193 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 56' ' ' GLY . 26.3 ttm-85 -145.4 132.11 19.98 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.592 -0.693 . . . . 1.0 109.864 -179.455 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 39.8 mm -87.88 112.72 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.335 -0.987 . . . . 1.0 108.335 178.734 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.5 t -69.95 -40.05 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.101 -0.999 . . . . 1.0 109.443 -179.418 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -162.17 156.97 22.5 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.777 -1.202 . . . . 1.0 110.152 -179.588 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.611 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 54.0 m-85 -96.91 -167.14 1.5 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.169 -1.419 . . . . 1.0 107.169 178.851 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.29 141.58 32.11 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.325 -0.859 . . . . 1.0 110.094 -179.439 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -66.89 -19.1 52.81 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 120.763 0.976 . . . . 1.0 110.365 178.83 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.43 -39.91 85.04 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.553 -0.749 . . . . 1.0 109.949 179.405 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 74.8 mtm -130.04 161.66 30.5 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.419 -0.801 . . . . 1.0 109.484 -179.43 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.0 p -70.79 158.26 36.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -0.911 . . . . 1.0 109.2 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.611 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 1.0 OUTLIER -60.73 -40.76 93.59 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.355 -0.841 . . . . 1.0 110.239 -179.169 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.539 ' O ' ' NZ ' ' A' ' 33' ' ' LYS . 73.8 m -59.94 -41.02 90.94 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.006 -1.059 . . . . 1.0 110.758 -179.455 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -64.61 -40.08 94.86 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.945 -1.097 . . . . 1.0 110.004 -179.629 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.4 t -67.28 -39.96 83.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.222 -0.924 . . . . 1.0 109.83 -179.71 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -60.04 -49.93 75.74 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.098 -1.001 . . . . 1.0 110.647 -178.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.539 ' NZ ' ' O ' ' A' ' 29' ' ' SER . 2.1 ptpp? -64.19 -30.34 71.41 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.131 -0.981 . . . . 1.0 109.911 -179.704 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.04 -48.87 79.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.064 -1.022 . . . . 1.0 109.669 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -67.15 -38.38 85.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.075 -1.015 . . . . 1.0 110.02 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -59.95 -42.66 94.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.008 -1.058 . . . . 1.0 109.657 -179.651 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -60.04 -43.71 95.14 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.027 -1.046 . . . . 1.0 109.02 179.355 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.06 -49.71 76.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.463 -0.773 . . . . 1.0 109.868 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -61.97 -39.97 93.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.265 -0.897 . . . . 1.0 109.291 -179.803 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -60.06 -50.0 75.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.212 -0.93 . . . . 1.0 109.197 -179.591 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 70.2 t -59.98 -40.73 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.249 -0.907 . . . . 1.0 109.869 -179.549 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.457 ' O ' ' OG1' ' A' ' 46' ' ' THR . 73.9 m95 -78.94 -37.77 38.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.026 -1.047 . . . . 1.0 109.861 -179.704 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.3 p -69.97 -15.32 63.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.267 -0.895 . . . . 1.0 109.829 -179.726 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -59.98 -40.0 87.61 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.136 -0.978 . . . . 1.0 110.091 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.3 m -115.06 -17.71 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.437 -0.789 . . . . 1.0 111.191 -178.483 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 42' ' ' TRP . 38.3 p -90.76 124.36 62.47 Favored Pre-proline 0 N--CA 1.501 2.078 0 O-C-N 120.463 -1.398 . . . . 1.0 109.416 179.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -73.69 15.47 0.56 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 CA-C-N 120.221 1.115 . . . . 1.0 111.434 178.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.412 ' H ' ' C ' ' A' ' 46' ' ' THR . 85.5 mt -69.61 140.26 53.71 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.41 -0.806 . . . . 1.0 110.369 -179.299 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -102.33 121.63 42.66 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.798 -0.816 . . . . 1.0 108.798 179.198 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -107.09 125.79 51.52 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.288 -0.882 . . . . 1.0 109.768 -179.204 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.2 m -120.03 129.98 54.5 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.576 -0.702 . . . . 1.0 109.882 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -82.23 131.96 35.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.244 -0.91 . . . . 1.0 109.487 179.752 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.493 ' O ' ' NH1' ' A' ' 18' ' ' ARG . 90.3 mt -106.63 134.0 50.45 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.301 -0.874 . . . . 1.0 109.274 179.502 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.435 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 59.1 m170 -66.23 -39.98 89.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.388 -0.82 . . . . 1.0 109.874 -179.641 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.464 ' O ' ' NH2' ' A' ' 18' ' ' ARG . 69.0 m-20 -154.42 178.84 9.6 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.087 -1.008 . . . . 1.0 109.635 -179.77 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.538 ' O ' ' NE ' ' A' ' 18' ' ' ARG . . . 96.62 -168.26 25.04 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.642 -1.383 . . . . 1.0 109.642 -179.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.7 mt -101.4 130.51 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.361 -1.082 . . . . 1.0 109.622 -179.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.45 154.73 26.53 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.422 -0.799 . . . . 1.0 109.447 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -60.01 -49.56 77.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.2 -0.938 . . . . 1.0 109.624 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.6 mt -104.11 94.99 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.334 -0.853 . . . . 1.0 109.608 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.3 ptm -100.73 127.39 47.17 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.208 -0.933 . . . . 1.0 109.61 179.754 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 87.2 mt -106.42 137.7 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.52 -0.738 . . . . 1.0 109.657 -179.643 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 66.3 p -152.69 161.92 41.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.224 -0.923 . . . . 1.0 109.71 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -109.97 149.98 29.15 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.531 -0.731 . . . . 1.0 109.329 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -143.71 -161.88 9.11 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.315 -1.514 . . . . 1.0 109.315 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.2 mt . . . . . 0 N--CA 1.498 1.952 0 O-C-N 121.344 -1.092 . . . . 1.0 109.269 -179.942 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 106.959 -1.497 . . . . 1.0 106.959 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.7 p-10 -106.09 20.0 19.64 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 120.927 -1.108 . . . . 1.0 110.934 -178.682 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.28 -150.38 18.11 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 109.493 -1.443 . . . . 1.0 109.493 179.608 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.442 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 8.8 Cg_exo -60.67 -62.72 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.524 0 CA-C-N 118.864 1.332 . . . . 1.0 112.896 -179.593 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 83.2 p -74.04 157.61 35.81 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.019 -1.051 . . . . 1.0 110.206 -179.268 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.65 -126.82 7.56 Favored Glycine 0 N--CA 1.502 3.075 0 N-CA-C 110.244 -1.142 . . . . 1.0 110.244 179.605 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.427 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 15.3 mt -69.75 102.73 1.98 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.43 -1.041 . . . . 1.0 109.3 -179.702 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 41.3 mt -75.67 -24.44 56.33 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.881 -1.137 . . . . 1.0 108.57 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.4 172.22 1.2 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.702 -0.851 . . . . 1.0 108.702 -179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.497 ' ND1' ' C ' ' A' ' 84' ' ' HIS . 2.8 p80 -161.61 171.41 18.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.128 -0.983 . . . . 1.0 109.238 178.938 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.41 160.91 43.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.172 -0.955 . . . . 1.0 109.467 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -101.32 154.33 37.27 Favored Pre-proline 0 N--CA 1.496 1.862 0 N-CA-C 108.367 -0.975 . . . . 1.0 108.367 179.687 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.87 168.64 0.76 Allowed 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 120.738 0.959 . . . . 1.0 111.588 179.68 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo . . . . . 0 C--N 1.312 -1.383 0 C-N-CA 120.862 1.041 . . . . 1.0 111.441 179.931 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.239 0.542 . . . . 1.0 109.66 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.05 124.53 9.64 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.159 -0.963 . . . . 1.0 109.848 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -107.05 131.01 54.57 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.483 -0.761 . . . . 1.0 109.529 179.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.494 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 38.4 m-85 -114.28 144.18 43.66 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.504 -0.748 . . . . 1.0 109.028 179.588 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.427 ' OD2' ' O ' ' A' ' 81' ' ' LEU . 91.7 m-20 -78.95 124.23 28.05 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.934 -1.104 . . . . 1.0 109.926 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 55.7 t0 -85.45 -6.77 59.17 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.211 -0.93 . . . . 1.0 109.233 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -81.9 -14.94 55.48 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.097 -1.002 . . . . 1.0 109.329 179.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.442 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 94.3 mt-10 -89.23 168.55 12.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.362 -0.836 . . . . 1.0 109.68 -178.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 26.3 m -98.51 105.17 17.28 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.199 -0.938 . . . . 1.0 109.494 -179.516 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.407 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 86.5 m95 -88.47 124.24 33.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.379 -0.826 . . . . 1.0 109.059 179.727 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.9 t -140.78 153.63 45.92 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.197 -0.939 . . . . 1.0 109.91 -179.476 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 85.0 p -93.2 -5.6 49.65 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.456 -0.942 . . . . 1.0 108.456 179.15 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 46.4 t -94.3 179.71 5.21 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.718 -0.845 . . . . 1.0 108.718 179.305 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.409 ' OG ' ' CZ ' ' A' ' 143' ' ' TYR . 3.9 m -80.79 75.75 7.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.004 -1.06 . . . . 1.0 109.372 179.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -148.61 151.52 35.16 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.308 -0.87 . . . . 1.0 108.828 179.364 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.53 -138.84 4.83 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.841 -1.304 . . . . 1.0 109.841 179.667 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -100.01 115.92 30.85 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.348 -1.09 . . . . 1.0 108.862 179.604 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -63.61 131.81 49.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.158 -0.964 . . . . 1.0 109.617 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.1 tp -60.0 -43.59 95.08 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.331 -0.856 . . . . 1.0 110.899 -179.484 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -59.91 -41.11 91.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.971 -1.081 . . . . 1.0 110.794 -178.592 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.96 -50.47 73.64 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.809 -1.182 . . . . 1.0 109.603 -179.468 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.1 t -70.01 -41.44 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.051 -1.031 . . . . 1.0 110.09 -179.365 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.45 -51.44 69.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.147 -0.971 . . . . 1.0 109.633 -179.318 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.05 -37.01 78.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.146 -0.971 . . . . 1.0 109.945 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.524 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 59.4 t60 -62.36 -49.94 73.55 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.249 -0.907 . . . . 1.0 111.182 -178.784 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.494 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 6.9 pt-20 -59.54 -39.49 84.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.654 -1.278 . . . . 1.0 109.529 -179.38 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -60.07 -39.96 87.87 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.892 -1.13 . . . . 1.0 108.615 179.205 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.36 -47.71 61.61 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.283 -1.527 . . . . 1.0 109.283 179.775 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.524 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 89.1 m-70 -66.1 -39.96 90.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.286 -1.126 . . . . 1.0 110.16 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 83.1 p -66.43 -22.19 66.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.131 -0.98 . . . . 1.0 109.897 -179.609 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 79.6 mt -81.9 1.84 33.3 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.134 -0.979 . . . . 1.0 109.948 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.12 4.99 70.96 Favored Glycine 0 N--CA 1.497 2.749 0 O-C-N 121.005 -1.059 . . . . 1.0 110.532 179.167 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.2 mt -86.99 147.85 25.56 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.984 -1.303 . . . . 1.0 109.787 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 37.6 t0 -101.98 172.39 6.95 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.878 -0.786 . . . . 1.0 108.878 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.513 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 59.3 m80 -56.58 132.72 52.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.004 -1.06 . . . . 1.0 109.54 -179.684 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 40.0 t -96.45 157.37 15.93 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.249 -0.907 . . . . 1.0 109.412 179.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -99.97 5.06 45.21 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.347 -0.845 . . . . 1.0 109.125 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -86.23 126.5 64.73 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 108.317 -0.994 . . . . 1.0 108.317 179.442 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -68.04 -22.07 42.1 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 CA-C-N 120.253 1.126 . . . . 1.0 112.273 -179.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -84.99 -5.69 85.81 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.684 -1.366 . . . . 1.0 109.684 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.15 135.19 33.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.186 -1.185 . . . . 1.0 108.842 179.467 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.502 ' C ' ' H ' ' A' ' 138' ' ' PHE . 89.2 mt -60.7 -40.05 90.79 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.076 -1.015 . . . . 1.0 110.238 -179.442 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 89.6 mtp -69.22 23.92 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.207 -0.933 . . . . 1.0 111.009 -178.425 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.502 ' H ' ' C ' ' A' ' 136' ' ' LEU . 17.3 t80 -69.92 130.33 90.1 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 120.761 -1.212 . . . . 1.0 108.328 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -49.07 -21.82 4.47 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 120.825 1.016 . . . . 1.0 114.392 -178.453 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 90.4 mt -106.37 139.81 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 O-C-N 120.886 -1.134 . . . . 1.0 110.87 -178.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -75.0 126.76 31.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.791 -0.568 . . . . 1.0 109.614 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.8 t -138.16 142.31 40.08 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.452 -0.78 . . . . 1.0 109.167 179.388 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.409 ' CZ ' ' OG ' ' A' ' 108' ' ' SER . 80.9 t80 -80.41 139.94 36.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.145 -0.972 . . . . 1.0 109.13 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.3 t -139.95 152.09 46.07 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.282 -0.886 . . . . 1.0 109.909 -179.322 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.96 101.1 0.83 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.33 -1.508 . . . . 1.0 109.33 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -76.79 -0.79 25.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.348 -1.09 . . . . 1.0 110.019 -179.718 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 53.9 m -59.97 -40.03 87.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.082 -1.011 . . . . 1.0 109.658 -179.6 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -138.91 21.06 2.65 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.144 -0.973 . . . . 1.0 109.989 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -62.03 139.94 58.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.78 -1.2 . . . . 1.0 109.721 -179.714 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 67.6 mtt -139.64 148.32 42.28 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.386 -0.968 . . . . 1.0 108.386 179.179 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 35.0 mt -54.94 129.78 66.3 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 120.945 -1.097 . . . . 1.0 109.202 -179.407 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -70.82 173.33 12.08 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 CA-C-N 119.863 0.987 . . . . 1.0 112.21 179.749 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -60.17 -39.62 87.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.328 -0.857 . . . . 1.0 109.519 179.403 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -53.06 -47.94 68.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.217 -0.927 . . . . 1.0 109.594 -179.517 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -70.33 -40.07 74.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.064 -1.022 . . . . 1.0 110.152 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 78.7 t -60.02 -47.35 92.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.88 -1.137 . . . . 1.0 109.176 -179.784 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -60.06 -39.97 87.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.071 -1.018 . . . . 1.0 110.434 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -73.23 -54.28 7.04 Favored Glycine 0 N--CA 1.496 2.672 0 O-C-N 121.215 -0.928 . . . . 1.0 111.685 -178.213 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.8 tp -59.98 -39.99 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.953 -1.322 . . . . 1.0 109.691 -178.808 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.571 ' O ' ' N ' ' A' ' 164' ' ' GLY . 93.0 mm-40 -64.94 -38.25 90.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.2 -0.938 . . . . 1.0 109.463 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 60.3 p -61.51 -33.34 73.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.071 -1.018 . . . . 1.0 110.346 -179.359 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.8 mt -84.84 -52.31 6.12 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.959 -1.088 . . . . 1.0 110.536 -179.001 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -91.31 -9.24 45.71 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.104 -0.997 . . . . 1.0 110.483 -178.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.496 2.66 0 N-CA-C 109.448 -1.461 . . . . 1.0 109.448 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.8 mt . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.162 -0.681 . . . . 1.0 109.162 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -161.71 161.44 29.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.878 . . . . 1.0 109.785 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -70.15 146.26 50.94 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.325 -0.86 . . . . 1.0 109.518 -179.623 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.9 t -85.94 1.42 50.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.342 -0.849 . . . . 1.0 109.818 -179.54 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -144.17 152.98 41.63 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.153 -0.967 . . . . 1.0 109.607 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.8 mmt -90.24 -0.02 57.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.358 -0.839 . . . . 1.0 109.769 -179.302 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -97.04 130.52 44.34 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.206 -0.933 . . . . 1.0 109.11 179.762 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.2 mt -141.75 148.94 39.8 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.196 -0.94 . . . . 1.0 109.406 -179.814 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.9 p -134.37 155.29 50.53 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.715 -0.846 . . . . 1.0 108.715 179.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -146.14 160.05 42.47 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.061 -1.024 . . . . 1.0 110.201 -179.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.486 ' NH1' ' N ' ' A' ' 56' ' ' GLY . 71.8 ttt180 -145.5 134.16 22.2 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.562 -0.711 . . . . 1.0 109.556 -179.736 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.406 HD11 HG22 ' A' ' 19' ' ' ILE . 32.0 mm -89.0 115.11 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.182 -0.949 . . . . 1.0 108.922 179.026 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.91 -40.58 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.173 -0.954 . . . . 1.0 109.295 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -164.98 160.52 19.15 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.929 -1.107 . . . . 1.0 110.008 -179.507 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.461 ' CD2' ' CG ' ' A' ' 28' ' ' HIS . 47.7 m-85 -101.68 -161.53 0.86 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.894 -1.15 . . . . 1.0 107.894 179.132 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.659 ' HG1' ' H ' ' A' ' 25' ' ' ASP . 0.1 OUTLIER -121.33 147.59 47.6 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.448 -0.782 . . . . 1.0 110.054 -179.809 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.424 ' N ' ' HG1' ' A' ' 23' ' ' THR . 12.2 Cg_endo -69.62 -14.99 37.36 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 120.916 1.078 . . . . 1.0 110.267 178.245 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.659 ' H ' ' HG1' ' A' ' 23' ' ' THR . 96.0 m-20 -59.42 -38.93 81.9 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.083 -0.962 . . . . 1.0 109.965 179.693 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 76.0 mtm -139.64 168.4 19.91 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.284 -0.885 . . . . 1.0 109.552 -179.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.4 p -73.45 156.61 38.07 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.445 -0.785 . . . . 1.0 109.771 -179.496 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.461 ' CG ' ' CD2' ' A' ' 22' ' ' TYR . 41.6 m170 -59.99 -40.09 87.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.431 -0.793 . . . . 1.0 110.463 -179.538 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 53.4 m -59.97 -39.96 87.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 1.0 110.202 -178.474 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.39 -39.95 89.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.033 -1.042 . . . . 1.0 109.325 179.574 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 76.6 t -68.7 -40.29 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.266 -0.896 . . . . 1.0 110.348 -179.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.96 -49.26 78.4 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.841 -1.162 . . . . 1.0 110.37 -179.186 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -61.34 -32.1 71.98 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.98 -1.075 . . . . 1.0 109.529 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.84 -48.57 81.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.977 -1.077 . . . . 1.0 109.649 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -66.03 -39.78 90.49 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.091 -1.006 . . . . 1.0 109.923 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.97 -40.65 89.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.924 -1.11 . . . . 1.0 109.284 -179.395 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -60.13 -41.78 93.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.034 -1.041 . . . . 1.0 108.927 179.085 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.97 -48.07 83.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.355 -0.841 . . . . 1.0 110.124 -179.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.414 ' O ' ' N ' ' A' ' 43' ' ' SER . 48.1 m-85 -64.89 -39.94 94.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.138 -0.976 . . . . 1.0 109.564 -179.858 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -59.96 -48.25 82.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.15 -0.969 . . . . 1.0 109.27 -179.65 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.9 t -60.02 -41.53 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.294 -0.879 . . . . 1.0 110.122 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.439 ' O ' ' OG1' ' A' ' 46' ' ' THR . 76.3 m95 -81.36 -31.5 33.35 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.978 -1.076 . . . . 1.0 109.99 -179.421 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 39' ' ' PHE . 80.0 p -70.02 -20.12 63.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.958 -1.089 . . . . 1.0 109.023 179.849 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -60.27 -39.96 88.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.404 -0.81 . . . . 1.0 110.263 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.1 m -113.15 -17.35 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 O-C-N 121.219 -0.926 . . . . 1.0 110.49 -179.17 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.52 ' C ' ' H ' ' A' ' 48' ' ' LEU . 44.8 p -94.02 114.41 63.11 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 120.779 -1.2 . . . . 1.0 108.982 179.729 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.76 16.36 0.22 Allowed 'Trans proline' 0 N--CA 1.491 1.327 0 CA-C-N 120.354 1.162 . . . . 1.0 111.237 179.462 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.52 ' H ' ' C ' ' A' ' 46' ' ' THR . 59.2 mt -69.52 142.87 53.59 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.567 -0.708 . . . . 1.0 109.511 -179.718 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -102.07 120.74 40.92 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.779 -0.823 . . . . 1.0 108.779 179.403 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -106.29 128.07 53.71 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.32 -0.863 . . . . 1.0 109.581 -179.438 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.0 m -120.04 130.01 54.5 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.58 -0.7 . . . . 1.0 109.469 179.642 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.8 ttp180 -82.62 129.99 35.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 1.0 109.558 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.4 mt -111.0 116.52 31.33 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.416 -0.802 . . . . 1.0 108.981 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.441 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 91.5 m-70 -74.61 -20.46 59.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.861 . . . . 1.0 110.065 -179.77 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 84.0 m-20 -145.13 160.66 41.08 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.18 -0.95 . . . . 1.0 109.639 -179.482 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.486 ' N ' ' NH1' ' A' ' 18' ' ' ARG . . . 90.02 173.95 45.22 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.677 -1.369 . . . . 1.0 109.677 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 87.2 mt -94.34 139.25 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.135 -1.215 . . . . 1.0 109.135 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.08 159.76 18.87 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.499 -0.75 . . . . 1.0 109.38 -179.739 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -59.94 -49.79 76.29 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.174 -0.954 . . . . 1.0 109.307 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.411 HG21 HD11 ' A' ' 60' ' ' ILE . 84.3 mt -103.12 98.88 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.449 -0.782 . . . . 1.0 109.568 179.866 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.2 ptm -101.85 129.23 48.03 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.295 -0.878 . . . . 1.0 109.206 179.455 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.418 HD11 HG23 ' A' ' 62' ' ' ILE . 86.9 mt -105.25 134.45 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.618 -0.676 . . . . 1.0 109.688 -179.125 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 54.6 p -149.73 153.54 37.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.208 -0.932 . . . . 1.0 109.623 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -103.89 124.02 48.2 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.937 -0.764 . . . . 1.0 108.937 179.904 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -107.13 -167.15 22.18 Favored Glycine 0 N--CA 1.502 3.044 0 N-CA-C 110.531 -1.028 . . . . 1.0 110.531 -179.232 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 77.0 mt . . . . . 0 N--CA 1.497 1.884 0 O-C-N 121.598 -0.943 . . . . 1.0 108.74 179.731 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.551 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 73.9 m-85 . . . . . 0 N--CA 1.494 1.759 0 N-CA-C 108.89 -0.781 . . . . 1.0 108.89 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.5 p-10 -100.01 10.47 41.24 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.315 -0.866 . . . . 1.0 110.614 -178.884 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 116.73 -152.31 17.92 Favored Glycine 0 N--CA 1.505 3.293 0 N-CA-C 109.432 -1.467 . . . . 1.0 109.432 179.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -58.07 -65.77 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.429 0 CA-C-N 118.905 1.352 . . . . 1.0 112.338 -179.768 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 80.7 p -76.27 159.26 30.76 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.232 -0.917 . . . . 1.0 109.878 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.86 -130.87 9.3 Favored Glycine 0 N--CA 1.503 3.148 0 N-CA-C 109.6 -1.4 . . . . 1.0 109.6 179.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.402 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 15.2 mt -70.18 105.03 2.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.07 -1.253 . . . . 1.0 109.046 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 40.2 mt -77.43 -18.29 57.35 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.295 -1.002 . . . . 1.0 108.295 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.98 172.49 1.04 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.417 -0.957 . . . . 1.0 108.417 179.846 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.433 ' ND1' ' C ' ' A' ' 84' ' ' HIS . 8.1 p80 -163.09 156.76 19.9 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.988 -1.07 . . . . 1.0 109.744 179.348 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.07 157.8 43.68 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.721 -0.844 . . . . 1.0 108.721 179.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -94.84 153.15 40.06 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.059 -1.026 . . . . 1.0 109.057 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -59.17 166.43 7.3 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 120.447 0.765 . . . . 1.0 111.01 179.576 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo . . . . . 0 N--CA 1.493 1.468 0 C-N-CA 121.252 1.302 . . . . 1.0 112.264 -179.843 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.238 0.542 . . . . 1.0 109.993 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.17 124.49 10.9 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.176 -0.952 . . . . 1.0 110.058 -179.638 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.426 ' ND1' ' CE1' ' A' ' 84' ' ' HIS . 54.1 m170 -108.95 141.64 40.74 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.497 -0.752 . . . . 1.0 110.222 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -124.19 144.09 50.13 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 109.036 -0.728 . . . . 1.0 109.036 179.223 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.551 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 77.4 m-20 -78.96 121.33 24.77 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.967 -1.083 . . . . 1.0 109.677 179.814 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -85.32 -7.19 59.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.337 -0.852 . . . . 1.0 109.004 179.424 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -84.04 -12.53 55.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.452 -0.78 . . . . 1.0 109.395 -179.801 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -89.31 169.95 10.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.45 -0.782 . . . . 1.0 109.766 -178.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 18.2 m -98.87 103.86 15.85 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.338 -0.851 . . . . 1.0 109.245 -179.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.435 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 89.0 m95 -88.17 127.11 35.43 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.814 -0.809 . . . . 1.0 108.814 179.763 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.7 t -143.03 154.13 43.66 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.168 -0.958 . . . . 1.0 109.929 -179.522 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.9 m -94.05 -10.56 33.05 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.208 -0.933 . . . . 1.0 108.597 179.382 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.7 m -91.29 177.67 6.18 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.597 -0.89 . . . . 1.0 108.597 179.355 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.7 t -76.5 80.17 3.2 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.012 -1.055 . . . . 1.0 109.648 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -153.53 150.12 28.38 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.328 -0.857 . . . . 1.0 109.283 179.499 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 43.48 -140.31 2.97 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.046 -1.222 . . . . 1.0 110.046 179.465 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -99.98 111.87 24.16 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.343 -1.093 . . . . 1.0 109.076 179.695 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.417 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 19.6 t-20 -61.55 136.53 58.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.072 -1.017 . . . . 1.0 109.9 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.2 tp -59.97 -44.11 94.67 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.357 -0.839 . . . . 1.0 110.467 179.815 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -59.96 -41.47 91.98 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.08 -1.013 . . . . 1.0 110.889 -178.22 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.99 -50.11 75.01 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.814 -1.179 . . . . 1.0 109.487 -179.395 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 56.3 t -70.0 -41.5 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.06 -1.025 . . . . 1.0 110.307 -179.47 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.33 -52.8 64.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.09 -1.006 . . . . 1.0 110.074 -178.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.55 -35.5 74.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.11 -0.994 . . . . 1.0 110.099 -179.728 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.601 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 74.1 t60 -63.93 -50.3 69.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.948 . . . . 1.0 111.254 -178.512 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -60.05 -39.21 85.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.645 -1.285 . . . . 1.0 110.091 -179.297 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -60.04 -39.87 87.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.967 -1.083 . . . . 1.0 108.844 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.68 -44.39 94.05 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.431 -1.468 . . . . 1.0 109.431 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.601 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 85.9 m-70 -64.95 -39.99 94.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.19 -1.182 . . . . 1.0 109.494 179.54 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 83.2 p -65.7 -22.9 66.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.228 -0.92 . . . . 1.0 109.523 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 82.2 mt -82.55 -1.2 49.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.241 -0.912 . . . . 1.0 109.283 179.709 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.73 8.71 65.16 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 110.819 -0.912 . . . . 1.0 110.819 178.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.4 mt -85.82 146.35 26.8 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.881 -1.364 . . . . 1.0 109.652 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 44.5 t0 -100.41 172.7 6.97 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.484 -0.76 . . . . 1.0 109.199 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.519 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 64.7 m80 -58.86 136.92 57.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.911 . . . . 1.0 109.703 -179.661 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 42.0 t -98.04 155.63 17.03 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.37 -0.831 . . . . 1.0 109.176 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -98.75 1.91 46.48 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.265 -0.897 . . . . 1.0 109.934 179.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -85.4 128.5 59.13 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.074 -1.016 . . . . 1.0 108.368 179.336 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -67.8 -17.4 47.15 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 CA-C-N 120.237 1.12 . . . . 1.0 112.519 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -90.32 -5.53 69.75 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.696 -1.361 . . . . 1.0 109.696 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -89.05 140.02 29.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.218 -1.166 . . . . 1.0 109.35 179.726 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.491 ' C ' ' H ' ' A' ' 138' ' ' PHE . 98.3 mt -63.86 -31.99 73.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.139 -0.976 . . . . 1.0 109.83 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 96.0 mmm -71.21 19.43 0.06 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.322 -0.861 . . . . 1.0 110.503 -179.027 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.491 ' H ' ' C ' ' A' ' 136' ' ' LEU . 11.3 t80 -69.31 132.14 89.94 Favored Pre-proline 0 N--CA 1.495 1.775 0 N-CA-C 107.817 -1.179 . . . . 1.0 107.817 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -61.88 -13.74 32.65 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 CA-C-N 119.837 0.977 . . . . 1.0 113.33 -178.346 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.419 HG23 HD11 ' A' ' 140' ' ' ILE . 96.5 mt -108.14 139.28 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.199 -0.938 . . . . 1.0 109.343 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.417 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 33.4 t80 -72.69 129.56 38.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.324 -0.86 . . . . 1.0 109.853 -179.464 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.2 t -140.15 143.74 36.31 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.868 -0.79 . . . . 1.0 108.868 179.762 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -81.01 144.8 31.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.137 -0.977 . . . . 1.0 109.289 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.5 t -140.5 151.94 45.21 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.184 -0.947 . . . . 1.0 109.825 -179.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -61.81 103.93 0.65 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.284 -1.126 . . . . 1.0 110.284 -179.478 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.413 ' CB ' ' NZ ' ' A' ' 146' ' ' LYS . 9.1 mtpm? -77.28 -7.94 56.8 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.337 -1.096 . . . . 1.0 109.236 179.638 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.477 ' HG ' ' N ' ' A' ' 148' ' ' HIS . 82.5 p -59.97 -40.01 87.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 1.0 109.832 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . 0.477 ' N ' ' HG ' ' A' ' 147' ' ' SER . 82.8 t60 -154.27 69.63 0.77 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.11 -0.993 . . . . 1.0 109.65 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -100.45 127.1 46.89 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.219 -0.926 . . . . 1.0 109.642 179.66 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 75.5 mtm -121.44 141.46 50.98 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.572 -0.899 . . . . 1.0 108.572 179.203 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.8 mt -52.6 128.47 43.55 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 120.917 -1.115 . . . . 1.0 108.82 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -68.64 175.48 7.08 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 CA-C-N 120.036 1.049 . . . . 1.0 111.903 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -59.97 -40.03 87.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.331 -0.856 . . . . 1.0 109.697 179.798 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -54.56 -49.21 70.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.256 -0.903 . . . . 1.0 110.172 -179.227 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -69.92 -39.97 75.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.993 -1.067 . . . . 1.0 110.026 -179.601 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 60.1 t -60.06 -47.1 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 1.0 109.218 -179.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -60.07 -40.01 88.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.125 -0.984 . . . . 1.0 110.203 -179.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.12 -55.27 9.39 Favored Glycine 0 N--CA 1.495 2.619 0 O-C-N 121.143 -0.973 . . . . 1.0 111.301 -178.567 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.8 tp -60.17 -40.09 82.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.946 -1.326 . . . . 1.0 109.734 -178.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.533 ' O ' ' N ' ' A' ' 164' ' ' GLY . 26.0 mm100 -64.35 -40.06 95.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.081 -1.012 . . . . 1.0 109.789 179.852 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 94.1 p -62.08 -30.44 71.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.11 -0.994 . . . . 1.0 110.196 -179.537 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 93.1 mt -84.92 -54.24 4.79 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.028 -1.045 . . . . 1.0 110.623 -179.099 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -89.73 -8.85 51.35 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.002 -1.061 . . . . 1.0 110.011 -179.094 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.584 0 N-CA-C 109.513 -1.435 . . . . 1.0 109.513 179.775 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.7 mt . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.367 0.603 . . . . 1.0 109.703 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -160.67 160.01 31.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.357 -0.839 . . . . 1.0 109.405 179.776 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 47.6 m95 -75.28 125.39 28.88 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.091 -1.005 . . . . 1.0 109.249 -179.923 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.7 p -73.28 -29.49 62.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.02 -1.05 . . . . 1.0 109.518 179.877 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -92.07 139.08 30.99 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.304 -0.999 . . . . 1.0 108.304 179.405 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.613 ' N ' ' SD ' ' A' ' 13' ' ' MET . 3.5 mmm -90.62 0.07 57.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.251 -0.906 . . . . 1.0 109.828 -178.372 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -98.17 125.86 43.39 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.707 -0.849 . . . . 1.0 108.707 179.46 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.7 mt -138.7 152.25 47.85 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.202 -0.937 . . . . 1.0 109.307 -179.503 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.6 p -132.98 154.16 50.76 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.997 -0.742 . . . . 1.0 108.997 -179.953 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -144.29 159.99 41.75 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.131 -0.981 . . . . 1.0 109.848 -179.656 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.537 ' NE ' ' O ' ' A' ' 56' ' ' GLY . 25.2 ttm-85 -142.17 134.54 27.88 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.397 -0.814 . . . . 1.0 109.585 -179.721 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 87.1 mt -87.92 117.97 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.482 -0.933 . . . . 1.0 108.482 178.73 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.9 t -69.32 -38.8 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.172 -0.955 . . . . 1.0 109.417 -179.32 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -159.19 157.88 31.62 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 122.217 1.008 . . . . 1.0 111.5 179.424 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.488 ' O ' ' O ' ' A' ' 23' ' ' THR . 15.5 m-85 -112.13 77.02 1.01 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 103.678 -2.712 . . . . 1.0 103.678 176.652 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.488 ' O ' ' O ' ' A' ' 22' ' ' TYR . 5.4 t -29.15 150.84 0.03 OUTLIER Pre-proline 0 C--N 1.282 -2.341 0 CA-C-N 115.741 -0.663 . . . . 1.0 112.178 -177.535 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -65.15 -6.55 13.31 Favored 'Trans proline' 0 N--CA 1.5 1.855 0 C-N-CA 121.275 1.317 . . . . 1.0 113.383 -178.56 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -59.15 -37.78 78.14 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 119.509 -0.876 . . . . 1.0 110.285 179.839 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 73.4 mtm -138.75 162.64 34.2 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.142 -0.974 . . . . 1.0 109.591 -179.776 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.4 p -71.45 160.4 32.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.363 -0.836 . . . . 1.0 109.436 -179.663 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.476 ' CD2' ' HB2' ' A' ' 22' ' ' TYR . 23.4 m170 -60.01 -40.44 89.26 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.313 -0.867 . . . . 1.0 109.869 -179.178 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.2 m -60.03 -42.48 94.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.136 -0.977 . . . . 1.0 110.501 -179.416 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.09 -40.0 82.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.085 -1.01 . . . . 1.0 110.023 -179.638 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 70.2 t -67.56 -44.84 86.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.164 -0.96 . . . . 1.0 110.288 -179.233 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -59.99 -49.42 77.75 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.139 -0.976 . . . . 1.0 111.13 -178.896 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -60.48 -33.47 72.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.818 -1.176 . . . . 1.0 109.847 -179.537 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.0 -49.97 75.57 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.967 -1.083 . . . . 1.0 109.95 -179.538 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -66.56 -38.81 87.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.912 -1.117 . . . . 1.0 109.894 -179.886 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.97 -42.42 94.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.078 -1.014 . . . . 1.0 109.514 -179.256 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -60.07 -39.96 87.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.133 -0.98 . . . . 1.0 109.137 179.394 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.06 -48.35 82.09 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.31 -0.868 . . . . 1.0 109.851 -179.592 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -66.26 -39.18 89.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 1.0 110.075 -179.747 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -60.01 -48.78 80.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.063 -1.023 . . . . 1.0 109.448 -179.248 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 86.2 t -59.98 -40.04 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.104 -0.997 . . . . 1.0 110.566 -179.376 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -81.47 -33.66 31.85 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.902 -1.124 . . . . 1.0 110.005 -179.555 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 94.3 p -72.05 -21.15 61.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.895 -1.128 . . . . 1.0 109.78 179.89 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.96 -39.98 87.47 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.243 -0.911 . . . . 1.0 110.626 -179.589 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 m -110.98 24.48 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 O-C-N 121.27 -0.894 . . . . 1.0 110.682 -179.118 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.5 p -149.15 135.23 10.05 Favored Pre-proline 0 N--CA 1.5 2.061 0 O-C-N 120.761 -1.212 . . . . 1.0 109.505 179.376 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -73.87 16.39 0.53 Allowed 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 120.693 0.928 . . . . 1.0 111.901 179.083 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 93.9 mt -68.31 139.35 55.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.071 -1.018 . . . . 1.0 109.756 -179.423 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -110.71 120.81 43.62 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.954 -0.758 . . . . 1.0 108.954 -179.961 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -108.38 123.49 48.92 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.393 -0.817 . . . . 1.0 109.466 -179.492 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -120.03 130.01 54.51 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.7 -0.625 . . . . 1.0 109.327 179.885 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -83.95 132.87 34.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.216 -0.927 . . . . 1.0 109.285 179.696 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.507 ' C ' HH12 ' A' ' 18' ' ' ARG . 91.2 mt -102.2 139.73 37.42 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.23 -0.919 . . . . 1.0 108.915 179.67 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.438 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 41.5 m170 -69.52 -40.0 77.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 1.0 110.228 -179.306 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.52 ' O ' ' NH2' ' A' ' 18' ' ' ARG . 70.4 m-20 -153.44 179.68 8.56 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.024 -1.047 . . . . 1.0 109.885 -179.636 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.537 ' O ' ' NE ' ' A' ' 18' ' ' ARG . . . 92.39 -170.84 33.06 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.75 -1.34 . . . . 1.0 109.75 179.928 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.0 mt -97.11 131.36 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.337 -1.096 . . . . 1.0 109.221 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.23 166.11 11.11 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.354 -0.841 . . . . 1.0 109.21 -179.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.01 -49.22 78.53 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.128 -0.982 . . . . 1.0 108.915 -179.928 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.5 mt -119.96 114.12 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.676 -0.64 . . . . 1.0 109.389 179.31 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.5 ptp -101.71 138.29 38.89 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.254 -0.904 . . . . 1.0 108.999 179.126 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.6 mt -109.99 131.86 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.359 -0.838 . . . . 1.0 109.794 -179.133 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 71.6 p -150.01 160.68 43.44 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.224 -0.923 . . . . 1.0 109.974 -179.541 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -107.13 122.57 46.75 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.463 -0.773 . . . . 1.0 109.388 179.987 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' A' ' 100' ' ' ASP . . . -96.45 167.67 24.88 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.208 -1.557 . . . . 1.0 109.208 179.6 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 11.3 tt . . . . . 0 N--CA 1.496 1.838 0 O-C-N 121.277 -1.131 . . . . 1.0 109.671 -179.4 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.493 ' CD2' ' OD1' ' A' ' 99' ' ' ASP . 33.1 m-85 . . . . . 0 N--CA 1.497 1.909 0 N-CA-C 109.162 -0.681 . . . . 1.0 109.162 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 79' ' ' SER . 32.8 p-10 -99.8 1.81 43.45 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.144 -0.972 . . . . 1.0 111.538 -178.425 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.406 ' O ' ' OE2' ' A' ' 102' ' ' GLU . . . 111.93 -117.91 4.58 Favored Glycine 0 N--CA 1.508 3.463 0 O-C-N 120.93 -1.106 . . . . 1.0 111.144 178.69 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.466 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 28.3 Cg_endo -73.51 -73.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.948 0 CA-C-N 120.015 1.908 . . . . 1.0 113.399 -178.88 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.451 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 99.2 p -78.17 173.89 11.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.949 -1.095 . . . . 1.0 109.475 -179.366 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 106.04 -134.39 12.09 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 110.152 -1.179 . . . . 1.0 110.152 179.64 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.459 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 19.6 mt -71.91 117.73 13.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.592 -0.946 . . . . 1.0 109.843 -179.397 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 66.1 mt -85.09 -22.77 28.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.986 -1.071 . . . . 1.0 109.127 179.343 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.13 174.46 1.05 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.86 -0.793 . . . . 1.0 108.86 -179.741 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.68 163.3 27.02 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.242 -0.911 . . . . 1.0 109.492 179.276 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -153.72 162.27 41.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.391 -0.818 . . . . 1.0 108.885 -179.743 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -106.41 151.11 40.21 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.373 -0.829 . . . . 1.0 108.85 179.754 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -66.27 164.48 27.92 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 120.768 0.979 . . . . 1.0 111.785 179.604 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.49 1.279 0 C-N-CA 121.037 1.158 . . . . 1.0 111.836 179.762 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.9 p-10 . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 109.178 -0.675 . . . . 1.0 109.178 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.95 129.64 14.1 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.038 -1.039 . . . . 1.0 109.671 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -127.18 132.39 50.49 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.557 -0.714 . . . . 1.0 109.679 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -109.97 156.74 20.07 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.652 -0.655 . . . . 1.0 109.462 -179.798 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.493 ' OD1' ' CD2' ' A' ' 75' ' ' PHE . 90.8 m-20 -80.06 130.14 35.03 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.014 -1.054 . . . . 1.0 109.816 179.455 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.532 ' N ' ' O ' ' A' ' 65' ' ' GLY . 8.3 t70 -87.75 -6.77 58.02 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.274 -0.891 . . . . 1.0 109.491 179.412 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -83.53 -10.22 58.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.237 -0.914 . . . . 1.0 110.08 -179.519 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.466 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 42.0 mm-40 -90.58 173.88 7.82 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.161 -0.962 . . . . 1.0 109.5 -179.171 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 56.2 m -105.26 107.48 18.49 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.458 -0.941 . . . . 1.0 108.458 179.152 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -86.55 121.37 28.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.243 -0.911 . . . . 1.0 109.3 -179.506 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.6 t -143.12 156.33 44.77 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.538 -0.726 . . . . 1.0 109.605 -179.273 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 29.4 t -95.31 -7.26 39.21 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.332 -0.988 . . . . 1.0 108.332 178.924 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 68.3 m -91.03 179.78 5.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.565 -0.709 . . . . 1.0 109.226 179.624 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 99.4 p -79.82 68.62 5.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.232 -0.917 . . . . 1.0 109.806 -179.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -143.18 149.51 38.11 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.2 -0.937 . . . . 1.0 108.809 179.5 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.51 -144.02 3.34 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.688 -1.365 . . . . 1.0 109.688 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -100.21 117.43 34.43 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.343 -1.092 . . . . 1.0 109.034 179.625 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.449 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 20.2 t-20 -62.26 132.66 53.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.912 . . . . 1.0 109.545 179.998 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.8 tp -59.96 -43.51 95.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.34 -0.85 . . . . 1.0 110.487 -179.498 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -59.97 -41.11 91.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.027 -1.046 . . . . 1.0 110.784 -178.485 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -58.49 -50.78 72.5 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.683 -1.261 . . . . 1.0 109.188 -179.584 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.0 t -70.04 -40.11 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.127 -0.983 . . . . 1.0 109.681 -179.556 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.94 -52.68 64.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.188 -0.945 . . . . 1.0 109.864 -179.341 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.99 -34.84 73.86 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.651 -1.281 . . . . 1.0 109.887 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -65.3 -50.05 67.16 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.264 -0.897 . . . . 1.0 111.617 -178.426 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -60.0 -40.01 87.75 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.63 -1.293 . . . . 1.0 109.408 -178.72 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -59.99 -40.03 87.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.026 -1.046 . . . . 1.0 108.723 179.879 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.31 -46.41 63.73 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.166 -1.573 . . . . 1.0 109.166 179.847 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.41 ' NE2' ' NE2' ' A' ' 129' ' ' HIS . 79.0 m-70 -65.26 -40.02 93.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.229 -1.159 . . . . 1.0 109.611 179.607 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 84.1 p -66.77 -23.95 66.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 1.0 109.998 -179.754 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 78.4 mt -82.26 -2.27 52.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.128 -0.983 . . . . 1.0 110.046 -179.544 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.57 6.24 68.24 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 110.443 -1.063 . . . . 1.0 110.443 179.357 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.3 mt -84.68 149.08 26.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.053 -1.263 . . . . 1.0 109.07 179.501 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 36.1 t0 -103.27 170.35 8.01 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.764 -0.828 . . . . 1.0 108.764 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.477 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 28.0 m170 -58.53 135.16 57.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.012 -1.055 . . . . 1.0 109.356 -179.631 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 41.9 t -98.18 155.29 17.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.382 -0.824 . . . . 1.0 109.106 179.879 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -98.05 5.58 48.55 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.23 -0.919 . . . . 1.0 110.014 -179.512 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -85.88 126.68 65.05 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 108.121 -1.066 . . . . 1.0 108.121 179.275 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -68.45 -8.81 24.14 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 CA-C-N 120.186 1.102 . . . . 1.0 112.011 -179.615 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -96.44 -7.52 58.03 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.509 -1.437 . . . . 1.0 109.509 179.863 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.87 137.05 33.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.133 -1.216 . . . . 1.0 109.412 179.814 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.471 ' C ' ' H ' ' A' ' 138' ' ' PHE . 64.7 mt -60.03 -39.84 87.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.121 -0.987 . . . . 1.0 110.239 179.86 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 89.8 mtp -71.28 25.52 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.275 -0.891 . . . . 1.0 111.417 -178.463 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.471 ' H ' ' C ' ' A' ' 136' ' ' LEU . 16.2 t80 -69.22 136.44 89.08 Favored Pre-proline 0 N--CA 1.498 1.955 0 N-CA-C 107.459 -1.311 . . . . 1.0 107.459 178.787 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -60.65 -14.28 30.48 Favored 'Trans proline' 0 N--CA 1.5 1.902 0 CA-C-N 120.185 1.102 . . . . 1.0 114.196 -178.062 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.403 HG22 HD12 ' A' ' 140' ' ' ILE . 96.3 mt -109.95 139.07 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 O-C-N 121.014 -1.054 . . . . 1.0 109.697 -179.693 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.449 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 34.2 t80 -74.12 125.42 28.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.354 -0.841 . . . . 1.0 110.119 -179.324 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 7.4 t -136.6 142.94 43.34 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.997 -0.742 . . . . 1.0 108.997 179.812 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -80.67 143.29 33.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.932 -1.105 . . . . 1.0 109.746 -179.775 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.4 m -134.71 138.59 44.52 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.531 -0.73 . . . . 1.0 109.838 -179.475 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 147' ' ' SER . . . -68.0 99.91 0.59 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 107.97 -2.052 . . . . 1.0 107.97 178.658 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -74.46 17.09 0.21 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -1.129 . . . . 1.0 110.484 -178.475 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.42 ' H ' ' C ' ' A' ' 145' ' ' GLY . 41.1 t -57.67 -46.57 84.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.905 -1.122 . . . . 1.0 109.31 -179.853 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -147.72 33.99 0.85 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.147 -0.971 . . . . 1.0 109.368 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -63.73 138.03 58.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.2 -0.938 . . . . 1.0 110.953 -179.104 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 74.0 mtm -134.11 148.53 51.0 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.133 -1.062 . . . . 1.0 108.133 178.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 70.7 mt -53.3 129.12 51.06 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 120.918 -1.114 . . . . 1.0 108.867 -179.862 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -69.52 177.05 5.8 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 CA-C-N 120.074 1.062 . . . . 1.0 112.019 179.643 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -60.29 -39.95 88.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.868 . . . . 1.0 110.023 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -55.55 -48.94 73.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.245 -0.91 . . . . 1.0 110.054 -179.047 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -70.03 -40.02 75.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.152 -0.967 . . . . 1.0 110.34 -179.63 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 60.3 t -60.03 -48.81 86.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.027 -1.046 . . . . 1.0 109.124 -179.556 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -60.0 -39.98 87.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.128 -0.983 . . . . 1.0 110.44 179.97 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.06 -54.59 7.93 Favored Glycine 0 N--CA 1.493 2.49 0 O-C-N 121.136 -0.978 . . . . 1.0 111.382 -178.35 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 7.1 tp -59.98 -40.11 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.937 -1.331 . . . . 1.0 109.618 -179.026 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.546 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.7 mt-30 -66.61 -39.93 88.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 1.0 109.594 179.597 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 83.1 p -61.52 -31.12 71.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.143 -0.973 . . . . 1.0 110.74 -179.308 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 88.6 mt -86.84 -51.36 6.12 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.779 -1.201 . . . . 1.0 110.551 -179.041 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -90.83 -9.16 47.46 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.984 -1.073 . . . . 1.0 109.931 -179.273 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.524 0 N-CA-C 109.489 -1.444 . . . . 1.0 109.489 -179.866 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.1 mt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.565 0.697 . . . . 1.0 110.04 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -160.6 160.2 31.43 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.471 -0.768 . . . . 1.0 109.018 179.598 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -73.45 147.95 43.69 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.13 -0.981 . . . . 1.0 109.463 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.3 p -84.93 0.13 52.28 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.203 -0.936 . . . . 1.0 109.742 -179.636 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -145.77 153.11 40.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.197 -0.939 . . . . 1.0 109.384 -179.877 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.2 mmt -90.02 -0.73 57.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.257 -0.902 . . . . 1.0 109.129 -179.645 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -96.19 128.2 42.88 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.341 -0.85 . . . . 1.0 108.989 -179.994 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.3 mt -140.02 150.17 44.09 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.232 -0.917 . . . . 1.0 109.04 -179.799 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 59.5 p -131.09 156.14 45.73 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.907 -0.775 . . . . 1.0 108.907 179.937 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.527 ' HH ' ' HE ' ' A' ' 52' ' ' ARG . 48.4 p90 -146.06 160.06 42.41 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.133 -0.98 . . . . 1.0 110.055 -179.672 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.57 HH12 ' H ' ' A' ' 56' ' ' GLY . 70.5 ttt180 -142.86 135.31 27.57 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.421 -0.8 . . . . 1.0 109.355 -179.939 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.5 mt -87.78 120.0 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.254 -0.904 . . . . 1.0 108.708 179.185 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 67.0 t -67.72 -39.04 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -0.925 . . . . 1.0 108.887 -179.812 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.44 ' OD1' ' N ' ' A' ' 21' ' ' ASN . 22.0 p-10 -160.61 152.9 20.44 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 119.937 -1.727 . . . . 1.0 111.289 179.687 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.644 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 33.3 m-85 -101.28 74.96 1.59 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 106.612 -1.625 . . . . 1.0 106.612 177.118 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.476 ' C ' ' O ' ' A' ' 22' ' ' TYR . 3.9 t -24.54 143.14 0.04 OUTLIER Pre-proline 0 N--CA 1.508 2.433 0 N-CA-C 112.069 0.396 . . . . 1.0 112.069 -177.786 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -62.58 -5.86 7.83 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 121.247 1.298 . . . . 1.0 112.743 -179.285 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -59.48 -36.93 76.94 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.424 -0.797 . . . . 1.0 109.939 179.704 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 78.2 mtm -138.53 161.23 37.58 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.194 -0.941 . . . . 1.0 109.556 -179.772 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.1 p -71.62 160.19 33.11 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.37 -0.831 . . . . 1.0 109.127 -179.878 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.644 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 2.1 m80 -59.96 -40.59 89.58 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.346 -0.846 . . . . 1.0 110.22 -179.083 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 74.9 m -61.28 -40.47 94.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.098 -1.001 . . . . 1.0 110.275 -179.587 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.35 -39.97 77.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.207 -0.933 . . . . 1.0 110.383 -179.478 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 77.2 t -68.29 -43.56 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.139 -0.975 . . . . 1.0 110.134 -179.258 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.01 -49.4 77.82 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.19 -0.944 . . . . 1.0 110.87 -179.063 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -61.47 -32.86 72.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.885 -1.134 . . . . 1.0 110.112 -179.531 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.97 -49.67 76.77 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.906 -1.121 . . . . 1.0 109.713 -179.579 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -66.27 -38.77 88.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.993 -1.067 . . . . 1.0 109.723 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -59.99 -43.37 95.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.045 -1.034 . . . . 1.0 109.795 -179.619 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -60.1 -41.24 92.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.99 -1.069 . . . . 1.0 109.475 179.58 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.29 -46.69 88.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.331 -0.856 . . . . 1.0 110.133 -179.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -67.2 -38.58 85.56 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.05 -1.031 . . . . 1.0 110.001 -179.767 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -59.96 -48.84 80.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.097 -1.002 . . . . 1.0 109.839 -179.349 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 79.7 t -60.09 -40.14 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.144 -0.973 . . . . 1.0 110.113 -179.412 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 69.2 m95 -81.35 -36.57 29.49 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.008 -1.058 . . . . 1.0 110.08 -179.413 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.3 p -70.19 -21.54 63.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.032 -1.043 . . . . 1.0 109.891 -179.632 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.07 -39.87 87.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.29 -0.881 . . . . 1.0 110.666 -179.739 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.463 ' O ' ' NE2' ' A' ' 160' ' ' GLN . 11.3 m -109.76 24.21 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.28 -0.888 . . . . 1.0 110.471 -178.824 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 43.3 p -149.83 134.41 9.32 Favored Pre-proline 0 N--CA 1.499 2.003 0 O-C-N 120.92 -1.113 . . . . 1.0 109.54 179.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -74.18 17.42 0.51 Allowed 'Trans proline' 0 N--CA 1.493 1.455 0 CA-C-N 119.702 0.929 . . . . 1.0 111.86 178.882 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 72.6 mt -68.53 139.9 55.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.117 -0.989 . . . . 1.0 109.413 -179.608 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -109.99 120.51 42.7 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 179.851 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -109.53 119.79 40.52 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.398 -0.814 . . . . 1.0 109.0 -179.687 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -120.06 130.03 54.49 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.533 -0.73 . . . . 1.0 109.944 -179.84 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.527 ' HE ' ' HH ' ' A' ' 17' ' ' TYR . 42.1 ttm180 -82.25 135.25 35.27 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.253 -0.904 . . . . 1.0 109.104 179.28 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.9 mt -101.3 129.29 47.25 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.161 -0.962 . . . . 1.0 109.483 -179.956 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.445 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 60.1 m170 -61.79 -40.0 93.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.413 -0.804 . . . . 1.0 109.443 179.879 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 77.9 m-20 -148.84 168.88 21.81 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.251 -0.906 . . . . 1.0 109.449 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.57 ' H ' HH12 ' A' ' 18' ' ' ARG . . . 98.72 178.07 32.31 Favored Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.54 -1.424 . . . . 1.0 109.54 -179.956 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.42 HG23 HD13 ' A' ' 57' ' ' ILE . 86.4 mt -95.87 135.06 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.241 -1.152 . . . . 1.0 109.291 179.863 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.02 160.76 16.15 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.492 -0.755 . . . . 1.0 109.155 -179.75 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -60.04 -49.51 77.38 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.17 -0.956 . . . . 1.0 109.306 -179.747 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.405 HG23 HD13 ' A' ' 60' ' ' ILE . 96.8 mt -105.37 103.51 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.356 -0.84 . . . . 1.0 109.978 179.883 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.1 ptp -100.43 133.96 44.08 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.188 -0.945 . . . . 1.0 108.766 178.773 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.4 mt -110.08 131.37 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.443 -0.785 . . . . 1.0 110.045 -178.56 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.1 p -150.56 160.3 43.89 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.153 -0.967 . . . . 1.0 109.93 -179.702 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -104.8 123.55 47.88 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 179.592 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 98' ' ' PHE . . . -95.55 -175.9 37.11 Favored Glycine 0 N--CA 1.499 2.894 0 N-CA-C 110.544 -1.023 . . . . 1.0 110.544 -179.274 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.434 HD11 HG22 ' A' ' 66' ' ' ILE . 61.1 mt . . . . . 0 N--CA 1.501 2.083 0 O-C-N 121.446 -1.031 . . . . 1.0 109.442 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.529 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 87.8 m-85 . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 121.274 0.559 . . . . 1.0 109.739 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -102.11 16.12 27.03 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.361 -0.837 . . . . 1.0 110.746 -178.86 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 114.93 -157.51 14.94 Favored Glycine 0 N--CA 1.505 3.285 0 N-CA-C 109.55 -1.42 . . . . 1.0 109.55 179.617 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -58.37 -65.75 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.469 0 CA-C-N 118.568 1.184 . . . . 1.0 112.406 -179.742 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 89.7 p -76.03 162.17 28.28 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.181 -0.949 . . . . 1.0 109.65 -179.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.17 -129.09 8.29 Favored Glycine 0 N--CA 1.502 3.058 0 N-CA-C 109.836 -1.306 . . . . 1.0 109.836 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.1 mt -69.63 107.58 3.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.323 -1.104 . . . . 1.0 109.077 -179.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 56.7 mt -78.47 -26.54 46.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.896 . . . . 1.0 108.924 179.982 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.53 164.46 1.64 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.342 -0.984 . . . . 1.0 108.342 -179.715 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -160.35 162.74 33.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.128 -0.982 . . . . 1.0 109.44 179.493 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -145.76 160.0 42.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.283 -0.886 . . . . 1.0 109.583 -179.645 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -93.88 152.97 40.99 Favored Pre-proline 0 N--CA 1.492 1.661 0 N-CA-C 107.944 -1.132 . . . . 1.0 107.944 179.433 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -56.95 165.79 4.64 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 CA-C-N 119.166 0.738 . . . . 1.0 111.673 179.778 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo . . . . . 0 N--CA 1.493 1.488 0 C-N-CA 121.346 1.364 . . . . 1.0 112.112 -179.564 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 121.281 0.562 . . . . 1.0 109.756 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.14 123.39 8.93 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.391 -0.818 . . . . 1.0 109.574 179.812 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -112.4 128.51 56.33 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.591 -0.693 . . . . 1.0 109.344 179.753 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.477 ' O ' ' N ' ' A' ' 65' ' ' GLY . 22.7 m-85 -107.71 155.85 19.73 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.478 -0.764 . . . . 1.0 109.063 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.529 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 1.3 m-20 -79.05 120.54 23.76 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.625 -1.297 . . . . 1.0 110.081 -179.616 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 65' ' ' GLY . 40.9 t0 -83.1 -11.88 57.58 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.171 -0.956 . . . . 1.0 108.947 179.389 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -83.17 -10.48 58.6 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.289 -0.882 . . . . 1.0 109.292 -179.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -92.46 170.05 10.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.395 -0.816 . . . . 1.0 109.155 -179.872 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 31.3 m -100.13 106.01 17.68 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.246 -0.909 . . . . 1.0 109.26 -179.76 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.445 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 94.5 m95 -88.76 123.39 33.13 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.568 -0.901 . . . . 1.0 108.568 179.537 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.1 t -140.05 154.84 47.2 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.355 -0.841 . . . . 1.0 109.942 -179.006 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 87.9 p -94.71 -5.51 45.3 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.284 -1.006 . . . . 1.0 108.284 179.011 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 31.4 t -94.47 178.95 5.44 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.709 -0.849 . . . . 1.0 108.709 179.35 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.2 m -80.2 76.84 6.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.962 -1.086 . . . . 1.0 109.599 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -148.52 149.39 31.54 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.257 -0.902 . . . . 1.0 108.678 179.429 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.22 -136.98 5.31 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.096 -1.202 . . . . 1.0 110.096 179.695 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -100.07 118.6 36.77 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.403 -1.057 . . . . 1.0 109.21 179.689 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.691 ' H ' ' HH ' ' A' ' 141' ' ' TYR . 2.6 t-20 -65.09 131.5 46.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.086 -1.009 . . . . 1.0 109.765 179.992 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.5 tp -60.01 -43.11 95.43 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.372 -0.83 . . . . 1.0 110.084 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -60.0 -43.01 95.48 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.27 -0.894 . . . . 1.0 111.214 -178.584 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.411 ' N ' HD22 ' A' ' 115' ' ' LEU . 4.0 mm? -60.03 -50.02 75.37 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.655 -1.278 . . . . 1.0 109.347 -179.182 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 75.5 t -69.95 -40.29 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.099 -1.0 . . . . 1.0 109.95 -179.405 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.12 -50.02 75.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.145 -0.972 . . . . 1.0 109.746 -179.306 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.84 -36.51 77.0 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.739 -1.226 . . . . 1.0 109.631 179.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.632 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 63.5 t60 -64.99 -49.97 68.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.129 -0.982 . . . . 1.0 111.541 -178.637 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.4 ' C ' ' OE1' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -59.98 -40.02 87.67 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.519 -1.363 . . . . 1.0 109.873 -178.731 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -60.04 -40.05 88.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.928 -1.107 . . . . 1.0 108.35 179.746 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -54.61 -44.13 78.95 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.128 -1.589 . . . . 1.0 109.128 179.717 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.632 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 85.9 m-70 -67.29 -39.99 86.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.194 -1.18 . . . . 1.0 109.828 179.66 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.9 p -66.0 -21.7 66.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.928 . . . . 1.0 109.115 179.888 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 76.2 mt -82.52 -0.84 48.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.39 -0.819 . . . . 1.0 110.028 -179.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 89.43 7.31 69.62 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.392 -1.083 . . . . 1.0 110.392 179.282 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.5 mt -84.57 150.13 25.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.898 -1.354 . . . . 1.0 110.092 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 10.0 t70 -101.09 171.13 7.81 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.509 -0.744 . . . . 1.0 109.066 179.509 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.515 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 75.2 m80 -59.65 137.38 58.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.088 -1.007 . . . . 1.0 109.555 -179.78 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 38.6 t -98.55 154.28 18.03 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.315 -0.865 . . . . 1.0 109.322 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -100.17 6.75 44.83 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.39 -0.819 . . . . 1.0 109.748 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -86.58 127.97 58.54 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.136 -0.978 . . . . 1.0 108.563 179.617 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -67.99 -20.21 44.93 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 CA-C-N 120.181 1.1 . . . . 1.0 112.169 -179.818 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -88.47 -4.98 76.07 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.621 -1.392 . . . . 1.0 109.621 -179.865 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.16 145.75 26.87 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.269 -1.136 . . . . 1.0 109.707 179.897 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.459 ' C ' ' H ' ' A' ' 138' ' ' PHE . 84.6 mt -70.05 -33.84 72.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.891 . . . . 1.0 109.553 179.887 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 80.3 mtp -74.41 23.36 0.09 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 1.0 110.481 -179.215 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.459 ' H ' ' C ' ' A' ' 136' ' ' LEU . 12.7 t80 -69.62 133.52 88.73 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 107.409 -1.33 . . . . 1.0 107.409 179.305 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -59.25 -9.94 9.51 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 CA-C-N 120.01 1.039 . . . . 1.0 113.785 -177.896 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 95.4 mt -113.9 138.36 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 O-C-N 121.123 -0.985 . . . . 1.0 109.686 -179.919 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.691 ' HH ' ' H ' ' A' ' 112' ' ' ASN . 43.1 t80 -73.37 131.12 41.5 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.461 -0.774 . . . . 1.0 110.068 -179.351 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.1 t -141.97 133.38 26.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.36 -0.838 . . . . 1.0 109.282 179.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -80.71 134.41 35.84 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.139 -0.975 . . . . 1.0 109.58 -179.909 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.8 t -130.91 147.34 52.54 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.376 -0.828 . . . . 1.0 109.406 -179.939 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -66.65 102.91 0.81 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.574 -1.411 . . . . 1.0 109.574 -179.729 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 147' ' ' SER . 8.5 mtmp? -71.34 140.68 50.32 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.301 -1.117 . . . . 1.0 109.468 179.934 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.442 ' CB ' ' O ' ' A' ' 146' ' ' LYS . 1.2 t 165.99 -89.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.844 -0.798 . . . . 1.0 108.844 -179.884 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . 0.477 ' O ' ' ND1' ' A' ' 148' ' ' HIS . 54.9 t-80 -97.79 15.53 23.44 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.615 -0.883 . . . . 1.0 108.615 179.484 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -60.43 137.36 58.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.583 -0.698 . . . . 1.0 110.005 -179.811 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 97.2 mmm -136.33 149.53 48.44 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.555 -0.905 . . . . 1.0 108.555 179.301 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 24.6 mt -53.18 129.78 50.46 Favored Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 120.981 -1.074 . . . . 1.0 108.63 -179.802 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -66.39 176.25 4.25 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 CA-C-N 120.01 1.039 . . . . 1.0 112.295 -179.813 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.05 -39.91 87.58 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.366 -0.834 . . . . 1.0 109.475 179.799 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -56.15 -49.94 72.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.311 -0.868 . . . . 1.0 109.939 -179.204 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -70.78 -39.99 72.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.071 -1.018 . . . . 1.0 110.308 -179.473 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 63.7 t -60.11 -47.55 91.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.083 -1.01 . . . . 1.0 109.424 -179.634 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -60.48 -40.01 89.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.847 -1.158 . . . . 1.0 110.182 -179.815 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.45 -54.4 10.69 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 120.272 -0.966 . . . . 1.0 111.323 -178.716 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 8.4 tp -59.98 -39.98 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.867 -1.372 . . . . 1.0 109.533 -179.075 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.486 ' O ' ' N ' ' A' ' 164' ' ' GLY . 91.9 mm-40 -64.63 -39.9 94.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.269 -0.894 . . . . 1.0 109.27 179.48 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 82.5 p -61.8 -29.18 69.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.286 -0.884 . . . . 1.0 110.812 -179.334 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 94.4 mt -86.38 -56.44 3.43 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.801 -1.187 . . . . 1.0 110.819 -179.133 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -89.94 -9.62 48.15 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.004 -1.06 . . . . 1.0 110.445 -178.712 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.497 2.715 0 N-CA-C 109.362 -1.495 . . . . 1.0 109.362 -179.995 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.9 mt . . . . . 0 N--CA 1.495 1.785 0 N-CA-C 109.379 -0.6 . . . . 1.0 109.379 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.02 160.0 35.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 1.0 109.463 179.717 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -74.43 149.47 40.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.38 -0.825 . . . . 1.0 109.987 -179.525 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.7 m -89.93 1.77 55.85 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.354 -0.841 . . . . 1.0 110.361 -179.643 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -141.62 153.77 44.97 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.09 -1.006 . . . . 1.0 109.619 -179.701 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.3 mmt -90.15 0.02 57.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.404 -0.81 . . . . 1.0 110.234 -178.889 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -96.84 129.63 44.24 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.127 -0.983 . . . . 1.0 109.687 -179.837 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.1 mt -142.32 146.74 35.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.26 -0.9 . . . . 1.0 109.033 179.744 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 70.0 p -130.1 160.12 34.71 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.625 -0.88 . . . . 1.0 108.625 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -146.42 159.93 42.74 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.088 -1.007 . . . . 1.0 110.381 179.98 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.456 ' HG2' HH11 ' A' ' 18' ' ' ARG . 1.9 tpt180 -145.38 129.83 17.84 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.294 -0.632 . . . . 1.0 109.294 -179.03 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.1 mt -89.38 117.27 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.137 -0.977 . . . . 1.0 108.542 178.742 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.6 t -69.98 -40.7 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.094 -1.003 . . . . 1.0 109.565 -179.608 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -163.74 159.01 20.91 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.697 -1.252 . . . . 1.0 110.276 -179.908 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.471 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 56.7 m-85 -100.55 -160.72 0.82 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.218 -1.401 . . . . 1.0 107.218 178.933 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.16 149.78 74.22 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.226 -0.921 . . . . 1.0 109.91 -179.874 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -69.81 -13.31 34.37 Favored 'Trans proline' 0 N--CA 1.487 1.116 0 C-N-CA 120.611 0.874 . . . . 1.0 109.947 178.399 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -59.78 -38.52 82.12 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.798 -0.637 . . . . 1.0 109.832 -179.555 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 76.8 mtm -137.95 166.12 24.84 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.289 -0.882 . . . . 1.0 109.52 -179.611 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 67.8 p -72.75 160.34 32.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.369 -0.832 . . . . 1.0 109.333 -179.746 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.531 ' H ' ' HD1' ' A' ' 28' ' ' HIS . 3.5 m80 -60.11 -40.04 88.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.262 -0.899 . . . . 1.0 109.89 -179.552 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 74.1 m -60.1 -40.04 88.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.35 -0.844 . . . . 1.0 110.876 -179.244 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -68.1 -40.04 82.7 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.023 -1.048 . . . . 1.0 110.479 -179.167 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.1 t -69.37 -40.32 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.064 -1.022 . . . . 1.0 110.133 -179.329 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.05 -49.01 79.33 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.055 -1.028 . . . . 1.0 110.412 -179.241 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.66 -32.38 72.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.9 -1.125 . . . . 1.0 109.755 -179.776 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.87 -49.36 77.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.002 -1.061 . . . . 1.0 109.536 -179.428 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -66.6 -39.14 88.25 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.13 -0.981 . . . . 1.0 109.856 179.846 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.96 -41.79 92.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.968 -1.082 . . . . 1.0 109.673 -179.321 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -60.1 -42.11 93.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.104 -0.997 . . . . 1.0 109.743 179.374 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.56 -48.07 83.41 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.223 -0.923 . . . . 1.0 110.317 -179.811 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.501 ' CZ ' ' CZ ' ' A' ' 121' ' ' PHE . 49.8 m-85 -64.27 -39.96 95.0 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.104 -0.997 . . . . 1.0 109.572 -179.415 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -59.98 -47.6 85.15 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.504 -0.748 . . . . 1.0 109.454 -179.069 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.2 t -59.94 -40.16 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.008 -1.057 . . . . 1.0 109.81 -179.683 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.429 ' O ' ' OG1' ' A' ' 46' ' ' THR . 71.9 m95 -78.69 -32.56 47.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.193 -0.942 . . . . 1.0 110.014 -179.714 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 85.3 p -71.39 -14.63 62.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.073 -1.017 . . . . 1.0 109.683 179.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -59.91 -39.98 87.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.437 -0.79 . . . . 1.0 110.229 -179.679 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.6 m -114.58 -19.72 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.455 -0.778 . . . . 1.0 110.461 -179.001 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.443 ' C ' ' H ' ' A' ' 48' ' ' LEU . 66.4 p -95.25 121.48 62.0 Favored Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 120.757 -1.215 . . . . 1.0 109.405 179.432 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -73.15 20.84 0.34 Allowed 'Trans proline' 0 N--CA 1.493 1.491 0 CA-C-N 120.236 1.12 . . . . 1.0 111.601 179.153 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.443 ' H ' ' C ' ' A' ' 46' ' ' THR . 77.9 mt -68.86 140.03 55.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 1.0 109.525 -179.85 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -103.26 120.58 41.02 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.679 -0.859 . . . . 1.0 108.679 179.704 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -106.36 120.8 42.83 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.426 -0.796 . . . . 1.0 109.77 -179.194 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.8 m -120.06 130.01 54.49 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 121.498 0.666 . . . . 1.0 110.236 179.895 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.4 ' NH1' ' HG2' ' A' ' 52' ' ' ARG . 10.1 tpt180 -82.85 138.61 33.87 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.476 -0.765 . . . . 1.0 109.166 179.288 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 90.0 mt -106.47 129.99 54.34 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.308 -0.87 . . . . 1.0 108.755 179.166 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.425 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 62.3 m170 -60.0 -40.04 87.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.955 -1.091 . . . . 1.0 109.701 -179.427 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 73.4 m-20 -151.08 172.34 15.91 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.274 -0.891 . . . . 1.0 109.464 -179.71 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.97 -179.51 32.63 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.583 -1.407 . . . . 1.0 109.583 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.7 mt -95.62 133.63 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.374 -1.074 . . . . 1.0 109.401 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.96 162.55 14.42 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.477 -0.765 . . . . 1.0 109.095 -179.89 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -59.95 -48.82 80.14 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.207 -0.933 . . . . 1.0 109.091 179.868 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 93.1 mt -109.55 103.38 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.473 -0.767 . . . . 1.0 110.215 179.807 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.3 ptp -102.32 137.31 40.74 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.183 -0.948 . . . . 1.0 109.297 178.788 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 88.4 mt -109.95 130.47 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.575 -0.703 . . . . 1.0 109.743 -179.542 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.8 p -150.31 158.93 44.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.351 -0.843 . . . . 1.0 109.597 -179.615 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -99.97 128.5 46.05 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.434 -0.95 . . . . 1.0 108.434 179.413 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.6 150.6 16.99 Favored Glycine 0 N--CA 1.498 2.804 0 N-CA-C 110.185 -1.166 . . . . 1.0 110.185 -178.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 7.1 tt . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 108.158 -1.053 . . . . 1.0 108.158 179.407 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.533 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 97.9 m-85 . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 108.663 -0.865 . . . . 1.0 108.663 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -101.27 13.78 34.01 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.155 -0.965 . . . . 1.0 110.209 -179.296 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 117.12 -156.91 15.36 Favored Glycine 0 N--CA 1.502 3.047 0 N-CA-C 108.894 -1.682 . . . . 1.0 108.894 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -58.48 -65.38 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.451 0 CA-C-N 118.633 1.217 . . . . 1.0 112.267 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 90.6 p -76.85 164.18 26.07 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.183 -0.948 . . . . 1.0 109.815 -179.93 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.85 -129.45 8.65 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 109.587 -1.405 . . . . 1.0 109.587 179.88 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.44 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 13.2 mt -68.99 106.48 2.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.435 -1.038 . . . . 1.0 109.09 179.961 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 50.8 mt -78.71 -23.71 45.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.017 -1.052 . . . . 1.0 108.884 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.11 169.56 1.9 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.709 -0.849 . . . . 1.0 108.709 179.837 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -161.7 161.89 29.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.159 -0.963 . . . . 1.0 109.127 179.304 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.78 157.03 44.67 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.2 -0.938 . . . . 1.0 109.724 -179.355 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -93.63 151.96 40.45 Favored Pre-proline 0 N--CA 1.494 1.726 0 N-CA-C 108.483 -0.932 . . . . 1.0 108.483 179.691 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -42.16 160.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.243 0 C-N-CA 120.663 0.909 . . . . 1.0 111.667 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo . . . . . 0 N--CA 1.49 1.276 0 C-N-CA 120.645 0.897 . . . . 1.0 111.955 -179.52 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 121.428 0.632 . . . . 1.0 110.116 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.35 124.11 9.86 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.408 -0.808 . . . . 1.0 109.32 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -111.38 137.61 48.93 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.605 -0.684 . . . . 1.0 109.942 -179.752 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.526 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 27.3 m-85 -114.38 154.23 28.45 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 109.111 -0.699 . . . . 1.0 109.111 179.638 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.533 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 1.7 m-20 -78.54 123.66 27.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.056 -1.028 . . . . 1.0 109.522 179.759 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 43.7 t0 -83.93 -12.38 55.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.229 -0.92 . . . . 1.0 109.391 179.724 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -84.14 -10.01 58.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.352 -0.842 . . . . 1.0 109.871 -179.818 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -91.48 169.65 10.6 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.204 -0.935 . . . . 1.0 110.033 -179.241 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 15.9 m -100.05 106.25 17.99 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.432 -0.792 . . . . 1.0 108.917 -179.788 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -89.18 124.45 34.36 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.76 -0.83 . . . . 1.0 108.76 179.813 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.7 t -140.04 159.29 42.5 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.422 -0.799 . . . . 1.0 109.944 -179.103 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.4 t -96.88 -13.3 22.58 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.332 -0.855 . . . . 1.0 109.011 179.485 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 65.6 m -90.62 179.14 5.9 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.768 -0.827 . . . . 1.0 108.768 179.388 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.2 m -79.43 80.18 5.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.983 -1.073 . . . . 1.0 109.349 -179.893 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 110' ' ' GLY . 68.3 mttm -148.88 149.53 31.42 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.654 -0.869 . . . . 1.0 108.654 179.379 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 109' ' ' LYS . . . 44.36 -137.3 5.33 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.602 -1.399 . . . . 1.0 109.602 179.71 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -99.6 117.66 34.46 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.32 -1.106 . . . . 1.0 109.017 179.304 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.467 HD21 ' HZ2' ' A' ' 146' ' ' LYS . 53.7 t-20 -62.25 130.3 44.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.326 -0.858 . . . . 1.0 109.733 -179.738 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.9 tp -59.99 -41.88 93.0 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.321 -0.862 . . . . 1.0 110.211 -179.579 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -59.97 -40.12 87.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.179 -0.951 . . . . 1.0 110.505 -179.319 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.04 -51.21 71.05 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.746 -1.221 . . . . 1.0 109.883 -179.675 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.8 t -69.96 -40.37 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.131 -0.981 . . . . 1.0 109.961 -178.905 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.22 -52.6 65.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -0.91 . . . . 1.0 109.943 -179.422 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.03 -39.05 84.57 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.095 -1.003 . . . . 1.0 110.157 -179.769 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.632 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 70.3 t60 -64.05 -50.0 70.13 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.408 -0.808 . . . . 1.0 111.428 -178.272 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.526 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 10.5 pt-20 -60.03 -39.5 86.09 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.664 -1.272 . . . . 1.0 110.319 -179.168 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.501 ' CZ ' ' CZ ' ' A' ' 39' ' ' PHE . 29.6 m-85 -60.0 -40.02 87.76 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.716 -1.24 . . . . 1.0 108.574 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.91 -42.07 94.55 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.526 -1.43 . . . . 1.0 109.526 -179.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.632 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 84.6 m-70 -66.89 -39.99 87.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.068 -1.254 . . . . 1.0 109.228 179.522 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.5 p -66.71 -24.44 66.24 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.328 -0.858 . . . . 1.0 108.856 179.542 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 71.4 mt -81.67 -0.58 43.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.394 -0.816 . . . . 1.0 109.357 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 88.77 6.79 72.17 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 120.349 -0.929 . . . . 1.0 110.782 178.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.9 mt -82.74 146.37 29.04 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.782 -1.422 . . . . 1.0 109.644 179.78 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 33.5 t0 -99.33 173.13 6.92 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.926 -0.768 . . . . 1.0 108.926 -179.73 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.493 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 76.4 m80 -59.97 138.45 57.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.175 -0.953 . . . . 1.0 109.807 -179.422 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 33.3 t -97.09 156.51 16.34 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.267 -0.896 . . . . 1.0 109.208 179.739 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -99.86 1.57 43.04 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.318 -0.864 . . . . 1.0 109.663 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -87.03 130.17 49.26 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.18 -0.95 . . . . 1.0 108.913 179.797 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -69.39 -25.35 30.41 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 CA-C-N 120.099 1.071 . . . . 1.0 112.27 -179.622 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -83.58 -4.99 88.81 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.409 -1.476 . . . . 1.0 109.409 -179.805 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.89 145.34 26.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -1.162 . . . . 1.0 109.319 179.567 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.463 ' C ' ' H ' ' A' ' 138' ' ' PHE . 80.5 mt -69.5 -33.13 72.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.294 -0.879 . . . . 1.0 109.723 179.727 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 93.9 mmm -71.8 18.4 0.08 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.152 -0.967 . . . . 1.0 110.687 -179.463 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.463 ' H ' ' C ' ' A' ' 136' ' ' LEU . 13.2 t80 -69.79 133.14 88.51 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.735 -1.228 . . . . 1.0 107.89 179.819 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -62.94 -15.28 46.57 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 CA-C-N 119.905 1.002 . . . . 1.0 113.792 -178.116 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.415 HG23 HD12 ' A' ' 140' ' ' ILE . 97.0 mt -105.91 141.91 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 120.943 -1.098 . . . . 1.0 109.986 -179.392 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -74.95 129.72 38.14 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.397 -0.815 . . . . 1.0 109.691 -179.723 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.6 t -143.13 139.93 30.62 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.348 -0.845 . . . . 1.0 108.853 179.317 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -81.88 143.73 31.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.99 -1.069 . . . . 1.0 109.407 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.448 ' O ' ' NZ ' ' A' ' 146' ' ' LYS . 1.3 m -140.19 150.97 44.83 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.39 -0.819 . . . . 1.0 109.763 -179.314 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.38 112.18 3.65 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 107.717 -2.153 . . . . 1.0 107.717 178.222 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.467 ' HZ2' HD21 ' A' ' 112' ' ' ASN . 33.6 mmtm -76.09 4.89 7.59 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.3 -1.118 . . . . 1.0 109.887 -178.607 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 86.8 p -71.79 122.74 21.22 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.181 -0.95 . . . . 1.0 109.119 179.737 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 52.03 40.0 27.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.283 -0.886 . . . . 1.0 110.078 179.848 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -92.5 129.8 38.34 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.927 -1.108 . . . . 1.0 109.74 179.613 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 96.2 mmm -131.45 150.02 52.31 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.499 -0.926 . . . . 1.0 108.499 179.117 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 22.0 mt -50.61 132.13 27.18 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 120.898 -1.126 . . . . 1.0 109.034 -179.515 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -68.53 174.52 8.25 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 CA-C-N 120.0 1.036 . . . . 1.0 111.639 179.364 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -60.04 -39.96 87.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.285 -0.884 . . . . 1.0 109.863 -179.882 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -55.22 -49.77 71.13 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.131 -0.98 . . . . 1.0 109.935 -179.278 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.12 -39.87 75.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.171 -0.956 . . . . 1.0 110.28 -179.349 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 64.4 t -60.08 -45.47 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.003 -1.061 . . . . 1.0 109.03 -179.563 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -60.96 -40.08 91.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.137 -0.977 . . . . 1.0 110.652 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.79 -53.6 9.46 Favored Glycine 0 N--CA 1.497 2.75 0 O-C-N 121.071 -1.018 . . . . 1.0 111.355 -178.518 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 7.8 tp -60.05 -40.02 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.94 -1.33 . . . . 1.0 109.637 -178.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.5 mt-30 -65.96 -39.6 90.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.091 -1.005 . . . . 1.0 109.716 179.448 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.409 ' HG ' ' N ' ' A' ' 162' ' ' LEU . 84.9 p -60.63 -32.19 71.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.09 -1.006 . . . . 1.0 110.688 -179.29 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.409 ' N ' ' HG ' ' A' ' 161' ' ' SER . 96.4 mt -85.64 -51.51 6.42 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.898 -1.126 . . . . 1.0 110.669 -178.993 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -91.24 -9.12 46.38 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.986 -1.071 . . . . 1.0 110.411 -178.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.517 0 N-CA-C 109.475 -1.45 . . . . 1.0 109.475 -179.947 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.1 mt . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 121.381 0.61 . . . . 1.0 109.519 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -160.79 162.29 32.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.367 -0.833 . . . . 1.0 109.617 179.847 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -72.14 149.74 44.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.213 -0.929 . . . . 1.0 109.373 -179.759 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 94.5 p -86.99 1.66 52.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.278 -0.889 . . . . 1.0 109.584 -179.743 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -146.25 154.7 42.02 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.236 -0.915 . . . . 1.0 109.605 -179.845 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.56 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -91.61 0.14 57.53 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.377 -0.827 . . . . 1.0 109.957 -179.631 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -95.16 125.79 40.05 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.109 -0.994 . . . . 1.0 109.192 179.768 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.8 mt -140.04 147.75 40.82 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.363 -0.835 . . . . 1.0 109.192 -179.637 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.0 p -131.44 153.54 49.62 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.482 -0.761 . . . . 1.0 109.032 179.97 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -145.46 160.02 42.22 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.123 -0.985 . . . . 1.0 109.96 -179.988 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.401 ' HG2' HH11 ' A' ' 18' ' ' ARG . 35.3 ttt-85 -142.36 133.8 26.49 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.434 -0.791 . . . . 1.0 109.492 -179.504 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.7 mt -86.61 116.47 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.088 -1.008 . . . . 1.0 108.634 178.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.9 t -69.94 -41.46 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.346 -0.846 . . . . 1.0 109.965 -179.311 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -164.48 158.98 18.89 Favored 'General case' 0 C--N 1.291 -1.952 0 O-C-N 119.238 -2.163 . . . . 1.0 111.548 -178.228 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -101.79 119.06 38.19 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.631 -1.618 . . . . 1.0 106.631 178.313 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.49 ' C ' ' H ' ' A' ' 25' ' ' ASP . 0.1 OUTLIER -61.92 138.0 95.51 Favored Pre-proline 0 C--N 1.303 -1.448 0 O-C-N 121.028 -1.045 . . . . 1.0 109.073 -178.327 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -56.46 -6.35 1.47 Allowed 'Trans proline' 0 N--CA 1.484 0.951 0 CA-C-N 119.614 0.898 . . . . 1.0 110.504 179.554 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.49 ' H ' ' C ' ' A' ' 23' ' ' THR . 81.9 m-20 -60.01 -38.69 83.4 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 120.075 -0.65 . . . . 1.0 110.444 -179.457 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 76.7 mtm -139.25 171.11 14.76 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.053 -1.029 . . . . 1.0 109.359 -179.376 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 82.0 p -75.28 164.98 25.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.332 -0.855 . . . . 1.0 109.829 -179.334 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 25.9 m170 -63.98 -43.79 94.67 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.317 -0.864 . . . . 1.0 110.037 -179.559 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 53.3 m -60.18 -40.08 88.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 1.0 110.712 -178.92 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -65.21 -46.78 79.27 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.011 -1.056 . . . . 1.0 110.359 -179.345 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 70.5 t -64.01 -39.92 87.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.471 -0.768 . . . . 1.0 109.48 -179.738 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -55.55 -55.18 34.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.517 -0.739 . . . . 1.0 111.321 -178.774 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.2 pttt -63.6 -32.12 73.49 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.899 -1.125 . . . . 1.0 110.843 -178.678 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.67 -49.99 74.67 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.728 -1.233 . . . . 1.0 109.563 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -67.15 -39.98 86.61 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.066 -1.021 . . . . 1.0 110.454 -179.822 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -59.97 -40.54 89.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.782 -1.199 . . . . 1.0 109.62 -179.581 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -60.42 -40.05 89.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.975 -1.078 . . . . 1.0 109.159 178.885 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.0 -46.3 89.91 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.434 -0.791 . . . . 1.0 109.689 -179.235 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -65.4 -38.91 91.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.136 -0.977 . . . . 1.0 109.466 179.851 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -59.69 -48.16 82.78 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.208 -0.932 . . . . 1.0 110.18 -179.352 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.06 -42.61 90.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.139 -0.976 . . . . 1.0 109.989 -179.61 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.444 ' O ' ' OG1' ' A' ' 46' ' ' THR . 76.6 m95 -77.8 -38.79 45.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.174 -0.953 . . . . 1.0 110.161 -179.383 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 84.0 p -70.01 -16.77 63.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.096 -1.002 . . . . 1.0 109.997 -179.645 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -59.9 -40.05 87.45 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.072 -1.018 . . . . 1.0 110.412 -179.614 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.6 m -111.81 -19.49 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.406 0 O-C-N 120.991 -1.068 . . . . 1.0 110.815 -179.41 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 42' ' ' TRP . 77.0 p -94.52 128.56 39.66 Favored Pre-proline 0 N--CA 1.5 2.041 0 O-C-N 120.761 -1.212 . . . . 1.0 109.392 179.845 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -73.76 16.46 0.51 Allowed 'Trans proline' 0 N--CA 1.494 1.519 0 CA-C-N 120.17 1.096 . . . . 1.0 111.963 179.27 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.2 mt -69.22 140.01 54.53 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.265 -0.897 . . . . 1.0 109.969 -179.667 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -106.65 121.29 44.05 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.764 -0.828 . . . . 1.0 108.764 179.644 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -106.81 126.03 51.77 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.18 -0.95 . . . . 1.0 109.358 -179.777 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.1 m -120.05 130.03 54.5 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.535 -0.728 . . . . 1.0 109.803 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.416 HH11 ' HG2' ' A' ' 52' ' ' ARG . 33.8 ttt-85 -82.41 133.95 35.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.302 -0.874 . . . . 1.0 109.213 179.51 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.8 mt -103.35 130.57 50.67 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.247 -0.908 . . . . 1.0 109.356 179.856 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.443 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 45.5 m170 -63.41 -39.99 95.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.342 -0.849 . . . . 1.0 110.04 -179.599 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 76.6 m-20 -148.94 172.89 13.98 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.116 -0.99 . . . . 1.0 109.93 -179.505 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.43 177.92 39.98 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.595 -1.402 . . . . 1.0 109.595 179.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.7 mt -94.03 133.7 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.237 -1.155 . . . . 1.0 109.06 179.96 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.75 163.5 13.21 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.515 -0.741 . . . . 1.0 109.378 -179.424 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -60.01 -49.41 77.77 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.182 -0.948 . . . . 1.0 109.398 -179.77 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.8 mt -107.54 102.97 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.386 -0.821 . . . . 1.0 109.896 179.827 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.5 ptm -103.27 130.7 50.59 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.149 -0.969 . . . . 1.0 109.613 179.471 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.8 mt -105.4 138.01 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.581 -0.699 . . . . 1.0 109.926 -179.289 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 63.8 p -153.69 158.64 41.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.217 -0.927 . . . . 1.0 109.985 179.885 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.81 123.07 48.02 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.477 -0.934 . . . . 1.0 108.477 179.517 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 100' ' ' ASP . . . -99.97 175.82 27.76 Favored Glycine 0 N--CA 1.504 3.173 0 O-C-N 121.091 -1.005 . . . . 1.0 111.482 -178.563 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 72.3 mt . . . . . 0 N--CA 1.5 2.034 0 O-C-N 121.612 -0.934 . . . . 1.0 108.769 179.504 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.498 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 87.0 m-85 . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -100.15 0.01 39.72 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.23 -0.919 . . . . 1.0 110.266 -179.054 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 136.22 -155.64 22.56 Favored Glycine 0 N--CA 1.498 2.816 0 N-CA-C 108.475 -1.85 . . . . 1.0 108.475 -179.474 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.444 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 7.4 Cg_exo -62.72 -63.76 0.08 OUTLIER 'Trans proline' 0 C--N 1.313 -1.318 0 CA-C-N 118.697 1.249 . . . . 1.0 111.67 179.414 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 83.3 p -77.11 160.02 29.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.074 -1.016 . . . . 1.0 109.323 179.566 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 117.1 -129.3 8.29 Favored Glycine 0 N--CA 1.502 3.084 0 N-CA-C 109.642 -1.383 . . . . 1.0 109.642 179.882 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.419 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 22.3 mt -69.82 109.68 4.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -1.174 . . . . 1.0 109.24 -179.836 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 46.7 mt -80.74 -19.22 45.47 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.135 -0.978 . . . . 1.0 108.996 -179.919 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.55 171.26 1.25 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.761 -0.829 . . . . 1.0 108.761 179.697 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -162.07 159.41 26.18 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.142 -0.974 . . . . 1.0 109.796 179.331 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.6 166.2 29.98 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.79 -0.819 . . . . 1.0 108.79 -179.593 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -101.5 152.77 38.09 Favored Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.217 -0.927 . . . . 1.0 108.873 -179.987 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -63.05 165.13 17.44 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 120.599 0.866 . . . . 1.0 111.615 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo . . . . . 0 N--CA 1.489 1.259 0 C-N-CA 121.191 1.261 . . . . 1.0 112.438 -179.814 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.5 p-10 . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.39 126.15 12.64 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.223 -0.923 . . . . 1.0 109.398 -179.72 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -119.25 153.6 34.74 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.535 -0.728 . . . . 1.0 109.863 -179.774 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -131.22 154.4 48.47 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.622 -0.674 . . . . 1.0 109.281 -179.915 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.498 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 1.2 m-20 -79.46 117.98 20.92 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.04 -1.037 . . . . 1.0 108.749 179.022 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 65' ' ' GLY . 35.5 t0 -82.86 -10.66 58.73 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.016 -1.053 . . . . 1.0 109.178 -179.996 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -82.97 -11.63 57.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.383 -0.823 . . . . 1.0 109.107 179.756 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.444 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 99.5 mt-10 -89.53 169.96 10.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.439 -0.788 . . . . 1.0 109.101 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 22.2 m -98.89 104.68 16.74 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.204 -0.935 . . . . 1.0 109.104 -179.671 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.428 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 97.0 m95 -87.63 121.61 30.27 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 179.632 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.9 t -139.74 153.81 47.28 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.348 -0.845 . . . . 1.0 109.748 -179.198 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.4 m -94.32 -9.11 36.97 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.308 -0.997 . . . . 1.0 108.308 179.187 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 61.6 p -90.99 174.35 7.46 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.601 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 23.1 t -74.04 73.88 1.7 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.183 -0.948 . . . . 1.0 109.543 179.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 110' ' ' GLY . 98.2 mttt -148.58 152.49 36.87 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.331 -0.855 . . . . 1.0 109.133 179.471 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 109' ' ' LYS . . . 42.01 -139.65 2.07 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.959 -1.256 . . . . 1.0 109.959 179.631 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -100.05 117.37 34.17 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.353 -1.086 . . . . 1.0 108.855 179.226 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.449 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 58.0 t-20 -63.52 131.2 47.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.154 -0.966 . . . . 1.0 109.939 -179.527 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.2 tp -60.07 -45.07 94.09 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.474 -0.766 . . . . 1.0 111.092 -179.519 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -59.89 -41.92 92.67 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.0 -1.062 . . . . 1.0 111.069 -178.407 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.09 -50.68 72.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.677 -1.264 . . . . 1.0 109.245 -179.49 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 67.6 t -70.44 -39.97 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.962 . . . . 1.0 110.219 -179.544 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.35 -51.77 68.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.063 -1.023 . . . . 1.0 109.597 -179.503 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.04 81.45 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.269 -0.894 . . . . 1.0 109.964 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.601 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 56.2 t60 -60.96 -50.14 74.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.338 -0.852 . . . . 1.0 110.766 -178.403 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -60.11 -40.13 88.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.625 -1.297 . . . . 1.0 109.874 -179.65 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -60.03 -40.09 88.17 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 120.966 -1.084 . . . . 1.0 108.437 179.614 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.58 -42.54 84.66 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.178 -1.569 . . . . 1.0 109.178 179.829 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.601 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 89.2 m-70 -67.48 -40.0 85.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -1.15 . . . . 1.0 109.369 179.529 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 73.0 p -65.96 -21.58 66.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 1.0 109.625 -179.908 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 84.2 mt -82.54 0.29 43.33 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.156 -0.965 . . . . 1.0 109.697 -179.796 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.47 3.32 72.03 Favored Glycine 0 N--CA 1.497 2.719 0 C-N-CA 120.221 -0.99 . . . . 1.0 110.754 179.048 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.7 mt -84.2 148.12 26.91 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.954 -1.321 . . . . 1.0 109.576 179.979 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 41.0 t0 -101.57 173.82 6.25 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.776 -0.824 . . . . 1.0 108.776 179.801 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.527 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 76.6 m80 -57.14 135.7 56.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.006 -1.059 . . . . 1.0 109.274 -179.749 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.477 ' HG ' ' H ' ' A' ' 132' ' ' ASP . 33.4 t -98.76 156.17 16.98 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.392 -0.818 . . . . 1.0 109.405 -179.839 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -99.65 8.38 44.42 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.303 -0.873 . . . . 1.0 109.344 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.477 ' H ' ' HG ' ' A' ' 130' ' ' SER . 30.8 t70 -87.18 122.18 71.09 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 1.0 108.688 179.657 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -66.76 -12.47 36.09 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 CA-C-N 120.267 1.131 . . . . 1.0 111.825 -179.765 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -95.51 -4.2 60.87 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.91 -1.276 . . . . 1.0 109.91 -179.843 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -87.87 142.27 27.94 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.069 -1.254 . . . . 1.0 109.816 -179.893 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.413 ' C ' ' H ' ' A' ' 138' ' ' PHE . 84.6 mt -61.47 -40.08 93.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.335 -0.853 . . . . 1.0 109.717 179.859 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 88.5 mtp -71.69 20.99 0.05 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.413 -0.804 . . . . 1.0 111.528 -178.552 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.413 ' H ' ' C ' ' A' ' 136' ' ' LEU . 18.0 t80 -68.38 132.63 91.36 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 120.498 -1.376 . . . . 1.0 108.067 179.681 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -48.76 -42.96 35.98 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 CA-C-N 119.88 0.993 . . . . 1.0 113.444 -178.798 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 98.4 mt -82.93 143.62 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.038 -1.039 . . . . 1.0 110.815 -178.853 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.449 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 26.2 t80 -77.42 131.33 37.95 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.693 -0.63 . . . . 1.0 109.52 179.738 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 13.3 t -139.66 140.41 36.89 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.291 -0.88 . . . . 1.0 109.274 179.575 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -82.46 140.55 33.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.212 -0.93 . . . . 1.0 108.939 179.639 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.1 t -140.39 151.28 44.82 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.295 -0.878 . . . . 1.0 109.741 -179.384 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.92 107.97 2.35 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.019 -1.633 . . . . 1.0 109.019 179.661 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 21.7 mtmm -78.13 -0.93 30.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -1.12 . . . . 1.0 109.758 -179.262 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 88.8 p -59.97 -38.35 82.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.283 -0.886 . . . . 1.0 110.133 -179.49 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -139.21 21.63 2.59 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.257 -0.902 . . . . 1.0 110.143 -179.308 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -68.26 137.57 54.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.931 -1.106 . . . . 1.0 109.578 -179.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 75.4 mtm -138.87 148.91 44.27 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.244 -1.021 . . . . 1.0 108.244 179.265 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 20.8 mt -51.81 124.03 26.37 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 120.796 -1.19 . . . . 1.0 108.436 -179.737 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -66.15 174.65 5.69 Favored 'Trans proline' 0 N--CA 1.49 1.299 0 CA-C-N 120.124 1.08 . . . . 1.0 112.233 -179.47 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -60.12 -39.81 87.55 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.424 -0.797 . . . . 1.0 109.167 179.816 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -56.45 -49.96 73.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 1.0 110.065 -179.413 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.81 -40.11 72.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.038 -1.039 . . . . 1.0 110.226 -179.411 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 79.0 t -61.37 -48.91 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.089 -1.007 . . . . 1.0 109.444 -179.553 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.18 -39.95 88.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.131 -0.981 . . . . 1.0 110.492 -179.792 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.26 -55.12 8.06 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 120.197 -1.001 . . . . 1.0 111.199 -178.632 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.4 ' CG2' ' N ' ' A' ' 160' ' ' GLN . 7.7 tp -60.14 -40.1 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.917 -1.343 . . . . 1.0 109.676 -179.096 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.547 ' O ' ' N ' ' A' ' 164' ' ' GLY . 27.1 mm100 -65.09 -39.74 93.61 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.225 -0.922 . . . . 1.0 109.402 179.675 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 86.6 p -62.92 -27.21 69.22 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.224 -0.922 . . . . 1.0 110.135 -179.612 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 92.5 mt -86.69 -53.53 4.89 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.912 -1.117 . . . . 1.0 110.437 -179.376 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -91.79 -9.41 43.66 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.07 -1.019 . . . . 1.0 110.051 -179.083 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.582 0 N-CA-C 109.434 -1.466 . . . . 1.0 109.434 -179.878 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.3 mt . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 109.439 -0.578 . . . . 1.0 109.439 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -162.28 161.25 27.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.294 -0.879 . . . . 1.0 109.669 -179.946 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -72.44 149.35 44.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.075 -1.016 . . . . 1.0 109.156 179.662 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.0 p -85.67 -0.9 56.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.258 -0.901 . . . . 1.0 109.815 -179.497 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -150.47 157.32 42.89 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.101 -0.999 . . . . 1.0 109.518 179.843 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.531 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.01 0.54 57.05 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.179 -0.951 . . . . 1.0 109.988 -179.627 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -94.76 128.35 41.4 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.139 -0.976 . . . . 1.0 108.948 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 97.8 mt -141.85 151.16 42.48 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.158 -0.964 . . . . 1.0 109.342 -179.585 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.7 p -132.86 158.61 42.11 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.055 -0.72 . . . . 1.0 109.055 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -146.27 162.66 37.61 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.1 -1.0 . . . . 1.0 109.988 -179.854 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -143.84 133.04 23.05 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.582 -0.699 . . . . 1.0 109.661 -179.622 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 86.0 mt -88.62 111.21 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.382 -0.97 . . . . 1.0 108.382 178.468 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.4 t -69.96 -40.35 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.012 -1.055 . . . . 1.0 109.679 -179.152 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.9 p-10 -162.37 160.99 27.19 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.839 -1.163 . . . . 1.0 110.431 -179.741 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.511 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 64.6 m-85 -101.75 -168.89 1.61 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.346 -1.353 . . . . 1.0 107.346 178.902 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.626 ' HG1' ' H ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -119.79 143.69 35.59 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.426 -0.796 . . . . 1.0 109.281 179.806 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -63.57 -11.93 28.57 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 CA-C-O 122.511 0.963 . . . . 1.0 110.177 179.067 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.626 ' H ' ' HG1' ' A' ' 23' ' ' THR . 95.5 m-20 -60.04 -39.99 87.86 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 114.942 -1.026 . . . . 1.0 110.126 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.5 mtm -142.53 168.3 20.05 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.22 -0.925 . . . . 1.0 110.118 -178.936 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.7 p -72.2 160.06 33.05 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.422 -0.799 . . . . 1.0 109.76 -179.791 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.511 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 54.5 m170 -60.13 -39.91 87.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.41 -0.807 . . . . 1.0 110.223 -179.589 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 63.2 m -59.91 -40.12 87.75 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.102 -0.999 . . . . 1.0 110.798 -178.674 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -67.32 -39.94 85.9 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.958 -1.089 . . . . 1.0 110.059 -179.698 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.0 t -69.0 -41.15 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.013 -1.054 . . . . 1.0 110.265 -179.29 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.02 -48.29 82.32 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.02 -1.05 . . . . 1.0 110.51 -179.194 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.54 -33.14 72.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.888 -1.132 . . . . 1.0 109.126 179.852 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.98 -49.35 78.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.087 -1.008 . . . . 1.0 109.849 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -67.47 -38.28 84.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.91 -1.119 . . . . 1.0 109.729 179.915 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.471 ' HZ3' HH12 ' A' ' 52' ' ' ARG . 63.5 mmtt -59.95 -43.37 95.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.06 -1.025 . . . . 1.0 109.285 -179.522 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -60.34 -40.26 90.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.019 -1.051 . . . . 1.0 108.92 179.376 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.04 -46.87 88.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.486 -0.759 . . . . 1.0 109.927 -179.947 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -65.68 -39.26 91.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.027 -1.046 . . . . 1.0 109.859 -179.711 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -60.04 -46.37 89.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.039 -1.038 . . . . 1.0 109.761 -179.707 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.8 t -60.12 -43.26 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.169 -0.957 . . . . 1.0 110.585 -179.567 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.426 ' O ' ' OG1' ' A' ' 46' ' ' THR . 82.0 m95 -77.68 -38.03 48.42 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.92 -1.112 . . . . 1.0 110.113 -179.192 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.9 p -70.43 -15.93 62.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.296 -0.877 . . . . 1.0 110.131 -179.385 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -60.02 -40.01 87.81 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.129 -0.982 . . . . 1.0 110.824 -179.636 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.6 m -112.17 -22.68 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.323 -0.861 . . . . 1.0 110.312 -178.685 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 42' ' ' TRP . 69.0 p -93.42 130.93 33.87 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 120.943 -1.098 . . . . 1.0 109.595 -179.992 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -74.61 17.48 0.55 Allowed 'Trans proline' 0 N--CA 1.496 1.638 0 CA-C-N 119.91 1.004 . . . . 1.0 112.043 179.233 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.8 mt -68.94 139.85 55.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.114 -0.991 . . . . 1.0 109.838 -179.444 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -106.62 121.21 43.87 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.933 -0.765 . . . . 1.0 108.933 179.417 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -106.86 124.76 50.09 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.281 -0.887 . . . . 1.0 109.727 -179.428 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.2 m -119.96 130.04 54.58 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.626 -0.671 . . . . 1.0 109.891 179.896 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.472 ' NH1' ' CB ' ' A' ' 52' ' ' ARG . 11.6 ttp-105 -82.88 134.84 35.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.268 -0.895 . . . . 1.0 109.556 179.579 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.3 mt -107.43 134.13 50.93 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.266 -0.896 . . . . 1.0 109.299 179.614 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.434 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 59.5 m170 -65.01 -39.9 94.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.438 -0.789 . . . . 1.0 109.46 -179.931 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 72.0 m-20 -151.44 -176.74 5.71 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.281 -0.887 . . . . 1.0 109.486 -179.805 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.21 -179.48 43.74 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.367 -1.493 . . . . 1.0 109.367 -179.662 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.414 HD13 HG22 ' A' ' 57' ' ' ILE . 93.3 mt -97.1 130.45 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.296 -1.12 . . . . 1.0 109.474 -179.908 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.05 160.46 16.42 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.453 -0.779 . . . . 1.0 109.67 -179.605 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.06 -49.1 78.97 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.284 -0.885 . . . . 1.0 109.348 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.9 mt -105.73 97.04 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.467 -0.771 . . . . 1.0 109.729 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.9 ptm -99.2 125.27 44.74 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.083 -1.01 . . . . 1.0 109.173 179.368 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 86.6 mt -102.81 137.52 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.458 -0.776 . . . . 1.0 109.434 -179.451 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.1 p -153.38 153.32 32.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.185 -0.947 . . . . 1.0 109.852 -179.896 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -104.09 121.36 43.05 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.225 -1.028 . . . . 1.0 108.225 179.116 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -108.22 -172.99 21.71 Favored Glycine 0 N--CA 1.5 2.907 0 N-CA-C 110.852 -0.899 . . . . 1.0 110.852 -178.784 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 83.3 mt . . . . . 0 N--CA 1.493 1.708 0 N-CA-C 108.098 -1.075 . . . . 1.0 108.098 179.29 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.55 ' CE2' ' OD1' ' A' ' 99' ' ' ASP . 89.8 m-85 . . . . . 0 N--CA 1.496 1.853 0 N-CA-C 108.505 -0.924 . . . . 1.0 108.505 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 79' ' ' SER . 20.7 p-10 -96.1 9.53 40.57 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.015 -1.053 . . . . 1.0 110.295 -179.091 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 120.88 -154.86 16.35 Favored Glycine 0 N--CA 1.504 3.181 0 N-CA-C 108.934 -1.666 . . . . 1.0 108.934 179.888 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.434 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 3.7 Cg_exo -63.12 -62.41 0.11 Allowed 'Trans proline' 0 N--CA 1.489 1.224 0 CA-C-N 118.962 1.381 . . . . 1.0 111.715 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.419 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 70.9 p -75.63 162.41 28.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.439 -0.788 . . . . 1.0 109.729 179.736 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 111.67 -126.35 7.64 Favored Glycine 0 N--CA 1.501 2.983 0 N-CA-C 109.9 -1.28 . . . . 1.0 109.9 179.71 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.401 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 7.2 mt -69.69 100.39 1.48 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.36 -1.082 . . . . 1.0 109.074 -179.787 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 46.4 mt -73.91 -29.75 62.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.033 -1.042 . . . . 1.0 109.252 -179.702 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -177.32 166.81 2.33 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.086 -1.079 . . . . 1.0 108.086 -179.661 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -163.07 159.91 23.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.753 -1.217 . . . . 1.0 110.033 179.652 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -138.69 160.32 39.94 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.924 -0.769 . . . . 1.0 108.924 179.898 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -97.45 152.06 38.0 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.248 -0.908 . . . . 1.0 109.278 -179.663 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -47.08 167.0 0.08 OUTLIER 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 120.437 0.758 . . . . 1.0 111.359 179.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo . . . . . 0 N--CA 1.494 1.536 0 C-N-CA 120.981 1.121 . . . . 1.0 112.416 -179.312 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.442 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 31.5 p-10 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.683 -0.488 . . . . 1.0 109.683 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.96 119.41 6.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.181 -0.949 . . . . 1.0 109.655 179.826 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -103.87 126.02 50.7 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.398 -0.814 . . . . 1.0 109.593 179.975 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.412 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 28.1 m-85 -106.14 145.92 30.88 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.549 -0.719 . . . . 1.0 109.266 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.55 ' OD1' ' CE2' ' A' ' 75' ' ' PHE . 94.7 m-20 -78.24 121.98 25.1 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.979 -1.076 . . . . 1.0 109.145 179.513 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 45.7 t0 -83.18 -10.89 58.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.232 -0.918 . . . . 1.0 109.622 179.976 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -81.91 -10.98 59.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.311 -0.868 . . . . 1.0 109.852 -179.732 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.434 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 98.7 mt-10 -89.15 169.05 11.8 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.185 -0.947 . . . . 1.0 109.614 -179.348 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 54.8 m -98.12 104.73 16.79 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.168 -0.958 . . . . 1.0 109.291 -179.521 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -89.35 120.95 31.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.882 . . . . 1.0 108.908 179.924 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.4 t -140.06 150.16 44.03 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.444 -0.785 . . . . 1.0 109.819 -179.046 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 66.3 m -91.64 -8.59 46.74 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.257 -1.016 . . . . 1.0 108.257 179.034 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 83.5 p -90.17 172.14 9.02 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.787 -0.82 . . . . 1.0 108.787 179.364 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.7 t -74.99 77.2 2.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.024 -1.047 . . . . 1.0 109.416 -179.962 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -148.85 147.52 28.82 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 179.456 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.14 -138.06 4.72 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.981 -1.248 . . . . 1.0 109.981 179.746 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -100.04 115.2 29.18 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.282 -1.128 . . . . 1.0 109.171 179.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.582 ' H ' ' HH ' ' A' ' 141' ' ' TYR . 15.8 t-20 -63.96 133.95 54.16 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.087 -1.008 . . . . 1.0 109.781 -179.685 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.4 tp -59.95 -45.09 93.74 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.357 -0.84 . . . . 1.0 111.165 -179.6 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -59.94 -40.97 90.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.988 -1.07 . . . . 1.0 110.695 -178.188 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -59.97 -50.2 74.68 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.838 -1.164 . . . . 1.0 109.436 -179.569 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.5 t -70.01 -40.48 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.099 -1.0 . . . . 1.0 110.109 -179.396 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.93 -51.27 70.77 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.115 -0.99 . . . . 1.0 109.6 -179.312 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.99 -36.56 77.45 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.282 -0.886 . . . . 1.0 110.425 -179.97 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.608 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 63.6 t60 -63.34 -49.88 72.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.166 -0.959 . . . . 1.0 110.806 -178.558 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.412 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 7.3 pt-20 -59.87 -39.15 84.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.746 -1.221 . . . . 1.0 109.999 -179.455 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -60.04 -40.05 88.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.788 -1.195 . . . . 1.0 108.829 179.421 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -56.97 -42.9 93.03 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.547 -1.421 . . . . 1.0 109.547 179.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.608 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 87.8 m-70 -67.23 -39.96 86.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.108 -1.231 . . . . 1.0 109.993 179.801 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 87.3 p -67.1 -22.18 65.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 1.0 109.909 -179.598 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 81.0 mt -80.84 -0.93 41.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.158 -0.964 . . . . 1.0 109.701 -179.853 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.92 6.14 67.49 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 110.414 -1.075 . . . . 1.0 110.414 179.264 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.4 mt -84.91 150.04 25.24 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.987 -1.302 . . . . 1.0 109.654 179.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 38.4 t0 -99.95 175.59 5.72 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.593 -0.891 . . . . 1.0 108.593 179.416 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.501 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 72.6 m80 -59.7 139.98 56.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.97 -1.081 . . . . 1.0 109.491 -179.742 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 44.2 t -98.09 148.1 23.88 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.381 -0.825 . . . . 1.0 109.334 -179.808 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -96.9 2.15 51.33 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.266 -0.896 . . . . 1.0 109.733 -179.646 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 8.2 t0 -86.48 128.14 58.13 Favored Pre-proline 0 N--CA 1.491 1.623 0 N-CA-C 107.947 -1.131 . . . . 1.0 107.947 179.296 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -65.39 -19.67 61.44 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 CA-C-N 120.344 1.158 . . . . 1.0 112.305 -179.665 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.426 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -88.09 -6.36 75.36 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.621 -1.392 . . . . 1.0 109.621 -179.929 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.61 135.41 34.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.244 -1.15 . . . . 1.0 109.235 179.787 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.478 ' C ' ' H ' ' A' ' 138' ' ' PHE . 92.2 mt -60.08 -38.92 84.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.108 -0.995 . . . . 1.0 109.685 -179.692 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 71.0 mtp -69.9 21.81 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.384 -0.823 . . . . 1.0 111.349 -178.631 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.478 ' H ' ' C ' ' A' ' 136' ' ' LEU . 16.1 t80 -67.06 134.43 93.78 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 120.726 -1.234 . . . . 1.0 107.848 179.542 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -61.64 -5.5 5.84 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 120.876 1.05 . . . . 1.0 114.215 -177.886 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 89.6 mt -118.05 136.55 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 O-C-N 120.918 -1.114 . . . . 1.0 109.269 179.55 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.582 ' HH ' ' H ' ' A' ' 112' ' ' ASN . 35.7 t80 -72.11 126.55 30.07 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.349 -0.845 . . . . 1.0 109.958 -178.928 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.8 t -139.55 142.19 37.2 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.81 -0.811 . . . . 1.0 108.81 179.79 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -80.77 145.03 31.69 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.002 -1.061 . . . . 1.0 109.545 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.8 t -140.03 156.66 46.51 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.412 -0.805 . . . . 1.0 109.438 -179.605 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.12 104.49 0.97 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.719 -1.352 . . . . 1.0 109.719 -179.859 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -77.1 -0.93 26.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.364 -1.08 . . . . 1.0 109.898 -179.892 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 42.1 t -60.01 -43.09 95.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.084 -1.01 . . . . 1.0 109.353 -179.562 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -156.05 74.31 0.85 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.096 -1.002 . . . . 1.0 109.556 179.545 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -99.13 122.91 42.98 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.297 -0.877 . . . . 1.0 109.166 179.555 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 96.7 mtp -114.57 140.18 48.99 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.021 -0.733 . . . . 1.0 109.021 179.854 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 57.0 mt -50.26 128.82 23.85 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.021 -1.049 . . . . 1.0 108.836 -179.94 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -69.01 176.97 5.52 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 CA-C-N 120.041 1.05 . . . . 1.0 112.335 179.889 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.04 -40.0 87.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.417 -0.802 . . . . 1.0 109.549 179.775 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -55.76 -49.97 71.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.342 -0.849 . . . . 1.0 109.943 -179.385 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -70.72 -40.0 73.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.023 -1.048 . . . . 1.0 110.151 -179.525 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 76.9 t -62.09 -48.58 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.106 -0.997 . . . . 1.0 109.335 -179.67 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -60.82 -39.98 91.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.975 -1.078 . . . . 1.0 110.283 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.401 ' O ' ' OG ' ' A' ' 161' ' ' SER . . . -70.68 -53.83 11.3 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 120.228 -0.987 . . . . 1.0 111.393 -178.634 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 6.0 tp -60.48 -40.04 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.868 -1.372 . . . . 1.0 109.795 -178.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 164' ' ' GLY . 95.1 mt-30 -64.01 -39.86 95.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.192 -0.943 . . . . 1.0 109.156 179.593 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' A' ' 158' ' ' GLY . 86.3 p -62.74 -28.58 70.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.885 . . . . 1.0 110.326 -179.805 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 85.4 mt -87.85 -49.95 6.76 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.947 -1.096 . . . . 1.0 110.401 -179.213 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -91.05 -9.52 45.5 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.067 -1.021 . . . . 1.0 110.148 -179.061 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.554 -1.418 . . . . 1.0 109.554 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.494 -0.558 . . . . 1.0 109.494 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.1 mt -94.41 128.33 40.88 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.19 -0.944 . . . . 1.0 109.529 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.05 162.25 34.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.335 -0.853 . . . . 1.0 108.815 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -71.99 149.21 45.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.999 -1.063 . . . . 1.0 109.071 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.0 t -79.41 -4.8 52.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.402 -0.811 . . . . 1.0 110.382 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.2 pttt -150.08 159.15 44.63 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.954 -1.091 . . . . 1.0 109.705 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.536 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.03 0.41 57.13 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.459 -0.776 . . . . 1.0 109.416 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -95.27 126.51 40.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.329 -0.857 . . . . 1.0 108.753 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.3 mt -140.14 152.11 45.82 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.279 -0.888 . . . . 1.0 109.069 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.8 p -130.27 155.29 46.54 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.893 -0.78 . . . . 1.0 108.893 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -145.62 158.72 43.81 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.039 -1.038 . . . . 1.0 109.89 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.556 HH12 ' H ' ' A' ' 56' ' ' GLY . 70.7 ttt180 -144.14 133.73 23.52 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.513 -0.742 . . . . 1.0 109.533 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.4 mt -89.43 117.59 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.091 -1.006 . . . . 1.0 109.125 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 56.6 t -69.94 -41.44 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.171 -0.956 . . . . 1.0 109.414 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.3 p-10 -163.2 162.99 25.71 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.775 -1.203 . . . . 1.0 110.125 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -102.12 -167.39 1.4 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.203 -1.406 . . . . 1.0 107.203 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.469 ' HG1' ' H ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -120.72 143.08 35.63 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.374 -0.829 . . . . 1.0 109.817 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -66.07 -15.58 49.12 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 120.854 1.036 . . . . 1.0 110.822 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.469 ' H ' ' HG1' ' A' ' 23' ' ' THR . 98.7 m-20 -59.17 -39.6 83.01 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.288 -0.869 . . . . 1.0 109.995 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.5 mtm -136.27 166.06 24.3 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.252 -0.905 . . . . 1.0 109.428 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.7 p -71.77 161.2 31.33 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.515 -0.74 . . . . 1.0 109.648 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 49.3 m170 -61.77 -39.91 93.32 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.553 -0.717 . . . . 1.0 109.741 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.7 m -59.9 -40.05 87.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.983 -1.073 . . . . 1.0 110.08 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -64.67 -40.08 94.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.924 -1.11 . . . . 1.0 109.975 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 63.2 t -70.02 -40.4 78.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 120.935 -1.103 . . . . 1.0 110.278 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.98 -52.87 63.56 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.235 -0.916 . . . . 1.0 110.899 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.5 ptmt -64.5 -28.82 69.92 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.196 -0.94 . . . . 1.0 109.992 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.12 -49.67 76.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.874 -1.141 . . . . 1.0 109.413 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -67.77 -38.53 83.53 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.994 -1.067 . . . . 1.0 110.083 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -59.88 -43.08 94.95 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.903 -1.123 . . . . 1.0 109.37 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -61.59 -40.09 93.55 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.058 -1.026 . . . . 1.0 108.781 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.08 -47.17 87.01 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.528 -0.733 . . . . 1.0 109.825 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -63.31 -39.85 95.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.992 -1.068 . . . . 1.0 109.57 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -59.8 -48.96 79.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.087 -1.008 . . . . 1.0 109.859 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.5 t -60.05 -40.41 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.255 -0.903 . . . . 1.0 110.602 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.436 ' CE3' ' CD1' ' A' ' 125' ' ' LEU . 73.5 m95 -79.4 -37.1 38.03 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.949 -1.094 . . . . 1.0 109.424 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.7 p -71.22 -20.0 62.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.104 -0.998 . . . . 1.0 110.029 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -60.65 -39.91 90.1 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.954 -1.091 . . . . 1.0 110.899 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.2 m -111.31 22.78 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.195 -0.941 . . . . 1.0 111.071 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.6 p -146.94 135.36 10.92 Favored Pre-proline 0 N--CA 1.501 2.11 0 O-C-N 120.843 -1.161 . . . . 1.0 109.361 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -74.28 17.57 0.51 Allowed 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 120.733 0.955 . . . . 1.0 111.967 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 78.2 mt -69.33 139.53 54.27 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.253 -0.904 . . . . 1.0 109.915 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -110.79 120.78 43.52 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.865 -0.791 . . . . 1.0 108.865 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -107.6 122.43 46.68 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.413 -0.804 . . . . 1.0 109.647 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -120.18 130.11 54.43 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.663 -0.648 . . . . 1.0 110.068 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -81.83 135.7 35.43 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.27 -0.894 . . . . 1.0 109.348 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.3 mt -104.27 126.23 51.2 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.364 -0.835 . . . . 1.0 109.181 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.41 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 45.8 m-70 -61.61 -40.16 93.83 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.329 -0.857 . . . . 1.0 109.737 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 77.3 m-20 -146.45 167.48 23.53 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.242 -0.911 . . . . 1.0 109.857 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.556 ' H ' HH12 ' A' ' 18' ' ' ARG . . . 98.22 175.73 33.09 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.136 -1.585 . . . . 1.0 109.136 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -93.55 136.81 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.228 -1.16 . . . . 1.0 108.579 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.66 161.08 15.74 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.423 -0.798 . . . . 1.0 109.281 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.02 -49.8 76.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.303 -0.873 . . . . 1.0 109.144 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.407 HG21 HD12 ' A' ' 60' ' ' ILE . 88.6 mt -106.64 102.59 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.377 -0.827 . . . . 1.0 109.702 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.1 ptm -102.47 131.49 49.13 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.348 -0.845 . . . . 1.0 109.148 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 88.3 mt -105.92 135.11 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.539 -0.725 . . . . 1.0 109.808 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 64.4 p -152.32 158.88 43.37 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.192 -0.942 . . . . 1.0 109.851 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -104.46 121.23 43.0 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.24 -170.01 23.97 Favored Glycine 0 N--CA 1.501 2.984 0 O-C-N 121.156 -0.965 . . . . 1.0 111.121 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.504 ' CG2' ' N ' ' A' ' 67' ' ' LYS . 78.0 mt -136.62 170.76 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 107.995 -1.113 . . . . 1.0 107.995 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.504 ' N ' ' CG2' ' A' ' 66' ' ' ILE . 21.6 tptm -29.92 -94.86 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 O-C-N 121.718 -0.614 . . . . 1.0 111.014 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -79.27 128.93 33.93 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.616 -1.302 . . . . 1.0 110.173 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.537 ' NE2' ' OD2' ' A' ' 71' ' ' ASP . 54.4 p-80 -153.01 9.87 0.45 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.072 -1.018 . . . . 1.0 109.813 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.403 ' O ' ' OD1' ' A' ' 71' ' ' ASP . . . 108.93 48.9 0.81 Allowed Glycine 0 N--CA 1.501 3.006 0 O-C-N 121.352 -0.843 . . . . 1.0 111.507 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.537 ' OD2' ' NE2' ' A' ' 69' ' ' HIS . 85.2 m-20 -139.95 150.49 44.57 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.828 -1.396 . . . . 1.0 109.154 178.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -65.79 -37.41 86.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.314 -0.866 . . . . 1.0 109.353 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 73' ' ' TYR . 3.0 p90 -130.5 77.45 75.89 Favored Pre-proline 0 N--CA 1.5 2.036 0 N-CA-C 108.79 -0.818 . . . . 1.0 108.79 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -60.98 -148.16 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 121.005 1.137 . . . . 1.0 112.751 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.53 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 72.2 m-85 -84.55 157.69 21.18 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.632 -0.668 . . . . 1.0 109.207 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -100.11 8.04 44.19 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.236 -0.915 . . . . 1.0 110.102 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 127.99 -156.4 20.69 Favored Glycine 0 N--CA 1.504 3.193 0 N-CA-C 108.608 -1.797 . . . . 1.0 108.608 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -60.7 -65.66 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.462 0 CA-C-N 118.855 1.328 . . . . 1.0 111.422 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 87.4 p -76.53 160.03 29.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.059 -1.026 . . . . 1.0 109.436 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.26 -126.87 7.24 Favored Glycine 0 N--CA 1.504 3.203 0 N-CA-C 110.016 -1.234 . . . . 1.0 110.016 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.427 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 28.4 mt -68.71 107.69 3.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.228 -1.16 . . . . 1.0 109.483 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 38.0 mt -79.67 -16.54 55.55 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.017 -1.052 . . . . 1.0 108.209 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.32 175.26 0.94 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.203 -1.036 . . . . 1.0 108.203 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.468 ' CE1' ' ND1' ' A' ' 97' ' ' HIS . 7.5 p80 -161.2 159.99 29.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.994 -1.066 . . . . 1.0 109.479 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.07 160.16 44.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.371 -0.831 . . . . 1.0 108.866 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -106.25 151.45 40.21 Favored Pre-proline 0 N--CA 1.499 1.984 0 N-CA-C 108.766 -0.827 . . . . 1.0 108.766 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -44.81 161.92 0.08 OUTLIER 'Trans proline' 0 N--CA 1.488 1.152 0 C-N-CA 120.694 0.93 . . . . 1.0 111.656 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -66.24 151.76 82.72 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.158 1.239 . . . . 1.0 112.529 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.403 ' C ' ' H ' ' A' ' 91' ' ' ASN . . . -177.02 153.1 13.03 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.282 -1.527 . . . . 1.0 109.282 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -70.7 37.44 0.29 Allowed 'Trans proline' 0 N--CA 1.493 1.48 0 CA-C-N 118.661 1.23 . . . . 1.0 112.055 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.403 ' H ' ' C ' ' A' ' 89' ' ' GLY . 52.6 p-10 -158.54 -130.13 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.981 -1.074 . . . . 1.0 110.566 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.409 ' O ' ' O ' ' A' ' 93' ' ' GLY . 68.3 m-85 -61.08 -38.8 87.54 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.543 -0.723 . . . . 1.0 110.355 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 92' ' ' TYR . . . -45.1 168.82 0.02 OUTLIER Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.244 -1.143 . . . . 1.0 110.244 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 71.13 4.8 57.14 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.046 -1.222 . . . . 1.0 110.046 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.6 p-10 -81.11 170.95 15.53 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.021 -1.281 . . . . 1.0 109.733 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.49 122.57 8.26 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.289 -0.882 . . . . 1.0 109.533 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.468 ' ND1' ' CE1' ' A' ' 84' ' ' HIS . 60.8 m170 -110.74 148.25 32.7 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.652 -0.655 . . . . 1.0 109.692 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -123.05 156.46 34.82 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.571 -0.706 . . . . 1.0 109.19 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.53 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 1.1 m-20 -81.2 121.35 26.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 1.0 109.633 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -84.67 -12.95 52.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.068 -1.02 . . . . 1.0 109.422 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -82.96 -11.54 58.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.311 -0.868 . . . . 1.0 109.879 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -87.82 173.01 9.21 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.36 -0.838 . . . . 1.0 110.075 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.0 m -99.88 104.85 16.53 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.411 -0.806 . . . . 1.0 108.871 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.494 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 95.9 m95 -88.71 125.28 34.78 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.633 -0.877 . . . . 1.0 108.633 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.8 t -140.35 150.46 43.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.492 -0.755 . . . . 1.0 109.308 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 75.7 m -92.17 -8.26 46.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.104 -0.998 . . . . 1.0 108.383 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.8 m -91.19 174.84 7.18 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.57 -0.9 . . . . 1.0 108.57 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.49 ' OG ' ' CZ ' ' A' ' 143' ' ' TYR . 4.2 m -78.06 77.59 4.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.835 -1.166 . . . . 1.0 109.429 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -146.98 149.58 33.44 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.707 -0.849 . . . . 1.0 108.707 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.81 -135.66 6.64 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.793 -1.323 . . . . 1.0 109.793 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -100.6 114.3 27.85 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.323 -1.104 . . . . 1.0 109.136 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -63.94 132.43 50.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.135 -0.978 . . . . 1.0 109.248 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.3 tp -59.8 -41.38 91.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.32 -0.862 . . . . 1.0 110.255 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -59.97 -43.8 94.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.311 -0.868 . . . . 1.0 111.095 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -59.42 -50.49 73.74 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.671 -1.268 . . . . 1.0 109.814 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.1 t -66.24 -40.8 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.933 -1.104 . . . . 1.0 109.407 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.32 -51.5 69.67 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.282 -0.887 . . . . 1.0 110.067 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.27 -36.44 73.26 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.383 -1.448 . . . . 1.0 110.181 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -66.77 -47.75 71.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.113 -0.992 . . . . 1.0 111.746 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -59.54 -39.86 85.34 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.624 -1.298 . . . . 1.0 109.515 -178.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -59.87 -39.37 85.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.11 -0.994 . . . . 1.0 108.513 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.95 -43.48 87.78 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.581 -1.408 . . . . 1.0 109.581 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -64.5 -39.83 94.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.015 -1.286 . . . . 1.0 109.289 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 90.5 p -66.72 -24.12 66.2 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.137 -0.977 . . . . 1.0 110.025 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.436 ' CD1' ' CE3' ' A' ' 42' ' ' TRP . 80.9 mt -81.71 -1.64 47.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.11 -0.994 . . . . 1.0 109.689 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 91.33 9.62 63.1 Favored Glycine 0 N--CA 1.499 2.835 0 C-N-CA 120.243 -0.979 . . . . 1.0 111.01 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.8 mt -86.92 146.18 26.26 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.903 -1.351 . . . . 1.0 109.903 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 36.9 t0 -103.62 172.02 7.04 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.694 -0.854 . . . . 1.0 108.694 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.545 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 35.5 m170 -59.94 134.67 57.26 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.001 -1.062 . . . . 1.0 109.612 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 37.4 t -97.4 164.83 12.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.283 -0.886 . . . . 1.0 109.513 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -99.16 1.88 45.37 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.294 -0.879 . . . . 1.0 109.237 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 17.3 t0 -85.67 125.11 70.11 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.299 -0.875 . . . . 1.0 108.971 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -68.82 -20.53 39.39 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 CA-C-N 120.146 1.088 . . . . 1.0 111.822 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.451 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -86.26 -7.2 80.27 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.739 -1.344 . . . . 1.0 109.739 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.11 148.52 26.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.128 -1.219 . . . . 1.0 109.913 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.8 mt -69.83 -29.03 66.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.348 -0.845 . . . . 1.0 109.461 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.6 mmm -73.93 8.74 1.84 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.572 -0.705 . . . . 1.0 110.81 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -67.37 132.78 93.14 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 120.795 -1.191 . . . . 1.0 108.38 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -60.32 -24.73 78.38 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 120.861 1.041 . . . . 1.0 113.477 -178.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.3 mt -93.49 139.18 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 120.909 -1.119 . . . . 1.0 110.369 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -73.94 131.59 41.59 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.495 0.664 . . . . 1.0 110.05 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.8 t -141.19 140.45 34.02 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.719 -0.613 . . . . 1.0 109.441 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.49 ' CZ ' ' OG ' ' A' ' 108' ' ' SER . 79.3 t80 -80.94 145.07 31.43 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.241 -0.912 . . . . 1.0 109.033 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.8 t -141.01 155.32 46.22 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.342 -0.849 . . . . 1.0 108.918 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -77.8 112.66 3.54 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.258 -1.537 . . . . 1.0 109.258 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -77.79 3.34 14.47 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.239 -1.154 . . . . 1.0 110.034 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.5 ' O ' ' ND1' ' A' ' 148' ' ' HIS . 86.5 p -59.9 -38.38 82.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.077 -1.014 . . . . 1.0 109.679 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . 0.5 ' ND1' ' O ' ' A' ' 147' ' ' SER . 89.3 m-70 -154.08 33.05 0.43 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.09 -1.006 . . . . 1.0 110.078 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -70.85 138.69 50.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.996 -1.065 . . . . 1.0 109.67 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 58.4 mtt -140.02 149.53 43.31 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.225 -1.028 . . . . 1.0 108.225 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.8 mp -52.25 127.38 38.59 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.87 -1.144 . . . . 1.0 108.833 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -65.1 -179.05 0.92 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 CA-C-N 120.088 1.067 . . . . 1.0 111.875 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -62.59 -40.14 95.96 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.456 -0.777 . . . . 1.0 110.175 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.407 ' C ' ' OD1' ' A' ' 154' ' ' ASP . 52.7 t0 -57.22 -49.71 75.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.964 -1.085 . . . . 1.0 110.138 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -70.44 -40.04 74.0 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.155 -0.966 . . . . 1.0 109.92 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 51.5 t -61.3 -44.74 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.051 -1.031 . . . . 1.0 109.591 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -61.61 -39.05 89.89 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.98 -1.075 . . . . 1.0 109.97 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -69.97 -53.27 15.52 Favored Glycine 0 N--CA 1.494 2.545 0 O-C-N 121.051 -1.03 . . . . 1.0 111.262 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 6.3 tp -62.04 -40.54 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.722 -1.457 . . . . 1.0 109.837 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 164' ' ' GLY . 97.6 mt-30 -64.48 -39.79 94.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.01 -1.056 . . . . 1.0 109.757 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 93.2 p -64.75 -26.61 68.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.139 -0.976 . . . . 1.0 110.271 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 92.2 mt -86.39 -54.02 4.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.164 -0.96 . . . . 1.0 110.174 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -91.0 -11.27 39.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.229 -0.919 . . . . 1.0 110.27 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.626 0 N-CA-C 109.386 -1.486 . . . . 1.0 109.386 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' WAY . . . . . 0.638 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.7 m . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.419 -0.585 . . . . 1.0 109.419 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.5 mt -67.62 139.85 56.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.132 -0.98 . . . . 1.0 109.316 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.5 pttt -161.26 162.05 30.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.372 -0.83 . . . . 1.0 109.499 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -70.65 146.53 49.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.205 -0.934 . . . . 1.0 109.419 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.3 m -99.57 17.82 19.49 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.36 -0.837 . . . . 1.0 110.043 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -147.82 147.63 30.03 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.001 -1.062 . . . . 1.0 109.438 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.538 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -91.82 -0.68 57.54 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.347 -0.845 . . . . 1.0 110.087 -179.707 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -99.28 119.9 38.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.264 -0.898 . . . . 1.0 108.589 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.7 mt -140.04 150.38 44.32 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.262 -0.899 . . . . 1.0 109.059 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.1 p -132.11 158.36 41.83 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.566 -0.709 . . . . 1.0 109.27 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -143.43 158.23 43.81 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.266 -0.896 . . . . 1.0 109.759 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.0 ttt-85 -143.14 132.65 23.58 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.483 -0.76 . . . . 1.0 109.796 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.8 mt -88.46 117.31 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.251 -0.906 . . . . 1.0 109.259 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.89 -40.05 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.079 -1.013 . . . . 1.0 108.937 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.689 HD22 ' H ' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -163.01 160.77 24.99 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.099 -1.001 . . . . 1.0 110.065 -179.656 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.639 ' CD1' ' CD2' ' A' ' 28' ' ' HIS . 46.9 m-85 -102.71 -160.39 0.78 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.086 -1.449 . . . . 1.0 107.086 178.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.798 ' HG1' ' H ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -127.62 153.76 77.66 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.053 -1.029 . . . . 1.0 110.704 -179.287 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -74.16 -16.9 22.28 Favored 'Trans proline' 0 N--CA 1.486 1.068 0 C-N-CA 121.089 1.193 . . . . 1.0 110.124 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.798 ' H ' ' HG1' ' A' ' 23' ' ' THR . 96.0 m-20 -59.46 -39.97 85.37 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.382 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 73.9 mtm -135.86 163.76 29.49 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.305 -0.872 . . . . 1.0 109.519 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.8 p -72.42 159.71 33.54 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.34 -0.85 . . . . 1.0 109.422 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.639 ' CD2' ' CD1' ' A' ' 22' ' ' TYR . 1.1 m80 -61.41 -40.03 92.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.434 -0.791 . . . . 1.0 110.399 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.5 m -60.08 -39.94 87.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.128 -0.982 . . . . 1.0 110.235 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -67.0 -39.98 87.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.136 -0.977 . . . . 1.0 109.871 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.4 t -68.21 -41.46 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.935 . . . . 1.0 110.457 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -60.05 -48.74 80.47 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.978 -1.076 . . . . 1.0 110.582 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -62.61 -32.46 73.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.979 -1.075 . . . . 1.0 109.948 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.07 -47.83 84.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.086 -1.009 . . . . 1.0 109.68 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -66.04 -39.73 90.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.074 -1.016 . . . . 1.0 109.868 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -60.02 -41.97 93.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.95 -1.094 . . . . 1.0 109.771 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -60.81 -41.93 96.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.966 -1.084 . . . . 1.0 109.201 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.39 -45.4 93.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.458 -0.776 . . . . 1.0 110.276 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -68.13 -38.37 82.12 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.986 -1.071 . . . . 1.0 110.162 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -59.93 -46.65 88.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.032 -1.043 . . . . 1.0 109.404 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.2 t -59.94 -41.0 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.943 . . . . 1.0 109.759 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 71.9 m95 -79.48 -36.56 38.52 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.983 -1.073 . . . . 1.0 110.293 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.8 p -71.23 -18.74 62.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.974 -1.078 . . . . 1.0 109.843 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.88 -39.66 90.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.188 -0.945 . . . . 1.0 110.847 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.9 m -110.05 23.25 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.28 -0.887 . . . . 1.0 110.836 -178.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.0 p -149.05 137.7 12.01 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 120.861 -1.149 . . . . 1.0 109.377 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -75.25 18.03 0.59 Allowed 'Trans proline' 0 N--CA 1.495 1.598 0 CA-C-N 119.68 0.921 . . . . 1.0 112.102 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.9 mt -68.19 138.39 55.58 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.048 -1.032 . . . . 1.0 109.991 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -110.15 120.35 42.17 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.665 -0.865 . . . . 1.0 108.665 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -108.12 121.32 44.59 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.42 -0.8 . . . . 1.0 109.589 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -120.01 130.03 54.54 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.598 -0.688 . . . . 1.0 109.333 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -82.53 134.7 35.2 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.198 -0.939 . . . . 1.0 109.441 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.4 mt -104.03 131.94 50.78 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.35 -0.844 . . . . 1.0 109.448 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.438 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 91.6 m-70 -65.03 -40.01 94.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.483 -0.761 . . . . 1.0 110.405 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 80.5 m-20 -146.74 170.02 17.86 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.106 -0.996 . . . . 1.0 109.985 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.26 177.51 40.35 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.483 -1.447 . . . . 1.0 109.483 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.5 mt -93.81 136.45 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.212 -1.17 . . . . 1.0 109.105 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -107.83 173.16 6.44 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.404 -0.81 . . . . 1.0 109.415 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -60.04 -49.18 78.66 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.193 -0.942 . . . . 1.0 109.216 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.0 mt -119.99 117.52 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.471 -0.768 . . . . 1.0 109.179 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.8 ptp -100.97 140.0 35.88 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.209 -0.932 . . . . 1.0 109.293 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 86.4 mt -110.01 130.09 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.622 -0.674 . . . . 1.0 109.802 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 31.0 p -150.51 156.21 40.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.217 -0.927 . . . . 1.0 109.826 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.689 ' H ' HD22 ' A' ' 21' ' ' ASN . 91.5 m-85 -102.76 122.79 45.2 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.292 -1.003 . . . . 1.0 108.292 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.7 -177.28 23.93 Favored Glycine 0 N--CA 1.499 2.891 0 N-CA-C 110.709 -0.956 . . . . 1.0 110.709 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.519 ' O ' ' C ' ' A' ' 67' ' ' LYS . 87.6 mt -136.62 164.63 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.71 -0.877 . . . . 1.0 108.813 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.519 ' C ' ' O ' ' A' ' 66' ' ' ILE . 20.1 tptm -15.04 -78.97 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.504 0 N-CA-C 112.377 0.51 . . . . 1.0 112.377 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -72.37 144.84 48.08 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.114 -0.991 . . . . 1.0 110.862 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.3 m80 -134.45 173.03 12.09 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 108.269 -1.011 . . . . 1.0 108.269 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.02 -42.86 98.57 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.057 -1.617 . . . . 1.0 109.057 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -80.19 161.38 25.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.287 -1.125 . . . . 1.0 108.855 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -90.32 97.84 11.42 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.985 -1.072 . . . . 1.0 109.764 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.558 ' O ' ' CG ' ' A' ' 73' ' ' TYR . 10.1 p90 -172.3 51.27 0.13 Allowed Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 108.797 -0.816 . . . . 1.0 108.797 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.515 ' CD ' ' N ' ' A' ' 73' ' ' TYR . 13.4 Cg_exo -41.61 160.91 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.159 0 C-N-CA 121.361 1.374 . . . . 1.0 113.083 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.517 ' CD2' ' OD2' ' A' ' 99' ' ' ASP . 34.0 m-85 -88.82 -176.16 5.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.706 -0.621 . . . . 1.0 109.507 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -99.94 0.04 40.41 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.217 -0.927 . . . . 1.0 110.478 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 128.05 -139.46 11.1 Favored Glycine 0 N--CA 1.502 3.056 0 N-CA-C 108.344 -1.902 . . . . 1.0 108.344 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.448 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 24.9 Cg_endo -79.02 -52.9 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.314 0 CA-C-N 119.917 1.859 . . . . 1.0 112.09 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 91.6 p -79.6 170.49 16.48 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.205 -0.934 . . . . 1.0 110.086 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.82 -122.5 7.6 Favored Glycine 0 N--CA 1.498 2.817 0 N-CA-C 110.488 -1.045 . . . . 1.0 110.488 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.465 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 9.8 mt -67.26 100.48 0.81 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.454 -1.027 . . . . 1.0 109.111 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 64.2 mt -79.06 -20.03 49.87 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.014 -1.054 . . . . 1.0 110.03 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.01 171.99 1.32 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 1.0 109.035 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.528 ' CE1' ' OH ' ' A' ' 73' ' ' TYR . 6.4 p80 -162.28 159.14 25.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.012 -1.055 . . . . 1.0 109.896 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.08 156.18 42.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.49 -0.756 . . . . 1.0 109.322 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -103.5 150.94 38.55 Favored Pre-proline 0 N--CA 1.496 1.863 0 N-CA-C 108.39 -0.967 . . . . 1.0 108.39 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.73 166.47 11.85 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 120.924 1.083 . . . . 1.0 111.42 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -55.52 139.71 82.58 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 120.661 0.907 . . . . 1.0 111.361 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -160.28 -172.02 26.96 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 109.384 -1.486 . . . . 1.0 109.384 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.44 -76.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.114 1.209 . . . . 1.0 112.189 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -119.96 -49.78 2.3 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.439 -0.788 . . . . 1.0 110.23 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.469 ' CD1' ' N ' ' A' ' 93' ' ' GLY . 40.4 p90 -62.76 -39.92 95.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.956 -1.09 . . . . 1.0 110.097 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.469 ' N ' ' CD1' ' A' ' 92' ' ' TYR . . . -69.32 168.1 45.91 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.909 -1.276 . . . . 1.0 109.909 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 71.87 64.26 2.74 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.906 -1.278 . . . . 1.0 109.906 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -153.41 160.89 42.72 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.234 -1.157 . . . . 1.0 109.602 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.04 122.43 9.05 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.209 -0.932 . . . . 1.0 109.526 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -109.72 155.98 20.86 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.596 -0.69 . . . . 1.0 109.392 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.524 ' CE2' ' OE2' ' A' ' 120' ' ' GLU . 29.1 m-85 -130.23 143.66 50.91 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.197 -1.038 . . . . 1.0 108.197 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.517 ' OD2' ' CD2' ' A' ' 75' ' ' PHE . 93.6 m-20 -80.01 117.06 20.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.725 -1.234 . . . . 1.0 109.576 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 39.1 t0 -81.59 2.74 27.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.386 -0.821 . . . . 1.0 109.559 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -81.2 -17.34 49.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 1.0 110.101 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.512 ' N ' ' OE1' ' A' ' 102' ' ' GLU . 58.0 mp0 -92.86 174.87 7.02 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.018 -1.051 . . . . 1.0 109.605 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 23.3 m -99.14 105.12 17.17 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.529 -0.915 . . . . 1.0 108.529 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -85.21 128.12 34.55 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.347 -0.845 . . . . 1.0 108.73 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.449 ' HG1' ' H ' ' A' ' 107' ' ' SER . 8.9 t -142.77 158.33 43.74 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.416 -0.803 . . . . 1.0 109.781 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.6 t -95.56 -9.09 33.28 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.253 -1.017 . . . . 1.0 108.253 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.644 ' HG ' ' H ' ' A' ' 108' ' ' SER . 11.4 t -92.1 -171.6 2.88 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.888 -0.782 . . . . 1.0 108.888 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.644 ' H ' ' HG ' ' A' ' 107' ' ' SER . 2.5 t -88.38 77.77 8.07 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.077 -1.014 . . . . 1.0 109.619 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -149.31 151.39 34.07 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.324 -0.86 . . . . 1.0 108.761 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.48 -137.7 5.29 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.949 -1.26 . . . . 1.0 109.949 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -100.06 118.97 37.55 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.376 -1.073 . . . . 1.0 109.316 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.694 HD22 ' HZ2' ' A' ' 146' ' ' LYS . 23.8 t-20 -65.52 130.11 42.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 1.0 110.059 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 58.6 tp -60.06 -47.11 87.24 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.368 -0.832 . . . . 1.0 111.295 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -59.79 -42.9 94.4 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.083 -1.01 . . . . 1.0 111.843 -177.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.403 ' N ' HD21 ' A' ' 115' ' ' LEU . 4.0 mm? -60.01 -49.99 75.5 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.532 -1.355 . . . . 1.0 109.21 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 65.3 t -66.66 -42.36 89.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.244 -0.91 . . . . 1.0 110.866 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.97 -48.74 79.06 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.081 -1.012 . . . . 1.0 110.325 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.35 -39.17 82.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.947 -1.096 . . . . 1.0 110.294 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 56.4 t60 -65.27 -52.42 54.41 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.137 -0.977 . . . . 1.0 111.411 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.524 ' OE2' ' CE2' ' A' ' 98' ' ' PHE . 10.1 pt-20 -60.03 -42.3 94.1 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.772 -1.205 . . . . 1.0 110.609 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.435 ' O ' ' OG ' ' A' ' 124' ' ' SER . 26.8 m-85 -60.09 -39.86 87.59 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.729 -1.232 . . . . 1.0 108.814 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -54.82 -42.74 80.1 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.366 -1.494 . . . . 1.0 109.366 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -65.68 -39.1 90.94 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.125 -1.221 . . . . 1.0 109.134 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 121' ' ' PHE . 79.1 p -62.14 -24.97 67.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -0.903 . . . . 1.0 109.892 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 88.8 mt -81.19 -0.08 38.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.057 -1.027 . . . . 1.0 109.792 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 91.89 10.36 61.49 Favored Glycine 0 N--CA 1.498 2.784 0 O-C-N 121.058 -1.026 . . . . 1.0 110.668 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.3 mt -84.71 150.01 25.4 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.931 -1.334 . . . . 1.0 109.462 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 37.1 t0 -100.65 169.99 8.66 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.435 -0.79 . . . . 1.0 109.06 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.526 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 74.8 m80 -59.99 139.74 57.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.153 -0.967 . . . . 1.0 109.545 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 41.2 t -96.25 156.16 16.46 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.27 -0.894 . . . . 1.0 108.913 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -99.13 3.95 46.75 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.127 -0.983 . . . . 1.0 109.574 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -87.07 129.49 51.73 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.089 -1.007 . . . . 1.0 108.726 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -67.9 -27.82 36.61 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 CA-C-N 120.086 1.066 . . . . 1.0 113.022 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -84.86 -2.31 88.58 Favored Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.824 -1.179 . . . . 1.0 110.454 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.83 146.81 26.07 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.022 -1.281 . . . . 1.0 110.015 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 86.5 mt -70.06 -29.96 67.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.221 -0.924 . . . . 1.0 109.677 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.2 mmm -73.6 8.3 1.94 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.183 -0.948 . . . . 1.0 110.171 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -69.41 132.64 89.48 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.096 -1.002 . . . . 1.0 108.595 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -63.41 14.19 0.07 OUTLIER 'Trans proline' 0 N--CA 1.505 2.182 0 C-N-CA 121.152 1.235 . . . . 1.0 115.167 -177.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 76.0 mt -130.78 138.02 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.382 0 O-C-N 120.785 -1.197 . . . . 1.0 109.495 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.464 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 21.5 t80 -73.37 128.3 35.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.444 -0.785 . . . . 1.0 109.957 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 10.0 t -136.56 137.0 39.76 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.579 -0.701 . . . . 1.0 109.197 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -85.11 143.18 29.0 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.17 -0.956 . . . . 1.0 109.265 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.7 t -140.38 151.19 44.77 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.3 -0.875 . . . . 1.0 109.52 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -68.89 109.39 2.87 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.734 -1.746 . . . . 1.0 108.734 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.694 ' HZ2' HD22 ' A' ' 112' ' ' ASN . 85.0 mttt -73.35 126.03 29.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.133 -1.216 . . . . 1.0 109.298 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 10.6 p -176.86 -93.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.307 -0.871 . . . . 1.0 109.111 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -98.81 18.83 16.09 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.664 -0.865 . . . . 1.0 108.664 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -60.15 134.62 57.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.592 -0.693 . . . . 1.0 109.829 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 95.0 mtp -136.96 150.14 47.98 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.732 -0.84 . . . . 1.0 108.732 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 20.8 mt -48.23 125.87 11.85 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.069 -1.02 . . . . 1.0 108.949 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -62.83 175.62 2.25 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 CA-C-N 120.118 1.078 . . . . 1.0 112.201 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.02 -39.95 87.62 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.311 -0.868 . . . . 1.0 109.553 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.403 ' OD1' ' C ' ' A' ' 154' ' ' ASP . 52.7 t0 -55.89 -50.02 71.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.911 . . . . 1.0 109.739 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -70.07 -39.94 75.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.143 -0.973 . . . . 1.0 110.427 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.3 t -59.97 -46.41 94.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.903 -1.123 . . . . 1.0 109.018 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -60.3 -40.04 89.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.977 -1.077 . . . . 1.0 110.278 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -67.93 -55.89 12.5 Favored Glycine 0 N--CA 1.494 2.526 0 O-C-N 121.12 -0.988 . . . . 1.0 111.152 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.3 tp -60.44 -39.98 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.909 -1.347 . . . . 1.0 109.523 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.492 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.5 mt-30 -65.28 -39.93 93.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.076 -1.015 . . . . 1.0 109.812 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 85.6 p -60.05 -33.92 72.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.064 -1.023 . . . . 1.0 110.488 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.4 mt -84.83 -56.71 3.44 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.004 -1.06 . . . . 1.0 111.167 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -89.66 -9.0 51.21 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.989 -1.07 . . . . 1.0 110.647 -178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.497 2.748 0 N-CA-C 109.538 -1.425 . . . . 1.0 109.538 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' WAY . . . . . 0.785 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 90.5 m . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.413 -0.588 . . . . 1.0 109.413 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.2 mt -68.1 139.28 56.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 1.0 109.343 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.5 pttm -165.12 167.04 18.61 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.37 -0.831 . . . . 1.0 109.442 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -71.88 142.32 49.54 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.182 -0.949 . . . . 1.0 109.188 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.3 t -89.86 4.47 49.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.253 -0.905 . . . . 1.0 109.924 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -145.07 154.1 42.13 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.182 -0.949 . . . . 1.0 109.452 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.1 mmt -90.47 0.51 57.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.287 -0.883 . . . . 1.0 109.684 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -95.73 126.9 41.31 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.218 -0.927 . . . . 1.0 109.554 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.8 mt -143.26 149.16 37.49 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.366 -0.834 . . . . 1.0 108.816 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.0 p -132.78 155.18 49.37 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.424 -0.798 . . . . 1.0 108.851 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.499 ' CD2' ' NH1' ' A' ' 52' ' ' ARG . 34.7 p90 -148.4 160.12 43.34 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.821 -1.174 . . . . 1.0 110.752 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.0 ttt-85 -145.72 134.77 22.68 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.387 -0.598 . . . . 1.0 109.387 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.679 ' H ' ' NH2' ' A' ' 52' ' ' ARG . 93.5 mt -89.9 119.1 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 120.792 -1.193 . . . . 1.0 108.684 178.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 56.1 t -69.0 -40.78 81.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.964 -1.085 . . . . 1.0 109.027 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.4 p-10 -162.95 164.12 25.9 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.032 -1.067 . . . . 1.0 110.203 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.516 ' CD2' ' CG ' ' A' ' 28' ' ' HIS . 36.7 m-85 -103.42 -161.08 0.81 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.646 -1.613 . . . . 1.0 106.646 178.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.12 151.84 74.95 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.614 -0.679 . . . . 1.0 110.668 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -70.19 -14.28 34.55 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.056 1.171 . . . . 1.0 110.062 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -59.45 -40.02 85.5 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 115.307 -0.86 . . . . 1.0 110.027 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.6 mtm -140.47 168.07 20.68 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.343 -0.848 . . . . 1.0 109.236 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.4 p -72.79 159.98 32.92 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.401 -0.812 . . . . 1.0 109.207 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.516 ' CG ' ' CD2' ' A' ' 22' ' ' TYR . 51.2 m170 -59.97 -40.0 87.56 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.442 -0.787 . . . . 1.0 110.007 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 61.9 m -60.01 -40.06 87.98 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.165 -0.959 . . . . 1.0 110.488 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.65 -39.96 91.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.96 -1.088 . . . . 1.0 109.838 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.4 t -69.51 -41.38 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.135 -0.978 . . . . 1.0 110.485 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.0 -49.05 79.18 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.989 -1.069 . . . . 1.0 110.495 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -62.17 -32.91 73.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.987 -1.071 . . . . 1.0 109.825 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.98 -50.43 73.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.184 -0.948 . . . . 1.0 110.042 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -65.82 -38.94 90.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.054 -1.029 . . . . 1.0 109.672 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.97 -42.36 93.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.06 -1.025 . . . . 1.0 109.808 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -60.56 -40.59 92.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.942 -1.098 . . . . 1.0 109.234 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.26 -43.1 96.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -0.89 . . . . 1.0 109.99 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -66.07 -40.01 90.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.03 -1.043 . . . . 1.0 109.705 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -59.94 -47.87 84.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -0.934 . . . . 1.0 110.139 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 70.5 t -59.95 -40.04 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.058 -1.026 . . . . 1.0 109.965 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -81.66 -35.31 30.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.895 -1.128 . . . . 1.0 110.182 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.7 p -70.46 -22.82 62.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.92 -1.113 . . . . 1.0 109.414 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -59.96 -40.01 87.58 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.433 -0.792 . . . . 1.0 110.606 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.5 m -112.14 25.35 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.372 -0.83 . . . . 1.0 110.729 -178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.422 ' C ' ' H ' ' A' ' 48' ' ' LEU . 59.9 p -148.91 131.62 7.95 Favored Pre-proline 0 N--CA 1.501 2.09 0 O-C-N 120.88 -1.137 . . . . 1.0 109.796 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -72.93 20.54 0.33 Allowed 'Trans proline' 0 N--CA 1.495 1.577 0 CA-C-N 119.668 0.917 . . . . 1.0 112.032 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.422 ' H ' ' C ' ' A' ' 46' ' ' THR . 83.9 mt -67.97 139.1 56.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.175 -0.953 . . . . 1.0 109.614 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -107.92 120.58 42.7 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.851 -0.796 . . . . 1.0 108.851 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -107.21 127.1 53.22 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.304 -0.873 . . . . 1.0 110.023 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.3 m -120.05 129.98 54.48 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.648 -0.657 . . . . 1.0 109.404 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.679 ' NH2' ' H ' ' A' ' 19' ' ' ILE . 28.9 tpt180 -84.03 136.5 34.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.247 -0.908 . . . . 1.0 109.833 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.0 mt -110.61 128.71 55.79 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.438 -0.789 . . . . 1.0 109.26 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.44 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 56.6 m170 -69.43 -39.78 77.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.396 -0.815 . . . . 1.0 109.708 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 76.7 m-20 -148.77 168.66 22.33 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.231 -0.918 . . . . 1.0 110.084 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.27 -175.48 29.52 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 109.868 -1.293 . . . . 1.0 109.868 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.7 mt -94.46 133.98 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.313 -1.11 . . . . 1.0 109.021 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.79 163.0 14.66 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.493 -0.754 . . . . 1.0 109.511 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -59.94 -49.25 78.41 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.279 -0.888 . . . . 1.0 109.045 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 95.8 mt -113.64 108.36 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.465 -0.772 . . . . 1.0 109.516 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.6 ptm -103.47 132.44 49.72 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.207 -0.933 . . . . 1.0 109.435 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 90.1 mt -102.34 138.25 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.506 -0.746 . . . . 1.0 109.777 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.8 p -153.63 157.34 39.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.249 -0.907 . . . . 1.0 109.49 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -102.08 125.28 48.73 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.8 -0.815 . . . . 1.0 108.8 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.14 158.04 16.21 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.424 -1.071 . . . . 1.0 110.424 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.417 HG12 ' H ' ' A' ' 67' ' ' LYS . 9.8 tt -109.8 -178.03 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.758 -0.83 . . . . 1.0 108.758 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.417 ' H ' HG12 ' A' ' 66' ' ' ILE . 22.0 tptm -38.52 -78.76 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.748 -0.595 . . . . 1.0 110.221 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -73.09 126.28 29.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.119 -0.988 . . . . 1.0 110.058 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.45 ' CE1' ' CE1' ' A' ' 75' ' ' PHE . 0.9 OUTLIER -100.09 -2.51 34.07 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.225 -0.922 . . . . 1.0 108.873 179.829 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.96 7.19 88.72 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.651 -1.78 . . . . 1.0 108.651 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.445 ' C ' ' H ' ' A' ' 73' ' ' TYR . 96.0 m-20 -131.51 170.02 15.29 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.676 -0.897 . . . . 1.0 108.929 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.411 ' CE2' ' CZ ' ' A' ' 73' ' ' TYR . 24.3 p90 -73.64 43.65 0.15 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.108 -0.995 . . . . 1.0 109.742 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.445 ' H ' ' C ' ' A' ' 71' ' ' ASP . 55.0 m-85 -132.48 74.75 74.97 Favored Pre-proline 0 N--CA 1.501 2.106 0 O-C-N 121.458 -0.776 . . . . 1.0 109.164 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -80.16 146.3 17.8 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.395 1.397 . . . . 1.0 112.391 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.537 ' CE2' ' OD1' ' A' ' 99' ' ' ASP . 27.2 m-85 -93.14 169.41 10.43 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.366 -0.976 . . . . 1.0 108.366 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 79' ' ' SER . 23.7 p-10 -99.95 10.25 41.61 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.046 -1.034 . . . . 1.0 110.948 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 110.73 -150.5 17.72 Favored Glycine 0 N--CA 1.507 3.395 0 N-CA-C 109.557 -1.417 . . . . 1.0 109.557 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -58.77 -65.81 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.577 0 CA-C-N 118.913 1.357 . . . . 1.0 112.846 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.433 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 78.9 p -75.24 159.16 31.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.095 -1.003 . . . . 1.0 109.693 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.22 -128.59 8.04 Favored Glycine 0 N--CA 1.5 2.944 0 N-CA-C 109.773 -1.331 . . . . 1.0 109.773 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.464 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 14.8 mt -69.4 105.84 2.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.326 -1.102 . . . . 1.0 109.41 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 72.2 mt -78.73 -24.4 44.88 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.127 -0.983 . . . . 1.0 108.738 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.65 169.99 1.31 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.053 -1.091 . . . . 1.0 108.053 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -163.0 161.39 25.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.855 -1.153 . . . . 1.0 110.209 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -145.5 162.31 37.68 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.502 -0.749 . . . . 1.0 109.193 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -103.06 151.92 38.5 Favored Pre-proline 0 N--CA 1.501 2.113 0 O-C-N 121.114 -0.991 . . . . 1.0 109.227 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.442 ' O ' ' N ' ' A' ' 89' ' ' GLY . 7.4 Cg_exo -49.67 167.15 0.19 Allowed 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 120.784 0.99 . . . . 1.0 112.518 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -61.61 73.83 0.09 OUTLIER 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.249 1.299 . . . . 1.0 111.845 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -89.76 -168.4 43.11 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 108.852 -1.699 . . . . 1.0 108.852 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 89' ' ' GLY . 17.0 Cg_exo -56.04 -147.41 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 121.215 1.277 . . . . 1.0 112.713 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -60.34 -40.0 89.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.292 -0.88 . . . . 1.0 110.172 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -70.04 -38.58 75.89 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.072 -1.018 . . . . 1.0 109.462 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -59.37 169.52 6.37 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.669 -1.372 . . . . 1.0 109.669 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 73.42 16.11 78.92 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.206 -1.158 . . . . 1.0 110.206 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.2 p-10 -79.93 166.26 21.8 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.967 -1.314 . . . . 1.0 109.716 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.87 123.17 10.26 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.279 -0.888 . . . . 1.0 109.27 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 57.5 m170 -112.31 154.8 25.12 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.571 -0.705 . . . . 1.0 109.973 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.519 ' CZ ' ' OE2' ' A' ' 120' ' ' GLU . 38.9 m-85 -133.12 149.79 52.09 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.625 -0.88 . . . . 1.0 108.625 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.537 ' OD1' ' CE2' ' A' ' 75' ' ' PHE . 64.4 m-20 -79.93 123.23 27.59 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.964 -1.085 . . . . 1.0 110.058 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -84.8 -9.72 57.89 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.297 -0.877 . . . . 1.0 109.621 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -84.73 -11.55 55.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.261 -0.899 . . . . 1.0 109.848 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -90.02 169.94 10.77 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.37 -0.831 . . . . 1.0 110.026 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 16.7 m -100.14 105.19 16.78 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.435 -0.79 . . . . 1.0 109.101 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -89.32 124.29 34.28 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.084 -0.71 . . . . 1.0 109.084 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.8 t -140.7 154.55 46.4 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.279 -0.888 . . . . 1.0 110.151 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 70.2 m -92.88 -8.01 44.59 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.427 -0.953 . . . . 1.0 108.427 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.4 m -92.63 176.78 6.32 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.9 m -79.72 76.64 6.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.998 -1.064 . . . . 1.0 109.428 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -147.26 148.66 31.67 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.392 -0.817 . . . . 1.0 108.866 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 46.11 -139.39 6.66 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.747 -1.341 . . . . 1.0 109.747 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -99.7 114.41 27.5 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.251 -1.146 . . . . 1.0 109.21 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.503 ' H ' ' HH ' ' A' ' 141' ' ' TYR . 18.9 t-20 -63.69 133.76 54.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.137 -0.977 . . . . 1.0 109.538 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.3 tp -59.99 -44.76 94.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.506 -0.747 . . . . 1.0 110.825 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -59.97 -42.75 94.84 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.005 -1.06 . . . . 1.0 110.561 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -59.61 -50.01 75.54 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.878 -1.139 . . . . 1.0 109.363 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.7 t -69.07 -41.46 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.15 -0.969 . . . . 1.0 109.691 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.63 -50.16 74.85 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.369 -0.832 . . . . 1.0 110.274 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.44 -38.71 81.41 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.865 -1.147 . . . . 1.0 110.218 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -64.02 -50.01 70.17 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.093 -1.004 . . . . 1.0 111.031 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.519 ' OE2' ' CZ ' ' A' ' 98' ' ' PHE . 7.4 pt-20 -59.99 -44.64 94.38 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.698 -1.251 . . . . 1.0 110.048 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.405 ' O ' ' OG ' ' A' ' 124' ' ' SER . 33.0 m-85 -59.99 -40.03 87.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.785 -1.197 . . . . 1.0 108.895 179.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.29 -43.75 64.85 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.241 -1.543 . . . . 1.0 109.241 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -66.29 -39.93 89.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.217 -1.166 . . . . 1.0 109.112 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 121' ' ' PHE . 77.4 p -62.39 -21.41 65.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.898 . . . . 1.0 109.561 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.5 mt -83.0 -3.55 57.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 1.0 109.391 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 92.4 8.14 62.92 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.524 -1.03 . . . . 1.0 110.524 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.3 mt -86.58 146.34 26.39 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.95 -1.324 . . . . 1.0 109.208 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 27.7 t0 -99.47 175.29 5.9 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.476 -0.765 . . . . 1.0 109.576 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.461 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 75.2 m80 -61.15 135.66 57.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 1.0 109.72 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.446 ' HG ' ' N ' ' A' ' 131' ' ' LYS . 41.5 t -97.37 156.7 16.34 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.21 -0.931 . . . . 1.0 109.358 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.446 ' N ' ' HG ' ' A' ' 130' ' ' SER . 63.2 mttp -97.33 0.39 47.9 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.155 -0.965 . . . . 1.0 109.632 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -83.7 130.23 56.46 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.171 -0.955 . . . . 1.0 108.476 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -70.58 -20.69 30.67 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 CA-C-N 120.022 1.044 . . . . 1.0 112.384 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -87.58 -5.05 79.2 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.823 -1.311 . . . . 1.0 109.823 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.73 145.72 26.55 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.173 -1.192 . . . . 1.0 109.267 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.502 ' C ' ' H ' ' A' ' 138' ' ' PHE . 95.5 mt -70.67 -30.98 67.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.078 -1.014 . . . . 1.0 109.477 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 98.2 mmm -70.23 14.14 0.13 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.364 -0.835 . . . . 1.0 109.766 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.502 ' H ' ' C ' ' A' ' 136' ' ' LEU . 13.5 t80 -68.89 134.03 90.07 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.071 -1.018 . . . . 1.0 108.297 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -62.67 -18.36 63.6 Favored 'Trans proline' 0 N--CA 1.501 1.957 0 C-N-CA 121.04 1.16 . . . . 1.0 113.985 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.422 HD13 HG22 ' A' ' 140' ' ' ILE . 96.8 mt -102.79 141.43 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 120.834 -1.166 . . . . 1.0 109.691 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.503 ' HH ' ' H ' ' A' ' 112' ' ' ASN . 46.3 t80 -75.58 126.01 30.16 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.331 -0.856 . . . . 1.0 110.221 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 11.0 t -134.73 137.46 43.5 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.426 -0.796 . . . . 1.0 109.268 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -80.1 143.56 33.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.966 -1.084 . . . . 1.0 108.6 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.9 t -139.83 151.73 45.94 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.313 -0.867 . . . . 1.0 109.615 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.55 104.75 1.51 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.374 -1.49 . . . . 1.0 109.374 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -77.9 1.72 19.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.26 -1.141 . . . . 1.0 109.95 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 73.3 m -60.05 -40.1 88.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.193 -0.942 . . . . 1.0 109.652 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -143.41 29.45 1.43 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.246 -0.909 . . . . 1.0 109.468 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -69.7 138.87 53.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.173 -0.955 . . . . 1.0 110.11 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 93.9 mtp -138.79 146.67 41.62 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.544 -0.91 . . . . 1.0 108.544 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 58.1 mt -51.74 129.03 36.29 Favored Pre-proline 0 C--N 1.302 -1.483 0 O-C-N 121.111 -0.993 . . . . 1.0 108.728 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -69.2 178.56 4.11 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 CA-C-N 119.985 1.03 . . . . 1.0 112.266 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -63.11 -39.89 96.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.476 -0.765 . . . . 1.0 110.12 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -55.64 -48.56 74.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.337 -0.852 . . . . 1.0 109.764 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -69.93 -40.03 75.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.97 . . . . 1.0 109.847 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.04 -48.13 89.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.075 -1.016 . . . . 1.0 108.995 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -60.11 -40.02 88.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.191 -0.943 . . . . 1.0 110.261 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.43 -55.0 7.11 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 120.199 -1.001 . . . . 1.0 111.477 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.408 ' CG2' ' N ' ' A' ' 160' ' ' GLN . 5.3 tp -60.0 -40.14 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.967 -1.313 . . . . 1.0 109.732 -178.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.55 ' O ' ' N ' ' A' ' 164' ' ' GLY . 12.4 mm100 -64.43 -39.34 93.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.209 -0.932 . . . . 1.0 109.316 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 79.9 p -60.95 -34.13 74.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.139 -0.976 . . . . 1.0 110.484 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.2 mt -84.43 -52.79 5.9 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.877 -1.139 . . . . 1.0 110.671 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -90.67 -8.01 51.1 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.046 -1.034 . . . . 1.0 110.541 -178.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.536 0 N-CA-C 109.288 -1.525 . . . . 1.0 109.288 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' WAY . . . . . 0.94 ' HC2' ' HJ ' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.51 ' H ' ' CD2' ' A' ' 162' ' ' LEU . 11.3 m . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.369 -0.604 . . . . 1.0 109.369 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.3 mt -60.68 139.99 57.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.92 -1.112 . . . . 1.0 109.328 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.444 ' NZ ' ' O ' ' A' ' 7' ' ' THR . 8.9 ptpp? -160.34 159.97 31.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.24 -0.913 . . . . 1.0 109.384 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -76.37 127.24 32.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.148 -0.97 . . . . 1.0 109.259 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.43 ' HG ' ' N ' ' A' ' 12' ' ' LYS . 78.4 p -69.24 -38.48 78.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.038 -1.039 . . . . 1.0 108.933 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.43 ' N ' ' HG ' ' A' ' 11' ' ' SER . 49.1 pttt -89.47 136.43 33.03 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.932 -1.136 . . . . 1.0 107.932 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.611 ' N ' ' SD ' ' A' ' 13' ' ' MET . 4.8 mmm -90.7 -0.27 57.64 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.065 -1.022 . . . . 1.0 109.872 -178.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -97.98 132.72 43.3 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.997 -1.112 . . . . 1.0 107.997 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.6 mt -139.57 149.92 44.43 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.202 -0.936 . . . . 1.0 109.376 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.7 p -135.67 156.43 48.85 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.661 -0.866 . . . . 1.0 108.661 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -145.86 160.04 42.35 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.137 -0.977 . . . . 1.0 109.958 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 37.0 ttt-85 -144.31 134.94 24.84 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.49 -0.756 . . . . 1.0 109.272 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.8 mt -87.54 119.68 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.244 -0.91 . . . . 1.0 108.748 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.5 t -69.17 -39.93 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.239 -0.913 . . . . 1.0 109.345 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -165.01 153.08 11.67 Favored 'General case' 0 C--N 1.29 -1.991 0 O-C-N 120.163 -1.586 . . . . 1.0 110.802 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -100.81 106.52 17.92 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 105.87 -1.9 . . . . 1.0 105.87 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.663 ' HG1' ' H ' ' A' ' 25' ' ' ASP . 0.4 OUTLIER -45.45 140.04 4.32 Favored Pre-proline 0 C--N 1.299 -1.612 0 O-C-N 121.487 -0.758 . . . . 1.0 109.591 -177.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -59.22 -3.05 1.51 Allowed 'Trans proline' 0 N--CA 1.487 1.111 0 CA-C-N 119.358 0.807 . . . . 1.0 110.75 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.663 ' H ' ' HG1' ' A' ' 23' ' ' THR . 94.3 m-20 -59.73 -36.04 75.79 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.585 -0.524 . . . . 1.0 109.585 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 78.0 mtm -140.0 166.75 23.8 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.219 -0.925 . . . . 1.0 109.801 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.6 p -71.63 160.15 33.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.417 -0.802 . . . . 1.0 109.335 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -60.09 -40.93 91.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.307 -0.871 . . . . 1.0 110.32 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.5 m -60.03 -40.34 88.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.935 -1.103 . . . . 1.0 110.875 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.01 -42.96 89.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.109 -0.994 . . . . 1.0 110.767 -178.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.7 t -65.37 -39.87 86.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 121.248 -0.907 . . . . 1.0 109.598 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -58.1 -54.97 41.0 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.371 -0.831 . . . . 1.0 111.708 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.9 pttt -63.47 -33.68 76.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.607 -1.308 . . . . 1.0 110.723 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.37 -50.78 70.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.637 -1.289 . . . . 1.0 109.666 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -67.69 -38.81 84.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.842 -1.161 . . . . 1.0 110.401 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -59.89 -40.69 89.58 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.724 -1.235 . . . . 1.0 109.438 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -60.72 -39.94 90.48 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.158 -0.964 . . . . 1.0 108.988 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.09 -47.12 87.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.432 -0.792 . . . . 1.0 109.834 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -65.21 -38.9 91.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.081 -1.012 . . . . 1.0 109.656 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 44.0 tptt -59.95 -47.83 84.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.079 -1.013 . . . . 1.0 109.893 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.5 t -60.07 -40.77 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.28 -0.887 . . . . 1.0 110.79 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.423 ' O ' ' OG1' ' A' ' 46' ' ' THR . 83.8 m95 -82.32 -35.38 27.96 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.86 -1.15 . . . . 1.0 110.483 -178.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.6 p -70.03 -17.3 63.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.13 -0.981 . . . . 1.0 109.606 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -59.82 -39.98 86.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.261 -0.9 . . . . 1.0 110.868 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.4 m -110.85 -19.46 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 O-C-N 121.147 -0.971 . . . . 1.0 110.487 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 42' ' ' TRP . 67.3 p -94.46 129.79 35.66 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 120.843 -1.161 . . . . 1.0 109.709 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -73.01 10.18 1.18 Allowed 'Trans proline' 0 N--CA 1.494 1.553 0 CA-C-N 119.831 0.975 . . . . 1.0 111.953 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.7 mt -67.95 140.61 56.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.215 -0.928 . . . . 1.0 109.822 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -104.47 121.97 44.55 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.933 -0.765 . . . . 1.0 108.933 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -107.69 122.42 46.69 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.293 -0.879 . . . . 1.0 109.699 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.0 m -119.88 129.98 54.64 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.483 -0.76 . . . . 1.0 109.615 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.475 ' NH1' ' CB ' ' A' ' 52' ' ' ARG . 11.1 ttp-105 -85.03 133.66 34.24 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.288 -0.883 . . . . 1.0 109.725 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 86.2 mt -102.52 126.72 49.67 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.269 -0.894 . . . . 1.0 109.353 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.425 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 54.8 m170 -61.41 -39.87 92.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.447 -0.783 . . . . 1.0 109.874 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 80.8 m-20 -146.19 171.4 14.99 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.225 -0.922 . . . . 1.0 109.563 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.24 179.87 38.12 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.758 -1.337 . . . . 1.0 109.758 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.5 mt -95.56 136.39 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.313 -1.11 . . . . 1.0 109.262 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.72 163.58 14.39 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.483 -0.761 . . . . 1.0 109.244 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -59.99 -49.77 76.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -0.895 . . . . 1.0 109.472 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.9 mt -108.48 104.17 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.488 -0.757 . . . . 1.0 109.753 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.8 ptp -100.83 135.06 42.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.218 -0.926 . . . . 1.0 109.181 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.5 mt -109.99 131.09 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.624 -0.673 . . . . 1.0 109.711 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.3 p -150.55 156.59 41.7 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.205 -0.935 . . . . 1.0 109.898 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -102.37 120.02 39.79 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.207 -1.035 . . . . 1.0 108.207 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.0 -169.48 23.25 Favored Glycine 0 N--CA 1.499 2.878 0 N-CA-C 110.629 -0.988 . . . . 1.0 110.629 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.534 ' O ' ' C ' ' A' ' 67' ' ' LYS . 93.2 mt -134.39 168.99 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.139 -1.06 . . . . 1.0 108.139 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.534 ' C ' ' O ' ' A' ' 66' ' ' ILE . 52.1 tptt -17.96 -98.01 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.649 0 CA-C-O 120.884 0.373 . . . . 1.0 111.455 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.547 ' H ' ' CD ' ' A' ' 68' ' ' GLU . 3.9 pm0 -74.26 139.49 44.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.817 -1.177 . . . . 1.0 109.973 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.497 ' CD2' ' OD2' ' A' ' 71' ' ' ASP . 44.2 p-80 -152.89 33.27 0.48 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.887 -1.133 . . . . 1.0 109.936 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.71 21.97 62.78 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 120.227 -0.987 . . . . 1.0 110.721 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.497 ' OD2' ' CD2' ' A' ' 69' ' ' HIS . 97.8 m-20 -129.98 145.53 51.64 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.216 -1.167 . . . . 1.0 109.545 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -74.02 156.14 37.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.368 -0.833 . . . . 1.0 109.332 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 49.96 60.03 15.77 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.139 -0.976 . . . . 1.0 109.354 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -60.28 -152.67 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 120.891 1.061 . . . . 1.0 111.987 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.585 ' CD1' ' OD1' ' A' ' 99' ' ' ASP . 90.6 m-85 -86.55 166.0 15.77 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.162 -0.961 . . . . 1.0 109.2 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -101.27 0.03 36.58 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.31 -0.869 . . . . 1.0 110.848 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 134.18 -150.27 19.97 Favored Glycine 0 N--CA 1.504 3.18 0 N-CA-C 108.767 -1.733 . . . . 1.0 108.767 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.424 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 2.8 Cg_exo -64.07 -64.1 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.339 0 CA-C-N 119.013 1.406 . . . . 1.0 111.473 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 94.3 p -77.83 160.85 28.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.118 -0.989 . . . . 1.0 109.331 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.98 -129.83 8.71 Favored Glycine 0 N--CA 1.501 3.007 0 N-CA-C 109.101 -1.6 . . . . 1.0 109.101 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.413 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 10.1 mt -69.41 107.5 3.35 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.132 -1.216 . . . . 1.0 108.735 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 55.6 mt -75.16 -25.77 58.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.942 -1.098 . . . . 1.0 109.31 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.92 172.94 1.25 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -164.61 160.01 19.65 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.999 -1.063 . . . . 1.0 109.648 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -142.86 153.77 43.49 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.412 -0.805 . . . . 1.0 108.867 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -89.18 151.92 47.31 Favored Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.047 -1.033 . . . . 1.0 108.683 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -58.64 165.37 8.01 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 120.951 1.101 . . . . 1.0 111.788 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -42.84 136.38 4.72 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 C-N-CA 121.215 1.277 . . . . 1.0 112.384 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -175.78 -169.35 37.3 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.212 -1.555 . . . . 1.0 109.212 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -61.44 -153.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 121.124 1.216 . . . . 1.0 112.038 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -60.08 -41.6 92.8 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.018 -1.051 . . . . 1.0 109.421 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -60.14 -43.42 95.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.153 -0.967 . . . . 1.0 109.69 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -78.1 168.26 53.92 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.28 -1.128 . . . . 1.0 110.28 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 72.5 7.03 67.57 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.343 -1.503 . . . . 1.0 109.343 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 -80.95 172.47 13.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.331 -1.099 . . . . 1.0 109.589 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.0 124.1 11.43 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.266 -0.896 . . . . 1.0 109.4 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -112.99 133.81 54.78 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.549 -0.72 . . . . 1.0 110.098 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.499 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 25.5 m-85 -116.15 149.41 39.08 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 109.005 -0.739 . . . . 1.0 109.005 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.585 ' OD1' ' CD1' ' A' ' 75' ' ' PHE . 82.0 m-20 -77.75 123.67 26.99 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.878 -1.138 . . . . 1.0 109.845 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 42.0 t0 -84.29 -11.56 56.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.447 -0.783 . . . . 1.0 109.184 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -82.19 -11.69 58.56 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.35 -0.844 . . . . 1.0 108.951 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.424 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 97.5 mt-10 -90.53 168.54 11.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.466 -0.771 . . . . 1.0 109.3 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 19.5 m -100.34 105.24 16.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.326 -0.859 . . . . 1.0 108.723 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.462 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 94.5 m95 -87.33 120.58 28.77 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.481 -0.762 . . . . 1.0 109.103 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.484 ' HG1' ' H ' ' A' ' 107' ' ' SER . 7.3 t -139.95 150.02 44.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.461 -0.774 . . . . 1.0 109.779 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 52.7 m -92.85 -6.14 49.43 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.214 -0.929 . . . . 1.0 108.534 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.484 ' H ' ' HG1' ' A' ' 105' ' ' THR . 16.6 t -92.03 175.69 6.78 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.871 -0.789 . . . . 1.0 108.871 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.1 t -75.59 75.29 2.61 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.028 -1.045 . . . . 1.0 109.222 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 110' ' ' GLY . 98.6 mttt -149.4 149.75 31.33 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.574 -0.898 . . . . 1.0 108.574 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 109' ' ' LYS . . . 42.98 -139.17 2.9 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 110.033 -1.227 . . . . 1.0 110.033 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -100.19 118.85 37.37 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.348 -1.089 . . . . 1.0 109.265 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.613 ' H ' ' HH ' ' A' ' 141' ' ' TYR . 62.0 t-20 -63.31 129.39 40.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.359 -0.838 . . . . 1.0 109.877 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.5 tp -60.01 -43.27 95.36 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.49 -0.756 . . . . 1.0 110.552 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -59.99 -41.63 92.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.214 -0.929 . . . . 1.0 111.177 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.61 -49.62 76.81 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.769 -1.207 . . . . 1.0 109.226 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 67.7 t -69.94 -41.32 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.301 -0.874 . . . . 1.0 110.712 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.34 -53.25 60.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.998 -1.064 . . . . 1.0 109.778 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.97 -34.43 73.27 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.186 -0.946 . . . . 1.0 109.785 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 60.0 t60 -63.12 -50.73 69.33 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.228 -0.92 . . . . 1.0 110.783 -178.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.499 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 6.9 pt-20 -60.0 -39.42 85.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.792 -1.192 . . . . 1.0 110.111 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -59.94 -40.01 87.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.904 -1.123 . . . . 1.0 108.798 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.67 -41.92 94.0 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.332 -1.507 . . . . 1.0 109.332 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -67.32 -39.96 85.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.139 -1.212 . . . . 1.0 109.577 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 95.4 p -68.97 -21.93 64.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.397 -0.814 . . . . 1.0 109.513 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 49.7 mt -82.99 -0.96 51.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 1.0 109.902 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 92.5 6.43 64.25 Favored Glycine 0 N--CA 1.498 2.77 0 C-N-CA 120.221 -0.99 . . . . 1.0 110.852 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.3 mt -85.1 144.86 27.95 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.745 -1.444 . . . . 1.0 109.916 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 44.6 t0 -99.01 172.43 7.41 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.167 -1.049 . . . . 1.0 108.167 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.485 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 74.6 m80 -61.76 132.17 52.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.757 -1.214 . . . . 1.0 109.281 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.7 t -97.35 158.39 15.49 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.253 -0.905 . . . . 1.0 109.135 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -99.92 8.45 44.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.322 -0.861 . . . . 1.0 109.279 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -85.14 125.35 70.46 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.188 -0.945 . . . . 1.0 108.895 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -66.91 -20.94 50.93 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 CA-C-N 120.195 1.105 . . . . 1.0 112.541 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -87.3 -7.14 77.06 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.078 -1.209 . . . . 1.0 110.078 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.87 139.58 31.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.117 -1.225 . . . . 1.0 109.458 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.493 ' C ' ' H ' ' A' ' 138' ' ' PHE . 91.6 mt -62.18 -40.05 94.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.142 -0.974 . . . . 1.0 109.88 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 85.8 mtp -70.5 24.72 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.245 -0.909 . . . . 1.0 111.04 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.493 ' H ' ' C ' ' A' ' 136' ' ' LEU . 23.5 t80 -69.94 129.99 90.41 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 120.766 -1.209 . . . . 1.0 108.331 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -49.55 -19.8 3.6 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 120.954 1.103 . . . . 1.0 114.505 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.4 HG23 HD11 ' A' ' 140' ' ' ILE . 90.6 mt -107.78 137.39 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 O-C-N 120.879 -1.138 . . . . 1.0 110.37 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.613 ' HH ' ' H ' ' A' ' 112' ' ' ASN . 28.8 t80 -74.13 128.27 35.1 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.554 -0.716 . . . . 1.0 109.519 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.9 t -139.55 143.4 37.36 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.915 -0.772 . . . . 1.0 108.915 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -81.53 142.85 32.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.108 -0.995 . . . . 1.0 108.885 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.2 t -139.7 150.96 45.49 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.172 -0.955 . . . . 1.0 110.151 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.64 105.13 1.66 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.218 -1.553 . . . . 1.0 109.218 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 21.8 mtmm -75.74 1.9 13.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.379 -1.071 . . . . 1.0 109.834 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 67.9 m -59.92 -40.02 87.44 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.171 -0.955 . . . . 1.0 109.712 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -144.18 27.7 1.41 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.096 -1.003 . . . . 1.0 110.1 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -68.78 137.4 53.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.919 -1.113 . . . . 1.0 109.768 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 67.1 mtt -138.86 147.94 43.06 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.38 -0.825 . . . . 1.0 108.955 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 74.2 mt -51.57 124.84 26.55 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.0 -1.062 . . . . 1.0 108.631 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -67.81 -179.42 2.06 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 CA-C-N 120.102 1.072 . . . . 1.0 112.329 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -61.77 -39.58 92.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.333 -0.854 . . . . 1.0 109.868 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -56.98 -49.55 75.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -0.945 . . . . 1.0 110.01 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -70.09 -39.97 75.23 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.99 -1.069 . . . . 1.0 110.31 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 76.4 t -60.84 -48.36 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.958 -1.089 . . . . 1.0 108.927 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -60.36 -39.98 89.13 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.16 -0.962 . . . . 1.0 110.856 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.77 -53.79 7.91 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 120.06 -1.067 . . . . 1.0 111.121 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 9.4 tp -60.56 -40.53 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.016 -1.284 . . . . 1.0 109.837 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.527 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.9 mt-30 -65.81 -38.69 89.63 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.136 -0.977 . . . . 1.0 109.54 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 83.9 p -65.72 -24.98 67.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.119 -0.988 . . . . 1.0 110.666 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.51 ' CD2' ' H ' ' A' ' 7' ' ' THR . 87.8 mt -87.34 -50.72 6.38 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.747 -1.22 . . . . 1.0 110.0 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -93.01 -9.11 41.01 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.04 -1.038 . . . . 1.0 110.048 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.607 0 N-CA-C 109.548 -1.421 . . . . 1.0 109.548 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' WAY . . . . . 0.958 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.432 ' H ' ' HG1' ' A' ' 7' ' ' THR . 9.2 m . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.6 mt -87.41 139.94 30.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.239 -0.913 . . . . 1.0 109.173 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -161.24 163.37 31.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.065 -1.022 . . . . 1.0 109.647 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -71.16 146.2 49.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.881 . . . . 1.0 109.543 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 87.8 p -90.06 3.44 53.27 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.4 -0.812 . . . . 1.0 110.148 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -144.7 154.01 42.31 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.065 -1.022 . . . . 1.0 109.51 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.5 mmt -90.46 -0.04 57.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.229 -0.919 . . . . 1.0 109.748 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -96.65 125.49 41.16 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.126 -0.983 . . . . 1.0 109.182 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.0 mt -140.01 152.34 46.19 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.293 -0.88 . . . . 1.0 109.187 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.5 p -133.61 154.29 51.0 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.494 -0.754 . . . . 1.0 109.312 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -145.1 160.0 42.09 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.186 -0.946 . . . . 1.0 109.811 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 44.9 ttt-85 -144.61 131.5 20.27 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.427 -0.796 . . . . 1.0 109.503 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 86.0 mt -86.94 119.98 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.278 -0.889 . . . . 1.0 108.818 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.6 t -69.47 -41.53 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.089 -1.007 . . . . 1.0 109.282 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -165.09 155.02 13.31 Favored 'General case' 0 C--N 1.289 -2.06 0 O-C-N 119.967 -1.708 . . . . 1.0 110.412 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.411 ' O ' ' C ' ' A' ' 23' ' ' THR . 23.9 m-85 -99.4 95.94 7.37 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 105.907 -1.886 . . . . 1.0 105.907 178.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.411 ' C ' ' O ' ' A' ' 22' ' ' TYR . 1.5 t -39.86 142.53 0.66 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.963 -0.461 . . . . 1.0 110.619 -177.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -59.68 -21.48 63.11 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 120.436 0.757 . . . . 1.0 110.994 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -58.4 -14.86 8.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.73 -0.606 . . . . 1.0 109.865 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 78.0 mtp -142.7 150.78 40.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.291 -0.881 . . . . 1.0 109.816 -178.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.1 p -75.52 160.05 30.61 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.476 -0.935 . . . . 1.0 108.476 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 27.9 m170 -60.64 -40.1 90.72 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.12 -0.988 . . . . 1.0 109.948 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.9 m -64.82 -42.35 95.04 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.065 -1.022 . . . . 1.0 110.922 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -66.4 -40.11 89.42 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.153 -0.967 . . . . 1.0 111.321 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.4 t -67.91 -42.07 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.969 -1.082 . . . . 1.0 110.535 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -59.94 -49.49 77.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.127 -0.983 . . . . 1.0 110.715 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -64.15 -32.66 74.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.823 -1.173 . . . . 1.0 110.377 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.35 -50.62 73.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.794 -1.191 . . . . 1.0 110.01 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -69.35 -37.51 77.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.043 -1.036 . . . . 1.0 110.218 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -59.95 -42.72 94.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.981 -1.074 . . . . 1.0 109.484 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -61.78 -40.18 94.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.091 -1.006 . . . . 1.0 108.849 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.82 -50.83 71.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.444 -0.785 . . . . 1.0 110.135 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -63.26 -39.95 96.03 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.952 -1.092 . . . . 1.0 109.947 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -60.05 -48.65 80.84 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.062 -1.024 . . . . 1.0 109.841 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 72.0 t -60.03 -41.84 87.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.34 -0.85 . . . . 1.0 110.435 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -78.43 -34.81 47.63 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.958 -1.089 . . . . 1.0 110.23 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 52.4 p -72.33 -20.0 61.55 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.95 -1.094 . . . . 1.0 109.814 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -60.07 -40.02 88.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.496 -0.752 . . . . 1.0 111.417 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.5 m -111.87 22.48 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.241 -0.912 . . . . 1.0 111.131 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.452 ' C ' ' H ' ' A' ' 48' ' ' LEU . 18.8 p -146.57 139.45 14.32 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 120.872 -1.142 . . . . 1.0 109.274 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -72.93 17.55 0.39 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 120.675 0.917 . . . . 1.0 111.178 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.452 ' H ' ' C ' ' A' ' 46' ' ' THR . 90.4 mt -67.65 134.12 50.58 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.361 -0.837 . . . . 1.0 110.374 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -108.78 120.53 42.77 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.531 -0.914 . . . . 1.0 108.531 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -108.4 130.34 55.23 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.309 -0.869 . . . . 1.0 109.418 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.5 m -120.03 130.01 54.51 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.571 -0.705 . . . . 1.0 110.147 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -82.83 129.54 35.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.397 -0.814 . . . . 1.0 109.277 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 89.4 mt -108.89 118.62 37.28 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 108.74 -0.837 . . . . 1.0 108.74 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.445 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 72.2 m-70 -70.18 -24.08 63.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.22 -0.925 . . . . 1.0 110.063 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 77.8 m-20 -148.33 162.88 38.63 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.216 -0.928 . . . . 1.0 109.876 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.21 174.9 39.14 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.746 -1.342 . . . . 1.0 109.746 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 87.5 mt -94.25 134.1 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.331 -1.1 . . . . 1.0 109.019 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.98 160.94 15.98 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.446 -0.784 . . . . 1.0 109.122 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.04 -49.34 78.06 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.178 -0.951 . . . . 1.0 109.113 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.9 mt -105.02 99.06 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.427 -0.796 . . . . 1.0 109.818 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.3 ptm -99.28 133.89 42.91 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.115 -0.99 . . . . 1.0 109.084 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 62' ' ' ILE . 85.5 mt -106.09 137.4 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.536 -0.728 . . . . 1.0 109.749 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 81.8 p -153.13 155.82 37.46 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.129 -0.982 . . . . 1.0 109.565 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -104.88 123.96 48.63 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.573 -0.704 . . . . 1.0 109.127 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -103.82 -169.9 25.36 Favored Glycine 0 N--CA 1.5 2.949 0 N-CA-C 110.48 -1.048 . . . . 1.0 110.48 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.493 ' O ' ' C ' ' A' ' 67' ' ' LYS . 70.9 mt -136.3 167.28 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.57 -0.959 . . . . 1.0 109.037 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.493 ' C ' ' O ' ' A' ' 66' ' ' ILE . 20.7 tptm -21.45 -76.48 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.481 0 CA-C-O 121.185 0.517 . . . . 1.0 111.708 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.553 ' H ' ' CD ' ' A' ' 68' ' ' GLU . 4.3 pm0 -66.08 146.05 55.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -0.913 . . . . 1.0 109.733 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -128.52 151.18 49.72 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.935 -0.765 . . . . 1.0 108.935 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.92 -44.42 97.16 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.264 -1.535 . . . . 1.0 109.264 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 73' ' ' TYR . 92.3 m-20 -80.01 159.4 26.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.22 -1.165 . . . . 1.0 109.194 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -69.75 52.57 0.11 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.142 -0.974 . . . . 1.0 109.059 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.44 ' N ' ' O ' ' A' ' 71' ' ' ASP . 57.2 t80 -139.95 70.54 35.73 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.37 -0.831 . . . . 1.0 108.859 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -78.45 161.44 28.39 Favored 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 121.439 1.426 . . . . 1.0 112.657 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.549 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 96.7 m-85 -88.75 170.31 10.89 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.622 -0.881 . . . . 1.0 108.622 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 79' ' ' SER . 22.8 p-10 -96.75 -0.27 48.41 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.992 -1.067 . . . . 1.0 110.829 -178.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.459 ' O ' ' OE2' ' A' ' 102' ' ' GLU . . . 117.44 -120.03 4.64 Favored Glycine 0 N--CA 1.506 3.325 0 N-CA-C 110.338 -1.105 . . . . 1.0 110.338 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.461 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 28.1 Cg_endo -74.29 -73.19 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.803 0 CA-C-N 120.26 2.03 . . . . 1.0 113.04 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.457 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 82.2 p -78.28 -178.9 5.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.925 -1.109 . . . . 1.0 109.806 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.34 -135.43 12.16 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.305 -1.118 . . . . 1.0 110.305 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.7 mt -71.17 111.11 6.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.552 -0.97 . . . . 1.0 110.033 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 55.2 mt -83.63 -17.3 42.02 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.128 -0.982 . . . . 1.0 108.927 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.86 176.0 0.97 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.023 -0.732 . . . . 1.0 109.023 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -161.84 163.37 29.37 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.103 -0.998 . . . . 1.0 109.444 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.34 170.01 19.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.289 -0.882 . . . . 1.0 109.404 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -107.2 154.06 40.71 Favored Pre-proline 0 N--CA 1.498 1.972 0 N-CA-C 108.849 -0.797 . . . . 1.0 108.849 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' A' ' 89' ' ' GLY . 8.8 Cg_endo -60.3 165.6 10.68 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 120.588 0.859 . . . . 1.0 111.558 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -56.29 77.55 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.149 1.233 . . . . 1.0 112.108 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -99.93 -168.25 29.51 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 108.812 -1.715 . . . . 1.0 108.812 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 89' ' ' GLY . 14.3 Cg_exo -57.47 -145.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 121.044 1.163 . . . . 1.0 112.276 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -64.24 -40.01 95.13 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.201 -0.937 . . . . 1.0 109.423 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -67.27 -39.89 86.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.367 -0.833 . . . . 1.0 109.787 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.32 171.82 42.67 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.94 -1.264 . . . . 1.0 109.94 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 71.71 15.03 75.55 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.976 -1.65 . . . . 1.0 108.976 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 40.4 p-10 -79.66 171.6 14.92 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.499 -1.0 . . . . 1.0 109.835 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.24 129.93 15.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.258 -0.901 . . . . 1.0 109.641 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 58.5 m170 -124.9 147.07 49.02 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.614 -0.679 . . . . 1.0 109.252 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -129.72 151.95 49.76 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.528 -0.732 . . . . 1.0 109.469 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.549 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 96.4 m-20 -79.6 120.55 24.09 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.045 -1.035 . . . . 1.0 109.104 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 43.0 t0 -83.54 -4.97 59.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.235 -0.916 . . . . 1.0 109.04 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -82.01 -10.81 59.12 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.412 -0.805 . . . . 1.0 109.075 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.461 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 49.2 mm-40 -90.68 179.1 5.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.385 -0.822 . . . . 1.0 108.991 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 39.0 m -104.93 104.55 14.32 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.445 -0.946 . . . . 1.0 108.445 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.419 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 88.6 m95 -87.95 120.0 28.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.929 . . . . 1.0 109.08 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.3 t -140.97 151.2 43.97 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.525 -0.734 . . . . 1.0 109.708 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 61.2 m -92.71 -5.64 50.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.104 -0.998 . . . . 1.0 108.546 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 34.0 t -92.93 174.78 7.06 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.6 -0.889 . . . . 1.0 108.6 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.515 ' OG ' ' CZ ' ' A' ' 143' ' ' TYR . 10.6 m -75.85 75.29 2.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.881 -1.137 . . . . 1.0 109.526 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 110' ' ' GLY . 61.3 mttp -147.5 148.84 31.63 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.58 -0.896 . . . . 1.0 108.58 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 109' ' ' LYS . . . 44.53 -139.18 4.65 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.644 -1.382 . . . . 1.0 109.644 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -98.91 118.97 36.88 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.284 -1.127 . . . . 1.0 109.025 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -64.65 130.24 42.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.459 -0.775 . . . . 1.0 110.044 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.3 tp -59.93 -40.45 88.98 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.256 -0.902 . . . . 1.0 110.056 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -59.92 -40.65 89.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 1.0 110.328 -178.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -60.04 -55.4 34.39 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.819 -1.176 . . . . 1.0 109.625 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.0 t -67.44 -42.49 87.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.278 -0.889 . . . . 1.0 109.318 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.94 -52.69 64.32 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.173 -0.954 . . . . 1.0 109.101 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.36 82.38 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.816 -1.177 . . . . 1.0 109.801 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 73.0 t60 -64.01 -49.85 70.82 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.452 -0.78 . . . . 1.0 111.644 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -59.95 -39.5 85.82 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.602 -1.311 . . . . 1.0 109.664 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -59.81 -40.07 87.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.893 -1.129 . . . . 1.0 108.237 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.38 -43.9 84.88 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.808 -1.717 . . . . 1.0 108.808 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -67.42 -40.05 85.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.224 -1.162 . . . . 1.0 109.546 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 84.2 p -64.71 -24.03 67.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.206 -0.934 . . . . 1.0 109.731 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 84.5 mt -81.15 0.87 34.42 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.182 -0.949 . . . . 1.0 110.005 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 89.76 4.17 73.09 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 120.056 -1.068 . . . . 1.0 110.738 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.8 mt -84.47 149.74 25.75 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.865 -1.374 . . . . 1.0 109.592 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 37.2 t0 -99.78 174.52 6.18 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.615 -0.883 . . . . 1.0 108.615 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.485 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 74.5 m80 -59.33 139.48 56.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.99 -1.069 . . . . 1.0 109.395 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 38.2 t -98.42 152.73 19.19 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.297 -0.877 . . . . 1.0 109.248 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -99.99 5.49 45.14 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.225 -0.922 . . . . 1.0 109.37 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -88.39 126.82 59.09 Favored Pre-proline 0 N--CA 1.493 1.714 0 N-CA-C 108.179 -1.045 . . . . 1.0 108.179 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -67.56 -15.02 44.06 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 CA-C-N 120.273 1.133 . . . . 1.0 111.94 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -90.72 -5.55 68.63 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.357 -1.497 . . . . 1.0 109.357 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.42 142.51 27.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -1.174 . . . . 1.0 108.901 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.521 ' C ' ' H ' ' A' ' 138' ' ' PHE . 74.5 mt -68.5 -36.9 79.55 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.08 -1.013 . . . . 1.0 109.902 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 76.2 mtp -69.92 20.88 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.133 -0.979 . . . . 1.0 110.405 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.521 ' H ' ' C ' ' A' ' 136' ' ' LEU . 14.6 t80 -66.26 135.5 94.95 Favored Pre-proline 0 N--CA 1.493 1.699 0 N-CA-C 107.853 -1.165 . . . . 1.0 107.853 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -62.92 -10.46 20.38 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 120.826 1.018 . . . . 1.0 114.052 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.403 HG21 HD12 ' A' ' 140' ' ' ILE . 91.5 mt -111.81 138.28 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.39 0 O-C-N 120.875 -1.14 . . . . 1.0 110.012 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -74.95 125.1 28.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.505 -0.747 . . . . 1.0 110.484 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 10.2 t -138.98 140.14 38.13 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.441 -0.787 . . . . 1.0 109.043 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.515 ' CZ ' ' OG ' ' A' ' 108' ' ' SER . 89.3 t80 -81.79 141.96 33.02 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.889 -1.132 . . . . 1.0 109.949 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.5 m -130.28 138.33 50.43 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.039 -0.726 . . . . 1.0 109.039 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -66.4 101.38 0.62 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.62 -1.792 . . . . 1.0 108.62 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 58.1 mmtt -75.96 129.33 36.74 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.288 -1.125 . . . . 1.0 109.302 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.5 t -179.78 -51.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.592 -0.892 . . . . 1.0 108.592 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -135.99 19.85 3.24 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.557 -0.905 . . . . 1.0 108.557 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -65.17 139.41 58.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.406 -0.808 . . . . 1.0 110.602 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 96.5 mtp -137.62 149.91 47.0 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.324 -0.991 . . . . 1.0 108.324 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.5 mt -51.83 131.44 38.32 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 120.902 -1.124 . . . . 1.0 109.03 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -71.41 177.96 6.12 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 CA-C-N 119.919 1.007 . . . . 1.0 112.083 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -62.12 -39.97 94.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.418 -0.801 . . . . 1.0 110.285 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -55.06 -48.68 73.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.035 -1.041 . . . . 1.0 109.778 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -69.96 -40.0 75.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.119 -0.988 . . . . 1.0 110.186 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.5 t -60.45 -47.78 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.968 -1.083 . . . . 1.0 109.302 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -60.61 -40.02 90.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.05 -1.031 . . . . 1.0 110.076 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.416 ' O ' ' OG ' ' A' ' 161' ' ' SER . . . -72.17 -52.39 11.25 Favored Glycine 0 N--CA 1.495 2.631 0 O-C-N 121.246 -0.909 . . . . 1.0 111.874 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 8.4 tp -59.94 -39.97 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.744 -1.445 . . . . 1.0 109.917 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.547 ' O ' ' N ' ' A' ' 164' ' ' GLY . 32.3 mt-30 -68.36 -35.21 77.38 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.059 -1.026 . . . . 1.0 109.425 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 158' ' ' GLY . 77.2 p -60.23 -35.06 74.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.131 -0.981 . . . . 1.0 110.344 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 94.5 mt -86.13 -49.61 7.63 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.958 -1.089 . . . . 1.0 110.671 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -90.04 -9.12 49.74 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.137 -0.977 . . . . 1.0 110.328 -178.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.513 0 N-CA-C 109.411 -1.476 . . . . 1.0 109.411 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' WAY . . . . . 0.848 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.6 m . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.373 -0.603 . . . . 1.0 109.373 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.8 mt -70.58 142.48 51.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.293 -0.879 . . . . 1.0 109.439 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -160.09 160.3 32.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.383 -0.823 . . . . 1.0 109.36 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -71.75 148.94 45.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.211 -0.93 . . . . 1.0 109.573 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 90.7 p -90.03 2.26 55.38 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.42 -0.8 . . . . 1.0 109.798 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.516 ' NZ ' ' O ' ' A' ' 14' ' ' ASN . 20.0 pttp -141.74 153.12 44.4 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.179 -0.95 . . . . 1.0 109.501 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.8 mmt -90.11 -0.04 57.4 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.323 -0.861 . . . . 1.0 109.814 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.516 ' O ' ' NZ ' ' A' ' 12' ' ' LYS . 28.1 m120 -96.97 129.25 44.45 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.197 -0.939 . . . . 1.0 109.286 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.7 mt -141.13 152.0 44.36 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.233 -0.917 . . . . 1.0 109.104 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 63.1 p -133.88 152.81 51.99 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.422 -0.799 . . . . 1.0 109.285 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -145.85 157.46 43.91 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.094 -1.004 . . . . 1.0 109.864 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.4 ' HG2' HH11 ' A' ' 18' ' ' ARG . 38.0 ttt-85 -144.54 135.26 24.81 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.376 -0.827 . . . . 1.0 109.356 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 86.3 mt -87.67 119.71 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.274 -0.891 . . . . 1.0 108.793 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 63.4 t -69.12 -40.22 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.315 -0.865 . . . . 1.0 109.409 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -162.86 156.63 20.32 Favored 'General case' 0 C--N 1.287 -2.146 0 O-C-N 119.38 -2.075 . . . . 1.0 111.369 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.438 ' CB ' ' CD2' ' A' ' 28' ' ' HIS . 64.4 m-85 -100.72 109.03 21.02 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 106.248 -1.76 . . . . 1.0 106.248 178.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.41 ' C ' ' H ' ' A' ' 25' ' ' ASP . 1.1 t -54.62 139.13 60.4 Favored Pre-proline 0 C--N 1.294 -1.842 0 O-C-N 121.38 -0.825 . . . . 1.0 109.309 -178.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -57.8 -6.94 2.84 Favored 'Trans proline' 0 N--CA 1.486 1.085 0 CA-C-N 119.443 0.837 . . . . 1.0 111.145 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 23' ' ' THR . 92.9 m-20 -60.07 -39.58 86.54 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 119.78 -0.768 . . . . 1.0 110.013 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.5 mtm -137.27 159.58 41.52 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.265 -0.897 . . . . 1.0 109.086 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.488 ' OG1' ' OE1' ' A' ' 30' ' ' GLU . 36.3 p -75.3 167.88 21.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.166 -0.959 . . . . 1.0 109.714 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.438 ' CD2' ' CB ' ' A' ' 22' ' ' TYR . 29.6 m170 -60.05 -40.43 89.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.434 -0.791 . . . . 1.0 111.057 -178.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.3 m -60.1 -46.09 90.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.886 -1.134 . . . . 1.0 110.733 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.576 ' N ' ' OE1' ' A' ' 30' ' ' GLU . 8.9 mp0 -66.75 -41.51 87.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.222 -0.924 . . . . 1.0 110.259 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 72.2 t -67.49 -44.77 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.995 -1.066 . . . . 1.0 110.134 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -60.0 -49.67 76.74 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.236 -0.915 . . . . 1.0 111.178 -178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -60.94 -33.81 73.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.692 -1.255 . . . . 1.0 109.852 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.03 -50.93 71.79 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.916 -1.115 . . . . 1.0 110.398 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -65.58 -38.43 89.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.925 -1.11 . . . . 1.0 110.387 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.01 -42.17 93.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.898 -1.127 . . . . 1.0 109.543 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.14 -40.06 88.53 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.219 -0.926 . . . . 1.0 109.291 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.94 -46.45 89.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 1.0 110.075 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -66.84 -38.13 85.81 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.091 -1.006 . . . . 1.0 109.791 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -59.68 -48.26 82.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.13 -0.981 . . . . 1.0 109.577 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.1 t -60.01 -43.08 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.136 -0.977 . . . . 1.0 110.122 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -78.14 -35.69 48.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.99 -1.069 . . . . 1.0 110.18 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.0 p -70.38 -22.43 62.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.096 -1.003 . . . . 1.0 109.741 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.03 -40.01 87.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.31 -0.869 . . . . 1.0 110.8 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.2 m -111.96 25.37 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.335 -0.853 . . . . 1.0 110.621 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.407 ' C ' ' H ' ' A' ' 48' ' ' LEU . 58.5 p -150.01 130.09 6.75 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.144 -0.973 . . . . 1.0 109.083 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -73.54 19.63 0.38 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 CA-C-N 119.974 1.026 . . . . 1.0 112.047 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.407 ' H ' ' C ' ' A' ' 46' ' ' THR . 81.6 mt -69.41 138.74 53.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.177 -0.952 . . . . 1.0 109.616 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -107.28 120.8 43.13 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.798 -0.816 . . . . 1.0 108.798 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -107.01 127.92 53.89 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.32 -0.862 . . . . 1.0 109.162 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -119.98 129.95 54.53 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.63 -0.669 . . . . 1.0 109.444 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.412 HH11 ' HG2' ' A' ' 52' ' ' ARG . 34.1 ttt-85 -82.74 130.0 35.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.398 -0.814 . . . . 1.0 109.424 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.4 mt -103.98 119.87 39.86 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.367 -0.833 . . . . 1.0 109.168 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.434 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 59.0 m-70 -62.28 -39.96 94.67 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.427 -0.796 . . . . 1.0 110.005 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 87.4 m-20 -143.4 164.0 31.52 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.259 -0.9 . . . . 1.0 109.86 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.76 177.81 33.72 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.726 -1.35 . . . . 1.0 109.726 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.8 mt -93.24 134.77 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.292 -1.122 . . . . 1.0 109.29 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.28 167.46 10.1 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.515 -0.74 . . . . 1.0 109.422 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -59.96 -48.94 79.64 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.31 -0.869 . . . . 1.0 109.031 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.7 mt -115.59 108.66 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.535 -0.728 . . . . 1.0 109.897 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.5 ptp -98.68 138.53 35.72 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.199 -0.938 . . . . 1.0 109.108 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.9 mt -109.96 133.57 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.499 -0.75 . . . . 1.0 109.747 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 77.6 p -150.98 159.29 44.67 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.059 -1.026 . . . . 1.0 110.022 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -110.47 126.55 54.46 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.564 -0.71 . . . . 1.0 109.248 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 100' ' ' ASP . . . -102.38 -170.74 26.96 Favored Glycine 0 N--CA 1.502 3.059 0 N-CA-C 110.786 -0.925 . . . . 1.0 110.786 -179.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.506 ' CG2' ' N ' ' A' ' 67' ' ' LYS . 62.1 mt -137.57 167.21 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.532 -0.981 . . . . 1.0 109.303 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.506 ' N ' ' CG2' ' A' ' 66' ' ' ILE . 48.3 tptt -22.34 -77.82 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.462 0 CA-C-O 120.961 0.41 . . . . 1.0 111.631 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -67.65 139.12 56.79 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.945 -1.097 . . . . 1.0 108.824 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -127.81 2.67 6.04 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.447 -0.783 . . . . 1.0 109.454 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.19 8.67 87.67 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.557 -1.417 . . . . 1.0 109.557 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -110.02 161.58 15.38 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.512 -0.993 . . . . 1.0 109.29 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -70.04 -15.48 63.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.252 -0.905 . . . . 1.0 109.212 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -138.93 75.12 36.28 Favored Pre-proline 0 N--CA 1.496 1.875 0 O-C-N 121.448 -0.782 . . . . 1.0 109.437 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -74.12 -151.55 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 121.261 1.308 . . . . 1.0 111.839 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.545 ' CD1' ' OD1' ' A' ' 99' ' ' ASP . 94.3 m-85 -85.17 166.93 16.18 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.2 -0.937 . . . . 1.0 108.799 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 79' ' ' SER . 27.2 p-10 -99.58 -4.12 31.79 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.084 -1.01 . . . . 1.0 110.709 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.441 ' O ' ' OE2' ' A' ' 102' ' ' GLU . . . 119.14 -115.32 3.03 Favored Glycine 0 N--CA 1.505 3.287 0 N-CA-C 110.267 -1.133 . . . . 1.0 110.267 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.468 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 29.1 Cg_endo -73.91 -75.11 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.956 0 CA-C-N 120.158 1.979 . . . . 1.0 113.402 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.459 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 88.5 p -76.61 177.88 7.14 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.915 -1.115 . . . . 1.0 110.151 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.11 -136.53 12.73 Favored Glycine 0 N--CA 1.498 2.819 0 N-CA-C 110.683 -0.967 . . . . 1.0 110.683 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.0 mt -71.81 110.41 6.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.375 -1.073 . . . . 1.0 109.763 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 55.4 mt -83.76 -18.3 38.27 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.73 173.96 1.22 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.502 -0.925 . . . . 1.0 108.502 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.497 ' CE1' ' ND1' ' A' ' 97' ' ' HIS . 9.4 p80 -162.29 164.33 27.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.971 -1.081 . . . . 1.0 109.985 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -157.17 160.52 38.84 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.823 -0.806 . . . . 1.0 108.823 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -106.75 151.36 40.48 Favored Pre-proline 0 N--CA 1.501 2.102 0 O-C-N 121.365 -0.834 . . . . 1.0 109.131 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.526 ' O ' ' N ' ' A' ' 89' ' ' GLY . 10.0 Cg_endo -62.51 165.56 15.26 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 120.987 1.124 . . . . 1.0 112.328 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -47.48 84.02 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.161 1.241 . . . . 1.0 112.356 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -96.47 -174.53 35.56 Favored Glycine 0 N--CA 1.498 2.792 0 N-CA-C 109.137 -1.585 . . . . 1.0 109.137 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -76.55 -95.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 121.372 1.381 . . . . 1.0 112.814 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -79.14 -57.28 3.81 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.035 -1.041 . . . . 1.0 111.062 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -69.88 -21.83 63.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.174 -0.954 . . . . 1.0 110.161 -178.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -61.36 169.03 10.94 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.269 -1.532 . . . . 1.0 109.269 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 68.98 72.99 0.76 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.929 -1.268 . . . . 1.0 109.929 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -158.85 159.84 35.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.213 -1.169 . . . . 1.0 109.386 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.89 119.83 6.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 1.0 109.191 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.497 ' ND1' ' CE1' ' A' ' 84' ' ' HIS . 52.4 m170 -103.85 145.78 29.61 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.539 -0.725 . . . . 1.0 109.994 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -129.68 147.03 51.43 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.447 -0.946 . . . . 1.0 108.447 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.545 ' OD1' ' CD1' ' A' ' 75' ' ' PHE . 98.3 m-20 -80.81 124.28 28.94 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.92 -1.113 . . . . 1.0 109.579 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 65' ' ' GLY . 39.2 t0 -84.24 -6.81 59.45 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.144 -0.973 . . . . 1.0 109.214 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -80.33 -9.91 59.75 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.633 -0.877 . . . . 1.0 108.633 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.468 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 57.5 mm-40 -89.57 173.3 8.4 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.985 -0.746 . . . . 1.0 108.985 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 54.2 m -105.29 107.62 18.7 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -88.58 119.98 29.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.304 -0.872 . . . . 1.0 108.739 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.0 t -140.24 157.85 44.94 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.365 -0.835 . . . . 1.0 109.79 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.4 t -95.76 -9.83 30.72 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.223 -0.923 . . . . 1.0 109.053 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 71.3 m -92.46 179.22 5.59 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.368 -0.833 . . . . 1.0 108.975 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.1 t -78.64 77.78 5.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.032 -1.043 . . . . 1.0 109.56 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -148.76 148.12 29.62 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.266 -0.896 . . . . 1.0 108.821 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.53 -141.3 4.72 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.746 -1.342 . . . . 1.0 109.746 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -100.33 117.02 33.66 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.352 -1.087 . . . . 1.0 108.925 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.693 ' H ' ' HH ' ' A' ' 141' ' ' TYR . 16.6 t-20 -62.74 133.85 55.42 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.076 -1.015 . . . . 1.0 109.219 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.9 tp -59.99 -42.82 95.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 1.0 109.823 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -59.86 -40.8 89.87 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.234 -0.916 . . . . 1.0 110.968 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -59.76 -52.12 66.85 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.604 -1.31 . . . . 1.0 109.722 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.3 t -69.91 -40.79 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.059 -1.026 . . . . 1.0 110.049 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.45 -50.15 74.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.153 -0.967 . . . . 1.0 109.547 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.0 -37.3 79.3 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.71 -1.244 . . . . 1.0 110.16 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 56.9 t60 -63.5 -50.1 70.96 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.219 -0.926 . . . . 1.0 111.315 -178.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.99 -39.03 84.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.748 -1.22 . . . . 1.0 109.858 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -59.99 -40.05 87.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.821 -1.174 . . . . 1.0 108.519 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.45 -46.8 79.51 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.807 -1.317 . . . . 1.0 109.807 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -65.85 -39.98 91.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.06 -1.259 . . . . 1.0 109.462 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.1 p -64.58 -25.1 67.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.228 -0.92 . . . . 1.0 109.8 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 72.8 mt -80.95 1.98 28.77 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.138 -0.976 . . . . 1.0 109.371 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 87.19 9.51 73.12 Favored Glycine 0 N--CA 1.495 2.629 0 O-C-N 121.2 -0.938 . . . . 1.0 110.834 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.4 mt -84.95 150.02 25.22 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.836 -1.39 . . . . 1.0 109.759 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 39.6 t0 -99.53 171.33 8.0 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.869 -0.789 . . . . 1.0 108.869 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.537 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 71.9 m80 -59.96 139.96 57.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.12 -0.987 . . . . 1.0 109.53 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 44.4 t -97.1 152.4 18.82 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.428 -0.795 . . . . 1.0 109.554 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -99.01 2.22 46.1 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.311 -0.868 . . . . 1.0 109.354 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 9.5 t70 -87.26 130.0 49.44 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.294 -0.879 . . . . 1.0 108.708 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -67.15 -22.22 47.4 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 CA-C-N 120.078 1.064 . . . . 1.0 112.437 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.444 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -86.89 -2.39 84.14 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.817 -1.313 . . . . 1.0 109.817 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.57 143.48 28.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.183 -1.186 . . . . 1.0 109.219 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.452 ' C ' ' H ' ' A' ' 138' ' ' PHE . 84.3 mt -69.26 -38.31 78.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.098 -1.001 . . . . 1.0 109.698 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 81.4 mtp -72.09 20.92 0.06 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 1.0 110.735 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.452 ' H ' ' C ' ' A' ' 136' ' ' LEU . 16.3 t80 -68.11 134.48 91.58 Favored Pre-proline 0 N--CA 1.496 1.857 0 N-CA-C 107.885 -1.154 . . . . 1.0 107.885 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -61.47 -9.46 13.31 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 120.836 1.024 . . . . 1.0 114.227 -177.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.415 HG21 HD11 ' A' ' 140' ' ' ILE . 86.4 mt -113.05 134.08 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 O-C-N 120.955 -1.091 . . . . 1.0 109.705 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.693 ' HH ' ' H ' ' A' ' 112' ' ' ASN . 36.1 t80 -72.34 127.24 31.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.467 -0.77 . . . . 1.0 110.402 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 14.1 t -141.29 141.14 33.95 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.582 -0.895 . . . . 1.0 108.582 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -78.95 143.83 35.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.09 -1.007 . . . . 1.0 109.199 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.6 t -138.8 150.78 46.45 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.292 -0.88 . . . . 1.0 109.71 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -66.15 101.59 0.63 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.465 -1.454 . . . . 1.0 109.465 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 20.9 mtmm -76.71 0.34 20.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.423 -1.046 . . . . 1.0 109.768 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 73.6 p -60.06 -39.97 87.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -0.901 . . . . 1.0 109.965 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -147.62 30.69 0.9 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.079 -1.013 . . . . 1.0 109.526 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -65.28 139.61 58.63 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.132 -0.98 . . . . 1.0 109.586 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 68.2 mtt -136.55 145.24 44.8 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.702 -0.851 . . . . 1.0 108.702 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 20.9 mt -52.86 128.86 46.7 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.091 -1.006 . . . . 1.0 108.719 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -70.13 178.69 4.54 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 CA-C-N 120.081 1.065 . . . . 1.0 112.286 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -60.36 -39.95 89.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.432 -0.792 . . . . 1.0 110.096 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -56.14 -49.12 74.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.199 -0.938 . . . . 1.0 109.969 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -70.08 -39.93 75.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.996 -1.065 . . . . 1.0 110.064 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 58.1 t -61.28 -47.43 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.012 -1.055 . . . . 1.0 109.498 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -60.43 -40.09 89.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.048 -1.032 . . . . 1.0 110.45 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.416 ' O ' ' OG ' ' A' ' 161' ' ' SER . . . -72.26 -53.72 8.67 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 120.374 -0.917 . . . . 1.0 111.477 -178.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 6.8 tp -59.97 -40.06 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.817 -1.402 . . . . 1.0 109.569 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.7 mt-30 -66.06 -39.94 90.5 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.101 -1.0 . . . . 1.0 109.202 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 158' ' ' GLY . 95.1 p -60.53 -28.75 68.66 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.01 -1.056 . . . . 1.0 109.853 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 86.5 mt -89.8 -51.64 5.4 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.047 -1.033 . . . . 1.0 110.643 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -98.04 -22.08 16.45 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.945 -1.097 . . . . 1.0 110.829 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.626 0 N-CA-C 109.692 -1.363 . . . . 1.0 109.692 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' WAY . . . . . 0.923 ' HC2' ' HJ ' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.0 mt -96.92 131.77 43.37 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.215 -0.928 . . . . 1.0 109.049 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -160.0 160.04 32.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 1.0 109.69 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -72.88 150.0 43.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.304 -0.873 . . . . 1.0 109.304 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.1 t -85.48 1.61 48.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.303 -0.873 . . . . 1.0 110.093 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.528 ' NZ ' ' O ' ' A' ' 14' ' ' ASN . 20.1 pttp -149.14 154.24 38.9 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.162 -0.961 . . . . 1.0 109.635 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.54 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.01 0.39 57.14 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.289 -0.882 . . . . 1.0 109.666 -179.549 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.528 ' O ' ' NZ ' ' A' ' 12' ' ' LYS . 98.5 m-20 -95.51 128.76 42.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.219 -0.926 . . . . 1.0 108.884 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.5 mt -141.31 149.93 41.85 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.186 -0.946 . . . . 1.0 109.253 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 74.3 p -130.9 155.46 46.71 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.03 -0.73 . . . . 1.0 109.03 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -145.86 160.16 42.18 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.146 -0.972 . . . . 1.0 109.835 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.511 ' NH1' ' N ' ' A' ' 56' ' ' GLY . 73.4 ttt180 -143.36 133.45 24.32 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.537 -0.727 . . . . 1.0 109.583 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 91.8 mt -88.36 117.09 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.189 -0.944 . . . . 1.0 108.663 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.54 -40.12 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.06 -1.025 . . . . 1.0 109.391 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -163.85 160.94 22.82 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.431 -1.418 . . . . 1.0 110.631 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -97.21 -173.33 2.64 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.56 -1.274 . . . . 1.0 107.56 178.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.598 ' HG1' ' H ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -117.7 148.4 43.01 Favored Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 121.377 -0.827 . . . . 1.0 110.029 -179.451 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -67.68 -20.64 46.35 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 120.833 1.022 . . . . 1.0 110.335 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.598 ' H ' ' HG1' ' A' ' 23' ' ' THR . 94.8 m-20 -59.4 -40.12 85.6 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.15 -0.932 . . . . 1.0 110.168 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 78.0 mtm -138.95 159.93 40.95 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.257 -0.902 . . . . 1.0 109.853 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 82.6 p -74.21 160.86 30.58 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.497 0.665 . . . . 1.0 109.417 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.634 ' CD2' ' H ' ' A' ' 28' ' ' HIS . 2.7 p80 -62.47 -35.88 80.72 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.552 -0.718 . . . . 1.0 110.148 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.9 m -60.04 -40.28 88.82 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.845 -1.16 . . . . 1.0 109.61 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -69.94 -40.04 75.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.114 -0.991 . . . . 1.0 109.035 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.0 t -69.13 -41.47 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.314 -0.866 . . . . 1.0 110.258 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.95 -48.13 82.95 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.931 -1.105 . . . . 1.0 110.346 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -63.75 -31.82 73.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.87 -1.144 . . . . 1.0 109.834 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.97 -49.96 75.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.07 -1.019 . . . . 1.0 110.031 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -65.55 -37.89 88.01 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.018 -1.051 . . . . 1.0 109.661 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.07 -41.24 92.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.096 -1.003 . . . . 1.0 109.878 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -60.07 -45.32 93.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.12 -0.987 . . . . 1.0 109.475 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.12 -48.06 83.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.44 -0.787 . . . . 1.0 110.717 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.42 ' CZ ' ' CZ ' ' A' ' 121' ' ' PHE . 49.7 m-85 -64.04 -40.05 95.44 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.956 -1.09 . . . . 1.0 109.529 -179.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.6 tptt -59.99 -47.33 86.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.029 -1.045 . . . . 1.0 109.543 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.02 -41.52 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.143 -0.973 . . . . 1.0 110.128 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -78.49 -36.71 44.74 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.012 -1.055 . . . . 1.0 110.376 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 96.1 p -70.91 -20.76 62.46 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.982 -1.074 . . . . 1.0 109.936 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.93 -39.89 87.04 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.252 -0.905 . . . . 1.0 110.558 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.1 m -110.01 23.84 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.201 -0.937 . . . . 1.0 110.944 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.4 p -150.27 139.8 13.42 Favored Pre-proline 0 N--CA 1.502 2.129 0 O-C-N 120.76 -1.213 . . . . 1.0 109.658 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -75.37 15.7 0.79 Allowed 'Trans proline' 0 N--CA 1.497 1.693 0 CA-C-N 119.743 0.944 . . . . 1.0 112.088 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 88.2 mt -67.1 139.92 57.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.079 -1.013 . . . . 1.0 109.71 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -111.81 121.38 44.91 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 109.045 -0.724 . . . . 1.0 109.045 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -107.8 119.01 38.24 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.33 -0.856 . . . . 1.0 109.251 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.1 m -119.95 129.98 54.57 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.64 -0.663 . . . . 1.0 109.946 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.404 ' HG2' HH11 ' A' ' 52' ' ' ARG . 33.6 ttt-85 -82.0 135.13 35.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 1.0 109.241 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.5 mt -102.1 132.0 48.25 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.343 -0.848 . . . . 1.0 109.188 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.447 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 42.0 m170 -63.95 -40.01 95.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -0.84 . . . . 1.0 109.733 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 76.7 m-20 -148.89 169.95 19.39 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.328 -0.857 . . . . 1.0 109.869 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.511 ' N ' ' NH1' ' A' ' 18' ' ' ARG . . . 95.06 178.52 37.5 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.7 -1.36 . . . . 1.0 109.7 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.4 mt -92.58 139.52 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.292 -1.122 . . . . 1.0 108.961 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.05 170.55 8.08 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.473 -0.767 . . . . 1.0 109.702 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.03 -49.05 79.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.242 -0.911 . . . . 1.0 108.935 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 90.2 mt -119.95 112.97 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.616 -0.678 . . . . 1.0 109.251 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.0 ptm -100.93 135.0 43.07 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.397 -0.814 . . . . 1.0 108.952 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 95.8 mt -104.43 135.17 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.505 -0.747 . . . . 1.0 110.365 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 79.4 p -152.9 159.03 42.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.345 -0.847 . . . . 1.0 109.278 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -102.81 127.71 49.87 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.413 -0.804 . . . . 1.0 109.564 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.89 157.95 17.86 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 109.436 -1.466 . . . . 1.0 109.436 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.421 ' O ' ' C ' ' A' ' 67' ' ' LYS . 6.9 tt -104.53 -178.71 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.465 -1.021 . . . . 1.0 108.719 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 66' ' ' ILE . 28.1 tptp -38.33 -77.99 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.819 -0.551 . . . . 1.0 110.585 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.576 ' H ' ' CD ' ' A' ' 68' ' ' GLU . 1.0 OUTLIER -72.2 119.98 17.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.317 -0.864 . . . . 1.0 110.749 -179.013 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.621 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 3.5 m80 -69.94 -47.81 60.89 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.098 -1.002 . . . . 1.0 108.673 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.05 -12.67 63.5 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.69 -1.364 . . . . 1.0 109.69 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -122.46 -15.6 7.55 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.474 -1.015 . . . . 1.0 110.542 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.504 ' CZ ' ' CE1' ' A' ' 69' ' ' HIS . 55.6 p90 -169.9 -169.99 0.95 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.694 -1.253 . . . . 1.0 110.537 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -42.68 120.94 2.71 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.644 -0.66 . . . . 1.0 109.848 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -76.96 -172.33 1.4 Allowed 'Trans proline' 0 N--CA 1.495 1.585 0 CA-C-N 119.868 0.989 . . . . 1.0 112.927 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.621 ' CE2' ' NE2' ' A' ' 69' ' ' HIS . 90.8 m-85 -87.71 168.01 13.36 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.604 -0.887 . . . . 1.0 108.604 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.6 p-10 -97.4 0.0 47.06 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.082 -1.011 . . . . 1.0 110.099 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.21 -157.89 22.9 Favored Glycine 0 N--CA 1.5 2.944 0 N-CA-C 108.722 -1.751 . . . . 1.0 108.722 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -59.68 -63.68 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.354 0 CA-C-N 118.655 1.228 . . . . 1.0 111.612 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 88.1 p -77.62 162.34 27.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.428 -0.795 . . . . 1.0 109.485 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.15 -129.95 9.03 Favored Glycine 0 N--CA 1.499 2.894 0 N-CA-C 109.709 -1.356 . . . . 1.0 109.709 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.449 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 10.2 mt -64.99 101.13 0.47 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.222 -1.164 . . . . 1.0 108.66 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 53.5 mt -75.66 -28.36 58.69 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.468 -0.938 . . . . 1.0 108.468 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -177.92 163.94 1.84 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.385 -0.969 . . . . 1.0 108.385 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -160.78 160.41 31.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.907 -1.121 . . . . 1.0 109.97 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -144.11 156.21 44.25 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.705 -0.85 . . . . 1.0 108.705 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -95.51 150.99 38.26 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.149 -0.969 . . . . 1.0 108.807 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -65.5 165.01 24.04 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 120.771 0.981 . . . . 1.0 111.556 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -42.34 136.22 4.07 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.164 1.243 . . . . 1.0 111.792 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 90' ' ' PRO . . . -172.39 -173.91 39.35 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.492 -1.337 . . . . 1.0 110.108 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 89' ' ' GLY . 6.0 Cg_exo -57.94 -148.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 120.913 1.075 . . . . 1.0 111.9 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -61.2 -39.92 92.01 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.355 -0.84 . . . . 1.0 109.865 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -65.36 -40.09 93.15 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.008 -1.057 . . . . 1.0 109.982 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.63 177.46 37.33 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.404 -1.478 . . . . 1.0 109.404 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 62.76 72.16 0.71 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.507 -1.437 . . . . 1.0 109.507 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -157.67 160.78 38.34 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.395 -1.062 . . . . 1.0 109.016 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.65 123.67 10.73 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.083 -1.011 . . . . 1.0 109.61 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -110.08 154.76 22.8 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.589 0.709 . . . . 1.0 110.015 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.486 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 44.9 m-85 -130.58 150.22 51.88 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.538 ' OD2' ' CD1' ' A' ' 75' ' ' PHE . 1.2 m-20 -78.96 122.86 26.68 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.991 -1.068 . . . . 1.0 109.591 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -84.44 -6.84 59.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.142 -0.974 . . . . 1.0 109.379 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -85.98 -14.74 43.7 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.336 -0.853 . . . . 1.0 110.067 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.574 ' N ' ' OE1' ' A' ' 102' ' ' GLU . 0.9 OUTLIER -88.66 169.91 11.27 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.176 -0.953 . . . . 1.0 109.687 -179.113 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.7 m -99.05 102.57 14.32 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.75 -0.833 . . . . 1.0 108.75 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.446 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 93.4 m95 -85.16 121.99 28.7 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.48 -0.762 . . . . 1.0 109.33 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.2 t -140.63 150.4 43.52 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.476 -0.765 . . . . 1.0 109.761 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 74.8 m -93.04 -6.2 48.77 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.193 -0.942 . . . . 1.0 108.52 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.1 p -91.3 178.63 5.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.571 -0.706 . . . . 1.0 109.208 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 89.7 p -77.0 70.0 3.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 1.0 109.376 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -146.22 150.81 36.52 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.192 -0.942 . . . . 1.0 109.484 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 43.56 -137.73 4.18 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.046 -1.221 . . . . 1.0 110.046 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -99.99 115.32 29.42 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.394 -1.063 . . . . 1.0 109.22 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.441 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 19.3 t-20 -63.18 130.63 45.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.212 -0.93 . . . . 1.0 109.873 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.7 tp -59.92 -43.54 94.83 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.402 -0.811 . . . . 1.0 110.832 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -60.07 -42.14 93.9 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.989 -1.07 . . . . 1.0 111.096 -178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -60.01 -50.05 75.26 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.672 -1.267 . . . . 1.0 109.509 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.5 t -70.03 -41.4 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.078 -1.014 . . . . 1.0 110.006 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.56 -50.52 72.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.227 -0.921 . . . . 1.0 109.891 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.96 -39.78 86.78 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.255 -0.903 . . . . 1.0 110.627 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -63.03 -48.4 78.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.115 -0.991 . . . . 1.0 111.156 -178.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.486 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 7.0 pt-20 -59.89 -39.6 85.91 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.589 -1.319 . . . . 1.0 110.011 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.42 ' CZ ' ' CZ ' ' A' ' 39' ' ' PHE . 32.3 m-85 -60.02 -40.11 88.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.912 -1.117 . . . . 1.0 108.479 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -56.42 -42.55 89.63 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.365 -1.494 . . . . 1.0 109.365 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -65.53 -40.02 92.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.073 -1.251 . . . . 1.0 109.592 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 80.0 p -67.15 -23.69 65.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.18 -0.95 . . . . 1.0 109.317 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.7 mt -81.96 -0.97 46.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.183 -0.948 . . . . 1.0 109.59 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 92.68 7.94 62.63 Favored Glycine 0 N--CA 1.497 2.735 0 O-C-N 121.149 -0.969 . . . . 1.0 110.933 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.4 mt -86.98 141.98 28.29 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.854 -1.38 . . . . 1.0 109.858 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 10.8 t70 -98.72 174.94 6.16 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.555 -0.715 . . . . 1.0 109.089 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.491 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 76.8 m80 -59.86 139.74 57.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.026 -1.046 . . . . 1.0 109.9 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 30.4 t -98.98 156.46 16.9 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.405 -0.809 . . . . 1.0 109.182 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -97.05 -1.43 45.4 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.229 -0.919 . . . . 1.0 109.016 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -85.43 129.32 55.76 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.079 -1.013 . . . . 1.0 108.976 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -68.69 -20.16 40.72 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 CA-C-N 120.027 1.045 . . . . 1.0 112.372 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -87.3 -7.14 77.05 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.895 -1.282 . . . . 1.0 109.895 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.58 145.7 26.65 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.086 -1.243 . . . . 1.0 109.427 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.455 ' C ' ' H ' ' A' ' 138' ' ' PHE . 96.1 mt -69.97 -29.13 66.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.047 -1.033 . . . . 1.0 109.696 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.1 mmm -72.2 13.49 0.31 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.332 -0.855 . . . . 1.0 110.262 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.455 ' H ' ' C ' ' A' ' 136' ' ' LEU . 12.2 t80 -70.0 131.83 88.83 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.071 -1.018 . . . . 1.0 108.768 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -63.56 -8.56 15.45 Favored 'Trans proline' 0 N--CA 1.501 1.93 0 C-N-CA 120.924 1.083 . . . . 1.0 114.37 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 84.2 mt -109.72 138.6 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 O-C-N 120.936 -1.103 . . . . 1.0 109.317 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.441 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 45.7 t80 -74.38 128.2 34.94 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.357 -0.839 . . . . 1.0 110.7 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.1 t -139.22 138.29 36.73 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.578 -0.702 . . . . 1.0 109.211 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.467 ' CE1' ' NZ ' ' A' ' 146' ' ' LYS . 70.6 t80 -80.83 150.12 29.28 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.975 -1.078 . . . . 1.0 109.352 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.6 t -142.4 158.56 43.57 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.116 -0.99 . . . . 1.0 109.992 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.07 113.91 4.75 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.423 -1.471 . . . . 1.0 109.423 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.467 ' NZ ' ' CE1' ' A' ' 143' ' ' TYR . 62.2 mttp -80.85 3.28 23.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.382 -1.069 . . . . 1.0 110.203 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 27.6 t -58.07 -41.29 83.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.845 -1.159 . . . . 1.0 109.532 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -160.96 68.66 0.34 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.32 -0.862 . . . . 1.0 109.18 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -94.36 120.54 34.75 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.249 -0.907 . . . . 1.0 109.812 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 75.0 mtm -116.62 142.5 46.81 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 22.3 mt -50.4 132.78 25.53 Favored Pre-proline 0 C--N 1.302 -1.498 0 O-C-N 121.043 -1.036 . . . . 1.0 108.914 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -68.87 179.42 3.23 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 CA-C-N 119.865 0.987 . . . . 1.0 112.355 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -62.43 -39.95 94.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.457 -0.777 . . . . 1.0 110.126 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -56.82 -48.62 77.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 1.0 110.071 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -70.11 -39.96 75.18 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.078 -1.014 . . . . 1.0 109.803 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 54.6 t -61.25 -48.08 90.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.18 -0.95 . . . . 1.0 109.162 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -61.05 -40.08 92.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.115 -0.991 . . . . 1.0 110.413 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.25 -53.66 13.24 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 120.243 -0.98 . . . . 1.0 111.253 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.2 tp -60.36 -40.0 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.889 -1.36 . . . . 1.0 109.749 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.4 mt-30 -64.71 -39.9 94.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.04 -1.038 . . . . 1.0 109.636 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 84.4 p -65.96 -24.4 66.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -0.949 . . . . 1.0 110.2 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 85.6 mt -88.42 -51.5 5.69 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.931 -1.106 . . . . 1.0 110.232 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -90.89 -8.78 48.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.939 -1.1 . . . . 1.0 109.539 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.493 2.448 0 N-CA-C 109.664 -1.375 . . . . 1.0 109.664 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' WAY . . . . . 0.554 ' HC2' ' HJ ' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 87.6 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.9 mt -70.09 144.24 52.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.896 . . . . 1.0 109.526 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -159.86 160.0 33.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 1.0 109.377 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -73.78 150.06 41.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.224 -0.922 . . . . 1.0 109.047 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.3 t -85.62 -0.07 54.06 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.159 -0.963 . . . . 1.0 110.249 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -150.22 159.57 44.34 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.98 -1.075 . . . . 1.0 109.878 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.557 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -91.8 -0.03 57.51 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.385 -0.822 . . . . 1.0 109.689 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -96.22 123.38 39.82 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.215 -0.928 . . . . 1.0 108.995 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.3 mt -140.0 152.29 46.16 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.368 -0.832 . . . . 1.0 108.997 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.6 p -132.89 155.48 48.96 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.492 -0.755 . . . . 1.0 109.103 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -144.69 158.71 43.67 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.231 -0.918 . . . . 1.0 109.648 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 37.2 ttt-85 -142.44 132.28 24.23 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.467 -0.77 . . . . 1.0 109.47 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 93.1 mt -87.05 119.62 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.331 -0.856 . . . . 1.0 109.113 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.4 t -69.84 -40.3 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.175 -0.953 . . . . 1.0 109.495 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.414 ' OD1' ' N ' ' A' ' 21' ' ' ASN . 18.6 p-10 -162.53 154.99 19.19 Favored 'General case' 0 C--N 1.288 -2.076 0 O-C-N 119.718 -1.864 . . . . 1.0 111.028 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.408 ' OH ' ' NH2' ' A' ' 52' ' ' ARG . 44.0 m-85 -99.87 108.85 21.22 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 105.582 -2.007 . . . . 1.0 105.582 177.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.1 t -57.55 139.58 80.97 Favored Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.055 -1.028 . . . . 1.0 109.727 -177.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -59.16 -10.15 9.77 Favored 'Trans proline' 0 N--CA 1.487 1.093 0 CA-C-N 119.246 0.766 . . . . 1.0 110.96 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -57.57 -28.21 63.37 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.848 -0.741 . . . . 1.0 110.078 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 77.4 mtm -143.44 162.48 35.68 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.085 -1.009 . . . . 1.0 109.862 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.2 p -71.81 160.83 31.91 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.309 -0.869 . . . . 1.0 109.205 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -61.41 -40.21 93.58 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.426 -0.796 . . . . 1.0 110.487 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.5 m -61.08 -41.23 96.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.968 -1.083 . . . . 1.0 110.705 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.89 -40.01 91.15 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.15 -0.969 . . . . 1.0 110.623 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 69.5 t -69.73 -42.22 80.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 120.936 -1.102 . . . . 1.0 110.275 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -59.97 -53.87 52.76 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.212 -0.93 . . . . 1.0 110.83 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.3 ptmm? -65.92 -29.83 70.32 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.586 -0.696 . . . . 1.0 110.821 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.04 -49.93 75.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.785 -1.197 . . . . 1.0 109.463 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -66.96 -38.26 85.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.018 -1.051 . . . . 1.0 110.211 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.06 -40.58 89.96 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.913 -1.117 . . . . 1.0 109.559 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.04 -41.41 96.54 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.889 -1.132 . . . . 1.0 108.964 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.99 -46.44 89.45 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.516 -0.74 . . . . 1.0 109.957 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.432 ' CE1' ' CD1' ' A' ' 50' ' ' PHE . 53.3 m-85 -65.15 -39.98 93.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.968 -1.083 . . . . 1.0 109.499 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -60.05 -48.46 81.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.052 -1.03 . . . . 1.0 109.852 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.7 t -60.0 -41.06 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.092 -1.005 . . . . 1.0 110.083 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -78.4 -36.42 45.78 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.92 -1.113 . . . . 1.0 110.135 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 81.7 p -71.78 -18.02 62.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.071 -1.018 . . . . 1.0 109.845 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -60.01 -39.69 86.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.239 -0.913 . . . . 1.0 110.285 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.478 ' O ' ' NE2' ' A' ' 160' ' ' GLN . 21.9 m -111.41 20.97 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.38 -0.825 . . . . 1.0 110.788 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 22.5 p -148.42 138.22 12.62 Favored Pre-proline 0 N--CA 1.504 2.255 0 O-C-N 120.77 -1.207 . . . . 1.0 109.914 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -73.95 21.23 0.38 Allowed 'Trans proline' 0 N--CA 1.498 1.793 0 C-N-CA 120.962 1.108 . . . . 1.0 112.495 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.3 mt -69.5 136.46 51.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.893 -1.13 . . . . 1.0 110.018 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -107.91 120.0 41.06 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.614 -0.884 . . . . 1.0 108.614 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.432 ' CD1' ' CE1' ' A' ' 39' ' ' PHE . 95.1 m-85 -108.5 125.29 51.63 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.311 -0.868 . . . . 1.0 109.723 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -120.05 130.03 54.5 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.67 -0.644 . . . . 1.0 109.792 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.408 ' NH2' ' OH ' ' A' ' 22' ' ' TYR . 68.6 ttt180 -82.38 130.73 35.17 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.365 -0.835 . . . . 1.0 109.892 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.0 mt -109.64 124.33 50.99 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.421 -0.799 . . . . 1.0 109.083 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.439 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 48.4 m170 -79.27 -19.08 51.44 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.197 -0.94 . . . . 1.0 110.111 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 79.9 m-20 -146.6 160.42 42.19 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.067 -1.02 . . . . 1.0 109.901 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.97 175.3 44.0 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.555 -1.418 . . . . 1.0 109.555 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.2 mt -96.43 136.46 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.212 -1.17 . . . . 1.0 108.965 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.98 160.86 16.43 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.388 -0.82 . . . . 1.0 109.449 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.04 -49.11 78.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.223 -0.923 . . . . 1.0 109.293 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.9 mt -104.32 98.52 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.416 -0.802 . . . . 1.0 109.839 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.4 ptm -100.11 131.69 45.91 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.191 -0.943 . . . . 1.0 109.399 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.414 HG22 HD12 ' A' ' 62' ' ' ILE . 92.1 mt -103.02 138.92 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.541 -0.724 . . . . 1.0 110.208 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 82.5 p -153.07 157.74 40.89 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.371 -0.83 . . . . 1.0 109.249 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -106.5 125.68 51.31 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.83 -0.804 . . . . 1.0 108.83 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 98' ' ' PHE . . . -98.11 178.78 32.11 Favored Glycine 0 N--CA 1.499 2.873 0 O-C-N 121.108 -0.995 . . . . 1.0 110.761 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.497 ' CG2' ' N ' ' A' ' 67' ' ' LYS . 41.1 mt -134.79 165.73 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.672 -0.899 . . . . 1.0 109.018 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.497 ' N ' ' CG2' ' A' ' 66' ' ' ILE . 47.2 tptt -30.47 -76.46 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 121.058 0.456 . . . . 1.0 111.486 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -66.36 56.57 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.255 -0.903 . . . . 1.0 110.311 -178.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 67' ' ' LYS . 45.3 t-80 -60.07 -42.03 93.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.503 -0.748 . . . . 1.0 109.783 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.31 -162.49 53.52 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.108 -1.197 . . . . 1.0 110.108 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.425 ' CG ' ' H ' ' A' ' 72' ' ' PHE . 50.4 t0 54.81 -128.02 2.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.391 -1.064 . . . . 1.0 109.293 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.425 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 96.6 m-85 -54.34 -178.74 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.254 -0.904 . . . . 1.0 108.884 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -52.6 130.91 45.78 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 120.988 -1.07 . . . . 1.0 108.68 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -71.12 -175.86 1.64 Allowed 'Trans proline' 0 N--CA 1.494 1.547 0 CA-C-N 119.885 0.995 . . . . 1.0 112.334 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.54 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 99.0 m-85 -86.72 166.67 15.11 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.657 -0.868 . . . . 1.0 108.657 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -100.15 5.51 44.82 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.181 -0.949 . . . . 1.0 110.82 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 126.1 -156.23 19.58 Favored Glycine 0 N--CA 1.504 3.169 0 N-CA-C 109.085 -1.606 . . . . 1.0 109.085 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -59.83 -66.48 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 0 CA-C-N 118.697 1.249 . . . . 1.0 112.372 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 80.3 p -75.56 160.06 30.56 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.12 -0.987 . . . . 1.0 109.529 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.37 -130.02 8.9 Favored Glycine 0 N--CA 1.502 3.04 0 N-CA-C 109.67 -1.372 . . . . 1.0 109.67 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.423 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 10.9 mt -68.6 105.37 2.23 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.252 -1.146 . . . . 1.0 109.065 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 39.2 mt -78.7 -16.29 57.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.98 -1.075 . . . . 1.0 108.951 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.83 176.1 0.97 Allowed 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.435 ' ND1' ' C ' ' A' ' 84' ' ' HIS . 7.0 p80 -161.08 162.25 31.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.015 -1.053 . . . . 1.0 109.557 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.63 165.73 31.42 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.223 -0.923 . . . . 1.0 109.651 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -113.66 153.39 45.88 Favored Pre-proline 0 N--CA 1.5 2.033 0 N-CA-C 108.873 -0.788 . . . . 1.0 108.873 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.475 ' O ' ' N ' ' A' ' 89' ' ' GLY . 1.9 Cg_endo -55.56 169.08 1.28 Allowed 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.023 1.149 . . . . 1.0 112.363 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -62.12 66.12 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.278 1.318 . . . . 1.0 112.451 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -70.18 167.01 49.77 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.968 -1.653 . . . . 1.0 108.968 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -43.03 -60.34 0.78 Allowed 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.25 1.3 . . . . 1.0 112.151 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.499 ' OD1' ' CD2' ' A' ' 92' ' ' TYR . 34.8 p-10 -141.72 -33.47 0.5 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.314 -0.866 . . . . 1.0 109.356 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.499 ' CD2' ' OD1' ' A' ' 91' ' ' ASN . 84.9 m-85 -69.79 -40.03 76.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.247 -0.908 . . . . 1.0 109.492 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.49 174.62 41.65 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.252 -1.139 . . . . 1.0 110.252 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.94 5.91 89.33 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.289 -1.524 . . . . 1.0 109.289 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -79.26 169.2 18.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.327 -1.102 . . . . 1.0 109.497 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.01 117.02 5.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.299 -0.876 . . . . 1.0 109.421 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -105.64 152.23 23.38 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.491 -0.755 . . . . 1.0 109.821 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.482 ' O ' ' N ' ' A' ' 65' ' ' GLY . 38.2 m-85 -131.81 148.82 52.58 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.774 -0.824 . . . . 1.0 108.774 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.54 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 89.5 m-20 -79.03 122.83 26.68 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.915 -1.116 . . . . 1.0 109.689 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -84.04 -11.78 56.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.355 -0.841 . . . . 1.0 109.077 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -81.6 -12.56 58.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.408 -0.807 . . . . 1.0 109.278 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -89.23 169.1 11.74 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.868 -0.79 . . . . 1.0 108.868 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 39.2 m -99.81 104.41 16.1 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.201 -0.937 . . . . 1.0 109.266 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.47 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 91.3 m95 -87.46 127.11 35.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.336 -0.852 . . . . 1.0 108.915 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.486 ' HG1' ' N ' ' A' ' 106' ' ' SER . 8.0 t -143.14 158.15 43.87 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.356 -0.84 . . . . 1.0 109.755 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.486 ' N ' ' HG1' ' A' ' 105' ' ' THR . 5.2 t -96.98 -10.41 26.31 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.453 -0.943 . . . . 1.0 108.453 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 81.1 p -90.41 -176.4 4.77 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.007 -0.738 . . . . 1.0 109.007 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 m -82.82 76.57 9.65 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.135 -0.978 . . . . 1.0 109.58 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -149.6 151.12 33.28 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.19 -0.944 . . . . 1.0 108.992 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 43.73 -139.44 3.63 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.992 -1.243 . . . . 1.0 109.992 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -100.08 116.46 32.17 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.359 -1.083 . . . . 1.0 109.161 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -64.56 132.13 48.97 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.899 -1.125 . . . . 1.0 109.785 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.6 tp -59.99 -42.97 95.38 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.352 -0.842 . . . . 1.0 110.552 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -60.01 -40.65 89.96 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.098 -1.001 . . . . 1.0 110.836 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -59.93 -50.77 72.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.765 -1.209 . . . . 1.0 109.25 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.9 t -70.03 -40.15 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.202 -0.936 . . . . 1.0 110.224 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.58 -52.15 66.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.112 -0.993 . . . . 1.0 109.552 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.98 -34.34 73.18 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.246 -0.909 . . . . 1.0 110.078 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -64.3 -50.04 69.41 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.224 -0.922 . . . . 1.0 111.051 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.451 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 7.1 pt-20 -60.01 -39.31 85.36 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.801 -1.187 . . . . 1.0 110.025 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -59.98 -40.0 87.62 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.934 -1.104 . . . . 1.0 108.851 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.32 -46.05 81.12 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.753 -1.739 . . . . 1.0 108.753 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -64.5 -40.0 94.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.335 -1.097 . . . . 1.0 109.413 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.0 p -67.42 -23.57 65.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.361 -0.837 . . . . 1.0 109.67 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 69.9 mt -82.81 -0.3 47.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.227 -0.921 . . . . 1.0 109.927 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 89.12 9.83 67.02 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 110.447 -1.061 . . . . 1.0 110.447 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.9 mt -85.79 150.05 24.84 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.067 -1.255 . . . . 1.0 110.251 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 12.0 t70 -101.0 169.98 8.59 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.833 -0.803 . . . . 1.0 108.833 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.529 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 23.9 m170 -59.34 136.39 57.95 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.997 -1.065 . . . . 1.0 108.961 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 35.8 t -97.93 155.0 17.28 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.312 -0.868 . . . . 1.0 109.63 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -99.87 4.84 45.33 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.275 -0.891 . . . . 1.0 109.621 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -86.11 128.54 57.4 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 108.323 -0.991 . . . . 1.0 108.323 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -67.78 -18.63 47.54 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 CA-C-N 120.208 1.11 . . . . 1.0 111.864 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -88.9 -5.52 73.67 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.574 -1.41 . . . . 1.0 109.574 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.76 135.95 33.9 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.247 -1.149 . . . . 1.0 109.056 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.459 ' C ' ' H ' ' A' ' 138' ' ' PHE . 94.9 mt -60.5 -39.99 89.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.073 -1.017 . . . . 1.0 109.894 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 92.4 mtp -71.16 24.35 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.337 -0.852 . . . . 1.0 111.558 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.459 ' H ' ' C ' ' A' ' 136' ' ' LEU . 15.5 t80 -68.78 132.8 90.6 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 120.811 -1.181 . . . . 1.0 108.013 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -57.98 -8.78 5.04 Favored 'Trans proline' 0 N--CA 1.5 1.892 0 C-N-CA 120.859 1.039 . . . . 1.0 114.353 -177.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.409 HD13 HG23 ' A' ' 140' ' ' ILE . 96.9 mt -114.83 137.34 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 120.971 -1.08 . . . . 1.0 109.155 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -71.64 129.72 39.4 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.26 -0.9 . . . . 1.0 109.943 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 10.1 t -140.12 135.87 32.96 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.423 -0.798 . . . . 1.0 109.011 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -79.52 144.47 33.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.105 -0.997 . . . . 1.0 109.098 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.7 t -140.97 153.25 45.51 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.203 -0.936 . . . . 1.0 109.465 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.17 112.08 3.88 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.445 -1.462 . . . . 1.0 109.445 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -78.55 7.92 6.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -1.135 . . . . 1.0 109.598 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 73.4 m -59.99 -40.04 87.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 1.0 109.34 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -158.82 68.2 0.45 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 1.0 109.265 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -100.51 124.62 46.28 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.379 -0.826 . . . . 1.0 109.741 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 76.0 mtm -120.61 141.65 50.14 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.487 -0.931 . . . . 1.0 108.487 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.6 mt -48.89 129.36 14.7 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.015 -1.053 . . . . 1.0 108.924 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -68.23 176.69 5.24 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 CA-C-N 119.939 1.014 . . . . 1.0 112.646 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.23 -40.02 88.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.481 -0.762 . . . . 1.0 109.793 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -56.38 -49.41 74.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -0.944 . . . . 1.0 109.691 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -70.03 -40.01 75.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.204 -0.935 . . . . 1.0 110.141 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 62.4 t -59.97 -46.56 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.936 -1.102 . . . . 1.0 109.099 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -60.73 -40.01 90.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.144 -0.973 . . . . 1.0 110.321 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.34 -54.7 10.17 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 120.199 -1.0 . . . . 1.0 111.188 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.403 ' CG2' ' N ' ' A' ' 160' ' ' GLN . 7.2 tp -61.7 -40.47 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.975 -1.309 . . . . 1.0 109.957 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.527 ' O ' ' N ' ' A' ' 164' ' ' GLY . 92.3 mm-40 -65.28 -39.61 92.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.182 -0.949 . . . . 1.0 109.539 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 78.0 p -64.7 -27.74 69.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.921 . . . . 1.0 110.273 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 94.0 mt -87.0 -53.18 5.02 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.978 -1.077 . . . . 1.0 110.322 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -92.04 -9.25 43.44 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.215 -0.928 . . . . 1.0 110.119 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.496 2.64 0 N-CA-C 109.401 -1.48 . . . . 1.0 109.401 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' WAY . . . . . 0.804 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.8 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.446 -0.575 . . . . 1.0 109.446 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.0 mt -78.09 124.66 28.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.299 -0.876 . . . . 1.0 109.326 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -165.63 163.66 19.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.216 -0.928 . . . . 1.0 110.126 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -70.45 147.01 49.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 1.0 109.443 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.2 t -89.41 2.2 54.8 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.301 -0.874 . . . . 1.0 109.987 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -147.94 155.39 41.52 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.064 -1.023 . . . . 1.0 109.688 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.535 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.55 1.92 56.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.352 -0.843 . . . . 1.0 109.842 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -95.41 120.95 36.53 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.1 -1.0 . . . . 1.0 109.205 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.9 mt -140.28 150.54 44.18 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.372 -0.83 . . . . 1.0 108.9 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 69.1 p -134.26 156.14 48.94 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.885 -0.783 . . . . 1.0 108.885 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -145.12 162.07 37.93 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.063 -1.023 . . . . 1.0 110.142 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.404 HH21 ' HA ' ' A' ' 57' ' ' ILE . 6.8 ttm180 -141.74 131.05 23.58 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.46 -0.775 . . . . 1.0 109.933 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 86.5 mt -86.76 111.16 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.938 -1.134 . . . . 1.0 107.938 178.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 79.6 t -66.56 -40.71 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.088 -1.008 . . . . 1.0 109.371 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' A' ' 21' ' ' ASN . 18.2 p-10 -161.11 150.55 16.84 Favored 'General case' 0 C--N 1.286 -2.178 0 C-N-CA 117.452 -1.699 . . . . 1.0 111.005 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -97.01 107.81 20.42 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 104.676 -2.342 . . . . 1.0 104.676 177.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.421 ' OG1' ' OD2' ' A' ' 25' ' ' ASP . 0.6 OUTLIER -55.75 141.51 65.42 Favored Pre-proline 0 C--N 1.299 -1.595 0 O-C-N 121.143 -0.973 . . . . 1.0 110.168 -176.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -61.19 -11.79 20.45 Favored 'Trans proline' 0 N--CA 1.485 1.028 0 CA-C-N 119.061 0.7 . . . . 1.0 110.869 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.421 ' OD2' ' OG1' ' A' ' 23' ' ' THR . 70.8 m-20 -56.77 -26.21 56.99 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.774 -0.77 . . . . 1.0 110.092 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 73.1 mtm -144.32 163.11 34.69 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.965 -1.085 . . . . 1.0 109.27 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.1 p -72.69 158.82 34.89 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.377 -0.827 . . . . 1.0 109.138 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -60.21 -41.48 93.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -0.917 . . . . 1.0 110.401 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.1 m -59.84 -40.38 88.33 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.967 -1.083 . . . . 1.0 110.569 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.93 -41.59 86.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.885 -1.134 . . . . 1.0 110.413 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.3 t -67.9 -40.09 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.86 -1.15 . . . . 1.0 109.818 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -57.48 -58.87 6.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.332 -0.855 . . . . 1.0 111.286 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -27.55 69.4 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.248 -0.908 . . . . 1.0 110.203 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.02 -51.47 69.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.961 -1.087 . . . . 1.0 110.223 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -68.79 -37.02 78.98 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.876 -1.14 . . . . 1.0 110.158 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -60.02 -44.95 94.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.945 -1.097 . . . . 1.0 109.398 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.4 mtpm? -59.96 -40.07 87.78 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.157 -0.964 . . . . 1.0 109.207 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.03 -46.86 88.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.341 -0.849 . . . . 1.0 110.049 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.418 ' CZ ' ' CZ ' ' A' ' 121' ' ' PHE . 62.5 m-85 -67.51 -38.64 84.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.926 -1.109 . . . . 1.0 109.747 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -60.02 -47.85 84.15 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.269 -0.895 . . . . 1.0 109.644 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.4 t -59.98 -40.61 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.142 -0.974 . . . . 1.0 109.972 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -79.49 -35.16 40.6 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.864 -1.147 . . . . 1.0 109.789 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.3 p -72.49 -20.26 61.4 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.908 -1.12 . . . . 1.0 109.865 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.88 -40.02 87.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.253 -0.905 . . . . 1.0 110.561 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.7 m -111.13 22.25 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.336 -0.852 . . . . 1.0 110.404 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.415 ' C ' ' H ' ' A' ' 48' ' ' LEU . 29.6 p -149.0 135.85 10.57 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 120.81 -1.181 . . . . 1.0 109.439 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -73.13 20.72 0.34 Allowed 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 120.682 0.921 . . . . 1.0 112.01 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.415 ' H ' ' C ' ' A' ' 46' ' ' THR . 95.0 mt -67.76 136.39 54.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 1.0 109.563 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -108.82 120.59 42.94 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.668 -0.864 . . . . 1.0 108.668 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -110.45 124.93 52.68 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.458 -0.776 . . . . 1.0 109.946 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.5 m -119.97 130.01 54.57 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.558 -0.713 . . . . 1.0 109.275 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.9 ttt-85 -81.28 130.5 35.06 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.201 -0.937 . . . . 1.0 110.003 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 89.8 mt -104.07 130.02 51.75 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.315 -0.866 . . . . 1.0 109.094 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.436 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 50.9 m170 -63.94 -40.1 95.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.307 -0.871 . . . . 1.0 109.823 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 70.7 m-20 -153.46 179.99 8.29 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.063 -1.023 . . . . 1.0 109.769 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.56 -173.05 32.07 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.839 -1.304 . . . . 1.0 109.839 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.404 ' HA ' HH21 ' A' ' 18' ' ' ARG . 90.2 mt -95.02 126.38 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.341 -1.093 . . . . 1.0 109.109 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.16 158.61 19.45 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.391 -0.818 . . . . 1.0 109.264 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -59.96 -49.94 75.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.232 -0.918 . . . . 1.0 109.87 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 92.7 mt -109.11 97.19 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.504 -0.748 . . . . 1.0 109.882 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.6 ptm -96.5 130.06 43.74 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.913 -1.117 . . . . 1.0 109.061 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.3 mt -108.71 133.38 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.609 -0.682 . . . . 1.0 109.788 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 79.3 p -152.31 158.44 42.76 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.144 -0.972 . . . . 1.0 109.854 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -100.18 135.0 42.28 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.464 -0.939 . . . . 1.0 108.464 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -121.83 167.82 14.54 Favored Glycine 0 N--CA 1.498 2.818 0 N-CA-C 110.243 -1.143 . . . . 1.0 110.243 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.547 ' O ' ' C ' ' A' ' 67' ' ' LYS . 96.5 mt -130.0 159.98 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.514 -0.921 . . . . 1.0 108.514 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.547 ' C ' ' O ' ' A' ' 66' ' ' ILE . 52.3 tptt -1.38 -93.19 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.748 0 C-N-CA 123.067 0.547 . . . . 1.0 111.89 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -78.97 136.19 37.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.107 -0.996 . . . . 1.0 109.348 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 36.6 p-80 -159.99 -171.3 3.18 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.94 -1.1 . . . . 1.0 110.323 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -39.96 -60.02 1.96 Allowed Glycine 0 N--CA 1.496 2.661 0 O-C-N 121.557 -0.714 . . . . 1.0 111.556 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -60.04 142.47 53.95 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.893 -1.357 . . . . 1.0 109.954 -179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -70.05 -19.51 63.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.36 -0.837 . . . . 1.0 110.119 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -90.7 112.89 55.72 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 121.3 -0.875 . . . . 1.0 109.439 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -77.43 178.47 7.58 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 CA-C-N 120.116 1.077 . . . . 1.0 112.546 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.543 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 89.3 m-85 -91.0 173.07 8.15 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.417 -0.802 . . . . 1.0 108.908 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -100.05 12.55 36.64 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.156 -0.965 . . . . 1.0 111.03 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 119.79 -146.8 18.06 Favored Glycine 0 N--CA 1.506 3.352 0 N-CA-C 109.03 -1.628 . . . . 1.0 109.03 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.43 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 13.2 Cg_endo -77.91 -51.94 0.07 OUTLIER 'Trans proline' 0 N--CA 1.49 1.31 0 CA-C-N 119.281 1.54 . . . . 1.0 111.762 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 81.3 p -80.4 161.9 24.74 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.243 -0.911 . . . . 1.0 109.69 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 105.52 -126.53 8.65 Favored Glycine 0 N--CA 1.501 2.972 0 N-CA-C 110.189 -1.165 . . . . 1.0 110.189 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.424 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 13.6 mt -67.12 100.13 0.74 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.414 -1.051 . . . . 1.0 109.344 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 31.0 mt -79.2 -19.15 51.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.083 -1.011 . . . . 1.0 108.765 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.99 171.02 1.42 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.684 -0.858 . . . . 1.0 108.684 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.455 ' ND1' ' C ' ' A' ' 84' ' ' HIS . 8.5 p80 -162.32 167.44 23.82 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.238 -0.914 . . . . 1.0 108.797 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.29 159.55 44.36 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.189 -0.944 . . . . 1.0 109.188 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -95.64 151.83 38.76 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 108.016 -1.105 . . . . 1.0 108.016 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.566 ' O ' ' N ' ' A' ' 89' ' ' GLY . 8.3 Cg_endo -62.49 166.49 13.22 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 120.47 0.78 . . . . 1.0 111.088 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -52.35 78.53 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 121.03 1.153 . . . . 1.0 111.792 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -101.06 -167.29 28.05 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.496 -1.441 . . . . 1.0 109.496 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 89' ' ' GLY . 14.8 Cg_exo -56.97 -148.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 121.148 1.232 . . . . 1.0 111.855 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -59.98 -39.94 87.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.995 -1.066 . . . . 1.0 109.819 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -66.71 -40.07 88.28 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.101 -0.999 . . . . 1.0 110.358 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -62.18 168.49 15.49 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.813 -1.315 . . . . 1.0 109.813 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.35 6.74 86.7 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.908 -1.277 . . . . 1.0 109.908 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -80.3 170.04 16.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.146 -1.208 . . . . 1.0 110.053 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.7 122.93 9.56 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.294 -0.879 . . . . 1.0 109.524 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.448 ' ND1' ' CE1' ' A' ' 84' ' ' HIS . 41.4 m170 -106.7 142.54 36.18 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.534 -0.729 . . . . 1.0 110.179 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.499 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 40.3 m-85 -124.11 138.24 54.46 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 108.801 -0.814 . . . . 1.0 108.801 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.543 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 93.4 m-20 -80.33 123.59 28.13 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.092 -1.005 . . . . 1.0 109.985 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 9.8 t70 -84.31 2.92 38.01 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.194 -0.941 . . . . 1.0 109.667 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -79.8 -18.8 50.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.227 -0.921 . . . . 1.0 109.42 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.516 ' N ' ' OE1' ' A' ' 102' ' ' GLU . 57.3 mp0 -91.83 169.96 10.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.366 -0.833 . . . . 1.0 109.166 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 11.9 m -98.59 108.16 20.78 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.433 -0.951 . . . . 1.0 108.433 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -85.63 128.32 34.74 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.248 -0.908 . . . . 1.0 108.565 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.6 t -143.87 155.96 44.29 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.265 -0.897 . . . . 1.0 110.071 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 83.6 p -94.91 -7.26 40.54 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.323 -0.991 . . . . 1.0 108.323 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 57.9 m -92.65 179.01 5.62 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.645 -0.872 . . . . 1.0 108.645 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.4 m -80.7 76.08 7.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.983 -1.073 . . . . 1.0 109.34 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -147.85 152.24 37.28 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.735 -0.839 . . . . 1.0 108.735 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 43.27 -140.0 2.89 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.111 -1.195 . . . . 1.0 110.111 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -100.02 114.46 27.78 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.386 -1.067 . . . . 1.0 109.321 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -62.27 132.11 51.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.093 -1.005 . . . . 1.0 109.26 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.06 -41.45 92.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.28 -0.888 . . . . 1.0 110.289 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -60.02 -43.91 94.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.214 -0.929 . . . . 1.0 111.344 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -57.81 -51.21 70.51 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.845 -1.159 . . . . 1.0 109.65 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 64.3 t -69.72 -40.02 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.108 -0.995 . . . . 1.0 109.691 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.54 -49.96 74.63 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.237 -0.914 . . . . 1.0 109.55 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.8 -38.99 83.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.321 -0.862 . . . . 1.0 110.47 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -62.46 -49.86 73.74 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.044 -1.035 . . . . 1.0 111.059 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.499 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 7.7 pt-20 -60.03 -39.48 86.03 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.719 -1.238 . . . . 1.0 110.302 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.418 ' CZ ' ' CZ ' ' A' ' 39' ' ' PHE . 30.4 m-85 -60.07 -40.12 88.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.882 -1.136 . . . . 1.0 108.732 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.11 -45.23 94.2 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.276 -1.53 . . . . 1.0 109.276 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -65.75 -39.94 91.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.107 -1.231 . . . . 1.0 109.405 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.3 p -62.02 -26.23 68.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.923 . . . . 1.0 109.195 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 84.5 mt -80.61 -4.27 53.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.186 -0.946 . . . . 1.0 109.718 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 92.41 10.09 61.03 Favored Glycine 0 N--CA 1.496 2.684 0 C-N-CA 120.178 -1.01 . . . . 1.0 110.907 178.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.7 mt -82.74 149.9 27.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.83 -1.394 . . . . 1.0 109.165 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 42.6 t0 -101.19 171.65 7.48 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.542 -0.724 . . . . 1.0 109.339 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.493 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 65.7 m80 -59.91 137.18 58.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.13 -0.982 . . . . 1.0 109.71 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 40.3 t -97.35 156.0 16.64 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.405 -0.81 . . . . 1.0 109.171 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -97.45 2.03 49.84 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.172 -0.955 . . . . 1.0 110.006 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 7.5 t70 -85.84 129.98 52.39 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.097 -1.002 . . . . 1.0 108.665 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -68.23 -28.02 34.31 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 CA-C-N 120.106 1.073 . . . . 1.0 112.377 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.475 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -81.97 -1.81 90.39 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.753 -1.339 . . . . 1.0 109.753 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.17 146.16 25.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.304 -1.115 . . . . 1.0 109.754 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.447 ' C ' ' H ' ' A' ' 138' ' ' PHE . 84.2 mt -69.98 -32.97 71.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.333 -0.855 . . . . 1.0 109.428 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 98.1 mmm -71.78 13.33 0.28 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.504 -0.747 . . . . 1.0 110.328 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.447 ' H ' ' C ' ' A' ' 136' ' ' LEU . 13.5 t80 -69.24 135.6 89.06 Favored Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 107.811 -1.181 . . . . 1.0 107.811 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -64.22 -0.42 2.81 Favored 'Trans proline' 0 N--CA 1.5 1.855 0 CA-C-N 119.96 1.021 . . . . 1.0 114.564 -177.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.412 HG21 HD11 ' A' ' 140' ' ' ILE . 96.7 mt -119.69 138.1 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.368 0 O-C-N 120.835 -1.166 . . . . 1.0 109.979 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.422 ' C ' ' CD1' ' A' ' 141' ' ' TYR . 24.3 t80 -72.75 130.22 40.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.692 -0.63 . . . . 1.0 110.012 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.7 t -140.53 139.98 35.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.429 -0.794 . . . . 1.0 109.198 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -82.72 140.72 32.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.972 -1.08 . . . . 1.0 109.52 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.5 t -138.64 155.46 48.28 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.296 -0.878 . . . . 1.0 109.927 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -75.48 109.64 2.84 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.096 -1.602 . . . . 1.0 109.096 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -78.23 0.29 25.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.284 -1.127 . . . . 1.0 110.033 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 22.9 t -60.01 -40.49 89.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.075 -1.016 . . . . 1.0 109.856 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -139.94 32.21 1.99 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.212 -0.93 . . . . 1.0 109.825 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -79.23 130.15 35.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.001 -1.062 . . . . 1.0 110.151 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 77.8 mtm -133.87 149.35 51.34 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.39 -0.967 . . . . 1.0 108.39 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 62.0 mt -51.58 128.71 34.39 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 120.957 -1.09 . . . . 1.0 108.898 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -69.63 177.47 5.46 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 CA-C-N 120.051 1.054 . . . . 1.0 112.175 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -62.24 -39.97 94.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.46 -0.775 . . . . 1.0 109.878 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -55.9 -48.46 75.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.15 -0.968 . . . . 1.0 109.87 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.04 -39.87 75.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.078 -1.013 . . . . 1.0 110.027 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.23 -47.15 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.123 -0.986 . . . . 1.0 109.341 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -60.34 -40.07 89.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.845 -1.159 . . . . 1.0 110.503 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.431 ' O ' ' OG ' ' A' ' 161' ' ' SER . . . -69.9 -54.65 11.21 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 120.176 -1.011 . . . . 1.0 111.129 -178.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.7 tp -60.05 -39.93 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.857 -1.378 . . . . 1.0 109.572 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -64.01 -39.99 95.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.932 -1.105 . . . . 1.0 109.473 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 158' ' ' GLY . 88.6 p -58.46 -30.16 66.75 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.747 -1.221 . . . . 1.0 108.871 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 92.5 mt -88.87 -69.62 0.7 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.245 -0.909 . . . . 1.0 111.079 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -89.17 -11.59 43.37 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.998 -1.064 . . . . 1.0 111.185 -177.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.72 0 N-CA-C 109.766 -1.334 . . . . 1.0 109.766 179.967 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' WAY . . . . . 0.86 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.2 m . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.445 -0.576 . . . . 1.0 109.445 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.9 mt -82.64 133.34 35.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.201 -0.937 . . . . 1.0 109.328 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -163.05 162.34 25.8 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 1.0 109.304 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -71.02 147.26 48.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.181 -0.949 . . . . 1.0 109.594 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.2 t -89.98 2.05 55.57 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.402 -0.811 . . . . 1.0 110.35 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -144.83 154.31 42.53 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.001 -1.062 . . . . 1.0 109.99 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.55 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.28 0.21 57.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.305 -0.872 . . . . 1.0 109.72 -179.734 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -94.0 121.99 36.05 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.148 -0.97 . . . . 1.0 109.007 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.2 mt -140.18 151.47 45.27 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.365 -0.834 . . . . 1.0 109.213 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.0 p -133.72 157.33 46.1 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.455 -0.778 . . . . 1.0 109.193 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -145.32 160.24 41.82 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.142 -0.974 . . . . 1.0 109.916 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -140.99 134.01 29.25 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.369 -0.832 . . . . 1.0 110.068 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.7 mm -89.04 111.21 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.011 -1.107 . . . . 1.0 108.011 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.6 t -67.84 -39.74 82.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.126 -0.984 . . . . 1.0 109.121 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.621 ' N ' HD21 ' A' ' 21' ' ' ASN . 0.0 OUTLIER -161.23 150.5 16.56 Favored 'General case' 0 C--N 1.29 -1.992 0 O-C-N 119.294 -2.129 . . . . 1.0 111.466 -179.628 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.63 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 52.4 m-85 -99.94 99.03 9.74 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 106.097 -1.816 . . . . 1.0 106.097 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.686 ' HG1' ' H ' ' A' ' 25' ' ' ASP . 1.1 t -47.67 141.15 7.58 Favored Pre-proline 0 C--N 1.299 -1.615 0 O-C-N 121.515 -0.74 . . . . 1.0 110.769 -177.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.86 -8.12 7.18 Favored 'Trans proline' 0 N--CA 1.488 1.166 0 C-N-CA 120.649 0.899 . . . . 1.0 111.223 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.686 ' H ' ' HG1' ' A' ' 23' ' ' THR . 96.6 m-20 -59.02 -35.5 73.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.461 -0.775 . . . . 1.0 109.821 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 74.0 mtm -139.59 160.99 38.58 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.192 -0.942 . . . . 1.0 109.657 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 55.1 p -70.71 160.37 32.76 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.401 -0.812 . . . . 1.0 109.397 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.63 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 3.8 m80 -60.1 -40.54 89.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.318 -0.864 . . . . 1.0 110.263 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.7 m -59.97 -42.36 93.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.085 -1.009 . . . . 1.0 110.526 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -67.87 -40.36 83.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.242 -0.911 . . . . 1.0 110.393 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 70.9 t -68.97 -43.01 82.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.166 -0.959 . . . . 1.0 110.242 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -60.04 -49.16 78.75 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.138 -0.976 . . . . 1.0 110.824 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -61.35 -33.12 73.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.908 -1.12 . . . . 1.0 110.068 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.0 -49.77 76.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.893 -1.129 . . . . 1.0 109.979 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -67.36 -39.98 85.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.022 -1.049 . . . . 1.0 110.185 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -60.01 -43.22 95.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.951 -1.093 . . . . 1.0 110.089 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.45 -40.18 95.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.06 -1.025 . . . . 1.0 109.676 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.18 -44.45 95.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.263 -0.898 . . . . 1.0 110.196 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -69.58 -38.2 77.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.04 -1.038 . . . . 1.0 109.697 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.415 ' O ' ' CG ' ' A' ' 44' ' ' ASP . 50.4 tptt -60.0 -48.05 83.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.063 -1.023 . . . . 1.0 109.594 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.3 t -59.97 -41.15 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.119 -0.988 . . . . 1.0 109.869 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -78.46 -37.96 42.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.854 -1.154 . . . . 1.0 109.903 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.3 p -71.18 -19.22 62.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.054 -1.029 . . . . 1.0 109.643 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.415 ' CG ' ' O ' ' A' ' 40' ' ' LYS . 95.0 m-20 -60.04 -40.02 87.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.911 . . . . 1.0 110.603 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.9 m -108.63 22.04 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 121.126 -0.984 . . . . 1.0 111.304 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.2 p -149.79 144.82 18.11 Favored Pre-proline 0 N--CA 1.502 2.129 0 O-C-N 120.678 -1.264 . . . . 1.0 109.418 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -75.27 19.56 0.51 Allowed 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 120.615 0.877 . . . . 1.0 111.502 178.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.7 mt -68.99 130.31 42.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.12 -0.988 . . . . 1.0 109.719 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -107.02 120.61 42.55 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.591 -0.892 . . . . 1.0 108.591 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -108.39 125.98 52.35 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.285 -0.884 . . . . 1.0 109.713 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -120.01 129.95 54.5 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.643 -0.661 . . . . 1.0 109.846 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -82.01 130.92 35.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.325 -0.859 . . . . 1.0 109.028 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 89.4 mt -102.84 135.19 44.95 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.284 -0.885 . . . . 1.0 109.021 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.447 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 91.9 m-70 -64.26 -40.4 95.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.243 -0.911 . . . . 1.0 109.905 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 69.3 m-20 -155.69 -173.76 4.67 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.191 -0.943 . . . . 1.0 109.706 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.59 -169.51 35.77 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.05 -1.22 . . . . 1.0 110.05 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 87.6 mt -93.75 129.42 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.414 -1.051 . . . . 1.0 108.978 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.79 164.31 12.69 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.395 -0.816 . . . . 1.0 109.156 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -59.95 -49.64 76.9 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.124 -0.985 . . . . 1.0 109.032 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.2 mt -122.34 112.81 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.916 -0.772 . . . . 1.0 108.916 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.7 ptp -97.96 137.06 37.34 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.996 -1.065 . . . . 1.0 109.238 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 97.5 mt -105.29 133.07 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.279 -0.888 . . . . 1.0 109.687 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 84.2 p -151.84 152.4 32.56 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.235 -0.916 . . . . 1.0 109.761 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.451 ' H ' HD22 ' A' ' 21' ' ' ASN . 55.3 m-85 -106.68 122.67 46.81 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.461 -0.774 . . . . 1.0 109.045 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 100' ' ' ASP . . . -97.31 -178.97 34.18 Favored Glycine 0 N--CA 1.497 2.756 0 O-C-N 121.187 -0.946 . . . . 1.0 111.187 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.531 ' O ' ' C ' ' A' ' 67' ' ' LYS . 67.5 mt -134.16 165.32 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.793 -0.827 . . . . 1.0 108.843 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.531 ' C ' ' O ' ' A' ' 66' ' ' ILE . 20.0 tptm -9.3 -77.41 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.594 0 C-N-CA 123.035 0.534 . . . . 1.0 112.265 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -64.62 94.15 0.12 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.075 -1.016 . . . . 1.0 109.506 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -60.01 -40.06 87.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.515 -0.74 . . . . 1.0 109.598 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.76 1.66 67.82 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.231 -1.548 . . . . 1.0 109.231 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.58 ' C ' ' H ' ' A' ' 73' ' ' TYR . 95.9 m-20 -129.04 170.02 13.99 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.665 -0.903 . . . . 1.0 108.586 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.617 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 6.4 p90 -71.0 25.33 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.007 -1.058 . . . . 1.0 109.895 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.617 ' CE2' ' CE2' ' A' ' 72' ' ' PHE . 42.4 m-85 -129.09 77.11 78.34 Favored Pre-proline 0 N--CA 1.499 1.981 0 N-CA-C 108.439 -0.949 . . . . 1.0 108.439 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -75.78 143.58 26.85 Favored 'Trans proline' 0 N--CA 1.488 1.2 0 C-N-CA 120.947 1.098 . . . . 1.0 112.468 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.556 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 99.8 m-85 -85.51 158.91 20.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.465 -0.772 . . . . 1.0 108.946 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 28.2 p-10 -96.53 -0.04 49.44 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.126 -0.984 . . . . 1.0 110.532 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.426 ' O ' ' OE2' ' A' ' 102' ' ' GLU . . . 117.4 -119.45 4.44 Favored Glycine 0 N--CA 1.504 3.225 0 N-CA-C 110.249 -1.141 . . . . 1.0 110.249 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.459 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 28.8 Cg_endo -74.69 -72.45 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.797 0 CA-C-N 120.179 1.989 . . . . 1.0 113.012 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.425 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 81.3 p -74.76 171.49 13.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.034 -1.041 . . . . 1.0 109.839 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 104.02 -135.19 12.29 Favored Glycine 0 N--CA 1.498 2.8 0 N-CA-C 110.231 -1.148 . . . . 1.0 110.231 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.6 mt -68.86 107.32 3.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.388 -1.066 . . . . 1.0 109.692 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 84.2 mt -79.65 -25.54 41.33 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.158 -0.964 . . . . 1.0 108.892 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.54 172.82 1.4 Allowed 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.733 -0.84 . . . . 1.0 108.733 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -162.78 166.23 24.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.79 -1.194 . . . . 1.0 109.982 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -153.34 159.73 42.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.439 -0.788 . . . . 1.0 109.21 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -106.77 151.63 40.58 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.366 -0.834 . . . . 1.0 109.128 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -64.38 165.51 19.79 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 121.045 1.164 . . . . 1.0 111.614 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -46.09 124.25 7.24 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 120.906 1.071 . . . . 1.0 112.003 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 90' ' ' PRO . . . -167.01 -169.66 30.89 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.347 -1.501 . . . . 1.0 109.347 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.405 ' O ' ' O ' ' A' ' 89' ' ' GLY . 13.0 Cg_exo -57.1 -151.55 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 121.133 1.222 . . . . 1.0 112.32 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -60.11 -40.71 90.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.348 -0.845 . . . . 1.0 110.007 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -68.2 -40.0 82.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.905 . . . . 1.0 109.159 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -80.05 169.92 53.37 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.914 -1.675 . . . . 1.0 108.914 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 58.67 65.43 3.5 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.47 -1.452 . . . . 1.0 109.47 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.5 p-10 -149.97 170.78 18.03 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.284 -1.127 . . . . 1.0 109.235 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -146.31 123.76 11.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.021 -1.05 . . . . 1.0 109.654 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -114.73 153.17 30.78 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.375 -0.602 . . . . 1.0 109.375 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.529 ' CE2' ' OE2' ' A' ' 120' ' ' GLU . 39.5 m-85 -137.69 149.78 46.8 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.609 -0.886 . . . . 1.0 108.609 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.556 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 88.1 m-20 -81.39 121.14 25.86 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.684 -1.26 . . . . 1.0 109.009 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 65' ' ' GLY . 28.6 t0 -82.65 -5.45 58.84 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.121 -0.987 . . . . 1.0 109.35 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -81.39 -9.33 59.75 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.347 -0.846 . . . . 1.0 109.209 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.459 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 52.7 mm-40 -89.03 176.05 7.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.334 -0.854 . . . . 1.0 109.422 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 26.0 m -106.96 107.01 17.82 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.475 -0.935 . . . . 1.0 108.475 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -86.88 122.9 31.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.365 -0.834 . . . . 1.0 109.127 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.8 t -141.54 150.76 42.54 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.363 -0.835 . . . . 1.0 109.925 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 59.8 p -93.01 -6.91 47.26 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.232 -1.025 . . . . 1.0 108.232 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 81.9 p -92.83 176.67 6.35 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.005 -0.739 . . . . 1.0 109.005 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.6 t -77.68 76.95 4.21 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.198 -0.939 . . . . 1.0 109.484 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -148.13 146.92 28.98 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.74 -139.92 5.81 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.881 -1.287 . . . . 1.0 109.881 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -100.11 115.19 29.21 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.304 -1.115 . . . . 1.0 109.365 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.655 ' H ' ' HH ' ' A' ' 141' ' ' TYR . 9.7 t-20 -61.76 133.04 55.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.117 -0.989 . . . . 1.0 109.469 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.5 tp -59.99 -42.95 95.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.32 -0.862 . . . . 1.0 110.482 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -59.93 -40.99 90.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.087 -1.008 . . . . 1.0 110.436 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -59.91 -50.69 72.78 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.872 -1.143 . . . . 1.0 110.014 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.5 t -68.36 -45.11 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.172 -0.955 . . . . 1.0 110.448 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.63 -47.43 82.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.308 -0.87 . . . . 1.0 110.018 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.98 -41.0 91.07 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.929 -1.107 . . . . 1.0 110.77 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 60.8 t60 -65.91 -49.02 69.5 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.055 -1.028 . . . . 1.0 111.78 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.529 ' OE2' ' CE2' ' A' ' 98' ' ' PHE . 9.0 pt-20 -60.02 -42.34 94.12 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.495 -1.378 . . . . 1.0 110.368 -178.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.421 ' O ' ' OG ' ' A' ' 124' ' ' SER . 27.8 m-85 -60.05 -40.04 88.08 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.682 -1.261 . . . . 1.0 108.655 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.32 -42.71 64.42 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.161 -1.576 . . . . 1.0 109.161 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -66.27 -40.0 89.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -1.13 . . . . 1.0 109.136 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 121' ' ' PHE . 86.2 p -64.58 -21.96 66.84 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.42 -0.8 . . . . 1.0 109.577 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.9 mt -83.51 1.51 41.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.298 -0.877 . . . . 1.0 109.972 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.93 4.88 68.8 Favored Glycine 0 N--CA 1.497 2.705 0 O-C-N 121.068 -1.02 . . . . 1.0 110.701 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.9 mt -85.52 146.14 27.06 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.887 -1.361 . . . . 1.0 109.387 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -102.56 174.84 5.72 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.47 -0.769 . . . . 1.0 109.373 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 66.9 m80 -59.97 137.93 57.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.142 -0.974 . . . . 1.0 109.374 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 34.2 t -98.25 158.07 15.79 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.361 -0.837 . . . . 1.0 109.48 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.433 ' HZ3' ' CB ' ' A' ' 131' ' ' LYS . 9.7 mtpm? -95.97 -0.42 50.71 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.225 -0.922 . . . . 1.0 109.663 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -86.08 128.47 57.73 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.108 -0.995 . . . . 1.0 108.935 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -68.41 -19.84 42.83 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 CA-C-N 120.065 1.059 . . . . 1.0 112.5 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -88.38 -5.0 76.38 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.772 -1.331 . . . . 1.0 109.772 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.79 145.62 27.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.33 -1.1 . . . . 1.0 109.664 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.43 ' C ' ' H ' ' A' ' 138' ' ' PHE . 84.5 mt -70.0 -30.98 68.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.876 . . . . 1.0 109.406 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.7 mmm -71.89 10.67 0.66 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.361 -0.837 . . . . 1.0 110.053 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.43 ' H ' ' C ' ' A' ' 136' ' ' LEU . 12.8 t80 -70.05 134.14 87.65 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 107.907 -1.146 . . . . 1.0 107.907 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -60.81 -20.36 65.86 Favored 'Trans proline' 0 N--CA 1.502 1.983 0 C-N-CA 120.968 1.112 . . . . 1.0 114.308 -177.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.419 HD13 HG23 ' A' ' 140' ' ' ILE . 96.6 mt -98.22 139.84 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 O-C-N 120.696 -1.253 . . . . 1.0 110.293 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.655 ' HH ' ' H ' ' A' ' 112' ' ' ASN . 28.3 t80 -75.97 132.28 40.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.482 -0.761 . . . . 1.0 109.901 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.4 t -141.5 142.25 33.6 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.26 -0.9 . . . . 1.0 109.412 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -79.41 143.35 35.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.092 -1.005 . . . . 1.0 108.681 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.3 t -139.99 150.01 43.93 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.172 -0.955 . . . . 1.0 109.684 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.19 108.03 2.32 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.617 -1.393 . . . . 1.0 109.617 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.446 ' CB ' ' NZ ' ' A' ' 146' ' ' LYS . 7.8 mtpm? -76.81 0.12 21.86 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.422 -1.046 . . . . 1.0 109.778 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.3 t -60.01 -44.81 94.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.192 -0.943 . . . . 1.0 110.148 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -142.34 29.61 1.6 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.17 -0.956 . . . . 1.0 110.11 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -66.44 138.03 57.27 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.836 -1.165 . . . . 1.0 109.34 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 76.9 mtm -139.54 142.74 37.2 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.356 -0.84 . . . . 1.0 109.124 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 46.9 mt -49.16 110.92 1.69 Allowed Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.151 -0.968 . . . . 1.0 109.164 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -56.01 177.09 0.15 Allowed 'Trans proline' 0 N--CA 1.494 1.555 0 CA-C-N 120.119 1.078 . . . . 1.0 112.887 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -60.02 -39.88 87.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.466 -0.771 . . . . 1.0 109.997 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -56.1 -48.63 75.79 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.174 -0.953 . . . . 1.0 110.029 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -70.05 -40.01 75.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.908 . . . . 1.0 109.904 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.64 -45.66 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.178 -0.951 . . . . 1.0 109.641 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -61.6 -40.12 93.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.993 -1.067 . . . . 1.0 110.448 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.16 -52.32 14.19 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 120.35 -0.928 . . . . 1.0 111.524 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.0 tp -60.59 -40.04 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.886 -1.361 . . . . 1.0 109.587 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 164' ' ' GLY . 97.4 mt-30 -65.33 -40.01 93.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.099 -1.001 . . . . 1.0 109.725 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 79.3 p -60.86 -32.25 71.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.112 -0.992 . . . . 1.0 110.483 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 89.5 mt -86.23 -51.83 6.03 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.874 -1.141 . . . . 1.0 110.921 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -92.0 -9.38 43.11 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.851 -1.156 . . . . 1.0 110.458 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.632 0 N-CA-C 109.676 -1.37 . . . . 1.0 109.676 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' WAY . . . . . 0.489 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 79.1 m . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.3 mt -69.27 140.35 54.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.149 -0.97 . . . . 1.0 109.217 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -161.69 166.96 25.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 1.0 109.508 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -70.46 140.6 51.99 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.24 -0.912 . . . . 1.0 109.794 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.4 t -88.0 1.79 53.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.407 -0.808 . . . . 1.0 110.249 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -143.01 153.5 43.04 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.075 -1.016 . . . . 1.0 109.59 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.519 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.95 0.89 57.41 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.479 -0.763 . . . . 1.0 109.597 -179.609 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -96.56 121.14 38.06 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.174 -0.954 . . . . 1.0 109.183 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.8 mt -139.97 148.0 41.29 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.3 -0.875 . . . . 1.0 109.169 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.9 p -130.6 153.77 48.56 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -143.4 157.5 44.41 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.184 -0.948 . . . . 1.0 110.074 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.488 ' NH1' ' N ' ' A' ' 56' ' ' GLY . 71.7 ttt180 -143.18 132.74 23.64 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.555 -0.715 . . . . 1.0 109.333 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 84.7 mt -87.66 118.31 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.063 -1.023 . . . . 1.0 108.581 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.0 t -69.91 -40.02 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.991 -1.068 . . . . 1.0 109.002 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.2 p-10 -160.4 157.0 27.02 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.733 -1.23 . . . . 1.0 110.169 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.592 ' CD1' ' CD2' ' A' ' 28' ' ' HIS . 47.6 m-85 -100.44 -163.01 0.99 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.38 -1.341 . . . . 1.0 107.38 178.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.405 ' HG1' ' H ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -123.73 148.26 55.82 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.371 -0.831 . . . . 1.0 110.336 -179.372 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -70.83 -21.64 28.27 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 120.661 0.907 . . . . 1.0 110.105 177.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.405 ' H ' ' HG1' ' A' ' 23' ' ' THR . 83.9 m-20 -56.67 -36.05 69.13 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 115.725 -0.671 . . . . 1.0 110.707 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.7 mtm -135.04 163.85 28.96 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.299 -0.876 . . . . 1.0 109.469 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.4 p -73.36 159.68 32.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.484 -0.76 . . . . 1.0 109.291 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.592 ' CD2' ' CD1' ' A' ' 22' ' ' TYR . 2.9 m80 -60.79 -40.03 91.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.465 -0.772 . . . . 1.0 110.031 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.3 m -60.09 -40.46 89.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.147 -0.97 . . . . 1.0 110.185 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -67.29 -40.53 86.12 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.146 -0.971 . . . . 1.0 110.395 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.7 t -68.12 -40.41 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.121 -0.987 . . . . 1.0 109.988 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -60.05 -49.64 76.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.05 -1.031 . . . . 1.0 110.534 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -61.98 -31.55 71.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.984 -1.073 . . . . 1.0 109.68 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.07 -50.29 74.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.089 -1.007 . . . . 1.0 109.802 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -67.41 -39.67 85.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.161 -0.962 . . . . 1.0 110.215 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -59.97 -42.88 95.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.978 -1.077 . . . . 1.0 109.494 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -60.34 -39.84 88.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 1.0 109.065 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.86 -46.2 90.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.51 -0.744 . . . . 1.0 110.024 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.4 ' CZ ' ' CZ ' ' A' ' 121' ' ' PHE . 59.1 m-85 -67.04 -39.4 86.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.051 -1.03 . . . . 1.0 109.196 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.404 ' O ' ' CG ' ' A' ' 44' ' ' ASP . 47.3 tptt -60.09 -47.77 84.52 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.372 -0.83 . . . . 1.0 109.737 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.2 t -60.0 -40.03 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.011 -1.055 . . . . 1.0 109.591 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 70.0 m95 -79.61 -37.16 36.79 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.049 -1.032 . . . . 1.0 110.022 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 62.3 p -70.44 -19.78 62.95 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.034 -1.042 . . . . 1.0 109.557 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.404 ' CG ' ' O ' ' A' ' 40' ' ' LYS . 96.1 m-20 -60.09 -38.55 83.26 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.402 -0.811 . . . . 1.0 110.749 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.3 m -112.33 22.57 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.302 -0.873 . . . . 1.0 110.641 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.7 p -149.81 139.77 13.51 Favored Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 120.928 -1.108 . . . . 1.0 109.655 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -76.97 22.17 0.56 Allowed 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 120.829 1.019 . . . . 1.0 112.378 178.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 77.5 mt -69.71 139.96 53.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.919 -1.113 . . . . 1.0 109.75 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -109.71 120.07 41.36 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -109.09 125.64 52.34 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.351 -0.843 . . . . 1.0 109.481 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 93.8 m -120.07 129.93 54.43 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.542 -0.724 . . . . 1.0 109.476 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.426 ' NH2' ' HH ' ' A' ' 22' ' ' TYR . 69.2 ttt180 -82.72 128.24 34.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.332 -0.855 . . . . 1.0 109.496 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.9 mt -105.37 119.27 38.65 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.363 -0.835 . . . . 1.0 108.844 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.448 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 85.6 m-70 -70.03 -25.17 63.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.419 -0.801 . . . . 1.0 109.993 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 78.3 m-20 -147.76 160.18 43.01 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.271 -0.893 . . . . 1.0 109.806 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.488 ' N ' ' NH1' ' A' ' 18' ' ' ARG . . . 98.54 174.12 32.41 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 109.624 -1.39 . . . . 1.0 109.624 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.431 HG22 HD11 ' A' ' 57' ' ' ILE . 85.4 mt -94.42 133.49 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.349 -1.089 . . . . 1.0 108.977 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.28 159.35 17.5 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.367 -0.833 . . . . 1.0 109.61 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -59.85 -49.8 76.27 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.238 -0.914 . . . . 1.0 109.196 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.3 mt -105.13 100.43 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.539 -0.726 . . . . 1.0 109.666 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.2 ptm -102.79 127.89 49.77 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.323 -0.861 . . . . 1.0 108.993 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.5 mt -102.65 139.45 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.441 -0.787 . . . . 1.0 109.313 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.0 p -151.38 154.94 37.64 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.169 -0.957 . . . . 1.0 109.522 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -104.44 122.67 45.98 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.767 -0.827 . . . . 1.0 108.767 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.27 -169.5 20.5 Favored Glycine 0 N--CA 1.5 2.956 0 N-CA-C 110.197 -1.161 . . . . 1.0 110.197 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.492 ' O ' ' C ' ' A' ' 67' ' ' LYS . 81.4 mt -138.51 167.76 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.501 -1.0 . . . . 1.0 108.824 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.492 ' C ' ' O ' ' A' ' 66' ' ' ILE . 21.0 tptm -22.04 -78.4 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.443 0 CA-C-O 121.061 0.458 . . . . 1.0 111.782 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.564 ' H ' ' CD ' ' A' ' 68' ' ' GLU . 1.0 OUTLIER -73.02 121.88 20.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.067 -1.021 . . . . 1.0 110.102 -179.421 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -100.5 -19.91 15.98 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.389 -0.967 . . . . 1.0 108.389 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.19 -4.87 84.57 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.075 -1.61 . . . . 1.0 109.075 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -119.76 -116.96 0.32 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.707 -0.878 . . . . 1.0 109.35 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -51.76 169.96 0.06 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.233 -0.917 . . . . 1.0 110.063 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -51.7 146.72 12.95 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 108.875 -0.787 . . . . 1.0 108.875 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -57.15 -171.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 120.676 0.917 . . . . 1.0 112.11 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.534 ' CE2' ' OD1' ' A' ' 99' ' ' ASP . 22.2 m-85 -90.05 -173.37 3.83 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.782 -0.822 . . . . 1.0 108.782 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.5 p-10 -101.08 6.93 43.52 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.234 -0.916 . . . . 1.0 110.841 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 125.4 -145.71 15.83 Favored Glycine 0 N--CA 1.506 3.321 0 N-CA-C 108.938 -1.665 . . . . 1.0 108.938 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.472 ' O ' ' CG ' ' A' ' 102' ' ' GLU . 12.9 Cg_endo -77.43 -56.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.3 0 CA-C-N 119.41 1.605 . . . . 1.0 111.936 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 83.4 p -78.92 170.63 16.38 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.2 -0.938 . . . . 1.0 110.571 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.79 -120.19 6.78 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 110.571 -1.012 . . . . 1.0 110.571 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.418 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 11.0 mt -66.39 100.66 0.66 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.422 -1.046 . . . . 1.0 109.113 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 66.9 mt -81.15 -19.97 42.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.074 -1.016 . . . . 1.0 109.538 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.78 172.27 1.11 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -162.1 159.52 26.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 1.0 109.241 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.03 163.84 35.64 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.322 -0.861 . . . . 1.0 109.358 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -99.72 153.25 37.87 Favored Pre-proline 0 N--CA 1.495 1.794 0 N-CA-C 108.678 -0.86 . . . . 1.0 108.678 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -59.06 167.22 5.95 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 CA-C-N 118.801 0.607 . . . . 1.0 111.338 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -46.56 132.4 16.21 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.031 1.154 . . . . 1.0 111.759 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -173.13 -172.28 38.55 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.473 -1.451 . . . . 1.0 109.473 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -57.04 -155.72 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 121.342 1.361 . . . . 1.0 112.191 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -60.01 -40.66 90.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.207 -0.933 . . . . 1.0 109.415 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -59.91 -48.02 83.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.438 -0.789 . . . . 1.0 109.248 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -76.73 169.0 54.92 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.841 -1.304 . . . . 1.0 109.841 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 72.71 6.65 67.44 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.341 -1.503 . . . . 1.0 109.341 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -80.0 167.95 19.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.063 -1.257 . . . . 1.0 109.556 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.75 124.69 10.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.245 -0.91 . . . . 1.0 109.184 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 46.3 m170 -112.33 146.22 38.67 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.484 -0.76 . . . . 1.0 110.141 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -125.44 141.49 52.03 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.819 -0.808 . . . . 1.0 108.819 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.534 ' OD1' ' CE2' ' A' ' 75' ' ' PHE . 95.8 m-20 -79.81 121.43 25.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.079 -1.013 . . . . 1.0 109.42 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 47.0 t0 -84.16 1.55 43.81 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.122 -0.986 . . . . 1.0 109.844 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -81.78 -15.18 55.06 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.004 -1.06 . . . . 1.0 110.312 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.567 ' N ' ' OE1' ' A' ' 102' ' ' GLU . 57.4 mp0 -93.15 177.3 6.1 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.114 -0.991 . . . . 1.0 109.911 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 16.6 m -100.17 108.11 20.14 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.724 -0.843 . . . . 1.0 108.724 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -90.18 121.8 32.54 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.796 -0.816 . . . . 1.0 108.796 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.448 ' CG2' ' O ' ' A' ' 109' ' ' LYS . 7.5 t -143.2 158.04 43.97 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.178 -0.951 . . . . 1.0 110.285 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.3 t -95.01 -6.99 41.02 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.459 -0.941 . . . . 1.0 108.459 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 45.0 t -90.81 170.03 10.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.577 -0.702 . . . . 1.0 109.216 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.6 m -70.67 63.37 0.28 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.145 -0.972 . . . . 1.0 109.152 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.448 ' O ' ' CG2' ' A' ' 105' ' ' THR . 67.9 mmtt -140.92 149.88 42.46 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.399 -0.813 . . . . 1.0 109.234 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 46.67 -146.16 3.57 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.477 -1.449 . . . . 1.0 109.477 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -98.61 115.27 28.28 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.33 -1.1 . . . . 1.0 108.836 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.431 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 61.4 t-20 -62.24 133.49 55.24 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.129 -0.982 . . . . 1.0 109.302 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.1 tp -59.95 -43.45 95.01 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.547 -0.721 . . . . 1.0 110.127 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -60.14 -42.41 94.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.345 -0.847 . . . . 1.0 111.274 -179.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -58.15 -52.83 63.93 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.749 -1.22 . . . . 1.0 109.585 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 71.1 t -66.85 -41.09 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.153 -0.967 . . . . 1.0 109.779 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.11 -49.51 76.7 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.253 -0.905 . . . . 1.0 109.71 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.31 -37.91 78.94 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 120.757 -1.214 . . . . 1.0 110.229 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -65.8 -49.24 69.02 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.157 -0.965 . . . . 1.0 111.884 -178.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -59.92 -39.34 85.13 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.534 -1.354 . . . . 1.0 109.609 -178.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.4 ' CZ ' ' CZ ' ' A' ' 39' ' ' PHE . 29.8 m-85 -59.92 -40.09 87.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.877 -1.14 . . . . 1.0 108.894 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.65 -41.28 93.63 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.761 -1.336 . . . . 1.0 109.761 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -66.52 -38.98 88.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.951 -1.323 . . . . 1.0 108.866 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 87.5 p -67.8 -22.51 65.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 1.0 109.639 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 84.3 mt -83.35 -1.87 54.39 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.122 -0.986 . . . . 1.0 110.09 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.07 5.4 62.44 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.382 -1.087 . . . . 1.0 110.382 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.6 mt -86.86 144.03 27.18 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.899 -1.353 . . . . 1.0 109.491 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 34.6 t0 -102.54 178.2 4.65 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.563 -0.711 . . . . 1.0 109.176 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.421 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 65.0 m80 -59.89 136.96 58.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.078 -1.014 . . . . 1.0 109.497 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 17.5 t -98.88 158.48 15.61 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.344 -0.848 . . . . 1.0 109.381 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -99.49 2.56 45.03 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.258 -0.902 . . . . 1.0 109.054 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -85.66 122.34 73.21 Favored Pre-proline 0 N--CA 1.488 1.452 0 N-CA-C 108.179 -1.045 . . . . 1.0 108.179 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -67.44 -15.01 44.4 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 CA-C-N 120.117 1.078 . . . . 1.0 111.903 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -90.26 -5.98 69.34 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.354 -1.498 . . . . 1.0 109.354 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -87.62 148.84 24.64 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.246 -1.149 . . . . 1.0 109.829 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.526 ' C ' ' H ' ' A' ' 138' ' ' PHE . 86.0 mt -70.08 -36.34 74.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.169 -0.957 . . . . 1.0 109.298 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.0 mmm -68.91 17.24 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.397 -0.814 . . . . 1.0 110.433 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.526 ' H ' ' C ' ' A' ' 136' ' ' LEU . 14.0 t80 -69.99 134.69 87.57 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 107.711 -1.218 . . . . 1.0 107.711 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -60.53 -6.89 6.17 Favored 'Trans proline' 0 N--CA 1.501 1.952 0 CA-C-N 119.833 0.976 . . . . 1.0 114.609 -177.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.85 137.77 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.43 0 O-C-N 121.054 -1.029 . . . . 1.0 109.656 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.431 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 29.4 t80 -73.14 130.72 40.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.611 -0.681 . . . . 1.0 110.014 -178.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.3 t -139.69 139.94 36.72 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.361 -0.837 . . . . 1.0 109.068 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -81.55 141.75 33.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 1.0 109.256 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.9 t -139.96 152.46 46.34 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.27 -0.894 . . . . 1.0 109.977 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.15 108.66 2.56 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.551 -1.42 . . . . 1.0 109.551 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -77.21 1.19 19.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -1.147 . . . . 1.0 109.659 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 33.9 p -59.97 -40.1 87.96 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.32 -0.862 . . . . 1.0 110.011 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -144.02 22.9 1.73 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.063 -1.023 . . . . 1.0 110.41 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -64.97 135.48 55.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.078 -1.014 . . . . 1.0 110.016 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 78.0 mtm -136.4 146.13 46.09 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.086 -1.079 . . . . 1.0 108.086 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 54.5 mt -51.25 129.63 31.94 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 120.862 -1.149 . . . . 1.0 108.595 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -69.16 177.87 4.75 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 CA-C-N 119.994 1.033 . . . . 1.0 112.19 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -61.75 -40.02 93.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.569 -0.707 . . . . 1.0 110.214 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -54.69 -46.13 74.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.166 -0.959 . . . . 1.0 110.189 -178.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -69.0 -39.43 79.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.056 -1.027 . . . . 1.0 109.913 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 58.2 t -60.11 -47.68 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.087 -1.008 . . . . 1.0 108.792 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -61.1 -40.21 92.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.118 -0.989 . . . . 1.0 110.428 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.03 -51.77 13.41 Favored Glycine 0 N--CA 1.495 2.586 0 O-C-N 121.16 -0.962 . . . . 1.0 111.261 -178.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' A' ' 160' ' ' GLN . 5.1 tp -62.19 -41.29 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.897 -1.355 . . . . 1.0 110.163 -178.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.536 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.2 mt-30 -63.42 -38.97 93.2 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.0 -1.062 . . . . 1.0 109.597 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 79.5 p -60.91 -34.52 74.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.906 . . . . 1.0 110.507 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 95.6 mt -84.13 -48.81 9.47 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.872 -1.142 . . . . 1.0 110.845 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -91.57 -9.81 42.86 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.824 -1.173 . . . . 1.0 110.322 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.493 2.446 0 N-CA-C 109.615 -1.394 . . . . 1.0 109.615 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' WAY . . . . . 0.992 ' HC2' ' HJ ' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.5 m . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.0 mt -92.22 136.47 33.16 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.264 -0.898 . . . . 1.0 108.859 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.465 ' NZ ' ' O ' ' A' ' 162' ' ' LEU . 0.8 OUTLIER -159.97 160.04 32.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.175 -0.953 . . . . 1.0 109.601 -179.827 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -72.88 134.66 44.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.906 . . . . 1.0 109.436 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.6 t -69.63 -42.06 74.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 1.0 109.515 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -95.09 149.97 20.69 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.245 -0.91 . . . . 1.0 109.661 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.3 mmt -90.7 -0.0 57.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.28 -0.887 . . . . 1.0 109.598 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -96.72 132.28 42.55 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.227 -0.921 . . . . 1.0 109.313 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.5 mt -140.22 149.99 43.57 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.283 -0.885 . . . . 1.0 109.226 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 70.5 p -133.38 157.24 46.04 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.559 -0.904 . . . . 1.0 108.559 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -143.88 162.93 34.83 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.002 -1.061 . . . . 1.0 110.464 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -141.66 127.45 19.24 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 91.1 mt -87.74 118.65 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.273 -0.892 . . . . 1.0 108.935 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.9 t -69.5 -39.97 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.392 -0.818 . . . . 1.0 109.613 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -164.83 152.94 11.93 Favored 'General case' 0 C--N 1.289 -2.023 0 O-C-N 119.927 -1.733 . . . . 1.0 110.964 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.608 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 27.3 m-85 -98.39 109.46 22.21 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 104.436 -2.431 . . . . 1.0 104.436 177.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.529 ' OG1' ' OD2' ' A' ' 25' ' ' ASP . 3.0 t -57.42 143.07 75.3 Favored Pre-proline 0 C--N 1.294 -1.824 0 C-N-CA 119.355 -0.938 . . . . 1.0 110.21 -176.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -60.16 -8.49 8.36 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 C-N-CA 120.436 0.757 . . . . 1.0 111.015 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.529 ' OD2' ' OG1' ' A' ' 23' ' ' THR . 66.1 m-20 -57.47 -32.56 67.09 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 120.054 -0.658 . . . . 1.0 109.597 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 73.5 mtm -140.06 160.88 38.94 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.208 -0.932 . . . . 1.0 109.317 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 76.4 p -71.41 161.06 31.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.315 -0.866 . . . . 1.0 109.244 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.608 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 9.2 m80 -61.1 -41.17 96.18 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.297 -0.877 . . . . 1.0 110.296 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.4 m -60.71 -40.59 92.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.989 -1.069 . . . . 1.0 110.204 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -68.9 -39.99 79.39 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.419 -0.801 . . . . 1.0 110.563 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 79.3 t -69.25 -42.8 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.1 -1.0 . . . . 1.0 110.399 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -59.98 -49.19 78.65 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.095 -1.003 . . . . 1.0 110.47 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -61.4 -33.35 73.54 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.054 -1.029 . . . . 1.0 109.915 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.96 -48.83 80.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.007 -1.058 . . . . 1.0 109.976 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -68.16 -39.96 82.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.892 -1.13 . . . . 1.0 110.217 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -60.05 -43.76 95.16 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.858 -1.151 . . . . 1.0 109.775 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -60.07 -39.98 87.9 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.087 -1.008 . . . . 1.0 110.107 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.01 -46.83 88.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.223 -0.923 . . . . 1.0 109.906 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -67.36 -36.21 80.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.067 -1.021 . . . . 1.0 109.531 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -60.0 -49.67 76.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.072 -1.018 . . . . 1.0 109.875 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.7 t -60.25 -40.35 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.086 -1.009 . . . . 1.0 110.357 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -81.36 -34.9 31.44 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.957 -1.089 . . . . 1.0 110.118 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.5 p -71.06 -16.91 62.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.04 -1.038 . . . . 1.0 109.645 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.96 -40.03 87.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.326 -0.858 . . . . 1.0 110.062 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.5 m -110.05 -22.02 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.369 -0.832 . . . . 1.0 110.562 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.1 p -94.84 127.73 42.12 Favored Pre-proline 0 N--CA 1.499 2.009 0 O-C-N 120.794 -1.191 . . . . 1.0 109.536 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -74.12 15.66 0.6 Allowed 'Trans proline' 0 N--CA 1.492 1.441 0 CA-C-N 120.067 1.06 . . . . 1.0 111.609 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 78.7 mt -68.06 139.99 56.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 1.0 109.555 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -105.28 121.0 42.95 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.773 -0.825 . . . . 1.0 108.773 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -107.0 120.88 43.26 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.383 -0.823 . . . . 1.0 109.748 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.2 m -120.0 130.03 54.55 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.613 -0.679 . . . . 1.0 109.827 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.472 ' NH1' ' CB ' ' A' ' 52' ' ' ARG . 11.6 ttp-105 -83.05 138.01 33.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.309 -0.869 . . . . 1.0 109.711 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.4 mt -103.6 132.58 49.73 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.289 -0.882 . . . . 1.0 109.025 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.446 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 61.2 m170 -60.12 -39.99 88.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.875 . . . . 1.0 109.857 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 71.9 m-20 -153.43 179.8 8.46 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.234 -0.916 . . . . 1.0 109.464 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.73 -178.47 42.52 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.961 -1.256 . . . . 1.0 109.961 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.419 HD13 HG22 ' A' ' 57' ' ' ILE . 85.7 mt -95.58 132.95 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.387 -1.067 . . . . 1.0 109.454 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.41 165.9 11.41 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.006 -0.738 . . . . 1.0 109.006 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -59.99 -49.64 76.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.012 -1.055 . . . . 1.0 109.396 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 92.9 mt -110.13 105.56 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.429 -0.795 . . . . 1.0 109.826 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.9 ptm -102.07 132.75 47.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.231 -0.918 . . . . 1.0 108.893 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.9 mt -109.39 133.11 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.61 -0.681 . . . . 1.0 109.63 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 43.6 p -149.99 160.74 43.39 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.222 -0.924 . . . . 1.0 109.926 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -106.71 123.12 47.66 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.557 -0.714 . . . . 1.0 109.15 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.48 -171.58 26.92 Favored Glycine 0 N--CA 1.499 2.879 0 N-CA-C 110.655 -0.978 . . . . 1.0 110.655 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.505 ' O ' ' C ' ' A' ' 67' ' ' LYS . 60.9 mt -136.72 167.68 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.656 -0.908 . . . . 1.0 108.669 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.518 ' HZ1' ' C ' ' A' ' 76' ' ' ASP . 50.0 tptt -21.73 -79.0 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.459 0 CA-C-O 121.099 0.476 . . . . 1.0 111.783 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -73.14 126.6 30.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.149 -0.97 . . . . 1.0 109.794 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.618 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 1.3 m170 -77.88 -20.6 52.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.065 -1.022 . . . . 1.0 108.598 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.84 -9.19 75.18 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.412 -1.875 . . . . 1.0 108.412 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -119.96 -88.98 0.61 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.836 -0.803 . . . . 1.0 109.106 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -155.74 162.23 40.56 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.219 -0.926 . . . . 1.0 109.661 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 52.5 t80 54.03 68.99 2.38 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.326 -0.859 . . . . 1.0 109.874 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -79.22 -170.55 1.03 Allowed 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.561 1.508 . . . . 1.0 112.147 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.618 ' CE2' ' NE2' ' A' ' 69' ' ' HIS . 94.0 m-85 -89.23 170.38 10.64 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.28 -0.888 . . . . 1.0 108.828 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.518 ' C ' ' HZ1' ' A' ' 67' ' ' LYS . 31.8 p-10 -99.77 0.89 42.57 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.197 -0.94 . . . . 1.0 110.944 -178.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.51 -148.38 19.36 Favored Glycine 0 N--CA 1.504 3.185 0 N-CA-C 108.876 -1.69 . . . . 1.0 108.876 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.456 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 2.5 Cg_endo -68.65 -63.15 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.302 0 CA-C-N 119.124 1.462 . . . . 1.0 111.273 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 87.7 p -79.14 166.68 21.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.123 -0.986 . . . . 1.0 109.161 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 112.86 -128.62 8.51 Favored Glycine 0 N--CA 1.501 2.976 0 N-CA-C 109.517 -1.433 . . . . 1.0 109.517 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.418 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 20.2 mt -70.43 112.47 6.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.334 -1.098 . . . . 1.0 109.367 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 46.0 mt -83.95 -15.18 48.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.943 -1.098 . . . . 1.0 109.037 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 179.06 172.52 0.82 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.033 -0.728 . . . . 1.0 109.033 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -162.71 158.26 22.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 1.0 109.196 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.33 158.86 44.53 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.178 -0.952 . . . . 1.0 109.437 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -96.48 153.54 38.84 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.173 -0.955 . . . . 1.0 108.849 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -64.84 166.04 19.38 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 120.719 0.946 . . . . 1.0 111.952 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -44.97 120.03 2.71 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 120.958 1.105 . . . . 1.0 111.691 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 90' ' ' PRO . . . -158.44 -166.86 18.39 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.164 -1.575 . . . . 1.0 109.164 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.451 ' O ' ' O ' ' A' ' 89' ' ' GLY . 16.6 Cg_exo -54.28 -157.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 120.972 1.115 . . . . 1.0 112.535 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -59.96 -40.03 87.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.213 -0.929 . . . . 1.0 110.265 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -63.79 -40.02 95.65 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.18 -0.95 . . . . 1.0 109.409 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -68.69 169.26 41.93 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.748 -1.341 . . . . 1.0 109.748 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 72.17 6.62 65.21 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.889 -1.285 . . . . 1.0 109.889 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -80.07 169.07 18.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.097 -1.237 . . . . 1.0 109.746 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.83 120.83 7.69 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.304 -0.873 . . . . 1.0 109.174 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -108.59 147.9 31.13 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.534 -0.728 . . . . 1.0 110.374 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -124.15 146.37 48.7 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.999 -0.741 . . . . 1.0 108.999 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.543 ' OD2' ' CD1' ' A' ' 75' ' ' PHE . 1.3 m-20 -79.6 123.73 27.88 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.057 -1.027 . . . . 1.0 109.347 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -89.22 -0.02 57.13 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.106 -0.996 . . . . 1.0 110.226 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -81.85 -16.1 51.88 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.074 -1.016 . . . . 1.0 110.08 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.604 ' N ' ' OE1' ' A' ' 102' ' ' GLU . 40.1 mp0 -93.97 173.89 7.43 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.307 -0.87 . . . . 1.0 109.202 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.8 m -99.69 105.42 17.24 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.216 -0.927 . . . . 1.0 108.862 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.496 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 90.2 m95 -85.87 126.06 33.77 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.761 -0.829 . . . . 1.0 108.761 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.8 t -141.07 153.61 45.56 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.467 -0.77 . . . . 1.0 109.635 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 52.5 m -90.94 -5.17 55.82 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.198 -1.038 . . . . 1.0 108.198 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.7 t -92.73 177.93 5.95 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.752 -0.833 . . . . 1.0 108.752 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.5 m -80.25 64.29 5.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.027 -1.046 . . . . 1.0 109.998 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -139.01 152.38 47.59 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.267 -0.896 . . . . 1.0 108.788 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.8 -139.42 6.2 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.759 -1.336 . . . . 1.0 109.759 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -99.72 113.8 26.5 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.338 -1.095 . . . . 1.0 109.057 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.574 HD21 ' N ' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -62.77 130.68 45.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.148 -0.97 . . . . 1.0 109.76 -179.822 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.574 ' N ' HD21 ' A' ' 112' ' ' ASN . 61.7 tp -60.01 -43.29 95.33 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.48 -0.763 . . . . 1.0 111.022 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -60.01 -39.99 87.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.165 -0.959 . . . . 1.0 110.645 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -59.95 -50.86 72.09 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.811 -1.181 . . . . 1.0 109.874 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 71.0 t -69.98 -40.06 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.931 -1.106 . . . . 1.0 110.196 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.19 -51.97 67.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -0.939 . . . . 1.0 110.089 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.84 -37.97 80.73 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.271 -0.893 . . . . 1.0 110.259 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -64.24 -50.2 68.92 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.182 -0.949 . . . . 1.0 111.267 -178.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -60.07 -37.83 81.07 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.552 -1.342 . . . . 1.0 110.329 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -59.98 -40.05 87.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.766 -1.208 . . . . 1.0 108.255 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.39 -41.83 93.4 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.382 -1.487 . . . . 1.0 109.382 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -68.74 -39.93 80.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.022 -1.281 . . . . 1.0 109.467 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.4 p -67.2 -33.08 74.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.318 -0.864 . . . . 1.0 109.618 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 81.6 mt -70.22 -39.68 74.96 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.23 -0.919 . . . . 1.0 109.84 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 135.31 7.59 1.92 Allowed Glycine 0 N--CA 1.5 2.959 0 N-CA-C 110.045 -1.222 . . . . 1.0 110.045 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.1 mt -87.65 141.21 28.78 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.08 -1.247 . . . . 1.0 110.042 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 34.5 t0 -99.15 175.34 5.93 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.88 -0.785 . . . . 1.0 108.88 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.517 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 63.2 m80 -60.05 133.49 56.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.033 -1.042 . . . . 1.0 109.606 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 47.8 t -98.76 158.1 15.85 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.359 -0.838 . . . . 1.0 109.1 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -98.35 3.05 48.58 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.265 -0.897 . . . . 1.0 109.369 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -85.64 129.55 54.47 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.205 -0.934 . . . . 1.0 108.62 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -69.54 -25.45 29.6 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 CA-C-N 120.012 1.04 . . . . 1.0 112.34 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -82.23 -3.86 90.41 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.413 -1.475 . . . . 1.0 109.413 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.15 143.93 26.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.421 -1.047 . . . . 1.0 109.467 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.534 ' C ' ' H ' ' A' ' 138' ' ' PHE . 89.0 mt -70.0 -34.1 72.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.076 -1.015 . . . . 1.0 109.6 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.3 mmm -70.02 18.19 0.05 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.394 -0.817 . . . . 1.0 109.997 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.534 ' H ' ' C ' ' A' ' 136' ' ' LEU . 13.7 t80 -69.5 133.62 88.94 Favored Pre-proline 0 N--CA 1.488 1.446 0 N-CA-C 107.552 -1.277 . . . . 1.0 107.552 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -60.51 -15.91 39.1 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 CA-C-N 119.805 0.966 . . . . 1.0 114.005 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 95.7 mt -106.59 138.82 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 120.988 -1.07 . . . . 1.0 110.083 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.464 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 35.0 t80 -73.75 129.98 39.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.579 -0.701 . . . . 1.0 109.967 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.1 t -141.31 141.96 33.87 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.43 -0.794 . . . . 1.0 109.246 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -79.98 144.5 33.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.013 -1.054 . . . . 1.0 109.381 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.5 t -140.01 150.64 44.68 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.437 -0.789 . . . . 1.0 109.266 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.61 105.11 1.44 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.422 -1.471 . . . . 1.0 109.422 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -73.61 -6.24 45.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.432 -1.04 . . . . 1.0 109.788 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 61.1 m -60.04 -40.09 88.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.257 -0.902 . . . . 1.0 110.819 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -141.75 19.87 2.16 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.036 -1.04 . . . . 1.0 110.4 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -61.03 140.0 57.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.843 -1.16 . . . . 1.0 109.953 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 67.8 mtt -138.47 145.44 40.85 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.661 -0.866 . . . . 1.0 108.661 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 45.5 mt -54.48 129.04 61.63 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.921 -1.112 . . . . 1.0 108.914 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -68.14 177.9 4.04 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 CA-C-N 119.996 1.034 . . . . 1.0 112.166 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -61.13 -39.96 92.02 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.315 -0.866 . . . . 1.0 110.141 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -56.32 -49.94 72.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.162 -0.961 . . . . 1.0 110.091 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -70.62 -40.03 73.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.137 -0.977 . . . . 1.0 110.252 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.452 ' O ' ' OE1' ' A' ' 160' ' ' GLN . 68.1 t -63.85 -50.06 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.963 . . . . 1.0 109.618 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.54 -40.01 89.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.844 -1.16 . . . . 1.0 110.063 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.411 ' O ' ' OG ' ' A' ' 161' ' ' SER . . . -71.42 -48.45 30.19 Favored Glycine 0 N--CA 1.493 2.473 0 O-C-N 121.352 -0.842 . . . . 1.0 112.227 -178.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.564 ' CG2' ' NE2' ' A' ' 160' ' ' GLN . 4.7 tp -60.9 -43.29 95.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.609 -1.524 . . . . 1.0 110.464 -177.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.564 ' NE2' ' CG2' ' A' ' 159' ' ' ILE . 5.9 mp0 -67.64 -36.38 80.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.579 -1.325 . . . . 1.0 108.903 179.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 158' ' ' GLY . 79.4 p -60.75 -27.99 68.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.131 -0.981 . . . . 1.0 109.878 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.465 ' O ' ' NZ ' ' A' ' 9' ' ' LYS . 88.1 mt -85.28 -45.93 11.5 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.02 -1.05 . . . . 1.0 110.381 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -91.36 -9.29 45.39 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.017 -1.052 . . . . 1.0 109.821 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.553 -1.419 . . . . 1.0 109.553 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' WAY . . . . . 0.538 ' HC2' ' HJ ' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 87.4 m . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.0 mt -85.54 129.98 34.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.239 -0.913 . . . . 1.0 109.54 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -160.76 160.68 31.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.499 -0.75 . . . . 1.0 109.499 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -71.47 148.74 46.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.185 -0.947 . . . . 1.0 109.61 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 91.6 p -88.44 3.39 50.21 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.333 -0.854 . . . . 1.0 109.98 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -145.07 153.24 41.24 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.067 -1.021 . . . . 1.0 109.609 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.6 mmt -90.38 -0.01 57.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.392 -0.818 . . . . 1.0 109.606 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -96.58 131.41 43.24 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.179 -0.951 . . . . 1.0 109.283 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.8 mt -143.95 151.03 39.23 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.117 -0.989 . . . . 1.0 109.399 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.436 ' HG1' ' H ' ' A' ' 59' ' ' ASP . 54.5 p -135.71 155.73 49.93 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.475 -0.765 . . . . 1.0 108.937 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -144.27 161.19 39.54 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.146 -0.971 . . . . 1.0 110.383 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.461 ' HG2' HH11 ' A' ' 18' ' ' ARG . 0.8 OUTLIER -139.17 131.08 27.72 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 109.084 -0.709 . . . . 1.0 109.084 -179.384 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.9 mt -89.79 116.49 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.161 -0.962 . . . . 1.0 108.765 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.5 t -68.67 -39.93 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.193 -0.942 . . . . 1.0 109.226 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.403 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 23.8 p-10 -164.7 152.98 12.24 Favored 'General case' 0 C--N 1.288 -2.081 0 O-C-N 120.051 -1.656 . . . . 1.0 110.873 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.624 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 36.7 m-85 -99.94 109.11 21.48 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 104.781 -2.303 . . . . 1.0 104.781 177.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 t -55.87 140.55 68.43 Favored Pre-proline 0 C--N 1.297 -1.712 0 O-C-N 121.124 -0.985 . . . . 1.0 110.111 -176.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.27 -11.04 9.61 Favored 'Trans proline' 0 N--CA 1.485 1.008 0 CA-C-N 119.194 0.748 . . . . 1.0 110.901 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -55.61 -29.88 59.92 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.898 -0.721 . . . . 1.0 110.007 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 73.9 mtm -144.42 162.2 37.09 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.035 -1.041 . . . . 1.0 109.587 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.9 p -72.95 159.89 32.98 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.395 -0.815 . . . . 1.0 109.391 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.624 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 1.9 m80 -60.16 -40.75 90.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.306 -0.871 . . . . 1.0 110.07 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.5 m -60.12 -41.39 92.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.151 -0.968 . . . . 1.0 110.336 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.82 -40.0 79.71 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.205 -0.934 . . . . 1.0 110.321 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 70.9 t -67.59 -43.96 86.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.24 -0.913 . . . . 1.0 110.23 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -59.98 -49.92 75.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.137 -0.977 . . . . 1.0 110.837 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -61.44 -32.73 72.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.928 -1.108 . . . . 1.0 110.22 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.98 -50.07 75.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.984 -1.072 . . . . 1.0 110.006 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -68.11 -37.25 80.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.0 -1.062 . . . . 1.0 110.034 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -60.05 -44.41 94.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.973 -1.08 . . . . 1.0 109.428 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -60.44 -40.03 89.64 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.165 -0.959 . . . . 1.0 109.204 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.1 -45.96 91.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.355 -0.841 . . . . 1.0 110.212 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -69.88 -39.82 76.07 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.009 -1.057 . . . . 1.0 109.746 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -59.89 -47.88 83.98 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.194 -0.941 . . . . 1.0 109.91 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.0 t -60.0 -41.9 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.095 -1.003 . . . . 1.0 109.8 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 63.1 m95 -79.0 -35.6 42.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.038 -1.039 . . . . 1.0 109.874 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.7 p -70.14 -20.35 63.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.808 -1.183 . . . . 1.0 109.217 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -59.97 -40.13 88.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.506 -0.746 . . . . 1.0 110.667 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.7 m -110.8 23.0 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.333 -0.855 . . . . 1.0 110.633 -178.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.403 ' C ' ' H ' ' A' ' 48' ' ' LEU . 28.6 p -149.95 139.63 13.35 Favored Pre-proline 0 N--CA 1.5 2.052 0 O-C-N 120.909 -1.119 . . . . 1.0 109.23 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -75.17 19.35 0.51 Allowed 'Trans proline' 0 N--CA 1.496 1.638 0 CA-C-N 119.664 0.916 . . . . 1.0 111.605 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.403 ' H ' ' C ' ' A' ' 46' ' ' THR . 84.0 mt -67.49 138.92 56.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -0.86 . . . . 1.0 109.933 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -112.91 120.8 42.68 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.947 -0.76 . . . . 1.0 108.947 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -109.14 122.24 46.88 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.325 -0.86 . . . . 1.0 109.354 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -119.99 130.07 54.58 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.572 0.701 . . . . 1.0 109.974 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -83.14 132.7 35.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.35 -0.844 . . . . 1.0 109.64 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.2 mt -101.76 132.68 47.36 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.198 -0.939 . . . . 1.0 108.894 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.446 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 43.1 m170 -61.27 -40.05 92.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.088 -1.007 . . . . 1.0 110.061 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 73.8 m-20 -152.31 178.01 9.97 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.19 -0.944 . . . . 1.0 109.546 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.07 -178.58 42.08 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.71 -1.356 . . . . 1.0 109.71 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.3 mt -94.45 134.82 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.393 -1.063 . . . . 1.0 109.115 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.92 174.09 6.03 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.505 -0.747 . . . . 1.0 109.154 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.436 ' H ' ' HG1' ' A' ' 16' ' ' THR . 97.8 m-20 -60.05 -49.09 79.02 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.081 -1.012 . . . . 1.0 108.513 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.8 mt -120.03 118.07 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.544 -0.723 . . . . 1.0 109.42 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.1 ptp -101.63 139.26 37.52 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.164 -0.96 . . . . 1.0 109.153 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.412 HD12 HG23 ' A' ' 62' ' ' ILE . 97.0 mt -107.46 133.56 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.393 -0.817 . . . . 1.0 109.927 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 79.7 p -152.45 156.75 40.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.292 -0.88 . . . . 1.0 109.368 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -100.77 125.58 47.26 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.288 -0.883 . . . . 1.0 109.161 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 100' ' ' ASP . . . -93.14 155.31 22.28 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.946 -1.261 . . . . 1.0 109.946 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.446 ' O ' ' C ' ' A' ' 67' ' ' LYS . 9.6 tt -108.71 -178.62 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.444 -1.033 . . . . 1.0 108.77 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 66' ' ' ILE . 52.7 tptt -36.11 -77.96 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.93 -0.481 . . . . 1.0 110.404 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -68.25 121.33 16.01 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.908 -1.12 . . . . 1.0 108.863 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.48 ' O ' ' O ' ' A' ' 70' ' ' GLY . 5.5 t-80 -165.46 127.01 1.99 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.408 -0.807 . . . . 1.0 109.254 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 69' ' ' HIS . . . 48.49 99.6 0.01 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.731 -1.348 . . . . 1.0 109.731 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.04 -39.85 87.38 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.956 -1.32 . . . . 1.0 109.742 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -61.33 -38.97 88.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.129 -0.982 . . . . 1.0 109.757 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -129.95 79.01 73.97 Favored Pre-proline 0 N--CA 1.503 2.211 0 O-C-N 121.368 -0.833 . . . . 1.0 109.541 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -83.7 165.5 13.81 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 121.551 1.501 . . . . 1.0 112.456 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.523 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 77.0 m-85 -87.25 155.32 20.13 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.438 -0.949 . . . . 1.0 108.438 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -100.62 9.19 42.82 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.277 -0.889 . . . . 1.0 111.168 -178.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 121.15 -159.94 15.59 Favored Glycine 0 N--CA 1.508 3.459 0 N-CA-C 109.161 -1.575 . . . . 1.0 109.161 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -56.36 -63.97 0.15 Allowed 'Trans proline' 0 N--CA 1.49 1.268 0 CA-C-N 118.771 1.285 . . . . 1.0 111.955 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 96.3 p -76.54 160.45 29.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.496 -0.752 . . . . 1.0 109.578 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.71 -130.8 9.29 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 110.177 -1.169 . . . . 1.0 110.177 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.1 mt -69.49 105.33 2.59 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.424 -1.045 . . . . 1.0 109.242 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 32.2 mt -79.82 -14.76 58.44 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.124 -0.985 . . . . 1.0 109.057 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.57 175.54 0.88 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.056 -0.72 . . . . 1.0 109.056 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.51 ' CE1' ' ND1' ' A' ' 97' ' ' HIS . 21.2 p80 -163.22 160.91 24.57 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.231 -0.918 . . . . 1.0 109.787 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -153.2 167.74 28.31 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.858 -0.793 . . . . 1.0 108.858 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -114.51 153.98 46.61 Favored Pre-proline 0 N--CA 1.499 2.006 0 N-CA-C 108.494 -0.928 . . . . 1.0 108.494 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -69.71 161.42 46.0 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 120.57 0.847 . . . . 1.0 111.503 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -43.74 128.02 6.56 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.068 1.179 . . . . 1.0 112.104 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -171.87 -170.78 36.23 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.649 -1.38 . . . . 1.0 109.649 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -60.26 -144.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.192 1.261 . . . . 1.0 111.558 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -61.31 -40.01 92.61 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.987 -1.071 . . . . 1.0 109.394 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -62.04 -43.65 98.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.078 -1.014 . . . . 1.0 109.486 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -78.94 168.76 53.72 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.387 -1.485 . . . . 1.0 109.387 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 68.68 68.71 1.57 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.65 -1.38 . . . . 1.0 109.65 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 45.5 p-10 -152.49 160.78 43.22 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.179 -1.189 . . . . 1.0 109.236 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.88 123.24 9.01 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.101 -0.999 . . . . 1.0 109.18 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.51 ' ND1' ' CE1' ' A' ' 84' ' ' HIS . 64.9 m170 -117.78 159.98 22.12 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.625 0.726 . . . . 1.0 109.933 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.536 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 47.1 m-85 -137.88 153.46 49.56 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.702 -0.851 . . . . 1.0 108.702 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.523 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 1.5 m-20 -79.39 124.0 28.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.844 -1.16 . . . . 1.0 109.662 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 65' ' ' GLY . 36.5 t0 -84.81 -12.67 53.13 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.473 -0.767 . . . . 1.0 109.416 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -82.26 -11.51 58.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.265 -0.897 . . . . 1.0 109.574 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -91.63 166.79 12.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.294 -0.879 . . . . 1.0 109.153 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.3 m -98.78 107.42 19.86 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.177 -0.952 . . . . 1.0 109.086 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.454 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 94.1 m95 -88.74 123.65 33.36 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.846 -0.798 . . . . 1.0 108.846 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.491 ' HG1' ' HG ' ' A' ' 107' ' ' SER . 8.7 t -140.36 153.16 46.3 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.378 -0.826 . . . . 1.0 109.439 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.8 t -92.06 -6.09 51.64 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.205 -1.035 . . . . 1.0 108.205 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.491 ' HG ' ' HG1' ' A' ' 105' ' ' THR . 65.1 p -93.16 179.44 5.43 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.713 -0.847 . . . . 1.0 108.713 179.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.2 m -82.04 77.06 8.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.016 -1.052 . . . . 1.0 109.467 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -149.31 150.03 31.86 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.74 -139.85 5.86 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.567 -1.413 . . . . 1.0 109.567 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -100.09 113.77 26.63 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.312 -1.111 . . . . 1.0 108.751 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -62.94 134.11 55.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.113 -0.992 . . . . 1.0 109.34 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.6 tp -59.98 -43.94 94.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.39 -0.819 . . . . 1.0 110.587 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -59.88 -43.22 94.87 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.965 -1.085 . . . . 1.0 110.603 -178.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -58.6 -51.91 67.9 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.74 -1.225 . . . . 1.0 109.644 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.6 t -68.47 -43.97 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.174 -0.954 . . . . 1.0 110.319 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.25 -52.79 63.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.304 -0.873 . . . . 1.0 110.014 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.95 -32.65 71.0 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.937 -1.102 . . . . 1.0 109.882 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 45.7 t60 -65.68 -52.95 47.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.969 -1.082 . . . . 1.0 110.654 -179.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.536 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 7.7 pt-20 -60.13 -40.97 91.63 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.902 -1.124 . . . . 1.0 110.453 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -60.03 -39.91 87.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.861 -1.149 . . . . 1.0 109.001 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -56.45 -42.8 90.13 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.128 -1.589 . . . . 1.0 109.128 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -67.44 -39.98 85.43 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.213 -1.169 . . . . 1.0 109.221 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 59.7 p -64.45 -25.01 67.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -0.895 . . . . 1.0 109.923 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.2 mt -80.19 -0.53 36.59 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.13 -0.981 . . . . 1.0 110.049 -179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 91.93 6.8 64.95 Favored Glycine 0 N--CA 1.497 2.744 0 O-C-N 120.997 -1.065 . . . . 1.0 110.562 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.4 mt -84.79 149.46 25.72 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.907 -1.349 . . . . 1.0 109.554 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 42.0 t0 -98.67 171.32 8.19 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.674 -0.861 . . . . 1.0 108.674 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.535 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 62.8 m80 -58.92 136.98 58.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.026 -1.046 . . . . 1.0 109.724 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.0 t -97.36 151.16 20.2 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.542 -0.724 . . . . 1.0 109.246 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -99.86 6.83 45.28 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.255 -0.903 . . . . 1.0 108.907 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -87.31 123.76 69.31 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.057 -1.027 . . . . 1.0 108.396 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -64.2 -17.1 58.47 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 CA-C-N 120.189 1.103 . . . . 1.0 112.168 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -89.98 -6.35 69.58 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.553 -1.419 . . . . 1.0 109.553 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.56 141.49 30.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.221 -1.164 . . . . 1.0 109.25 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.499 ' C ' ' H ' ' A' ' 138' ' ' PHE . 97.0 mt -65.78 -39.74 91.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.15 -0.969 . . . . 1.0 109.6 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 91.1 mtp -70.36 23.35 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.32 -0.862 . . . . 1.0 111.117 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.499 ' H ' ' C ' ' A' ' 136' ' ' LEU . 11.5 t80 -67.26 133.11 93.33 Favored Pre-proline 0 N--CA 1.493 1.692 0 N-CA-C 107.522 -1.288 . . . . 1.0 107.522 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -61.7 -9.79 14.87 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 CA-C-N 119.958 1.021 . . . . 1.0 113.644 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.433 HD13 HG23 ' A' ' 140' ' ' ILE . 88.4 mt -113.45 133.28 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.162 -0.961 . . . . 1.0 109.14 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -71.36 128.51 36.1 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.168 -0.957 . . . . 1.0 110.102 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.8 t -141.84 143.59 33.46 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.637 -0.875 . . . . 1.0 108.637 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -81.24 146.03 30.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.079 -1.013 . . . . 1.0 109.766 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.0 t -140.8 157.49 45.32 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.371 -0.831 . . . . 1.0 109.662 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.95 106.47 1.97 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.534 -1.426 . . . . 1.0 109.534 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.458 ' CB ' ' NZ ' ' A' ' 146' ' ' LYS . 8.4 mtpm? -77.43 2.9 14.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -1.15 . . . . 1.0 109.597 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.471 ' O ' ' ND1' ' A' ' 148' ' ' HIS . 34.7 t -59.44 -46.06 89.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 1.0 110.067 -179.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . 0.471 ' ND1' ' O ' ' A' ' 147' ' ' SER . 50.0 m-70 -146.58 30.77 0.99 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.014 -1.054 . . . . 1.0 109.472 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -61.0 136.0 57.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.145 -0.972 . . . . 1.0 109.7 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 65.9 mtt -133.47 144.56 49.53 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.476 -0.765 . . . . 1.0 108.939 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 36.4 mt -51.48 125.77 28.06 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.177 -0.952 . . . . 1.0 108.767 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -67.63 177.52 4.0 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 CA-C-N 120.04 1.05 . . . . 1.0 112.253 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.21 -39.98 88.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.395 -0.816 . . . . 1.0 109.955 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -55.11 -48.34 73.74 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.183 -0.948 . . . . 1.0 109.998 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -69.98 -39.96 75.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.042 -1.037 . . . . 1.0 110.115 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 56.3 t -59.95 -49.13 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.158 -0.964 . . . . 1.0 109.478 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -60.34 -40.11 89.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.878 -1.138 . . . . 1.0 110.468 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.63 -53.28 12.66 Favored Glycine 0 N--CA 1.496 2.638 0 O-C-N 121.046 -1.034 . . . . 1.0 111.512 -178.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 6.3 tp -61.19 -40.0 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.97 -1.312 . . . . 1.0 109.617 -178.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 164' ' ' GLY . 97.1 mt-30 -65.49 -39.69 92.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 1.0 109.566 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 83.3 p -60.0 -34.65 73.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 1.0 110.625 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 83.7 mt -87.47 -50.47 6.52 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.843 -1.161 . . . . 1.0 110.884 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -90.62 -9.12 48.16 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.969 -1.082 . . . . 1.0 110.226 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.568 0 N-CA-C 109.512 -1.435 . . . . 1.0 109.512 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' WAY . . . . . 0.974 ' HC2' ' HJ ' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.0 m . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.484 -0.561 . . . . 1.0 109.484 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.3 mt -73.52 144.73 46.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.178 -0.951 . . . . 1.0 109.075 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -159.84 159.88 33.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.198 -0.939 . . . . 1.0 109.525 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -71.76 145.54 48.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -0.868 . . . . 1.0 109.193 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.1 t -80.83 -0.86 40.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.413 -0.805 . . . . 1.0 110.369 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -149.27 154.8 39.58 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.067 -1.02 . . . . 1.0 109.574 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.551 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.07 0.03 57.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.34 -0.85 . . . . 1.0 109.723 -179.644 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -97.65 124.76 42.08 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.279 -0.888 . . . . 1.0 108.954 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.4 mt -140.03 150.07 43.96 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.263 -0.898 . . . . 1.0 109.713 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.0 p -130.7 157.3 43.16 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.61 -0.885 . . . . 1.0 108.61 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -144.18 160.05 41.61 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.082 -1.011 . . . . 1.0 110.251 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.462 ' CZ ' ' O ' ' A' ' 54' ' ' HIS . 26.1 tpt180 -143.61 129.4 19.36 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.652 -0.655 . . . . 1.0 109.566 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.41 HG21 HD11 ' A' ' 19' ' ' ILE . 86.8 mt -88.11 119.68 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.149 -0.969 . . . . 1.0 109.132 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.6 t -69.48 -40.53 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.169 -0.957 . . . . 1.0 109.259 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.632 ' N ' HD21 ' A' ' 21' ' ' ASN . 0.0 OUTLIER -163.8 165.21 23.2 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.496 -1.378 . . . . 1.0 110.948 -179.126 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -104.22 -172.98 2.2 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.78 -1.193 . . . . 1.0 107.78 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.69 ' HG1' ' H ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -119.85 148.81 47.28 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.445 -0.784 . . . . 1.0 109.901 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -64.93 -16.11 53.8 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 120.926 1.084 . . . . 1.0 110.156 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.69 ' H ' ' HG1' ' A' ' 23' ' ' THR . 95.9 m-20 -59.94 -39.99 87.41 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.348 -0.842 . . . . 1.0 110.471 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.6 mtm -144.21 160.16 41.43 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.128 -0.982 . . . . 1.0 109.663 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 69.3 p -73.48 159.98 32.39 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.393 -0.817 . . . . 1.0 109.373 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.634 ' CD2' ' H ' ' A' ' 28' ' ' HIS . 2.8 p80 -60.95 -31.82 71.36 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.337 -0.852 . . . . 1.0 109.972 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 56.0 m -60.02 -42.11 93.63 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.855 -1.153 . . . . 1.0 109.446 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -69.92 -40.06 75.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.09 -1.006 . . . . 1.0 109.544 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 56.2 t -69.58 -40.07 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.232 -0.917 . . . . 1.0 110.001 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -59.73 -49.92 75.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.088 -1.008 . . . . 1.0 110.107 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -63.25 -31.54 72.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.976 -1.078 . . . . 1.0 109.958 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.01 -49.96 75.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.017 -1.052 . . . . 1.0 110.197 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -67.66 -36.94 81.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.98 -1.075 . . . . 1.0 109.978 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -59.93 -41.07 90.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.987 -1.071 . . . . 1.0 109.721 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -62.2 -40.18 95.21 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.071 -1.018 . . . . 1.0 108.868 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.97 -45.89 91.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.511 -0.743 . . . . 1.0 110.139 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.508 ' CD1' ' CD1' ' A' ' 50' ' ' PHE . 63.4 m-85 -68.4 -40.06 81.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.963 -1.085 . . . . 1.0 110.02 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.402 ' O ' ' CG ' ' A' ' 44' ' ' ASP . 27.4 tptp -60.01 -47.54 85.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.122 -0.987 . . . . 1.0 109.665 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.5 t -60.01 -40.09 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.184 -0.948 . . . . 1.0 110.119 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -81.54 -35.46 30.27 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.876 -1.14 . . . . 1.0 109.985 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.5 p -71.64 -20.1 62.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.905 -1.122 . . . . 1.0 109.725 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.402 ' CG ' ' O ' ' A' ' 40' ' ' LYS . 95.3 m-20 -59.95 -39.89 87.12 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.246 -0.909 . . . . 1.0 111.048 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 m -109.52 20.25 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 O-C-N 121.191 -0.943 . . . . 1.0 110.797 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.408 ' C ' ' H ' ' A' ' 48' ' ' LEU . 19.3 p -147.93 140.38 14.6 Favored Pre-proline 0 N--CA 1.502 2.128 0 O-C-N 120.83 -1.169 . . . . 1.0 109.221 179.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -72.83 18.37 0.36 Allowed 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 120.716 0.944 . . . . 1.0 111.999 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.408 ' H ' ' C ' ' A' ' 46' ' ' THR . 79.0 mt -68.1 137.12 54.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.122 -0.986 . . . . 1.0 109.916 -179.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -111.46 120.75 43.19 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.885 -0.783 . . . . 1.0 108.885 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.508 ' CD1' ' CD1' ' A' ' 39' ' ' PHE . 92.4 m-85 -109.16 123.3 48.99 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.367 -0.833 . . . . 1.0 109.335 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.1 m -119.95 130.02 54.6 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.55 -0.718 . . . . 1.0 109.679 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -82.32 132.35 35.22 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.467 -0.77 . . . . 1.0 109.566 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.4 mt -104.96 131.16 52.83 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.326 -0.859 . . . . 1.0 108.819 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.462 ' O ' ' CZ ' ' A' ' 18' ' ' ARG . 42.2 m170 -61.73 -40.24 94.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.177 -0.952 . . . . 1.0 110.005 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 74.9 m-20 -151.74 176.33 11.5 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.112 -0.992 . . . . 1.0 109.924 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.87 -179.76 35.63 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.858 -1.297 . . . . 1.0 109.858 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 91.3 mt -93.51 130.44 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.366 -1.079 . . . . 1.0 109.583 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.46 164.52 12.62 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.971 -0.752 . . . . 1.0 108.971 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.87 -49.52 77.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.067 -1.021 . . . . 1.0 109.332 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.7 mt -111.81 109.63 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.506 -0.746 . . . . 1.0 109.534 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.5 ptm -106.46 132.0 53.0 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.328 -0.858 . . . . 1.0 109.481 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.41 HG21 HD12 ' A' ' 62' ' ' ILE . 86.1 mt -103.22 137.72 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.619 -0.675 . . . . 1.0 109.383 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.2 p -152.08 152.96 33.03 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.07 -1.019 . . . . 1.0 109.755 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.612 ' H ' HD22 ' A' ' 21' ' ' ASN . 93.4 m-85 -100.42 120.27 39.73 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.891 -0.781 . . . . 1.0 108.891 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -103.85 -170.6 25.37 Favored Glycine 0 N--CA 1.5 2.966 0 N-CA-C 110.773 -0.931 . . . . 1.0 110.773 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.509 ' O ' ' ND1' ' A' ' 69' ' ' HIS . 74.4 mt -137.16 165.37 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.569 -0.959 . . . . 1.0 109.111 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.482 ' N ' ' CG2' ' A' ' 66' ' ' ILE . 27.2 tptp -27.94 -80.55 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 120.99 0.424 . . . . 1.0 111.387 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.544 ' H ' ' CD ' ' A' ' 68' ' ' GLU . 0.9 OUTLIER -77.17 95.72 4.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.929 -1.107 . . . . 1.0 109.91 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.509 ' ND1' ' O ' ' A' ' 66' ' ' ILE . 6.1 p-80 -157.94 4.98 0.12 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.059 -1.026 . . . . 1.0 109.644 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -156.26 89.01 0.12 Allowed Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.122 -1.591 . . . . 1.0 109.122 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -60.05 -43.95 95.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.139 -1.213 . . . . 1.0 109.547 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -60.39 -39.96 89.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.148 -0.97 . . . . 1.0 109.012 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -128.75 79.98 73.47 Favored Pre-proline 0 N--CA 1.5 2.045 0 N-CA-C 109.075 -0.713 . . . . 1.0 109.075 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -76.55 149.77 30.94 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 C-N-CA 121.044 1.163 . . . . 1.0 112.085 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -94.84 168.41 10.82 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.249 -0.907 . . . . 1.0 109.609 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.5 p-10 -101.81 -0.07 34.85 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.331 -0.855 . . . . 1.0 111.127 -178.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 128.04 -149.16 18.04 Favored Glycine 0 N--CA 1.505 3.261 0 N-CA-C 109.381 -1.488 . . . . 1.0 109.381 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.425 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 3.5 Cg_exo -64.39 -64.36 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.501 0 CA-C-N 118.953 1.376 . . . . 1.0 112.114 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 77.0 p -75.9 158.67 31.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.12 -0.987 . . . . 1.0 109.039 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.26 -128.34 8.04 Favored Glycine 0 N--CA 1.501 3.012 0 N-CA-C 109.594 -1.402 . . . . 1.0 109.594 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.425 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 18.4 mt -67.28 106.35 2.02 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.389 -1.065 . . . . 1.0 109.555 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 46.3 mt -75.81 -23.63 55.83 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.919 -1.113 . . . . 1.0 109.063 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -177.68 173.89 1.56 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.635 -0.876 . . . . 1.0 108.635 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -161.08 165.75 29.18 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.175 -0.953 . . . . 1.0 109.177 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -155.3 159.15 39.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.388 -0.82 . . . . 1.0 109.162 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -99.05 153.9 37.57 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 121.097 -1.002 . . . . 1.0 108.499 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -62.75 160.39 33.11 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 120.847 1.031 . . . . 1.0 112.396 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -41.01 121.21 1.25 Allowed 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 121.806 1.67 . . . . 1.0 113.212 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.98 -169.23 26.11 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.816 -1.314 . . . . 1.0 109.816 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -58.94 -151.98 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.118 1.212 . . . . 1.0 111.622 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -60.33 -41.58 93.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.798 -1.189 . . . . 1.0 109.432 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -60.16 -41.49 92.88 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.296 -0.877 . . . . 1.0 109.858 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -80.02 169.09 52.74 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.32 -1.112 . . . . 1.0 110.32 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 70.19 5.08 52.66 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.985 -1.246 . . . . 1.0 109.985 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 43.0 p-10 -80.65 160.25 25.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.103 -1.234 . . . . 1.0 109.218 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.87 121.39 8.53 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.086 -1.009 . . . . 1.0 109.423 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -109.63 147.25 33.4 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.7 -0.625 . . . . 1.0 109.575 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -121.21 151.73 39.63 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.66 -0.867 . . . . 1.0 108.66 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.425 ' OD2' ' O ' ' A' ' 81' ' ' LEU . 88.7 m-20 -78.67 120.63 23.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.973 -1.079 . . . . 1.0 109.386 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -83.11 -10.44 58.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.318 -0.864 . . . . 1.0 109.334 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -83.08 -10.07 58.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.892 . . . . 1.0 109.471 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 97.8 mt-10 -91.63 168.19 11.67 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.308 -0.87 . . . . 1.0 109.618 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 8.2 m -97.73 106.48 18.79 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.335 -0.853 . . . . 1.0 109.007 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -89.13 121.17 31.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.429 -0.794 . . . . 1.0 108.887 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.655 ' HG1' ' H ' ' A' ' 107' ' ' SER . 6.1 t -140.31 152.55 45.94 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.325 -0.86 . . . . 1.0 110.103 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 69.8 m -95.03 -8.42 36.81 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.774 -0.824 . . . . 1.0 108.774 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.655 ' H ' ' HG1' ' A' ' 105' ' ' THR . 90.3 p -91.89 175.33 6.92 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.467 -0.771 . . . . 1.0 108.957 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.1 t -72.82 71.85 1.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.04 -1.038 . . . . 1.0 109.485 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.474 ' O ' ' CG2' ' A' ' 105' ' ' THR . 43.7 mtpt -148.47 154.76 40.3 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.287 -0.883 . . . . 1.0 108.836 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 109' ' ' LYS . . . 40.83 -141.89 0.88 Allowed Glycine 0 N--CA 1.499 2.864 0 N-CA-C 110.473 -1.051 . . . . 1.0 110.473 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -99.53 119.55 38.22 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.336 -1.096 . . . . 1.0 108.962 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.416 ' H ' ' HH ' ' A' ' 141' ' ' TYR . 1.6 t-20 -64.08 130.39 43.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.157 -0.965 . . . . 1.0 109.623 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.9 tp -60.0 -43.45 95.17 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.436 -0.79 . . . . 1.0 110.814 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -59.84 -40.22 87.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.103 -0.998 . . . . 1.0 110.774 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -59.28 -51.35 70.32 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.845 -1.16 . . . . 1.0 109.197 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.6 t -69.99 -41.78 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.161 -0.962 . . . . 1.0 109.728 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.1 -51.76 68.36 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.032 -1.043 . . . . 1.0 109.264 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.59 -40.63 88.11 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.428 -0.795 . . . . 1.0 110.662 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -62.54 -49.17 76.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.204 -0.935 . . . . 1.0 111.022 -178.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -59.83 -38.8 83.05 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.619 -1.301 . . . . 1.0 109.701 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -59.85 -40.02 87.16 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.818 -1.176 . . . . 1.0 108.46 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -56.99 -40.44 91.16 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.576 -1.41 . . . . 1.0 109.576 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -67.36 -40.06 85.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.957 -1.319 . . . . 1.0 109.311 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 86.1 p -66.03 -26.09 67.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.131 -0.981 . . . . 1.0 109.056 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 83.2 mt -80.51 2.55 24.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.365 -0.834 . . . . 1.0 109.552 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 85.14 9.77 79.49 Favored Glycine 0 N--CA 1.494 2.562 0 C-N-CA 120.2 -1.0 . . . . 1.0 110.921 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 77.5 mt -87.05 141.06 28.94 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.712 -1.464 . . . . 1.0 109.673 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 30.8 t0 -98.98 173.01 7.04 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.432 -0.792 . . . . 1.0 109.263 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.507 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 66.9 m80 -60.08 132.69 54.71 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.272 -0.892 . . . . 1.0 109.821 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.6 t -100.26 156.03 17.45 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.812 -0.81 . . . . 1.0 108.812 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -98.28 6.29 47.52 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.1 -1.0 . . . . 1.0 109.514 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -86.16 125.27 68.67 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.15 -0.969 . . . . 1.0 108.476 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -67.26 -19.34 50.33 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 CA-C-N 120.226 1.116 . . . . 1.0 112.57 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -87.21 -8.03 75.78 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.88 -1.288 . . . . 1.0 109.88 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.6 145.65 25.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.04 -1.271 . . . . 1.0 109.443 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.482 ' C ' ' H ' ' A' ' 138' ' ' PHE . 95.0 mt -68.38 -31.19 70.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.23 -0.919 . . . . 1.0 109.39 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 96.4 mmm -71.22 17.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.427 -0.796 . . . . 1.0 110.743 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.482 ' H ' ' C ' ' A' ' 136' ' ' LEU . 12.5 t80 -70.01 130.17 90.12 Favored Pre-proline 0 N--CA 1.494 1.764 0 N-CA-C 107.901 -1.148 . . . . 1.0 107.901 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -68.13 4.96 1.29 Allowed 'Trans proline' 0 N--CA 1.505 2.173 0 C-N-CA 121.041 1.16 . . . . 1.0 114.623 -177.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.418 HG23 HD12 ' A' ' 140' ' ' ILE . 96.6 mt -119.63 134.37 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 O-C-N 120.984 -1.072 . . . . 1.0 108.446 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.416 ' HH ' ' H ' ' A' ' 112' ' ' ASN . 60.3 t80 -71.74 130.8 42.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.022 -1.049 . . . . 1.0 109.666 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 15.0 t -145.11 144.98 31.22 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.56 -0.904 . . . . 1.0 108.56 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -80.8 147.68 30.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.99 -1.069 . . . . 1.0 109.912 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 19.3 m -137.77 145.14 42.04 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.481 -0.762 . . . . 1.0 110.008 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.17 97.16 0.57 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 107.646 -2.181 . . . . 1.0 107.646 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -73.97 5.1 4.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.379 -1.071 . . . . 1.0 109.805 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 70.0 m -60.05 -40.09 88.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.132 -0.98 . . . . 1.0 110.052 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -147.5 39.95 0.99 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.021 -1.05 . . . . 1.0 109.911 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -78.87 130.59 35.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.099 -1.001 . . . . 1.0 110.915 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 97.9 mmm -128.67 145.02 51.27 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.108 -1.071 . . . . 1.0 108.108 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 26.8 mt -50.26 129.43 24.11 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 120.841 -1.162 . . . . 1.0 108.981 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -71.97 179.44 4.85 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 CA-C-N 119.939 1.014 . . . . 1.0 112.084 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -61.42 -40.02 92.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.431 -0.793 . . . . 1.0 110.171 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -57.46 -45.11 85.13 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.185 -0.947 . . . . 1.0 110.353 -178.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -70.0 -39.9 75.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.804 -1.185 . . . . 1.0 109.49 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.5 t -59.75 -45.61 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.094 -1.004 . . . . 1.0 109.379 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -62.09 -40.07 94.59 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.945 -1.097 . . . . 1.0 110.016 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.4 -54.49 8.77 Favored Glycine 0 N--CA 1.494 2.523 0 C-N-CA 120.253 -0.975 . . . . 1.0 111.197 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.42 ' CG2' ' N ' ' A' ' 160' ' ' GLN . 8.8 tp -60.18 -40.33 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.934 -1.333 . . . . 1.0 109.644 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.553 ' O ' ' N ' ' A' ' 164' ' ' GLY . 92.1 mm-40 -65.15 -39.87 93.6 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.191 -0.943 . . . . 1.0 109.416 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 78.7 p -61.56 -28.62 69.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.085 -1.009 . . . . 1.0 110.279 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.4 mt -87.27 -52.58 5.31 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.94 -1.1 . . . . 1.0 110.477 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -90.81 -10.04 44.24 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.088 -1.007 . . . . 1.0 110.103 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.523 0 N-CA-C 109.348 -1.501 . . . . 1.0 109.348 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' WAY . . . . . 0.899 ' HC2' ' HJ ' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.18 -0.674 . . . . 1.0 109.18 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.1 mt -74.83 150.01 39.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.438 -0.789 . . . . 1.0 109.032 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -159.69 160.05 33.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.214 -0.929 . . . . 1.0 109.339 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -73.41 151.09 41.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.115 -0.991 . . . . 1.0 109.683 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.0 t -87.54 0.5 55.5 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.456 -0.777 . . . . 1.0 109.478 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -144.82 150.91 37.96 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.262 -0.899 . . . . 1.0 109.217 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.9 mmt -90.01 -0.1 57.4 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.357 -0.839 . . . . 1.0 109.952 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -98.2 131.02 44.91 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.266 -0.897 . . . . 1.0 108.896 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.9 mt -139.84 150.51 44.75 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.288 -0.882 . . . . 1.0 109.088 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 48.8 p -133.09 157.65 44.76 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.414 -0.804 . . . . 1.0 109.32 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -146.47 160.23 42.37 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.062 -1.024 . . . . 1.0 110.049 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.6 ttt-85 -144.32 133.29 22.68 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.381 -0.824 . . . . 1.0 109.429 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 84.9 mt -87.69 117.62 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.198 -0.939 . . . . 1.0 108.961 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.4 t -69.99 -39.97 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.16 -0.963 . . . . 1.0 109.767 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.436 HD22 ' H ' ' A' ' 64' ' ' PHE . 15.7 p30 -162.06 152.13 16.74 Favored 'General case' 0 C--N 1.292 -1.895 0 O-C-N 119.798 -1.814 . . . . 1.0 111.656 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -99.04 105.64 17.79 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 103.924 -2.621 . . . . 1.0 103.924 176.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.64 145.34 50.93 Favored Pre-proline 0 C--N 1.295 -1.8 0 O-C-N 121.127 -0.983 . . . . 1.0 110.532 -175.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -56.1 -14.14 10.95 Favored 'Trans proline' 0 N--CA 1.486 1.078 0 C-N-CA 120.668 0.912 . . . . 1.0 110.865 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -59.79 -39.2 84.16 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.523 -0.871 . . . . 1.0 109.708 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.7 mtm -139.66 156.18 46.98 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.211 -0.931 . . . . 1.0 109.496 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 82.5 p -75.6 163.88 26.88 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.423 -0.798 . . . . 1.0 109.681 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.504 ' CD2' ' H ' ' A' ' 28' ' ' HIS . 6.9 p80 -59.97 -39.03 84.27 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.542 -0.724 . . . . 1.0 110.079 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.4 m -60.02 -45.27 93.34 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.854 -1.154 . . . . 1.0 109.696 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -69.99 -40.2 75.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.136 -0.978 . . . . 1.0 109.846 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 77.6 t -68.48 -44.59 83.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.275 -0.891 . . . . 1.0 109.989 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -59.87 -48.54 81.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.052 -1.03 . . . . 1.0 111.033 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -61.11 -34.65 75.3 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.632 -1.292 . . . . 1.0 110.223 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.2 -48.66 80.81 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.868 -1.145 . . . . 1.0 109.619 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -66.47 -37.81 85.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.074 -1.016 . . . . 1.0 109.523 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.06 -40.82 90.8 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.899 -1.126 . . . . 1.0 109.307 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -60.11 -42.74 95.36 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.941 -1.099 . . . . 1.0 108.27 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.0 -48.47 81.56 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.427 -0.796 . . . . 1.0 109.599 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -65.62 -39.01 91.04 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.01 -1.056 . . . . 1.0 109.852 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -59.4 -47.19 86.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.1 -1.0 . . . . 1.0 109.728 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.4 t -61.37 -41.34 89.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.216 -0.928 . . . . 1.0 110.303 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -77.99 -36.89 48.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.067 -1.021 . . . . 1.0 109.809 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 86.7 p -71.22 -15.5 62.46 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.506 -0.746 . . . . 1.0 109.634 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -59.19 -40.07 84.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.3 -0.875 . . . . 1.0 109.909 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.9 m -112.94 -21.79 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.301 -0.874 . . . . 1.0 110.874 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.1 p -91.4 128.32 47.38 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 120.697 -1.252 . . . . 1.0 110.268 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -75.81 15.67 0.87 Allowed 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 120.855 1.037 . . . . 1.0 111.471 179.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 79.1 mt -69.16 140.62 54.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.335 -0.853 . . . . 1.0 109.55 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -106.11 121.04 43.34 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -106.93 123.18 47.81 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.303 -0.873 . . . . 1.0 109.194 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -120.0 130.24 54.64 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.589 -0.694 . . . . 1.0 109.728 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -82.09 135.85 35.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.185 -0.947 . . . . 1.0 109.073 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 84.7 mt -103.67 129.68 51.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.317 -0.864 . . . . 1.0 108.837 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.43 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 18.5 m170 -61.3 -40.01 92.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 1.0 109.869 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 75.1 m-20 -149.11 169.86 19.73 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.188 -0.945 . . . . 1.0 109.809 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.0 -178.03 34.42 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.726 -1.35 . . . . 1.0 109.726 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.2 mt -93.87 139.13 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.269 -1.136 . . . . 1.0 109.3 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.35 169.23 9.1 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.517 -0.739 . . . . 1.0 109.439 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -59.99 -48.42 81.78 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.27 -0.894 . . . . 1.0 109.147 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.0 mt -119.92 112.34 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.503 -0.748 . . . . 1.0 109.401 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.7 ptm -103.58 133.81 47.98 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.306 -0.871 . . . . 1.0 108.9 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.416 HD12 HG22 ' A' ' 62' ' ' ILE . 84.6 mt -107.54 133.83 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.568 -0.707 . . . . 1.0 109.394 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 76.6 p -151.74 157.57 42.19 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.072 -1.017 . . . . 1.0 109.988 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.436 ' H ' HD22 ' A' ' 21' ' ' ASN . 73.7 m-85 -110.02 121.72 45.91 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.823 -0.806 . . . . 1.0 108.823 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -114.24 -167.23 15.93 Favored Glycine 0 N--CA 1.501 2.977 0 N-CA-C 110.289 -1.124 . . . . 1.0 110.289 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.563 ' O ' ' C ' ' A' ' 67' ' ' LYS . 96.9 mt -134.95 159.07 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.653 -0.91 . . . . 1.0 108.594 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.563 ' C ' ' O ' ' A' ' 66' ' ' ILE . 50.0 tptt -1.18 -93.24 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.757 0 C-N-CA 123.004 0.522 . . . . 1.0 111.806 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -80.41 130.63 35.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.927 -1.108 . . . . 1.0 109.854 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.541 ' NE2' ' OD2' ' A' ' 71' ' ' ASP . 35.1 p-80 -139.95 24.85 2.35 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.064 -1.022 . . . . 1.0 109.622 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.415 ' O ' ' OD1' ' A' ' 71' ' ' ASP . . . 82.98 44.49 7.1 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 120.218 -0.991 . . . . 1.0 110.942 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.541 ' OD2' ' NE2' ' A' ' 69' ' ' HIS . 88.2 m-20 -139.17 150.31 45.45 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.157 -1.202 . . . . 1.0 109.197 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.445 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 60.1 t80 -69.15 -16.53 63.67 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.342 -0.848 . . . . 1.0 110.125 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -121.83 81.45 41.83 Favored Pre-proline 0 N--CA 1.505 2.316 0 O-C-N 121.303 -0.873 . . . . 1.0 110.06 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.36 179.98 2.19 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 120.671 0.914 . . . . 1.0 112.175 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.544 ' CD1' ' OD1' ' A' ' 99' ' ' ASP . 96.3 m-85 -89.49 170.44 10.51 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.366 -0.834 . . . . 1.0 108.894 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.1 p-10 -100.26 0.56 40.51 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.911 -1.118 . . . . 1.0 110.81 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 129.85 -146.15 17.11 Favored Glycine 0 N--CA 1.502 3.091 0 N-CA-C 108.663 -1.775 . . . . 1.0 108.663 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.426 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 5.7 Cg_exo -65.54 -63.4 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.331 0 CA-C-N 119.314 1.557 . . . . 1.0 111.63 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 84.4 p -78.58 161.1 27.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.206 -0.934 . . . . 1.0 110.001 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.47 -133.06 10.85 Favored Glycine 0 N--CA 1.502 3.047 0 N-CA-C 109.916 -1.273 . . . . 1.0 109.916 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.7 mt -65.56 107.92 1.86 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.345 -1.091 . . . . 1.0 108.287 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 50.9 mt -75.65 -29.95 59.28 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.113 -0.992 . . . . 1.0 109.123 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -177.07 168.6 2.4 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -160.63 162.39 32.73 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.18 -0.95 . . . . 1.0 109.6 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -146.25 158.67 43.9 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.256 -0.903 . . . . 1.0 109.511 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -101.78 151.98 38.03 Favored Pre-proline 0 N--CA 1.498 1.963 0 N-CA-C 108.469 -0.937 . . . . 1.0 108.469 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -63.68 165.36 18.46 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 120.535 0.823 . . . . 1.0 111.93 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -47.27 122.35 6.4 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 121.035 1.157 . . . . 1.0 111.753 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 90' ' ' PRO . . . -160.76 -170.74 25.77 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.778 -1.329 . . . . 1.0 109.778 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 89' ' ' GLY . 28.1 Cg_exo -54.53 -144.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.56 1.507 . . . . 1.0 113.311 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -61.26 -42.2 98.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.464 -0.772 . . . . 1.0 110.698 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -73.43 -27.76 61.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.9 -1.125 . . . . 1.0 110.168 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.63 171.03 50.38 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.278 -1.529 . . . . 1.0 109.278 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 55.14 71.1 0.77 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.704 -1.358 . . . . 1.0 109.704 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 48.7 p-10 -153.74 162.34 41.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.349 -1.089 . . . . 1.0 109.282 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.15 118.84 7.0 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.225 -0.922 . . . . 1.0 110.126 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -104.12 136.02 44.52 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.505 -0.747 . . . . 1.0 109.845 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.44 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 19.4 m-85 -116.15 142.51 46.72 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.745 -0.835 . . . . 1.0 108.745 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.544 ' OD1' ' CD1' ' A' ' 75' ' ' PHE . 93.4 m-20 -79.22 124.09 28.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.935 -1.103 . . . . 1.0 109.523 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 48.3 t0 -84.32 -0.02 50.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.323 -0.861 . . . . 1.0 109.662 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -79.62 -16.39 55.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.022 -1.049 . . . . 1.0 110.157 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.509 ' N ' ' OE1' ' A' ' 102' ' ' GLU . 56.1 mp0 -93.53 171.17 9.06 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.177 -0.952 . . . . 1.0 109.128 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 13.7 m -99.48 108.57 21.05 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.352 -0.981 . . . . 1.0 108.352 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -85.84 127.57 34.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 1.0 109.368 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.451 ' CG2' ' O ' ' A' ' 109' ' ' LYS . 1.8 t -139.86 153.11 46.95 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.428 -0.795 . . . . 1.0 109.638 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.5 t -98.69 -4.28 34.03 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.418 -0.801 . . . . 1.0 108.972 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 53.1 m -89.65 -116.47 0.06 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.327 -0.858 . . . . 1.0 109.626 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.8 p -141.84 64.58 1.39 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.134 -0.979 . . . . 1.0 110.147 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.451 ' O ' ' CG2' ' A' ' 105' ' ' THR . 98.7 mttt -144.87 155.29 43.38 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.09 -1.006 . . . . 1.0 108.848 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 49.97 -138.62 20.3 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.485 -1.446 . . . . 1.0 109.485 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -99.55 118.96 37.25 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.241 -1.152 . . . . 1.0 109.337 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.425 HD21 ' HZ3' ' A' ' 146' ' ' LYS . 49.2 t-20 -62.24 127.48 31.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.296 -0.878 . . . . 1.0 109.927 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.7 tp -59.98 -40.29 88.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.3 -0.875 . . . . 1.0 110.237 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -59.89 -40.96 90.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.237 -0.915 . . . . 1.0 110.233 -178.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -60.76 -51.31 69.88 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.511 -1.368 . . . . 1.0 110.173 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.1 t -68.96 -43.77 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -0.889 . . . . 1.0 110.296 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.5 -52.24 66.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.074 -1.016 . . . . 1.0 109.739 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.23 -39.62 87.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.875 . . . . 1.0 110.374 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -62.04 -50.01 73.73 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.366 -0.834 . . . . 1.0 111.481 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.44 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 9.5 pt-20 -59.6 -39.77 85.26 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.842 -1.161 . . . . 1.0 109.943 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -60.39 -39.8 88.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.955 -1.091 . . . . 1.0 108.738 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.76 -43.29 86.79 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.162 -1.575 . . . . 1.0 109.162 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -67.53 -39.91 85.04 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.221 -1.164 . . . . 1.0 109.864 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 72.3 p -66.72 -21.61 66.07 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.134 -0.979 . . . . 1.0 109.463 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 77.1 mt -81.67 -0.73 44.01 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.457 -0.777 . . . . 1.0 109.484 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.82 6.96 66.85 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 110.902 -0.879 . . . . 1.0 110.902 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.5 mt -86.84 149.51 24.78 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.815 -1.403 . . . . 1.0 109.733 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 36.3 t0 -100.78 173.9 6.3 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.546 -0.721 . . . . 1.0 109.056 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.482 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 76.3 m80 -58.06 137.78 56.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.079 -1.013 . . . . 1.0 109.069 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 41.1 t -98.35 151.12 20.87 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.383 -0.823 . . . . 1.0 109.719 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -97.65 1.54 48.81 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.329 -0.857 . . . . 1.0 109.487 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -87.04 128.88 54.12 Favored Pre-proline 0 N--CA 1.489 1.487 0 N-CA-C 108.217 -1.031 . . . . 1.0 108.217 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -69.08 -11.04 30.76 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 CA-C-N 120.128 1.081 . . . . 1.0 112.059 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -93.43 -8.87 60.79 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.425 -1.47 . . . . 1.0 109.425 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.54 136.28 33.87 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.4 -1.059 . . . . 1.0 109.195 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.478 ' C ' ' H ' ' A' ' 138' ' ' PHE . 89.8 mt -60.84 -37.15 81.07 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.027 -1.046 . . . . 1.0 109.638 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 72.8 mtp -70.06 21.42 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.473 -0.767 . . . . 1.0 111.361 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.478 ' H ' ' C ' ' A' ' 136' ' ' LEU . 12.1 t80 -67.69 132.68 92.58 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 120.941 -1.099 . . . . 1.0 108.089 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -62.2 -2.07 2.82 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 CA-C-N 119.851 0.982 . . . . 1.0 114.56 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 95.7 mt -118.46 140.61 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.683 0 O-C-N 120.831 -1.168 . . . . 1.0 110.081 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -75.84 126.49 31.11 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.544 -0.723 . . . . 1.0 110.528 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 14.3 t -144.43 141.88 29.93 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.327 -0.858 . . . . 1.0 109.502 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -80.68 149.63 29.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.094 -1.004 . . . . 1.0 109.571 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.635 ' H ' ' HZ2' ' A' ' 146' ' ' LYS . 3.9 m -146.19 162.49 37.9 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.232 -0.918 . . . . 1.0 109.761 -178.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.439 ' N ' ' CG2' ' A' ' 144' ' ' THR . . . -84.88 103.17 2.64 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.134 -1.586 . . . . 1.0 109.134 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.635 ' HZ2' ' H ' ' A' ' 144' ' ' THR . 9.8 mptt -77.7 3.42 14.05 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.206 -1.173 . . . . 1.0 109.74 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 18.5 t -59.97 -47.56 85.3 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.464 -0.772 . . . . 1.0 109.793 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -133.65 19.12 3.89 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.267 -0.896 . . . . 1.0 110.097 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -65.35 139.84 58.61 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.901 -1.124 . . . . 1.0 110.416 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 76.6 mtm -138.04 149.69 46.26 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.284 -1.006 . . . . 1.0 108.284 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.1 mt -53.07 128.63 48.22 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.819 -1.176 . . . . 1.0 108.882 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.37 175.55 5.79 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 CA-C-N 120.201 1.107 . . . . 1.0 112.334 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -60.06 -39.69 86.89 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.529 -0.732 . . . . 1.0 109.968 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -56.65 -48.43 77.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.264 -0.897 . . . . 1.0 110.107 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -70.15 -40.03 75.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.137 -0.977 . . . . 1.0 109.677 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 76.7 t -63.09 -48.47 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.097 -1.002 . . . . 1.0 109.661 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -60.32 -40.24 89.91 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.904 -1.123 . . . . 1.0 110.298 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.67 -54.55 8.38 Favored Glycine 0 N--CA 1.496 2.659 0 O-C-N 121.168 -0.958 . . . . 1.0 111.41 -178.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.401 ' CG2' ' N ' ' A' ' 160' ' ' GLN . 6.3 tp -60.94 -40.22 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.813 -1.404 . . . . 1.0 109.59 -179.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.2 mm-40 -65.27 -39.71 92.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.16 -0.963 . . . . 1.0 109.434 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 83.9 p -66.68 -26.62 67.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.231 -0.918 . . . . 1.0 110.265 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 84.9 mt -87.0 -50.85 6.38 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.954 -1.091 . . . . 1.0 110.202 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -91.47 -9.19 45.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.104 -0.998 . . . . 1.0 110.286 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.492 2.429 0 N-CA-C 109.549 -1.42 . . . . 1.0 109.549 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' WAY . . . . . 0.418 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.6 m . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.549 -0.537 . . . . 1.0 109.549 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.2 mt -67.19 140.11 57.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.91 . . . . 1.0 109.233 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -160.6 160.4 31.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 1.0 109.016 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -72.25 151.67 42.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.101 -0.999 . . . . 1.0 109.214 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 82.8 p -86.51 1.92 49.82 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.243 -0.91 . . . . 1.0 110.487 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -149.63 154.59 38.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.082 -1.011 . . . . 1.0 109.342 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.504 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.02 0.96 56.83 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.219 -0.925 . . . . 1.0 109.88 -179.529 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -95.85 127.69 42.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.107 -0.996 . . . . 1.0 108.687 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.6 mt -141.36 151.0 43.18 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.154 -0.966 . . . . 1.0 109.256 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.3 p -132.11 155.58 47.87 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.439 -0.788 . . . . 1.0 109.088 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -144.02 159.98 41.66 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.163 -0.96 . . . . 1.0 109.934 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.535 ' NE ' ' O ' ' A' ' 56' ' ' GLY . 25.2 ttm-85 -145.87 136.09 23.83 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.533 -0.729 . . . . 1.0 109.906 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.405 HG21 HD11 ' A' ' 19' ' ' ILE . 87.4 mt -88.81 113.93 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 108.339 -0.985 . . . . 1.0 108.339 178.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.66 -40.27 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.104 -0.997 . . . . 1.0 109.094 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -161.9 160.98 28.6 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.856 -1.152 . . . . 1.0 110.473 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.557 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 62.8 m-85 -101.95 -168.05 1.49 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.607 -1.257 . . . . 1.0 107.607 179.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.22 149.02 50.83 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.165 -0.959 . . . . 1.0 110.131 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -70.63 -12.03 30.62 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 120.827 1.018 . . . . 1.0 110.148 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -59.62 -39.96 85.99 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 115.334 -0.848 . . . . 1.0 110.531 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.9 mtm -139.99 169.93 16.8 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.163 -0.96 . . . . 1.0 109.634 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 78.8 p -73.15 160.05 32.57 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.137 -0.977 . . . . 1.0 109.472 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.557 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 1.8 m80 -60.16 -39.79 87.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.52 -0.738 . . . . 1.0 110.344 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.1 m -59.97 -39.9 87.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.08 -1.012 . . . . 1.0 109.549 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -62.47 -46.57 87.88 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.099 -1.001 . . . . 1.0 110.31 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.2 t -66.32 -39.92 85.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.401 -0.812 . . . . 1.0 109.804 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -54.44 -57.08 12.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.276 -0.89 . . . . 1.0 111.221 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.8 pttt -62.32 -32.17 72.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.683 -1.261 . . . . 1.0 110.439 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.34 -49.95 70.9 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.887 -1.133 . . . . 1.0 109.687 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -65.17 -39.67 93.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.027 -1.046 . . . . 1.0 109.759 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.15 -40.22 89.12 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.062 -1.024 . . . . 1.0 109.485 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -60.06 -43.45 95.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.979 -1.076 . . . . 1.0 108.845 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.21 -47.33 84.91 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.471 -0.768 . . . . 1.0 110.39 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.429 ' CZ ' ' CZ ' ' A' ' 121' ' ' PHE . 43.0 m-85 -63.32 -40.25 96.79 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.816 -1.178 . . . . 1.0 109.767 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -60.01 -44.43 94.57 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.163 -0.961 . . . . 1.0 110.043 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.8 t -60.11 -41.88 88.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.292 -0.88 . . . . 1.0 110.26 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -79.68 -37.49 35.72 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.157 -0.964 . . . . 1.0 111.162 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.3 p -69.85 -17.58 63.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.889 -1.132 . . . . 1.0 109.664 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.77 -40.14 91.41 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.546 -0.721 . . . . 1.0 110.833 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.8 m -118.65 35.3 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.257 -0.902 . . . . 1.0 110.69 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.6 p -151.12 134.62 9.08 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 120.917 -1.114 . . . . 1.0 109.925 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -73.39 10.64 1.17 Allowed 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 120.809 1.006 . . . . 1.0 111.908 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.0 mt -68.93 136.85 53.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.001 -1.062 . . . . 1.0 110.02 -179.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -107.21 120.76 42.99 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.501 -0.926 . . . . 1.0 108.501 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -108.25 124.57 50.51 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.309 -0.869 . . . . 1.0 109.599 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -120.37 130.02 54.21 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.56 -0.712 . . . . 1.0 110.088 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -81.37 130.03 34.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.235 -0.916 . . . . 1.0 109.288 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.521 ' C ' HH12 ' A' ' 18' ' ' ARG . 85.1 mt -106.04 139.94 39.8 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.391 -0.818 . . . . 1.0 108.942 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.444 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 41.3 m170 -95.33 -14.35 23.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.254 -0.904 . . . . 1.0 109.704 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 77.2 m-20 -149.66 160.28 43.64 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.309 -0.869 . . . . 1.0 109.865 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.535 ' O ' ' NE ' ' A' ' 18' ' ' ARG . . . 88.12 179.6 47.06 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.751 -1.34 . . . . 1.0 109.751 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.6 mt -97.36 139.77 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.322 -1.105 . . . . 1.0 109.514 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.04 155.75 22.3 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.478 -0.763 . . . . 1.0 109.16 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -59.92 -49.83 76.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.113 -0.992 . . . . 1.0 109.257 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.7 mt -103.91 99.85 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.405 -0.809 . . . . 1.0 109.786 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.5 ptp -99.8 138.94 36.18 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.161 -0.962 . . . . 1.0 109.166 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.2 mt -110.19 132.15 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.999 -0.741 . . . . 1.0 108.999 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 71.5 p -149.3 149.91 31.68 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.896 -1.127 . . . . 1.0 109.879 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -101.98 123.45 45.91 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.727 -0.842 . . . . 1.0 108.727 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.73 -165.96 22.51 Favored Glycine 0 N--CA 1.499 2.838 0 N-CA-C 110.107 -1.197 . . . . 1.0 110.107 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.471 ' O ' ' C ' ' A' ' 67' ' ' LYS . 71.8 mt -133.17 166.47 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.671 -0.899 . . . . 1.0 108.822 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' A' ' 66' ' ' ILE . 19.9 tptm -28.8 -82.47 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 CA-C-O 120.999 0.428 . . . . 1.0 111.539 -179.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -76.64 128.87 35.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.927 -1.108 . . . . 1.0 110.125 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.611 ' CE1' ' CE2' ' A' ' 75' ' ' PHE . 51.5 p-80 -160.0 169.19 23.96 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.291 -0.88 . . . . 1.0 108.96 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -57.51 94.66 0.04 OUTLIER Glycine 0 N--CA 1.492 2.378 0 C-N-CA 120.031 -1.08 . . . . 1.0 110.44 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.484 ' OD1' ' CD1' ' A' ' 73' ' ' TYR . 55.9 t0 -171.38 140.29 1.41 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.239 -1.154 . . . . 1.0 109.304 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.513 ' CZ ' ' CD1' ' A' ' 73' ' ' TYR . 54.0 p90 -70.44 -19.98 62.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.037 -1.039 . . . . 1.0 109.71 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.559 ' O ' ' CG ' ' A' ' 73' ' ' TYR . 8.0 p90 -129.91 76.82 77.69 Favored Pre-proline 0 N--CA 1.501 2.117 0 O-C-N 121.408 -0.808 . . . . 1.0 109.142 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -53.67 -170.02 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 120.957 1.105 . . . . 1.0 112.56 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.611 ' CE2' ' CE1' ' A' ' 69' ' ' HIS . 89.2 m-85 -87.17 168.09 13.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 1.0 108.609 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -105.18 20.01 19.61 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.319 -0.863 . . . . 1.0 110.811 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 112.37 -156.71 15.41 Favored Glycine 0 N--CA 1.504 3.222 0 N-CA-C 109.149 -1.58 . . . . 1.0 109.149 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -57.41 -68.25 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.49 0 CA-C-N 118.657 1.228 . . . . 1.0 112.423 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 84.9 p -76.36 162.86 27.53 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.326 -0.859 . . . . 1.0 109.982 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.78 -129.16 8.37 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 109.734 -1.346 . . . . 1.0 109.734 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.0 mt -69.12 107.71 3.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.44 -1.035 . . . . 1.0 109.123 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 60.1 mt -78.92 -22.4 45.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.894 -1.129 . . . . 1.0 109.016 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -177.49 173.03 1.73 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.755 -0.831 . . . . 1.0 108.755 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.571 ' CE1' ' ND1' ' A' ' 97' ' ' HIS . 19.8 p80 -161.56 162.2 30.11 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.047 -1.033 . . . . 1.0 109.652 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.4 155.13 40.85 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.745 -0.835 . . . . 1.0 108.745 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -93.44 151.67 40.4 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.176 -0.952 . . . . 1.0 108.559 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.491 ' O ' ' N ' ' A' ' 89' ' ' GLY . 2.8 Cg_exo -50.0 169.38 0.14 Allowed 'Trans proline' 0 N--CA 1.488 1.176 0 CA-C-N 119.189 0.746 . . . . 1.0 111.295 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.69 75.37 0.06 OUTLIER 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 120.661 0.908 . . . . 1.0 111.849 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -93.01 -174.0 40.85 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.241 -1.544 . . . . 1.0 109.241 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 89' ' ' GLY . 14.3 Cg_exo -54.91 -144.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 121.452 1.435 . . . . 1.0 113.089 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -60.02 -39.88 87.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.478 -0.764 . . . . 1.0 109.551 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -68.35 -39.7 81.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.274 -0.891 . . . . 1.0 109.947 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -68.07 169.87 38.49 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.567 -1.013 . . . . 1.0 110.567 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.73 6.75 87.19 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.346 -1.501 . . . . 1.0 109.346 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -80.19 170.01 17.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.215 -1.167 . . . . 1.0 109.895 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.08 122.75 10.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.267 -0.896 . . . . 1.0 109.428 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.571 ' ND1' ' CE1' ' A' ' 84' ' ' HIS . 46.1 m170 -105.31 136.36 44.99 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.652 -0.655 . . . . 1.0 109.853 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -120.23 145.0 47.44 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.896 -0.779 . . . . 1.0 108.896 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.551 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 82.9 m-20 -78.56 121.75 25.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.034 -1.041 . . . . 1.0 109.856 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.402 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 37.8 t0 -85.63 -7.36 58.88 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.905 -0.776 . . . . 1.0 108.905 179.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -82.39 -12.56 57.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.432 -0.793 . . . . 1.0 109.197 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -91.1 170.56 9.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.378 -0.826 . . . . 1.0 109.291 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.9 m -101.29 105.37 16.45 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.382 -0.824 . . . . 1.0 109.097 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -88.41 123.77 33.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.342 -0.849 . . . . 1.0 109.057 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.1 t -140.52 157.67 45.14 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.331 -0.856 . . . . 1.0 110.198 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 53.4 m -96.1 -9.18 31.4 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.181 -1.044 . . . . 1.0 108.181 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 72.4 m -92.35 171.58 8.96 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.58 -0.896 . . . . 1.0 108.58 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.6 t -72.09 76.19 0.95 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.07 -1.018 . . . . 1.0 109.928 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -149.53 150.29 32.06 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.204 -0.935 . . . . 1.0 108.982 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.07 -137.46 4.91 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.702 -1.359 . . . . 1.0 109.702 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -102.68 117.57 34.95 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.436 -1.038 . . . . 1.0 109.405 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.569 HD21 ' NZ ' ' A' ' 146' ' ' LYS . 55.3 t-20 -64.2 130.09 42.52 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.22 -0.925 . . . . 1.0 109.583 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.2 tp -60.13 -40.56 90.19 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.41 -0.806 . . . . 1.0 110.94 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -58.71 -40.13 82.79 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.793 -1.192 . . . . 1.0 110.346 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -58.68 -59.92 4.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.944 -1.097 . . . . 1.0 109.749 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 86.9 t -62.99 -42.13 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.53 -0.732 . . . . 1.0 110.216 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.69 -49.99 75.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.119 -0.988 . . . . 1.0 109.403 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.99 -39.69 86.59 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.918 -1.114 . . . . 1.0 109.803 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.507 ' CD2' ' HB1' ' A' ' 169' ' ' WAY . 68.4 t60 -65.08 -48.55 73.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.347 -0.846 . . . . 1.0 111.946 -178.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.506 ' OE2' ' CD1' ' A' ' 121' ' ' PHE . 1.1 pp20? -59.13 -40.05 84.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.535 -1.353 . . . . 1.0 109.281 -178.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.506 ' CD1' ' OE2' ' A' ' 120' ' ' GLU . 28.4 m-85 -60.04 -39.87 87.42 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.857 -1.152 . . . . 1.0 109.175 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.76 -45.36 85.81 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.843 -1.303 . . . . 1.0 109.843 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -64.89 -40.06 94.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.004 -1.292 . . . . 1.0 109.645 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 82.2 p -63.78 -23.48 67.38 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.251 -0.906 . . . . 1.0 109.421 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.6 mt -84.16 -1.09 54.42 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.046 -1.034 . . . . 1.0 109.876 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.48 10.83 63.18 Favored Glycine 0 N--CA 1.496 2.698 0 C-N-CA 120.025 -1.084 . . . . 1.0 110.747 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 77.9 mt -84.65 144.0 28.87 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.888 -1.36 . . . . 1.0 109.944 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 11.6 t70 -99.15 170.1 8.93 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.302 -0.874 . . . . 1.0 109.029 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.493 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 65.7 m80 -60.0 137.35 58.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.153 -0.967 . . . . 1.0 110.154 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 28.6 t -100.62 154.15 18.82 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -97.98 5.72 48.5 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.096 -1.003 . . . . 1.0 109.911 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -86.98 129.48 51.93 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.066 -1.021 . . . . 1.0 108.66 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -66.4 -24.0 50.38 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 CA-C-N 120.188 1.103 . . . . 1.0 112.406 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -86.15 -5.09 83.47 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.012 -1.235 . . . . 1.0 110.012 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.59 144.48 27.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.933 -1.334 . . . . 1.0 108.731 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.475 ' C ' ' H ' ' A' ' 138' ' ' PHE . 88.4 mt -68.99 -33.22 73.33 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.307 -0.871 . . . . 1.0 109.181 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 96.3 mmm -71.58 19.87 0.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.462 -0.774 . . . . 1.0 110.771 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.475 ' H ' ' C ' ' A' ' 136' ' ' LEU . 12.0 t80 -69.16 132.34 90.1 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 120.826 -1.171 . . . . 1.0 108.532 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -64.53 -3.65 6.92 Favored 'Trans proline' 0 N--CA 1.501 1.926 0 CA-C-N 119.888 0.996 . . . . 1.0 113.936 -178.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.0 mt -118.67 141.11 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 O-C-N 121.012 -1.055 . . . . 1.0 109.104 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.497 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 38.3 t80 -74.73 130.63 39.82 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.489 -0.757 . . . . 1.0 110.252 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.8 t -140.63 142.48 35.0 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.431 -0.951 . . . . 1.0 108.431 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -79.8 144.17 33.77 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.918 -1.114 . . . . 1.0 110.074 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.4 m -130.42 140.03 50.58 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.04 -0.726 . . . . 1.0 109.04 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.41 113.92 3.98 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 107.655 -2.178 . . . . 1.0 107.655 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.569 ' NZ ' HD21 ' A' ' 112' ' ' ASN . 33.0 mmtm -73.25 98.77 2.72 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.063 -1.257 . . . . 1.0 109.297 -178.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.462 ' HG ' ' C ' ' A' ' 146' ' ' LYS . 6.9 m -159.72 104.75 1.58 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.301 -0.875 . . . . 1.0 108.846 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 72.9 m80 50.1 40.57 21.97 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.408 -0.807 . . . . 1.0 109.399 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -85.19 129.96 34.7 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.16 -0.963 . . . . 1.0 109.393 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 66.9 mtt -124.28 149.06 46.93 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.981 -0.748 . . . . 1.0 108.981 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 29.1 mt -51.84 131.54 38.42 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.099 -1.001 . . . . 1.0 108.408 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -66.14 174.41 6.0 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 CA-C-N 119.992 1.033 . . . . 1.0 112.32 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -60.08 -39.65 86.81 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.429 -0.794 . . . . 1.0 110.152 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -57.16 -49.67 75.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.135 -0.978 . . . . 1.0 109.809 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.01 -40.19 75.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.088 -1.008 . . . . 1.0 110.516 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 67.5 t -60.74 -45.72 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.949 -1.094 . . . . 1.0 108.989 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -60.17 -39.92 88.13 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.137 -0.977 . . . . 1.0 110.398 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -69.54 -52.45 21.09 Favored Glycine 0 N--CA 1.494 2.546 0 O-C-N 121.145 -0.972 . . . . 1.0 111.504 -178.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.3 tp -62.25 -40.01 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.754 -1.439 . . . . 1.0 109.661 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.8 mt-30 -65.01 -38.99 92.74 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.246 -0.909 . . . . 1.0 109.628 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 79.5 p -69.26 -22.25 63.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.174 -0.953 . . . . 1.0 110.174 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 88.8 mt -88.24 -50.68 6.2 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.888 -1.132 . . . . 1.0 110.065 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -93.53 -9.32 38.67 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.034 -1.041 . . . . 1.0 109.67 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.509 0 N-CA-C 109.473 -1.451 . . . . 1.0 109.473 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' WAY . . . . . 0.507 ' HB1' ' CD2' ' A' ' 119' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.8 m . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.237 0.542 . . . . 1.0 109.614 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.4 mt -76.55 138.36 40.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.252 -0.905 . . . . 1.0 109.582 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.544 ' CB ' ' NZ ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -161.41 159.82 28.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.149 -0.969 . . . . 1.0 109.56 179.502 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -76.23 152.6 36.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 1.0 109.407 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 99.0 p -87.51 0.03 56.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.361 -0.837 . . . . 1.0 109.809 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -148.57 154.59 39.96 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.154 -0.966 . . . . 1.0 109.686 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.567 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.49 -0.03 57.5 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.377 -0.827 . . . . 1.0 110.222 -179.577 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -96.6 122.38 39.46 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.181 -0.949 . . . . 1.0 108.863 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 71.8 mt -138.85 149.08 44.49 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.471 -0.768 . . . . 1.0 108.98 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.3 p -131.67 160.01 36.68 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.703 -0.851 . . . . 1.0 108.703 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -142.89 161.19 38.77 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.13 -0.981 . . . . 1.0 110.435 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -142.63 129.75 20.85 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.137 -0.69 . . . . 1.0 109.137 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.7 mt -88.13 118.25 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.182 -0.949 . . . . 1.0 108.908 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.67 -39.53 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.218 -0.926 . . . . 1.0 109.505 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.46 ' OD1' ' N ' ' A' ' 21' ' ' ASN . 21.4 p-10 -162.47 155.5 19.94 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.212 -1.555 . . . . 1.0 111.366 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.482 ' O ' ' O ' ' A' ' 23' ' ' THR . 19.3 m-85 -104.96 75.73 1.2 Allowed 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 106.358 -1.719 . . . . 1.0 106.358 176.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.482 ' O ' ' O ' ' A' ' 22' ' ' TYR . 3.0 t -23.45 144.71 0.02 OUTLIER Pre-proline 0 N--CA 1.512 2.636 0 C-N-CA 122.83 0.452 . . . . 1.0 111.744 -177.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -63.94 -4.74 7.92 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 121.631 1.554 . . . . 1.0 112.915 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -59.09 -36.84 75.82 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.442 -0.786 . . . . 1.0 109.557 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 76.8 mtm -138.47 164.17 30.08 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.298 -0.876 . . . . 1.0 109.582 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.416 ' HG1' ' H ' ' A' ' 30' ' ' GLU . 76.0 p -70.58 160.03 33.25 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.378 -0.826 . . . . 1.0 109.154 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.452 ' CD2' ' HB2' ' A' ' 22' ' ' TYR . 26.2 m170 -60.03 -42.45 94.4 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.291 -0.881 . . . . 1.0 110.206 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.2 m -60.41 -40.6 91.58 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.166 -0.959 . . . . 1.0 110.735 -179.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.416 ' H ' ' HG1' ' A' ' 27' ' ' THR . 47.1 mt-10 -65.78 -41.04 92.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.973 -1.079 . . . . 1.0 110.144 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 69.5 t -66.6 -40.0 85.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 121.422 -0.799 . . . . 1.0 109.978 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -59.78 -52.54 65.03 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.404 -0.81 . . . . 1.0 112.144 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.2 pttt -65.13 -32.63 74.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.558 -1.339 . . . . 1.0 110.277 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.57 -51.31 70.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.941 -1.1 . . . . 1.0 110.181 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -65.87 -37.39 86.03 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.825 -1.172 . . . . 1.0 110.099 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -59.99 -40.55 89.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.942 -1.098 . . . . 1.0 109.67 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -61.55 -40.31 94.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.067 -1.021 . . . . 1.0 109.529 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.08 -46.12 90.64 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.422 -0.799 . . . . 1.0 110.44 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -68.07 -39.67 82.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.01 -1.056 . . . . 1.0 109.86 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.408 ' O ' ' CG ' ' A' ' 44' ' ' ASP . 49.9 tptt -60.02 -47.17 86.94 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.186 -0.946 . . . . 1.0 109.878 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.2 t -60.08 -42.07 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.145 -0.972 . . . . 1.0 110.846 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.412 ' O ' ' OG1' ' A' ' 46' ' ' THR . 76.9 m95 -79.31 -35.36 41.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.85 -1.156 . . . . 1.0 110.148 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 38.8 p -71.5 -16.26 62.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.098 -1.001 . . . . 1.0 109.62 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.408 ' CG ' ' O ' ' A' ' 40' ' ' LYS . 96.0 m-20 -59.98 -39.59 86.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.339 -0.851 . . . . 1.0 110.314 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.4 m -112.18 -21.85 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.306 -0.871 . . . . 1.0 110.65 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' A' ' 42' ' ' TRP . 69.6 p -93.78 133.05 28.49 Favored Pre-proline 0 N--CA 1.501 2.109 0 O-C-N 120.759 -1.213 . . . . 1.0 109.611 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -75.43 15.95 0.77 Allowed 'Trans proline' 0 N--CA 1.496 1.622 0 CA-C-N 120.204 1.109 . . . . 1.0 112.039 178.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 78.8 mt -68.31 140.02 55.93 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.195 -0.941 . . . . 1.0 109.912 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -108.19 121.73 45.46 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 108.993 -0.743 . . . . 1.0 108.993 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -108.95 124.52 50.81 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.249 -0.907 . . . . 1.0 109.958 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.0 m -119.96 129.95 54.55 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.418 0.628 . . . . 1.0 109.306 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -83.82 137.9 33.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.307 -0.871 . . . . 1.0 110.042 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 77.3 mt -102.79 129.29 49.4 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.703 -0.851 . . . . 1.0 108.703 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.448 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 61.0 m170 -61.67 -40.04 93.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.914 . . . . 1.0 109.428 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 75.0 m-20 -151.0 168.02 25.85 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.379 -0.825 . . . . 1.0 109.249 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.03 -178.64 29.57 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.543 -1.423 . . . . 1.0 109.543 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.0 mt -96.3 132.82 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.353 -1.087 . . . . 1.0 109.76 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.96 164.71 12.34 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.367 -0.833 . . . . 1.0 109.071 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.04 -49.48 77.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.189 -0.944 . . . . 1.0 109.527 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 95.2 mt -107.28 101.85 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.51 -0.743 . . . . 1.0 109.691 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.2 ptp -100.21 135.97 40.82 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.248 -0.908 . . . . 1.0 109.469 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.411 HD11 HG22 ' A' ' 62' ' ' ILE . 85.4 mt -110.0 133.92 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.726 -0.609 . . . . 1.0 109.945 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.2 p -152.47 155.18 37.0 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.017 -1.052 . . . . 1.0 110.274 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -102.68 121.86 43.28 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.499 -0.926 . . . . 1.0 108.499 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.78 -173.45 22.86 Favored Glycine 0 N--CA 1.499 2.894 0 N-CA-C 110.761 -0.935 . . . . 1.0 110.761 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.501 ' CG2' ' H ' ' A' ' 67' ' ' LYS . 96.7 mt -136.38 175.53 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 107.755 -1.202 . . . . 1.0 107.755 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.521 ' NZ ' ' O ' ' A' ' 75' ' ' PHE . 50.8 tptt -28.94 -89.22 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.818 -0.551 . . . . 1.0 110.75 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -76.79 127.99 33.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.934 -1.104 . . . . 1.0 109.464 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.467 ' CE1' ' OD2' ' A' ' 71' ' ' ASP . 32.0 p-80 -145.19 24.67 1.43 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.921 -1.112 . . . . 1.0 109.737 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.03 50.26 3.75 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 110.139 -1.185 . . . . 1.0 110.139 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.467 ' OD2' ' CE1' ' A' ' 69' ' ' HIS . 21.8 p-10 -148.18 161.34 41.66 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.145 -1.209 . . . . 1.0 109.262 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -91.25 -2.37 57.46 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.145 -0.972 . . . . 1.0 110.235 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.535 ' CD2' ' O ' ' A' ' 73' ' ' TYR . 10.7 p90 -134.33 72.27 70.99 Favored Pre-proline 0 N--CA 1.5 2.073 0 O-C-N 121.318 -0.864 . . . . 1.0 109.189 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -57.45 -171.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.036 1.157 . . . . 1.0 112.504 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.561 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 94.4 m-85 -91.1 171.74 9.04 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.29 -0.881 . . . . 1.0 109.106 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 79' ' ' SER . 23.2 p-10 -99.72 18.61 17.7 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.132 -0.98 . . . . 1.0 110.61 -178.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 110.21 -151.87 17.4 Favored Glycine 0 N--CA 1.503 3.16 0 N-CA-C 109.337 -1.505 . . . . 1.0 109.337 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.439 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 6.3 Cg_exo -62.16 -63.67 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.563 0 CA-C-N 118.919 1.359 . . . . 1.0 112.408 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.434 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 95.9 p -77.36 162.77 27.0 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.934 -1.104 . . . . 1.0 109.882 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.68 -130.05 9.01 Favored Glycine 0 N--CA 1.502 3.081 0 N-CA-C 110.341 -1.104 . . . . 1.0 110.341 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.429 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 8.9 mt -68.54 108.32 3.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.607 -0.937 . . . . 1.0 108.589 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 74.4 mt -80.67 -17.98 49.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.969 -1.082 . . . . 1.0 109.818 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.64 174.13 1.23 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.427 -0.796 . . . . 1.0 109.194 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.424 ' CE1' ' ND1' ' A' ' 97' ' ' HIS . 11.5 p80 -161.99 159.35 26.36 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.357 -0.84 . . . . 1.0 109.236 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.22 154.6 40.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.154 -0.966 . . . . 1.0 109.368 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -92.15 152.11 42.32 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.096 -1.002 . . . . 1.0 108.418 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.442 ' O ' ' N ' ' A' ' 89' ' ' GLY . 5.3 Cg_exo -50.01 171.08 0.1 OUTLIER 'Trans proline' 0 N--CA 1.49 1.265 0 CA-C-N 119.139 0.728 . . . . 1.0 111.191 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -63.59 75.88 0.14 Allowed 'Trans proline' 0 C--N 1.315 -1.21 0 CA-C-O 121.932 0.722 . . . . 1.0 111.402 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -88.97 -172.36 46.21 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.837 -1.705 . . . . 1.0 108.837 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 89' ' ' GLY . 14.0 Cg_exo -56.06 -152.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.031 1.154 . . . . 1.0 111.91 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -61.06 -40.28 93.07 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.144 -0.973 . . . . 1.0 109.311 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -60.65 -45.5 93.85 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.22 -0.925 . . . . 1.0 109.272 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -69.11 177.5 28.29 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.537 -1.025 . . . . 1.0 110.537 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.46 13.56 83.41 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.603 -1.399 . . . . 1.0 109.603 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.2 p-10 -80.83 173.81 12.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.109 -1.23 . . . . 1.0 109.856 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.0 120.48 7.42 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.434 -0.792 . . . . 1.0 109.02 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.424 ' ND1' ' CE1' ' A' ' 84' ' ' HIS . 48.7 m170 -105.61 139.51 40.1 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.561 -0.712 . . . . 1.0 110.265 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.528 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 29.2 m-85 -120.78 140.97 50.95 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.733 -0.84 . . . . 1.0 108.733 179.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.561 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 93.9 m-20 -78.92 122.94 26.75 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.834 -1.166 . . . . 1.0 109.65 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.401 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 34.4 t0 -84.39 1.61 44.42 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.281 -0.887 . . . . 1.0 109.722 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -80.74 -17.95 49.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.124 -0.985 . . . . 1.0 109.57 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.534 ' N ' ' OE1' ' A' ' 102' ' ' GLU . 56.9 mp0 -91.27 172.13 8.75 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.315 -0.865 . . . . 1.0 109.012 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 15.5 m -100.93 107.02 18.41 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.292 -1.003 . . . . 1.0 108.292 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -85.2 127.29 34.23 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.533 -0.914 . . . . 1.0 108.533 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.9 t -141.8 153.63 44.67 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.343 -0.848 . . . . 1.0 109.979 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 96.6 p -91.88 -5.66 52.88 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.911 -1.144 . . . . 1.0 107.911 178.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 65.2 m -93.1 -176.94 4.32 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.899 -0.778 . . . . 1.0 108.899 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.8 t -85.08 75.51 10.35 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.017 -1.052 . . . . 1.0 109.454 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -148.67 152.82 37.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.321 -0.862 . . . . 1.0 108.889 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 43.37 -138.72 3.54 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 110.169 -1.172 . . . . 1.0 110.169 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -99.99 117.4 34.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.35 -1.088 . . . . 1.0 109.277 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.577 ' ND2' ' HZ1' ' A' ' 146' ' ' LYS . 17.2 t-20 -64.24 132.6 50.76 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.105 -0.997 . . . . 1.0 109.426 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.3 tp -59.97 -44.1 94.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 1.0 110.309 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -59.98 -40.9 90.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.167 -0.958 . . . . 1.0 111.585 -178.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -59.38 -49.98 75.71 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.443 -1.41 . . . . 1.0 109.415 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 66.0 t -69.97 -40.01 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.136 -0.977 . . . . 1.0 110.047 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.21 -52.8 63.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.089 -1.007 . . . . 1.0 109.807 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.0 -39.54 86.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.824 . . . . 1.0 110.695 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -61.94 -50.03 73.77 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.047 -1.033 . . . . 1.0 111.387 -178.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.528 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 8.2 pt-20 -60.04 -38.57 83.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.608 -1.308 . . . . 1.0 110.113 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -60.03 -40.03 87.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.82 -1.175 . . . . 1.0 108.588 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.79 -43.18 94.74 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.449 -1.46 . . . . 1.0 109.449 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -65.62 -40.01 92.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.05 -1.265 . . . . 1.0 109.291 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 93.3 p -67.19 -25.39 66.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.179 -0.951 . . . . 1.0 109.438 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 83.2 mt -82.53 -3.0 55.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.22 -0.925 . . . . 1.0 109.791 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 96.94 7.53 57.45 Favored Glycine 0 N--CA 1.5 2.906 0 O-C-N 121.101 -1.0 . . . . 1.0 111.108 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.3 mt -85.25 148.0 26.29 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.698 -1.472 . . . . 1.0 109.693 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 39.7 t0 -102.75 171.49 7.39 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.993 -0.743 . . . . 1.0 108.993 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.488 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 76.9 m80 -59.22 136.26 57.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.012 -1.055 . . . . 1.0 109.106 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.451 ' HG ' ' N ' ' A' ' 131' ' ' LYS . 40.3 t -97.38 155.28 16.98 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.237 -0.915 . . . . 1.0 109.541 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.451 ' N ' ' HG ' ' A' ' 130' ' ' SER . 92.7 mttt -98.61 1.3 46.24 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.351 -0.843 . . . . 1.0 109.75 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -85.4 130.18 52.53 Favored Pre-proline 0 N--CA 1.495 1.79 0 N-CA-C 107.843 -1.169 . . . . 1.0 107.843 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -67.44 -26.18 41.01 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 CA-C-N 120.212 1.111 . . . . 1.0 113.285 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -85.92 -2.75 86.09 Favored Glycine 0 N--CA 1.497 2.709 0 C-N-CA 119.799 -1.191 . . . . 1.0 110.342 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.63 144.42 27.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.047 -1.266 . . . . 1.0 109.146 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.451 ' C ' ' H ' ' A' ' 138' ' ' PHE . 91.5 mt -67.05 -33.46 75.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.177 -0.952 . . . . 1.0 109.813 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 94.8 mmm -69.17 9.61 0.41 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.164 -0.96 . . . . 1.0 110.2 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.451 ' H ' ' C ' ' A' ' 136' ' ' LEU . 13.2 t80 -67.43 135.9 93.18 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 107.738 -1.208 . . . . 1.0 107.738 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -65.13 -31.83 53.79 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 CA-C-N 119.898 0.999 . . . . 1.0 113.818 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 90.6 mt -83.42 140.41 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.481 -1.387 . . . . 1.0 110.119 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -76.07 128.92 36.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.491 -0.756 . . . . 1.0 109.591 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 10.2 t -140.16 142.41 35.95 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.221 -0.924 . . . . 1.0 109.55 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -82.5 144.93 30.08 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.359 -0.838 . . . . 1.0 109.643 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.8 t -140.79 156.09 46.24 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.259 -0.9 . . . . 1.0 110.076 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.0 110.36 3.17 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.92 -1.672 . . . . 1.0 108.92 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.577 ' HZ1' ' ND2' ' A' ' 112' ' ' ASN . 57.7 mttp -78.63 -3.38 43.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.328 -1.101 . . . . 1.0 109.708 -179.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.0 t -60.04 -41.14 91.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.234 -0.916 . . . . 1.0 110.635 -178.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -143.01 28.89 1.52 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.939 -1.101 . . . . 1.0 110.513 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -68.32 135.65 52.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.754 -1.216 . . . . 1.0 109.071 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 98.7 mtp -138.39 148.2 44.23 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.502 -0.925 . . . . 1.0 108.502 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 88.0 mt -50.83 121.25 14.76 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 120.959 -1.088 . . . . 1.0 108.682 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -66.57 178.55 2.61 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 CA-C-N 120.275 1.134 . . . . 1.0 112.153 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.16 -39.97 88.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.474 -0.766 . . . . 1.0 109.669 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -56.94 -49.2 76.38 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.238 -0.914 . . . . 1.0 109.678 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.68 -40.01 73.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.961 -1.087 . . . . 1.0 110.299 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 72.9 t -62.15 -46.67 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.915 -1.116 . . . . 1.0 109.159 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -60.28 -40.05 89.02 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 1.0 110.212 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.13 -53.77 8.8 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 120.219 -0.991 . . . . 1.0 111.436 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.414 ' CG2' ' N ' ' A' ' 160' ' ' GLN . 9.9 tp -60.45 -40.31 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.74 -1.447 . . . . 1.0 109.971 -178.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.536 ' O ' ' N ' ' A' ' 164' ' ' GLY . 25.8 mm100 -65.68 -39.6 91.49 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.323 -0.861 . . . . 1.0 109.352 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 79.2 p -63.46 -25.82 68.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.197 -0.94 . . . . 1.0 110.14 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 84.5 mt -86.95 -52.56 5.39 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.959 -1.088 . . . . 1.0 110.456 -179.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -92.7 -9.01 42.31 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.035 -1.041 . . . . 1.0 110.135 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.522 0 N-CA-C 109.502 -1.439 . . . . 1.0 109.502 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' WAY . . . . . 0.86 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.9 m . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.284 0.564 . . . . 1.0 109.494 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.1 mt -95.57 125.13 39.95 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.219 -0.926 . . . . 1.0 109.575 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.9 pttt -161.96 160.05 27.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 1.0 109.85 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -73.56 147.25 44.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.403 -0.81 . . . . 1.0 109.411 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 99.4 p -89.33 3.1 53.26 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.192 -0.942 . . . . 1.0 110.091 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -143.21 153.61 43.0 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.118 -0.989 . . . . 1.0 109.435 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.1 mmt -90.17 -0.1 57.44 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.399 -0.813 . . . . 1.0 110.219 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -97.27 127.98 43.72 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.111 -0.993 . . . . 1.0 109.632 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.7 mt -142.28 148.65 38.4 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.101 -1.0 . . . . 1.0 109.123 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.4 p -135.28 158.57 44.03 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -145.1 160.99 40.54 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.038 -1.039 . . . . 1.0 110.615 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.477 ' HG2' HH11 ' A' ' 18' ' ' ARG . 0.5 OUTLIER -141.81 131.14 23.59 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 -179.141 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.7 mt -88.14 115.24 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.127 -0.983 . . . . 1.0 108.694 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.08 -41.7 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.122 -0.986 . . . . 1.0 109.537 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.499 HD22 ' H ' ' A' ' 64' ' ' PHE . 1.8 p30 -164.36 160.94 21.36 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.271 -1.518 . . . . 1.0 110.114 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.587 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 51.1 m-85 -102.06 -169.92 1.74 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.157 -1.053 . . . . 1.0 108.157 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.25 147.02 42.1 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.343 -0.848 . . . . 1.0 110.154 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -68.61 -14.42 39.47 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 120.876 1.05 . . . . 1.0 110.912 178.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -59.86 -39.59 85.74 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.601 -0.727 . . . . 1.0 110.186 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 74.3 mtm -137.23 165.26 26.54 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.283 -0.886 . . . . 1.0 109.425 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.7 p -72.51 159.63 33.62 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.289 -0.882 . . . . 1.0 109.406 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.628 ' N ' ' HD1' ' A' ' 28' ' ' HIS . 0.9 OUTLIER -60.16 -39.98 88.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.422 -0.799 . . . . 1.0 110.346 -179.25 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.1 m -59.91 -40.11 87.7 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.151 -0.968 . . . . 1.0 110.266 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -66.0 -40.0 90.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.126 -0.984 . . . . 1.0 110.087 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.6 t -68.8 -40.38 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.209 -0.932 . . . . 1.0 110.272 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.94 -49.91 75.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.031 -1.043 . . . . 1.0 110.197 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -61.7 -32.52 72.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.039 -1.038 . . . . 1.0 110.015 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.89 -48.51 81.4 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.888 -1.133 . . . . 1.0 110.007 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -66.89 -39.04 87.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.94 -1.1 . . . . 1.0 109.815 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -60.04 -42.5 94.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.111 -0.993 . . . . 1.0 109.516 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -60.14 -41.21 92.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.09 -1.006 . . . . 1.0 109.203 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.71 -45.3 94.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.503 -0.748 . . . . 1.0 110.224 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -65.64 -38.55 89.68 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.065 -1.022 . . . . 1.0 109.95 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -59.59 -48.82 80.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.102 -0.999 . . . . 1.0 109.782 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 76.1 t -60.0 -40.36 82.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.163 -0.961 . . . . 1.0 110.556 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.413 ' O ' ' OG1' ' A' ' 46' ' ' THR . 82.6 m95 -81.18 -36.54 30.03 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.842 -1.161 . . . . 1.0 109.823 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.6 p -70.22 -17.08 63.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.179 -0.951 . . . . 1.0 109.666 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -60.03 -40.04 87.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.938 . . . . 1.0 110.3 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -112.16 -17.61 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.338 -0.851 . . . . 1.0 110.782 -179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.414 ' C ' ' H ' ' A' ' 48' ' ' LEU . 67.9 p -94.93 125.5 50.63 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 120.744 -1.223 . . . . 1.0 109.48 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -72.37 16.14 0.39 Allowed 'Trans proline' 0 N--CA 1.495 1.578 0 CA-C-N 120.177 1.099 . . . . 1.0 111.8 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.414 ' H ' ' C ' ' A' ' 46' ' ' THR . 66.3 mt -69.17 140.01 54.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.297 -0.877 . . . . 1.0 109.934 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -106.32 120.56 42.19 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.79 -0.819 . . . . 1.0 108.79 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -106.75 127.22 53.2 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.273 -0.892 . . . . 1.0 109.42 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.9 m -119.99 129.69 54.4 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -84.04 132.57 34.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.517 -0.739 . . . . 1.0 109.116 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.9 mt -105.4 131.7 52.51 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.175 -0.953 . . . . 1.0 109.171 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.44 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 43.0 m170 -61.02 -40.01 91.94 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.146 -0.971 . . . . 1.0 109.284 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 71.9 m-20 -151.95 180.0 7.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.365 -0.834 . . . . 1.0 109.624 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.67 178.71 39.43 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.364 -1.494 . . . . 1.0 109.364 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.5 mt -96.9 130.28 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.284 -1.127 . . . . 1.0 109.673 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.54 162.67 14.48 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.581 -0.699 . . . . 1.0 109.163 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -59.92 -49.83 76.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.187 -0.945 . . . . 1.0 109.499 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.405 HD11 HG23 ' A' ' 60' ' ' ILE . 94.8 mt -104.81 101.24 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.412 -0.805 . . . . 1.0 109.898 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.2 ptp -100.93 132.13 46.48 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.319 -0.863 . . . . 1.0 109.161 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.6 mt -102.5 138.09 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.454 -0.779 . . . . 1.0 109.724 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 81.4 p -151.34 160.02 43.99 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.312 -0.867 . . . . 1.0 109.716 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.499 ' H ' HD22 ' A' ' 21' ' ' ASN . 86.1 m-85 -109.61 125.87 53.02 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.516 -0.74 . . . . 1.0 109.515 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -101.78 -178.26 28.15 Favored Glycine 0 N--CA 1.5 2.921 0 N-CA-C 110.839 -0.904 . . . . 1.0 110.839 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.494 ' CG2' ' N ' ' A' ' 67' ' ' LYS . 61.5 mt -136.82 163.72 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.613 -0.933 . . . . 1.0 109.721 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.494 ' N ' ' CG2' ' A' ' 66' ' ' ILE . 46.8 tptt -11.33 -76.37 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.314 0 N-CA-C 113.332 0.864 . . . . 1.0 113.332 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.412 ' O ' ' C ' ' A' ' 69' ' ' HIS . 12.1 pt-20 -59.88 -49.98 75.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.057 -1.027 . . . . 1.0 110.834 -177.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.565 ' O ' ' N ' ' A' ' 71' ' ' ASP . 42.3 t-80 45.1 51.37 8.99 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.81 -1.181 . . . . 1.0 109.677 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 69' ' ' HIS . . . -28.6 84.32 0.0 OUTLIER Glycine 0 N--CA 1.505 3.266 0 CA-C-O 121.292 0.385 . . . . 1.0 112.188 -178.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 69' ' ' HIS . 64.7 m-20 -160.72 176.99 10.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.521 -0.987 . . . . 1.0 109.449 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -70.03 137.34 51.23 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.271 -0.893 . . . . 1.0 109.107 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 8.3 t80 44.73 69.47 2.49 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 121.283 -0.886 . . . . 1.0 109.777 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -66.6 -158.3 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.104 1.203 . . . . 1.0 112.503 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.536 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 67.8 m-85 -85.33 157.77 20.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.514 -0.741 . . . . 1.0 109.48 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.6 p-10 -101.0 0.29 37.87 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.454 -0.779 . . . . 1.0 109.994 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 135.19 -155.29 22.01 Favored Glycine 0 N--CA 1.501 2.976 0 N-CA-C 108.707 -1.757 . . . . 1.0 108.707 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.425 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 12.3 Cg_exo -59.41 -68.2 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.39 0 CA-C-N 118.843 1.322 . . . . 1.0 111.776 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 88.1 p -76.0 160.69 29.59 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.311 -0.868 . . . . 1.0 109.203 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.75 -131.09 8.95 Favored Glycine 0 N--CA 1.501 3.031 0 N-CA-C 109.369 -1.493 . . . . 1.0 109.369 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.425 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 24.1 mt -69.81 111.81 5.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.069 -1.254 . . . . 1.0 109.06 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 30.8 mt -82.17 -13.8 56.6 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.237 -0.915 . . . . 1.0 108.625 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 179.39 169.43 1.05 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.999 -0.741 . . . . 1.0 108.999 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.424 ' CD2' ' ND1' ' A' ' 97' ' ' HIS . 3.4 p-80 -162.54 160.88 26.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.077 -1.015 . . . . 1.0 109.572 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -147.48 164.53 33.09 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.193 -0.942 . . . . 1.0 109.577 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -100.8 152.81 37.94 Favored Pre-proline 0 N--CA 1.498 1.966 0 N-CA-C 108.713 -0.847 . . . . 1.0 108.713 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.472 ' O ' ' N ' ' A' ' 89' ' ' GLY . 1.0 OUTLIER -56.42 169.07 1.78 Allowed 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 120.582 0.855 . . . . 1.0 111.774 179.876 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -62.7 71.77 0.12 Allowed 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 120.745 0.963 . . . . 1.0 111.608 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -78.39 177.24 53.79 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.334 -1.506 . . . . 1.0 109.334 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -48.05 -75.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 120.991 1.127 . . . . 1.0 112.121 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -121.04 -49.66 2.18 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.419 -0.801 . . . . 1.0 109.766 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -60.29 -39.99 88.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.316 -0.865 . . . . 1.0 110.225 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.06 170.44 25.35 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.839 -1.304 . . . . 1.0 109.839 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 80.11 4.26 89.7 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.616 -1.394 . . . . 1.0 109.616 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -80.64 170.17 16.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.113 -1.227 . . . . 1.0 109.508 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.87 139.2 23.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.232 -0.917 . . . . 1.0 109.38 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.424 ' ND1' ' CD2' ' A' ' 84' ' ' HIS . 18.0 m170 -130.13 157.71 41.68 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.56 -0.713 . . . . 1.0 109.884 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -136.72 153.81 50.76 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.011 -0.737 . . . . 1.0 109.011 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.536 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 0.6 OUTLIER -79.99 122.09 26.29 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.062 -1.024 . . . . 1.0 109.495 179.842 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -85.28 -11.62 54.32 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.095 -1.003 . . . . 1.0 109.347 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -81.33 -10.68 59.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.873 . . . . 1.0 109.47 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 98.3 mt-10 -90.81 169.98 10.49 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.311 -0.868 . . . . 1.0 109.466 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 22.3 m -98.43 106.23 18.48 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.103 -0.998 . . . . 1.0 109.728 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.427 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 93.5 m95 -89.82 127.48 35.99 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.704 -0.85 . . . . 1.0 108.704 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.2 t -143.19 155.65 44.58 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.237 -0.915 . . . . 1.0 109.583 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 60.0 p -94.82 -5.7 44.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.111 -0.993 . . . . 1.0 108.431 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 70.3 m -93.48 179.17 5.47 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.955 -0.757 . . . . 1.0 108.955 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.416 ' OG ' ' CZ ' ' A' ' 143' ' ' TYR . 19.6 m -81.04 77.02 7.98 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.008 -1.058 . . . . 1.0 108.988 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -149.06 150.19 32.35 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.739 -0.838 . . . . 1.0 108.739 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.21 -138.77 4.48 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.203 -1.159 . . . . 1.0 110.203 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -99.5 116.68 32.21 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.303 -1.116 . . . . 1.0 109.487 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.66 131.42 47.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.156 -0.965 . . . . 1.0 109.246 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.7 tp -59.86 -41.66 91.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 1.0 110.12 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -59.98 -43.0 95.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.133 -0.979 . . . . 1.0 111.106 -178.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -59.38 -50.17 74.98 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.661 -1.274 . . . . 1.0 109.319 -178.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 95.7 t -70.54 -42.2 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.059 -1.025 . . . . 1.0 109.974 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.13 -50.66 73.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.004 -1.06 . . . . 1.0 110.12 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.09 -36.44 77.4 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.581 -1.325 . . . . 1.0 109.577 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.418 ' CD2' ' H15' ' A' ' 169' ' ' WAY . 72.3 t60 -65.5 -48.71 71.65 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.29 -0.881 . . . . 1.0 111.353 -178.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.67 -39.95 82.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.642 -1.286 . . . . 1.0 109.419 -178.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -60.04 -39.99 87.82 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.945 -1.097 . . . . 1.0 109.077 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.4 -46.51 80.07 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.795 -1.322 . . . . 1.0 109.795 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -65.37 -39.93 92.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.135 -1.215 . . . . 1.0 109.3 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.8 p -64.64 -23.61 67.31 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.291 -0.88 . . . . 1.0 108.998 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 50.6 mt -82.49 -4.97 58.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 1.0 109.59 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 95.27 5.83 60.36 Favored Glycine 0 N--CA 1.499 2.869 0 O-C-N 121.154 -0.966 . . . . 1.0 111.075 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.2 mt -84.21 150.27 25.58 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.811 -1.405 . . . . 1.0 109.94 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 11.0 t70 -103.16 173.19 6.42 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.558 -0.714 . . . . 1.0 109.477 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.483 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 69.2 m80 -59.97 136.35 57.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.132 -0.98 . . . . 1.0 109.221 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 47.7 t -99.45 156.02 17.25 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.324 -0.86 . . . . 1.0 109.516 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -98.72 2.37 47.0 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.165 -0.959 . . . . 1.0 109.358 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -85.66 128.46 58.75 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 120.955 -1.091 . . . . 1.0 108.409 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -68.44 -17.04 43.95 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 CA-C-N 120.14 1.086 . . . . 1.0 112.094 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -89.32 -7.48 69.65 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.091 -1.203 . . . . 1.0 110.091 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.09 144.99 26.18 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.159 -1.201 . . . . 1.0 109.125 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.516 ' C ' ' H ' ' A' ' 138' ' ' PHE . 96.2 mt -69.71 -31.51 69.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.035 -1.04 . . . . 1.0 109.599 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 94.1 mmm -70.88 19.82 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.178 -0.951 . . . . 1.0 110.372 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.516 ' H ' ' C ' ' A' ' 136' ' ' LEU . 13.5 t80 -69.2 131.86 90.28 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.104 -0.997 . . . . 1.0 108.367 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -62.95 -2.22 3.45 Favored 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 120.831 1.021 . . . . 1.0 114.149 -178.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.426 HD11 HG23 ' A' ' 140' ' ' ILE . 97.0 mt -120.43 136.77 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 O-C-N 120.987 -1.071 . . . . 1.0 109.944 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -71.97 127.73 33.49 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.278 -0.889 . . . . 1.0 110.437 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.7 t -139.83 133.61 30.57 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.436 -0.79 . . . . 1.0 109.346 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.416 ' CZ ' ' OG ' ' A' ' 108' ' ' SER . 79.0 t80 -82.16 144.89 30.41 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.065 -1.022 . . . . 1.0 108.749 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 2.5 t -141.86 159.98 41.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.101 -0.999 . . . . 1.0 109.473 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.27 105.66 1.7 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.928 -1.669 . . . . 1.0 108.928 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -78.06 9.8 3.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.342 -1.093 . . . . 1.0 109.37 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 59.2 m -59.91 -40.09 87.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.908 . . . . 1.0 109.826 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -150.25 29.92 0.7 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.006 -1.059 . . . . 1.0 109.575 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -61.59 138.78 58.31 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.154 -0.966 . . . . 1.0 109.59 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 66.9 mtt -137.83 145.86 42.78 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.689 -0.856 . . . . 1.0 108.689 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 45.4 mt -52.31 129.32 41.92 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.043 -1.036 . . . . 1.0 108.883 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -70.19 175.74 8.05 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 CA-C-N 119.985 1.03 . . . . 1.0 112.33 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.44 -39.9 89.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.54 -0.725 . . . . 1.0 110.097 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -56.73 -47.55 79.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.081 -1.012 . . . . 1.0 109.593 -179.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -70.33 -39.98 74.42 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.101 -1.0 . . . . 1.0 110.121 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 74.2 t -60.81 -47.74 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.028 -1.045 . . . . 1.0 109.098 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -60.26 -39.93 88.53 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.136 -0.977 . . . . 1.0 110.389 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.75 -54.55 7.24 Favored Glycine 0 N--CA 1.495 2.577 0 O-C-N 121.029 -1.044 . . . . 1.0 111.276 -178.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 7.1 tp -60.1 -40.02 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.996 -1.297 . . . . 1.0 109.672 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.554 ' O ' ' N ' ' A' ' 164' ' ' GLY . 26.4 mt-30 -65.51 -39.56 91.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.106 -0.996 . . . . 1.0 109.492 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.459 ' HG ' ' N ' ' A' ' 162' ' ' LEU . 83.3 p -60.61 -32.0 71.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.214 -0.929 . . . . 1.0 110.688 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.459 ' N ' ' HG ' ' A' ' 161' ' ' SER . 97.4 mt -85.13 -49.97 7.81 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.772 -1.205 . . . . 1.0 110.606 -178.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -91.39 -8.92 46.6 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.023 -1.048 . . . . 1.0 110.173 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.492 2.41 0 N-CA-C 109.563 -1.415 . . . . 1.0 109.563 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' WAY . . . . . 0.893 ' HC2' ' HJ ' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.402 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 26.6 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.479 -0.563 . . . . 1.0 109.479 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.6 mt -92.38 135.1 34.31 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.283 -0.886 . . . . 1.0 109.357 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.543 ' CB ' ' HZ3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -159.96 162.17 34.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.898 . . . . 1.0 109.547 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -73.05 150.45 42.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.196 -0.94 . . . . 1.0 109.666 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.0 t -80.21 -2.63 45.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.332 -0.855 . . . . 1.0 109.749 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -145.88 152.38 39.38 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.235 -0.915 . . . . 1.0 109.284 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.1 mmt -89.99 -0.68 57.71 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.211 -0.931 . . . . 1.0 109.771 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -96.9 131.17 43.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.205 -0.934 . . . . 1.0 109.059 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.8 mt -139.97 149.94 43.87 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.204 -0.935 . . . . 1.0 109.173 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 54.6 p -131.36 155.35 47.4 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.573 -0.899 . . . . 1.0 108.573 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -146.15 159.59 43.1 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.04 -1.038 . . . . 1.0 110.067 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.404 ' HG2' HH11 ' A' ' 18' ' ' ARG . 36.9 ttt-85 -145.26 133.98 22.24 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.48 -0.763 . . . . 1.0 109.296 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.9 mt -86.59 119.63 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 1.0 108.915 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 69.7 t -69.62 -41.11 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.353 -0.842 . . . . 1.0 109.207 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -164.56 157.87 17.51 Favored 'General case' 0 C--N 1.286 -2.175 0 O-C-N 119.686 -1.884 . . . . 1.0 110.819 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -100.41 113.0 25.41 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 106.475 -1.676 . . . . 1.0 106.475 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.458 ' C ' ' H ' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -56.87 136.54 79.25 Favored Pre-proline 0 C--N 1.299 -1.588 0 C-N-CA 119.103 -1.039 . . . . 1.0 109.199 -177.938 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -57.48 -7.87 3.4 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 CA-C-N 119.606 0.895 . . . . 1.0 110.31 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' A' ' 23' ' ' THR . 68.2 m-20 -58.27 -31.55 67.55 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 120.036 -0.666 . . . . 1.0 109.656 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 78.0 mtm -142.55 163.25 33.35 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.228 -0.92 . . . . 1.0 109.895 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 42.3 p -72.56 161.23 31.05 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.454 -0.778 . . . . 1.0 109.648 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -61.22 -40.06 92.58 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.274 -0.891 . . . . 1.0 110.045 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.3 m -61.1 -42.52 98.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.997 -1.065 . . . . 1.0 110.545 -179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.0 -40.03 87.25 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.077 -1.014 . . . . 1.0 110.297 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 79.7 t -68.12 -43.35 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.122 -0.986 . . . . 1.0 110.555 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.04 -49.31 78.18 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.044 -1.035 . . . . 1.0 110.676 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -61.87 -33.81 74.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.946 -1.097 . . . . 1.0 110.176 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.02 -49.74 76.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.833 -1.167 . . . . 1.0 110.31 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -67.2 -39.94 86.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.915 -1.116 . . . . 1.0 110.449 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -60.02 -40.54 89.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.873 -1.142 . . . . 1.0 109.793 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -60.09 -40.73 90.61 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.918 -1.114 . . . . 1.0 108.763 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.94 -46.99 87.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.49 -0.756 . . . . 1.0 110.254 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -66.57 -39.04 88.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.032 -1.043 . . . . 1.0 109.98 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -60.03 -46.62 88.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.08 -1.012 . . . . 1.0 109.882 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 67.8 t -60.01 -41.46 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.148 -0.97 . . . . 1.0 110.36 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -79.39 -36.8 38.62 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.875 -1.14 . . . . 1.0 110.587 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.1 p -70.0 -18.86 63.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.024 -1.047 . . . . 1.0 109.995 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.04 -39.96 87.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.166 -0.959 . . . . 1.0 110.549 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.4 m -117.96 33.84 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.276 -0.89 . . . . 1.0 110.756 -178.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.7 p -151.4 134.48 8.91 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 120.769 -1.207 . . . . 1.0 109.604 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -73.5 13.14 0.75 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 CA-C-N 119.677 0.92 . . . . 1.0 112.004 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 79.9 mt -68.36 139.78 55.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.061 -1.024 . . . . 1.0 109.865 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -110.5 120.98 44.18 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.83 -0.804 . . . . 1.0 108.83 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -106.28 125.27 50.79 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.334 -0.854 . . . . 1.0 109.509 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.1 m -119.92 129.97 54.59 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.648 -0.658 . . . . 1.0 109.929 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -83.29 130.25 35.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.366 -0.834 . . . . 1.0 109.149 179.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 98.4 mt -101.33 123.21 45.06 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.246 -0.909 . . . . 1.0 109.199 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.439 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 48.8 m170 -60.85 -40.0 91.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.313 -0.867 . . . . 1.0 109.792 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 83.0 m-20 -146.67 169.99 17.89 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.21 -0.931 . . . . 1.0 109.827 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.04 179.1 35.93 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.451 -1.46 . . . . 1.0 109.451 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.5 mt -95.8 134.6 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.234 -1.156 . . . . 1.0 109.377 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.52 159.79 17.21 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.429 -0.794 . . . . 1.0 109.337 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.02 -49.11 78.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.156 -0.965 . . . . 1.0 109.436 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.6 mt -104.84 99.18 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.387 -0.821 . . . . 1.0 109.939 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.1 ptp -100.16 132.83 45.3 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.141 -0.975 . . . . 1.0 109.047 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.5 mt -110.03 130.48 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.588 -0.695 . . . . 1.0 109.534 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.3 p -151.2 158.53 44.06 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.128 -0.983 . . . . 1.0 110.245 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -102.84 127.64 49.94 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.212 -1.033 . . . . 1.0 108.212 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -117.73 -166.83 14.04 Favored Glycine 0 N--CA 1.499 2.863 0 N-CA-C 110.018 -1.233 . . . . 1.0 110.018 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.512 ' O ' ' ND1' ' A' ' 69' ' ' HIS . 83.0 mt -134.3 167.14 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.669 -0.901 . . . . 1.0 108.702 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.493 ' N ' ' CG2' ' A' ' 66' ' ' ILE . 61.7 tttm -35.52 -77.48 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.806 -0.559 . . . . 1.0 111.188 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -70.02 73.52 0.45 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.969 -1.082 . . . . 1.0 110.283 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.512 ' ND1' ' O ' ' A' ' 66' ' ' ILE . 51.8 m80 -59.97 -40.0 87.57 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.201 -0.937 . . . . 1.0 108.997 178.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 139.93 20.01 0.39 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 108.352 -1.899 . . . . 1.0 108.352 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -140.81 168.47 19.71 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.646 -0.914 . . . . 1.0 108.835 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.428 ' O ' ' C ' ' A' ' 73' ' ' TYR . 91.9 m-85 -60.02 -50.23 74.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.049 -1.032 . . . . 1.0 110.56 -179.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.428 ' C ' ' O ' ' A' ' 72' ' ' PHE . 76.0 m-85 -35.31 95.73 0.09 OUTLIER Pre-proline 0 N--CA 1.507 2.394 0 O-C-N 121.934 -0.479 . . . . 1.0 110.814 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -92.16 145.57 2.88 Favored 'Trans proline' 0 N--CA 1.488 1.178 0 C-N-CA 120.99 1.127 . . . . 1.0 112.706 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.475 ' CE2' ' OD1' ' A' ' 99' ' ' ASP . 37.4 m-85 -88.75 169.36 11.71 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.94 -1.133 . . . . 1.0 107.94 178.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 79' ' ' SER . 24.2 p-10 -103.27 13.34 34.08 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.054 -1.029 . . . . 1.0 110.569 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 108.89 -151.54 17.09 Favored Glycine 0 N--CA 1.503 3.103 0 N-CA-C 109.223 -1.551 . . . . 1.0 109.223 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.404 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 13.6 Cg_exo -58.58 -64.13 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.552 0 CA-C-N 118.892 1.346 . . . . 1.0 112.737 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.447 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 79.2 p -75.04 159.83 31.25 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.976 -1.078 . . . . 1.0 109.828 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.97 -129.8 8.83 Favored Glycine 0 N--CA 1.502 3.068 0 N-CA-C 109.992 -1.243 . . . . 1.0 109.992 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.441 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 23.0 mt -66.17 104.38 1.16 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.358 -1.084 . . . . 1.0 108.889 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 33.8 mt -80.04 -15.73 56.57 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.991 -1.068 . . . . 1.0 108.727 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 179.61 170.8 1.05 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.07 -0.715 . . . . 1.0 109.07 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -160.03 153.46 22.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.184 -0.947 . . . . 1.0 109.423 178.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -142.2 158.58 43.58 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.409 -0.807 . . . . 1.0 109.297 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -96.18 153.32 39.1 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 108.287 -1.005 . . . . 1.0 108.287 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.454 ' O ' ' N ' ' A' ' 89' ' ' GLY . 2.9 Cg_exo -49.38 170.02 0.1 OUTLIER 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 120.529 0.819 . . . . 1.0 111.549 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -64.98 58.92 0.29 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.021 1.147 . . . . 1.0 112.08 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -66.75 -172.4 5.06 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.269 -1.532 . . . . 1.0 109.269 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -72.82 -92.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.169 1.246 . . . . 1.0 112.938 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -85.05 -53.61 5.17 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.991 -1.068 . . . . 1.0 111.362 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -68.96 -40.01 79.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.091 -1.006 . . . . 1.0 110.154 -178.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -55.72 169.31 2.43 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.019 -1.232 . . . . 1.0 110.019 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.43 5.76 78.55 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.656 -1.378 . . . . 1.0 109.656 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.7 p-10 -79.03 162.64 25.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.047 -1.267 . . . . 1.0 109.542 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.24 124.43 11.49 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.229 -0.919 . . . . 1.0 109.468 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -111.84 146.35 37.83 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.486 0.66 . . . . 1.0 109.963 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -126.64 148.98 49.76 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.343 -0.984 . . . . 1.0 108.343 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.475 ' OD1' ' CE2' ' A' ' 75' ' ' PHE . 87.8 m-20 -78.57 123.52 27.18 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.862 -1.149 . . . . 1.0 109.367 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -83.08 -9.38 59.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.893 . . . . 1.0 109.257 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -83.08 -13.5 55.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.335 -0.853 . . . . 1.0 108.897 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.404 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 99.1 mt-10 -89.09 166.19 14.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.508 -0.745 . . . . 1.0 109.168 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.7 m -99.12 105.82 17.95 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.225 -0.922 . . . . 1.0 109.342 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -88.04 124.11 33.42 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.557 -0.905 . . . . 1.0 108.557 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.0 t -140.2 160.03 40.87 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.232 -0.917 . . . . 1.0 110.115 -178.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 32.2 t -96.63 -10.02 28.0 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.415 -0.958 . . . . 1.0 108.415 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.3 t -91.06 -176.34 4.58 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.681 -0.859 . . . . 1.0 108.681 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.4 t -85.59 77.81 9.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.995 -1.066 . . . . 1.0 109.373 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -148.44 149.93 32.59 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.372 -0.973 . . . . 1.0 108.372 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.13 -139.71 5.08 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.764 -1.335 . . . . 1.0 109.764 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -101.01 115.58 30.83 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.451 -1.029 . . . . 1.0 108.923 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.444 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 17.4 t-20 -62.69 134.52 56.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.115 -0.99 . . . . 1.0 109.945 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.7 tp -60.03 -46.19 90.34 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.513 -0.742 . . . . 1.0 110.867 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -59.51 -40.04 85.78 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.261 -0.899 . . . . 1.0 110.743 -178.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -58.41 -51.09 71.31 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.686 -1.259 . . . . 1.0 109.337 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 64.6 t -70.04 -40.77 78.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.097 -1.002 . . . . 1.0 110.235 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.93 -49.42 76.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.172 -0.955 . . . . 1.0 109.738 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.97 -39.68 86.5 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.197 -0.939 . . . . 1.0 110.366 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -63.52 -49.85 71.9 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.14 -0.975 . . . . 1.0 111.416 -178.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -60.03 -38.81 83.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.602 -1.311 . . . . 1.0 110.276 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -60.06 -39.95 87.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.698 -1.251 . . . . 1.0 108.493 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.23 -40.27 91.44 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.571 -1.411 . . . . 1.0 109.571 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -66.53 -39.99 88.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.037 -1.272 . . . . 1.0 109.132 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 84.3 p -66.38 -24.44 66.49 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.278 -0.889 . . . . 1.0 109.566 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 92.9 mt -81.78 -1.69 48.15 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.152 -0.967 . . . . 1.0 109.607 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 89.69 9.64 66.14 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 110.645 -0.982 . . . . 1.0 110.645 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 82.6 mt -84.82 147.13 26.98 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.924 -1.339 . . . . 1.0 109.302 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 41.3 t0 -102.2 172.9 6.63 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.462 -0.774 . . . . 1.0 109.49 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.505 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 61.3 m80 -59.05 136.93 58.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.878 . . . . 1.0 109.612 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 47.3 t -98.57 157.01 16.51 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.369 -0.832 . . . . 1.0 109.293 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -99.71 0.01 40.97 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.383 -0.823 . . . . 1.0 109.582 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 9.6 t70 -85.46 129.45 55.2 Favored Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 108.225 -1.028 . . . . 1.0 108.225 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -68.47 -21.07 40.9 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 CA-C-N 120.126 1.081 . . . . 1.0 112.004 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.459 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -87.5 -4.61 80.0 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.443 -1.463 . . . . 1.0 109.443 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.09 145.71 26.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.241 -1.152 . . . . 1.0 109.496 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.495 ' C ' ' H ' ' A' ' 138' ' ' PHE . 84.5 mt -69.95 -34.9 74.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.249 -0.907 . . . . 1.0 109.493 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 96.8 mmm -70.98 18.84 0.06 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.341 -0.85 . . . . 1.0 110.533 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.495 ' H ' ' C ' ' A' ' 136' ' ' LEU . 11.9 t80 -68.73 133.29 90.53 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.902 -1.124 . . . . 1.0 108.096 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -63.43 -13.15 34.43 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 120.782 0.988 . . . . 1.0 113.843 -178.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.7 mt -108.36 139.96 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.036 -1.04 . . . . 1.0 109.884 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.444 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 56.0 t80 -73.63 129.37 37.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.511 -0.743 . . . . 1.0 110.127 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.6 t -138.49 140.12 39.06 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.589 -0.893 . . . . 1.0 108.589 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -79.88 130.0 34.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.036 -1.04 . . . . 1.0 109.537 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 20.6 m -115.81 125.51 52.81 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.705 -0.622 . . . . 1.0 109.639 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.9 100.06 0.22 Allowed Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.068 -2.013 . . . . 1.0 108.068 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.445 ' O ' ' OG ' ' A' ' 147' ' ' SER . 8.3 mtpm? -70.14 138.24 51.73 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.292 -1.122 . . . . 1.0 109.955 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 146' ' ' LYS . 3.1 m 176.26 -81.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.51 -0.922 . . . . 1.0 108.51 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -112.93 19.87 16.91 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -61.16 137.48 58.23 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 1.0 110.492 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 96.6 mmm -137.53 146.99 44.81 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.336 -0.986 . . . . 1.0 108.336 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.9 mt -47.84 111.38 1.7 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.183 -0.948 . . . . 1.0 109.377 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -54.9 178.24 0.09 OUTLIER 'Trans proline' 0 N--CA 1.494 1.516 0 CA-C-N 120.051 1.054 . . . . 1.0 112.379 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -60.39 -39.96 89.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.4 -0.813 . . . . 1.0 110.065 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -57.27 -47.87 80.34 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.142 -0.974 . . . . 1.0 109.597 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.04 -39.98 75.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.237 -0.914 . . . . 1.0 110.231 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 55.9 t -63.41 -46.95 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.989 -1.07 . . . . 1.0 109.261 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -60.01 -40.04 87.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.16 -0.962 . . . . 1.0 110.208 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -68.8 -56.63 9.05 Favored Glycine 0 N--CA 1.493 2.463 0 O-C-N 121.142 -0.974 . . . . 1.0 111.131 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.4 tp -61.27 -40.02 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.941 -1.329 . . . . 1.0 109.711 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 164' ' ' GLY . 93.1 mm-40 -64.99 -39.94 94.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 1.0 109.613 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 87.5 p -65.25 -26.76 68.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.185 -0.947 . . . . 1.0 110.051 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.402 ' CD2' ' N ' ' A' ' 7' ' ' THR . 89.5 mt -88.38 -50.59 6.23 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.993 -1.067 . . . . 1.0 110.263 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -94.47 -9.53 35.2 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.027 -1.046 . . . . 1.0 110.422 -179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.496 2.678 0 N-CA-C 109.509 -1.437 . . . . 1.0 109.509 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' WAY . . . . . 0.754 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.501 ' H ' ' CD2' ' A' ' 162' ' ' LEU . 18.3 m . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.481 -0.562 . . . . 1.0 109.481 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.6 mt -70.15 139.41 52.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 1.0 109.212 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -160.77 159.99 30.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.342 -0.849 . . . . 1.0 109.476 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -71.29 148.77 46.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.007 -1.058 . . . . 1.0 109.278 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.9 t -81.93 0.87 37.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.905 . . . . 1.0 109.766 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -149.97 155.68 40.39 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.017 -1.052 . . . . 1.0 110.054 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.544 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.93 0.01 57.62 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.405 -0.809 . . . . 1.0 109.731 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -95.89 126.95 41.49 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.234 -0.916 . . . . 1.0 108.696 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.8 mt -140.48 151.35 44.76 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.276 -0.89 . . . . 1.0 109.377 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.9 p -130.42 152.1 50.19 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.825 -0.806 . . . . 1.0 108.825 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -145.4 160.04 42.15 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.116 -0.99 . . . . 1.0 109.911 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.722 HH12 ' H ' ' A' ' 58' ' ' ALA . 13.9 ttp-105 -143.4 137.6 28.78 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.294 -0.879 . . . . 1.0 109.793 -179.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 92.0 mt -88.53 119.08 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.219 -0.925 . . . . 1.0 108.837 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.0 t -69.92 -39.98 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 1.0 109.722 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.616 HD22 ' H ' ' A' ' 64' ' ' PHE . 9.7 p30 -163.0 150.99 13.67 Favored 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 117.243 -1.783 . . . . 1.0 111.744 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -99.79 105.13 16.88 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 104.313 -2.477 . . . . 1.0 104.313 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.1 t -58.32 145.74 73.79 Favored Pre-proline 0 C--N 1.294 -1.807 0 O-C-N 121.027 -1.046 . . . . 1.0 110.419 -176.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -60.86 -11.65 18.82 Favored 'Trans proline' 0 N--CA 1.488 1.16 0 C-N-CA 120.961 1.108 . . . . 1.0 111.57 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -56.7 -32.43 65.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.326 -0.859 . . . . 1.0 110.002 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.6 mtm -140.13 160.52 39.75 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.185 -0.947 . . . . 1.0 109.415 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 66.3 p -73.59 162.34 29.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.255 -0.903 . . . . 1.0 109.781 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 30.3 m170 -60.87 -41.75 96.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.213 -0.929 . . . . 1.0 109.98 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.6 m -60.44 -41.88 94.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.083 -1.011 . . . . 1.0 110.183 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.59 -40.03 80.64 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.187 -0.946 . . . . 1.0 110.277 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 69.3 t -68.73 -43.67 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.117 -0.989 . . . . 1.0 110.205 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -59.93 -48.6 81.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.127 -0.983 . . . . 1.0 110.754 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.412 ' HA ' ' HZ3' ' A' ' 36' ' ' LYS . 16.7 ptpt -62.01 -33.45 74.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.765 -1.209 . . . . 1.0 110.118 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.99 -50.84 72.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.919 -1.113 . . . . 1.0 110.215 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -69.15 -39.78 78.61 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.85 -1.156 . . . . 1.0 110.609 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.485 ' CB ' ' HZ2' ' A' ' 36' ' ' LYS . 9.6 mtmp? -59.93 -41.85 92.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.913 -1.117 . . . . 1.0 109.715 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -60.6 -40.04 90.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.79 -1.194 . . . . 1.0 108.725 178.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.99 -44.06 94.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -0.871 . . . . 1.0 110.059 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -65.58 -40.15 92.43 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.867 -1.146 . . . . 1.0 109.106 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.4 ' O ' ' CG ' ' A' ' 44' ' ' ASP . 48.1 tptt -60.12 -49.65 76.8 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.496 -0.752 . . . . 1.0 110.718 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.8 t -60.18 -43.03 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 120.799 -1.188 . . . . 1.0 110.487 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -76.98 -36.83 56.15 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.801 -1.187 . . . . 1.0 109.996 -178.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.1 p -71.0 -20.73 62.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.058 -1.026 . . . . 1.0 109.882 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.4 ' CG ' ' O ' ' A' ' 40' ' ' LYS . 81.7 m-20 -59.95 -40.12 87.93 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.354 -0.841 . . . . 1.0 110.6 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.446 ' O ' ' NE2' ' A' ' 160' ' ' GLN . 12.5 m -110.04 24.13 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 121.187 -0.945 . . . . 1.0 110.73 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.4 p -150.15 134.09 9.02 Favored Pre-proline 0 N--CA 1.501 2.094 0 O-C-N 120.973 -1.079 . . . . 1.0 109.588 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -74.49 21.91 0.4 Allowed 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 120.794 0.996 . . . . 1.0 112.166 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 79.6 mt -69.74 138.71 53.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.132 -0.98 . . . . 1.0 109.954 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -106.86 120.78 42.95 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -109.9 125.59 52.98 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.44 -0.787 . . . . 1.0 109.547 -179.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 93.8 m -120.05 130.1 54.54 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.641 -0.662 . . . . 1.0 109.735 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.407 ' NH1' ' HG3' ' A' ' 52' ' ' ARG . 39.0 ttm-85 -81.32 130.27 34.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.368 -0.832 . . . . 1.0 109.226 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.1 mt -102.38 126.92 49.55 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.189 -0.944 . . . . 1.0 109.37 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.447 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 43.6 m170 -62.86 -40.12 96.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.368 -0.833 . . . . 1.0 109.666 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 78.7 m-20 -148.52 173.32 13.26 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.354 -0.841 . . . . 1.0 109.799 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.519 ' O ' ' NH1' ' A' ' 18' ' ' ARG . . . 95.85 178.51 36.36 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.411 -1.476 . . . . 1.0 109.411 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.5 mt -95.5 133.79 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.114 -1.227 . . . . 1.0 109.245 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.722 ' H ' HH12 ' A' ' 18' ' ' ARG . . . -110.15 159.04 17.7 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.401 -0.812 . . . . 1.0 109.232 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.06 -49.41 77.75 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.227 -0.921 . . . . 1.0 109.249 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.43 HD12 HG21 ' A' ' 60' ' ' ILE . 93.9 mt -106.4 102.13 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.428 -0.795 . . . . 1.0 109.83 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.8 ptp -101.87 134.27 45.32 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.213 -0.93 . . . . 1.0 109.102 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.5 mt -109.94 130.53 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 109.091 -0.707 . . . . 1.0 109.091 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.6 p -151.15 157.03 42.19 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.929 -1.107 . . . . 1.0 110.577 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.616 ' H ' HD22 ' A' ' 21' ' ' ASN . 90.8 m-85 -105.68 120.08 40.78 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.769 -1.197 . . . . 1.0 107.769 178.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -111.68 -171.06 18.88 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 110.739 -0.944 . . . . 1.0 110.739 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.566 ' O ' ' C ' ' A' ' 67' ' ' LYS . 96.6 mt -136.33 163.9 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 107.892 -1.151 . . . . 1.0 107.892 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.566 ' C ' ' O ' ' A' ' 66' ' ' ILE . 28.0 tptp -0.29 -91.95 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.874 0 CA-C-O 120.983 0.421 . . . . 1.0 111.757 -179.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -79.01 136.65 37.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.947 -1.096 . . . . 1.0 109.018 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.554 ' CE1' ' OD2' ' A' ' 71' ' ' ASP . 44.3 p-80 -138.48 29.56 2.41 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.995 -1.065 . . . . 1.0 110.543 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.77 22.51 18.07 Favored Glycine 0 N--CA 1.501 2.998 0 O-C-N 121.066 -1.021 . . . . 1.0 111.327 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.554 ' OD2' ' CE1' ' A' ' 69' ' ' HIS . 29.7 p-10 -149.44 173.96 13.0 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.695 -1.473 . . . . 1.0 110.13 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.612 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 2.1 p90 -98.18 29.69 3.43 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.458 -0.776 . . . . 1.0 109.657 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.612 ' CE2' ' CE2' ' A' ' 72' ' ' PHE . 52.0 m-85 -130.02 75.71 79.07 Favored Pre-proline 0 N--CA 1.499 2.018 0 N-CA-C 108.552 -0.907 . . . . 1.0 108.552 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -70.35 168.32 22.68 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 120.788 0.992 . . . . 1.0 112.485 -179.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.552 ' CE2' ' OD1' ' A' ' 99' ' ' ASP . 88.7 m-85 -90.85 172.7 8.43 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.239 -1.023 . . . . 1.0 108.239 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.0 p-10 -100.72 9.71 42.08 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.218 -0.926 . . . . 1.0 111.119 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 118.01 -149.68 18.4 Favored Glycine 0 N--CA 1.506 3.304 0 N-CA-C 109.012 -1.635 . . . . 1.0 109.012 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.439 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 9.6 Cg_exo -60.11 -65.72 0.07 OUTLIER 'Trans proline' 0 N--CA 1.492 1.395 0 CA-C-N 119.157 1.479 . . . . 1.0 112.392 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 90.0 p -76.54 164.74 25.66 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.966 -1.084 . . . . 1.0 110.079 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.38 -130.87 9.67 Favored Glycine 0 N--CA 1.502 3.057 0 N-CA-C 109.998 -1.241 . . . . 1.0 109.998 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.435 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 5.0 mt -68.62 105.43 2.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.509 -0.995 . . . . 1.0 108.624 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 82.1 mt -75.87 -32.6 59.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.091 -1.006 . . . . 1.0 109.535 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -176.44 161.95 2.27 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.929 -0.767 . . . . 1.0 108.929 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -160.24 162.41 33.71 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.154 -0.966 . . . . 1.0 110.084 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -139.65 157.97 44.9 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.168 -1.049 . . . . 1.0 108.168 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -90.92 152.23 44.22 Favored Pre-proline 0 N--CA 1.497 1.918 0 N-CA-C 108.186 -1.042 . . . . 1.0 108.186 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -54.97 167.95 1.4 Allowed 'Trans proline' 0 N--CA 1.492 1.401 0 CA-C-N 119.437 0.835 . . . . 1.0 111.44 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -49.7 123.76 11.13 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 120.558 0.839 . . . . 1.0 111.84 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 90' ' ' PRO . . . -159.19 -170.93 24.35 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.311 -1.516 . . . . 1.0 109.311 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 89' ' ' GLY . 8.1 Cg_exo -55.49 -148.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.001 1.134 . . . . 1.0 112.693 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -59.56 -39.96 85.75 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.586 -0.696 . . . . 1.0 109.697 -179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -66.48 -40.01 89.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.073 -1.017 . . . . 1.0 109.732 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.29 168.94 37.27 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.851 -1.3 . . . . 1.0 109.851 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 66.43 8.54 45.91 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.158 -1.177 . . . . 1.0 110.158 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 42.5 p-10 -81.4 169.03 17.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.998 -1.295 . . . . 1.0 109.78 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.31 116.4 6.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.088 -1.008 . . . . 1.0 109.13 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -105.54 130.52 53.58 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.515 -0.74 . . . . 1.0 109.824 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -112.59 142.6 44.98 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.522 -0.918 . . . . 1.0 108.522 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.552 ' OD1' ' CE2' ' A' ' 75' ' ' PHE . 94.1 m-20 -79.32 124.6 28.55 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.082 -1.011 . . . . 1.0 109.938 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 44.7 t0 -84.08 2.34 39.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.362 -0.836 . . . . 1.0 109.189 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -81.31 -16.06 53.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.345 -0.847 . . . . 1.0 109.952 -179.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.549 ' N ' ' OE1' ' A' ' 102' ' ' GLU . 58.1 mp0 -93.43 170.14 9.83 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.174 -0.954 . . . . 1.0 109.49 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 47.7 m -98.96 105.42 17.56 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.462 -0.94 . . . . 1.0 108.462 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -84.29 127.93 34.27 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.319 -0.863 . . . . 1.0 108.941 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.2 t -139.95 159.93 41.05 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.391 -0.818 . . . . 1.0 110.066 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.1 t -93.64 -10.46 34.46 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.923 -1.14 . . . . 1.0 107.923 178.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 81.7 p -92.13 179.08 5.68 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.577 -0.897 . . . . 1.0 108.577 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.3 t -85.34 75.95 10.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.94 -1.1 . . . . 1.0 109.564 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.0 mmmm -140.02 144.86 37.13 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 107.987 -1.116 . . . . 1.0 107.987 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 49.89 -129.97 27.15 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.119 -1.592 . . . . 1.0 109.119 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -104.97 115.44 30.28 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.318 -1.107 . . . . 1.0 109.309 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.694 HD22 ' NZ ' ' A' ' 146' ' ' LYS . 62.2 t-20 -65.3 131.77 47.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.905 . . . . 1.0 109.581 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.1 tp -59.96 -45.09 93.8 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.445 -0.784 . . . . 1.0 111.215 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -59.93 -40.02 87.46 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.046 -1.033 . . . . 1.0 110.69 -178.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -59.34 -52.68 64.59 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.849 -1.157 . . . . 1.0 109.835 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.4 t -69.93 -40.06 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.924 -1.11 . . . . 1.0 109.409 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.74 -52.3 65.52 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.138 -0.976 . . . . 1.0 108.839 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.78 -32.59 67.67 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 120.64 -1.288 . . . . 1.0 109.686 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -66.48 -55.82 13.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.031 -1.043 . . . . 1.0 111.666 -178.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.29 -31.88 70.67 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.487 -1.383 . . . . 1.0 110.131 -179.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -59.8 -41.52 91.41 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.752 -1.218 . . . . 1.0 108.396 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.0 -43.46 98.15 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.364 -1.494 . . . . 1.0 109.364 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -64.5 -39.86 94.57 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.047 -1.267 . . . . 1.0 109.248 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.0 p -67.82 -25.85 65.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.354 -0.841 . . . . 1.0 109.525 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 75.2 mt -81.57 -3.1 52.37 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.234 -0.916 . . . . 1.0 109.94 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.67 9.3 58.83 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 110.534 -1.027 . . . . 1.0 110.534 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.1 mt -85.88 144.59 27.59 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.917 -1.343 . . . . 1.0 109.559 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 28.6 t0 -101.63 173.41 6.44 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.97 -0.752 . . . . 1.0 108.97 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.501 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 75.7 m80 -60.01 134.61 57.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.203 -0.936 . . . . 1.0 109.236 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 47.6 t -96.77 160.24 14.48 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.023 -1.048 . . . . 1.0 109.376 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -99.67 2.17 44.15 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.353 -0.842 . . . . 1.0 109.655 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 9.6 t70 -85.18 129.48 55.67 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.901 . . . . 1.0 108.713 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -68.13 -25.48 37.38 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 CA-C-N 119.984 1.03 . . . . 1.0 112.389 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.437 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -84.9 -3.82 87.62 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.837 -1.305 . . . . 1.0 109.837 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.03 144.84 27.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.35 -1.088 . . . . 1.0 109.663 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.419 ' C ' ' H ' ' A' ' 138' ' ' PHE . 93.8 mt -70.03 -30.68 68.02 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.316 -0.865 . . . . 1.0 109.187 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 98.1 mmm -72.67 15.47 0.19 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.385 -0.822 . . . . 1.0 110.603 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.419 ' H ' ' C ' ' A' ' 136' ' ' LEU . 11.5 t80 -72.13 137.59 81.77 Favored Pre-proline 0 N--CA 1.5 2.061 0 O-C-N 121.02 -1.05 . . . . 1.0 108.421 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -61.8 -11.92 23.07 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 120.862 1.041 . . . . 1.0 114.29 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 95.9 mt -109.97 139.08 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.443 0 O-C-N 120.655 -1.278 . . . . 1.0 109.744 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.565 ' HH ' ' H ' ' A' ' 112' ' ' ASN . 33.6 t80 -73.55 129.87 38.88 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.582 -0.699 . . . . 1.0 110.08 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 15.2 t -140.1 143.33 36.2 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.482 -0.762 . . . . 1.0 109.139 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -81.21 149.44 29.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.957 -1.089 . . . . 1.0 109.532 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.9 t -140.23 155.5 46.87 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.906 -0.776 . . . . 1.0 108.906 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.45 111.43 3.57 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.465 -1.454 . . . . 1.0 109.465 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.694 ' NZ ' HD22 ' A' ' 112' ' ' ASN . 49.7 mtmt -76.78 -1.48 28.36 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.297 -1.119 . . . . 1.0 109.391 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.2 m -60.0 -40.13 88.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.372 -0.83 . . . . 1.0 109.762 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -160.36 67.48 0.35 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.238 -0.914 . . . . 1.0 109.336 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' A' ' 149' ' ' PHE . 39.0 t80 -99.16 125.04 44.63 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.333 -0.855 . . . . 1.0 109.36 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 75.2 mtm -120.24 141.3 50.07 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.843 -0.799 . . . . 1.0 108.843 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 49.0 mt -49.17 129.06 16.22 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.041 -1.037 . . . . 1.0 108.654 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -66.08 176.93 3.4 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 CA-C-N 119.944 1.016 . . . . 1.0 112.798 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.28 -39.78 88.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.623 -0.673 . . . . 1.0 109.588 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -58.06 -49.28 77.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.315 -0.866 . . . . 1.0 109.86 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -70.03 -40.01 75.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.014 -1.054 . . . . 1.0 109.774 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.3 t -60.1 -46.35 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.129 -0.982 . . . . 1.0 109.335 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -60.23 -39.99 88.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.904 -1.123 . . . . 1.0 110.131 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -68.63 -55.28 12.1 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.154 -1.022 . . . . 1.0 111.113 -178.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.409 ' CG2' ' N ' ' A' ' 160' ' ' GLN . 5.7 tp -61.93 -40.39 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.941 -1.329 . . . . 1.0 109.74 -179.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.446 ' NE2' ' O ' ' A' ' 45' ' ' VAL . 94.2 mm-40 -66.39 -39.93 89.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 1.0 109.648 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 91.9 p -70.17 -22.59 62.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 1.0 110.044 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.501 ' CD2' ' H ' ' A' ' 7' ' ' THR . 86.9 mt -88.1 -50.39 6.42 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.957 -1.089 . . . . 1.0 110.188 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -93.0 -9.78 38.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.96 -1.087 . . . . 1.0 109.697 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.524 0 N-CA-C 109.621 -1.392 . . . . 1.0 109.621 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' WAY . . . . . 0.458 ' HE3' ' CJ ' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.284 -0.636 . . . . 1.0 109.284 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.4 mt -81.92 144.58 30.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.287 -0.883 . . . . 1.0 109.346 179.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -160.92 163.03 32.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 1.0 109.242 179.72 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 62.7 m95 -72.42 145.35 47.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -0.923 . . . . 1.0 109.806 -179.435 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 61.1 m -88.84 4.24 48.4 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.33 -0.856 . . . . 1.0 110.235 -179.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.483 ' NZ ' ' O ' ' A' ' 14' ' ' ASN . 21.5 pttp -140.76 150.78 43.82 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.123 -0.986 . . . . 1.0 109.394 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.1 mmt -90.03 0.23 57.23 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.394 -0.816 . . . . 1.0 109.798 -179.043 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.483 ' O ' ' NZ ' ' A' ' 12' ' ' LYS . 33.2 m120 -94.89 128.59 41.78 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.2 -0.938 . . . . 1.0 109.349 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.7 mt -141.43 150.01 41.76 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.156 -0.965 . . . . 1.0 108.974 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.8 p -132.66 155.39 48.85 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.565 -0.71 . . . . 1.0 109.145 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -145.69 162.7 36.96 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.045 -1.034 . . . . 1.0 110.119 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.552 ' NE ' ' O ' ' A' ' 56' ' ' GLY . 36.8 ttm-85 -144.25 131.43 20.66 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.629 -0.669 . . . . 1.0 109.44 -179.378 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.5 mt -88.92 114.55 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.074 -1.016 . . . . 1.0 108.624 178.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.7 -40.55 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 1.0 109.906 -179.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.6 p-10 -165.56 154.46 11.89 Favored 'General case' 0 C--N 1.285 -2.2 0 O-C-N 119.675 -1.89 . . . . 1.0 111.168 -179.154 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -99.95 113.0 25.27 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 105.814 -1.921 . . . . 1.0 105.814 178.081 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.442 ' C ' ' H ' ' A' ' 25' ' ' ASP . 0.4 OUTLIER -56.45 137.79 75.94 Favored Pre-proline 0 C--N 1.297 -1.707 0 O-C-N 120.957 -1.09 . . . . 1.0 109.201 -177.805 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -56.76 -9.29 3.86 Favored 'Trans proline' 0 N--CA 1.483 0.872 0 CA-C-N 119.503 0.858 . . . . 1.0 110.352 179.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.442 ' H ' ' C ' ' A' ' 23' ' ' THR . 98.0 m-20 -57.1 -32.08 65.93 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 120.13 -0.628 . . . . 1.0 110.086 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.8 mtm -140.94 164.36 30.48 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.117 -0.99 . . . . 1.0 109.441 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 75.6 p -71.96 160.69 32.1 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.373 -0.829 . . . . 1.0 109.131 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 24.1 m170 -60.12 -42.34 94.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.173 -0.954 . . . . 1.0 110.2 -179.105 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.546 ' O ' ' NZ ' ' A' ' 33' ' ' LYS . 73.2 m -60.23 -43.18 96.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.103 -0.998 . . . . 1.0 111.006 -179.163 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.25 -40.89 96.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.083 -1.011 . . . . 1.0 110.802 -178.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 63.2 t -67.18 -40.21 84.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.101 -0.999 . . . . 1.0 109.746 -179.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -60.02 -50.13 74.94 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.261 -0.899 . . . . 1.0 110.929 -179.259 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.546 ' NZ ' ' O ' ' A' ' 29' ' ' SER . 1.7 ptpp? -63.9 -31.03 72.08 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.04 -1.037 . . . . 1.0 110.015 -179.517 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.9 -49.55 77.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.046 -1.034 . . . . 1.0 109.566 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -67.54 -38.97 84.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.118 -0.989 . . . . 1.0 109.797 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.0 -41.91 93.15 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.982 -1.074 . . . . 1.0 109.429 -179.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -60.96 -40.87 95.03 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.911 -1.118 . . . . 1.0 108.693 178.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.55 -47.08 85.43 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.369 -0.832 . . . . 1.0 109.743 179.447 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.428 ' CZ ' ' CZ ' ' A' ' 121' ' ' PHE . 48.7 m-85 -67.68 -39.98 84.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.063 -1.023 . . . . 1.0 109.742 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -59.95 -45.58 92.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.163 -0.96 . . . . 1.0 109.618 -179.085 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.5 t -60.01 -45.53 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.328 -0.858 . . . . 1.0 109.913 -179.42 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.445 ' O ' ' OG1' ' A' ' 46' ' ' THR . 76.8 m95 -76.71 -35.23 57.97 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.075 -1.015 . . . . 1.0 109.995 -179.54 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 62.9 p -71.62 -19.6 62.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.075 -1.016 . . . . 1.0 109.873 -179.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -60.0 -39.22 85.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.252 -0.905 . . . . 1.0 110.562 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.9 m -110.5 -22.96 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.249 -0.907 . . . . 1.0 110.62 -178.592 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.454 ' C ' ' H ' ' A' ' 48' ' ' LEU . 56.1 p -95.73 130.4 31.84 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 120.888 -1.132 . . . . 1.0 110.108 -179.623 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -72.32 18.48 0.33 Allowed 'Trans proline' 0 N--CA 1.492 1.4 0 CA-C-N 119.873 0.99 . . . . 1.0 111.463 178.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.454 ' H ' ' C ' ' A' ' 46' ' ' THR . 77.4 mt -69.3 138.7 54.04 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.207 -0.933 . . . . 1.0 109.602 -179.47 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -109.26 121.88 46.12 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 179.532 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -107.13 128.93 54.83 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.369 -0.832 . . . . 1.0 109.359 -179.269 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 90.2 m -121.88 130.26 53.22 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.524 -0.735 . . . . 1.0 109.961 -179.526 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -80.14 130.05 34.95 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.236 -0.915 . . . . 1.0 109.163 179.656 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.499 ' O ' ' NH1' ' A' ' 18' ' ' ARG . 94.3 mt -102.53 132.42 48.6 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.165 -0.959 . . . . 1.0 109.415 179.331 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.475 ' C ' HH12 ' A' ' 18' ' ' ARG . 23.9 m-70 -68.83 -39.91 79.74 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.662 -0.649 . . . . 1.0 110.206 -179.702 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.484 ' C ' ' NH2' ' A' ' 18' ' ' ARG . 74.1 m-20 -150.09 166.75 28.84 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.115 -0.99 . . . . 1.0 109.992 -179.565 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.552 ' O ' ' NE ' ' A' ' 18' ' ' ARG . . . 99.95 -176.42 28.27 Favored Glycine 0 N--CA 1.498 2.825 0 N-CA-C 109.53 -1.428 . . . . 1.0 109.53 -179.696 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.4 mt -95.5 135.25 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.192 -1.181 . . . . 1.0 109.261 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.04 158.94 18.25 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.436 -0.79 . . . . 1.0 109.284 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -59.99 -49.57 77.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.2 -0.937 . . . . 1.0 109.51 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 92.5 mt -108.35 98.47 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.434 -0.791 . . . . 1.0 109.698 179.634 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.5 ptm -97.96 126.07 43.19 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.487 -0.931 . . . . 1.0 108.487 179.134 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.8 mt -104.84 136.84 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.455 -0.778 . . . . 1.0 110.58 -178.509 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.1 p -153.68 160.03 42.22 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.398 -0.814 . . . . 1.0 109.548 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -102.13 122.28 43.84 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.605 -0.887 . . . . 1.0 108.605 179.486 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 98' ' ' PHE . . . -99.76 -172.76 30.51 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 110.822 -0.911 . . . . 1.0 110.822 -178.677 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.494 ' CG2' ' N ' ' A' ' 67' ' ' LYS . 73.4 mt -135.7 167.86 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.784 -0.833 . . . . 1.0 109.043 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.494 ' N ' ' CG2' ' A' ' 66' ' ' ILE . 19.8 tptm -23.88 -77.98 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 CA-C-O 121.128 0.49 . . . . 1.0 111.84 -179.374 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -70.25 149.29 47.6 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.086 -1.009 . . . . 1.0 110.443 -179.235 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.495 ' C ' ' H ' ' A' ' 71' ' ' ASP . 1.5 m80 -138.62 153.05 48.61 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.56 -0.904 . . . . 1.0 108.56 179.607 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.7 40.76 0.98 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.098 -1.601 . . . . 1.0 109.098 179.364 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.495 ' H ' ' C ' ' A' ' 69' ' ' HIS . 32.9 p-10 -140.14 -178.95 5.7 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.457 -1.025 . . . . 1.0 109.092 -179.791 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -98.26 22.76 9.15 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.291 -0.881 . . . . 1.0 109.734 -179.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -129.41 78.33 75.91 Favored Pre-proline 0 N--CA 1.502 2.142 0 O-C-N 121.453 -0.78 . . . . 1.0 109.334 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -73.78 167.01 28.3 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.165 1.243 . . . . 1.0 112.441 -179.596 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.533 ' CE2' ' OD1' ' A' ' 99' ' ' ASP . 40.6 m-85 -93.5 171.08 9.12 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.409 -0.807 . . . . 1.0 109.305 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 79' ' ' SER . 34.5 p-10 -101.05 10.65 40.79 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.352 -0.842 . . . . 1.0 110.474 -179.288 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 114.96 -155.61 16.22 Favored Glycine 0 N--CA 1.504 3.188 0 N-CA-C 109.092 -1.603 . . . . 1.0 109.092 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.424 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 15.8 Cg_exo -56.64 -64.12 0.14 Allowed 'Trans proline' 0 N--CA 1.492 1.403 0 CA-C-N 118.827 1.314 . . . . 1.0 112.308 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.43 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 83.9 p -75.0 159.03 32.26 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.896 -1.128 . . . . 1.0 109.384 179.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.03 -129.67 8.22 Favored Glycine 0 N--CA 1.502 3.045 0 N-CA-C 110.218 -1.153 . . . . 1.0 110.218 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.401 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 19.0 mt -70.19 112.72 6.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.351 -1.087 . . . . 1.0 109.406 -179.584 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 38.1 mt -79.22 -24.54 43.02 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.155 -0.966 . . . . 1.0 108.703 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -177.07 170.68 2.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.531 -0.731 . . . . 1.0 109.412 -179.733 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -162.41 163.33 27.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.104 -0.997 . . . . 1.0 109.968 179.676 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -147.2 153.48 39.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.385 -0.822 . . . . 1.0 109.071 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -88.44 152.67 50.07 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.151 -0.968 . . . . 1.0 109.23 -179.607 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -53.5 162.58 3.2 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 CA-C-N 119.214 0.755 . . . . 1.0 111.716 179.583 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -45.09 157.66 0.21 Allowed 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 121.12 1.213 . . . . 1.0 111.942 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -174.57 173.54 46.14 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.728 -1.349 . . . . 1.0 109.728 -179.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -49.86 -75.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 120.881 1.054 . . . . 1.0 111.675 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -130.08 -40.81 1.3 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.395 -0.816 . . . . 1.0 109.369 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -63.01 -44.15 96.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.544 -0.722 . . . . 1.0 110.213 -179.377 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -69.51 170.1 43.13 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.467 -1.453 . . . . 1.0 109.467 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 80.08 6.25 89.25 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.05 -1.22 . . . . 1.0 110.05 179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.2 p-10 -80.52 167.59 19.95 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.074 -1.25 . . . . 1.0 109.409 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.08 120.72 7.49 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.019 -1.051 . . . . 1.0 110.014 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -106.06 154.03 21.22 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.58 -0.7 . . . . 1.0 109.633 179.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' A' ' 65' ' ' GLY . 28.0 m-85 -129.94 152.01 49.87 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.289 -1.004 . . . . 1.0 108.289 179.177 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.533 ' OD1' ' CE2' ' A' ' 75' ' ' PHE . 86.5 m-20 -78.5 120.81 23.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.913 -1.117 . . . . 1.0 109.987 -179.63 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -84.06 -7.85 59.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.311 -0.868 . . . . 1.0 109.056 179.286 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -82.63 -15.93 50.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.3 -0.875 . . . . 1.0 109.178 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.424 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 97.2 mt-10 -89.88 169.92 10.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.502 -0.749 . . . . 1.0 109.07 -179.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 16.9 m -99.23 108.5 21.09 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.26 -0.9 . . . . 1.0 109.286 -179.555 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.491 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 93.7 m95 -91.08 125.14 35.78 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.705 -0.85 . . . . 1.0 108.705 179.505 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.3 t -140.16 151.17 45.04 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.376 -0.828 . . . . 1.0 109.885 -179.156 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 55.7 m -90.25 -8.23 51.51 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.074 -1.084 . . . . 1.0 108.074 178.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.1 p -90.65 177.27 6.39 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.625 -0.879 . . . . 1.0 108.625 178.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 m -81.09 76.53 8.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.981 -1.074 . . . . 1.0 109.628 -179.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -147.03 149.67 33.57 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.367 -0.833 . . . . 1.0 108.884 179.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.31 -135.88 7.38 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.935 -1.266 . . . . 1.0 109.935 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -100.11 118.22 36.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.413 -1.051 . . . . 1.0 109.143 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -66.58 129.09 38.69 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.365 -0.835 . . . . 1.0 110.294 -179.567 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.6 tp -60.02 -40.66 90.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.357 -0.84 . . . . 1.0 109.875 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -59.96 -47.76 84.47 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.416 -0.802 . . . . 1.0 110.587 -178.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -58.66 -50.63 73.16 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.854 -1.154 . . . . 1.0 109.761 -179.612 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 77.9 t -69.1 -40.11 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.918 -1.114 . . . . 1.0 109.668 -179.22 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.99 -50.26 74.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.098 -1.001 . . . . 1.0 109.976 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.78 -37.84 80.2 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.564 -1.335 . . . . 1.0 109.521 -179.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 67.1 t60 -63.8 -49.98 70.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.316 -0.865 . . . . 1.0 111.624 -178.594 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.84 -38.55 78.97 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.512 -1.367 . . . . 1.0 109.723 -178.735 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.428 ' CZ ' ' CZ ' ' A' ' 39' ' ' PHE . 29.9 m-85 -60.02 -39.86 87.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.92 -1.112 . . . . 1.0 108.535 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.55 -46.83 91.6 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.69 -1.364 . . . . 1.0 109.69 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -63.94 -40.08 95.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.13 -1.217 . . . . 1.0 109.449 179.66 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 91.9 p -68.49 -22.73 64.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.277 -0.89 . . . . 1.0 109.571 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 35.7 mt -81.68 -7.03 59.55 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.103 -0.998 . . . . 1.0 109.472 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 99.54 2.74 56.47 Favored Glycine 0 N--CA 1.499 2.887 0 N-CA-C 110.674 -0.971 . . . . 1.0 110.674 178.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 75.2 mt -85.11 147.23 26.74 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.947 -1.325 . . . . 1.0 109.775 179.653 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 35.5 t0 -102.96 -178.73 3.75 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.86 -0.792 . . . . 1.0 108.86 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.482 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 75.9 m80 -60.1 139.99 57.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.088 -1.008 . . . . 1.0 109.764 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 27.2 t -96.21 162.05 13.69 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.242 -0.912 . . . . 1.0 109.244 179.513 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -101.11 1.92 39.77 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.344 -0.848 . . . . 1.0 109.857 -179.692 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -90.52 114.14 60.14 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.212 -0.93 . . . . 1.0 109.206 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -53.77 -22.75 24.29 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 CA-C-N 120.27 1.132 . . . . 1.0 112.216 -179.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -86.8 -7.68 77.78 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.49 -1.044 . . . . 1.0 110.49 -179.306 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.44 149.42 26.67 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.985 -1.303 . . . . 1.0 109.576 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.415 ' C ' ' H ' ' A' ' 138' ' ' PHE . 92.9 mt -70.07 -30.97 68.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.142 -0.974 . . . . 1.0 109.473 179.69 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 98.0 mmm -73.42 13.56 0.44 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.368 -0.833 . . . . 1.0 110.396 -178.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.415 ' H ' ' C ' ' A' ' 136' ' ' LEU . 11.6 t80 -70.37 134.61 86.8 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.964 -1.085 . . . . 1.0 108.114 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -65.35 15.42 0.09 OUTLIER 'Trans proline' 0 N--CA 1.506 2.229 0 C-N-CA 121.065 1.177 . . . . 1.0 115.048 -177.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.403 HD12 HG21 ' A' ' 140' ' ' ILE . 90.0 mt -133.69 140.49 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 O-C-N 120.73 -1.231 . . . . 1.0 109.609 179.453 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -72.87 130.67 40.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.517 -0.739 . . . . 1.0 110.046 -179.25 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.2 t -143.15 137.63 29.2 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.322 -0.861 . . . . 1.0 109.479 179.777 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -81.41 143.98 31.75 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.081 -1.012 . . . . 1.0 109.18 179.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.7 t -139.11 156.53 47.09 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.208 -0.932 . . . . 1.0 110.117 -179.362 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.38 108.87 2.63 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.409 -1.476 . . . . 1.0 109.409 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -77.11 2.8 14.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.325 -1.103 . . . . 1.0 109.44 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 44.2 t -59.97 -45.01 94.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.228 -0.92 . . . . 1.0 110.149 -179.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -150.01 29.97 0.72 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.965 -1.084 . . . . 1.0 110.134 -179.536 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -60.44 139.17 57.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.054 -1.029 . . . . 1.0 109.647 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 73.7 mtm -138.55 148.5 44.28 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.353 -0.842 . . . . 1.0 108.762 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.7 mt -53.84 129.68 56.34 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 120.987 -1.071 . . . . 1.0 108.612 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -68.94 175.36 7.52 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 CA-C-N 120.112 1.076 . . . . 1.0 111.715 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.04 -38.78 83.76 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.344 -0.848 . . . . 1.0 109.48 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -55.07 -50.21 69.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.879 . . . . 1.0 110.057 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -70.2 -39.97 74.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.184 -0.947 . . . . 1.0 110.28 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 66.5 t -59.87 -47.02 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.006 -1.059 . . . . 1.0 109.035 -179.467 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -60.53 -40.07 90.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.055 -1.028 . . . . 1.0 110.463 179.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.409 ' O ' ' OG ' ' A' ' 161' ' ' SER . . . -73.82 -52.42 8.16 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.328 -0.939 . . . . 1.0 111.49 -178.465 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 8.4 tp -60.49 -39.93 82.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.637 -1.508 . . . . 1.0 109.705 -178.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.8 mt-30 -66.37 -38.81 88.42 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.198 -0.939 . . . . 1.0 109.58 179.503 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 158' ' ' GLY . 96.6 p -60.06 -34.94 74.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.394 -0.816 . . . . 1.0 110.686 -179.021 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 93.3 mt -85.17 -47.59 9.97 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.857 -1.152 . . . . 1.0 111.027 -178.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -91.68 -8.46 47.0 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.894 -1.129 . . . . 1.0 110.176 -179.007 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.404 -1.479 . . . . 1.0 109.404 -179.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 169' ' ' WAY . . . . . 0.664 ' HC2' ' HJ ' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.2 m . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.6 mt -94.96 129.1 42.16 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.184 -0.948 . . . . 1.0 108.988 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -160.09 163.24 34.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.255 -0.903 . . . . 1.0 109.628 -179.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -70.9 144.43 50.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -0.907 . . . . 1.0 109.439 -179.828 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.8 t -95.91 14.25 24.12 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.289 -0.882 . . . . 1.0 109.434 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.51 149.62 37.75 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.236 -0.915 . . . . 1.0 109.438 -179.764 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.3 mmt -91.71 -2.95 56.79 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.33 -0.856 . . . . 1.0 109.731 -179.634 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -101.59 125.63 48.27 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.295 -0.878 . . . . 1.0 109.362 179.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.7 mt -140.48 149.35 42.41 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.246 -0.909 . . . . 1.0 109.16 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.1 p -131.77 153.86 49.67 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.875 -0.787 . . . . 1.0 108.875 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -143.11 158.46 43.59 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.145 -0.972 . . . . 1.0 110.385 179.877 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.545 ' NH1' ' N ' ' A' ' 56' ' ' GLY . 72.1 ttt180 -146.55 134.97 21.94 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.469 -0.769 . . . . 1.0 109.59 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.429 HG23 HD11 ' A' ' 19' ' ' ILE . 85.9 mt -89.89 118.92 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.112 -0.992 . . . . 1.0 108.963 179.008 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.67 -40.58 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.091 -1.006 . . . . 1.0 109.107 -179.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -162.11 162.22 28.5 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.667 -1.27 . . . . 1.0 110.26 -179.184 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -103.25 -162.92 0.95 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.521 -1.288 . . . . 1.0 107.521 178.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.74 152.04 61.54 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.459 -0.775 . . . . 1.0 109.744 -179.708 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -68.1 -35.99 18.33 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 120.923 1.082 . . . . 1.0 111.512 179.271 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -59.01 -48.6 81.01 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.359 0.599 . . . . 1.0 110.756 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 56.2 mtp -96.29 145.99 25.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.373 -0.829 . . . . 1.0 110.47 -178.435 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.1 p -74.93 160.85 30.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.889 . . . . 1.0 108.783 179.361 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -61.23 -46.2 91.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.219 -0.925 . . . . 1.0 110.777 -179.146 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.8 m -62.2 -40.03 94.74 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.024 -1.047 . . . . 1.0 110.89 -178.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.55 -40.08 88.86 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.106 -0.996 . . . . 1.0 110.947 -179.156 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 71.3 t -68.49 -40.53 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.834 -1.166 . . . . 1.0 110.318 -179.173 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.97 -49.8 76.25 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.042 -1.036 . . . . 1.0 110.564 -179.134 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.19 -32.72 72.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.058 -1.026 . . . . 1.0 110.089 -179.502 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.03 -49.94 75.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.114 -0.991 . . . . 1.0 110.045 -179.447 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -66.4 -37.32 84.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.021 -1.05 . . . . 1.0 110.062 -179.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -59.97 -40.56 89.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.974 -1.079 . . . . 1.0 109.533 -179.68 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -61.95 -40.65 96.28 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.949 -1.094 . . . . 1.0 108.88 179.227 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.44 -49.75 76.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.377 -0.827 . . . . 1.0 110.528 -179.285 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.414 ' CZ ' ' CZ ' ' A' ' 121' ' ' PHE . 53.8 m-85 -65.27 -40.53 94.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.985 -1.072 . . . . 1.0 109.962 -179.262 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -59.99 -47.42 85.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.107 -0.995 . . . . 1.0 109.7 -179.579 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 70.8 t -59.99 -40.51 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.339 -0.851 . . . . 1.0 110.426 -179.394 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -79.87 -34.57 39.12 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.911 -1.118 . . . . 1.0 110.202 -179.236 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 94.8 p -72.82 -20.62 61.11 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.966 -1.083 . . . . 1.0 109.916 -179.761 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -59.99 -39.74 86.79 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 1.0 110.342 -179.36 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.4 m -111.81 30.72 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 O-C-N 121.264 -0.897 . . . . 1.0 110.69 -179.474 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.7 p -152.21 137.95 11.4 Favored Pre-proline 0 N--CA 1.502 2.14 0 O-C-N 120.607 -1.308 . . . . 1.0 109.756 179.015 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -74.72 11.83 1.28 Allowed 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 120.746 0.964 . . . . 1.0 112.285 178.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 77.9 mt -67.95 137.69 55.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.031 -1.043 . . . . 1.0 109.655 -179.095 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -106.93 120.7 42.74 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.028 -0.73 . . . . 1.0 109.028 179.664 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -108.25 123.33 48.61 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.446 -0.784 . . . . 1.0 109.238 -179.545 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.9 m -120.01 130.03 54.54 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.579 -0.701 . . . . 1.0 109.492 -179.795 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -82.12 132.55 35.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.438 -0.789 . . . . 1.0 109.406 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.3 mt -105.13 128.45 53.38 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.413 -0.804 . . . . 1.0 109.488 179.813 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.417 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 61.7 m170 -68.56 -39.74 80.9 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.481 -0.762 . . . . 1.0 109.347 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 89.4 m-20 -142.84 166.92 23.33 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.294 -0.879 . . . . 1.0 109.328 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.545 ' N ' ' NH1' ' A' ' 18' ' ' ARG . . . 97.24 172.4 33.91 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.646 -1.381 . . . . 1.0 109.646 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 93.5 mt -95.09 139.23 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.284 -1.127 . . . . 1.0 109.242 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -114.2 164.3 14.07 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.441 -0.787 . . . . 1.0 109.598 -179.634 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -59.94 -47.85 84.09 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.475 -0.935 . . . . 1.0 108.475 179.413 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.3 mt -105.27 133.84 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.697 -0.853 . . . . 1.0 108.697 179.697 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.2 ptm -139.31 129.79 25.71 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.63 -1.294 . . . . 1.0 109.491 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 93.5 mt -102.5 140.2 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.351 0.596 . . . . 1.0 109.958 -179.067 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 81.6 p -151.46 154.75 37.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.318 -0.864 . . . . 1.0 109.623 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -109.18 144.09 37.73 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.048 -0.723 . . . . 1.0 109.048 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.81 -162.82 9.73 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.457 -1.457 . . . . 1.0 109.457 -179.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.466 ' CG2' ' N ' ' A' ' 67' ' ' LYS . 92.6 mt -130.01 164.09 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.583 -0.951 . . . . 1.0 109.247 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.466 ' N ' ' CG2' ' A' ' 66' ' ' ILE . 49.1 tttm -35.6 -77.91 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 122.052 -0.405 . . . . 1.0 111.609 -179.005 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -69.22 119.32 13.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.84 -1.163 . . . . 1.0 110.043 -178.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.537 ' O ' ' N ' ' A' ' 71' ' ' ASP . 33.0 p-80 -159.99 163.51 34.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.326 -0.859 . . . . 1.0 108.957 179.454 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -51.42 86.44 0.01 OUTLIER Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.52 -1.032 . . . . 1.0 110.52 -179.213 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.537 ' N ' ' O ' ' A' ' 69' ' ' HIS . 51.6 t0 -161.51 147.78 14.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.116 -1.226 . . . . 1.0 109.525 179.385 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.469 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 54.4 p90 -81.84 -14.51 56.19 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.117 -0.989 . . . . 1.0 110.309 -179.863 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.549 ' O ' ' CG ' ' A' ' 73' ' ' TYR . 10.5 p90 -130.64 78.67 73.51 Favored Pre-proline 0 N--CA 1.502 2.165 0 O-C-N 121.302 -0.874 . . . . 1.0 109.484 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -56.7 -177.31 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.098 1.199 . . . . 1.0 112.649 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.554 ' CD2' ' OD2' ' A' ' 99' ' ' ASP . 94.6 m-85 -90.6 175.08 7.18 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.365 -0.834 . . . . 1.0 109.471 -179.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.405 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 33.4 p-10 -99.56 -1.01 39.33 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.203 -0.935 . . . . 1.0 110.758 -178.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.55 -138.04 9.8 Favored Glycine 0 N--CA 1.503 3.114 0 N-CA-C 108.816 -1.714 . . . . 1.0 108.816 -179.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.427 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 18.6 Cg_endo -77.67 -58.42 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.376 0 CA-C-N 119.872 1.836 . . . . 1.0 111.932 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 92.2 p -79.42 167.45 20.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.341 -0.849 . . . . 1.0 109.566 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 105.76 -129.33 9.74 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 109.882 -1.287 . . . . 1.0 109.882 179.715 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.43 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 8.3 mt -67.06 105.91 1.8 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.391 -1.064 . . . . 1.0 108.939 -179.781 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 71.9 mt -80.66 -14.25 58.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.114 -0.992 . . . . 1.0 109.027 -179.672 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.93 177.51 0.66 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.468 ' ND1' ' C ' ' A' ' 84' ' ' HIS . 3.2 p80 -161.89 160.61 28.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.101 -1.0 . . . . 1.0 109.508 179.341 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.31 165.02 34.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.884 . . . . 1.0 109.423 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -108.04 151.96 41.54 Favored Pre-proline 0 N--CA 1.498 1.962 0 N-CA-C 108.494 -0.928 . . . . 1.0 108.494 179.576 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -62.52 165.76 14.85 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 120.643 0.895 . . . . 1.0 111.675 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -50.93 129.21 27.13 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 120.85 1.033 . . . . 1.0 111.371 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 90' ' ' PRO . . . -164.68 -169.95 28.97 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.728 -1.349 . . . . 1.0 109.728 -179.658 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.409 ' O ' ' O ' ' A' ' 89' ' ' GLY . 14.1 Cg_exo -57.99 -150.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 121.009 1.139 . . . . 1.0 111.736 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -60.13 -41.52 92.83 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.149 -0.969 . . . . 1.0 109.793 -179.597 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -60.85 -39.99 91.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.107 -0.996 . . . . 1.0 109.241 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.44 169.6 49.52 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.231 -1.547 . . . . 1.0 109.231 179.654 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 67.93 69.9 1.27 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.983 -1.247 . . . . 1.0 109.983 179.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 31.6 p-10 -149.41 161.88 41.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.177 -1.19 . . . . 1.0 108.982 179.402 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.95 120.96 8.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.151 -0.968 . . . . 1.0 109.78 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -104.29 139.83 38.73 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.566 -0.709 . . . . 1.0 110.069 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.476 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 25.8 m-85 -119.95 139.93 51.7 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.483 -0.761 . . . . 1.0 108.976 179.081 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.554 ' OD2' ' CD2' ' A' ' 75' ' ' PHE . 99.0 m-20 -79.98 126.19 30.72 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.915 -1.116 . . . . 1.0 109.787 179.907 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 49.1 t0 -87.75 0.94 55.07 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.306 -0.871 . . . . 1.0 109.844 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -81.34 -16.52 52.13 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.934 -1.104 . . . . 1.0 110.246 -179.428 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.545 ' N ' ' OE1' ' A' ' 102' ' ' GLU . 56.6 mp0 -93.02 174.99 6.95 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.183 -0.948 . . . . 1.0 109.445 -179.769 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 27.6 m -99.43 107.49 19.73 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.341 -0.849 . . . . 1.0 109.051 179.921 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -87.32 123.08 31.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 1.0 108.987 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.593 ' HG1' ' HG ' ' A' ' 107' ' ' SER . 8.1 t -141.75 159.09 42.93 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.335 -0.853 . . . . 1.0 109.931 -179.192 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 44.3 t -96.03 -9.76 30.17 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.288 -1.005 . . . . 1.0 108.288 178.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.593 ' HG ' ' HG1' ' A' ' 105' ' ' THR . 94.6 p -90.64 178.04 6.18 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.007 -0.738 . . . . 1.0 109.007 179.542 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.2 t -78.81 74.01 5.35 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.137 -0.977 . . . . 1.0 109.678 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -146.66 148.69 32.31 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.463 -0.94 . . . . 1.0 108.463 179.093 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 46.28 -139.91 6.57 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.89 -1.284 . . . . 1.0 109.89 179.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -100.0 116.35 31.84 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.323 -1.104 . . . . 1.0 109.173 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.43 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 2.2 t-20 -63.54 133.91 54.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.11 -0.994 . . . . 1.0 109.842 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.3 tp -59.98 -44.03 94.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.464 -0.772 . . . . 1.0 110.436 -179.744 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -60.04 -40.02 87.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.108 -0.995 . . . . 1.0 110.357 -178.733 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -59.48 -51.43 69.93 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.711 -1.243 . . . . 1.0 109.543 -179.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.6 t -69.95 -42.63 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.961 -1.087 . . . . 1.0 110.087 -179.174 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.43 -52.15 66.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.933 . . . . 1.0 109.764 -179.331 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.69 -38.09 80.58 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.414 -0.804 . . . . 1.0 110.343 -179.613 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -63.41 -50.1 71.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -0.927 . . . . 1.0 111.2 -178.401 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.476 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 8.2 pt-20 -59.97 -39.79 86.86 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.691 -1.256 . . . . 1.0 110.298 -179.233 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.414 ' CZ ' ' CZ ' ' A' ' 39' ' ' PHE . 30.9 m-85 -60.03 -39.96 87.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.78 -1.2 . . . . 1.0 108.95 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.81 -42.35 94.49 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.648 -1.381 . . . . 1.0 109.648 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -66.01 -39.78 90.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.99 -1.3 . . . . 1.0 109.033 179.394 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 80.6 p -64.56 -23.98 67.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.345 -0.847 . . . . 1.0 109.462 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.2 mt -82.56 -1.84 51.87 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.132 -0.98 . . . . 1.0 109.577 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.05 10.21 64.73 Favored Glycine 0 N--CA 1.497 2.728 0 C-N-CA 120.304 -0.951 . . . . 1.0 110.812 179.191 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.5 mt -85.38 146.97 26.74 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.899 -1.354 . . . . 1.0 109.682 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 12.3 t70 -99.69 172.47 7.25 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.479 -0.763 . . . . 1.0 109.22 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.46 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 66.2 m80 -59.99 139.48 57.4 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.182 -0.949 . . . . 1.0 109.66 -179.534 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 34.1 t -98.76 152.97 19.11 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.346 -0.846 . . . . 1.0 109.407 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -96.67 -0.02 49.05 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.208 -0.933 . . . . 1.0 109.683 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -85.24 130.49 51.64 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.057 -1.027 . . . . 1.0 108.237 179.227 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -68.48 -21.37 40.38 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 CA-C-N 120.121 1.079 . . . . 1.0 112.147 -179.457 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -86.1 -4.83 83.86 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.942 -1.263 . . . . 1.0 109.942 -179.704 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -87.33 145.1 26.47 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.127 -1.219 . . . . 1.0 109.534 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.467 ' C ' ' H ' ' A' ' 138' ' ' PHE . 91.6 mt -70.0 -31.06 68.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.087 -1.008 . . . . 1.0 108.975 179.643 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.3 mmm -73.0 19.14 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.441 -0.787 . . . . 1.0 110.201 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.467 ' H ' ' C ' ' A' ' 136' ' ' LEU . 16.0 t80 -70.0 131.7 88.9 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 120.914 -1.116 . . . . 1.0 108.087 179.866 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -63.9 0.48 2.02 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 121.012 1.142 . . . . 1.0 114.536 -177.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.426 HG21 HD11 ' A' ' 140' ' ' ILE . 95.7 mt -123.19 139.45 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 120.935 -1.103 . . . . 1.0 109.321 179.677 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.43 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 58.8 t80 -73.1 125.03 26.72 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.288 -0.882 . . . . 1.0 109.896 -179.396 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.9 t -138.2 140.05 39.58 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.719 -0.845 . . . . 1.0 108.719 179.388 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -81.25 130.5 35.05 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.081 -1.012 . . . . 1.0 109.921 -179.763 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.7 m -118.91 137.07 53.71 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.97 -0.752 . . . . 1.0 108.97 179.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -62.12 103.04 0.53 Allowed Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.121 -1.992 . . . . 1.0 108.121 178.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -72.64 114.62 10.97 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.19 -1.182 . . . . 1.0 108.728 -179.241 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.4 p -178.37 109.18 0.05 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.377 -0.972 . . . . 1.0 108.377 -179.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 49.99 39.88 19.87 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.046 -1.034 . . . . 1.0 108.752 -179.249 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -88.39 119.18 28.57 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.363 -0.836 . . . . 1.0 109.398 -179.699 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 97.3 mtp -110.17 148.29 32.08 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.343 -0.984 . . . . 1.0 108.343 179.368 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.7 mt -52.46 136.86 41.84 Favored Pre-proline 0 C--N 1.3 -1.552 0 O-C-N 121.158 -0.964 . . . . 1.0 109.214 -179.514 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -68.78 174.23 8.93 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 CA-C-N 119.569 0.882 . . . . 1.0 112.177 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -60.36 -39.99 89.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.498 -0.752 . . . . 1.0 109.951 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -55.09 -49.35 71.91 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.123 -0.986 . . . . 1.0 109.852 -179.347 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.12 -40.01 75.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.244 -0.91 . . . . 1.0 110.214 -179.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.8 t -59.99 -46.47 94.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.163 -0.961 . . . . 1.0 109.067 -179.661 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -61.58 -40.01 93.25 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.083 -1.01 . . . . 1.0 110.075 179.71 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.39 -53.38 13.45 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 120.312 -0.947 . . . . 1.0 111.468 -178.483 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 6.0 tp -60.73 -39.98 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.835 -1.391 . . . . 1.0 109.778 -178.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.544 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.3 mt-30 -66.07 -39.98 90.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.115 -0.991 . . . . 1.0 109.51 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 86.2 p -61.24 -30.37 70.41 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.175 -0.953 . . . . 1.0 110.263 -179.642 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 85.5 mt -86.69 -51.8 5.91 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.001 -1.062 . . . . 1.0 110.656 -179.025 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -91.85 -9.23 44.11 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.067 -1.02 . . . . 1.0 110.312 -178.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.511 0 N-CA-C 109.457 -1.457 . . . . 1.0 109.457 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 169' ' ' WAY . . . . . 0.913 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 m . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.415 -0.587 . . . . 1.0 109.415 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.0 mt -86.07 126.38 34.13 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.199 -0.938 . . . . 1.0 109.412 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.9 pttt -162.7 163.35 26.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.284 -0.885 . . . . 1.0 109.301 179.671 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -70.21 149.56 47.36 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.113 -0.992 . . . . 1.0 109.566 -179.51 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 98.3 p -90.03 1.19 56.6 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.29 -0.881 . . . . 1.0 109.757 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -146.92 154.86 41.78 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.074 -1.016 . . . . 1.0 110.039 -179.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.549 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.5 0.37 57.35 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.382 -0.824 . . . . 1.0 109.713 -179.81 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -93.93 125.09 38.35 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.152 -0.968 . . . . 1.0 109.203 -179.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.5 mt -142.27 150.23 40.6 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.355 -0.841 . . . . 1.0 108.982 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.9 p -130.75 153.12 49.36 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.411 -0.959 . . . . 1.0 108.411 179.643 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -145.11 159.99 42.12 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.059 -1.026 . . . . 1.0 109.902 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.494 ' NH1' ' O ' ' A' ' 56' ' ' GLY . 43.3 ttp180 -144.75 139.18 27.69 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.604 -0.685 . . . . 1.0 109.316 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.8 mm -88.15 118.45 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.266 -1.013 . . . . 1.0 108.266 179.212 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.3 t -69.79 -39.95 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.131 -0.981 . . . . 1.0 108.985 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.587 HD22 ' H ' ' A' ' 64' ' ' PHE . 15.2 p30 -160.71 153.8 21.51 Favored 'General case' 0 C--N 1.287 -2.124 0 O-C-N 120.028 -1.67 . . . . 1.0 110.697 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -97.02 101.28 12.82 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 104.895 -2.261 . . . . 1.0 104.895 177.091 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.632 ' HG1' ' H ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -55.33 116.55 11.96 Favored Pre-proline 0 C--N 1.299 -1.598 0 C-N-CA 118.849 -1.141 . . . . 1.0 108.408 -177.588 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -50.23 -1.17 0.04 OUTLIER 'Trans proline' 0 N--CA 1.486 1.055 0 CA-C-N 119.804 0.966 . . . . 1.0 112.447 -179.592 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.632 ' H ' ' HG1' ' A' ' 23' ' ' THR . 87.0 m-20 -60.1 -18.5 47.6 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 118.826 -1.149 . . . . 1.0 108.065 178.455 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 76.2 mtm -147.99 163.84 35.61 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.617 -0.883 . . . . 1.0 108.617 179.281 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.0 p -73.23 157.36 37.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.17 -0.956 . . . . 1.0 109.123 179.735 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -60.68 -40.09 90.87 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.293 -0.879 . . . . 1.0 109.964 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 63.6 m -60.29 -41.96 94.46 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.206 -0.934 . . . . 1.0 109.616 -179.405 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.32 -40.15 85.92 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.446 -0.784 . . . . 1.0 110.397 179.737 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 70.7 t -67.4 -44.98 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 1.0 110.708 -179.02 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.87 -48.12 82.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.134 -0.979 . . . . 1.0 110.388 -178.362 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -62.47 -32.86 73.81 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.884 -1.135 . . . . 1.0 110.285 -179.783 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.01 -49.72 76.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.015 -1.053 . . . . 1.0 110.072 -179.274 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -68.63 -40.01 80.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.968 -1.083 . . . . 1.0 109.805 -179.648 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.3 mmtt -60.04 -44.87 94.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.019 -1.051 . . . . 1.0 109.642 -179.468 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -60.12 -40.26 89.11 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.149 -0.97 . . . . 1.0 109.219 179.726 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.17 -45.36 93.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.528 -0.732 . . . . 1.0 109.642 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -66.15 -34.66 78.54 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.884 -1.135 . . . . 1.0 109.605 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.7 tptt -59.82 -52.59 64.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.168 -0.957 . . . . 1.0 110.166 -179.665 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.0 m -60.91 -39.86 83.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 O-C-N 120.895 -1.128 . . . . 1.0 110.556 -179.678 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -79.35 -38.34 35.33 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.99 -1.069 . . . . 1.0 110.161 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.3 p -71.68 -22.96 61.58 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.709 -1.244 . . . . 1.0 110.123 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -60.09 -40.02 88.14 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.193 -0.942 . . . . 1.0 111.104 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.6 m -111.42 25.12 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 O-C-N 121.211 -0.931 . . . . 1.0 111.122 -178.309 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.42 ' C ' ' H ' ' A' ' 48' ' ' LEU . 34.3 p -148.79 133.84 9.27 Favored Pre-proline 0 N--CA 1.501 2.122 0 O-C-N 120.701 -1.249 . . . . 1.0 109.617 179.495 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -72.37 17.49 0.35 Allowed 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 120.696 0.931 . . . . 1.0 111.902 179.335 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.42 ' H ' ' C ' ' A' ' 46' ' ' THR . 75.3 mt -67.23 137.92 56.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.195 -0.941 . . . . 1.0 109.829 -179.273 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -108.29 121.42 44.87 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.095 -0.706 . . . . 1.0 109.095 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -109.57 127.65 54.64 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.488 -0.758 . . . . 1.0 109.264 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.7 m -119.99 129.95 54.52 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.482 0.658 . . . . 1.0 109.559 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -82.45 131.25 35.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.359 -0.838 . . . . 1.0 109.529 179.85 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.9 mt -105.94 128.85 54.07 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.274 -0.891 . . . . 1.0 109.514 179.639 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.41 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 17.5 m-70 -66.44 -40.08 89.26 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.436 -0.79 . . . . 1.0 109.839 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 68.0 m-20 -150.07 173.12 14.22 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.222 -0.924 . . . . 1.0 109.468 -179.709 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.494 ' O ' ' NH1' ' A' ' 18' ' ' ARG . . . 95.37 178.68 37.03 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.071 -1.612 . . . . 1.0 109.071 -179.723 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.5 mt -93.7 133.62 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.139 -1.213 . . . . 1.0 109.439 -179.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.68 158.26 18.26 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.483 -0.76 . . . . 1.0 109.167 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -59.72 -49.41 77.84 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.21 -0.931 . . . . 1.0 109.238 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 90.4 mt -105.77 99.74 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.335 -0.853 . . . . 1.0 109.875 179.562 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.7 ptp -99.21 134.77 41.59 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.146 -0.971 . . . . 1.0 109.145 179.048 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.5 mt -109.93 132.33 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.655 -0.653 . . . . 1.0 109.462 -179.014 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.0 p -151.67 157.74 42.5 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.875 -1.141 . . . . 1.0 110.562 -179.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.587 ' H ' HD22 ' A' ' 21' ' ' ASN . 62.0 m-85 -109.62 120.79 43.58 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.55 -0.907 . . . . 1.0 108.55 179.28 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.28 -169.78 23.01 Favored Glycine 0 N--CA 1.499 2.87 0 N-CA-C 110.24 -1.144 . . . . 1.0 110.24 -179.515 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.545 ' O ' ' C ' ' A' ' 67' ' ' LYS . 87.4 mt -134.91 165.61 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.644 -0.915 . . . . 1.0 108.836 179.809 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.545 ' C ' ' O ' ' A' ' 66' ' ' ILE . 20.7 tptm -9.87 -78.73 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.714 0 C-N-CA 122.91 0.484 . . . . 1.0 112.088 179.857 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.561 ' H ' ' CD ' ' A' ' 68' ' ' GLU . 3.6 pm0 -68.94 140.69 55.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.051 -1.03 . . . . 1.0 109.171 179.792 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -126.93 7.58 6.69 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.3 -0.875 . . . . 1.0 109.657 -178.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 70.24 20.73 76.88 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.024 -1.63 . . . . 1.0 109.024 -179.573 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 72' ' ' PHE . 46.6 t0 -149.52 160.12 43.74 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.608 -0.937 . . . . 1.0 108.617 -179.627 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.533 ' O ' ' CD1' ' A' ' 73' ' ' TYR . 1.8 p90 -70.91 -174.14 0.89 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.778 -1.201 . . . . 1.0 109.716 -179.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.625 ' O ' ' CG ' ' A' ' 73' ' ' TYR . 3.5 p90 40.29 60.48 7.0 Favored Pre-proline 0 N--CA 1.497 1.903 0 CA-C-O 121.869 0.843 . . . . 1.0 110.106 -178.674 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -74.18 -161.94 0.13 Allowed 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 120.984 1.123 . . . . 1.0 111.875 179.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.55 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 83.0 m-85 -87.04 164.09 16.67 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.419 -0.801 . . . . 1.0 109.33 179.661 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.3 p-10 -101.01 3.96 41.97 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.35 -0.844 . . . . 1.0 110.961 -178.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 126.32 -151.61 18.03 Favored Glycine 0 N--CA 1.507 3.383 0 N-CA-C 108.911 -1.676 . . . . 1.0 108.911 -179.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -60.0 -66.21 0.07 OUTLIER 'Trans proline' 0 N--CA 1.492 1.438 0 CA-C-N 119.116 1.458 . . . . 1.0 112.02 179.617 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 91.7 p -76.82 161.89 28.09 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.183 -0.948 . . . . 1.0 109.525 179.811 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 117.48 -133.21 10.4 Favored Glycine 0 N--CA 1.501 3.002 0 N-CA-C 109.307 -1.517 . . . . 1.0 109.307 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.8 mt -70.16 111.55 5.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.088 -1.242 . . . . 1.0 108.456 179.541 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 38.3 mt -79.33 -17.48 54.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.963 -1.085 . . . . 1.0 108.806 -179.431 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 179.97 175.45 0.8 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.719 -0.845 . . . . 1.0 108.719 179.762 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -166.0 157.7 13.99 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.188 -0.945 . . . . 1.0 109.298 178.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -144.93 157.9 43.99 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -96.89 151.29 37.7 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 107.881 -1.155 . . . . 1.0 107.881 179.478 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -61.54 163.52 17.89 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 CA-C-N 119.324 0.794 . . . . 1.0 111.751 -179.32 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -41.1 135.25 2.54 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.113 1.208 . . . . 1.0 112.253 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 90' ' ' PRO . . . -162.61 -169.48 26.06 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 109.2 -1.56 . . . . 1.0 109.2 -179.62 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.435 ' O ' ' O ' ' A' ' 89' ' ' GLY . 18.6 Cg_exo -55.94 -146.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.424 1.416 . . . . 1.0 112.686 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -61.36 -40.3 93.78 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.303 -0.873 . . . . 1.0 111.096 -179.19 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -80.19 -11.98 59.69 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.734 -1.229 . . . . 1.0 110.621 -179.092 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -74.16 168.41 54.32 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.96 -1.656 . . . . 1.0 108.96 179.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 65.21 17.54 63.88 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.531 -1.427 . . . . 1.0 109.531 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.4 p-10 -80.02 164.32 23.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.214 -1.168 . . . . 1.0 109.707 -179.64 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.61 124.42 9.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.234 -0.916 . . . . 1.0 109.529 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -112.91 147.59 36.74 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.592 -0.693 . . . . 1.0 109.937 -179.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -125.57 149.44 48.34 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 -179.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.55 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 84.7 m-20 -78.92 123.23 27.06 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.078 -1.014 . . . . 1.0 109.627 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -84.93 -7.73 59.04 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.233 -0.917 . . . . 1.0 109.275 179.577 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -83.5 -14.01 53.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.401 -0.812 . . . . 1.0 109.186 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -88.73 168.67 12.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.503 -0.748 . . . . 1.0 109.166 -179.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 30.9 m -99.94 106.08 17.85 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.209 -0.932 . . . . 1.0 109.214 -179.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -87.11 123.38 32.11 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.577 -0.897 . . . . 1.0 108.577 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.606 ' HG1' ' H ' ' A' ' 107' ' ' SER . 8.7 t -141.99 156.57 45.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.38 -0.825 . . . . 1.0 109.901 -178.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.408 ' N ' ' HG1' ' A' ' 105' ' ' THR . 5.7 t -96.8 -7.69 33.03 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.594 -0.891 . . . . 1.0 108.594 179.21 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.606 ' H ' ' HG1' ' A' ' 105' ' ' THR . 79.4 p -93.62 173.43 7.69 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.524 -0.735 . . . . 1.0 109.428 179.522 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.0 t -70.72 70.34 0.46 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 1.0 109.617 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 110' ' ' GLY . 44.6 mtpt -146.55 153.8 40.79 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.213 -0.93 . . . . 1.0 109.22 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 109' ' ' LYS . . . 41.89 -139.78 1.95 Allowed Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.037 -1.225 . . . . 1.0 110.037 179.494 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -101.0 119.12 38.28 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.33 -1.1 . . . . 1.0 108.943 179.524 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -63.88 132.19 50.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.177 -0.952 . . . . 1.0 109.796 -179.585 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 58.7 tp -59.88 -39.97 87.08 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.351 -0.843 . . . . 1.0 109.923 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -59.91 -41.05 90.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.218 -0.926 . . . . 1.0 110.261 -179.218 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -58.85 -57.92 10.89 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.829 -1.169 . . . . 1.0 110.294 -179.482 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.7 t -66.3 -41.12 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.402 -0.811 . . . . 1.0 109.964 -178.431 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.84 -51.66 68.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.966 -1.084 . . . . 1.0 109.192 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.06 -39.49 86.19 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.336 -0.852 . . . . 1.0 110.246 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 76.7 t60 -63.8 -49.86 71.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.894 . . . . 1.0 111.443 -178.194 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -59.95 -37.7 80.3 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.671 -1.268 . . . . 1.0 110.086 -179.046 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -60.15 -39.81 87.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.645 -1.284 . . . . 1.0 108.453 179.302 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -59.06 -40.38 95.51 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.246 -1.542 . . . . 1.0 109.246 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -68.48 -39.99 81.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.043 -1.269 . . . . 1.0 108.832 179.192 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.1 p -65.76 -24.75 67.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.411 -0.806 . . . . 1.0 109.12 179.703 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 65.9 mt -81.86 -4.91 57.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.361 -0.837 . . . . 1.0 109.47 179.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 92.22 10.03 61.36 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.659 -0.976 . . . . 1.0 110.659 179.105 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.8 mt -85.21 147.91 26.36 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.871 -1.37 . . . . 1.0 109.671 179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 44.1 t0 -100.63 175.46 5.65 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.476 -0.765 . . . . 1.0 108.97 -179.884 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.515 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 74.0 m80 -59.93 138.89 57.72 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.973 . . . . 1.0 109.72 -179.597 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 46.7 t -97.34 155.66 16.79 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.32 -0.863 . . . . 1.0 109.226 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -99.26 0.21 42.66 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.144 -0.973 . . . . 1.0 109.754 -179.893 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -85.32 130.4 51.82 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.306 -0.871 . . . . 1.0 108.695 179.85 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -68.1 -19.88 44.67 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 CA-C-N 120.136 1.084 . . . . 1.0 112.456 -179.668 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -91.2 -4.63 68.47 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 110.243 -1.143 . . . . 1.0 110.243 -179.558 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.86 145.63 27.1 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.014 -1.286 . . . . 1.0 109.31 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.521 ' C ' ' H ' ' A' ' 138' ' ' PHE . 70.3 mt -66.34 -38.63 88.08 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.911 -1.118 . . . . 1.0 110.01 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 94.5 mmm -69.97 19.84 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.315 -0.866 . . . . 1.0 110.585 -178.529 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.521 ' H ' ' C ' ' A' ' 136' ' ' LEU . 17.3 t80 -70.15 129.59 90.5 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 108.094 -1.076 . . . . 1.0 108.094 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -54.68 -10.98 2.85 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 CA-C-N 119.996 1.034 . . . . 1.0 114.079 -179.061 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.9 mt -113.93 140.63 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.512 0 O-C-N 120.891 -1.13 . . . . 1.0 110.664 -178.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.433 ' CD1' ' C ' ' A' ' 141' ' ' TYR . 20.7 t80 -74.7 129.58 37.97 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.513 -0.742 . . . . 1.0 110.069 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.0 t -139.0 142.4 38.32 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.434 -0.792 . . . . 1.0 109.402 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -83.05 152.18 25.48 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.994 -1.066 . . . . 1.0 109.721 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.526 ' O ' ' NZ ' ' A' ' 146' ' ' LYS . 2.7 m -145.66 154.45 42.12 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.399 -0.813 . . . . 1.0 109.863 -179.771 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.92 103.93 1.55 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.312 -1.915 . . . . 1.0 108.312 178.633 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.526 ' NZ ' ' O ' ' A' ' 144' ' ' THR . 37.3 mmtm -77.3 12.49 1.49 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.212 -1.169 . . . . 1.0 110.095 -178.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 48.5 t -60.0 -39.96 87.58 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.032 -1.043 . . . . 1.0 108.633 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -160.01 69.81 0.42 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.355 -0.841 . . . . 1.0 109.071 179.053 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -97.7 139.74 33.13 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.308 -0.87 . . . . 1.0 110.498 -179.547 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 97.4 mmm -136.9 149.72 47.8 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.983 -1.118 . . . . 1.0 107.983 178.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.9 mt -53.57 131.13 54.84 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.058 -1.026 . . . . 1.0 109.566 -179.134 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -68.49 175.47 6.95 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 CA-C-N 119.835 0.977 . . . . 1.0 112.136 179.638 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -60.08 -39.9 87.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.514 -0.741 . . . . 1.0 110.027 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -57.19 -47.31 81.56 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.221 -0.925 . . . . 1.0 110.067 -179.146 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -69.86 -39.83 76.12 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.188 -0.945 . . . . 1.0 109.435 -179.751 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.28 -45.02 96.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.198 -0.939 . . . . 1.0 109.196 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -60.23 -39.72 87.66 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.926 -1.109 . . . . 1.0 109.748 179.519 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.425 ' O ' ' OG ' ' A' ' 161' ' ' SER . . . -70.71 -54.41 10.02 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 120.501 -0.857 . . . . 1.0 111.669 -178.471 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 8.4 tp -60.03 -40.18 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.666 -1.491 . . . . 1.0 109.621 -178.728 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.546 ' O ' ' N ' ' A' ' 164' ' ' GLY . 26.5 mt-30 -65.54 -39.39 91.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.089 -1.007 . . . . 1.0 109.466 179.217 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.468 ' HG ' ' N ' ' A' ' 162' ' ' LEU . 84.7 p -59.13 -30.91 68.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.055 -1.028 . . . . 1.0 110.032 -179.553 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.468 ' N ' ' HG ' ' A' ' 161' ' ' SER . 88.7 mt -86.92 -53.61 4.8 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.938 -1.101 . . . . 1.0 110.725 -179.147 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -91.92 -9.98 41.19 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.91 -1.119 . . . . 1.0 110.933 -178.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.597 0 N-CA-C 109.292 -1.523 . . . . 1.0 109.292 -179.633 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 169' ' ' WAY . . . . . 0.938 ' HC2' ' HJ ' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.7 m . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.475 -0.565 . . . . 1.0 109.475 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.0 mt -70.04 138.96 52.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.151 -0.968 . . . . 1.0 108.934 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -162.48 166.52 24.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 1.0 109.867 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -72.19 140.75 48.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.185 -0.947 . . . . 1.0 110.043 -179.398 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.3 t -89.99 0.02 57.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.406 -0.809 . . . . 1.0 109.722 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.538 ' NZ ' ' O ' ' A' ' 14' ' ' ASN . 20.7 pttp -141.98 154.21 44.86 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.185 -0.947 . . . . 1.0 109.622 -179.651 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.4 mmt -90.47 -0.13 57.54 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.363 -0.835 . . . . 1.0 110.203 -178.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.538 ' O ' ' NZ ' ' A' ' 12' ' ' LYS . 30.1 m120 -97.02 128.61 44.15 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.224 -0.922 . . . . 1.0 109.151 -179.844 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.4 mt -141.66 149.54 40.76 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.265 -0.897 . . . . 1.0 109.307 -179.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.5 p -132.11 154.11 49.8 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.004 -0.739 . . . . 1.0 109.004 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -144.58 159.1 43.35 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.11 -0.994 . . . . 1.0 110.193 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 56' ' ' GLY . 26.3 ttm-85 -145.4 132.11 19.98 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.592 -0.693 . . . . 1.0 109.864 -179.455 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 39.8 mm -87.88 112.72 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.335 -0.987 . . . . 1.0 108.335 178.734 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.5 t -69.95 -40.05 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.101 -0.999 . . . . 1.0 109.443 -179.418 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -162.17 156.97 22.5 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.777 -1.202 . . . . 1.0 110.152 -179.588 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.611 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 54.0 m-85 -96.91 -167.14 1.5 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.169 -1.419 . . . . 1.0 107.169 178.851 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.29 141.58 32.11 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.325 -0.859 . . . . 1.0 110.094 -179.439 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -66.89 -19.1 52.81 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 120.763 0.976 . . . . 1.0 110.365 178.83 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.43 -39.91 85.04 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.553 -0.749 . . . . 1.0 109.949 179.405 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 74.8 mtm -130.04 161.66 30.5 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.419 -0.801 . . . . 1.0 109.484 -179.43 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.0 p -70.79 158.26 36.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -0.911 . . . . 1.0 109.2 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.611 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 1.0 OUTLIER -60.73 -40.76 93.59 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.355 -0.841 . . . . 1.0 110.239 -179.169 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.539 ' O ' ' NZ ' ' A' ' 33' ' ' LYS . 73.8 m -59.94 -41.02 90.94 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.006 -1.059 . . . . 1.0 110.758 -179.455 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -64.61 -40.08 94.86 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.945 -1.097 . . . . 1.0 110.004 -179.629 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.4 t -67.28 -39.96 83.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.222 -0.924 . . . . 1.0 109.83 -179.71 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -60.04 -49.93 75.74 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.098 -1.001 . . . . 1.0 110.647 -178.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.539 ' NZ ' ' O ' ' A' ' 29' ' ' SER . 2.1 ptpp? -64.19 -30.34 71.41 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.131 -0.981 . . . . 1.0 109.911 -179.704 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.04 -48.87 79.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.064 -1.022 . . . . 1.0 109.669 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -67.15 -38.38 85.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.075 -1.015 . . . . 1.0 110.02 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -59.95 -42.66 94.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.008 -1.058 . . . . 1.0 109.657 -179.651 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -60.04 -43.71 95.14 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.027 -1.046 . . . . 1.0 109.02 179.355 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.06 -49.71 76.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.463 -0.773 . . . . 1.0 109.868 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -61.97 -39.97 93.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.265 -0.897 . . . . 1.0 109.291 -179.803 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -60.06 -50.0 75.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.212 -0.93 . . . . 1.0 109.197 -179.591 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 70.2 t -59.98 -40.73 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.249 -0.907 . . . . 1.0 109.869 -179.549 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.457 ' O ' ' OG1' ' A' ' 46' ' ' THR . 73.9 m95 -78.94 -37.77 38.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.026 -1.047 . . . . 1.0 109.861 -179.704 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.3 p -69.97 -15.32 63.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.267 -0.895 . . . . 1.0 109.829 -179.726 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -59.98 -40.0 87.61 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.136 -0.978 . . . . 1.0 110.091 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.3 m -115.06 -17.71 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.437 -0.789 . . . . 1.0 111.191 -178.483 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 42' ' ' TRP . 38.3 p -90.76 124.36 62.47 Favored Pre-proline 0 N--CA 1.501 2.078 0 O-C-N 120.463 -1.398 . . . . 1.0 109.416 179.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -73.69 15.47 0.56 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 CA-C-N 120.221 1.115 . . . . 1.0 111.434 178.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.412 ' H ' ' C ' ' A' ' 46' ' ' THR . 85.5 mt -69.61 140.26 53.71 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.41 -0.806 . . . . 1.0 110.369 -179.299 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -102.33 121.63 42.66 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.798 -0.816 . . . . 1.0 108.798 179.198 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -107.09 125.79 51.52 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.288 -0.882 . . . . 1.0 109.768 -179.204 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.2 m -120.03 129.98 54.5 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.576 -0.702 . . . . 1.0 109.882 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -82.23 131.96 35.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.244 -0.91 . . . . 1.0 109.487 179.752 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.493 ' O ' ' NH1' ' A' ' 18' ' ' ARG . 90.3 mt -106.63 134.0 50.45 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.301 -0.874 . . . . 1.0 109.274 179.502 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.435 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 59.1 m170 -66.23 -39.98 89.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.388 -0.82 . . . . 1.0 109.874 -179.641 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.464 ' O ' ' NH2' ' A' ' 18' ' ' ARG . 69.0 m-20 -154.42 178.84 9.6 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.087 -1.008 . . . . 1.0 109.635 -179.77 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.538 ' O ' ' NE ' ' A' ' 18' ' ' ARG . . . 96.62 -168.26 25.04 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.642 -1.383 . . . . 1.0 109.642 -179.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.7 mt -101.4 130.51 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.361 -1.082 . . . . 1.0 109.622 -179.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.45 154.73 26.53 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.422 -0.799 . . . . 1.0 109.447 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -60.01 -49.56 77.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.2 -0.938 . . . . 1.0 109.624 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.6 mt -104.11 94.99 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.334 -0.853 . . . . 1.0 109.608 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.3 ptm -100.73 127.39 47.17 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.208 -0.933 . . . . 1.0 109.61 179.754 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 87.2 mt -106.42 137.7 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.52 -0.738 . . . . 1.0 109.657 -179.643 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 66.3 p -152.69 161.92 41.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.224 -0.923 . . . . 1.0 109.71 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -109.97 149.98 29.15 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.531 -0.731 . . . . 1.0 109.329 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -143.71 -161.88 9.11 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.315 -1.514 . . . . 1.0 109.315 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.537 ' O ' ' C ' ' A' ' 67' ' ' LYS . 81.2 mt -130.04 159.98 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.344 -1.092 . . . . 1.0 109.269 -179.942 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.537 ' C ' ' O ' ' A' ' 66' ' ' ILE . 7.5 ttpm? -8.74 -107.47 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 CA-C-N 115.878 -0.601 . . . . 1.0 111.909 -178.112 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -74.95 126.5 31.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.665 -1.272 . . . . 1.0 109.496 179.784 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.463 ' CE1' ' CE1' ' A' ' 75' ' ' PHE . 1.8 m80 -69.77 -40.03 76.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.024 -1.047 . . . . 1.0 109.443 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 175.61 -57.14 0.11 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.394 -1.482 . . . . 1.0 109.394 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 72' ' ' PHE . 45.7 t0 -156.35 153.5 29.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.177 -1.19 . . . . 1.0 109.64 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.51 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 97.7 m-85 57.81 15.38 2.97 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.669 -0.645 . . . . 1.0 110.47 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -143.53 70.0 17.43 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 120.928 -1.107 . . . . 1.0 109.208 178.869 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -86.06 110.64 1.07 Allowed 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 121.458 1.439 . . . . 1.0 113.249 -179.452 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.518 ' CD1' ' O ' ' A' ' 67' ' ' LYS . 32.8 m-85 -87.38 166.08 15.11 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 106.959 -1.497 . . . . 1.0 106.959 177.951 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.7 p-10 -106.09 20.0 19.64 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 120.927 -1.108 . . . . 1.0 110.934 -178.682 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.28 -150.38 18.11 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 109.493 -1.443 . . . . 1.0 109.493 179.608 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.442 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 8.8 Cg_exo -60.67 -62.72 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.524 0 CA-C-N 118.864 1.332 . . . . 1.0 112.896 -179.593 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 83.2 p -74.04 157.61 35.81 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.019 -1.051 . . . . 1.0 110.206 -179.268 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.65 -126.82 7.56 Favored Glycine 0 N--CA 1.502 3.075 0 N-CA-C 110.244 -1.142 . . . . 1.0 110.244 179.605 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.427 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 15.3 mt -69.75 102.73 1.98 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.43 -1.041 . . . . 1.0 109.3 -179.702 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 41.3 mt -75.67 -24.44 56.33 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.881 -1.137 . . . . 1.0 108.57 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.4 172.22 1.2 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.702 -0.851 . . . . 1.0 108.702 -179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.497 ' ND1' ' C ' ' A' ' 84' ' ' HIS . 2.8 p80 -161.61 171.41 18.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.128 -0.983 . . . . 1.0 109.238 178.938 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.41 160.91 43.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.172 -0.955 . . . . 1.0 109.467 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -101.32 154.33 37.27 Favored Pre-proline 0 N--CA 1.496 1.862 0 N-CA-C 108.367 -0.975 . . . . 1.0 108.367 179.687 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.87 168.64 0.76 Allowed 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 120.738 0.959 . . . . 1.0 111.588 179.68 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -55.78 126.21 21.69 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 120.862 1.041 . . . . 1.0 111.441 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.63 125.69 1.38 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.384 -1.886 . . . . 1.0 108.384 -179.778 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -69.6 -29.61 24.35 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 CA-C-N 120.181 1.991 . . . . 1.0 112.022 -179.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.45 ' O ' ' CG ' ' A' ' 92' ' ' TYR . 42.5 t30 -61.42 -51.24 69.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.901 . . . . 1.0 109.753 -179.599 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.45 ' CG ' ' O ' ' A' ' 91' ' ' ASN . 86.6 m-85 -157.71 -7.94 0.09 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.098 -1.001 . . . . 1.0 109.543 179.532 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -64.2 168.4 25.23 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.904 -1.279 . . . . 1.0 109.904 -179.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.31 4.49 74.06 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.722 -1.351 . . . . 1.0 109.722 179.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -80.33 171.98 14.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.053 -1.263 . . . . 1.0 109.66 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.05 124.53 9.64 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.159 -0.963 . . . . 1.0 109.848 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -107.05 131.01 54.57 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.483 -0.761 . . . . 1.0 109.529 179.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.494 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 38.4 m-85 -114.28 144.18 43.66 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.504 -0.748 . . . . 1.0 109.028 179.588 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.427 ' OD2' ' O ' ' A' ' 81' ' ' LEU . 91.7 m-20 -78.95 124.23 28.05 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.934 -1.104 . . . . 1.0 109.926 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 55.7 t0 -85.45 -6.77 59.17 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.211 -0.93 . . . . 1.0 109.233 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -81.9 -14.94 55.48 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.097 -1.002 . . . . 1.0 109.329 179.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.442 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 94.3 mt-10 -89.23 168.55 12.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.362 -0.836 . . . . 1.0 109.68 -178.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 26.3 m -98.51 105.17 17.28 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.199 -0.938 . . . . 1.0 109.494 -179.516 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.407 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 86.5 m95 -88.47 124.24 33.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.379 -0.826 . . . . 1.0 109.059 179.727 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.9 t -140.78 153.63 45.92 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.197 -0.939 . . . . 1.0 109.91 -179.476 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 85.0 p -93.2 -5.6 49.65 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.456 -0.942 . . . . 1.0 108.456 179.15 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 46.4 t -94.3 179.71 5.21 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.718 -0.845 . . . . 1.0 108.718 179.305 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.409 ' OG ' ' CZ ' ' A' ' 143' ' ' TYR . 3.9 m -80.79 75.75 7.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.004 -1.06 . . . . 1.0 109.372 179.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -148.61 151.52 35.16 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.308 -0.87 . . . . 1.0 108.828 179.364 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.53 -138.84 4.83 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.841 -1.304 . . . . 1.0 109.841 179.667 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -100.01 115.92 30.85 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.348 -1.09 . . . . 1.0 108.862 179.604 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -63.61 131.81 49.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.158 -0.964 . . . . 1.0 109.617 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.1 tp -60.0 -43.59 95.08 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.331 -0.856 . . . . 1.0 110.899 -179.484 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -59.91 -41.11 91.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.971 -1.081 . . . . 1.0 110.794 -178.592 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.96 -50.47 73.64 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.809 -1.182 . . . . 1.0 109.603 -179.468 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.1 t -70.01 -41.44 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.051 -1.031 . . . . 1.0 110.09 -179.365 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.45 -51.44 69.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.147 -0.971 . . . . 1.0 109.633 -179.318 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.05 -37.01 78.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.146 -0.971 . . . . 1.0 109.945 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 59.4 t60 -62.36 -49.94 73.55 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.249 -0.907 . . . . 1.0 111.182 -178.784 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.494 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 6.9 pt-20 -59.54 -39.49 84.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.654 -1.278 . . . . 1.0 109.529 -179.38 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -60.07 -39.96 87.87 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.892 -1.13 . . . . 1.0 108.615 179.205 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.36 -47.71 61.61 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.283 -1.527 . . . . 1.0 109.283 179.775 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -66.1 -39.96 90.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.286 -1.126 . . . . 1.0 110.16 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 83.1 p -66.43 -22.19 66.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.131 -0.98 . . . . 1.0 109.897 -179.609 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 79.6 mt -81.9 1.84 33.3 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.134 -0.979 . . . . 1.0 109.948 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.12 4.99 70.96 Favored Glycine 0 N--CA 1.497 2.749 0 O-C-N 121.005 -1.059 . . . . 1.0 110.532 179.167 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.2 mt -86.99 147.85 25.56 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.984 -1.303 . . . . 1.0 109.787 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 37.6 t0 -101.98 172.39 6.95 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.878 -0.786 . . . . 1.0 108.878 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.513 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 59.3 m80 -56.58 132.72 52.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.004 -1.06 . . . . 1.0 109.54 -179.684 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 40.0 t -96.45 157.37 15.93 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.249 -0.907 . . . . 1.0 109.412 179.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -99.97 5.06 45.21 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.347 -0.845 . . . . 1.0 109.125 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -86.23 126.5 64.73 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 108.317 -0.994 . . . . 1.0 108.317 179.442 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -68.04 -22.07 42.1 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 CA-C-N 120.253 1.126 . . . . 1.0 112.273 -179.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -84.99 -5.69 85.81 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.684 -1.366 . . . . 1.0 109.684 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.15 135.19 33.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.186 -1.185 . . . . 1.0 108.842 179.467 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.502 ' C ' ' H ' ' A' ' 138' ' ' PHE . 89.2 mt -60.7 -40.05 90.79 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.076 -1.015 . . . . 1.0 110.238 -179.442 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 89.6 mtp -69.22 23.92 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.207 -0.933 . . . . 1.0 111.009 -178.425 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.502 ' H ' ' C ' ' A' ' 136' ' ' LEU . 17.3 t80 -69.92 130.33 90.1 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 120.761 -1.212 . . . . 1.0 108.328 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -49.07 -21.82 4.47 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 120.825 1.016 . . . . 1.0 114.392 -178.453 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 90.4 mt -106.37 139.81 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 O-C-N 120.886 -1.134 . . . . 1.0 110.87 -178.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -75.0 126.76 31.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.791 -0.568 . . . . 1.0 109.614 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.8 t -138.16 142.31 40.08 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.452 -0.78 . . . . 1.0 109.167 179.388 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.409 ' CZ ' ' OG ' ' A' ' 108' ' ' SER . 80.9 t80 -80.41 139.94 36.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.145 -0.972 . . . . 1.0 109.13 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.3 t -139.95 152.09 46.07 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.282 -0.886 . . . . 1.0 109.909 -179.322 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.96 101.1 0.83 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.33 -1.508 . . . . 1.0 109.33 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -76.79 -0.79 25.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.348 -1.09 . . . . 1.0 110.019 -179.718 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 53.9 m -59.97 -40.03 87.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.082 -1.011 . . . . 1.0 109.658 -179.6 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -138.91 21.06 2.65 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.144 -0.973 . . . . 1.0 109.989 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -62.03 139.94 58.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.78 -1.2 . . . . 1.0 109.721 -179.714 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 67.6 mtt -139.64 148.32 42.28 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.386 -0.968 . . . . 1.0 108.386 179.179 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 35.0 mt -54.94 129.78 66.3 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 120.945 -1.097 . . . . 1.0 109.202 -179.407 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -70.82 173.33 12.08 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 CA-C-N 119.863 0.987 . . . . 1.0 112.21 179.749 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -60.17 -39.62 87.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.328 -0.857 . . . . 1.0 109.519 179.403 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -53.06 -47.94 68.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.217 -0.927 . . . . 1.0 109.594 -179.517 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -70.33 -40.07 74.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.064 -1.022 . . . . 1.0 110.152 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 78.7 t -60.02 -47.35 92.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.88 -1.137 . . . . 1.0 109.176 -179.784 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -60.06 -39.97 87.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.071 -1.018 . . . . 1.0 110.434 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -73.23 -54.28 7.04 Favored Glycine 0 N--CA 1.496 2.672 0 O-C-N 121.215 -0.928 . . . . 1.0 111.685 -178.213 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.8 tp -59.98 -39.99 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.953 -1.322 . . . . 1.0 109.691 -178.808 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.571 ' O ' ' N ' ' A' ' 164' ' ' GLY . 93.0 mm-40 -64.94 -38.25 90.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.2 -0.938 . . . . 1.0 109.463 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 60.3 p -61.51 -33.34 73.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.071 -1.018 . . . . 1.0 110.346 -179.359 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.8 mt -84.84 -52.31 6.12 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.959 -1.088 . . . . 1.0 110.536 -179.001 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -91.31 -9.24 45.71 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.104 -0.997 . . . . 1.0 110.483 -178.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.496 2.66 0 N-CA-C 109.448 -1.461 . . . . 1.0 109.448 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 169' ' ' WAY . . . . . 0.762 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.46 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 10.6 m . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.297 -0.631 . . . . 1.0 109.297 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.8 mt -66.87 130.25 42.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.841 -1.162 . . . . 1.0 109.162 179.856 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -161.71 161.44 29.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.878 . . . . 1.0 109.785 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -70.15 146.26 50.94 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.325 -0.86 . . . . 1.0 109.518 -179.623 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.9 t -85.94 1.42 50.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.342 -0.849 . . . . 1.0 109.818 -179.54 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -144.17 152.98 41.63 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.153 -0.967 . . . . 1.0 109.607 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.8 mmt -90.24 -0.02 57.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.358 -0.839 . . . . 1.0 109.769 -179.302 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -97.04 130.52 44.34 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.206 -0.933 . . . . 1.0 109.11 179.762 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.2 mt -141.75 148.94 39.8 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.196 -0.94 . . . . 1.0 109.406 -179.814 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.9 p -134.37 155.29 50.53 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.715 -0.846 . . . . 1.0 108.715 179.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -146.14 160.05 42.47 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.061 -1.024 . . . . 1.0 110.201 -179.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.486 ' NH1' ' N ' ' A' ' 56' ' ' GLY . 71.8 ttt180 -145.5 134.16 22.2 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.562 -0.711 . . . . 1.0 109.556 -179.736 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.406 HD11 HG22 ' A' ' 19' ' ' ILE . 32.0 mm -89.0 115.11 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.182 -0.949 . . . . 1.0 108.922 179.026 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.91 -40.58 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.173 -0.954 . . . . 1.0 109.295 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -164.98 160.52 19.15 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.929 -1.107 . . . . 1.0 110.008 -179.507 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.461 ' CD2' ' CG ' ' A' ' 28' ' ' HIS . 47.7 m-85 -101.68 -161.53 0.86 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.894 -1.15 . . . . 1.0 107.894 179.132 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.659 ' HG1' ' H ' ' A' ' 25' ' ' ASP . 0.1 OUTLIER -121.33 147.59 47.6 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.448 -0.782 . . . . 1.0 110.054 -179.809 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.424 ' N ' ' HG1' ' A' ' 23' ' ' THR . 12.2 Cg_endo -69.62 -14.99 37.36 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 120.916 1.078 . . . . 1.0 110.267 178.245 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.659 ' H ' ' HG1' ' A' ' 23' ' ' THR . 96.0 m-20 -59.42 -38.93 81.9 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.083 -0.962 . . . . 1.0 109.965 179.693 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 76.0 mtm -139.64 168.4 19.91 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.284 -0.885 . . . . 1.0 109.552 -179.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.4 p -73.45 156.61 38.07 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.445 -0.785 . . . . 1.0 109.771 -179.496 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.461 ' CG ' ' CD2' ' A' ' 22' ' ' TYR . 41.6 m170 -59.99 -40.09 87.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.431 -0.793 . . . . 1.0 110.463 -179.538 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 53.4 m -59.97 -39.96 87.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 1.0 110.202 -178.474 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.39 -39.95 89.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.033 -1.042 . . . . 1.0 109.325 179.574 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 76.6 t -68.7 -40.29 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.266 -0.896 . . . . 1.0 110.348 -179.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.96 -49.26 78.4 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.841 -1.162 . . . . 1.0 110.37 -179.186 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -61.34 -32.1 71.98 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.98 -1.075 . . . . 1.0 109.529 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.84 -48.57 81.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.977 -1.077 . . . . 1.0 109.649 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -66.03 -39.78 90.49 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.091 -1.006 . . . . 1.0 109.923 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.97 -40.65 89.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.924 -1.11 . . . . 1.0 109.284 -179.395 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -60.13 -41.78 93.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.034 -1.041 . . . . 1.0 108.927 179.085 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.97 -48.07 83.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.355 -0.841 . . . . 1.0 110.124 -179.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.414 ' O ' ' N ' ' A' ' 43' ' ' SER . 48.1 m-85 -64.89 -39.94 94.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.138 -0.976 . . . . 1.0 109.564 -179.858 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -59.96 -48.25 82.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.15 -0.969 . . . . 1.0 109.27 -179.65 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.9 t -60.02 -41.53 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.294 -0.879 . . . . 1.0 110.122 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.439 ' O ' ' OG1' ' A' ' 46' ' ' THR . 76.3 m95 -81.36 -31.5 33.35 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.978 -1.076 . . . . 1.0 109.99 -179.421 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 39' ' ' PHE . 80.0 p -70.02 -20.12 63.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.958 -1.089 . . . . 1.0 109.023 179.849 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -60.27 -39.96 88.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.404 -0.81 . . . . 1.0 110.263 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.1 m -113.15 -17.35 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 O-C-N 121.219 -0.926 . . . . 1.0 110.49 -179.17 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.52 ' C ' ' H ' ' A' ' 48' ' ' LEU . 44.8 p -94.02 114.41 63.11 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 120.779 -1.2 . . . . 1.0 108.982 179.729 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.76 16.36 0.22 Allowed 'Trans proline' 0 N--CA 1.491 1.327 0 CA-C-N 120.354 1.162 . . . . 1.0 111.237 179.462 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.52 ' H ' ' C ' ' A' ' 46' ' ' THR . 59.2 mt -69.52 142.87 53.59 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.567 -0.708 . . . . 1.0 109.511 -179.718 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -102.07 120.74 40.92 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.779 -0.823 . . . . 1.0 108.779 179.403 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -106.29 128.07 53.71 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.32 -0.863 . . . . 1.0 109.581 -179.438 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.0 m -120.04 130.01 54.5 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.58 -0.7 . . . . 1.0 109.469 179.642 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.8 ttp180 -82.62 129.99 35.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 1.0 109.558 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.4 mt -111.0 116.52 31.33 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.416 -0.802 . . . . 1.0 108.981 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.441 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 91.5 m-70 -74.61 -20.46 59.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.861 . . . . 1.0 110.065 -179.77 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 84.0 m-20 -145.13 160.66 41.08 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.18 -0.95 . . . . 1.0 109.639 -179.482 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.486 ' N ' ' NH1' ' A' ' 18' ' ' ARG . . . 90.02 173.95 45.22 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.677 -1.369 . . . . 1.0 109.677 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 87.2 mt -94.34 139.25 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.135 -1.215 . . . . 1.0 109.135 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.08 159.76 18.87 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.499 -0.75 . . . . 1.0 109.38 -179.739 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -59.94 -49.79 76.29 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.174 -0.954 . . . . 1.0 109.307 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.411 HG21 HD11 ' A' ' 60' ' ' ILE . 84.3 mt -103.12 98.88 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.449 -0.782 . . . . 1.0 109.568 179.866 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.2 ptm -101.85 129.23 48.03 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.295 -0.878 . . . . 1.0 109.206 179.455 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.418 HD11 HG23 ' A' ' 62' ' ' ILE . 86.9 mt -105.25 134.45 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.618 -0.676 . . . . 1.0 109.688 -179.125 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 54.6 p -149.73 153.54 37.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.208 -0.932 . . . . 1.0 109.623 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -103.89 124.02 48.2 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.937 -0.764 . . . . 1.0 108.937 179.904 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -107.13 -167.15 22.18 Favored Glycine 0 N--CA 1.502 3.044 0 N-CA-C 110.531 -1.028 . . . . 1.0 110.531 -179.232 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.495 ' CG2' ' N ' ' A' ' 67' ' ' LYS . 77.0 mt -137.39 167.4 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.598 -0.943 . . . . 1.0 108.74 179.731 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.495 ' N ' ' CG2' ' A' ' 66' ' ' ILE . 47.6 tptt -27.6 -78.95 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.292 0 CA-C-O 120.943 0.401 . . . . 1.0 111.248 -179.43 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -75.12 128.9 36.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.926 -1.109 . . . . 1.0 109.701 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -165.21 -21.63 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.14 -0.975 . . . . 1.0 109.304 179.601 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -177.84 135.98 2.89 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.366 -1.494 . . . . 1.0 109.366 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -61.77 -40.02 93.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.329 -1.1 . . . . 1.0 109.809 -179.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.491 ' C ' ' CG ' ' A' ' 73' ' ' TYR . 97.4 m-85 -68.95 142.28 54.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.215 -0.928 . . . . 1.0 109.878 -179.423 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.491 ' CG ' ' C ' ' A' ' 72' ' ' PHE . 3.4 p90 41.66 64.31 5.64 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.615 -0.678 . . . . 1.0 110.238 -179.248 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -75.85 157.7 39.12 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.1 1.2 . . . . 1.0 111.984 179.648 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.551 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 73.9 m-85 -90.38 150.28 21.93 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.201 -0.937 . . . . 1.0 108.89 179.51 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.5 p-10 -100.01 10.47 41.24 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.315 -0.866 . . . . 1.0 110.614 -178.884 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 116.73 -152.31 17.92 Favored Glycine 0 N--CA 1.505 3.293 0 N-CA-C 109.432 -1.467 . . . . 1.0 109.432 179.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -58.07 -65.77 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.429 0 CA-C-N 118.905 1.352 . . . . 1.0 112.338 -179.768 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 80.7 p -76.27 159.26 30.76 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.232 -0.917 . . . . 1.0 109.878 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.86 -130.87 9.3 Favored Glycine 0 N--CA 1.503 3.148 0 N-CA-C 109.6 -1.4 . . . . 1.0 109.6 179.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.402 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 15.2 mt -70.18 105.03 2.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.07 -1.253 . . . . 1.0 109.046 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 40.2 mt -77.43 -18.29 57.35 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.295 -1.002 . . . . 1.0 108.295 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.98 172.49 1.04 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.417 -0.957 . . . . 1.0 108.417 179.846 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.433 ' ND1' ' C ' ' A' ' 84' ' ' HIS . 8.1 p80 -163.09 156.76 19.9 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.988 -1.07 . . . . 1.0 109.744 179.348 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.07 157.8 43.68 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.721 -0.844 . . . . 1.0 108.721 179.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -94.84 153.15 40.06 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.059 -1.026 . . . . 1.0 109.057 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.577 ' O ' ' N ' ' A' ' 89' ' ' GLY . 5.3 Cg_endo -59.17 166.43 7.3 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 120.447 0.765 . . . . 1.0 111.01 179.576 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -50.05 77.99 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.252 1.302 . . . . 1.0 112.264 -179.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -99.27 -170.52 30.7 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.202 -1.559 . . . . 1.0 109.202 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.409 ' O ' ' O ' ' A' ' 89' ' ' GLY . 12.8 Cg_exo -55.84 -155.36 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.175 1.25 . . . . 1.0 112.622 -179.685 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -60.03 -40.3 88.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.277 -0.889 . . . . 1.0 109.79 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -67.11 -40.01 86.78 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.184 -0.947 . . . . 1.0 109.298 179.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.53 169.48 37.18 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.699 -1.36 . . . . 1.0 109.699 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.44 8.55 86.94 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.573 -1.411 . . . . 1.0 109.573 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -79.86 170.01 17.1 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.221 -1.164 . . . . 1.0 109.993 -179.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.17 124.49 10.9 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.176 -0.952 . . . . 1.0 110.058 -179.638 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.426 ' ND1' ' CE1' ' A' ' 84' ' ' HIS . 54.1 m170 -108.95 141.64 40.74 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.497 -0.752 . . . . 1.0 110.222 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -124.19 144.09 50.13 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 109.036 -0.728 . . . . 1.0 109.036 179.223 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.551 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 77.4 m-20 -78.96 121.33 24.77 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.967 -1.083 . . . . 1.0 109.677 179.814 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -85.32 -7.19 59.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.337 -0.852 . . . . 1.0 109.004 179.424 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -84.04 -12.53 55.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.452 -0.78 . . . . 1.0 109.395 -179.801 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -89.31 169.95 10.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.45 -0.782 . . . . 1.0 109.766 -178.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 18.2 m -98.87 103.86 15.85 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.338 -0.851 . . . . 1.0 109.245 -179.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.435 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 89.0 m95 -88.17 127.11 35.43 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.814 -0.809 . . . . 1.0 108.814 179.763 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.7 t -143.03 154.13 43.66 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.168 -0.958 . . . . 1.0 109.929 -179.522 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.9 m -94.05 -10.56 33.05 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.208 -0.933 . . . . 1.0 108.597 179.382 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.7 m -91.29 177.67 6.18 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.597 -0.89 . . . . 1.0 108.597 179.355 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.7 t -76.5 80.17 3.2 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.012 -1.055 . . . . 1.0 109.648 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -153.53 150.12 28.38 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.328 -0.857 . . . . 1.0 109.283 179.499 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 43.48 -140.31 2.97 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.046 -1.222 . . . . 1.0 110.046 179.465 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -99.98 111.87 24.16 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.343 -1.093 . . . . 1.0 109.076 179.695 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.417 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 19.6 t-20 -61.55 136.53 58.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.072 -1.017 . . . . 1.0 109.9 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.2 tp -59.97 -44.11 94.67 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.357 -0.839 . . . . 1.0 110.467 179.815 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -59.96 -41.47 91.98 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.08 -1.013 . . . . 1.0 110.889 -178.22 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.99 -50.11 75.01 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.814 -1.179 . . . . 1.0 109.487 -179.395 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 56.3 t -70.0 -41.5 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.06 -1.025 . . . . 1.0 110.307 -179.47 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.33 -52.8 64.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.09 -1.006 . . . . 1.0 110.074 -178.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.55 -35.5 74.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.11 -0.994 . . . . 1.0 110.099 -179.728 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -63.93 -50.3 69.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.948 . . . . 1.0 111.254 -178.512 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -60.05 -39.21 85.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.645 -1.285 . . . . 1.0 110.091 -179.297 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -60.04 -39.87 87.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.967 -1.083 . . . . 1.0 108.844 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.68 -44.39 94.05 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.431 -1.468 . . . . 1.0 109.431 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -64.95 -39.99 94.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.19 -1.182 . . . . 1.0 109.494 179.54 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 83.2 p -65.7 -22.9 66.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.228 -0.92 . . . . 1.0 109.523 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 82.2 mt -82.55 -1.2 49.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.241 -0.912 . . . . 1.0 109.283 179.709 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.73 8.71 65.16 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 110.819 -0.912 . . . . 1.0 110.819 178.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.4 mt -85.82 146.35 26.8 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.881 -1.364 . . . . 1.0 109.652 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 44.5 t0 -100.41 172.7 6.97 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.484 -0.76 . . . . 1.0 109.199 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.519 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 64.7 m80 -58.86 136.92 57.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.911 . . . . 1.0 109.703 -179.661 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 42.0 t -98.04 155.63 17.03 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.37 -0.831 . . . . 1.0 109.176 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -98.75 1.91 46.48 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.265 -0.897 . . . . 1.0 109.934 179.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -85.4 128.5 59.13 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.074 -1.016 . . . . 1.0 108.368 179.336 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -67.8 -17.4 47.15 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 CA-C-N 120.237 1.12 . . . . 1.0 112.519 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -90.32 -5.53 69.75 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.696 -1.361 . . . . 1.0 109.696 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -89.05 140.02 29.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.218 -1.166 . . . . 1.0 109.35 179.726 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.491 ' C ' ' H ' ' A' ' 138' ' ' PHE . 98.3 mt -63.86 -31.99 73.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.139 -0.976 . . . . 1.0 109.83 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 96.0 mmm -71.21 19.43 0.06 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.322 -0.861 . . . . 1.0 110.503 -179.027 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.491 ' H ' ' C ' ' A' ' 136' ' ' LEU . 11.3 t80 -69.31 132.14 89.94 Favored Pre-proline 0 N--CA 1.495 1.775 0 N-CA-C 107.817 -1.179 . . . . 1.0 107.817 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -61.88 -13.74 32.65 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 CA-C-N 119.837 0.977 . . . . 1.0 113.33 -178.346 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.419 HG23 HD11 ' A' ' 140' ' ' ILE . 96.5 mt -108.14 139.28 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.199 -0.938 . . . . 1.0 109.343 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.417 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 33.4 t80 -72.69 129.56 38.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.324 -0.86 . . . . 1.0 109.853 -179.464 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.2 t -140.15 143.74 36.31 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.868 -0.79 . . . . 1.0 108.868 179.762 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -81.01 144.8 31.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.137 -0.977 . . . . 1.0 109.289 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.5 t -140.5 151.94 45.21 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.184 -0.947 . . . . 1.0 109.825 -179.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -61.81 103.93 0.65 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.284 -1.126 . . . . 1.0 110.284 -179.478 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.413 ' CB ' ' NZ ' ' A' ' 146' ' ' LYS . 9.1 mtpm? -77.28 -7.94 56.8 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.337 -1.096 . . . . 1.0 109.236 179.638 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.477 ' HG ' ' N ' ' A' ' 148' ' ' HIS . 82.5 p -59.97 -40.01 87.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 1.0 109.832 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . 0.477 ' N ' ' HG ' ' A' ' 147' ' ' SER . 82.8 t60 -154.27 69.63 0.77 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.11 -0.993 . . . . 1.0 109.65 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -100.45 127.1 46.89 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.219 -0.926 . . . . 1.0 109.642 179.66 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 75.5 mtm -121.44 141.46 50.98 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.572 -0.899 . . . . 1.0 108.572 179.203 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.8 mt -52.6 128.47 43.55 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 120.917 -1.115 . . . . 1.0 108.82 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -68.64 175.48 7.08 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 CA-C-N 120.036 1.049 . . . . 1.0 111.903 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -59.97 -40.03 87.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.331 -0.856 . . . . 1.0 109.697 179.798 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -54.56 -49.21 70.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.256 -0.903 . . . . 1.0 110.172 -179.227 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -69.92 -39.97 75.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.993 -1.067 . . . . 1.0 110.026 -179.601 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 60.1 t -60.06 -47.1 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 1.0 109.218 -179.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -60.07 -40.01 88.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.125 -0.984 . . . . 1.0 110.203 -179.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.12 -55.27 9.39 Favored Glycine 0 N--CA 1.495 2.619 0 O-C-N 121.143 -0.973 . . . . 1.0 111.301 -178.567 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.8 tp -60.17 -40.09 82.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.946 -1.326 . . . . 1.0 109.734 -178.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.533 ' O ' ' N ' ' A' ' 164' ' ' GLY . 26.0 mm100 -64.35 -40.06 95.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.081 -1.012 . . . . 1.0 109.789 179.852 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 94.1 p -62.08 -30.44 71.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.11 -0.994 . . . . 1.0 110.196 -179.537 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.46 ' CD2' ' N ' ' A' ' 7' ' ' THR . 93.1 mt -84.92 -54.24 4.79 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.028 -1.045 . . . . 1.0 110.623 -179.099 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -89.73 -8.85 51.35 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.002 -1.061 . . . . 1.0 110.011 -179.094 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.584 0 N-CA-C 109.513 -1.435 . . . . 1.0 109.513 179.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 169' ' ' WAY . . . . . 0.941 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 96.0 m . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.303 0.573 . . . . 1.0 109.513 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.7 mt -70.03 142.98 52.67 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.389 -0.82 . . . . 1.0 109.703 -179.616 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -160.67 160.01 31.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.357 -0.839 . . . . 1.0 109.405 179.776 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 47.6 m95 -75.28 125.39 28.88 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.091 -1.005 . . . . 1.0 109.249 -179.923 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.7 p -73.28 -29.49 62.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.02 -1.05 . . . . 1.0 109.518 179.877 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -92.07 139.08 30.99 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.304 -0.999 . . . . 1.0 108.304 179.405 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.613 ' N ' ' SD ' ' A' ' 13' ' ' MET . 3.5 mmm -90.62 0.07 57.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.251 -0.906 . . . . 1.0 109.828 -178.372 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -98.17 125.86 43.39 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.707 -0.849 . . . . 1.0 108.707 179.46 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.7 mt -138.7 152.25 47.85 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.202 -0.937 . . . . 1.0 109.307 -179.503 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.6 p -132.98 154.16 50.76 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.997 -0.742 . . . . 1.0 108.997 -179.953 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -144.29 159.99 41.75 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.131 -0.981 . . . . 1.0 109.848 -179.656 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.537 ' NE ' ' O ' ' A' ' 56' ' ' GLY . 25.2 ttm-85 -142.17 134.54 27.88 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.397 -0.814 . . . . 1.0 109.585 -179.721 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 87.1 mt -87.92 117.97 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.482 -0.933 . . . . 1.0 108.482 178.73 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.9 t -69.32 -38.8 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.172 -0.955 . . . . 1.0 109.417 -179.32 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -159.19 157.88 31.62 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 122.217 1.008 . . . . 1.0 111.5 179.424 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.488 ' O ' ' O ' ' A' ' 23' ' ' THR . 15.5 m-85 -112.13 77.02 1.01 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 103.678 -2.712 . . . . 1.0 103.678 176.652 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.488 ' O ' ' O ' ' A' ' 22' ' ' TYR . 5.4 t -29.15 150.84 0.03 OUTLIER Pre-proline 0 C--N 1.282 -2.341 0 CA-C-N 115.741 -0.663 . . . . 1.0 112.178 -177.535 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -65.15 -6.55 13.31 Favored 'Trans proline' 0 N--CA 1.5 1.855 0 C-N-CA 121.275 1.317 . . . . 1.0 113.383 -178.56 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -59.15 -37.78 78.14 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 119.509 -0.876 . . . . 1.0 110.285 179.839 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 73.4 mtm -138.75 162.64 34.2 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.142 -0.974 . . . . 1.0 109.591 -179.776 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.4 p -71.45 160.4 32.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.363 -0.836 . . . . 1.0 109.436 -179.663 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.476 ' CD2' ' HB2' ' A' ' 22' ' ' TYR . 23.4 m170 -60.01 -40.44 89.26 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.313 -0.867 . . . . 1.0 109.869 -179.178 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.2 m -60.03 -42.48 94.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.136 -0.977 . . . . 1.0 110.501 -179.416 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.09 -40.0 82.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.085 -1.01 . . . . 1.0 110.023 -179.638 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 70.2 t -67.56 -44.84 86.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.164 -0.96 . . . . 1.0 110.288 -179.233 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -59.99 -49.42 77.75 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.139 -0.976 . . . . 1.0 111.13 -178.896 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -60.48 -33.47 72.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.818 -1.176 . . . . 1.0 109.847 -179.537 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.0 -49.97 75.57 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.967 -1.083 . . . . 1.0 109.95 -179.538 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -66.56 -38.81 87.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.912 -1.117 . . . . 1.0 109.894 -179.886 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.97 -42.42 94.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.078 -1.014 . . . . 1.0 109.514 -179.256 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -60.07 -39.96 87.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.133 -0.98 . . . . 1.0 109.137 179.394 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.06 -48.35 82.09 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.31 -0.868 . . . . 1.0 109.851 -179.592 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -66.26 -39.18 89.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 1.0 110.075 -179.747 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -60.01 -48.78 80.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.063 -1.023 . . . . 1.0 109.448 -179.248 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 86.2 t -59.98 -40.04 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.104 -0.997 . . . . 1.0 110.566 -179.376 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -81.47 -33.66 31.85 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.902 -1.124 . . . . 1.0 110.005 -179.555 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 94.3 p -72.05 -21.15 61.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.895 -1.128 . . . . 1.0 109.78 179.89 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.96 -39.98 87.47 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.243 -0.911 . . . . 1.0 110.626 -179.589 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 m -110.98 24.48 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 O-C-N 121.27 -0.894 . . . . 1.0 110.682 -179.118 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.5 p -149.15 135.23 10.05 Favored Pre-proline 0 N--CA 1.5 2.061 0 O-C-N 120.761 -1.212 . . . . 1.0 109.505 179.376 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -73.87 16.39 0.53 Allowed 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 120.693 0.928 . . . . 1.0 111.901 179.083 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 93.9 mt -68.31 139.35 55.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.071 -1.018 . . . . 1.0 109.756 -179.423 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -110.71 120.81 43.62 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.954 -0.758 . . . . 1.0 108.954 -179.961 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -108.38 123.49 48.92 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.393 -0.817 . . . . 1.0 109.466 -179.492 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -120.03 130.01 54.51 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.7 -0.625 . . . . 1.0 109.327 179.885 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -83.95 132.87 34.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.216 -0.927 . . . . 1.0 109.285 179.696 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.507 ' C ' HH12 ' A' ' 18' ' ' ARG . 91.2 mt -102.2 139.73 37.42 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.23 -0.919 . . . . 1.0 108.915 179.67 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.438 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 41.5 m170 -69.52 -40.0 77.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 1.0 110.228 -179.306 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.52 ' O ' ' NH2' ' A' ' 18' ' ' ARG . 70.4 m-20 -153.44 179.68 8.56 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.024 -1.047 . . . . 1.0 109.885 -179.636 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.537 ' O ' ' NE ' ' A' ' 18' ' ' ARG . . . 92.39 -170.84 33.06 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.75 -1.34 . . . . 1.0 109.75 179.928 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.0 mt -97.11 131.36 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.337 -1.096 . . . . 1.0 109.221 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.23 166.11 11.11 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.354 -0.841 . . . . 1.0 109.21 -179.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.01 -49.22 78.53 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.128 -0.982 . . . . 1.0 108.915 -179.928 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.5 mt -119.96 114.12 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.676 -0.64 . . . . 1.0 109.389 179.31 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.5 ptp -101.71 138.29 38.89 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.254 -0.904 . . . . 1.0 108.999 179.126 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.6 mt -109.99 131.86 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.359 -0.838 . . . . 1.0 109.794 -179.133 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 71.6 p -150.01 160.68 43.44 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.224 -0.923 . . . . 1.0 109.974 -179.541 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -107.13 122.57 46.75 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.463 -0.773 . . . . 1.0 109.388 179.987 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' A' ' 100' ' ' ASP . . . -96.45 167.67 24.88 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.208 -1.557 . . . . 1.0 109.208 179.6 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.484 ' O ' ' C ' ' A' ' 67' ' ' LYS . 11.3 tt -110.03 179.99 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.277 -1.131 . . . . 1.0 109.671 -179.4 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 66' ' ' ILE . 28.2 tptp -25.58 -76.56 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.243 0 CA-C-O 121.061 0.458 . . . . 1.0 111.799 179.741 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.582 ' O ' ' N ' ' A' ' 70' ' ' GLY . 20.5 pt-20 -60.79 -39.86 90.47 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.094 -1.004 . . . . 1.0 109.848 -178.754 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.553 ' ND1' ' CE1' ' A' ' 75' ' ' PHE . 2.8 t-160 57.42 -77.35 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.164 -0.96 . . . . 1.0 109.764 179.335 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 68' ' ' GLU . . . -138.48 146.84 18.71 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 108.844 -1.702 . . . . 1.0 108.844 179.635 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -66.58 -39.96 88.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -1.165 . . . . 1.0 110.026 -179.846 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -68.53 -38.96 81.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.346 -0.846 . . . . 1.0 110.8 -179.142 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 73' ' ' TYR . 2.1 p90 -129.97 79.29 73.38 Favored Pre-proline 0 N--CA 1.503 2.207 0 O-C-N 121.147 -0.971 . . . . 1.0 110.037 -179.395 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -78.72 147.28 21.76 Favored 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 121.187 1.258 . . . . 1.0 111.873 179.217 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.553 ' CE1' ' ND1' ' A' ' 69' ' ' HIS . 33.1 m-85 -90.29 172.61 8.65 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.242 -0.911 . . . . 1.0 109.162 179.839 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 79' ' ' SER . 32.8 p-10 -99.8 1.81 43.45 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.144 -0.972 . . . . 1.0 111.538 -178.425 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.406 ' O ' ' OE2' ' A' ' 102' ' ' GLU . . . 111.93 -117.91 4.58 Favored Glycine 0 N--CA 1.508 3.463 0 O-C-N 120.93 -1.106 . . . . 1.0 111.144 178.69 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.466 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 28.3 Cg_endo -73.51 -73.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.948 0 CA-C-N 120.015 1.908 . . . . 1.0 113.399 -178.88 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.451 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 99.2 p -78.17 173.89 11.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.949 -1.095 . . . . 1.0 109.475 -179.366 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 106.04 -134.39 12.09 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 110.152 -1.179 . . . . 1.0 110.152 179.64 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.459 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 19.6 mt -71.91 117.73 13.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.592 -0.946 . . . . 1.0 109.843 -179.397 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 66.1 mt -85.09 -22.77 28.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.986 -1.071 . . . . 1.0 109.127 179.343 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.13 174.46 1.05 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.86 -0.793 . . . . 1.0 108.86 -179.741 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.68 163.3 27.02 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.242 -0.911 . . . . 1.0 109.492 179.276 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -153.72 162.27 41.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.391 -0.818 . . . . 1.0 108.885 -179.743 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -106.41 151.11 40.21 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.373 -0.829 . . . . 1.0 108.85 179.754 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.534 ' O ' ' N ' ' A' ' 89' ' ' GLY . 13.5 Cg_endo -66.27 164.48 27.92 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 120.768 0.979 . . . . 1.0 111.785 179.604 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -51.49 81.68 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 121.037 1.158 . . . . 1.0 111.836 179.762 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -99.71 -169.74 30.02 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.84 -1.304 . . . . 1.0 109.84 -179.609 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 89' ' ' GLY . 21.2 Cg_exo -55.22 -143.83 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.758 1.639 . . . . 1.0 113.236 -179.637 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.404 ' OD1' ' N ' ' A' ' 92' ' ' TYR . 34.2 p-10 -62.26 -40.01 94.78 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.377 -0.827 . . . . 1.0 110.594 -179.154 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.404 ' N ' ' OD1' ' A' ' 91' ' ' ASN . 41.5 p90 -80.0 -10.38 59.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.806 -1.184 . . . . 1.0 109.449 179.942 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -76.41 169.25 54.89 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.457 -1.457 . . . . 1.0 109.457 179.894 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 66.69 76.69 0.34 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.869 -1.292 . . . . 1.0 109.869 179.787 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.9 p-10 -150.54 164.25 36.46 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.176 -1.191 . . . . 1.0 109.178 179.633 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.95 129.64 14.1 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.038 -1.039 . . . . 1.0 109.671 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -127.18 132.39 50.49 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.557 -0.714 . . . . 1.0 109.679 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -109.97 156.74 20.07 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.652 -0.655 . . . . 1.0 109.462 -179.798 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.493 ' OD1' ' CD2' ' A' ' 75' ' ' PHE . 90.8 m-20 -80.06 130.14 35.03 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.014 -1.054 . . . . 1.0 109.816 179.455 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.532 ' N ' ' O ' ' A' ' 65' ' ' GLY . 8.3 t70 -87.75 -6.77 58.02 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.274 -0.891 . . . . 1.0 109.491 179.412 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -83.53 -10.22 58.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.237 -0.914 . . . . 1.0 110.08 -179.519 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.466 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 42.0 mm-40 -90.58 173.88 7.82 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.161 -0.962 . . . . 1.0 109.5 -179.171 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 56.2 m -105.26 107.48 18.49 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.458 -0.941 . . . . 1.0 108.458 179.152 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -86.55 121.37 28.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.243 -0.911 . . . . 1.0 109.3 -179.506 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.6 t -143.12 156.33 44.77 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.538 -0.726 . . . . 1.0 109.605 -179.273 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 29.4 t -95.31 -7.26 39.21 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.332 -0.988 . . . . 1.0 108.332 178.924 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 68.3 m -91.03 179.78 5.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.565 -0.709 . . . . 1.0 109.226 179.624 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 99.4 p -79.82 68.62 5.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.232 -0.917 . . . . 1.0 109.806 -179.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -143.18 149.51 38.11 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.2 -0.937 . . . . 1.0 108.809 179.5 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.51 -144.02 3.34 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.688 -1.365 . . . . 1.0 109.688 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -100.21 117.43 34.43 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.343 -1.092 . . . . 1.0 109.034 179.625 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.449 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 20.2 t-20 -62.26 132.66 53.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.912 . . . . 1.0 109.545 179.998 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.8 tp -59.96 -43.51 95.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.34 -0.85 . . . . 1.0 110.487 -179.498 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -59.97 -41.11 91.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.027 -1.046 . . . . 1.0 110.784 -178.485 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -58.49 -50.78 72.5 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.683 -1.261 . . . . 1.0 109.188 -179.584 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.0 t -70.04 -40.11 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.127 -0.983 . . . . 1.0 109.681 -179.556 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.94 -52.68 64.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.188 -0.945 . . . . 1.0 109.864 -179.341 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.99 -34.84 73.86 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.651 -1.281 . . . . 1.0 109.887 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -65.3 -50.05 67.16 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.264 -0.897 . . . . 1.0 111.617 -178.426 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -60.0 -40.01 87.75 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.63 -1.293 . . . . 1.0 109.408 -178.72 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -59.99 -40.03 87.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.026 -1.046 . . . . 1.0 108.723 179.879 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.31 -46.41 63.73 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.166 -1.573 . . . . 1.0 109.166 179.847 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.402 ' CE1' ' NE2' ' A' ' 129' ' ' HIS . 79.0 m-70 -65.26 -40.02 93.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.229 -1.159 . . . . 1.0 109.611 179.607 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 84.1 p -66.77 -23.95 66.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 1.0 109.998 -179.754 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 78.4 mt -82.26 -2.27 52.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.128 -0.983 . . . . 1.0 110.046 -179.544 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.57 6.24 68.24 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 110.443 -1.063 . . . . 1.0 110.443 179.357 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.3 mt -84.68 149.08 26.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.053 -1.263 . . . . 1.0 109.07 179.501 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 36.1 t0 -103.27 170.35 8.01 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.764 -0.828 . . . . 1.0 108.764 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.477 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 28.0 m170 -58.53 135.16 57.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.012 -1.055 . . . . 1.0 109.356 -179.631 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 41.9 t -98.18 155.29 17.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.382 -0.824 . . . . 1.0 109.106 179.879 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -98.05 5.58 48.55 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.23 -0.919 . . . . 1.0 110.014 -179.512 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -85.88 126.68 65.05 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 108.121 -1.066 . . . . 1.0 108.121 179.275 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -68.45 -8.81 24.14 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 CA-C-N 120.186 1.102 . . . . 1.0 112.011 -179.615 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -96.44 -7.52 58.03 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.509 -1.437 . . . . 1.0 109.509 179.863 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.87 137.05 33.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.133 -1.216 . . . . 1.0 109.412 179.814 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.471 ' C ' ' H ' ' A' ' 138' ' ' PHE . 64.7 mt -60.03 -39.84 87.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.121 -0.987 . . . . 1.0 110.239 179.86 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 89.8 mtp -71.28 25.52 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.275 -0.891 . . . . 1.0 111.417 -178.463 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.471 ' H ' ' C ' ' A' ' 136' ' ' LEU . 16.2 t80 -69.22 136.44 89.08 Favored Pre-proline 0 N--CA 1.498 1.955 0 N-CA-C 107.459 -1.311 . . . . 1.0 107.459 178.787 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -60.65 -14.28 30.48 Favored 'Trans proline' 0 N--CA 1.5 1.902 0 CA-C-N 120.185 1.102 . . . . 1.0 114.196 -178.062 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.403 HG22 HD12 ' A' ' 140' ' ' ILE . 96.3 mt -109.95 139.07 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 O-C-N 121.014 -1.054 . . . . 1.0 109.697 -179.693 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.449 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 34.2 t80 -74.12 125.42 28.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.354 -0.841 . . . . 1.0 110.119 -179.324 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 7.4 t -136.6 142.94 43.34 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.997 -0.742 . . . . 1.0 108.997 179.812 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -80.67 143.29 33.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.932 -1.105 . . . . 1.0 109.746 -179.775 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.4 m -134.71 138.59 44.52 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.531 -0.73 . . . . 1.0 109.838 -179.475 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 147' ' ' SER . . . -68.0 99.91 0.59 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 107.97 -2.052 . . . . 1.0 107.97 178.658 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -74.46 17.09 0.21 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -1.129 . . . . 1.0 110.484 -178.475 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.42 ' H ' ' C ' ' A' ' 145' ' ' GLY . 41.1 t -57.67 -46.57 84.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.905 -1.122 . . . . 1.0 109.31 -179.853 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -147.72 33.99 0.85 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.147 -0.971 . . . . 1.0 109.368 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -63.73 138.03 58.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.2 -0.938 . . . . 1.0 110.953 -179.104 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 74.0 mtm -134.11 148.53 51.0 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.133 -1.062 . . . . 1.0 108.133 178.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 70.7 mt -53.3 129.12 51.06 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 120.918 -1.114 . . . . 1.0 108.867 -179.862 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -69.52 177.05 5.8 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 CA-C-N 120.074 1.062 . . . . 1.0 112.019 179.643 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -60.29 -39.95 88.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.868 . . . . 1.0 110.023 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -55.55 -48.94 73.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.245 -0.91 . . . . 1.0 110.054 -179.047 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -70.03 -40.02 75.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.152 -0.967 . . . . 1.0 110.34 -179.63 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 60.3 t -60.03 -48.81 86.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.027 -1.046 . . . . 1.0 109.124 -179.556 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -60.0 -39.98 87.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.128 -0.983 . . . . 1.0 110.44 179.97 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.06 -54.59 7.93 Favored Glycine 0 N--CA 1.493 2.49 0 O-C-N 121.136 -0.978 . . . . 1.0 111.382 -178.35 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 7.1 tp -59.98 -40.11 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.937 -1.331 . . . . 1.0 109.618 -179.026 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.546 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.7 mt-30 -66.61 -39.93 88.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 1.0 109.594 179.597 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 83.1 p -61.52 -31.12 71.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.143 -0.973 . . . . 1.0 110.74 -179.308 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 88.6 mt -86.84 -51.36 6.12 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.779 -1.201 . . . . 1.0 110.551 -179.041 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -90.83 -9.16 47.46 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.984 -1.073 . . . . 1.0 109.931 -179.273 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.524 0 N-CA-C 109.489 -1.444 . . . . 1.0 109.489 -179.866 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 169' ' ' WAY . . . . . 0.611 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 84.7 m . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.296 0.57 . . . . 1.0 109.636 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.1 mt -68.01 142.01 56.05 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.255 -0.903 . . . . 1.0 110.04 -179.618 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -160.6 160.2 31.43 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.471 -0.768 . . . . 1.0 109.018 179.598 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -73.45 147.95 43.69 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.13 -0.981 . . . . 1.0 109.463 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.3 p -84.93 0.13 52.28 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.203 -0.936 . . . . 1.0 109.742 -179.636 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -145.77 153.11 40.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.197 -0.939 . . . . 1.0 109.384 -179.877 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.2 mmt -90.02 -0.73 57.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.257 -0.902 . . . . 1.0 109.129 -179.645 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -96.19 128.2 42.88 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.341 -0.85 . . . . 1.0 108.989 -179.994 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.3 mt -140.02 150.17 44.09 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.232 -0.917 . . . . 1.0 109.04 -179.799 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 59.5 p -131.09 156.14 45.73 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.907 -0.775 . . . . 1.0 108.907 179.937 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.527 ' HH ' ' HE ' ' A' ' 52' ' ' ARG . 48.4 p90 -146.06 160.06 42.41 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.133 -0.98 . . . . 1.0 110.055 -179.672 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.57 HH12 ' H ' ' A' ' 56' ' ' GLY . 70.5 ttt180 -142.86 135.31 27.57 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.421 -0.8 . . . . 1.0 109.355 -179.939 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.5 mt -87.78 120.0 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.254 -0.904 . . . . 1.0 108.708 179.185 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 67.0 t -67.72 -39.04 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -0.925 . . . . 1.0 108.887 -179.812 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.44 ' OD1' ' N ' ' A' ' 21' ' ' ASN . 22.0 p-10 -160.61 152.9 20.44 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 119.937 -1.727 . . . . 1.0 111.289 179.687 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.644 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 33.3 m-85 -101.28 74.96 1.59 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 106.612 -1.625 . . . . 1.0 106.612 177.118 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.476 ' C ' ' O ' ' A' ' 22' ' ' TYR . 3.9 t -24.54 143.14 0.04 OUTLIER Pre-proline 0 N--CA 1.508 2.433 0 N-CA-C 112.069 0.396 . . . . 1.0 112.069 -177.786 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -62.58 -5.86 7.83 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 121.247 1.298 . . . . 1.0 112.743 -179.285 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -59.48 -36.93 76.94 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.424 -0.797 . . . . 1.0 109.939 179.704 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 78.2 mtm -138.53 161.23 37.58 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.194 -0.941 . . . . 1.0 109.556 -179.772 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.1 p -71.62 160.19 33.11 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.37 -0.831 . . . . 1.0 109.127 -179.878 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.644 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 2.1 m80 -59.96 -40.59 89.58 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.346 -0.846 . . . . 1.0 110.22 -179.083 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 74.9 m -61.28 -40.47 94.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.098 -1.001 . . . . 1.0 110.275 -179.587 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.35 -39.97 77.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.207 -0.933 . . . . 1.0 110.383 -179.478 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 77.2 t -68.29 -43.56 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.139 -0.975 . . . . 1.0 110.134 -179.258 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.01 -49.4 77.82 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.19 -0.944 . . . . 1.0 110.87 -179.063 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -61.47 -32.86 72.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.885 -1.134 . . . . 1.0 110.112 -179.531 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.97 -49.67 76.77 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.906 -1.121 . . . . 1.0 109.713 -179.579 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -66.27 -38.77 88.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.993 -1.067 . . . . 1.0 109.723 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -59.99 -43.37 95.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.045 -1.034 . . . . 1.0 109.795 -179.619 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -60.1 -41.24 92.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.99 -1.069 . . . . 1.0 109.475 179.58 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.29 -46.69 88.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.331 -0.856 . . . . 1.0 110.133 -179.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -67.2 -38.58 85.56 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.05 -1.031 . . . . 1.0 110.001 -179.767 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -59.96 -48.84 80.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.097 -1.002 . . . . 1.0 109.839 -179.349 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 79.7 t -60.09 -40.14 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.144 -0.973 . . . . 1.0 110.113 -179.412 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 69.2 m95 -81.35 -36.57 29.49 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.008 -1.058 . . . . 1.0 110.08 -179.413 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.3 p -70.19 -21.54 63.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.032 -1.043 . . . . 1.0 109.891 -179.632 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.07 -39.87 87.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.29 -0.881 . . . . 1.0 110.666 -179.739 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.463 ' O ' ' NE2' ' A' ' 160' ' ' GLN . 11.3 m -109.76 24.21 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.28 -0.888 . . . . 1.0 110.471 -178.824 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 43.3 p -149.83 134.41 9.32 Favored Pre-proline 0 N--CA 1.499 2.003 0 O-C-N 120.92 -1.113 . . . . 1.0 109.54 179.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -74.18 17.42 0.51 Allowed 'Trans proline' 0 N--CA 1.493 1.455 0 CA-C-N 119.702 0.929 . . . . 1.0 111.86 178.882 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 72.6 mt -68.53 139.9 55.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.117 -0.989 . . . . 1.0 109.413 -179.608 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -109.99 120.51 42.7 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 179.851 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -109.53 119.79 40.52 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.398 -0.814 . . . . 1.0 109.0 -179.687 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -120.06 130.03 54.49 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.533 -0.73 . . . . 1.0 109.944 -179.84 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.527 ' HE ' ' HH ' ' A' ' 17' ' ' TYR . 42.1 ttm180 -82.25 135.25 35.27 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.253 -0.904 . . . . 1.0 109.104 179.28 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.9 mt -101.3 129.29 47.25 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.161 -0.962 . . . . 1.0 109.483 -179.956 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.445 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 60.1 m170 -61.79 -40.0 93.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.413 -0.804 . . . . 1.0 109.443 179.879 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 77.9 m-20 -148.84 168.88 21.81 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.251 -0.906 . . . . 1.0 109.449 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.57 ' H ' HH12 ' A' ' 18' ' ' ARG . . . 98.72 178.07 32.31 Favored Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.54 -1.424 . . . . 1.0 109.54 -179.956 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.42 HG23 HD13 ' A' ' 57' ' ' ILE . 86.4 mt -95.87 135.06 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.241 -1.152 . . . . 1.0 109.291 179.863 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.02 160.76 16.15 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.492 -0.755 . . . . 1.0 109.155 -179.75 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -60.04 -49.51 77.38 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.17 -0.956 . . . . 1.0 109.306 -179.747 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.405 HG23 HD13 ' A' ' 60' ' ' ILE . 96.8 mt -105.37 103.51 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.356 -0.84 . . . . 1.0 109.978 179.883 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.1 ptp -100.43 133.96 44.08 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.188 -0.945 . . . . 1.0 108.766 178.773 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.4 mt -110.08 131.37 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.443 -0.785 . . . . 1.0 110.045 -178.56 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.1 p -150.56 160.3 43.89 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.153 -0.967 . . . . 1.0 109.93 -179.702 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -104.8 123.55 47.88 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 179.592 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 98' ' ' PHE . . . -95.55 -175.9 37.11 Favored Glycine 0 N--CA 1.499 2.894 0 N-CA-C 110.544 -1.023 . . . . 1.0 110.544 -179.274 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.5 ' CG2' ' N ' ' A' ' 67' ' ' LYS . 61.1 mt -131.81 165.72 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.446 -1.031 . . . . 1.0 109.442 -179.967 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.5 ' N ' ' CG2' ' A' ' 66' ' ' ILE . 20.5 tptm -22.53 -77.74 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.325 0 CA-C-O 121.165 0.507 . . . . 1.0 111.476 -179.825 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.559 ' H ' ' CD ' ' A' ' 68' ' ' GLU . 4.3 pm0 -68.42 138.4 55.28 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.084 -1.01 . . . . 1.0 109.224 -179.849 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -124.46 8.25 8.37 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.348 -0.845 . . . . 1.0 109.153 -179.34 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 70.01 32.83 69.63 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.373 -1.491 . . . . 1.0 109.373 -179.759 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -141.21 163.18 33.66 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.222 -1.164 . . . . 1.0 109.935 -179.671 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -66.23 -21.68 66.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.262 -0.899 . . . . 1.0 110.254 -179.897 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.534 ' CD2' ' O ' ' A' ' 73' ' ' TYR . 12.7 p90 -128.46 74.12 80.11 Favored Pre-proline 0 N--CA 1.504 2.255 0 O-C-N 121.229 -0.919 . . . . 1.0 110.532 -179.664 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -74.65 -152.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 121.195 1.264 . . . . 1.0 110.991 178.847 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.529 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 87.8 m-85 -83.74 162.67 20.59 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.988 -1.07 . . . . 1.0 109.739 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -102.11 16.12 27.03 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.361 -0.837 . . . . 1.0 110.746 -178.86 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 114.93 -157.51 14.94 Favored Glycine 0 N--CA 1.505 3.285 0 N-CA-C 109.55 -1.42 . . . . 1.0 109.55 179.617 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -58.37 -65.75 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.469 0 CA-C-N 118.568 1.184 . . . . 1.0 112.406 -179.742 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 89.7 p -76.03 162.17 28.28 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.181 -0.949 . . . . 1.0 109.65 -179.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.17 -129.09 8.29 Favored Glycine 0 N--CA 1.502 3.058 0 N-CA-C 109.836 -1.306 . . . . 1.0 109.836 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.1 mt -69.63 107.58 3.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.323 -1.104 . . . . 1.0 109.077 -179.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 56.7 mt -78.47 -26.54 46.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.896 . . . . 1.0 108.924 179.982 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.53 164.46 1.64 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.342 -0.984 . . . . 1.0 108.342 -179.715 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -160.35 162.74 33.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.128 -0.982 . . . . 1.0 109.44 179.493 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -145.76 160.0 42.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.283 -0.886 . . . . 1.0 109.583 -179.645 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -93.88 152.97 40.99 Favored Pre-proline 0 N--CA 1.492 1.661 0 N-CA-C 107.944 -1.132 . . . . 1.0 107.944 179.433 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.527 ' O ' ' N ' ' A' ' 89' ' ' GLY . 2.4 Cg_endo -56.95 165.79 4.64 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 CA-C-N 119.166 0.738 . . . . 1.0 111.673 179.778 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -55.62 75.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.346 1.364 . . . . 1.0 112.112 -179.564 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -94.43 -173.69 38.55 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.658 -1.777 . . . . 1.0 108.658 179.5 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.502 ' O ' ' O ' ' A' ' 89' ' ' GLY . 25.6 Cg_exo -51.56 -143.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.77 1.647 . . . . 1.0 113.462 -179.986 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.465 ' OD1' ' N ' ' A' ' 92' ' ' TYR . 34.6 p-10 -60.89 -47.64 85.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.653 -1.279 . . . . 1.0 111.163 -178.619 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.465 ' N ' ' OD1' ' A' ' 91' ' ' ASN . 35.4 p90 -68.36 -29.27 67.95 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.664 -1.273 . . . . 1.0 109.838 -179.372 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.434 ' N ' ' CD1' ' A' ' 92' ' ' TYR . . . -64.17 168.71 24.46 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.857 -1.297 . . . . 1.0 109.857 -179.862 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 69.92 17.02 73.1 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.16 -1.176 . . . . 1.0 110.16 179.679 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -86.81 171.07 11.16 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.092 -1.24 . . . . 1.0 109.756 -179.959 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.14 123.39 8.93 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.391 -0.818 . . . . 1.0 109.574 179.812 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -112.4 128.51 56.33 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.591 -0.693 . . . . 1.0 109.344 179.753 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.477 ' O ' ' N ' ' A' ' 65' ' ' GLY . 22.7 m-85 -107.71 155.85 19.73 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.478 -0.764 . . . . 1.0 109.063 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.529 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 1.3 m-20 -79.05 120.54 23.76 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.625 -1.297 . . . . 1.0 110.081 -179.616 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 65' ' ' GLY . 40.9 t0 -83.1 -11.88 57.58 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.171 -0.956 . . . . 1.0 108.947 179.389 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -83.17 -10.48 58.6 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.289 -0.882 . . . . 1.0 109.292 -179.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -92.46 170.05 10.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.395 -0.816 . . . . 1.0 109.155 -179.872 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 31.3 m -100.13 106.01 17.68 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.246 -0.909 . . . . 1.0 109.26 -179.76 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.445 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 94.5 m95 -88.76 123.39 33.13 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.568 -0.901 . . . . 1.0 108.568 179.537 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.1 t -140.05 154.84 47.2 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.355 -0.841 . . . . 1.0 109.942 -179.006 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 87.9 p -94.71 -5.51 45.3 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.284 -1.006 . . . . 1.0 108.284 179.011 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 31.4 t -94.47 178.95 5.44 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.709 -0.849 . . . . 1.0 108.709 179.35 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.2 m -80.2 76.84 6.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.962 -1.086 . . . . 1.0 109.599 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -148.52 149.39 31.54 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.257 -0.902 . . . . 1.0 108.678 179.429 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.22 -136.98 5.31 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.096 -1.202 . . . . 1.0 110.096 179.695 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -100.07 118.6 36.77 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.403 -1.057 . . . . 1.0 109.21 179.689 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.691 ' H ' ' HH ' ' A' ' 141' ' ' TYR . 2.6 t-20 -65.09 131.5 46.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.086 -1.009 . . . . 1.0 109.765 179.992 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.5 tp -60.01 -43.11 95.43 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.372 -0.83 . . . . 1.0 110.084 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -60.0 -43.01 95.48 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.27 -0.894 . . . . 1.0 111.214 -178.584 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.411 ' N ' HD22 ' A' ' 115' ' ' LEU . 4.0 mm? -60.03 -50.02 75.37 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.655 -1.278 . . . . 1.0 109.347 -179.182 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 75.5 t -69.95 -40.29 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.099 -1.0 . . . . 1.0 109.95 -179.405 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.12 -50.02 75.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.145 -0.972 . . . . 1.0 109.746 -179.306 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.84 -36.51 77.0 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.739 -1.226 . . . . 1.0 109.631 179.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 63.5 t60 -64.99 -49.97 68.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.129 -0.982 . . . . 1.0 111.541 -178.637 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.4 ' C ' ' OE1' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -59.98 -40.02 87.67 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.519 -1.363 . . . . 1.0 109.873 -178.731 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -60.04 -40.05 88.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.928 -1.107 . . . . 1.0 108.35 179.746 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -54.61 -44.13 78.95 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.128 -1.589 . . . . 1.0 109.128 179.717 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -67.29 -39.99 86.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.194 -1.18 . . . . 1.0 109.828 179.66 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.9 p -66.0 -21.7 66.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.928 . . . . 1.0 109.115 179.888 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 76.2 mt -82.52 -0.84 48.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.39 -0.819 . . . . 1.0 110.028 -179.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 89.43 7.31 69.62 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.392 -1.083 . . . . 1.0 110.392 179.282 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.5 mt -84.57 150.13 25.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.898 -1.354 . . . . 1.0 110.092 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 10.0 t70 -101.09 171.13 7.81 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.509 -0.744 . . . . 1.0 109.066 179.509 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.515 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 75.2 m80 -59.65 137.38 58.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.088 -1.007 . . . . 1.0 109.555 -179.78 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 38.6 t -98.55 154.28 18.03 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.315 -0.865 . . . . 1.0 109.322 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -100.17 6.75 44.83 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.39 -0.819 . . . . 1.0 109.748 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -86.58 127.97 58.54 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.136 -0.978 . . . . 1.0 108.563 179.617 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -67.99 -20.21 44.93 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 CA-C-N 120.181 1.1 . . . . 1.0 112.169 -179.818 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -88.47 -4.98 76.07 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.621 -1.392 . . . . 1.0 109.621 -179.865 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.16 145.75 26.87 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.269 -1.136 . . . . 1.0 109.707 179.897 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.459 ' C ' ' H ' ' A' ' 138' ' ' PHE . 84.6 mt -70.05 -33.84 72.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.891 . . . . 1.0 109.553 179.887 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 80.3 mtp -74.41 23.36 0.09 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 1.0 110.481 -179.215 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.459 ' H ' ' C ' ' A' ' 136' ' ' LEU . 12.7 t80 -69.62 133.52 88.73 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 107.409 -1.33 . . . . 1.0 107.409 179.305 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -59.25 -9.94 9.51 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 CA-C-N 120.01 1.039 . . . . 1.0 113.785 -177.896 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 95.4 mt -113.9 138.36 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 O-C-N 121.123 -0.985 . . . . 1.0 109.686 -179.919 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.691 ' HH ' ' H ' ' A' ' 112' ' ' ASN . 43.1 t80 -73.37 131.12 41.5 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.461 -0.774 . . . . 1.0 110.068 -179.351 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.1 t -141.97 133.38 26.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.36 -0.838 . . . . 1.0 109.282 179.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -80.71 134.41 35.84 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.139 -0.975 . . . . 1.0 109.58 -179.909 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.8 t -130.91 147.34 52.54 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.376 -0.828 . . . . 1.0 109.406 -179.939 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -66.65 102.91 0.81 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.574 -1.411 . . . . 1.0 109.574 -179.729 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 147' ' ' SER . 8.5 mtmp? -71.34 140.68 50.32 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.301 -1.117 . . . . 1.0 109.468 179.934 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.442 ' CB ' ' O ' ' A' ' 146' ' ' LYS . 1.2 t 165.99 -89.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.844 -0.798 . . . . 1.0 108.844 -179.884 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . 0.477 ' O ' ' ND1' ' A' ' 148' ' ' HIS . 54.9 t-80 -97.79 15.53 23.44 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.615 -0.883 . . . . 1.0 108.615 179.484 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -60.43 137.36 58.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.583 -0.698 . . . . 1.0 110.005 -179.811 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 97.2 mmm -136.33 149.53 48.44 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.555 -0.905 . . . . 1.0 108.555 179.301 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 24.6 mt -53.18 129.78 50.46 Favored Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 120.981 -1.074 . . . . 1.0 108.63 -179.802 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -66.39 176.25 4.25 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 CA-C-N 120.01 1.039 . . . . 1.0 112.295 -179.813 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.05 -39.91 87.58 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.366 -0.834 . . . . 1.0 109.475 179.799 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -56.15 -49.94 72.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.311 -0.868 . . . . 1.0 109.939 -179.204 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -70.78 -39.99 72.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.071 -1.018 . . . . 1.0 110.308 -179.473 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 63.7 t -60.11 -47.55 91.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.083 -1.01 . . . . 1.0 109.424 -179.634 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -60.48 -40.01 89.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.847 -1.158 . . . . 1.0 110.182 -179.815 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.45 -54.4 10.69 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 120.272 -0.966 . . . . 1.0 111.323 -178.716 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 8.4 tp -59.98 -39.98 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.867 -1.372 . . . . 1.0 109.533 -179.075 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.486 ' O ' ' N ' ' A' ' 164' ' ' GLY . 91.9 mm-40 -64.63 -39.9 94.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.269 -0.894 . . . . 1.0 109.27 179.48 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 82.5 p -61.8 -29.18 69.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.286 -0.884 . . . . 1.0 110.812 -179.334 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 94.4 mt -86.38 -56.44 3.43 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.801 -1.187 . . . . 1.0 110.819 -179.133 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -89.94 -9.62 48.15 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.004 -1.06 . . . . 1.0 110.445 -178.712 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.497 2.715 0 N-CA-C 109.362 -1.495 . . . . 1.0 109.362 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 169' ' ' WAY . . . . . 0.667 ' HC2' ' HJ ' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.3 m . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.231 0.538 . . . . 1.0 109.563 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.9 mt -98.83 130.14 45.24 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.274 -0.892 . . . . 1.0 109.379 -179.814 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.02 160.0 35.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 1.0 109.463 179.717 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -74.43 149.47 40.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.38 -0.825 . . . . 1.0 109.987 -179.525 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.7 m -89.93 1.77 55.85 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.354 -0.841 . . . . 1.0 110.361 -179.643 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -141.62 153.77 44.97 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.09 -1.006 . . . . 1.0 109.619 -179.701 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.3 mmt -90.15 0.02 57.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.404 -0.81 . . . . 1.0 110.234 -178.889 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -96.84 129.63 44.24 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.127 -0.983 . . . . 1.0 109.687 -179.837 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.1 mt -142.32 146.74 35.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.26 -0.9 . . . . 1.0 109.033 179.744 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 70.0 p -130.1 160.12 34.71 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.625 -0.88 . . . . 1.0 108.625 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -146.42 159.93 42.74 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.088 -1.007 . . . . 1.0 110.381 179.98 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.456 ' HG2' HH11 ' A' ' 18' ' ' ARG . 1.9 tpt180 -145.38 129.83 17.84 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.294 -0.632 . . . . 1.0 109.294 -179.03 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.1 mt -89.38 117.27 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.137 -0.977 . . . . 1.0 108.542 178.742 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.6 t -69.98 -40.7 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.094 -1.003 . . . . 1.0 109.565 -179.608 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -163.74 159.01 20.91 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.697 -1.252 . . . . 1.0 110.276 -179.908 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.471 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 56.7 m-85 -100.55 -160.72 0.82 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.218 -1.401 . . . . 1.0 107.218 178.933 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.16 149.78 74.22 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.226 -0.921 . . . . 1.0 109.91 -179.874 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -69.81 -13.31 34.37 Favored 'Trans proline' 0 N--CA 1.487 1.116 0 C-N-CA 120.611 0.874 . . . . 1.0 109.947 178.399 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -59.78 -38.52 82.12 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.798 -0.637 . . . . 1.0 109.832 -179.555 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 76.8 mtm -137.95 166.12 24.84 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.289 -0.882 . . . . 1.0 109.52 -179.611 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 67.8 p -72.75 160.34 32.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.369 -0.832 . . . . 1.0 109.333 -179.746 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.531 ' H ' ' HD1' ' A' ' 28' ' ' HIS . 3.5 m80 -60.11 -40.04 88.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.262 -0.899 . . . . 1.0 109.89 -179.552 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 74.1 m -60.1 -40.04 88.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.35 -0.844 . . . . 1.0 110.876 -179.244 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -68.1 -40.04 82.7 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.023 -1.048 . . . . 1.0 110.479 -179.167 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.1 t -69.37 -40.32 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.064 -1.022 . . . . 1.0 110.133 -179.329 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.05 -49.01 79.33 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.055 -1.028 . . . . 1.0 110.412 -179.241 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.66 -32.38 72.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.9 -1.125 . . . . 1.0 109.755 -179.776 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.87 -49.36 77.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.002 -1.061 . . . . 1.0 109.536 -179.428 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -66.6 -39.14 88.25 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.13 -0.981 . . . . 1.0 109.856 179.846 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.96 -41.79 92.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.968 -1.082 . . . . 1.0 109.673 -179.321 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -60.1 -42.11 93.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.104 -0.997 . . . . 1.0 109.743 179.374 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.56 -48.07 83.41 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.223 -0.923 . . . . 1.0 110.317 -179.811 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.501 ' CZ ' ' CZ ' ' A' ' 121' ' ' PHE . 49.8 m-85 -64.27 -39.96 95.0 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.104 -0.997 . . . . 1.0 109.572 -179.415 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -59.98 -47.6 85.15 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.504 -0.748 . . . . 1.0 109.454 -179.069 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.2 t -59.94 -40.16 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.008 -1.057 . . . . 1.0 109.81 -179.683 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.429 ' O ' ' OG1' ' A' ' 46' ' ' THR . 71.9 m95 -78.69 -32.56 47.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.193 -0.942 . . . . 1.0 110.014 -179.714 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 85.3 p -71.39 -14.63 62.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.073 -1.017 . . . . 1.0 109.683 179.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -59.91 -39.98 87.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.437 -0.79 . . . . 1.0 110.229 -179.679 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.6 m -114.58 -19.72 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.455 -0.778 . . . . 1.0 110.461 -179.001 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.443 ' C ' ' H ' ' A' ' 48' ' ' LEU . 66.4 p -95.25 121.48 62.0 Favored Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 120.757 -1.215 . . . . 1.0 109.405 179.432 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -73.15 20.84 0.34 Allowed 'Trans proline' 0 N--CA 1.493 1.491 0 CA-C-N 120.236 1.12 . . . . 1.0 111.601 179.153 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.443 ' H ' ' C ' ' A' ' 46' ' ' THR . 77.9 mt -68.86 140.03 55.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 1.0 109.525 -179.85 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -103.26 120.58 41.02 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.679 -0.859 . . . . 1.0 108.679 179.704 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -106.36 120.8 42.83 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.426 -0.796 . . . . 1.0 109.77 -179.194 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.8 m -120.06 130.01 54.49 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 121.498 0.666 . . . . 1.0 110.236 179.895 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.4 ' NH1' ' HG2' ' A' ' 52' ' ' ARG . 10.1 tpt180 -82.85 138.61 33.87 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.476 -0.765 . . . . 1.0 109.166 179.288 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 90.0 mt -106.47 129.99 54.34 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.308 -0.87 . . . . 1.0 108.755 179.166 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.425 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 62.3 m170 -60.0 -40.04 87.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.955 -1.091 . . . . 1.0 109.701 -179.427 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 73.4 m-20 -151.08 172.34 15.91 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.274 -0.891 . . . . 1.0 109.464 -179.71 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.97 -179.51 32.63 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.583 -1.407 . . . . 1.0 109.583 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.7 mt -95.62 133.63 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.374 -1.074 . . . . 1.0 109.401 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.96 162.55 14.42 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.477 -0.765 . . . . 1.0 109.095 -179.89 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -59.95 -48.82 80.14 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.207 -0.933 . . . . 1.0 109.091 179.868 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 93.1 mt -109.55 103.38 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.473 -0.767 . . . . 1.0 110.215 179.807 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.3 ptp -102.32 137.31 40.74 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.183 -0.948 . . . . 1.0 109.297 178.788 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 88.4 mt -109.95 130.47 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.575 -0.703 . . . . 1.0 109.743 -179.542 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.8 p -150.31 158.93 44.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.351 -0.843 . . . . 1.0 109.597 -179.615 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -99.97 128.5 46.05 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.434 -0.95 . . . . 1.0 108.434 179.413 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.6 150.6 16.99 Favored Glycine 0 N--CA 1.498 2.804 0 N-CA-C 110.185 -1.166 . . . . 1.0 110.185 -178.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.462 ' O ' ' C ' ' A' ' 67' ' ' LYS . 7.1 tt -101.89 -177.31 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.158 -1.053 . . . . 1.0 108.158 179.407 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 66' ' ' ILE . 52.3 tptt -33.94 -93.9 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.951 -0.468 . . . . 1.0 110.671 -179.732 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -77.95 135.34 37.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.982 -1.074 . . . . 1.0 110.038 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.527 ' O ' ' N ' ' A' ' 71' ' ' ASP . 46.7 p-80 -162.2 -171.08 2.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.11 -0.994 . . . . 1.0 109.937 179.226 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -40.16 -20.24 0.02 OUTLIER Glycine 0 N--CA 1.495 2.621 0 O-C-N 121.566 -0.708 . . . . 1.0 111.85 -178.403 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 69' ' ' HIS . 98.0 m-20 -87.84 132.6 34.13 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.54 -1.565 . . . . 1.0 110.249 -179.456 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -60.06 -42.12 93.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.414 -0.804 . . . . 1.0 109.503 179.366 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.522 ' CD2' ' O ' ' A' ' 73' ' ' TYR . 21.6 p90 -90.55 114.28 60.65 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.275 -0.89 . . . . 1.0 109.391 -179.818 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -73.53 -167.96 0.41 Allowed 'Trans proline' 0 N--CA 1.492 1.427 0 CA-C-N 120.114 1.076 . . . . 1.0 112.064 179.888 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.533 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 97.9 m-85 -89.77 169.9 10.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.312 -0.868 . . . . 1.0 108.663 179.43 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -101.27 13.78 34.01 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.155 -0.965 . . . . 1.0 110.209 -179.296 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 117.12 -156.91 15.36 Favored Glycine 0 N--CA 1.502 3.047 0 N-CA-C 108.894 -1.682 . . . . 1.0 108.894 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -58.48 -65.38 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.451 0 CA-C-N 118.633 1.217 . . . . 1.0 112.267 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 90.6 p -76.85 164.18 26.07 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.183 -0.948 . . . . 1.0 109.815 -179.93 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.85 -129.45 8.65 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 109.587 -1.405 . . . . 1.0 109.587 179.88 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.44 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 13.2 mt -68.99 106.48 2.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.435 -1.038 . . . . 1.0 109.09 179.961 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 50.8 mt -78.71 -23.71 45.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.017 -1.052 . . . . 1.0 108.884 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.11 169.56 1.9 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.709 -0.849 . . . . 1.0 108.709 179.837 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -161.7 161.89 29.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.159 -0.963 . . . . 1.0 109.127 179.304 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.78 157.03 44.67 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.2 -0.938 . . . . 1.0 109.724 -179.355 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -93.63 151.96 40.45 Favored Pre-proline 0 N--CA 1.494 1.726 0 N-CA-C 108.483 -0.932 . . . . 1.0 108.483 179.691 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -42.16 160.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.243 0 C-N-CA 120.663 0.909 . . . . 1.0 111.667 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -66.77 74.66 0.42 Allowed 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 120.645 0.897 . . . . 1.0 111.955 -179.52 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -82.27 167.92 47.79 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.134 -1.586 . . . . 1.0 109.134 179.771 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -71.16 -34.04 10.68 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 121.417 1.411 . . . . 1.0 112.538 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -110.03 -98.2 0.4 Allowed 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.335 -0.853 . . . . 1.0 111.532 -178.52 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -59.98 -40.01 87.64 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.371 -0.831 . . . . 1.0 110.503 -177.861 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.57 168.38 0.84 Allowed Glycine 0 N--CA 1.489 2.17 0 C-N-CA 119.461 -1.352 . . . . 1.0 109.917 -179.328 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.41 4.94 76.05 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.539 -1.424 . . . . 1.0 109.539 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -86.4 174.56 8.93 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.214 -1.168 . . . . 1.0 110.116 -179.623 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.35 124.11 9.86 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.408 -0.808 . . . . 1.0 109.32 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -111.38 137.61 48.93 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.605 -0.684 . . . . 1.0 109.942 -179.752 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.526 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 27.3 m-85 -114.38 154.23 28.45 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 109.111 -0.699 . . . . 1.0 109.111 179.638 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.533 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 1.7 m-20 -78.54 123.66 27.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.056 -1.028 . . . . 1.0 109.522 179.759 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 43.7 t0 -83.93 -12.38 55.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.229 -0.92 . . . . 1.0 109.391 179.724 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -84.14 -10.01 58.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.352 -0.842 . . . . 1.0 109.871 -179.818 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -91.48 169.65 10.6 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.204 -0.935 . . . . 1.0 110.033 -179.241 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 15.9 m -100.05 106.25 17.99 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.432 -0.792 . . . . 1.0 108.917 -179.788 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -89.18 124.45 34.36 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.76 -0.83 . . . . 1.0 108.76 179.813 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.7 t -140.04 159.29 42.5 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.422 -0.799 . . . . 1.0 109.944 -179.103 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.4 t -96.88 -13.3 22.58 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.332 -0.855 . . . . 1.0 109.011 179.485 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 65.6 m -90.62 179.14 5.9 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.768 -0.827 . . . . 1.0 108.768 179.388 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.2 m -79.43 80.18 5.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.983 -1.073 . . . . 1.0 109.349 -179.893 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 110' ' ' GLY . 68.3 mttm -148.88 149.53 31.42 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.654 -0.869 . . . . 1.0 108.654 179.379 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 109' ' ' LYS . . . 44.36 -137.3 5.33 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.602 -1.399 . . . . 1.0 109.602 179.71 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -99.6 117.66 34.46 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.32 -1.106 . . . . 1.0 109.017 179.304 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.467 HD21 ' HZ2' ' A' ' 146' ' ' LYS . 53.7 t-20 -62.25 130.3 44.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.326 -0.858 . . . . 1.0 109.733 -179.738 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.9 tp -59.99 -41.88 93.0 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.321 -0.862 . . . . 1.0 110.211 -179.579 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -59.97 -40.12 87.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.179 -0.951 . . . . 1.0 110.505 -179.319 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.04 -51.21 71.05 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.746 -1.221 . . . . 1.0 109.883 -179.675 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.8 t -69.96 -40.37 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.131 -0.981 . . . . 1.0 109.961 -178.905 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.22 -52.6 65.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -0.91 . . . . 1.0 109.943 -179.422 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.03 -39.05 84.57 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.095 -1.003 . . . . 1.0 110.157 -179.769 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -64.05 -50.0 70.13 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.408 -0.808 . . . . 1.0 111.428 -178.272 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.526 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 10.5 pt-20 -60.03 -39.5 86.09 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.664 -1.272 . . . . 1.0 110.319 -179.168 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.501 ' CZ ' ' CZ ' ' A' ' 39' ' ' PHE . 29.6 m-85 -60.0 -40.02 87.76 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.716 -1.24 . . . . 1.0 108.574 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.91 -42.07 94.55 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.526 -1.43 . . . . 1.0 109.526 -179.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -66.89 -39.99 87.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.068 -1.254 . . . . 1.0 109.228 179.522 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.5 p -66.71 -24.44 66.24 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.328 -0.858 . . . . 1.0 108.856 179.542 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 71.4 mt -81.67 -0.58 43.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.394 -0.816 . . . . 1.0 109.357 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 88.77 6.79 72.17 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 120.349 -0.929 . . . . 1.0 110.782 178.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.9 mt -82.74 146.37 29.04 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.782 -1.422 . . . . 1.0 109.644 179.78 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 33.5 t0 -99.33 173.13 6.92 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.926 -0.768 . . . . 1.0 108.926 -179.73 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.493 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 76.4 m80 -59.97 138.45 57.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.175 -0.953 . . . . 1.0 109.807 -179.422 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 33.3 t -97.09 156.51 16.34 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.267 -0.896 . . . . 1.0 109.208 179.739 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -99.86 1.57 43.04 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.318 -0.864 . . . . 1.0 109.663 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -87.03 130.17 49.26 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.18 -0.95 . . . . 1.0 108.913 179.797 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -69.39 -25.35 30.41 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 CA-C-N 120.099 1.071 . . . . 1.0 112.27 -179.622 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -83.58 -4.99 88.81 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.409 -1.476 . . . . 1.0 109.409 -179.805 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.89 145.34 26.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -1.162 . . . . 1.0 109.319 179.567 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.463 ' C ' ' H ' ' A' ' 138' ' ' PHE . 80.5 mt -69.5 -33.13 72.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.294 -0.879 . . . . 1.0 109.723 179.727 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 93.9 mmm -71.8 18.4 0.08 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.152 -0.967 . . . . 1.0 110.687 -179.463 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.463 ' H ' ' C ' ' A' ' 136' ' ' LEU . 13.2 t80 -69.79 133.14 88.51 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.735 -1.228 . . . . 1.0 107.89 179.819 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -62.94 -15.28 46.57 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 CA-C-N 119.905 1.002 . . . . 1.0 113.792 -178.116 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.415 HG23 HD12 ' A' ' 140' ' ' ILE . 97.0 mt -105.91 141.91 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 120.943 -1.098 . . . . 1.0 109.986 -179.392 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -74.95 129.72 38.14 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.397 -0.815 . . . . 1.0 109.691 -179.723 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.6 t -143.13 139.93 30.62 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.348 -0.845 . . . . 1.0 108.853 179.317 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -81.88 143.73 31.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.99 -1.069 . . . . 1.0 109.407 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.448 ' O ' ' NZ ' ' A' ' 146' ' ' LYS . 1.3 m -140.19 150.97 44.83 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.39 -0.819 . . . . 1.0 109.763 -179.314 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.38 112.18 3.65 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 107.717 -2.153 . . . . 1.0 107.717 178.222 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.467 ' HZ2' HD21 ' A' ' 112' ' ' ASN . 33.6 mmtm -76.09 4.89 7.59 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.3 -1.118 . . . . 1.0 109.887 -178.607 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 86.8 p -71.79 122.74 21.22 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.181 -0.95 . . . . 1.0 109.119 179.737 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 52.03 40.0 27.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.283 -0.886 . . . . 1.0 110.078 179.848 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -92.5 129.8 38.34 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.927 -1.108 . . . . 1.0 109.74 179.613 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 96.2 mmm -131.45 150.02 52.31 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.499 -0.926 . . . . 1.0 108.499 179.117 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 22.0 mt -50.61 132.13 27.18 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 120.898 -1.126 . . . . 1.0 109.034 -179.515 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -68.53 174.52 8.25 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 CA-C-N 120.0 1.036 . . . . 1.0 111.639 179.364 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -60.04 -39.96 87.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.285 -0.884 . . . . 1.0 109.863 -179.882 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -55.22 -49.77 71.13 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.131 -0.98 . . . . 1.0 109.935 -179.278 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.12 -39.87 75.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.171 -0.956 . . . . 1.0 110.28 -179.349 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 64.4 t -60.08 -45.47 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.003 -1.061 . . . . 1.0 109.03 -179.563 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -60.96 -40.08 91.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.137 -0.977 . . . . 1.0 110.652 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.79 -53.6 9.46 Favored Glycine 0 N--CA 1.497 2.75 0 O-C-N 121.071 -1.018 . . . . 1.0 111.355 -178.518 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 7.8 tp -60.05 -40.02 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.94 -1.33 . . . . 1.0 109.637 -178.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.5 mt-30 -65.96 -39.6 90.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.091 -1.005 . . . . 1.0 109.716 179.448 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.409 ' HG ' ' N ' ' A' ' 162' ' ' LEU . 84.9 p -60.63 -32.19 71.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.09 -1.006 . . . . 1.0 110.688 -179.29 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.409 ' N ' ' HG ' ' A' ' 161' ' ' SER . 96.4 mt -85.64 -51.51 6.42 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.898 -1.126 . . . . 1.0 110.669 -178.993 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -91.24 -9.12 46.38 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.986 -1.071 . . . . 1.0 110.411 -178.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.517 0 N-CA-C 109.475 -1.45 . . . . 1.0 109.475 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 169' ' ' WAY . . . . . 0.836 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.7 m . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.275 0.559 . . . . 1.0 109.581 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.1 mt -94.19 129.41 40.81 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.353 -0.842 . . . . 1.0 109.519 -179.63 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -160.79 162.29 32.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.367 -0.833 . . . . 1.0 109.617 179.847 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -72.14 149.74 44.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.213 -0.929 . . . . 1.0 109.373 -179.759 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 94.5 p -86.99 1.66 52.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.278 -0.889 . . . . 1.0 109.584 -179.743 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -146.25 154.7 42.02 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.236 -0.915 . . . . 1.0 109.605 -179.845 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.56 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -91.61 0.14 57.53 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.377 -0.827 . . . . 1.0 109.957 -179.631 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -95.16 125.79 40.05 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.109 -0.994 . . . . 1.0 109.192 179.768 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.8 mt -140.04 147.75 40.82 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.363 -0.835 . . . . 1.0 109.192 -179.637 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.0 p -131.44 153.54 49.62 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.482 -0.761 . . . . 1.0 109.032 179.97 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -145.46 160.02 42.22 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.123 -0.985 . . . . 1.0 109.96 -179.988 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.401 ' HG2' HH11 ' A' ' 18' ' ' ARG . 35.3 ttt-85 -142.36 133.8 26.49 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.434 -0.791 . . . . 1.0 109.492 -179.504 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.7 mt -86.61 116.47 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.088 -1.008 . . . . 1.0 108.634 178.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.9 t -69.94 -41.46 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.346 -0.846 . . . . 1.0 109.965 -179.311 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -164.48 158.98 18.89 Favored 'General case' 0 C--N 1.291 -1.952 0 O-C-N 119.238 -2.163 . . . . 1.0 111.548 -178.228 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -101.79 119.06 38.19 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.631 -1.618 . . . . 1.0 106.631 178.313 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.49 ' C ' ' H ' ' A' ' 25' ' ' ASP . 0.1 OUTLIER -61.92 138.0 95.51 Favored Pre-proline 0 C--N 1.303 -1.448 0 O-C-N 121.028 -1.045 . . . . 1.0 109.073 -178.327 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -56.46 -6.35 1.47 Allowed 'Trans proline' 0 N--CA 1.484 0.951 0 CA-C-N 119.614 0.898 . . . . 1.0 110.504 179.554 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.49 ' H ' ' C ' ' A' ' 23' ' ' THR . 81.9 m-20 -60.01 -38.69 83.4 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 120.075 -0.65 . . . . 1.0 110.444 -179.457 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 76.7 mtm -139.25 171.11 14.76 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.053 -1.029 . . . . 1.0 109.359 -179.376 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 82.0 p -75.28 164.98 25.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.332 -0.855 . . . . 1.0 109.829 -179.334 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 25.9 m170 -63.98 -43.79 94.67 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.317 -0.864 . . . . 1.0 110.037 -179.559 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 53.3 m -60.18 -40.08 88.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 1.0 110.712 -178.92 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -65.21 -46.78 79.27 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.011 -1.056 . . . . 1.0 110.359 -179.345 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 70.5 t -64.01 -39.92 87.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.471 -0.768 . . . . 1.0 109.48 -179.738 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -55.55 -55.18 34.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.517 -0.739 . . . . 1.0 111.321 -178.774 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.2 pttt -63.6 -32.12 73.49 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.899 -1.125 . . . . 1.0 110.843 -178.678 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.67 -49.99 74.67 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.728 -1.233 . . . . 1.0 109.563 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -67.15 -39.98 86.61 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.066 -1.021 . . . . 1.0 110.454 -179.822 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -59.97 -40.54 89.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.782 -1.199 . . . . 1.0 109.62 -179.581 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -60.42 -40.05 89.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.975 -1.078 . . . . 1.0 109.159 178.885 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.0 -46.3 89.91 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.434 -0.791 . . . . 1.0 109.689 -179.235 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -65.4 -38.91 91.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.136 -0.977 . . . . 1.0 109.466 179.851 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -59.69 -48.16 82.78 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.208 -0.932 . . . . 1.0 110.18 -179.352 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.06 -42.61 90.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.139 -0.976 . . . . 1.0 109.989 -179.61 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.444 ' O ' ' OG1' ' A' ' 46' ' ' THR . 76.6 m95 -77.8 -38.79 45.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.174 -0.953 . . . . 1.0 110.161 -179.383 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 84.0 p -70.01 -16.77 63.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.096 -1.002 . . . . 1.0 109.997 -179.645 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -59.9 -40.05 87.45 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.072 -1.018 . . . . 1.0 110.412 -179.614 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.6 m -111.81 -19.49 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.406 0 O-C-N 120.991 -1.068 . . . . 1.0 110.815 -179.41 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 42' ' ' TRP . 77.0 p -94.52 128.56 39.66 Favored Pre-proline 0 N--CA 1.5 2.041 0 O-C-N 120.761 -1.212 . . . . 1.0 109.392 179.845 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -73.76 16.46 0.51 Allowed 'Trans proline' 0 N--CA 1.494 1.519 0 CA-C-N 120.17 1.096 . . . . 1.0 111.963 179.27 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.2 mt -69.22 140.01 54.53 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.265 -0.897 . . . . 1.0 109.969 -179.667 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -106.65 121.29 44.05 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.764 -0.828 . . . . 1.0 108.764 179.644 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -106.81 126.03 51.77 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.18 -0.95 . . . . 1.0 109.358 -179.777 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.1 m -120.05 130.03 54.5 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.535 -0.728 . . . . 1.0 109.803 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.416 HH11 ' HG2' ' A' ' 52' ' ' ARG . 33.8 ttt-85 -82.41 133.95 35.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.302 -0.874 . . . . 1.0 109.213 179.51 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.8 mt -103.35 130.57 50.67 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.247 -0.908 . . . . 1.0 109.356 179.856 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.443 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 45.5 m170 -63.41 -39.99 95.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.342 -0.849 . . . . 1.0 110.04 -179.599 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 76.6 m-20 -148.94 172.89 13.98 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.116 -0.99 . . . . 1.0 109.93 -179.505 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.43 177.92 39.98 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.595 -1.402 . . . . 1.0 109.595 179.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.7 mt -94.03 133.7 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.237 -1.155 . . . . 1.0 109.06 179.96 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.75 163.5 13.21 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.515 -0.741 . . . . 1.0 109.378 -179.424 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -60.01 -49.41 77.77 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.182 -0.948 . . . . 1.0 109.398 -179.77 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.8 mt -107.54 102.97 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.386 -0.821 . . . . 1.0 109.896 179.827 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.5 ptm -103.27 130.7 50.59 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.149 -0.969 . . . . 1.0 109.613 179.471 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.8 mt -105.4 138.01 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.581 -0.699 . . . . 1.0 109.926 -179.289 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 63.8 p -153.69 158.64 41.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.217 -0.927 . . . . 1.0 109.985 179.885 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.81 123.07 48.02 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.477 -0.934 . . . . 1.0 108.477 179.517 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 100' ' ' ASP . . . -99.97 175.82 27.76 Favored Glycine 0 N--CA 1.504 3.173 0 O-C-N 121.091 -1.005 . . . . 1.0 111.482 -178.563 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.536 ' O ' ' C ' ' A' ' 67' ' ' LYS . 72.3 mt -129.74 164.56 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.612 -0.934 . . . . 1.0 108.769 179.504 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.536 ' C ' ' O ' ' A' ' 66' ' ' ILE . 28.1 tptp -9.76 -78.51 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.687 0 CA-C-O 121.066 0.46 . . . . 1.0 112.084 179.968 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -69.35 114.55 7.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.041 -1.037 . . . . 1.0 109.212 179.906 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -99.71 -11.69 20.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.322 -0.861 . . . . 1.0 109.503 -179.471 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 70.0 32.35 69.63 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.477 -1.449 . . . . 1.0 109.477 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 72' ' ' PHE . 33.5 t0 -130.04 170.02 14.54 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.543 -0.975 . . . . 1.0 109.225 -179.709 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.5 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 86.3 m-85 -68.65 -28.95 67.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 1.0 109.855 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -125.35 79.77 66.17 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 121.449 -0.782 . . . . 1.0 109.236 179.954 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -70.09 -164.04 0.12 Allowed 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 120.751 0.967 . . . . 1.0 112.375 -179.539 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.498 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 87.0 m-85 -85.02 156.52 21.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.461 -0.774 . . . . 1.0 109.138 -179.863 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -100.15 0.01 39.72 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.23 -0.919 . . . . 1.0 110.266 -179.054 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 136.22 -155.64 22.56 Favored Glycine 0 N--CA 1.498 2.816 0 N-CA-C 108.475 -1.85 . . . . 1.0 108.475 -179.474 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.444 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 7.4 Cg_exo -62.72 -63.76 0.08 OUTLIER 'Trans proline' 0 C--N 1.313 -1.318 0 CA-C-N 118.697 1.249 . . . . 1.0 111.67 179.414 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 83.3 p -77.11 160.02 29.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.074 -1.016 . . . . 1.0 109.323 179.566 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 117.1 -129.3 8.29 Favored Glycine 0 N--CA 1.502 3.084 0 N-CA-C 109.642 -1.383 . . . . 1.0 109.642 179.882 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.419 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 22.3 mt -69.82 109.68 4.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -1.174 . . . . 1.0 109.24 -179.836 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 46.7 mt -80.74 -19.22 45.47 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.135 -0.978 . . . . 1.0 108.996 -179.919 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.55 171.26 1.25 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.761 -0.829 . . . . 1.0 108.761 179.697 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -162.07 159.41 26.18 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.142 -0.974 . . . . 1.0 109.796 179.331 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.6 166.2 29.98 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.79 -0.819 . . . . 1.0 108.79 -179.593 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -101.5 152.77 38.09 Favored Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.217 -0.927 . . . . 1.0 108.873 -179.987 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.559 ' O ' ' N ' ' A' ' 89' ' ' GLY . 10.4 Cg_endo -63.05 165.13 17.44 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 120.599 0.866 . . . . 1.0 111.615 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -47.84 81.7 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.259 0 C-N-CA 121.191 1.261 . . . . 1.0 112.438 -179.814 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -99.57 -168.56 29.99 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 108.361 -1.896 . . . . 1.0 108.361 179.419 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -72.15 -115.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 CA-C-N 118.304 1.052 . . . . 1.0 111.412 -179.704 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -74.9 -40.35 60.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.313 -1.492 . . . . 1.0 110.498 -179.584 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -70.01 -39.96 75.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.175 -0.953 . . . . 1.0 110.57 -178.779 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -60.99 168.92 9.5 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.888 -1.149 . . . . 1.0 110.39 -179.317 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.21 4.61 73.9 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.001 -1.24 . . . . 1.0 110.001 179.511 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.5 p-10 -79.27 162.01 25.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.981 -1.305 . . . . 1.0 109.34 -179.892 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.39 126.15 12.64 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.223 -0.923 . . . . 1.0 109.398 -179.72 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -119.25 153.6 34.74 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.535 -0.728 . . . . 1.0 109.863 -179.774 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -131.22 154.4 48.47 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.622 -0.674 . . . . 1.0 109.281 -179.915 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.498 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 1.2 m-20 -79.46 117.98 20.92 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.04 -1.037 . . . . 1.0 108.749 179.022 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 65' ' ' GLY . 35.5 t0 -82.86 -10.66 58.73 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.016 -1.053 . . . . 1.0 109.178 -179.996 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -82.97 -11.63 57.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.383 -0.823 . . . . 1.0 109.107 179.756 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.444 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 99.5 mt-10 -89.53 169.96 10.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.439 -0.788 . . . . 1.0 109.101 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 22.2 m -98.89 104.68 16.74 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.204 -0.935 . . . . 1.0 109.104 -179.671 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.428 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 97.0 m95 -87.63 121.61 30.27 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 179.632 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.9 t -139.74 153.81 47.28 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.348 -0.845 . . . . 1.0 109.748 -179.198 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.4 m -94.32 -9.11 36.97 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.308 -0.997 . . . . 1.0 108.308 179.187 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 61.6 p -90.99 174.35 7.46 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.601 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 23.1 t -74.04 73.88 1.7 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.183 -0.948 . . . . 1.0 109.543 179.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 110' ' ' GLY . 98.2 mttt -148.58 152.49 36.87 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.331 -0.855 . . . . 1.0 109.133 179.471 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 109' ' ' LYS . . . 42.01 -139.65 2.07 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.959 -1.256 . . . . 1.0 109.959 179.631 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -100.05 117.37 34.17 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.353 -1.086 . . . . 1.0 108.855 179.226 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.449 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 58.0 t-20 -63.52 131.2 47.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.154 -0.966 . . . . 1.0 109.939 -179.527 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.2 tp -60.07 -45.07 94.09 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.474 -0.766 . . . . 1.0 111.092 -179.519 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -59.89 -41.92 92.67 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.0 -1.062 . . . . 1.0 111.069 -178.407 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.09 -50.68 72.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.677 -1.264 . . . . 1.0 109.245 -179.49 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 67.6 t -70.44 -39.97 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.962 . . . . 1.0 110.219 -179.544 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.35 -51.77 68.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.063 -1.023 . . . . 1.0 109.597 -179.503 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.04 81.45 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.269 -0.894 . . . . 1.0 109.964 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -60.96 -50.14 74.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.338 -0.852 . . . . 1.0 110.766 -178.403 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -60.11 -40.13 88.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.625 -1.297 . . . . 1.0 109.874 -179.65 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -60.03 -40.09 88.17 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 120.966 -1.084 . . . . 1.0 108.437 179.614 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.58 -42.54 84.66 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.178 -1.569 . . . . 1.0 109.178 179.829 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -67.48 -40.0 85.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -1.15 . . . . 1.0 109.369 179.529 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 73.0 p -65.96 -21.58 66.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 1.0 109.625 -179.908 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 84.2 mt -82.54 0.29 43.33 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.156 -0.965 . . . . 1.0 109.697 -179.796 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.47 3.32 72.03 Favored Glycine 0 N--CA 1.497 2.719 0 C-N-CA 120.221 -0.99 . . . . 1.0 110.754 179.048 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.7 mt -84.2 148.12 26.91 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.954 -1.321 . . . . 1.0 109.576 179.979 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 41.0 t0 -101.57 173.82 6.25 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.776 -0.824 . . . . 1.0 108.776 179.801 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.527 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 76.6 m80 -57.14 135.7 56.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.006 -1.059 . . . . 1.0 109.274 -179.749 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.477 ' HG ' ' H ' ' A' ' 132' ' ' ASP . 33.4 t -98.76 156.17 16.98 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.392 -0.818 . . . . 1.0 109.405 -179.839 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -99.65 8.38 44.42 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.303 -0.873 . . . . 1.0 109.344 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.477 ' H ' ' HG ' ' A' ' 130' ' ' SER . 30.8 t70 -87.18 122.18 71.09 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 1.0 108.688 179.657 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -66.76 -12.47 36.09 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 CA-C-N 120.267 1.131 . . . . 1.0 111.825 -179.765 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -95.51 -4.2 60.87 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.91 -1.276 . . . . 1.0 109.91 -179.843 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -87.87 142.27 27.94 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.069 -1.254 . . . . 1.0 109.816 -179.893 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.413 ' C ' ' H ' ' A' ' 138' ' ' PHE . 84.6 mt -61.47 -40.08 93.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.335 -0.853 . . . . 1.0 109.717 179.859 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 88.5 mtp -71.69 20.99 0.05 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.413 -0.804 . . . . 1.0 111.528 -178.552 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.413 ' H ' ' C ' ' A' ' 136' ' ' LEU . 18.0 t80 -68.38 132.63 91.36 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 120.498 -1.376 . . . . 1.0 108.067 179.681 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.409 ' O ' ' HD1' ' A' ' 169' ' ' WAY . 13.8 Cg_exo -48.76 -42.96 35.98 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 CA-C-N 119.88 0.993 . . . . 1.0 113.444 -178.798 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 98.4 mt -82.93 143.62 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.038 -1.039 . . . . 1.0 110.815 -178.853 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.449 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 26.2 t80 -77.42 131.33 37.95 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.693 -0.63 . . . . 1.0 109.52 179.738 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 13.3 t -139.66 140.41 36.89 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.291 -0.88 . . . . 1.0 109.274 179.575 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -82.46 140.55 33.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.212 -0.93 . . . . 1.0 108.939 179.639 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.1 t -140.39 151.28 44.82 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.295 -0.878 . . . . 1.0 109.741 -179.384 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.92 107.97 2.35 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.019 -1.633 . . . . 1.0 109.019 179.661 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 21.7 mtmm -78.13 -0.93 30.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -1.12 . . . . 1.0 109.758 -179.262 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 88.8 p -59.97 -38.35 82.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.283 -0.886 . . . . 1.0 110.133 -179.49 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -139.21 21.63 2.59 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.257 -0.902 . . . . 1.0 110.143 -179.308 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -68.26 137.57 54.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.931 -1.106 . . . . 1.0 109.578 -179.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 75.4 mtm -138.87 148.91 44.27 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.244 -1.021 . . . . 1.0 108.244 179.265 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 20.8 mt -51.81 124.03 26.37 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 120.796 -1.19 . . . . 1.0 108.436 -179.737 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -66.15 174.65 5.69 Favored 'Trans proline' 0 N--CA 1.49 1.299 0 CA-C-N 120.124 1.08 . . . . 1.0 112.233 -179.47 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -60.12 -39.81 87.55 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.424 -0.797 . . . . 1.0 109.167 179.816 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -56.45 -49.96 73.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 1.0 110.065 -179.413 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.81 -40.11 72.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.038 -1.039 . . . . 1.0 110.226 -179.411 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 79.0 t -61.37 -48.91 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.089 -1.007 . . . . 1.0 109.444 -179.553 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.18 -39.95 88.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.131 -0.981 . . . . 1.0 110.492 -179.792 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.26 -55.12 8.06 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 120.197 -1.001 . . . . 1.0 111.199 -178.632 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.4 ' CG2' ' N ' ' A' ' 160' ' ' GLN . 7.7 tp -60.14 -40.1 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.917 -1.343 . . . . 1.0 109.676 -179.096 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.547 ' O ' ' N ' ' A' ' 164' ' ' GLY . 27.1 mm100 -65.09 -39.74 93.61 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.225 -0.922 . . . . 1.0 109.402 179.675 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 86.6 p -62.92 -27.21 69.22 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.224 -0.922 . . . . 1.0 110.135 -179.612 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 92.5 mt -86.69 -53.53 4.89 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.912 -1.117 . . . . 1.0 110.437 -179.376 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -91.79 -9.41 43.66 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.07 -1.019 . . . . 1.0 110.051 -179.083 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.582 0 N-CA-C 109.434 -1.466 . . . . 1.0 109.434 -179.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 169' ' ' WAY . . . . . 0.845 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 84.3 m . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.3 mt -75.77 148.54 38.41 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.199 -0.938 . . . . 1.0 109.439 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -162.28 161.25 27.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.294 -0.879 . . . . 1.0 109.669 -179.946 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -72.44 149.35 44.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.075 -1.016 . . . . 1.0 109.156 179.662 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.0 p -85.67 -0.9 56.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.258 -0.901 . . . . 1.0 109.815 -179.497 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -150.47 157.32 42.89 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.101 -0.999 . . . . 1.0 109.518 179.843 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.531 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.01 0.54 57.05 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.179 -0.951 . . . . 1.0 109.988 -179.627 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -94.76 128.35 41.4 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.139 -0.976 . . . . 1.0 108.948 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 97.8 mt -141.85 151.16 42.48 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.158 -0.964 . . . . 1.0 109.342 -179.585 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.7 p -132.86 158.61 42.11 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.055 -0.72 . . . . 1.0 109.055 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -146.27 162.66 37.61 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.1 -1.0 . . . . 1.0 109.988 -179.854 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -143.84 133.04 23.05 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.582 -0.699 . . . . 1.0 109.661 -179.622 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 86.0 mt -88.62 111.21 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.382 -0.97 . . . . 1.0 108.382 178.468 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.4 t -69.96 -40.35 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.012 -1.055 . . . . 1.0 109.679 -179.152 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.9 p-10 -162.37 160.99 27.19 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.839 -1.163 . . . . 1.0 110.431 -179.741 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.511 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 64.6 m-85 -101.75 -168.89 1.61 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.346 -1.353 . . . . 1.0 107.346 178.902 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.626 ' HG1' ' H ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -119.79 143.69 35.59 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.426 -0.796 . . . . 1.0 109.281 179.806 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -63.57 -11.93 28.57 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 CA-C-O 122.511 0.963 . . . . 1.0 110.177 179.067 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.626 ' H ' ' HG1' ' A' ' 23' ' ' THR . 95.5 m-20 -60.04 -39.99 87.86 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 114.942 -1.026 . . . . 1.0 110.126 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.5 mtm -142.53 168.3 20.05 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.22 -0.925 . . . . 1.0 110.118 -178.936 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.7 p -72.2 160.06 33.05 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.422 -0.799 . . . . 1.0 109.76 -179.791 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.511 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 54.5 m170 -60.13 -39.91 87.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.41 -0.807 . . . . 1.0 110.223 -179.589 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 63.2 m -59.91 -40.12 87.75 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.102 -0.999 . . . . 1.0 110.798 -178.674 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -67.32 -39.94 85.9 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.958 -1.089 . . . . 1.0 110.059 -179.698 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.0 t -69.0 -41.15 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.013 -1.054 . . . . 1.0 110.265 -179.29 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.02 -48.29 82.32 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.02 -1.05 . . . . 1.0 110.51 -179.194 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.54 -33.14 72.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.888 -1.132 . . . . 1.0 109.126 179.852 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.98 -49.35 78.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.087 -1.008 . . . . 1.0 109.849 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -67.47 -38.28 84.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.91 -1.119 . . . . 1.0 109.729 179.915 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.471 ' HZ3' HH12 ' A' ' 52' ' ' ARG . 63.5 mmtt -59.95 -43.37 95.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.06 -1.025 . . . . 1.0 109.285 -179.522 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -60.34 -40.26 90.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.019 -1.051 . . . . 1.0 108.92 179.376 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.04 -46.87 88.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.486 -0.759 . . . . 1.0 109.927 -179.947 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -65.68 -39.26 91.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.027 -1.046 . . . . 1.0 109.859 -179.711 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -60.04 -46.37 89.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.039 -1.038 . . . . 1.0 109.761 -179.707 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.8 t -60.12 -43.26 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.169 -0.957 . . . . 1.0 110.585 -179.567 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.426 ' O ' ' OG1' ' A' ' 46' ' ' THR . 82.0 m95 -77.68 -38.03 48.42 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.92 -1.112 . . . . 1.0 110.113 -179.192 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.9 p -70.43 -15.93 62.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.296 -0.877 . . . . 1.0 110.131 -179.385 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -60.02 -40.01 87.81 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.129 -0.982 . . . . 1.0 110.824 -179.636 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.6 m -112.17 -22.68 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.323 -0.861 . . . . 1.0 110.312 -178.685 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 42' ' ' TRP . 69.0 p -93.42 130.93 33.87 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 120.943 -1.098 . . . . 1.0 109.595 -179.992 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -74.61 17.48 0.55 Allowed 'Trans proline' 0 N--CA 1.496 1.638 0 CA-C-N 119.91 1.004 . . . . 1.0 112.043 179.233 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.8 mt -68.94 139.85 55.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.114 -0.991 . . . . 1.0 109.838 -179.444 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -106.62 121.21 43.87 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.933 -0.765 . . . . 1.0 108.933 179.417 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -106.86 124.76 50.09 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.281 -0.887 . . . . 1.0 109.727 -179.428 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.2 m -119.96 130.04 54.58 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.626 -0.671 . . . . 1.0 109.891 179.896 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.472 ' NH1' ' CB ' ' A' ' 52' ' ' ARG . 11.6 ttp-105 -82.88 134.84 35.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.268 -0.895 . . . . 1.0 109.556 179.579 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.3 mt -107.43 134.13 50.93 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.266 -0.896 . . . . 1.0 109.299 179.614 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.434 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 59.5 m170 -65.01 -39.9 94.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.438 -0.789 . . . . 1.0 109.46 -179.931 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 72.0 m-20 -151.44 -176.74 5.71 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.281 -0.887 . . . . 1.0 109.486 -179.805 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.21 -179.48 43.74 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.367 -1.493 . . . . 1.0 109.367 -179.662 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.414 HD13 HG22 ' A' ' 57' ' ' ILE . 93.3 mt -97.1 130.45 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.296 -1.12 . . . . 1.0 109.474 -179.908 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.05 160.46 16.42 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.453 -0.779 . . . . 1.0 109.67 -179.605 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.06 -49.1 78.97 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.284 -0.885 . . . . 1.0 109.348 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.9 mt -105.73 97.04 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.467 -0.771 . . . . 1.0 109.729 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.9 ptm -99.2 125.27 44.74 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.083 -1.01 . . . . 1.0 109.173 179.368 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 86.6 mt -102.81 137.52 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.458 -0.776 . . . . 1.0 109.434 -179.451 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.1 p -153.38 153.32 32.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.185 -0.947 . . . . 1.0 109.852 -179.896 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -104.09 121.36 43.05 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.225 -1.028 . . . . 1.0 108.225 179.116 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -108.22 -172.99 21.71 Favored Glycine 0 N--CA 1.5 2.907 0 N-CA-C 110.852 -0.899 . . . . 1.0 110.852 -178.784 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.57 ' O ' ' C ' ' A' ' 67' ' ' LYS . 83.3 mt -134.99 159.91 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.098 -1.075 . . . . 1.0 108.098 179.29 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.57 ' C ' ' O ' ' A' ' 66' ' ' ILE . 28.2 tptp -0.93 -88.52 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.765 0 CA-C-O 121.283 0.563 . . . . 1.0 111.696 -179.597 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 66' ' ' ILE . 21.1 pt-20 -77.78 150.79 34.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.261 -0.9 . . . . 1.0 109.385 179.152 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.418 ' O ' ' C ' ' A' ' 70' ' ' GLY . 33.4 p-80 -161.24 -155.76 0.42 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.975 -1.078 . . . . 1.0 109.812 179.604 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 69' ' ' HIS . . . -39.59 -84.4 0.01 OUTLIER Glycine 0 N--CA 1.498 2.795 0 N-CA-C 110.628 -0.989 . . . . 1.0 110.628 -179.386 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -65.05 147.18 53.95 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.112 -1.228 . . . . 1.0 108.988 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.619 ' CD1' ' N ' ' A' ' 73' ' ' TYR . 51.6 p90 -59.9 -44.79 94.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.202 -0.936 . . . . 1.0 109.836 -179.199 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.619 ' N ' ' CD1' ' A' ' 72' ' ' PHE . 12.3 t80 -42.08 103.54 0.31 Allowed Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.673 -0.642 . . . . 1.0 109.923 -179.851 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -84.26 -174.23 1.78 Allowed 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 120.921 1.081 . . . . 1.0 113.176 -179.381 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.55 ' CE2' ' OD1' ' A' ' 99' ' ' ASP . 89.8 m-85 -90.63 171.21 9.54 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.505 -0.924 . . . . 1.0 108.505 179.217 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 79' ' ' SER . 20.7 p-10 -96.1 9.53 40.57 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.015 -1.053 . . . . 1.0 110.295 -179.091 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 120.88 -154.86 16.35 Favored Glycine 0 N--CA 1.504 3.181 0 N-CA-C 108.934 -1.666 . . . . 1.0 108.934 179.888 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.434 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 3.7 Cg_exo -63.12 -62.41 0.11 Allowed 'Trans proline' 0 N--CA 1.489 1.224 0 CA-C-N 118.962 1.381 . . . . 1.0 111.715 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.419 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 70.9 p -75.63 162.41 28.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.439 -0.788 . . . . 1.0 109.729 179.736 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 111.67 -126.35 7.64 Favored Glycine 0 N--CA 1.501 2.983 0 N-CA-C 109.9 -1.28 . . . . 1.0 109.9 179.71 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.401 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 7.2 mt -69.69 100.39 1.48 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.36 -1.082 . . . . 1.0 109.074 -179.787 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 46.4 mt -73.91 -29.75 62.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.033 -1.042 . . . . 1.0 109.252 -179.702 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -177.32 166.81 2.33 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.086 -1.079 . . . . 1.0 108.086 -179.661 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -163.07 159.91 23.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.753 -1.217 . . . . 1.0 110.033 179.652 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -138.69 160.32 39.94 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.924 -0.769 . . . . 1.0 108.924 179.898 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -97.45 152.06 38.0 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.248 -0.908 . . . . 1.0 109.278 -179.663 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.529 ' O ' ' N ' ' A' ' 89' ' ' GLY . 12.6 Cg_exo -47.08 167.0 0.08 OUTLIER 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 120.437 0.758 . . . . 1.0 111.359 179.976 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -61.61 63.68 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 120.981 1.121 . . . . 1.0 112.416 -179.312 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -64.64 177.72 9.38 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.936 -1.666 . . . . 1.0 108.936 179.433 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -52.72 -82.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 CA-C-N 118.27 1.035 . . . . 1.0 111.675 -179.655 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -112.49 -45.28 3.26 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.19 -0.944 . . . . 1.0 109.293 179.75 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -59.98 -42.19 93.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.321 -0.862 . . . . 1.0 110.2 179.869 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -61.75 169.43 12.01 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.449 -1.06 . . . . 1.0 110.449 -178.996 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.21 4.17 88.79 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 108.929 -1.669 . . . . 1.0 108.929 -179.823 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.442 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 31.5 p-10 -80.55 167.69 19.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.348 -1.089 . . . . 1.0 109.683 179.932 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.96 119.41 6.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.181 -0.949 . . . . 1.0 109.655 179.826 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -103.87 126.02 50.7 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.398 -0.814 . . . . 1.0 109.593 179.975 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.412 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 28.1 m-85 -106.14 145.92 30.88 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.549 -0.719 . . . . 1.0 109.266 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.55 ' OD1' ' CE2' ' A' ' 75' ' ' PHE . 94.7 m-20 -78.24 121.98 25.1 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.979 -1.076 . . . . 1.0 109.145 179.513 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 45.7 t0 -83.18 -10.89 58.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.232 -0.918 . . . . 1.0 109.622 179.976 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -81.91 -10.98 59.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.311 -0.868 . . . . 1.0 109.852 -179.732 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.434 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 98.7 mt-10 -89.15 169.05 11.8 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.185 -0.947 . . . . 1.0 109.614 -179.348 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 54.8 m -98.12 104.73 16.79 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.168 -0.958 . . . . 1.0 109.291 -179.521 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -89.35 120.95 31.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.882 . . . . 1.0 108.908 179.924 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.4 t -140.06 150.16 44.03 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.444 -0.785 . . . . 1.0 109.819 -179.046 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 66.3 m -91.64 -8.59 46.74 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.257 -1.016 . . . . 1.0 108.257 179.034 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 83.5 p -90.17 172.14 9.02 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.787 -0.82 . . . . 1.0 108.787 179.364 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.7 t -74.99 77.2 2.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.024 -1.047 . . . . 1.0 109.416 -179.962 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -148.85 147.52 28.82 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 179.456 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.14 -138.06 4.72 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.981 -1.248 . . . . 1.0 109.981 179.746 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -100.04 115.2 29.18 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.282 -1.128 . . . . 1.0 109.171 179.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.582 ' H ' ' HH ' ' A' ' 141' ' ' TYR . 15.8 t-20 -63.96 133.95 54.16 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.087 -1.008 . . . . 1.0 109.781 -179.685 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.4 tp -59.95 -45.09 93.74 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.357 -0.84 . . . . 1.0 111.165 -179.6 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -59.94 -40.97 90.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.988 -1.07 . . . . 1.0 110.695 -178.188 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -59.97 -50.2 74.68 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.838 -1.164 . . . . 1.0 109.436 -179.569 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.5 t -70.01 -40.48 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.099 -1.0 . . . . 1.0 110.109 -179.396 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.93 -51.27 70.77 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.115 -0.99 . . . . 1.0 109.6 -179.312 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.99 -36.56 77.45 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.282 -0.886 . . . . 1.0 110.425 -179.97 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -63.34 -49.88 72.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.166 -0.959 . . . . 1.0 110.806 -178.558 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.412 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 7.3 pt-20 -59.87 -39.15 84.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.746 -1.221 . . . . 1.0 109.999 -179.455 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -60.04 -40.05 88.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.788 -1.195 . . . . 1.0 108.829 179.421 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -56.97 -42.9 93.03 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.547 -1.421 . . . . 1.0 109.547 179.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -67.23 -39.96 86.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.108 -1.231 . . . . 1.0 109.993 179.801 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 87.3 p -67.1 -22.18 65.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 1.0 109.909 -179.598 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 81.0 mt -80.84 -0.93 41.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.158 -0.964 . . . . 1.0 109.701 -179.853 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.92 6.14 67.49 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 110.414 -1.075 . . . . 1.0 110.414 179.264 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.4 mt -84.91 150.04 25.24 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.987 -1.302 . . . . 1.0 109.654 179.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 38.4 t0 -99.95 175.59 5.72 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.593 -0.891 . . . . 1.0 108.593 179.416 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.501 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 72.6 m80 -59.7 139.98 56.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.97 -1.081 . . . . 1.0 109.491 -179.742 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 44.2 t -98.09 148.1 23.88 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.381 -0.825 . . . . 1.0 109.334 -179.808 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -96.9 2.15 51.33 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.266 -0.896 . . . . 1.0 109.733 -179.646 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 8.2 t0 -86.48 128.14 58.13 Favored Pre-proline 0 N--CA 1.491 1.623 0 N-CA-C 107.947 -1.131 . . . . 1.0 107.947 179.296 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -65.39 -19.67 61.44 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 CA-C-N 120.344 1.158 . . . . 1.0 112.305 -179.665 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.426 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -88.09 -6.36 75.36 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.621 -1.392 . . . . 1.0 109.621 -179.929 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.61 135.41 34.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.244 -1.15 . . . . 1.0 109.235 179.787 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.478 ' C ' ' H ' ' A' ' 138' ' ' PHE . 92.2 mt -60.08 -38.92 84.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.108 -0.995 . . . . 1.0 109.685 -179.692 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 71.0 mtp -69.9 21.81 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.384 -0.823 . . . . 1.0 111.349 -178.631 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.478 ' H ' ' C ' ' A' ' 136' ' ' LEU . 16.1 t80 -67.06 134.43 93.78 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 120.726 -1.234 . . . . 1.0 107.848 179.542 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -61.64 -5.5 5.84 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 120.876 1.05 . . . . 1.0 114.215 -177.886 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 89.6 mt -118.05 136.55 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 O-C-N 120.918 -1.114 . . . . 1.0 109.269 179.55 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.582 ' HH ' ' H ' ' A' ' 112' ' ' ASN . 35.7 t80 -72.11 126.55 30.07 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.349 -0.845 . . . . 1.0 109.958 -178.928 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.8 t -139.55 142.19 37.2 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.81 -0.811 . . . . 1.0 108.81 179.79 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -80.77 145.03 31.69 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.002 -1.061 . . . . 1.0 109.545 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.8 t -140.03 156.66 46.51 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.412 -0.805 . . . . 1.0 109.438 -179.605 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.12 104.49 0.97 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.719 -1.352 . . . . 1.0 109.719 -179.859 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -77.1 -0.93 26.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.364 -1.08 . . . . 1.0 109.898 -179.892 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 42.1 t -60.01 -43.09 95.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.084 -1.01 . . . . 1.0 109.353 -179.562 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -156.05 74.31 0.85 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.096 -1.002 . . . . 1.0 109.556 179.545 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -99.13 122.91 42.98 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.297 -0.877 . . . . 1.0 109.166 179.555 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 96.7 mtp -114.57 140.18 48.99 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.021 -0.733 . . . . 1.0 109.021 179.854 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 57.0 mt -50.26 128.82 23.85 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.021 -1.049 . . . . 1.0 108.836 -179.94 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -69.01 176.97 5.52 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 CA-C-N 120.041 1.05 . . . . 1.0 112.335 179.889 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.04 -40.0 87.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.417 -0.802 . . . . 1.0 109.549 179.775 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -55.76 -49.97 71.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.342 -0.849 . . . . 1.0 109.943 -179.385 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -70.72 -40.0 73.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.023 -1.048 . . . . 1.0 110.151 -179.525 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 76.9 t -62.09 -48.58 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.106 -0.997 . . . . 1.0 109.335 -179.67 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -60.82 -39.98 91.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.975 -1.078 . . . . 1.0 110.283 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.401 ' O ' ' OG ' ' A' ' 161' ' ' SER . . . -70.68 -53.83 11.3 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 120.228 -0.987 . . . . 1.0 111.393 -178.634 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 6.0 tp -60.48 -40.04 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.868 -1.372 . . . . 1.0 109.795 -178.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 164' ' ' GLY . 95.1 mt-30 -64.01 -39.86 95.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.192 -0.943 . . . . 1.0 109.156 179.593 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' A' ' 158' ' ' GLY . 86.3 p -62.74 -28.58 70.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.885 . . . . 1.0 110.326 -179.805 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 85.4 mt -87.85 -49.95 6.76 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.947 -1.096 . . . . 1.0 110.401 -179.213 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -91.05 -9.52 45.5 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.067 -1.021 . . . . 1.0 110.148 -179.061 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.554 -1.418 . . . . 1.0 109.554 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 169' ' ' WAY . . . . . 0.936 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.1 mt . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 121.417 0.627 . . . . 1.0 109.529 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.05 162.25 34.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.335 -0.853 . . . . 1.0 108.815 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -71.99 149.21 45.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.999 -1.063 . . . . 1.0 109.071 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.0 t -79.41 -4.8 52.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.402 -0.811 . . . . 1.0 110.382 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.2 pttt -150.08 159.15 44.63 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.954 -1.091 . . . . 1.0 109.705 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.536 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.03 0.41 57.13 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.459 -0.776 . . . . 1.0 109.416 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -95.27 126.51 40.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.329 -0.857 . . . . 1.0 108.753 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.3 mt -140.14 152.11 45.82 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.279 -0.888 . . . . 1.0 109.069 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.8 p -130.27 155.29 46.54 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.893 -0.78 . . . . 1.0 108.893 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -145.62 158.72 43.81 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.039 -1.038 . . . . 1.0 109.89 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.603 HH12 ' H ' ' A' ' 56' ' ' GLY . 70.7 ttt180 -144.14 133.73 23.52 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.513 -0.742 . . . . 1.0 109.533 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.4 mt -89.43 117.59 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.091 -1.006 . . . . 1.0 109.125 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 56.6 t -69.94 -41.44 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.171 -0.956 . . . . 1.0 109.414 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.3 p-10 -163.2 162.99 25.71 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.775 -1.203 . . . . 1.0 110.125 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -102.12 -167.39 1.4 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.203 -1.406 . . . . 1.0 107.203 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.72 143.08 35.63 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.374 -0.829 . . . . 1.0 109.817 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -66.07 -15.58 49.12 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 120.854 1.036 . . . . 1.0 110.822 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -59.17 -39.6 83.01 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.288 -0.869 . . . . 1.0 109.995 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.5 mtm -136.27 166.06 24.3 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.252 -0.905 . . . . 1.0 109.428 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.7 p -71.77 161.2 31.33 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.515 -0.74 . . . . 1.0 109.648 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -61.77 -39.91 93.32 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.553 -0.717 . . . . 1.0 109.741 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.7 m -59.9 -40.05 87.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.983 -1.073 . . . . 1.0 110.08 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -64.67 -40.08 94.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.924 -1.11 . . . . 1.0 109.975 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 63.2 t -70.02 -40.4 78.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 120.935 -1.103 . . . . 1.0 110.278 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.98 -52.87 63.56 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.235 -0.916 . . . . 1.0 110.899 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.5 ptmt -64.5 -28.82 69.92 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.196 -0.94 . . . . 1.0 109.992 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.12 -49.67 76.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.874 -1.141 . . . . 1.0 109.413 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -67.77 -38.53 83.53 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.994 -1.067 . . . . 1.0 110.083 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -59.88 -43.08 94.95 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.903 -1.123 . . . . 1.0 109.37 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -61.59 -40.09 93.55 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.058 -1.026 . . . . 1.0 108.781 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.08 -47.17 87.01 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.528 -0.733 . . . . 1.0 109.825 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -63.31 -39.85 95.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.992 -1.068 . . . . 1.0 109.57 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -59.8 -48.96 79.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.087 -1.008 . . . . 1.0 109.859 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.5 t -60.05 -40.41 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.255 -0.903 . . . . 1.0 110.602 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.436 ' CE3' ' CD1' ' A' ' 125' ' ' LEU . 73.5 m95 -79.4 -37.1 38.03 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.949 -1.094 . . . . 1.0 109.424 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.7 p -71.22 -20.0 62.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.104 -0.998 . . . . 1.0 110.029 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -60.65 -39.91 90.1 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.954 -1.091 . . . . 1.0 110.899 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.2 m -111.31 22.78 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.195 -0.941 . . . . 1.0 111.071 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.6 p -146.94 135.36 10.92 Favored Pre-proline 0 N--CA 1.501 2.11 0 O-C-N 120.843 -1.161 . . . . 1.0 109.361 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -74.28 17.57 0.51 Allowed 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 120.733 0.955 . . . . 1.0 111.967 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 78.2 mt -69.33 139.53 54.27 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.253 -0.904 . . . . 1.0 109.915 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -110.79 120.78 43.52 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.865 -0.791 . . . . 1.0 108.865 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -107.6 122.43 46.68 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.413 -0.804 . . . . 1.0 109.647 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -120.18 130.11 54.43 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.663 -0.648 . . . . 1.0 110.068 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -81.83 135.7 35.43 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.27 -0.894 . . . . 1.0 109.348 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.3 mt -104.27 126.23 51.2 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.364 -0.835 . . . . 1.0 109.181 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.41 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 45.8 m-70 -61.61 -40.16 93.83 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.329 -0.857 . . . . 1.0 109.737 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 77.3 m-20 -146.45 167.48 23.53 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.242 -0.911 . . . . 1.0 109.857 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.603 ' H ' HH12 ' A' ' 18' ' ' ARG . . . 98.22 175.73 33.09 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.136 -1.585 . . . . 1.0 109.136 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -93.55 136.81 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.228 -1.16 . . . . 1.0 108.579 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.66 161.08 15.74 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.423 -0.798 . . . . 1.0 109.281 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.02 -49.8 76.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.303 -0.873 . . . . 1.0 109.144 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 88.6 mt -106.64 102.59 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.377 -0.827 . . . . 1.0 109.702 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.1 ptm -102.47 131.49 49.13 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.348 -0.845 . . . . 1.0 109.148 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 88.3 mt -105.92 135.11 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.539 -0.725 . . . . 1.0 109.808 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 64.4 p -152.32 158.88 43.37 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.192 -0.942 . . . . 1.0 109.851 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -104.46 121.23 43.0 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.24 -170.01 23.97 Favored Glycine 0 N--CA 1.501 2.984 0 O-C-N 121.156 -0.965 . . . . 1.0 111.121 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 78.0 mt . . . . . 0 N--CA 1.498 1.937 0 N-CA-C 107.995 -1.113 . . . . 1.0 107.995 179.521 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.53 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 72.2 m-85 . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 109.207 -0.664 . . . . 1.0 109.207 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -100.11 8.04 44.19 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.236 -0.915 . . . . 1.0 110.102 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 127.99 -156.4 20.69 Favored Glycine 0 N--CA 1.504 3.193 0 N-CA-C 108.608 -1.797 . . . . 1.0 108.608 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -60.7 -65.66 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.462 0 CA-C-N 118.855 1.328 . . . . 1.0 111.422 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 87.4 p -76.53 160.03 29.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.059 -1.026 . . . . 1.0 109.436 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.26 -126.87 7.24 Favored Glycine 0 N--CA 1.504 3.203 0 N-CA-C 110.016 -1.234 . . . . 1.0 110.016 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.427 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 28.4 mt -68.71 107.69 3.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.228 -1.16 . . . . 1.0 109.483 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 38.0 mt -79.67 -16.54 55.55 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.017 -1.052 . . . . 1.0 108.209 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.32 175.26 0.94 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.203 -1.036 . . . . 1.0 108.203 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.468 ' CE1' ' ND1' ' A' ' 97' ' ' HIS . 7.5 p80 -161.2 159.99 29.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.994 -1.066 . . . . 1.0 109.479 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.07 160.16 44.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.371 -0.831 . . . . 1.0 108.866 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -106.25 151.45 40.21 Favored Pre-proline 0 N--CA 1.499 1.984 0 N-CA-C 108.766 -0.827 . . . . 1.0 108.766 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -44.81 161.92 0.08 OUTLIER 'Trans proline' 0 N--CA 1.488 1.152 0 C-N-CA 120.694 0.93 . . . . 1.0 111.656 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo . . . . . 0 N--CA 1.494 1.543 0 C-N-CA 121.158 1.239 . . . . 1.0 112.529 -179.477 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.6 p-10 . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 121.191 0.52 . . . . 1.0 109.733 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.49 122.57 8.26 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.289 -0.882 . . . . 1.0 109.533 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.468 ' ND1' ' CE1' ' A' ' 84' ' ' HIS . 60.8 m170 -110.74 148.25 32.7 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.652 -0.655 . . . . 1.0 109.692 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -123.05 156.46 34.82 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.571 -0.706 . . . . 1.0 109.19 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.53 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 1.1 m-20 -81.2 121.35 26.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 1.0 109.633 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -84.67 -12.95 52.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.068 -1.02 . . . . 1.0 109.422 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -82.96 -11.54 58.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.311 -0.868 . . . . 1.0 109.879 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -87.82 173.01 9.21 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.36 -0.838 . . . . 1.0 110.075 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.0 m -99.88 104.85 16.53 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.411 -0.806 . . . . 1.0 108.871 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.523 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 95.9 m95 -88.71 125.28 34.78 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.633 -0.877 . . . . 1.0 108.633 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.658 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.8 t -140.35 150.46 43.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.492 -0.755 . . . . 1.0 109.308 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 75.7 m -92.17 -8.26 46.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.104 -0.998 . . . . 1.0 108.383 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.8 m -91.19 174.84 7.18 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.57 -0.9 . . . . 1.0 108.57 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.485 ' OG ' ' CZ ' ' A' ' 143' ' ' TYR . 4.2 m -78.06 77.59 4.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.835 -1.166 . . . . 1.0 109.429 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.658 ' HB2' HG21 ' A' ' 105' ' ' THR . 99.2 mttt -146.98 149.58 33.44 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.707 -0.849 . . . . 1.0 108.707 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.81 -135.66 6.64 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.793 -1.323 . . . . 1.0 109.793 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -100.6 114.3 27.85 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.323 -1.104 . . . . 1.0 109.136 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -63.94 132.43 50.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.135 -0.978 . . . . 1.0 109.248 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.3 tp -59.8 -41.38 91.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.32 -0.862 . . . . 1.0 110.255 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -59.97 -43.8 94.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.311 -0.868 . . . . 1.0 111.095 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.453 HD21 HG22 ' A' ' 144' ' ' THR . 1.8 mm? -59.42 -50.49 73.74 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.671 -1.268 . . . . 1.0 109.814 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.1 t -66.24 -40.8 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.933 -1.104 . . . . 1.0 109.407 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.32 -51.5 69.67 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.282 -0.887 . . . . 1.0 110.067 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.27 -36.44 73.26 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.383 -1.448 . . . . 1.0 110.181 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.533 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 56.7 t60 -66.77 -47.75 71.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.113 -0.992 . . . . 1.0 111.746 -178.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -59.54 -39.86 85.34 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.624 -1.298 . . . . 1.0 109.515 -178.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -59.87 -39.37 85.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.11 -0.994 . . . . 1.0 108.513 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.95 -43.48 87.78 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.581 -1.408 . . . . 1.0 109.581 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.533 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 78.0 m-70 -64.5 -39.83 94.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.015 -1.286 . . . . 1.0 109.289 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 90.5 p -66.72 -24.12 66.2 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.137 -0.977 . . . . 1.0 110.025 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.436 ' CD1' ' CE3' ' A' ' 42' ' ' TRP . 80.9 mt -81.71 -1.64 47.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.11 -0.994 . . . . 1.0 109.689 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 91.33 9.62 63.1 Favored Glycine 0 N--CA 1.499 2.835 0 C-N-CA 120.243 -0.979 . . . . 1.0 111.01 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.8 mt -86.92 146.18 26.26 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.903 -1.351 . . . . 1.0 109.903 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 36.9 t0 -103.62 172.02 7.04 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.694 -0.854 . . . . 1.0 108.694 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.545 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 35.5 m170 -59.94 134.67 57.26 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.001 -1.062 . . . . 1.0 109.612 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 37.4 t -97.4 164.83 12.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.283 -0.886 . . . . 1.0 109.513 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -99.16 1.88 45.37 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.294 -0.879 . . . . 1.0 109.237 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 17.3 t0 -85.67 125.11 70.11 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.299 -0.875 . . . . 1.0 108.971 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -68.82 -20.53 39.39 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 CA-C-N 120.146 1.088 . . . . 1.0 111.822 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.451 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -86.26 -7.2 80.27 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.739 -1.344 . . . . 1.0 109.739 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.11 148.52 26.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.128 -1.219 . . . . 1.0 109.913 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.8 mt -69.83 -29.03 66.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.348 -0.845 . . . . 1.0 109.461 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.6 mmm -73.93 8.74 1.84 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.572 -0.705 . . . . 1.0 110.81 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -67.37 132.78 93.14 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 120.795 -1.191 . . . . 1.0 108.38 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -60.32 -24.73 78.38 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 120.861 1.041 . . . . 1.0 113.477 -178.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.3 mt -93.49 139.18 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 120.909 -1.119 . . . . 1.0 110.369 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -73.94 131.59 41.59 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.495 0.664 . . . . 1.0 110.05 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.8 t -141.19 140.45 34.02 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.719 -0.613 . . . . 1.0 109.441 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.485 ' CZ ' ' OG ' ' A' ' 108' ' ' SER . 79.3 t80 -80.94 145.07 31.43 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.241 -0.912 . . . . 1.0 109.033 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.453 HG22 HD21 ' A' ' 115' ' ' LEU . 6.8 t -141.01 155.32 46.22 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.342 -0.849 . . . . 1.0 108.918 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -77.8 112.66 3.54 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.258 -1.537 . . . . 1.0 109.258 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -77.79 3.34 14.47 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.239 -1.154 . . . . 1.0 110.034 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.5 ' O ' ' ND1' ' A' ' 148' ' ' HIS . 86.5 p -59.9 -38.38 82.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.077 -1.014 . . . . 1.0 109.679 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' HIS . . . . . 0.5 ' ND1' ' O ' ' A' ' 147' ' ' SER . 89.3 m-70 -154.08 33.05 0.43 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.09 -1.006 . . . . 1.0 110.078 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -70.85 138.69 50.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.996 -1.065 . . . . 1.0 109.67 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 58.4 mtt -140.02 149.53 43.31 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.225 -1.028 . . . . 1.0 108.225 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.697 ' H ' HD12 ' A' ' 151' ' ' LEU . 6.8 mp -52.25 127.38 38.59 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.87 -1.144 . . . . 1.0 108.833 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -65.1 -179.05 0.92 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 CA-C-N 120.088 1.067 . . . . 1.0 111.875 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -62.59 -40.14 95.96 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.456 -0.777 . . . . 1.0 110.175 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.407 ' C ' ' OD1' ' A' ' 154' ' ' ASP . 52.7 t0 -57.22 -49.71 75.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.964 -1.085 . . . . 1.0 110.138 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -70.44 -40.04 74.0 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.155 -0.966 . . . . 1.0 109.92 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 51.5 t -61.3 -44.74 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.051 -1.031 . . . . 1.0 109.591 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -61.61 -39.05 89.89 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.98 -1.075 . . . . 1.0 109.97 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -69.97 -53.27 15.52 Favored Glycine 0 N--CA 1.494 2.545 0 O-C-N 121.051 -1.03 . . . . 1.0 111.262 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.46 HG23 ' N ' ' A' ' 160' ' ' GLN . 6.3 tp -62.04 -40.54 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.722 -1.457 . . . . 1.0 109.837 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 164' ' ' GLY . 97.6 mt-30 -64.48 -39.79 94.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.01 -1.056 . . . . 1.0 109.757 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 93.2 p -64.75 -26.61 68.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.139 -0.976 . . . . 1.0 110.271 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 92.2 mt -86.39 -54.02 4.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.164 -0.96 . . . . 1.0 110.174 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -91.0 -11.27 39.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.229 -0.919 . . . . 1.0 110.27 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.626 0 N-CA-C 109.386 -1.486 . . . . 1.0 109.386 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.5 mt . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.5 pttt -161.26 162.05 30.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.372 -0.83 . . . . 1.0 109.499 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -70.65 146.53 49.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.205 -0.934 . . . . 1.0 109.419 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.3 m -99.57 17.82 19.49 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.36 -0.837 . . . . 1.0 110.043 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -147.82 147.63 30.03 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.001 -1.062 . . . . 1.0 109.438 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.538 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -91.82 -0.68 57.54 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.347 -0.845 . . . . 1.0 110.087 -179.707 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -99.28 119.9 38.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.264 -0.898 . . . . 1.0 108.589 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.7 mt -140.04 150.38 44.32 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.262 -0.899 . . . . 1.0 109.059 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.1 p -132.11 158.36 41.83 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.566 -0.709 . . . . 1.0 109.27 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -143.43 158.23 43.81 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.266 -0.896 . . . . 1.0 109.759 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.0 ttt-85 -143.14 132.65 23.58 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.483 -0.76 . . . . 1.0 109.796 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.8 mt -88.46 117.31 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.251 -0.906 . . . . 1.0 109.259 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.89 -40.05 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.079 -1.013 . . . . 1.0 108.937 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -163.01 160.77 24.99 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.099 -1.001 . . . . 1.0 110.065 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.639 ' CD1' ' CD2' ' A' ' 28' ' ' HIS . 46.9 m-85 -102.71 -160.39 0.78 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.086 -1.449 . . . . 1.0 107.086 178.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.62 153.76 77.66 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.053 -1.029 . . . . 1.0 110.704 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -74.16 -16.9 22.28 Favored 'Trans proline' 0 N--CA 1.486 1.068 0 C-N-CA 121.089 1.193 . . . . 1.0 110.124 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.46 -39.97 85.37 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.382 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 73.9 mtm -135.86 163.76 29.49 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.305 -0.872 . . . . 1.0 109.519 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.8 p -72.42 159.71 33.54 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.34 -0.85 . . . . 1.0 109.422 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.639 ' CD2' ' CD1' ' A' ' 22' ' ' TYR . 1.1 m80 -61.41 -40.03 92.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.434 -0.791 . . . . 1.0 110.399 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.5 m -60.08 -39.94 87.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.128 -0.982 . . . . 1.0 110.235 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -67.0 -39.98 87.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.136 -0.977 . . . . 1.0 109.871 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.4 t -68.21 -41.46 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.935 . . . . 1.0 110.457 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -60.05 -48.74 80.47 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.978 -1.076 . . . . 1.0 110.582 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -62.61 -32.46 73.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.979 -1.075 . . . . 1.0 109.948 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.07 -47.83 84.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.086 -1.009 . . . . 1.0 109.68 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.4 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 49.2 m-85 -66.04 -39.73 90.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.074 -1.016 . . . . 1.0 109.868 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -60.02 -41.97 93.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.95 -1.094 . . . . 1.0 109.771 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -60.81 -41.93 96.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.966 -1.084 . . . . 1.0 109.201 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.39 -45.4 93.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.458 -0.776 . . . . 1.0 110.276 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -68.13 -38.37 82.12 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.986 -1.071 . . . . 1.0 110.162 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -59.93 -46.65 88.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.032 -1.043 . . . . 1.0 109.404 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.2 t -59.94 -41.0 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.943 . . . . 1.0 109.759 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.404 ' CZ3' HD22 ' A' ' 151' ' ' LEU . 71.9 m95 -79.48 -36.56 38.52 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.983 -1.073 . . . . 1.0 110.293 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.8 p -71.23 -18.74 62.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.974 -1.078 . . . . 1.0 109.843 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.88 -39.66 90.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.188 -0.945 . . . . 1.0 110.847 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.9 m -110.05 23.25 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.28 -0.887 . . . . 1.0 110.836 -178.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.0 p -149.05 137.7 12.01 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 120.861 -1.149 . . . . 1.0 109.377 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -75.25 18.03 0.59 Allowed 'Trans proline' 0 N--CA 1.495 1.598 0 CA-C-N 119.68 0.921 . . . . 1.0 112.102 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.9 mt -68.19 138.39 55.58 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.048 -1.032 . . . . 1.0 109.991 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -110.15 120.35 42.17 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.665 -0.865 . . . . 1.0 108.665 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -108.12 121.32 44.59 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.42 -0.8 . . . . 1.0 109.589 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -120.01 130.03 54.54 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.598 -0.688 . . . . 1.0 109.333 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -82.53 134.7 35.2 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.198 -0.939 . . . . 1.0 109.441 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.4 mt -104.03 131.94 50.78 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.35 -0.844 . . . . 1.0 109.448 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.438 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 91.6 m-70 -65.03 -40.01 94.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.483 -0.761 . . . . 1.0 110.405 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 80.5 m-20 -146.74 170.02 17.86 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.106 -0.996 . . . . 1.0 109.985 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.26 177.51 40.35 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.483 -1.447 . . . . 1.0 109.483 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.5 mt -93.81 136.45 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.212 -1.17 . . . . 1.0 109.105 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -107.83 173.16 6.44 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.404 -0.81 . . . . 1.0 109.415 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -60.04 -49.18 78.66 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.193 -0.942 . . . . 1.0 109.216 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.0 mt -119.99 117.52 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.471 -0.768 . . . . 1.0 109.179 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.8 ptp -100.97 140.0 35.88 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.209 -0.932 . . . . 1.0 109.293 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.4 HG21 ' CZ ' ' A' ' 35' ' ' PHE . 86.4 mt -110.01 130.09 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.622 -0.674 . . . . 1.0 109.802 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 31.0 p -150.51 156.21 40.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.217 -0.927 . . . . 1.0 109.826 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -102.76 122.79 45.2 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.292 -1.003 . . . . 1.0 108.292 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.7 -177.28 23.93 Favored Glycine 0 N--CA 1.499 2.891 0 N-CA-C 110.709 -0.956 . . . . 1.0 110.709 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 87.6 mt . . . . . 0 N--CA 1.493 1.708 0 O-C-N 121.71 -0.877 . . . . 1.0 108.813 179.481 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.517 ' CD2' ' OD2' ' A' ' 99' ' ' ASP . 34.0 m-85 . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -99.94 0.04 40.41 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.217 -0.927 . . . . 1.0 110.478 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 128.05 -139.46 11.1 Favored Glycine 0 N--CA 1.502 3.056 0 N-CA-C 108.344 -1.902 . . . . 1.0 108.344 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.448 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 24.9 Cg_endo -79.02 -52.9 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.314 0 CA-C-N 119.917 1.859 . . . . 1.0 112.09 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 91.6 p -79.6 170.49 16.48 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.205 -0.934 . . . . 1.0 110.086 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.82 -122.5 7.6 Favored Glycine 0 N--CA 1.498 2.817 0 N-CA-C 110.488 -1.045 . . . . 1.0 110.488 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.465 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 9.8 mt -67.26 100.48 0.81 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.454 -1.027 . . . . 1.0 109.111 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 64.2 mt -79.06 -20.03 49.87 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.014 -1.054 . . . . 1.0 110.03 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.01 171.99 1.32 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 1.0 109.035 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -162.28 159.14 25.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.012 -1.055 . . . . 1.0 109.896 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.08 156.18 42.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.49 -0.756 . . . . 1.0 109.322 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -103.5 150.94 38.55 Favored Pre-proline 0 N--CA 1.496 1.863 0 N-CA-C 108.39 -0.967 . . . . 1.0 108.39 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.73 166.47 11.85 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 120.924 1.083 . . . . 1.0 111.42 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo . . . . . 0 C--N 1.313 -1.34 0 C-N-CA 120.661 0.907 . . . . 1.0 111.361 -179.897 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 109.602 -0.518 . . . . 1.0 109.602 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.04 122.43 9.05 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.209 -0.932 . . . . 1.0 109.526 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -109.72 155.98 20.86 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.596 -0.69 . . . . 1.0 109.392 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.524 ' CE2' ' OE2' ' A' ' 120' ' ' GLU . 29.1 m-85 -130.23 143.66 50.91 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.197 -1.038 . . . . 1.0 108.197 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.517 ' OD2' ' CD2' ' A' ' 75' ' ' PHE . 93.6 m-20 -80.01 117.06 20.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.725 -1.234 . . . . 1.0 109.576 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 39.1 t0 -81.59 2.74 27.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.386 -0.821 . . . . 1.0 109.559 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -81.2 -17.34 49.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 1.0 110.101 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' A' ' 102' ' ' GLU . 58.0 mp0 -92.86 174.87 7.02 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.018 -1.051 . . . . 1.0 109.605 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 23.3 m -99.14 105.12 17.17 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.529 -0.915 . . . . 1.0 108.529 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -85.21 128.12 34.55 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.347 -0.845 . . . . 1.0 108.73 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.661 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.9 t -142.77 158.33 43.74 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.416 -0.803 . . . . 1.0 109.781 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.6 t -95.56 -9.09 33.28 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.253 -1.017 . . . . 1.0 108.253 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.4 t -92.1 -171.6 2.88 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.888 -0.782 . . . . 1.0 108.888 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.5 t -88.38 77.77 8.07 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.077 -1.014 . . . . 1.0 109.619 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.661 ' HB2' HG21 ' A' ' 105' ' ' THR . 60.4 mttp -149.31 151.39 34.07 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.324 -0.86 . . . . 1.0 108.761 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.48 -137.7 5.29 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.949 -1.26 . . . . 1.0 109.949 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -100.06 118.97 37.55 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.376 -1.073 . . . . 1.0 109.316 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.65 HD21 ' HZ2' ' A' ' 146' ' ' LYS . 23.8 t-20 -65.52 130.11 42.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 1.0 110.059 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 58.6 tp -60.06 -47.11 87.24 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.368 -0.832 . . . . 1.0 111.295 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -59.79 -42.9 94.4 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.083 -1.01 . . . . 1.0 111.843 -177.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 115' ' ' LEU . 4.0 mm? -60.01 -49.99 75.5 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.532 -1.355 . . . . 1.0 109.21 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 65.3 t -66.66 -42.36 89.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.244 -0.91 . . . . 1.0 110.866 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.97 -48.74 79.06 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.081 -1.012 . . . . 1.0 110.325 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.35 -39.17 82.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.947 -1.096 . . . . 1.0 110.294 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.599 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 56.4 t60 -65.27 -52.42 54.41 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.137 -0.977 . . . . 1.0 111.411 -178.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.524 ' OE2' ' CE2' ' A' ' 98' ' ' PHE . 10.1 pt-20 -60.03 -42.3 94.1 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.772 -1.205 . . . . 1.0 110.609 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -60.09 -39.86 87.59 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.729 -1.232 . . . . 1.0 108.814 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -54.82 -42.74 80.1 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.366 -1.494 . . . . 1.0 109.366 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.599 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 90.1 m-70 -65.68 -39.1 90.94 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.125 -1.221 . . . . 1.0 109.134 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.1 p -62.14 -24.97 67.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -0.903 . . . . 1.0 109.892 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 88.8 mt -81.19 -0.08 38.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.057 -1.027 . . . . 1.0 109.792 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 91.89 10.36 61.49 Favored Glycine 0 N--CA 1.498 2.784 0 O-C-N 121.058 -1.026 . . . . 1.0 110.668 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.3 mt -84.71 150.01 25.4 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.931 -1.334 . . . . 1.0 109.462 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 37.1 t0 -100.65 169.99 8.66 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.435 -0.79 . . . . 1.0 109.06 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.526 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 74.8 m80 -59.99 139.74 57.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.153 -0.967 . . . . 1.0 109.545 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 41.2 t -96.25 156.16 16.46 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.27 -0.894 . . . . 1.0 108.913 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -99.13 3.95 46.75 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.127 -0.983 . . . . 1.0 109.574 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -87.07 129.49 51.73 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.089 -1.007 . . . . 1.0 108.726 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -67.9 -27.82 36.61 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 CA-C-N 120.086 1.066 . . . . 1.0 113.022 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -84.86 -2.31 88.58 Favored Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.824 -1.179 . . . . 1.0 110.454 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.83 146.81 26.07 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.022 -1.281 . . . . 1.0 110.015 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 86.5 mt -70.06 -29.96 67.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.221 -0.924 . . . . 1.0 109.677 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.2 mmm -73.6 8.3 1.94 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.183 -0.948 . . . . 1.0 110.171 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -69.41 132.64 89.48 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.096 -1.002 . . . . 1.0 108.595 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -63.41 14.19 0.07 OUTLIER 'Trans proline' 0 N--CA 1.505 2.182 0 C-N-CA 121.152 1.235 . . . . 1.0 115.167 -177.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 76.0 mt -130.78 138.02 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.382 0 O-C-N 120.785 -1.197 . . . . 1.0 109.495 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' TYR . . . . . 0.42 ' CD1' ' C ' ' A' ' 141' ' ' TYR . 21.5 t80 -73.37 128.3 35.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.444 -0.785 . . . . 1.0 109.957 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 10.0 t -136.56 137.0 39.76 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.579 -0.701 . . . . 1.0 109.197 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -85.11 143.18 29.0 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.17 -0.956 . . . . 1.0 109.265 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.7 t -140.38 151.19 44.77 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.3 -0.875 . . . . 1.0 109.52 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -68.89 109.39 2.87 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.734 -1.746 . . . . 1.0 108.734 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.65 ' HZ2' HD21 ' A' ' 112' ' ' ASN . 85.0 mttt -73.35 126.03 29.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.133 -1.216 . . . . 1.0 109.298 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 10.6 p -176.86 -93.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.307 -0.871 . . . . 1.0 109.111 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -98.81 18.83 16.09 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.664 -0.865 . . . . 1.0 108.664 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -60.15 134.62 57.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.592 -0.693 . . . . 1.0 109.829 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 95.0 mtp -136.96 150.14 47.98 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.732 -0.84 . . . . 1.0 108.732 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.404 HD22 ' CZ3' ' A' ' 42' ' ' TRP . 20.8 mt -48.23 125.87 11.85 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.069 -1.02 . . . . 1.0 108.949 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -62.83 175.62 2.25 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 CA-C-N 120.118 1.078 . . . . 1.0 112.201 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.02 -39.95 87.62 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.311 -0.868 . . . . 1.0 109.553 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.403 ' OD1' ' C ' ' A' ' 154' ' ' ASP . 52.7 t0 -55.89 -50.02 71.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.911 . . . . 1.0 109.739 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -70.07 -39.94 75.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.143 -0.973 . . . . 1.0 110.427 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.3 t -59.97 -46.41 94.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.903 -1.123 . . . . 1.0 109.018 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -60.3 -40.04 89.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.977 -1.077 . . . . 1.0 110.278 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -67.93 -55.89 12.5 Favored Glycine 0 N--CA 1.494 2.526 0 O-C-N 121.12 -0.988 . . . . 1.0 111.152 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.468 HG23 ' N ' ' A' ' 160' ' ' GLN . 5.3 tp -60.44 -39.98 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.909 -1.347 . . . . 1.0 109.523 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.472 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.5 mt-30 -65.28 -39.93 93.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.076 -1.015 . . . . 1.0 109.812 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 85.6 p -60.05 -33.92 72.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.064 -1.023 . . . . 1.0 110.488 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.4 mt -84.83 -56.71 3.44 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.004 -1.06 . . . . 1.0 111.167 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -89.66 -9.0 51.21 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.989 -1.07 . . . . 1.0 110.647 -178.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.497 2.748 0 N-CA-C 109.538 -1.425 . . . . 1.0 109.538 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.2 mt . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.422 0.63 . . . . 1.0 109.343 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.5 pttm -165.12 167.04 18.61 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.37 -0.831 . . . . 1.0 109.442 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -71.88 142.32 49.54 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.182 -0.949 . . . . 1.0 109.188 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.3 t -89.86 4.47 49.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.253 -0.905 . . . . 1.0 109.924 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -145.07 154.1 42.13 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.182 -0.949 . . . . 1.0 109.452 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.1 mmt -90.47 0.51 57.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.287 -0.883 . . . . 1.0 109.684 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -95.73 126.9 41.31 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.218 -0.927 . . . . 1.0 109.554 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.8 mt -143.26 149.16 37.49 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.366 -0.834 . . . . 1.0 108.816 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.0 p -132.78 155.18 49.37 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.424 -0.798 . . . . 1.0 108.851 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.499 ' CD2' ' NH1' ' A' ' 52' ' ' ARG . 34.7 p90 -148.4 160.12 43.34 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.821 -1.174 . . . . 1.0 110.752 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.403 ' NH1' ' HG2' ' A' ' 18' ' ' ARG . 35.0 ttt-85 -145.72 134.77 22.68 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.387 -0.598 . . . . 1.0 109.387 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.745 ' H ' HH22 ' A' ' 52' ' ' ARG . 93.5 mt -89.9 119.1 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 120.792 -1.193 . . . . 1.0 108.684 178.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 56.1 t -69.0 -40.78 81.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.964 -1.085 . . . . 1.0 109.027 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.4 p-10 -162.95 164.12 25.9 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.032 -1.067 . . . . 1.0 110.203 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.516 ' CD2' ' CG ' ' A' ' 28' ' ' HIS . 36.7 m-85 -103.42 -161.08 0.81 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.646 -1.613 . . . . 1.0 106.646 178.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.12 151.84 74.95 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.614 -0.679 . . . . 1.0 110.668 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -70.19 -14.28 34.55 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.056 1.171 . . . . 1.0 110.062 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -59.45 -40.02 85.5 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 115.307 -0.86 . . . . 1.0 110.027 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.6 mtm -140.47 168.07 20.68 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.343 -0.848 . . . . 1.0 109.236 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.4 p -72.79 159.98 32.92 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.401 -0.812 . . . . 1.0 109.207 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.516 ' CG ' ' CD2' ' A' ' 22' ' ' TYR . 2.8 m-70 -59.97 -40.0 87.56 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.442 -0.787 . . . . 1.0 110.007 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 61.9 m -60.01 -40.06 87.98 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.165 -0.959 . . . . 1.0 110.488 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.65 -39.96 91.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.96 -1.088 . . . . 1.0 109.838 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.4 t -69.51 -41.38 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.135 -0.978 . . . . 1.0 110.485 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.0 -49.05 79.18 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.989 -1.069 . . . . 1.0 110.495 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -62.17 -32.91 73.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.987 -1.071 . . . . 1.0 109.825 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.98 -50.43 73.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.184 -0.948 . . . . 1.0 110.042 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -65.82 -38.94 90.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.054 -1.029 . . . . 1.0 109.672 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.97 -42.36 93.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.06 -1.025 . . . . 1.0 109.808 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -60.56 -40.59 92.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.942 -1.098 . . . . 1.0 109.234 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.26 -43.1 96.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -0.89 . . . . 1.0 109.99 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -66.07 -40.01 90.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.03 -1.043 . . . . 1.0 109.705 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -59.94 -47.87 84.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -0.934 . . . . 1.0 110.139 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 70.5 t -59.95 -40.04 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.058 -1.026 . . . . 1.0 109.965 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -81.66 -35.31 30.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.895 -1.128 . . . . 1.0 110.182 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.7 p -70.46 -22.82 62.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.92 -1.113 . . . . 1.0 109.414 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -59.96 -40.01 87.58 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.433 -0.792 . . . . 1.0 110.606 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.416 HG23 HG23 ' A' ' 46' ' ' THR . 8.5 m -112.14 25.35 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.372 -0.83 . . . . 1.0 110.729 -178.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.416 HG23 HG23 ' A' ' 45' ' ' VAL . 59.9 p -148.91 131.62 7.95 Favored Pre-proline 0 N--CA 1.501 2.09 0 O-C-N 120.88 -1.137 . . . . 1.0 109.796 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -72.93 20.54 0.33 Allowed 'Trans proline' 0 N--CA 1.495 1.577 0 CA-C-N 119.668 0.917 . . . . 1.0 112.032 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.9 mt -67.97 139.1 56.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.175 -0.953 . . . . 1.0 109.614 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -107.92 120.58 42.7 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.851 -0.796 . . . . 1.0 108.851 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -107.21 127.1 53.22 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.304 -0.873 . . . . 1.0 110.023 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.3 m -120.05 129.98 54.48 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.648 -0.657 . . . . 1.0 109.404 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.745 HH22 ' H ' ' A' ' 19' ' ' ILE . 28.9 tpt180 -84.03 136.5 34.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.247 -0.908 . . . . 1.0 109.833 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.0 mt -110.61 128.71 55.79 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.438 -0.789 . . . . 1.0 109.26 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.44 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 56.6 m170 -69.43 -39.78 77.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.396 -0.815 . . . . 1.0 109.708 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 76.7 m-20 -148.77 168.66 22.33 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.231 -0.918 . . . . 1.0 110.084 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.27 -175.48 29.52 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 109.868 -1.293 . . . . 1.0 109.868 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.7 mt -94.46 133.98 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.313 -1.11 . . . . 1.0 109.021 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.79 163.0 14.66 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.493 -0.754 . . . . 1.0 109.511 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -59.94 -49.25 78.41 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.279 -0.888 . . . . 1.0 109.045 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 95.8 mt -113.64 108.36 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.465 -0.772 . . . . 1.0 109.516 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.6 ptm -103.47 132.44 49.72 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.207 -0.933 . . . . 1.0 109.435 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 90.1 mt -102.34 138.25 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.506 -0.746 . . . . 1.0 109.777 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.8 p -153.63 157.34 39.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.249 -0.907 . . . . 1.0 109.49 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -102.08 125.28 48.73 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.8 -0.815 . . . . 1.0 108.8 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.14 158.04 16.21 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.424 -1.071 . . . . 1.0 110.424 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 9.8 tt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 108.758 -0.83 . . . . 1.0 108.758 179.985 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.537 ' CE2' ' OD1' ' A' ' 99' ' ' ASP . 27.2 m-85 . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 108.366 -0.976 . . . . 1.0 108.366 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 79' ' ' SER . 23.7 p-10 -99.95 10.25 41.61 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.046 -1.034 . . . . 1.0 110.948 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 110.73 -150.5 17.72 Favored Glycine 0 N--CA 1.507 3.395 0 N-CA-C 109.557 -1.417 . . . . 1.0 109.557 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -58.77 -65.81 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.577 0 CA-C-N 118.913 1.357 . . . . 1.0 112.846 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.433 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 78.9 p -75.24 159.16 31.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.095 -1.003 . . . . 1.0 109.693 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.22 -128.59 8.04 Favored Glycine 0 N--CA 1.5 2.944 0 N-CA-C 109.773 -1.331 . . . . 1.0 109.773 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.464 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 14.8 mt -69.4 105.84 2.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.326 -1.102 . . . . 1.0 109.41 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.42 HD23 ' OE2' ' A' ' 102' ' ' GLU . 72.2 mt -78.73 -24.4 44.88 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.127 -0.983 . . . . 1.0 108.738 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.65 169.99 1.31 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.053 -1.091 . . . . 1.0 108.053 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -163.0 161.39 25.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.855 -1.153 . . . . 1.0 110.209 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -145.5 162.31 37.68 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.502 -0.749 . . . . 1.0 109.193 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -103.06 151.92 38.5 Favored Pre-proline 0 N--CA 1.501 2.113 0 O-C-N 121.114 -0.991 . . . . 1.0 109.227 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -49.67 167.15 0.19 Allowed 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 120.784 0.99 . . . . 1.0 112.518 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo . . . . . 0 N--CA 1.494 1.545 0 C-N-CA 121.249 1.299 . . . . 1.0 111.845 179.131 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.2 p-10 . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.139 0.495 . . . . 1.0 109.716 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.87 123.17 10.26 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.279 -0.888 . . . . 1.0 109.27 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 57.5 m170 -112.31 154.8 25.12 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.571 -0.705 . . . . 1.0 109.973 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.519 ' CZ ' ' OE2' ' A' ' 120' ' ' GLU . 38.9 m-85 -133.12 149.79 52.09 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.625 -0.88 . . . . 1.0 108.625 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.537 ' OD1' ' CE2' ' A' ' 75' ' ' PHE . 64.4 m-20 -79.93 123.23 27.59 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.964 -1.085 . . . . 1.0 110.058 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -84.8 -9.72 57.89 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.297 -0.877 . . . . 1.0 109.621 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -84.73 -11.55 55.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.261 -0.899 . . . . 1.0 109.848 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.42 ' OE2' HD23 ' A' ' 82' ' ' LEU . 96.1 mt-10 -90.02 169.94 10.77 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.37 -0.831 . . . . 1.0 110.026 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 16.7 m -100.14 105.19 16.78 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.435 -0.79 . . . . 1.0 109.101 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -89.32 124.29 34.28 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.084 -0.71 . . . . 1.0 109.084 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.686 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.8 t -140.7 154.55 46.4 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.279 -0.888 . . . . 1.0 110.151 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 70.2 m -92.88 -8.01 44.59 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.427 -0.953 . . . . 1.0 108.427 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.4 m -92.63 176.78 6.32 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.9 m -79.72 76.64 6.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.998 -1.064 . . . . 1.0 109.428 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.686 ' HB2' HG21 ' A' ' 105' ' ' THR . 98.2 mttt -147.26 148.66 31.67 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.392 -0.817 . . . . 1.0 108.866 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 46.11 -139.39 6.66 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.747 -1.341 . . . . 1.0 109.747 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -99.7 114.41 27.5 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.251 -1.146 . . . . 1.0 109.21 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -63.69 133.76 54.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.137 -0.977 . . . . 1.0 109.538 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.3 tp -59.99 -44.76 94.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.506 -0.747 . . . . 1.0 110.825 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -59.97 -42.75 94.84 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.005 -1.06 . . . . 1.0 110.561 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -59.61 -50.01 75.54 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.878 -1.139 . . . . 1.0 109.363 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.7 t -69.07 -41.46 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.15 -0.969 . . . . 1.0 109.691 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.63 -50.16 74.85 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.369 -0.832 . . . . 1.0 110.274 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.44 -38.71 81.41 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.865 -1.147 . . . . 1.0 110.218 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.595 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 57.3 t60 -64.02 -50.01 70.17 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.093 -1.004 . . . . 1.0 111.031 -178.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.519 ' OE2' ' CZ ' ' A' ' 98' ' ' PHE . 7.4 pt-20 -59.99 -44.64 94.38 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.698 -1.251 . . . . 1.0 110.048 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -59.99 -40.03 87.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.785 -1.197 . . . . 1.0 108.895 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.29 -43.75 64.85 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.241 -1.543 . . . . 1.0 109.241 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.595 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 87.8 m-70 -66.29 -39.93 89.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.217 -1.166 . . . . 1.0 109.112 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 77.4 p -62.39 -21.41 65.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.898 . . . . 1.0 109.561 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.5 mt -83.0 -3.55 57.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 1.0 109.391 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 92.4 8.14 62.92 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.524 -1.03 . . . . 1.0 110.524 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.3 mt -86.58 146.34 26.39 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.95 -1.324 . . . . 1.0 109.208 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 27.7 t0 -99.47 175.29 5.9 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.476 -0.765 . . . . 1.0 109.576 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.512 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 75.2 m80 -61.15 135.66 57.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 1.0 109.72 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 41.5 t -97.37 156.7 16.34 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.21 -0.931 . . . . 1.0 109.358 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -97.33 0.39 47.9 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.155 -0.965 . . . . 1.0 109.632 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -83.7 130.23 56.46 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.171 -0.955 . . . . 1.0 108.476 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -70.58 -20.69 30.67 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 CA-C-N 120.022 1.044 . . . . 1.0 112.384 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -87.58 -5.05 79.2 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.823 -1.311 . . . . 1.0 109.823 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.73 145.72 26.55 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.173 -1.192 . . . . 1.0 109.267 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 138' ' ' PHE . 95.5 mt -70.67 -30.98 67.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.078 -1.014 . . . . 1.0 109.477 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 98.2 mmm -70.23 14.14 0.13 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.364 -0.835 . . . . 1.0 109.766 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.468 ' H ' ' C ' ' A' ' 136' ' ' LEU . 13.5 t80 -68.89 134.03 90.07 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.071 -1.018 . . . . 1.0 108.297 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -62.67 -18.36 63.6 Favored 'Trans proline' 0 N--CA 1.501 1.957 0 C-N-CA 121.04 1.16 . . . . 1.0 113.985 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.8 mt -102.79 141.43 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 120.834 -1.166 . . . . 1.0 109.691 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -75.58 126.01 30.16 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.331 -0.856 . . . . 1.0 110.221 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 11.0 t -134.73 137.46 43.5 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.426 -0.796 . . . . 1.0 109.268 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -80.1 143.56 33.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.966 -1.084 . . . . 1.0 108.6 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.9 t -139.83 151.73 45.94 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.313 -0.867 . . . . 1.0 109.615 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.55 104.75 1.51 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.374 -1.49 . . . . 1.0 109.374 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -77.9 1.72 19.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.26 -1.141 . . . . 1.0 109.95 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 73.3 m -60.05 -40.1 88.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.193 -0.942 . . . . 1.0 109.652 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -143.41 29.45 1.43 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.246 -0.909 . . . . 1.0 109.468 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -69.7 138.87 53.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.173 -0.955 . . . . 1.0 110.11 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 93.9 mtp -138.79 146.67 41.62 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.544 -0.91 . . . . 1.0 108.544 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 58.1 mt -51.74 129.03 36.29 Favored Pre-proline 0 C--N 1.302 -1.483 0 O-C-N 121.111 -0.993 . . . . 1.0 108.728 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -69.2 178.56 4.11 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 CA-C-N 119.985 1.03 . . . . 1.0 112.266 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -63.11 -39.89 96.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.476 -0.765 . . . . 1.0 110.12 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -55.64 -48.56 74.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.337 -0.852 . . . . 1.0 109.764 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -69.93 -40.03 75.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.97 . . . . 1.0 109.847 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.04 -48.13 89.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.075 -1.016 . . . . 1.0 108.995 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -60.11 -40.02 88.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.191 -0.943 . . . . 1.0 110.261 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.43 -55.0 7.11 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 120.199 -1.001 . . . . 1.0 111.477 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.49 HG23 ' N ' ' A' ' 160' ' ' GLN . 5.3 tp -60.0 -40.14 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.967 -1.313 . . . . 1.0 109.732 -178.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.55 ' O ' ' N ' ' A' ' 164' ' ' GLY . 79.8 mm-40 -64.43 -39.34 93.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.209 -0.932 . . . . 1.0 109.316 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 79.9 p -60.95 -34.13 74.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.139 -0.976 . . . . 1.0 110.484 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.2 mt -84.43 -52.79 5.9 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.877 -1.139 . . . . 1.0 110.671 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -90.67 -8.01 51.1 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.046 -1.034 . . . . 1.0 110.541 -178.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.536 0 N-CA-C 109.288 -1.525 . . . . 1.0 109.288 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.3 mt . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.328 -0.619 . . . . 1.0 109.328 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -160.34 159.97 31.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.24 -0.913 . . . . 1.0 109.384 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -76.37 127.24 32.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.148 -0.97 . . . . 1.0 109.259 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.4 p -69.24 -38.48 78.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.038 -1.039 . . . . 1.0 108.933 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.404 ' H ' ' HG2' ' A' ' 12' ' ' LYS . 49.1 pttt -89.47 136.43 33.03 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.932 -1.136 . . . . 1.0 107.932 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.611 ' N ' ' SD ' ' A' ' 13' ' ' MET . 4.8 mmm -90.7 -0.27 57.64 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.065 -1.022 . . . . 1.0 109.872 -178.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -97.98 132.72 43.3 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.997 -1.112 . . . . 1.0 107.997 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.6 mt -139.57 149.92 44.43 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.202 -0.936 . . . . 1.0 109.376 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.7 p -135.67 156.43 48.85 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.661 -0.866 . . . . 1.0 108.661 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -145.86 160.04 42.35 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.137 -0.977 . . . . 1.0 109.958 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.435 ' HE ' ' HA ' ' A' ' 55' ' ' ASP . 37.0 ttt-85 -144.31 134.94 24.84 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.49 -0.756 . . . . 1.0 109.272 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.8 mt -87.54 119.68 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.244 -0.91 . . . . 1.0 108.748 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.5 t -69.17 -39.93 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.239 -0.913 . . . . 1.0 109.345 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -165.01 153.08 11.67 Favored 'General case' 0 C--N 1.29 -1.991 0 O-C-N 120.163 -1.586 . . . . 1.0 110.802 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -100.81 106.52 17.92 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 105.87 -1.9 . . . . 1.0 105.87 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.459 ' C ' ' H ' ' A' ' 25' ' ' ASP . 0.4 OUTLIER -45.45 140.04 4.32 Favored Pre-proline 0 C--N 1.299 -1.612 0 O-C-N 121.487 -0.758 . . . . 1.0 109.591 -177.985 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -59.22 -3.05 1.51 Allowed 'Trans proline' 0 N--CA 1.487 1.111 0 CA-C-N 119.358 0.807 . . . . 1.0 110.75 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.459 ' H ' ' C ' ' A' ' 23' ' ' THR . 94.3 m-20 -59.73 -36.04 75.79 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.585 -0.524 . . . . 1.0 109.585 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 78.0 mtm -140.0 166.75 23.8 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.219 -0.925 . . . . 1.0 109.801 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.6 p -71.63 160.15 33.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.417 -0.802 . . . . 1.0 109.335 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -60.09 -40.93 91.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.307 -0.871 . . . . 1.0 110.32 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.5 m -60.03 -40.34 88.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.935 -1.103 . . . . 1.0 110.875 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.01 -42.96 89.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.109 -0.994 . . . . 1.0 110.767 -178.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.7 t -65.37 -39.87 86.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 121.248 -0.907 . . . . 1.0 109.598 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -58.1 -54.97 41.0 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.371 -0.831 . . . . 1.0 111.708 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.9 pttt -63.47 -33.68 76.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.607 -1.308 . . . . 1.0 110.723 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.37 -50.78 70.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.637 -1.289 . . . . 1.0 109.666 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.45 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 47.3 m-85 -67.69 -38.81 84.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.842 -1.161 . . . . 1.0 110.401 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -59.89 -40.69 89.58 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.724 -1.235 . . . . 1.0 109.438 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -60.72 -39.94 90.48 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.158 -0.964 . . . . 1.0 108.988 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.09 -47.12 87.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.432 -0.792 . . . . 1.0 109.834 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -65.21 -38.9 91.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.081 -1.012 . . . . 1.0 109.656 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 44.0 tptt -59.95 -47.83 84.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.079 -1.013 . . . . 1.0 109.893 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.5 t -60.07 -40.77 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.28 -0.887 . . . . 1.0 110.79 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -82.32 -35.38 27.96 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.86 -1.15 . . . . 1.0 110.483 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.6 p -70.03 -17.3 63.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.13 -0.981 . . . . 1.0 109.606 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -59.82 -39.98 86.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.261 -0.9 . . . . 1.0 110.868 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.4 m -110.85 -19.46 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 O-C-N 121.147 -0.971 . . . . 1.0 110.487 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.3 p -94.46 129.79 35.66 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 120.843 -1.161 . . . . 1.0 109.709 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -73.01 10.18 1.18 Allowed 'Trans proline' 0 N--CA 1.494 1.553 0 CA-C-N 119.831 0.975 . . . . 1.0 111.953 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.7 mt -67.95 140.61 56.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.215 -0.928 . . . . 1.0 109.822 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -104.47 121.97 44.55 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.933 -0.765 . . . . 1.0 108.933 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -107.69 122.42 46.69 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.293 -0.879 . . . . 1.0 109.699 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.0 m -119.88 129.98 54.64 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.483 -0.76 . . . . 1.0 109.615 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.475 ' CB ' ' NH1' ' A' ' 52' ' ' ARG . 11.1 ttp-105 -85.03 133.66 34.24 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.288 -0.883 . . . . 1.0 109.725 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 86.2 mt -102.52 126.72 49.67 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.269 -0.894 . . . . 1.0 109.353 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.425 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 54.8 m170 -61.41 -39.87 92.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.447 -0.783 . . . . 1.0 109.874 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.435 ' HA ' ' HE ' ' A' ' 18' ' ' ARG . 80.8 m-20 -146.19 171.4 14.99 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.225 -0.922 . . . . 1.0 109.563 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.24 179.87 38.12 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.758 -1.337 . . . . 1.0 109.758 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.5 mt -95.56 136.39 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.313 -1.11 . . . . 1.0 109.262 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.72 163.58 14.39 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.483 -0.761 . . . . 1.0 109.244 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -59.99 -49.77 76.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -0.895 . . . . 1.0 109.472 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.9 mt -108.48 104.17 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.488 -0.757 . . . . 1.0 109.753 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.8 ptp -100.83 135.06 42.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.218 -0.926 . . . . 1.0 109.181 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.45 HG21 ' CZ ' ' A' ' 35' ' ' PHE . 85.5 mt -109.99 131.09 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.624 -0.673 . . . . 1.0 109.711 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.3 p -150.55 156.59 41.7 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.205 -0.935 . . . . 1.0 109.898 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -102.37 120.02 39.79 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.207 -1.035 . . . . 1.0 108.207 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.0 -169.48 23.25 Favored Glycine 0 N--CA 1.499 2.878 0 N-CA-C 110.629 -0.988 . . . . 1.0 110.629 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 93.2 mt . . . . . 0 N--CA 1.495 1.784 0 N-CA-C 108.139 -1.06 . . . . 1.0 108.139 179.613 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.585 ' CD1' ' OD1' ' A' ' 99' ' ' ASP . 90.6 m-85 . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -101.27 0.03 36.58 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.31 -0.869 . . . . 1.0 110.848 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 134.18 -150.27 19.97 Favored Glycine 0 N--CA 1.504 3.18 0 N-CA-C 108.767 -1.733 . . . . 1.0 108.767 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.424 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 2.8 Cg_exo -64.07 -64.1 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.339 0 CA-C-N 119.013 1.406 . . . . 1.0 111.473 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 94.3 p -77.83 160.85 28.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.118 -0.989 . . . . 1.0 109.331 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.98 -129.83 8.71 Favored Glycine 0 N--CA 1.501 3.007 0 N-CA-C 109.101 -1.6 . . . . 1.0 109.101 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.413 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 10.1 mt -69.41 107.5 3.35 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.132 -1.216 . . . . 1.0 108.735 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 55.6 mt -75.16 -25.77 58.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.942 -1.098 . . . . 1.0 109.31 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.92 172.94 1.25 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -164.61 160.01 19.65 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.999 -1.063 . . . . 1.0 109.648 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -142.86 153.77 43.49 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.412 -0.805 . . . . 1.0 108.867 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -89.18 151.92 47.31 Favored Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.047 -1.033 . . . . 1.0 108.683 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -58.64 165.37 8.01 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 120.951 1.101 . . . . 1.0 111.788 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo . . . . . 0 C--N 1.316 -1.175 0 C-N-CA 121.215 1.277 . . . . 1.0 112.384 179.758 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.204 0.526 . . . . 1.0 109.589 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.0 124.1 11.43 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.266 -0.896 . . . . 1.0 109.4 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -112.99 133.81 54.78 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.549 -0.72 . . . . 1.0 110.098 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.499 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 25.5 m-85 -116.15 149.41 39.08 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 109.005 -0.739 . . . . 1.0 109.005 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.585 ' OD1' ' CD1' ' A' ' 75' ' ' PHE . 82.0 m-20 -77.75 123.67 26.99 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.878 -1.138 . . . . 1.0 109.845 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 42.0 t0 -84.29 -11.56 56.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.447 -0.783 . . . . 1.0 109.184 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -82.19 -11.69 58.56 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.35 -0.844 . . . . 1.0 108.951 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.424 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 97.5 mt-10 -90.53 168.54 11.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.466 -0.771 . . . . 1.0 109.3 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 19.5 m -100.34 105.24 16.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.326 -0.859 . . . . 1.0 108.723 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.462 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 94.5 m95 -87.33 120.58 28.77 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.481 -0.762 . . . . 1.0 109.103 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.662 HG21 ' HB2' ' A' ' 109' ' ' LYS . 7.3 t -139.95 150.02 44.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.461 -0.774 . . . . 1.0 109.779 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 52.7 m -92.85 -6.14 49.43 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.214 -0.929 . . . . 1.0 108.534 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.6 t -92.03 175.69 6.78 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.871 -0.789 . . . . 1.0 108.871 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.1 t -75.59 75.29 2.61 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.028 -1.045 . . . . 1.0 109.222 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.662 ' HB2' HG21 ' A' ' 105' ' ' THR . 98.6 mttt -149.4 149.75 31.33 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.574 -0.898 . . . . 1.0 108.574 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 109' ' ' LYS . . . 42.98 -139.17 2.9 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 110.033 -1.227 . . . . 1.0 110.033 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -100.19 118.85 37.37 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.348 -1.089 . . . . 1.0 109.265 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -63.31 129.39 40.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.359 -0.838 . . . . 1.0 109.877 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.5 tp -60.01 -43.27 95.36 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.49 -0.756 . . . . 1.0 110.552 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -59.99 -41.63 92.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.214 -0.929 . . . . 1.0 111.177 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.61 -49.62 76.81 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.769 -1.207 . . . . 1.0 109.226 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 67.7 t -69.94 -41.32 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.301 -0.874 . . . . 1.0 110.712 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.34 -53.25 60.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.998 -1.064 . . . . 1.0 109.778 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.97 -34.43 73.27 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.186 -0.946 . . . . 1.0 109.785 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.633 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 60.0 t60 -63.12 -50.73 69.33 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.228 -0.92 . . . . 1.0 110.783 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.499 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 6.9 pt-20 -60.0 -39.42 85.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.792 -1.192 . . . . 1.0 110.111 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -59.94 -40.01 87.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.904 -1.123 . . . . 1.0 108.798 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.67 -41.92 94.0 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.332 -1.507 . . . . 1.0 109.332 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.633 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 83.9 m-70 -67.32 -39.96 85.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.139 -1.212 . . . . 1.0 109.577 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 95.4 p -68.97 -21.93 64.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.397 -0.814 . . . . 1.0 109.513 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 49.7 mt -82.99 -0.96 51.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 1.0 109.902 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 92.5 6.43 64.25 Favored Glycine 0 N--CA 1.498 2.77 0 C-N-CA 120.221 -0.99 . . . . 1.0 110.852 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.3 mt -85.1 144.86 27.95 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.745 -1.444 . . . . 1.0 109.916 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 44.6 t0 -99.01 172.43 7.41 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.167 -1.049 . . . . 1.0 108.167 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.528 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 74.6 m80 -61.76 132.17 52.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.757 -1.214 . . . . 1.0 109.281 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.7 t -97.35 158.39 15.49 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.253 -0.905 . . . . 1.0 109.135 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -99.92 8.45 44.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.322 -0.861 . . . . 1.0 109.279 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -85.14 125.35 70.46 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.188 -0.945 . . . . 1.0 108.895 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -66.91 -20.94 50.93 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 CA-C-N 120.195 1.105 . . . . 1.0 112.541 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -87.3 -7.14 77.06 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.078 -1.209 . . . . 1.0 110.078 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.87 139.58 31.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.117 -1.225 . . . . 1.0 109.458 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.453 ' C ' ' H ' ' A' ' 138' ' ' PHE . 91.6 mt -62.18 -40.05 94.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.142 -0.974 . . . . 1.0 109.88 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 85.8 mtp -70.5 24.72 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.245 -0.909 . . . . 1.0 111.04 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.453 ' H ' ' C ' ' A' ' 136' ' ' LEU . 23.5 t80 -69.94 129.99 90.41 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 120.766 -1.209 . . . . 1.0 108.331 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -49.55 -19.8 3.6 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 120.954 1.103 . . . . 1.0 114.505 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 90.6 mt -107.78 137.39 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 O-C-N 120.879 -1.138 . . . . 1.0 110.37 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -74.13 128.27 35.1 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.554 -0.716 . . . . 1.0 109.519 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.9 t -139.55 143.4 37.36 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.915 -0.772 . . . . 1.0 108.915 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -81.53 142.85 32.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.108 -0.995 . . . . 1.0 108.885 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.2 t -139.7 150.96 45.49 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.172 -0.955 . . . . 1.0 110.151 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.64 105.13 1.66 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.218 -1.553 . . . . 1.0 109.218 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 21.8 mtmm -75.74 1.9 13.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.379 -1.071 . . . . 1.0 109.834 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 67.9 m -59.92 -40.02 87.44 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.171 -0.955 . . . . 1.0 109.712 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -144.18 27.7 1.41 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.096 -1.003 . . . . 1.0 110.1 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -68.78 137.4 53.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.919 -1.113 . . . . 1.0 109.768 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 67.1 mtt -138.86 147.94 43.06 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.38 -0.825 . . . . 1.0 108.955 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 74.2 mt -51.57 124.84 26.55 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.0 -1.062 . . . . 1.0 108.631 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -67.81 -179.42 2.06 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 CA-C-N 120.102 1.072 . . . . 1.0 112.329 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -61.77 -39.58 92.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.333 -0.854 . . . . 1.0 109.868 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -56.98 -49.55 75.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -0.945 . . . . 1.0 110.01 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -70.09 -39.97 75.23 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.99 -1.069 . . . . 1.0 110.31 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 76.4 t -60.84 -48.36 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.958 -1.089 . . . . 1.0 108.927 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -60.36 -39.98 89.13 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.16 -0.962 . . . . 1.0 110.856 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.77 -53.79 7.91 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 120.06 -1.067 . . . . 1.0 111.121 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.461 HG23 ' N ' ' A' ' 160' ' ' GLN . 9.4 tp -60.56 -40.53 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.016 -1.284 . . . . 1.0 109.837 -178.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.527 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.9 mt-30 -65.81 -38.69 89.63 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.136 -0.977 . . . . 1.0 109.54 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 83.9 p -65.72 -24.98 67.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.119 -0.988 . . . . 1.0 110.666 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 87.8 mt -87.34 -50.72 6.38 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.747 -1.22 . . . . 1.0 110.0 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -93.01 -9.11 41.01 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.04 -1.038 . . . . 1.0 110.048 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.607 0 N-CA-C 109.548 -1.421 . . . . 1.0 109.548 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.6 mt . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 109.173 -0.677 . . . . 1.0 109.173 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -161.24 163.37 31.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.065 -1.022 . . . . 1.0 109.647 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -71.16 146.2 49.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.881 . . . . 1.0 109.543 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 87.8 p -90.06 3.44 53.27 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.4 -0.812 . . . . 1.0 110.148 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -144.7 154.01 42.31 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.065 -1.022 . . . . 1.0 109.51 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.5 mmt -90.46 -0.04 57.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.229 -0.919 . . . . 1.0 109.748 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -96.65 125.49 41.16 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.126 -0.983 . . . . 1.0 109.182 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.0 mt -140.01 152.34 46.19 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.293 -0.88 . . . . 1.0 109.187 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.5 p -133.61 154.29 51.0 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.494 -0.754 . . . . 1.0 109.312 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -145.1 160.0 42.09 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.186 -0.946 . . . . 1.0 109.811 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 44.9 ttt-85 -144.61 131.5 20.27 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.427 -0.796 . . . . 1.0 109.503 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 86.0 mt -86.94 119.98 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.278 -0.889 . . . . 1.0 108.818 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.6 t -69.47 -41.53 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.089 -1.007 . . . . 1.0 109.282 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -165.09 155.02 13.31 Favored 'General case' 0 C--N 1.289 -2.06 0 O-C-N 119.967 -1.708 . . . . 1.0 110.412 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.411 ' O ' ' C ' ' A' ' 23' ' ' THR . 23.9 m-85 -99.4 95.94 7.37 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 105.907 -1.886 . . . . 1.0 105.907 178.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.411 ' C ' ' O ' ' A' ' 22' ' ' TYR . 1.5 t -39.86 142.53 0.66 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.963 -0.461 . . . . 1.0 110.619 -177.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -59.68 -21.48 63.11 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 120.436 0.757 . . . . 1.0 110.994 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -58.4 -14.86 8.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.73 -0.606 . . . . 1.0 109.865 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 78.0 mtp -142.7 150.78 40.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.291 -0.881 . . . . 1.0 109.816 -178.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.1 p -75.52 160.05 30.61 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.476 -0.935 . . . . 1.0 108.476 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.64 -40.1 90.72 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.12 -0.988 . . . . 1.0 109.948 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.9 m -64.82 -42.35 95.04 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.065 -1.022 . . . . 1.0 110.922 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -66.4 -40.11 89.42 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.153 -0.967 . . . . 1.0 111.321 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.4 t -67.91 -42.07 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.969 -1.082 . . . . 1.0 110.535 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -59.94 -49.49 77.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.127 -0.983 . . . . 1.0 110.715 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -64.15 -32.66 74.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.823 -1.173 . . . . 1.0 110.377 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.35 -50.62 73.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.794 -1.191 . . . . 1.0 110.01 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -69.35 -37.51 77.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.043 -1.036 . . . . 1.0 110.218 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -59.95 -42.72 94.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.981 -1.074 . . . . 1.0 109.484 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -61.78 -40.18 94.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.091 -1.006 . . . . 1.0 108.849 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.82 -50.83 71.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.444 -0.785 . . . . 1.0 110.135 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -63.26 -39.95 96.03 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.952 -1.092 . . . . 1.0 109.947 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -60.05 -48.65 80.84 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.062 -1.024 . . . . 1.0 109.841 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 72.0 t -60.03 -41.84 87.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.34 -0.85 . . . . 1.0 110.435 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -78.43 -34.81 47.63 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.958 -1.089 . . . . 1.0 110.23 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 52.4 p -72.33 -20.0 61.55 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.95 -1.094 . . . . 1.0 109.814 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -60.07 -40.02 88.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.496 -0.752 . . . . 1.0 111.417 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.5 m -111.87 22.48 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.241 -0.912 . . . . 1.0 111.131 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 48' ' ' LEU . 18.8 p -146.57 139.45 14.32 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 120.872 -1.142 . . . . 1.0 109.274 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -72.93 17.55 0.39 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 120.675 0.917 . . . . 1.0 111.178 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.411 ' H ' ' C ' ' A' ' 46' ' ' THR . 90.4 mt -67.65 134.12 50.58 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.361 -0.837 . . . . 1.0 110.374 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -108.78 120.53 42.77 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.531 -0.914 . . . . 1.0 108.531 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -108.4 130.34 55.23 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.309 -0.869 . . . . 1.0 109.418 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.5 m -120.03 130.01 54.51 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.571 -0.705 . . . . 1.0 110.147 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -82.83 129.54 35.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.397 -0.814 . . . . 1.0 109.277 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 89.4 mt -108.89 118.62 37.28 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 108.74 -0.837 . . . . 1.0 108.74 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.445 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 72.2 m-70 -70.18 -24.08 63.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.22 -0.925 . . . . 1.0 110.063 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 77.8 m-20 -148.33 162.88 38.63 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.216 -0.928 . . . . 1.0 109.876 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.21 174.9 39.14 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.746 -1.342 . . . . 1.0 109.746 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 87.5 mt -94.25 134.1 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.331 -1.1 . . . . 1.0 109.019 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.98 160.94 15.98 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.446 -0.784 . . . . 1.0 109.122 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.04 -49.34 78.06 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.178 -0.951 . . . . 1.0 109.113 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.9 mt -105.02 99.06 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.427 -0.796 . . . . 1.0 109.818 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.3 ptm -99.28 133.89 42.91 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.115 -0.99 . . . . 1.0 109.084 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.5 mt -106.09 137.4 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.536 -0.728 . . . . 1.0 109.749 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 81.8 p -153.13 155.82 37.46 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.129 -0.982 . . . . 1.0 109.565 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -104.88 123.96 48.63 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.573 -0.704 . . . . 1.0 109.127 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -103.82 -169.9 25.36 Favored Glycine 0 N--CA 1.5 2.949 0 N-CA-C 110.48 -1.048 . . . . 1.0 110.48 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 70.9 mt . . . . . 0 N--CA 1.498 1.934 0 O-C-N 121.57 -0.959 . . . . 1.0 109.037 -179.973 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.549 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 96.7 m-85 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 108.622 -0.881 . . . . 1.0 108.622 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 79' ' ' SER . 22.8 p-10 -96.75 -0.27 48.41 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.992 -1.067 . . . . 1.0 110.829 -178.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.459 ' O ' ' OE2' ' A' ' 102' ' ' GLU . . . 117.44 -120.03 4.64 Favored Glycine 0 N--CA 1.506 3.325 0 N-CA-C 110.338 -1.105 . . . . 1.0 110.338 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.461 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 28.1 Cg_endo -74.29 -73.19 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.803 0 CA-C-N 120.26 2.03 . . . . 1.0 113.04 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.457 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 82.2 p -78.28 -178.9 5.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.925 -1.109 . . . . 1.0 109.806 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.34 -135.43 12.16 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.305 -1.118 . . . . 1.0 110.305 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.7 mt -71.17 111.11 6.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.552 -0.97 . . . . 1.0 110.033 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 55.2 mt -83.63 -17.3 42.02 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.128 -0.982 . . . . 1.0 108.927 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.86 176.0 0.97 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.023 -0.732 . . . . 1.0 109.023 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -161.84 163.37 29.37 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.103 -0.998 . . . . 1.0 109.444 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.34 170.01 19.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.289 -0.882 . . . . 1.0 109.404 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -107.2 154.06 40.71 Favored Pre-proline 0 N--CA 1.498 1.972 0 N-CA-C 108.849 -0.797 . . . . 1.0 108.849 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -60.3 165.6 10.68 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 120.588 0.859 . . . . 1.0 111.558 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo . . . . . 0 N--CA 1.491 1.354 0 C-N-CA 121.149 1.233 . . . . 1.0 112.108 -179.654 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 40.4 p-10 . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 121.387 0.613 . . . . 1.0 109.835 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.24 129.93 15.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.258 -0.901 . . . . 1.0 109.641 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 58.5 m170 -124.9 147.07 49.02 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.614 -0.679 . . . . 1.0 109.252 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -129.72 151.95 49.76 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.528 -0.732 . . . . 1.0 109.469 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.549 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 96.4 m-20 -79.6 120.55 24.09 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.045 -1.035 . . . . 1.0 109.104 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 43.0 t0 -83.54 -4.97 59.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.235 -0.916 . . . . 1.0 109.04 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -82.01 -10.81 59.12 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.412 -0.805 . . . . 1.0 109.075 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.461 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 49.2 mm-40 -90.68 179.1 5.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.385 -0.822 . . . . 1.0 108.991 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 39.0 m -104.93 104.55 14.32 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.445 -0.946 . . . . 1.0 108.445 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.419 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 88.6 m95 -87.95 120.0 28.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.929 . . . . 1.0 109.08 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.678 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.3 t -140.97 151.2 43.97 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.525 -0.734 . . . . 1.0 109.708 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 61.2 m -92.71 -5.64 50.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.104 -0.998 . . . . 1.0 108.546 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 34.0 t -92.93 174.78 7.06 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.6 -0.889 . . . . 1.0 108.6 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.515 ' OG ' ' CZ ' ' A' ' 143' ' ' TYR . 10.6 m -75.85 75.29 2.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.881 -1.137 . . . . 1.0 109.526 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.678 ' HB2' HG21 ' A' ' 105' ' ' THR . 61.3 mttp -147.5 148.84 31.63 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.58 -0.896 . . . . 1.0 108.58 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 109' ' ' LYS . . . 44.53 -139.18 4.65 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.644 -1.382 . . . . 1.0 109.644 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -98.91 118.97 36.88 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.284 -1.127 . . . . 1.0 109.025 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -64.65 130.24 42.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.459 -0.775 . . . . 1.0 110.044 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.3 tp -59.93 -40.45 88.98 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.256 -0.902 . . . . 1.0 110.056 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -59.92 -40.65 89.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 1.0 110.328 -178.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.486 HD21 ' CE ' ' A' ' 146' ' ' LYS . 3.3 mm? -60.04 -55.4 34.39 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.819 -1.176 . . . . 1.0 109.625 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.0 t -67.44 -42.49 87.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.278 -0.889 . . . . 1.0 109.318 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.94 -52.69 64.32 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.173 -0.954 . . . . 1.0 109.101 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.36 82.38 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.816 -1.177 . . . . 1.0 109.801 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.635 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 73.0 t60 -64.01 -49.85 70.82 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.452 -0.78 . . . . 1.0 111.644 -178.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -59.95 -39.5 85.82 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.602 -1.311 . . . . 1.0 109.664 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -59.81 -40.07 87.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.893 -1.129 . . . . 1.0 108.237 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.38 -43.9 84.88 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.808 -1.717 . . . . 1.0 108.808 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.635 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 87.0 m-70 -67.42 -40.05 85.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.224 -1.162 . . . . 1.0 109.546 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 84.2 p -64.71 -24.03 67.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.206 -0.934 . . . . 1.0 109.731 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 84.5 mt -81.15 0.87 34.42 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.182 -0.949 . . . . 1.0 110.005 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 89.76 4.17 73.09 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 120.056 -1.068 . . . . 1.0 110.738 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.8 mt -84.47 149.74 25.75 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.865 -1.374 . . . . 1.0 109.592 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 37.2 t0 -99.78 174.52 6.18 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.615 -0.883 . . . . 1.0 108.615 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.501 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 74.5 m80 -59.33 139.48 56.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.99 -1.069 . . . . 1.0 109.395 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 38.2 t -98.42 152.73 19.19 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.297 -0.877 . . . . 1.0 109.248 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -99.99 5.49 45.14 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.225 -0.922 . . . . 1.0 109.37 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -88.39 126.82 59.09 Favored Pre-proline 0 N--CA 1.493 1.714 0 N-CA-C 108.179 -1.045 . . . . 1.0 108.179 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -67.56 -15.02 44.06 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 CA-C-N 120.273 1.133 . . . . 1.0 111.94 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -90.72 -5.55 68.63 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.357 -1.497 . . . . 1.0 109.357 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.42 142.51 27.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -1.174 . . . . 1.0 108.901 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.497 ' C ' ' H ' ' A' ' 138' ' ' PHE . 74.5 mt -68.5 -36.9 79.55 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.08 -1.013 . . . . 1.0 109.902 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 76.2 mtp -69.92 20.88 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.133 -0.979 . . . . 1.0 110.405 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.497 ' H ' ' C ' ' A' ' 136' ' ' LEU . 14.6 t80 -66.26 135.5 94.95 Favored Pre-proline 0 N--CA 1.493 1.699 0 N-CA-C 107.853 -1.165 . . . . 1.0 107.853 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -62.92 -10.46 20.38 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 120.826 1.018 . . . . 1.0 114.052 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 91.5 mt -111.81 138.28 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.39 0 O-C-N 120.875 -1.14 . . . . 1.0 110.012 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -74.95 125.1 28.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.505 -0.747 . . . . 1.0 110.484 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 10.2 t -138.98 140.14 38.13 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.441 -0.787 . . . . 1.0 109.043 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.515 ' CZ ' ' OG ' ' A' ' 108' ' ' SER . 89.3 t80 -81.79 141.96 33.02 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.889 -1.132 . . . . 1.0 109.949 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.5 m -130.28 138.33 50.43 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.039 -0.726 . . . . 1.0 109.039 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -66.4 101.38 0.62 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.62 -1.792 . . . . 1.0 108.62 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.486 ' CE ' HD21 ' A' ' 115' ' ' LEU . 58.1 mmtt -75.96 129.33 36.74 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.288 -1.125 . . . . 1.0 109.302 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.5 t -179.78 -51.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.592 -0.892 . . . . 1.0 108.592 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -135.99 19.85 3.24 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.557 -0.905 . . . . 1.0 108.557 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -65.17 139.41 58.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.406 -0.808 . . . . 1.0 110.602 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 96.5 mtp -137.62 149.91 47.0 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.324 -0.991 . . . . 1.0 108.324 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.5 mt -51.83 131.44 38.32 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 120.902 -1.124 . . . . 1.0 109.03 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -71.41 177.96 6.12 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 CA-C-N 119.919 1.007 . . . . 1.0 112.083 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -62.12 -39.97 94.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.418 -0.801 . . . . 1.0 110.285 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -55.06 -48.68 73.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.035 -1.041 . . . . 1.0 109.778 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -69.96 -40.0 75.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.119 -0.988 . . . . 1.0 110.186 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.5 t -60.45 -47.78 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.968 -1.083 . . . . 1.0 109.302 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -60.61 -40.02 90.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.05 -1.031 . . . . 1.0 110.076 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.17 -52.39 11.25 Favored Glycine 0 N--CA 1.495 2.631 0 O-C-N 121.246 -0.909 . . . . 1.0 111.874 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.47 HG23 ' N ' ' A' ' 160' ' ' GLN . 8.4 tp -59.94 -39.97 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.744 -1.445 . . . . 1.0 109.917 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.547 ' O ' ' N ' ' A' ' 164' ' ' GLY . 87.9 mt-30 -68.36 -35.21 77.38 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.059 -1.026 . . . . 1.0 109.425 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 77.2 p -60.23 -35.06 74.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.131 -0.981 . . . . 1.0 110.344 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 94.5 mt -86.13 -49.61 7.63 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.958 -1.089 . . . . 1.0 110.671 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -90.04 -9.12 49.74 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.137 -0.977 . . . . 1.0 110.328 -178.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.513 0 N-CA-C 109.411 -1.476 . . . . 1.0 109.411 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.8 mt . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.322 0.582 . . . . 1.0 109.439 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -160.09 160.3 32.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.383 -0.823 . . . . 1.0 109.36 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -71.75 148.94 45.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.211 -0.93 . . . . 1.0 109.573 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 90.7 p -90.03 2.26 55.38 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.42 -0.8 . . . . 1.0 109.798 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.516 ' NZ ' ' O ' ' A' ' 14' ' ' ASN . 20.0 pttp -141.74 153.12 44.4 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.179 -0.95 . . . . 1.0 109.501 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.8 mmt -90.11 -0.04 57.4 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.323 -0.861 . . . . 1.0 109.814 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.516 ' O ' ' NZ ' ' A' ' 12' ' ' LYS . 28.1 m120 -96.97 129.25 44.45 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.197 -0.939 . . . . 1.0 109.286 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.7 mt -141.13 152.0 44.36 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.233 -0.917 . . . . 1.0 109.104 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 63.1 p -133.88 152.81 51.99 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.422 -0.799 . . . . 1.0 109.285 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -145.85 157.46 43.91 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.094 -1.004 . . . . 1.0 109.864 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.412 ' HE ' ' HA ' ' A' ' 55' ' ' ASP . 38.0 ttt-85 -144.54 135.26 24.81 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.376 -0.827 . . . . 1.0 109.356 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 86.3 mt -87.67 119.71 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.274 -0.891 . . . . 1.0 108.793 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 63.4 t -69.12 -40.22 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.315 -0.865 . . . . 1.0 109.409 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -162.86 156.63 20.32 Favored 'General case' 0 C--N 1.287 -2.146 0 O-C-N 119.38 -2.075 . . . . 1.0 111.369 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.44 ' CD2' ' CE1' ' A' ' 28' ' ' HIS . 64.4 m-85 -100.72 109.03 21.02 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 106.248 -1.76 . . . . 1.0 106.248 178.007 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.423 ' H ' HG22 ' A' ' 23' ' ' THR . 1.1 t -54.62 139.13 60.4 Favored Pre-proline 0 C--N 1.294 -1.842 0 O-C-N 121.38 -0.825 . . . . 1.0 109.309 -178.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -57.8 -6.94 2.84 Favored 'Trans proline' 0 N--CA 1.486 1.085 0 CA-C-N 119.443 0.837 . . . . 1.0 111.145 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -60.07 -39.58 86.54 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 119.78 -0.768 . . . . 1.0 110.013 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.5 mtm -137.27 159.58 41.52 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.265 -0.897 . . . . 1.0 109.086 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.488 ' OG1' ' OE1' ' A' ' 30' ' ' GLU . 36.3 p -75.3 167.88 21.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.166 -0.959 . . . . 1.0 109.714 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.44 ' CE1' ' CD2' ' A' ' 22' ' ' TYR . 1.2 m-70 -60.05 -40.43 89.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.434 -0.791 . . . . 1.0 111.057 -178.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.3 m -60.1 -46.09 90.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.886 -1.134 . . . . 1.0 110.733 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.576 ' OE1' ' N ' ' A' ' 30' ' ' GLU . 8.9 mp0 -66.75 -41.51 87.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.222 -0.924 . . . . 1.0 110.259 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 72.2 t -67.49 -44.77 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.995 -1.066 . . . . 1.0 110.134 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -60.0 -49.67 76.74 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.236 -0.915 . . . . 1.0 111.178 -178.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -60.94 -33.81 73.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.692 -1.255 . . . . 1.0 109.852 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.03 -50.93 71.79 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.916 -1.115 . . . . 1.0 110.398 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -65.58 -38.43 89.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.925 -1.11 . . . . 1.0 110.387 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.01 -42.17 93.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.898 -1.127 . . . . 1.0 109.543 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.14 -40.06 88.53 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.219 -0.926 . . . . 1.0 109.291 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.94 -46.45 89.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 1.0 110.075 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -66.84 -38.13 85.81 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.091 -1.006 . . . . 1.0 109.791 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -59.68 -48.26 82.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.13 -0.981 . . . . 1.0 109.577 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.1 t -60.01 -43.08 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.136 -0.977 . . . . 1.0 110.122 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -78.14 -35.69 48.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.99 -1.069 . . . . 1.0 110.18 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.0 p -70.38 -22.43 62.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.096 -1.003 . . . . 1.0 109.741 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.03 -40.01 87.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.31 -0.869 . . . . 1.0 110.8 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.439 HG23 HG23 ' A' ' 46' ' ' THR . 17.2 m -111.96 25.37 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.335 -0.853 . . . . 1.0 110.621 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.439 HG23 HG23 ' A' ' 45' ' ' VAL . 58.5 p -150.01 130.09 6.75 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.144 -0.973 . . . . 1.0 109.083 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -73.54 19.63 0.38 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 CA-C-N 119.974 1.026 . . . . 1.0 112.047 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.6 mt -69.41 138.74 53.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.177 -0.952 . . . . 1.0 109.616 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -107.28 120.8 43.13 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.798 -0.816 . . . . 1.0 108.798 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -107.01 127.92 53.89 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.32 -0.862 . . . . 1.0 109.162 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -119.98 129.95 54.53 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.63 -0.669 . . . . 1.0 109.444 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.429 ' HG2' HH11 ' A' ' 52' ' ' ARG . 34.1 ttt-85 -82.74 130.0 35.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.398 -0.814 . . . . 1.0 109.424 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.4 mt -103.98 119.87 39.86 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.367 -0.833 . . . . 1.0 109.168 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.434 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 59.0 m-70 -62.28 -39.96 94.67 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.427 -0.796 . . . . 1.0 110.005 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 87.4 m-20 -143.4 164.0 31.52 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.259 -0.9 . . . . 1.0 109.86 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.76 177.81 33.72 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.726 -1.35 . . . . 1.0 109.726 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.8 mt -93.24 134.77 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.292 -1.122 . . . . 1.0 109.29 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.28 167.46 10.1 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.515 -0.74 . . . . 1.0 109.422 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -59.96 -48.94 79.64 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.31 -0.869 . . . . 1.0 109.031 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.7 mt -115.59 108.66 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.535 -0.728 . . . . 1.0 109.897 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.5 ptp -98.68 138.53 35.72 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.199 -0.938 . . . . 1.0 109.108 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.9 mt -109.96 133.57 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.499 -0.75 . . . . 1.0 109.747 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 77.6 p -150.98 159.29 44.67 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.059 -1.026 . . . . 1.0 110.022 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -110.47 126.55 54.46 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.564 -0.71 . . . . 1.0 109.248 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 100' ' ' ASP . . . -102.38 -170.74 26.96 Favored Glycine 0 N--CA 1.502 3.059 0 N-CA-C 110.786 -0.925 . . . . 1.0 110.786 -179.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 62.1 mt . . . . . 0 N--CA 1.498 1.97 0 O-C-N 121.532 -0.981 . . . . 1.0 109.303 -179.941 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.545 ' CD1' ' OD1' ' A' ' 99' ' ' ASP . 94.3 m-85 . . . . . 0 N--CA 1.494 1.725 0 N-CA-C 108.799 -0.815 . . . . 1.0 108.799 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 79' ' ' SER . 27.2 p-10 -99.58 -4.12 31.79 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.084 -1.01 . . . . 1.0 110.709 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.441 ' O ' ' OE2' ' A' ' 102' ' ' GLU . . . 119.14 -115.32 3.03 Favored Glycine 0 N--CA 1.505 3.287 0 N-CA-C 110.267 -1.133 . . . . 1.0 110.267 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.468 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 29.1 Cg_endo -73.91 -75.11 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.956 0 CA-C-N 120.158 1.979 . . . . 1.0 113.402 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.459 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 88.5 p -76.61 177.88 7.14 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.915 -1.115 . . . . 1.0 110.151 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.11 -136.53 12.73 Favored Glycine 0 N--CA 1.498 2.819 0 N-CA-C 110.683 -0.967 . . . . 1.0 110.683 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.0 mt -71.81 110.41 6.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.375 -1.073 . . . . 1.0 109.763 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 55.4 mt -83.76 -18.3 38.27 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.73 173.96 1.22 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.502 -0.925 . . . . 1.0 108.502 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.497 ' CE1' ' ND1' ' A' ' 97' ' ' HIS . 9.4 p80 -162.29 164.33 27.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.971 -1.081 . . . . 1.0 109.985 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -157.17 160.52 38.84 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.823 -0.806 . . . . 1.0 108.823 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -106.75 151.36 40.48 Favored Pre-proline 0 N--CA 1.501 2.102 0 O-C-N 121.365 -0.834 . . . . 1.0 109.131 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -62.51 165.56 15.26 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 120.987 1.124 . . . . 1.0 112.328 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo . . . . . 0 N--CA 1.489 1.263 0 C-N-CA 121.161 1.241 . . . . 1.0 112.356 179.898 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.386 -0.598 . . . . 1.0 109.386 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.89 119.83 6.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 1.0 109.191 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.497 ' ND1' ' CE1' ' A' ' 84' ' ' HIS . 52.4 m170 -103.85 145.78 29.61 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.539 -0.725 . . . . 1.0 109.994 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -129.68 147.03 51.43 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.447 -0.946 . . . . 1.0 108.447 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.545 ' OD1' ' CD1' ' A' ' 75' ' ' PHE . 98.3 m-20 -80.81 124.28 28.94 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.92 -1.113 . . . . 1.0 109.579 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 65' ' ' GLY . 39.2 t0 -84.24 -6.81 59.45 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.144 -0.973 . . . . 1.0 109.214 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -80.33 -9.91 59.75 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.633 -0.877 . . . . 1.0 108.633 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.468 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 57.5 mm-40 -89.57 173.3 8.4 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.985 -0.746 . . . . 1.0 108.985 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 54.2 m -105.29 107.62 18.7 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -88.58 119.98 29.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.304 -0.872 . . . . 1.0 108.739 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.663 HG21 ' HB2' ' A' ' 109' ' ' LYS . 9.0 t -140.24 157.85 44.94 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.365 -0.835 . . . . 1.0 109.79 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.4 t -95.76 -9.83 30.72 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.223 -0.923 . . . . 1.0 109.053 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 71.3 m -92.46 179.22 5.59 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.368 -0.833 . . . . 1.0 108.975 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.1 t -78.64 77.78 5.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.032 -1.043 . . . . 1.0 109.56 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.663 ' HB2' HG21 ' A' ' 105' ' ' THR . 68.6 mttm -148.76 148.12 29.62 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.266 -0.896 . . . . 1.0 108.821 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.53 -141.3 4.72 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.746 -1.342 . . . . 1.0 109.746 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -100.33 117.02 33.66 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.352 -1.087 . . . . 1.0 108.925 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -62.74 133.85 55.42 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.076 -1.015 . . . . 1.0 109.219 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.9 tp -59.99 -42.82 95.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 1.0 109.823 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -59.86 -40.8 89.87 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.234 -0.916 . . . . 1.0 110.968 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -59.76 -52.12 66.85 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.604 -1.31 . . . . 1.0 109.722 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.3 t -69.91 -40.79 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.059 -1.026 . . . . 1.0 110.049 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.45 -50.15 74.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.153 -0.967 . . . . 1.0 109.547 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.0 -37.3 79.3 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.71 -1.244 . . . . 1.0 110.16 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.592 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 56.9 t60 -63.5 -50.1 70.96 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.219 -0.926 . . . . 1.0 111.315 -178.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.99 -39.03 84.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.748 -1.22 . . . . 1.0 109.858 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -59.99 -40.05 87.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.821 -1.174 . . . . 1.0 108.519 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.45 -46.8 79.51 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.807 -1.317 . . . . 1.0 109.807 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.592 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 86.0 m-70 -65.85 -39.98 91.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.06 -1.259 . . . . 1.0 109.462 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.1 p -64.58 -25.1 67.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.228 -0.92 . . . . 1.0 109.8 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 72.8 mt -80.95 1.98 28.77 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.138 -0.976 . . . . 1.0 109.371 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 87.19 9.51 73.12 Favored Glycine 0 N--CA 1.495 2.629 0 O-C-N 121.2 -0.938 . . . . 1.0 110.834 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.4 mt -84.95 150.02 25.22 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.836 -1.39 . . . . 1.0 109.759 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 39.6 t0 -99.53 171.33 8.0 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.869 -0.789 . . . . 1.0 108.869 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.537 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 71.9 m80 -59.96 139.96 57.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.12 -0.987 . . . . 1.0 109.53 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 44.4 t -97.1 152.4 18.82 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.428 -0.795 . . . . 1.0 109.554 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -99.01 2.22 46.1 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.311 -0.868 . . . . 1.0 109.354 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 9.5 t70 -87.26 130.0 49.44 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.294 -0.879 . . . . 1.0 108.708 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -67.15 -22.22 47.4 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 CA-C-N 120.078 1.064 . . . . 1.0 112.437 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.444 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -86.89 -2.39 84.14 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.817 -1.313 . . . . 1.0 109.817 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.57 143.48 28.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.183 -1.186 . . . . 1.0 109.219 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.436 ' C ' ' H ' ' A' ' 138' ' ' PHE . 84.3 mt -69.26 -38.31 78.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.098 -1.001 . . . . 1.0 109.698 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 81.4 mtp -72.09 20.92 0.06 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 1.0 110.735 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.436 ' H ' ' C ' ' A' ' 136' ' ' LEU . 16.3 t80 -68.11 134.48 91.58 Favored Pre-proline 0 N--CA 1.496 1.857 0 N-CA-C 107.885 -1.154 . . . . 1.0 107.885 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -61.47 -9.46 13.31 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 120.836 1.024 . . . . 1.0 114.227 -177.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 86.4 mt -113.05 134.08 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 O-C-N 120.955 -1.091 . . . . 1.0 109.705 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -72.34 127.24 31.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.467 -0.77 . . . . 1.0 110.402 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 14.1 t -141.29 141.14 33.95 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.582 -0.895 . . . . 1.0 108.582 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -78.95 143.83 35.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.09 -1.007 . . . . 1.0 109.199 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.6 t -138.8 150.78 46.45 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.292 -0.88 . . . . 1.0 109.71 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -66.15 101.59 0.63 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.465 -1.454 . . . . 1.0 109.465 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 20.9 mtmm -76.71 0.34 20.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.423 -1.046 . . . . 1.0 109.768 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 73.6 p -60.06 -39.97 87.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -0.901 . . . . 1.0 109.965 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -147.62 30.69 0.9 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.079 -1.013 . . . . 1.0 109.526 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -65.28 139.61 58.63 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.132 -0.98 . . . . 1.0 109.586 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 68.2 mtt -136.55 145.24 44.8 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.702 -0.851 . . . . 1.0 108.702 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 20.9 mt -52.86 128.86 46.7 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.091 -1.006 . . . . 1.0 108.719 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -70.13 178.69 4.54 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 CA-C-N 120.081 1.065 . . . . 1.0 112.286 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -60.36 -39.95 89.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.432 -0.792 . . . . 1.0 110.096 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -56.14 -49.12 74.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.199 -0.938 . . . . 1.0 109.969 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -70.08 -39.93 75.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.996 -1.065 . . . . 1.0 110.064 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 58.1 t -61.28 -47.43 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.012 -1.055 . . . . 1.0 109.498 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -60.43 -40.09 89.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.048 -1.032 . . . . 1.0 110.45 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.26 -53.72 8.67 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 120.374 -0.917 . . . . 1.0 111.477 -178.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.476 HG23 ' N ' ' A' ' 160' ' ' GLN . 6.8 tp -59.97 -40.06 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.817 -1.402 . . . . 1.0 109.569 -178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.7 mt-30 -66.06 -39.94 90.5 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.101 -1.0 . . . . 1.0 109.202 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 95.1 p -60.53 -28.75 68.66 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.01 -1.056 . . . . 1.0 109.853 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 86.5 mt -89.8 -51.64 5.4 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.047 -1.033 . . . . 1.0 110.643 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -98.04 -22.08 16.45 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.945 -1.097 . . . . 1.0 110.829 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.626 0 N-CA-C 109.692 -1.363 . . . . 1.0 109.692 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.0 mt . . . . . 0 N--CA 1.496 1.841 0 N-CA-C 109.049 -0.723 . . . . 1.0 109.049 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -160.0 160.04 32.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 1.0 109.69 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -72.88 150.0 43.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.304 -0.873 . . . . 1.0 109.304 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.1 t -85.48 1.61 48.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.303 -0.873 . . . . 1.0 110.093 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.521 ' NZ ' ' O ' ' A' ' 14' ' ' ASN . 20.1 pttp -149.14 154.24 38.9 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.162 -0.961 . . . . 1.0 109.635 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.54 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.01 0.39 57.14 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.289 -0.882 . . . . 1.0 109.666 -179.549 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.521 ' O ' ' NZ ' ' A' ' 12' ' ' LYS . 98.5 m-20 -95.51 128.76 42.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.219 -0.926 . . . . 1.0 108.884 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.5 mt -141.31 149.93 41.85 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.186 -0.946 . . . . 1.0 109.253 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 74.3 p -130.9 155.46 46.71 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.03 -0.73 . . . . 1.0 109.03 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -145.86 160.16 42.18 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.146 -0.972 . . . . 1.0 109.835 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.531 HH12 ' H ' ' A' ' 56' ' ' GLY . 73.4 ttt180 -143.36 133.45 24.32 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.537 -0.727 . . . . 1.0 109.583 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 91.8 mt -88.36 117.09 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.189 -0.944 . . . . 1.0 108.663 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.54 -40.12 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.06 -1.025 . . . . 1.0 109.391 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -163.85 160.94 22.82 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.431 -1.418 . . . . 1.0 110.631 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -97.21 -173.33 2.64 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.56 -1.274 . . . . 1.0 107.56 178.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.7 148.4 43.01 Favored Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 121.377 -0.827 . . . . 1.0 110.029 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -67.68 -20.64 46.35 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 120.833 1.022 . . . . 1.0 110.335 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -59.4 -40.12 85.6 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.15 -0.932 . . . . 1.0 110.168 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 78.0 mtm -138.95 159.93 40.95 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.257 -0.902 . . . . 1.0 109.853 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 82.6 p -74.21 160.86 30.58 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.497 0.665 . . . . 1.0 109.417 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -62.47 -35.88 80.72 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.552 -0.718 . . . . 1.0 110.148 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.9 m -60.04 -40.28 88.82 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.845 -1.16 . . . . 1.0 109.61 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -69.94 -40.04 75.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.114 -0.991 . . . . 1.0 109.035 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.0 t -69.13 -41.47 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.314 -0.866 . . . . 1.0 110.258 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.95 -48.13 82.95 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.931 -1.105 . . . . 1.0 110.346 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -63.75 -31.82 73.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.87 -1.144 . . . . 1.0 109.834 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.97 -49.96 75.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.07 -1.019 . . . . 1.0 110.031 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -65.55 -37.89 88.01 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.018 -1.051 . . . . 1.0 109.661 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.07 -41.24 92.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.096 -1.003 . . . . 1.0 109.878 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -60.07 -45.32 93.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.12 -0.987 . . . . 1.0 109.475 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.12 -48.06 83.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.44 -0.787 . . . . 1.0 110.717 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.42 ' CZ ' ' CZ ' ' A' ' 121' ' ' PHE . 49.7 m-85 -64.04 -40.05 95.44 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.956 -1.09 . . . . 1.0 109.529 -179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.6 tptt -59.99 -47.33 86.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.029 -1.045 . . . . 1.0 109.543 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.02 -41.52 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.143 -0.973 . . . . 1.0 110.128 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -78.49 -36.71 44.74 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.012 -1.055 . . . . 1.0 110.376 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 96.1 p -70.91 -20.76 62.46 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.982 -1.074 . . . . 1.0 109.936 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.93 -39.89 87.04 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.252 -0.905 . . . . 1.0 110.558 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.1 m -110.01 23.84 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.201 -0.937 . . . . 1.0 110.944 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.4 p -150.27 139.8 13.42 Favored Pre-proline 0 N--CA 1.502 2.129 0 O-C-N 120.76 -1.213 . . . . 1.0 109.658 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -75.37 15.7 0.79 Allowed 'Trans proline' 0 N--CA 1.497 1.693 0 CA-C-N 119.743 0.944 . . . . 1.0 112.088 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 88.2 mt -67.1 139.92 57.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.079 -1.013 . . . . 1.0 109.71 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -111.81 121.38 44.91 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 109.045 -0.724 . . . . 1.0 109.045 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -107.8 119.01 38.24 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.33 -0.856 . . . . 1.0 109.251 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.1 m -119.95 129.98 54.57 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.64 -0.663 . . . . 1.0 109.946 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.417 ' HG2' HH11 ' A' ' 52' ' ' ARG . 33.6 ttt-85 -82.0 135.13 35.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 1.0 109.241 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.5 mt -102.1 132.0 48.25 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.343 -0.848 . . . . 1.0 109.188 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.447 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 42.0 m170 -63.95 -40.01 95.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -0.84 . . . . 1.0 109.733 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 76.7 m-20 -148.89 169.95 19.39 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.328 -0.857 . . . . 1.0 109.869 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.531 ' H ' HH12 ' A' ' 18' ' ' ARG . . . 95.06 178.52 37.5 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.7 -1.36 . . . . 1.0 109.7 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.4 mt -92.58 139.52 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.292 -1.122 . . . . 1.0 108.961 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.05 170.55 8.08 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.473 -0.767 . . . . 1.0 109.702 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.03 -49.05 79.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.242 -0.911 . . . . 1.0 108.935 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 90.2 mt -119.95 112.97 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.616 -0.678 . . . . 1.0 109.251 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.0 ptm -100.93 135.0 43.07 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.397 -0.814 . . . . 1.0 108.952 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 95.8 mt -104.43 135.17 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.505 -0.747 . . . . 1.0 110.365 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 79.4 p -152.9 159.03 42.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.345 -0.847 . . . . 1.0 109.278 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -102.81 127.71 49.87 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.413 -0.804 . . . . 1.0 109.564 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.89 157.95 17.86 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 109.436 -1.466 . . . . 1.0 109.436 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.9 tt . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.465 -1.021 . . . . 1.0 108.719 179.995 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.538 ' CD1' ' OD2' ' A' ' 99' ' ' ASP . 90.8 m-85 . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 108.604 -0.887 . . . . 1.0 108.604 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.6 p-10 -97.4 0.0 47.06 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.082 -1.011 . . . . 1.0 110.099 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.21 -157.89 22.9 Favored Glycine 0 N--CA 1.5 2.944 0 N-CA-C 108.722 -1.751 . . . . 1.0 108.722 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -59.68 -63.68 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.354 0 CA-C-N 118.655 1.228 . . . . 1.0 111.612 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 88.1 p -77.62 162.34 27.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.428 -0.795 . . . . 1.0 109.485 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.15 -129.95 9.03 Favored Glycine 0 N--CA 1.499 2.894 0 N-CA-C 109.709 -1.356 . . . . 1.0 109.709 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.449 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 10.2 mt -64.99 101.13 0.47 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.222 -1.164 . . . . 1.0 108.66 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 53.5 mt -75.66 -28.36 58.69 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.468 -0.938 . . . . 1.0 108.468 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -177.92 163.94 1.84 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.385 -0.969 . . . . 1.0 108.385 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -160.78 160.41 31.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.907 -1.121 . . . . 1.0 109.97 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -144.11 156.21 44.25 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.705 -0.85 . . . . 1.0 108.705 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -95.51 150.99 38.26 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.149 -0.969 . . . . 1.0 108.807 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -65.5 165.01 24.04 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 120.771 0.981 . . . . 1.0 111.556 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo . . . . . 0 C--N 1.314 -1.238 0 C-N-CA 121.164 1.243 . . . . 1.0 111.792 179.865 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.016 -0.735 . . . . 1.0 109.016 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.65 123.67 10.73 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.083 -1.011 . . . . 1.0 109.61 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -110.08 154.76 22.8 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.589 0.709 . . . . 1.0 110.015 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.486 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 44.9 m-85 -130.58 150.22 51.88 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.538 ' OD2' ' CD1' ' A' ' 75' ' ' PHE . 1.2 m-20 -78.96 122.86 26.68 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.991 -1.068 . . . . 1.0 109.591 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -84.44 -6.84 59.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.142 -0.974 . . . . 1.0 109.379 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -85.98 -14.74 43.7 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.336 -0.853 . . . . 1.0 110.067 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.574 ' OE1' ' N ' ' A' ' 102' ' ' GLU . 0.9 OUTLIER -88.66 169.91 11.27 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.176 -0.953 . . . . 1.0 109.687 -179.113 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.7 m -99.05 102.57 14.32 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.75 -0.833 . . . . 1.0 108.75 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.446 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 93.4 m95 -85.16 121.99 28.7 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.48 -0.762 . . . . 1.0 109.33 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.646 HG21 ' HB2' ' A' ' 109' ' ' LYS . 7.2 t -140.63 150.4 43.52 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.476 -0.765 . . . . 1.0 109.761 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 74.8 m -93.04 -6.2 48.77 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.193 -0.942 . . . . 1.0 108.52 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.1 p -91.3 178.63 5.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.571 -0.706 . . . . 1.0 109.208 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 89.7 p -77.0 70.0 3.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 1.0 109.376 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.646 ' HB2' HG21 ' A' ' 105' ' ' THR . 68.3 mttm -146.22 150.81 36.52 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.192 -0.942 . . . . 1.0 109.484 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 43.56 -137.73 4.18 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.046 -1.221 . . . . 1.0 110.046 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -99.99 115.32 29.42 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.394 -1.063 . . . . 1.0 109.22 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.441 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 19.3 t-20 -63.18 130.63 45.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.212 -0.93 . . . . 1.0 109.873 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.7 tp -59.92 -43.54 94.83 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.402 -0.811 . . . . 1.0 110.832 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -60.07 -42.14 93.9 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.989 -1.07 . . . . 1.0 111.096 -178.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -60.01 -50.05 75.26 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.672 -1.267 . . . . 1.0 109.509 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.5 t -70.03 -41.4 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.078 -1.014 . . . . 1.0 110.006 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.56 -50.52 72.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.227 -0.921 . . . . 1.0 109.891 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.96 -39.78 86.78 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.255 -0.903 . . . . 1.0 110.627 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.627 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 67.9 t60 -63.03 -48.4 78.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.115 -0.991 . . . . 1.0 111.156 -178.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.486 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 7.0 pt-20 -59.89 -39.6 85.91 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.589 -1.319 . . . . 1.0 110.011 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.42 ' CZ ' ' CZ ' ' A' ' 39' ' ' PHE . 32.3 m-85 -60.02 -40.11 88.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.912 -1.117 . . . . 1.0 108.479 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -56.42 -42.55 89.63 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.365 -1.494 . . . . 1.0 109.365 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.627 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 81.9 m-70 -65.53 -40.02 92.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.073 -1.251 . . . . 1.0 109.592 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 80.0 p -67.15 -23.69 65.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.18 -0.95 . . . . 1.0 109.317 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.7 mt -81.96 -0.97 46.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.183 -0.948 . . . . 1.0 109.59 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 92.68 7.94 62.63 Favored Glycine 0 N--CA 1.497 2.735 0 O-C-N 121.149 -0.969 . . . . 1.0 110.933 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.4 mt -86.98 141.98 28.29 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.854 -1.38 . . . . 1.0 109.858 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 10.8 t70 -98.72 174.94 6.16 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.555 -0.715 . . . . 1.0 109.089 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.491 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 76.8 m80 -59.86 139.74 57.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.026 -1.046 . . . . 1.0 109.9 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 30.4 t -98.98 156.46 16.9 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.405 -0.809 . . . . 1.0 109.182 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -97.05 -1.43 45.4 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.229 -0.919 . . . . 1.0 109.016 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -85.43 129.32 55.76 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.079 -1.013 . . . . 1.0 108.976 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -68.69 -20.16 40.72 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 CA-C-N 120.027 1.045 . . . . 1.0 112.372 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -87.3 -7.14 77.05 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.895 -1.282 . . . . 1.0 109.895 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.58 145.7 26.65 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.086 -1.243 . . . . 1.0 109.427 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.418 ' C ' ' H ' ' A' ' 138' ' ' PHE . 96.1 mt -69.97 -29.13 66.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.047 -1.033 . . . . 1.0 109.696 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.1 mmm -72.2 13.49 0.31 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.332 -0.855 . . . . 1.0 110.262 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.418 ' H ' ' C ' ' A' ' 136' ' ' LEU . 12.2 t80 -70.0 131.83 88.83 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.071 -1.018 . . . . 1.0 108.768 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -63.56 -8.56 15.45 Favored 'Trans proline' 0 N--CA 1.501 1.93 0 C-N-CA 120.924 1.083 . . . . 1.0 114.37 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 84.2 mt -109.72 138.6 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 O-C-N 120.936 -1.103 . . . . 1.0 109.317 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' TYR . . . . . 0.441 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 45.7 t80 -74.38 128.2 34.94 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.357 -0.839 . . . . 1.0 110.7 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.1 t -139.22 138.29 36.73 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.578 -0.702 . . . . 1.0 109.211 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.467 ' CE1' ' NZ ' ' A' ' 146' ' ' LYS . 70.6 t80 -80.83 150.12 29.28 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.975 -1.078 . . . . 1.0 109.352 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.6 t -142.4 158.56 43.57 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.116 -0.99 . . . . 1.0 109.992 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.07 113.91 4.75 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.423 -1.471 . . . . 1.0 109.423 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.467 ' NZ ' ' CE1' ' A' ' 143' ' ' TYR . 62.2 mttp -80.85 3.28 23.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.382 -1.069 . . . . 1.0 110.203 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 27.6 t -58.07 -41.29 83.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.845 -1.159 . . . . 1.0 109.532 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -160.96 68.66 0.34 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.32 -0.862 . . . . 1.0 109.18 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -94.36 120.54 34.75 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.249 -0.907 . . . . 1.0 109.812 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 75.0 mtm -116.62 142.5 46.81 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 22.3 mt -50.4 132.78 25.53 Favored Pre-proline 0 C--N 1.302 -1.498 0 O-C-N 121.043 -1.036 . . . . 1.0 108.914 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -68.87 179.42 3.23 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 CA-C-N 119.865 0.987 . . . . 1.0 112.355 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -62.43 -39.95 94.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.457 -0.777 . . . . 1.0 110.126 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -56.82 -48.62 77.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 1.0 110.071 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -70.11 -39.96 75.18 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.078 -1.014 . . . . 1.0 109.803 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 54.6 t -61.25 -48.08 90.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.18 -0.95 . . . . 1.0 109.162 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -61.05 -40.08 92.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.115 -0.991 . . . . 1.0 110.413 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.25 -53.66 13.24 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 120.243 -0.98 . . . . 1.0 111.253 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.457 HG23 ' N ' ' A' ' 160' ' ' GLN . 5.2 tp -60.36 -40.0 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.889 -1.36 . . . . 1.0 109.749 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.4 mt-30 -64.71 -39.9 94.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.04 -1.038 . . . . 1.0 109.636 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 84.4 p -65.96 -24.4 66.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -0.949 . . . . 1.0 110.2 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 85.6 mt -88.42 -51.5 5.69 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.931 -1.106 . . . . 1.0 110.232 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -90.89 -8.78 48.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.939 -1.1 . . . . 1.0 109.539 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.493 2.448 0 N-CA-C 109.664 -1.375 . . . . 1.0 109.664 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.9 mt . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.526 -0.546 . . . . 1.0 109.526 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -159.86 160.0 33.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 1.0 109.377 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -73.78 150.06 41.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.224 -0.922 . . . . 1.0 109.047 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.3 t -85.62 -0.07 54.06 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.159 -0.963 . . . . 1.0 110.249 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -150.22 159.57 44.34 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.98 -1.075 . . . . 1.0 109.878 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.557 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -91.8 -0.03 57.51 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.385 -0.822 . . . . 1.0 109.689 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -96.22 123.38 39.82 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.215 -0.928 . . . . 1.0 108.995 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.3 mt -140.0 152.29 46.16 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.368 -0.832 . . . . 1.0 108.997 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.6 p -132.89 155.48 48.96 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.492 -0.755 . . . . 1.0 109.103 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -144.69 158.71 43.67 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.231 -0.918 . . . . 1.0 109.648 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.412 HH11 ' HG2' ' A' ' 18' ' ' ARG . 37.2 ttt-85 -142.44 132.28 24.23 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.467 -0.77 . . . . 1.0 109.47 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 93.1 mt -87.05 119.62 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.331 -0.856 . . . . 1.0 109.113 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.4 t -69.84 -40.3 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.175 -0.953 . . . . 1.0 109.495 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.414 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 18.6 p-10 -162.53 154.99 19.19 Favored 'General case' 0 C--N 1.288 -2.076 0 O-C-N 119.718 -1.864 . . . . 1.0 111.028 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.408 ' OH ' ' NH2' ' A' ' 52' ' ' ARG . 44.0 m-85 -99.87 108.85 21.22 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 105.582 -2.007 . . . . 1.0 105.582 177.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 23' ' ' THR . 1.1 t -57.55 139.58 80.97 Favored Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.055 -1.028 . . . . 1.0 109.727 -177.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -59.16 -10.15 9.77 Favored 'Trans proline' 0 N--CA 1.487 1.093 0 CA-C-N 119.246 0.766 . . . . 1.0 110.96 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -57.57 -28.21 63.37 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.848 -0.741 . . . . 1.0 110.078 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 77.4 mtm -143.44 162.48 35.68 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.085 -1.009 . . . . 1.0 109.862 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.2 p -71.81 160.83 31.91 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.309 -0.869 . . . . 1.0 109.205 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -61.41 -40.21 93.58 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.426 -0.796 . . . . 1.0 110.487 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.5 m -61.08 -41.23 96.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.968 -1.083 . . . . 1.0 110.705 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.89 -40.01 91.15 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.15 -0.969 . . . . 1.0 110.623 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 69.5 t -69.73 -42.22 80.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 120.936 -1.102 . . . . 1.0 110.275 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -59.97 -53.87 52.76 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.212 -0.93 . . . . 1.0 110.83 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.3 ptmm? -65.92 -29.83 70.32 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.586 -0.696 . . . . 1.0 110.821 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.04 -49.93 75.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.785 -1.197 . . . . 1.0 109.463 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -66.96 -38.26 85.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.018 -1.051 . . . . 1.0 110.211 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.06 -40.58 89.96 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.913 -1.117 . . . . 1.0 109.559 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.04 -41.41 96.54 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.889 -1.132 . . . . 1.0 108.964 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.99 -46.44 89.45 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.516 -0.74 . . . . 1.0 109.957 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.432 ' CE1' ' CD1' ' A' ' 50' ' ' PHE . 53.3 m-85 -65.15 -39.98 93.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.968 -1.083 . . . . 1.0 109.499 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -60.05 -48.46 81.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.052 -1.03 . . . . 1.0 109.852 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.7 t -60.0 -41.06 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.092 -1.005 . . . . 1.0 110.083 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -78.4 -36.42 45.78 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.92 -1.113 . . . . 1.0 110.135 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 81.7 p -71.78 -18.02 62.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.071 -1.018 . . . . 1.0 109.845 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -60.01 -39.69 86.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.239 -0.913 . . . . 1.0 110.285 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.434 HG23 HG23 ' A' ' 46' ' ' THR . 21.9 m -111.41 20.97 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.38 -0.825 . . . . 1.0 110.788 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.434 HG23 HG23 ' A' ' 45' ' ' VAL . 22.5 p -148.42 138.22 12.62 Favored Pre-proline 0 N--CA 1.504 2.255 0 O-C-N 120.77 -1.207 . . . . 1.0 109.914 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -73.95 21.23 0.38 Allowed 'Trans proline' 0 N--CA 1.498 1.793 0 C-N-CA 120.962 1.108 . . . . 1.0 112.495 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.3 mt -69.5 136.46 51.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.893 -1.13 . . . . 1.0 110.018 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -107.91 120.0 41.06 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.614 -0.884 . . . . 1.0 108.614 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.432 ' CD1' ' CE1' ' A' ' 39' ' ' PHE . 95.1 m-85 -108.5 125.29 51.63 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.311 -0.868 . . . . 1.0 109.723 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -120.05 130.03 54.5 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.67 -0.644 . . . . 1.0 109.792 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.408 ' NH2' ' OH ' ' A' ' 22' ' ' TYR . 68.6 ttt180 -82.38 130.73 35.17 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.365 -0.835 . . . . 1.0 109.892 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.0 mt -109.64 124.33 50.99 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.421 -0.799 . . . . 1.0 109.083 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.439 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 48.4 m170 -79.27 -19.08 51.44 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.197 -0.94 . . . . 1.0 110.111 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 79.9 m-20 -146.6 160.42 42.19 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.067 -1.02 . . . . 1.0 109.901 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.97 175.3 44.0 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.555 -1.418 . . . . 1.0 109.555 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.2 mt -96.43 136.46 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.212 -1.17 . . . . 1.0 108.965 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.98 160.86 16.43 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.388 -0.82 . . . . 1.0 109.449 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.04 -49.11 78.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.223 -0.923 . . . . 1.0 109.293 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.9 mt -104.32 98.52 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.416 -0.802 . . . . 1.0 109.839 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.4 ptm -100.11 131.69 45.91 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.191 -0.943 . . . . 1.0 109.399 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 92.1 mt -103.02 138.92 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.541 -0.724 . . . . 1.0 110.208 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 82.5 p -153.07 157.74 40.89 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.371 -0.83 . . . . 1.0 109.249 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -106.5 125.68 51.31 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.83 -0.804 . . . . 1.0 108.83 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 98' ' ' PHE . . . -98.11 178.78 32.11 Favored Glycine 0 N--CA 1.499 2.873 0 O-C-N 121.108 -0.995 . . . . 1.0 110.761 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 41.1 mt . . . . . 0 N--CA 1.497 1.917 0 O-C-N 121.672 -0.899 . . . . 1.0 109.018 179.717 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.54 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 99.0 m-85 . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 108.657 -0.868 . . . . 1.0 108.657 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -100.15 5.51 44.82 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.181 -0.949 . . . . 1.0 110.82 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 126.1 -156.23 19.58 Favored Glycine 0 N--CA 1.504 3.169 0 N-CA-C 109.085 -1.606 . . . . 1.0 109.085 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -59.83 -66.48 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 0 CA-C-N 118.697 1.249 . . . . 1.0 112.372 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 80.3 p -75.56 160.06 30.56 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.12 -0.987 . . . . 1.0 109.529 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.37 -130.02 8.9 Favored Glycine 0 N--CA 1.502 3.04 0 N-CA-C 109.67 -1.372 . . . . 1.0 109.67 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.423 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 10.9 mt -68.6 105.37 2.23 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.252 -1.146 . . . . 1.0 109.065 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 39.2 mt -78.7 -16.29 57.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.98 -1.075 . . . . 1.0 108.951 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 97' ' ' HIS . . . -178.83 176.1 0.97 Allowed 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.435 ' ND1' ' C ' ' A' ' 84' ' ' HIS . 7.0 p80 -161.08 162.25 31.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.015 -1.053 . . . . 1.0 109.557 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.63 165.73 31.42 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.223 -0.923 . . . . 1.0 109.651 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -113.66 153.39 45.88 Favored Pre-proline 0 N--CA 1.5 2.033 0 N-CA-C 108.873 -0.788 . . . . 1.0 108.873 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -55.56 169.08 1.28 Allowed 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.023 1.149 . . . . 1.0 112.363 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo . . . . . 0 N--CA 1.494 1.545 0 C-N-CA 121.278 1.318 . . . . 1.0 112.451 -179.754 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.497 -0.557 . . . . 1.0 109.497 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.01 117.02 5.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.299 -0.876 . . . . 1.0 109.421 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.411 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 38.2 m170 -105.64 152.23 23.38 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.491 -0.755 . . . . 1.0 109.821 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.482 ' O ' ' N ' ' A' ' 65' ' ' GLY . 38.2 m-85 -131.81 148.82 52.58 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.774 -0.824 . . . . 1.0 108.774 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.54 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 89.5 m-20 -79.03 122.83 26.68 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.915 -1.116 . . . . 1.0 109.689 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -84.04 -11.78 56.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.355 -0.841 . . . . 1.0 109.077 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -81.6 -12.56 58.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.408 -0.807 . . . . 1.0 109.278 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -89.23 169.1 11.74 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.868 -0.79 . . . . 1.0 108.868 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 39.2 m -99.81 104.41 16.1 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.201 -0.937 . . . . 1.0 109.266 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.47 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 91.3 m95 -87.46 127.11 35.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.336 -0.852 . . . . 1.0 108.915 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.642 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.0 t -143.14 158.15 43.87 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.356 -0.84 . . . . 1.0 109.755 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.2 t -96.98 -10.41 26.31 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.453 -0.943 . . . . 1.0 108.453 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 81.1 p -90.41 -176.4 4.77 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.007 -0.738 . . . . 1.0 109.007 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 m -82.82 76.57 9.65 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.135 -0.978 . . . . 1.0 109.58 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.642 ' HB2' HG21 ' A' ' 105' ' ' THR . 98.0 mttt -149.6 151.12 33.28 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.19 -0.944 . . . . 1.0 108.992 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 43.73 -139.44 3.63 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.992 -1.243 . . . . 1.0 109.992 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -100.08 116.46 32.17 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.359 -1.083 . . . . 1.0 109.161 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -64.56 132.13 48.97 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.899 -1.125 . . . . 1.0 109.785 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.6 tp -59.99 -42.97 95.38 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.352 -0.842 . . . . 1.0 110.552 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -60.01 -40.65 89.96 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.098 -1.001 . . . . 1.0 110.836 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -59.93 -50.77 72.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.765 -1.209 . . . . 1.0 109.25 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.9 t -70.03 -40.15 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.202 -0.936 . . . . 1.0 110.224 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.58 -52.15 66.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.112 -0.993 . . . . 1.0 109.552 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.98 -34.34 73.18 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.246 -0.909 . . . . 1.0 110.078 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -64.3 -50.04 69.41 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.224 -0.922 . . . . 1.0 111.051 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.451 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 7.1 pt-20 -60.01 -39.31 85.36 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.801 -1.187 . . . . 1.0 110.025 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -59.98 -40.0 87.62 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.934 -1.104 . . . . 1.0 108.851 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.32 -46.05 81.12 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.753 -1.739 . . . . 1.0 108.753 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -64.5 -40.0 94.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.335 -1.097 . . . . 1.0 109.413 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.0 p -67.42 -23.57 65.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.361 -0.837 . . . . 1.0 109.67 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 69.9 mt -82.81 -0.3 47.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.227 -0.921 . . . . 1.0 109.927 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 89.12 9.83 67.02 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 110.447 -1.061 . . . . 1.0 110.447 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.9 mt -85.79 150.05 24.84 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.067 -1.255 . . . . 1.0 110.251 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 12.0 t70 -101.0 169.98 8.59 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.833 -0.803 . . . . 1.0 108.833 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.529 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 23.9 m170 -59.34 136.39 57.95 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.997 -1.065 . . . . 1.0 108.961 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 35.8 t -97.93 155.0 17.28 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.312 -0.868 . . . . 1.0 109.63 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -99.87 4.84 45.33 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.275 -0.891 . . . . 1.0 109.621 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -86.11 128.54 57.4 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 108.323 -0.991 . . . . 1.0 108.323 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -67.78 -18.63 47.54 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 CA-C-N 120.208 1.11 . . . . 1.0 111.864 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -88.9 -5.52 73.67 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.574 -1.41 . . . . 1.0 109.574 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.76 135.95 33.9 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.247 -1.149 . . . . 1.0 109.056 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.421 ' C ' ' H ' ' A' ' 138' ' ' PHE . 94.9 mt -60.5 -39.99 89.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.073 -1.017 . . . . 1.0 109.894 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 92.4 mtp -71.16 24.35 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.337 -0.852 . . . . 1.0 111.558 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.421 ' H ' ' C ' ' A' ' 136' ' ' LEU . 15.5 t80 -68.78 132.8 90.6 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 120.811 -1.181 . . . . 1.0 108.013 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -57.98 -8.78 5.04 Favored 'Trans proline' 0 N--CA 1.5 1.892 0 C-N-CA 120.859 1.039 . . . . 1.0 114.353 -177.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.9 mt -114.83 137.34 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 120.971 -1.08 . . . . 1.0 109.155 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -71.64 129.72 39.4 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.26 -0.9 . . . . 1.0 109.943 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 10.1 t -140.12 135.87 32.96 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.423 -0.798 . . . . 1.0 109.011 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -79.52 144.47 33.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.105 -0.997 . . . . 1.0 109.098 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.7 t -140.97 153.25 45.51 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.203 -0.936 . . . . 1.0 109.465 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.17 112.08 3.88 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.445 -1.462 . . . . 1.0 109.445 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -78.55 7.92 6.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -1.135 . . . . 1.0 109.598 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 73.4 m -59.99 -40.04 87.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 1.0 109.34 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -158.82 68.2 0.45 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 1.0 109.265 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -100.51 124.62 46.28 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.379 -0.826 . . . . 1.0 109.741 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 76.0 mtm -120.61 141.65 50.14 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.487 -0.931 . . . . 1.0 108.487 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.6 mt -48.89 129.36 14.7 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.015 -1.053 . . . . 1.0 108.924 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -68.23 176.69 5.24 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 CA-C-N 119.939 1.014 . . . . 1.0 112.646 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.23 -40.02 88.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.481 -0.762 . . . . 1.0 109.793 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -56.38 -49.41 74.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -0.944 . . . . 1.0 109.691 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -70.03 -40.01 75.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.204 -0.935 . . . . 1.0 110.141 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 62.4 t -59.97 -46.56 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.936 -1.102 . . . . 1.0 109.099 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -60.73 -40.01 90.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.144 -0.973 . . . . 1.0 110.321 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.34 -54.7 10.17 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 120.199 -1.0 . . . . 1.0 111.188 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.48 HG23 ' N ' ' A' ' 160' ' ' GLN . 7.2 tp -61.7 -40.47 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.975 -1.309 . . . . 1.0 109.957 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.527 ' O ' ' N ' ' A' ' 164' ' ' GLY . 25.4 mm100 -65.28 -39.61 92.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.182 -0.949 . . . . 1.0 109.539 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 78.0 p -64.7 -27.74 69.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.921 . . . . 1.0 110.273 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 94.0 mt -87.0 -53.18 5.02 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.978 -1.077 . . . . 1.0 110.322 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -92.04 -9.25 43.44 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.215 -0.928 . . . . 1.0 110.119 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.496 2.64 0 N-CA-C 109.401 -1.48 . . . . 1.0 109.401 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.0 mt . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.326 -0.62 . . . . 1.0 109.326 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -165.63 163.66 19.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.216 -0.928 . . . . 1.0 110.126 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -70.45 147.01 49.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 1.0 109.443 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.2 t -89.41 2.2 54.8 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.301 -0.874 . . . . 1.0 109.987 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -147.94 155.39 41.52 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.064 -1.023 . . . . 1.0 109.688 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.535 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.55 1.92 56.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.352 -0.843 . . . . 1.0 109.842 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -95.41 120.95 36.53 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.1 -1.0 . . . . 1.0 109.205 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.9 mt -140.28 150.54 44.18 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.372 -0.83 . . . . 1.0 108.9 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 69.1 p -134.26 156.14 48.94 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.885 -0.783 . . . . 1.0 108.885 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -145.12 162.07 37.93 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.063 -1.023 . . . . 1.0 110.142 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.421 HH21 ' HA ' ' A' ' 57' ' ' ILE . 6.8 ttm180 -141.74 131.05 23.58 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.46 -0.775 . . . . 1.0 109.933 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 86.5 mt -86.76 111.16 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.938 -1.134 . . . . 1.0 107.938 178.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 79.6 t -66.56 -40.71 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.088 -1.008 . . . . 1.0 109.371 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' A' ' 21' ' ' ASN . 18.2 p-10 -161.11 150.55 16.84 Favored 'General case' 0 C--N 1.286 -2.178 0 C-N-CA 117.452 -1.699 . . . . 1.0 111.005 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -97.01 107.81 20.42 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 104.676 -2.342 . . . . 1.0 104.676 177.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 23' ' ' THR . 0.6 OUTLIER -55.75 141.51 65.42 Favored Pre-proline 0 C--N 1.299 -1.595 0 O-C-N 121.143 -0.973 . . . . 1.0 110.168 -176.962 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -61.19 -11.79 20.45 Favored 'Trans proline' 0 N--CA 1.485 1.028 0 CA-C-N 119.061 0.7 . . . . 1.0 110.869 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -56.77 -26.21 56.99 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.774 -0.77 . . . . 1.0 110.092 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 73.1 mtm -144.32 163.11 34.69 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.965 -1.085 . . . . 1.0 109.27 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.1 p -72.69 158.82 34.89 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.377 -0.827 . . . . 1.0 109.138 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -60.21 -41.48 93.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -0.917 . . . . 1.0 110.401 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.1 m -59.84 -40.38 88.33 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.967 -1.083 . . . . 1.0 110.569 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.93 -41.59 86.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.885 -1.134 . . . . 1.0 110.413 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.3 t -67.9 -40.09 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.86 -1.15 . . . . 1.0 109.818 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -57.48 -58.87 6.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.332 -0.855 . . . . 1.0 111.286 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -27.55 69.4 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.248 -0.908 . . . . 1.0 110.203 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.02 -51.47 69.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.961 -1.087 . . . . 1.0 110.223 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -68.79 -37.02 78.98 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.876 -1.14 . . . . 1.0 110.158 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -60.02 -44.95 94.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.945 -1.097 . . . . 1.0 109.398 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.468 ' HB3' ' HZ3' ' A' ' 37' ' ' LYS . 10.4 mtpm? -59.96 -40.07 87.78 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.157 -0.964 . . . . 1.0 109.207 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.03 -46.86 88.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.341 -0.849 . . . . 1.0 110.049 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.418 ' CZ ' ' CZ ' ' A' ' 121' ' ' PHE . 62.5 m-85 -67.51 -38.64 84.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.926 -1.109 . . . . 1.0 109.747 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -60.02 -47.85 84.15 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.269 -0.895 . . . . 1.0 109.644 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.4 t -59.98 -40.61 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.142 -0.974 . . . . 1.0 109.972 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -79.49 -35.16 40.6 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.864 -1.147 . . . . 1.0 109.789 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.3 p -72.49 -20.26 61.4 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.908 -1.12 . . . . 1.0 109.865 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.88 -40.02 87.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.253 -0.905 . . . . 1.0 110.561 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.7 m -111.13 22.25 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.336 -0.852 . . . . 1.0 110.404 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.6 p -149.0 135.85 10.57 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 120.81 -1.181 . . . . 1.0 109.439 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -73.13 20.72 0.34 Allowed 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 120.682 0.921 . . . . 1.0 112.01 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.76 136.39 54.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 1.0 109.563 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -108.82 120.59 42.94 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.668 -0.864 . . . . 1.0 108.668 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -110.45 124.93 52.68 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.458 -0.776 . . . . 1.0 109.946 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.5 m -119.97 130.01 54.57 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.558 -0.713 . . . . 1.0 109.275 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.412 ' HG2' HH11 ' A' ' 52' ' ' ARG . 33.9 ttt-85 -81.28 130.5 35.06 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.201 -0.937 . . . . 1.0 110.003 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 89.8 mt -104.07 130.02 51.75 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.315 -0.866 . . . . 1.0 109.094 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.436 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 50.9 m170 -63.94 -40.1 95.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.307 -0.871 . . . . 1.0 109.823 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 70.7 m-20 -153.46 179.99 8.29 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.063 -1.023 . . . . 1.0 109.769 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.56 -173.05 32.07 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.839 -1.304 . . . . 1.0 109.839 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.421 ' HA ' HH21 ' A' ' 18' ' ' ARG . 90.2 mt -95.02 126.38 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.341 -1.093 . . . . 1.0 109.109 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.16 158.61 19.45 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.391 -0.818 . . . . 1.0 109.264 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -59.96 -49.94 75.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.232 -0.918 . . . . 1.0 109.87 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 92.7 mt -109.11 97.19 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.504 -0.748 . . . . 1.0 109.882 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.6 ptm -96.5 130.06 43.74 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.913 -1.117 . . . . 1.0 109.061 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.3 mt -108.71 133.38 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.609 -0.682 . . . . 1.0 109.788 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 79.3 p -152.31 158.44 42.76 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.144 -0.972 . . . . 1.0 109.854 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -100.18 135.0 42.28 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.464 -0.939 . . . . 1.0 108.464 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -121.83 167.82 14.54 Favored Glycine 0 N--CA 1.498 2.818 0 N-CA-C 110.243 -1.143 . . . . 1.0 110.243 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 108.514 -0.921 . . . . 1.0 108.514 179.378 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.543 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 89.3 m-85 . . . . . 0 N--CA 1.495 1.797 0 N-CA-C 108.908 -0.775 . . . . 1.0 108.908 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -100.05 12.55 36.64 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.156 -0.965 . . . . 1.0 111.03 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 119.79 -146.8 18.06 Favored Glycine 0 N--CA 1.506 3.352 0 N-CA-C 109.03 -1.628 . . . . 1.0 109.03 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.43 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 13.2 Cg_endo -77.91 -51.94 0.07 OUTLIER 'Trans proline' 0 N--CA 1.49 1.31 0 CA-C-N 119.281 1.54 . . . . 1.0 111.762 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 81.3 p -80.4 161.9 24.74 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.243 -0.911 . . . . 1.0 109.69 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 105.52 -126.53 8.65 Favored Glycine 0 N--CA 1.501 2.972 0 N-CA-C 110.189 -1.165 . . . . 1.0 110.189 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.424 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 13.6 mt -67.12 100.13 0.74 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.414 -1.051 . . . . 1.0 109.344 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 31.0 mt -79.2 -19.15 51.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.083 -1.011 . . . . 1.0 108.765 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.99 171.02 1.42 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.684 -0.858 . . . . 1.0 108.684 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.455 ' ND1' ' C ' ' A' ' 84' ' ' HIS . 8.5 p80 -162.32 167.44 23.82 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.238 -0.914 . . . . 1.0 108.797 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.29 159.55 44.36 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.189 -0.944 . . . . 1.0 109.188 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -95.64 151.83 38.76 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 108.016 -1.105 . . . . 1.0 108.016 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -62.49 166.49 13.22 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 120.47 0.78 . . . . 1.0 111.088 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo . . . . . 0 N--CA 1.491 1.337 0 C-N-CA 121.03 1.153 . . . . 1.0 111.792 -179.748 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 121.197 0.522 . . . . 1.0 110.053 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.7 122.93 9.56 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.294 -0.879 . . . . 1.0 109.524 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.448 ' ND1' ' CE1' ' A' ' 84' ' ' HIS . 41.4 m170 -106.7 142.54 36.18 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.534 -0.729 . . . . 1.0 110.179 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.499 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 40.3 m-85 -124.11 138.24 54.46 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 108.801 -0.814 . . . . 1.0 108.801 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.543 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 93.4 m-20 -80.33 123.59 28.13 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.092 -1.005 . . . . 1.0 109.985 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 9.8 t70 -84.31 2.92 38.01 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.194 -0.941 . . . . 1.0 109.667 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -79.8 -18.8 50.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.227 -0.921 . . . . 1.0 109.42 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 102' ' ' GLU . 57.3 mp0 -91.83 169.96 10.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.366 -0.833 . . . . 1.0 109.166 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 11.9 m -98.59 108.16 20.78 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.433 -0.951 . . . . 1.0 108.433 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -85.63 128.32 34.74 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.248 -0.908 . . . . 1.0 108.565 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.643 HG21 ' HB2' ' A' ' 109' ' ' LYS . 7.6 t -143.87 155.96 44.29 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.265 -0.897 . . . . 1.0 110.071 -178.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 83.6 p -94.91 -7.26 40.54 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.323 -0.991 . . . . 1.0 108.323 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 57.9 m -92.65 179.01 5.62 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.645 -0.872 . . . . 1.0 108.645 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.4 m -80.7 76.08 7.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.983 -1.073 . . . . 1.0 109.34 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.643 ' HB2' HG21 ' A' ' 105' ' ' THR . 58.8 mttp -147.85 152.24 37.28 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.735 -0.839 . . . . 1.0 108.735 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 43.27 -140.0 2.89 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.111 -1.195 . . . . 1.0 110.111 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -100.02 114.46 27.78 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.386 -1.067 . . . . 1.0 109.321 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.452 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 57.8 t-20 -62.27 132.11 51.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.093 -1.005 . . . . 1.0 109.26 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.06 -41.45 92.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.28 -0.888 . . . . 1.0 110.289 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -60.02 -43.91 94.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.214 -0.929 . . . . 1.0 111.344 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -57.81 -51.21 70.51 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.845 -1.159 . . . . 1.0 109.65 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 64.3 t -69.72 -40.02 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.108 -0.995 . . . . 1.0 109.691 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.54 -49.96 74.63 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.237 -0.914 . . . . 1.0 109.55 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.8 -38.99 83.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.321 -0.862 . . . . 1.0 110.47 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.603 ' CE1' ' HE2' ' A' ' 123' ' ' HIS . 77.9 t60 -62.46 -49.86 73.74 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.044 -1.035 . . . . 1.0 111.059 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.499 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 7.7 pt-20 -60.03 -39.48 86.03 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.719 -1.238 . . . . 1.0 110.302 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.418 ' CZ ' ' CZ ' ' A' ' 39' ' ' PHE . 30.4 m-85 -60.07 -40.12 88.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.882 -1.136 . . . . 1.0 108.732 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.11 -45.23 94.2 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.276 -1.53 . . . . 1.0 109.276 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.603 ' HE2' ' CE1' ' A' ' 119' ' ' HIS . 84.8 m-70 -65.75 -39.94 91.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.107 -1.231 . . . . 1.0 109.405 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.3 p -62.02 -26.23 68.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.923 . . . . 1.0 109.195 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 84.5 mt -80.61 -4.27 53.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.186 -0.946 . . . . 1.0 109.718 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 92.41 10.09 61.03 Favored Glycine 0 N--CA 1.496 2.684 0 C-N-CA 120.178 -1.01 . . . . 1.0 110.907 178.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.7 mt -82.74 149.9 27.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.83 -1.394 . . . . 1.0 109.165 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 42.6 t0 -101.19 171.65 7.48 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.542 -0.724 . . . . 1.0 109.339 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.54 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 65.7 m80 -59.91 137.18 58.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.13 -0.982 . . . . 1.0 109.71 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 40.3 t -97.35 156.0 16.64 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.405 -0.81 . . . . 1.0 109.171 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -97.45 2.03 49.84 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.172 -0.955 . . . . 1.0 110.006 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 7.5 t70 -85.84 129.98 52.39 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.097 -1.002 . . . . 1.0 108.665 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -68.23 -28.02 34.31 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 CA-C-N 120.106 1.073 . . . . 1.0 112.377 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.475 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -81.97 -1.81 90.39 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.753 -1.339 . . . . 1.0 109.753 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.17 146.16 25.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.304 -1.115 . . . . 1.0 109.754 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.407 ' C ' ' H ' ' A' ' 138' ' ' PHE . 84.2 mt -69.98 -32.97 71.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.333 -0.855 . . . . 1.0 109.428 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 98.1 mmm -71.78 13.33 0.28 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.504 -0.747 . . . . 1.0 110.328 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.407 ' H ' ' C ' ' A' ' 136' ' ' LEU . 13.5 t80 -69.24 135.6 89.06 Favored Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 107.811 -1.181 . . . . 1.0 107.811 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -64.22 -0.42 2.81 Favored 'Trans proline' 0 N--CA 1.5 1.855 0 CA-C-N 119.96 1.021 . . . . 1.0 114.564 -177.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.7 mt -119.69 138.1 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.368 0 O-C-N 120.835 -1.166 . . . . 1.0 109.979 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' TYR . . . . . 0.452 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 24.3 t80 -72.75 130.22 40.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.692 -0.63 . . . . 1.0 110.012 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.7 t -140.53 139.98 35.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.429 -0.794 . . . . 1.0 109.198 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -82.72 140.72 32.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.972 -1.08 . . . . 1.0 109.52 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.5 t -138.64 155.46 48.28 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.296 -0.878 . . . . 1.0 109.927 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -75.48 109.64 2.84 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.096 -1.602 . . . . 1.0 109.096 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.449 ' HE2' HD21 ' A' ' 112' ' ' ASN . 8.5 mtmp? -78.23 0.29 25.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.284 -1.127 . . . . 1.0 110.033 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 22.9 t -60.01 -40.49 89.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.075 -1.016 . . . . 1.0 109.856 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -139.94 32.21 1.99 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.212 -0.93 . . . . 1.0 109.825 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -79.23 130.15 35.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.001 -1.062 . . . . 1.0 110.151 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 77.8 mtm -133.87 149.35 51.34 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.39 -0.967 . . . . 1.0 108.39 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 62.0 mt -51.58 128.71 34.39 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 120.957 -1.09 . . . . 1.0 108.898 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -69.63 177.47 5.46 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 CA-C-N 120.051 1.054 . . . . 1.0 112.175 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -62.24 -39.97 94.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.46 -0.775 . . . . 1.0 109.878 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -55.9 -48.46 75.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.15 -0.968 . . . . 1.0 109.87 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.04 -39.87 75.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.078 -1.013 . . . . 1.0 110.027 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.23 -47.15 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.123 -0.986 . . . . 1.0 109.341 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -60.34 -40.07 89.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.845 -1.159 . . . . 1.0 110.503 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -69.9 -54.65 11.21 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 120.176 -1.011 . . . . 1.0 111.129 -178.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.456 HG23 ' N ' ' A' ' 160' ' ' GLN . 4.7 tp -60.05 -39.93 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.857 -1.378 . . . . 1.0 109.572 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.456 ' N ' HG23 ' A' ' 159' ' ' ILE . 95.7 mt-30 -64.01 -39.99 95.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.932 -1.105 . . . . 1.0 109.473 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 88.6 p -58.46 -30.16 66.75 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.747 -1.221 . . . . 1.0 108.871 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 92.5 mt -88.87 -69.62 0.7 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.245 -0.909 . . . . 1.0 111.079 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -89.17 -11.59 43.37 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.998 -1.064 . . . . 1.0 111.185 -177.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.72 0 N-CA-C 109.766 -1.334 . . . . 1.0 109.766 179.967 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.9 mt . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.328 -0.619 . . . . 1.0 109.328 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -163.05 162.34 25.8 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 1.0 109.304 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -71.02 147.26 48.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.181 -0.949 . . . . 1.0 109.594 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.2 t -89.98 2.05 55.57 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.402 -0.811 . . . . 1.0 110.35 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -144.83 154.31 42.53 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.001 -1.062 . . . . 1.0 109.99 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.55 ' SD ' ' N ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.28 0.21 57.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.305 -0.872 . . . . 1.0 109.72 -179.734 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -94.0 121.99 36.05 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.148 -0.97 . . . . 1.0 109.007 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.2 mt -140.18 151.47 45.27 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.365 -0.834 . . . . 1.0 109.213 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.0 p -133.72 157.33 46.1 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.455 -0.778 . . . . 1.0 109.193 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -145.32 160.24 41.82 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.142 -0.974 . . . . 1.0 109.916 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -140.99 134.01 29.25 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.369 -0.832 . . . . 1.0 110.068 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.7 mm -89.04 111.21 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.011 -1.107 . . . . 1.0 108.011 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.6 t -67.84 -39.74 82.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.126 -0.984 . . . . 1.0 109.121 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -161.23 150.5 16.56 Favored 'General case' 0 C--N 1.29 -1.992 0 O-C-N 119.294 -2.129 . . . . 1.0 111.466 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.63 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 52.4 m-85 -99.94 99.03 9.74 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 106.097 -1.816 . . . . 1.0 106.097 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.1 t -47.67 141.15 7.58 Favored Pre-proline 0 C--N 1.299 -1.615 0 O-C-N 121.515 -0.74 . . . . 1.0 110.769 -177.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.86 -8.12 7.18 Favored 'Trans proline' 0 N--CA 1.488 1.166 0 C-N-CA 120.649 0.899 . . . . 1.0 111.223 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -59.02 -35.5 73.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.461 -0.775 . . . . 1.0 109.821 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 74.0 mtm -139.59 160.99 38.58 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.192 -0.942 . . . . 1.0 109.657 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 55.1 p -70.71 160.37 32.76 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.401 -0.812 . . . . 1.0 109.397 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.63 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 3.8 m80 -60.1 -40.54 89.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.318 -0.864 . . . . 1.0 110.263 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.7 m -59.97 -42.36 93.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.085 -1.009 . . . . 1.0 110.526 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -67.87 -40.36 83.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.242 -0.911 . . . . 1.0 110.393 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 70.9 t -68.97 -43.01 82.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.166 -0.959 . . . . 1.0 110.242 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -60.04 -49.16 78.75 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.138 -0.976 . . . . 1.0 110.824 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -61.35 -33.12 73.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.908 -1.12 . . . . 1.0 110.068 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.0 -49.77 76.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.893 -1.129 . . . . 1.0 109.979 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.497 ' CE1' HD13 ' A' ' 62' ' ' ILE . 53.5 m-85 -67.36 -39.98 85.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.022 -1.049 . . . . 1.0 110.185 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -60.01 -43.22 95.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.951 -1.093 . . . . 1.0 110.089 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.45 -40.18 95.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.06 -1.025 . . . . 1.0 109.676 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.18 -44.45 95.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.263 -0.898 . . . . 1.0 110.196 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -69.58 -38.2 77.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.04 -1.038 . . . . 1.0 109.697 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.415 ' O ' ' CG ' ' A' ' 44' ' ' ASP . 50.4 tptt -60.0 -48.05 83.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.063 -1.023 . . . . 1.0 109.594 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.3 t -59.97 -41.15 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.119 -0.988 . . . . 1.0 109.869 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -78.46 -37.96 42.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.854 -1.154 . . . . 1.0 109.903 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.3 p -71.18 -19.22 62.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.054 -1.029 . . . . 1.0 109.643 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.415 ' CG ' ' O ' ' A' ' 40' ' ' LYS . 95.0 m-20 -60.04 -40.02 87.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.911 . . . . 1.0 110.603 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.9 m -108.63 22.04 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 121.126 -0.984 . . . . 1.0 111.304 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.2 p -149.79 144.82 18.11 Favored Pre-proline 0 N--CA 1.502 2.129 0 O-C-N 120.678 -1.264 . . . . 1.0 109.418 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -75.27 19.56 0.51 Allowed 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 120.615 0.877 . . . . 1.0 111.502 178.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.7 mt -68.99 130.31 42.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.12 -0.988 . . . . 1.0 109.719 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -107.02 120.61 42.55 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.591 -0.892 . . . . 1.0 108.591 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -108.39 125.98 52.35 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.285 -0.884 . . . . 1.0 109.713 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -120.01 129.95 54.5 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.643 -0.661 . . . . 1.0 109.846 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -82.01 130.92 35.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.325 -0.859 . . . . 1.0 109.028 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 89.4 mt -102.84 135.19 44.95 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.284 -0.885 . . . . 1.0 109.021 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.447 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 91.9 m-70 -64.26 -40.4 95.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.243 -0.911 . . . . 1.0 109.905 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 69.3 m-20 -155.69 -173.76 4.67 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.191 -0.943 . . . . 1.0 109.706 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.59 -169.51 35.77 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.05 -1.22 . . . . 1.0 110.05 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 87.6 mt -93.75 129.42 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.414 -1.051 . . . . 1.0 108.978 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.79 164.31 12.69 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.395 -0.816 . . . . 1.0 109.156 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -59.95 -49.64 76.9 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.124 -0.985 . . . . 1.0 109.032 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.2 mt -122.34 112.81 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.916 -0.772 . . . . 1.0 108.916 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.7 ptp -97.96 137.06 37.34 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.996 -1.065 . . . . 1.0 109.238 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.497 HD13 ' CE1' ' A' ' 35' ' ' PHE . 97.5 mt -105.29 133.07 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.279 -0.888 . . . . 1.0 109.687 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 84.2 p -151.84 152.4 32.56 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.235 -0.916 . . . . 1.0 109.761 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -106.68 122.67 46.81 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.461 -0.774 . . . . 1.0 109.045 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -97.31 -178.97 34.18 Favored Glycine 0 N--CA 1.497 2.756 0 O-C-N 121.187 -0.946 . . . . 1.0 111.187 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 67.5 mt . . . . . 0 N--CA 1.497 1.922 0 O-C-N 121.793 -0.827 . . . . 1.0 108.843 179.761 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.556 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 99.8 m-85 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 108.946 -0.761 . . . . 1.0 108.946 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 28.2 p-10 -96.53 -0.04 49.44 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.126 -0.984 . . . . 1.0 110.532 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.426 ' O ' ' OE2' ' A' ' 102' ' ' GLU . . . 117.4 -119.45 4.44 Favored Glycine 0 N--CA 1.504 3.225 0 N-CA-C 110.249 -1.141 . . . . 1.0 110.249 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.459 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 28.8 Cg_endo -74.69 -72.45 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.797 0 CA-C-N 120.179 1.989 . . . . 1.0 113.012 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.425 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 81.3 p -74.76 171.49 13.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.034 -1.041 . . . . 1.0 109.839 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 104.02 -135.19 12.29 Favored Glycine 0 N--CA 1.498 2.8 0 N-CA-C 110.231 -1.148 . . . . 1.0 110.231 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.6 mt -68.86 107.32 3.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.388 -1.066 . . . . 1.0 109.692 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 84.2 mt -79.65 -25.54 41.33 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.158 -0.964 . . . . 1.0 108.892 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.54 172.82 1.4 Allowed 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.733 -0.84 . . . . 1.0 108.733 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -162.78 166.23 24.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.79 -1.194 . . . . 1.0 109.982 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -153.34 159.73 42.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.439 -0.788 . . . . 1.0 109.21 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -106.77 151.63 40.58 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.366 -0.834 . . . . 1.0 109.128 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -64.38 165.51 19.79 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 121.045 1.164 . . . . 1.0 111.614 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo . . . . . 0 C--N 1.316 -1.162 0 C-N-CA 120.906 1.071 . . . . 1.0 112.003 -179.847 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.5 p-10 . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 109.235 -0.654 . . . . 1.0 109.235 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -146.31 123.76 11.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.021 -1.05 . . . . 1.0 109.654 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -114.73 153.17 30.78 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.375 -0.602 . . . . 1.0 109.375 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.529 ' CE2' ' OE2' ' A' ' 120' ' ' GLU . 39.5 m-85 -137.69 149.78 46.8 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.609 -0.886 . . . . 1.0 108.609 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.556 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 88.1 m-20 -81.39 121.14 25.86 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.684 -1.26 . . . . 1.0 109.009 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -82.65 -5.45 58.84 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.121 -0.987 . . . . 1.0 109.35 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -81.39 -9.33 59.75 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.347 -0.846 . . . . 1.0 109.209 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.459 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 52.7 mm-40 -89.03 176.05 7.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.334 -0.854 . . . . 1.0 109.422 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 26.0 m -106.96 107.01 17.82 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.475 -0.935 . . . . 1.0 108.475 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -86.88 122.9 31.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.365 -0.834 . . . . 1.0 109.127 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.637 HG21 ' HB2' ' A' ' 109' ' ' LYS . 7.8 t -141.54 150.76 42.54 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.363 -0.835 . . . . 1.0 109.925 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 59.8 p -93.01 -6.91 47.26 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.232 -1.025 . . . . 1.0 108.232 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 81.9 p -92.83 176.67 6.35 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.005 -0.739 . . . . 1.0 109.005 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.6 t -77.68 76.95 4.21 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.198 -0.939 . . . . 1.0 109.484 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.637 ' HB2' HG21 ' A' ' 105' ' ' THR . 62.9 mttp -148.13 146.92 28.98 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.74 -139.92 5.81 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.881 -1.287 . . . . 1.0 109.881 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -100.11 115.19 29.21 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.304 -1.115 . . . . 1.0 109.365 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.408 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 9.7 t-20 -61.76 133.04 55.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.117 -0.989 . . . . 1.0 109.469 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.5 tp -59.99 -42.95 95.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.32 -0.862 . . . . 1.0 110.482 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -59.93 -40.99 90.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.087 -1.008 . . . . 1.0 110.436 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -59.91 -50.69 72.78 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.872 -1.143 . . . . 1.0 110.014 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.5 t -68.36 -45.11 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.172 -0.955 . . . . 1.0 110.448 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.63 -47.43 82.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.308 -0.87 . . . . 1.0 110.018 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.98 -41.0 91.07 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.929 -1.107 . . . . 1.0 110.77 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.612 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 60.8 t60 -65.91 -49.02 69.5 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.055 -1.028 . . . . 1.0 111.78 -178.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.529 ' OE2' ' CE2' ' A' ' 98' ' ' PHE . 9.0 pt-20 -60.02 -42.34 94.12 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.495 -1.378 . . . . 1.0 110.368 -178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -60.05 -40.04 88.08 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.682 -1.261 . . . . 1.0 108.655 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.32 -42.71 64.42 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.161 -1.576 . . . . 1.0 109.161 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.612 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 83.3 m-70 -66.27 -40.0 89.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -1.13 . . . . 1.0 109.136 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 86.2 p -64.58 -21.96 66.84 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.42 -0.8 . . . . 1.0 109.577 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.9 mt -83.51 1.51 41.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.298 -0.877 . . . . 1.0 109.972 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.93 4.88 68.8 Favored Glycine 0 N--CA 1.497 2.705 0 O-C-N 121.068 -1.02 . . . . 1.0 110.701 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.9 mt -85.52 146.14 27.06 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.887 -1.361 . . . . 1.0 109.387 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 30.8 t0 -102.56 174.84 5.72 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.47 -0.769 . . . . 1.0 109.373 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.451 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 66.9 m80 -59.97 137.93 57.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.142 -0.974 . . . . 1.0 109.374 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 34.2 t -98.25 158.07 15.79 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.361 -0.837 . . . . 1.0 109.48 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -95.97 -0.42 50.71 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.225 -0.922 . . . . 1.0 109.663 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -86.08 128.47 57.73 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.108 -0.995 . . . . 1.0 108.935 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -68.41 -19.84 42.83 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 CA-C-N 120.065 1.059 . . . . 1.0 112.5 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -88.38 -5.0 76.38 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.772 -1.331 . . . . 1.0 109.772 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.79 145.62 27.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.33 -1.1 . . . . 1.0 109.664 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.5 mt -70.0 -30.98 68.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.876 . . . . 1.0 109.406 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.7 mmm -71.89 10.67 0.66 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.361 -0.837 . . . . 1.0 110.053 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -70.05 134.14 87.65 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 107.907 -1.146 . . . . 1.0 107.907 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -60.81 -20.36 65.86 Favored 'Trans proline' 0 N--CA 1.502 1.983 0 C-N-CA 120.968 1.112 . . . . 1.0 114.308 -177.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.6 mt -98.22 139.84 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 O-C-N 120.696 -1.253 . . . . 1.0 110.293 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' TYR . . . . . 0.408 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 28.3 t80 -75.97 132.28 40.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.482 -0.761 . . . . 1.0 109.901 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.4 t -141.5 142.25 33.6 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.26 -0.9 . . . . 1.0 109.412 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -79.41 143.35 35.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.092 -1.005 . . . . 1.0 108.681 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.3 t -139.99 150.01 43.93 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.172 -0.955 . . . . 1.0 109.684 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.19 108.03 2.32 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.617 -1.393 . . . . 1.0 109.617 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.446 ' NZ ' ' CB ' ' A' ' 146' ' ' LYS . 7.8 mtpm? -76.81 0.12 21.86 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.422 -1.046 . . . . 1.0 109.778 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.3 t -60.01 -44.81 94.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.192 -0.943 . . . . 1.0 110.148 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -142.34 29.61 1.6 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.17 -0.956 . . . . 1.0 110.11 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -66.44 138.03 57.27 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.836 -1.165 . . . . 1.0 109.34 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 76.9 mtm -139.54 142.74 37.2 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.356 -0.84 . . . . 1.0 109.124 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 46.9 mt -49.16 110.92 1.69 Allowed Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.151 -0.968 . . . . 1.0 109.164 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -56.01 177.09 0.15 Allowed 'Trans proline' 0 N--CA 1.494 1.555 0 CA-C-N 120.119 1.078 . . . . 1.0 112.887 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -60.02 -39.88 87.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.466 -0.771 . . . . 1.0 109.997 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -56.1 -48.63 75.79 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.174 -0.953 . . . . 1.0 110.029 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -70.05 -40.01 75.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.908 . . . . 1.0 109.904 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.64 -45.66 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.178 -0.951 . . . . 1.0 109.641 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -61.6 -40.12 93.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.993 -1.067 . . . . 1.0 110.448 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.16 -52.32 14.19 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 120.35 -0.928 . . . . 1.0 111.524 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.448 HG23 ' N ' ' A' ' 160' ' ' GLN . 5.0 tp -60.59 -40.04 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.886 -1.361 . . . . 1.0 109.587 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 164' ' ' GLY . 97.4 mt-30 -65.33 -40.01 93.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.099 -1.001 . . . . 1.0 109.725 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 79.3 p -60.86 -32.25 71.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.112 -0.992 . . . . 1.0 110.483 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 89.5 mt -86.23 -51.83 6.03 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.874 -1.141 . . . . 1.0 110.921 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -92.0 -9.38 43.11 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.851 -1.156 . . . . 1.0 110.458 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.632 0 N-CA-C 109.676 -1.37 . . . . 1.0 109.676 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.3 mt . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.217 -0.66 . . . . 1.0 109.217 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -161.69 166.96 25.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 1.0 109.508 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -70.46 140.6 51.99 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.24 -0.912 . . . . 1.0 109.794 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.4 t -88.0 1.79 53.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.407 -0.808 . . . . 1.0 110.249 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -143.01 153.5 43.04 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.075 -1.016 . . . . 1.0 109.59 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.519 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.95 0.89 57.41 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.479 -0.763 . . . . 1.0 109.597 -179.609 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -96.56 121.14 38.06 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.174 -0.954 . . . . 1.0 109.183 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.8 mt -139.97 148.0 41.29 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.3 -0.875 . . . . 1.0 109.169 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.9 p -130.6 153.77 48.56 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -143.4 157.5 44.41 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.184 -0.948 . . . . 1.0 110.074 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.489 HH12 ' H ' ' A' ' 56' ' ' GLY . 71.7 ttt180 -143.18 132.74 23.64 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.555 -0.715 . . . . 1.0 109.333 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 84.7 mt -87.66 118.31 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.063 -1.023 . . . . 1.0 108.581 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.0 t -69.91 -40.02 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.991 -1.068 . . . . 1.0 109.002 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.2 p-10 -160.4 157.0 27.02 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.733 -1.23 . . . . 1.0 110.169 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.592 ' CD1' ' CD2' ' A' ' 28' ' ' HIS . 47.6 m-85 -100.44 -163.01 0.99 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.38 -1.341 . . . . 1.0 107.38 178.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.73 148.26 55.82 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.371 -0.831 . . . . 1.0 110.336 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -70.83 -21.64 28.27 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 120.661 0.907 . . . . 1.0 110.105 177.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -56.67 -36.05 69.13 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 115.725 -0.671 . . . . 1.0 110.707 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.7 mtm -135.04 163.85 28.96 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.299 -0.876 . . . . 1.0 109.469 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.4 p -73.36 159.68 32.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.484 -0.76 . . . . 1.0 109.291 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.592 ' CD2' ' CD1' ' A' ' 22' ' ' TYR . 2.9 m80 -60.79 -40.03 91.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.465 -0.772 . . . . 1.0 110.031 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.3 m -60.09 -40.46 89.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.147 -0.97 . . . . 1.0 110.185 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -67.29 -40.53 86.12 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.146 -0.971 . . . . 1.0 110.395 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.7 t -68.12 -40.41 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.121 -0.987 . . . . 1.0 109.988 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -60.05 -49.64 76.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.05 -1.031 . . . . 1.0 110.534 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -61.98 -31.55 71.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.984 -1.073 . . . . 1.0 109.68 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.07 -50.29 74.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.089 -1.007 . . . . 1.0 109.802 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -67.41 -39.67 85.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.161 -0.962 . . . . 1.0 110.215 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -59.97 -42.88 95.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.978 -1.077 . . . . 1.0 109.494 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -60.34 -39.84 88.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 1.0 109.065 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.86 -46.2 90.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.51 -0.744 . . . . 1.0 110.024 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.4 ' CZ ' ' CZ ' ' A' ' 121' ' ' PHE . 59.1 m-85 -67.04 -39.4 86.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.051 -1.03 . . . . 1.0 109.196 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.404 ' O ' ' CG ' ' A' ' 44' ' ' ASP . 47.3 tptt -60.09 -47.77 84.52 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.372 -0.83 . . . . 1.0 109.737 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.2 t -60.0 -40.03 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.011 -1.055 . . . . 1.0 109.591 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 70.0 m95 -79.61 -37.16 36.79 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.049 -1.032 . . . . 1.0 110.022 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 62.3 p -70.44 -19.78 62.95 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.034 -1.042 . . . . 1.0 109.557 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.404 ' CG ' ' O ' ' A' ' 40' ' ' LYS . 96.1 m-20 -60.09 -38.55 83.26 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.402 -0.811 . . . . 1.0 110.749 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.3 m -112.33 22.57 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.302 -0.873 . . . . 1.0 110.641 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.7 p -149.81 139.77 13.51 Favored Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 120.928 -1.108 . . . . 1.0 109.655 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -76.97 22.17 0.56 Allowed 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 120.829 1.019 . . . . 1.0 112.378 178.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 77.5 mt -69.71 139.96 53.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.919 -1.113 . . . . 1.0 109.75 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -109.71 120.07 41.36 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -109.09 125.64 52.34 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.351 -0.843 . . . . 1.0 109.481 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 93.8 m -120.07 129.93 54.43 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.542 -0.724 . . . . 1.0 109.476 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -82.72 128.24 34.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.332 -0.855 . . . . 1.0 109.496 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.9 mt -105.37 119.27 38.65 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.363 -0.835 . . . . 1.0 108.844 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.448 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 85.6 m-70 -70.03 -25.17 63.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.419 -0.801 . . . . 1.0 109.993 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 78.3 m-20 -147.76 160.18 43.01 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.271 -0.893 . . . . 1.0 109.806 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.489 ' H ' HH12 ' A' ' 18' ' ' ARG . . . 98.54 174.12 32.41 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 109.624 -1.39 . . . . 1.0 109.624 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.4 mt -94.42 133.49 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.349 -1.089 . . . . 1.0 108.977 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.28 159.35 17.5 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.367 -0.833 . . . . 1.0 109.61 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -59.85 -49.8 76.27 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.238 -0.914 . . . . 1.0 109.196 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.3 mt -105.13 100.43 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.539 -0.726 . . . . 1.0 109.666 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.2 ptm -102.79 127.89 49.77 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.323 -0.861 . . . . 1.0 108.993 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.5 mt -102.65 139.45 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.441 -0.787 . . . . 1.0 109.313 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.0 p -151.38 154.94 37.64 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.169 -0.957 . . . . 1.0 109.522 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -104.44 122.67 45.98 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.767 -0.827 . . . . 1.0 108.767 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.27 -169.5 20.5 Favored Glycine 0 N--CA 1.5 2.956 0 N-CA-C 110.197 -1.161 . . . . 1.0 110.197 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.4 mt . . . . . 0 N--CA 1.495 1.804 0 O-C-N 121.501 -1.0 . . . . 1.0 108.824 -179.855 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.534 ' CE2' ' OD1' ' A' ' 99' ' ' ASP . 22.2 m-85 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 108.782 -0.822 . . . . 1.0 108.782 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.5 p-10 -101.08 6.93 43.52 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.234 -0.916 . . . . 1.0 110.841 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 125.4 -145.71 15.83 Favored Glycine 0 N--CA 1.506 3.321 0 N-CA-C 108.938 -1.665 . . . . 1.0 108.938 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.472 ' O ' ' CG ' ' A' ' 102' ' ' GLU . 12.9 Cg_endo -77.43 -56.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.3 0 CA-C-N 119.41 1.605 . . . . 1.0 111.936 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 83.4 p -78.92 170.63 16.38 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.2 -0.938 . . . . 1.0 110.571 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.79 -120.19 6.78 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 110.571 -1.012 . . . . 1.0 110.571 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.418 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 11.0 mt -66.39 100.66 0.66 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.422 -1.046 . . . . 1.0 109.113 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 66.9 mt -81.15 -19.97 42.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.074 -1.016 . . . . 1.0 109.538 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.78 172.27 1.11 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -162.1 159.52 26.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 1.0 109.241 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.03 163.84 35.64 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.322 -0.861 . . . . 1.0 109.358 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -99.72 153.25 37.87 Favored Pre-proline 0 N--CA 1.495 1.794 0 N-CA-C 108.678 -0.86 . . . . 1.0 108.678 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -59.06 167.22 5.95 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 CA-C-N 118.801 0.607 . . . . 1.0 111.338 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo . . . . . 0 C--N 1.312 -1.379 0 C-N-CA 121.031 1.154 . . . . 1.0 111.759 179.915 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.556 -0.535 . . . . 1.0 109.556 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.75 124.69 10.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.245 -0.91 . . . . 1.0 109.184 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 46.3 m170 -112.33 146.22 38.67 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.484 -0.76 . . . . 1.0 110.141 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -125.44 141.49 52.03 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.819 -0.808 . . . . 1.0 108.819 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.534 ' OD1' ' CE2' ' A' ' 75' ' ' PHE . 95.8 m-20 -79.81 121.43 25.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.079 -1.013 . . . . 1.0 109.42 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 47.0 t0 -84.16 1.55 43.81 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.122 -0.986 . . . . 1.0 109.844 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -81.78 -15.18 55.06 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.004 -1.06 . . . . 1.0 110.312 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.567 ' OE1' ' N ' ' A' ' 102' ' ' GLU . 57.4 mp0 -93.15 177.3 6.1 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.114 -0.991 . . . . 1.0 109.911 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 16.6 m -100.17 108.11 20.14 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.724 -0.843 . . . . 1.0 108.724 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -90.18 121.8 32.54 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.796 -0.816 . . . . 1.0 108.796 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.647 HG21 ' HB2' ' A' ' 109' ' ' LYS . 7.5 t -143.2 158.04 43.97 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.178 -0.951 . . . . 1.0 110.285 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.3 t -95.01 -6.99 41.02 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.459 -0.941 . . . . 1.0 108.459 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 109' ' ' LYS . 45.0 t -90.81 170.03 10.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.577 -0.702 . . . . 1.0 109.216 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.6 m -70.67 63.37 0.28 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.145 -0.972 . . . . 1.0 109.152 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.647 ' HB2' HG21 ' A' ' 105' ' ' THR . 67.9 mmtt -140.92 149.88 42.46 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.399 -0.813 . . . . 1.0 109.234 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 46.67 -146.16 3.57 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.477 -1.449 . . . . 1.0 109.477 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -98.61 115.27 28.28 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.33 -1.1 . . . . 1.0 108.836 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.431 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 61.4 t-20 -62.24 133.49 55.24 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.129 -0.982 . . . . 1.0 109.302 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.1 tp -59.95 -43.45 95.01 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.547 -0.721 . . . . 1.0 110.127 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -60.14 -42.41 94.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.345 -0.847 . . . . 1.0 111.274 -179.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -58.15 -52.83 63.93 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.749 -1.22 . . . . 1.0 109.585 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 71.1 t -66.85 -41.09 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.153 -0.967 . . . . 1.0 109.779 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.11 -49.51 76.7 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.253 -0.905 . . . . 1.0 109.71 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.31 -37.91 78.94 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 120.757 -1.214 . . . . 1.0 110.229 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.636 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 68.3 t60 -65.8 -49.24 69.02 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.157 -0.965 . . . . 1.0 111.884 -178.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -59.92 -39.34 85.13 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.534 -1.354 . . . . 1.0 109.609 -178.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.4 ' CZ ' ' CZ ' ' A' ' 39' ' ' PHE . 29.8 m-85 -59.92 -40.09 87.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.877 -1.14 . . . . 1.0 108.894 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.65 -41.28 93.63 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.761 -1.336 . . . . 1.0 109.761 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.636 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 87.4 m-70 -66.52 -38.98 88.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.951 -1.323 . . . . 1.0 108.866 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 87.5 p -67.8 -22.51 65.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 1.0 109.639 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 84.3 mt -83.35 -1.87 54.39 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.122 -0.986 . . . . 1.0 110.09 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.07 5.4 62.44 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.382 -1.087 . . . . 1.0 110.382 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.6 mt -86.86 144.03 27.18 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.899 -1.353 . . . . 1.0 109.491 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 34.6 t0 -102.54 178.2 4.65 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.563 -0.711 . . . . 1.0 109.176 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.489 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 65.0 m80 -59.89 136.96 58.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.078 -1.014 . . . . 1.0 109.497 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 17.5 t -98.88 158.48 15.61 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.344 -0.848 . . . . 1.0 109.381 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -99.49 2.56 45.03 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.258 -0.902 . . . . 1.0 109.054 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -85.66 122.34 73.21 Favored Pre-proline 0 N--CA 1.488 1.452 0 N-CA-C 108.179 -1.045 . . . . 1.0 108.179 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -67.44 -15.01 44.4 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 CA-C-N 120.117 1.078 . . . . 1.0 111.903 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -90.26 -5.98 69.34 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.354 -1.498 . . . . 1.0 109.354 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -87.62 148.84 24.64 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.246 -1.149 . . . . 1.0 109.829 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.494 ' C ' ' H ' ' A' ' 138' ' ' PHE . 86.0 mt -70.08 -36.34 74.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.169 -0.957 . . . . 1.0 109.298 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.0 mmm -68.91 17.24 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.397 -0.814 . . . . 1.0 110.433 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.494 ' H ' ' C ' ' A' ' 136' ' ' LEU . 14.0 t80 -69.99 134.69 87.57 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 107.711 -1.218 . . . . 1.0 107.711 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -60.53 -6.89 6.17 Favored 'Trans proline' 0 N--CA 1.501 1.952 0 CA-C-N 119.833 0.976 . . . . 1.0 114.609 -177.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.85 137.77 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.43 0 O-C-N 121.054 -1.029 . . . . 1.0 109.656 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' TYR . . . . . 0.431 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 29.4 t80 -73.14 130.72 40.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.611 -0.681 . . . . 1.0 110.014 -178.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.3 t -139.69 139.94 36.72 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.361 -0.837 . . . . 1.0 109.068 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -81.55 141.75 33.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 1.0 109.256 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.9 t -139.96 152.46 46.34 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.27 -0.894 . . . . 1.0 109.977 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.15 108.66 2.56 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.551 -1.42 . . . . 1.0 109.551 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -77.21 1.19 19.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -1.147 . . . . 1.0 109.659 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 33.9 p -59.97 -40.1 87.96 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.32 -0.862 . . . . 1.0 110.011 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -144.02 22.9 1.73 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.063 -1.023 . . . . 1.0 110.41 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -64.97 135.48 55.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.078 -1.014 . . . . 1.0 110.016 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 78.0 mtm -136.4 146.13 46.09 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.086 -1.079 . . . . 1.0 108.086 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 54.5 mt -51.25 129.63 31.94 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 120.862 -1.149 . . . . 1.0 108.595 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -69.16 177.87 4.75 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 CA-C-N 119.994 1.033 . . . . 1.0 112.19 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -61.75 -40.02 93.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.569 -0.707 . . . . 1.0 110.214 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -54.69 -46.13 74.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.166 -0.959 . . . . 1.0 110.189 -178.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -69.0 -39.43 79.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.056 -1.027 . . . . 1.0 109.913 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 58.2 t -60.11 -47.68 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.087 -1.008 . . . . 1.0 108.792 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -61.1 -40.21 92.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.118 -0.989 . . . . 1.0 110.428 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.03 -51.77 13.41 Favored Glycine 0 N--CA 1.495 2.586 0 O-C-N 121.16 -0.962 . . . . 1.0 111.261 -178.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.484 HG23 ' N ' ' A' ' 160' ' ' GLN . 5.1 tp -62.19 -41.29 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.897 -1.355 . . . . 1.0 110.163 -178.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.536 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.2 mt-30 -63.42 -38.97 93.2 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.0 -1.062 . . . . 1.0 109.597 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 79.5 p -60.91 -34.52 74.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.906 . . . . 1.0 110.507 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 95.6 mt -84.13 -48.81 9.47 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.872 -1.142 . . . . 1.0 110.845 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -91.57 -9.81 42.86 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.824 -1.173 . . . . 1.0 110.322 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.493 2.446 0 N-CA-C 109.615 -1.394 . . . . 1.0 109.615 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.0 mt . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 108.859 -0.793 . . . . 1.0 108.859 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.459 ' NZ ' ' O ' ' A' ' 162' ' ' LEU . 0.8 OUTLIER -159.97 160.04 32.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.175 -0.953 . . . . 1.0 109.601 -179.827 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -72.88 134.66 44.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.906 . . . . 1.0 109.436 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.6 t -69.63 -42.06 74.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 1.0 109.515 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -95.09 149.97 20.69 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.245 -0.91 . . . . 1.0 109.661 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.3 mmt -90.7 -0.0 57.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.28 -0.887 . . . . 1.0 109.598 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -96.72 132.28 42.55 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.227 -0.921 . . . . 1.0 109.313 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.5 mt -140.22 149.99 43.57 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.283 -0.885 . . . . 1.0 109.226 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 70.5 p -133.38 157.24 46.04 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.559 -0.904 . . . . 1.0 108.559 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -143.88 162.93 34.83 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.002 -1.061 . . . . 1.0 110.464 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -141.66 127.45 19.24 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 91.1 mt -87.74 118.65 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.273 -0.892 . . . . 1.0 108.935 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.9 t -69.5 -39.97 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.392 -0.818 . . . . 1.0 109.613 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -164.83 152.94 11.93 Favored 'General case' 0 C--N 1.289 -2.023 0 O-C-N 119.927 -1.733 . . . . 1.0 110.964 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.608 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 27.3 m-85 -98.39 109.46 22.21 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 104.436 -2.431 . . . . 1.0 104.436 177.105 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.474 ' OG1' ' OD2' ' A' ' 25' ' ' ASP . 3.0 t -57.42 143.07 75.3 Favored Pre-proline 0 C--N 1.294 -1.824 0 C-N-CA 119.355 -0.938 . . . . 1.0 110.21 -176.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -60.16 -8.49 8.36 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 C-N-CA 120.436 0.757 . . . . 1.0 111.015 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.474 ' OD2' ' OG1' ' A' ' 23' ' ' THR . 66.1 m-20 -57.47 -32.56 67.09 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 120.054 -0.658 . . . . 1.0 109.597 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 73.5 mtm -140.06 160.88 38.94 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.208 -0.932 . . . . 1.0 109.317 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 76.4 p -71.41 161.06 31.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.315 -0.866 . . . . 1.0 109.244 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.608 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 9.2 m80 -61.1 -41.17 96.18 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.297 -0.877 . . . . 1.0 110.296 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.4 m -60.71 -40.59 92.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.989 -1.069 . . . . 1.0 110.204 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -68.9 -39.99 79.39 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.419 -0.801 . . . . 1.0 110.563 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 79.3 t -69.25 -42.8 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.1 -1.0 . . . . 1.0 110.399 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -59.98 -49.19 78.65 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.095 -1.003 . . . . 1.0 110.47 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -61.4 -33.35 73.54 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.054 -1.029 . . . . 1.0 109.915 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.96 -48.83 80.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.007 -1.058 . . . . 1.0 109.976 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.418 ' CE1' HD13 ' A' ' 62' ' ' ILE . 55.2 m-85 -68.16 -39.96 82.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.892 -1.13 . . . . 1.0 110.217 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -60.05 -43.76 95.16 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.858 -1.151 . . . . 1.0 109.775 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -60.07 -39.98 87.9 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.087 -1.008 . . . . 1.0 110.107 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.01 -46.83 88.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.223 -0.923 . . . . 1.0 109.906 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -67.36 -36.21 80.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.067 -1.021 . . . . 1.0 109.531 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -60.0 -49.67 76.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.072 -1.018 . . . . 1.0 109.875 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.7 t -60.25 -40.35 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.086 -1.009 . . . . 1.0 110.357 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -81.36 -34.9 31.44 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.957 -1.089 . . . . 1.0 110.118 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.5 p -71.06 -16.91 62.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.04 -1.038 . . . . 1.0 109.645 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.96 -40.03 87.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.326 -0.858 . . . . 1.0 110.062 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.5 m -110.05 -22.02 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.369 -0.832 . . . . 1.0 110.562 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.1 p -94.84 127.73 42.12 Favored Pre-proline 0 N--CA 1.499 2.009 0 O-C-N 120.794 -1.191 . . . . 1.0 109.536 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -74.12 15.66 0.6 Allowed 'Trans proline' 0 N--CA 1.492 1.441 0 CA-C-N 120.067 1.06 . . . . 1.0 111.609 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 78.7 mt -68.06 139.99 56.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 1.0 109.555 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -105.28 121.0 42.95 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.773 -0.825 . . . . 1.0 108.773 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -107.0 120.88 43.26 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.383 -0.823 . . . . 1.0 109.748 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.2 m -120.0 130.03 54.55 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.613 -0.679 . . . . 1.0 109.827 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.472 ' CB ' ' NH1' ' A' ' 52' ' ' ARG . 11.6 ttp-105 -83.05 138.01 33.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.309 -0.869 . . . . 1.0 109.711 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.4 mt -103.6 132.58 49.73 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.289 -0.882 . . . . 1.0 109.025 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.446 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 61.2 m170 -60.12 -39.99 88.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.875 . . . . 1.0 109.857 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 71.9 m-20 -153.43 179.8 8.46 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.234 -0.916 . . . . 1.0 109.464 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.73 -178.47 42.52 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.961 -1.256 . . . . 1.0 109.961 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.7 mt -95.58 132.95 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.387 -1.067 . . . . 1.0 109.454 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.41 165.9 11.41 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.006 -0.738 . . . . 1.0 109.006 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -59.99 -49.64 76.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.012 -1.055 . . . . 1.0 109.396 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 92.9 mt -110.13 105.56 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.429 -0.795 . . . . 1.0 109.826 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.9 ptm -102.07 132.75 47.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.231 -0.918 . . . . 1.0 108.893 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.418 HD13 ' CE1' ' A' ' 35' ' ' PHE . 85.9 mt -109.39 133.11 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.61 -0.681 . . . . 1.0 109.63 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 43.6 p -149.99 160.74 43.39 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.222 -0.924 . . . . 1.0 109.926 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -106.71 123.12 47.66 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.557 -0.714 . . . . 1.0 109.15 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.48 -171.58 26.92 Favored Glycine 0 N--CA 1.499 2.879 0 N-CA-C 110.655 -0.978 . . . . 1.0 110.655 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 60.9 mt . . . . . 0 N--CA 1.496 1.87 0 O-C-N 121.656 -0.908 . . . . 1.0 108.669 179.802 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.543 ' CD1' ' OD2' ' A' ' 99' ' ' ASP . 94.0 m-85 . . . . . 0 N--CA 1.494 1.769 0 N-CA-C 108.828 -0.805 . . . . 1.0 108.828 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -99.77 0.89 42.57 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.197 -0.94 . . . . 1.0 110.944 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.51 -148.38 19.36 Favored Glycine 0 N--CA 1.504 3.185 0 N-CA-C 108.876 -1.69 . . . . 1.0 108.876 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.456 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 2.5 Cg_endo -68.65 -63.15 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.302 0 CA-C-N 119.124 1.462 . . . . 1.0 111.273 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 87.7 p -79.14 166.68 21.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.123 -0.986 . . . . 1.0 109.161 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 112.86 -128.62 8.51 Favored Glycine 0 N--CA 1.501 2.976 0 N-CA-C 109.517 -1.433 . . . . 1.0 109.517 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.418 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 20.2 mt -70.43 112.47 6.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.334 -1.098 . . . . 1.0 109.367 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 46.0 mt -83.95 -15.18 48.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.943 -1.098 . . . . 1.0 109.037 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 179.06 172.52 0.82 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.033 -0.728 . . . . 1.0 109.033 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -162.71 158.26 22.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 1.0 109.196 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.33 158.86 44.53 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.178 -0.952 . . . . 1.0 109.437 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -96.48 153.54 38.84 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.173 -0.955 . . . . 1.0 108.849 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -64.84 166.04 19.38 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 120.719 0.946 . . . . 1.0 111.952 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo . . . . . 0 C--N 1.314 -1.286 0 C-N-CA 120.958 1.105 . . . . 1.0 111.691 179.533 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.279 0.562 . . . . 1.0 109.746 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.83 120.83 7.69 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.304 -0.873 . . . . 1.0 109.174 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -108.59 147.9 31.13 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.534 -0.728 . . . . 1.0 110.374 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -124.15 146.37 48.7 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.999 -0.741 . . . . 1.0 108.999 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.543 ' OD2' ' CD1' ' A' ' 75' ' ' PHE . 1.3 m-20 -79.6 123.73 27.88 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.057 -1.027 . . . . 1.0 109.347 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -89.22 -0.02 57.13 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.106 -0.996 . . . . 1.0 110.226 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -81.85 -16.1 51.88 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.074 -1.016 . . . . 1.0 110.08 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.604 ' OE1' ' N ' ' A' ' 102' ' ' GLU . 40.1 mp0 -93.97 173.89 7.43 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.307 -0.87 . . . . 1.0 109.202 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.8 m -99.69 105.42 17.24 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.216 -0.927 . . . . 1.0 108.862 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.496 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 90.2 m95 -85.87 126.06 33.77 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.761 -0.829 . . . . 1.0 108.761 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.699 HG21 ' HB2' ' A' ' 109' ' ' LYS . 7.8 t -141.07 153.61 45.56 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.467 -0.77 . . . . 1.0 109.635 -179.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 52.5 m -90.94 -5.17 55.82 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.198 -1.038 . . . . 1.0 108.198 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.7 t -92.73 177.93 5.95 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.752 -0.833 . . . . 1.0 108.752 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.5 m -80.25 64.29 5.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.027 -1.046 . . . . 1.0 109.998 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.699 ' HB2' HG21 ' A' ' 105' ' ' THR . 69.6 mmtt -139.01 152.38 47.59 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.267 -0.896 . . . . 1.0 108.788 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.8 -139.42 6.2 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.759 -1.336 . . . . 1.0 109.759 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -99.72 113.8 26.5 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.338 -1.095 . . . . 1.0 109.057 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -62.77 130.68 45.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.148 -0.97 . . . . 1.0 109.76 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.7 tp -60.01 -43.29 95.33 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.48 -0.763 . . . . 1.0 111.022 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -60.01 -39.99 87.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.165 -0.959 . . . . 1.0 110.645 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -59.95 -50.86 72.09 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.811 -1.181 . . . . 1.0 109.874 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 71.0 t -69.98 -40.06 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.931 -1.106 . . . . 1.0 110.196 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.19 -51.97 67.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -0.939 . . . . 1.0 110.089 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.84 -37.97 80.73 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.271 -0.893 . . . . 1.0 110.259 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.627 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 67.8 t60 -64.24 -50.2 68.92 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.182 -0.949 . . . . 1.0 111.267 -178.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -60.07 -37.83 81.07 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.552 -1.342 . . . . 1.0 110.329 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -59.98 -40.05 87.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.766 -1.208 . . . . 1.0 108.255 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.39 -41.83 93.4 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.382 -1.487 . . . . 1.0 109.382 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.627 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 90.0 m-70 -68.74 -39.93 80.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.022 -1.281 . . . . 1.0 109.467 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.4 p -67.2 -33.08 74.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.318 -0.864 . . . . 1.0 109.618 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.486 HD13 HD11 ' A' ' 159' ' ' ILE . 81.6 mt -70.22 -39.68 74.96 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.23 -0.919 . . . . 1.0 109.84 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 135.31 7.59 1.92 Allowed Glycine 0 N--CA 1.5 2.959 0 N-CA-C 110.045 -1.222 . . . . 1.0 110.045 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.1 mt -87.65 141.21 28.78 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.08 -1.247 . . . . 1.0 110.042 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 34.5 t0 -99.15 175.34 5.93 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.88 -0.785 . . . . 1.0 108.88 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.517 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 63.2 m80 -60.05 133.49 56.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.033 -1.042 . . . . 1.0 109.606 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 47.8 t -98.76 158.1 15.85 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.359 -0.838 . . . . 1.0 109.1 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -98.35 3.05 48.58 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.265 -0.897 . . . . 1.0 109.369 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -85.64 129.55 54.47 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.205 -0.934 . . . . 1.0 108.62 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -69.54 -25.45 29.6 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 CA-C-N 120.012 1.04 . . . . 1.0 112.34 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -82.23 -3.86 90.41 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.413 -1.475 . . . . 1.0 109.413 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.15 143.93 26.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.421 -1.047 . . . . 1.0 109.467 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.501 ' C ' ' H ' ' A' ' 138' ' ' PHE . 89.0 mt -70.0 -34.1 72.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.076 -1.015 . . . . 1.0 109.6 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.3 mmm -70.02 18.19 0.05 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.394 -0.817 . . . . 1.0 109.997 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.501 ' H ' ' C ' ' A' ' 136' ' ' LEU . 13.7 t80 -69.5 133.62 88.94 Favored Pre-proline 0 N--CA 1.488 1.446 0 N-CA-C 107.552 -1.277 . . . . 1.0 107.552 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -60.51 -15.91 39.1 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 CA-C-N 119.805 0.966 . . . . 1.0 114.005 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 95.7 mt -106.59 138.82 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 120.988 -1.07 . . . . 1.0 110.083 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -73.75 129.98 39.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.579 -0.701 . . . . 1.0 109.967 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.1 t -141.31 141.96 33.87 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.43 -0.794 . . . . 1.0 109.246 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -79.98 144.5 33.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.013 -1.054 . . . . 1.0 109.381 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.5 t -140.01 150.64 44.68 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.437 -0.789 . . . . 1.0 109.266 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.61 105.11 1.44 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.422 -1.471 . . . . 1.0 109.422 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -73.61 -6.24 45.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.432 -1.04 . . . . 1.0 109.788 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 61.1 m -60.04 -40.09 88.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.257 -0.902 . . . . 1.0 110.819 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -141.75 19.87 2.16 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.036 -1.04 . . . . 1.0 110.4 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -61.03 140.0 57.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.843 -1.16 . . . . 1.0 109.953 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 67.8 mtt -138.47 145.44 40.85 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.661 -0.866 . . . . 1.0 108.661 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 45.5 mt -54.48 129.04 61.63 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.921 -1.112 . . . . 1.0 108.914 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -68.14 177.9 4.04 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 CA-C-N 119.996 1.034 . . . . 1.0 112.166 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -61.13 -39.96 92.02 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.315 -0.866 . . . . 1.0 110.141 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -56.32 -49.94 72.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.162 -0.961 . . . . 1.0 110.091 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -70.62 -40.03 73.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.137 -0.977 . . . . 1.0 110.252 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.452 ' O ' ' OE1' ' A' ' 160' ' ' GLN . 68.1 t -63.85 -50.06 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.963 . . . . 1.0 109.618 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.54 -40.01 89.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.844 -1.16 . . . . 1.0 110.063 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.42 -48.45 30.19 Favored Glycine 0 N--CA 1.493 2.473 0 O-C-N 121.352 -0.842 . . . . 1.0 112.227 -178.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.564 ' CG2' ' NE2' ' A' ' 160' ' ' GLN . 4.7 tp -60.9 -43.29 95.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.609 -1.524 . . . . 1.0 110.464 -177.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.564 ' NE2' ' CG2' ' A' ' 159' ' ' ILE . 5.9 mp0 -67.64 -36.38 80.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.579 -1.325 . . . . 1.0 108.903 179.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 79.4 p -60.75 -27.99 68.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.131 -0.981 . . . . 1.0 109.878 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.459 ' O ' ' NZ ' ' A' ' 9' ' ' LYS . 88.1 mt -85.28 -45.93 11.5 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.02 -1.05 . . . . 1.0 110.381 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -91.36 -9.29 45.39 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.017 -1.052 . . . . 1.0 109.821 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.553 -1.419 . . . . 1.0 109.553 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.0 mt . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.427 0.632 . . . . 1.0 109.54 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -160.76 160.68 31.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.499 -0.75 . . . . 1.0 109.499 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -71.47 148.74 46.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.185 -0.947 . . . . 1.0 109.61 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 91.6 p -88.44 3.39 50.21 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.333 -0.854 . . . . 1.0 109.98 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -145.07 153.24 41.24 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.067 -1.021 . . . . 1.0 109.609 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.6 mmt -90.38 -0.01 57.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.392 -0.818 . . . . 1.0 109.606 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -96.58 131.41 43.24 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.179 -0.951 . . . . 1.0 109.283 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.8 mt -143.95 151.03 39.23 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.117 -0.989 . . . . 1.0 109.399 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 54.5 p -135.71 155.73 49.93 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.475 -0.765 . . . . 1.0 108.937 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -144.27 161.19 39.54 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.146 -0.971 . . . . 1.0 110.383 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.494 HH11 ' HG2' ' A' ' 18' ' ' ARG . 0.8 OUTLIER -139.17 131.08 27.72 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 109.084 -0.709 . . . . 1.0 109.084 -179.384 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.9 mt -89.79 116.49 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.161 -0.962 . . . . 1.0 108.765 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.5 t -68.67 -39.93 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.193 -0.942 . . . . 1.0 109.226 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.403 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 23.8 p-10 -164.7 152.98 12.24 Favored 'General case' 0 C--N 1.288 -2.081 0 O-C-N 120.051 -1.656 . . . . 1.0 110.873 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.624 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 36.7 m-85 -99.94 109.11 21.48 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 104.781 -2.303 . . . . 1.0 104.781 177.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 t -55.87 140.55 68.43 Favored Pre-proline 0 C--N 1.297 -1.712 0 O-C-N 121.124 -0.985 . . . . 1.0 110.111 -176.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.27 -11.04 9.61 Favored 'Trans proline' 0 N--CA 1.485 1.008 0 CA-C-N 119.194 0.748 . . . . 1.0 110.901 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -55.61 -29.88 59.92 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.898 -0.721 . . . . 1.0 110.007 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 73.9 mtm -144.42 162.2 37.09 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.035 -1.041 . . . . 1.0 109.587 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.9 p -72.95 159.89 32.98 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.395 -0.815 . . . . 1.0 109.391 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.624 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 1.9 m80 -60.16 -40.75 90.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.306 -0.871 . . . . 1.0 110.07 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.5 m -60.12 -41.39 92.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.151 -0.968 . . . . 1.0 110.336 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.82 -40.0 79.71 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.205 -0.934 . . . . 1.0 110.321 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 70.9 t -67.59 -43.96 86.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.24 -0.913 . . . . 1.0 110.23 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -59.98 -49.92 75.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.137 -0.977 . . . . 1.0 110.837 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -61.44 -32.73 72.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.928 -1.108 . . . . 1.0 110.22 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.98 -50.07 75.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.984 -1.072 . . . . 1.0 110.006 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -68.11 -37.25 80.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.0 -1.062 . . . . 1.0 110.034 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -60.05 -44.41 94.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.973 -1.08 . . . . 1.0 109.428 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -60.44 -40.03 89.64 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.165 -0.959 . . . . 1.0 109.204 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.1 -45.96 91.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.355 -0.841 . . . . 1.0 110.212 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -69.88 -39.82 76.07 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.009 -1.057 . . . . 1.0 109.746 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -59.89 -47.88 83.98 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.194 -0.941 . . . . 1.0 109.91 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.0 t -60.0 -41.9 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.095 -1.003 . . . . 1.0 109.8 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 63.1 m95 -79.0 -35.6 42.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.038 -1.039 . . . . 1.0 109.874 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.7 p -70.14 -20.35 63.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.808 -1.183 . . . . 1.0 109.217 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -59.97 -40.13 88.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.506 -0.746 . . . . 1.0 110.667 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.7 m -110.8 23.0 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.333 -0.855 . . . . 1.0 110.633 -178.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 28.6 p -149.95 139.63 13.35 Favored Pre-proline 0 N--CA 1.5 2.052 0 O-C-N 120.909 -1.119 . . . . 1.0 109.23 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -75.17 19.35 0.51 Allowed 'Trans proline' 0 N--CA 1.496 1.638 0 CA-C-N 119.664 0.916 . . . . 1.0 111.605 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.0 mt -67.49 138.92 56.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -0.86 . . . . 1.0 109.933 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -112.91 120.8 42.68 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.947 -0.76 . . . . 1.0 108.947 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -109.14 122.24 46.88 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.325 -0.86 . . . . 1.0 109.354 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -119.99 130.07 54.58 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.572 0.701 . . . . 1.0 109.974 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -83.14 132.7 35.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.35 -0.844 . . . . 1.0 109.64 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.2 mt -101.76 132.68 47.36 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.198 -0.939 . . . . 1.0 108.894 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.446 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 43.1 m170 -61.27 -40.05 92.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.088 -1.007 . . . . 1.0 110.061 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 73.8 m-20 -152.31 178.01 9.97 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.19 -0.944 . . . . 1.0 109.546 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.07 -178.58 42.08 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.71 -1.356 . . . . 1.0 109.71 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.3 mt -94.45 134.82 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.393 -1.063 . . . . 1.0 109.115 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.92 174.09 6.03 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.505 -0.747 . . . . 1.0 109.154 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -60.05 -49.09 79.02 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.081 -1.012 . . . . 1.0 108.513 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.8 mt -120.03 118.07 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.544 -0.723 . . . . 1.0 109.42 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.1 ptp -101.63 139.26 37.52 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.164 -0.96 . . . . 1.0 109.153 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 97.0 mt -107.46 133.56 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.393 -0.817 . . . . 1.0 109.927 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 79.7 p -152.45 156.75 40.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.292 -0.88 . . . . 1.0 109.368 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -100.77 125.58 47.26 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.288 -0.883 . . . . 1.0 109.161 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 100' ' ' ASP . . . -93.14 155.31 22.28 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.946 -1.261 . . . . 1.0 109.946 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 9.6 tt . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.444 -1.033 . . . . 1.0 108.77 179.931 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.523 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 77.0 m-85 . . . . . 0 N--CA 1.495 1.791 0 N-CA-C 108.438 -0.949 . . . . 1.0 108.438 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -100.62 9.19 42.82 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.277 -0.889 . . . . 1.0 111.168 -178.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 121.15 -159.94 15.59 Favored Glycine 0 N--CA 1.508 3.459 0 N-CA-C 109.161 -1.575 . . . . 1.0 109.161 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -56.36 -63.97 0.15 Allowed 'Trans proline' 0 N--CA 1.49 1.268 0 CA-C-N 118.771 1.285 . . . . 1.0 111.955 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 96.3 p -76.54 160.45 29.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.496 -0.752 . . . . 1.0 109.578 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.71 -130.8 9.29 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 110.177 -1.169 . . . . 1.0 110.177 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.1 mt -69.49 105.33 2.59 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.424 -1.045 . . . . 1.0 109.242 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.449 HD23 ' OE2' ' A' ' 102' ' ' GLU . 32.2 mt -79.82 -14.76 58.44 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.124 -0.985 . . . . 1.0 109.057 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.57 175.54 0.88 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.056 -0.72 . . . . 1.0 109.056 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.523 ' CE1' ' ND1' ' A' ' 97' ' ' HIS . 21.2 p80 -163.22 160.91 24.57 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.231 -0.918 . . . . 1.0 109.787 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -153.2 167.74 28.31 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.858 -0.793 . . . . 1.0 108.858 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -114.51 153.98 46.61 Favored Pre-proline 0 N--CA 1.499 2.006 0 N-CA-C 108.494 -0.928 . . . . 1.0 108.494 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -69.71 161.42 46.0 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 120.57 0.847 . . . . 1.0 111.503 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo . . . . . 0 C--N 1.313 -1.331 0 C-N-CA 121.068 1.179 . . . . 1.0 112.104 -179.902 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 45.5 p-10 . . . . . 0 N--CA 1.494 1.761 0 N-CA-C 109.236 -0.653 . . . . 1.0 109.236 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.88 123.24 9.01 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.101 -0.999 . . . . 1.0 109.18 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.523 ' ND1' ' CE1' ' A' ' 84' ' ' HIS . 64.9 m170 -117.78 159.98 22.12 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.625 0.726 . . . . 1.0 109.933 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.536 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 47.1 m-85 -137.88 153.46 49.56 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.702 -0.851 . . . . 1.0 108.702 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.523 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 1.5 m-20 -79.39 124.0 28.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.844 -1.16 . . . . 1.0 109.662 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 65' ' ' GLY . 36.5 t0 -84.81 -12.67 53.13 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.473 -0.767 . . . . 1.0 109.416 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -82.26 -11.51 58.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.265 -0.897 . . . . 1.0 109.574 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.449 ' OE2' HD23 ' A' ' 82' ' ' LEU . 98.0 mt-10 -91.63 166.79 12.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.294 -0.879 . . . . 1.0 109.153 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.3 m -98.78 107.42 19.86 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.177 -0.952 . . . . 1.0 109.086 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.454 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 94.1 m95 -88.74 123.65 33.36 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.846 -0.798 . . . . 1.0 108.846 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.679 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.7 t -140.36 153.16 46.3 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.378 -0.826 . . . . 1.0 109.439 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.8 t -92.06 -6.09 51.64 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.205 -1.035 . . . . 1.0 108.205 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 65.1 p -93.16 179.44 5.43 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.713 -0.847 . . . . 1.0 108.713 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.2 m -82.04 77.06 8.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.016 -1.052 . . . . 1.0 109.467 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.679 ' HB2' HG21 ' A' ' 105' ' ' THR . 52.6 mtmt -149.31 150.03 31.86 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.74 -139.85 5.86 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.567 -1.413 . . . . 1.0 109.567 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.418 ' CD1' HD13 ' A' ' 82' ' ' LEU . 95.2 m-85 -100.09 113.77 26.63 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.312 -1.111 . . . . 1.0 108.751 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -62.94 134.11 55.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.113 -0.992 . . . . 1.0 109.34 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.6 tp -59.98 -43.94 94.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.39 -0.819 . . . . 1.0 110.587 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -59.88 -43.22 94.87 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.965 -1.085 . . . . 1.0 110.603 -178.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -58.6 -51.91 67.9 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.74 -1.225 . . . . 1.0 109.644 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.6 t -68.47 -43.97 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.174 -0.954 . . . . 1.0 110.319 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.25 -52.79 63.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.304 -0.873 . . . . 1.0 110.014 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.95 -32.65 71.0 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.937 -1.102 . . . . 1.0 109.882 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.443 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 45.7 t60 -65.68 -52.95 47.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.969 -1.082 . . . . 1.0 110.654 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.536 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 7.7 pt-20 -60.13 -40.97 91.63 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.902 -1.124 . . . . 1.0 110.453 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -60.03 -39.91 87.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.861 -1.149 . . . . 1.0 109.001 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -56.45 -42.8 90.13 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.128 -1.589 . . . . 1.0 109.128 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.443 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 90.6 m-70 -67.44 -39.98 85.43 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.213 -1.169 . . . . 1.0 109.221 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 59.7 p -64.45 -25.01 67.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -0.895 . . . . 1.0 109.923 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.2 mt -80.19 -0.53 36.59 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.13 -0.981 . . . . 1.0 110.049 -179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 91.93 6.8 64.95 Favored Glycine 0 N--CA 1.497 2.744 0 O-C-N 120.997 -1.065 . . . . 1.0 110.562 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.4 mt -84.79 149.46 25.72 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.907 -1.349 . . . . 1.0 109.554 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 42.0 t0 -98.67 171.32 8.19 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.674 -0.861 . . . . 1.0 108.674 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.535 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 62.8 m80 -58.92 136.98 58.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.026 -1.046 . . . . 1.0 109.724 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.0 t -97.36 151.16 20.2 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.542 -0.724 . . . . 1.0 109.246 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -99.86 6.83 45.28 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.255 -0.903 . . . . 1.0 108.907 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -87.31 123.76 69.31 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.057 -1.027 . . . . 1.0 108.396 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -64.2 -17.1 58.47 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 CA-C-N 120.189 1.103 . . . . 1.0 112.168 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -89.98 -6.35 69.58 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.553 -1.419 . . . . 1.0 109.553 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.56 141.49 30.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.221 -1.164 . . . . 1.0 109.25 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.461 ' C ' ' H ' ' A' ' 138' ' ' PHE . 97.0 mt -65.78 -39.74 91.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.15 -0.969 . . . . 1.0 109.6 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 91.1 mtp -70.36 23.35 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.32 -0.862 . . . . 1.0 111.117 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.461 ' H ' ' C ' ' A' ' 136' ' ' LEU . 11.5 t80 -67.26 133.11 93.33 Favored Pre-proline 0 N--CA 1.493 1.692 0 N-CA-C 107.522 -1.288 . . . . 1.0 107.522 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -61.7 -9.79 14.87 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 CA-C-N 119.958 1.021 . . . . 1.0 113.644 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 88.4 mt -113.45 133.28 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.162 -0.961 . . . . 1.0 109.14 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -71.36 128.51 36.1 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.168 -0.957 . . . . 1.0 110.102 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.8 t -141.84 143.59 33.46 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.637 -0.875 . . . . 1.0 108.637 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -81.24 146.03 30.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.079 -1.013 . . . . 1.0 109.766 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.0 t -140.8 157.49 45.32 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.371 -0.831 . . . . 1.0 109.662 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.95 106.47 1.97 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.534 -1.426 . . . . 1.0 109.534 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.458 ' NZ ' ' CB ' ' A' ' 146' ' ' LYS . 8.4 mtpm? -77.43 2.9 14.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -1.15 . . . . 1.0 109.597 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.471 ' O ' ' ND1' ' A' ' 148' ' ' HIS . 34.7 t -59.44 -46.06 89.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 1.0 110.067 -179.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' HIS . . . . . 0.471 ' ND1' ' O ' ' A' ' 147' ' ' SER . 50.0 m-70 -146.58 30.77 0.99 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.014 -1.054 . . . . 1.0 109.472 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -61.0 136.0 57.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.145 -0.972 . . . . 1.0 109.7 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 65.9 mtt -133.47 144.56 49.53 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.476 -0.765 . . . . 1.0 108.939 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 36.4 mt -51.48 125.77 28.06 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.177 -0.952 . . . . 1.0 108.767 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -67.63 177.52 4.0 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 CA-C-N 120.04 1.05 . . . . 1.0 112.253 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.21 -39.98 88.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.395 -0.816 . . . . 1.0 109.955 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -55.11 -48.34 73.74 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.183 -0.948 . . . . 1.0 109.998 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -69.98 -39.96 75.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.042 -1.037 . . . . 1.0 110.115 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 56.3 t -59.95 -49.13 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.158 -0.964 . . . . 1.0 109.478 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -60.34 -40.11 89.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.878 -1.138 . . . . 1.0 110.468 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.63 -53.28 12.66 Favored Glycine 0 N--CA 1.496 2.638 0 O-C-N 121.046 -1.034 . . . . 1.0 111.512 -178.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.476 HG23 ' N ' ' A' ' 160' ' ' GLN . 6.3 tp -61.19 -40.0 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.97 -1.312 . . . . 1.0 109.617 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 164' ' ' GLY . 97.1 mt-30 -65.49 -39.69 92.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 1.0 109.566 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 83.3 p -60.0 -34.65 73.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 1.0 110.625 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 83.7 mt -87.47 -50.47 6.52 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.843 -1.161 . . . . 1.0 110.884 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -90.62 -9.12 48.16 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.969 -1.082 . . . . 1.0 110.226 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.568 0 N-CA-C 109.512 -1.435 . . . . 1.0 109.512 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.3 mt . . . . . 0 N--CA 1.488 1.436 0 N-CA-C 109.075 -0.713 . . . . 1.0 109.075 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -159.84 159.88 33.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.198 -0.939 . . . . 1.0 109.525 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -71.76 145.54 48.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -0.868 . . . . 1.0 109.193 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.1 t -80.83 -0.86 40.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.413 -0.805 . . . . 1.0 110.369 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -149.27 154.8 39.58 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.067 -1.02 . . . . 1.0 109.574 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.551 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.07 0.03 57.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.34 -0.85 . . . . 1.0 109.723 -179.644 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -97.65 124.76 42.08 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.279 -0.888 . . . . 1.0 108.954 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.4 mt -140.03 150.07 43.96 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.263 -0.898 . . . . 1.0 109.713 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.0 p -130.7 157.3 43.16 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.61 -0.885 . . . . 1.0 108.61 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -144.18 160.05 41.61 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.082 -1.011 . . . . 1.0 110.251 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.462 ' CZ ' ' O ' ' A' ' 54' ' ' HIS . 26.1 tpt180 -143.61 129.4 19.36 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.652 -0.655 . . . . 1.0 109.566 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 86.8 mt -88.11 119.68 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.149 -0.969 . . . . 1.0 109.132 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.6 t -69.48 -40.53 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.169 -0.957 . . . . 1.0 109.259 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -163.8 165.21 23.2 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.496 -1.378 . . . . 1.0 110.948 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -104.22 -172.98 2.2 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.78 -1.193 . . . . 1.0 107.78 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.85 148.81 47.28 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.445 -0.784 . . . . 1.0 109.901 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -64.93 -16.11 53.8 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 120.926 1.084 . . . . 1.0 110.156 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.94 -39.99 87.41 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.348 -0.842 . . . . 1.0 110.471 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.6 mtm -144.21 160.16 41.43 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.128 -0.982 . . . . 1.0 109.663 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 69.3 p -73.48 159.98 32.39 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.393 -0.817 . . . . 1.0 109.373 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -60.95 -31.82 71.36 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.337 -0.852 . . . . 1.0 109.972 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 56.0 m -60.02 -42.11 93.63 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.855 -1.153 . . . . 1.0 109.446 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -69.92 -40.06 75.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.09 -1.006 . . . . 1.0 109.544 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 56.2 t -69.58 -40.07 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.232 -0.917 . . . . 1.0 110.001 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -59.73 -49.92 75.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.088 -1.008 . . . . 1.0 110.107 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -63.25 -31.54 72.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.976 -1.078 . . . . 1.0 109.958 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.01 -49.96 75.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.017 -1.052 . . . . 1.0 110.197 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.424 ' CE1' HD13 ' A' ' 62' ' ' ILE . 52.1 m-85 -67.66 -36.94 81.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.98 -1.075 . . . . 1.0 109.978 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -59.93 -41.07 90.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.987 -1.071 . . . . 1.0 109.721 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -62.2 -40.18 95.21 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.071 -1.018 . . . . 1.0 108.868 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.97 -45.89 91.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.511 -0.743 . . . . 1.0 110.139 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.508 ' CD1' ' CD1' ' A' ' 50' ' ' PHE . 63.4 m-85 -68.4 -40.06 81.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.963 -1.085 . . . . 1.0 110.02 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.402 ' O ' ' CG ' ' A' ' 44' ' ' ASP . 27.4 tptp -60.01 -47.54 85.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.122 -0.987 . . . . 1.0 109.665 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.5 t -60.01 -40.09 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.184 -0.948 . . . . 1.0 110.119 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -81.54 -35.46 30.27 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.876 -1.14 . . . . 1.0 109.985 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.5 p -71.64 -20.1 62.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.905 -1.122 . . . . 1.0 109.725 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.402 ' CG ' ' O ' ' A' ' 40' ' ' LYS . 95.3 m-20 -59.95 -39.89 87.12 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.246 -0.909 . . . . 1.0 111.048 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 m -109.52 20.25 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 O-C-N 121.191 -0.943 . . . . 1.0 110.797 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.3 p -147.93 140.38 14.6 Favored Pre-proline 0 N--CA 1.502 2.128 0 O-C-N 120.83 -1.169 . . . . 1.0 109.221 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -72.83 18.37 0.36 Allowed 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 120.716 0.944 . . . . 1.0 111.999 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 79.0 mt -68.1 137.12 54.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.122 -0.986 . . . . 1.0 109.916 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -111.46 120.75 43.19 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.885 -0.783 . . . . 1.0 108.885 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.508 ' CD1' ' CD1' ' A' ' 39' ' ' PHE . 92.4 m-85 -109.16 123.3 48.99 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.367 -0.833 . . . . 1.0 109.335 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.1 m -119.95 130.02 54.6 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.55 -0.718 . . . . 1.0 109.679 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -82.32 132.35 35.22 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.467 -0.77 . . . . 1.0 109.566 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.4 mt -104.96 131.16 52.83 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.326 -0.859 . . . . 1.0 108.819 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.462 ' O ' ' CZ ' ' A' ' 18' ' ' ARG . 42.2 m170 -61.73 -40.24 94.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.177 -0.952 . . . . 1.0 110.005 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 74.9 m-20 -151.74 176.33 11.5 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.112 -0.992 . . . . 1.0 109.924 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.87 -179.76 35.63 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.858 -1.297 . . . . 1.0 109.858 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 91.3 mt -93.51 130.44 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.366 -1.079 . . . . 1.0 109.583 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.46 164.52 12.62 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.971 -0.752 . . . . 1.0 108.971 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.87 -49.52 77.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.067 -1.021 . . . . 1.0 109.332 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.7 mt -111.81 109.63 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.506 -0.746 . . . . 1.0 109.534 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.5 ptm -106.46 132.0 53.0 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.328 -0.858 . . . . 1.0 109.481 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.424 HD13 ' CE1' ' A' ' 35' ' ' PHE . 86.1 mt -103.22 137.72 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.619 -0.675 . . . . 1.0 109.383 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.2 p -152.08 152.96 33.03 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.07 -1.019 . . . . 1.0 109.755 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -100.42 120.27 39.73 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.891 -0.781 . . . . 1.0 108.891 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -103.85 -170.6 25.37 Favored Glycine 0 N--CA 1.5 2.966 0 N-CA-C 110.773 -0.931 . . . . 1.0 110.773 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 74.4 mt . . . . . 0 N--CA 1.497 1.889 0 O-C-N 121.569 -0.959 . . . . 1.0 109.111 179.838 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 . . . . . 0 N--CA 1.495 1.824 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.5 p-10 -101.81 -0.07 34.85 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.331 -0.855 . . . . 1.0 111.127 -178.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 128.04 -149.16 18.04 Favored Glycine 0 N--CA 1.505 3.261 0 N-CA-C 109.381 -1.488 . . . . 1.0 109.381 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.425 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 3.5 Cg_exo -64.39 -64.36 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.501 0 CA-C-N 118.953 1.376 . . . . 1.0 112.114 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 77.0 p -75.9 158.67 31.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.12 -0.987 . . . . 1.0 109.039 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.26 -128.34 8.04 Favored Glycine 0 N--CA 1.501 3.012 0 N-CA-C 109.594 -1.402 . . . . 1.0 109.594 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.425 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 18.4 mt -67.28 106.35 2.02 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.389 -1.065 . . . . 1.0 109.555 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 46.3 mt -75.81 -23.63 55.83 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.919 -1.113 . . . . 1.0 109.063 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -177.68 173.89 1.56 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.635 -0.876 . . . . 1.0 108.635 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.558 ' NE2' ' ND1' ' A' ' 97' ' ' HIS . 0.3 OUTLIER -161.08 165.75 29.18 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.175 -0.953 . . . . 1.0 109.177 179.521 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -155.3 159.15 39.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.388 -0.82 . . . . 1.0 109.162 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -99.05 153.9 37.57 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 121.097 -1.002 . . . . 1.0 108.499 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -62.75 160.39 33.11 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 120.847 1.031 . . . . 1.0 112.396 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo . . . . . 0 N--CA 1.492 1.419 0 C-N-CA 121.806 1.67 . . . . 1.0 113.212 -179.716 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 43.0 p-10 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.218 -0.66 . . . . 1.0 109.218 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.87 121.39 8.53 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.086 -1.009 . . . . 1.0 109.423 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.558 ' ND1' ' NE2' ' A' ' 84' ' ' HIS . 3.4 m170 -109.63 147.25 33.4 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.7 -0.625 . . . . 1.0 109.575 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -121.21 151.73 39.63 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.66 -0.867 . . . . 1.0 108.66 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.425 ' OD2' ' O ' ' A' ' 81' ' ' LEU . 88.7 m-20 -78.67 120.63 23.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.973 -1.079 . . . . 1.0 109.386 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -83.11 -10.44 58.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.318 -0.864 . . . . 1.0 109.334 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -83.08 -10.07 58.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.892 . . . . 1.0 109.471 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 97.8 mt-10 -91.63 168.19 11.67 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.308 -0.87 . . . . 1.0 109.618 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 8.2 m -97.73 106.48 18.79 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.335 -0.853 . . . . 1.0 109.007 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -89.13 121.17 31.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.429 -0.794 . . . . 1.0 108.887 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.607 HG21 ' HB2' ' A' ' 109' ' ' LYS . 6.1 t -140.31 152.55 45.94 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.325 -0.86 . . . . 1.0 110.103 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 69.8 m -95.03 -8.42 36.81 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.774 -0.824 . . . . 1.0 108.774 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 90.3 p -91.89 175.33 6.92 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.467 -0.771 . . . . 1.0 108.957 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.1 t -72.82 71.85 1.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.04 -1.038 . . . . 1.0 109.485 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.607 ' HB2' HG21 ' A' ' 105' ' ' THR . 43.7 mtpt -148.47 154.76 40.3 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.287 -0.883 . . . . 1.0 108.836 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 109' ' ' LYS . . . 40.83 -141.89 0.88 Allowed Glycine 0 N--CA 1.499 2.864 0 N-CA-C 110.473 -1.051 . . . . 1.0 110.473 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -99.53 119.55 38.22 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.336 -1.096 . . . . 1.0 108.962 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -64.08 130.39 43.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.157 -0.965 . . . . 1.0 109.623 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.9 tp -60.0 -43.45 95.17 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.436 -0.79 . . . . 1.0 110.814 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -59.84 -40.22 87.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.103 -0.998 . . . . 1.0 110.774 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -59.28 -51.35 70.32 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.845 -1.16 . . . . 1.0 109.197 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.6 t -69.99 -41.78 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.161 -0.962 . . . . 1.0 109.728 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.1 -51.76 68.36 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.032 -1.043 . . . . 1.0 109.264 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.59 -40.63 88.11 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.428 -0.795 . . . . 1.0 110.662 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.63 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 63.4 t60 -62.54 -49.17 76.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.204 -0.935 . . . . 1.0 111.022 -178.155 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -59.83 -38.8 83.05 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.619 -1.301 . . . . 1.0 109.701 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -59.85 -40.02 87.16 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.818 -1.176 . . . . 1.0 108.46 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -56.99 -40.44 91.16 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.576 -1.41 . . . . 1.0 109.576 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.63 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 86.7 m-70 -67.36 -40.06 85.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.957 -1.319 . . . . 1.0 109.311 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 86.1 p -66.03 -26.09 67.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.131 -0.981 . . . . 1.0 109.056 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 83.2 mt -80.51 2.55 24.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.365 -0.834 . . . . 1.0 109.552 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 85.14 9.77 79.49 Favored Glycine 0 N--CA 1.494 2.562 0 C-N-CA 120.2 -1.0 . . . . 1.0 110.921 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 77.5 mt -87.05 141.06 28.94 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.712 -1.464 . . . . 1.0 109.673 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 30.8 t0 -98.98 173.01 7.04 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.432 -0.792 . . . . 1.0 109.263 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.507 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 66.9 m80 -60.08 132.69 54.71 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.272 -0.892 . . . . 1.0 109.821 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.6 t -100.26 156.03 17.45 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.812 -0.81 . . . . 1.0 108.812 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -98.28 6.29 47.52 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.1 -1.0 . . . . 1.0 109.514 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -86.16 125.27 68.67 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.15 -0.969 . . . . 1.0 108.476 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -67.26 -19.34 50.33 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 CA-C-N 120.226 1.116 . . . . 1.0 112.57 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -87.21 -8.03 75.78 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.88 -1.288 . . . . 1.0 109.88 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.6 145.65 25.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.04 -1.271 . . . . 1.0 109.443 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.437 ' C ' ' H ' ' A' ' 138' ' ' PHE . 95.0 mt -68.38 -31.19 70.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.23 -0.919 . . . . 1.0 109.39 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 96.4 mmm -71.22 17.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.427 -0.796 . . . . 1.0 110.743 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.437 ' H ' ' C ' ' A' ' 136' ' ' LEU . 12.5 t80 -70.01 130.17 90.12 Favored Pre-proline 0 N--CA 1.494 1.764 0 N-CA-C 107.901 -1.148 . . . . 1.0 107.901 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -68.13 4.96 1.29 Allowed 'Trans proline' 0 N--CA 1.505 2.173 0 C-N-CA 121.041 1.16 . . . . 1.0 114.623 -177.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.6 mt -119.63 134.37 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 O-C-N 120.984 -1.072 . . . . 1.0 108.446 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -71.74 130.8 42.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.022 -1.049 . . . . 1.0 109.666 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 15.0 t -145.11 144.98 31.22 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.56 -0.904 . . . . 1.0 108.56 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -80.8 147.68 30.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.99 -1.069 . . . . 1.0 109.912 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 19.3 m -137.77 145.14 42.04 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.481 -0.762 . . . . 1.0 110.008 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.17 97.16 0.57 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 107.646 -2.181 . . . . 1.0 107.646 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -73.97 5.1 4.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.379 -1.071 . . . . 1.0 109.805 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 70.0 m -60.05 -40.09 88.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.132 -0.98 . . . . 1.0 110.052 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -147.5 39.95 0.99 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.021 -1.05 . . . . 1.0 109.911 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -78.87 130.59 35.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.099 -1.001 . . . . 1.0 110.915 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 97.9 mmm -128.67 145.02 51.27 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.108 -1.071 . . . . 1.0 108.108 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 26.8 mt -50.26 129.43 24.11 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 120.841 -1.162 . . . . 1.0 108.981 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -71.97 179.44 4.85 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 CA-C-N 119.939 1.014 . . . . 1.0 112.084 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -61.42 -40.02 92.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.431 -0.793 . . . . 1.0 110.171 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -57.46 -45.11 85.13 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.185 -0.947 . . . . 1.0 110.353 -178.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -70.0 -39.9 75.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.804 -1.185 . . . . 1.0 109.49 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.5 t -59.75 -45.61 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.094 -1.004 . . . . 1.0 109.379 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -62.09 -40.07 94.59 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.945 -1.097 . . . . 1.0 110.016 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.4 -54.49 8.77 Favored Glycine 0 N--CA 1.494 2.523 0 C-N-CA 120.253 -0.975 . . . . 1.0 111.197 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.474 HG23 ' N ' ' A' ' 160' ' ' GLN . 8.8 tp -60.18 -40.33 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.934 -1.333 . . . . 1.0 109.644 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.553 ' O ' ' N ' ' A' ' 164' ' ' GLY . 92.1 mm-40 -65.15 -39.87 93.6 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.191 -0.943 . . . . 1.0 109.416 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 78.7 p -61.56 -28.62 69.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.085 -1.009 . . . . 1.0 110.279 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.4 mt -87.27 -52.58 5.31 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.94 -1.1 . . . . 1.0 110.477 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -90.81 -10.04 44.24 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.088 -1.007 . . . . 1.0 110.103 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.523 0 N-CA-C 109.348 -1.501 . . . . 1.0 109.348 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.1 mt . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.032 -0.729 . . . . 1.0 109.032 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -159.69 160.05 33.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.214 -0.929 . . . . 1.0 109.339 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -73.41 151.09 41.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.115 -0.991 . . . . 1.0 109.683 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.0 t -87.54 0.5 55.5 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.456 -0.777 . . . . 1.0 109.478 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -144.82 150.91 37.96 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.262 -0.899 . . . . 1.0 109.217 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.9 mmt -90.01 -0.1 57.4 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.357 -0.839 . . . . 1.0 109.952 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -98.2 131.02 44.91 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.266 -0.897 . . . . 1.0 108.896 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.9 mt -139.84 150.51 44.75 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.288 -0.882 . . . . 1.0 109.088 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 48.8 p -133.09 157.65 44.76 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.414 -0.804 . . . . 1.0 109.32 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -146.47 160.23 42.37 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.062 -1.024 . . . . 1.0 110.049 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.407 ' HE ' ' HA ' ' A' ' 55' ' ' ASP . 42.6 ttt-85 -144.32 133.29 22.68 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.381 -0.824 . . . . 1.0 109.429 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 84.9 mt -87.69 117.62 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.198 -0.939 . . . . 1.0 108.961 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.4 t -69.99 -39.97 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.16 -0.963 . . . . 1.0 109.767 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.534 HD21 ' H ' ' A' ' 64' ' ' PHE . 15.7 p30 -162.06 152.13 16.74 Favored 'General case' 0 C--N 1.292 -1.895 0 O-C-N 119.798 -1.814 . . . . 1.0 111.656 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -99.04 105.64 17.79 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 103.924 -2.621 . . . . 1.0 103.924 176.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.64 145.34 50.93 Favored Pre-proline 0 C--N 1.295 -1.8 0 O-C-N 121.127 -0.983 . . . . 1.0 110.532 -175.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -56.1 -14.14 10.95 Favored 'Trans proline' 0 N--CA 1.486 1.078 0 C-N-CA 120.668 0.912 . . . . 1.0 110.865 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -59.79 -39.2 84.16 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.523 -0.871 . . . . 1.0 109.708 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.7 mtm -139.66 156.18 46.98 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.211 -0.931 . . . . 1.0 109.496 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 82.5 p -75.6 163.88 26.88 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.423 -0.798 . . . . 1.0 109.681 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 -59.97 -39.03 84.27 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.542 -0.724 . . . . 1.0 110.079 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.4 m -60.02 -45.27 93.34 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.854 -1.154 . . . . 1.0 109.696 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -69.99 -40.2 75.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.136 -0.978 . . . . 1.0 109.846 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 77.6 t -68.48 -44.59 83.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.275 -0.891 . . . . 1.0 109.989 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -59.87 -48.54 81.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.052 -1.03 . . . . 1.0 111.033 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -61.11 -34.65 75.3 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.632 -1.292 . . . . 1.0 110.223 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.2 -48.66 80.81 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.868 -1.145 . . . . 1.0 109.619 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.404 ' CE1' HD13 ' A' ' 62' ' ' ILE . 53.1 m-85 -66.47 -37.81 85.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.074 -1.016 . . . . 1.0 109.523 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.06 -40.82 90.8 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.899 -1.126 . . . . 1.0 109.307 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -60.11 -42.74 95.36 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.941 -1.099 . . . . 1.0 108.27 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.0 -48.47 81.56 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.427 -0.796 . . . . 1.0 109.599 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -65.62 -39.01 91.04 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.01 -1.056 . . . . 1.0 109.852 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -59.4 -47.19 86.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.1 -1.0 . . . . 1.0 109.728 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.4 t -61.37 -41.34 89.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.216 -0.928 . . . . 1.0 110.303 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -77.99 -36.89 48.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.067 -1.021 . . . . 1.0 109.809 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 86.7 p -71.22 -15.5 62.46 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.506 -0.746 . . . . 1.0 109.634 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -59.19 -40.07 84.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.3 -0.875 . . . . 1.0 109.909 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.9 m -112.94 -21.79 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.301 -0.874 . . . . 1.0 110.874 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.1 p -91.4 128.32 47.38 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 120.697 -1.252 . . . . 1.0 110.268 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -75.81 15.67 0.87 Allowed 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 120.855 1.037 . . . . 1.0 111.471 179.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 79.1 mt -69.16 140.62 54.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.335 -0.853 . . . . 1.0 109.55 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -106.11 121.04 43.34 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -106.93 123.18 47.81 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.303 -0.873 . . . . 1.0 109.194 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -120.0 130.24 54.64 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.589 -0.694 . . . . 1.0 109.728 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -82.09 135.85 35.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.185 -0.947 . . . . 1.0 109.073 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 84.7 mt -103.67 129.68 51.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.317 -0.864 . . . . 1.0 108.837 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.43 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 18.5 m170 -61.3 -40.01 92.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 1.0 109.869 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 75.1 m-20 -149.11 169.86 19.73 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.188 -0.945 . . . . 1.0 109.809 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.0 -178.03 34.42 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.726 -1.35 . . . . 1.0 109.726 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.2 mt -93.87 139.13 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.269 -1.136 . . . . 1.0 109.3 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.35 169.23 9.1 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.517 -0.739 . . . . 1.0 109.439 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -59.99 -48.42 81.78 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.27 -0.894 . . . . 1.0 109.147 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.0 mt -119.92 112.34 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.503 -0.748 . . . . 1.0 109.401 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.7 ptm -103.58 133.81 47.98 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.306 -0.871 . . . . 1.0 108.9 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.404 HD13 ' CE1' ' A' ' 35' ' ' PHE . 84.6 mt -107.54 133.83 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.568 -0.707 . . . . 1.0 109.394 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 76.6 p -151.74 157.57 42.19 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.072 -1.017 . . . . 1.0 109.988 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.534 ' H ' HD21 ' A' ' 21' ' ' ASN . 73.7 m-85 -110.02 121.72 45.91 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.823 -0.806 . . . . 1.0 108.823 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -114.24 -167.23 15.93 Favored Glycine 0 N--CA 1.501 2.977 0 N-CA-C 110.289 -1.124 . . . . 1.0 110.289 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 96.9 mt . . . . . 0 N--CA 1.496 1.83 0 O-C-N 121.653 -0.91 . . . . 1.0 108.594 179.271 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.544 ' CD1' ' OD1' ' A' ' 99' ' ' ASP . 96.3 m-85 . . . . . 0 N--CA 1.495 1.782 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.1 p-10 -100.26 0.56 40.51 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.911 -1.118 . . . . 1.0 110.81 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 129.85 -146.15 17.11 Favored Glycine 0 N--CA 1.502 3.091 0 N-CA-C 108.663 -1.775 . . . . 1.0 108.663 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.426 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 5.7 Cg_exo -65.54 -63.4 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.331 0 CA-C-N 119.314 1.557 . . . . 1.0 111.63 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 84.4 p -78.58 161.1 27.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.206 -0.934 . . . . 1.0 110.001 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.47 -133.06 10.85 Favored Glycine 0 N--CA 1.502 3.047 0 N-CA-C 109.916 -1.273 . . . . 1.0 109.916 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.7 mt -65.56 107.92 1.86 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.345 -1.091 . . . . 1.0 108.287 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 50.9 mt -75.65 -29.95 59.28 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.113 -0.992 . . . . 1.0 109.123 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -177.07 168.6 2.4 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -160.63 162.39 32.73 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.18 -0.95 . . . . 1.0 109.6 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' A' ' 95' ' ' ASP . . . -146.25 158.67 43.9 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.256 -0.903 . . . . 1.0 109.511 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -101.78 151.98 38.03 Favored Pre-proline 0 N--CA 1.498 1.963 0 N-CA-C 108.469 -0.937 . . . . 1.0 108.469 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -63.68 165.36 18.46 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 120.535 0.823 . . . . 1.0 111.93 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo . . . . . 0 N--CA 1.489 1.233 0 C-N-CA 121.035 1.157 . . . . 1.0 111.753 179.609 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.4 ' O ' ' HB1' ' A' ' 85' ' ' ALA . 48.7 p-10 . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 109.282 -0.636 . . . . 1.0 109.282 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.15 118.84 7.0 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.225 -0.922 . . . . 1.0 110.126 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -104.12 136.02 44.52 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.505 -0.747 . . . . 1.0 109.845 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.44 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 19.4 m-85 -116.15 142.51 46.72 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.745 -0.835 . . . . 1.0 108.745 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.544 ' OD1' ' CD1' ' A' ' 75' ' ' PHE . 93.4 m-20 -79.22 124.09 28.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.935 -1.103 . . . . 1.0 109.523 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 48.3 t0 -84.32 -0.02 50.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.323 -0.861 . . . . 1.0 109.662 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -79.62 -16.39 55.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.022 -1.049 . . . . 1.0 110.157 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' A' ' 102' ' ' GLU . 56.1 mp0 -93.53 171.17 9.06 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.177 -0.952 . . . . 1.0 109.128 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 13.7 m -99.48 108.57 21.05 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.352 -0.981 . . . . 1.0 108.352 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -85.84 127.57 34.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 1.0 109.368 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.451 ' CG2' ' O ' ' A' ' 109' ' ' LYS . 1.8 t -139.86 153.11 46.95 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.428 -0.795 . . . . 1.0 109.638 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.5 t -98.69 -4.28 34.03 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.418 -0.801 . . . . 1.0 108.972 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 53.1 m -89.65 -116.47 0.06 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.327 -0.858 . . . . 1.0 109.626 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.8 p -141.84 64.58 1.39 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.134 -0.979 . . . . 1.0 110.147 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.451 ' O ' ' CG2' ' A' ' 105' ' ' THR . 98.7 mttt -144.87 155.29 43.38 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.09 -1.006 . . . . 1.0 108.848 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 49.97 -138.62 20.3 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.485 -1.446 . . . . 1.0 109.485 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -99.55 118.96 37.25 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.241 -1.152 . . . . 1.0 109.337 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -62.24 127.48 31.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.296 -0.878 . . . . 1.0 109.927 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.7 tp -59.98 -40.29 88.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.3 -0.875 . . . . 1.0 110.237 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -59.89 -40.96 90.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.237 -0.915 . . . . 1.0 110.233 -178.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.431 HD21 ' HZ1' ' A' ' 146' ' ' LYS . 3.0 mm? -60.76 -51.31 69.88 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.511 -1.368 . . . . 1.0 110.173 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.1 t -68.96 -43.77 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -0.889 . . . . 1.0 110.296 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.5 -52.24 66.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.074 -1.016 . . . . 1.0 109.739 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.23 -39.62 87.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.875 . . . . 1.0 110.374 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.625 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 68.2 t60 -62.04 -50.01 73.73 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.366 -0.834 . . . . 1.0 111.481 -178.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.44 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 9.5 pt-20 -59.6 -39.77 85.26 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.842 -1.161 . . . . 1.0 109.943 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -60.39 -39.8 88.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.955 -1.091 . . . . 1.0 108.738 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.76 -43.29 86.79 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.162 -1.575 . . . . 1.0 109.162 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.625 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 89.2 m-70 -67.53 -39.91 85.04 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.221 -1.164 . . . . 1.0 109.864 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 72.3 p -66.72 -21.61 66.07 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.134 -0.979 . . . . 1.0 109.463 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 77.1 mt -81.67 -0.73 44.01 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.457 -0.777 . . . . 1.0 109.484 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.82 6.96 66.85 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 110.902 -0.879 . . . . 1.0 110.902 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.5 mt -86.84 149.51 24.78 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.815 -1.403 . . . . 1.0 109.733 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 36.3 t0 -100.78 173.9 6.3 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.546 -0.721 . . . . 1.0 109.056 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.482 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 76.3 m80 -58.06 137.78 56.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.079 -1.013 . . . . 1.0 109.069 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 41.1 t -98.35 151.12 20.87 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.383 -0.823 . . . . 1.0 109.719 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -97.65 1.54 48.81 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.329 -0.857 . . . . 1.0 109.487 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -87.04 128.88 54.12 Favored Pre-proline 0 N--CA 1.489 1.487 0 N-CA-C 108.217 -1.031 . . . . 1.0 108.217 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -69.08 -11.04 30.76 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 CA-C-N 120.128 1.081 . . . . 1.0 112.059 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -93.43 -8.87 60.79 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.425 -1.47 . . . . 1.0 109.425 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.54 136.28 33.87 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.4 -1.059 . . . . 1.0 109.195 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.439 ' C ' ' H ' ' A' ' 138' ' ' PHE . 89.8 mt -60.84 -37.15 81.07 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.027 -1.046 . . . . 1.0 109.638 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 72.8 mtp -70.06 21.42 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.473 -0.767 . . . . 1.0 111.361 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.439 ' H ' ' C ' ' A' ' 136' ' ' LEU . 12.1 t80 -67.69 132.68 92.58 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 120.941 -1.099 . . . . 1.0 108.089 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -62.2 -2.07 2.82 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 CA-C-N 119.851 0.982 . . . . 1.0 114.56 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 95.7 mt -118.46 140.61 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.683 0 O-C-N 120.831 -1.168 . . . . 1.0 110.081 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -75.84 126.49 31.11 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.544 -0.723 . . . . 1.0 110.528 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 14.3 t -144.43 141.88 29.93 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.327 -0.858 . . . . 1.0 109.502 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -80.68 149.63 29.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.094 -1.004 . . . . 1.0 109.571 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.558 ' H ' ' NZ ' ' A' ' 146' ' ' LYS . 3.9 m -146.19 162.49 37.9 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.232 -0.918 . . . . 1.0 109.761 -178.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.439 ' N ' ' CG2' ' A' ' 144' ' ' THR . . . -84.88 103.17 2.64 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.134 -1.586 . . . . 1.0 109.134 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.558 ' NZ ' ' H ' ' A' ' 144' ' ' THR . 9.8 mptt -77.7 3.42 14.05 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.206 -1.173 . . . . 1.0 109.74 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 18.5 t -59.97 -47.56 85.3 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.464 -0.772 . . . . 1.0 109.793 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -133.65 19.12 3.89 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.267 -0.896 . . . . 1.0 110.097 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -65.35 139.84 58.61 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.901 -1.124 . . . . 1.0 110.416 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 76.6 mtm -138.04 149.69 46.26 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.284 -1.006 . . . . 1.0 108.284 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.1 mt -53.07 128.63 48.22 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.819 -1.176 . . . . 1.0 108.882 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.37 175.55 5.79 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 CA-C-N 120.201 1.107 . . . . 1.0 112.334 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -60.06 -39.69 86.89 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.529 -0.732 . . . . 1.0 109.968 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -56.65 -48.43 77.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.264 -0.897 . . . . 1.0 110.107 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -70.15 -40.03 75.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.137 -0.977 . . . . 1.0 109.677 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 76.7 t -63.09 -48.47 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.097 -1.002 . . . . 1.0 109.661 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -60.32 -40.24 89.91 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.904 -1.123 . . . . 1.0 110.298 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.67 -54.55 8.38 Favored Glycine 0 N--CA 1.496 2.659 0 O-C-N 121.168 -0.958 . . . . 1.0 111.41 -178.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.454 HG23 ' N ' ' A' ' 160' ' ' GLN . 6.3 tp -60.94 -40.22 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.813 -1.404 . . . . 1.0 109.59 -179.071 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.2 mm-40 -65.27 -39.71 92.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.16 -0.963 . . . . 1.0 109.434 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 83.9 p -66.68 -26.62 67.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.231 -0.918 . . . . 1.0 110.265 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 84.9 mt -87.0 -50.85 6.38 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.954 -1.091 . . . . 1.0 110.202 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -91.47 -9.19 45.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.104 -0.998 . . . . 1.0 110.286 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.492 2.429 0 N-CA-C 109.549 -1.42 . . . . 1.0 109.549 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.2 mt . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.233 -0.655 . . . . 1.0 109.233 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -160.6 160.4 31.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 1.0 109.016 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -72.25 151.67 42.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.101 -0.999 . . . . 1.0 109.214 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 82.8 p -86.51 1.92 49.82 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.243 -0.91 . . . . 1.0 110.487 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -149.63 154.59 38.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.082 -1.011 . . . . 1.0 109.342 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.504 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.02 0.96 56.83 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.219 -0.925 . . . . 1.0 109.88 -179.529 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -95.85 127.69 42.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.107 -0.996 . . . . 1.0 108.687 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.6 mt -141.36 151.0 43.18 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.154 -0.966 . . . . 1.0 109.256 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.3 p -132.11 155.58 47.87 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.439 -0.788 . . . . 1.0 109.088 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -144.02 159.98 41.66 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.163 -0.96 . . . . 1.0 109.934 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.535 HH12 ' C ' ' A' ' 53' ' ' LEU . 25.2 ttm-85 -145.87 136.09 23.83 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.533 -0.729 . . . . 1.0 109.906 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 87.4 mt -88.81 113.93 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 108.339 -0.985 . . . . 1.0 108.339 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.66 -40.27 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.104 -0.997 . . . . 1.0 109.094 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -161.9 160.98 28.6 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.856 -1.152 . . . . 1.0 110.473 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.557 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 62.8 m-85 -101.95 -168.05 1.49 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.607 -1.257 . . . . 1.0 107.607 179.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.22 149.02 50.83 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.165 -0.959 . . . . 1.0 110.131 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -70.63 -12.03 30.62 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 120.827 1.018 . . . . 1.0 110.148 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -59.62 -39.96 85.99 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 115.334 -0.848 . . . . 1.0 110.531 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.9 mtm -139.99 169.93 16.8 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.163 -0.96 . . . . 1.0 109.634 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 78.8 p -73.15 160.05 32.57 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.137 -0.977 . . . . 1.0 109.472 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.557 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 1.8 m80 -60.16 -39.79 87.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.52 -0.738 . . . . 1.0 110.344 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.1 m -59.97 -39.9 87.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.08 -1.012 . . . . 1.0 109.549 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -62.47 -46.57 87.88 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.099 -1.001 . . . . 1.0 110.31 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.2 t -66.32 -39.92 85.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.401 -0.812 . . . . 1.0 109.804 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -54.44 -57.08 12.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.276 -0.89 . . . . 1.0 111.221 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.8 pttt -62.32 -32.17 72.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.683 -1.261 . . . . 1.0 110.439 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.34 -49.95 70.9 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.887 -1.133 . . . . 1.0 109.687 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -65.17 -39.67 93.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.027 -1.046 . . . . 1.0 109.759 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.15 -40.22 89.12 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.062 -1.024 . . . . 1.0 109.485 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -60.06 -43.45 95.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.979 -1.076 . . . . 1.0 108.845 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.21 -47.33 84.91 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.471 -0.768 . . . . 1.0 110.39 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.429 ' CZ ' ' CZ ' ' A' ' 121' ' ' PHE . 43.0 m-85 -63.32 -40.25 96.79 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.816 -1.178 . . . . 1.0 109.767 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -60.01 -44.43 94.57 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.163 -0.961 . . . . 1.0 110.043 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.8 t -60.11 -41.88 88.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.292 -0.88 . . . . 1.0 110.26 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -79.68 -37.49 35.72 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.157 -0.964 . . . . 1.0 111.162 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.3 p -69.85 -17.58 63.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.889 -1.132 . . . . 1.0 109.664 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.77 -40.14 91.41 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.546 -0.721 . . . . 1.0 110.833 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.8 m -118.65 35.3 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.257 -0.902 . . . . 1.0 110.69 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.6 p -151.12 134.62 9.08 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 120.917 -1.114 . . . . 1.0 109.925 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -73.39 10.64 1.17 Allowed 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 120.809 1.006 . . . . 1.0 111.908 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.0 mt -68.93 136.85 53.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.001 -1.062 . . . . 1.0 110.02 -179.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -107.21 120.76 42.99 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.501 -0.926 . . . . 1.0 108.501 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -108.25 124.57 50.51 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.309 -0.869 . . . . 1.0 109.599 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -120.37 130.02 54.21 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.56 -0.712 . . . . 1.0 110.088 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -81.37 130.03 34.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.235 -0.916 . . . . 1.0 109.288 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.535 ' C ' HH12 ' A' ' 18' ' ' ARG . 85.1 mt -106.04 139.94 39.8 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.391 -0.818 . . . . 1.0 108.942 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.444 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 41.3 m170 -95.33 -14.35 23.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.254 -0.904 . . . . 1.0 109.704 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 77.2 m-20 -149.66 160.28 43.64 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.309 -0.869 . . . . 1.0 109.865 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.535 ' O ' ' NE ' ' A' ' 18' ' ' ARG . . . 88.12 179.6 47.06 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.751 -1.34 . . . . 1.0 109.751 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.6 mt -97.36 139.77 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.322 -1.105 . . . . 1.0 109.514 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.04 155.75 22.3 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.478 -0.763 . . . . 1.0 109.16 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -59.92 -49.83 76.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.113 -0.992 . . . . 1.0 109.257 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.7 mt -103.91 99.85 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.405 -0.809 . . . . 1.0 109.786 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.5 ptp -99.8 138.94 36.18 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.161 -0.962 . . . . 1.0 109.166 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.2 mt -110.19 132.15 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.999 -0.741 . . . . 1.0 108.999 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 71.5 p -149.3 149.91 31.68 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.896 -1.127 . . . . 1.0 109.879 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -101.98 123.45 45.91 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.727 -0.842 . . . . 1.0 108.727 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.73 -165.96 22.51 Favored Glycine 0 N--CA 1.499 2.838 0 N-CA-C 110.107 -1.197 . . . . 1.0 110.107 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 71.8 mt . . . . . 0 N--CA 1.495 1.811 0 O-C-N 121.671 -0.899 . . . . 1.0 108.822 179.895 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.551 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 89.2 m-85 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 108.609 -0.886 . . . . 1.0 108.609 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -105.18 20.01 19.61 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.319 -0.863 . . . . 1.0 110.811 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 112.37 -156.71 15.41 Favored Glycine 0 N--CA 1.504 3.222 0 N-CA-C 109.149 -1.58 . . . . 1.0 109.149 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -57.41 -68.25 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.49 0 CA-C-N 118.657 1.228 . . . . 1.0 112.423 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 84.9 p -76.36 162.86 27.53 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.326 -0.859 . . . . 1.0 109.982 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.78 -129.16 8.37 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 109.734 -1.346 . . . . 1.0 109.734 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.0 mt -69.12 107.71 3.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.44 -1.035 . . . . 1.0 109.123 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 60.1 mt -78.92 -22.4 45.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.894 -1.129 . . . . 1.0 109.016 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -177.49 173.03 1.73 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.755 -0.831 . . . . 1.0 108.755 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.572 ' CE1' ' ND1' ' A' ' 97' ' ' HIS . 19.8 p80 -161.56 162.2 30.11 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.047 -1.033 . . . . 1.0 109.652 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.4 155.13 40.85 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.745 -0.835 . . . . 1.0 108.745 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -93.44 151.67 40.4 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.176 -0.952 . . . . 1.0 108.559 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -50.0 169.38 0.14 Allowed 'Trans proline' 0 N--CA 1.488 1.176 0 CA-C-N 119.189 0.746 . . . . 1.0 111.295 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo . . . . . 0 C--N 1.314 -1.274 0 C-N-CA 120.661 0.908 . . . . 1.0 111.849 179.903 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.244 0.545 . . . . 1.0 109.895 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.08 122.75 10.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.267 -0.896 . . . . 1.0 109.428 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.572 ' ND1' ' CE1' ' A' ' 84' ' ' HIS . 46.1 m170 -105.31 136.36 44.99 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.652 -0.655 . . . . 1.0 109.853 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -120.23 145.0 47.44 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.896 -0.779 . . . . 1.0 108.896 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.551 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 82.9 m-20 -78.56 121.75 25.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.034 -1.041 . . . . 1.0 109.856 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 37.8 t0 -85.63 -7.36 58.88 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.905 -0.776 . . . . 1.0 108.905 179.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -82.39 -12.56 57.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.432 -0.793 . . . . 1.0 109.197 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -91.1 170.56 9.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.378 -0.826 . . . . 1.0 109.291 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.9 m -101.29 105.37 16.45 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.382 -0.824 . . . . 1.0 109.097 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.426 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 88.2 m95 -88.41 123.77 33.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.342 -0.849 . . . . 1.0 109.057 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.669 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.1 t -140.52 157.67 45.14 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.331 -0.856 . . . . 1.0 110.198 -179.244 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 53.4 m -96.1 -9.18 31.4 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.181 -1.044 . . . . 1.0 108.181 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 72.4 m -92.35 171.58 8.96 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.58 -0.896 . . . . 1.0 108.58 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.6 t -72.09 76.19 0.95 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.07 -1.018 . . . . 1.0 109.928 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.669 ' HB2' HG21 ' A' ' 105' ' ' THR . 64.2 mttp -149.53 150.29 32.06 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.204 -0.935 . . . . 1.0 108.982 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.07 -137.46 4.91 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.702 -1.359 . . . . 1.0 109.702 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -102.68 117.57 34.95 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.436 -1.038 . . . . 1.0 109.405 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.621 HD21 ' N ' ' A' ' 113' ' ' LEU . 0.7 OUTLIER -64.2 130.09 42.52 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.22 -0.925 . . . . 1.0 109.583 179.768 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.621 ' N ' HD21 ' A' ' 112' ' ' ASN . 59.2 tp -60.13 -40.56 90.19 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.41 -0.806 . . . . 1.0 110.94 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -58.71 -40.13 82.79 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.793 -1.192 . . . . 1.0 110.346 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -58.68 -59.92 4.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.944 -1.097 . . . . 1.0 109.749 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 86.9 t -62.99 -42.13 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.53 -0.732 . . . . 1.0 110.216 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.69 -49.99 75.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.119 -0.988 . . . . 1.0 109.403 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.99 -39.69 86.59 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.918 -1.114 . . . . 1.0 109.803 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.632 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 68.4 t60 -65.08 -48.55 73.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.347 -0.846 . . . . 1.0 111.946 -178.074 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.506 ' OE2' ' CD1' ' A' ' 121' ' ' PHE . 1.1 pp20? -59.13 -40.05 84.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.535 -1.353 . . . . 1.0 109.281 -178.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.506 ' CD1' ' OE2' ' A' ' 120' ' ' GLU . 28.4 m-85 -60.04 -39.87 87.42 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.857 -1.152 . . . . 1.0 109.175 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.76 -45.36 85.81 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.843 -1.303 . . . . 1.0 109.843 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.632 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 87.6 m-70 -64.89 -40.06 94.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.004 -1.292 . . . . 1.0 109.645 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 82.2 p -63.78 -23.48 67.38 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.251 -0.906 . . . . 1.0 109.421 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.6 mt -84.16 -1.09 54.42 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.046 -1.034 . . . . 1.0 109.876 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.48 10.83 63.18 Favored Glycine 0 N--CA 1.496 2.698 0 C-N-CA 120.025 -1.084 . . . . 1.0 110.747 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 77.9 mt -84.65 144.0 28.87 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.888 -1.36 . . . . 1.0 109.944 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 11.6 t70 -99.15 170.1 8.93 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.302 -0.874 . . . . 1.0 109.029 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.493 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 65.7 m80 -60.0 137.35 58.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.153 -0.967 . . . . 1.0 110.154 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 28.6 t -100.62 154.15 18.82 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -97.98 5.72 48.5 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.096 -1.003 . . . . 1.0 109.911 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -86.98 129.48 51.93 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.066 -1.021 . . . . 1.0 108.66 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -66.4 -24.0 50.38 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 CA-C-N 120.188 1.103 . . . . 1.0 112.406 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -86.15 -5.09 83.47 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.012 -1.235 . . . . 1.0 110.012 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.59 144.48 27.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.933 -1.334 . . . . 1.0 108.731 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.433 ' C ' ' H ' ' A' ' 138' ' ' PHE . 88.4 mt -68.99 -33.22 73.33 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.307 -0.871 . . . . 1.0 109.181 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 96.3 mmm -71.58 19.87 0.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.462 -0.774 . . . . 1.0 110.771 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.433 ' H ' ' C ' ' A' ' 136' ' ' LEU . 12.0 t80 -69.16 132.34 90.1 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 120.826 -1.171 . . . . 1.0 108.532 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -64.53 -3.65 6.92 Favored 'Trans proline' 0 N--CA 1.501 1.926 0 CA-C-N 119.888 0.996 . . . . 1.0 113.936 -178.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.0 mt -118.67 141.11 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 O-C-N 121.012 -1.055 . . . . 1.0 109.104 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' TYR . . . . . 0.497 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 38.3 t80 -74.73 130.63 39.82 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.489 -0.757 . . . . 1.0 110.252 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.8 t -140.63 142.48 35.0 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.431 -0.951 . . . . 1.0 108.431 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -79.8 144.17 33.77 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.918 -1.114 . . . . 1.0 110.074 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.4 m -130.42 140.03 50.58 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.04 -0.726 . . . . 1.0 109.04 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.41 113.92 3.98 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 107.655 -2.178 . . . . 1.0 107.655 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm -73.25 98.77 2.72 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.063 -1.257 . . . . 1.0 109.297 -178.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.9 m -159.72 104.75 1.58 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.301 -0.875 . . . . 1.0 108.846 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 72.9 m80 50.1 40.57 21.97 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.408 -0.807 . . . . 1.0 109.399 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -85.19 129.96 34.7 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.16 -0.963 . . . . 1.0 109.393 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 66.9 mtt -124.28 149.06 46.93 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.981 -0.748 . . . . 1.0 108.981 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 29.1 mt -51.84 131.54 38.42 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.099 -1.001 . . . . 1.0 108.408 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -66.14 174.41 6.0 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 CA-C-N 119.992 1.033 . . . . 1.0 112.32 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -60.08 -39.65 86.81 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.429 -0.794 . . . . 1.0 110.152 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -57.16 -49.67 75.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.135 -0.978 . . . . 1.0 109.809 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.01 -40.19 75.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.088 -1.008 . . . . 1.0 110.516 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 67.5 t -60.74 -45.72 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.949 -1.094 . . . . 1.0 108.989 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -60.17 -39.92 88.13 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.137 -0.977 . . . . 1.0 110.398 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -69.54 -52.45 21.09 Favored Glycine 0 N--CA 1.494 2.546 0 O-C-N 121.145 -0.972 . . . . 1.0 111.504 -178.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.455 HG23 ' N ' ' A' ' 160' ' ' GLN . 5.3 tp -62.25 -40.01 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.754 -1.439 . . . . 1.0 109.661 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.8 mt-30 -65.01 -38.99 92.74 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.246 -0.909 . . . . 1.0 109.628 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 79.5 p -69.26 -22.25 63.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.174 -0.953 . . . . 1.0 110.174 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 88.8 mt -88.24 -50.68 6.2 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.888 -1.132 . . . . 1.0 110.065 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -93.53 -9.32 38.67 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.034 -1.041 . . . . 1.0 109.67 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.509 0 N-CA-C 109.473 -1.451 . . . . 1.0 109.473 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.4 mt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.582 -0.525 . . . . 1.0 109.582 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.55 ' HB3' ' HZ3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -161.41 159.82 28.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.149 -0.969 . . . . 1.0 109.56 179.502 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -76.23 152.6 36.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 1.0 109.407 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 99.0 p -87.51 0.03 56.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.361 -0.837 . . . . 1.0 109.809 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -148.57 154.59 39.96 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.154 -0.966 . . . . 1.0 109.686 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.567 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.49 -0.03 57.5 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.377 -0.827 . . . . 1.0 110.222 -179.577 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -96.6 122.38 39.46 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.181 -0.949 . . . . 1.0 108.863 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 71.8 mt -138.85 149.08 44.49 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.471 -0.768 . . . . 1.0 108.98 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.3 p -131.67 160.01 36.68 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.703 -0.851 . . . . 1.0 108.703 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -142.89 161.19 38.77 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.13 -0.981 . . . . 1.0 110.435 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -142.63 129.75 20.85 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.137 -0.69 . . . . 1.0 109.137 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.7 mt -88.13 118.25 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.182 -0.949 . . . . 1.0 108.908 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.67 -39.53 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.218 -0.926 . . . . 1.0 109.505 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.46 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 21.4 p-10 -162.47 155.5 19.94 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.212 -1.555 . . . . 1.0 111.366 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.482 ' O ' ' O ' ' A' ' 23' ' ' THR . 19.3 m-85 -104.96 75.73 1.2 Allowed 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 106.358 -1.719 . . . . 1.0 106.358 176.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.482 ' O ' ' O ' ' A' ' 22' ' ' TYR . 3.0 t -23.45 144.71 0.02 OUTLIER Pre-proline 0 N--CA 1.512 2.636 0 C-N-CA 122.83 0.452 . . . . 1.0 111.744 -177.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -63.94 -4.74 7.92 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 121.631 1.554 . . . . 1.0 112.915 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -59.09 -36.84 75.82 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.442 -0.786 . . . . 1.0 109.557 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 76.8 mtm -138.47 164.17 30.08 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.298 -0.876 . . . . 1.0 109.582 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 76.0 p -70.58 160.03 33.25 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.378 -0.826 . . . . 1.0 109.154 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.03 -42.45 94.4 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.291 -0.881 . . . . 1.0 110.206 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.2 m -60.41 -40.6 91.58 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.166 -0.959 . . . . 1.0 110.735 -179.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -65.78 -41.04 92.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.973 -1.079 . . . . 1.0 110.144 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 69.5 t -66.6 -40.0 85.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 121.422 -0.799 . . . . 1.0 109.978 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -59.78 -52.54 65.03 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.404 -0.81 . . . . 1.0 112.144 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.2 pttt -65.13 -32.63 74.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.558 -1.339 . . . . 1.0 110.277 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.57 -51.31 70.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.941 -1.1 . . . . 1.0 110.181 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.437 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 45.0 m-85 -65.87 -37.39 86.03 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.825 -1.172 . . . . 1.0 110.099 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -59.99 -40.55 89.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.942 -1.098 . . . . 1.0 109.67 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -61.55 -40.31 94.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.067 -1.021 . . . . 1.0 109.529 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.08 -46.12 90.64 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.422 -0.799 . . . . 1.0 110.44 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -68.07 -39.67 82.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.01 -1.056 . . . . 1.0 109.86 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.408 ' O ' ' CG ' ' A' ' 44' ' ' ASP . 49.9 tptt -60.02 -47.17 86.94 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.186 -0.946 . . . . 1.0 109.878 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.2 t -60.08 -42.07 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.145 -0.972 . . . . 1.0 110.846 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -79.31 -35.36 41.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.85 -1.156 . . . . 1.0 110.148 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 38.8 p -71.5 -16.26 62.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.098 -1.001 . . . . 1.0 109.62 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.408 ' CG ' ' O ' ' A' ' 40' ' ' LYS . 96.0 m-20 -59.98 -39.59 86.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.339 -0.851 . . . . 1.0 110.314 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.4 m -112.18 -21.85 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.306 -0.871 . . . . 1.0 110.65 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.6 p -93.78 133.05 28.49 Favored Pre-proline 0 N--CA 1.501 2.109 0 O-C-N 120.759 -1.213 . . . . 1.0 109.611 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -75.43 15.95 0.77 Allowed 'Trans proline' 0 N--CA 1.496 1.622 0 CA-C-N 120.204 1.109 . . . . 1.0 112.039 178.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 78.8 mt -68.31 140.02 55.93 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.195 -0.941 . . . . 1.0 109.912 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -108.19 121.73 45.46 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 108.993 -0.743 . . . . 1.0 108.993 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -108.95 124.52 50.81 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.249 -0.907 . . . . 1.0 109.958 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.0 m -119.96 129.95 54.55 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.418 0.628 . . . . 1.0 109.306 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -83.82 137.9 33.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.307 -0.871 . . . . 1.0 110.042 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 77.3 mt -102.79 129.29 49.4 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.703 -0.851 . . . . 1.0 108.703 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.448 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 61.0 m170 -61.67 -40.04 93.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.914 . . . . 1.0 109.428 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 75.0 m-20 -151.0 168.02 25.85 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.379 -0.825 . . . . 1.0 109.249 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.03 -178.64 29.57 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.543 -1.423 . . . . 1.0 109.543 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.0 mt -96.3 132.82 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.353 -1.087 . . . . 1.0 109.76 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.96 164.71 12.34 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.367 -0.833 . . . . 1.0 109.071 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.04 -49.48 77.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.189 -0.944 . . . . 1.0 109.527 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 95.2 mt -107.28 101.85 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.51 -0.743 . . . . 1.0 109.691 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.2 ptp -100.21 135.97 40.82 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.248 -0.908 . . . . 1.0 109.469 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.437 HG21 ' CZ ' ' A' ' 35' ' ' PHE . 85.4 mt -110.0 133.92 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.726 -0.609 . . . . 1.0 109.945 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.2 p -152.47 155.18 37.0 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.017 -1.052 . . . . 1.0 110.274 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -102.68 121.86 43.28 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.499 -0.926 . . . . 1.0 108.499 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.78 -173.45 22.86 Favored Glycine 0 N--CA 1.499 2.894 0 N-CA-C 110.761 -0.935 . . . . 1.0 110.761 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 96.7 mt . . . . . 0 N--CA 1.497 1.91 0 N-CA-C 107.755 -1.202 . . . . 1.0 107.755 179.413 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.561 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 94.4 m-85 . . . . . 0 N--CA 1.494 1.739 0 N-CA-C 109.106 -0.701 . . . . 1.0 109.106 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 79' ' ' SER . 23.2 p-10 -99.72 18.61 17.7 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.132 -0.98 . . . . 1.0 110.61 -178.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 110.21 -151.87 17.4 Favored Glycine 0 N--CA 1.503 3.16 0 N-CA-C 109.337 -1.505 . . . . 1.0 109.337 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.439 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 6.3 Cg_exo -62.16 -63.67 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.563 0 CA-C-N 118.919 1.359 . . . . 1.0 112.408 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.434 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 95.9 p -77.36 162.77 27.0 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.934 -1.104 . . . . 1.0 109.882 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.68 -130.05 9.01 Favored Glycine 0 N--CA 1.502 3.081 0 N-CA-C 110.341 -1.104 . . . . 1.0 110.341 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.429 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 8.9 mt -68.54 108.32 3.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.607 -0.937 . . . . 1.0 108.589 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 74.4 mt -80.67 -17.98 49.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.969 -1.082 . . . . 1.0 109.818 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.64 174.13 1.23 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.427 -0.796 . . . . 1.0 109.194 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.434 ' CE1' ' ND1' ' A' ' 97' ' ' HIS . 11.5 p80 -161.99 159.35 26.36 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.357 -0.84 . . . . 1.0 109.236 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.22 154.6 40.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.154 -0.966 . . . . 1.0 109.368 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -92.15 152.11 42.32 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.096 -1.002 . . . . 1.0 108.418 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -50.01 171.08 0.1 OUTLIER 'Trans proline' 0 N--CA 1.49 1.265 0 CA-C-N 119.139 0.728 . . . . 1.0 111.191 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo . . . . . 0 C--N 1.315 -1.21 0 CA-C-O 121.932 0.722 . . . . 1.0 111.402 -179.693 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.2 p-10 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.446 0.641 . . . . 1.0 109.856 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.0 120.48 7.42 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.434 -0.792 . . . . 1.0 109.02 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.434 ' ND1' ' CE1' ' A' ' 84' ' ' HIS . 48.7 m170 -105.61 139.51 40.1 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.561 -0.712 . . . . 1.0 110.265 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.528 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 29.2 m-85 -120.78 140.97 50.95 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.733 -0.84 . . . . 1.0 108.733 179.114 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.561 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 93.9 m-20 -78.92 122.94 26.75 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.834 -1.166 . . . . 1.0 109.65 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 34.4 t0 -84.39 1.61 44.42 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.281 -0.887 . . . . 1.0 109.722 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -80.74 -17.95 49.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.124 -0.985 . . . . 1.0 109.57 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' A' ' 102' ' ' GLU . 56.9 mp0 -91.27 172.13 8.75 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.315 -0.865 . . . . 1.0 109.012 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 15.5 m -100.93 107.02 18.41 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.292 -1.003 . . . . 1.0 108.292 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -85.2 127.29 34.23 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.533 -0.914 . . . . 1.0 108.533 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.681 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.9 t -141.8 153.63 44.67 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.343 -0.848 . . . . 1.0 109.979 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 96.6 p -91.88 -5.66 52.88 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.911 -1.144 . . . . 1.0 107.911 178.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 65.2 m -93.1 -176.94 4.32 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.899 -0.778 . . . . 1.0 108.899 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.8 t -85.08 75.51 10.35 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.017 -1.052 . . . . 1.0 109.454 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.681 ' HB2' HG21 ' A' ' 105' ' ' THR . 98.2 mttt -148.67 152.82 37.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.321 -0.862 . . . . 1.0 108.889 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 43.37 -138.72 3.54 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 110.169 -1.172 . . . . 1.0 110.169 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -99.99 117.4 34.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.35 -1.088 . . . . 1.0 109.277 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -64.24 132.6 50.76 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.105 -0.997 . . . . 1.0 109.426 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.3 tp -59.97 -44.1 94.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 1.0 110.309 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -59.98 -40.9 90.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.167 -0.958 . . . . 1.0 111.585 -178.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -59.38 -49.98 75.71 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.443 -1.41 . . . . 1.0 109.415 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 66.0 t -69.97 -40.01 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.136 -0.977 . . . . 1.0 110.047 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.21 -52.8 63.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.089 -1.007 . . . . 1.0 109.807 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.0 -39.54 86.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.824 . . . . 1.0 110.695 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.616 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 69.0 t60 -61.94 -50.03 73.77 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.047 -1.033 . . . . 1.0 111.387 -178.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.528 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 8.2 pt-20 -60.04 -38.57 83.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.608 -1.308 . . . . 1.0 110.113 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -60.03 -40.03 87.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.82 -1.175 . . . . 1.0 108.588 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.79 -43.18 94.74 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.449 -1.46 . . . . 1.0 109.449 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.616 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 90.5 m-70 -65.62 -40.01 92.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.05 -1.265 . . . . 1.0 109.291 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 93.3 p -67.19 -25.39 66.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.179 -0.951 . . . . 1.0 109.438 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 83.2 mt -82.53 -3.0 55.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.22 -0.925 . . . . 1.0 109.791 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 96.94 7.53 57.45 Favored Glycine 0 N--CA 1.5 2.906 0 O-C-N 121.101 -1.0 . . . . 1.0 111.108 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.3 mt -85.25 148.0 26.29 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.698 -1.472 . . . . 1.0 109.693 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 39.7 t0 -102.75 171.49 7.39 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.993 -0.743 . . . . 1.0 108.993 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.536 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 76.9 m80 -59.22 136.26 57.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.012 -1.055 . . . . 1.0 109.106 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 40.3 t -97.38 155.28 16.98 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.237 -0.915 . . . . 1.0 109.541 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -98.61 1.3 46.24 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.351 -0.843 . . . . 1.0 109.75 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -85.4 130.18 52.53 Favored Pre-proline 0 N--CA 1.495 1.79 0 N-CA-C 107.843 -1.169 . . . . 1.0 107.843 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -67.44 -26.18 41.01 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 CA-C-N 120.212 1.111 . . . . 1.0 113.285 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -85.92 -2.75 86.09 Favored Glycine 0 N--CA 1.497 2.709 0 C-N-CA 119.799 -1.191 . . . . 1.0 110.342 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.63 144.42 27.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.047 -1.266 . . . . 1.0 109.146 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.407 ' C ' ' H ' ' A' ' 138' ' ' PHE . 91.5 mt -67.05 -33.46 75.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.177 -0.952 . . . . 1.0 109.813 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 94.8 mmm -69.17 9.61 0.41 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.164 -0.96 . . . . 1.0 110.2 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.407 ' H ' ' C ' ' A' ' 136' ' ' LEU . 13.2 t80 -67.43 135.9 93.18 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 107.738 -1.208 . . . . 1.0 107.738 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -65.13 -31.83 53.79 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 CA-C-N 119.898 0.999 . . . . 1.0 113.818 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 90.6 mt -83.42 140.41 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.481 -1.387 . . . . 1.0 110.119 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -76.07 128.92 36.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.491 -0.756 . . . . 1.0 109.591 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 10.2 t -140.16 142.41 35.95 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.221 -0.924 . . . . 1.0 109.55 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -82.5 144.93 30.08 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.359 -0.838 . . . . 1.0 109.643 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.8 t -140.79 156.09 46.24 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.259 -0.9 . . . . 1.0 110.076 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.0 110.36 3.17 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.92 -1.672 . . . . 1.0 108.92 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -78.63 -3.38 43.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.328 -1.101 . . . . 1.0 109.708 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.0 t -60.04 -41.14 91.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.234 -0.916 . . . . 1.0 110.635 -178.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -143.01 28.89 1.52 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.939 -1.101 . . . . 1.0 110.513 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -68.32 135.65 52.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.754 -1.216 . . . . 1.0 109.071 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 98.7 mtp -138.39 148.2 44.23 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.502 -0.925 . . . . 1.0 108.502 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 88.0 mt -50.83 121.25 14.76 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 120.959 -1.088 . . . . 1.0 108.682 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -66.57 178.55 2.61 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 CA-C-N 120.275 1.134 . . . . 1.0 112.153 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.16 -39.97 88.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.474 -0.766 . . . . 1.0 109.669 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -56.94 -49.2 76.38 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.238 -0.914 . . . . 1.0 109.678 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.68 -40.01 73.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.961 -1.087 . . . . 1.0 110.299 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 72.9 t -62.15 -46.67 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.915 -1.116 . . . . 1.0 109.159 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -60.28 -40.05 89.02 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 1.0 110.212 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.13 -53.77 8.8 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 120.219 -0.991 . . . . 1.0 111.436 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.468 HG23 ' N ' ' A' ' 160' ' ' GLN . 9.9 tp -60.45 -40.31 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.74 -1.447 . . . . 1.0 109.971 -178.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.536 ' O ' ' N ' ' A' ' 164' ' ' GLY . 25.8 mm100 -65.68 -39.6 91.49 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.323 -0.861 . . . . 1.0 109.352 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 79.2 p -63.46 -25.82 68.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.197 -0.94 . . . . 1.0 110.14 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 84.5 mt -86.95 -52.56 5.39 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.959 -1.088 . . . . 1.0 110.456 -179.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -92.7 -9.01 42.31 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.035 -1.041 . . . . 1.0 110.135 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.522 0 N-CA-C 109.502 -1.439 . . . . 1.0 109.502 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.1 mt . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 121.27 0.557 . . . . 1.0 109.575 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.9 pttt -161.96 160.05 27.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 1.0 109.85 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -73.56 147.25 44.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.403 -0.81 . . . . 1.0 109.411 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 99.4 p -89.33 3.1 53.26 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.192 -0.942 . . . . 1.0 110.091 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -143.21 153.61 43.0 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.118 -0.989 . . . . 1.0 109.435 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.1 mmt -90.17 -0.1 57.44 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.399 -0.813 . . . . 1.0 110.219 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -97.27 127.98 43.72 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.111 -0.993 . . . . 1.0 109.632 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.7 mt -142.28 148.65 38.4 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.101 -1.0 . . . . 1.0 109.123 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.4 p -135.28 158.57 44.03 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -145.1 160.99 40.54 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.038 -1.039 . . . . 1.0 110.615 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.51 HH11 ' HG2' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -141.81 131.14 23.59 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 -179.141 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.7 mt -88.14 115.24 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.127 -0.983 . . . . 1.0 108.694 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.08 -41.7 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.122 -0.986 . . . . 1.0 109.537 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.485 HD22 ' HB2' ' A' ' 64' ' ' PHE . 11.5 p-10 -164.36 160.94 21.36 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.271 -1.518 . . . . 1.0 110.114 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.587 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 51.1 m-85 -102.06 -169.92 1.74 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.157 -1.053 . . . . 1.0 108.157 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.25 147.02 42.1 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.343 -0.848 . . . . 1.0 110.154 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -68.61 -14.42 39.47 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 120.876 1.05 . . . . 1.0 110.912 178.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -59.86 -39.59 85.74 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.601 -0.727 . . . . 1.0 110.186 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 74.3 mtm -137.23 165.26 26.54 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.283 -0.886 . . . . 1.0 109.425 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.7 p -72.51 159.63 33.62 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.289 -0.882 . . . . 1.0 109.406 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.587 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 0.9 OUTLIER -60.16 -39.98 88.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.422 -0.799 . . . . 1.0 110.346 -179.25 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.1 m -59.91 -40.11 87.7 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.151 -0.968 . . . . 1.0 110.266 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -66.0 -40.0 90.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.126 -0.984 . . . . 1.0 110.087 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.6 t -68.8 -40.38 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.209 -0.932 . . . . 1.0 110.272 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.94 -49.91 75.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.031 -1.043 . . . . 1.0 110.197 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -61.7 -32.52 72.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.039 -1.038 . . . . 1.0 110.015 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.89 -48.51 81.4 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.888 -1.133 . . . . 1.0 110.007 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -66.89 -39.04 87.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.94 -1.1 . . . . 1.0 109.815 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -60.04 -42.5 94.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.111 -0.993 . . . . 1.0 109.516 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -60.14 -41.21 92.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.09 -1.006 . . . . 1.0 109.203 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.71 -45.3 94.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.503 -0.748 . . . . 1.0 110.224 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -65.64 -38.55 89.68 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.065 -1.022 . . . . 1.0 109.95 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -59.59 -48.82 80.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.102 -0.999 . . . . 1.0 109.782 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 76.1 t -60.0 -40.36 82.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.163 -0.961 . . . . 1.0 110.556 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -81.18 -36.54 30.03 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.842 -1.161 . . . . 1.0 109.823 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.6 p -70.22 -17.08 63.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.179 -0.951 . . . . 1.0 109.666 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -60.03 -40.04 87.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.938 . . . . 1.0 110.3 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -112.16 -17.61 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.338 -0.851 . . . . 1.0 110.782 -179.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.9 p -94.93 125.5 50.63 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 120.744 -1.223 . . . . 1.0 109.48 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -72.37 16.14 0.39 Allowed 'Trans proline' 0 N--CA 1.495 1.578 0 CA-C-N 120.177 1.099 . . . . 1.0 111.8 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 66.3 mt -69.17 140.01 54.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.297 -0.877 . . . . 1.0 109.934 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -106.32 120.56 42.19 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.79 -0.819 . . . . 1.0 108.79 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -106.75 127.22 53.2 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.273 -0.892 . . . . 1.0 109.42 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.9 m -119.99 129.69 54.4 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -84.04 132.57 34.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.517 -0.739 . . . . 1.0 109.116 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.9 mt -105.4 131.7 52.51 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.175 -0.953 . . . . 1.0 109.171 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.44 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 43.0 m170 -61.02 -40.01 91.94 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.146 -0.971 . . . . 1.0 109.284 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 71.9 m-20 -151.95 180.0 7.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.365 -0.834 . . . . 1.0 109.624 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.67 178.71 39.43 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.364 -1.494 . . . . 1.0 109.364 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.5 mt -96.9 130.28 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.284 -1.127 . . . . 1.0 109.673 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.54 162.67 14.48 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.581 -0.699 . . . . 1.0 109.163 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -59.92 -49.83 76.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.187 -0.945 . . . . 1.0 109.499 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 94.8 mt -104.81 101.24 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.412 -0.805 . . . . 1.0 109.898 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.2 ptp -100.93 132.13 46.48 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.319 -0.863 . . . . 1.0 109.161 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.6 mt -102.5 138.09 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.454 -0.779 . . . . 1.0 109.724 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 81.4 p -151.34 160.02 43.99 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.312 -0.867 . . . . 1.0 109.716 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.485 ' HB2' HD22 ' A' ' 21' ' ' ASN . 86.1 m-85 -109.61 125.87 53.02 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.516 -0.74 . . . . 1.0 109.515 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -101.78 -178.26 28.15 Favored Glycine 0 N--CA 1.5 2.921 0 N-CA-C 110.839 -0.904 . . . . 1.0 110.839 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.5 mt . . . . . 0 N--CA 1.498 1.964 0 O-C-N 121.613 -0.933 . . . . 1.0 109.721 179.786 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.536 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 67.8 m-85 . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 109.48 -0.563 . . . . 1.0 109.48 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.6 p-10 -101.0 0.29 37.87 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.454 -0.779 . . . . 1.0 109.994 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 135.19 -155.29 22.01 Favored Glycine 0 N--CA 1.501 2.976 0 N-CA-C 108.707 -1.757 . . . . 1.0 108.707 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.425 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 12.3 Cg_exo -59.41 -68.2 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.39 0 CA-C-N 118.843 1.322 . . . . 1.0 111.776 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 88.1 p -76.0 160.69 29.59 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.311 -0.868 . . . . 1.0 109.203 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.75 -131.09 8.95 Favored Glycine 0 N--CA 1.501 3.031 0 N-CA-C 109.369 -1.493 . . . . 1.0 109.369 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.425 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 24.1 mt -69.81 111.81 5.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.069 -1.254 . . . . 1.0 109.06 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 30.8 mt -82.17 -13.8 56.6 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.237 -0.915 . . . . 1.0 108.625 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 179.39 169.43 1.05 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.999 -0.741 . . . . 1.0 108.999 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.479 ' NE2' ' ND1' ' A' ' 97' ' ' HIS . 3.4 p-80 -162.54 160.88 26.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.077 -1.015 . . . . 1.0 109.572 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -147.48 164.53 33.09 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.193 -0.942 . . . . 1.0 109.577 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -100.8 152.81 37.94 Favored Pre-proline 0 N--CA 1.498 1.966 0 N-CA-C 108.713 -0.847 . . . . 1.0 108.713 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -56.42 169.07 1.78 Allowed 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 120.582 0.855 . . . . 1.0 111.774 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo . . . . . 0 N--CA 1.49 1.314 0 C-N-CA 120.745 0.963 . . . . 1.0 111.608 179.729 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.508 -0.553 . . . . 1.0 109.508 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.87 139.2 23.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.232 -0.917 . . . . 1.0 109.38 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.479 ' ND1' ' NE2' ' A' ' 84' ' ' HIS . 18.0 m170 -130.13 157.71 41.68 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.56 -0.713 . . . . 1.0 109.884 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -136.72 153.81 50.76 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.011 -0.737 . . . . 1.0 109.011 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.536 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 0.6 OUTLIER -79.99 122.09 26.29 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.062 -1.024 . . . . 1.0 109.495 179.842 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -85.28 -11.62 54.32 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.095 -1.003 . . . . 1.0 109.347 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -81.33 -10.68 59.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.873 . . . . 1.0 109.47 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 98.3 mt-10 -90.81 169.98 10.49 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.311 -0.868 . . . . 1.0 109.466 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 22.3 m -98.43 106.23 18.48 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.103 -0.998 . . . . 1.0 109.728 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.427 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 93.5 m95 -89.82 127.48 35.99 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.704 -0.85 . . . . 1.0 108.704 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.674 HG21 ' HB2' ' A' ' 109' ' ' LYS . 9.2 t -143.19 155.65 44.58 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.237 -0.915 . . . . 1.0 109.583 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 60.0 p -94.82 -5.7 44.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.111 -0.993 . . . . 1.0 108.431 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 70.3 m -93.48 179.17 5.47 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.955 -0.757 . . . . 1.0 108.955 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 19.6 m -81.04 77.02 7.98 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.008 -1.058 . . . . 1.0 108.988 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.674 ' HB2' HG21 ' A' ' 105' ' ' THR . 67.9 mttm -149.06 150.19 32.35 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.739 -0.838 . . . . 1.0 108.739 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.21 -138.77 4.48 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.203 -1.159 . . . . 1.0 110.203 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -99.5 116.68 32.21 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.303 -1.116 . . . . 1.0 109.487 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -63.66 131.42 47.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.156 -0.965 . . . . 1.0 109.246 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.7 tp -59.86 -41.66 91.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 1.0 110.12 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -59.98 -43.0 95.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.133 -0.979 . . . . 1.0 111.106 -178.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 115' ' ' LEU . 3.8 mm? -59.38 -50.17 74.98 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.661 -1.274 . . . . 1.0 109.319 -178.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 95.7 t -70.54 -42.2 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.059 -1.025 . . . . 1.0 109.974 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.13 -50.66 73.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.004 -1.06 . . . . 1.0 110.12 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.09 -36.44 77.4 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.581 -1.325 . . . . 1.0 109.577 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.599 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 72.3 t60 -65.5 -48.71 71.65 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.29 -0.881 . . . . 1.0 111.353 -178.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.67 -39.95 82.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.642 -1.286 . . . . 1.0 109.419 -178.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -60.04 -39.99 87.82 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.945 -1.097 . . . . 1.0 109.077 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.4 -46.51 80.07 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.795 -1.322 . . . . 1.0 109.795 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.599 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 85.9 m-70 -65.37 -39.93 92.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.135 -1.215 . . . . 1.0 109.3 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.8 p -64.64 -23.61 67.31 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.291 -0.88 . . . . 1.0 108.998 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 50.6 mt -82.49 -4.97 58.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 1.0 109.59 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 95.27 5.83 60.36 Favored Glycine 0 N--CA 1.499 2.869 0 O-C-N 121.154 -0.966 . . . . 1.0 111.075 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.2 mt -84.21 150.27 25.58 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.811 -1.405 . . . . 1.0 109.94 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 11.0 t70 -103.16 173.19 6.42 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.558 -0.714 . . . . 1.0 109.477 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.483 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 69.2 m80 -59.97 136.35 57.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.132 -0.98 . . . . 1.0 109.221 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 47.7 t -99.45 156.02 17.25 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.324 -0.86 . . . . 1.0 109.516 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -98.72 2.37 47.0 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.165 -0.959 . . . . 1.0 109.358 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -85.66 128.46 58.75 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 120.955 -1.091 . . . . 1.0 108.409 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -68.44 -17.04 43.95 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 CA-C-N 120.14 1.086 . . . . 1.0 112.094 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -89.32 -7.48 69.65 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.091 -1.203 . . . . 1.0 110.091 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.09 144.99 26.18 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.159 -1.201 . . . . 1.0 109.125 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.482 ' C ' ' H ' ' A' ' 138' ' ' PHE . 96.2 mt -69.71 -31.51 69.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.035 -1.04 . . . . 1.0 109.599 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 94.1 mmm -70.88 19.82 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.178 -0.951 . . . . 1.0 110.372 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.482 ' H ' ' C ' ' A' ' 136' ' ' LEU . 13.5 t80 -69.2 131.86 90.28 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.104 -0.997 . . . . 1.0 108.367 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -62.95 -2.22 3.45 Favored 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 120.831 1.021 . . . . 1.0 114.149 -178.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.0 mt -120.43 136.77 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 O-C-N 120.987 -1.071 . . . . 1.0 109.944 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -71.97 127.73 33.49 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.278 -0.889 . . . . 1.0 110.437 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.413 ' O ' HG23 ' A' ' 142' ' ' THR . 9.7 t -139.83 133.61 30.57 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.436 -0.79 . . . . 1.0 109.346 179.245 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -82.16 144.89 30.41 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.065 -1.022 . . . . 1.0 108.749 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 2.5 t -141.86 159.98 41.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.101 -0.999 . . . . 1.0 109.473 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.27 105.66 1.7 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.928 -1.669 . . . . 1.0 108.928 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -78.06 9.8 3.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.342 -1.093 . . . . 1.0 109.37 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 59.2 m -59.91 -40.09 87.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.908 . . . . 1.0 109.826 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -150.25 29.92 0.7 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.006 -1.059 . . . . 1.0 109.575 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -61.59 138.78 58.31 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.154 -0.966 . . . . 1.0 109.59 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 66.9 mtt -137.83 145.86 42.78 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.689 -0.856 . . . . 1.0 108.689 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 45.4 mt -52.31 129.32 41.92 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.043 -1.036 . . . . 1.0 108.883 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -70.19 175.74 8.05 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 CA-C-N 119.985 1.03 . . . . 1.0 112.33 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.44 -39.9 89.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.54 -0.725 . . . . 1.0 110.097 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -56.73 -47.55 79.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.081 -1.012 . . . . 1.0 109.593 -179.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.417 ' O ' HG22 ' A' ' 159' ' ' ILE . 97.0 m-20 -70.33 -39.98 74.42 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.101 -1.0 . . . . 1.0 110.121 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 74.2 t -60.81 -47.74 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.028 -1.045 . . . . 1.0 109.098 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -60.26 -39.93 88.53 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.136 -0.977 . . . . 1.0 110.389 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.75 -54.55 7.24 Favored Glycine 0 N--CA 1.495 2.577 0 O-C-N 121.029 -1.044 . . . . 1.0 111.276 -178.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.475 HG23 ' N ' ' A' ' 160' ' ' GLN . 7.1 tp -60.1 -40.02 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.996 -1.297 . . . . 1.0 109.672 -178.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.554 ' O ' ' N ' ' A' ' 164' ' ' GLY . 93.5 mt-30 -65.51 -39.56 91.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.106 -0.996 . . . . 1.0 109.492 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 83.3 p -60.61 -32.0 71.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.214 -0.929 . . . . 1.0 110.688 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 97.4 mt -85.13 -49.97 7.81 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.772 -1.205 . . . . 1.0 110.606 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -91.39 -8.92 46.6 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.023 -1.048 . . . . 1.0 110.173 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.492 2.41 0 N-CA-C 109.563 -1.415 . . . . 1.0 109.563 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.6 mt . . . . . 0 N--CA 1.494 1.74 0 N-CA-C 109.357 -0.608 . . . . 1.0 109.357 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.96 162.17 34.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.898 . . . . 1.0 109.547 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -73.05 150.45 42.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.196 -0.94 . . . . 1.0 109.666 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.0 t -80.21 -2.63 45.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.332 -0.855 . . . . 1.0 109.749 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -145.88 152.38 39.38 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.235 -0.915 . . . . 1.0 109.284 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.1 mmt -89.99 -0.68 57.71 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.211 -0.931 . . . . 1.0 109.771 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -96.9 131.17 43.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.205 -0.934 . . . . 1.0 109.059 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.8 mt -139.97 149.94 43.87 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.204 -0.935 . . . . 1.0 109.173 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 54.6 p -131.36 155.35 47.4 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.573 -0.899 . . . . 1.0 108.573 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -146.15 159.59 43.1 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.04 -1.038 . . . . 1.0 110.067 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.415 ' HG2' HH11 ' A' ' 18' ' ' ARG . 36.9 ttt-85 -145.26 133.98 22.24 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.48 -0.763 . . . . 1.0 109.296 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.9 mt -86.59 119.63 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 1.0 108.915 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 69.7 t -69.62 -41.11 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.353 -0.842 . . . . 1.0 109.207 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -164.56 157.87 17.51 Favored 'General case' 0 C--N 1.286 -2.175 0 O-C-N 119.686 -1.884 . . . . 1.0 110.819 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.473 ' HB2' ' CE1' ' A' ' 28' ' ' HIS . 56.7 m-85 -100.41 113.0 25.41 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 106.475 -1.676 . . . . 1.0 106.475 178.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.425 ' C ' ' H ' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -56.87 136.54 79.25 Favored Pre-proline 0 C--N 1.299 -1.588 0 C-N-CA 119.103 -1.039 . . . . 1.0 109.199 -177.938 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -57.48 -7.87 3.4 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 CA-C-N 119.606 0.895 . . . . 1.0 110.31 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.425 ' H ' ' C ' ' A' ' 23' ' ' THR . 68.2 m-20 -58.27 -31.55 67.55 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 120.036 -0.666 . . . . 1.0 109.656 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 78.0 mtm -142.55 163.25 33.35 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.228 -0.92 . . . . 1.0 109.895 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 42.3 p -72.56 161.23 31.05 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.454 -0.778 . . . . 1.0 109.648 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.473 ' CE1' ' HB2' ' A' ' 22' ' ' TYR . 0.4 OUTLIER -61.22 -40.06 92.58 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.274 -0.891 . . . . 1.0 110.045 -179.447 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.3 m -61.1 -42.52 98.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.997 -1.065 . . . . 1.0 110.545 -179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.0 -40.03 87.25 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.077 -1.014 . . . . 1.0 110.297 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 79.7 t -68.12 -43.35 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.122 -0.986 . . . . 1.0 110.555 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.04 -49.31 78.18 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.044 -1.035 . . . . 1.0 110.676 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -61.87 -33.81 74.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.946 -1.097 . . . . 1.0 110.176 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.02 -49.74 76.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.833 -1.167 . . . . 1.0 110.31 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.448 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 49.7 m-85 -67.2 -39.94 86.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.915 -1.116 . . . . 1.0 110.449 -179.335 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -60.02 -40.54 89.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.873 -1.142 . . . . 1.0 109.793 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -60.09 -40.73 90.61 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.918 -1.114 . . . . 1.0 108.763 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.94 -46.99 87.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.49 -0.756 . . . . 1.0 110.254 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -66.57 -39.04 88.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.032 -1.043 . . . . 1.0 109.98 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -60.03 -46.62 88.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.08 -1.012 . . . . 1.0 109.882 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 67.8 t -60.01 -41.46 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.148 -0.97 . . . . 1.0 110.36 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -79.39 -36.8 38.62 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.875 -1.14 . . . . 1.0 110.587 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.1 p -70.0 -18.86 63.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.024 -1.047 . . . . 1.0 109.995 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.04 -39.96 87.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.166 -0.959 . . . . 1.0 110.549 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.4 m -117.96 33.84 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.276 -0.89 . . . . 1.0 110.756 -178.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.7 p -151.4 134.48 8.91 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 120.769 -1.207 . . . . 1.0 109.604 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -73.5 13.14 0.75 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 CA-C-N 119.677 0.92 . . . . 1.0 112.004 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 79.9 mt -68.36 139.78 55.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.061 -1.024 . . . . 1.0 109.865 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -110.5 120.98 44.18 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.83 -0.804 . . . . 1.0 108.83 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -106.28 125.27 50.79 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.334 -0.854 . . . . 1.0 109.509 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.1 m -119.92 129.97 54.59 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.648 -0.658 . . . . 1.0 109.929 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -83.29 130.25 35.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.366 -0.834 . . . . 1.0 109.149 179.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 98.4 mt -101.33 123.21 45.06 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.246 -0.909 . . . . 1.0 109.199 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.439 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 48.8 m170 -60.85 -40.0 91.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.313 -0.867 . . . . 1.0 109.792 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 83.0 m-20 -146.67 169.99 17.89 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.21 -0.931 . . . . 1.0 109.827 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.04 179.1 35.93 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.451 -1.46 . . . . 1.0 109.451 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.5 mt -95.8 134.6 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.234 -1.156 . . . . 1.0 109.377 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.52 159.79 17.21 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.429 -0.794 . . . . 1.0 109.337 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.02 -49.11 78.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.156 -0.965 . . . . 1.0 109.436 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.6 mt -104.84 99.18 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.387 -0.821 . . . . 1.0 109.939 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.1 ptp -100.16 132.83 45.3 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.141 -0.975 . . . . 1.0 109.047 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.448 HG21 ' CZ ' ' A' ' 35' ' ' PHE . 85.5 mt -110.03 130.48 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.588 -0.695 . . . . 1.0 109.534 -179.349 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.3 p -151.2 158.53 44.06 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.128 -0.983 . . . . 1.0 110.245 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -102.84 127.64 49.94 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.212 -1.033 . . . . 1.0 108.212 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -117.73 -166.83 14.04 Favored Glycine 0 N--CA 1.499 2.863 0 N-CA-C 110.018 -1.233 . . . . 1.0 110.018 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 83.0 mt . . . . . 0 N--CA 1.494 1.767 0 O-C-N 121.669 -0.901 . . . . 1.0 108.702 -179.883 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.475 ' CE2' ' OD1' ' A' ' 99' ' ' ASP . 37.4 m-85 . . . . . 0 N--CA 1.493 1.72 0 N-CA-C 107.94 -1.133 . . . . 1.0 107.94 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 79' ' ' SER . 24.2 p-10 -103.27 13.34 34.08 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.054 -1.029 . . . . 1.0 110.569 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 108.89 -151.54 17.09 Favored Glycine 0 N--CA 1.503 3.103 0 N-CA-C 109.223 -1.551 . . . . 1.0 109.223 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.404 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 13.6 Cg_exo -58.58 -64.13 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.552 0 CA-C-N 118.892 1.346 . . . . 1.0 112.737 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.447 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 79.2 p -75.04 159.83 31.25 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.976 -1.078 . . . . 1.0 109.828 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.97 -129.8 8.83 Favored Glycine 0 N--CA 1.502 3.068 0 N-CA-C 109.992 -1.243 . . . . 1.0 109.992 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.441 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 23.0 mt -66.17 104.38 1.16 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.358 -1.084 . . . . 1.0 108.889 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 33.8 mt -80.04 -15.73 56.57 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.991 -1.068 . . . . 1.0 108.727 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 97' ' ' HIS . . . 179.61 170.8 1.05 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.07 -0.715 . . . . 1.0 109.07 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -160.03 153.46 22.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.184 -0.947 . . . . 1.0 109.423 178.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -142.2 158.58 43.58 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.409 -0.807 . . . . 1.0 109.297 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -96.18 153.32 39.1 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 108.287 -1.005 . . . . 1.0 108.287 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -49.38 170.02 0.1 OUTLIER 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 120.529 0.819 . . . . 1.0 111.549 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo . . . . . 0 N--CA 1.493 1.493 0 C-N-CA 121.021 1.147 . . . . 1.0 112.08 -179.296 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.7 p-10 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.542 -0.54 . . . . 1.0 109.542 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.24 124.43 11.49 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.229 -0.919 . . . . 1.0 109.468 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.415 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 8.9 m170 -111.84 146.35 37.83 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.486 0.66 . . . . 1.0 109.963 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -126.64 148.98 49.76 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.343 -0.984 . . . . 1.0 108.343 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.475 ' OD1' ' CE2' ' A' ' 75' ' ' PHE . 87.8 m-20 -78.57 123.52 27.18 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.862 -1.149 . . . . 1.0 109.367 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -83.08 -9.38 59.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.893 . . . . 1.0 109.257 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -83.08 -13.5 55.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.335 -0.853 . . . . 1.0 108.897 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.404 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 99.1 mt-10 -89.09 166.19 14.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.508 -0.745 . . . . 1.0 109.168 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.7 m -99.12 105.82 17.95 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.225 -0.922 . . . . 1.0 109.342 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -88.04 124.11 33.42 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.557 -0.905 . . . . 1.0 108.557 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.643 HG21 ' HB2' ' A' ' 109' ' ' LYS . 9.0 t -140.2 160.03 40.87 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.232 -0.917 . . . . 1.0 110.115 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 32.2 t -96.63 -10.02 28.0 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.415 -0.958 . . . . 1.0 108.415 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.3 t -91.06 -176.34 4.58 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.681 -0.859 . . . . 1.0 108.681 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.4 t -85.59 77.81 9.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.995 -1.066 . . . . 1.0 109.373 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.643 ' HB2' HG21 ' A' ' 105' ' ' THR . 66.5 mttm -148.44 149.93 32.59 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.372 -0.973 . . . . 1.0 108.372 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.13 -139.71 5.08 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.764 -1.335 . . . . 1.0 109.764 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -101.01 115.58 30.83 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.451 -1.029 . . . . 1.0 108.923 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.444 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 17.4 t-20 -62.69 134.52 56.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.115 -0.99 . . . . 1.0 109.945 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.7 tp -60.03 -46.19 90.34 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.513 -0.742 . . . . 1.0 110.867 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -59.51 -40.04 85.78 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.261 -0.899 . . . . 1.0 110.743 -178.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -58.41 -51.09 71.31 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.686 -1.259 . . . . 1.0 109.337 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 64.6 t -70.04 -40.77 78.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.097 -1.002 . . . . 1.0 110.235 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.93 -49.42 76.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.172 -0.955 . . . . 1.0 109.738 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.97 -39.68 86.5 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.197 -0.939 . . . . 1.0 110.366 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.615 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 71.0 t60 -63.52 -49.85 71.9 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.14 -0.975 . . . . 1.0 111.416 -178.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -60.03 -38.81 83.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.602 -1.311 . . . . 1.0 110.276 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -60.06 -39.95 87.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.698 -1.251 . . . . 1.0 108.493 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.23 -40.27 91.44 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.571 -1.411 . . . . 1.0 109.571 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.615 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 78.4 m-70 -66.53 -39.99 88.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.037 -1.272 . . . . 1.0 109.132 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 84.3 p -66.38 -24.44 66.49 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.278 -0.889 . . . . 1.0 109.566 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 92.9 mt -81.78 -1.69 48.15 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.152 -0.967 . . . . 1.0 109.607 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 89.69 9.64 66.14 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 110.645 -0.982 . . . . 1.0 110.645 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 82.6 mt -84.82 147.13 26.98 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.924 -1.339 . . . . 1.0 109.302 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 41.3 t0 -102.2 172.9 6.63 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.462 -0.774 . . . . 1.0 109.49 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.527 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 61.3 m80 -59.05 136.93 58.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.878 . . . . 1.0 109.612 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 47.3 t -98.57 157.01 16.51 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.369 -0.832 . . . . 1.0 109.293 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -99.71 0.01 40.97 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.383 -0.823 . . . . 1.0 109.582 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 9.6 t70 -85.46 129.45 55.2 Favored Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 108.225 -1.028 . . . . 1.0 108.225 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -68.47 -21.07 40.9 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 CA-C-N 120.126 1.081 . . . . 1.0 112.004 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.459 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -87.5 -4.61 80.0 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.443 -1.463 . . . . 1.0 109.443 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.09 145.71 26.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.241 -1.152 . . . . 1.0 109.496 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.454 ' C ' ' H ' ' A' ' 138' ' ' PHE . 84.5 mt -69.95 -34.9 74.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.249 -0.907 . . . . 1.0 109.493 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 96.8 mmm -70.98 18.84 0.06 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.341 -0.85 . . . . 1.0 110.533 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.454 ' H ' ' C ' ' A' ' 136' ' ' LEU . 11.9 t80 -68.73 133.29 90.53 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.902 -1.124 . . . . 1.0 108.096 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -63.43 -13.15 34.43 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 120.782 0.988 . . . . 1.0 113.843 -178.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.7 mt -108.36 139.96 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.036 -1.04 . . . . 1.0 109.884 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' TYR . . . . . 0.444 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 56.0 t80 -73.63 129.37 37.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.511 -0.743 . . . . 1.0 110.127 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.6 t -138.49 140.12 39.06 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.589 -0.893 . . . . 1.0 108.589 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -79.88 130.0 34.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.036 -1.04 . . . . 1.0 109.537 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 20.6 m -115.81 125.51 52.81 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.705 -0.622 . . . . 1.0 109.639 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.9 100.06 0.22 Allowed Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.068 -2.013 . . . . 1.0 108.068 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -70.14 138.24 51.73 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.292 -1.122 . . . . 1.0 109.955 -178.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.1 m 176.26 -81.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.51 -0.922 . . . . 1.0 108.51 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -112.93 19.87 16.91 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -61.16 137.48 58.23 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 1.0 110.492 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 96.6 mmm -137.53 146.99 44.81 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.336 -0.986 . . . . 1.0 108.336 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.9 mt -47.84 111.38 1.7 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.183 -0.948 . . . . 1.0 109.377 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -54.9 178.24 0.09 OUTLIER 'Trans proline' 0 N--CA 1.494 1.516 0 CA-C-N 120.051 1.054 . . . . 1.0 112.379 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -60.39 -39.96 89.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.4 -0.813 . . . . 1.0 110.065 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -57.27 -47.87 80.34 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.142 -0.974 . . . . 1.0 109.597 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.04 -39.98 75.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.237 -0.914 . . . . 1.0 110.231 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 55.9 t -63.41 -46.95 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.989 -1.07 . . . . 1.0 109.261 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -60.01 -40.04 87.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.16 -0.962 . . . . 1.0 110.208 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -68.8 -56.63 9.05 Favored Glycine 0 N--CA 1.493 2.463 0 O-C-N 121.142 -0.974 . . . . 1.0 111.131 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.49 HG23 ' N ' ' A' ' 160' ' ' GLN . 5.4 tp -61.27 -40.02 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.941 -1.329 . . . . 1.0 109.711 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 164' ' ' GLY . 93.1 mm-40 -64.99 -39.94 94.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 1.0 109.613 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 87.5 p -65.25 -26.76 68.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.185 -0.947 . . . . 1.0 110.051 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 89.5 mt -88.38 -50.59 6.23 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.993 -1.067 . . . . 1.0 110.263 -179.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -94.47 -9.53 35.2 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.027 -1.046 . . . . 1.0 110.422 -179.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.496 2.678 0 N-CA-C 109.509 -1.437 . . . . 1.0 109.509 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.6 mt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.212 -0.662 . . . . 1.0 109.212 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -160.77 159.99 30.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.342 -0.849 . . . . 1.0 109.476 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -71.29 148.77 46.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.007 -1.058 . . . . 1.0 109.278 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.9 t -81.93 0.87 37.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.905 . . . . 1.0 109.766 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -149.97 155.68 40.39 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.017 -1.052 . . . . 1.0 110.054 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.544 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.93 0.01 57.62 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.405 -0.809 . . . . 1.0 109.731 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -95.89 126.95 41.49 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.234 -0.916 . . . . 1.0 108.696 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.8 mt -140.48 151.35 44.76 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.276 -0.89 . . . . 1.0 109.377 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.9 p -130.42 152.1 50.19 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.825 -0.806 . . . . 1.0 108.825 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -145.4 160.04 42.15 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.116 -0.99 . . . . 1.0 109.911 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.716 HH12 ' H ' ' A' ' 58' ' ' ALA . 13.9 ttp-105 -143.4 137.6 28.78 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.294 -0.879 . . . . 1.0 109.793 -179.474 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 92.0 mt -88.53 119.08 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.219 -0.925 . . . . 1.0 108.837 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.0 t -69.92 -39.98 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 1.0 109.722 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -163.0 150.99 13.67 Favored 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 117.243 -1.783 . . . . 1.0 111.744 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.446 ' HB2' ' CE1' ' A' ' 28' ' ' HIS . 43.2 m-85 -99.79 105.13 16.88 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 104.313 -2.477 . . . . 1.0 104.313 176.289 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.1 t -58.32 145.74 73.79 Favored Pre-proline 0 C--N 1.294 -1.807 0 O-C-N 121.027 -1.046 . . . . 1.0 110.419 -176.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -60.86 -11.65 18.82 Favored 'Trans proline' 0 N--CA 1.488 1.16 0 C-N-CA 120.961 1.108 . . . . 1.0 111.57 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -56.7 -32.43 65.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.326 -0.859 . . . . 1.0 110.002 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.6 mtm -140.13 160.52 39.75 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.185 -0.947 . . . . 1.0 109.415 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 66.3 p -73.59 162.34 29.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.255 -0.903 . . . . 1.0 109.781 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.446 ' CE1' ' HB2' ' A' ' 22' ' ' TYR . 1.1 m-70 -60.87 -41.75 96.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.213 -0.929 . . . . 1.0 109.98 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.6 m -60.44 -41.88 94.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.083 -1.011 . . . . 1.0 110.183 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.59 -40.03 80.64 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.187 -0.946 . . . . 1.0 110.277 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 69.3 t -68.73 -43.67 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.117 -0.989 . . . . 1.0 110.205 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -59.93 -48.6 81.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.127 -0.983 . . . . 1.0 110.754 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.445 ' HA ' ' HZ2' ' A' ' 36' ' ' LYS . 16.7 ptpt -62.01 -33.45 74.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.765 -1.209 . . . . 1.0 110.118 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.99 -50.84 72.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.919 -1.113 . . . . 1.0 110.215 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.43 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 57.5 m-85 -69.15 -39.78 78.61 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.85 -1.156 . . . . 1.0 110.609 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.445 ' HZ2' ' HA ' ' A' ' 33' ' ' LYS . 9.6 mtmp? -59.93 -41.85 92.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.913 -1.117 . . . . 1.0 109.715 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -60.6 -40.04 90.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.79 -1.194 . . . . 1.0 108.725 178.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.99 -44.06 94.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -0.871 . . . . 1.0 110.059 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -65.58 -40.15 92.43 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.867 -1.146 . . . . 1.0 109.106 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.4 ' O ' ' CG ' ' A' ' 44' ' ' ASP . 48.1 tptt -60.12 -49.65 76.8 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.496 -0.752 . . . . 1.0 110.718 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.8 t -60.18 -43.03 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 120.799 -1.188 . . . . 1.0 110.487 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -76.98 -36.83 56.15 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.801 -1.187 . . . . 1.0 109.996 -178.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.1 p -71.0 -20.73 62.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.058 -1.026 . . . . 1.0 109.882 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.4 ' CG ' ' O ' ' A' ' 40' ' ' LYS . 81.7 m-20 -59.95 -40.12 87.93 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.354 -0.841 . . . . 1.0 110.6 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.5 m -110.04 24.13 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 121.187 -0.945 . . . . 1.0 110.73 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.4 p -150.15 134.09 9.02 Favored Pre-proline 0 N--CA 1.501 2.094 0 O-C-N 120.973 -1.079 . . . . 1.0 109.588 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -74.49 21.91 0.4 Allowed 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 120.794 0.996 . . . . 1.0 112.166 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 79.6 mt -69.74 138.71 53.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.132 -0.98 . . . . 1.0 109.954 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -106.86 120.78 42.95 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -109.9 125.59 52.98 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.44 -0.787 . . . . 1.0 109.547 -179.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 93.8 m -120.05 130.1 54.54 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.641 -0.662 . . . . 1.0 109.735 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.41 ' NH1' ' HG3' ' A' ' 52' ' ' ARG . 39.0 ttm-85 -81.32 130.27 34.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.368 -0.832 . . . . 1.0 109.226 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.1 mt -102.38 126.92 49.55 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.189 -0.944 . . . . 1.0 109.37 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.447 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 43.6 m170 -62.86 -40.12 96.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.368 -0.833 . . . . 1.0 109.666 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 78.7 m-20 -148.52 173.32 13.26 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.354 -0.841 . . . . 1.0 109.799 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.519 ' O ' ' NH1' ' A' ' 18' ' ' ARG . . . 95.85 178.51 36.36 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.411 -1.476 . . . . 1.0 109.411 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.5 mt -95.5 133.79 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.114 -1.227 . . . . 1.0 109.245 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.716 ' H ' HH12 ' A' ' 18' ' ' ARG . . . -110.15 159.04 17.7 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.401 -0.812 . . . . 1.0 109.232 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.06 -49.41 77.75 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.227 -0.921 . . . . 1.0 109.249 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 93.9 mt -106.4 102.13 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.428 -0.795 . . . . 1.0 109.83 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.8 ptp -101.87 134.27 45.32 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.213 -0.93 . . . . 1.0 109.102 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.43 HG21 ' CZ ' ' A' ' 35' ' ' PHE . 84.5 mt -109.94 130.53 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 109.091 -0.707 . . . . 1.0 109.091 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.6 p -151.15 157.03 42.19 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.929 -1.107 . . . . 1.0 110.577 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -105.68 120.08 40.78 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.769 -1.197 . . . . 1.0 107.769 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -111.68 -171.06 18.88 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 110.739 -0.944 . . . . 1.0 110.739 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.493 1.675 0 N-CA-C 107.892 -1.151 . . . . 1.0 107.892 179.401 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.552 ' CE2' ' OD1' ' A' ' 99' ' ' ASP . 88.7 m-85 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 108.239 -1.023 . . . . 1.0 108.239 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.0 p-10 -100.72 9.71 42.08 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.218 -0.926 . . . . 1.0 111.119 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 118.01 -149.68 18.4 Favored Glycine 0 N--CA 1.506 3.304 0 N-CA-C 109.012 -1.635 . . . . 1.0 109.012 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.439 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 9.6 Cg_exo -60.11 -65.72 0.07 OUTLIER 'Trans proline' 0 N--CA 1.492 1.395 0 CA-C-N 119.157 1.479 . . . . 1.0 112.392 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 90.0 p -76.54 164.74 25.66 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.966 -1.084 . . . . 1.0 110.079 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.38 -130.87 9.67 Favored Glycine 0 N--CA 1.502 3.057 0 N-CA-C 109.998 -1.241 . . . . 1.0 109.998 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.435 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 5.0 mt -68.62 105.43 2.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.509 -0.995 . . . . 1.0 108.624 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 82.1 mt -75.87 -32.6 59.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.091 -1.006 . . . . 1.0 109.535 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -176.44 161.95 2.27 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.929 -0.767 . . . . 1.0 108.929 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -160.24 162.41 33.71 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.154 -0.966 . . . . 1.0 110.084 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 95' ' ' ASP . . . -139.65 157.97 44.9 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.168 -1.049 . . . . 1.0 108.168 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -90.92 152.23 44.22 Favored Pre-proline 0 N--CA 1.497 1.918 0 N-CA-C 108.186 -1.042 . . . . 1.0 108.186 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -54.97 167.95 1.4 Allowed 'Trans proline' 0 N--CA 1.492 1.401 0 CA-C-N 119.437 0.835 . . . . 1.0 111.44 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo . . . . . 0 C--N 1.307 -1.654 0 C-N-CA 120.558 0.839 . . . . 1.0 111.84 -179.861 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.437 ' O ' ' HB1' ' A' ' 85' ' ' ALA . 42.5 p-10 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.31 0.576 . . . . 1.0 109.78 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.31 116.4 6.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.088 -1.008 . . . . 1.0 109.13 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -105.54 130.52 53.58 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.515 -0.74 . . . . 1.0 109.824 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -112.59 142.6 44.98 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.522 -0.918 . . . . 1.0 108.522 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.552 ' OD1' ' CE2' ' A' ' 75' ' ' PHE . 94.1 m-20 -79.32 124.6 28.55 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.082 -1.011 . . . . 1.0 109.938 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 44.7 t0 -84.08 2.34 39.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.362 -0.836 . . . . 1.0 109.189 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -81.31 -16.06 53.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.345 -0.847 . . . . 1.0 109.952 -179.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.549 ' OE1' ' N ' ' A' ' 102' ' ' GLU . 58.1 mp0 -93.43 170.14 9.83 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.174 -0.954 . . . . 1.0 109.49 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 47.7 m -98.96 105.42 17.56 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.462 -0.94 . . . . 1.0 108.462 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -84.29 127.93 34.27 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.319 -0.863 . . . . 1.0 108.941 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.679 HG21 ' HB2' ' A' ' 109' ' ' LYS . 9.2 t -139.95 159.93 41.05 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.391 -0.818 . . . . 1.0 110.066 -179.078 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.1 t -93.64 -10.46 34.46 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.923 -1.14 . . . . 1.0 107.923 178.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 81.7 p -92.13 179.08 5.68 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.577 -0.897 . . . . 1.0 108.577 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.3 t -85.34 75.95 10.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.94 -1.1 . . . . 1.0 109.564 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.679 ' HB2' HG21 ' A' ' 105' ' ' THR . 4.0 mmmm -140.02 144.86 37.13 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 107.987 -1.116 . . . . 1.0 107.987 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 49.89 -129.97 27.15 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.119 -1.592 . . . . 1.0 109.119 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -104.97 115.44 30.28 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.318 -1.107 . . . . 1.0 109.309 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.717 HD21 ' N ' ' A' ' 113' ' ' LEU . 0.4 OUTLIER -65.3 131.77 47.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.905 . . . . 1.0 109.581 179.636 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.717 ' N ' HD21 ' A' ' 112' ' ' ASN . 63.1 tp -59.96 -45.09 93.8 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.445 -0.784 . . . . 1.0 111.215 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -59.93 -40.02 87.46 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.046 -1.033 . . . . 1.0 110.69 -178.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -59.34 -52.68 64.59 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.849 -1.157 . . . . 1.0 109.835 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.4 t -69.93 -40.06 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.924 -1.11 . . . . 1.0 109.409 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.74 -52.3 65.52 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.138 -0.976 . . . . 1.0 108.839 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.78 -32.59 67.67 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 120.64 -1.288 . . . . 1.0 109.686 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.548 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 76.4 t60 -66.48 -55.82 13.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.031 -1.043 . . . . 1.0 111.666 -178.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.29 -31.88 70.67 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.487 -1.383 . . . . 1.0 110.131 -179.029 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -59.8 -41.52 91.41 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.752 -1.218 . . . . 1.0 108.396 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.0 -43.46 98.15 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.364 -1.494 . . . . 1.0 109.364 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.548 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 84.4 m-70 -64.5 -39.86 94.57 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.047 -1.267 . . . . 1.0 109.248 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.0 p -67.82 -25.85 65.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.354 -0.841 . . . . 1.0 109.525 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 75.2 mt -81.57 -3.1 52.37 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.234 -0.916 . . . . 1.0 109.94 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.67 9.3 58.83 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 110.534 -1.027 . . . . 1.0 110.534 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.1 mt -85.88 144.59 27.59 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.917 -1.343 . . . . 1.0 109.559 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 28.6 t0 -101.63 173.41 6.44 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.97 -0.752 . . . . 1.0 108.97 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.509 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 75.7 m80 -60.01 134.61 57.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.203 -0.936 . . . . 1.0 109.236 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 47.6 t -96.77 160.24 14.48 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.023 -1.048 . . . . 1.0 109.376 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -99.67 2.17 44.15 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.353 -0.842 . . . . 1.0 109.655 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 9.6 t70 -85.18 129.48 55.67 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.901 . . . . 1.0 108.713 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -68.13 -25.48 37.38 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 CA-C-N 119.984 1.03 . . . . 1.0 112.389 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.437 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -84.9 -3.82 87.62 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.837 -1.305 . . . . 1.0 109.837 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.03 144.84 27.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.35 -1.088 . . . . 1.0 109.663 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 93.8 mt -70.03 -30.68 68.02 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.316 -0.865 . . . . 1.0 109.187 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 98.1 mmm -72.67 15.47 0.19 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.385 -0.822 . . . . 1.0 110.603 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -72.13 137.59 81.77 Favored Pre-proline 0 N--CA 1.5 2.061 0 O-C-N 121.02 -1.05 . . . . 1.0 108.421 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -61.8 -11.92 23.07 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 120.862 1.041 . . . . 1.0 114.29 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 95.9 mt -109.97 139.08 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.443 0 O-C-N 120.655 -1.278 . . . . 1.0 109.744 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -73.55 129.87 38.88 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.582 -0.699 . . . . 1.0 110.08 -179.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 15.2 t -140.1 143.33 36.2 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.482 -0.762 . . . . 1.0 109.139 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -81.21 149.44 29.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.957 -1.089 . . . . 1.0 109.532 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.9 t -140.23 155.5 46.87 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.906 -0.776 . . . . 1.0 108.906 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.45 111.43 3.57 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.465 -1.454 . . . . 1.0 109.465 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -76.78 -1.48 28.36 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.297 -1.119 . . . . 1.0 109.391 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.2 m -60.0 -40.13 88.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.372 -0.83 . . . . 1.0 109.762 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -160.36 67.48 0.35 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.238 -0.914 . . . . 1.0 109.336 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' A' ' 149' ' ' PHE . 39.0 t80 -99.16 125.04 44.63 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.333 -0.855 . . . . 1.0 109.36 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 75.2 mtm -120.24 141.3 50.07 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.843 -0.799 . . . . 1.0 108.843 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 49.0 mt -49.17 129.06 16.22 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.041 -1.037 . . . . 1.0 108.654 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -66.08 176.93 3.4 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 CA-C-N 119.944 1.016 . . . . 1.0 112.798 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.28 -39.78 88.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.623 -0.673 . . . . 1.0 109.588 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -58.06 -49.28 77.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.315 -0.866 . . . . 1.0 109.86 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -70.03 -40.01 75.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.014 -1.054 . . . . 1.0 109.774 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.3 t -60.1 -46.35 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.129 -0.982 . . . . 1.0 109.335 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -60.23 -39.99 88.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.904 -1.123 . . . . 1.0 110.131 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -68.63 -55.28 12.1 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.154 -1.022 . . . . 1.0 111.113 -178.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.477 HG23 ' N ' ' A' ' 160' ' ' GLN . 5.7 tp -61.93 -40.39 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.941 -1.329 . . . . 1.0 109.74 -179.109 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.477 ' N ' HG23 ' A' ' 159' ' ' ILE . 26.4 mm100 -66.39 -39.93 89.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 1.0 109.648 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 91.9 p -70.17 -22.59 62.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 1.0 110.044 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 86.9 mt -88.1 -50.39 6.42 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.957 -1.089 . . . . 1.0 110.188 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -93.0 -9.78 38.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.96 -1.087 . . . . 1.0 109.697 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.524 0 N-CA-C 109.621 -1.392 . . . . 1.0 109.621 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.4 mt . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.346 -0.612 . . . . 1.0 109.346 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -160.92 163.03 32.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 1.0 109.242 179.72 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 62.7 m95 -72.42 145.35 47.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -0.923 . . . . 1.0 109.806 -179.435 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 61.1 m -88.84 4.24 48.4 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.33 -0.856 . . . . 1.0 110.235 -179.522 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.452 ' NZ ' ' O ' ' A' ' 14' ' ' ASN . 21.5 pttp -140.76 150.78 43.82 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.123 -0.986 . . . . 1.0 109.394 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.1 mmt -90.03 0.23 57.23 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.394 -0.816 . . . . 1.0 109.798 -179.043 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.452 ' O ' ' NZ ' ' A' ' 12' ' ' LYS . 33.2 m120 -94.89 128.59 41.78 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.2 -0.938 . . . . 1.0 109.349 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.7 mt -141.43 150.01 41.76 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.156 -0.965 . . . . 1.0 108.974 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.8 p -132.66 155.39 48.85 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.565 -0.71 . . . . 1.0 109.145 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -145.69 162.7 36.96 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.045 -1.034 . . . . 1.0 110.119 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.544 ' NE ' ' O ' ' A' ' 56' ' ' GLY . 36.8 ttm-85 -144.25 131.43 20.66 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.629 -0.669 . . . . 1.0 109.44 -179.378 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.5 mt -88.92 114.55 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.074 -1.016 . . . . 1.0 108.624 178.64 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.7 -40.55 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 1.0 109.906 -179.58 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.6 p-10 -165.56 154.46 11.89 Favored 'General case' 0 C--N 1.285 -2.2 0 O-C-N 119.675 -1.89 . . . . 1.0 111.168 -179.154 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -99.95 113.0 25.27 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 105.814 -1.921 . . . . 1.0 105.814 178.081 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 23' ' ' THR . 0.4 OUTLIER -56.45 137.79 75.94 Favored Pre-proline 0 C--N 1.297 -1.707 0 O-C-N 120.957 -1.09 . . . . 1.0 109.201 -177.805 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -56.76 -9.29 3.86 Favored 'Trans proline' 0 N--CA 1.483 0.872 0 CA-C-N 119.503 0.858 . . . . 1.0 110.352 179.528 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.412 ' H ' ' C ' ' A' ' 23' ' ' THR . 98.0 m-20 -57.1 -32.08 65.93 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 120.13 -0.628 . . . . 1.0 110.086 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.8 mtm -140.94 164.36 30.48 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.117 -0.99 . . . . 1.0 109.441 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 75.6 p -71.96 160.69 32.1 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.373 -0.829 . . . . 1.0 109.131 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -60.12 -42.34 94.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.173 -0.954 . . . . 1.0 110.2 -179.105 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.546 ' O ' ' NZ ' ' A' ' 33' ' ' LYS . 73.2 m -60.23 -43.18 96.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.103 -0.998 . . . . 1.0 111.006 -179.163 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.25 -40.89 96.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.083 -1.011 . . . . 1.0 110.802 -178.708 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 63.2 t -67.18 -40.21 84.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.101 -0.999 . . . . 1.0 109.746 -179.624 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -60.02 -50.13 74.94 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.261 -0.899 . . . . 1.0 110.929 -179.259 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.546 ' NZ ' ' O ' ' A' ' 29' ' ' SER . 1.7 ptpp? -63.9 -31.03 72.08 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.04 -1.037 . . . . 1.0 110.015 -179.517 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.9 -49.55 77.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.046 -1.034 . . . . 1.0 109.566 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -67.54 -38.97 84.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.118 -0.989 . . . . 1.0 109.797 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.0 -41.91 93.15 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.982 -1.074 . . . . 1.0 109.429 -179.518 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -60.96 -40.87 95.03 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.911 -1.118 . . . . 1.0 108.693 178.936 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.55 -47.08 85.43 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.369 -0.832 . . . . 1.0 109.743 179.447 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.428 ' CZ ' ' CZ ' ' A' ' 121' ' ' PHE . 48.7 m-85 -67.68 -39.98 84.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.063 -1.023 . . . . 1.0 109.742 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -59.95 -45.58 92.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.163 -0.96 . . . . 1.0 109.618 -179.085 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.5 t -60.01 -45.53 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.328 -0.858 . . . . 1.0 109.913 -179.42 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 76.8 m95 -76.71 -35.23 57.97 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.075 -1.015 . . . . 1.0 109.995 -179.54 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 62.9 p -71.62 -19.6 62.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.075 -1.016 . . . . 1.0 109.873 -179.771 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -60.0 -39.22 85.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.252 -0.905 . . . . 1.0 110.562 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.9 m -110.5 -22.96 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.249 -0.907 . . . . 1.0 110.62 -178.592 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.418 ' C ' ' H ' ' A' ' 48' ' ' LEU . 56.1 p -95.73 130.4 31.84 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 120.888 -1.132 . . . . 1.0 110.108 -179.623 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -72.32 18.48 0.33 Allowed 'Trans proline' 0 N--CA 1.492 1.4 0 CA-C-N 119.873 0.99 . . . . 1.0 111.463 178.621 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.418 ' H ' ' C ' ' A' ' 46' ' ' THR . 77.4 mt -69.3 138.7 54.04 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.207 -0.933 . . . . 1.0 109.602 -179.47 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -109.26 121.88 46.12 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 179.532 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -107.13 128.93 54.83 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.369 -0.832 . . . . 1.0 109.359 -179.269 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 90.2 m -121.88 130.26 53.22 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.524 -0.735 . . . . 1.0 109.961 -179.526 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -80.14 130.05 34.95 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.236 -0.915 . . . . 1.0 109.163 179.656 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.499 ' O ' ' NH1' ' A' ' 18' ' ' ARG . 94.3 mt -102.53 132.42 48.6 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.165 -0.959 . . . . 1.0 109.415 179.331 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.491 ' C ' HH12 ' A' ' 18' ' ' ARG . 23.9 m-70 -68.83 -39.91 79.74 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.662 -0.649 . . . . 1.0 110.206 -179.702 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.484 ' C ' ' NH2' ' A' ' 18' ' ' ARG . 74.1 m-20 -150.09 166.75 28.84 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.115 -0.99 . . . . 1.0 109.992 -179.565 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.544 ' O ' ' NE ' ' A' ' 18' ' ' ARG . . . 99.95 -176.42 28.27 Favored Glycine 0 N--CA 1.498 2.825 0 N-CA-C 109.53 -1.428 . . . . 1.0 109.53 -179.696 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.4 mt -95.5 135.25 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.192 -1.181 . . . . 1.0 109.261 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.04 158.94 18.25 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.436 -0.79 . . . . 1.0 109.284 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -59.99 -49.57 77.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.2 -0.937 . . . . 1.0 109.51 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 92.5 mt -108.35 98.47 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.434 -0.791 . . . . 1.0 109.698 179.634 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.5 ptm -97.96 126.07 43.19 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.487 -0.931 . . . . 1.0 108.487 179.134 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.8 mt -104.84 136.84 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.455 -0.778 . . . . 1.0 110.58 -178.509 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.1 p -153.68 160.03 42.22 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.398 -0.814 . . . . 1.0 109.548 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -102.13 122.28 43.84 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.605 -0.887 . . . . 1.0 108.605 179.486 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 98' ' ' PHE . . . -99.76 -172.76 30.51 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 110.822 -0.911 . . . . 1.0 110.822 -178.677 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 73.4 mt . . . . . 0 N--CA 1.497 1.883 0 O-C-N 121.784 -0.833 . . . . 1.0 109.043 179.935 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.533 ' CE2' ' OD1' ' A' ' 99' ' ' ASP . 40.6 m-85 . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 109.305 -0.628 . . . . 1.0 109.305 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 79' ' ' SER . 34.5 p-10 -101.05 10.65 40.79 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.352 -0.842 . . . . 1.0 110.474 -179.288 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 114.96 -155.61 16.22 Favored Glycine 0 N--CA 1.504 3.188 0 N-CA-C 109.092 -1.603 . . . . 1.0 109.092 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.424 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 15.8 Cg_exo -56.64 -64.12 0.14 Allowed 'Trans proline' 0 N--CA 1.492 1.403 0 CA-C-N 118.827 1.314 . . . . 1.0 112.308 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.43 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 83.9 p -75.0 159.03 32.26 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.896 -1.128 . . . . 1.0 109.384 179.715 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.03 -129.67 8.22 Favored Glycine 0 N--CA 1.502 3.045 0 N-CA-C 110.218 -1.153 . . . . 1.0 110.218 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.401 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 19.0 mt -70.19 112.72 6.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.351 -1.087 . . . . 1.0 109.406 -179.584 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 38.1 mt -79.22 -24.54 43.02 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.155 -0.966 . . . . 1.0 108.703 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -177.07 170.68 2.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.531 -0.731 . . . . 1.0 109.412 -179.733 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -162.41 163.33 27.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.104 -0.997 . . . . 1.0 109.968 179.676 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -147.2 153.48 39.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.385 -0.822 . . . . 1.0 109.071 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -88.44 152.67 50.07 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.151 -0.968 . . . . 1.0 109.23 -179.607 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -53.5 162.58 3.2 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 CA-C-N 119.214 0.755 . . . . 1.0 111.716 179.583 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo . . . . . 0 N--CA 1.49 1.28 0 C-N-CA 121.12 1.213 . . . . 1.0 111.942 179.68 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.2 p-10 . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 109.409 -0.589 . . . . 1.0 109.409 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.08 120.72 7.49 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.019 -1.051 . . . . 1.0 110.014 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -106.06 154.03 21.22 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.58 -0.7 . . . . 1.0 109.633 179.772 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' A' ' 65' ' ' GLY . 28.0 m-85 -129.94 152.01 49.87 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.289 -1.004 . . . . 1.0 108.289 179.177 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.533 ' OD1' ' CE2' ' A' ' 75' ' ' PHE . 86.5 m-20 -78.5 120.81 23.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.913 -1.117 . . . . 1.0 109.987 -179.63 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -84.06 -7.85 59.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.311 -0.868 . . . . 1.0 109.056 179.286 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -82.63 -15.93 50.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.3 -0.875 . . . . 1.0 109.178 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.424 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 97.2 mt-10 -89.88 169.92 10.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.502 -0.749 . . . . 1.0 109.07 -179.727 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 16.9 m -99.23 108.5 21.09 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.26 -0.9 . . . . 1.0 109.286 -179.555 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.491 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 93.7 m95 -91.08 125.14 35.78 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.705 -0.85 . . . . 1.0 108.705 179.505 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.665 HG21 ' HB2' ' A' ' 109' ' ' LYS . 7.3 t -140.16 151.17 45.04 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.376 -0.828 . . . . 1.0 109.885 -179.156 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 55.7 m -90.25 -8.23 51.51 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.074 -1.084 . . . . 1.0 108.074 178.937 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.1 p -90.65 177.27 6.39 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.625 -0.879 . . . . 1.0 108.625 178.875 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 m -81.09 76.53 8.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.981 -1.074 . . . . 1.0 109.628 -179.853 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.665 ' HB2' HG21 ' A' ' 105' ' ' THR . 98.5 mttt -147.03 149.67 33.57 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.367 -0.833 . . . . 1.0 108.884 179.585 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.31 -135.88 7.38 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.935 -1.266 . . . . 1.0 109.935 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -100.11 118.22 36.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.413 -1.051 . . . . 1.0 109.143 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -66.58 129.09 38.69 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.365 -0.835 . . . . 1.0 110.294 -179.567 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.6 tp -60.02 -40.66 90.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.357 -0.84 . . . . 1.0 109.875 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -59.96 -47.76 84.47 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.416 -0.802 . . . . 1.0 110.587 -178.893 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -58.66 -50.63 73.16 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.854 -1.154 . . . . 1.0 109.761 -179.612 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 77.9 t -69.1 -40.11 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.918 -1.114 . . . . 1.0 109.668 -179.22 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.99 -50.26 74.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.098 -1.001 . . . . 1.0 109.976 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.78 -37.84 80.2 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.564 -1.335 . . . . 1.0 109.521 -179.835 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.487 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 67.1 t60 -63.8 -49.98 70.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.316 -0.865 . . . . 1.0 111.624 -178.594 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.84 -38.55 78.97 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.512 -1.367 . . . . 1.0 109.723 -178.735 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.428 ' CZ ' ' CZ ' ' A' ' 39' ' ' PHE . 29.9 m-85 -60.02 -39.86 87.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.92 -1.112 . . . . 1.0 108.535 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.55 -46.83 91.6 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.69 -1.364 . . . . 1.0 109.69 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.487 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 81.8 m-70 -63.94 -40.08 95.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.13 -1.217 . . . . 1.0 109.449 179.66 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 91.9 p -68.49 -22.73 64.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.277 -0.89 . . . . 1.0 109.571 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 35.7 mt -81.68 -7.03 59.55 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.103 -0.998 . . . . 1.0 109.472 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 99.54 2.74 56.47 Favored Glycine 0 N--CA 1.499 2.887 0 N-CA-C 110.674 -0.971 . . . . 1.0 110.674 178.996 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 75.2 mt -85.11 147.23 26.74 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.947 -1.325 . . . . 1.0 109.775 179.653 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 35.5 t0 -102.96 -178.73 3.75 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.86 -0.792 . . . . 1.0 108.86 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.499 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 75.9 m80 -60.1 139.99 57.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.088 -1.008 . . . . 1.0 109.764 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 27.2 t -96.21 162.05 13.69 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.242 -0.912 . . . . 1.0 109.244 179.513 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -101.11 1.92 39.77 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.344 -0.848 . . . . 1.0 109.857 -179.692 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -90.52 114.14 60.14 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.212 -0.93 . . . . 1.0 109.206 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -53.77 -22.75 24.29 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 CA-C-N 120.27 1.132 . . . . 1.0 112.216 -179.796 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -86.8 -7.68 77.78 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.49 -1.044 . . . . 1.0 110.49 -179.306 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.44 149.42 26.67 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.985 -1.303 . . . . 1.0 109.576 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 92.9 mt -70.07 -30.97 68.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.142 -0.974 . . . . 1.0 109.473 179.69 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 98.0 mmm -73.42 13.56 0.44 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.368 -0.833 . . . . 1.0 110.396 -178.952 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -70.37 134.61 86.8 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.964 -1.085 . . . . 1.0 108.114 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -65.35 15.42 0.09 OUTLIER 'Trans proline' 0 N--CA 1.506 2.229 0 C-N-CA 121.065 1.177 . . . . 1.0 115.048 -177.785 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 90.0 mt -133.69 140.49 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 O-C-N 120.73 -1.231 . . . . 1.0 109.609 179.453 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -72.87 130.67 40.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.517 -0.739 . . . . 1.0 110.046 -179.25 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.2 t -143.15 137.63 29.2 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.322 -0.861 . . . . 1.0 109.479 179.777 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -81.41 143.98 31.75 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.081 -1.012 . . . . 1.0 109.18 179.785 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.7 t -139.11 156.53 47.09 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.208 -0.932 . . . . 1.0 110.117 -179.362 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.38 108.87 2.63 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.409 -1.476 . . . . 1.0 109.409 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -77.11 2.8 14.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.325 -1.103 . . . . 1.0 109.44 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 44.2 t -59.97 -45.01 94.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.228 -0.92 . . . . 1.0 110.149 -179.445 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -150.01 29.97 0.72 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.965 -1.084 . . . . 1.0 110.134 -179.536 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -60.44 139.17 57.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.054 -1.029 . . . . 1.0 109.647 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 73.7 mtm -138.55 148.5 44.28 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.353 -0.842 . . . . 1.0 108.762 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.7 mt -53.84 129.68 56.34 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 120.987 -1.071 . . . . 1.0 108.612 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -68.94 175.36 7.52 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 CA-C-N 120.112 1.076 . . . . 1.0 111.715 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.04 -38.78 83.76 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.344 -0.848 . . . . 1.0 109.48 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -55.07 -50.21 69.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.879 . . . . 1.0 110.057 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -70.2 -39.97 74.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.184 -0.947 . . . . 1.0 110.28 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 66.5 t -59.87 -47.02 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.006 -1.059 . . . . 1.0 109.035 -179.467 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -60.53 -40.07 90.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.055 -1.028 . . . . 1.0 110.463 179.772 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -73.82 -52.42 8.16 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.328 -0.939 . . . . 1.0 111.49 -178.465 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.454 HG23 ' N ' ' A' ' 160' ' ' GLN . 8.4 tp -60.49 -39.93 82.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.637 -1.508 . . . . 1.0 109.705 -178.956 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.8 mt-30 -66.37 -38.81 88.42 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.198 -0.939 . . . . 1.0 109.58 179.503 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 96.6 p -60.06 -34.94 74.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.394 -0.816 . . . . 1.0 110.686 -179.021 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 93.3 mt -85.17 -47.59 9.97 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.857 -1.152 . . . . 1.0 111.027 -178.814 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -91.68 -8.46 47.0 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.894 -1.129 . . . . 1.0 110.176 -179.007 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.404 -1.479 . . . . 1.0 109.404 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.6 mt . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -160.09 163.24 34.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.255 -0.903 . . . . 1.0 109.628 -179.594 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -70.9 144.43 50.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -0.907 . . . . 1.0 109.439 -179.828 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.8 t -95.91 14.25 24.12 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.289 -0.882 . . . . 1.0 109.434 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.51 149.62 37.75 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.236 -0.915 . . . . 1.0 109.438 -179.764 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.3 mmt -91.71 -2.95 56.79 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.33 -0.856 . . . . 1.0 109.731 -179.634 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -101.59 125.63 48.27 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.295 -0.878 . . . . 1.0 109.362 179.767 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.7 mt -140.48 149.35 42.41 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.246 -0.909 . . . . 1.0 109.16 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.1 p -131.77 153.86 49.67 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.875 -0.787 . . . . 1.0 108.875 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -143.11 158.46 43.59 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.145 -0.972 . . . . 1.0 110.385 179.877 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.577 HH12 ' H ' ' A' ' 56' ' ' GLY . 72.1 ttt180 -146.55 134.97 21.94 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.469 -0.769 . . . . 1.0 109.59 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.9 mt -89.89 118.92 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.112 -0.992 . . . . 1.0 108.963 179.008 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.67 -40.58 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.091 -1.006 . . . . 1.0 109.107 -179.801 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -162.11 162.22 28.5 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.667 -1.27 . . . . 1.0 110.26 -179.184 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -103.25 -162.92 0.95 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.521 -1.288 . . . . 1.0 107.521 178.978 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.74 152.04 61.54 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.459 -0.775 . . . . 1.0 109.744 -179.708 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -68.1 -35.99 18.33 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 120.923 1.082 . . . . 1.0 111.512 179.271 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -59.01 -48.6 81.01 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.359 0.599 . . . . 1.0 110.756 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 56.2 mtp -96.29 145.99 25.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.373 -0.829 . . . . 1.0 110.47 -178.435 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.1 p -74.93 160.85 30.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.889 . . . . 1.0 108.783 179.361 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -61.23 -46.2 91.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.219 -0.925 . . . . 1.0 110.777 -179.146 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.8 m -62.2 -40.03 94.74 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.024 -1.047 . . . . 1.0 110.89 -178.988 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.55 -40.08 88.86 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.106 -0.996 . . . . 1.0 110.947 -179.156 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 71.3 t -68.49 -40.53 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.834 -1.166 . . . . 1.0 110.318 -179.173 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.97 -49.8 76.25 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.042 -1.036 . . . . 1.0 110.564 -179.134 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.19 -32.72 72.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.058 -1.026 . . . . 1.0 110.089 -179.502 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.03 -49.94 75.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.114 -0.991 . . . . 1.0 110.045 -179.447 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -66.4 -37.32 84.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.021 -1.05 . . . . 1.0 110.062 -179.719 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -59.97 -40.56 89.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.974 -1.079 . . . . 1.0 109.533 -179.68 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -61.95 -40.65 96.28 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.949 -1.094 . . . . 1.0 108.88 179.227 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.44 -49.75 76.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.377 -0.827 . . . . 1.0 110.528 -179.285 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.414 ' CZ ' ' CZ ' ' A' ' 121' ' ' PHE . 53.8 m-85 -65.27 -40.53 94.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.985 -1.072 . . . . 1.0 109.962 -179.262 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -59.99 -47.42 85.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.107 -0.995 . . . . 1.0 109.7 -179.579 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 70.8 t -59.99 -40.51 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.339 -0.851 . . . . 1.0 110.426 -179.394 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -79.87 -34.57 39.12 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.911 -1.118 . . . . 1.0 110.202 -179.236 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 94.8 p -72.82 -20.62 61.11 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.966 -1.083 . . . . 1.0 109.916 -179.761 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -59.99 -39.74 86.79 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 1.0 110.342 -179.36 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.4 m -111.81 30.72 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 O-C-N 121.264 -0.897 . . . . 1.0 110.69 -179.474 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.7 p -152.21 137.95 11.4 Favored Pre-proline 0 N--CA 1.502 2.14 0 O-C-N 120.607 -1.308 . . . . 1.0 109.756 179.015 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -74.72 11.83 1.28 Allowed 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 120.746 0.964 . . . . 1.0 112.285 178.686 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 77.9 mt -67.95 137.69 55.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.031 -1.043 . . . . 1.0 109.655 -179.095 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -106.93 120.7 42.74 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.028 -0.73 . . . . 1.0 109.028 179.664 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -108.25 123.33 48.61 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.446 -0.784 . . . . 1.0 109.238 -179.545 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.9 m -120.01 130.03 54.54 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.579 -0.701 . . . . 1.0 109.492 -179.795 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -82.12 132.55 35.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.438 -0.789 . . . . 1.0 109.406 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.3 mt -105.13 128.45 53.38 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.413 -0.804 . . . . 1.0 109.488 179.813 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.417 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 61.7 m170 -68.56 -39.74 80.9 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.481 -0.762 . . . . 1.0 109.347 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 89.4 m-20 -142.84 166.92 23.33 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.294 -0.879 . . . . 1.0 109.328 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.577 ' H ' HH12 ' A' ' 18' ' ' ARG . . . 97.24 172.4 33.91 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.646 -1.381 . . . . 1.0 109.646 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 93.5 mt -95.09 139.23 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.284 -1.127 . . . . 1.0 109.242 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -114.2 164.3 14.07 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.441 -0.787 . . . . 1.0 109.598 -179.634 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -59.94 -47.85 84.09 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.475 -0.935 . . . . 1.0 108.475 179.413 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.3 mt -105.27 133.84 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.697 -0.853 . . . . 1.0 108.697 179.697 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.2 ptm -139.31 129.79 25.71 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.63 -1.294 . . . . 1.0 109.491 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 93.5 mt -102.5 140.2 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.351 0.596 . . . . 1.0 109.958 -179.067 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 81.6 p -151.46 154.75 37.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.318 -0.864 . . . . 1.0 109.623 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -109.18 144.09 37.73 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.048 -0.723 . . . . 1.0 109.048 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.81 -162.82 9.73 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.457 -1.457 . . . . 1.0 109.457 -179.845 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 92.6 mt . . . . . 0 N--CA 1.497 1.902 0 O-C-N 121.583 -0.951 . . . . 1.0 109.247 -179.933 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.554 ' CD2' ' OD2' ' A' ' 99' ' ' ASP . 94.6 m-85 . . . . . 0 N--CA 1.495 1.787 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -99.56 -1.01 39.33 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.203 -0.935 . . . . 1.0 110.758 -178.981 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.55 -138.04 9.8 Favored Glycine 0 N--CA 1.503 3.114 0 N-CA-C 108.816 -1.714 . . . . 1.0 108.816 -179.729 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.427 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 18.6 Cg_endo -77.67 -58.42 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.376 0 CA-C-N 119.872 1.836 . . . . 1.0 111.932 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 92.2 p -79.42 167.45 20.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.341 -0.849 . . . . 1.0 109.566 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 105.76 -129.33 9.74 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 109.882 -1.287 . . . . 1.0 109.882 179.715 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.43 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 8.3 mt -67.06 105.91 1.8 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.391 -1.064 . . . . 1.0 108.939 -179.781 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.411 HD11 ' CD1' ' A' ' 111' ' ' TYR . 71.9 mt -80.66 -14.25 58.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.114 -0.992 . . . . 1.0 109.027 -179.672 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.93 177.51 0.66 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.468 ' ND1' ' C ' ' A' ' 84' ' ' HIS . 3.2 p80 -161.89 160.61 28.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.101 -1.0 . . . . 1.0 109.508 179.341 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.31 165.02 34.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.884 . . . . 1.0 109.423 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -108.04 151.96 41.54 Favored Pre-proline 0 N--CA 1.498 1.962 0 N-CA-C 108.494 -0.928 . . . . 1.0 108.494 179.576 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -62.52 165.76 14.85 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 120.643 0.895 . . . . 1.0 111.675 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo . . . . . 0 C--N 1.314 -1.263 0 C-N-CA 120.85 1.033 . . . . 1.0 111.371 179.967 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 31.6 p-10 . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 108.982 -0.747 . . . . 1.0 108.982 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.95 120.96 8.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.151 -0.968 . . . . 1.0 109.78 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -104.29 139.83 38.73 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.566 -0.709 . . . . 1.0 110.069 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.476 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 25.8 m-85 -119.95 139.93 51.7 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.483 -0.761 . . . . 1.0 108.976 179.081 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.554 ' OD2' ' CD2' ' A' ' 75' ' ' PHE . 99.0 m-20 -79.98 126.19 30.72 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.915 -1.116 . . . . 1.0 109.787 179.907 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 49.1 t0 -87.75 0.94 55.07 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.306 -0.871 . . . . 1.0 109.844 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -81.34 -16.52 52.13 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.934 -1.104 . . . . 1.0 110.246 -179.428 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.545 ' OE1' ' N ' ' A' ' 102' ' ' GLU . 56.6 mp0 -93.02 174.99 6.95 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.183 -0.948 . . . . 1.0 109.445 -179.769 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 27.6 m -99.43 107.49 19.73 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.341 -0.849 . . . . 1.0 109.051 179.921 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -87.32 123.08 31.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 1.0 108.987 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.671 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.1 t -141.75 159.09 42.93 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.335 -0.853 . . . . 1.0 109.931 -179.192 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 44.3 t -96.03 -9.76 30.17 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.288 -1.005 . . . . 1.0 108.288 178.91 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 94.6 p -90.64 178.04 6.18 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.007 -0.738 . . . . 1.0 109.007 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.2 t -78.81 74.01 5.35 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.137 -0.977 . . . . 1.0 109.678 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.671 ' HB2' HG21 ' A' ' 105' ' ' THR . 98.4 mttt -146.66 148.69 32.31 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.463 -0.94 . . . . 1.0 108.463 179.093 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 46.28 -139.91 6.57 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.89 -1.284 . . . . 1.0 109.89 179.927 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.411 ' CD1' HD11 ' A' ' 82' ' ' LEU . 93.1 m-85 -100.0 116.35 31.84 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.323 -1.104 . . . . 1.0 109.173 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.43 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 2.2 t-20 -63.54 133.91 54.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.11 -0.994 . . . . 1.0 109.842 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.3 tp -59.98 -44.03 94.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.464 -0.772 . . . . 1.0 110.436 -179.744 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -60.04 -40.02 87.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.108 -0.995 . . . . 1.0 110.357 -178.733 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -59.48 -51.43 69.93 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.711 -1.243 . . . . 1.0 109.543 -179.702 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.6 t -69.95 -42.63 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.961 -1.087 . . . . 1.0 110.087 -179.174 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.43 -52.15 66.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.933 . . . . 1.0 109.764 -179.331 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.69 -38.09 80.58 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.414 -0.804 . . . . 1.0 110.343 -179.613 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.621 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 66.7 t60 -63.41 -50.1 71.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -0.927 . . . . 1.0 111.2 -178.401 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.476 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 8.2 pt-20 -59.97 -39.79 86.86 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.691 -1.256 . . . . 1.0 110.298 -179.233 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.414 ' CZ ' ' CZ ' ' A' ' 39' ' ' PHE . 30.9 m-85 -60.03 -39.96 87.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.78 -1.2 . . . . 1.0 108.95 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.81 -42.35 94.49 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.648 -1.381 . . . . 1.0 109.648 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.621 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 88.0 m-70 -66.01 -39.78 90.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.99 -1.3 . . . . 1.0 109.033 179.394 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 80.6 p -64.56 -23.98 67.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.345 -0.847 . . . . 1.0 109.462 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.2 mt -82.56 -1.84 51.87 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.132 -0.98 . . . . 1.0 109.577 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.05 10.21 64.73 Favored Glycine 0 N--CA 1.497 2.728 0 C-N-CA 120.304 -0.951 . . . . 1.0 110.812 179.191 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.5 mt -85.38 146.97 26.74 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.899 -1.354 . . . . 1.0 109.682 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 12.3 t70 -99.69 172.47 7.25 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.479 -0.763 . . . . 1.0 109.22 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.46 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 66.2 m80 -59.99 139.48 57.4 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.182 -0.949 . . . . 1.0 109.66 -179.534 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 34.1 t -98.76 152.97 19.11 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.346 -0.846 . . . . 1.0 109.407 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -96.67 -0.02 49.05 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.208 -0.933 . . . . 1.0 109.683 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -85.24 130.49 51.64 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.057 -1.027 . . . . 1.0 108.237 179.227 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -68.48 -21.37 40.38 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 CA-C-N 120.121 1.079 . . . . 1.0 112.147 -179.457 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -86.1 -4.83 83.86 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.942 -1.263 . . . . 1.0 109.942 -179.704 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -87.33 145.1 26.47 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.127 -1.219 . . . . 1.0 109.534 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.427 ' C ' ' H ' ' A' ' 138' ' ' PHE . 91.6 mt -70.0 -31.06 68.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.087 -1.008 . . . . 1.0 108.975 179.643 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.3 mmm -73.0 19.14 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.441 -0.787 . . . . 1.0 110.201 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.427 ' H ' ' C ' ' A' ' 136' ' ' LEU . 16.0 t80 -70.0 131.7 88.9 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 120.914 -1.116 . . . . 1.0 108.087 179.866 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -63.9 0.48 2.02 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 121.012 1.142 . . . . 1.0 114.536 -177.864 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 95.7 mt -123.19 139.45 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 120.935 -1.103 . . . . 1.0 109.321 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' TYR . . . . . 0.43 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 58.8 t80 -73.1 125.03 26.72 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.288 -0.882 . . . . 1.0 109.896 -179.396 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.9 t -138.2 140.05 39.58 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.719 -0.845 . . . . 1.0 108.719 179.388 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -81.25 130.5 35.05 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.081 -1.012 . . . . 1.0 109.921 -179.763 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.7 m -118.91 137.07 53.71 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.97 -0.752 . . . . 1.0 108.97 179.832 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -62.12 103.04 0.53 Allowed Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.121 -1.992 . . . . 1.0 108.121 178.841 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -72.64 114.62 10.97 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.19 -1.182 . . . . 1.0 108.728 -179.241 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.4 p -178.37 109.18 0.05 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.377 -0.972 . . . . 1.0 108.377 -179.694 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 49.99 39.88 19.87 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.046 -1.034 . . . . 1.0 108.752 -179.249 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -88.39 119.18 28.57 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.363 -0.836 . . . . 1.0 109.398 -179.699 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 97.3 mtp -110.17 148.29 32.08 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.343 -0.984 . . . . 1.0 108.343 179.368 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.7 mt -52.46 136.86 41.84 Favored Pre-proline 0 C--N 1.3 -1.552 0 O-C-N 121.158 -0.964 . . . . 1.0 109.214 -179.514 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -68.78 174.23 8.93 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 CA-C-N 119.569 0.882 . . . . 1.0 112.177 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -60.36 -39.99 89.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.498 -0.752 . . . . 1.0 109.951 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -55.09 -49.35 71.91 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.123 -0.986 . . . . 1.0 109.852 -179.347 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.12 -40.01 75.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.244 -0.91 . . . . 1.0 110.214 -179.688 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.8 t -59.99 -46.47 94.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.163 -0.961 . . . . 1.0 109.067 -179.661 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -61.58 -40.01 93.25 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.083 -1.01 . . . . 1.0 110.075 179.71 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.39 -53.38 13.45 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 120.312 -0.947 . . . . 1.0 111.468 -178.483 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.494 HG23 ' N ' ' A' ' 160' ' ' GLN . 6.0 tp -60.73 -39.98 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.835 -1.391 . . . . 1.0 109.778 -178.818 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.544 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.3 mt-30 -66.07 -39.98 90.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.115 -0.991 . . . . 1.0 109.51 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 86.2 p -61.24 -30.37 70.41 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.175 -0.953 . . . . 1.0 110.263 -179.642 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 85.5 mt -86.69 -51.8 5.91 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.001 -1.062 . . . . 1.0 110.656 -179.025 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -91.85 -9.23 44.11 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.067 -1.02 . . . . 1.0 110.312 -178.931 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.511 0 N-CA-C 109.457 -1.457 . . . . 1.0 109.457 -179.922 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.0 mt . . . . . 0 N--CA 1.494 1.726 0 N-CA-C 109.412 -0.588 . . . . 1.0 109.412 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.9 pttt -162.7 163.35 26.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.284 -0.885 . . . . 1.0 109.301 179.671 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -70.21 149.56 47.36 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.113 -0.992 . . . . 1.0 109.566 -179.51 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 98.3 p -90.03 1.19 56.6 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.29 -0.881 . . . . 1.0 109.757 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -146.92 154.86 41.78 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.074 -1.016 . . . . 1.0 110.039 -179.6 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.549 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.5 0.37 57.35 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.382 -0.824 . . . . 1.0 109.713 -179.81 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -93.93 125.09 38.35 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.152 -0.968 . . . . 1.0 109.203 -179.747 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.5 mt -142.27 150.23 40.6 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.355 -0.841 . . . . 1.0 108.982 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.9 p -130.75 153.12 49.36 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.411 -0.959 . . . . 1.0 108.411 179.643 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -145.11 159.99 42.12 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.059 -1.026 . . . . 1.0 109.902 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.494 ' NH1' ' O ' ' A' ' 56' ' ' GLY . 43.3 ttp180 -144.75 139.18 27.69 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.604 -0.685 . . . . 1.0 109.316 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.8 mm -88.15 118.45 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.266 -1.013 . . . . 1.0 108.266 179.212 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.3 t -69.79 -39.95 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.131 -0.981 . . . . 1.0 108.985 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.678 HD21 ' H ' ' A' ' 64' ' ' PHE . 15.2 p30 -160.71 153.8 21.51 Favored 'General case' 0 C--N 1.287 -2.124 0 O-C-N 120.028 -1.67 . . . . 1.0 110.697 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -97.02 101.28 12.82 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 104.895 -2.261 . . . . 1.0 104.895 177.091 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.559 ' O ' ' N ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -55.33 116.55 11.96 Favored Pre-proline 0 C--N 1.299 -1.598 0 C-N-CA 118.849 -1.141 . . . . 1.0 108.408 -177.588 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -50.23 -1.17 0.04 OUTLIER 'Trans proline' 0 N--CA 1.486 1.055 0 CA-C-N 119.804 0.966 . . . . 1.0 112.447 -179.592 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.559 ' N ' ' O ' ' A' ' 23' ' ' THR . 87.0 m-20 -60.1 -18.5 47.6 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 118.826 -1.149 . . . . 1.0 108.065 178.455 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 76.2 mtm -147.99 163.84 35.61 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.617 -0.883 . . . . 1.0 108.617 179.281 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.0 p -73.23 157.36 37.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.17 -0.956 . . . . 1.0 109.123 179.735 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -60.68 -40.09 90.87 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.293 -0.879 . . . . 1.0 109.964 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 63.6 m -60.29 -41.96 94.46 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.206 -0.934 . . . . 1.0 109.616 -179.405 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.32 -40.15 85.92 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.446 -0.784 . . . . 1.0 110.397 179.737 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 70.7 t -67.4 -44.98 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 1.0 110.708 -179.02 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.87 -48.12 82.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.134 -0.979 . . . . 1.0 110.388 -178.362 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -62.47 -32.86 73.81 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.884 -1.135 . . . . 1.0 110.285 -179.783 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.408 ' CB ' HD23 ' A' ' 113' ' ' LEU . . . -60.01 -49.72 76.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.015 -1.053 . . . . 1.0 110.072 -179.274 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.433 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 53.7 m-85 -68.63 -40.01 80.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.968 -1.083 . . . . 1.0 109.805 -179.648 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.3 mmtt -60.04 -44.87 94.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.019 -1.051 . . . . 1.0 109.642 -179.468 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -60.12 -40.26 89.11 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.149 -0.97 . . . . 1.0 109.219 179.726 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.17 -45.36 93.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.528 -0.732 . . . . 1.0 109.642 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -66.15 -34.66 78.54 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.884 -1.135 . . . . 1.0 109.605 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.7 tptt -59.82 -52.59 64.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.168 -0.957 . . . . 1.0 110.166 -179.665 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.0 m -60.91 -39.86 83.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 O-C-N 120.895 -1.128 . . . . 1.0 110.556 -179.678 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -79.35 -38.34 35.33 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.99 -1.069 . . . . 1.0 110.161 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.3 p -71.68 -22.96 61.58 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.709 -1.244 . . . . 1.0 110.123 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -60.09 -40.02 88.14 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.193 -0.942 . . . . 1.0 111.104 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.6 m -111.42 25.12 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 O-C-N 121.211 -0.931 . . . . 1.0 111.122 -178.309 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.3 p -148.79 133.84 9.27 Favored Pre-proline 0 N--CA 1.501 2.122 0 O-C-N 120.701 -1.249 . . . . 1.0 109.617 179.495 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -72.37 17.49 0.35 Allowed 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 120.696 0.931 . . . . 1.0 111.902 179.335 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 75.3 mt -67.23 137.92 56.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.195 -0.941 . . . . 1.0 109.829 -179.273 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -108.29 121.42 44.87 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.095 -0.706 . . . . 1.0 109.095 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -109.57 127.65 54.64 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.488 -0.758 . . . . 1.0 109.264 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.7 m -119.99 129.95 54.52 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.482 0.658 . . . . 1.0 109.559 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -82.45 131.25 35.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.359 -0.838 . . . . 1.0 109.529 179.85 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.9 mt -105.94 128.85 54.07 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.274 -0.891 . . . . 1.0 109.514 179.639 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.41 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 17.5 m-70 -66.44 -40.08 89.26 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.436 -0.79 . . . . 1.0 109.839 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 68.0 m-20 -150.07 173.12 14.22 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.222 -0.924 . . . . 1.0 109.468 -179.709 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.494 ' O ' ' NH1' ' A' ' 18' ' ' ARG . . . 95.37 178.68 37.03 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.071 -1.612 . . . . 1.0 109.071 -179.723 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.5 mt -93.7 133.62 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.139 -1.213 . . . . 1.0 109.439 -179.679 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.68 158.26 18.26 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.483 -0.76 . . . . 1.0 109.167 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -59.72 -49.41 77.84 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.21 -0.931 . . . . 1.0 109.238 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 90.4 mt -105.77 99.74 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.335 -0.853 . . . . 1.0 109.875 179.562 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.7 ptp -99.21 134.77 41.59 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.146 -0.971 . . . . 1.0 109.145 179.048 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.433 HG21 ' CZ ' ' A' ' 35' ' ' PHE . 85.5 mt -109.93 132.33 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.655 -0.653 . . . . 1.0 109.462 -179.014 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.0 p -151.67 157.74 42.5 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.875 -1.141 . . . . 1.0 110.562 -179.775 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.678 ' H ' HD21 ' A' ' 21' ' ' ASN . 62.0 m-85 -109.62 120.79 43.58 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.55 -0.907 . . . . 1.0 108.55 179.28 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.28 -169.78 23.01 Favored Glycine 0 N--CA 1.499 2.87 0 N-CA-C 110.24 -1.144 . . . . 1.0 110.24 -179.515 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 87.4 mt . . . . . 0 N--CA 1.498 1.951 0 O-C-N 121.644 -0.915 . . . . 1.0 108.836 179.809 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.55 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 83.0 m-85 . . . . . 0 N--CA 1.493 1.675 0 N-CA-C 109.33 -0.619 . . . . 1.0 109.33 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.3 p-10 -101.01 3.96 41.97 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.35 -0.844 . . . . 1.0 110.961 -178.955 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 126.32 -151.61 18.03 Favored Glycine 0 N--CA 1.507 3.383 0 N-CA-C 108.911 -1.676 . . . . 1.0 108.911 -179.68 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -60.0 -66.21 0.07 OUTLIER 'Trans proline' 0 N--CA 1.492 1.438 0 CA-C-N 119.116 1.458 . . . . 1.0 112.02 179.617 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 91.7 p -76.82 161.89 28.09 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.183 -0.948 . . . . 1.0 109.525 179.811 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 117.48 -133.21 10.4 Favored Glycine 0 N--CA 1.501 3.002 0 N-CA-C 109.307 -1.517 . . . . 1.0 109.307 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.8 mt -70.16 111.55 5.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.088 -1.242 . . . . 1.0 108.456 179.541 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 38.3 mt -79.33 -17.48 54.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.963 -1.085 . . . . 1.0 108.806 -179.431 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 179.97 175.45 0.8 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.719 -0.845 . . . . 1.0 108.719 179.762 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -166.0 157.7 13.99 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.188 -0.945 . . . . 1.0 109.298 178.86 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -144.93 157.9 43.99 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -96.89 151.29 37.7 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 107.881 -1.155 . . . . 1.0 107.881 179.478 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -61.54 163.52 17.89 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 CA-C-N 119.324 0.794 . . . . 1.0 111.751 -179.32 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo . . . . . 0 C--N 1.314 -1.267 0 C-N-CA 121.113 1.208 . . . . 1.0 112.253 179.917 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.4 p-10 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.272 0.558 . . . . 1.0 109.707 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.61 124.42 9.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.234 -0.916 . . . . 1.0 109.529 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -112.91 147.59 36.74 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.592 -0.693 . . . . 1.0 109.937 -179.8 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -125.57 149.44 48.34 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 -179.839 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.55 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 84.7 m-20 -78.92 123.23 27.06 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.078 -1.014 . . . . 1.0 109.627 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -84.93 -7.73 59.04 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.233 -0.917 . . . . 1.0 109.275 179.577 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -83.5 -14.01 53.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.401 -0.812 . . . . 1.0 109.186 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -88.73 168.67 12.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.503 -0.748 . . . . 1.0 109.166 -179.579 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 30.9 m -99.94 106.08 17.85 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.209 -0.932 . . . . 1.0 109.214 -179.6 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -87.11 123.38 32.11 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.577 -0.897 . . . . 1.0 108.577 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.637 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.7 t -141.99 156.57 45.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.38 -0.825 . . . . 1.0 109.901 -178.892 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.7 t -96.8 -7.69 33.03 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.594 -0.891 . . . . 1.0 108.594 179.21 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 79.4 p -93.62 173.43 7.69 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.524 -0.735 . . . . 1.0 109.428 179.522 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.0 t -70.72 70.34 0.46 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 1.0 109.617 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.637 ' HB2' HG21 ' A' ' 105' ' ' THR . 44.6 mtpt -146.55 153.8 40.79 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.213 -0.93 . . . . 1.0 109.22 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 109' ' ' LYS . . . 41.89 -139.78 1.95 Allowed Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.037 -1.225 . . . . 1.0 110.037 179.494 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -101.0 119.12 38.28 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.33 -1.1 . . . . 1.0 108.943 179.524 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -63.88 132.19 50.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.177 -0.952 . . . . 1.0 109.796 -179.585 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.408 HD23 ' CB ' ' A' ' 34' ' ' ALA . 58.7 tp -59.88 -39.97 87.08 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.351 -0.843 . . . . 1.0 109.923 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -59.91 -41.05 90.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.218 -0.926 . . . . 1.0 110.261 -179.218 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -58.85 -57.92 10.89 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.829 -1.169 . . . . 1.0 110.294 -179.482 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.7 t -66.3 -41.12 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.402 -0.811 . . . . 1.0 109.964 -178.431 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.84 -51.66 68.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.966 -1.084 . . . . 1.0 109.192 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.548 ' HB1' HD13 ' A' ' 136' ' ' LEU . . . -60.06 -39.49 86.19 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.336 -0.852 . . . . 1.0 110.246 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.638 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 76.7 t60 -63.8 -49.86 71.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.894 . . . . 1.0 111.443 -178.194 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -59.95 -37.7 80.3 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.671 -1.268 . . . . 1.0 110.086 -179.046 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -60.15 -39.81 87.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.645 -1.284 . . . . 1.0 108.453 179.302 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -59.06 -40.38 95.51 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.246 -1.542 . . . . 1.0 109.246 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.638 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 80.7 m-70 -68.48 -39.99 81.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.043 -1.269 . . . . 1.0 108.832 179.192 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.1 p -65.76 -24.75 67.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.411 -0.806 . . . . 1.0 109.12 179.703 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 65.9 mt -81.86 -4.91 57.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.361 -0.837 . . . . 1.0 109.47 179.851 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 92.22 10.03 61.36 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.659 -0.976 . . . . 1.0 110.659 179.105 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.8 mt -85.21 147.91 26.36 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.871 -1.37 . . . . 1.0 109.671 179.933 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 44.1 t0 -100.63 175.46 5.65 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.476 -0.765 . . . . 1.0 108.97 -179.884 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.515 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 74.0 m80 -59.93 138.89 57.72 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.973 . . . . 1.0 109.72 -179.597 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 46.7 t -97.34 155.66 16.79 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.32 -0.863 . . . . 1.0 109.226 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -99.26 0.21 42.66 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.144 -0.973 . . . . 1.0 109.754 -179.893 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -85.32 130.4 51.82 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.306 -0.871 . . . . 1.0 108.695 179.85 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -68.1 -19.88 44.67 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 CA-C-N 120.136 1.084 . . . . 1.0 112.456 -179.668 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -91.2 -4.63 68.47 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 110.243 -1.143 . . . . 1.0 110.243 -179.558 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.86 145.63 27.1 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.014 -1.286 . . . . 1.0 109.31 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.548 HD13 ' HB1' ' A' ' 118' ' ' ALA . 70.3 mt -66.34 -38.63 88.08 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.911 -1.118 . . . . 1.0 110.01 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 94.5 mmm -69.97 19.84 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.315 -0.866 . . . . 1.0 110.585 -178.529 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.482 ' H ' ' C ' ' A' ' 136' ' ' LEU . 17.3 t80 -70.15 129.59 90.5 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 108.094 -1.076 . . . . 1.0 108.094 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -54.68 -10.98 2.85 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 CA-C-N 119.996 1.034 . . . . 1.0 114.079 -179.061 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.9 mt -113.93 140.63 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.512 0 O-C-N 120.891 -1.13 . . . . 1.0 110.664 -178.867 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 141' ' ' TYR . . . . . 0.433 ' CD1' ' C ' ' A' ' 141' ' ' TYR . 20.7 t80 -74.7 129.58 37.97 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.513 -0.742 . . . . 1.0 110.069 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.0 t -139.0 142.4 38.32 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.434 -0.792 . . . . 1.0 109.402 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -83.05 152.18 25.48 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.994 -1.066 . . . . 1.0 109.721 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.43 ' H ' ' NZ ' ' A' ' 146' ' ' LYS . 2.7 m -145.66 154.45 42.12 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.399 -0.813 . . . . 1.0 109.863 -179.771 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.92 103.93 1.55 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.312 -1.915 . . . . 1.0 108.312 178.633 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.43 ' NZ ' ' H ' ' A' ' 144' ' ' THR . 37.3 mmtm -77.3 12.49 1.49 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.212 -1.169 . . . . 1.0 110.095 -178.998 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 48.5 t -60.0 -39.96 87.58 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.032 -1.043 . . . . 1.0 108.633 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -160.01 69.81 0.42 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.355 -0.841 . . . . 1.0 109.071 179.053 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -97.7 139.74 33.13 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.308 -0.87 . . . . 1.0 110.498 -179.547 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 97.4 mmm -136.9 149.72 47.8 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.983 -1.118 . . . . 1.0 107.983 178.844 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.9 mt -53.57 131.13 54.84 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.058 -1.026 . . . . 1.0 109.566 -179.134 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -68.49 175.47 6.95 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 CA-C-N 119.835 0.977 . . . . 1.0 112.136 179.638 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -60.08 -39.9 87.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.514 -0.741 . . . . 1.0 110.027 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -57.19 -47.31 81.56 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.221 -0.925 . . . . 1.0 110.067 -179.146 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -69.86 -39.83 76.12 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.188 -0.945 . . . . 1.0 109.435 -179.751 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.28 -45.02 96.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.198 -0.939 . . . . 1.0 109.196 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -60.23 -39.72 87.66 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.926 -1.109 . . . . 1.0 109.748 179.519 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.71 -54.41 10.02 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 120.501 -0.857 . . . . 1.0 111.669 -178.471 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 160' ' ' GLN . 8.4 tp -60.03 -40.18 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.666 -1.491 . . . . 1.0 109.621 -178.728 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.546 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.7 mt-30 -65.54 -39.39 91.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.089 -1.007 . . . . 1.0 109.466 179.217 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 84.7 p -59.13 -30.91 68.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.055 -1.028 . . . . 1.0 110.032 -179.553 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 88.7 mt -86.92 -53.61 4.8 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.938 -1.101 . . . . 1.0 110.725 -179.147 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -91.92 -9.98 41.19 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.91 -1.119 . . . . 1.0 110.933 -178.727 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.597 0 N-CA-C 109.292 -1.523 . . . . 1.0 109.292 -179.633 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.0 mt . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 108.934 -0.765 . . . . 1.0 108.934 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -162.48 166.52 24.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 1.0 109.867 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -72.19 140.75 48.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.185 -0.947 . . . . 1.0 110.043 -179.398 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.3 t -89.99 0.02 57.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.406 -0.809 . . . . 1.0 109.722 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.538 ' NZ ' ' O ' ' A' ' 14' ' ' ASN . 20.7 pttp -141.98 154.21 44.86 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.185 -0.947 . . . . 1.0 109.622 -179.651 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.4 mmt -90.47 -0.13 57.54 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.363 -0.835 . . . . 1.0 110.203 -178.834 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.538 ' O ' ' NZ ' ' A' ' 12' ' ' LYS . 30.1 m120 -97.02 128.61 44.15 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.224 -0.922 . . . . 1.0 109.151 -179.844 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.4 mt -141.66 149.54 40.76 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.265 -0.897 . . . . 1.0 109.307 -179.824 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.5 p -132.11 154.11 49.8 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.004 -0.739 . . . . 1.0 109.004 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -144.58 159.1 43.35 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.11 -0.994 . . . . 1.0 110.193 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 56' ' ' GLY . 26.3 ttm-85 -145.4 132.11 19.98 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.592 -0.693 . . . . 1.0 109.864 -179.455 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 39.8 mm -87.88 112.72 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.335 -0.987 . . . . 1.0 108.335 178.734 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.5 t -69.95 -40.05 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.101 -0.999 . . . . 1.0 109.443 -179.418 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -162.17 156.97 22.5 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.777 -1.202 . . . . 1.0 110.152 -179.588 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.611 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 54.0 m-85 -96.91 -167.14 1.5 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.169 -1.419 . . . . 1.0 107.169 178.851 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.29 141.58 32.11 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.325 -0.859 . . . . 1.0 110.094 -179.439 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -66.89 -19.1 52.81 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 120.763 0.976 . . . . 1.0 110.365 178.83 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.43 -39.91 85.04 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.553 -0.749 . . . . 1.0 109.949 179.405 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 74.8 mtm -130.04 161.66 30.5 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.419 -0.801 . . . . 1.0 109.484 -179.43 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.0 p -70.79 158.26 36.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -0.911 . . . . 1.0 109.2 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.611 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 1.0 OUTLIER -60.73 -40.76 93.59 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.355 -0.841 . . . . 1.0 110.239 -179.169 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.539 ' O ' ' NZ ' ' A' ' 33' ' ' LYS . 73.8 m -59.94 -41.02 90.94 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.006 -1.059 . . . . 1.0 110.758 -179.455 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -64.61 -40.08 94.86 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.945 -1.097 . . . . 1.0 110.004 -179.629 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.4 t -67.28 -39.96 83.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.222 -0.924 . . . . 1.0 109.83 -179.71 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -60.04 -49.93 75.74 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.098 -1.001 . . . . 1.0 110.647 -178.878 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.539 ' NZ ' ' O ' ' A' ' 29' ' ' SER . 2.1 ptpp? -64.19 -30.34 71.41 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.131 -0.981 . . . . 1.0 109.911 -179.704 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.04 -48.87 79.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.064 -1.022 . . . . 1.0 109.669 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -67.15 -38.38 85.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.075 -1.015 . . . . 1.0 110.02 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -59.95 -42.66 94.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.008 -1.058 . . . . 1.0 109.657 -179.651 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -60.04 -43.71 95.14 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.027 -1.046 . . . . 1.0 109.02 179.355 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.06 -49.71 76.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.463 -0.773 . . . . 1.0 109.868 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -61.97 -39.97 93.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.265 -0.897 . . . . 1.0 109.291 -179.803 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -60.06 -50.0 75.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.212 -0.93 . . . . 1.0 109.197 -179.591 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 70.2 t -59.98 -40.73 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.249 -0.907 . . . . 1.0 109.869 -179.549 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -78.94 -37.77 38.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.026 -1.047 . . . . 1.0 109.861 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.3 p -69.97 -15.32 63.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.267 -0.895 . . . . 1.0 109.829 -179.726 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -59.98 -40.0 87.61 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.136 -0.978 . . . . 1.0 110.091 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.3 m -115.06 -17.71 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.437 -0.789 . . . . 1.0 111.191 -178.483 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.3 p -90.76 124.36 62.47 Favored Pre-proline 0 N--CA 1.501 2.078 0 O-C-N 120.463 -1.398 . . . . 1.0 109.416 179.926 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -73.69 15.47 0.56 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 CA-C-N 120.221 1.115 . . . . 1.0 111.434 178.88 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.5 mt -69.61 140.26 53.71 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.41 -0.806 . . . . 1.0 110.369 -179.299 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -102.33 121.63 42.66 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.798 -0.816 . . . . 1.0 108.798 179.198 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -107.09 125.79 51.52 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.288 -0.882 . . . . 1.0 109.768 -179.204 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.2 m -120.03 129.98 54.5 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.576 -0.702 . . . . 1.0 109.882 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -82.23 131.96 35.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.244 -0.91 . . . . 1.0 109.487 179.752 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.493 ' O ' ' NH1' ' A' ' 18' ' ' ARG . 90.3 mt -106.63 134.0 50.45 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.301 -0.874 . . . . 1.0 109.274 179.502 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.435 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 59.1 m170 -66.23 -39.98 89.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.388 -0.82 . . . . 1.0 109.874 -179.641 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.464 ' O ' ' NH2' ' A' ' 18' ' ' ARG . 69.0 m-20 -154.42 178.84 9.6 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.087 -1.008 . . . . 1.0 109.635 -179.77 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.538 ' O ' ' NE ' ' A' ' 18' ' ' ARG . . . 96.62 -168.26 25.04 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.642 -1.383 . . . . 1.0 109.642 -179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.7 mt -101.4 130.51 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.361 -1.082 . . . . 1.0 109.622 -179.813 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.45 154.73 26.53 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.422 -0.799 . . . . 1.0 109.447 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -60.01 -49.56 77.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.2 -0.938 . . . . 1.0 109.624 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.6 mt -104.11 94.99 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.334 -0.853 . . . . 1.0 109.608 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.3 ptm -100.73 127.39 47.17 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.208 -0.933 . . . . 1.0 109.61 179.754 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 87.2 mt -106.42 137.7 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.52 -0.738 . . . . 1.0 109.657 -179.643 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 66.3 p -152.69 161.92 41.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.224 -0.923 . . . . 1.0 109.71 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -109.97 149.98 29.15 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.531 -0.731 . . . . 1.0 109.329 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -143.71 -161.88 9.11 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.315 -1.514 . . . . 1.0 109.315 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.2 mt . . . . . 0 N--CA 1.498 1.952 0 O-C-N 121.344 -1.092 . . . . 1.0 109.269 -179.942 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 106.959 -1.497 . . . . 1.0 106.959 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.7 p-10 -106.09 20.0 19.64 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 120.927 -1.108 . . . . 1.0 110.934 -178.682 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.28 -150.38 18.11 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 109.493 -1.443 . . . . 1.0 109.493 179.608 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.442 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 8.8 Cg_exo -60.67 -62.72 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.524 0 CA-C-N 118.864 1.332 . . . . 1.0 112.896 -179.593 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 83.2 p -74.04 157.61 35.81 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.019 -1.051 . . . . 1.0 110.206 -179.268 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.65 -126.82 7.56 Favored Glycine 0 N--CA 1.502 3.075 0 N-CA-C 110.244 -1.142 . . . . 1.0 110.244 179.605 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.427 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 15.3 mt -69.75 102.73 1.98 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.43 -1.041 . . . . 1.0 109.3 -179.702 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 41.3 mt -75.67 -24.44 56.33 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.881 -1.137 . . . . 1.0 108.57 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.4 172.22 1.2 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.702 -0.851 . . . . 1.0 108.702 -179.963 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.497 ' ND1' ' C ' ' A' ' 84' ' ' HIS . 2.8 p80 -161.61 171.41 18.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.128 -0.983 . . . . 1.0 109.238 178.938 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.41 160.91 43.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.172 -0.955 . . . . 1.0 109.467 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -101.32 154.33 37.27 Favored Pre-proline 0 N--CA 1.496 1.862 0 N-CA-C 108.367 -0.975 . . . . 1.0 108.367 179.687 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.87 168.64 0.76 Allowed 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 120.738 0.959 . . . . 1.0 111.588 179.68 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo . . . . . 0 C--N 1.312 -1.383 0 C-N-CA 120.862 1.041 . . . . 1.0 111.441 179.931 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.239 0.542 . . . . 1.0 109.66 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.05 124.53 9.64 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.159 -0.963 . . . . 1.0 109.848 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -107.05 131.01 54.57 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.483 -0.761 . . . . 1.0 109.529 179.75 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.494 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 38.4 m-85 -114.28 144.18 43.66 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.504 -0.748 . . . . 1.0 109.028 179.588 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.427 ' OD2' ' O ' ' A' ' 81' ' ' LEU . 91.7 m-20 -78.95 124.23 28.05 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.934 -1.104 . . . . 1.0 109.926 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 55.7 t0 -85.45 -6.77 59.17 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.211 -0.93 . . . . 1.0 109.233 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -81.9 -14.94 55.48 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.097 -1.002 . . . . 1.0 109.329 179.863 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.442 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 94.3 mt-10 -89.23 168.55 12.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.362 -0.836 . . . . 1.0 109.68 -178.943 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 26.3 m -98.51 105.17 17.28 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.199 -0.938 . . . . 1.0 109.494 -179.516 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.422 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 86.5 m95 -88.47 124.24 33.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.379 -0.826 . . . . 1.0 109.059 179.727 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.668 HG21 ' HB2' ' A' ' 109' ' ' LYS . 7.9 t -140.78 153.63 45.92 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.197 -0.939 . . . . 1.0 109.91 -179.476 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 85.0 p -93.2 -5.6 49.65 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.456 -0.942 . . . . 1.0 108.456 179.15 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 46.4 t -94.3 179.71 5.21 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.718 -0.845 . . . . 1.0 108.718 179.305 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.9 m -80.79 75.75 7.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.004 -1.06 . . . . 1.0 109.372 179.862 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.668 ' HB2' HG21 ' A' ' 105' ' ' THR . 68.5 mttm -148.61 151.52 35.16 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.308 -0.87 . . . . 1.0 108.828 179.364 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.53 -138.84 4.83 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.841 -1.304 . . . . 1.0 109.841 179.667 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -100.01 115.92 30.85 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.348 -1.09 . . . . 1.0 108.862 179.604 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -63.61 131.81 49.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.158 -0.964 . . . . 1.0 109.617 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.1 tp -60.0 -43.59 95.08 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.331 -0.856 . . . . 1.0 110.899 -179.484 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -59.91 -41.11 91.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.971 -1.081 . . . . 1.0 110.794 -178.592 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.96 -50.47 73.64 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.809 -1.182 . . . . 1.0 109.603 -179.468 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.1 t -70.01 -41.44 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.051 -1.031 . . . . 1.0 110.09 -179.365 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.45 -51.44 69.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.147 -0.971 . . . . 1.0 109.633 -179.318 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.05 -37.01 78.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.146 -0.971 . . . . 1.0 109.945 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.511 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 59.4 t60 -62.36 -49.94 73.55 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.249 -0.907 . . . . 1.0 111.182 -178.784 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.494 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 6.9 pt-20 -59.54 -39.49 84.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.654 -1.278 . . . . 1.0 109.529 -179.38 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -60.07 -39.96 87.87 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.892 -1.13 . . . . 1.0 108.615 179.205 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.36 -47.71 61.61 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.283 -1.527 . . . . 1.0 109.283 179.775 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.511 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 89.1 m-70 -66.1 -39.96 90.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.286 -1.126 . . . . 1.0 110.16 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 83.1 p -66.43 -22.19 66.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.131 -0.98 . . . . 1.0 109.897 -179.609 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 79.6 mt -81.9 1.84 33.3 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.134 -0.979 . . . . 1.0 109.948 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.12 4.99 70.96 Favored Glycine 0 N--CA 1.497 2.749 0 O-C-N 121.005 -1.059 . . . . 1.0 110.532 179.167 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.2 mt -86.99 147.85 25.56 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.984 -1.303 . . . . 1.0 109.787 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 37.6 t0 -101.98 172.39 6.95 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.878 -0.786 . . . . 1.0 108.878 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.513 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 59.3 m80 -56.58 132.72 52.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.004 -1.06 . . . . 1.0 109.54 -179.684 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 40.0 t -96.45 157.37 15.93 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.249 -0.907 . . . . 1.0 109.412 179.839 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -99.97 5.06 45.21 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.347 -0.845 . . . . 1.0 109.125 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -86.23 126.5 64.73 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 108.317 -0.994 . . . . 1.0 108.317 179.442 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -68.04 -22.07 42.1 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 CA-C-N 120.253 1.126 . . . . 1.0 112.273 -179.686 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -84.99 -5.69 85.81 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.684 -1.366 . . . . 1.0 109.684 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.15 135.19 33.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.186 -1.185 . . . . 1.0 108.842 179.467 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.466 ' C ' ' H ' ' A' ' 138' ' ' PHE . 89.2 mt -60.7 -40.05 90.79 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.076 -1.015 . . . . 1.0 110.238 -179.442 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 89.6 mtp -69.22 23.92 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.207 -0.933 . . . . 1.0 111.009 -178.425 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.466 ' H ' ' C ' ' A' ' 136' ' ' LEU . 17.3 t80 -69.92 130.33 90.1 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 120.761 -1.212 . . . . 1.0 108.328 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -49.07 -21.82 4.47 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 120.825 1.016 . . . . 1.0 114.392 -178.453 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 90.4 mt -106.37 139.81 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 O-C-N 120.886 -1.134 . . . . 1.0 110.87 -178.576 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -75.0 126.76 31.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.791 -0.568 . . . . 1.0 109.614 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.8 t -138.16 142.31 40.08 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.452 -0.78 . . . . 1.0 109.167 179.388 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -80.41 139.94 36.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.145 -0.972 . . . . 1.0 109.13 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.3 t -139.95 152.09 46.07 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.282 -0.886 . . . . 1.0 109.909 -179.322 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.96 101.1 0.83 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.33 -1.508 . . . . 1.0 109.33 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -76.79 -0.79 25.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.348 -1.09 . . . . 1.0 110.019 -179.718 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 53.9 m -59.97 -40.03 87.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.082 -1.011 . . . . 1.0 109.658 -179.6 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -138.91 21.06 2.65 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.144 -0.973 . . . . 1.0 109.989 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -62.03 139.94 58.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.78 -1.2 . . . . 1.0 109.721 -179.714 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 67.6 mtt -139.64 148.32 42.28 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.386 -0.968 . . . . 1.0 108.386 179.179 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 35.0 mt -54.94 129.78 66.3 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 120.945 -1.097 . . . . 1.0 109.202 -179.407 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -70.82 173.33 12.08 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 CA-C-N 119.863 0.987 . . . . 1.0 112.21 179.749 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -60.17 -39.62 87.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.328 -0.857 . . . . 1.0 109.519 179.403 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -53.06 -47.94 68.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.217 -0.927 . . . . 1.0 109.594 -179.517 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.411 ' O ' HG22 ' A' ' 159' ' ' ILE . 96.9 m-20 -70.33 -40.07 74.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.064 -1.022 . . . . 1.0 110.152 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 78.7 t -60.02 -47.35 92.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.88 -1.137 . . . . 1.0 109.176 -179.784 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -60.06 -39.97 87.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.071 -1.018 . . . . 1.0 110.434 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -73.23 -54.28 7.04 Favored Glycine 0 N--CA 1.496 2.672 0 O-C-N 121.215 -0.928 . . . . 1.0 111.685 -178.213 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.492 HG23 ' N ' ' A' ' 160' ' ' GLN . 4.8 tp -59.98 -39.99 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.953 -1.322 . . . . 1.0 109.691 -178.808 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.571 ' O ' ' N ' ' A' ' 164' ' ' GLY . 93.0 mm-40 -64.94 -38.25 90.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.2 -0.938 . . . . 1.0 109.463 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 60.3 p -61.51 -33.34 73.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.071 -1.018 . . . . 1.0 110.346 -179.359 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.8 mt -84.84 -52.31 6.12 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.959 -1.088 . . . . 1.0 110.536 -179.001 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -91.31 -9.24 45.71 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.104 -0.997 . . . . 1.0 110.483 -178.902 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.496 2.66 0 N-CA-C 109.448 -1.461 . . . . 1.0 109.448 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.8 mt . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.162 -0.681 . . . . 1.0 109.162 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -161.71 161.44 29.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.878 . . . . 1.0 109.785 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -70.15 146.26 50.94 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.325 -0.86 . . . . 1.0 109.518 -179.623 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.9 t -85.94 1.42 50.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.342 -0.849 . . . . 1.0 109.818 -179.54 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -144.17 152.98 41.63 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.153 -0.967 . . . . 1.0 109.607 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.8 mmt -90.24 -0.02 57.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.358 -0.839 . . . . 1.0 109.769 -179.302 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -97.04 130.52 44.34 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.206 -0.933 . . . . 1.0 109.11 179.762 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.2 mt -141.75 148.94 39.8 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.196 -0.94 . . . . 1.0 109.406 -179.814 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.9 p -134.37 155.29 50.53 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.715 -0.846 . . . . 1.0 108.715 179.819 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -146.14 160.05 42.47 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.061 -1.024 . . . . 1.0 110.201 -179.9 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.486 ' NH1' ' N ' ' A' ' 56' ' ' GLY . 71.8 ttt180 -145.5 134.16 22.2 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.562 -0.711 . . . . 1.0 109.556 -179.736 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 32.0 mm -89.0 115.11 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.182 -0.949 . . . . 1.0 108.922 179.026 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.91 -40.58 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.173 -0.954 . . . . 1.0 109.295 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -164.98 160.52 19.15 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.929 -1.107 . . . . 1.0 110.008 -179.507 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.461 ' CD2' ' CG ' ' A' ' 28' ' ' HIS . 47.7 m-85 -101.68 -161.53 0.86 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.894 -1.15 . . . . 1.0 107.894 179.132 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.33 147.59 47.6 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.448 -0.782 . . . . 1.0 110.054 -179.809 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -69.62 -14.99 37.36 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 120.916 1.078 . . . . 1.0 110.267 178.245 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.42 -38.93 81.9 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.083 -0.962 . . . . 1.0 109.965 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 76.0 mtm -139.64 168.4 19.91 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.284 -0.885 . . . . 1.0 109.552 -179.756 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.4 p -73.45 156.61 38.07 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.445 -0.785 . . . . 1.0 109.771 -179.496 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.461 ' CG ' ' CD2' ' A' ' 22' ' ' TYR . 2.2 m-70 -59.99 -40.09 87.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.431 -0.793 . . . . 1.0 110.463 -179.538 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 53.4 m -59.97 -39.96 87.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 1.0 110.202 -178.474 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.39 -39.95 89.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.033 -1.042 . . . . 1.0 109.325 179.574 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 76.6 t -68.7 -40.29 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.266 -0.896 . . . . 1.0 110.348 -179.561 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.96 -49.26 78.4 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.841 -1.162 . . . . 1.0 110.37 -179.186 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -61.34 -32.1 71.98 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.98 -1.075 . . . . 1.0 109.529 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.84 -48.57 81.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.977 -1.077 . . . . 1.0 109.649 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -66.03 -39.78 90.49 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.091 -1.006 . . . . 1.0 109.923 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.97 -40.65 89.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.924 -1.11 . . . . 1.0 109.284 -179.395 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -60.13 -41.78 93.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.034 -1.041 . . . . 1.0 108.927 179.085 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.97 -48.07 83.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.355 -0.841 . . . . 1.0 110.124 -179.683 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -64.89 -39.94 94.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.138 -0.976 . . . . 1.0 109.564 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -59.96 -48.25 82.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.15 -0.969 . . . . 1.0 109.27 -179.65 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.9 t -60.02 -41.53 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.294 -0.879 . . . . 1.0 110.122 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.468 ' O ' HG23 ' A' ' 46' ' ' THR . 76.3 m95 -81.36 -31.5 33.35 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.978 -1.076 . . . . 1.0 109.99 -179.421 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.0 p -70.02 -20.12 63.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.958 -1.089 . . . . 1.0 109.023 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -60.27 -39.96 88.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.404 -0.81 . . . . 1.0 110.263 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.1 m -113.15 -17.35 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 O-C-N 121.219 -0.926 . . . . 1.0 110.49 -179.17 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.478 ' C ' ' H ' ' A' ' 48' ' ' LEU . 44.8 p -94.02 114.41 63.11 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 120.779 -1.2 . . . . 1.0 108.982 179.729 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.76 16.36 0.22 Allowed 'Trans proline' 0 N--CA 1.491 1.327 0 CA-C-N 120.354 1.162 . . . . 1.0 111.237 179.462 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.478 ' H ' ' C ' ' A' ' 46' ' ' THR . 59.2 mt -69.52 142.87 53.59 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.567 -0.708 . . . . 1.0 109.511 -179.718 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -102.07 120.74 40.92 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.779 -0.823 . . . . 1.0 108.779 179.403 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -106.29 128.07 53.71 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.32 -0.863 . . . . 1.0 109.581 -179.438 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.0 m -120.04 130.01 54.5 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.58 -0.7 . . . . 1.0 109.469 179.642 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.8 ttp180 -82.62 129.99 35.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 1.0 109.558 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.4 mt -111.0 116.52 31.33 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.416 -0.802 . . . . 1.0 108.981 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.441 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 91.5 m-70 -74.61 -20.46 59.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.861 . . . . 1.0 110.065 -179.77 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 84.0 m-20 -145.13 160.66 41.08 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.18 -0.95 . . . . 1.0 109.639 -179.482 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.486 ' N ' ' NH1' ' A' ' 18' ' ' ARG . . . 90.02 173.95 45.22 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.677 -1.369 . . . . 1.0 109.677 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 87.2 mt -94.34 139.25 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.135 -1.215 . . . . 1.0 109.135 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.08 159.76 18.87 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.499 -0.75 . . . . 1.0 109.38 -179.739 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -59.94 -49.79 76.29 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.174 -0.954 . . . . 1.0 109.307 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 84.3 mt -103.12 98.88 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.449 -0.782 . . . . 1.0 109.568 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.2 ptm -101.85 129.23 48.03 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.295 -0.878 . . . . 1.0 109.206 179.455 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 86.9 mt -105.25 134.45 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.618 -0.676 . . . . 1.0 109.688 -179.125 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 54.6 p -149.73 153.54 37.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.208 -0.932 . . . . 1.0 109.623 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -103.89 124.02 48.2 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.937 -0.764 . . . . 1.0 108.937 179.904 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -107.13 -167.15 22.18 Favored Glycine 0 N--CA 1.502 3.044 0 N-CA-C 110.531 -1.028 . . . . 1.0 110.531 -179.232 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 77.0 mt . . . . . 0 N--CA 1.497 1.884 0 O-C-N 121.598 -0.943 . . . . 1.0 108.74 179.731 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.551 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 73.9 m-85 . . . . . 0 N--CA 1.494 1.759 0 N-CA-C 108.89 -0.781 . . . . 1.0 108.89 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.5 p-10 -100.01 10.47 41.24 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.315 -0.866 . . . . 1.0 110.614 -178.884 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 116.73 -152.31 17.92 Favored Glycine 0 N--CA 1.505 3.293 0 N-CA-C 109.432 -1.467 . . . . 1.0 109.432 179.689 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -58.07 -65.77 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.429 0 CA-C-N 118.905 1.352 . . . . 1.0 112.338 -179.768 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 80.7 p -76.27 159.26 30.76 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.232 -0.917 . . . . 1.0 109.878 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.86 -130.87 9.3 Favored Glycine 0 N--CA 1.503 3.148 0 N-CA-C 109.6 -1.4 . . . . 1.0 109.6 179.836 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.402 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 15.2 mt -70.18 105.03 2.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.07 -1.253 . . . . 1.0 109.046 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 40.2 mt -77.43 -18.29 57.35 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.295 -1.002 . . . . 1.0 108.295 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.98 172.49 1.04 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.417 -0.957 . . . . 1.0 108.417 179.846 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.433 ' ND1' ' C ' ' A' ' 84' ' ' HIS . 8.1 p80 -163.09 156.76 19.9 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.988 -1.07 . . . . 1.0 109.744 179.348 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.07 157.8 43.68 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.721 -0.844 . . . . 1.0 108.721 179.836 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -94.84 153.15 40.06 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.059 -1.026 . . . . 1.0 109.057 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -59.17 166.43 7.3 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 120.447 0.765 . . . . 1.0 111.01 179.576 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo . . . . . 0 N--CA 1.493 1.468 0 C-N-CA 121.252 1.302 . . . . 1.0 112.264 -179.843 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.238 0.542 . . . . 1.0 109.993 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.17 124.49 10.9 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.176 -0.952 . . . . 1.0 110.058 -179.638 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.426 ' ND1' ' CE1' ' A' ' 84' ' ' HIS . 54.1 m170 -108.95 141.64 40.74 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.497 -0.752 . . . . 1.0 110.222 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -124.19 144.09 50.13 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 109.036 -0.728 . . . . 1.0 109.036 179.223 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.551 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 77.4 m-20 -78.96 121.33 24.77 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.967 -1.083 . . . . 1.0 109.677 179.814 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -85.32 -7.19 59.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.337 -0.852 . . . . 1.0 109.004 179.424 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -84.04 -12.53 55.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.452 -0.78 . . . . 1.0 109.395 -179.801 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -89.31 169.95 10.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.45 -0.782 . . . . 1.0 109.766 -178.915 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 18.2 m -98.87 103.86 15.85 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.338 -0.851 . . . . 1.0 109.245 -179.657 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.435 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 89.0 m95 -88.17 127.11 35.43 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.814 -0.809 . . . . 1.0 108.814 179.763 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.668 HG21 ' HB2' ' A' ' 109' ' ' LYS . 5.7 t -143.03 154.13 43.66 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.168 -0.958 . . . . 1.0 109.929 -179.522 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.9 m -94.05 -10.56 33.05 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.208 -0.933 . . . . 1.0 108.597 179.382 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.7 m -91.29 177.67 6.18 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.597 -0.89 . . . . 1.0 108.597 179.355 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.7 t -76.5 80.17 3.2 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.012 -1.055 . . . . 1.0 109.648 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.668 ' HB2' HG21 ' A' ' 105' ' ' THR . 9.5 mtmp? -153.53 150.12 28.38 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.328 -0.857 . . . . 1.0 109.283 179.499 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 43.48 -140.31 2.97 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.046 -1.222 . . . . 1.0 110.046 179.465 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -99.98 111.87 24.16 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.343 -1.093 . . . . 1.0 109.076 179.695 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.417 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 19.6 t-20 -61.55 136.53 58.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.072 -1.017 . . . . 1.0 109.9 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.2 tp -59.97 -44.11 94.67 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.357 -0.839 . . . . 1.0 110.467 179.815 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -59.96 -41.47 91.98 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.08 -1.013 . . . . 1.0 110.889 -178.22 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.99 -50.11 75.01 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.814 -1.179 . . . . 1.0 109.487 -179.395 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 56.3 t -70.0 -41.5 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.06 -1.025 . . . . 1.0 110.307 -179.47 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.33 -52.8 64.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.09 -1.006 . . . . 1.0 110.074 -178.973 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.55 -35.5 74.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.11 -0.994 . . . . 1.0 110.099 -179.728 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.597 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 74.1 t60 -63.93 -50.3 69.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.948 . . . . 1.0 111.254 -178.512 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -60.05 -39.21 85.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.645 -1.285 . . . . 1.0 110.091 -179.297 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -60.04 -39.87 87.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.967 -1.083 . . . . 1.0 108.844 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.68 -44.39 94.05 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.431 -1.468 . . . . 1.0 109.431 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.597 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 85.9 m-70 -64.95 -39.99 94.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.19 -1.182 . . . . 1.0 109.494 179.54 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 83.2 p -65.7 -22.9 66.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.228 -0.92 . . . . 1.0 109.523 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 82.2 mt -82.55 -1.2 49.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.241 -0.912 . . . . 1.0 109.283 179.709 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.73 8.71 65.16 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 110.819 -0.912 . . . . 1.0 110.819 178.985 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.4 mt -85.82 146.35 26.8 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.881 -1.364 . . . . 1.0 109.652 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 44.5 t0 -100.41 172.7 6.97 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.484 -0.76 . . . . 1.0 109.199 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.519 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 64.7 m80 -58.86 136.92 57.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.911 . . . . 1.0 109.703 -179.661 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 42.0 t -98.04 155.63 17.03 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.37 -0.831 . . . . 1.0 109.176 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -98.75 1.91 46.48 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.265 -0.897 . . . . 1.0 109.934 179.953 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -85.4 128.5 59.13 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.074 -1.016 . . . . 1.0 108.368 179.336 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -67.8 -17.4 47.15 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 CA-C-N 120.237 1.12 . . . . 1.0 112.519 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -90.32 -5.53 69.75 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.696 -1.361 . . . . 1.0 109.696 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -89.05 140.02 29.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.218 -1.166 . . . . 1.0 109.35 179.726 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.449 ' C ' ' H ' ' A' ' 138' ' ' PHE . 98.3 mt -63.86 -31.99 73.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.139 -0.976 . . . . 1.0 109.83 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 96.0 mmm -71.21 19.43 0.06 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.322 -0.861 . . . . 1.0 110.503 -179.027 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.449 ' H ' ' C ' ' A' ' 136' ' ' LEU . 11.3 t80 -69.31 132.14 89.94 Favored Pre-proline 0 N--CA 1.495 1.775 0 N-CA-C 107.817 -1.179 . . . . 1.0 107.817 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -61.88 -13.74 32.65 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 CA-C-N 119.837 0.977 . . . . 1.0 113.33 -178.346 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.5 mt -108.14 139.28 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.199 -0.938 . . . . 1.0 109.343 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 141' ' ' TYR . . . . . 0.417 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 33.4 t80 -72.69 129.56 38.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.324 -0.86 . . . . 1.0 109.853 -179.464 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.2 t -140.15 143.74 36.31 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.868 -0.79 . . . . 1.0 108.868 179.762 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -81.01 144.8 31.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.137 -0.977 . . . . 1.0 109.289 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.5 t -140.5 151.94 45.21 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.184 -0.947 . . . . 1.0 109.825 -179.863 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -61.81 103.93 0.65 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.284 -1.126 . . . . 1.0 110.284 -179.478 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.413 ' NZ ' ' CB ' ' A' ' 146' ' ' LYS . 9.1 mtpm? -77.28 -7.94 56.8 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.337 -1.096 . . . . 1.0 109.236 179.638 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 82.5 p -59.97 -40.01 87.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 1.0 109.832 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -154.27 69.63 0.77 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.11 -0.993 . . . . 1.0 109.65 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -100.45 127.1 46.89 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.219 -0.926 . . . . 1.0 109.642 179.66 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 75.5 mtm -121.44 141.46 50.98 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.572 -0.899 . . . . 1.0 108.572 179.203 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.8 mt -52.6 128.47 43.55 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 120.917 -1.115 . . . . 1.0 108.82 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -68.64 175.48 7.08 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 CA-C-N 120.036 1.049 . . . . 1.0 111.903 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -59.97 -40.03 87.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.331 -0.856 . . . . 1.0 109.697 179.798 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -54.56 -49.21 70.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.256 -0.903 . . . . 1.0 110.172 -179.227 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -69.92 -39.97 75.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.993 -1.067 . . . . 1.0 110.026 -179.601 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 60.1 t -60.06 -47.1 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 1.0 109.218 -179.831 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -60.07 -40.01 88.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.125 -0.984 . . . . 1.0 110.203 -179.75 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.12 -55.27 9.39 Favored Glycine 0 N--CA 1.495 2.619 0 O-C-N 121.143 -0.973 . . . . 1.0 111.301 -178.567 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.484 HG23 ' N ' ' A' ' 160' ' ' GLN . 4.8 tp -60.17 -40.09 82.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.946 -1.326 . . . . 1.0 109.734 -178.996 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.533 ' O ' ' N ' ' A' ' 164' ' ' GLY . 26.0 mm100 -64.35 -40.06 95.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.081 -1.012 . . . . 1.0 109.789 179.852 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 94.1 p -62.08 -30.44 71.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.11 -0.994 . . . . 1.0 110.196 -179.537 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 93.1 mt -84.92 -54.24 4.79 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.028 -1.045 . . . . 1.0 110.623 -179.099 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -89.73 -8.85 51.35 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.002 -1.061 . . . . 1.0 110.011 -179.094 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.584 0 N-CA-C 109.513 -1.435 . . . . 1.0 109.513 179.775 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.7 mt . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.367 0.603 . . . . 1.0 109.703 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -160.67 160.01 31.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.357 -0.839 . . . . 1.0 109.405 179.776 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 47.6 m95 -75.28 125.39 28.88 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.091 -1.005 . . . . 1.0 109.249 -179.923 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.7 p -73.28 -29.49 62.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.02 -1.05 . . . . 1.0 109.518 179.877 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -92.07 139.08 30.99 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.304 -0.999 . . . . 1.0 108.304 179.405 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.613 ' N ' ' SD ' ' A' ' 13' ' ' MET . 3.5 mmm -90.62 0.07 57.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.251 -0.906 . . . . 1.0 109.828 -178.372 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -98.17 125.86 43.39 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.707 -0.849 . . . . 1.0 108.707 179.46 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.7 mt -138.7 152.25 47.85 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.202 -0.937 . . . . 1.0 109.307 -179.503 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.6 p -132.98 154.16 50.76 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.997 -0.742 . . . . 1.0 108.997 -179.953 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -144.29 159.99 41.75 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.131 -0.981 . . . . 1.0 109.848 -179.656 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.537 ' NE ' ' O ' ' A' ' 56' ' ' GLY . 25.2 ttm-85 -142.17 134.54 27.88 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.397 -0.814 . . . . 1.0 109.585 -179.721 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 87.1 mt -87.92 117.97 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.482 -0.933 . . . . 1.0 108.482 178.73 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.9 t -69.32 -38.8 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.172 -0.955 . . . . 1.0 109.417 -179.32 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -159.19 157.88 31.62 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 122.217 1.008 . . . . 1.0 111.5 179.424 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.488 ' O ' ' O ' ' A' ' 23' ' ' THR . 15.5 m-85 -112.13 77.02 1.01 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 103.678 -2.712 . . . . 1.0 103.678 176.652 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.488 ' O ' ' O ' ' A' ' 22' ' ' TYR . 5.4 t -29.15 150.84 0.03 OUTLIER Pre-proline 0 C--N 1.282 -2.341 0 CA-C-N 115.741 -0.663 . . . . 1.0 112.178 -177.535 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -65.15 -6.55 13.31 Favored 'Trans proline' 0 N--CA 1.5 1.855 0 C-N-CA 121.275 1.317 . . . . 1.0 113.383 -178.56 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -59.15 -37.78 78.14 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 119.509 -0.876 . . . . 1.0 110.285 179.839 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 73.4 mtm -138.75 162.64 34.2 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.142 -0.974 . . . . 1.0 109.591 -179.776 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.4 p -71.45 160.4 32.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.363 -0.836 . . . . 1.0 109.436 -179.663 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -60.01 -40.44 89.26 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.313 -0.867 . . . . 1.0 109.869 -179.178 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.2 m -60.03 -42.48 94.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.136 -0.977 . . . . 1.0 110.501 -179.416 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.09 -40.0 82.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.085 -1.01 . . . . 1.0 110.023 -179.638 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 70.2 t -67.56 -44.84 86.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.164 -0.96 . . . . 1.0 110.288 -179.233 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -59.99 -49.42 77.75 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.139 -0.976 . . . . 1.0 111.13 -178.896 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -60.48 -33.47 72.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.818 -1.176 . . . . 1.0 109.847 -179.537 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.0 -49.97 75.57 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.967 -1.083 . . . . 1.0 109.95 -179.538 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -66.56 -38.81 87.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.912 -1.117 . . . . 1.0 109.894 -179.886 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.97 -42.42 94.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.078 -1.014 . . . . 1.0 109.514 -179.256 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -60.07 -39.96 87.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.133 -0.98 . . . . 1.0 109.137 179.394 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.06 -48.35 82.09 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.31 -0.868 . . . . 1.0 109.851 -179.592 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -66.26 -39.18 89.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 1.0 110.075 -179.747 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -60.01 -48.78 80.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.063 -1.023 . . . . 1.0 109.448 -179.248 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 86.2 t -59.98 -40.04 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.104 -0.997 . . . . 1.0 110.566 -179.376 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -81.47 -33.66 31.85 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.902 -1.124 . . . . 1.0 110.005 -179.555 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 94.3 p -72.05 -21.15 61.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.895 -1.128 . . . . 1.0 109.78 179.89 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.96 -39.98 87.47 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.243 -0.911 . . . . 1.0 110.626 -179.589 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 m -110.98 24.48 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 O-C-N 121.27 -0.894 . . . . 1.0 110.682 -179.118 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.5 p -149.15 135.23 10.05 Favored Pre-proline 0 N--CA 1.5 2.061 0 O-C-N 120.761 -1.212 . . . . 1.0 109.505 179.376 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -73.87 16.39 0.53 Allowed 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 120.693 0.928 . . . . 1.0 111.901 179.083 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 93.9 mt -68.31 139.35 55.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.071 -1.018 . . . . 1.0 109.756 -179.423 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -110.71 120.81 43.62 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.954 -0.758 . . . . 1.0 108.954 -179.961 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -108.38 123.49 48.92 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.393 -0.817 . . . . 1.0 109.466 -179.492 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -120.03 130.01 54.51 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.7 -0.625 . . . . 1.0 109.327 179.885 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -83.95 132.87 34.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.216 -0.927 . . . . 1.0 109.285 179.696 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.521 ' C ' HH12 ' A' ' 18' ' ' ARG . 91.2 mt -102.2 139.73 37.42 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.23 -0.919 . . . . 1.0 108.915 179.67 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.438 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 41.5 m170 -69.52 -40.0 77.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 1.0 110.228 -179.306 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.52 ' O ' ' NH2' ' A' ' 18' ' ' ARG . 70.4 m-20 -153.44 179.68 8.56 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.024 -1.047 . . . . 1.0 109.885 -179.636 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.537 ' O ' ' NE ' ' A' ' 18' ' ' ARG . . . 92.39 -170.84 33.06 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.75 -1.34 . . . . 1.0 109.75 179.928 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.0 mt -97.11 131.36 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.337 -1.096 . . . . 1.0 109.221 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.23 166.11 11.11 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.354 -0.841 . . . . 1.0 109.21 -179.949 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.01 -49.22 78.53 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.128 -0.982 . . . . 1.0 108.915 -179.928 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.5 mt -119.96 114.12 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.676 -0.64 . . . . 1.0 109.389 179.31 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.5 ptp -101.71 138.29 38.89 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.254 -0.904 . . . . 1.0 108.999 179.126 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.6 mt -109.99 131.86 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.359 -0.838 . . . . 1.0 109.794 -179.133 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 71.6 p -150.01 160.68 43.44 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.224 -0.923 . . . . 1.0 109.974 -179.541 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -107.13 122.57 46.75 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.463 -0.773 . . . . 1.0 109.388 179.987 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' A' ' 100' ' ' ASP . . . -96.45 167.67 24.88 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.208 -1.557 . . . . 1.0 109.208 179.6 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 11.3 tt . . . . . 0 N--CA 1.496 1.838 0 O-C-N 121.277 -1.131 . . . . 1.0 109.671 -179.4 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.493 ' CD2' ' OD1' ' A' ' 99' ' ' ASP . 33.1 m-85 . . . . . 0 N--CA 1.497 1.909 0 N-CA-C 109.162 -0.681 . . . . 1.0 109.162 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 79' ' ' SER . 32.8 p-10 -99.8 1.81 43.45 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.144 -0.972 . . . . 1.0 111.538 -178.425 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.406 ' O ' ' OE2' ' A' ' 102' ' ' GLU . . . 111.93 -117.91 4.58 Favored Glycine 0 N--CA 1.508 3.463 0 O-C-N 120.93 -1.106 . . . . 1.0 111.144 178.69 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.466 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 28.3 Cg_endo -73.51 -73.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.948 0 CA-C-N 120.015 1.908 . . . . 1.0 113.399 -178.88 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.451 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 99.2 p -78.17 173.89 11.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.949 -1.095 . . . . 1.0 109.475 -179.366 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 106.04 -134.39 12.09 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 110.152 -1.179 . . . . 1.0 110.152 179.64 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.459 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 19.6 mt -71.91 117.73 13.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.592 -0.946 . . . . 1.0 109.843 -179.397 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 66.1 mt -85.09 -22.77 28.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.986 -1.071 . . . . 1.0 109.127 179.343 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.13 174.46 1.05 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.86 -0.793 . . . . 1.0 108.86 -179.741 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.68 163.3 27.02 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.242 -0.911 . . . . 1.0 109.492 179.276 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -153.72 162.27 41.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.391 -0.818 . . . . 1.0 108.885 -179.743 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -106.41 151.11 40.21 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.373 -0.829 . . . . 1.0 108.85 179.754 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -66.27 164.48 27.92 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 120.768 0.979 . . . . 1.0 111.785 179.604 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.49 1.279 0 C-N-CA 121.037 1.158 . . . . 1.0 111.836 179.762 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.9 p-10 . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 109.178 -0.675 . . . . 1.0 109.178 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.95 129.64 14.1 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.038 -1.039 . . . . 1.0 109.671 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -127.18 132.39 50.49 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.557 -0.714 . . . . 1.0 109.679 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -109.97 156.74 20.07 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.652 -0.655 . . . . 1.0 109.462 -179.798 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.493 ' OD1' ' CD2' ' A' ' 75' ' ' PHE . 90.8 m-20 -80.06 130.14 35.03 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.014 -1.054 . . . . 1.0 109.816 179.455 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.532 ' N ' ' O ' ' A' ' 65' ' ' GLY . 8.3 t70 -87.75 -6.77 58.02 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.274 -0.891 . . . . 1.0 109.491 179.412 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -83.53 -10.22 58.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.237 -0.914 . . . . 1.0 110.08 -179.519 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.466 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 42.0 mm-40 -90.58 173.88 7.82 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.161 -0.962 . . . . 1.0 109.5 -179.171 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 56.2 m -105.26 107.48 18.49 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.458 -0.941 . . . . 1.0 108.458 179.152 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -86.55 121.37 28.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.243 -0.911 . . . . 1.0 109.3 -179.506 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.666 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.6 t -143.12 156.33 44.77 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.538 -0.726 . . . . 1.0 109.605 -179.273 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 29.4 t -95.31 -7.26 39.21 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.332 -0.988 . . . . 1.0 108.332 178.924 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 68.3 m -91.03 179.78 5.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.565 -0.709 . . . . 1.0 109.226 179.624 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 99.4 p -79.82 68.62 5.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.232 -0.917 . . . . 1.0 109.806 -179.858 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.666 ' HB2' HG21 ' A' ' 105' ' ' THR . 98.4 mttt -143.18 149.51 38.11 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.2 -0.937 . . . . 1.0 108.809 179.5 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.51 -144.02 3.34 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.688 -1.365 . . . . 1.0 109.688 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -100.21 117.43 34.43 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.343 -1.092 . . . . 1.0 109.034 179.625 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.449 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 20.2 t-20 -62.26 132.66 53.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.912 . . . . 1.0 109.545 179.998 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.8 tp -59.96 -43.51 95.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.34 -0.85 . . . . 1.0 110.487 -179.498 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -59.97 -41.11 91.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.027 -1.046 . . . . 1.0 110.784 -178.485 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -58.49 -50.78 72.5 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.683 -1.261 . . . . 1.0 109.188 -179.584 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.0 t -70.04 -40.11 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.127 -0.983 . . . . 1.0 109.681 -179.556 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.94 -52.68 64.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.188 -0.945 . . . . 1.0 109.864 -179.341 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.99 -34.84 73.86 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.651 -1.281 . . . . 1.0 109.887 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -65.3 -50.05 67.16 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.264 -0.897 . . . . 1.0 111.617 -178.426 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -60.0 -40.01 87.75 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.63 -1.293 . . . . 1.0 109.408 -178.72 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -59.99 -40.03 87.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.026 -1.046 . . . . 1.0 108.723 179.879 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.31 -46.41 63.73 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.166 -1.573 . . . . 1.0 109.166 179.847 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.41 ' NE2' ' NE2' ' A' ' 129' ' ' HIS . 79.0 m-70 -65.26 -40.02 93.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.229 -1.159 . . . . 1.0 109.611 179.607 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 84.1 p -66.77 -23.95 66.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 1.0 109.998 -179.754 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 78.4 mt -82.26 -2.27 52.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.128 -0.983 . . . . 1.0 110.046 -179.544 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.57 6.24 68.24 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 110.443 -1.063 . . . . 1.0 110.443 179.357 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.3 mt -84.68 149.08 26.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.053 -1.263 . . . . 1.0 109.07 179.501 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 36.1 t0 -103.27 170.35 8.01 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.764 -0.828 . . . . 1.0 108.764 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.51 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 28.0 m170 -58.53 135.16 57.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.012 -1.055 . . . . 1.0 109.356 -179.631 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 41.9 t -98.18 155.29 17.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.382 -0.824 . . . . 1.0 109.106 179.879 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -98.05 5.58 48.55 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.23 -0.919 . . . . 1.0 110.014 -179.512 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -85.88 126.68 65.05 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 108.121 -1.066 . . . . 1.0 108.121 179.275 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -68.45 -8.81 24.14 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 CA-C-N 120.186 1.102 . . . . 1.0 112.011 -179.615 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -96.44 -7.52 58.03 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.509 -1.437 . . . . 1.0 109.509 179.863 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.87 137.05 33.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.133 -1.216 . . . . 1.0 109.412 179.814 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.435 ' C ' ' H ' ' A' ' 138' ' ' PHE . 64.7 mt -60.03 -39.84 87.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.121 -0.987 . . . . 1.0 110.239 179.86 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 89.8 mtp -71.28 25.52 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.275 -0.891 . . . . 1.0 111.417 -178.463 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.435 ' H ' ' C ' ' A' ' 136' ' ' LEU . 16.2 t80 -69.22 136.44 89.08 Favored Pre-proline 0 N--CA 1.498 1.955 0 N-CA-C 107.459 -1.311 . . . . 1.0 107.459 178.787 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -60.65 -14.28 30.48 Favored 'Trans proline' 0 N--CA 1.5 1.902 0 CA-C-N 120.185 1.102 . . . . 1.0 114.196 -178.062 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.3 mt -109.95 139.07 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 O-C-N 121.014 -1.054 . . . . 1.0 109.697 -179.693 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 141' ' ' TYR . . . . . 0.449 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 34.2 t80 -74.12 125.42 28.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.354 -0.841 . . . . 1.0 110.119 -179.324 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 7.4 t -136.6 142.94 43.34 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.997 -0.742 . . . . 1.0 108.997 179.812 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -80.67 143.29 33.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.932 -1.105 . . . . 1.0 109.746 -179.775 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.4 m -134.71 138.59 44.52 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.531 -0.73 . . . . 1.0 109.838 -179.475 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -68.0 99.91 0.59 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 107.97 -2.052 . . . . 1.0 107.97 178.658 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -74.46 17.09 0.21 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -1.129 . . . . 1.0 110.484 -178.475 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 41.1 t -57.67 -46.57 84.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.905 -1.122 . . . . 1.0 109.31 -179.853 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -147.72 33.99 0.85 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.147 -0.971 . . . . 1.0 109.368 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -63.73 138.03 58.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.2 -0.938 . . . . 1.0 110.953 -179.104 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 74.0 mtm -134.11 148.53 51.0 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.133 -1.062 . . . . 1.0 108.133 178.954 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 70.7 mt -53.3 129.12 51.06 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 120.918 -1.114 . . . . 1.0 108.867 -179.862 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -69.52 177.05 5.8 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 CA-C-N 120.074 1.062 . . . . 1.0 112.019 179.643 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -60.29 -39.95 88.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.868 . . . . 1.0 110.023 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -55.55 -48.94 73.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.245 -0.91 . . . . 1.0 110.054 -179.047 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -70.03 -40.02 75.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.152 -0.967 . . . . 1.0 110.34 -179.63 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 60.3 t -60.03 -48.81 86.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.027 -1.046 . . . . 1.0 109.124 -179.556 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -60.0 -39.98 87.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.128 -0.983 . . . . 1.0 110.44 179.97 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.06 -54.59 7.93 Favored Glycine 0 N--CA 1.493 2.49 0 O-C-N 121.136 -0.978 . . . . 1.0 111.382 -178.35 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.476 HG23 ' N ' ' A' ' 160' ' ' GLN . 7.1 tp -59.98 -40.11 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.937 -1.331 . . . . 1.0 109.618 -179.026 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.546 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.7 mt-30 -66.61 -39.93 88.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 1.0 109.594 179.597 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 83.1 p -61.52 -31.12 71.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.143 -0.973 . . . . 1.0 110.74 -179.308 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 88.6 mt -86.84 -51.36 6.12 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.779 -1.201 . . . . 1.0 110.551 -179.041 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -90.83 -9.16 47.46 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.984 -1.073 . . . . 1.0 109.931 -179.273 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.524 0 N-CA-C 109.489 -1.444 . . . . 1.0 109.489 -179.866 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.1 mt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.565 0.697 . . . . 1.0 110.04 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -160.6 160.2 31.43 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.471 -0.768 . . . . 1.0 109.018 179.598 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -73.45 147.95 43.69 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.13 -0.981 . . . . 1.0 109.463 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.3 p -84.93 0.13 52.28 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.203 -0.936 . . . . 1.0 109.742 -179.636 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -145.77 153.11 40.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.197 -0.939 . . . . 1.0 109.384 -179.877 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.2 mmt -90.02 -0.73 57.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.257 -0.902 . . . . 1.0 109.129 -179.645 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -96.19 128.2 42.88 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.341 -0.85 . . . . 1.0 108.989 -179.994 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.3 mt -140.02 150.17 44.09 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.232 -0.917 . . . . 1.0 109.04 -179.799 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 59.5 p -131.09 156.14 45.73 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.907 -0.775 . . . . 1.0 108.907 179.937 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -146.06 160.06 42.41 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.133 -0.98 . . . . 1.0 110.055 -179.672 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.598 HH12 ' H ' ' A' ' 56' ' ' GLY . 70.5 ttt180 -142.86 135.31 27.57 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.421 -0.8 . . . . 1.0 109.355 -179.939 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.5 mt -87.78 120.0 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.254 -0.904 . . . . 1.0 108.708 179.185 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 67.0 t -67.72 -39.04 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -0.925 . . . . 1.0 108.887 -179.812 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.44 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 22.0 p-10 -160.61 152.9 20.44 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 119.937 -1.727 . . . . 1.0 111.289 179.687 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.644 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 33.3 m-85 -101.28 74.96 1.59 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 106.612 -1.625 . . . . 1.0 106.612 177.118 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.476 ' C ' ' O ' ' A' ' 22' ' ' TYR . 3.9 t -24.54 143.14 0.04 OUTLIER Pre-proline 0 N--CA 1.508 2.433 0 N-CA-C 112.069 0.396 . . . . 1.0 112.069 -177.786 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -62.58 -5.86 7.83 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 121.247 1.298 . . . . 1.0 112.743 -179.285 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -59.48 -36.93 76.94 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.424 -0.797 . . . . 1.0 109.939 179.704 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 78.2 mtm -138.53 161.23 37.58 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.194 -0.941 . . . . 1.0 109.556 -179.772 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.1 p -71.62 160.19 33.11 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.37 -0.831 . . . . 1.0 109.127 -179.878 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.644 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 2.1 m80 -59.96 -40.59 89.58 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.346 -0.846 . . . . 1.0 110.22 -179.083 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 74.9 m -61.28 -40.47 94.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.098 -1.001 . . . . 1.0 110.275 -179.587 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.35 -39.97 77.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.207 -0.933 . . . . 1.0 110.383 -179.478 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 77.2 t -68.29 -43.56 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.139 -0.975 . . . . 1.0 110.134 -179.258 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.01 -49.4 77.82 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.19 -0.944 . . . . 1.0 110.87 -179.063 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -61.47 -32.86 72.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.885 -1.134 . . . . 1.0 110.112 -179.531 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.97 -49.67 76.77 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.906 -1.121 . . . . 1.0 109.713 -179.579 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.419 ' CE1' HD13 ' A' ' 62' ' ' ILE . 53.7 m-85 -66.27 -38.77 88.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.993 -1.067 . . . . 1.0 109.723 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -59.99 -43.37 95.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.045 -1.034 . . . . 1.0 109.795 -179.619 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -60.1 -41.24 92.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.99 -1.069 . . . . 1.0 109.475 179.58 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.29 -46.69 88.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.331 -0.856 . . . . 1.0 110.133 -179.389 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -67.2 -38.58 85.56 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.05 -1.031 . . . . 1.0 110.001 -179.767 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -59.96 -48.84 80.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.097 -1.002 . . . . 1.0 109.839 -179.349 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 79.7 t -60.09 -40.14 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.144 -0.973 . . . . 1.0 110.113 -179.412 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.456 ' CH2' HD22 ' A' ' 151' ' ' LEU . 69.2 m95 -81.35 -36.57 29.49 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.008 -1.058 . . . . 1.0 110.08 -179.413 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.3 p -70.19 -21.54 63.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.032 -1.043 . . . . 1.0 109.891 -179.632 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.07 -39.87 87.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.29 -0.881 . . . . 1.0 110.666 -179.739 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.411 HG23 HG23 ' A' ' 46' ' ' THR . 11.3 m -109.76 24.21 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.28 -0.888 . . . . 1.0 110.471 -178.824 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.411 HG23 HG23 ' A' ' 45' ' ' VAL . 43.3 p -149.83 134.41 9.32 Favored Pre-proline 0 N--CA 1.499 2.003 0 O-C-N 120.92 -1.113 . . . . 1.0 109.54 179.543 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -74.18 17.42 0.51 Allowed 'Trans proline' 0 N--CA 1.493 1.455 0 CA-C-N 119.702 0.929 . . . . 1.0 111.86 178.882 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 72.6 mt -68.53 139.9 55.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.117 -0.989 . . . . 1.0 109.413 -179.608 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -109.99 120.51 42.7 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 179.851 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -109.53 119.79 40.52 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.398 -0.814 . . . . 1.0 109.0 -179.687 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -120.06 130.03 54.49 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.533 -0.73 . . . . 1.0 109.944 -179.84 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -82.25 135.25 35.27 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.253 -0.904 . . . . 1.0 109.104 179.28 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.9 mt -101.3 129.29 47.25 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.161 -0.962 . . . . 1.0 109.483 -179.956 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.445 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 60.1 m170 -61.79 -40.0 93.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.413 -0.804 . . . . 1.0 109.443 179.879 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 77.9 m-20 -148.84 168.88 21.81 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.251 -0.906 . . . . 1.0 109.449 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.598 ' H ' HH12 ' A' ' 18' ' ' ARG . . . 98.72 178.07 32.31 Favored Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.54 -1.424 . . . . 1.0 109.54 -179.956 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.4 mt -95.87 135.06 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.241 -1.152 . . . . 1.0 109.291 179.863 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.02 160.76 16.15 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.492 -0.755 . . . . 1.0 109.155 -179.75 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -60.04 -49.51 77.38 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.17 -0.956 . . . . 1.0 109.306 -179.747 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.8 mt -105.37 103.51 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.356 -0.84 . . . . 1.0 109.978 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.1 ptp -100.43 133.96 44.08 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.188 -0.945 . . . . 1.0 108.766 178.773 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.419 HD13 ' CE1' ' A' ' 35' ' ' PHE . 85.4 mt -110.08 131.37 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.443 -0.785 . . . . 1.0 110.045 -178.56 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.1 p -150.56 160.3 43.89 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.153 -0.967 . . . . 1.0 109.93 -179.702 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -104.8 123.55 47.88 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 179.592 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 98' ' ' PHE . . . -95.55 -175.9 37.11 Favored Glycine 0 N--CA 1.499 2.894 0 N-CA-C 110.544 -1.023 . . . . 1.0 110.544 -179.274 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.1 mt . . . . . 0 N--CA 1.501 2.083 0 O-C-N 121.446 -1.031 . . . . 1.0 109.442 -179.967 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.529 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 87.8 m-85 . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 121.274 0.559 . . . . 1.0 109.739 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -102.11 16.12 27.03 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.361 -0.837 . . . . 1.0 110.746 -178.86 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 114.93 -157.51 14.94 Favored Glycine 0 N--CA 1.505 3.285 0 N-CA-C 109.55 -1.42 . . . . 1.0 109.55 179.617 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -58.37 -65.75 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.469 0 CA-C-N 118.568 1.184 . . . . 1.0 112.406 -179.742 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 89.7 p -76.03 162.17 28.28 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.181 -0.949 . . . . 1.0 109.65 -179.948 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.17 -129.09 8.29 Favored Glycine 0 N--CA 1.502 3.058 0 N-CA-C 109.836 -1.306 . . . . 1.0 109.836 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.1 mt -69.63 107.58 3.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.323 -1.104 . . . . 1.0 109.077 -179.958 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 56.7 mt -78.47 -26.54 46.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.896 . . . . 1.0 108.924 179.982 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.53 164.46 1.64 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.342 -0.984 . . . . 1.0 108.342 -179.715 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -160.35 162.74 33.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.128 -0.982 . . . . 1.0 109.44 179.493 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 95' ' ' ASP . . . -145.76 160.0 42.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.283 -0.886 . . . . 1.0 109.583 -179.645 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -93.88 152.97 40.99 Favored Pre-proline 0 N--CA 1.492 1.661 0 N-CA-C 107.944 -1.132 . . . . 1.0 107.944 179.433 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -56.95 165.79 4.64 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 CA-C-N 119.166 0.738 . . . . 1.0 111.673 179.778 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo . . . . . 0 N--CA 1.493 1.488 0 C-N-CA 121.346 1.364 . . . . 1.0 112.112 -179.564 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.442 ' O ' ' HB1' ' A' ' 85' ' ' ALA . 35.7 p-10 . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 121.281 0.562 . . . . 1.0 109.756 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.14 123.39 8.93 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.391 -0.818 . . . . 1.0 109.574 179.812 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -112.4 128.51 56.33 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.591 -0.693 . . . . 1.0 109.344 179.753 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.506 ' O ' ' N ' ' A' ' 65' ' ' GLY . 22.7 m-85 -107.71 155.85 19.73 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.478 -0.764 . . . . 1.0 109.063 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.529 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 1.3 m-20 -79.05 120.54 23.76 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.625 -1.297 . . . . 1.0 110.081 -179.616 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 65' ' ' GLY . 40.9 t0 -83.1 -11.88 57.58 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.171 -0.956 . . . . 1.0 108.947 179.389 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -83.17 -10.48 58.6 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.289 -0.882 . . . . 1.0 109.292 -179.543 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -92.46 170.05 10.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.395 -0.816 . . . . 1.0 109.155 -179.872 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 31.3 m -100.13 106.01 17.68 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.246 -0.909 . . . . 1.0 109.26 -179.76 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.481 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 94.5 m95 -88.76 123.39 33.13 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.568 -0.901 . . . . 1.0 108.568 179.537 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.69 HG21 ' HB2' ' A' ' 109' ' ' LYS . 10.1 t -140.05 154.84 47.2 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.355 -0.841 . . . . 1.0 109.942 -179.006 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 87.9 p -94.71 -5.51 45.3 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.284 -1.006 . . . . 1.0 108.284 179.011 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 31.4 t -94.47 178.95 5.44 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.709 -0.849 . . . . 1.0 108.709 179.35 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.2 m -80.2 76.84 6.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.962 -1.086 . . . . 1.0 109.599 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.69 ' HB2' HG21 ' A' ' 105' ' ' THR . 68.7 mttm -148.52 149.39 31.54 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.257 -0.902 . . . . 1.0 108.678 179.429 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.22 -136.98 5.31 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.096 -1.202 . . . . 1.0 110.096 179.695 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -100.07 118.6 36.77 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.403 -1.057 . . . . 1.0 109.21 179.689 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.4 ' HB3' HD23 ' A' ' 115' ' ' LEU . 2.6 t-20 -65.09 131.5 46.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.086 -1.009 . . . . 1.0 109.765 179.992 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.5 tp -60.01 -43.11 95.43 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.372 -0.83 . . . . 1.0 110.084 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -60.0 -43.01 95.48 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.27 -0.894 . . . . 1.0 111.214 -178.584 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 115' ' ' LEU . 4.0 mm? -60.03 -50.02 75.37 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.655 -1.278 . . . . 1.0 109.347 -179.182 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 75.5 t -69.95 -40.29 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.099 -1.0 . . . . 1.0 109.95 -179.405 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.12 -50.02 75.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.145 -0.972 . . . . 1.0 109.746 -179.306 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.84 -36.51 77.0 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.739 -1.226 . . . . 1.0 109.631 179.973 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.632 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 63.5 t60 -64.99 -49.97 68.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.129 -0.982 . . . . 1.0 111.541 -178.637 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.4 ' C ' ' OE1' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -59.98 -40.02 87.67 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.519 -1.363 . . . . 1.0 109.873 -178.731 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -60.04 -40.05 88.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.928 -1.107 . . . . 1.0 108.35 179.746 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -54.61 -44.13 78.95 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.128 -1.589 . . . . 1.0 109.128 179.717 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.632 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 85.9 m-70 -67.29 -39.99 86.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.194 -1.18 . . . . 1.0 109.828 179.66 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.9 p -66.0 -21.7 66.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.928 . . . . 1.0 109.115 179.888 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 76.2 mt -82.52 -0.84 48.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.39 -0.819 . . . . 1.0 110.028 -179.89 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 89.43 7.31 69.62 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.392 -1.083 . . . . 1.0 110.392 179.282 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.5 mt -84.57 150.13 25.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.898 -1.354 . . . . 1.0 110.092 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 10.0 t70 -101.09 171.13 7.81 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.509 -0.744 . . . . 1.0 109.066 179.509 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.526 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 75.2 m80 -59.65 137.38 58.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.088 -1.007 . . . . 1.0 109.555 -179.78 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 38.6 t -98.55 154.28 18.03 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.315 -0.865 . . . . 1.0 109.322 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -100.17 6.75 44.83 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.39 -0.819 . . . . 1.0 109.748 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -86.58 127.97 58.54 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.136 -0.978 . . . . 1.0 108.563 179.617 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -67.99 -20.21 44.93 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 CA-C-N 120.181 1.1 . . . . 1.0 112.169 -179.818 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -88.47 -4.98 76.07 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.621 -1.392 . . . . 1.0 109.621 -179.865 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.16 145.75 26.87 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.269 -1.136 . . . . 1.0 109.707 179.897 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.419 ' C ' ' H ' ' A' ' 138' ' ' PHE . 84.6 mt -70.05 -33.84 72.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.891 . . . . 1.0 109.553 179.887 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 80.3 mtp -74.41 23.36 0.09 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 1.0 110.481 -179.215 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.419 ' H ' ' C ' ' A' ' 136' ' ' LEU . 12.7 t80 -69.62 133.52 88.73 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 107.409 -1.33 . . . . 1.0 107.409 179.305 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -59.25 -9.94 9.51 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 CA-C-N 120.01 1.039 . . . . 1.0 113.785 -177.896 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 95.4 mt -113.9 138.36 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 O-C-N 121.123 -0.985 . . . . 1.0 109.686 -179.919 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -73.37 131.12 41.5 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.461 -0.774 . . . . 1.0 110.068 -179.351 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.1 t -141.97 133.38 26.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.36 -0.838 . . . . 1.0 109.282 179.697 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -80.71 134.41 35.84 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.139 -0.975 . . . . 1.0 109.58 -179.909 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.8 t -130.91 147.34 52.54 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.376 -0.828 . . . . 1.0 109.406 -179.939 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -66.65 102.91 0.81 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.574 -1.411 . . . . 1.0 109.574 -179.729 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 147' ' ' SER . 8.5 mtmp? -71.34 140.68 50.32 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.301 -1.117 . . . . 1.0 109.468 179.934 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.442 ' CB ' ' O ' ' A' ' 146' ' ' LYS . 1.2 t 165.99 -89.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.844 -0.798 . . . . 1.0 108.844 -179.884 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 148' ' ' HIS . . . . . 0.477 ' O ' ' ND1' ' A' ' 148' ' ' HIS . 54.9 t-80 -97.79 15.53 23.44 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.615 -0.883 . . . . 1.0 108.615 179.484 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -60.43 137.36 58.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.583 -0.698 . . . . 1.0 110.005 -179.811 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 97.2 mmm -136.33 149.53 48.44 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.555 -0.905 . . . . 1.0 108.555 179.301 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.456 HD22 ' CH2' ' A' ' 42' ' ' TRP . 24.6 mt -53.18 129.78 50.46 Favored Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 120.981 -1.074 . . . . 1.0 108.63 -179.802 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -66.39 176.25 4.25 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 CA-C-N 120.01 1.039 . . . . 1.0 112.295 -179.813 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.05 -39.91 87.58 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.366 -0.834 . . . . 1.0 109.475 179.799 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -56.15 -49.94 72.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.311 -0.868 . . . . 1.0 109.939 -179.204 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -70.78 -39.99 72.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.071 -1.018 . . . . 1.0 110.308 -179.473 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 63.7 t -60.11 -47.55 91.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.083 -1.01 . . . . 1.0 109.424 -179.634 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -60.48 -40.01 89.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.847 -1.158 . . . . 1.0 110.182 -179.815 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.45 -54.4 10.69 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 120.272 -0.966 . . . . 1.0 111.323 -178.716 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.477 HG23 ' N ' ' A' ' 160' ' ' GLN . 8.4 tp -59.98 -39.98 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.867 -1.372 . . . . 1.0 109.533 -179.075 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.486 ' O ' ' N ' ' A' ' 164' ' ' GLY . 25.4 mm100 -64.63 -39.9 94.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.269 -0.894 . . . . 1.0 109.27 179.48 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 82.5 p -61.8 -29.18 69.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.286 -0.884 . . . . 1.0 110.812 -179.334 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 94.4 mt -86.38 -56.44 3.43 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.801 -1.187 . . . . 1.0 110.819 -179.133 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -89.94 -9.62 48.15 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.004 -1.06 . . . . 1.0 110.445 -178.712 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.497 2.715 0 N-CA-C 109.362 -1.495 . . . . 1.0 109.362 -179.995 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.9 mt . . . . . 0 N--CA 1.495 1.785 0 N-CA-C 109.379 -0.6 . . . . 1.0 109.379 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.02 160.0 35.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 1.0 109.463 179.717 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -74.43 149.47 40.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.38 -0.825 . . . . 1.0 109.987 -179.525 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.7 m -89.93 1.77 55.85 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.354 -0.841 . . . . 1.0 110.361 -179.643 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -141.62 153.77 44.97 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.09 -1.006 . . . . 1.0 109.619 -179.701 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.3 mmt -90.15 0.02 57.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.404 -0.81 . . . . 1.0 110.234 -178.889 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -96.84 129.63 44.24 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.127 -0.983 . . . . 1.0 109.687 -179.837 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.1 mt -142.32 146.74 35.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.26 -0.9 . . . . 1.0 109.033 179.744 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 70.0 p -130.1 160.12 34.71 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.625 -0.88 . . . . 1.0 108.625 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -146.42 159.93 42.74 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.088 -1.007 . . . . 1.0 110.381 179.98 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.488 HH11 ' HG2' ' A' ' 18' ' ' ARG . 1.9 tpt180 -145.38 129.83 17.84 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.294 -0.632 . . . . 1.0 109.294 -179.03 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.1 mt -89.38 117.27 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.137 -0.977 . . . . 1.0 108.542 178.742 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.6 t -69.98 -40.7 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.094 -1.003 . . . . 1.0 109.565 -179.608 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -163.74 159.01 20.91 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.697 -1.252 . . . . 1.0 110.276 -179.908 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.471 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 56.7 m-85 -100.55 -160.72 0.82 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.218 -1.401 . . . . 1.0 107.218 178.933 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.16 149.78 74.22 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.226 -0.921 . . . . 1.0 109.91 -179.874 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -69.81 -13.31 34.37 Favored 'Trans proline' 0 N--CA 1.487 1.116 0 C-N-CA 120.611 0.874 . . . . 1.0 109.947 178.399 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -59.78 -38.52 82.12 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.798 -0.637 . . . . 1.0 109.832 -179.555 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 76.8 mtm -137.95 166.12 24.84 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.289 -0.882 . . . . 1.0 109.52 -179.611 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 67.8 p -72.75 160.34 32.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.369 -0.832 . . . . 1.0 109.333 -179.746 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.471 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 3.5 m80 -60.11 -40.04 88.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.262 -0.899 . . . . 1.0 109.89 -179.552 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 74.1 m -60.1 -40.04 88.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.35 -0.844 . . . . 1.0 110.876 -179.244 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -68.1 -40.04 82.7 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.023 -1.048 . . . . 1.0 110.479 -179.167 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.1 t -69.37 -40.32 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.064 -1.022 . . . . 1.0 110.133 -179.329 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.05 -49.01 79.33 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.055 -1.028 . . . . 1.0 110.412 -179.241 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.66 -32.38 72.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.9 -1.125 . . . . 1.0 109.755 -179.776 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.87 -49.36 77.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.002 -1.061 . . . . 1.0 109.536 -179.428 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -66.6 -39.14 88.25 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.13 -0.981 . . . . 1.0 109.856 179.846 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.96 -41.79 92.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.968 -1.082 . . . . 1.0 109.673 -179.321 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -60.1 -42.11 93.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.104 -0.997 . . . . 1.0 109.743 179.374 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.56 -48.07 83.41 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.223 -0.923 . . . . 1.0 110.317 -179.811 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.501 ' CZ ' ' CZ ' ' A' ' 121' ' ' PHE . 49.8 m-85 -64.27 -39.96 95.0 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.104 -0.997 . . . . 1.0 109.572 -179.415 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -59.98 -47.6 85.15 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.504 -0.748 . . . . 1.0 109.454 -179.069 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.2 t -59.94 -40.16 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.008 -1.057 . . . . 1.0 109.81 -179.683 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 71.9 m95 -78.69 -32.56 47.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.193 -0.942 . . . . 1.0 110.014 -179.714 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 85.3 p -71.39 -14.63 62.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.073 -1.017 . . . . 1.0 109.683 179.923 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -59.91 -39.98 87.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.437 -0.79 . . . . 1.0 110.229 -179.679 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.6 m -114.58 -19.72 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.455 -0.778 . . . . 1.0 110.461 -179.001 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.415 ' C ' ' H ' ' A' ' 48' ' ' LEU . 66.4 p -95.25 121.48 62.0 Favored Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 120.757 -1.215 . . . . 1.0 109.405 179.432 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -73.15 20.84 0.34 Allowed 'Trans proline' 0 N--CA 1.493 1.491 0 CA-C-N 120.236 1.12 . . . . 1.0 111.601 179.153 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.415 ' H ' ' C ' ' A' ' 46' ' ' THR . 77.9 mt -68.86 140.03 55.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 1.0 109.525 -179.85 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -103.26 120.58 41.02 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.679 -0.859 . . . . 1.0 108.679 179.704 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -106.36 120.8 42.83 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.426 -0.796 . . . . 1.0 109.77 -179.194 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.8 m -120.06 130.01 54.49 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 121.498 0.666 . . . . 1.0 110.236 179.895 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.411 ' HG2' ' NH1' ' A' ' 52' ' ' ARG . 10.1 tpt180 -82.85 138.61 33.87 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.476 -0.765 . . . . 1.0 109.166 179.288 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 90.0 mt -106.47 129.99 54.34 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.308 -0.87 . . . . 1.0 108.755 179.166 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.425 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 62.3 m170 -60.0 -40.04 87.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.955 -1.091 . . . . 1.0 109.701 -179.427 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 73.4 m-20 -151.08 172.34 15.91 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.274 -0.891 . . . . 1.0 109.464 -179.71 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.97 -179.51 32.63 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.583 -1.407 . . . . 1.0 109.583 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.7 mt -95.62 133.63 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.374 -1.074 . . . . 1.0 109.401 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.96 162.55 14.42 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.477 -0.765 . . . . 1.0 109.095 -179.89 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -59.95 -48.82 80.14 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.207 -0.933 . . . . 1.0 109.091 179.868 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 93.1 mt -109.55 103.38 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.473 -0.767 . . . . 1.0 110.215 179.807 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.3 ptp -102.32 137.31 40.74 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.183 -0.948 . . . . 1.0 109.297 178.788 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 88.4 mt -109.95 130.47 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.575 -0.703 . . . . 1.0 109.743 -179.542 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.8 p -150.31 158.93 44.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.351 -0.843 . . . . 1.0 109.597 -179.615 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -99.97 128.5 46.05 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.434 -0.95 . . . . 1.0 108.434 179.413 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.6 150.6 16.99 Favored Glycine 0 N--CA 1.498 2.804 0 N-CA-C 110.185 -1.166 . . . . 1.0 110.185 -178.979 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 7.1 tt . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 108.158 -1.053 . . . . 1.0 108.158 179.407 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.533 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 97.9 m-85 . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 108.663 -0.865 . . . . 1.0 108.663 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -101.27 13.78 34.01 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.155 -0.965 . . . . 1.0 110.209 -179.296 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 117.12 -156.91 15.36 Favored Glycine 0 N--CA 1.502 3.047 0 N-CA-C 108.894 -1.682 . . . . 1.0 108.894 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -58.48 -65.38 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.451 0 CA-C-N 118.633 1.217 . . . . 1.0 112.267 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 90.6 p -76.85 164.18 26.07 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.183 -0.948 . . . . 1.0 109.815 -179.93 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.85 -129.45 8.65 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 109.587 -1.405 . . . . 1.0 109.587 179.88 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.44 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 13.2 mt -68.99 106.48 2.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.435 -1.038 . . . . 1.0 109.09 179.961 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.417 HD23 ' OE2' ' A' ' 102' ' ' GLU . 50.8 mt -78.71 -23.71 45.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.017 -1.052 . . . . 1.0 108.884 179.95 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.11 169.56 1.9 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.709 -0.849 . . . . 1.0 108.709 179.837 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -161.7 161.89 29.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.159 -0.963 . . . . 1.0 109.127 179.304 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.78 157.03 44.67 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.2 -0.938 . . . . 1.0 109.724 -179.355 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -93.63 151.96 40.45 Favored Pre-proline 0 N--CA 1.494 1.726 0 N-CA-C 108.483 -0.932 . . . . 1.0 108.483 179.691 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -42.16 160.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.243 0 C-N-CA 120.663 0.909 . . . . 1.0 111.667 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo . . . . . 0 N--CA 1.49 1.276 0 C-N-CA 120.645 0.897 . . . . 1.0 111.955 -179.52 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 121.428 0.632 . . . . 1.0 110.116 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.35 124.11 9.86 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.408 -0.808 . . . . 1.0 109.32 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -111.38 137.61 48.93 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.605 -0.684 . . . . 1.0 109.942 -179.752 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.526 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 27.3 m-85 -114.38 154.23 28.45 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 109.111 -0.699 . . . . 1.0 109.111 179.638 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.533 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 1.7 m-20 -78.54 123.66 27.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.056 -1.028 . . . . 1.0 109.522 179.759 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 43.7 t0 -83.93 -12.38 55.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.229 -0.92 . . . . 1.0 109.391 179.724 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -84.14 -10.01 58.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.352 -0.842 . . . . 1.0 109.871 -179.818 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.417 ' OE2' HD23 ' A' ' 82' ' ' LEU . 99.3 mt-10 -91.48 169.65 10.6 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.204 -0.935 . . . . 1.0 110.033 -179.241 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 15.9 m -100.05 106.25 17.99 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.432 -0.792 . . . . 1.0 108.917 -179.788 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.418 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 91.1 m95 -89.18 124.45 34.36 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.76 -0.83 . . . . 1.0 108.76 179.813 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.652 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.7 t -140.04 159.29 42.5 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.422 -0.799 . . . . 1.0 109.944 -179.103 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.4 t -96.88 -13.3 22.58 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.332 -0.855 . . . . 1.0 109.011 179.485 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 65.6 m -90.62 179.14 5.9 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.768 -0.827 . . . . 1.0 108.768 179.388 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.2 m -79.43 80.18 5.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.983 -1.073 . . . . 1.0 109.349 -179.893 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.652 ' HB2' HG21 ' A' ' 105' ' ' THR . 68.3 mttm -148.88 149.53 31.42 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.654 -0.869 . . . . 1.0 108.654 179.379 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 109' ' ' LYS . . . 44.36 -137.3 5.33 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.602 -1.399 . . . . 1.0 109.602 179.71 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -99.6 117.66 34.46 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.32 -1.106 . . . . 1.0 109.017 179.304 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -62.25 130.3 44.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.326 -0.858 . . . . 1.0 109.733 -179.738 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.9 tp -59.99 -41.88 93.0 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.321 -0.862 . . . . 1.0 110.211 -179.579 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -59.97 -40.12 87.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.179 -0.951 . . . . 1.0 110.505 -179.319 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.447 HD21 ' CE ' ' A' ' 146' ' ' LYS . 3.6 mm? -59.04 -51.21 71.05 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.746 -1.221 . . . . 1.0 109.883 -179.675 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.8 t -69.96 -40.37 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.131 -0.981 . . . . 1.0 109.961 -178.905 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.22 -52.6 65.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -0.91 . . . . 1.0 109.943 -179.422 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.03 -39.05 84.57 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.095 -1.003 . . . . 1.0 110.157 -179.769 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.624 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 70.3 t60 -64.05 -50.0 70.13 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.408 -0.808 . . . . 1.0 111.428 -178.272 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.526 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 10.5 pt-20 -60.03 -39.5 86.09 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.664 -1.272 . . . . 1.0 110.319 -179.168 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.501 ' CZ ' ' CZ ' ' A' ' 39' ' ' PHE . 29.6 m-85 -60.0 -40.02 87.76 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.716 -1.24 . . . . 1.0 108.574 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.91 -42.07 94.55 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.526 -1.43 . . . . 1.0 109.526 -179.949 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.624 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 84.6 m-70 -66.89 -39.99 87.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.068 -1.254 . . . . 1.0 109.228 179.522 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.5 p -66.71 -24.44 66.24 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.328 -0.858 . . . . 1.0 108.856 179.542 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 71.4 mt -81.67 -0.58 43.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.394 -0.816 . . . . 1.0 109.357 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 88.77 6.79 72.17 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 120.349 -0.929 . . . . 1.0 110.782 178.834 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.9 mt -82.74 146.37 29.04 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.782 -1.422 . . . . 1.0 109.644 179.78 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 33.5 t0 -99.33 173.13 6.92 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.926 -0.768 . . . . 1.0 108.926 -179.73 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.493 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 76.4 m80 -59.97 138.45 57.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.175 -0.953 . . . . 1.0 109.807 -179.422 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 33.3 t -97.09 156.51 16.34 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.267 -0.896 . . . . 1.0 109.208 179.739 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -99.86 1.57 43.04 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.318 -0.864 . . . . 1.0 109.663 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -87.03 130.17 49.26 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.18 -0.95 . . . . 1.0 108.913 179.797 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -69.39 -25.35 30.41 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 CA-C-N 120.099 1.071 . . . . 1.0 112.27 -179.622 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -83.58 -4.99 88.81 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.409 -1.476 . . . . 1.0 109.409 -179.805 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.89 145.34 26.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -1.162 . . . . 1.0 109.319 179.567 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.424 ' C ' ' H ' ' A' ' 138' ' ' PHE . 80.5 mt -69.5 -33.13 72.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.294 -0.879 . . . . 1.0 109.723 179.727 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 93.9 mmm -71.8 18.4 0.08 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.152 -0.967 . . . . 1.0 110.687 -179.463 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.424 ' H ' ' C ' ' A' ' 136' ' ' LEU . 13.2 t80 -69.79 133.14 88.51 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.735 -1.228 . . . . 1.0 107.89 179.819 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -62.94 -15.28 46.57 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 CA-C-N 119.905 1.002 . . . . 1.0 113.792 -178.116 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.0 mt -105.91 141.91 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 120.943 -1.098 . . . . 1.0 109.986 -179.392 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -74.95 129.72 38.14 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.397 -0.815 . . . . 1.0 109.691 -179.723 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.6 t -143.13 139.93 30.62 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.348 -0.845 . . . . 1.0 108.853 179.317 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -81.88 143.73 31.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.99 -1.069 . . . . 1.0 109.407 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 m -140.19 150.97 44.83 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.39 -0.819 . . . . 1.0 109.763 -179.314 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.38 112.18 3.65 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 107.717 -2.153 . . . . 1.0 107.717 178.222 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.447 ' CE ' HD21 ' A' ' 115' ' ' LEU . 33.6 mmtm -76.09 4.89 7.59 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.3 -1.118 . . . . 1.0 109.887 -178.607 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 86.8 p -71.79 122.74 21.22 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.181 -0.95 . . . . 1.0 109.119 179.737 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 52.03 40.0 27.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.283 -0.886 . . . . 1.0 110.078 179.848 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -92.5 129.8 38.34 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.927 -1.108 . . . . 1.0 109.74 179.613 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 96.2 mmm -131.45 150.02 52.31 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.499 -0.926 . . . . 1.0 108.499 179.117 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 22.0 mt -50.61 132.13 27.18 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 120.898 -1.126 . . . . 1.0 109.034 -179.515 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -68.53 174.52 8.25 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 CA-C-N 120.0 1.036 . . . . 1.0 111.639 179.364 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -60.04 -39.96 87.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.285 -0.884 . . . . 1.0 109.863 -179.882 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -55.22 -49.77 71.13 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.131 -0.98 . . . . 1.0 109.935 -179.278 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.12 -39.87 75.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.171 -0.956 . . . . 1.0 110.28 -179.349 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 64.4 t -60.08 -45.47 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.003 -1.061 . . . . 1.0 109.03 -179.563 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -60.96 -40.08 91.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.137 -0.977 . . . . 1.0 110.652 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.79 -53.6 9.46 Favored Glycine 0 N--CA 1.497 2.75 0 O-C-N 121.071 -1.018 . . . . 1.0 111.355 -178.518 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.47 HG23 ' N ' ' A' ' 160' ' ' GLN . 7.8 tp -60.05 -40.02 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.94 -1.33 . . . . 1.0 109.637 -178.923 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.5 mt-30 -65.96 -39.6 90.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.091 -1.005 . . . . 1.0 109.716 179.448 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 84.9 p -60.63 -32.19 71.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.09 -1.006 . . . . 1.0 110.688 -179.29 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.4 mt -85.64 -51.51 6.42 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.898 -1.126 . . . . 1.0 110.669 -178.993 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -91.24 -9.12 46.38 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.986 -1.071 . . . . 1.0 110.411 -178.927 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.517 0 N-CA-C 109.475 -1.45 . . . . 1.0 109.475 -179.947 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.1 mt . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 121.381 0.61 . . . . 1.0 109.519 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -160.79 162.29 32.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.367 -0.833 . . . . 1.0 109.617 179.847 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -72.14 149.74 44.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.213 -0.929 . . . . 1.0 109.373 -179.759 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 94.5 p -86.99 1.66 52.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.278 -0.889 . . . . 1.0 109.584 -179.743 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -146.25 154.7 42.02 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.236 -0.915 . . . . 1.0 109.605 -179.845 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.56 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -91.61 0.14 57.53 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.377 -0.827 . . . . 1.0 109.957 -179.631 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -95.16 125.79 40.05 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.109 -0.994 . . . . 1.0 109.192 179.768 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.8 mt -140.04 147.75 40.82 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.363 -0.835 . . . . 1.0 109.192 -179.637 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.0 p -131.44 153.54 49.62 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.482 -0.761 . . . . 1.0 109.032 179.97 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -145.46 160.02 42.22 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.123 -0.985 . . . . 1.0 109.96 -179.988 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.423 HH11 ' HG2' ' A' ' 18' ' ' ARG . 35.3 ttt-85 -142.36 133.8 26.49 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.434 -0.791 . . . . 1.0 109.492 -179.504 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.7 mt -86.61 116.47 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.088 -1.008 . . . . 1.0 108.634 178.917 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.9 t -69.94 -41.46 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.346 -0.846 . . . . 1.0 109.965 -179.311 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -164.48 158.98 18.89 Favored 'General case' 0 C--N 1.291 -1.952 0 O-C-N 119.238 -2.163 . . . . 1.0 111.548 -178.228 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -101.79 119.06 38.19 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.631 -1.618 . . . . 1.0 106.631 178.313 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 23' ' ' THR . 0.1 OUTLIER -61.92 138.0 95.51 Favored Pre-proline 0 C--N 1.303 -1.448 0 O-C-N 121.028 -1.045 . . . . 1.0 109.073 -178.327 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -56.46 -6.35 1.47 Allowed 'Trans proline' 0 N--CA 1.484 0.951 0 CA-C-N 119.614 0.898 . . . . 1.0 110.504 179.554 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 23' ' ' THR . 81.9 m-20 -60.01 -38.69 83.4 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 120.075 -0.65 . . . . 1.0 110.444 -179.457 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 76.7 mtm -139.25 171.11 14.76 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.053 -1.029 . . . . 1.0 109.359 -179.376 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 82.0 p -75.28 164.98 25.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.332 -0.855 . . . . 1.0 109.829 -179.334 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -63.98 -43.79 94.67 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.317 -0.864 . . . . 1.0 110.037 -179.559 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 53.3 m -60.18 -40.08 88.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 1.0 110.712 -178.92 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -65.21 -46.78 79.27 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.011 -1.056 . . . . 1.0 110.359 -179.345 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 70.5 t -64.01 -39.92 87.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.471 -0.768 . . . . 1.0 109.48 -179.738 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -55.55 -55.18 34.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.517 -0.739 . . . . 1.0 111.321 -178.774 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.2 pttt -63.6 -32.12 73.49 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.899 -1.125 . . . . 1.0 110.843 -178.678 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.67 -49.99 74.67 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.728 -1.233 . . . . 1.0 109.563 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -67.15 -39.98 86.61 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.066 -1.021 . . . . 1.0 110.454 -179.822 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -59.97 -40.54 89.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.782 -1.199 . . . . 1.0 109.62 -179.581 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -60.42 -40.05 89.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.975 -1.078 . . . . 1.0 109.159 178.885 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.0 -46.3 89.91 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.434 -0.791 . . . . 1.0 109.689 -179.235 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -65.4 -38.91 91.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.136 -0.977 . . . . 1.0 109.466 179.851 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -59.69 -48.16 82.78 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.208 -0.932 . . . . 1.0 110.18 -179.352 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.06 -42.61 90.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.139 -0.976 . . . . 1.0 109.989 -179.61 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -77.8 -38.79 45.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.174 -0.953 . . . . 1.0 110.161 -179.383 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 84.0 p -70.01 -16.77 63.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.096 -1.002 . . . . 1.0 109.997 -179.645 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -59.9 -40.05 87.45 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.072 -1.018 . . . . 1.0 110.412 -179.614 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.6 m -111.81 -19.49 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.406 0 O-C-N 120.991 -1.068 . . . . 1.0 110.815 -179.41 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.0 p -94.52 128.56 39.66 Favored Pre-proline 0 N--CA 1.5 2.041 0 O-C-N 120.761 -1.212 . . . . 1.0 109.392 179.845 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -73.76 16.46 0.51 Allowed 'Trans proline' 0 N--CA 1.494 1.519 0 CA-C-N 120.17 1.096 . . . . 1.0 111.963 179.27 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.2 mt -69.22 140.01 54.53 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.265 -0.897 . . . . 1.0 109.969 -179.667 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -106.65 121.29 44.05 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.764 -0.828 . . . . 1.0 108.764 179.644 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -106.81 126.03 51.77 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.18 -0.95 . . . . 1.0 109.358 -179.777 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.1 m -120.05 130.03 54.5 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.535 -0.728 . . . . 1.0 109.803 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.434 ' HG2' HH11 ' A' ' 52' ' ' ARG . 33.8 ttt-85 -82.41 133.95 35.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.302 -0.874 . . . . 1.0 109.213 179.51 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.8 mt -103.35 130.57 50.67 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.247 -0.908 . . . . 1.0 109.356 179.856 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.443 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 45.5 m170 -63.41 -39.99 95.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.342 -0.849 . . . . 1.0 110.04 -179.599 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 76.6 m-20 -148.94 172.89 13.98 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.116 -0.99 . . . . 1.0 109.93 -179.505 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.43 177.92 39.98 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.595 -1.402 . . . . 1.0 109.595 179.984 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.7 mt -94.03 133.7 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.237 -1.155 . . . . 1.0 109.06 179.96 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.75 163.5 13.21 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.515 -0.741 . . . . 1.0 109.378 -179.424 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -60.01 -49.41 77.77 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.182 -0.948 . . . . 1.0 109.398 -179.77 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.8 mt -107.54 102.97 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.386 -0.821 . . . . 1.0 109.896 179.827 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.5 ptm -103.27 130.7 50.59 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.149 -0.969 . . . . 1.0 109.613 179.471 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.8 mt -105.4 138.01 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.581 -0.699 . . . . 1.0 109.926 -179.289 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 63.8 p -153.69 158.64 41.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.217 -0.927 . . . . 1.0 109.985 179.885 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.81 123.07 48.02 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.477 -0.934 . . . . 1.0 108.477 179.517 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.429 ' O ' ' CB ' ' A' ' 100' ' ' ASP . . . -99.97 175.82 27.76 Favored Glycine 0 N--CA 1.504 3.173 0 O-C-N 121.091 -1.005 . . . . 1.0 111.482 -178.563 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 72.3 mt . . . . . 0 N--CA 1.5 2.034 0 O-C-N 121.612 -0.934 . . . . 1.0 108.769 179.504 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.498 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 87.0 m-85 . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -100.15 0.01 39.72 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.23 -0.919 . . . . 1.0 110.266 -179.054 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 136.22 -155.64 22.56 Favored Glycine 0 N--CA 1.498 2.816 0 N-CA-C 108.475 -1.85 . . . . 1.0 108.475 -179.474 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.444 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 7.4 Cg_exo -62.72 -63.76 0.08 OUTLIER 'Trans proline' 0 C--N 1.313 -1.318 0 CA-C-N 118.697 1.249 . . . . 1.0 111.67 179.414 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 83.3 p -77.11 160.02 29.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.074 -1.016 . . . . 1.0 109.323 179.566 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 117.1 -129.3 8.29 Favored Glycine 0 N--CA 1.502 3.084 0 N-CA-C 109.642 -1.383 . . . . 1.0 109.642 179.882 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.419 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 22.3 mt -69.82 109.68 4.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -1.174 . . . . 1.0 109.24 -179.836 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 46.7 mt -80.74 -19.22 45.47 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.135 -0.978 . . . . 1.0 108.996 -179.919 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.55 171.26 1.25 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.761 -0.829 . . . . 1.0 108.761 179.697 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -162.07 159.41 26.18 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.142 -0.974 . . . . 1.0 109.796 179.331 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.6 166.2 29.98 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.79 -0.819 . . . . 1.0 108.79 -179.593 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -101.5 152.77 38.09 Favored Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.217 -0.927 . . . . 1.0 108.873 -179.987 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -63.05 165.13 17.44 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 120.599 0.866 . . . . 1.0 111.615 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo . . . . . 0 N--CA 1.489 1.259 0 C-N-CA 121.191 1.261 . . . . 1.0 112.438 -179.814 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.5 p-10 . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.39 126.15 12.64 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.223 -0.923 . . . . 1.0 109.398 -179.72 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -119.25 153.6 34.74 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.535 -0.728 . . . . 1.0 109.863 -179.774 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -131.22 154.4 48.47 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.622 -0.674 . . . . 1.0 109.281 -179.915 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.498 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 1.2 m-20 -79.46 117.98 20.92 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.04 -1.037 . . . . 1.0 108.749 179.022 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.429 ' CB ' ' O ' ' A' ' 65' ' ' GLY . 35.5 t0 -82.86 -10.66 58.73 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.016 -1.053 . . . . 1.0 109.178 -179.996 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -82.97 -11.63 57.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.383 -0.823 . . . . 1.0 109.107 179.756 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.444 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 99.5 mt-10 -89.53 169.96 10.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.439 -0.788 . . . . 1.0 109.101 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 22.2 m -98.89 104.68 16.74 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.204 -0.935 . . . . 1.0 109.104 -179.671 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.476 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 97.0 m95 -87.63 121.61 30.27 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 179.632 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.651 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.9 t -139.74 153.81 47.28 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.348 -0.845 . . . . 1.0 109.748 -179.198 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.4 m -94.32 -9.11 36.97 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.308 -0.997 . . . . 1.0 108.308 179.187 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 61.6 p -90.99 174.35 7.46 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.601 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 23.1 t -74.04 73.88 1.7 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.183 -0.948 . . . . 1.0 109.543 179.984 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.651 ' HB2' HG21 ' A' ' 105' ' ' THR . 98.2 mttt -148.58 152.49 36.87 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.331 -0.855 . . . . 1.0 109.133 179.471 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 109' ' ' LYS . . . 42.01 -139.65 2.07 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.959 -1.256 . . . . 1.0 109.959 179.631 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -100.05 117.37 34.17 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.353 -1.086 . . . . 1.0 108.855 179.226 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.449 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 58.0 t-20 -63.52 131.2 47.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.154 -0.966 . . . . 1.0 109.939 -179.527 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.2 tp -60.07 -45.07 94.09 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.474 -0.766 . . . . 1.0 111.092 -179.519 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -59.89 -41.92 92.67 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.0 -1.062 . . . . 1.0 111.069 -178.407 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 115' ' ' LEU . 4.1 mm? -58.09 -50.68 72.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.677 -1.264 . . . . 1.0 109.245 -179.49 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 67.6 t -70.44 -39.97 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.962 . . . . 1.0 110.219 -179.544 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.35 -51.77 68.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.063 -1.023 . . . . 1.0 109.597 -179.503 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.04 81.45 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.269 -0.894 . . . . 1.0 109.964 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.601 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 56.2 t60 -60.96 -50.14 74.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.338 -0.852 . . . . 1.0 110.766 -178.403 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -60.11 -40.13 88.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.625 -1.297 . . . . 1.0 109.874 -179.65 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -60.03 -40.09 88.17 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 120.966 -1.084 . . . . 1.0 108.437 179.614 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.58 -42.54 84.66 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.178 -1.569 . . . . 1.0 109.178 179.829 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.601 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 89.2 m-70 -67.48 -40.0 85.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -1.15 . . . . 1.0 109.369 179.529 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 73.0 p -65.96 -21.58 66.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 1.0 109.625 -179.908 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 84.2 mt -82.54 0.29 43.33 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.156 -0.965 . . . . 1.0 109.697 -179.796 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.47 3.32 72.03 Favored Glycine 0 N--CA 1.497 2.719 0 C-N-CA 120.221 -0.99 . . . . 1.0 110.754 179.048 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.7 mt -84.2 148.12 26.91 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.954 -1.321 . . . . 1.0 109.576 179.979 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 41.0 t0 -101.57 173.82 6.25 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.776 -0.824 . . . . 1.0 108.776 179.801 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.527 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 76.6 m80 -57.14 135.7 56.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.006 -1.059 . . . . 1.0 109.274 -179.749 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 33.4 t -98.76 156.17 16.98 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.392 -0.818 . . . . 1.0 109.405 -179.839 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -99.65 8.38 44.42 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.303 -0.873 . . . . 1.0 109.344 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -87.18 122.18 71.09 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 1.0 108.688 179.657 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -66.76 -12.47 36.09 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 CA-C-N 120.267 1.131 . . . . 1.0 111.825 -179.765 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -95.51 -4.2 60.87 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.91 -1.276 . . . . 1.0 109.91 -179.843 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -87.87 142.27 27.94 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.069 -1.254 . . . . 1.0 109.816 -179.893 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.6 mt -61.47 -40.08 93.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.335 -0.853 . . . . 1.0 109.717 179.859 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 88.5 mtp -71.69 20.99 0.05 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.413 -0.804 . . . . 1.0 111.528 -178.552 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -68.38 132.63 91.36 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 120.498 -1.376 . . . . 1.0 108.067 179.681 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -48.76 -42.96 35.98 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 CA-C-N 119.88 0.993 . . . . 1.0 113.444 -178.798 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 98.4 mt -82.93 143.62 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.038 -1.039 . . . . 1.0 110.815 -178.853 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 141' ' ' TYR . . . . . 0.449 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 26.2 t80 -77.42 131.33 37.95 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.693 -0.63 . . . . 1.0 109.52 179.738 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 13.3 t -139.66 140.41 36.89 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.291 -0.88 . . . . 1.0 109.274 179.575 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -82.46 140.55 33.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.212 -0.93 . . . . 1.0 108.939 179.639 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.1 t -140.39 151.28 44.82 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.295 -0.878 . . . . 1.0 109.741 -179.384 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.92 107.97 2.35 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.019 -1.633 . . . . 1.0 109.019 179.661 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 21.7 mtmm -78.13 -0.93 30.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -1.12 . . . . 1.0 109.758 -179.262 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 88.8 p -59.97 -38.35 82.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.283 -0.886 . . . . 1.0 110.133 -179.49 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -139.21 21.63 2.59 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.257 -0.902 . . . . 1.0 110.143 -179.308 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -68.26 137.57 54.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.931 -1.106 . . . . 1.0 109.578 -179.836 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 75.4 mtm -138.87 148.91 44.27 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.244 -1.021 . . . . 1.0 108.244 179.265 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 20.8 mt -51.81 124.03 26.37 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 120.796 -1.19 . . . . 1.0 108.436 -179.737 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -66.15 174.65 5.69 Favored 'Trans proline' 0 N--CA 1.49 1.299 0 CA-C-N 120.124 1.08 . . . . 1.0 112.233 -179.47 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -60.12 -39.81 87.55 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.424 -0.797 . . . . 1.0 109.167 179.816 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -56.45 -49.96 73.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 1.0 110.065 -179.413 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.81 -40.11 72.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.038 -1.039 . . . . 1.0 110.226 -179.411 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 79.0 t -61.37 -48.91 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.089 -1.007 . . . . 1.0 109.444 -179.553 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.18 -39.95 88.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.131 -0.981 . . . . 1.0 110.492 -179.792 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.26 -55.12 8.06 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 120.197 -1.001 . . . . 1.0 111.199 -178.632 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.472 HG23 ' N ' ' A' ' 160' ' ' GLN . 7.7 tp -60.14 -40.1 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.917 -1.343 . . . . 1.0 109.676 -179.096 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.544 ' O ' ' N ' ' A' ' 164' ' ' GLY . 27.1 mm100 -65.09 -39.74 93.61 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.225 -0.922 . . . . 1.0 109.402 179.675 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 86.6 p -62.92 -27.21 69.22 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.224 -0.922 . . . . 1.0 110.135 -179.612 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 92.5 mt -86.69 -53.53 4.89 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.912 -1.117 . . . . 1.0 110.437 -179.376 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -91.79 -9.41 43.66 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.07 -1.019 . . . . 1.0 110.051 -179.083 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.582 0 N-CA-C 109.434 -1.466 . . . . 1.0 109.434 -179.878 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.3 mt . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 109.439 -0.578 . . . . 1.0 109.439 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -162.28 161.25 27.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.294 -0.879 . . . . 1.0 109.669 -179.946 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -72.44 149.35 44.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.075 -1.016 . . . . 1.0 109.156 179.662 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.0 p -85.67 -0.9 56.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.258 -0.901 . . . . 1.0 109.815 -179.497 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -150.47 157.32 42.89 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.101 -0.999 . . . . 1.0 109.518 179.843 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.531 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.01 0.54 57.05 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.179 -0.951 . . . . 1.0 109.988 -179.627 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -94.76 128.35 41.4 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.139 -0.976 . . . . 1.0 108.948 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 97.8 mt -141.85 151.16 42.48 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.158 -0.964 . . . . 1.0 109.342 -179.585 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.7 p -132.86 158.61 42.11 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.055 -0.72 . . . . 1.0 109.055 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -146.27 162.66 37.61 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.1 -1.0 . . . . 1.0 109.988 -179.854 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -143.84 133.04 23.05 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.582 -0.699 . . . . 1.0 109.661 -179.622 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 86.0 mt -88.62 111.21 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.382 -0.97 . . . . 1.0 108.382 178.468 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.4 t -69.96 -40.35 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.012 -1.055 . . . . 1.0 109.679 -179.152 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.9 p-10 -162.37 160.99 27.19 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.839 -1.163 . . . . 1.0 110.431 -179.741 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.428 ' CD2' ' CE1' ' A' ' 28' ' ' HIS . 64.6 m-85 -101.75 -168.89 1.61 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.346 -1.353 . . . . 1.0 107.346 178.902 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.79 143.69 35.59 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.426 -0.796 . . . . 1.0 109.281 179.806 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -63.57 -11.93 28.57 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 CA-C-O 122.511 0.963 . . . . 1.0 110.177 179.067 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -60.04 -39.99 87.86 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 114.942 -1.026 . . . . 1.0 110.126 -179.974 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.5 mtm -142.53 168.3 20.05 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.22 -0.925 . . . . 1.0 110.118 -178.936 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.7 p -72.2 160.06 33.05 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.422 -0.799 . . . . 1.0 109.76 -179.791 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.428 ' CE1' ' CD2' ' A' ' 22' ' ' TYR . 2.8 m-70 -60.13 -39.91 87.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.41 -0.807 . . . . 1.0 110.223 -179.589 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 63.2 m -59.91 -40.12 87.75 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.102 -0.999 . . . . 1.0 110.798 -178.674 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -67.32 -39.94 85.9 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.958 -1.089 . . . . 1.0 110.059 -179.698 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.0 t -69.0 -41.15 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.013 -1.054 . . . . 1.0 110.265 -179.29 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.02 -48.29 82.32 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.02 -1.05 . . . . 1.0 110.51 -179.194 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.54 -33.14 72.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.888 -1.132 . . . . 1.0 109.126 179.852 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.98 -49.35 78.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.087 -1.008 . . . . 1.0 109.849 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -67.47 -38.28 84.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.91 -1.119 . . . . 1.0 109.729 179.915 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.411 ' NZ ' ' NH1' ' A' ' 52' ' ' ARG . 63.5 mmtt -59.95 -43.37 95.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.06 -1.025 . . . . 1.0 109.285 -179.522 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -60.34 -40.26 90.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.019 -1.051 . . . . 1.0 108.92 179.376 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.04 -46.87 88.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.486 -0.759 . . . . 1.0 109.927 -179.947 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -65.68 -39.26 91.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.027 -1.046 . . . . 1.0 109.859 -179.711 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -60.04 -46.37 89.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.039 -1.038 . . . . 1.0 109.761 -179.707 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.8 t -60.12 -43.26 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.169 -0.957 . . . . 1.0 110.585 -179.567 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -77.68 -38.03 48.42 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.92 -1.112 . . . . 1.0 110.113 -179.192 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.9 p -70.43 -15.93 62.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.296 -0.877 . . . . 1.0 110.131 -179.385 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -60.02 -40.01 87.81 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.129 -0.982 . . . . 1.0 110.824 -179.636 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.6 m -112.17 -22.68 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.323 -0.861 . . . . 1.0 110.312 -178.685 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.0 p -93.42 130.93 33.87 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 120.943 -1.098 . . . . 1.0 109.595 -179.992 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -74.61 17.48 0.55 Allowed 'Trans proline' 0 N--CA 1.496 1.638 0 CA-C-N 119.91 1.004 . . . . 1.0 112.043 179.233 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.8 mt -68.94 139.85 55.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.114 -0.991 . . . . 1.0 109.838 -179.444 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -106.62 121.21 43.87 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.933 -0.765 . . . . 1.0 108.933 179.417 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -106.86 124.76 50.09 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.281 -0.887 . . . . 1.0 109.727 -179.428 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.2 m -119.96 130.04 54.58 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.626 -0.671 . . . . 1.0 109.891 179.896 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.472 ' CB ' ' NH1' ' A' ' 52' ' ' ARG . 11.6 ttp-105 -82.88 134.84 35.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.268 -0.895 . . . . 1.0 109.556 179.579 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.3 mt -107.43 134.13 50.93 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.266 -0.896 . . . . 1.0 109.299 179.614 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.434 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 59.5 m170 -65.01 -39.9 94.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.438 -0.789 . . . . 1.0 109.46 -179.931 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 72.0 m-20 -151.44 -176.74 5.71 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.281 -0.887 . . . . 1.0 109.486 -179.805 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.21 -179.48 43.74 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.367 -1.493 . . . . 1.0 109.367 -179.662 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 93.3 mt -97.1 130.45 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.296 -1.12 . . . . 1.0 109.474 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.05 160.46 16.42 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.453 -0.779 . . . . 1.0 109.67 -179.605 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.06 -49.1 78.97 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.284 -0.885 . . . . 1.0 109.348 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.9 mt -105.73 97.04 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.467 -0.771 . . . . 1.0 109.729 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.9 ptm -99.2 125.27 44.74 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.083 -1.01 . . . . 1.0 109.173 179.368 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 86.6 mt -102.81 137.52 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.458 -0.776 . . . . 1.0 109.434 -179.451 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.1 p -153.38 153.32 32.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.185 -0.947 . . . . 1.0 109.852 -179.896 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -104.09 121.36 43.05 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.225 -1.028 . . . . 1.0 108.225 179.116 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -108.22 -172.99 21.71 Favored Glycine 0 N--CA 1.5 2.907 0 N-CA-C 110.852 -0.899 . . . . 1.0 110.852 -178.784 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 83.3 mt . . . . . 0 N--CA 1.493 1.708 0 N-CA-C 108.098 -1.075 . . . . 1.0 108.098 179.29 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.55 ' CE2' ' OD1' ' A' ' 99' ' ' ASP . 89.8 m-85 . . . . . 0 N--CA 1.496 1.853 0 N-CA-C 108.505 -0.924 . . . . 1.0 108.505 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 79' ' ' SER . 20.7 p-10 -96.1 9.53 40.57 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.015 -1.053 . . . . 1.0 110.295 -179.091 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 120.88 -154.86 16.35 Favored Glycine 0 N--CA 1.504 3.181 0 N-CA-C 108.934 -1.666 . . . . 1.0 108.934 179.888 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.434 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 3.7 Cg_exo -63.12 -62.41 0.11 Allowed 'Trans proline' 0 N--CA 1.489 1.224 0 CA-C-N 118.962 1.381 . . . . 1.0 111.715 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.419 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 70.9 p -75.63 162.41 28.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.439 -0.788 . . . . 1.0 109.729 179.736 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 111.67 -126.35 7.64 Favored Glycine 0 N--CA 1.501 2.983 0 N-CA-C 109.9 -1.28 . . . . 1.0 109.9 179.71 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.401 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 7.2 mt -69.69 100.39 1.48 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.36 -1.082 . . . . 1.0 109.074 -179.787 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 46.4 mt -73.91 -29.75 62.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.033 -1.042 . . . . 1.0 109.252 -179.702 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -177.32 166.81 2.33 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.086 -1.079 . . . . 1.0 108.086 -179.661 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -163.07 159.91 23.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.753 -1.217 . . . . 1.0 110.033 179.652 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -138.69 160.32 39.94 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.924 -0.769 . . . . 1.0 108.924 179.898 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -97.45 152.06 38.0 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.248 -0.908 . . . . 1.0 109.278 -179.663 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -47.08 167.0 0.08 OUTLIER 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 120.437 0.758 . . . . 1.0 111.359 179.976 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo . . . . . 0 N--CA 1.494 1.536 0 C-N-CA 120.981 1.121 . . . . 1.0 112.416 -179.312 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.442 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 31.5 p-10 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.683 -0.488 . . . . 1.0 109.683 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.96 119.41 6.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.181 -0.949 . . . . 1.0 109.655 179.826 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -103.87 126.02 50.7 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.398 -0.814 . . . . 1.0 109.593 179.975 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.412 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 28.1 m-85 -106.14 145.92 30.88 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.549 -0.719 . . . . 1.0 109.266 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.55 ' OD1' ' CE2' ' A' ' 75' ' ' PHE . 94.7 m-20 -78.24 121.98 25.1 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.979 -1.076 . . . . 1.0 109.145 179.513 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 45.7 t0 -83.18 -10.89 58.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.232 -0.918 . . . . 1.0 109.622 179.976 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -81.91 -10.98 59.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.311 -0.868 . . . . 1.0 109.852 -179.732 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.434 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 98.7 mt-10 -89.15 169.05 11.8 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.185 -0.947 . . . . 1.0 109.614 -179.348 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 54.8 m -98.12 104.73 16.79 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.168 -0.958 . . . . 1.0 109.291 -179.521 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -89.35 120.95 31.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.882 . . . . 1.0 108.908 179.924 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.638 HG21 ' HB2' ' A' ' 109' ' ' LYS . 6.4 t -140.06 150.16 44.03 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.444 -0.785 . . . . 1.0 109.819 -179.046 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 66.3 m -91.64 -8.59 46.74 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.257 -1.016 . . . . 1.0 108.257 179.034 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 83.5 p -90.17 172.14 9.02 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.787 -0.82 . . . . 1.0 108.787 179.364 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.7 t -74.99 77.2 2.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.024 -1.047 . . . . 1.0 109.416 -179.962 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.638 ' HB2' HG21 ' A' ' 105' ' ' THR . 96.4 mttt -148.85 147.52 28.82 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 179.456 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.14 -138.06 4.72 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.981 -1.248 . . . . 1.0 109.981 179.746 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -100.04 115.2 29.18 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.282 -1.128 . . . . 1.0 109.171 179.906 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -63.96 133.95 54.16 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.087 -1.008 . . . . 1.0 109.781 -179.685 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.4 tp -59.95 -45.09 93.74 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.357 -0.84 . . . . 1.0 111.165 -179.6 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -59.94 -40.97 90.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.988 -1.07 . . . . 1.0 110.695 -178.188 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -59.97 -50.2 74.68 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.838 -1.164 . . . . 1.0 109.436 -179.569 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.5 t -70.01 -40.48 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.099 -1.0 . . . . 1.0 110.109 -179.396 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.93 -51.27 70.77 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.115 -0.99 . . . . 1.0 109.6 -179.312 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.99 -36.56 77.45 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.282 -0.886 . . . . 1.0 110.425 -179.97 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.607 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 63.6 t60 -63.34 -49.88 72.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.166 -0.959 . . . . 1.0 110.806 -178.558 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.412 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 7.3 pt-20 -59.87 -39.15 84.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.746 -1.221 . . . . 1.0 109.999 -179.455 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -60.04 -40.05 88.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.788 -1.195 . . . . 1.0 108.829 179.421 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -56.97 -42.9 93.03 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.547 -1.421 . . . . 1.0 109.547 179.988 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.607 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 87.8 m-70 -67.23 -39.96 86.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.108 -1.231 . . . . 1.0 109.993 179.801 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 87.3 p -67.1 -22.18 65.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 1.0 109.909 -179.598 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 81.0 mt -80.84 -0.93 41.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.158 -0.964 . . . . 1.0 109.701 -179.853 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.92 6.14 67.49 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 110.414 -1.075 . . . . 1.0 110.414 179.264 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.4 mt -84.91 150.04 25.24 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.987 -1.302 . . . . 1.0 109.654 179.903 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 38.4 t0 -99.95 175.59 5.72 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.593 -0.891 . . . . 1.0 108.593 179.416 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.501 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 72.6 m80 -59.7 139.98 56.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.97 -1.081 . . . . 1.0 109.491 -179.742 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 44.2 t -98.09 148.1 23.88 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.381 -0.825 . . . . 1.0 109.334 -179.808 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -96.9 2.15 51.33 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.266 -0.896 . . . . 1.0 109.733 -179.646 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 8.2 t0 -86.48 128.14 58.13 Favored Pre-proline 0 N--CA 1.491 1.623 0 N-CA-C 107.947 -1.131 . . . . 1.0 107.947 179.296 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -65.39 -19.67 61.44 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 CA-C-N 120.344 1.158 . . . . 1.0 112.305 -179.665 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.426 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -88.09 -6.36 75.36 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.621 -1.392 . . . . 1.0 109.621 -179.929 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.61 135.41 34.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.244 -1.15 . . . . 1.0 109.235 179.787 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.437 ' C ' ' H ' ' A' ' 138' ' ' PHE . 92.2 mt -60.08 -38.92 84.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.108 -0.995 . . . . 1.0 109.685 -179.692 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 71.0 mtp -69.9 21.81 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.384 -0.823 . . . . 1.0 111.349 -178.631 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.437 ' H ' ' C ' ' A' ' 136' ' ' LEU . 16.1 t80 -67.06 134.43 93.78 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 120.726 -1.234 . . . . 1.0 107.848 179.542 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -61.64 -5.5 5.84 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 120.876 1.05 . . . . 1.0 114.215 -177.886 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 89.6 mt -118.05 136.55 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 O-C-N 120.918 -1.114 . . . . 1.0 109.269 179.55 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -72.11 126.55 30.07 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.349 -0.845 . . . . 1.0 109.958 -178.928 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.8 t -139.55 142.19 37.2 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.81 -0.811 . . . . 1.0 108.81 179.79 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -80.77 145.03 31.69 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.002 -1.061 . . . . 1.0 109.545 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.8 t -140.03 156.66 46.51 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.412 -0.805 . . . . 1.0 109.438 -179.605 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.12 104.49 0.97 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.719 -1.352 . . . . 1.0 109.719 -179.859 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -77.1 -0.93 26.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.364 -1.08 . . . . 1.0 109.898 -179.892 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 42.1 t -60.01 -43.09 95.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.084 -1.01 . . . . 1.0 109.353 -179.562 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -156.05 74.31 0.85 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.096 -1.002 . . . . 1.0 109.556 179.545 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -99.13 122.91 42.98 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.297 -0.877 . . . . 1.0 109.166 179.555 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 96.7 mtp -114.57 140.18 48.99 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.021 -0.733 . . . . 1.0 109.021 179.854 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 57.0 mt -50.26 128.82 23.85 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.021 -1.049 . . . . 1.0 108.836 -179.94 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -69.01 176.97 5.52 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 CA-C-N 120.041 1.05 . . . . 1.0 112.335 179.889 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.04 -40.0 87.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.417 -0.802 . . . . 1.0 109.549 179.775 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -55.76 -49.97 71.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.342 -0.849 . . . . 1.0 109.943 -179.385 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -70.72 -40.0 73.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.023 -1.048 . . . . 1.0 110.151 -179.525 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 76.9 t -62.09 -48.58 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.106 -0.997 . . . . 1.0 109.335 -179.67 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -60.82 -39.98 91.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.975 -1.078 . . . . 1.0 110.283 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.68 -53.83 11.3 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 120.228 -0.987 . . . . 1.0 111.393 -178.634 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.454 HG23 ' N ' ' A' ' 160' ' ' GLN . 6.0 tp -60.48 -40.04 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.868 -1.372 . . . . 1.0 109.795 -178.981 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 164' ' ' GLY . 95.1 mt-30 -64.01 -39.86 95.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.192 -0.943 . . . . 1.0 109.156 179.593 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 86.3 p -62.74 -28.58 70.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.885 . . . . 1.0 110.326 -179.805 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 85.4 mt -87.85 -49.95 6.76 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.947 -1.096 . . . . 1.0 110.401 -179.213 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -91.05 -9.52 45.5 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.067 -1.021 . . . . 1.0 110.148 -179.061 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.554 -1.418 . . . . 1.0 109.554 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.494 -0.558 . . . . 1.0 109.494 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.1 mt -94.41 128.33 40.88 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.19 -0.944 . . . . 1.0 109.529 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.05 162.25 34.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.335 -0.853 . . . . 1.0 108.815 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -71.99 149.21 45.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.999 -1.063 . . . . 1.0 109.071 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.0 t -79.41 -4.8 52.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.402 -0.811 . . . . 1.0 110.382 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.2 pttt -150.08 159.15 44.63 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.954 -1.091 . . . . 1.0 109.705 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.536 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.03 0.41 57.13 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.459 -0.776 . . . . 1.0 109.416 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -95.27 126.51 40.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.329 -0.857 . . . . 1.0 108.753 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.3 mt -140.14 152.11 45.82 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.279 -0.888 . . . . 1.0 109.069 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.8 p -130.27 155.29 46.54 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.893 -0.78 . . . . 1.0 108.893 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -145.62 158.72 43.81 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.039 -1.038 . . . . 1.0 109.89 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.603 HH12 ' H ' ' A' ' 56' ' ' GLY . 70.7 ttt180 -144.14 133.73 23.52 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.513 -0.742 . . . . 1.0 109.533 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.4 mt -89.43 117.59 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.091 -1.006 . . . . 1.0 109.125 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 56.6 t -69.94 -41.44 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.171 -0.956 . . . . 1.0 109.414 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.3 p-10 -163.2 162.99 25.71 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.775 -1.203 . . . . 1.0 110.125 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -102.12 -167.39 1.4 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.203 -1.406 . . . . 1.0 107.203 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.72 143.08 35.63 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.374 -0.829 . . . . 1.0 109.817 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -66.07 -15.58 49.12 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 120.854 1.036 . . . . 1.0 110.822 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -59.17 -39.6 83.01 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.288 -0.869 . . . . 1.0 109.995 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.5 mtm -136.27 166.06 24.3 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.252 -0.905 . . . . 1.0 109.428 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.7 p -71.77 161.2 31.33 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.515 -0.74 . . . . 1.0 109.648 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -61.77 -39.91 93.32 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.553 -0.717 . . . . 1.0 109.741 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.7 m -59.9 -40.05 87.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.983 -1.073 . . . . 1.0 110.08 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -64.67 -40.08 94.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.924 -1.11 . . . . 1.0 109.975 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 63.2 t -70.02 -40.4 78.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 120.935 -1.103 . . . . 1.0 110.278 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.98 -52.87 63.56 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.235 -0.916 . . . . 1.0 110.899 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.5 ptmt -64.5 -28.82 69.92 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.196 -0.94 . . . . 1.0 109.992 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.12 -49.67 76.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.874 -1.141 . . . . 1.0 109.413 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -67.77 -38.53 83.53 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.994 -1.067 . . . . 1.0 110.083 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -59.88 -43.08 94.95 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.903 -1.123 . . . . 1.0 109.37 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -61.59 -40.09 93.55 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.058 -1.026 . . . . 1.0 108.781 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.08 -47.17 87.01 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.528 -0.733 . . . . 1.0 109.825 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -63.31 -39.85 95.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.992 -1.068 . . . . 1.0 109.57 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -59.8 -48.96 79.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.087 -1.008 . . . . 1.0 109.859 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.5 t -60.05 -40.41 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.255 -0.903 . . . . 1.0 110.602 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.436 ' CE3' ' CD1' ' A' ' 125' ' ' LEU . 73.5 m95 -79.4 -37.1 38.03 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.949 -1.094 . . . . 1.0 109.424 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.7 p -71.22 -20.0 62.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.104 -0.998 . . . . 1.0 110.029 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -60.65 -39.91 90.1 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.954 -1.091 . . . . 1.0 110.899 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.2 m -111.31 22.78 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.195 -0.941 . . . . 1.0 111.071 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.6 p -146.94 135.36 10.92 Favored Pre-proline 0 N--CA 1.501 2.11 0 O-C-N 120.843 -1.161 . . . . 1.0 109.361 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -74.28 17.57 0.51 Allowed 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 120.733 0.955 . . . . 1.0 111.967 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 78.2 mt -69.33 139.53 54.27 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.253 -0.904 . . . . 1.0 109.915 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -110.79 120.78 43.52 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.865 -0.791 . . . . 1.0 108.865 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -107.6 122.43 46.68 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.413 -0.804 . . . . 1.0 109.647 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -120.18 130.11 54.43 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.663 -0.648 . . . . 1.0 110.068 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -81.83 135.7 35.43 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.27 -0.894 . . . . 1.0 109.348 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.3 mt -104.27 126.23 51.2 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.364 -0.835 . . . . 1.0 109.181 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.41 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 45.8 m-70 -61.61 -40.16 93.83 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.329 -0.857 . . . . 1.0 109.737 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 77.3 m-20 -146.45 167.48 23.53 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.242 -0.911 . . . . 1.0 109.857 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.603 ' H ' HH12 ' A' ' 18' ' ' ARG . . . 98.22 175.73 33.09 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.136 -1.585 . . . . 1.0 109.136 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -93.55 136.81 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.228 -1.16 . . . . 1.0 108.579 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.66 161.08 15.74 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.423 -0.798 . . . . 1.0 109.281 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.02 -49.8 76.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.303 -0.873 . . . . 1.0 109.144 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 88.6 mt -106.64 102.59 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.377 -0.827 . . . . 1.0 109.702 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.1 ptm -102.47 131.49 49.13 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.348 -0.845 . . . . 1.0 109.148 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 88.3 mt -105.92 135.11 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.539 -0.725 . . . . 1.0 109.808 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 64.4 p -152.32 158.88 43.37 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.192 -0.942 . . . . 1.0 109.851 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -104.46 121.23 43.0 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.24 -170.01 23.97 Favored Glycine 0 N--CA 1.501 2.984 0 O-C-N 121.156 -0.965 . . . . 1.0 111.121 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.609 HG22 ' N ' ' A' ' 67' ' ' LYS . 78.0 mt -136.62 170.76 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 107.995 -1.113 . . . . 1.0 107.995 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.609 ' N ' HG22 ' A' ' 66' ' ' ILE . 21.6 tptm -29.92 -94.86 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 O-C-N 121.718 -0.614 . . . . 1.0 111.014 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -79.27 128.93 33.93 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.616 -1.302 . . . . 1.0 110.173 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.536 ' NE2' ' OD2' ' A' ' 71' ' ' ASP . 54.4 p-80 -153.01 9.87 0.45 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.072 -1.018 . . . . 1.0 109.813 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.403 ' O ' ' OD1' ' A' ' 71' ' ' ASP . . . 108.93 48.9 0.81 Allowed Glycine 0 N--CA 1.501 3.006 0 O-C-N 121.352 -0.843 . . . . 1.0 111.507 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.536 ' OD2' ' NE2' ' A' ' 69' ' ' HIS . 85.2 m-20 -139.95 150.49 44.57 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.828 -1.396 . . . . 1.0 109.154 178.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -65.79 -37.41 86.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.314 -0.866 . . . . 1.0 109.353 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 73' ' ' TYR . 3.0 p90 -130.5 77.45 75.89 Favored Pre-proline 0 N--CA 1.5 2.036 0 N-CA-C 108.79 -0.818 . . . . 1.0 108.79 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -60.98 -148.16 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 121.005 1.137 . . . . 1.0 112.751 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.53 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 72.2 m-85 -84.55 157.69 21.18 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.632 -0.668 . . . . 1.0 109.207 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -100.11 8.04 44.19 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.236 -0.915 . . . . 1.0 110.102 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 127.99 -156.4 20.69 Favored Glycine 0 N--CA 1.504 3.193 0 N-CA-C 108.608 -1.797 . . . . 1.0 108.608 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -60.7 -65.66 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.462 0 CA-C-N 118.855 1.328 . . . . 1.0 111.422 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 87.4 p -76.53 160.03 29.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.059 -1.026 . . . . 1.0 109.436 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.26 -126.87 7.24 Favored Glycine 0 N--CA 1.504 3.203 0 N-CA-C 110.016 -1.234 . . . . 1.0 110.016 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.427 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 28.4 mt -68.71 107.69 3.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.228 -1.16 . . . . 1.0 109.483 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 38.0 mt -79.67 -16.54 55.55 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.017 -1.052 . . . . 1.0 108.209 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.32 175.26 0.94 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.203 -1.036 . . . . 1.0 108.203 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.468 ' CE1' ' ND1' ' A' ' 97' ' ' HIS . 7.5 p80 -161.2 159.99 29.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.994 -1.066 . . . . 1.0 109.479 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.07 160.16 44.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.371 -0.831 . . . . 1.0 108.866 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -106.25 151.45 40.21 Favored Pre-proline 0 N--CA 1.499 1.984 0 N-CA-C 108.766 -0.827 . . . . 1.0 108.766 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -44.81 161.92 0.08 OUTLIER 'Trans proline' 0 N--CA 1.488 1.152 0 C-N-CA 120.694 0.93 . . . . 1.0 111.656 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -66.24 151.76 82.72 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.158 1.239 . . . . 1.0 112.529 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -177.02 153.1 13.03 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.282 -1.527 . . . . 1.0 109.282 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -70.7 37.44 0.29 Allowed 'Trans proline' 0 N--CA 1.493 1.48 0 CA-C-N 118.661 1.23 . . . . 1.0 112.055 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -158.54 -130.13 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.981 -1.074 . . . . 1.0 110.566 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.409 ' O ' ' O ' ' A' ' 93' ' ' GLY . 68.3 m-85 -61.08 -38.8 87.54 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.543 -0.723 . . . . 1.0 110.355 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 92' ' ' TYR . . . -45.1 168.82 0.02 OUTLIER Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.244 -1.143 . . . . 1.0 110.244 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 71.13 4.8 57.14 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.046 -1.222 . . . . 1.0 110.046 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.6 p-10 -81.11 170.95 15.53 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.021 -1.281 . . . . 1.0 109.733 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.49 122.57 8.26 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.289 -0.882 . . . . 1.0 109.533 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.468 ' ND1' ' CE1' ' A' ' 84' ' ' HIS . 60.8 m170 -110.74 148.25 32.7 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.652 -0.655 . . . . 1.0 109.692 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -123.05 156.46 34.82 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.571 -0.706 . . . . 1.0 109.19 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.53 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 1.1 m-20 -81.2 121.35 26.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 1.0 109.633 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -84.67 -12.95 52.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.068 -1.02 . . . . 1.0 109.422 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -82.96 -11.54 58.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.311 -0.868 . . . . 1.0 109.879 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -87.82 173.01 9.21 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.36 -0.838 . . . . 1.0 110.075 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.0 m -99.88 104.85 16.53 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.411 -0.806 . . . . 1.0 108.871 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.523 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 95.9 m95 -88.71 125.28 34.78 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.633 -0.877 . . . . 1.0 108.633 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.658 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.8 t -140.35 150.46 43.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.492 -0.755 . . . . 1.0 109.308 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 75.7 m -92.17 -8.26 46.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.104 -0.998 . . . . 1.0 108.383 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.8 m -91.19 174.84 7.18 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.57 -0.9 . . . . 1.0 108.57 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.485 ' OG ' ' CZ ' ' A' ' 143' ' ' TYR . 4.2 m -78.06 77.59 4.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.835 -1.166 . . . . 1.0 109.429 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.658 ' HB2' HG21 ' A' ' 105' ' ' THR . 99.2 mttt -146.98 149.58 33.44 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.707 -0.849 . . . . 1.0 108.707 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.81 -135.66 6.64 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.793 -1.323 . . . . 1.0 109.793 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -100.6 114.3 27.85 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.323 -1.104 . . . . 1.0 109.136 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -63.94 132.43 50.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.135 -0.978 . . . . 1.0 109.248 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.3 tp -59.8 -41.38 91.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.32 -0.862 . . . . 1.0 110.255 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -59.97 -43.8 94.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.311 -0.868 . . . . 1.0 111.095 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.453 HD21 HG22 ' A' ' 144' ' ' THR . 1.8 mm? -59.42 -50.49 73.74 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.671 -1.268 . . . . 1.0 109.814 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.1 t -66.24 -40.8 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.933 -1.104 . . . . 1.0 109.407 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.32 -51.5 69.67 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.282 -0.887 . . . . 1.0 110.067 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.27 -36.44 73.26 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.383 -1.448 . . . . 1.0 110.181 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -66.77 -47.75 71.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.113 -0.992 . . . . 1.0 111.746 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -59.54 -39.86 85.34 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.624 -1.298 . . . . 1.0 109.515 -178.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -59.87 -39.37 85.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.11 -0.994 . . . . 1.0 108.513 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.95 -43.48 87.78 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.581 -1.408 . . . . 1.0 109.581 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -64.5 -39.83 94.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.015 -1.286 . . . . 1.0 109.289 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 90.5 p -66.72 -24.12 66.2 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.137 -0.977 . . . . 1.0 110.025 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.436 ' CD1' ' CE3' ' A' ' 42' ' ' TRP . 80.9 mt -81.71 -1.64 47.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.11 -0.994 . . . . 1.0 109.689 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 91.33 9.62 63.1 Favored Glycine 0 N--CA 1.499 2.835 0 C-N-CA 120.243 -0.979 . . . . 1.0 111.01 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.8 mt -86.92 146.18 26.26 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.903 -1.351 . . . . 1.0 109.903 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 36.9 t0 -103.62 172.02 7.04 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.694 -0.854 . . . . 1.0 108.694 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.545 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 35.5 m170 -59.94 134.67 57.26 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.001 -1.062 . . . . 1.0 109.612 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 37.4 t -97.4 164.83 12.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.283 -0.886 . . . . 1.0 109.513 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -99.16 1.88 45.37 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.294 -0.879 . . . . 1.0 109.237 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 17.3 t0 -85.67 125.11 70.11 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.299 -0.875 . . . . 1.0 108.971 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -68.82 -20.53 39.39 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 CA-C-N 120.146 1.088 . . . . 1.0 111.822 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.451 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -86.26 -7.2 80.27 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.739 -1.344 . . . . 1.0 109.739 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.11 148.52 26.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.128 -1.219 . . . . 1.0 109.913 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.8 mt -69.83 -29.03 66.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.348 -0.845 . . . . 1.0 109.461 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.6 mmm -73.93 8.74 1.84 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.572 -0.705 . . . . 1.0 110.81 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -67.37 132.78 93.14 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 120.795 -1.191 . . . . 1.0 108.38 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -60.32 -24.73 78.38 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 120.861 1.041 . . . . 1.0 113.477 -178.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.3 mt -93.49 139.18 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 120.909 -1.119 . . . . 1.0 110.369 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -73.94 131.59 41.59 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.495 0.664 . . . . 1.0 110.05 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.8 t -141.19 140.45 34.02 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.719 -0.613 . . . . 1.0 109.441 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.485 ' CZ ' ' OG ' ' A' ' 108' ' ' SER . 79.3 t80 -80.94 145.07 31.43 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.241 -0.912 . . . . 1.0 109.033 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.453 HG22 HD21 ' A' ' 115' ' ' LEU . 6.8 t -141.01 155.32 46.22 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.342 -0.849 . . . . 1.0 108.918 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -77.8 112.66 3.54 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.258 -1.537 . . . . 1.0 109.258 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -77.79 3.34 14.47 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.239 -1.154 . . . . 1.0 110.034 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.5 ' O ' ' ND1' ' A' ' 148' ' ' HIS . 86.5 p -59.9 -38.38 82.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.077 -1.014 . . . . 1.0 109.679 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' HIS . . . . . 0.5 ' ND1' ' O ' ' A' ' 147' ' ' SER . 89.3 m-70 -154.08 33.05 0.43 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.09 -1.006 . . . . 1.0 110.078 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -70.85 138.69 50.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.996 -1.065 . . . . 1.0 109.67 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 58.4 mtt -140.02 149.53 43.31 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.225 -1.028 . . . . 1.0 108.225 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.697 ' H ' HD12 ' A' ' 151' ' ' LEU . 6.8 mp -52.25 127.38 38.59 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.87 -1.144 . . . . 1.0 108.833 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -65.1 -179.05 0.92 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 CA-C-N 120.088 1.067 . . . . 1.0 111.875 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -62.59 -40.14 95.96 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.456 -0.777 . . . . 1.0 110.175 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.407 ' C ' ' OD1' ' A' ' 154' ' ' ASP . 52.7 t0 -57.22 -49.71 75.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.964 -1.085 . . . . 1.0 110.138 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -70.44 -40.04 74.0 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.155 -0.966 . . . . 1.0 109.92 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 51.5 t -61.3 -44.74 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.051 -1.031 . . . . 1.0 109.591 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -61.61 -39.05 89.89 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.98 -1.075 . . . . 1.0 109.97 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -69.97 -53.27 15.52 Favored Glycine 0 N--CA 1.494 2.545 0 O-C-N 121.051 -1.03 . . . . 1.0 111.262 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.46 HG23 ' N ' ' A' ' 160' ' ' GLN . 6.3 tp -62.04 -40.54 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.722 -1.457 . . . . 1.0 109.837 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 164' ' ' GLY . 97.6 mt-30 -64.48 -39.79 94.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.01 -1.056 . . . . 1.0 109.757 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 93.2 p -64.75 -26.61 68.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.139 -0.976 . . . . 1.0 110.271 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 92.2 mt -86.39 -54.02 4.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.164 -0.96 . . . . 1.0 110.174 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -91.0 -11.27 39.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.229 -0.919 . . . . 1.0 110.27 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.626 0 N-CA-C 109.386 -1.486 . . . . 1.0 109.386 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 169' ' ' WAY . . . . . 0.65 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.7 m . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.419 -0.585 . . . . 1.0 109.419 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.5 mt -67.62 139.85 56.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.132 -0.98 . . . . 1.0 109.316 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.5 pttt -161.26 162.05 30.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.372 -0.83 . . . . 1.0 109.499 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -70.65 146.53 49.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.205 -0.934 . . . . 1.0 109.419 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.3 m -99.57 17.82 19.49 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.36 -0.837 . . . . 1.0 110.043 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -147.82 147.63 30.03 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.001 -1.062 . . . . 1.0 109.438 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.538 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -91.82 -0.68 57.54 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.347 -0.845 . . . . 1.0 110.087 -179.707 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -99.28 119.9 38.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.264 -0.898 . . . . 1.0 108.589 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.7 mt -140.04 150.38 44.32 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.262 -0.899 . . . . 1.0 109.059 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.1 p -132.11 158.36 41.83 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.566 -0.709 . . . . 1.0 109.27 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -143.43 158.23 43.81 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.266 -0.896 . . . . 1.0 109.759 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.0 ttt-85 -143.14 132.65 23.58 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.483 -0.76 . . . . 1.0 109.796 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.8 mt -88.46 117.31 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.251 -0.906 . . . . 1.0 109.259 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.89 -40.05 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.079 -1.013 . . . . 1.0 108.937 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -163.01 160.77 24.99 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.099 -1.001 . . . . 1.0 110.065 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.639 ' CD1' ' CD2' ' A' ' 28' ' ' HIS . 46.9 m-85 -102.71 -160.39 0.78 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.086 -1.449 . . . . 1.0 107.086 178.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.62 153.76 77.66 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.053 -1.029 . . . . 1.0 110.704 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -74.16 -16.9 22.28 Favored 'Trans proline' 0 N--CA 1.486 1.068 0 C-N-CA 121.089 1.193 . . . . 1.0 110.124 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.46 -39.97 85.37 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.382 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 73.9 mtm -135.86 163.76 29.49 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.305 -0.872 . . . . 1.0 109.519 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.8 p -72.42 159.71 33.54 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.34 -0.85 . . . . 1.0 109.422 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.639 ' CD2' ' CD1' ' A' ' 22' ' ' TYR . 1.1 m80 -61.41 -40.03 92.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.434 -0.791 . . . . 1.0 110.399 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.5 m -60.08 -39.94 87.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.128 -0.982 . . . . 1.0 110.235 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -67.0 -39.98 87.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.136 -0.977 . . . . 1.0 109.871 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.4 t -68.21 -41.46 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.935 . . . . 1.0 110.457 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -60.05 -48.74 80.47 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.978 -1.076 . . . . 1.0 110.582 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -62.61 -32.46 73.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.979 -1.075 . . . . 1.0 109.948 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.07 -47.83 84.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.086 -1.009 . . . . 1.0 109.68 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.4 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 49.2 m-85 -66.04 -39.73 90.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.074 -1.016 . . . . 1.0 109.868 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -60.02 -41.97 93.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.95 -1.094 . . . . 1.0 109.771 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -60.81 -41.93 96.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.966 -1.084 . . . . 1.0 109.201 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.39 -45.4 93.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.458 -0.776 . . . . 1.0 110.276 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -68.13 -38.37 82.12 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.986 -1.071 . . . . 1.0 110.162 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -59.93 -46.65 88.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.032 -1.043 . . . . 1.0 109.404 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.2 t -59.94 -41.0 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.943 . . . . 1.0 109.759 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.404 ' CZ3' HD22 ' A' ' 151' ' ' LEU . 71.9 m95 -79.48 -36.56 38.52 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.983 -1.073 . . . . 1.0 110.293 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.8 p -71.23 -18.74 62.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.974 -1.078 . . . . 1.0 109.843 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.88 -39.66 90.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.188 -0.945 . . . . 1.0 110.847 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.9 m -110.05 23.25 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.28 -0.887 . . . . 1.0 110.836 -178.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.0 p -149.05 137.7 12.01 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 120.861 -1.149 . . . . 1.0 109.377 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -75.25 18.03 0.59 Allowed 'Trans proline' 0 N--CA 1.495 1.598 0 CA-C-N 119.68 0.921 . . . . 1.0 112.102 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.9 mt -68.19 138.39 55.58 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.048 -1.032 . . . . 1.0 109.991 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -110.15 120.35 42.17 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.665 -0.865 . . . . 1.0 108.665 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -108.12 121.32 44.59 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.42 -0.8 . . . . 1.0 109.589 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -120.01 130.03 54.54 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.598 -0.688 . . . . 1.0 109.333 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -82.53 134.7 35.2 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.198 -0.939 . . . . 1.0 109.441 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.4 mt -104.03 131.94 50.78 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.35 -0.844 . . . . 1.0 109.448 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.438 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 91.6 m-70 -65.03 -40.01 94.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.483 -0.761 . . . . 1.0 110.405 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 80.5 m-20 -146.74 170.02 17.86 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.106 -0.996 . . . . 1.0 109.985 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.26 177.51 40.35 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.483 -1.447 . . . . 1.0 109.483 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.5 mt -93.81 136.45 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.212 -1.17 . . . . 1.0 109.105 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -107.83 173.16 6.44 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.404 -0.81 . . . . 1.0 109.415 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -60.04 -49.18 78.66 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.193 -0.942 . . . . 1.0 109.216 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.0 mt -119.99 117.52 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.471 -0.768 . . . . 1.0 109.179 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.8 ptp -100.97 140.0 35.88 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.209 -0.932 . . . . 1.0 109.293 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.4 HG21 ' CZ ' ' A' ' 35' ' ' PHE . 86.4 mt -110.01 130.09 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.622 -0.674 . . . . 1.0 109.802 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 31.0 p -150.51 156.21 40.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.217 -0.927 . . . . 1.0 109.826 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -102.76 122.79 45.2 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.292 -1.003 . . . . 1.0 108.292 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.7 -177.28 23.93 Favored Glycine 0 N--CA 1.499 2.891 0 N-CA-C 110.709 -0.956 . . . . 1.0 110.709 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.568 HG22 ' N ' ' A' ' 67' ' ' LYS . 87.6 mt -136.62 164.63 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.71 -0.877 . . . . 1.0 108.813 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.568 ' N ' HG22 ' A' ' 66' ' ' ILE . 20.1 tptm -15.04 -78.97 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.504 0 N-CA-C 112.377 0.51 . . . . 1.0 112.377 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -72.37 144.84 48.08 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.114 -0.991 . . . . 1.0 110.862 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.3 m80 -134.45 173.03 12.09 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 108.269 -1.011 . . . . 1.0 108.269 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.02 -42.86 98.57 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.057 -1.617 . . . . 1.0 109.057 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -80.19 161.38 25.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.287 -1.125 . . . . 1.0 108.855 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -90.32 97.84 11.42 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.985 -1.072 . . . . 1.0 109.764 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.558 ' O ' ' CG ' ' A' ' 73' ' ' TYR . 10.1 p90 -172.3 51.27 0.13 Allowed Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 108.797 -0.816 . . . . 1.0 108.797 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.515 ' CD ' ' N ' ' A' ' 73' ' ' TYR . 13.4 Cg_exo -41.61 160.91 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.159 0 C-N-CA 121.361 1.374 . . . . 1.0 113.083 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.517 ' CD2' ' OD2' ' A' ' 99' ' ' ASP . 34.0 m-85 -88.82 -176.16 5.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.706 -0.621 . . . . 1.0 109.507 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -99.94 0.04 40.41 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.217 -0.927 . . . . 1.0 110.478 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 128.05 -139.46 11.1 Favored Glycine 0 N--CA 1.502 3.056 0 N-CA-C 108.344 -1.902 . . . . 1.0 108.344 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.448 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 24.9 Cg_endo -79.02 -52.9 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.314 0 CA-C-N 119.917 1.859 . . . . 1.0 112.09 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 91.6 p -79.6 170.49 16.48 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.205 -0.934 . . . . 1.0 110.086 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.82 -122.5 7.6 Favored Glycine 0 N--CA 1.498 2.817 0 N-CA-C 110.488 -1.045 . . . . 1.0 110.488 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.465 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 9.8 mt -67.26 100.48 0.81 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.454 -1.027 . . . . 1.0 109.111 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 64.2 mt -79.06 -20.03 49.87 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.014 -1.054 . . . . 1.0 110.03 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.01 171.99 1.32 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 1.0 109.035 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.528 ' CE1' ' OH ' ' A' ' 73' ' ' TYR . 6.4 p80 -162.28 159.14 25.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.012 -1.055 . . . . 1.0 109.896 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.08 156.18 42.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.49 -0.756 . . . . 1.0 109.322 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -103.5 150.94 38.55 Favored Pre-proline 0 N--CA 1.496 1.863 0 N-CA-C 108.39 -0.967 . . . . 1.0 108.39 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.73 166.47 11.85 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 120.924 1.083 . . . . 1.0 111.42 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -55.52 139.71 82.58 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 120.661 0.907 . . . . 1.0 111.361 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -160.28 -172.02 26.96 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 109.384 -1.486 . . . . 1.0 109.384 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.44 -76.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.114 1.209 . . . . 1.0 112.189 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -119.96 -49.78 2.3 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.439 -0.788 . . . . 1.0 110.23 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.469 ' CD1' ' N ' ' A' ' 93' ' ' GLY . 40.4 p90 -62.76 -39.92 95.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.956 -1.09 . . . . 1.0 110.097 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.469 ' N ' ' CD1' ' A' ' 92' ' ' TYR . . . -69.32 168.1 45.91 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.909 -1.276 . . . . 1.0 109.909 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 71.87 64.26 2.74 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.906 -1.278 . . . . 1.0 109.906 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -153.41 160.89 42.72 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.234 -1.157 . . . . 1.0 109.602 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.04 122.43 9.05 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.209 -0.932 . . . . 1.0 109.526 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -109.72 155.98 20.86 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.596 -0.69 . . . . 1.0 109.392 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.524 ' CE2' ' OE2' ' A' ' 120' ' ' GLU . 29.1 m-85 -130.23 143.66 50.91 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.197 -1.038 . . . . 1.0 108.197 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.517 ' OD2' ' CD2' ' A' ' 75' ' ' PHE . 93.6 m-20 -80.01 117.06 20.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.725 -1.234 . . . . 1.0 109.576 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 39.1 t0 -81.59 2.74 27.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.386 -0.821 . . . . 1.0 109.559 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -81.2 -17.34 49.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 1.0 110.101 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' A' ' 102' ' ' GLU . 58.0 mp0 -92.86 174.87 7.02 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.018 -1.051 . . . . 1.0 109.605 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 23.3 m -99.14 105.12 17.17 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.529 -0.915 . . . . 1.0 108.529 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -85.21 128.12 34.55 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.347 -0.845 . . . . 1.0 108.73 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.661 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.9 t -142.77 158.33 43.74 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.416 -0.803 . . . . 1.0 109.781 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.6 t -95.56 -9.09 33.28 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.253 -1.017 . . . . 1.0 108.253 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.4 t -92.1 -171.6 2.88 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.888 -0.782 . . . . 1.0 108.888 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.5 t -88.38 77.77 8.07 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.077 -1.014 . . . . 1.0 109.619 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.661 ' HB2' HG21 ' A' ' 105' ' ' THR . 60.4 mttp -149.31 151.39 34.07 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.324 -0.86 . . . . 1.0 108.761 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.48 -137.7 5.29 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.949 -1.26 . . . . 1.0 109.949 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -100.06 118.97 37.55 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.376 -1.073 . . . . 1.0 109.316 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.65 HD21 ' HZ2' ' A' ' 146' ' ' LYS . 23.8 t-20 -65.52 130.11 42.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 1.0 110.059 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 58.6 tp -60.06 -47.11 87.24 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.368 -0.832 . . . . 1.0 111.295 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -59.79 -42.9 94.4 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.083 -1.01 . . . . 1.0 111.843 -177.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 115' ' ' LEU . 4.0 mm? -60.01 -49.99 75.5 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.532 -1.355 . . . . 1.0 109.21 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 65.3 t -66.66 -42.36 89.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.244 -0.91 . . . . 1.0 110.866 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.97 -48.74 79.06 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.081 -1.012 . . . . 1.0 110.325 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.35 -39.17 82.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.947 -1.096 . . . . 1.0 110.294 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.441 ' CE1' ' HE2' ' A' ' 123' ' ' HIS . 56.4 t60 -65.27 -52.42 54.41 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.137 -0.977 . . . . 1.0 111.411 -178.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.524 ' OE2' ' CE2' ' A' ' 98' ' ' PHE . 10.1 pt-20 -60.03 -42.3 94.1 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.772 -1.205 . . . . 1.0 110.609 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -60.09 -39.86 87.59 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.729 -1.232 . . . . 1.0 108.814 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -54.82 -42.74 80.1 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.366 -1.494 . . . . 1.0 109.366 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.441 ' HE2' ' CE1' ' A' ' 119' ' ' HIS . 90.1 m-70 -65.68 -39.1 90.94 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.125 -1.221 . . . . 1.0 109.134 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.1 p -62.14 -24.97 67.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -0.903 . . . . 1.0 109.892 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 88.8 mt -81.19 -0.08 38.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.057 -1.027 . . . . 1.0 109.792 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 91.89 10.36 61.49 Favored Glycine 0 N--CA 1.498 2.784 0 O-C-N 121.058 -1.026 . . . . 1.0 110.668 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.3 mt -84.71 150.01 25.4 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.931 -1.334 . . . . 1.0 109.462 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 37.1 t0 -100.65 169.99 8.66 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.435 -0.79 . . . . 1.0 109.06 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.526 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 74.8 m80 -59.99 139.74 57.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.153 -0.967 . . . . 1.0 109.545 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 41.2 t -96.25 156.16 16.46 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.27 -0.894 . . . . 1.0 108.913 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -99.13 3.95 46.75 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.127 -0.983 . . . . 1.0 109.574 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -87.07 129.49 51.73 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.089 -1.007 . . . . 1.0 108.726 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -67.9 -27.82 36.61 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 CA-C-N 120.086 1.066 . . . . 1.0 113.022 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -84.86 -2.31 88.58 Favored Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.824 -1.179 . . . . 1.0 110.454 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.83 146.81 26.07 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.022 -1.281 . . . . 1.0 110.015 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 86.5 mt -70.06 -29.96 67.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.221 -0.924 . . . . 1.0 109.677 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.2 mmm -73.6 8.3 1.94 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.183 -0.948 . . . . 1.0 110.171 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -69.41 132.64 89.48 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.096 -1.002 . . . . 1.0 108.595 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -63.41 14.19 0.07 OUTLIER 'Trans proline' 0 N--CA 1.505 2.182 0 C-N-CA 121.152 1.235 . . . . 1.0 115.167 -177.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 76.0 mt -130.78 138.02 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.382 0 O-C-N 120.785 -1.197 . . . . 1.0 109.495 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.42 ' CD1' ' C ' ' A' ' 141' ' ' TYR . 21.5 t80 -73.37 128.3 35.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.444 -0.785 . . . . 1.0 109.957 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 10.0 t -136.56 137.0 39.76 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.579 -0.701 . . . . 1.0 109.197 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -85.11 143.18 29.0 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.17 -0.956 . . . . 1.0 109.265 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.7 t -140.38 151.19 44.77 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.3 -0.875 . . . . 1.0 109.52 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -68.89 109.39 2.87 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.734 -1.746 . . . . 1.0 108.734 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.65 ' HZ2' HD21 ' A' ' 112' ' ' ASN . 85.0 mttt -73.35 126.03 29.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.133 -1.216 . . . . 1.0 109.298 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 10.6 p -176.86 -93.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.307 -0.871 . . . . 1.0 109.111 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -98.81 18.83 16.09 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.664 -0.865 . . . . 1.0 108.664 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -60.15 134.62 57.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.592 -0.693 . . . . 1.0 109.829 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 95.0 mtp -136.96 150.14 47.98 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.732 -0.84 . . . . 1.0 108.732 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.404 HD22 ' CZ3' ' A' ' 42' ' ' TRP . 20.8 mt -48.23 125.87 11.85 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.069 -1.02 . . . . 1.0 108.949 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -62.83 175.62 2.25 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 CA-C-N 120.118 1.078 . . . . 1.0 112.201 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.02 -39.95 87.62 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.311 -0.868 . . . . 1.0 109.553 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.403 ' OD1' ' C ' ' A' ' 154' ' ' ASP . 52.7 t0 -55.89 -50.02 71.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.911 . . . . 1.0 109.739 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -70.07 -39.94 75.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.143 -0.973 . . . . 1.0 110.427 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.3 t -59.97 -46.41 94.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.903 -1.123 . . . . 1.0 109.018 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -60.3 -40.04 89.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.977 -1.077 . . . . 1.0 110.278 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -67.93 -55.89 12.5 Favored Glycine 0 N--CA 1.494 2.526 0 O-C-N 121.12 -0.988 . . . . 1.0 111.152 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.468 HG23 ' N ' ' A' ' 160' ' ' GLN . 5.3 tp -60.44 -39.98 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.909 -1.347 . . . . 1.0 109.523 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.472 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.5 mt-30 -65.28 -39.93 93.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.076 -1.015 . . . . 1.0 109.812 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 85.6 p -60.05 -33.92 72.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.064 -1.023 . . . . 1.0 110.488 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.4 mt -84.83 -56.71 3.44 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.004 -1.06 . . . . 1.0 111.167 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -89.66 -9.0 51.21 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.989 -1.07 . . . . 1.0 110.647 -178.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.497 2.748 0 N-CA-C 109.538 -1.425 . . . . 1.0 109.538 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 169' ' ' WAY . . . . . 0.803 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 90.5 m . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.413 -0.588 . . . . 1.0 109.413 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.2 mt -68.1 139.28 56.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 1.0 109.343 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.5 pttm -165.12 167.04 18.61 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.37 -0.831 . . . . 1.0 109.442 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -71.88 142.32 49.54 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.182 -0.949 . . . . 1.0 109.188 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.3 t -89.86 4.47 49.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.253 -0.905 . . . . 1.0 109.924 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -145.07 154.1 42.13 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.182 -0.949 . . . . 1.0 109.452 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.1 mmt -90.47 0.51 57.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.287 -0.883 . . . . 1.0 109.684 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -95.73 126.9 41.31 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.218 -0.927 . . . . 1.0 109.554 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.8 mt -143.26 149.16 37.49 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.366 -0.834 . . . . 1.0 108.816 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.0 p -132.78 155.18 49.37 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.424 -0.798 . . . . 1.0 108.851 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.499 ' CD2' ' NH1' ' A' ' 52' ' ' ARG . 34.7 p90 -148.4 160.12 43.34 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.821 -1.174 . . . . 1.0 110.752 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.403 ' NH1' ' HG2' ' A' ' 18' ' ' ARG . 35.0 ttt-85 -145.72 134.77 22.68 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.387 -0.598 . . . . 1.0 109.387 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.745 ' H ' HH22 ' A' ' 52' ' ' ARG . 93.5 mt -89.9 119.1 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 120.792 -1.193 . . . . 1.0 108.684 178.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 56.1 t -69.0 -40.78 81.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.964 -1.085 . . . . 1.0 109.027 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.4 p-10 -162.95 164.12 25.9 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.032 -1.067 . . . . 1.0 110.203 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.516 ' CD2' ' CG ' ' A' ' 28' ' ' HIS . 36.7 m-85 -103.42 -161.08 0.81 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.646 -1.613 . . . . 1.0 106.646 178.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.12 151.84 74.95 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.614 -0.679 . . . . 1.0 110.668 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -70.19 -14.28 34.55 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.056 1.171 . . . . 1.0 110.062 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -59.45 -40.02 85.5 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 115.307 -0.86 . . . . 1.0 110.027 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.6 mtm -140.47 168.07 20.68 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.343 -0.848 . . . . 1.0 109.236 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.4 p -72.79 159.98 32.92 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.401 -0.812 . . . . 1.0 109.207 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.516 ' CG ' ' CD2' ' A' ' 22' ' ' TYR . 2.8 m-70 -59.97 -40.0 87.56 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.442 -0.787 . . . . 1.0 110.007 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 61.9 m -60.01 -40.06 87.98 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.165 -0.959 . . . . 1.0 110.488 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.65 -39.96 91.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.96 -1.088 . . . . 1.0 109.838 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.4 t -69.51 -41.38 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.135 -0.978 . . . . 1.0 110.485 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.0 -49.05 79.18 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.989 -1.069 . . . . 1.0 110.495 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -62.17 -32.91 73.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.987 -1.071 . . . . 1.0 109.825 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.98 -50.43 73.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.184 -0.948 . . . . 1.0 110.042 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -65.82 -38.94 90.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.054 -1.029 . . . . 1.0 109.672 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.97 -42.36 93.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.06 -1.025 . . . . 1.0 109.808 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -60.56 -40.59 92.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.942 -1.098 . . . . 1.0 109.234 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.26 -43.1 96.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -0.89 . . . . 1.0 109.99 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -66.07 -40.01 90.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.03 -1.043 . . . . 1.0 109.705 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -59.94 -47.87 84.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -0.934 . . . . 1.0 110.139 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 70.5 t -59.95 -40.04 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.058 -1.026 . . . . 1.0 109.965 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -81.66 -35.31 30.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.895 -1.128 . . . . 1.0 110.182 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.7 p -70.46 -22.82 62.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.92 -1.113 . . . . 1.0 109.414 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -59.96 -40.01 87.58 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.433 -0.792 . . . . 1.0 110.606 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.416 HG23 HG23 ' A' ' 46' ' ' THR . 8.5 m -112.14 25.35 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.372 -0.83 . . . . 1.0 110.729 -178.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.416 HG23 HG23 ' A' ' 45' ' ' VAL . 59.9 p -148.91 131.62 7.95 Favored Pre-proline 0 N--CA 1.501 2.09 0 O-C-N 120.88 -1.137 . . . . 1.0 109.796 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -72.93 20.54 0.33 Allowed 'Trans proline' 0 N--CA 1.495 1.577 0 CA-C-N 119.668 0.917 . . . . 1.0 112.032 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.9 mt -67.97 139.1 56.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.175 -0.953 . . . . 1.0 109.614 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -107.92 120.58 42.7 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.851 -0.796 . . . . 1.0 108.851 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -107.21 127.1 53.22 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.304 -0.873 . . . . 1.0 110.023 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.3 m -120.05 129.98 54.48 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.648 -0.657 . . . . 1.0 109.404 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.745 HH22 ' H ' ' A' ' 19' ' ' ILE . 28.9 tpt180 -84.03 136.5 34.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.247 -0.908 . . . . 1.0 109.833 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.0 mt -110.61 128.71 55.79 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.438 -0.789 . . . . 1.0 109.26 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.44 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 56.6 m170 -69.43 -39.78 77.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.396 -0.815 . . . . 1.0 109.708 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 76.7 m-20 -148.77 168.66 22.33 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.231 -0.918 . . . . 1.0 110.084 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.27 -175.48 29.52 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 109.868 -1.293 . . . . 1.0 109.868 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.7 mt -94.46 133.98 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.313 -1.11 . . . . 1.0 109.021 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.79 163.0 14.66 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.493 -0.754 . . . . 1.0 109.511 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -59.94 -49.25 78.41 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.279 -0.888 . . . . 1.0 109.045 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.418 HG23 ' O ' ' A' ' 94' ' ' GLY . 95.8 mt -113.64 108.36 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.465 -0.772 . . . . 1.0 109.516 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.6 ptm -103.47 132.44 49.72 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.207 -0.933 . . . . 1.0 109.435 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 90.1 mt -102.34 138.25 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.506 -0.746 . . . . 1.0 109.777 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.8 p -153.63 157.34 39.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.249 -0.907 . . . . 1.0 109.49 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -102.08 125.28 48.73 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.8 -0.815 . . . . 1.0 108.8 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.14 158.04 16.21 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.424 -1.071 . . . . 1.0 110.424 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.414 HG12 ' H ' ' A' ' 67' ' ' LYS . 9.8 tt -109.8 -178.03 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.758 -0.83 . . . . 1.0 108.758 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.414 ' H ' HG12 ' A' ' 66' ' ' ILE . 22.0 tptm -38.52 -78.76 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.748 -0.595 . . . . 1.0 110.221 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -73.09 126.28 29.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.119 -0.988 . . . . 1.0 110.058 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.45 ' CE1' ' CE1' ' A' ' 75' ' ' PHE . 0.9 OUTLIER -100.09 -2.51 34.07 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.225 -0.922 . . . . 1.0 108.873 179.829 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.96 7.19 88.72 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.651 -1.78 . . . . 1.0 108.651 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.401 ' C ' ' H ' ' A' ' 73' ' ' TYR . 96.0 m-20 -131.51 170.02 15.29 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.676 -0.897 . . . . 1.0 108.929 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.411 ' CE2' ' CZ ' ' A' ' 73' ' ' TYR . 24.3 p90 -73.64 43.65 0.15 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.108 -0.995 . . . . 1.0 109.742 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.411 ' CZ ' ' CE2' ' A' ' 72' ' ' PHE . 55.0 m-85 -132.48 74.75 74.97 Favored Pre-proline 0 N--CA 1.501 2.106 0 O-C-N 121.458 -0.776 . . . . 1.0 109.164 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -80.16 146.3 17.8 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.395 1.397 . . . . 1.0 112.391 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.537 ' CE2' ' OD1' ' A' ' 99' ' ' ASP . 27.2 m-85 -93.14 169.41 10.43 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.366 -0.976 . . . . 1.0 108.366 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 79' ' ' SER . 23.7 p-10 -99.95 10.25 41.61 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.046 -1.034 . . . . 1.0 110.948 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 110.73 -150.5 17.72 Favored Glycine 0 N--CA 1.507 3.395 0 N-CA-C 109.557 -1.417 . . . . 1.0 109.557 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -58.77 -65.81 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.577 0 CA-C-N 118.913 1.357 . . . . 1.0 112.846 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.433 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 78.9 p -75.24 159.16 31.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.095 -1.003 . . . . 1.0 109.693 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.22 -128.59 8.04 Favored Glycine 0 N--CA 1.5 2.944 0 N-CA-C 109.773 -1.331 . . . . 1.0 109.773 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.464 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 14.8 mt -69.4 105.84 2.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.326 -1.102 . . . . 1.0 109.41 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.42 HD23 ' OE2' ' A' ' 102' ' ' GLU . 72.2 mt -78.73 -24.4 44.88 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.127 -0.983 . . . . 1.0 108.738 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.65 169.99 1.31 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.053 -1.091 . . . . 1.0 108.053 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -163.0 161.39 25.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.855 -1.153 . . . . 1.0 110.209 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -145.5 162.31 37.68 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.502 -0.749 . . . . 1.0 109.193 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -103.06 151.92 38.5 Favored Pre-proline 0 N--CA 1.501 2.113 0 O-C-N 121.114 -0.991 . . . . 1.0 109.227 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.442 ' O ' ' N ' ' A' ' 89' ' ' GLY . 7.4 Cg_exo -49.67 167.15 0.19 Allowed 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 120.784 0.99 . . . . 1.0 112.518 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -61.61 73.83 0.09 OUTLIER 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.249 1.299 . . . . 1.0 111.845 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -89.76 -168.4 43.11 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 108.852 -1.699 . . . . 1.0 108.852 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 89' ' ' GLY . 17.0 Cg_exo -56.04 -147.41 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 121.215 1.277 . . . . 1.0 112.713 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -60.34 -40.0 89.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.292 -0.88 . . . . 1.0 110.172 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -70.04 -38.58 75.89 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.072 -1.018 . . . . 1.0 109.462 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -59.37 169.52 6.37 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.669 -1.372 . . . . 1.0 109.669 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.418 ' O ' HG23 ' A' ' 60' ' ' ILE . . . 73.42 16.11 78.92 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.206 -1.158 . . . . 1.0 110.206 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.2 p-10 -79.93 166.26 21.8 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.967 -1.314 . . . . 1.0 109.716 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.87 123.17 10.26 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.279 -0.888 . . . . 1.0 109.27 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 57.5 m170 -112.31 154.8 25.12 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.571 -0.705 . . . . 1.0 109.973 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.519 ' CZ ' ' OE2' ' A' ' 120' ' ' GLU . 38.9 m-85 -133.12 149.79 52.09 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.625 -0.88 . . . . 1.0 108.625 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.537 ' OD1' ' CE2' ' A' ' 75' ' ' PHE . 64.4 m-20 -79.93 123.23 27.59 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.964 -1.085 . . . . 1.0 110.058 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -84.8 -9.72 57.89 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.297 -0.877 . . . . 1.0 109.621 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -84.73 -11.55 55.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.261 -0.899 . . . . 1.0 109.848 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.42 ' OE2' HD23 ' A' ' 82' ' ' LEU . 96.1 mt-10 -90.02 169.94 10.77 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.37 -0.831 . . . . 1.0 110.026 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 16.7 m -100.14 105.19 16.78 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.435 -0.79 . . . . 1.0 109.101 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -89.32 124.29 34.28 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.084 -0.71 . . . . 1.0 109.084 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.686 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.8 t -140.7 154.55 46.4 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.279 -0.888 . . . . 1.0 110.151 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 70.2 m -92.88 -8.01 44.59 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.427 -0.953 . . . . 1.0 108.427 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.4 m -92.63 176.78 6.32 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.9 m -79.72 76.64 6.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.998 -1.064 . . . . 1.0 109.428 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.686 ' HB2' HG21 ' A' ' 105' ' ' THR . 98.2 mttt -147.26 148.66 31.67 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.392 -0.817 . . . . 1.0 108.866 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 46.11 -139.39 6.66 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.747 -1.341 . . . . 1.0 109.747 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -99.7 114.41 27.5 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.251 -1.146 . . . . 1.0 109.21 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -63.69 133.76 54.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.137 -0.977 . . . . 1.0 109.538 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.3 tp -59.99 -44.76 94.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.506 -0.747 . . . . 1.0 110.825 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -59.97 -42.75 94.84 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.005 -1.06 . . . . 1.0 110.561 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -59.61 -50.01 75.54 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.878 -1.139 . . . . 1.0 109.363 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.7 t -69.07 -41.46 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.15 -0.969 . . . . 1.0 109.691 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.63 -50.16 74.85 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.369 -0.832 . . . . 1.0 110.274 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.44 -38.71 81.41 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.865 -1.147 . . . . 1.0 110.218 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -64.02 -50.01 70.17 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.093 -1.004 . . . . 1.0 111.031 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.519 ' OE2' ' CZ ' ' A' ' 98' ' ' PHE . 7.4 pt-20 -59.99 -44.64 94.38 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.698 -1.251 . . . . 1.0 110.048 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -59.99 -40.03 87.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.785 -1.197 . . . . 1.0 108.895 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.29 -43.75 64.85 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.241 -1.543 . . . . 1.0 109.241 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -66.29 -39.93 89.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.217 -1.166 . . . . 1.0 109.112 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 77.4 p -62.39 -21.41 65.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.898 . . . . 1.0 109.561 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.5 mt -83.0 -3.55 57.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 1.0 109.391 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 92.4 8.14 62.92 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.524 -1.03 . . . . 1.0 110.524 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.3 mt -86.58 146.34 26.39 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.95 -1.324 . . . . 1.0 109.208 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 27.7 t0 -99.47 175.29 5.9 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.476 -0.765 . . . . 1.0 109.576 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.512 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 75.2 m80 -61.15 135.66 57.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 1.0 109.72 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 41.5 t -97.37 156.7 16.34 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.21 -0.931 . . . . 1.0 109.358 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -97.33 0.39 47.9 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.155 -0.965 . . . . 1.0 109.632 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -83.7 130.23 56.46 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.171 -0.955 . . . . 1.0 108.476 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -70.58 -20.69 30.67 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 CA-C-N 120.022 1.044 . . . . 1.0 112.384 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -87.58 -5.05 79.2 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.823 -1.311 . . . . 1.0 109.823 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.73 145.72 26.55 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.173 -1.192 . . . . 1.0 109.267 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 138' ' ' PHE . 95.5 mt -70.67 -30.98 67.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.078 -1.014 . . . . 1.0 109.477 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 98.2 mmm -70.23 14.14 0.13 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.364 -0.835 . . . . 1.0 109.766 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.468 ' H ' ' C ' ' A' ' 136' ' ' LEU . 13.5 t80 -68.89 134.03 90.07 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.071 -1.018 . . . . 1.0 108.297 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -62.67 -18.36 63.6 Favored 'Trans proline' 0 N--CA 1.501 1.957 0 C-N-CA 121.04 1.16 . . . . 1.0 113.985 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.8 mt -102.79 141.43 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 120.834 -1.166 . . . . 1.0 109.691 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -75.58 126.01 30.16 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.331 -0.856 . . . . 1.0 110.221 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 11.0 t -134.73 137.46 43.5 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.426 -0.796 . . . . 1.0 109.268 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -80.1 143.56 33.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.966 -1.084 . . . . 1.0 108.6 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.9 t -139.83 151.73 45.94 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.313 -0.867 . . . . 1.0 109.615 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.55 104.75 1.51 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.374 -1.49 . . . . 1.0 109.374 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -77.9 1.72 19.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.26 -1.141 . . . . 1.0 109.95 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 73.3 m -60.05 -40.1 88.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.193 -0.942 . . . . 1.0 109.652 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -143.41 29.45 1.43 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.246 -0.909 . . . . 1.0 109.468 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -69.7 138.87 53.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.173 -0.955 . . . . 1.0 110.11 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 93.9 mtp -138.79 146.67 41.62 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.544 -0.91 . . . . 1.0 108.544 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 58.1 mt -51.74 129.03 36.29 Favored Pre-proline 0 C--N 1.302 -1.483 0 O-C-N 121.111 -0.993 . . . . 1.0 108.728 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -69.2 178.56 4.11 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 CA-C-N 119.985 1.03 . . . . 1.0 112.266 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -63.11 -39.89 96.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.476 -0.765 . . . . 1.0 110.12 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -55.64 -48.56 74.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.337 -0.852 . . . . 1.0 109.764 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -69.93 -40.03 75.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.97 . . . . 1.0 109.847 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.04 -48.13 89.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.075 -1.016 . . . . 1.0 108.995 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -60.11 -40.02 88.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.191 -0.943 . . . . 1.0 110.261 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.43 -55.0 7.11 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 120.199 -1.001 . . . . 1.0 111.477 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.49 HG23 ' N ' ' A' ' 160' ' ' GLN . 5.3 tp -60.0 -40.14 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.967 -1.313 . . . . 1.0 109.732 -178.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.55 ' O ' ' N ' ' A' ' 164' ' ' GLY . 79.8 mm-40 -64.43 -39.34 93.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.209 -0.932 . . . . 1.0 109.316 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 79.9 p -60.95 -34.13 74.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.139 -0.976 . . . . 1.0 110.484 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.2 mt -84.43 -52.79 5.9 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.877 -1.139 . . . . 1.0 110.671 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -90.67 -8.01 51.1 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.046 -1.034 . . . . 1.0 110.541 -178.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.536 0 N-CA-C 109.288 -1.525 . . . . 1.0 109.288 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 169' ' ' WAY . . . . . 0.946 ' HC2' ' HJ ' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.3 m . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.369 -0.604 . . . . 1.0 109.369 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.3 mt -60.68 139.99 57.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.92 -1.112 . . . . 1.0 109.328 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -160.34 159.97 31.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.24 -0.913 . . . . 1.0 109.384 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -76.37 127.24 32.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.148 -0.97 . . . . 1.0 109.259 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.4 p -69.24 -38.48 78.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.038 -1.039 . . . . 1.0 108.933 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.404 ' H ' ' HG2' ' A' ' 12' ' ' LYS . 49.1 pttt -89.47 136.43 33.03 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.932 -1.136 . . . . 1.0 107.932 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.611 ' N ' ' SD ' ' A' ' 13' ' ' MET . 4.8 mmm -90.7 -0.27 57.64 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.065 -1.022 . . . . 1.0 109.872 -178.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -97.98 132.72 43.3 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.997 -1.112 . . . . 1.0 107.997 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.6 mt -139.57 149.92 44.43 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.202 -0.936 . . . . 1.0 109.376 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.7 p -135.67 156.43 48.85 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.661 -0.866 . . . . 1.0 108.661 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -145.86 160.04 42.35 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.137 -0.977 . . . . 1.0 109.958 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.435 ' HE ' ' HA ' ' A' ' 55' ' ' ASP . 37.0 ttt-85 -144.31 134.94 24.84 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.49 -0.756 . . . . 1.0 109.272 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.8 mt -87.54 119.68 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.244 -0.91 . . . . 1.0 108.748 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.5 t -69.17 -39.93 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.239 -0.913 . . . . 1.0 109.345 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -165.01 153.08 11.67 Favored 'General case' 0 C--N 1.29 -1.991 0 O-C-N 120.163 -1.586 . . . . 1.0 110.802 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -100.81 106.52 17.92 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 105.87 -1.9 . . . . 1.0 105.87 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.459 ' C ' ' H ' ' A' ' 25' ' ' ASP . 0.4 OUTLIER -45.45 140.04 4.32 Favored Pre-proline 0 C--N 1.299 -1.612 0 O-C-N 121.487 -0.758 . . . . 1.0 109.591 -177.985 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -59.22 -3.05 1.51 Allowed 'Trans proline' 0 N--CA 1.487 1.111 0 CA-C-N 119.358 0.807 . . . . 1.0 110.75 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.459 ' H ' ' C ' ' A' ' 23' ' ' THR . 94.3 m-20 -59.73 -36.04 75.79 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.585 -0.524 . . . . 1.0 109.585 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 78.0 mtm -140.0 166.75 23.8 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.219 -0.925 . . . . 1.0 109.801 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.6 p -71.63 160.15 33.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.417 -0.802 . . . . 1.0 109.335 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -60.09 -40.93 91.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.307 -0.871 . . . . 1.0 110.32 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.5 m -60.03 -40.34 88.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.935 -1.103 . . . . 1.0 110.875 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.01 -42.96 89.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.109 -0.994 . . . . 1.0 110.767 -178.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.7 t -65.37 -39.87 86.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 121.248 -0.907 . . . . 1.0 109.598 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -58.1 -54.97 41.0 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.371 -0.831 . . . . 1.0 111.708 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.9 pttt -63.47 -33.68 76.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.607 -1.308 . . . . 1.0 110.723 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.37 -50.78 70.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.637 -1.289 . . . . 1.0 109.666 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.45 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 47.3 m-85 -67.69 -38.81 84.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.842 -1.161 . . . . 1.0 110.401 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -59.89 -40.69 89.58 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.724 -1.235 . . . . 1.0 109.438 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -60.72 -39.94 90.48 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.158 -0.964 . . . . 1.0 108.988 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.09 -47.12 87.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.432 -0.792 . . . . 1.0 109.834 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -65.21 -38.9 91.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.081 -1.012 . . . . 1.0 109.656 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 44.0 tptt -59.95 -47.83 84.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.079 -1.013 . . . . 1.0 109.893 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.5 t -60.07 -40.77 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.28 -0.887 . . . . 1.0 110.79 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -82.32 -35.38 27.96 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.86 -1.15 . . . . 1.0 110.483 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.6 p -70.03 -17.3 63.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.13 -0.981 . . . . 1.0 109.606 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -59.82 -39.98 86.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.261 -0.9 . . . . 1.0 110.868 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.4 m -110.85 -19.46 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 O-C-N 121.147 -0.971 . . . . 1.0 110.487 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.3 p -94.46 129.79 35.66 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 120.843 -1.161 . . . . 1.0 109.709 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -73.01 10.18 1.18 Allowed 'Trans proline' 0 N--CA 1.494 1.553 0 CA-C-N 119.831 0.975 . . . . 1.0 111.953 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.7 mt -67.95 140.61 56.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.215 -0.928 . . . . 1.0 109.822 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -104.47 121.97 44.55 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.933 -0.765 . . . . 1.0 108.933 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -107.69 122.42 46.69 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.293 -0.879 . . . . 1.0 109.699 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.0 m -119.88 129.98 54.64 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.483 -0.76 . . . . 1.0 109.615 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.475 ' CB ' ' NH1' ' A' ' 52' ' ' ARG . 11.1 ttp-105 -85.03 133.66 34.24 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.288 -0.883 . . . . 1.0 109.725 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 86.2 mt -102.52 126.72 49.67 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.269 -0.894 . . . . 1.0 109.353 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.425 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 54.8 m170 -61.41 -39.87 92.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.447 -0.783 . . . . 1.0 109.874 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.435 ' HA ' ' HE ' ' A' ' 18' ' ' ARG . 80.8 m-20 -146.19 171.4 14.99 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.225 -0.922 . . . . 1.0 109.563 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.24 179.87 38.12 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.758 -1.337 . . . . 1.0 109.758 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.5 mt -95.56 136.39 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.313 -1.11 . . . . 1.0 109.262 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.72 163.58 14.39 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.483 -0.761 . . . . 1.0 109.244 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -59.99 -49.77 76.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -0.895 . . . . 1.0 109.472 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.9 mt -108.48 104.17 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.488 -0.757 . . . . 1.0 109.753 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.8 ptp -100.83 135.06 42.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.218 -0.926 . . . . 1.0 109.181 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.45 HG21 ' CZ ' ' A' ' 35' ' ' PHE . 85.5 mt -109.99 131.09 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.624 -0.673 . . . . 1.0 109.711 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.3 p -150.55 156.59 41.7 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.205 -0.935 . . . . 1.0 109.898 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -102.37 120.02 39.79 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.207 -1.035 . . . . 1.0 108.207 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.0 -169.48 23.25 Favored Glycine 0 N--CA 1.499 2.878 0 N-CA-C 110.629 -0.988 . . . . 1.0 110.629 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.603 HG22 ' N ' ' A' ' 67' ' ' LYS . 93.2 mt -134.39 168.99 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.139 -1.06 . . . . 1.0 108.139 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.603 ' N ' HG22 ' A' ' 66' ' ' ILE . 52.1 tptt -17.96 -98.01 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.649 0 CA-C-O 120.884 0.373 . . . . 1.0 111.455 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.632 ' CD ' ' H ' ' A' ' 68' ' ' GLU . 3.9 pm0 -74.26 139.49 44.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.817 -1.177 . . . . 1.0 109.973 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.497 ' CD2' ' OD2' ' A' ' 71' ' ' ASP . 44.2 p-80 -152.89 33.27 0.48 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.887 -1.133 . . . . 1.0 109.936 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.71 21.97 62.78 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 120.227 -0.987 . . . . 1.0 110.721 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.497 ' OD2' ' CD2' ' A' ' 69' ' ' HIS . 97.8 m-20 -129.98 145.53 51.64 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.216 -1.167 . . . . 1.0 109.545 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -74.02 156.14 37.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.368 -0.833 . . . . 1.0 109.332 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 49.96 60.03 15.77 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.139 -0.976 . . . . 1.0 109.354 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -60.28 -152.67 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 120.891 1.061 . . . . 1.0 111.987 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.585 ' CD1' ' OD1' ' A' ' 99' ' ' ASP . 90.6 m-85 -86.55 166.0 15.77 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.162 -0.961 . . . . 1.0 109.2 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -101.27 0.03 36.58 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.31 -0.869 . . . . 1.0 110.848 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 134.18 -150.27 19.97 Favored Glycine 0 N--CA 1.504 3.18 0 N-CA-C 108.767 -1.733 . . . . 1.0 108.767 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.424 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 2.8 Cg_exo -64.07 -64.1 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.339 0 CA-C-N 119.013 1.406 . . . . 1.0 111.473 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 94.3 p -77.83 160.85 28.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.118 -0.989 . . . . 1.0 109.331 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.98 -129.83 8.71 Favored Glycine 0 N--CA 1.501 3.007 0 N-CA-C 109.101 -1.6 . . . . 1.0 109.101 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.413 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 10.1 mt -69.41 107.5 3.35 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.132 -1.216 . . . . 1.0 108.735 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 55.6 mt -75.16 -25.77 58.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.942 -1.098 . . . . 1.0 109.31 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.92 172.94 1.25 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -164.61 160.01 19.65 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.999 -1.063 . . . . 1.0 109.648 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -142.86 153.77 43.49 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.412 -0.805 . . . . 1.0 108.867 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -89.18 151.92 47.31 Favored Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.047 -1.033 . . . . 1.0 108.683 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -58.64 165.37 8.01 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 120.951 1.101 . . . . 1.0 111.788 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -42.84 136.38 4.72 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 C-N-CA 121.215 1.277 . . . . 1.0 112.384 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -175.78 -169.35 37.3 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.212 -1.555 . . . . 1.0 109.212 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -61.44 -153.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 121.124 1.216 . . . . 1.0 112.038 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -60.08 -41.6 92.8 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.018 -1.051 . . . . 1.0 109.421 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -60.14 -43.42 95.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.153 -0.967 . . . . 1.0 109.69 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -78.1 168.26 53.92 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.28 -1.128 . . . . 1.0 110.28 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 72.5 7.03 67.57 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.343 -1.503 . . . . 1.0 109.343 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 -80.95 172.47 13.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.331 -1.099 . . . . 1.0 109.589 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.0 124.1 11.43 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.266 -0.896 . . . . 1.0 109.4 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -112.99 133.81 54.78 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.549 -0.72 . . . . 1.0 110.098 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.499 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 25.5 m-85 -116.15 149.41 39.08 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 109.005 -0.739 . . . . 1.0 109.005 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.585 ' OD1' ' CD1' ' A' ' 75' ' ' PHE . 82.0 m-20 -77.75 123.67 26.99 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.878 -1.138 . . . . 1.0 109.845 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 42.0 t0 -84.29 -11.56 56.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.447 -0.783 . . . . 1.0 109.184 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -82.19 -11.69 58.56 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.35 -0.844 . . . . 1.0 108.951 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.424 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 97.5 mt-10 -90.53 168.54 11.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.466 -0.771 . . . . 1.0 109.3 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 19.5 m -100.34 105.24 16.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.326 -0.859 . . . . 1.0 108.723 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.462 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 94.5 m95 -87.33 120.58 28.77 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.481 -0.762 . . . . 1.0 109.103 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.662 HG21 ' HB2' ' A' ' 109' ' ' LYS . 7.3 t -139.95 150.02 44.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.461 -0.774 . . . . 1.0 109.779 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 52.7 m -92.85 -6.14 49.43 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.214 -0.929 . . . . 1.0 108.534 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.6 t -92.03 175.69 6.78 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.871 -0.789 . . . . 1.0 108.871 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.1 t -75.59 75.29 2.61 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.028 -1.045 . . . . 1.0 109.222 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.662 ' HB2' HG21 ' A' ' 105' ' ' THR . 98.6 mttt -149.4 149.75 31.33 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.574 -0.898 . . . . 1.0 108.574 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 109' ' ' LYS . . . 42.98 -139.17 2.9 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 110.033 -1.227 . . . . 1.0 110.033 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -100.19 118.85 37.37 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.348 -1.089 . . . . 1.0 109.265 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -63.31 129.39 40.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.359 -0.838 . . . . 1.0 109.877 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.5 tp -60.01 -43.27 95.36 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.49 -0.756 . . . . 1.0 110.552 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -59.99 -41.63 92.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.214 -0.929 . . . . 1.0 111.177 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.61 -49.62 76.81 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.769 -1.207 . . . . 1.0 109.226 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 67.7 t -69.94 -41.32 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.301 -0.874 . . . . 1.0 110.712 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.34 -53.25 60.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.998 -1.064 . . . . 1.0 109.778 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.97 -34.43 73.27 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.186 -0.946 . . . . 1.0 109.785 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 60.0 t60 -63.12 -50.73 69.33 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.228 -0.92 . . . . 1.0 110.783 -178.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.499 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 6.9 pt-20 -60.0 -39.42 85.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.792 -1.192 . . . . 1.0 110.111 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -59.94 -40.01 87.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.904 -1.123 . . . . 1.0 108.798 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.67 -41.92 94.0 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.332 -1.507 . . . . 1.0 109.332 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -67.32 -39.96 85.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.139 -1.212 . . . . 1.0 109.577 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 95.4 p -68.97 -21.93 64.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.397 -0.814 . . . . 1.0 109.513 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 49.7 mt -82.99 -0.96 51.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 1.0 109.902 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 92.5 6.43 64.25 Favored Glycine 0 N--CA 1.498 2.77 0 C-N-CA 120.221 -0.99 . . . . 1.0 110.852 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.3 mt -85.1 144.86 27.95 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.745 -1.444 . . . . 1.0 109.916 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 44.6 t0 -99.01 172.43 7.41 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.167 -1.049 . . . . 1.0 108.167 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.528 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 74.6 m80 -61.76 132.17 52.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.757 -1.214 . . . . 1.0 109.281 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.7 t -97.35 158.39 15.49 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.253 -0.905 . . . . 1.0 109.135 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -99.92 8.45 44.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.322 -0.861 . . . . 1.0 109.279 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -85.14 125.35 70.46 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.188 -0.945 . . . . 1.0 108.895 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -66.91 -20.94 50.93 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 CA-C-N 120.195 1.105 . . . . 1.0 112.541 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -87.3 -7.14 77.06 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.078 -1.209 . . . . 1.0 110.078 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.87 139.58 31.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.117 -1.225 . . . . 1.0 109.458 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.453 ' C ' ' H ' ' A' ' 138' ' ' PHE . 91.6 mt -62.18 -40.05 94.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.142 -0.974 . . . . 1.0 109.88 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 85.8 mtp -70.5 24.72 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.245 -0.909 . . . . 1.0 111.04 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.453 ' H ' ' C ' ' A' ' 136' ' ' LEU . 23.5 t80 -69.94 129.99 90.41 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 120.766 -1.209 . . . . 1.0 108.331 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -49.55 -19.8 3.6 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 120.954 1.103 . . . . 1.0 114.505 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 90.6 mt -107.78 137.39 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 O-C-N 120.879 -1.138 . . . . 1.0 110.37 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -74.13 128.27 35.1 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.554 -0.716 . . . . 1.0 109.519 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.9 t -139.55 143.4 37.36 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.915 -0.772 . . . . 1.0 108.915 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -81.53 142.85 32.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.108 -0.995 . . . . 1.0 108.885 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.2 t -139.7 150.96 45.49 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.172 -0.955 . . . . 1.0 110.151 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.64 105.13 1.66 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.218 -1.553 . . . . 1.0 109.218 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 21.8 mtmm -75.74 1.9 13.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.379 -1.071 . . . . 1.0 109.834 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 67.9 m -59.92 -40.02 87.44 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.171 -0.955 . . . . 1.0 109.712 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -144.18 27.7 1.41 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.096 -1.003 . . . . 1.0 110.1 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -68.78 137.4 53.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.919 -1.113 . . . . 1.0 109.768 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 67.1 mtt -138.86 147.94 43.06 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.38 -0.825 . . . . 1.0 108.955 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 74.2 mt -51.57 124.84 26.55 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.0 -1.062 . . . . 1.0 108.631 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -67.81 -179.42 2.06 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 CA-C-N 120.102 1.072 . . . . 1.0 112.329 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -61.77 -39.58 92.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.333 -0.854 . . . . 1.0 109.868 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -56.98 -49.55 75.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -0.945 . . . . 1.0 110.01 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -70.09 -39.97 75.23 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.99 -1.069 . . . . 1.0 110.31 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 76.4 t -60.84 -48.36 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.958 -1.089 . . . . 1.0 108.927 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -60.36 -39.98 89.13 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.16 -0.962 . . . . 1.0 110.856 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.77 -53.79 7.91 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 120.06 -1.067 . . . . 1.0 111.121 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.461 HG23 ' N ' ' A' ' 160' ' ' GLN . 9.4 tp -60.56 -40.53 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.016 -1.284 . . . . 1.0 109.837 -178.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.527 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.9 mt-30 -65.81 -38.69 89.63 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.136 -0.977 . . . . 1.0 109.54 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 83.9 p -65.72 -24.98 67.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.119 -0.988 . . . . 1.0 110.666 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 87.8 mt -87.34 -50.72 6.38 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.747 -1.22 . . . . 1.0 110.0 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -93.01 -9.11 41.01 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.04 -1.038 . . . . 1.0 110.048 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.607 0 N-CA-C 109.548 -1.421 . . . . 1.0 109.548 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 169' ' ' WAY . . . . . 0.961 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.2 m . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.6 mt -87.41 139.94 30.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.239 -0.913 . . . . 1.0 109.173 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -161.24 163.37 31.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.065 -1.022 . . . . 1.0 109.647 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -71.16 146.2 49.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.881 . . . . 1.0 109.543 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 87.8 p -90.06 3.44 53.27 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.4 -0.812 . . . . 1.0 110.148 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -144.7 154.01 42.31 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.065 -1.022 . . . . 1.0 109.51 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.5 mmt -90.46 -0.04 57.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.229 -0.919 . . . . 1.0 109.748 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -96.65 125.49 41.16 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.126 -0.983 . . . . 1.0 109.182 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.0 mt -140.01 152.34 46.19 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.293 -0.88 . . . . 1.0 109.187 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.5 p -133.61 154.29 51.0 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.494 -0.754 . . . . 1.0 109.312 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -145.1 160.0 42.09 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.186 -0.946 . . . . 1.0 109.811 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 44.9 ttt-85 -144.61 131.5 20.27 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.427 -0.796 . . . . 1.0 109.503 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 86.0 mt -86.94 119.98 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.278 -0.889 . . . . 1.0 108.818 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.6 t -69.47 -41.53 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.089 -1.007 . . . . 1.0 109.282 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -165.09 155.02 13.31 Favored 'General case' 0 C--N 1.289 -2.06 0 O-C-N 119.967 -1.708 . . . . 1.0 110.412 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.411 ' O ' ' C ' ' A' ' 23' ' ' THR . 23.9 m-85 -99.4 95.94 7.37 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 105.907 -1.886 . . . . 1.0 105.907 178.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.411 ' C ' ' O ' ' A' ' 22' ' ' TYR . 1.5 t -39.86 142.53 0.66 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.963 -0.461 . . . . 1.0 110.619 -177.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -59.68 -21.48 63.11 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 120.436 0.757 . . . . 1.0 110.994 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -58.4 -14.86 8.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.73 -0.606 . . . . 1.0 109.865 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 78.0 mtp -142.7 150.78 40.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.291 -0.881 . . . . 1.0 109.816 -178.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.1 p -75.52 160.05 30.61 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.476 -0.935 . . . . 1.0 108.476 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.64 -40.1 90.72 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.12 -0.988 . . . . 1.0 109.948 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.9 m -64.82 -42.35 95.04 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.065 -1.022 . . . . 1.0 110.922 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -66.4 -40.11 89.42 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.153 -0.967 . . . . 1.0 111.321 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.4 t -67.91 -42.07 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.969 -1.082 . . . . 1.0 110.535 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -59.94 -49.49 77.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.127 -0.983 . . . . 1.0 110.715 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -64.15 -32.66 74.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.823 -1.173 . . . . 1.0 110.377 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.35 -50.62 73.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.794 -1.191 . . . . 1.0 110.01 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -69.35 -37.51 77.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.043 -1.036 . . . . 1.0 110.218 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -59.95 -42.72 94.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.981 -1.074 . . . . 1.0 109.484 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -61.78 -40.18 94.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.091 -1.006 . . . . 1.0 108.849 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.82 -50.83 71.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.444 -0.785 . . . . 1.0 110.135 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -63.26 -39.95 96.03 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.952 -1.092 . . . . 1.0 109.947 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -60.05 -48.65 80.84 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.062 -1.024 . . . . 1.0 109.841 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 72.0 t -60.03 -41.84 87.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.34 -0.85 . . . . 1.0 110.435 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -78.43 -34.81 47.63 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.958 -1.089 . . . . 1.0 110.23 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 52.4 p -72.33 -20.0 61.55 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.95 -1.094 . . . . 1.0 109.814 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -60.07 -40.02 88.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.496 -0.752 . . . . 1.0 111.417 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.5 m -111.87 22.48 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.241 -0.912 . . . . 1.0 111.131 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 48' ' ' LEU . 18.8 p -146.57 139.45 14.32 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 120.872 -1.142 . . . . 1.0 109.274 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -72.93 17.55 0.39 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 120.675 0.917 . . . . 1.0 111.178 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.411 ' H ' ' C ' ' A' ' 46' ' ' THR . 90.4 mt -67.65 134.12 50.58 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.361 -0.837 . . . . 1.0 110.374 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -108.78 120.53 42.77 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.531 -0.914 . . . . 1.0 108.531 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -108.4 130.34 55.23 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.309 -0.869 . . . . 1.0 109.418 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.5 m -120.03 130.01 54.51 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.571 -0.705 . . . . 1.0 110.147 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -82.83 129.54 35.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.397 -0.814 . . . . 1.0 109.277 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 89.4 mt -108.89 118.62 37.28 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 108.74 -0.837 . . . . 1.0 108.74 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.445 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 72.2 m-70 -70.18 -24.08 63.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.22 -0.925 . . . . 1.0 110.063 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 77.8 m-20 -148.33 162.88 38.63 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.216 -0.928 . . . . 1.0 109.876 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.21 174.9 39.14 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.746 -1.342 . . . . 1.0 109.746 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 87.5 mt -94.25 134.1 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.331 -1.1 . . . . 1.0 109.019 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.98 160.94 15.98 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.446 -0.784 . . . . 1.0 109.122 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.04 -49.34 78.06 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.178 -0.951 . . . . 1.0 109.113 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.9 mt -105.02 99.06 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.427 -0.796 . . . . 1.0 109.818 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.3 ptm -99.28 133.89 42.91 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.115 -0.99 . . . . 1.0 109.084 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.5 mt -106.09 137.4 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.536 -0.728 . . . . 1.0 109.749 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 81.8 p -153.13 155.82 37.46 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.129 -0.982 . . . . 1.0 109.565 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -104.88 123.96 48.63 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.573 -0.704 . . . . 1.0 109.127 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -103.82 -169.9 25.36 Favored Glycine 0 N--CA 1.5 2.949 0 N-CA-C 110.48 -1.048 . . . . 1.0 110.48 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.555 HG22 ' N ' ' A' ' 67' ' ' LYS . 70.9 mt -136.3 167.28 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.57 -0.959 . . . . 1.0 109.037 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.555 ' N ' HG22 ' A' ' 66' ' ' ILE . 20.7 tptm -21.45 -76.48 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.481 0 CA-C-O 121.185 0.517 . . . . 1.0 111.708 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.637 ' CD ' ' H ' ' A' ' 68' ' ' GLU . 4.3 pm0 -66.08 146.05 55.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -0.913 . . . . 1.0 109.733 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -128.52 151.18 49.72 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.935 -0.765 . . . . 1.0 108.935 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.92 -44.42 97.16 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.264 -1.535 . . . . 1.0 109.264 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 73' ' ' TYR . 92.3 m-20 -80.01 159.4 26.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.22 -1.165 . . . . 1.0 109.194 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -69.75 52.57 0.11 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.142 -0.974 . . . . 1.0 109.059 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.45 ' N ' ' O ' ' A' ' 71' ' ' ASP . 57.2 t80 -139.95 70.54 35.73 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.37 -0.831 . . . . 1.0 108.859 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -78.45 161.44 28.39 Favored 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 121.439 1.426 . . . . 1.0 112.657 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.549 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 96.7 m-85 -88.75 170.31 10.89 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.622 -0.881 . . . . 1.0 108.622 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 79' ' ' SER . 22.8 p-10 -96.75 -0.27 48.41 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.992 -1.067 . . . . 1.0 110.829 -178.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.459 ' O ' ' OE2' ' A' ' 102' ' ' GLU . . . 117.44 -120.03 4.64 Favored Glycine 0 N--CA 1.506 3.325 0 N-CA-C 110.338 -1.105 . . . . 1.0 110.338 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.461 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 28.1 Cg_endo -74.29 -73.19 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.803 0 CA-C-N 120.26 2.03 . . . . 1.0 113.04 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.457 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 82.2 p -78.28 -178.9 5.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.925 -1.109 . . . . 1.0 109.806 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.34 -135.43 12.16 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.305 -1.118 . . . . 1.0 110.305 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.7 mt -71.17 111.11 6.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.552 -0.97 . . . . 1.0 110.033 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 55.2 mt -83.63 -17.3 42.02 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.128 -0.982 . . . . 1.0 108.927 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.86 176.0 0.97 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.023 -0.732 . . . . 1.0 109.023 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -161.84 163.37 29.37 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.103 -0.998 . . . . 1.0 109.444 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.34 170.01 19.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.289 -0.882 . . . . 1.0 109.404 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -107.2 154.06 40.71 Favored Pre-proline 0 N--CA 1.498 1.972 0 N-CA-C 108.849 -0.797 . . . . 1.0 108.849 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' A' ' 89' ' ' GLY . 8.8 Cg_endo -60.3 165.6 10.68 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 120.588 0.859 . . . . 1.0 111.558 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -56.29 77.55 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.149 1.233 . . . . 1.0 112.108 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -99.93 -168.25 29.51 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 108.812 -1.715 . . . . 1.0 108.812 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 89' ' ' GLY . 14.3 Cg_exo -57.47 -145.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 121.044 1.163 . . . . 1.0 112.276 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -64.24 -40.01 95.13 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.201 -0.937 . . . . 1.0 109.423 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -67.27 -39.89 86.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.367 -0.833 . . . . 1.0 109.787 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.32 171.82 42.67 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.94 -1.264 . . . . 1.0 109.94 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 71.71 15.03 75.55 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.976 -1.65 . . . . 1.0 108.976 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 40.4 p-10 -79.66 171.6 14.92 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.499 -1.0 . . . . 1.0 109.835 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.24 129.93 15.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.258 -0.901 . . . . 1.0 109.641 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 58.5 m170 -124.9 147.07 49.02 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.614 -0.679 . . . . 1.0 109.252 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -129.72 151.95 49.76 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.528 -0.732 . . . . 1.0 109.469 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.549 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 96.4 m-20 -79.6 120.55 24.09 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.045 -1.035 . . . . 1.0 109.104 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 43.0 t0 -83.54 -4.97 59.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.235 -0.916 . . . . 1.0 109.04 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -82.01 -10.81 59.12 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.412 -0.805 . . . . 1.0 109.075 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.461 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 49.2 mm-40 -90.68 179.1 5.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.385 -0.822 . . . . 1.0 108.991 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 39.0 m -104.93 104.55 14.32 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.445 -0.946 . . . . 1.0 108.445 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.419 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 88.6 m95 -87.95 120.0 28.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.929 . . . . 1.0 109.08 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.678 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.3 t -140.97 151.2 43.97 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.525 -0.734 . . . . 1.0 109.708 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 61.2 m -92.71 -5.64 50.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.104 -0.998 . . . . 1.0 108.546 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 34.0 t -92.93 174.78 7.06 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.6 -0.889 . . . . 1.0 108.6 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.515 ' OG ' ' CZ ' ' A' ' 143' ' ' TYR . 10.6 m -75.85 75.29 2.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.881 -1.137 . . . . 1.0 109.526 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.678 ' HB2' HG21 ' A' ' 105' ' ' THR . 61.3 mttp -147.5 148.84 31.63 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.58 -0.896 . . . . 1.0 108.58 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 109' ' ' LYS . . . 44.53 -139.18 4.65 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.644 -1.382 . . . . 1.0 109.644 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -98.91 118.97 36.88 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.284 -1.127 . . . . 1.0 109.025 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -64.65 130.24 42.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.459 -0.775 . . . . 1.0 110.044 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.3 tp -59.93 -40.45 88.98 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.256 -0.902 . . . . 1.0 110.056 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -59.92 -40.65 89.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 1.0 110.328 -178.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.486 HD21 ' CE ' ' A' ' 146' ' ' LYS . 3.3 mm? -60.04 -55.4 34.39 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.819 -1.176 . . . . 1.0 109.625 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.0 t -67.44 -42.49 87.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.278 -0.889 . . . . 1.0 109.318 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.94 -52.69 64.32 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.173 -0.954 . . . . 1.0 109.101 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.36 82.38 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.816 -1.177 . . . . 1.0 109.801 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 73.0 t60 -64.01 -49.85 70.82 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.452 -0.78 . . . . 1.0 111.644 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -59.95 -39.5 85.82 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.602 -1.311 . . . . 1.0 109.664 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -59.81 -40.07 87.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.893 -1.129 . . . . 1.0 108.237 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.38 -43.9 84.88 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.808 -1.717 . . . . 1.0 108.808 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -67.42 -40.05 85.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.224 -1.162 . . . . 1.0 109.546 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 84.2 p -64.71 -24.03 67.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.206 -0.934 . . . . 1.0 109.731 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 84.5 mt -81.15 0.87 34.42 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.182 -0.949 . . . . 1.0 110.005 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 89.76 4.17 73.09 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 120.056 -1.068 . . . . 1.0 110.738 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.8 mt -84.47 149.74 25.75 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.865 -1.374 . . . . 1.0 109.592 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 37.2 t0 -99.78 174.52 6.18 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.615 -0.883 . . . . 1.0 108.615 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.501 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 74.5 m80 -59.33 139.48 56.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.99 -1.069 . . . . 1.0 109.395 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 38.2 t -98.42 152.73 19.19 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.297 -0.877 . . . . 1.0 109.248 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -99.99 5.49 45.14 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.225 -0.922 . . . . 1.0 109.37 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -88.39 126.82 59.09 Favored Pre-proline 0 N--CA 1.493 1.714 0 N-CA-C 108.179 -1.045 . . . . 1.0 108.179 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -67.56 -15.02 44.06 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 CA-C-N 120.273 1.133 . . . . 1.0 111.94 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -90.72 -5.55 68.63 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.357 -1.497 . . . . 1.0 109.357 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.42 142.51 27.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -1.174 . . . . 1.0 108.901 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.497 ' C ' ' H ' ' A' ' 138' ' ' PHE . 74.5 mt -68.5 -36.9 79.55 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.08 -1.013 . . . . 1.0 109.902 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 76.2 mtp -69.92 20.88 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.133 -0.979 . . . . 1.0 110.405 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.497 ' H ' ' C ' ' A' ' 136' ' ' LEU . 14.6 t80 -66.26 135.5 94.95 Favored Pre-proline 0 N--CA 1.493 1.699 0 N-CA-C 107.853 -1.165 . . . . 1.0 107.853 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -62.92 -10.46 20.38 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 120.826 1.018 . . . . 1.0 114.052 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 91.5 mt -111.81 138.28 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.39 0 O-C-N 120.875 -1.14 . . . . 1.0 110.012 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -74.95 125.1 28.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.505 -0.747 . . . . 1.0 110.484 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 10.2 t -138.98 140.14 38.13 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.441 -0.787 . . . . 1.0 109.043 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.515 ' CZ ' ' OG ' ' A' ' 108' ' ' SER . 89.3 t80 -81.79 141.96 33.02 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.889 -1.132 . . . . 1.0 109.949 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.5 m -130.28 138.33 50.43 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.039 -0.726 . . . . 1.0 109.039 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -66.4 101.38 0.62 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.62 -1.792 . . . . 1.0 108.62 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.486 ' CE ' HD21 ' A' ' 115' ' ' LEU . 58.1 mmtt -75.96 129.33 36.74 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.288 -1.125 . . . . 1.0 109.302 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.5 t -179.78 -51.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.592 -0.892 . . . . 1.0 108.592 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -135.99 19.85 3.24 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.557 -0.905 . . . . 1.0 108.557 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -65.17 139.41 58.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.406 -0.808 . . . . 1.0 110.602 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 96.5 mtp -137.62 149.91 47.0 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.324 -0.991 . . . . 1.0 108.324 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.5 mt -51.83 131.44 38.32 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 120.902 -1.124 . . . . 1.0 109.03 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -71.41 177.96 6.12 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 CA-C-N 119.919 1.007 . . . . 1.0 112.083 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -62.12 -39.97 94.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.418 -0.801 . . . . 1.0 110.285 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -55.06 -48.68 73.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.035 -1.041 . . . . 1.0 109.778 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -69.96 -40.0 75.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.119 -0.988 . . . . 1.0 110.186 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.5 t -60.45 -47.78 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.968 -1.083 . . . . 1.0 109.302 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -60.61 -40.02 90.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.05 -1.031 . . . . 1.0 110.076 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.17 -52.39 11.25 Favored Glycine 0 N--CA 1.495 2.631 0 O-C-N 121.246 -0.909 . . . . 1.0 111.874 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.47 HG23 ' N ' ' A' ' 160' ' ' GLN . 8.4 tp -59.94 -39.97 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.744 -1.445 . . . . 1.0 109.917 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.547 ' O ' ' N ' ' A' ' 164' ' ' GLY . 87.9 mt-30 -68.36 -35.21 77.38 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.059 -1.026 . . . . 1.0 109.425 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 77.2 p -60.23 -35.06 74.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.131 -0.981 . . . . 1.0 110.344 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 94.5 mt -86.13 -49.61 7.63 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.958 -1.089 . . . . 1.0 110.671 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -90.04 -9.12 49.74 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.137 -0.977 . . . . 1.0 110.328 -178.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.513 0 N-CA-C 109.411 -1.476 . . . . 1.0 109.411 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 169' ' ' WAY . . . . . 0.862 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.6 m . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.373 -0.603 . . . . 1.0 109.373 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.8 mt -70.58 142.48 51.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.293 -0.879 . . . . 1.0 109.439 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -160.09 160.3 32.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.383 -0.823 . . . . 1.0 109.36 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -71.75 148.94 45.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.211 -0.93 . . . . 1.0 109.573 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 90.7 p -90.03 2.26 55.38 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.42 -0.8 . . . . 1.0 109.798 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.516 ' NZ ' ' O ' ' A' ' 14' ' ' ASN . 20.0 pttp -141.74 153.12 44.4 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.179 -0.95 . . . . 1.0 109.501 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.8 mmt -90.11 -0.04 57.4 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.323 -0.861 . . . . 1.0 109.814 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.516 ' O ' ' NZ ' ' A' ' 12' ' ' LYS . 28.1 m120 -96.97 129.25 44.45 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.197 -0.939 . . . . 1.0 109.286 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.7 mt -141.13 152.0 44.36 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.233 -0.917 . . . . 1.0 109.104 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 63.1 p -133.88 152.81 51.99 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.422 -0.799 . . . . 1.0 109.285 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -145.85 157.46 43.91 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.094 -1.004 . . . . 1.0 109.864 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.412 ' HE ' ' HA ' ' A' ' 55' ' ' ASP . 38.0 ttt-85 -144.54 135.26 24.81 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.376 -0.827 . . . . 1.0 109.356 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 86.3 mt -87.67 119.71 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.274 -0.891 . . . . 1.0 108.793 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 63.4 t -69.12 -40.22 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.315 -0.865 . . . . 1.0 109.409 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -162.86 156.63 20.32 Favored 'General case' 0 C--N 1.287 -2.146 0 O-C-N 119.38 -2.075 . . . . 1.0 111.369 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.44 ' CD2' ' CE1' ' A' ' 28' ' ' HIS . 64.4 m-85 -100.72 109.03 21.02 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 106.248 -1.76 . . . . 1.0 106.248 178.007 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.423 ' H ' HG22 ' A' ' 23' ' ' THR . 1.1 t -54.62 139.13 60.4 Favored Pre-proline 0 C--N 1.294 -1.842 0 O-C-N 121.38 -0.825 . . . . 1.0 109.309 -178.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -57.8 -6.94 2.84 Favored 'Trans proline' 0 N--CA 1.486 1.085 0 CA-C-N 119.443 0.837 . . . . 1.0 111.145 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -60.07 -39.58 86.54 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 119.78 -0.768 . . . . 1.0 110.013 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.5 mtm -137.27 159.58 41.52 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.265 -0.897 . . . . 1.0 109.086 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.488 ' OG1' ' OE1' ' A' ' 30' ' ' GLU . 36.3 p -75.3 167.88 21.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.166 -0.959 . . . . 1.0 109.714 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.44 ' CE1' ' CD2' ' A' ' 22' ' ' TYR . 1.2 m-70 -60.05 -40.43 89.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.434 -0.791 . . . . 1.0 111.057 -178.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.3 m -60.1 -46.09 90.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.886 -1.134 . . . . 1.0 110.733 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.576 ' OE1' ' N ' ' A' ' 30' ' ' GLU . 8.9 mp0 -66.75 -41.51 87.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.222 -0.924 . . . . 1.0 110.259 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 72.2 t -67.49 -44.77 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.995 -1.066 . . . . 1.0 110.134 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -60.0 -49.67 76.74 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.236 -0.915 . . . . 1.0 111.178 -178.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -60.94 -33.81 73.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.692 -1.255 . . . . 1.0 109.852 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.03 -50.93 71.79 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.916 -1.115 . . . . 1.0 110.398 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -65.58 -38.43 89.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.925 -1.11 . . . . 1.0 110.387 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.01 -42.17 93.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.898 -1.127 . . . . 1.0 109.543 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.14 -40.06 88.53 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.219 -0.926 . . . . 1.0 109.291 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.94 -46.45 89.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 1.0 110.075 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -66.84 -38.13 85.81 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.091 -1.006 . . . . 1.0 109.791 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -59.68 -48.26 82.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.13 -0.981 . . . . 1.0 109.577 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.1 t -60.01 -43.08 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.136 -0.977 . . . . 1.0 110.122 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -78.14 -35.69 48.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.99 -1.069 . . . . 1.0 110.18 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.0 p -70.38 -22.43 62.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.096 -1.003 . . . . 1.0 109.741 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.03 -40.01 87.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.31 -0.869 . . . . 1.0 110.8 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.439 HG23 HG23 ' A' ' 46' ' ' THR . 17.2 m -111.96 25.37 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.335 -0.853 . . . . 1.0 110.621 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.439 HG23 HG23 ' A' ' 45' ' ' VAL . 58.5 p -150.01 130.09 6.75 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.144 -0.973 . . . . 1.0 109.083 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -73.54 19.63 0.38 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 CA-C-N 119.974 1.026 . . . . 1.0 112.047 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.6 mt -69.41 138.74 53.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.177 -0.952 . . . . 1.0 109.616 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -107.28 120.8 43.13 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.798 -0.816 . . . . 1.0 108.798 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -107.01 127.92 53.89 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.32 -0.862 . . . . 1.0 109.162 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -119.98 129.95 54.53 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.63 -0.669 . . . . 1.0 109.444 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.429 ' HG2' HH11 ' A' ' 52' ' ' ARG . 34.1 ttt-85 -82.74 130.0 35.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.398 -0.814 . . . . 1.0 109.424 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.4 mt -103.98 119.87 39.86 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.367 -0.833 . . . . 1.0 109.168 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.434 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 59.0 m-70 -62.28 -39.96 94.67 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.427 -0.796 . . . . 1.0 110.005 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 87.4 m-20 -143.4 164.0 31.52 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.259 -0.9 . . . . 1.0 109.86 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.76 177.81 33.72 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.726 -1.35 . . . . 1.0 109.726 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.8 mt -93.24 134.77 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.292 -1.122 . . . . 1.0 109.29 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.28 167.46 10.1 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.515 -0.74 . . . . 1.0 109.422 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -59.96 -48.94 79.64 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.31 -0.869 . . . . 1.0 109.031 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.7 mt -115.59 108.66 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.535 -0.728 . . . . 1.0 109.897 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.5 ptp -98.68 138.53 35.72 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.199 -0.938 . . . . 1.0 109.108 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.9 mt -109.96 133.57 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.499 -0.75 . . . . 1.0 109.747 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 77.6 p -150.98 159.29 44.67 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.059 -1.026 . . . . 1.0 110.022 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -110.47 126.55 54.46 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.564 -0.71 . . . . 1.0 109.248 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 100' ' ' ASP . . . -102.38 -170.74 26.96 Favored Glycine 0 N--CA 1.502 3.059 0 N-CA-C 110.786 -0.925 . . . . 1.0 110.786 -179.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.554 HG22 ' N ' ' A' ' 67' ' ' LYS . 62.1 mt -137.57 167.21 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.532 -0.981 . . . . 1.0 109.303 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.554 ' N ' HG22 ' A' ' 66' ' ' ILE . 48.3 tptt -22.34 -77.82 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.462 0 CA-C-O 120.961 0.41 . . . . 1.0 111.631 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -67.65 139.12 56.79 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.945 -1.097 . . . . 1.0 108.824 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -127.81 2.67 6.04 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.447 -0.783 . . . . 1.0 109.454 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.19 8.67 87.67 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.557 -1.417 . . . . 1.0 109.557 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -110.02 161.58 15.38 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.512 -0.993 . . . . 1.0 109.29 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -70.04 -15.48 63.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.252 -0.905 . . . . 1.0 109.212 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -138.93 75.12 36.28 Favored Pre-proline 0 N--CA 1.496 1.875 0 O-C-N 121.448 -0.782 . . . . 1.0 109.437 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -74.12 -151.55 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 121.261 1.308 . . . . 1.0 111.839 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.545 ' CD1' ' OD1' ' A' ' 99' ' ' ASP . 94.3 m-85 -85.17 166.93 16.18 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.2 -0.937 . . . . 1.0 108.799 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 79' ' ' SER . 27.2 p-10 -99.58 -4.12 31.79 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.084 -1.01 . . . . 1.0 110.709 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.441 ' O ' ' OE2' ' A' ' 102' ' ' GLU . . . 119.14 -115.32 3.03 Favored Glycine 0 N--CA 1.505 3.287 0 N-CA-C 110.267 -1.133 . . . . 1.0 110.267 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.468 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 29.1 Cg_endo -73.91 -75.11 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.956 0 CA-C-N 120.158 1.979 . . . . 1.0 113.402 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.459 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 88.5 p -76.61 177.88 7.14 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.915 -1.115 . . . . 1.0 110.151 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.11 -136.53 12.73 Favored Glycine 0 N--CA 1.498 2.819 0 N-CA-C 110.683 -0.967 . . . . 1.0 110.683 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.0 mt -71.81 110.41 6.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.375 -1.073 . . . . 1.0 109.763 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 55.4 mt -83.76 -18.3 38.27 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.73 173.96 1.22 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.502 -0.925 . . . . 1.0 108.502 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.497 ' CE1' ' ND1' ' A' ' 97' ' ' HIS . 9.4 p80 -162.29 164.33 27.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.971 -1.081 . . . . 1.0 109.985 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -157.17 160.52 38.84 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.823 -0.806 . . . . 1.0 108.823 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -106.75 151.36 40.48 Favored Pre-proline 0 N--CA 1.501 2.102 0 O-C-N 121.365 -0.834 . . . . 1.0 109.131 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.526 ' O ' ' N ' ' A' ' 89' ' ' GLY . 10.0 Cg_endo -62.51 165.56 15.26 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 120.987 1.124 . . . . 1.0 112.328 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -47.48 84.02 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.161 1.241 . . . . 1.0 112.356 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -96.47 -174.53 35.56 Favored Glycine 0 N--CA 1.498 2.792 0 N-CA-C 109.137 -1.585 . . . . 1.0 109.137 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -76.55 -95.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 121.372 1.381 . . . . 1.0 112.814 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -79.14 -57.28 3.81 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.035 -1.041 . . . . 1.0 111.062 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -69.88 -21.83 63.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.174 -0.954 . . . . 1.0 110.161 -178.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -61.36 169.03 10.94 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.269 -1.532 . . . . 1.0 109.269 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 68.98 72.99 0.76 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.929 -1.268 . . . . 1.0 109.929 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -158.85 159.84 35.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.213 -1.169 . . . . 1.0 109.386 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.89 119.83 6.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 1.0 109.191 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.497 ' ND1' ' CE1' ' A' ' 84' ' ' HIS . 52.4 m170 -103.85 145.78 29.61 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.539 -0.725 . . . . 1.0 109.994 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -129.68 147.03 51.43 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.447 -0.946 . . . . 1.0 108.447 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.545 ' OD1' ' CD1' ' A' ' 75' ' ' PHE . 98.3 m-20 -80.81 124.28 28.94 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.92 -1.113 . . . . 1.0 109.579 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 65' ' ' GLY . 39.2 t0 -84.24 -6.81 59.45 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.144 -0.973 . . . . 1.0 109.214 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -80.33 -9.91 59.75 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.633 -0.877 . . . . 1.0 108.633 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.468 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 57.5 mm-40 -89.57 173.3 8.4 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.985 -0.746 . . . . 1.0 108.985 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 54.2 m -105.29 107.62 18.7 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -88.58 119.98 29.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.304 -0.872 . . . . 1.0 108.739 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.663 HG21 ' HB2' ' A' ' 109' ' ' LYS . 9.0 t -140.24 157.85 44.94 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.365 -0.835 . . . . 1.0 109.79 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.4 t -95.76 -9.83 30.72 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.223 -0.923 . . . . 1.0 109.053 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 71.3 m -92.46 179.22 5.59 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.368 -0.833 . . . . 1.0 108.975 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.1 t -78.64 77.78 5.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.032 -1.043 . . . . 1.0 109.56 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.663 ' HB2' HG21 ' A' ' 105' ' ' THR . 68.6 mttm -148.76 148.12 29.62 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.266 -0.896 . . . . 1.0 108.821 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.53 -141.3 4.72 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.746 -1.342 . . . . 1.0 109.746 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -100.33 117.02 33.66 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.352 -1.087 . . . . 1.0 108.925 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -62.74 133.85 55.42 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.076 -1.015 . . . . 1.0 109.219 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.9 tp -59.99 -42.82 95.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 1.0 109.823 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -59.86 -40.8 89.87 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.234 -0.916 . . . . 1.0 110.968 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -59.76 -52.12 66.85 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.604 -1.31 . . . . 1.0 109.722 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.3 t -69.91 -40.79 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.059 -1.026 . . . . 1.0 110.049 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.45 -50.15 74.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.153 -0.967 . . . . 1.0 109.547 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.0 -37.3 79.3 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.71 -1.244 . . . . 1.0 110.16 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 56.9 t60 -63.5 -50.1 70.96 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.219 -0.926 . . . . 1.0 111.315 -178.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.99 -39.03 84.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.748 -1.22 . . . . 1.0 109.858 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -59.99 -40.05 87.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.821 -1.174 . . . . 1.0 108.519 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.45 -46.8 79.51 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.807 -1.317 . . . . 1.0 109.807 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -65.85 -39.98 91.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.06 -1.259 . . . . 1.0 109.462 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.1 p -64.58 -25.1 67.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.228 -0.92 . . . . 1.0 109.8 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 72.8 mt -80.95 1.98 28.77 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.138 -0.976 . . . . 1.0 109.371 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 87.19 9.51 73.12 Favored Glycine 0 N--CA 1.495 2.629 0 O-C-N 121.2 -0.938 . . . . 1.0 110.834 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.4 mt -84.95 150.02 25.22 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.836 -1.39 . . . . 1.0 109.759 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 39.6 t0 -99.53 171.33 8.0 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.869 -0.789 . . . . 1.0 108.869 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.537 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 71.9 m80 -59.96 139.96 57.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.12 -0.987 . . . . 1.0 109.53 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 44.4 t -97.1 152.4 18.82 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.428 -0.795 . . . . 1.0 109.554 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -99.01 2.22 46.1 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.311 -0.868 . . . . 1.0 109.354 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 9.5 t70 -87.26 130.0 49.44 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.294 -0.879 . . . . 1.0 108.708 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -67.15 -22.22 47.4 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 CA-C-N 120.078 1.064 . . . . 1.0 112.437 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.444 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -86.89 -2.39 84.14 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.817 -1.313 . . . . 1.0 109.817 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.57 143.48 28.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.183 -1.186 . . . . 1.0 109.219 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.436 ' C ' ' H ' ' A' ' 138' ' ' PHE . 84.3 mt -69.26 -38.31 78.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.098 -1.001 . . . . 1.0 109.698 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 81.4 mtp -72.09 20.92 0.06 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 1.0 110.735 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.436 ' H ' ' C ' ' A' ' 136' ' ' LEU . 16.3 t80 -68.11 134.48 91.58 Favored Pre-proline 0 N--CA 1.496 1.857 0 N-CA-C 107.885 -1.154 . . . . 1.0 107.885 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -61.47 -9.46 13.31 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 120.836 1.024 . . . . 1.0 114.227 -177.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 86.4 mt -113.05 134.08 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 O-C-N 120.955 -1.091 . . . . 1.0 109.705 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -72.34 127.24 31.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.467 -0.77 . . . . 1.0 110.402 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 14.1 t -141.29 141.14 33.95 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.582 -0.895 . . . . 1.0 108.582 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -78.95 143.83 35.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.09 -1.007 . . . . 1.0 109.199 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.6 t -138.8 150.78 46.45 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.292 -0.88 . . . . 1.0 109.71 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -66.15 101.59 0.63 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.465 -1.454 . . . . 1.0 109.465 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 20.9 mtmm -76.71 0.34 20.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.423 -1.046 . . . . 1.0 109.768 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 73.6 p -60.06 -39.97 87.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -0.901 . . . . 1.0 109.965 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -147.62 30.69 0.9 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.079 -1.013 . . . . 1.0 109.526 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -65.28 139.61 58.63 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.132 -0.98 . . . . 1.0 109.586 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 68.2 mtt -136.55 145.24 44.8 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.702 -0.851 . . . . 1.0 108.702 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 20.9 mt -52.86 128.86 46.7 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.091 -1.006 . . . . 1.0 108.719 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -70.13 178.69 4.54 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 CA-C-N 120.081 1.065 . . . . 1.0 112.286 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -60.36 -39.95 89.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.432 -0.792 . . . . 1.0 110.096 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -56.14 -49.12 74.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.199 -0.938 . . . . 1.0 109.969 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -70.08 -39.93 75.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.996 -1.065 . . . . 1.0 110.064 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 58.1 t -61.28 -47.43 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.012 -1.055 . . . . 1.0 109.498 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -60.43 -40.09 89.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.048 -1.032 . . . . 1.0 110.45 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.26 -53.72 8.67 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 120.374 -0.917 . . . . 1.0 111.477 -178.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.476 HG23 ' N ' ' A' ' 160' ' ' GLN . 6.8 tp -59.97 -40.06 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.817 -1.402 . . . . 1.0 109.569 -178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.7 mt-30 -66.06 -39.94 90.5 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.101 -1.0 . . . . 1.0 109.202 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 95.1 p -60.53 -28.75 68.66 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.01 -1.056 . . . . 1.0 109.853 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 86.5 mt -89.8 -51.64 5.4 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.047 -1.033 . . . . 1.0 110.643 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -98.04 -22.08 16.45 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.945 -1.097 . . . . 1.0 110.829 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.626 0 N-CA-C 109.692 -1.363 . . . . 1.0 109.692 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 169' ' ' WAY . . . . . 0.925 ' HC2' ' HJ ' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.0 mt -96.92 131.77 43.37 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.215 -0.928 . . . . 1.0 109.049 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -160.0 160.04 32.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 1.0 109.69 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -72.88 150.0 43.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.304 -0.873 . . . . 1.0 109.304 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.1 t -85.48 1.61 48.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.303 -0.873 . . . . 1.0 110.093 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.521 ' NZ ' ' O ' ' A' ' 14' ' ' ASN . 20.1 pttp -149.14 154.24 38.9 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.162 -0.961 . . . . 1.0 109.635 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.54 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.01 0.39 57.14 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.289 -0.882 . . . . 1.0 109.666 -179.549 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.521 ' O ' ' NZ ' ' A' ' 12' ' ' LYS . 98.5 m-20 -95.51 128.76 42.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.219 -0.926 . . . . 1.0 108.884 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.5 mt -141.31 149.93 41.85 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.186 -0.946 . . . . 1.0 109.253 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 74.3 p -130.9 155.46 46.71 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.03 -0.73 . . . . 1.0 109.03 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -145.86 160.16 42.18 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.146 -0.972 . . . . 1.0 109.835 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.531 HH12 ' H ' ' A' ' 56' ' ' GLY . 73.4 ttt180 -143.36 133.45 24.32 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.537 -0.727 . . . . 1.0 109.583 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 91.8 mt -88.36 117.09 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.189 -0.944 . . . . 1.0 108.663 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.54 -40.12 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.06 -1.025 . . . . 1.0 109.391 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -163.85 160.94 22.82 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.431 -1.418 . . . . 1.0 110.631 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -97.21 -173.33 2.64 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.56 -1.274 . . . . 1.0 107.56 178.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.7 148.4 43.01 Favored Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 121.377 -0.827 . . . . 1.0 110.029 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -67.68 -20.64 46.35 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 120.833 1.022 . . . . 1.0 110.335 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -59.4 -40.12 85.6 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.15 -0.932 . . . . 1.0 110.168 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 78.0 mtm -138.95 159.93 40.95 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.257 -0.902 . . . . 1.0 109.853 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 82.6 p -74.21 160.86 30.58 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.497 0.665 . . . . 1.0 109.417 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -62.47 -35.88 80.72 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.552 -0.718 . . . . 1.0 110.148 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.9 m -60.04 -40.28 88.82 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.845 -1.16 . . . . 1.0 109.61 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -69.94 -40.04 75.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.114 -0.991 . . . . 1.0 109.035 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.0 t -69.13 -41.47 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.314 -0.866 . . . . 1.0 110.258 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.95 -48.13 82.95 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.931 -1.105 . . . . 1.0 110.346 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -63.75 -31.82 73.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.87 -1.144 . . . . 1.0 109.834 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.97 -49.96 75.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.07 -1.019 . . . . 1.0 110.031 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -65.55 -37.89 88.01 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.018 -1.051 . . . . 1.0 109.661 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.07 -41.24 92.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.096 -1.003 . . . . 1.0 109.878 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -60.07 -45.32 93.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.12 -0.987 . . . . 1.0 109.475 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.12 -48.06 83.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.44 -0.787 . . . . 1.0 110.717 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.42 ' CZ ' ' CZ ' ' A' ' 121' ' ' PHE . 49.7 m-85 -64.04 -40.05 95.44 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.956 -1.09 . . . . 1.0 109.529 -179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.6 tptt -59.99 -47.33 86.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.029 -1.045 . . . . 1.0 109.543 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.02 -41.52 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.143 -0.973 . . . . 1.0 110.128 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -78.49 -36.71 44.74 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.012 -1.055 . . . . 1.0 110.376 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 96.1 p -70.91 -20.76 62.46 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.982 -1.074 . . . . 1.0 109.936 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.93 -39.89 87.04 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.252 -0.905 . . . . 1.0 110.558 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.1 m -110.01 23.84 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.201 -0.937 . . . . 1.0 110.944 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.4 p -150.27 139.8 13.42 Favored Pre-proline 0 N--CA 1.502 2.129 0 O-C-N 120.76 -1.213 . . . . 1.0 109.658 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -75.37 15.7 0.79 Allowed 'Trans proline' 0 N--CA 1.497 1.693 0 CA-C-N 119.743 0.944 . . . . 1.0 112.088 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 88.2 mt -67.1 139.92 57.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.079 -1.013 . . . . 1.0 109.71 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -111.81 121.38 44.91 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 109.045 -0.724 . . . . 1.0 109.045 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -107.8 119.01 38.24 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.33 -0.856 . . . . 1.0 109.251 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.1 m -119.95 129.98 54.57 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.64 -0.663 . . . . 1.0 109.946 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.417 ' HG2' HH11 ' A' ' 52' ' ' ARG . 33.6 ttt-85 -82.0 135.13 35.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 1.0 109.241 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.5 mt -102.1 132.0 48.25 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.343 -0.848 . . . . 1.0 109.188 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.447 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 42.0 m170 -63.95 -40.01 95.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -0.84 . . . . 1.0 109.733 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 76.7 m-20 -148.89 169.95 19.39 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.328 -0.857 . . . . 1.0 109.869 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.531 ' H ' HH12 ' A' ' 18' ' ' ARG . . . 95.06 178.52 37.5 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.7 -1.36 . . . . 1.0 109.7 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.4 mt -92.58 139.52 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.292 -1.122 . . . . 1.0 108.961 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.05 170.55 8.08 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.473 -0.767 . . . . 1.0 109.702 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.03 -49.05 79.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.242 -0.911 . . . . 1.0 108.935 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 90.2 mt -119.95 112.97 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.616 -0.678 . . . . 1.0 109.251 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.0 ptm -100.93 135.0 43.07 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.397 -0.814 . . . . 1.0 108.952 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 95.8 mt -104.43 135.17 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.505 -0.747 . . . . 1.0 110.365 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 79.4 p -152.9 159.03 42.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.345 -0.847 . . . . 1.0 109.278 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -102.81 127.71 49.87 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.413 -0.804 . . . . 1.0 109.564 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.89 157.95 17.86 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 109.436 -1.466 . . . . 1.0 109.436 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.421 ' O ' ' C ' ' A' ' 67' ' ' LYS . 6.9 tt -104.53 -178.71 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.465 -1.021 . . . . 1.0 108.719 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 66' ' ' ILE . 28.1 tptp -38.33 -77.99 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.819 -0.551 . . . . 1.0 110.585 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.663 ' CD ' ' H ' ' A' ' 68' ' ' GLU . 1.0 OUTLIER -72.2 119.98 17.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.317 -0.864 . . . . 1.0 110.749 -179.013 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.621 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 3.5 m80 -69.94 -47.81 60.89 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.098 -1.002 . . . . 1.0 108.673 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.05 -12.67 63.5 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.69 -1.364 . . . . 1.0 109.69 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -122.46 -15.6 7.55 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.474 -1.015 . . . . 1.0 110.542 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.504 ' CZ ' ' CE1' ' A' ' 69' ' ' HIS . 55.6 p90 -169.9 -169.99 0.95 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.694 -1.253 . . . . 1.0 110.537 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -42.68 120.94 2.71 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.644 -0.66 . . . . 1.0 109.848 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.442 ' HA ' ' HD1' ' A' ' 69' ' ' HIS . 38.3 Cg_endo -76.96 -172.33 1.4 Allowed 'Trans proline' 0 N--CA 1.495 1.585 0 CA-C-N 119.868 0.989 . . . . 1.0 112.927 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.621 ' CE2' ' NE2' ' A' ' 69' ' ' HIS . 90.8 m-85 -87.71 168.01 13.36 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.604 -0.887 . . . . 1.0 108.604 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.6 p-10 -97.4 0.0 47.06 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.082 -1.011 . . . . 1.0 110.099 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.21 -157.89 22.9 Favored Glycine 0 N--CA 1.5 2.944 0 N-CA-C 108.722 -1.751 . . . . 1.0 108.722 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -59.68 -63.68 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.354 0 CA-C-N 118.655 1.228 . . . . 1.0 111.612 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 88.1 p -77.62 162.34 27.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.428 -0.795 . . . . 1.0 109.485 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.15 -129.95 9.03 Favored Glycine 0 N--CA 1.499 2.894 0 N-CA-C 109.709 -1.356 . . . . 1.0 109.709 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.449 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 10.2 mt -64.99 101.13 0.47 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.222 -1.164 . . . . 1.0 108.66 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 53.5 mt -75.66 -28.36 58.69 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.468 -0.938 . . . . 1.0 108.468 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -177.92 163.94 1.84 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.385 -0.969 . . . . 1.0 108.385 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -160.78 160.41 31.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.907 -1.121 . . . . 1.0 109.97 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -144.11 156.21 44.25 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.705 -0.85 . . . . 1.0 108.705 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -95.51 150.99 38.26 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.149 -0.969 . . . . 1.0 108.807 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -65.5 165.01 24.04 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 120.771 0.981 . . . . 1.0 111.556 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -42.34 136.22 4.07 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.164 1.243 . . . . 1.0 111.792 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 90' ' ' PRO . . . -172.39 -173.91 39.35 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.492 -1.337 . . . . 1.0 110.108 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 89' ' ' GLY . 6.0 Cg_exo -57.94 -148.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 120.913 1.075 . . . . 1.0 111.9 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -61.2 -39.92 92.01 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.355 -0.84 . . . . 1.0 109.865 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -65.36 -40.09 93.15 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.008 -1.057 . . . . 1.0 109.982 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.63 177.46 37.33 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.404 -1.478 . . . . 1.0 109.404 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 62.76 72.16 0.71 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.507 -1.437 . . . . 1.0 109.507 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -157.67 160.78 38.34 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.395 -1.062 . . . . 1.0 109.016 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.65 123.67 10.73 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.083 -1.011 . . . . 1.0 109.61 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -110.08 154.76 22.8 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.589 0.709 . . . . 1.0 110.015 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.486 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 44.9 m-85 -130.58 150.22 51.88 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.538 ' OD2' ' CD1' ' A' ' 75' ' ' PHE . 1.2 m-20 -78.96 122.86 26.68 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.991 -1.068 . . . . 1.0 109.591 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -84.44 -6.84 59.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.142 -0.974 . . . . 1.0 109.379 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -85.98 -14.74 43.7 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.336 -0.853 . . . . 1.0 110.067 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.574 ' OE1' ' N ' ' A' ' 102' ' ' GLU . 0.9 OUTLIER -88.66 169.91 11.27 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.176 -0.953 . . . . 1.0 109.687 -179.113 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.7 m -99.05 102.57 14.32 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.75 -0.833 . . . . 1.0 108.75 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.446 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 93.4 m95 -85.16 121.99 28.7 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.48 -0.762 . . . . 1.0 109.33 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.646 HG21 ' HB2' ' A' ' 109' ' ' LYS . 7.2 t -140.63 150.4 43.52 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.476 -0.765 . . . . 1.0 109.761 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 74.8 m -93.04 -6.2 48.77 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.193 -0.942 . . . . 1.0 108.52 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.1 p -91.3 178.63 5.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.571 -0.706 . . . . 1.0 109.208 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 89.7 p -77.0 70.0 3.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 1.0 109.376 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.646 ' HB2' HG21 ' A' ' 105' ' ' THR . 68.3 mttm -146.22 150.81 36.52 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.192 -0.942 . . . . 1.0 109.484 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 43.56 -137.73 4.18 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.046 -1.221 . . . . 1.0 110.046 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -99.99 115.32 29.42 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.394 -1.063 . . . . 1.0 109.22 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.441 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 19.3 t-20 -63.18 130.63 45.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.212 -0.93 . . . . 1.0 109.873 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.7 tp -59.92 -43.54 94.83 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.402 -0.811 . . . . 1.0 110.832 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -60.07 -42.14 93.9 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.989 -1.07 . . . . 1.0 111.096 -178.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -60.01 -50.05 75.26 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.672 -1.267 . . . . 1.0 109.509 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.5 t -70.03 -41.4 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.078 -1.014 . . . . 1.0 110.006 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.56 -50.52 72.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.227 -0.921 . . . . 1.0 109.891 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.96 -39.78 86.78 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.255 -0.903 . . . . 1.0 110.627 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -63.03 -48.4 78.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.115 -0.991 . . . . 1.0 111.156 -178.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.486 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 7.0 pt-20 -59.89 -39.6 85.91 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.589 -1.319 . . . . 1.0 110.011 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.42 ' CZ ' ' CZ ' ' A' ' 39' ' ' PHE . 32.3 m-85 -60.02 -40.11 88.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.912 -1.117 . . . . 1.0 108.479 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -56.42 -42.55 89.63 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.365 -1.494 . . . . 1.0 109.365 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -65.53 -40.02 92.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.073 -1.251 . . . . 1.0 109.592 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 80.0 p -67.15 -23.69 65.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.18 -0.95 . . . . 1.0 109.317 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.7 mt -81.96 -0.97 46.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.183 -0.948 . . . . 1.0 109.59 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 92.68 7.94 62.63 Favored Glycine 0 N--CA 1.497 2.735 0 O-C-N 121.149 -0.969 . . . . 1.0 110.933 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.4 mt -86.98 141.98 28.29 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.854 -1.38 . . . . 1.0 109.858 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 10.8 t70 -98.72 174.94 6.16 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.555 -0.715 . . . . 1.0 109.089 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.491 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 76.8 m80 -59.86 139.74 57.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.026 -1.046 . . . . 1.0 109.9 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 30.4 t -98.98 156.46 16.9 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.405 -0.809 . . . . 1.0 109.182 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -97.05 -1.43 45.4 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.229 -0.919 . . . . 1.0 109.016 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -85.43 129.32 55.76 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.079 -1.013 . . . . 1.0 108.976 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -68.69 -20.16 40.72 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 CA-C-N 120.027 1.045 . . . . 1.0 112.372 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -87.3 -7.14 77.05 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.895 -1.282 . . . . 1.0 109.895 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.58 145.7 26.65 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.086 -1.243 . . . . 1.0 109.427 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.418 ' C ' ' H ' ' A' ' 138' ' ' PHE . 96.1 mt -69.97 -29.13 66.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.047 -1.033 . . . . 1.0 109.696 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.1 mmm -72.2 13.49 0.31 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.332 -0.855 . . . . 1.0 110.262 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.418 ' H ' ' C ' ' A' ' 136' ' ' LEU . 12.2 t80 -70.0 131.83 88.83 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.071 -1.018 . . . . 1.0 108.768 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -63.56 -8.56 15.45 Favored 'Trans proline' 0 N--CA 1.501 1.93 0 C-N-CA 120.924 1.083 . . . . 1.0 114.37 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 84.2 mt -109.72 138.6 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 O-C-N 120.936 -1.103 . . . . 1.0 109.317 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.441 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 45.7 t80 -74.38 128.2 34.94 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.357 -0.839 . . . . 1.0 110.7 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.1 t -139.22 138.29 36.73 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.578 -0.702 . . . . 1.0 109.211 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.467 ' CE1' ' NZ ' ' A' ' 146' ' ' LYS . 70.6 t80 -80.83 150.12 29.28 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.975 -1.078 . . . . 1.0 109.352 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.6 t -142.4 158.56 43.57 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.116 -0.99 . . . . 1.0 109.992 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.07 113.91 4.75 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.423 -1.471 . . . . 1.0 109.423 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.467 ' NZ ' ' CE1' ' A' ' 143' ' ' TYR . 62.2 mttp -80.85 3.28 23.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.382 -1.069 . . . . 1.0 110.203 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 27.6 t -58.07 -41.29 83.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.845 -1.159 . . . . 1.0 109.532 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -160.96 68.66 0.34 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.32 -0.862 . . . . 1.0 109.18 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -94.36 120.54 34.75 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.249 -0.907 . . . . 1.0 109.812 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 75.0 mtm -116.62 142.5 46.81 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 22.3 mt -50.4 132.78 25.53 Favored Pre-proline 0 C--N 1.302 -1.498 0 O-C-N 121.043 -1.036 . . . . 1.0 108.914 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -68.87 179.42 3.23 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 CA-C-N 119.865 0.987 . . . . 1.0 112.355 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -62.43 -39.95 94.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.457 -0.777 . . . . 1.0 110.126 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -56.82 -48.62 77.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 1.0 110.071 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -70.11 -39.96 75.18 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.078 -1.014 . . . . 1.0 109.803 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 54.6 t -61.25 -48.08 90.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.18 -0.95 . . . . 1.0 109.162 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -61.05 -40.08 92.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.115 -0.991 . . . . 1.0 110.413 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.25 -53.66 13.24 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 120.243 -0.98 . . . . 1.0 111.253 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.457 HG23 ' N ' ' A' ' 160' ' ' GLN . 5.2 tp -60.36 -40.0 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.889 -1.36 . . . . 1.0 109.749 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.4 mt-30 -64.71 -39.9 94.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.04 -1.038 . . . . 1.0 109.636 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 84.4 p -65.96 -24.4 66.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -0.949 . . . . 1.0 110.2 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 85.6 mt -88.42 -51.5 5.69 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.931 -1.106 . . . . 1.0 110.232 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -90.89 -8.78 48.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.939 -1.1 . . . . 1.0 109.539 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.493 2.448 0 N-CA-C 109.664 -1.375 . . . . 1.0 109.664 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 169' ' ' WAY . . . . . 0.55 ' HC2' ' HJ ' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 87.6 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.9 mt -70.09 144.24 52.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.896 . . . . 1.0 109.526 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -159.86 160.0 33.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 1.0 109.377 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -73.78 150.06 41.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.224 -0.922 . . . . 1.0 109.047 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.3 t -85.62 -0.07 54.06 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.159 -0.963 . . . . 1.0 110.249 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -150.22 159.57 44.34 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.98 -1.075 . . . . 1.0 109.878 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.557 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -91.8 -0.03 57.51 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.385 -0.822 . . . . 1.0 109.689 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -96.22 123.38 39.82 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.215 -0.928 . . . . 1.0 108.995 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.3 mt -140.0 152.29 46.16 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.368 -0.832 . . . . 1.0 108.997 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.6 p -132.89 155.48 48.96 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.492 -0.755 . . . . 1.0 109.103 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -144.69 158.71 43.67 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.231 -0.918 . . . . 1.0 109.648 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.412 HH11 ' HG2' ' A' ' 18' ' ' ARG . 37.2 ttt-85 -142.44 132.28 24.23 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.467 -0.77 . . . . 1.0 109.47 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 93.1 mt -87.05 119.62 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.331 -0.856 . . . . 1.0 109.113 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.4 t -69.84 -40.3 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.175 -0.953 . . . . 1.0 109.495 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.414 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 18.6 p-10 -162.53 154.99 19.19 Favored 'General case' 0 C--N 1.288 -2.076 0 O-C-N 119.718 -1.864 . . . . 1.0 111.028 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.408 ' OH ' ' NH2' ' A' ' 52' ' ' ARG . 44.0 m-85 -99.87 108.85 21.22 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 105.582 -2.007 . . . . 1.0 105.582 177.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 23' ' ' THR . 1.1 t -57.55 139.58 80.97 Favored Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.055 -1.028 . . . . 1.0 109.727 -177.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -59.16 -10.15 9.77 Favored 'Trans proline' 0 N--CA 1.487 1.093 0 CA-C-N 119.246 0.766 . . . . 1.0 110.96 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -57.57 -28.21 63.37 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.848 -0.741 . . . . 1.0 110.078 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 77.4 mtm -143.44 162.48 35.68 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.085 -1.009 . . . . 1.0 109.862 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.2 p -71.81 160.83 31.91 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.309 -0.869 . . . . 1.0 109.205 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -61.41 -40.21 93.58 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.426 -0.796 . . . . 1.0 110.487 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.5 m -61.08 -41.23 96.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.968 -1.083 . . . . 1.0 110.705 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.89 -40.01 91.15 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.15 -0.969 . . . . 1.0 110.623 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 69.5 t -69.73 -42.22 80.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 120.936 -1.102 . . . . 1.0 110.275 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -59.97 -53.87 52.76 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.212 -0.93 . . . . 1.0 110.83 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.3 ptmm? -65.92 -29.83 70.32 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.586 -0.696 . . . . 1.0 110.821 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.04 -49.93 75.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.785 -1.197 . . . . 1.0 109.463 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -66.96 -38.26 85.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.018 -1.051 . . . . 1.0 110.211 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.06 -40.58 89.96 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.913 -1.117 . . . . 1.0 109.559 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.04 -41.41 96.54 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.889 -1.132 . . . . 1.0 108.964 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.99 -46.44 89.45 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.516 -0.74 . . . . 1.0 109.957 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.432 ' CE1' ' CD1' ' A' ' 50' ' ' PHE . 53.3 m-85 -65.15 -39.98 93.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.968 -1.083 . . . . 1.0 109.499 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -60.05 -48.46 81.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.052 -1.03 . . . . 1.0 109.852 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.7 t -60.0 -41.06 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.092 -1.005 . . . . 1.0 110.083 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -78.4 -36.42 45.78 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.92 -1.113 . . . . 1.0 110.135 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 81.7 p -71.78 -18.02 62.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.071 -1.018 . . . . 1.0 109.845 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -60.01 -39.69 86.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.239 -0.913 . . . . 1.0 110.285 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.434 HG23 HG23 ' A' ' 46' ' ' THR . 21.9 m -111.41 20.97 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.38 -0.825 . . . . 1.0 110.788 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.434 HG23 HG23 ' A' ' 45' ' ' VAL . 22.5 p -148.42 138.22 12.62 Favored Pre-proline 0 N--CA 1.504 2.255 0 O-C-N 120.77 -1.207 . . . . 1.0 109.914 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -73.95 21.23 0.38 Allowed 'Trans proline' 0 N--CA 1.498 1.793 0 C-N-CA 120.962 1.108 . . . . 1.0 112.495 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.3 mt -69.5 136.46 51.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.893 -1.13 . . . . 1.0 110.018 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -107.91 120.0 41.06 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.614 -0.884 . . . . 1.0 108.614 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.432 ' CD1' ' CE1' ' A' ' 39' ' ' PHE . 95.1 m-85 -108.5 125.29 51.63 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.311 -0.868 . . . . 1.0 109.723 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -120.05 130.03 54.5 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.67 -0.644 . . . . 1.0 109.792 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.408 ' NH2' ' OH ' ' A' ' 22' ' ' TYR . 68.6 ttt180 -82.38 130.73 35.17 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.365 -0.835 . . . . 1.0 109.892 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.0 mt -109.64 124.33 50.99 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.421 -0.799 . . . . 1.0 109.083 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.439 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 48.4 m170 -79.27 -19.08 51.44 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.197 -0.94 . . . . 1.0 110.111 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 79.9 m-20 -146.6 160.42 42.19 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.067 -1.02 . . . . 1.0 109.901 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.97 175.3 44.0 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.555 -1.418 . . . . 1.0 109.555 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.2 mt -96.43 136.46 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.212 -1.17 . . . . 1.0 108.965 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.98 160.86 16.43 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.388 -0.82 . . . . 1.0 109.449 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.04 -49.11 78.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.223 -0.923 . . . . 1.0 109.293 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.9 mt -104.32 98.52 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.416 -0.802 . . . . 1.0 109.839 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.4 ptm -100.11 131.69 45.91 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.191 -0.943 . . . . 1.0 109.399 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 92.1 mt -103.02 138.92 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.541 -0.724 . . . . 1.0 110.208 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 82.5 p -153.07 157.74 40.89 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.371 -0.83 . . . . 1.0 109.249 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -106.5 125.68 51.31 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.83 -0.804 . . . . 1.0 108.83 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 98' ' ' PHE . . . -98.11 178.78 32.11 Favored Glycine 0 N--CA 1.499 2.873 0 O-C-N 121.108 -0.995 . . . . 1.0 110.761 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.497 ' CG2' ' N ' ' A' ' 67' ' ' LYS . 41.1 mt -134.79 165.73 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.672 -0.899 . . . . 1.0 109.018 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.497 ' N ' ' CG2' ' A' ' 66' ' ' ILE . 47.2 tptt -30.47 -76.46 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 121.058 0.456 . . . . 1.0 111.486 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -66.36 56.57 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.255 -0.903 . . . . 1.0 110.311 -178.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 67' ' ' LYS . 45.3 t-80 -60.07 -42.03 93.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.503 -0.748 . . . . 1.0 109.783 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.31 -162.49 53.52 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.108 -1.197 . . . . 1.0 110.108 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 72' ' ' PHE . 50.4 t0 54.81 -128.02 2.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.391 -1.064 . . . . 1.0 109.293 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.403 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 96.6 m-85 -54.34 -178.74 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.254 -0.904 . . . . 1.0 108.884 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -52.6 130.91 45.78 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 120.988 -1.07 . . . . 1.0 108.68 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -71.12 -175.86 1.64 Allowed 'Trans proline' 0 N--CA 1.494 1.547 0 CA-C-N 119.885 0.995 . . . . 1.0 112.334 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.54 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 99.0 m-85 -86.72 166.67 15.11 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.657 -0.868 . . . . 1.0 108.657 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -100.15 5.51 44.82 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.181 -0.949 . . . . 1.0 110.82 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 126.1 -156.23 19.58 Favored Glycine 0 N--CA 1.504 3.169 0 N-CA-C 109.085 -1.606 . . . . 1.0 109.085 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -59.83 -66.48 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 0 CA-C-N 118.697 1.249 . . . . 1.0 112.372 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 80.3 p -75.56 160.06 30.56 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.12 -0.987 . . . . 1.0 109.529 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.37 -130.02 8.9 Favored Glycine 0 N--CA 1.502 3.04 0 N-CA-C 109.67 -1.372 . . . . 1.0 109.67 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.423 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 10.9 mt -68.6 105.37 2.23 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.252 -1.146 . . . . 1.0 109.065 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 39.2 mt -78.7 -16.29 57.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.98 -1.075 . . . . 1.0 108.951 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 97' ' ' HIS . . . -178.83 176.1 0.97 Allowed 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.435 ' ND1' ' C ' ' A' ' 84' ' ' HIS . 7.0 p80 -161.08 162.25 31.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.015 -1.053 . . . . 1.0 109.557 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.63 165.73 31.42 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.223 -0.923 . . . . 1.0 109.651 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -113.66 153.39 45.88 Favored Pre-proline 0 N--CA 1.5 2.033 0 N-CA-C 108.873 -0.788 . . . . 1.0 108.873 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.475 ' O ' ' N ' ' A' ' 89' ' ' GLY . 1.9 Cg_endo -55.56 169.08 1.28 Allowed 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.023 1.149 . . . . 1.0 112.363 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -62.12 66.12 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.278 1.318 . . . . 1.0 112.451 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -70.18 167.01 49.77 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.968 -1.653 . . . . 1.0 108.968 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -43.03 -60.34 0.78 Allowed 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.25 1.3 . . . . 1.0 112.151 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.499 ' OD1' ' CD2' ' A' ' 92' ' ' TYR . 34.8 p-10 -141.72 -33.47 0.5 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.314 -0.866 . . . . 1.0 109.356 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.499 ' CD2' ' OD1' ' A' ' 91' ' ' ASN . 84.9 m-85 -69.79 -40.03 76.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.247 -0.908 . . . . 1.0 109.492 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.421 ' HA3' ' H ' ' A' ' 89' ' ' GLY . . . -71.49 174.62 41.65 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.252 -1.139 . . . . 1.0 110.252 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.94 5.91 89.33 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.289 -1.524 . . . . 1.0 109.289 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -79.26 169.2 18.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.327 -1.102 . . . . 1.0 109.497 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.01 117.02 5.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.299 -0.876 . . . . 1.0 109.421 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.411 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 38.2 m170 -105.64 152.23 23.38 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.491 -0.755 . . . . 1.0 109.821 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.482 ' O ' ' N ' ' A' ' 65' ' ' GLY . 38.2 m-85 -131.81 148.82 52.58 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.774 -0.824 . . . . 1.0 108.774 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.54 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 89.5 m-20 -79.03 122.83 26.68 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.915 -1.116 . . . . 1.0 109.689 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -84.04 -11.78 56.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.355 -0.841 . . . . 1.0 109.077 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -81.6 -12.56 58.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.408 -0.807 . . . . 1.0 109.278 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -89.23 169.1 11.74 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.868 -0.79 . . . . 1.0 108.868 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 39.2 m -99.81 104.41 16.1 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.201 -0.937 . . . . 1.0 109.266 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.47 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 91.3 m95 -87.46 127.11 35.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.336 -0.852 . . . . 1.0 108.915 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.642 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.0 t -143.14 158.15 43.87 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.356 -0.84 . . . . 1.0 109.755 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.2 t -96.98 -10.41 26.31 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.453 -0.943 . . . . 1.0 108.453 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 81.1 p -90.41 -176.4 4.77 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.007 -0.738 . . . . 1.0 109.007 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 m -82.82 76.57 9.65 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.135 -0.978 . . . . 1.0 109.58 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.642 ' HB2' HG21 ' A' ' 105' ' ' THR . 98.0 mttt -149.6 151.12 33.28 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.19 -0.944 . . . . 1.0 108.992 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 43.73 -139.44 3.63 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.992 -1.243 . . . . 1.0 109.992 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -100.08 116.46 32.17 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.359 -1.083 . . . . 1.0 109.161 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -64.56 132.13 48.97 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.899 -1.125 . . . . 1.0 109.785 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.6 tp -59.99 -42.97 95.38 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.352 -0.842 . . . . 1.0 110.552 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -60.01 -40.65 89.96 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.098 -1.001 . . . . 1.0 110.836 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -59.93 -50.77 72.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.765 -1.209 . . . . 1.0 109.25 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.9 t -70.03 -40.15 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.202 -0.936 . . . . 1.0 110.224 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.58 -52.15 66.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.112 -0.993 . . . . 1.0 109.552 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.98 -34.34 73.18 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.246 -0.909 . . . . 1.0 110.078 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -64.3 -50.04 69.41 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.224 -0.922 . . . . 1.0 111.051 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.451 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 7.1 pt-20 -60.01 -39.31 85.36 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.801 -1.187 . . . . 1.0 110.025 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -59.98 -40.0 87.62 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.934 -1.104 . . . . 1.0 108.851 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.32 -46.05 81.12 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.753 -1.739 . . . . 1.0 108.753 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -64.5 -40.0 94.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.335 -1.097 . . . . 1.0 109.413 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.0 p -67.42 -23.57 65.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.361 -0.837 . . . . 1.0 109.67 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 69.9 mt -82.81 -0.3 47.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.227 -0.921 . . . . 1.0 109.927 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 89.12 9.83 67.02 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 110.447 -1.061 . . . . 1.0 110.447 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.9 mt -85.79 150.05 24.84 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.067 -1.255 . . . . 1.0 110.251 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 12.0 t70 -101.0 169.98 8.59 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.833 -0.803 . . . . 1.0 108.833 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.529 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 23.9 m170 -59.34 136.39 57.95 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.997 -1.065 . . . . 1.0 108.961 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 35.8 t -97.93 155.0 17.28 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.312 -0.868 . . . . 1.0 109.63 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -99.87 4.84 45.33 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.275 -0.891 . . . . 1.0 109.621 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -86.11 128.54 57.4 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 108.323 -0.991 . . . . 1.0 108.323 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -67.78 -18.63 47.54 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 CA-C-N 120.208 1.11 . . . . 1.0 111.864 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -88.9 -5.52 73.67 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.574 -1.41 . . . . 1.0 109.574 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.76 135.95 33.9 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.247 -1.149 . . . . 1.0 109.056 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.421 ' C ' ' H ' ' A' ' 138' ' ' PHE . 94.9 mt -60.5 -39.99 89.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.073 -1.017 . . . . 1.0 109.894 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 92.4 mtp -71.16 24.35 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.337 -0.852 . . . . 1.0 111.558 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.421 ' H ' ' C ' ' A' ' 136' ' ' LEU . 15.5 t80 -68.78 132.8 90.6 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 120.811 -1.181 . . . . 1.0 108.013 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -57.98 -8.78 5.04 Favored 'Trans proline' 0 N--CA 1.5 1.892 0 C-N-CA 120.859 1.039 . . . . 1.0 114.353 -177.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.9 mt -114.83 137.34 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 120.971 -1.08 . . . . 1.0 109.155 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -71.64 129.72 39.4 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.26 -0.9 . . . . 1.0 109.943 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 10.1 t -140.12 135.87 32.96 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.423 -0.798 . . . . 1.0 109.011 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -79.52 144.47 33.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.105 -0.997 . . . . 1.0 109.098 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.7 t -140.97 153.25 45.51 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.203 -0.936 . . . . 1.0 109.465 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.17 112.08 3.88 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.445 -1.462 . . . . 1.0 109.445 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -78.55 7.92 6.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -1.135 . . . . 1.0 109.598 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 73.4 m -59.99 -40.04 87.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 1.0 109.34 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -158.82 68.2 0.45 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 1.0 109.265 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -100.51 124.62 46.28 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.379 -0.826 . . . . 1.0 109.741 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 76.0 mtm -120.61 141.65 50.14 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.487 -0.931 . . . . 1.0 108.487 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.6 mt -48.89 129.36 14.7 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.015 -1.053 . . . . 1.0 108.924 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -68.23 176.69 5.24 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 CA-C-N 119.939 1.014 . . . . 1.0 112.646 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.23 -40.02 88.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.481 -0.762 . . . . 1.0 109.793 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -56.38 -49.41 74.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -0.944 . . . . 1.0 109.691 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -70.03 -40.01 75.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.204 -0.935 . . . . 1.0 110.141 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 62.4 t -59.97 -46.56 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.936 -1.102 . . . . 1.0 109.099 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -60.73 -40.01 90.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.144 -0.973 . . . . 1.0 110.321 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.34 -54.7 10.17 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 120.199 -1.0 . . . . 1.0 111.188 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.48 HG23 ' N ' ' A' ' 160' ' ' GLN . 7.2 tp -61.7 -40.47 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.975 -1.309 . . . . 1.0 109.957 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.527 ' O ' ' N ' ' A' ' 164' ' ' GLY . 25.4 mm100 -65.28 -39.61 92.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.182 -0.949 . . . . 1.0 109.539 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 78.0 p -64.7 -27.74 69.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.921 . . . . 1.0 110.273 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 94.0 mt -87.0 -53.18 5.02 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.978 -1.077 . . . . 1.0 110.322 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -92.04 -9.25 43.44 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.215 -0.928 . . . . 1.0 110.119 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.496 2.64 0 N-CA-C 109.401 -1.48 . . . . 1.0 109.401 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 169' ' ' WAY . . . . . 0.822 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.8 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.446 -0.575 . . . . 1.0 109.446 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.0 mt -78.09 124.66 28.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.299 -0.876 . . . . 1.0 109.326 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -165.63 163.66 19.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.216 -0.928 . . . . 1.0 110.126 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -70.45 147.01 49.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 1.0 109.443 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.2 t -89.41 2.2 54.8 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.301 -0.874 . . . . 1.0 109.987 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -147.94 155.39 41.52 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.064 -1.023 . . . . 1.0 109.688 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.535 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.55 1.92 56.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.352 -0.843 . . . . 1.0 109.842 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -95.41 120.95 36.53 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.1 -1.0 . . . . 1.0 109.205 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.9 mt -140.28 150.54 44.18 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.372 -0.83 . . . . 1.0 108.9 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 69.1 p -134.26 156.14 48.94 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.885 -0.783 . . . . 1.0 108.885 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -145.12 162.07 37.93 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.063 -1.023 . . . . 1.0 110.142 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.421 HH21 ' HA ' ' A' ' 57' ' ' ILE . 6.8 ttm180 -141.74 131.05 23.58 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.46 -0.775 . . . . 1.0 109.933 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 86.5 mt -86.76 111.16 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.938 -1.134 . . . . 1.0 107.938 178.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 79.6 t -66.56 -40.71 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.088 -1.008 . . . . 1.0 109.371 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' A' ' 21' ' ' ASN . 18.2 p-10 -161.11 150.55 16.84 Favored 'General case' 0 C--N 1.286 -2.178 0 C-N-CA 117.452 -1.699 . . . . 1.0 111.005 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -97.01 107.81 20.42 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 104.676 -2.342 . . . . 1.0 104.676 177.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 23' ' ' THR . 0.6 OUTLIER -55.75 141.51 65.42 Favored Pre-proline 0 C--N 1.299 -1.595 0 O-C-N 121.143 -0.973 . . . . 1.0 110.168 -176.962 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -61.19 -11.79 20.45 Favored 'Trans proline' 0 N--CA 1.485 1.028 0 CA-C-N 119.061 0.7 . . . . 1.0 110.869 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -56.77 -26.21 56.99 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.774 -0.77 . . . . 1.0 110.092 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 73.1 mtm -144.32 163.11 34.69 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.965 -1.085 . . . . 1.0 109.27 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.1 p -72.69 158.82 34.89 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.377 -0.827 . . . . 1.0 109.138 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -60.21 -41.48 93.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -0.917 . . . . 1.0 110.401 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.1 m -59.84 -40.38 88.33 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.967 -1.083 . . . . 1.0 110.569 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.93 -41.59 86.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.885 -1.134 . . . . 1.0 110.413 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.3 t -67.9 -40.09 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.86 -1.15 . . . . 1.0 109.818 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -57.48 -58.87 6.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.332 -0.855 . . . . 1.0 111.286 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -27.55 69.4 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.248 -0.908 . . . . 1.0 110.203 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.02 -51.47 69.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.961 -1.087 . . . . 1.0 110.223 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -68.79 -37.02 78.98 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.876 -1.14 . . . . 1.0 110.158 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -60.02 -44.95 94.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.945 -1.097 . . . . 1.0 109.398 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.468 ' HB3' ' HZ3' ' A' ' 37' ' ' LYS . 10.4 mtpm? -59.96 -40.07 87.78 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.157 -0.964 . . . . 1.0 109.207 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.03 -46.86 88.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.341 -0.849 . . . . 1.0 110.049 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.418 ' CZ ' ' CZ ' ' A' ' 121' ' ' PHE . 62.5 m-85 -67.51 -38.64 84.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.926 -1.109 . . . . 1.0 109.747 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -60.02 -47.85 84.15 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.269 -0.895 . . . . 1.0 109.644 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.4 t -59.98 -40.61 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.142 -0.974 . . . . 1.0 109.972 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -79.49 -35.16 40.6 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.864 -1.147 . . . . 1.0 109.789 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.3 p -72.49 -20.26 61.4 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.908 -1.12 . . . . 1.0 109.865 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.88 -40.02 87.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.253 -0.905 . . . . 1.0 110.561 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.7 m -111.13 22.25 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.336 -0.852 . . . . 1.0 110.404 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.6 p -149.0 135.85 10.57 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 120.81 -1.181 . . . . 1.0 109.439 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -73.13 20.72 0.34 Allowed 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 120.682 0.921 . . . . 1.0 112.01 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.76 136.39 54.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 1.0 109.563 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -108.82 120.59 42.94 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.668 -0.864 . . . . 1.0 108.668 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -110.45 124.93 52.68 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.458 -0.776 . . . . 1.0 109.946 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.5 m -119.97 130.01 54.57 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.558 -0.713 . . . . 1.0 109.275 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.412 ' HG2' HH11 ' A' ' 52' ' ' ARG . 33.9 ttt-85 -81.28 130.5 35.06 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.201 -0.937 . . . . 1.0 110.003 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 89.8 mt -104.07 130.02 51.75 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.315 -0.866 . . . . 1.0 109.094 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.436 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 50.9 m170 -63.94 -40.1 95.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.307 -0.871 . . . . 1.0 109.823 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 70.7 m-20 -153.46 179.99 8.29 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.063 -1.023 . . . . 1.0 109.769 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.56 -173.05 32.07 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.839 -1.304 . . . . 1.0 109.839 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.421 ' HA ' HH21 ' A' ' 18' ' ' ARG . 90.2 mt -95.02 126.38 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.341 -1.093 . . . . 1.0 109.109 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.16 158.61 19.45 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.391 -0.818 . . . . 1.0 109.264 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -59.96 -49.94 75.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.232 -0.918 . . . . 1.0 109.87 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 92.7 mt -109.11 97.19 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.504 -0.748 . . . . 1.0 109.882 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.6 ptm -96.5 130.06 43.74 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.913 -1.117 . . . . 1.0 109.061 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.3 mt -108.71 133.38 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.609 -0.682 . . . . 1.0 109.788 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 79.3 p -152.31 158.44 42.76 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.144 -0.972 . . . . 1.0 109.854 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -100.18 135.0 42.28 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.464 -0.939 . . . . 1.0 108.464 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -121.83 167.82 14.54 Favored Glycine 0 N--CA 1.498 2.818 0 N-CA-C 110.243 -1.143 . . . . 1.0 110.243 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.547 ' O ' ' C ' ' A' ' 67' ' ' LYS . 96.5 mt -130.0 159.98 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.514 -0.921 . . . . 1.0 108.514 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.547 ' C ' ' O ' ' A' ' 66' ' ' ILE . 52.3 tptt -1.38 -93.19 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.748 0 C-N-CA 123.067 0.547 . . . . 1.0 111.89 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -78.97 136.19 37.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.107 -0.996 . . . . 1.0 109.348 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 36.6 p-80 -159.99 -171.3 3.18 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.94 -1.1 . . . . 1.0 110.323 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -39.96 -60.02 1.96 Allowed Glycine 0 N--CA 1.496 2.661 0 O-C-N 121.557 -0.714 . . . . 1.0 111.556 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -60.04 142.47 53.95 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.893 -1.357 . . . . 1.0 109.954 -179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -70.05 -19.51 63.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.36 -0.837 . . . . 1.0 110.119 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -90.7 112.89 55.72 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 121.3 -0.875 . . . . 1.0 109.439 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -77.43 178.47 7.58 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 CA-C-N 120.116 1.077 . . . . 1.0 112.546 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.543 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 89.3 m-85 -91.0 173.07 8.15 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.417 -0.802 . . . . 1.0 108.908 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -100.05 12.55 36.64 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.156 -0.965 . . . . 1.0 111.03 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 119.79 -146.8 18.06 Favored Glycine 0 N--CA 1.506 3.352 0 N-CA-C 109.03 -1.628 . . . . 1.0 109.03 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.43 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 13.2 Cg_endo -77.91 -51.94 0.07 OUTLIER 'Trans proline' 0 N--CA 1.49 1.31 0 CA-C-N 119.281 1.54 . . . . 1.0 111.762 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 81.3 p -80.4 161.9 24.74 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.243 -0.911 . . . . 1.0 109.69 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 105.52 -126.53 8.65 Favored Glycine 0 N--CA 1.501 2.972 0 N-CA-C 110.189 -1.165 . . . . 1.0 110.189 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.424 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 13.6 mt -67.12 100.13 0.74 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.414 -1.051 . . . . 1.0 109.344 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 31.0 mt -79.2 -19.15 51.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.083 -1.011 . . . . 1.0 108.765 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.99 171.02 1.42 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.684 -0.858 . . . . 1.0 108.684 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.455 ' ND1' ' C ' ' A' ' 84' ' ' HIS . 8.5 p80 -162.32 167.44 23.82 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.238 -0.914 . . . . 1.0 108.797 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.29 159.55 44.36 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.189 -0.944 . . . . 1.0 109.188 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -95.64 151.83 38.76 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 108.016 -1.105 . . . . 1.0 108.016 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.566 ' O ' ' N ' ' A' ' 89' ' ' GLY . 8.3 Cg_endo -62.49 166.49 13.22 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 120.47 0.78 . . . . 1.0 111.088 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -52.35 78.53 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 121.03 1.153 . . . . 1.0 111.792 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -101.06 -167.29 28.05 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.496 -1.441 . . . . 1.0 109.496 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 89' ' ' GLY . 14.8 Cg_exo -56.97 -148.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 121.148 1.232 . . . . 1.0 111.855 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -59.98 -39.94 87.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.995 -1.066 . . . . 1.0 109.819 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -66.71 -40.07 88.28 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.101 -0.999 . . . . 1.0 110.358 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -62.18 168.49 15.49 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.813 -1.315 . . . . 1.0 109.813 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.35 6.74 86.7 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.908 -1.277 . . . . 1.0 109.908 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -80.3 170.04 16.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.146 -1.208 . . . . 1.0 110.053 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.7 122.93 9.56 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.294 -0.879 . . . . 1.0 109.524 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.448 ' ND1' ' CE1' ' A' ' 84' ' ' HIS . 41.4 m170 -106.7 142.54 36.18 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.534 -0.729 . . . . 1.0 110.179 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.499 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 40.3 m-85 -124.11 138.24 54.46 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 108.801 -0.814 . . . . 1.0 108.801 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.543 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 93.4 m-20 -80.33 123.59 28.13 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.092 -1.005 . . . . 1.0 109.985 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 9.8 t70 -84.31 2.92 38.01 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.194 -0.941 . . . . 1.0 109.667 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -79.8 -18.8 50.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.227 -0.921 . . . . 1.0 109.42 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 102' ' ' GLU . 57.3 mp0 -91.83 169.96 10.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.366 -0.833 . . . . 1.0 109.166 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 11.9 m -98.59 108.16 20.78 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.433 -0.951 . . . . 1.0 108.433 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -85.63 128.32 34.74 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.248 -0.908 . . . . 1.0 108.565 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.643 HG21 ' HB2' ' A' ' 109' ' ' LYS . 7.6 t -143.87 155.96 44.29 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.265 -0.897 . . . . 1.0 110.071 -178.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 83.6 p -94.91 -7.26 40.54 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.323 -0.991 . . . . 1.0 108.323 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 57.9 m -92.65 179.01 5.62 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.645 -0.872 . . . . 1.0 108.645 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.4 m -80.7 76.08 7.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.983 -1.073 . . . . 1.0 109.34 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.643 ' HB2' HG21 ' A' ' 105' ' ' THR . 58.8 mttp -147.85 152.24 37.28 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.735 -0.839 . . . . 1.0 108.735 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 43.27 -140.0 2.89 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.111 -1.195 . . . . 1.0 110.111 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -100.02 114.46 27.78 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.386 -1.067 . . . . 1.0 109.321 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.452 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 57.8 t-20 -62.27 132.11 51.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.093 -1.005 . . . . 1.0 109.26 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.06 -41.45 92.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.28 -0.888 . . . . 1.0 110.289 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -60.02 -43.91 94.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.214 -0.929 . . . . 1.0 111.344 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -57.81 -51.21 70.51 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.845 -1.159 . . . . 1.0 109.65 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 64.3 t -69.72 -40.02 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.108 -0.995 . . . . 1.0 109.691 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.54 -49.96 74.63 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.237 -0.914 . . . . 1.0 109.55 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.8 -38.99 83.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.321 -0.862 . . . . 1.0 110.47 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -62.46 -49.86 73.74 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.044 -1.035 . . . . 1.0 111.059 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.499 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 7.7 pt-20 -60.03 -39.48 86.03 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.719 -1.238 . . . . 1.0 110.302 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.418 ' CZ ' ' CZ ' ' A' ' 39' ' ' PHE . 30.4 m-85 -60.07 -40.12 88.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.882 -1.136 . . . . 1.0 108.732 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.11 -45.23 94.2 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.276 -1.53 . . . . 1.0 109.276 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -65.75 -39.94 91.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.107 -1.231 . . . . 1.0 109.405 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.3 p -62.02 -26.23 68.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.923 . . . . 1.0 109.195 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 84.5 mt -80.61 -4.27 53.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.186 -0.946 . . . . 1.0 109.718 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 92.41 10.09 61.03 Favored Glycine 0 N--CA 1.496 2.684 0 C-N-CA 120.178 -1.01 . . . . 1.0 110.907 178.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.7 mt -82.74 149.9 27.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.83 -1.394 . . . . 1.0 109.165 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 42.6 t0 -101.19 171.65 7.48 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.542 -0.724 . . . . 1.0 109.339 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.54 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 65.7 m80 -59.91 137.18 58.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.13 -0.982 . . . . 1.0 109.71 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 40.3 t -97.35 156.0 16.64 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.405 -0.81 . . . . 1.0 109.171 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -97.45 2.03 49.84 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.172 -0.955 . . . . 1.0 110.006 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 7.5 t70 -85.84 129.98 52.39 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.097 -1.002 . . . . 1.0 108.665 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -68.23 -28.02 34.31 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 CA-C-N 120.106 1.073 . . . . 1.0 112.377 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.475 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -81.97 -1.81 90.39 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.753 -1.339 . . . . 1.0 109.753 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.17 146.16 25.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.304 -1.115 . . . . 1.0 109.754 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.407 ' C ' ' H ' ' A' ' 138' ' ' PHE . 84.2 mt -69.98 -32.97 71.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.333 -0.855 . . . . 1.0 109.428 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 98.1 mmm -71.78 13.33 0.28 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.504 -0.747 . . . . 1.0 110.328 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.407 ' H ' ' C ' ' A' ' 136' ' ' LEU . 13.5 t80 -69.24 135.6 89.06 Favored Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 107.811 -1.181 . . . . 1.0 107.811 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -64.22 -0.42 2.81 Favored 'Trans proline' 0 N--CA 1.5 1.855 0 CA-C-N 119.96 1.021 . . . . 1.0 114.564 -177.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.7 mt -119.69 138.1 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.368 0 O-C-N 120.835 -1.166 . . . . 1.0 109.979 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.452 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 24.3 t80 -72.75 130.22 40.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.692 -0.63 . . . . 1.0 110.012 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.7 t -140.53 139.98 35.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.429 -0.794 . . . . 1.0 109.198 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -82.72 140.72 32.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.972 -1.08 . . . . 1.0 109.52 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.5 t -138.64 155.46 48.28 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.296 -0.878 . . . . 1.0 109.927 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -75.48 109.64 2.84 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.096 -1.602 . . . . 1.0 109.096 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.449 ' HE2' HD21 ' A' ' 112' ' ' ASN . 8.5 mtmp? -78.23 0.29 25.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.284 -1.127 . . . . 1.0 110.033 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 22.9 t -60.01 -40.49 89.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.075 -1.016 . . . . 1.0 109.856 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -139.94 32.21 1.99 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.212 -0.93 . . . . 1.0 109.825 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -79.23 130.15 35.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.001 -1.062 . . . . 1.0 110.151 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 77.8 mtm -133.87 149.35 51.34 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.39 -0.967 . . . . 1.0 108.39 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 62.0 mt -51.58 128.71 34.39 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 120.957 -1.09 . . . . 1.0 108.898 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -69.63 177.47 5.46 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 CA-C-N 120.051 1.054 . . . . 1.0 112.175 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -62.24 -39.97 94.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.46 -0.775 . . . . 1.0 109.878 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -55.9 -48.46 75.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.15 -0.968 . . . . 1.0 109.87 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.04 -39.87 75.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.078 -1.013 . . . . 1.0 110.027 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.23 -47.15 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.123 -0.986 . . . . 1.0 109.341 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -60.34 -40.07 89.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.845 -1.159 . . . . 1.0 110.503 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -69.9 -54.65 11.21 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 120.176 -1.011 . . . . 1.0 111.129 -178.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.456 HG23 ' N ' ' A' ' 160' ' ' GLN . 4.7 tp -60.05 -39.93 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.857 -1.378 . . . . 1.0 109.572 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.456 ' N ' HG23 ' A' ' 159' ' ' ILE . 95.7 mt-30 -64.01 -39.99 95.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.932 -1.105 . . . . 1.0 109.473 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 88.6 p -58.46 -30.16 66.75 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.747 -1.221 . . . . 1.0 108.871 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 92.5 mt -88.87 -69.62 0.7 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.245 -0.909 . . . . 1.0 111.079 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -89.17 -11.59 43.37 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.998 -1.064 . . . . 1.0 111.185 -177.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.72 0 N-CA-C 109.766 -1.334 . . . . 1.0 109.766 179.967 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 169' ' ' WAY . . . . . 0.878 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.2 m . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.445 -0.576 . . . . 1.0 109.445 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.9 mt -82.64 133.34 35.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.201 -0.937 . . . . 1.0 109.328 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -163.05 162.34 25.8 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 1.0 109.304 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -71.02 147.26 48.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.181 -0.949 . . . . 1.0 109.594 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.2 t -89.98 2.05 55.57 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.402 -0.811 . . . . 1.0 110.35 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -144.83 154.31 42.53 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.001 -1.062 . . . . 1.0 109.99 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.55 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.28 0.21 57.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.305 -0.872 . . . . 1.0 109.72 -179.734 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -94.0 121.99 36.05 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.148 -0.97 . . . . 1.0 109.007 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.2 mt -140.18 151.47 45.27 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.365 -0.834 . . . . 1.0 109.213 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.0 p -133.72 157.33 46.1 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.455 -0.778 . . . . 1.0 109.193 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -145.32 160.24 41.82 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.142 -0.974 . . . . 1.0 109.916 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -140.99 134.01 29.25 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.369 -0.832 . . . . 1.0 110.068 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.7 mm -89.04 111.21 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.011 -1.107 . . . . 1.0 108.011 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.6 t -67.84 -39.74 82.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.126 -0.984 . . . . 1.0 109.121 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -161.23 150.5 16.56 Favored 'General case' 0 C--N 1.29 -1.992 0 O-C-N 119.294 -2.129 . . . . 1.0 111.466 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.63 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 52.4 m-85 -99.94 99.03 9.74 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 106.097 -1.816 . . . . 1.0 106.097 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.1 t -47.67 141.15 7.58 Favored Pre-proline 0 C--N 1.299 -1.615 0 O-C-N 121.515 -0.74 . . . . 1.0 110.769 -177.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.86 -8.12 7.18 Favored 'Trans proline' 0 N--CA 1.488 1.166 0 C-N-CA 120.649 0.899 . . . . 1.0 111.223 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -59.02 -35.5 73.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.461 -0.775 . . . . 1.0 109.821 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 74.0 mtm -139.59 160.99 38.58 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.192 -0.942 . . . . 1.0 109.657 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 55.1 p -70.71 160.37 32.76 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.401 -0.812 . . . . 1.0 109.397 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.63 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 3.8 m80 -60.1 -40.54 89.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.318 -0.864 . . . . 1.0 110.263 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.7 m -59.97 -42.36 93.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.085 -1.009 . . . . 1.0 110.526 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -67.87 -40.36 83.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.242 -0.911 . . . . 1.0 110.393 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 70.9 t -68.97 -43.01 82.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.166 -0.959 . . . . 1.0 110.242 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -60.04 -49.16 78.75 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.138 -0.976 . . . . 1.0 110.824 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -61.35 -33.12 73.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.908 -1.12 . . . . 1.0 110.068 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.0 -49.77 76.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.893 -1.129 . . . . 1.0 109.979 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.497 ' CE1' HD13 ' A' ' 62' ' ' ILE . 53.5 m-85 -67.36 -39.98 85.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.022 -1.049 . . . . 1.0 110.185 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -60.01 -43.22 95.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.951 -1.093 . . . . 1.0 110.089 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.45 -40.18 95.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.06 -1.025 . . . . 1.0 109.676 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.18 -44.45 95.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.263 -0.898 . . . . 1.0 110.196 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -69.58 -38.2 77.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.04 -1.038 . . . . 1.0 109.697 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.415 ' O ' ' CG ' ' A' ' 44' ' ' ASP . 50.4 tptt -60.0 -48.05 83.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.063 -1.023 . . . . 1.0 109.594 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.3 t -59.97 -41.15 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.119 -0.988 . . . . 1.0 109.869 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -78.46 -37.96 42.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.854 -1.154 . . . . 1.0 109.903 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.3 p -71.18 -19.22 62.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.054 -1.029 . . . . 1.0 109.643 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.415 ' CG ' ' O ' ' A' ' 40' ' ' LYS . 95.0 m-20 -60.04 -40.02 87.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.911 . . . . 1.0 110.603 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.9 m -108.63 22.04 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 121.126 -0.984 . . . . 1.0 111.304 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.2 p -149.79 144.82 18.11 Favored Pre-proline 0 N--CA 1.502 2.129 0 O-C-N 120.678 -1.264 . . . . 1.0 109.418 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -75.27 19.56 0.51 Allowed 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 120.615 0.877 . . . . 1.0 111.502 178.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.7 mt -68.99 130.31 42.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.12 -0.988 . . . . 1.0 109.719 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -107.02 120.61 42.55 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.591 -0.892 . . . . 1.0 108.591 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -108.39 125.98 52.35 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.285 -0.884 . . . . 1.0 109.713 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -120.01 129.95 54.5 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.643 -0.661 . . . . 1.0 109.846 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -82.01 130.92 35.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.325 -0.859 . . . . 1.0 109.028 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 89.4 mt -102.84 135.19 44.95 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.284 -0.885 . . . . 1.0 109.021 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.447 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 91.9 m-70 -64.26 -40.4 95.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.243 -0.911 . . . . 1.0 109.905 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 69.3 m-20 -155.69 -173.76 4.67 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.191 -0.943 . . . . 1.0 109.706 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.59 -169.51 35.77 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.05 -1.22 . . . . 1.0 110.05 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 87.6 mt -93.75 129.42 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.414 -1.051 . . . . 1.0 108.978 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.79 164.31 12.69 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.395 -0.816 . . . . 1.0 109.156 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -59.95 -49.64 76.9 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.124 -0.985 . . . . 1.0 109.032 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.2 mt -122.34 112.81 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.916 -0.772 . . . . 1.0 108.916 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.7 ptp -97.96 137.06 37.34 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.996 -1.065 . . . . 1.0 109.238 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.497 HD13 ' CE1' ' A' ' 35' ' ' PHE . 97.5 mt -105.29 133.07 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.279 -0.888 . . . . 1.0 109.687 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 84.2 p -151.84 152.4 32.56 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.235 -0.916 . . . . 1.0 109.761 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -106.68 122.67 46.81 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.461 -0.774 . . . . 1.0 109.045 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -97.31 -178.97 34.18 Favored Glycine 0 N--CA 1.497 2.756 0 O-C-N 121.187 -0.946 . . . . 1.0 111.187 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.532 HG22 ' N ' ' A' ' 67' ' ' LYS . 67.5 mt -134.16 165.32 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.793 -0.827 . . . . 1.0 108.843 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.532 ' N ' HG22 ' A' ' 66' ' ' ILE . 20.0 tptm -9.3 -77.41 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.594 0 C-N-CA 123.035 0.534 . . . . 1.0 112.265 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.407 ' HG2' ' H ' ' A' ' 68' ' ' GLU . 9.4 pt-20 -64.62 94.15 0.12 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.075 -1.016 . . . . 1.0 109.506 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -60.01 -40.06 87.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.515 -0.74 . . . . 1.0 109.598 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.76 1.66 67.82 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.231 -1.548 . . . . 1.0 109.231 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.541 ' C ' ' H ' ' A' ' 73' ' ' TYR . 95.9 m-20 -129.04 170.02 13.99 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.665 -0.903 . . . . 1.0 108.586 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.617 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 6.4 p90 -71.0 25.33 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.007 -1.058 . . . . 1.0 109.895 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.617 ' CE2' ' CE2' ' A' ' 72' ' ' PHE . 42.4 m-85 -129.09 77.11 78.34 Favored Pre-proline 0 N--CA 1.499 1.981 0 N-CA-C 108.439 -0.949 . . . . 1.0 108.439 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -75.78 143.58 26.85 Favored 'Trans proline' 0 N--CA 1.488 1.2 0 C-N-CA 120.947 1.098 . . . . 1.0 112.468 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.556 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 99.8 m-85 -85.51 158.91 20.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.465 -0.772 . . . . 1.0 108.946 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 28.2 p-10 -96.53 -0.04 49.44 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.126 -0.984 . . . . 1.0 110.532 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.426 ' O ' ' OE2' ' A' ' 102' ' ' GLU . . . 117.4 -119.45 4.44 Favored Glycine 0 N--CA 1.504 3.225 0 N-CA-C 110.249 -1.141 . . . . 1.0 110.249 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.459 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 28.8 Cg_endo -74.69 -72.45 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.797 0 CA-C-N 120.179 1.989 . . . . 1.0 113.012 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.425 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 81.3 p -74.76 171.49 13.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.034 -1.041 . . . . 1.0 109.839 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 104.02 -135.19 12.29 Favored Glycine 0 N--CA 1.498 2.8 0 N-CA-C 110.231 -1.148 . . . . 1.0 110.231 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.6 mt -68.86 107.32 3.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.388 -1.066 . . . . 1.0 109.692 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 84.2 mt -79.65 -25.54 41.33 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.158 -0.964 . . . . 1.0 108.892 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.54 172.82 1.4 Allowed 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.733 -0.84 . . . . 1.0 108.733 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -162.78 166.23 24.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.79 -1.194 . . . . 1.0 109.982 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -153.34 159.73 42.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.439 -0.788 . . . . 1.0 109.21 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -106.77 151.63 40.58 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.366 -0.834 . . . . 1.0 109.128 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -64.38 165.51 19.79 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 121.045 1.164 . . . . 1.0 111.614 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -46.09 124.25 7.24 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 120.906 1.071 . . . . 1.0 112.003 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 90' ' ' PRO . . . -167.01 -169.66 30.89 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.347 -1.501 . . . . 1.0 109.347 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.405 ' O ' ' O ' ' A' ' 89' ' ' GLY . 13.0 Cg_exo -57.1 -151.55 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 121.133 1.222 . . . . 1.0 112.32 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -60.11 -40.71 90.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.348 -0.845 . . . . 1.0 110.007 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -68.2 -40.0 82.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.905 . . . . 1.0 109.159 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -80.05 169.92 53.37 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.914 -1.675 . . . . 1.0 108.914 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 58.67 65.43 3.5 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.47 -1.452 . . . . 1.0 109.47 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.5 p-10 -149.97 170.78 18.03 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.284 -1.127 . . . . 1.0 109.235 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -146.31 123.76 11.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.021 -1.05 . . . . 1.0 109.654 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -114.73 153.17 30.78 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.375 -0.602 . . . . 1.0 109.375 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.529 ' CE2' ' OE2' ' A' ' 120' ' ' GLU . 39.5 m-85 -137.69 149.78 46.8 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.609 -0.886 . . . . 1.0 108.609 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.556 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 88.1 m-20 -81.39 121.14 25.86 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.684 -1.26 . . . . 1.0 109.009 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -82.65 -5.45 58.84 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.121 -0.987 . . . . 1.0 109.35 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -81.39 -9.33 59.75 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.347 -0.846 . . . . 1.0 109.209 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.459 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 52.7 mm-40 -89.03 176.05 7.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.334 -0.854 . . . . 1.0 109.422 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 26.0 m -106.96 107.01 17.82 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.475 -0.935 . . . . 1.0 108.475 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -86.88 122.9 31.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.365 -0.834 . . . . 1.0 109.127 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.637 HG21 ' HB2' ' A' ' 109' ' ' LYS . 7.8 t -141.54 150.76 42.54 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.363 -0.835 . . . . 1.0 109.925 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 59.8 p -93.01 -6.91 47.26 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.232 -1.025 . . . . 1.0 108.232 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 81.9 p -92.83 176.67 6.35 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.005 -0.739 . . . . 1.0 109.005 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.6 t -77.68 76.95 4.21 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.198 -0.939 . . . . 1.0 109.484 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.637 ' HB2' HG21 ' A' ' 105' ' ' THR . 62.9 mttp -148.13 146.92 28.98 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.74 -139.92 5.81 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.881 -1.287 . . . . 1.0 109.881 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -100.11 115.19 29.21 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.304 -1.115 . . . . 1.0 109.365 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.408 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 9.7 t-20 -61.76 133.04 55.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.117 -0.989 . . . . 1.0 109.469 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.5 tp -59.99 -42.95 95.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.32 -0.862 . . . . 1.0 110.482 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -59.93 -40.99 90.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.087 -1.008 . . . . 1.0 110.436 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -59.91 -50.69 72.78 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.872 -1.143 . . . . 1.0 110.014 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.5 t -68.36 -45.11 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.172 -0.955 . . . . 1.0 110.448 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.63 -47.43 82.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.308 -0.87 . . . . 1.0 110.018 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.98 -41.0 91.07 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.929 -1.107 . . . . 1.0 110.77 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 60.8 t60 -65.91 -49.02 69.5 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.055 -1.028 . . . . 1.0 111.78 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.529 ' OE2' ' CE2' ' A' ' 98' ' ' PHE . 9.0 pt-20 -60.02 -42.34 94.12 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.495 -1.378 . . . . 1.0 110.368 -178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -60.05 -40.04 88.08 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.682 -1.261 . . . . 1.0 108.655 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.32 -42.71 64.42 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.161 -1.576 . . . . 1.0 109.161 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -66.27 -40.0 89.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -1.13 . . . . 1.0 109.136 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 86.2 p -64.58 -21.96 66.84 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.42 -0.8 . . . . 1.0 109.577 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.9 mt -83.51 1.51 41.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.298 -0.877 . . . . 1.0 109.972 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.93 4.88 68.8 Favored Glycine 0 N--CA 1.497 2.705 0 O-C-N 121.068 -1.02 . . . . 1.0 110.701 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.9 mt -85.52 146.14 27.06 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.887 -1.361 . . . . 1.0 109.387 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 30.8 t0 -102.56 174.84 5.72 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.47 -0.769 . . . . 1.0 109.373 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.451 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 66.9 m80 -59.97 137.93 57.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.142 -0.974 . . . . 1.0 109.374 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 34.2 t -98.25 158.07 15.79 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.361 -0.837 . . . . 1.0 109.48 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -95.97 -0.42 50.71 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.225 -0.922 . . . . 1.0 109.663 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -86.08 128.47 57.73 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.108 -0.995 . . . . 1.0 108.935 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -68.41 -19.84 42.83 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 CA-C-N 120.065 1.059 . . . . 1.0 112.5 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -88.38 -5.0 76.38 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.772 -1.331 . . . . 1.0 109.772 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.79 145.62 27.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.33 -1.1 . . . . 1.0 109.664 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.5 mt -70.0 -30.98 68.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.876 . . . . 1.0 109.406 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.7 mmm -71.89 10.67 0.66 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.361 -0.837 . . . . 1.0 110.053 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -70.05 134.14 87.65 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 107.907 -1.146 . . . . 1.0 107.907 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -60.81 -20.36 65.86 Favored 'Trans proline' 0 N--CA 1.502 1.983 0 C-N-CA 120.968 1.112 . . . . 1.0 114.308 -177.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.6 mt -98.22 139.84 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 O-C-N 120.696 -1.253 . . . . 1.0 110.293 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.408 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 28.3 t80 -75.97 132.28 40.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.482 -0.761 . . . . 1.0 109.901 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.4 t -141.5 142.25 33.6 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.26 -0.9 . . . . 1.0 109.412 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -79.41 143.35 35.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.092 -1.005 . . . . 1.0 108.681 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.3 t -139.99 150.01 43.93 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.172 -0.955 . . . . 1.0 109.684 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.19 108.03 2.32 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.617 -1.393 . . . . 1.0 109.617 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.446 ' NZ ' ' CB ' ' A' ' 146' ' ' LYS . 7.8 mtpm? -76.81 0.12 21.86 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.422 -1.046 . . . . 1.0 109.778 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.3 t -60.01 -44.81 94.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.192 -0.943 . . . . 1.0 110.148 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -142.34 29.61 1.6 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.17 -0.956 . . . . 1.0 110.11 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -66.44 138.03 57.27 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.836 -1.165 . . . . 1.0 109.34 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 76.9 mtm -139.54 142.74 37.2 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.356 -0.84 . . . . 1.0 109.124 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 46.9 mt -49.16 110.92 1.69 Allowed Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.151 -0.968 . . . . 1.0 109.164 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -56.01 177.09 0.15 Allowed 'Trans proline' 0 N--CA 1.494 1.555 0 CA-C-N 120.119 1.078 . . . . 1.0 112.887 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -60.02 -39.88 87.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.466 -0.771 . . . . 1.0 109.997 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -56.1 -48.63 75.79 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.174 -0.953 . . . . 1.0 110.029 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -70.05 -40.01 75.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.908 . . . . 1.0 109.904 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.64 -45.66 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.178 -0.951 . . . . 1.0 109.641 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -61.6 -40.12 93.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.993 -1.067 . . . . 1.0 110.448 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.16 -52.32 14.19 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 120.35 -0.928 . . . . 1.0 111.524 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.448 HG23 ' N ' ' A' ' 160' ' ' GLN . 5.0 tp -60.59 -40.04 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.886 -1.361 . . . . 1.0 109.587 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 164' ' ' GLY . 97.4 mt-30 -65.33 -40.01 93.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.099 -1.001 . . . . 1.0 109.725 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 79.3 p -60.86 -32.25 71.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.112 -0.992 . . . . 1.0 110.483 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 89.5 mt -86.23 -51.83 6.03 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.874 -1.141 . . . . 1.0 110.921 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -92.0 -9.38 43.11 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.851 -1.156 . . . . 1.0 110.458 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.632 0 N-CA-C 109.676 -1.37 . . . . 1.0 109.676 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 169' ' ' WAY . . . . . 0.507 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 79.1 m . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.3 mt -69.27 140.35 54.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.149 -0.97 . . . . 1.0 109.217 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -161.69 166.96 25.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 1.0 109.508 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -70.46 140.6 51.99 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.24 -0.912 . . . . 1.0 109.794 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.4 t -88.0 1.79 53.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.407 -0.808 . . . . 1.0 110.249 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -143.01 153.5 43.04 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.075 -1.016 . . . . 1.0 109.59 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.519 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.95 0.89 57.41 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.479 -0.763 . . . . 1.0 109.597 -179.609 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -96.56 121.14 38.06 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.174 -0.954 . . . . 1.0 109.183 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.8 mt -139.97 148.0 41.29 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.3 -0.875 . . . . 1.0 109.169 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.9 p -130.6 153.77 48.56 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -143.4 157.5 44.41 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.184 -0.948 . . . . 1.0 110.074 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.489 HH12 ' H ' ' A' ' 56' ' ' GLY . 71.7 ttt180 -143.18 132.74 23.64 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.555 -0.715 . . . . 1.0 109.333 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 84.7 mt -87.66 118.31 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.063 -1.023 . . . . 1.0 108.581 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.0 t -69.91 -40.02 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.991 -1.068 . . . . 1.0 109.002 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.2 p-10 -160.4 157.0 27.02 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.733 -1.23 . . . . 1.0 110.169 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.592 ' CD1' ' CD2' ' A' ' 28' ' ' HIS . 47.6 m-85 -100.44 -163.01 0.99 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.38 -1.341 . . . . 1.0 107.38 178.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.73 148.26 55.82 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.371 -0.831 . . . . 1.0 110.336 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -70.83 -21.64 28.27 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 120.661 0.907 . . . . 1.0 110.105 177.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -56.67 -36.05 69.13 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 115.725 -0.671 . . . . 1.0 110.707 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.7 mtm -135.04 163.85 28.96 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.299 -0.876 . . . . 1.0 109.469 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.4 p -73.36 159.68 32.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.484 -0.76 . . . . 1.0 109.291 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.592 ' CD2' ' CD1' ' A' ' 22' ' ' TYR . 2.9 m80 -60.79 -40.03 91.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.465 -0.772 . . . . 1.0 110.031 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.3 m -60.09 -40.46 89.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.147 -0.97 . . . . 1.0 110.185 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -67.29 -40.53 86.12 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.146 -0.971 . . . . 1.0 110.395 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.7 t -68.12 -40.41 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.121 -0.987 . . . . 1.0 109.988 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -60.05 -49.64 76.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.05 -1.031 . . . . 1.0 110.534 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -61.98 -31.55 71.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.984 -1.073 . . . . 1.0 109.68 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.07 -50.29 74.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.089 -1.007 . . . . 1.0 109.802 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -67.41 -39.67 85.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.161 -0.962 . . . . 1.0 110.215 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -59.97 -42.88 95.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.978 -1.077 . . . . 1.0 109.494 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -60.34 -39.84 88.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 1.0 109.065 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.86 -46.2 90.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.51 -0.744 . . . . 1.0 110.024 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.4 ' CZ ' ' CZ ' ' A' ' 121' ' ' PHE . 59.1 m-85 -67.04 -39.4 86.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.051 -1.03 . . . . 1.0 109.196 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.404 ' O ' ' CG ' ' A' ' 44' ' ' ASP . 47.3 tptt -60.09 -47.77 84.52 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.372 -0.83 . . . . 1.0 109.737 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.2 t -60.0 -40.03 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.011 -1.055 . . . . 1.0 109.591 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 70.0 m95 -79.61 -37.16 36.79 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.049 -1.032 . . . . 1.0 110.022 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 62.3 p -70.44 -19.78 62.95 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.034 -1.042 . . . . 1.0 109.557 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.404 ' CG ' ' O ' ' A' ' 40' ' ' LYS . 96.1 m-20 -60.09 -38.55 83.26 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.402 -0.811 . . . . 1.0 110.749 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.3 m -112.33 22.57 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.302 -0.873 . . . . 1.0 110.641 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.7 p -149.81 139.77 13.51 Favored Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 120.928 -1.108 . . . . 1.0 109.655 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -76.97 22.17 0.56 Allowed 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 120.829 1.019 . . . . 1.0 112.378 178.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 77.5 mt -69.71 139.96 53.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.919 -1.113 . . . . 1.0 109.75 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -109.71 120.07 41.36 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -109.09 125.64 52.34 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.351 -0.843 . . . . 1.0 109.481 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 93.8 m -120.07 129.93 54.43 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.542 -0.724 . . . . 1.0 109.476 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -82.72 128.24 34.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.332 -0.855 . . . . 1.0 109.496 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.9 mt -105.37 119.27 38.65 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.363 -0.835 . . . . 1.0 108.844 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.448 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 85.6 m-70 -70.03 -25.17 63.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.419 -0.801 . . . . 1.0 109.993 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 78.3 m-20 -147.76 160.18 43.01 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.271 -0.893 . . . . 1.0 109.806 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.489 ' H ' HH12 ' A' ' 18' ' ' ARG . . . 98.54 174.12 32.41 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 109.624 -1.39 . . . . 1.0 109.624 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.4 mt -94.42 133.49 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.349 -1.089 . . . . 1.0 108.977 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.28 159.35 17.5 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.367 -0.833 . . . . 1.0 109.61 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -59.85 -49.8 76.27 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.238 -0.914 . . . . 1.0 109.196 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.3 mt -105.13 100.43 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.539 -0.726 . . . . 1.0 109.666 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.2 ptm -102.79 127.89 49.77 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.323 -0.861 . . . . 1.0 108.993 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.5 mt -102.65 139.45 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.441 -0.787 . . . . 1.0 109.313 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.0 p -151.38 154.94 37.64 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.169 -0.957 . . . . 1.0 109.522 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -104.44 122.67 45.98 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.767 -0.827 . . . . 1.0 108.767 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.27 -169.5 20.5 Favored Glycine 0 N--CA 1.5 2.956 0 N-CA-C 110.197 -1.161 . . . . 1.0 110.197 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.591 HG22 ' N ' ' A' ' 67' ' ' LYS . 81.4 mt -138.51 167.76 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.501 -1.0 . . . . 1.0 108.824 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.591 ' N ' HG22 ' A' ' 66' ' ' ILE . 21.0 tptm -22.04 -78.4 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.443 0 CA-C-O 121.061 0.458 . . . . 1.0 111.782 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.632 ' CD ' ' H ' ' A' ' 68' ' ' GLU . 1.0 OUTLIER -73.02 121.88 20.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.067 -1.021 . . . . 1.0 110.102 -179.421 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -100.5 -19.91 15.98 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.389 -0.967 . . . . 1.0 108.389 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.19 -4.87 84.57 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.075 -1.61 . . . . 1.0 109.075 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -119.76 -116.96 0.32 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.707 -0.878 . . . . 1.0 109.35 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -51.76 169.96 0.06 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.233 -0.917 . . . . 1.0 110.063 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -51.7 146.72 12.95 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 108.875 -0.787 . . . . 1.0 108.875 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -57.15 -171.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 120.676 0.917 . . . . 1.0 112.11 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.534 ' CE2' ' OD1' ' A' ' 99' ' ' ASP . 22.2 m-85 -90.05 -173.37 3.83 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.782 -0.822 . . . . 1.0 108.782 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.5 p-10 -101.08 6.93 43.52 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.234 -0.916 . . . . 1.0 110.841 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 125.4 -145.71 15.83 Favored Glycine 0 N--CA 1.506 3.321 0 N-CA-C 108.938 -1.665 . . . . 1.0 108.938 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.472 ' O ' ' CG ' ' A' ' 102' ' ' GLU . 12.9 Cg_endo -77.43 -56.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.3 0 CA-C-N 119.41 1.605 . . . . 1.0 111.936 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 83.4 p -78.92 170.63 16.38 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.2 -0.938 . . . . 1.0 110.571 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.79 -120.19 6.78 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 110.571 -1.012 . . . . 1.0 110.571 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.418 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 11.0 mt -66.39 100.66 0.66 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.422 -1.046 . . . . 1.0 109.113 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 66.9 mt -81.15 -19.97 42.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.074 -1.016 . . . . 1.0 109.538 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.78 172.27 1.11 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -162.1 159.52 26.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 1.0 109.241 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.03 163.84 35.64 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.322 -0.861 . . . . 1.0 109.358 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -99.72 153.25 37.87 Favored Pre-proline 0 N--CA 1.495 1.794 0 N-CA-C 108.678 -0.86 . . . . 1.0 108.678 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -59.06 167.22 5.95 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 CA-C-N 118.801 0.607 . . . . 1.0 111.338 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -46.56 132.4 16.21 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.031 1.154 . . . . 1.0 111.759 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -173.13 -172.28 38.55 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.473 -1.451 . . . . 1.0 109.473 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -57.04 -155.72 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 121.342 1.361 . . . . 1.0 112.191 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -60.01 -40.66 90.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.207 -0.933 . . . . 1.0 109.415 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -59.91 -48.02 83.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.438 -0.789 . . . . 1.0 109.248 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -76.73 169.0 54.92 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.841 -1.304 . . . . 1.0 109.841 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 72.71 6.65 67.44 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.341 -1.503 . . . . 1.0 109.341 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -80.0 167.95 19.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.063 -1.257 . . . . 1.0 109.556 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.75 124.69 10.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.245 -0.91 . . . . 1.0 109.184 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 46.3 m170 -112.33 146.22 38.67 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.484 -0.76 . . . . 1.0 110.141 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -125.44 141.49 52.03 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.819 -0.808 . . . . 1.0 108.819 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.534 ' OD1' ' CE2' ' A' ' 75' ' ' PHE . 95.8 m-20 -79.81 121.43 25.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.079 -1.013 . . . . 1.0 109.42 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 47.0 t0 -84.16 1.55 43.81 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.122 -0.986 . . . . 1.0 109.844 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -81.78 -15.18 55.06 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.004 -1.06 . . . . 1.0 110.312 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.567 ' OE1' ' N ' ' A' ' 102' ' ' GLU . 57.4 mp0 -93.15 177.3 6.1 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.114 -0.991 . . . . 1.0 109.911 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 16.6 m -100.17 108.11 20.14 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.724 -0.843 . . . . 1.0 108.724 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -90.18 121.8 32.54 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.796 -0.816 . . . . 1.0 108.796 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.647 HG21 ' HB2' ' A' ' 109' ' ' LYS . 7.5 t -143.2 158.04 43.97 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.178 -0.951 . . . . 1.0 110.285 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.3 t -95.01 -6.99 41.02 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.459 -0.941 . . . . 1.0 108.459 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 109' ' ' LYS . 45.0 t -90.81 170.03 10.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.577 -0.702 . . . . 1.0 109.216 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.6 m -70.67 63.37 0.28 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.145 -0.972 . . . . 1.0 109.152 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.647 ' HB2' HG21 ' A' ' 105' ' ' THR . 67.9 mmtt -140.92 149.88 42.46 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.399 -0.813 . . . . 1.0 109.234 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 46.67 -146.16 3.57 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.477 -1.449 . . . . 1.0 109.477 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -98.61 115.27 28.28 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.33 -1.1 . . . . 1.0 108.836 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.431 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 61.4 t-20 -62.24 133.49 55.24 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.129 -0.982 . . . . 1.0 109.302 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.1 tp -59.95 -43.45 95.01 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.547 -0.721 . . . . 1.0 110.127 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -60.14 -42.41 94.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.345 -0.847 . . . . 1.0 111.274 -179.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -58.15 -52.83 63.93 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.749 -1.22 . . . . 1.0 109.585 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 71.1 t -66.85 -41.09 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.153 -0.967 . . . . 1.0 109.779 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.11 -49.51 76.7 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.253 -0.905 . . . . 1.0 109.71 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.31 -37.91 78.94 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 120.757 -1.214 . . . . 1.0 110.229 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -65.8 -49.24 69.02 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.157 -0.965 . . . . 1.0 111.884 -178.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -59.92 -39.34 85.13 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.534 -1.354 . . . . 1.0 109.609 -178.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.4 ' CZ ' ' CZ ' ' A' ' 39' ' ' PHE . 29.8 m-85 -59.92 -40.09 87.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.877 -1.14 . . . . 1.0 108.894 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.65 -41.28 93.63 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.761 -1.336 . . . . 1.0 109.761 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -66.52 -38.98 88.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.951 -1.323 . . . . 1.0 108.866 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 87.5 p -67.8 -22.51 65.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 1.0 109.639 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 84.3 mt -83.35 -1.87 54.39 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.122 -0.986 . . . . 1.0 110.09 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.07 5.4 62.44 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.382 -1.087 . . . . 1.0 110.382 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.6 mt -86.86 144.03 27.18 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.899 -1.353 . . . . 1.0 109.491 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 34.6 t0 -102.54 178.2 4.65 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.563 -0.711 . . . . 1.0 109.176 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.489 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 65.0 m80 -59.89 136.96 58.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.078 -1.014 . . . . 1.0 109.497 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 17.5 t -98.88 158.48 15.61 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.344 -0.848 . . . . 1.0 109.381 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -99.49 2.56 45.03 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.258 -0.902 . . . . 1.0 109.054 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -85.66 122.34 73.21 Favored Pre-proline 0 N--CA 1.488 1.452 0 N-CA-C 108.179 -1.045 . . . . 1.0 108.179 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -67.44 -15.01 44.4 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 CA-C-N 120.117 1.078 . . . . 1.0 111.903 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -90.26 -5.98 69.34 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.354 -1.498 . . . . 1.0 109.354 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -87.62 148.84 24.64 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.246 -1.149 . . . . 1.0 109.829 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.494 ' C ' ' H ' ' A' ' 138' ' ' PHE . 86.0 mt -70.08 -36.34 74.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.169 -0.957 . . . . 1.0 109.298 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.0 mmm -68.91 17.24 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.397 -0.814 . . . . 1.0 110.433 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.494 ' H ' ' C ' ' A' ' 136' ' ' LEU . 14.0 t80 -69.99 134.69 87.57 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 107.711 -1.218 . . . . 1.0 107.711 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -60.53 -6.89 6.17 Favored 'Trans proline' 0 N--CA 1.501 1.952 0 CA-C-N 119.833 0.976 . . . . 1.0 114.609 -177.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.85 137.77 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.43 0 O-C-N 121.054 -1.029 . . . . 1.0 109.656 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.431 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 29.4 t80 -73.14 130.72 40.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.611 -0.681 . . . . 1.0 110.014 -178.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.3 t -139.69 139.94 36.72 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.361 -0.837 . . . . 1.0 109.068 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -81.55 141.75 33.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 1.0 109.256 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.9 t -139.96 152.46 46.34 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.27 -0.894 . . . . 1.0 109.977 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.15 108.66 2.56 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.551 -1.42 . . . . 1.0 109.551 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -77.21 1.19 19.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -1.147 . . . . 1.0 109.659 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 33.9 p -59.97 -40.1 87.96 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.32 -0.862 . . . . 1.0 110.011 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -144.02 22.9 1.73 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.063 -1.023 . . . . 1.0 110.41 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -64.97 135.48 55.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.078 -1.014 . . . . 1.0 110.016 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 78.0 mtm -136.4 146.13 46.09 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.086 -1.079 . . . . 1.0 108.086 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 54.5 mt -51.25 129.63 31.94 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 120.862 -1.149 . . . . 1.0 108.595 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -69.16 177.87 4.75 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 CA-C-N 119.994 1.033 . . . . 1.0 112.19 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -61.75 -40.02 93.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.569 -0.707 . . . . 1.0 110.214 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -54.69 -46.13 74.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.166 -0.959 . . . . 1.0 110.189 -178.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -69.0 -39.43 79.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.056 -1.027 . . . . 1.0 109.913 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 58.2 t -60.11 -47.68 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.087 -1.008 . . . . 1.0 108.792 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -61.1 -40.21 92.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.118 -0.989 . . . . 1.0 110.428 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.03 -51.77 13.41 Favored Glycine 0 N--CA 1.495 2.586 0 O-C-N 121.16 -0.962 . . . . 1.0 111.261 -178.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.484 HG23 ' N ' ' A' ' 160' ' ' GLN . 5.1 tp -62.19 -41.29 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.897 -1.355 . . . . 1.0 110.163 -178.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.536 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.2 mt-30 -63.42 -38.97 93.2 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.0 -1.062 . . . . 1.0 109.597 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 79.5 p -60.91 -34.52 74.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.906 . . . . 1.0 110.507 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 95.6 mt -84.13 -48.81 9.47 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.872 -1.142 . . . . 1.0 110.845 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -91.57 -9.81 42.86 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.824 -1.173 . . . . 1.0 110.322 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.493 2.446 0 N-CA-C 109.615 -1.394 . . . . 1.0 109.615 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 169' ' ' WAY . . . . . 0.999 ' HC2' ' HJ ' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.5 m . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.0 mt -92.22 136.47 33.16 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.264 -0.898 . . . . 1.0 108.859 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.459 ' NZ ' ' O ' ' A' ' 162' ' ' LEU . 0.8 OUTLIER -159.97 160.04 32.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.175 -0.953 . . . . 1.0 109.601 -179.827 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -72.88 134.66 44.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.906 . . . . 1.0 109.436 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.6 t -69.63 -42.06 74.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 1.0 109.515 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -95.09 149.97 20.69 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.245 -0.91 . . . . 1.0 109.661 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.3 mmt -90.7 -0.0 57.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.28 -0.887 . . . . 1.0 109.598 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -96.72 132.28 42.55 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.227 -0.921 . . . . 1.0 109.313 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.5 mt -140.22 149.99 43.57 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.283 -0.885 . . . . 1.0 109.226 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 70.5 p -133.38 157.24 46.04 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.559 -0.904 . . . . 1.0 108.559 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -143.88 162.93 34.83 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.002 -1.061 . . . . 1.0 110.464 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -141.66 127.45 19.24 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 91.1 mt -87.74 118.65 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.273 -0.892 . . . . 1.0 108.935 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.9 t -69.5 -39.97 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.392 -0.818 . . . . 1.0 109.613 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -164.83 152.94 11.93 Favored 'General case' 0 C--N 1.289 -2.023 0 O-C-N 119.927 -1.733 . . . . 1.0 110.964 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.608 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 27.3 m-85 -98.39 109.46 22.21 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 104.436 -2.431 . . . . 1.0 104.436 177.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.474 ' OG1' ' OD2' ' A' ' 25' ' ' ASP . 3.0 t -57.42 143.07 75.3 Favored Pre-proline 0 C--N 1.294 -1.824 0 C-N-CA 119.355 -0.938 . . . . 1.0 110.21 -176.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -60.16 -8.49 8.36 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 C-N-CA 120.436 0.757 . . . . 1.0 111.015 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.474 ' OD2' ' OG1' ' A' ' 23' ' ' THR . 66.1 m-20 -57.47 -32.56 67.09 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 120.054 -0.658 . . . . 1.0 109.597 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 73.5 mtm -140.06 160.88 38.94 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.208 -0.932 . . . . 1.0 109.317 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 76.4 p -71.41 161.06 31.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.315 -0.866 . . . . 1.0 109.244 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.608 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 9.2 m80 -61.1 -41.17 96.18 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.297 -0.877 . . . . 1.0 110.296 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.4 m -60.71 -40.59 92.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.989 -1.069 . . . . 1.0 110.204 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -68.9 -39.99 79.39 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.419 -0.801 . . . . 1.0 110.563 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 79.3 t -69.25 -42.8 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.1 -1.0 . . . . 1.0 110.399 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -59.98 -49.19 78.65 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.095 -1.003 . . . . 1.0 110.47 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -61.4 -33.35 73.54 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.054 -1.029 . . . . 1.0 109.915 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.96 -48.83 80.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.007 -1.058 . . . . 1.0 109.976 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.418 ' CE1' HD13 ' A' ' 62' ' ' ILE . 55.2 m-85 -68.16 -39.96 82.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.892 -1.13 . . . . 1.0 110.217 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -60.05 -43.76 95.16 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.858 -1.151 . . . . 1.0 109.775 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -60.07 -39.98 87.9 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.087 -1.008 . . . . 1.0 110.107 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.01 -46.83 88.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.223 -0.923 . . . . 1.0 109.906 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -67.36 -36.21 80.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.067 -1.021 . . . . 1.0 109.531 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -60.0 -49.67 76.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.072 -1.018 . . . . 1.0 109.875 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.7 t -60.25 -40.35 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.086 -1.009 . . . . 1.0 110.357 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -81.36 -34.9 31.44 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.957 -1.089 . . . . 1.0 110.118 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.5 p -71.06 -16.91 62.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.04 -1.038 . . . . 1.0 109.645 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.96 -40.03 87.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.326 -0.858 . . . . 1.0 110.062 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.5 m -110.05 -22.02 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.369 -0.832 . . . . 1.0 110.562 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.1 p -94.84 127.73 42.12 Favored Pre-proline 0 N--CA 1.499 2.009 0 O-C-N 120.794 -1.191 . . . . 1.0 109.536 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -74.12 15.66 0.6 Allowed 'Trans proline' 0 N--CA 1.492 1.441 0 CA-C-N 120.067 1.06 . . . . 1.0 111.609 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 78.7 mt -68.06 139.99 56.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 1.0 109.555 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -105.28 121.0 42.95 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.773 -0.825 . . . . 1.0 108.773 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -107.0 120.88 43.26 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.383 -0.823 . . . . 1.0 109.748 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.2 m -120.0 130.03 54.55 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.613 -0.679 . . . . 1.0 109.827 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.472 ' CB ' ' NH1' ' A' ' 52' ' ' ARG . 11.6 ttp-105 -83.05 138.01 33.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.309 -0.869 . . . . 1.0 109.711 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.4 mt -103.6 132.58 49.73 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.289 -0.882 . . . . 1.0 109.025 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.446 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 61.2 m170 -60.12 -39.99 88.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.875 . . . . 1.0 109.857 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 71.9 m-20 -153.43 179.8 8.46 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.234 -0.916 . . . . 1.0 109.464 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.73 -178.47 42.52 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.961 -1.256 . . . . 1.0 109.961 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.7 mt -95.58 132.95 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.387 -1.067 . . . . 1.0 109.454 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.41 165.9 11.41 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.006 -0.738 . . . . 1.0 109.006 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -59.99 -49.64 76.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.012 -1.055 . . . . 1.0 109.396 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 92.9 mt -110.13 105.56 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.429 -0.795 . . . . 1.0 109.826 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.9 ptm -102.07 132.75 47.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.231 -0.918 . . . . 1.0 108.893 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.418 HD13 ' CE1' ' A' ' 35' ' ' PHE . 85.9 mt -109.39 133.11 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.61 -0.681 . . . . 1.0 109.63 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 43.6 p -149.99 160.74 43.39 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.222 -0.924 . . . . 1.0 109.926 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -106.71 123.12 47.66 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.557 -0.714 . . . . 1.0 109.15 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.48 -171.58 26.92 Favored Glycine 0 N--CA 1.499 2.879 0 N-CA-C 110.655 -0.978 . . . . 1.0 110.655 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.546 HG22 ' N ' ' A' ' 67' ' ' LYS . 60.9 mt -136.72 167.68 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.656 -0.908 . . . . 1.0 108.669 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.546 ' N ' HG22 ' A' ' 66' ' ' ILE . 50.0 tptt -21.73 -79.0 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.459 0 CA-C-O 121.099 0.476 . . . . 1.0 111.783 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.407 ' HG2' ' H ' ' A' ' 68' ' ' GLU . 15.2 pt-20 -73.14 126.6 30.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.149 -0.97 . . . . 1.0 109.794 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.618 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 1.3 m170 -77.88 -20.6 52.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.065 -1.022 . . . . 1.0 108.598 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.84 -9.19 75.18 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.412 -1.875 . . . . 1.0 108.412 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -119.96 -88.98 0.61 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.836 -0.803 . . . . 1.0 109.106 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -155.74 162.23 40.56 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.219 -0.926 . . . . 1.0 109.661 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 52.5 t80 54.03 68.99 2.38 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.326 -0.859 . . . . 1.0 109.874 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -79.22 -170.55 1.03 Allowed 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.561 1.508 . . . . 1.0 112.147 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.618 ' CE2' ' NE2' ' A' ' 69' ' ' HIS . 94.0 m-85 -89.23 170.38 10.64 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.28 -0.888 . . . . 1.0 108.828 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.466 ' C ' ' NZ ' ' A' ' 67' ' ' LYS . 31.8 p-10 -99.77 0.89 42.57 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.197 -0.94 . . . . 1.0 110.944 -178.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.51 -148.38 19.36 Favored Glycine 0 N--CA 1.504 3.185 0 N-CA-C 108.876 -1.69 . . . . 1.0 108.876 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.456 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 2.5 Cg_endo -68.65 -63.15 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.302 0 CA-C-N 119.124 1.462 . . . . 1.0 111.273 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 87.7 p -79.14 166.68 21.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.123 -0.986 . . . . 1.0 109.161 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 112.86 -128.62 8.51 Favored Glycine 0 N--CA 1.501 2.976 0 N-CA-C 109.517 -1.433 . . . . 1.0 109.517 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.418 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 20.2 mt -70.43 112.47 6.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.334 -1.098 . . . . 1.0 109.367 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 46.0 mt -83.95 -15.18 48.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.943 -1.098 . . . . 1.0 109.037 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 179.06 172.52 0.82 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.033 -0.728 . . . . 1.0 109.033 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -162.71 158.26 22.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 1.0 109.196 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.33 158.86 44.53 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.178 -0.952 . . . . 1.0 109.437 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -96.48 153.54 38.84 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.173 -0.955 . . . . 1.0 108.849 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -64.84 166.04 19.38 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 120.719 0.946 . . . . 1.0 111.952 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -44.97 120.03 2.71 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 120.958 1.105 . . . . 1.0 111.691 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 90' ' ' PRO . . . -158.44 -166.86 18.39 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.164 -1.575 . . . . 1.0 109.164 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.451 ' O ' ' O ' ' A' ' 89' ' ' GLY . 16.6 Cg_exo -54.28 -157.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 120.972 1.115 . . . . 1.0 112.535 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -59.96 -40.03 87.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.213 -0.929 . . . . 1.0 110.265 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -63.79 -40.02 95.65 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.18 -0.95 . . . . 1.0 109.409 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -68.69 169.26 41.93 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.748 -1.341 . . . . 1.0 109.748 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 72.17 6.62 65.21 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.889 -1.285 . . . . 1.0 109.889 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -80.07 169.07 18.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.097 -1.237 . . . . 1.0 109.746 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.83 120.83 7.69 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.304 -0.873 . . . . 1.0 109.174 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -108.59 147.9 31.13 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.534 -0.728 . . . . 1.0 110.374 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -124.15 146.37 48.7 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.999 -0.741 . . . . 1.0 108.999 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.543 ' OD2' ' CD1' ' A' ' 75' ' ' PHE . 1.3 m-20 -79.6 123.73 27.88 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.057 -1.027 . . . . 1.0 109.347 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -89.22 -0.02 57.13 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.106 -0.996 . . . . 1.0 110.226 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -81.85 -16.1 51.88 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.074 -1.016 . . . . 1.0 110.08 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.604 ' OE1' ' N ' ' A' ' 102' ' ' GLU . 40.1 mp0 -93.97 173.89 7.43 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.307 -0.87 . . . . 1.0 109.202 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.8 m -99.69 105.42 17.24 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.216 -0.927 . . . . 1.0 108.862 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.496 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 90.2 m95 -85.87 126.06 33.77 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.761 -0.829 . . . . 1.0 108.761 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.699 HG21 ' HB2' ' A' ' 109' ' ' LYS . 7.8 t -141.07 153.61 45.56 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.467 -0.77 . . . . 1.0 109.635 -179.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 52.5 m -90.94 -5.17 55.82 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.198 -1.038 . . . . 1.0 108.198 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.7 t -92.73 177.93 5.95 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.752 -0.833 . . . . 1.0 108.752 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.5 m -80.25 64.29 5.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.027 -1.046 . . . . 1.0 109.998 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.699 ' HB2' HG21 ' A' ' 105' ' ' THR . 69.6 mmtt -139.01 152.38 47.59 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.267 -0.896 . . . . 1.0 108.788 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.8 -139.42 6.2 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.759 -1.336 . . . . 1.0 109.759 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -99.72 113.8 26.5 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.338 -1.095 . . . . 1.0 109.057 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -62.77 130.68 45.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.148 -0.97 . . . . 1.0 109.76 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.7 tp -60.01 -43.29 95.33 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.48 -0.763 . . . . 1.0 111.022 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -60.01 -39.99 87.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.165 -0.959 . . . . 1.0 110.645 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -59.95 -50.86 72.09 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.811 -1.181 . . . . 1.0 109.874 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 71.0 t -69.98 -40.06 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.931 -1.106 . . . . 1.0 110.196 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.19 -51.97 67.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -0.939 . . . . 1.0 110.089 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.84 -37.97 80.73 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.271 -0.893 . . . . 1.0 110.259 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -64.24 -50.2 68.92 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.182 -0.949 . . . . 1.0 111.267 -178.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -60.07 -37.83 81.07 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.552 -1.342 . . . . 1.0 110.329 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -59.98 -40.05 87.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.766 -1.208 . . . . 1.0 108.255 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.39 -41.83 93.4 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.382 -1.487 . . . . 1.0 109.382 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -68.74 -39.93 80.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.022 -1.281 . . . . 1.0 109.467 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.4 p -67.2 -33.08 74.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.318 -0.864 . . . . 1.0 109.618 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.486 HD13 HD11 ' A' ' 159' ' ' ILE . 81.6 mt -70.22 -39.68 74.96 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.23 -0.919 . . . . 1.0 109.84 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 135.31 7.59 1.92 Allowed Glycine 0 N--CA 1.5 2.959 0 N-CA-C 110.045 -1.222 . . . . 1.0 110.045 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.1 mt -87.65 141.21 28.78 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.08 -1.247 . . . . 1.0 110.042 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 34.5 t0 -99.15 175.34 5.93 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.88 -0.785 . . . . 1.0 108.88 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.517 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 63.2 m80 -60.05 133.49 56.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.033 -1.042 . . . . 1.0 109.606 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 47.8 t -98.76 158.1 15.85 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.359 -0.838 . . . . 1.0 109.1 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -98.35 3.05 48.58 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.265 -0.897 . . . . 1.0 109.369 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -85.64 129.55 54.47 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.205 -0.934 . . . . 1.0 108.62 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -69.54 -25.45 29.6 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 CA-C-N 120.012 1.04 . . . . 1.0 112.34 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -82.23 -3.86 90.41 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.413 -1.475 . . . . 1.0 109.413 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.15 143.93 26.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.421 -1.047 . . . . 1.0 109.467 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.501 ' C ' ' H ' ' A' ' 138' ' ' PHE . 89.0 mt -70.0 -34.1 72.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.076 -1.015 . . . . 1.0 109.6 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.3 mmm -70.02 18.19 0.05 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.394 -0.817 . . . . 1.0 109.997 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.501 ' H ' ' C ' ' A' ' 136' ' ' LEU . 13.7 t80 -69.5 133.62 88.94 Favored Pre-proline 0 N--CA 1.488 1.446 0 N-CA-C 107.552 -1.277 . . . . 1.0 107.552 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -60.51 -15.91 39.1 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 CA-C-N 119.805 0.966 . . . . 1.0 114.005 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 95.7 mt -106.59 138.82 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 120.988 -1.07 . . . . 1.0 110.083 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -73.75 129.98 39.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.579 -0.701 . . . . 1.0 109.967 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.1 t -141.31 141.96 33.87 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.43 -0.794 . . . . 1.0 109.246 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -79.98 144.5 33.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.013 -1.054 . . . . 1.0 109.381 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.5 t -140.01 150.64 44.68 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.437 -0.789 . . . . 1.0 109.266 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.61 105.11 1.44 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.422 -1.471 . . . . 1.0 109.422 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -73.61 -6.24 45.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.432 -1.04 . . . . 1.0 109.788 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 61.1 m -60.04 -40.09 88.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.257 -0.902 . . . . 1.0 110.819 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -141.75 19.87 2.16 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.036 -1.04 . . . . 1.0 110.4 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -61.03 140.0 57.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.843 -1.16 . . . . 1.0 109.953 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 67.8 mtt -138.47 145.44 40.85 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.661 -0.866 . . . . 1.0 108.661 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 45.5 mt -54.48 129.04 61.63 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.921 -1.112 . . . . 1.0 108.914 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -68.14 177.9 4.04 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 CA-C-N 119.996 1.034 . . . . 1.0 112.166 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -61.13 -39.96 92.02 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.315 -0.866 . . . . 1.0 110.141 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -56.32 -49.94 72.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.162 -0.961 . . . . 1.0 110.091 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -70.62 -40.03 73.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.137 -0.977 . . . . 1.0 110.252 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.452 ' O ' ' OE1' ' A' ' 160' ' ' GLN . 68.1 t -63.85 -50.06 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.963 . . . . 1.0 109.618 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.54 -40.01 89.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.844 -1.16 . . . . 1.0 110.063 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.42 -48.45 30.19 Favored Glycine 0 N--CA 1.493 2.473 0 O-C-N 121.352 -0.842 . . . . 1.0 112.227 -178.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.564 ' CG2' ' NE2' ' A' ' 160' ' ' GLN . 4.7 tp -60.9 -43.29 95.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.609 -1.524 . . . . 1.0 110.464 -177.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.564 ' NE2' ' CG2' ' A' ' 159' ' ' ILE . 5.9 mp0 -67.64 -36.38 80.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.579 -1.325 . . . . 1.0 108.903 179.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 79.4 p -60.75 -27.99 68.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.131 -0.981 . . . . 1.0 109.878 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.459 ' O ' ' NZ ' ' A' ' 9' ' ' LYS . 88.1 mt -85.28 -45.93 11.5 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.02 -1.05 . . . . 1.0 110.381 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -91.36 -9.29 45.39 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.017 -1.052 . . . . 1.0 109.821 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.553 -1.419 . . . . 1.0 109.553 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 169' ' ' WAY . . . . . 0.539 ' HC2' ' HJ ' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 87.4 m . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.0 mt -85.54 129.98 34.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.239 -0.913 . . . . 1.0 109.54 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -160.76 160.68 31.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.499 -0.75 . . . . 1.0 109.499 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -71.47 148.74 46.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.185 -0.947 . . . . 1.0 109.61 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 91.6 p -88.44 3.39 50.21 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.333 -0.854 . . . . 1.0 109.98 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -145.07 153.24 41.24 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.067 -1.021 . . . . 1.0 109.609 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.6 mmt -90.38 -0.01 57.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.392 -0.818 . . . . 1.0 109.606 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -96.58 131.41 43.24 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.179 -0.951 . . . . 1.0 109.283 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.8 mt -143.95 151.03 39.23 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.117 -0.989 . . . . 1.0 109.399 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 54.5 p -135.71 155.73 49.93 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.475 -0.765 . . . . 1.0 108.937 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -144.27 161.19 39.54 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.146 -0.971 . . . . 1.0 110.383 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.494 HH11 ' HG2' ' A' ' 18' ' ' ARG . 0.8 OUTLIER -139.17 131.08 27.72 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 109.084 -0.709 . . . . 1.0 109.084 -179.384 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.9 mt -89.79 116.49 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.161 -0.962 . . . . 1.0 108.765 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.5 t -68.67 -39.93 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.193 -0.942 . . . . 1.0 109.226 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.403 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 23.8 p-10 -164.7 152.98 12.24 Favored 'General case' 0 C--N 1.288 -2.081 0 O-C-N 120.051 -1.656 . . . . 1.0 110.873 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.624 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 36.7 m-85 -99.94 109.11 21.48 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 104.781 -2.303 . . . . 1.0 104.781 177.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 t -55.87 140.55 68.43 Favored Pre-proline 0 C--N 1.297 -1.712 0 O-C-N 121.124 -0.985 . . . . 1.0 110.111 -176.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.27 -11.04 9.61 Favored 'Trans proline' 0 N--CA 1.485 1.008 0 CA-C-N 119.194 0.748 . . . . 1.0 110.901 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -55.61 -29.88 59.92 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.898 -0.721 . . . . 1.0 110.007 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 73.9 mtm -144.42 162.2 37.09 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.035 -1.041 . . . . 1.0 109.587 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.9 p -72.95 159.89 32.98 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.395 -0.815 . . . . 1.0 109.391 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.624 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 1.9 m80 -60.16 -40.75 90.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.306 -0.871 . . . . 1.0 110.07 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.5 m -60.12 -41.39 92.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.151 -0.968 . . . . 1.0 110.336 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.82 -40.0 79.71 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.205 -0.934 . . . . 1.0 110.321 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 70.9 t -67.59 -43.96 86.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.24 -0.913 . . . . 1.0 110.23 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -59.98 -49.92 75.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.137 -0.977 . . . . 1.0 110.837 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -61.44 -32.73 72.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.928 -1.108 . . . . 1.0 110.22 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.98 -50.07 75.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.984 -1.072 . . . . 1.0 110.006 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -68.11 -37.25 80.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.0 -1.062 . . . . 1.0 110.034 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -60.05 -44.41 94.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.973 -1.08 . . . . 1.0 109.428 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -60.44 -40.03 89.64 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.165 -0.959 . . . . 1.0 109.204 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.1 -45.96 91.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.355 -0.841 . . . . 1.0 110.212 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -69.88 -39.82 76.07 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.009 -1.057 . . . . 1.0 109.746 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -59.89 -47.88 83.98 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.194 -0.941 . . . . 1.0 109.91 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.0 t -60.0 -41.9 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.095 -1.003 . . . . 1.0 109.8 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 63.1 m95 -79.0 -35.6 42.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.038 -1.039 . . . . 1.0 109.874 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.7 p -70.14 -20.35 63.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.808 -1.183 . . . . 1.0 109.217 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -59.97 -40.13 88.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.506 -0.746 . . . . 1.0 110.667 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.7 m -110.8 23.0 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.333 -0.855 . . . . 1.0 110.633 -178.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 28.6 p -149.95 139.63 13.35 Favored Pre-proline 0 N--CA 1.5 2.052 0 O-C-N 120.909 -1.119 . . . . 1.0 109.23 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -75.17 19.35 0.51 Allowed 'Trans proline' 0 N--CA 1.496 1.638 0 CA-C-N 119.664 0.916 . . . . 1.0 111.605 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.0 mt -67.49 138.92 56.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -0.86 . . . . 1.0 109.933 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -112.91 120.8 42.68 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.947 -0.76 . . . . 1.0 108.947 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -109.14 122.24 46.88 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.325 -0.86 . . . . 1.0 109.354 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -119.99 130.07 54.58 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.572 0.701 . . . . 1.0 109.974 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -83.14 132.7 35.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.35 -0.844 . . . . 1.0 109.64 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.2 mt -101.76 132.68 47.36 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.198 -0.939 . . . . 1.0 108.894 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.446 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 43.1 m170 -61.27 -40.05 92.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.088 -1.007 . . . . 1.0 110.061 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 73.8 m-20 -152.31 178.01 9.97 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.19 -0.944 . . . . 1.0 109.546 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.07 -178.58 42.08 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.71 -1.356 . . . . 1.0 109.71 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.3 mt -94.45 134.82 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.393 -1.063 . . . . 1.0 109.115 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.92 174.09 6.03 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.505 -0.747 . . . . 1.0 109.154 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -60.05 -49.09 79.02 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.081 -1.012 . . . . 1.0 108.513 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.8 mt -120.03 118.07 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.544 -0.723 . . . . 1.0 109.42 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.1 ptp -101.63 139.26 37.52 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.164 -0.96 . . . . 1.0 109.153 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 97.0 mt -107.46 133.56 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.393 -0.817 . . . . 1.0 109.927 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 79.7 p -152.45 156.75 40.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.292 -0.88 . . . . 1.0 109.368 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -100.77 125.58 47.26 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.288 -0.883 . . . . 1.0 109.161 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 100' ' ' ASP . . . -93.14 155.31 22.28 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.946 -1.261 . . . . 1.0 109.946 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.446 ' O ' ' C ' ' A' ' 67' ' ' LYS . 9.6 tt -108.71 -178.62 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.444 -1.033 . . . . 1.0 108.77 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 66' ' ' ILE . 52.7 tptt -36.11 -77.96 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.93 -0.481 . . . . 1.0 110.404 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -68.25 121.33 16.01 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.908 -1.12 . . . . 1.0 108.863 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.48 ' O ' ' O ' ' A' ' 70' ' ' GLY . 5.5 t-80 -165.46 127.01 1.99 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.408 -0.807 . . . . 1.0 109.254 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 69' ' ' HIS . . . 48.49 99.6 0.01 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.731 -1.348 . . . . 1.0 109.731 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.04 -39.85 87.38 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.956 -1.32 . . . . 1.0 109.742 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -61.33 -38.97 88.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.129 -0.982 . . . . 1.0 109.757 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -129.95 79.01 73.97 Favored Pre-proline 0 N--CA 1.503 2.211 0 O-C-N 121.368 -0.833 . . . . 1.0 109.541 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -83.7 165.5 13.81 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 121.551 1.501 . . . . 1.0 112.456 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.523 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 77.0 m-85 -87.25 155.32 20.13 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.438 -0.949 . . . . 1.0 108.438 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -100.62 9.19 42.82 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.277 -0.889 . . . . 1.0 111.168 -178.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 121.15 -159.94 15.59 Favored Glycine 0 N--CA 1.508 3.459 0 N-CA-C 109.161 -1.575 . . . . 1.0 109.161 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -56.36 -63.97 0.15 Allowed 'Trans proline' 0 N--CA 1.49 1.268 0 CA-C-N 118.771 1.285 . . . . 1.0 111.955 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 96.3 p -76.54 160.45 29.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.496 -0.752 . . . . 1.0 109.578 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.71 -130.8 9.29 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 110.177 -1.169 . . . . 1.0 110.177 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.1 mt -69.49 105.33 2.59 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.424 -1.045 . . . . 1.0 109.242 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.449 HD23 ' OE2' ' A' ' 102' ' ' GLU . 32.2 mt -79.82 -14.76 58.44 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.124 -0.985 . . . . 1.0 109.057 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.57 175.54 0.88 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.056 -0.72 . . . . 1.0 109.056 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.51 ' CE1' ' ND1' ' A' ' 97' ' ' HIS . 21.2 p80 -163.22 160.91 24.57 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.231 -0.918 . . . . 1.0 109.787 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -153.2 167.74 28.31 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.858 -0.793 . . . . 1.0 108.858 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -114.51 153.98 46.61 Favored Pre-proline 0 N--CA 1.499 2.006 0 N-CA-C 108.494 -0.928 . . . . 1.0 108.494 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -69.71 161.42 46.0 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 120.57 0.847 . . . . 1.0 111.503 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -43.74 128.02 6.56 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.068 1.179 . . . . 1.0 112.104 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -171.87 -170.78 36.23 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.649 -1.38 . . . . 1.0 109.649 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -60.26 -144.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.192 1.261 . . . . 1.0 111.558 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -61.31 -40.01 92.61 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.987 -1.071 . . . . 1.0 109.394 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -62.04 -43.65 98.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.078 -1.014 . . . . 1.0 109.486 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -78.94 168.76 53.72 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.387 -1.485 . . . . 1.0 109.387 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 68.68 68.71 1.57 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.65 -1.38 . . . . 1.0 109.65 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 45.5 p-10 -152.49 160.78 43.22 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.179 -1.189 . . . . 1.0 109.236 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.88 123.24 9.01 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.101 -0.999 . . . . 1.0 109.18 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.51 ' ND1' ' CE1' ' A' ' 84' ' ' HIS . 64.9 m170 -117.78 159.98 22.12 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.625 0.726 . . . . 1.0 109.933 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.536 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 47.1 m-85 -137.88 153.46 49.56 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.702 -0.851 . . . . 1.0 108.702 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.523 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 1.5 m-20 -79.39 124.0 28.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.844 -1.16 . . . . 1.0 109.662 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 65' ' ' GLY . 36.5 t0 -84.81 -12.67 53.13 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.473 -0.767 . . . . 1.0 109.416 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -82.26 -11.51 58.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.265 -0.897 . . . . 1.0 109.574 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.449 ' OE2' HD23 ' A' ' 82' ' ' LEU . 98.0 mt-10 -91.63 166.79 12.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.294 -0.879 . . . . 1.0 109.153 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.3 m -98.78 107.42 19.86 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.177 -0.952 . . . . 1.0 109.086 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.454 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 94.1 m95 -88.74 123.65 33.36 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.846 -0.798 . . . . 1.0 108.846 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.679 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.7 t -140.36 153.16 46.3 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.378 -0.826 . . . . 1.0 109.439 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.8 t -92.06 -6.09 51.64 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.205 -1.035 . . . . 1.0 108.205 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 65.1 p -93.16 179.44 5.43 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.713 -0.847 . . . . 1.0 108.713 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.2 m -82.04 77.06 8.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.016 -1.052 . . . . 1.0 109.467 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.679 ' HB2' HG21 ' A' ' 105' ' ' THR . 52.6 mtmt -149.31 150.03 31.86 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.74 -139.85 5.86 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.567 -1.413 . . . . 1.0 109.567 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.418 ' CD1' HD13 ' A' ' 82' ' ' LEU . 95.2 m-85 -100.09 113.77 26.63 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.312 -1.111 . . . . 1.0 108.751 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -62.94 134.11 55.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.113 -0.992 . . . . 1.0 109.34 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.6 tp -59.98 -43.94 94.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.39 -0.819 . . . . 1.0 110.587 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -59.88 -43.22 94.87 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.965 -1.085 . . . . 1.0 110.603 -178.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -58.6 -51.91 67.9 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.74 -1.225 . . . . 1.0 109.644 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.6 t -68.47 -43.97 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.174 -0.954 . . . . 1.0 110.319 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.25 -52.79 63.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.304 -0.873 . . . . 1.0 110.014 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.95 -32.65 71.0 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.937 -1.102 . . . . 1.0 109.882 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 45.7 t60 -65.68 -52.95 47.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.969 -1.082 . . . . 1.0 110.654 -179.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.536 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 7.7 pt-20 -60.13 -40.97 91.63 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.902 -1.124 . . . . 1.0 110.453 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -60.03 -39.91 87.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.861 -1.149 . . . . 1.0 109.001 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -56.45 -42.8 90.13 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.128 -1.589 . . . . 1.0 109.128 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -67.44 -39.98 85.43 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.213 -1.169 . . . . 1.0 109.221 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 59.7 p -64.45 -25.01 67.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -0.895 . . . . 1.0 109.923 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.2 mt -80.19 -0.53 36.59 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.13 -0.981 . . . . 1.0 110.049 -179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 91.93 6.8 64.95 Favored Glycine 0 N--CA 1.497 2.744 0 O-C-N 120.997 -1.065 . . . . 1.0 110.562 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.4 mt -84.79 149.46 25.72 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.907 -1.349 . . . . 1.0 109.554 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 42.0 t0 -98.67 171.32 8.19 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.674 -0.861 . . . . 1.0 108.674 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.535 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 62.8 m80 -58.92 136.98 58.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.026 -1.046 . . . . 1.0 109.724 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.0 t -97.36 151.16 20.2 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.542 -0.724 . . . . 1.0 109.246 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -99.86 6.83 45.28 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.255 -0.903 . . . . 1.0 108.907 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -87.31 123.76 69.31 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.057 -1.027 . . . . 1.0 108.396 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -64.2 -17.1 58.47 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 CA-C-N 120.189 1.103 . . . . 1.0 112.168 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -89.98 -6.35 69.58 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.553 -1.419 . . . . 1.0 109.553 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.56 141.49 30.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.221 -1.164 . . . . 1.0 109.25 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.461 ' C ' ' H ' ' A' ' 138' ' ' PHE . 97.0 mt -65.78 -39.74 91.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.15 -0.969 . . . . 1.0 109.6 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 91.1 mtp -70.36 23.35 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.32 -0.862 . . . . 1.0 111.117 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.461 ' H ' ' C ' ' A' ' 136' ' ' LEU . 11.5 t80 -67.26 133.11 93.33 Favored Pre-proline 0 N--CA 1.493 1.692 0 N-CA-C 107.522 -1.288 . . . . 1.0 107.522 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -61.7 -9.79 14.87 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 CA-C-N 119.958 1.021 . . . . 1.0 113.644 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 88.4 mt -113.45 133.28 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.162 -0.961 . . . . 1.0 109.14 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -71.36 128.51 36.1 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.168 -0.957 . . . . 1.0 110.102 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.8 t -141.84 143.59 33.46 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.637 -0.875 . . . . 1.0 108.637 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -81.24 146.03 30.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.079 -1.013 . . . . 1.0 109.766 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.0 t -140.8 157.49 45.32 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.371 -0.831 . . . . 1.0 109.662 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.95 106.47 1.97 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.534 -1.426 . . . . 1.0 109.534 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.458 ' NZ ' ' CB ' ' A' ' 146' ' ' LYS . 8.4 mtpm? -77.43 2.9 14.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -1.15 . . . . 1.0 109.597 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.471 ' O ' ' ND1' ' A' ' 148' ' ' HIS . 34.7 t -59.44 -46.06 89.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 1.0 110.067 -179.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' HIS . . . . . 0.471 ' ND1' ' O ' ' A' ' 147' ' ' SER . 50.0 m-70 -146.58 30.77 0.99 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.014 -1.054 . . . . 1.0 109.472 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -61.0 136.0 57.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.145 -0.972 . . . . 1.0 109.7 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 65.9 mtt -133.47 144.56 49.53 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.476 -0.765 . . . . 1.0 108.939 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 36.4 mt -51.48 125.77 28.06 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.177 -0.952 . . . . 1.0 108.767 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -67.63 177.52 4.0 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 CA-C-N 120.04 1.05 . . . . 1.0 112.253 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.21 -39.98 88.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.395 -0.816 . . . . 1.0 109.955 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -55.11 -48.34 73.74 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.183 -0.948 . . . . 1.0 109.998 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -69.98 -39.96 75.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.042 -1.037 . . . . 1.0 110.115 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 56.3 t -59.95 -49.13 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.158 -0.964 . . . . 1.0 109.478 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -60.34 -40.11 89.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.878 -1.138 . . . . 1.0 110.468 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.63 -53.28 12.66 Favored Glycine 0 N--CA 1.496 2.638 0 O-C-N 121.046 -1.034 . . . . 1.0 111.512 -178.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.476 HG23 ' N ' ' A' ' 160' ' ' GLN . 6.3 tp -61.19 -40.0 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.97 -1.312 . . . . 1.0 109.617 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 164' ' ' GLY . 97.1 mt-30 -65.49 -39.69 92.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 1.0 109.566 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 83.3 p -60.0 -34.65 73.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 1.0 110.625 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 83.7 mt -87.47 -50.47 6.52 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.843 -1.161 . . . . 1.0 110.884 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -90.62 -9.12 48.16 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.969 -1.082 . . . . 1.0 110.226 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.568 0 N-CA-C 109.512 -1.435 . . . . 1.0 109.512 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 169' ' ' WAY . . . . . 0.978 ' HC2' ' HJ ' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.0 m . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.484 -0.561 . . . . 1.0 109.484 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.3 mt -73.52 144.73 46.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.178 -0.951 . . . . 1.0 109.075 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -159.84 159.88 33.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.198 -0.939 . . . . 1.0 109.525 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -71.76 145.54 48.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -0.868 . . . . 1.0 109.193 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.1 t -80.83 -0.86 40.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.413 -0.805 . . . . 1.0 110.369 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -149.27 154.8 39.58 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.067 -1.02 . . . . 1.0 109.574 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.551 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.07 0.03 57.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.34 -0.85 . . . . 1.0 109.723 -179.644 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -97.65 124.76 42.08 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.279 -0.888 . . . . 1.0 108.954 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.4 mt -140.03 150.07 43.96 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.263 -0.898 . . . . 1.0 109.713 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.0 p -130.7 157.3 43.16 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.61 -0.885 . . . . 1.0 108.61 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -144.18 160.05 41.61 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.082 -1.011 . . . . 1.0 110.251 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.462 ' CZ ' ' O ' ' A' ' 54' ' ' HIS . 26.1 tpt180 -143.61 129.4 19.36 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.652 -0.655 . . . . 1.0 109.566 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 86.8 mt -88.11 119.68 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.149 -0.969 . . . . 1.0 109.132 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.6 t -69.48 -40.53 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.169 -0.957 . . . . 1.0 109.259 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -163.8 165.21 23.2 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.496 -1.378 . . . . 1.0 110.948 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -104.22 -172.98 2.2 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.78 -1.193 . . . . 1.0 107.78 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.85 148.81 47.28 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.445 -0.784 . . . . 1.0 109.901 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -64.93 -16.11 53.8 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 120.926 1.084 . . . . 1.0 110.156 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.94 -39.99 87.41 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.348 -0.842 . . . . 1.0 110.471 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.6 mtm -144.21 160.16 41.43 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.128 -0.982 . . . . 1.0 109.663 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 69.3 p -73.48 159.98 32.39 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.393 -0.817 . . . . 1.0 109.373 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -60.95 -31.82 71.36 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.337 -0.852 . . . . 1.0 109.972 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 56.0 m -60.02 -42.11 93.63 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.855 -1.153 . . . . 1.0 109.446 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -69.92 -40.06 75.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.09 -1.006 . . . . 1.0 109.544 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 56.2 t -69.58 -40.07 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.232 -0.917 . . . . 1.0 110.001 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -59.73 -49.92 75.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.088 -1.008 . . . . 1.0 110.107 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -63.25 -31.54 72.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.976 -1.078 . . . . 1.0 109.958 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.01 -49.96 75.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.017 -1.052 . . . . 1.0 110.197 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.424 ' CE1' HD13 ' A' ' 62' ' ' ILE . 52.1 m-85 -67.66 -36.94 81.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.98 -1.075 . . . . 1.0 109.978 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -59.93 -41.07 90.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.987 -1.071 . . . . 1.0 109.721 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -62.2 -40.18 95.21 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.071 -1.018 . . . . 1.0 108.868 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.97 -45.89 91.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.511 -0.743 . . . . 1.0 110.139 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.508 ' CD1' ' CD1' ' A' ' 50' ' ' PHE . 63.4 m-85 -68.4 -40.06 81.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.963 -1.085 . . . . 1.0 110.02 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.402 ' O ' ' CG ' ' A' ' 44' ' ' ASP . 27.4 tptp -60.01 -47.54 85.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.122 -0.987 . . . . 1.0 109.665 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.5 t -60.01 -40.09 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.184 -0.948 . . . . 1.0 110.119 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -81.54 -35.46 30.27 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.876 -1.14 . . . . 1.0 109.985 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.5 p -71.64 -20.1 62.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.905 -1.122 . . . . 1.0 109.725 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.402 ' CG ' ' O ' ' A' ' 40' ' ' LYS . 95.3 m-20 -59.95 -39.89 87.12 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.246 -0.909 . . . . 1.0 111.048 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 m -109.52 20.25 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 O-C-N 121.191 -0.943 . . . . 1.0 110.797 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.3 p -147.93 140.38 14.6 Favored Pre-proline 0 N--CA 1.502 2.128 0 O-C-N 120.83 -1.169 . . . . 1.0 109.221 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -72.83 18.37 0.36 Allowed 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 120.716 0.944 . . . . 1.0 111.999 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 79.0 mt -68.1 137.12 54.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.122 -0.986 . . . . 1.0 109.916 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -111.46 120.75 43.19 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.885 -0.783 . . . . 1.0 108.885 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.508 ' CD1' ' CD1' ' A' ' 39' ' ' PHE . 92.4 m-85 -109.16 123.3 48.99 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.367 -0.833 . . . . 1.0 109.335 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.1 m -119.95 130.02 54.6 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.55 -0.718 . . . . 1.0 109.679 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -82.32 132.35 35.22 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.467 -0.77 . . . . 1.0 109.566 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.4 mt -104.96 131.16 52.83 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.326 -0.859 . . . . 1.0 108.819 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.462 ' O ' ' CZ ' ' A' ' 18' ' ' ARG . 42.2 m170 -61.73 -40.24 94.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.177 -0.952 . . . . 1.0 110.005 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 74.9 m-20 -151.74 176.33 11.5 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.112 -0.992 . . . . 1.0 109.924 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.87 -179.76 35.63 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.858 -1.297 . . . . 1.0 109.858 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 91.3 mt -93.51 130.44 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.366 -1.079 . . . . 1.0 109.583 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.46 164.52 12.62 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.971 -0.752 . . . . 1.0 108.971 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.87 -49.52 77.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.067 -1.021 . . . . 1.0 109.332 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.7 mt -111.81 109.63 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.506 -0.746 . . . . 1.0 109.534 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.5 ptm -106.46 132.0 53.0 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.328 -0.858 . . . . 1.0 109.481 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.424 HD13 ' CE1' ' A' ' 35' ' ' PHE . 86.1 mt -103.22 137.72 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.619 -0.675 . . . . 1.0 109.383 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.2 p -152.08 152.96 33.03 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.07 -1.019 . . . . 1.0 109.755 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -100.42 120.27 39.73 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.891 -0.781 . . . . 1.0 108.891 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -103.85 -170.6 25.37 Favored Glycine 0 N--CA 1.5 2.966 0 N-CA-C 110.773 -0.931 . . . . 1.0 110.773 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.528 HG22 ' N ' ' A' ' 67' ' ' LYS . 74.4 mt -137.16 165.37 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.569 -0.959 . . . . 1.0 109.111 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.528 ' N ' HG22 ' A' ' 66' ' ' ILE . 27.2 tptp -27.94 -80.55 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 120.99 0.424 . . . . 1.0 111.387 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.619 ' CD ' ' H ' ' A' ' 68' ' ' GLU . 0.9 OUTLIER -77.17 95.72 4.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.929 -1.107 . . . . 1.0 109.91 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.509 ' ND1' ' O ' ' A' ' 66' ' ' ILE . 6.1 p-80 -157.94 4.98 0.12 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.059 -1.026 . . . . 1.0 109.644 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -156.26 89.01 0.12 Allowed Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.122 -1.591 . . . . 1.0 109.122 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -60.05 -43.95 95.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.139 -1.213 . . . . 1.0 109.547 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -60.39 -39.96 89.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.148 -0.97 . . . . 1.0 109.012 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -128.75 79.98 73.47 Favored Pre-proline 0 N--CA 1.5 2.045 0 N-CA-C 109.075 -0.713 . . . . 1.0 109.075 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -76.55 149.77 30.94 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 C-N-CA 121.044 1.163 . . . . 1.0 112.085 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -94.84 168.41 10.82 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.249 -0.907 . . . . 1.0 109.609 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.5 p-10 -101.81 -0.07 34.85 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.331 -0.855 . . . . 1.0 111.127 -178.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 128.04 -149.16 18.04 Favored Glycine 0 N--CA 1.505 3.261 0 N-CA-C 109.381 -1.488 . . . . 1.0 109.381 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.425 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 3.5 Cg_exo -64.39 -64.36 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.501 0 CA-C-N 118.953 1.376 . . . . 1.0 112.114 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 77.0 p -75.9 158.67 31.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.12 -0.987 . . . . 1.0 109.039 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.26 -128.34 8.04 Favored Glycine 0 N--CA 1.501 3.012 0 N-CA-C 109.594 -1.402 . . . . 1.0 109.594 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.425 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 18.4 mt -67.28 106.35 2.02 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.389 -1.065 . . . . 1.0 109.555 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 46.3 mt -75.81 -23.63 55.83 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.919 -1.113 . . . . 1.0 109.063 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -177.68 173.89 1.56 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.635 -0.876 . . . . 1.0 108.635 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -161.08 165.75 29.18 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.175 -0.953 . . . . 1.0 109.177 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -155.3 159.15 39.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.388 -0.82 . . . . 1.0 109.162 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -99.05 153.9 37.57 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 121.097 -1.002 . . . . 1.0 108.499 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -62.75 160.39 33.11 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 120.847 1.031 . . . . 1.0 112.396 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -41.01 121.21 1.25 Allowed 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 121.806 1.67 . . . . 1.0 113.212 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.98 -169.23 26.11 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.816 -1.314 . . . . 1.0 109.816 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -58.94 -151.98 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.118 1.212 . . . . 1.0 111.622 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -60.33 -41.58 93.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.798 -1.189 . . . . 1.0 109.432 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -60.16 -41.49 92.88 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.296 -0.877 . . . . 1.0 109.858 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -80.02 169.09 52.74 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.32 -1.112 . . . . 1.0 110.32 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 70.19 5.08 52.66 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.985 -1.246 . . . . 1.0 109.985 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 43.0 p-10 -80.65 160.25 25.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.103 -1.234 . . . . 1.0 109.218 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.87 121.39 8.53 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.086 -1.009 . . . . 1.0 109.423 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -109.63 147.25 33.4 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.7 -0.625 . . . . 1.0 109.575 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -121.21 151.73 39.63 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.66 -0.867 . . . . 1.0 108.66 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.425 ' OD2' ' O ' ' A' ' 81' ' ' LEU . 88.7 m-20 -78.67 120.63 23.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.973 -1.079 . . . . 1.0 109.386 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -83.11 -10.44 58.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.318 -0.864 . . . . 1.0 109.334 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -83.08 -10.07 58.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.892 . . . . 1.0 109.471 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 97.8 mt-10 -91.63 168.19 11.67 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.308 -0.87 . . . . 1.0 109.618 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 8.2 m -97.73 106.48 18.79 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.335 -0.853 . . . . 1.0 109.007 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -89.13 121.17 31.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.429 -0.794 . . . . 1.0 108.887 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.607 HG21 ' HB2' ' A' ' 109' ' ' LYS . 6.1 t -140.31 152.55 45.94 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.325 -0.86 . . . . 1.0 110.103 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 69.8 m -95.03 -8.42 36.81 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.774 -0.824 . . . . 1.0 108.774 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 90.3 p -91.89 175.33 6.92 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.467 -0.771 . . . . 1.0 108.957 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.1 t -72.82 71.85 1.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.04 -1.038 . . . . 1.0 109.485 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.607 ' HB2' HG21 ' A' ' 105' ' ' THR . 43.7 mtpt -148.47 154.76 40.3 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.287 -0.883 . . . . 1.0 108.836 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 109' ' ' LYS . . . 40.83 -141.89 0.88 Allowed Glycine 0 N--CA 1.499 2.864 0 N-CA-C 110.473 -1.051 . . . . 1.0 110.473 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -99.53 119.55 38.22 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.336 -1.096 . . . . 1.0 108.962 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -64.08 130.39 43.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.157 -0.965 . . . . 1.0 109.623 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.9 tp -60.0 -43.45 95.17 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.436 -0.79 . . . . 1.0 110.814 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -59.84 -40.22 87.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.103 -0.998 . . . . 1.0 110.774 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -59.28 -51.35 70.32 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.845 -1.16 . . . . 1.0 109.197 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.6 t -69.99 -41.78 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.161 -0.962 . . . . 1.0 109.728 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.1 -51.76 68.36 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.032 -1.043 . . . . 1.0 109.264 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.59 -40.63 88.11 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.428 -0.795 . . . . 1.0 110.662 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -62.54 -49.17 76.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.204 -0.935 . . . . 1.0 111.022 -178.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -59.83 -38.8 83.05 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.619 -1.301 . . . . 1.0 109.701 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -59.85 -40.02 87.16 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.818 -1.176 . . . . 1.0 108.46 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -56.99 -40.44 91.16 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.576 -1.41 . . . . 1.0 109.576 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -67.36 -40.06 85.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.957 -1.319 . . . . 1.0 109.311 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 86.1 p -66.03 -26.09 67.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.131 -0.981 . . . . 1.0 109.056 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 83.2 mt -80.51 2.55 24.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.365 -0.834 . . . . 1.0 109.552 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 85.14 9.77 79.49 Favored Glycine 0 N--CA 1.494 2.562 0 C-N-CA 120.2 -1.0 . . . . 1.0 110.921 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 77.5 mt -87.05 141.06 28.94 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.712 -1.464 . . . . 1.0 109.673 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 30.8 t0 -98.98 173.01 7.04 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.432 -0.792 . . . . 1.0 109.263 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.507 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 66.9 m80 -60.08 132.69 54.71 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.272 -0.892 . . . . 1.0 109.821 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.6 t -100.26 156.03 17.45 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.812 -0.81 . . . . 1.0 108.812 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -98.28 6.29 47.52 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.1 -1.0 . . . . 1.0 109.514 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -86.16 125.27 68.67 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.15 -0.969 . . . . 1.0 108.476 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -67.26 -19.34 50.33 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 CA-C-N 120.226 1.116 . . . . 1.0 112.57 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -87.21 -8.03 75.78 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.88 -1.288 . . . . 1.0 109.88 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.6 145.65 25.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.04 -1.271 . . . . 1.0 109.443 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.437 ' C ' ' H ' ' A' ' 138' ' ' PHE . 95.0 mt -68.38 -31.19 70.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.23 -0.919 . . . . 1.0 109.39 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 96.4 mmm -71.22 17.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.427 -0.796 . . . . 1.0 110.743 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.437 ' H ' ' C ' ' A' ' 136' ' ' LEU . 12.5 t80 -70.01 130.17 90.12 Favored Pre-proline 0 N--CA 1.494 1.764 0 N-CA-C 107.901 -1.148 . . . . 1.0 107.901 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -68.13 4.96 1.29 Allowed 'Trans proline' 0 N--CA 1.505 2.173 0 C-N-CA 121.041 1.16 . . . . 1.0 114.623 -177.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.6 mt -119.63 134.37 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 O-C-N 120.984 -1.072 . . . . 1.0 108.446 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -71.74 130.8 42.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.022 -1.049 . . . . 1.0 109.666 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 15.0 t -145.11 144.98 31.22 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.56 -0.904 . . . . 1.0 108.56 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -80.8 147.68 30.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.99 -1.069 . . . . 1.0 109.912 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 19.3 m -137.77 145.14 42.04 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.481 -0.762 . . . . 1.0 110.008 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.17 97.16 0.57 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 107.646 -2.181 . . . . 1.0 107.646 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -73.97 5.1 4.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.379 -1.071 . . . . 1.0 109.805 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 70.0 m -60.05 -40.09 88.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.132 -0.98 . . . . 1.0 110.052 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -147.5 39.95 0.99 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.021 -1.05 . . . . 1.0 109.911 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -78.87 130.59 35.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.099 -1.001 . . . . 1.0 110.915 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 97.9 mmm -128.67 145.02 51.27 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.108 -1.071 . . . . 1.0 108.108 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 26.8 mt -50.26 129.43 24.11 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 120.841 -1.162 . . . . 1.0 108.981 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -71.97 179.44 4.85 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 CA-C-N 119.939 1.014 . . . . 1.0 112.084 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -61.42 -40.02 92.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.431 -0.793 . . . . 1.0 110.171 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -57.46 -45.11 85.13 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.185 -0.947 . . . . 1.0 110.353 -178.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -70.0 -39.9 75.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.804 -1.185 . . . . 1.0 109.49 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.5 t -59.75 -45.61 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.094 -1.004 . . . . 1.0 109.379 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -62.09 -40.07 94.59 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.945 -1.097 . . . . 1.0 110.016 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.4 -54.49 8.77 Favored Glycine 0 N--CA 1.494 2.523 0 C-N-CA 120.253 -0.975 . . . . 1.0 111.197 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.474 HG23 ' N ' ' A' ' 160' ' ' GLN . 8.8 tp -60.18 -40.33 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.934 -1.333 . . . . 1.0 109.644 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.553 ' O ' ' N ' ' A' ' 164' ' ' GLY . 92.1 mm-40 -65.15 -39.87 93.6 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.191 -0.943 . . . . 1.0 109.416 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 78.7 p -61.56 -28.62 69.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.085 -1.009 . . . . 1.0 110.279 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.4 mt -87.27 -52.58 5.31 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.94 -1.1 . . . . 1.0 110.477 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -90.81 -10.04 44.24 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.088 -1.007 . . . . 1.0 110.103 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.523 0 N-CA-C 109.348 -1.501 . . . . 1.0 109.348 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 169' ' ' WAY . . . . . 0.897 ' HC2' ' HJ ' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.18 -0.674 . . . . 1.0 109.18 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.1 mt -74.83 150.01 39.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.438 -0.789 . . . . 1.0 109.032 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -159.69 160.05 33.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.214 -0.929 . . . . 1.0 109.339 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -73.41 151.09 41.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.115 -0.991 . . . . 1.0 109.683 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.0 t -87.54 0.5 55.5 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.456 -0.777 . . . . 1.0 109.478 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -144.82 150.91 37.96 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.262 -0.899 . . . . 1.0 109.217 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.9 mmt -90.01 -0.1 57.4 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.357 -0.839 . . . . 1.0 109.952 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -98.2 131.02 44.91 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.266 -0.897 . . . . 1.0 108.896 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.9 mt -139.84 150.51 44.75 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.288 -0.882 . . . . 1.0 109.088 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 48.8 p -133.09 157.65 44.76 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.414 -0.804 . . . . 1.0 109.32 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -146.47 160.23 42.37 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.062 -1.024 . . . . 1.0 110.049 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.407 ' HE ' ' HA ' ' A' ' 55' ' ' ASP . 42.6 ttt-85 -144.32 133.29 22.68 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.381 -0.824 . . . . 1.0 109.429 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 84.9 mt -87.69 117.62 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.198 -0.939 . . . . 1.0 108.961 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.4 t -69.99 -39.97 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.16 -0.963 . . . . 1.0 109.767 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.534 HD21 ' H ' ' A' ' 64' ' ' PHE . 15.7 p30 -162.06 152.13 16.74 Favored 'General case' 0 C--N 1.292 -1.895 0 O-C-N 119.798 -1.814 . . . . 1.0 111.656 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -99.04 105.64 17.79 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 103.924 -2.621 . . . . 1.0 103.924 176.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.64 145.34 50.93 Favored Pre-proline 0 C--N 1.295 -1.8 0 O-C-N 121.127 -0.983 . . . . 1.0 110.532 -175.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -56.1 -14.14 10.95 Favored 'Trans proline' 0 N--CA 1.486 1.078 0 C-N-CA 120.668 0.912 . . . . 1.0 110.865 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -59.79 -39.2 84.16 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.523 -0.871 . . . . 1.0 109.708 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.7 mtm -139.66 156.18 46.98 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.211 -0.931 . . . . 1.0 109.496 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 82.5 p -75.6 163.88 26.88 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.423 -0.798 . . . . 1.0 109.681 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 -59.97 -39.03 84.27 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.542 -0.724 . . . . 1.0 110.079 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.4 m -60.02 -45.27 93.34 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.854 -1.154 . . . . 1.0 109.696 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -69.99 -40.2 75.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.136 -0.978 . . . . 1.0 109.846 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 77.6 t -68.48 -44.59 83.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.275 -0.891 . . . . 1.0 109.989 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -59.87 -48.54 81.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.052 -1.03 . . . . 1.0 111.033 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -61.11 -34.65 75.3 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.632 -1.292 . . . . 1.0 110.223 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.2 -48.66 80.81 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.868 -1.145 . . . . 1.0 109.619 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.404 ' CE1' HD13 ' A' ' 62' ' ' ILE . 53.1 m-85 -66.47 -37.81 85.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.074 -1.016 . . . . 1.0 109.523 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.06 -40.82 90.8 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.899 -1.126 . . . . 1.0 109.307 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -60.11 -42.74 95.36 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.941 -1.099 . . . . 1.0 108.27 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.0 -48.47 81.56 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.427 -0.796 . . . . 1.0 109.599 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -65.62 -39.01 91.04 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.01 -1.056 . . . . 1.0 109.852 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -59.4 -47.19 86.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.1 -1.0 . . . . 1.0 109.728 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.4 t -61.37 -41.34 89.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.216 -0.928 . . . . 1.0 110.303 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -77.99 -36.89 48.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.067 -1.021 . . . . 1.0 109.809 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 86.7 p -71.22 -15.5 62.46 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.506 -0.746 . . . . 1.0 109.634 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -59.19 -40.07 84.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.3 -0.875 . . . . 1.0 109.909 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.9 m -112.94 -21.79 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.301 -0.874 . . . . 1.0 110.874 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.1 p -91.4 128.32 47.38 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 120.697 -1.252 . . . . 1.0 110.268 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -75.81 15.67 0.87 Allowed 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 120.855 1.037 . . . . 1.0 111.471 179.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 79.1 mt -69.16 140.62 54.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.335 -0.853 . . . . 1.0 109.55 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -106.11 121.04 43.34 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -106.93 123.18 47.81 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.303 -0.873 . . . . 1.0 109.194 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -120.0 130.24 54.64 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.589 -0.694 . . . . 1.0 109.728 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -82.09 135.85 35.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.185 -0.947 . . . . 1.0 109.073 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 84.7 mt -103.67 129.68 51.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.317 -0.864 . . . . 1.0 108.837 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.43 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 18.5 m170 -61.3 -40.01 92.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 1.0 109.869 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 75.1 m-20 -149.11 169.86 19.73 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.188 -0.945 . . . . 1.0 109.809 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.0 -178.03 34.42 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.726 -1.35 . . . . 1.0 109.726 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.2 mt -93.87 139.13 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.269 -1.136 . . . . 1.0 109.3 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.35 169.23 9.1 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.517 -0.739 . . . . 1.0 109.439 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -59.99 -48.42 81.78 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.27 -0.894 . . . . 1.0 109.147 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.0 mt -119.92 112.34 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.503 -0.748 . . . . 1.0 109.401 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.7 ptm -103.58 133.81 47.98 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.306 -0.871 . . . . 1.0 108.9 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.404 HD13 ' CE1' ' A' ' 35' ' ' PHE . 84.6 mt -107.54 133.83 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.568 -0.707 . . . . 1.0 109.394 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 76.6 p -151.74 157.57 42.19 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.072 -1.017 . . . . 1.0 109.988 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.534 ' H ' HD21 ' A' ' 21' ' ' ASN . 73.7 m-85 -110.02 121.72 45.91 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.823 -0.806 . . . . 1.0 108.823 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -114.24 -167.23 15.93 Favored Glycine 0 N--CA 1.501 2.977 0 N-CA-C 110.289 -1.124 . . . . 1.0 110.289 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.563 ' O ' ' C ' ' A' ' 67' ' ' LYS . 96.9 mt -134.95 159.07 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.653 -0.91 . . . . 1.0 108.594 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.563 ' C ' ' O ' ' A' ' 66' ' ' ILE . 50.0 tptt -1.18 -93.24 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.757 0 C-N-CA 123.004 0.522 . . . . 1.0 111.806 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -80.41 130.63 35.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.927 -1.108 . . . . 1.0 109.854 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.541 ' NE2' ' OD2' ' A' ' 71' ' ' ASP . 35.1 p-80 -139.95 24.85 2.35 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.064 -1.022 . . . . 1.0 109.622 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.415 ' O ' ' OD1' ' A' ' 71' ' ' ASP . . . 82.98 44.49 7.1 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 120.218 -0.991 . . . . 1.0 110.942 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.541 ' OD2' ' NE2' ' A' ' 69' ' ' HIS . 88.2 m-20 -139.17 150.31 45.45 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.157 -1.202 . . . . 1.0 109.197 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.445 ' CD1' ' O ' ' A' ' 72' ' ' PHE . 60.1 t80 -69.15 -16.53 63.67 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.342 -0.848 . . . . 1.0 110.125 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -121.83 81.45 41.83 Favored Pre-proline 0 N--CA 1.505 2.316 0 O-C-N 121.303 -0.873 . . . . 1.0 110.06 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.36 179.98 2.19 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 120.671 0.914 . . . . 1.0 112.175 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.544 ' CD1' ' OD1' ' A' ' 99' ' ' ASP . 96.3 m-85 -89.49 170.44 10.51 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.366 -0.834 . . . . 1.0 108.894 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.1 p-10 -100.26 0.56 40.51 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.911 -1.118 . . . . 1.0 110.81 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 129.85 -146.15 17.11 Favored Glycine 0 N--CA 1.502 3.091 0 N-CA-C 108.663 -1.775 . . . . 1.0 108.663 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.426 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 5.7 Cg_exo -65.54 -63.4 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.331 0 CA-C-N 119.314 1.557 . . . . 1.0 111.63 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 84.4 p -78.58 161.1 27.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.206 -0.934 . . . . 1.0 110.001 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.47 -133.06 10.85 Favored Glycine 0 N--CA 1.502 3.047 0 N-CA-C 109.916 -1.273 . . . . 1.0 109.916 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.7 mt -65.56 107.92 1.86 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.345 -1.091 . . . . 1.0 108.287 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 50.9 mt -75.65 -29.95 59.28 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.113 -0.992 . . . . 1.0 109.123 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -177.07 168.6 2.4 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -160.63 162.39 32.73 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.18 -0.95 . . . . 1.0 109.6 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' A' ' 95' ' ' ASP . . . -146.25 158.67 43.9 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.256 -0.903 . . . . 1.0 109.511 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -101.78 151.98 38.03 Favored Pre-proline 0 N--CA 1.498 1.963 0 N-CA-C 108.469 -0.937 . . . . 1.0 108.469 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -63.68 165.36 18.46 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 120.535 0.823 . . . . 1.0 111.93 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -47.27 122.35 6.4 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 121.035 1.157 . . . . 1.0 111.753 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 90' ' ' PRO . . . -160.76 -170.74 25.77 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.778 -1.329 . . . . 1.0 109.778 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 89' ' ' GLY . 28.1 Cg_exo -54.53 -144.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.56 1.507 . . . . 1.0 113.311 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -61.26 -42.2 98.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.464 -0.772 . . . . 1.0 110.698 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -73.43 -27.76 61.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.9 -1.125 . . . . 1.0 110.168 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.63 171.03 50.38 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.278 -1.529 . . . . 1.0 109.278 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 55.14 71.1 0.77 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.704 -1.358 . . . . 1.0 109.704 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.4 ' O ' ' HB1' ' A' ' 85' ' ' ALA . 48.7 p-10 -153.74 162.34 41.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.349 -1.089 . . . . 1.0 109.282 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.15 118.84 7.0 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.225 -0.922 . . . . 1.0 110.126 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -104.12 136.02 44.52 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.505 -0.747 . . . . 1.0 109.845 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.44 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 19.4 m-85 -116.15 142.51 46.72 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.745 -0.835 . . . . 1.0 108.745 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.544 ' OD1' ' CD1' ' A' ' 75' ' ' PHE . 93.4 m-20 -79.22 124.09 28.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.935 -1.103 . . . . 1.0 109.523 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 48.3 t0 -84.32 -0.02 50.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.323 -0.861 . . . . 1.0 109.662 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -79.62 -16.39 55.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.022 -1.049 . . . . 1.0 110.157 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' A' ' 102' ' ' GLU . 56.1 mp0 -93.53 171.17 9.06 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.177 -0.952 . . . . 1.0 109.128 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 13.7 m -99.48 108.57 21.05 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.352 -0.981 . . . . 1.0 108.352 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -85.84 127.57 34.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 1.0 109.368 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.451 ' CG2' ' O ' ' A' ' 109' ' ' LYS . 1.8 t -139.86 153.11 46.95 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.428 -0.795 . . . . 1.0 109.638 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.5 t -98.69 -4.28 34.03 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.418 -0.801 . . . . 1.0 108.972 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 53.1 m -89.65 -116.47 0.06 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.327 -0.858 . . . . 1.0 109.626 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.8 p -141.84 64.58 1.39 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.134 -0.979 . . . . 1.0 110.147 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.451 ' O ' ' CG2' ' A' ' 105' ' ' THR . 98.7 mttt -144.87 155.29 43.38 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.09 -1.006 . . . . 1.0 108.848 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 49.97 -138.62 20.3 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.485 -1.446 . . . . 1.0 109.485 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -99.55 118.96 37.25 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.241 -1.152 . . . . 1.0 109.337 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -62.24 127.48 31.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.296 -0.878 . . . . 1.0 109.927 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.7 tp -59.98 -40.29 88.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.3 -0.875 . . . . 1.0 110.237 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -59.89 -40.96 90.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.237 -0.915 . . . . 1.0 110.233 -178.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.431 HD21 ' HZ1' ' A' ' 146' ' ' LYS . 3.0 mm? -60.76 -51.31 69.88 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.511 -1.368 . . . . 1.0 110.173 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.1 t -68.96 -43.77 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -0.889 . . . . 1.0 110.296 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.5 -52.24 66.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.074 -1.016 . . . . 1.0 109.739 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.23 -39.62 87.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.875 . . . . 1.0 110.374 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -62.04 -50.01 73.73 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.366 -0.834 . . . . 1.0 111.481 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.44 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 9.5 pt-20 -59.6 -39.77 85.26 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.842 -1.161 . . . . 1.0 109.943 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -60.39 -39.8 88.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.955 -1.091 . . . . 1.0 108.738 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.76 -43.29 86.79 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.162 -1.575 . . . . 1.0 109.162 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -67.53 -39.91 85.04 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.221 -1.164 . . . . 1.0 109.864 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 72.3 p -66.72 -21.61 66.07 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.134 -0.979 . . . . 1.0 109.463 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 77.1 mt -81.67 -0.73 44.01 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.457 -0.777 . . . . 1.0 109.484 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.82 6.96 66.85 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 110.902 -0.879 . . . . 1.0 110.902 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.5 mt -86.84 149.51 24.78 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.815 -1.403 . . . . 1.0 109.733 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 36.3 t0 -100.78 173.9 6.3 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.546 -0.721 . . . . 1.0 109.056 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.482 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 76.3 m80 -58.06 137.78 56.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.079 -1.013 . . . . 1.0 109.069 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 41.1 t -98.35 151.12 20.87 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.383 -0.823 . . . . 1.0 109.719 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -97.65 1.54 48.81 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.329 -0.857 . . . . 1.0 109.487 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -87.04 128.88 54.12 Favored Pre-proline 0 N--CA 1.489 1.487 0 N-CA-C 108.217 -1.031 . . . . 1.0 108.217 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -69.08 -11.04 30.76 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 CA-C-N 120.128 1.081 . . . . 1.0 112.059 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -93.43 -8.87 60.79 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.425 -1.47 . . . . 1.0 109.425 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.54 136.28 33.87 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.4 -1.059 . . . . 1.0 109.195 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.439 ' C ' ' H ' ' A' ' 138' ' ' PHE . 89.8 mt -60.84 -37.15 81.07 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.027 -1.046 . . . . 1.0 109.638 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 72.8 mtp -70.06 21.42 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.473 -0.767 . . . . 1.0 111.361 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.439 ' H ' ' C ' ' A' ' 136' ' ' LEU . 12.1 t80 -67.69 132.68 92.58 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 120.941 -1.099 . . . . 1.0 108.089 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -62.2 -2.07 2.82 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 CA-C-N 119.851 0.982 . . . . 1.0 114.56 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 95.7 mt -118.46 140.61 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.683 0 O-C-N 120.831 -1.168 . . . . 1.0 110.081 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -75.84 126.49 31.11 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.544 -0.723 . . . . 1.0 110.528 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 14.3 t -144.43 141.88 29.93 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.327 -0.858 . . . . 1.0 109.502 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -80.68 149.63 29.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.094 -1.004 . . . . 1.0 109.571 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.558 ' H ' ' NZ ' ' A' ' 146' ' ' LYS . 3.9 m -146.19 162.49 37.9 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.232 -0.918 . . . . 1.0 109.761 -178.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.439 ' N ' ' CG2' ' A' ' 144' ' ' THR . . . -84.88 103.17 2.64 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.134 -1.586 . . . . 1.0 109.134 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.558 ' NZ ' ' H ' ' A' ' 144' ' ' THR . 9.8 mptt -77.7 3.42 14.05 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.206 -1.173 . . . . 1.0 109.74 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 18.5 t -59.97 -47.56 85.3 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.464 -0.772 . . . . 1.0 109.793 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -133.65 19.12 3.89 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.267 -0.896 . . . . 1.0 110.097 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -65.35 139.84 58.61 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.901 -1.124 . . . . 1.0 110.416 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 76.6 mtm -138.04 149.69 46.26 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.284 -1.006 . . . . 1.0 108.284 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.1 mt -53.07 128.63 48.22 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.819 -1.176 . . . . 1.0 108.882 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.37 175.55 5.79 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 CA-C-N 120.201 1.107 . . . . 1.0 112.334 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -60.06 -39.69 86.89 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.529 -0.732 . . . . 1.0 109.968 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -56.65 -48.43 77.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.264 -0.897 . . . . 1.0 110.107 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -70.15 -40.03 75.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.137 -0.977 . . . . 1.0 109.677 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 76.7 t -63.09 -48.47 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.097 -1.002 . . . . 1.0 109.661 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -60.32 -40.24 89.91 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.904 -1.123 . . . . 1.0 110.298 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.67 -54.55 8.38 Favored Glycine 0 N--CA 1.496 2.659 0 O-C-N 121.168 -0.958 . . . . 1.0 111.41 -178.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.454 HG23 ' N ' ' A' ' 160' ' ' GLN . 6.3 tp -60.94 -40.22 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.813 -1.404 . . . . 1.0 109.59 -179.071 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.2 mm-40 -65.27 -39.71 92.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.16 -0.963 . . . . 1.0 109.434 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 83.9 p -66.68 -26.62 67.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.231 -0.918 . . . . 1.0 110.265 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 84.9 mt -87.0 -50.85 6.38 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.954 -1.091 . . . . 1.0 110.202 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -91.47 -9.19 45.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.104 -0.998 . . . . 1.0 110.286 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.492 2.429 0 N-CA-C 109.549 -1.42 . . . . 1.0 109.549 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 169' ' ' WAY . . . . . 0.512 ' CJ ' ' HE3' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.6 m . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.549 -0.537 . . . . 1.0 109.549 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.2 mt -67.19 140.11 57.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.91 . . . . 1.0 109.233 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -160.6 160.4 31.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 1.0 109.016 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -72.25 151.67 42.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.101 -0.999 . . . . 1.0 109.214 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 82.8 p -86.51 1.92 49.82 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.243 -0.91 . . . . 1.0 110.487 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -149.63 154.59 38.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.082 -1.011 . . . . 1.0 109.342 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.504 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.02 0.96 56.83 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.219 -0.925 . . . . 1.0 109.88 -179.529 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -95.85 127.69 42.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.107 -0.996 . . . . 1.0 108.687 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.6 mt -141.36 151.0 43.18 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.154 -0.966 . . . . 1.0 109.256 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.3 p -132.11 155.58 47.87 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.439 -0.788 . . . . 1.0 109.088 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -144.02 159.98 41.66 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.163 -0.96 . . . . 1.0 109.934 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.535 HH12 ' C ' ' A' ' 53' ' ' LEU . 25.2 ttm-85 -145.87 136.09 23.83 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.533 -0.729 . . . . 1.0 109.906 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 87.4 mt -88.81 113.93 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 108.339 -0.985 . . . . 1.0 108.339 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.66 -40.27 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.104 -0.997 . . . . 1.0 109.094 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -161.9 160.98 28.6 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.856 -1.152 . . . . 1.0 110.473 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.557 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 62.8 m-85 -101.95 -168.05 1.49 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.607 -1.257 . . . . 1.0 107.607 179.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.22 149.02 50.83 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.165 -0.959 . . . . 1.0 110.131 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -70.63 -12.03 30.62 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 120.827 1.018 . . . . 1.0 110.148 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -59.62 -39.96 85.99 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 115.334 -0.848 . . . . 1.0 110.531 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.9 mtm -139.99 169.93 16.8 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.163 -0.96 . . . . 1.0 109.634 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 78.8 p -73.15 160.05 32.57 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.137 -0.977 . . . . 1.0 109.472 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.557 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 1.8 m80 -60.16 -39.79 87.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.52 -0.738 . . . . 1.0 110.344 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.1 m -59.97 -39.9 87.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.08 -1.012 . . . . 1.0 109.549 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -62.47 -46.57 87.88 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.099 -1.001 . . . . 1.0 110.31 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.2 t -66.32 -39.92 85.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.401 -0.812 . . . . 1.0 109.804 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -54.44 -57.08 12.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.276 -0.89 . . . . 1.0 111.221 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.8 pttt -62.32 -32.17 72.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.683 -1.261 . . . . 1.0 110.439 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.34 -49.95 70.9 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.887 -1.133 . . . . 1.0 109.687 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -65.17 -39.67 93.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.027 -1.046 . . . . 1.0 109.759 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.15 -40.22 89.12 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.062 -1.024 . . . . 1.0 109.485 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -60.06 -43.45 95.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.979 -1.076 . . . . 1.0 108.845 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.21 -47.33 84.91 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.471 -0.768 . . . . 1.0 110.39 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.429 ' CZ ' ' CZ ' ' A' ' 121' ' ' PHE . 43.0 m-85 -63.32 -40.25 96.79 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.816 -1.178 . . . . 1.0 109.767 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -60.01 -44.43 94.57 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.163 -0.961 . . . . 1.0 110.043 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.8 t -60.11 -41.88 88.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.292 -0.88 . . . . 1.0 110.26 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -79.68 -37.49 35.72 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.157 -0.964 . . . . 1.0 111.162 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.3 p -69.85 -17.58 63.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.889 -1.132 . . . . 1.0 109.664 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.77 -40.14 91.41 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.546 -0.721 . . . . 1.0 110.833 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.8 m -118.65 35.3 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.257 -0.902 . . . . 1.0 110.69 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.6 p -151.12 134.62 9.08 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 120.917 -1.114 . . . . 1.0 109.925 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -73.39 10.64 1.17 Allowed 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 120.809 1.006 . . . . 1.0 111.908 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.0 mt -68.93 136.85 53.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.001 -1.062 . . . . 1.0 110.02 -179.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -107.21 120.76 42.99 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.501 -0.926 . . . . 1.0 108.501 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -108.25 124.57 50.51 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.309 -0.869 . . . . 1.0 109.599 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -120.37 130.02 54.21 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.56 -0.712 . . . . 1.0 110.088 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -81.37 130.03 34.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.235 -0.916 . . . . 1.0 109.288 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.535 ' C ' HH12 ' A' ' 18' ' ' ARG . 85.1 mt -106.04 139.94 39.8 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.391 -0.818 . . . . 1.0 108.942 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.444 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 41.3 m170 -95.33 -14.35 23.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.254 -0.904 . . . . 1.0 109.704 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 77.2 m-20 -149.66 160.28 43.64 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.309 -0.869 . . . . 1.0 109.865 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.535 ' O ' ' NE ' ' A' ' 18' ' ' ARG . . . 88.12 179.6 47.06 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.751 -1.34 . . . . 1.0 109.751 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.6 mt -97.36 139.77 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.322 -1.105 . . . . 1.0 109.514 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.04 155.75 22.3 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.478 -0.763 . . . . 1.0 109.16 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -59.92 -49.83 76.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.113 -0.992 . . . . 1.0 109.257 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.7 mt -103.91 99.85 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.405 -0.809 . . . . 1.0 109.786 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.5 ptp -99.8 138.94 36.18 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.161 -0.962 . . . . 1.0 109.166 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.2 mt -110.19 132.15 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.999 -0.741 . . . . 1.0 108.999 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 71.5 p -149.3 149.91 31.68 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.896 -1.127 . . . . 1.0 109.879 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -101.98 123.45 45.91 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.727 -0.842 . . . . 1.0 108.727 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.73 -165.96 22.51 Favored Glycine 0 N--CA 1.499 2.838 0 N-CA-C 110.107 -1.197 . . . . 1.0 110.107 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.531 HG22 ' N ' ' A' ' 67' ' ' LYS . 71.8 mt -133.17 166.47 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.671 -0.899 . . . . 1.0 108.822 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.531 ' N ' HG22 ' A' ' 66' ' ' ILE . 19.9 tptm -28.8 -82.47 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 CA-C-O 120.999 0.428 . . . . 1.0 111.539 -179.09 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.406 ' HG2' ' H ' ' A' ' 68' ' ' GLU . 15.7 pt-20 -76.64 128.87 35.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.927 -1.108 . . . . 1.0 110.125 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.611 ' CE1' ' CE2' ' A' ' 75' ' ' PHE . 51.5 p-80 -160.0 169.19 23.96 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.291 -0.88 . . . . 1.0 108.96 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -57.51 94.66 0.04 OUTLIER Glycine 0 N--CA 1.492 2.378 0 C-N-CA 120.031 -1.08 . . . . 1.0 110.44 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.484 ' OD1' ' CD1' ' A' ' 73' ' ' TYR . 55.9 t0 -171.38 140.29 1.41 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.239 -1.154 . . . . 1.0 109.304 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.513 ' CZ ' ' CD1' ' A' ' 73' ' ' TYR . 54.0 p90 -70.44 -19.98 62.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.037 -1.039 . . . . 1.0 109.71 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.559 ' O ' ' CG ' ' A' ' 73' ' ' TYR . 8.0 p90 -129.91 76.82 77.69 Favored Pre-proline 0 N--CA 1.501 2.117 0 O-C-N 121.408 -0.808 . . . . 1.0 109.142 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -53.67 -170.02 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 120.957 1.105 . . . . 1.0 112.56 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.611 ' CE2' ' CE1' ' A' ' 69' ' ' HIS . 89.2 m-85 -87.17 168.09 13.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 1.0 108.609 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -105.18 20.01 19.61 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.319 -0.863 . . . . 1.0 110.811 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 112.37 -156.71 15.41 Favored Glycine 0 N--CA 1.504 3.222 0 N-CA-C 109.149 -1.58 . . . . 1.0 109.149 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -57.41 -68.25 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.49 0 CA-C-N 118.657 1.228 . . . . 1.0 112.423 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 84.9 p -76.36 162.86 27.53 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.326 -0.859 . . . . 1.0 109.982 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.78 -129.16 8.37 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 109.734 -1.346 . . . . 1.0 109.734 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.0 mt -69.12 107.71 3.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.44 -1.035 . . . . 1.0 109.123 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 60.1 mt -78.92 -22.4 45.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.894 -1.129 . . . . 1.0 109.016 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -177.49 173.03 1.73 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.755 -0.831 . . . . 1.0 108.755 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.571 ' CE1' ' ND1' ' A' ' 97' ' ' HIS . 19.8 p80 -161.56 162.2 30.11 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.047 -1.033 . . . . 1.0 109.652 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.4 155.13 40.85 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.745 -0.835 . . . . 1.0 108.745 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -93.44 151.67 40.4 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.176 -0.952 . . . . 1.0 108.559 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.491 ' O ' ' N ' ' A' ' 89' ' ' GLY . 2.8 Cg_exo -50.0 169.38 0.14 Allowed 'Trans proline' 0 N--CA 1.488 1.176 0 CA-C-N 119.189 0.746 . . . . 1.0 111.295 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.69 75.37 0.06 OUTLIER 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 120.661 0.908 . . . . 1.0 111.849 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -93.01 -174.0 40.85 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.241 -1.544 . . . . 1.0 109.241 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 89' ' ' GLY . 14.3 Cg_exo -54.91 -144.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 121.452 1.435 . . . . 1.0 113.089 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -60.02 -39.88 87.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.478 -0.764 . . . . 1.0 109.551 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -68.35 -39.7 81.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.274 -0.891 . . . . 1.0 109.947 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -68.07 169.87 38.49 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.567 -1.013 . . . . 1.0 110.567 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.73 6.75 87.19 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.346 -1.501 . . . . 1.0 109.346 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -80.19 170.01 17.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.215 -1.167 . . . . 1.0 109.895 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.08 122.75 10.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.267 -0.896 . . . . 1.0 109.428 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.571 ' ND1' ' CE1' ' A' ' 84' ' ' HIS . 46.1 m170 -105.31 136.36 44.99 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.652 -0.655 . . . . 1.0 109.853 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -120.23 145.0 47.44 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.896 -0.779 . . . . 1.0 108.896 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.551 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 82.9 m-20 -78.56 121.75 25.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.034 -1.041 . . . . 1.0 109.856 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 37.8 t0 -85.63 -7.36 58.88 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.905 -0.776 . . . . 1.0 108.905 179.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -82.39 -12.56 57.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.432 -0.793 . . . . 1.0 109.197 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -91.1 170.56 9.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.378 -0.826 . . . . 1.0 109.291 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.9 m -101.29 105.37 16.45 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.382 -0.824 . . . . 1.0 109.097 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.426 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 88.2 m95 -88.41 123.77 33.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.342 -0.849 . . . . 1.0 109.057 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.669 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.1 t -140.52 157.67 45.14 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.331 -0.856 . . . . 1.0 110.198 -179.244 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 53.4 m -96.1 -9.18 31.4 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.181 -1.044 . . . . 1.0 108.181 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 72.4 m -92.35 171.58 8.96 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.58 -0.896 . . . . 1.0 108.58 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.6 t -72.09 76.19 0.95 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.07 -1.018 . . . . 1.0 109.928 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.669 ' HB2' HG21 ' A' ' 105' ' ' THR . 64.2 mttp -149.53 150.29 32.06 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.204 -0.935 . . . . 1.0 108.982 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.07 -137.46 4.91 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.702 -1.359 . . . . 1.0 109.702 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -102.68 117.57 34.95 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.436 -1.038 . . . . 1.0 109.405 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.621 HD21 ' N ' ' A' ' 113' ' ' LEU . 0.7 OUTLIER -64.2 130.09 42.52 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.22 -0.925 . . . . 1.0 109.583 179.768 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.621 ' N ' HD21 ' A' ' 112' ' ' ASN . 59.2 tp -60.13 -40.56 90.19 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.41 -0.806 . . . . 1.0 110.94 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -58.71 -40.13 82.79 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.793 -1.192 . . . . 1.0 110.346 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -58.68 -59.92 4.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.944 -1.097 . . . . 1.0 109.749 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 86.9 t -62.99 -42.13 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.53 -0.732 . . . . 1.0 110.216 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.69 -49.99 75.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.119 -0.988 . . . . 1.0 109.403 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.99 -39.69 86.59 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.918 -1.114 . . . . 1.0 109.803 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.518 ' CD2' ' HB1' ' A' ' 169' ' ' WAY . 68.4 t60 -65.08 -48.55 73.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.347 -0.846 . . . . 1.0 111.946 -178.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.506 ' OE2' ' CD1' ' A' ' 121' ' ' PHE . 1.1 pp20? -59.13 -40.05 84.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.535 -1.353 . . . . 1.0 109.281 -178.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.506 ' CD1' ' OE2' ' A' ' 120' ' ' GLU . 28.4 m-85 -60.04 -39.87 87.42 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.857 -1.152 . . . . 1.0 109.175 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.76 -45.36 85.81 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.843 -1.303 . . . . 1.0 109.843 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -64.89 -40.06 94.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.004 -1.292 . . . . 1.0 109.645 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 82.2 p -63.78 -23.48 67.38 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.251 -0.906 . . . . 1.0 109.421 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.6 mt -84.16 -1.09 54.42 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.046 -1.034 . . . . 1.0 109.876 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.48 10.83 63.18 Favored Glycine 0 N--CA 1.496 2.698 0 C-N-CA 120.025 -1.084 . . . . 1.0 110.747 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 77.9 mt -84.65 144.0 28.87 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.888 -1.36 . . . . 1.0 109.944 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 11.6 t70 -99.15 170.1 8.93 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.302 -0.874 . . . . 1.0 109.029 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.493 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 65.7 m80 -60.0 137.35 58.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.153 -0.967 . . . . 1.0 110.154 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 28.6 t -100.62 154.15 18.82 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -97.98 5.72 48.5 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.096 -1.003 . . . . 1.0 109.911 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -86.98 129.48 51.93 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.066 -1.021 . . . . 1.0 108.66 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -66.4 -24.0 50.38 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 CA-C-N 120.188 1.103 . . . . 1.0 112.406 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -86.15 -5.09 83.47 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.012 -1.235 . . . . 1.0 110.012 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.59 144.48 27.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.933 -1.334 . . . . 1.0 108.731 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.433 ' C ' ' H ' ' A' ' 138' ' ' PHE . 88.4 mt -68.99 -33.22 73.33 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.307 -0.871 . . . . 1.0 109.181 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 96.3 mmm -71.58 19.87 0.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.462 -0.774 . . . . 1.0 110.771 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.433 ' H ' ' C ' ' A' ' 136' ' ' LEU . 12.0 t80 -69.16 132.34 90.1 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 120.826 -1.171 . . . . 1.0 108.532 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -64.53 -3.65 6.92 Favored 'Trans proline' 0 N--CA 1.501 1.926 0 CA-C-N 119.888 0.996 . . . . 1.0 113.936 -178.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.0 mt -118.67 141.11 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 O-C-N 121.012 -1.055 . . . . 1.0 109.104 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.497 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 38.3 t80 -74.73 130.63 39.82 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.489 -0.757 . . . . 1.0 110.252 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.8 t -140.63 142.48 35.0 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.431 -0.951 . . . . 1.0 108.431 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -79.8 144.17 33.77 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.918 -1.114 . . . . 1.0 110.074 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.4 m -130.42 140.03 50.58 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.04 -0.726 . . . . 1.0 109.04 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.41 113.92 3.98 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 107.655 -2.178 . . . . 1.0 107.655 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm -73.25 98.77 2.72 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.063 -1.257 . . . . 1.0 109.297 -178.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.9 m -159.72 104.75 1.58 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.301 -0.875 . . . . 1.0 108.846 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 72.9 m80 50.1 40.57 21.97 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.408 -0.807 . . . . 1.0 109.399 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -85.19 129.96 34.7 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.16 -0.963 . . . . 1.0 109.393 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 66.9 mtt -124.28 149.06 46.93 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.981 -0.748 . . . . 1.0 108.981 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 29.1 mt -51.84 131.54 38.42 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.099 -1.001 . . . . 1.0 108.408 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -66.14 174.41 6.0 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 CA-C-N 119.992 1.033 . . . . 1.0 112.32 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -60.08 -39.65 86.81 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.429 -0.794 . . . . 1.0 110.152 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -57.16 -49.67 75.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.135 -0.978 . . . . 1.0 109.809 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.01 -40.19 75.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.088 -1.008 . . . . 1.0 110.516 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 67.5 t -60.74 -45.72 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.949 -1.094 . . . . 1.0 108.989 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -60.17 -39.92 88.13 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.137 -0.977 . . . . 1.0 110.398 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -69.54 -52.45 21.09 Favored Glycine 0 N--CA 1.494 2.546 0 O-C-N 121.145 -0.972 . . . . 1.0 111.504 -178.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.455 HG23 ' N ' ' A' ' 160' ' ' GLN . 5.3 tp -62.25 -40.01 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.754 -1.439 . . . . 1.0 109.661 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.8 mt-30 -65.01 -38.99 92.74 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.246 -0.909 . . . . 1.0 109.628 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 79.5 p -69.26 -22.25 63.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.174 -0.953 . . . . 1.0 110.174 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 88.8 mt -88.24 -50.68 6.2 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.888 -1.132 . . . . 1.0 110.065 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -93.53 -9.32 38.67 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.034 -1.041 . . . . 1.0 109.67 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.509 0 N-CA-C 109.473 -1.451 . . . . 1.0 109.473 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 169' ' ' WAY . . . . . 0.518 ' HB1' ' CD2' ' A' ' 119' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.8 m . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.237 0.542 . . . . 1.0 109.614 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.4 mt -76.55 138.36 40.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.252 -0.905 . . . . 1.0 109.582 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.55 ' HB3' ' HZ3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -161.41 159.82 28.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.149 -0.969 . . . . 1.0 109.56 179.502 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -76.23 152.6 36.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 1.0 109.407 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 99.0 p -87.51 0.03 56.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.361 -0.837 . . . . 1.0 109.809 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -148.57 154.59 39.96 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.154 -0.966 . . . . 1.0 109.686 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.567 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.49 -0.03 57.5 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.377 -0.827 . . . . 1.0 110.222 -179.577 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -96.6 122.38 39.46 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.181 -0.949 . . . . 1.0 108.863 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 71.8 mt -138.85 149.08 44.49 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.471 -0.768 . . . . 1.0 108.98 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.3 p -131.67 160.01 36.68 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.703 -0.851 . . . . 1.0 108.703 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -142.89 161.19 38.77 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.13 -0.981 . . . . 1.0 110.435 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -142.63 129.75 20.85 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.137 -0.69 . . . . 1.0 109.137 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.7 mt -88.13 118.25 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.182 -0.949 . . . . 1.0 108.908 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.67 -39.53 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.218 -0.926 . . . . 1.0 109.505 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.46 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 21.4 p-10 -162.47 155.5 19.94 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.212 -1.555 . . . . 1.0 111.366 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.482 ' O ' ' O ' ' A' ' 23' ' ' THR . 19.3 m-85 -104.96 75.73 1.2 Allowed 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 106.358 -1.719 . . . . 1.0 106.358 176.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.482 ' O ' ' O ' ' A' ' 22' ' ' TYR . 3.0 t -23.45 144.71 0.02 OUTLIER Pre-proline 0 N--CA 1.512 2.636 0 C-N-CA 122.83 0.452 . . . . 1.0 111.744 -177.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -63.94 -4.74 7.92 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 121.631 1.554 . . . . 1.0 112.915 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -59.09 -36.84 75.82 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.442 -0.786 . . . . 1.0 109.557 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 76.8 mtm -138.47 164.17 30.08 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.298 -0.876 . . . . 1.0 109.582 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 76.0 p -70.58 160.03 33.25 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.378 -0.826 . . . . 1.0 109.154 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.03 -42.45 94.4 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.291 -0.881 . . . . 1.0 110.206 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.2 m -60.41 -40.6 91.58 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.166 -0.959 . . . . 1.0 110.735 -179.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -65.78 -41.04 92.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.973 -1.079 . . . . 1.0 110.144 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 69.5 t -66.6 -40.0 85.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 121.422 -0.799 . . . . 1.0 109.978 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -59.78 -52.54 65.03 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.404 -0.81 . . . . 1.0 112.144 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.2 pttt -65.13 -32.63 74.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.558 -1.339 . . . . 1.0 110.277 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.57 -51.31 70.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.941 -1.1 . . . . 1.0 110.181 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.437 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 45.0 m-85 -65.87 -37.39 86.03 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.825 -1.172 . . . . 1.0 110.099 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -59.99 -40.55 89.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.942 -1.098 . . . . 1.0 109.67 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -61.55 -40.31 94.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.067 -1.021 . . . . 1.0 109.529 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.08 -46.12 90.64 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.422 -0.799 . . . . 1.0 110.44 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -68.07 -39.67 82.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.01 -1.056 . . . . 1.0 109.86 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.408 ' O ' ' CG ' ' A' ' 44' ' ' ASP . 49.9 tptt -60.02 -47.17 86.94 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.186 -0.946 . . . . 1.0 109.878 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.2 t -60.08 -42.07 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.145 -0.972 . . . . 1.0 110.846 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -79.31 -35.36 41.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.85 -1.156 . . . . 1.0 110.148 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 38.8 p -71.5 -16.26 62.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.098 -1.001 . . . . 1.0 109.62 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.408 ' CG ' ' O ' ' A' ' 40' ' ' LYS . 96.0 m-20 -59.98 -39.59 86.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.339 -0.851 . . . . 1.0 110.314 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.4 m -112.18 -21.85 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.306 -0.871 . . . . 1.0 110.65 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.6 p -93.78 133.05 28.49 Favored Pre-proline 0 N--CA 1.501 2.109 0 O-C-N 120.759 -1.213 . . . . 1.0 109.611 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -75.43 15.95 0.77 Allowed 'Trans proline' 0 N--CA 1.496 1.622 0 CA-C-N 120.204 1.109 . . . . 1.0 112.039 178.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 78.8 mt -68.31 140.02 55.93 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.195 -0.941 . . . . 1.0 109.912 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -108.19 121.73 45.46 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 108.993 -0.743 . . . . 1.0 108.993 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -108.95 124.52 50.81 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.249 -0.907 . . . . 1.0 109.958 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.0 m -119.96 129.95 54.55 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.418 0.628 . . . . 1.0 109.306 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -83.82 137.9 33.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.307 -0.871 . . . . 1.0 110.042 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 77.3 mt -102.79 129.29 49.4 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.703 -0.851 . . . . 1.0 108.703 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.448 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 61.0 m170 -61.67 -40.04 93.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.914 . . . . 1.0 109.428 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 75.0 m-20 -151.0 168.02 25.85 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.379 -0.825 . . . . 1.0 109.249 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.03 -178.64 29.57 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.543 -1.423 . . . . 1.0 109.543 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.0 mt -96.3 132.82 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.353 -1.087 . . . . 1.0 109.76 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.96 164.71 12.34 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.367 -0.833 . . . . 1.0 109.071 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.04 -49.48 77.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.189 -0.944 . . . . 1.0 109.527 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 95.2 mt -107.28 101.85 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.51 -0.743 . . . . 1.0 109.691 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.2 ptp -100.21 135.97 40.82 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.248 -0.908 . . . . 1.0 109.469 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.437 HG21 ' CZ ' ' A' ' 35' ' ' PHE . 85.4 mt -110.0 133.92 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.726 -0.609 . . . . 1.0 109.945 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.2 p -152.47 155.18 37.0 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.017 -1.052 . . . . 1.0 110.274 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -102.68 121.86 43.28 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.499 -0.926 . . . . 1.0 108.499 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.78 -173.45 22.86 Favored Glycine 0 N--CA 1.499 2.894 0 N-CA-C 110.761 -0.935 . . . . 1.0 110.761 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.678 HG22 ' N ' ' A' ' 67' ' ' LYS . 96.7 mt -136.38 175.53 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 107.755 -1.202 . . . . 1.0 107.755 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.678 ' N ' HG22 ' A' ' 66' ' ' ILE . 50.8 tptt -28.94 -89.22 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.818 -0.551 . . . . 1.0 110.75 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -76.79 127.99 33.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.934 -1.104 . . . . 1.0 109.464 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.467 ' CE1' ' OD2' ' A' ' 71' ' ' ASP . 32.0 p-80 -145.19 24.67 1.43 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.921 -1.112 . . . . 1.0 109.737 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.03 50.26 3.75 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 110.139 -1.185 . . . . 1.0 110.139 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.467 ' OD2' ' CE1' ' A' ' 69' ' ' HIS . 21.8 p-10 -148.18 161.34 41.66 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.145 -1.209 . . . . 1.0 109.262 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -91.25 -2.37 57.46 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.145 -0.972 . . . . 1.0 110.235 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.535 ' CD2' ' O ' ' A' ' 73' ' ' TYR . 10.7 p90 -134.33 72.27 70.99 Favored Pre-proline 0 N--CA 1.5 2.073 0 O-C-N 121.318 -0.864 . . . . 1.0 109.189 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -57.45 -171.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.036 1.157 . . . . 1.0 112.504 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.561 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 94.4 m-85 -91.1 171.74 9.04 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.29 -0.881 . . . . 1.0 109.106 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 79' ' ' SER . 23.2 p-10 -99.72 18.61 17.7 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.132 -0.98 . . . . 1.0 110.61 -178.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 110.21 -151.87 17.4 Favored Glycine 0 N--CA 1.503 3.16 0 N-CA-C 109.337 -1.505 . . . . 1.0 109.337 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.439 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 6.3 Cg_exo -62.16 -63.67 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.563 0 CA-C-N 118.919 1.359 . . . . 1.0 112.408 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.434 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 95.9 p -77.36 162.77 27.0 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.934 -1.104 . . . . 1.0 109.882 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.68 -130.05 9.01 Favored Glycine 0 N--CA 1.502 3.081 0 N-CA-C 110.341 -1.104 . . . . 1.0 110.341 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.429 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 8.9 mt -68.54 108.32 3.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.607 -0.937 . . . . 1.0 108.589 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 74.4 mt -80.67 -17.98 49.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.969 -1.082 . . . . 1.0 109.818 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.64 174.13 1.23 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.427 -0.796 . . . . 1.0 109.194 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.424 ' CE1' ' ND1' ' A' ' 97' ' ' HIS . 11.5 p80 -161.99 159.35 26.36 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.357 -0.84 . . . . 1.0 109.236 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.22 154.6 40.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.154 -0.966 . . . . 1.0 109.368 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -92.15 152.11 42.32 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.096 -1.002 . . . . 1.0 108.418 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.442 ' O ' ' N ' ' A' ' 89' ' ' GLY . 5.3 Cg_exo -50.01 171.08 0.1 OUTLIER 'Trans proline' 0 N--CA 1.49 1.265 0 CA-C-N 119.139 0.728 . . . . 1.0 111.191 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -63.59 75.88 0.14 Allowed 'Trans proline' 0 C--N 1.315 -1.21 0 CA-C-O 121.932 0.722 . . . . 1.0 111.402 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -88.97 -172.36 46.21 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.837 -1.705 . . . . 1.0 108.837 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 89' ' ' GLY . 14.0 Cg_exo -56.06 -152.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.031 1.154 . . . . 1.0 111.91 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -61.06 -40.28 93.07 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.144 -0.973 . . . . 1.0 109.311 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -60.65 -45.5 93.85 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.22 -0.925 . . . . 1.0 109.272 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -69.11 177.5 28.29 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.537 -1.025 . . . . 1.0 110.537 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.46 13.56 83.41 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.603 -1.399 . . . . 1.0 109.603 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.2 p-10 -80.83 173.81 12.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.109 -1.23 . . . . 1.0 109.856 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.0 120.48 7.42 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.434 -0.792 . . . . 1.0 109.02 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.424 ' ND1' ' CE1' ' A' ' 84' ' ' HIS . 48.7 m170 -105.61 139.51 40.1 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.561 -0.712 . . . . 1.0 110.265 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.528 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 29.2 m-85 -120.78 140.97 50.95 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.733 -0.84 . . . . 1.0 108.733 179.114 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.561 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 93.9 m-20 -78.92 122.94 26.75 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.834 -1.166 . . . . 1.0 109.65 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 34.4 t0 -84.39 1.61 44.42 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.281 -0.887 . . . . 1.0 109.722 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -80.74 -17.95 49.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.124 -0.985 . . . . 1.0 109.57 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' A' ' 102' ' ' GLU . 56.9 mp0 -91.27 172.13 8.75 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.315 -0.865 . . . . 1.0 109.012 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 15.5 m -100.93 107.02 18.41 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.292 -1.003 . . . . 1.0 108.292 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -85.2 127.29 34.23 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.533 -0.914 . . . . 1.0 108.533 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.681 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.9 t -141.8 153.63 44.67 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.343 -0.848 . . . . 1.0 109.979 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 96.6 p -91.88 -5.66 52.88 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.911 -1.144 . . . . 1.0 107.911 178.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 65.2 m -93.1 -176.94 4.32 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.899 -0.778 . . . . 1.0 108.899 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.8 t -85.08 75.51 10.35 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.017 -1.052 . . . . 1.0 109.454 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.681 ' HB2' HG21 ' A' ' 105' ' ' THR . 98.2 mttt -148.67 152.82 37.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.321 -0.862 . . . . 1.0 108.889 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 43.37 -138.72 3.54 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 110.169 -1.172 . . . . 1.0 110.169 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -99.99 117.4 34.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.35 -1.088 . . . . 1.0 109.277 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -64.24 132.6 50.76 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.105 -0.997 . . . . 1.0 109.426 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.3 tp -59.97 -44.1 94.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 1.0 110.309 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -59.98 -40.9 90.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.167 -0.958 . . . . 1.0 111.585 -178.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -59.38 -49.98 75.71 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.443 -1.41 . . . . 1.0 109.415 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 66.0 t -69.97 -40.01 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.136 -0.977 . . . . 1.0 110.047 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.21 -52.8 63.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.089 -1.007 . . . . 1.0 109.807 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.0 -39.54 86.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.824 . . . . 1.0 110.695 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.437 ' CE1' ' HE2' ' A' ' 123' ' ' HIS . 69.0 t60 -61.94 -50.03 73.77 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.047 -1.033 . . . . 1.0 111.387 -178.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.528 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 8.2 pt-20 -60.04 -38.57 83.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.608 -1.308 . . . . 1.0 110.113 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -60.03 -40.03 87.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.82 -1.175 . . . . 1.0 108.588 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.79 -43.18 94.74 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.449 -1.46 . . . . 1.0 109.449 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.437 ' HE2' ' CE1' ' A' ' 119' ' ' HIS . 90.5 m-70 -65.62 -40.01 92.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.05 -1.265 . . . . 1.0 109.291 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 93.3 p -67.19 -25.39 66.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.179 -0.951 . . . . 1.0 109.438 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 83.2 mt -82.53 -3.0 55.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.22 -0.925 . . . . 1.0 109.791 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 96.94 7.53 57.45 Favored Glycine 0 N--CA 1.5 2.906 0 O-C-N 121.101 -1.0 . . . . 1.0 111.108 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.3 mt -85.25 148.0 26.29 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.698 -1.472 . . . . 1.0 109.693 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 39.7 t0 -102.75 171.49 7.39 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.993 -0.743 . . . . 1.0 108.993 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.536 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 76.9 m80 -59.22 136.26 57.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.012 -1.055 . . . . 1.0 109.106 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 40.3 t -97.38 155.28 16.98 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.237 -0.915 . . . . 1.0 109.541 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -98.61 1.3 46.24 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.351 -0.843 . . . . 1.0 109.75 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -85.4 130.18 52.53 Favored Pre-proline 0 N--CA 1.495 1.79 0 N-CA-C 107.843 -1.169 . . . . 1.0 107.843 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -67.44 -26.18 41.01 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 CA-C-N 120.212 1.111 . . . . 1.0 113.285 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -85.92 -2.75 86.09 Favored Glycine 0 N--CA 1.497 2.709 0 C-N-CA 119.799 -1.191 . . . . 1.0 110.342 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.63 144.42 27.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.047 -1.266 . . . . 1.0 109.146 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.407 ' C ' ' H ' ' A' ' 138' ' ' PHE . 91.5 mt -67.05 -33.46 75.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.177 -0.952 . . . . 1.0 109.813 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 94.8 mmm -69.17 9.61 0.41 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.164 -0.96 . . . . 1.0 110.2 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.407 ' H ' ' C ' ' A' ' 136' ' ' LEU . 13.2 t80 -67.43 135.9 93.18 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 107.738 -1.208 . . . . 1.0 107.738 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -65.13 -31.83 53.79 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 CA-C-N 119.898 0.999 . . . . 1.0 113.818 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 90.6 mt -83.42 140.41 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.481 -1.387 . . . . 1.0 110.119 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -76.07 128.92 36.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.491 -0.756 . . . . 1.0 109.591 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 10.2 t -140.16 142.41 35.95 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.221 -0.924 . . . . 1.0 109.55 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -82.5 144.93 30.08 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.359 -0.838 . . . . 1.0 109.643 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.8 t -140.79 156.09 46.24 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.259 -0.9 . . . . 1.0 110.076 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.0 110.36 3.17 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.92 -1.672 . . . . 1.0 108.92 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -78.63 -3.38 43.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.328 -1.101 . . . . 1.0 109.708 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.0 t -60.04 -41.14 91.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.234 -0.916 . . . . 1.0 110.635 -178.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -143.01 28.89 1.52 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.939 -1.101 . . . . 1.0 110.513 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -68.32 135.65 52.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.754 -1.216 . . . . 1.0 109.071 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 98.7 mtp -138.39 148.2 44.23 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.502 -0.925 . . . . 1.0 108.502 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 88.0 mt -50.83 121.25 14.76 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 120.959 -1.088 . . . . 1.0 108.682 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -66.57 178.55 2.61 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 CA-C-N 120.275 1.134 . . . . 1.0 112.153 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.16 -39.97 88.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.474 -0.766 . . . . 1.0 109.669 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -56.94 -49.2 76.38 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.238 -0.914 . . . . 1.0 109.678 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.68 -40.01 73.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.961 -1.087 . . . . 1.0 110.299 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 72.9 t -62.15 -46.67 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.915 -1.116 . . . . 1.0 109.159 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -60.28 -40.05 89.02 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 1.0 110.212 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.13 -53.77 8.8 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 120.219 -0.991 . . . . 1.0 111.436 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.468 HG23 ' N ' ' A' ' 160' ' ' GLN . 9.9 tp -60.45 -40.31 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.74 -1.447 . . . . 1.0 109.971 -178.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.536 ' O ' ' N ' ' A' ' 164' ' ' GLY . 25.8 mm100 -65.68 -39.6 91.49 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.323 -0.861 . . . . 1.0 109.352 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 79.2 p -63.46 -25.82 68.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.197 -0.94 . . . . 1.0 110.14 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 84.5 mt -86.95 -52.56 5.39 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.959 -1.088 . . . . 1.0 110.456 -179.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -92.7 -9.01 42.31 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.035 -1.041 . . . . 1.0 110.135 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.522 0 N-CA-C 109.502 -1.439 . . . . 1.0 109.502 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 169' ' ' WAY . . . . . 0.867 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.9 m . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.284 0.564 . . . . 1.0 109.494 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.1 mt -95.57 125.13 39.95 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.219 -0.926 . . . . 1.0 109.575 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.9 pttt -161.96 160.05 27.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 1.0 109.85 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -73.56 147.25 44.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.403 -0.81 . . . . 1.0 109.411 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 99.4 p -89.33 3.1 53.26 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.192 -0.942 . . . . 1.0 110.091 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -143.21 153.61 43.0 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.118 -0.989 . . . . 1.0 109.435 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.1 mmt -90.17 -0.1 57.44 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.399 -0.813 . . . . 1.0 110.219 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -97.27 127.98 43.72 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.111 -0.993 . . . . 1.0 109.632 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.7 mt -142.28 148.65 38.4 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.101 -1.0 . . . . 1.0 109.123 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.4 p -135.28 158.57 44.03 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -145.1 160.99 40.54 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.038 -1.039 . . . . 1.0 110.615 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.51 HH11 ' HG2' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -141.81 131.14 23.59 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 -179.141 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.7 mt -88.14 115.24 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.127 -0.983 . . . . 1.0 108.694 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.08 -41.7 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.122 -0.986 . . . . 1.0 109.537 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.485 HD22 ' HB2' ' A' ' 64' ' ' PHE . 11.5 p-10 -164.36 160.94 21.36 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.271 -1.518 . . . . 1.0 110.114 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.587 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 51.1 m-85 -102.06 -169.92 1.74 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.157 -1.053 . . . . 1.0 108.157 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.25 147.02 42.1 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.343 -0.848 . . . . 1.0 110.154 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -68.61 -14.42 39.47 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 120.876 1.05 . . . . 1.0 110.912 178.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -59.86 -39.59 85.74 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.601 -0.727 . . . . 1.0 110.186 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 74.3 mtm -137.23 165.26 26.54 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.283 -0.886 . . . . 1.0 109.425 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.7 p -72.51 159.63 33.62 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.289 -0.882 . . . . 1.0 109.406 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.587 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 0.9 OUTLIER -60.16 -39.98 88.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.422 -0.799 . . . . 1.0 110.346 -179.25 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.1 m -59.91 -40.11 87.7 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.151 -0.968 . . . . 1.0 110.266 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -66.0 -40.0 90.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.126 -0.984 . . . . 1.0 110.087 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.6 t -68.8 -40.38 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.209 -0.932 . . . . 1.0 110.272 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.94 -49.91 75.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.031 -1.043 . . . . 1.0 110.197 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -61.7 -32.52 72.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.039 -1.038 . . . . 1.0 110.015 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.89 -48.51 81.4 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.888 -1.133 . . . . 1.0 110.007 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -66.89 -39.04 87.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.94 -1.1 . . . . 1.0 109.815 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -60.04 -42.5 94.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.111 -0.993 . . . . 1.0 109.516 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -60.14 -41.21 92.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.09 -1.006 . . . . 1.0 109.203 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.71 -45.3 94.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.503 -0.748 . . . . 1.0 110.224 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -65.64 -38.55 89.68 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.065 -1.022 . . . . 1.0 109.95 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -59.59 -48.82 80.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.102 -0.999 . . . . 1.0 109.782 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 76.1 t -60.0 -40.36 82.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.163 -0.961 . . . . 1.0 110.556 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -81.18 -36.54 30.03 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.842 -1.161 . . . . 1.0 109.823 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.6 p -70.22 -17.08 63.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.179 -0.951 . . . . 1.0 109.666 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -60.03 -40.04 87.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.938 . . . . 1.0 110.3 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -112.16 -17.61 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.338 -0.851 . . . . 1.0 110.782 -179.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.9 p -94.93 125.5 50.63 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 120.744 -1.223 . . . . 1.0 109.48 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -72.37 16.14 0.39 Allowed 'Trans proline' 0 N--CA 1.495 1.578 0 CA-C-N 120.177 1.099 . . . . 1.0 111.8 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 66.3 mt -69.17 140.01 54.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.297 -0.877 . . . . 1.0 109.934 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -106.32 120.56 42.19 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.79 -0.819 . . . . 1.0 108.79 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -106.75 127.22 53.2 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.273 -0.892 . . . . 1.0 109.42 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.9 m -119.99 129.69 54.4 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -84.04 132.57 34.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.517 -0.739 . . . . 1.0 109.116 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.9 mt -105.4 131.7 52.51 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.175 -0.953 . . . . 1.0 109.171 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.44 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 43.0 m170 -61.02 -40.01 91.94 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.146 -0.971 . . . . 1.0 109.284 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 71.9 m-20 -151.95 180.0 7.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.365 -0.834 . . . . 1.0 109.624 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.67 178.71 39.43 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.364 -1.494 . . . . 1.0 109.364 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.5 mt -96.9 130.28 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.284 -1.127 . . . . 1.0 109.673 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.54 162.67 14.48 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.581 -0.699 . . . . 1.0 109.163 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -59.92 -49.83 76.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.187 -0.945 . . . . 1.0 109.499 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 94.8 mt -104.81 101.24 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.412 -0.805 . . . . 1.0 109.898 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.2 ptp -100.93 132.13 46.48 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.319 -0.863 . . . . 1.0 109.161 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.6 mt -102.5 138.09 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.454 -0.779 . . . . 1.0 109.724 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 81.4 p -151.34 160.02 43.99 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.312 -0.867 . . . . 1.0 109.716 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.485 ' HB2' HD22 ' A' ' 21' ' ' ASN . 86.1 m-85 -109.61 125.87 53.02 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.516 -0.74 . . . . 1.0 109.515 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -101.78 -178.26 28.15 Favored Glycine 0 N--CA 1.5 2.921 0 N-CA-C 110.839 -0.904 . . . . 1.0 110.839 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.525 HG22 ' N ' ' A' ' 67' ' ' LYS . 61.5 mt -136.82 163.72 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.613 -0.933 . . . . 1.0 109.721 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.525 ' N ' HG22 ' A' ' 66' ' ' ILE . 46.8 tptt -11.33 -76.37 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.314 0 N-CA-C 113.332 0.864 . . . . 1.0 113.332 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.421 ' H ' ' HG2' ' A' ' 68' ' ' GLU . 12.1 pt-20 -59.88 -49.98 75.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.057 -1.027 . . . . 1.0 110.834 -177.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.565 ' O ' ' N ' ' A' ' 71' ' ' ASP . 42.3 t-80 45.1 51.37 8.99 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.81 -1.181 . . . . 1.0 109.677 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 69' ' ' HIS . . . -28.6 84.32 0.0 OUTLIER Glycine 0 N--CA 1.505 3.266 0 CA-C-O 121.292 0.385 . . . . 1.0 112.188 -178.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 69' ' ' HIS . 64.7 m-20 -160.72 176.99 10.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.521 -0.987 . . . . 1.0 109.449 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -70.03 137.34 51.23 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.271 -0.893 . . . . 1.0 109.107 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 8.3 t80 44.73 69.47 2.49 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 121.283 -0.886 . . . . 1.0 109.777 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -66.6 -158.3 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.104 1.203 . . . . 1.0 112.503 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.536 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 67.8 m-85 -85.33 157.77 20.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.514 -0.741 . . . . 1.0 109.48 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.6 p-10 -101.0 0.29 37.87 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.454 -0.779 . . . . 1.0 109.994 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 135.19 -155.29 22.01 Favored Glycine 0 N--CA 1.501 2.976 0 N-CA-C 108.707 -1.757 . . . . 1.0 108.707 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.425 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 12.3 Cg_exo -59.41 -68.2 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.39 0 CA-C-N 118.843 1.322 . . . . 1.0 111.776 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 88.1 p -76.0 160.69 29.59 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.311 -0.868 . . . . 1.0 109.203 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.75 -131.09 8.95 Favored Glycine 0 N--CA 1.501 3.031 0 N-CA-C 109.369 -1.493 . . . . 1.0 109.369 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.425 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 24.1 mt -69.81 111.81 5.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.069 -1.254 . . . . 1.0 109.06 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 30.8 mt -82.17 -13.8 56.6 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.237 -0.915 . . . . 1.0 108.625 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 179.39 169.43 1.05 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.999 -0.741 . . . . 1.0 108.999 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.801 ' CD2' ' HD1' ' A' ' 97' ' ' HIS . 3.4 p-80 -162.54 160.88 26.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.077 -1.015 . . . . 1.0 109.572 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -147.48 164.53 33.09 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.193 -0.942 . . . . 1.0 109.577 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -100.8 152.81 37.94 Favored Pre-proline 0 N--CA 1.498 1.966 0 N-CA-C 108.713 -0.847 . . . . 1.0 108.713 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.472 ' O ' ' N ' ' A' ' 89' ' ' GLY . 1.0 OUTLIER -56.42 169.07 1.78 Allowed 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 120.582 0.855 . . . . 1.0 111.774 179.876 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -62.7 71.77 0.12 Allowed 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 120.745 0.963 . . . . 1.0 111.608 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -78.39 177.24 53.79 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.334 -1.506 . . . . 1.0 109.334 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -48.05 -75.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 120.991 1.127 . . . . 1.0 112.121 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -121.04 -49.66 2.18 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.419 -0.801 . . . . 1.0 109.766 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -60.29 -39.99 88.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.316 -0.865 . . . . 1.0 110.225 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.447 ' HA3' ' H ' ' A' ' 89' ' ' GLY . . . -65.06 170.44 25.35 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.839 -1.304 . . . . 1.0 109.839 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 80.11 4.26 89.7 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.616 -1.394 . . . . 1.0 109.616 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -80.64 170.17 16.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.113 -1.227 . . . . 1.0 109.508 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.87 139.2 23.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.232 -0.917 . . . . 1.0 109.38 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.801 ' HD1' ' CD2' ' A' ' 84' ' ' HIS . 18.0 m170 -130.13 157.71 41.68 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.56 -0.713 . . . . 1.0 109.884 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -136.72 153.81 50.76 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.011 -0.737 . . . . 1.0 109.011 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.536 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 0.6 OUTLIER -79.99 122.09 26.29 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.062 -1.024 . . . . 1.0 109.495 179.842 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -85.28 -11.62 54.32 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.095 -1.003 . . . . 1.0 109.347 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -81.33 -10.68 59.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.873 . . . . 1.0 109.47 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 98.3 mt-10 -90.81 169.98 10.49 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.311 -0.868 . . . . 1.0 109.466 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 22.3 m -98.43 106.23 18.48 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.103 -0.998 . . . . 1.0 109.728 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.427 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 93.5 m95 -89.82 127.48 35.99 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.704 -0.85 . . . . 1.0 108.704 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.674 HG21 ' HB2' ' A' ' 109' ' ' LYS . 9.2 t -143.19 155.65 44.58 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.237 -0.915 . . . . 1.0 109.583 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 60.0 p -94.82 -5.7 44.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.111 -0.993 . . . . 1.0 108.431 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 70.3 m -93.48 179.17 5.47 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.955 -0.757 . . . . 1.0 108.955 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 19.6 m -81.04 77.02 7.98 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.008 -1.058 . . . . 1.0 108.988 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.674 ' HB2' HG21 ' A' ' 105' ' ' THR . 67.9 mttm -149.06 150.19 32.35 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.739 -0.838 . . . . 1.0 108.739 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.21 -138.77 4.48 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.203 -1.159 . . . . 1.0 110.203 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -99.5 116.68 32.21 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.303 -1.116 . . . . 1.0 109.487 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -63.66 131.42 47.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.156 -0.965 . . . . 1.0 109.246 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.7 tp -59.86 -41.66 91.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 1.0 110.12 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -59.98 -43.0 95.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.133 -0.979 . . . . 1.0 111.106 -178.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 115' ' ' LEU . 3.8 mm? -59.38 -50.17 74.98 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.661 -1.274 . . . . 1.0 109.319 -178.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 95.7 t -70.54 -42.2 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.059 -1.025 . . . . 1.0 109.974 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.13 -50.66 73.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.004 -1.06 . . . . 1.0 110.12 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.09 -36.44 77.4 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.581 -1.325 . . . . 1.0 109.577 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -65.5 -48.71 71.65 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.29 -0.881 . . . . 1.0 111.353 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.67 -39.95 82.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.642 -1.286 . . . . 1.0 109.419 -178.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -60.04 -39.99 87.82 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.945 -1.097 . . . . 1.0 109.077 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.4 -46.51 80.07 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.795 -1.322 . . . . 1.0 109.795 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -65.37 -39.93 92.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.135 -1.215 . . . . 1.0 109.3 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.8 p -64.64 -23.61 67.31 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.291 -0.88 . . . . 1.0 108.998 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 50.6 mt -82.49 -4.97 58.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 1.0 109.59 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 95.27 5.83 60.36 Favored Glycine 0 N--CA 1.499 2.869 0 O-C-N 121.154 -0.966 . . . . 1.0 111.075 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.2 mt -84.21 150.27 25.58 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.811 -1.405 . . . . 1.0 109.94 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 11.0 t70 -103.16 173.19 6.42 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.558 -0.714 . . . . 1.0 109.477 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.483 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 69.2 m80 -59.97 136.35 57.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.132 -0.98 . . . . 1.0 109.221 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 47.7 t -99.45 156.02 17.25 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.324 -0.86 . . . . 1.0 109.516 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -98.72 2.37 47.0 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.165 -0.959 . . . . 1.0 109.358 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -85.66 128.46 58.75 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 120.955 -1.091 . . . . 1.0 108.409 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -68.44 -17.04 43.95 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 CA-C-N 120.14 1.086 . . . . 1.0 112.094 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -89.32 -7.48 69.65 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.091 -1.203 . . . . 1.0 110.091 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.09 144.99 26.18 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.159 -1.201 . . . . 1.0 109.125 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.482 ' C ' ' H ' ' A' ' 138' ' ' PHE . 96.2 mt -69.71 -31.51 69.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.035 -1.04 . . . . 1.0 109.599 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 94.1 mmm -70.88 19.82 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.178 -0.951 . . . . 1.0 110.372 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.482 ' H ' ' C ' ' A' ' 136' ' ' LEU . 13.5 t80 -69.2 131.86 90.28 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.104 -0.997 . . . . 1.0 108.367 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -62.95 -2.22 3.45 Favored 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 120.831 1.021 . . . . 1.0 114.149 -178.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.0 mt -120.43 136.77 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 O-C-N 120.987 -1.071 . . . . 1.0 109.944 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -71.97 127.73 33.49 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.278 -0.889 . . . . 1.0 110.437 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.413 ' O ' HG23 ' A' ' 142' ' ' THR . 9.7 t -139.83 133.61 30.57 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.436 -0.79 . . . . 1.0 109.346 179.245 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -82.16 144.89 30.41 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.065 -1.022 . . . . 1.0 108.749 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 2.5 t -141.86 159.98 41.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.101 -0.999 . . . . 1.0 109.473 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.27 105.66 1.7 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.928 -1.669 . . . . 1.0 108.928 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -78.06 9.8 3.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.342 -1.093 . . . . 1.0 109.37 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 59.2 m -59.91 -40.09 87.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.908 . . . . 1.0 109.826 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -150.25 29.92 0.7 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.006 -1.059 . . . . 1.0 109.575 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -61.59 138.78 58.31 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.154 -0.966 . . . . 1.0 109.59 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 66.9 mtt -137.83 145.86 42.78 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.689 -0.856 . . . . 1.0 108.689 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 45.4 mt -52.31 129.32 41.92 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.043 -1.036 . . . . 1.0 108.883 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -70.19 175.74 8.05 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 CA-C-N 119.985 1.03 . . . . 1.0 112.33 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.44 -39.9 89.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.54 -0.725 . . . . 1.0 110.097 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -56.73 -47.55 79.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.081 -1.012 . . . . 1.0 109.593 -179.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.417 ' O ' HG22 ' A' ' 159' ' ' ILE . 97.0 m-20 -70.33 -39.98 74.42 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.101 -1.0 . . . . 1.0 110.121 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 74.2 t -60.81 -47.74 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.028 -1.045 . . . . 1.0 109.098 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -60.26 -39.93 88.53 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.136 -0.977 . . . . 1.0 110.389 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.75 -54.55 7.24 Favored Glycine 0 N--CA 1.495 2.577 0 O-C-N 121.029 -1.044 . . . . 1.0 111.276 -178.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.475 HG23 ' N ' ' A' ' 160' ' ' GLN . 7.1 tp -60.1 -40.02 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.996 -1.297 . . . . 1.0 109.672 -178.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.554 ' O ' ' N ' ' A' ' 164' ' ' GLY . 93.5 mt-30 -65.51 -39.56 91.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.106 -0.996 . . . . 1.0 109.492 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 83.3 p -60.61 -32.0 71.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.214 -0.929 . . . . 1.0 110.688 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 97.4 mt -85.13 -49.97 7.81 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.772 -1.205 . . . . 1.0 110.606 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -91.39 -8.92 46.6 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.023 -1.048 . . . . 1.0 110.173 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.492 2.41 0 N-CA-C 109.563 -1.415 . . . . 1.0 109.563 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 169' ' ' WAY . . . . . 0.895 ' HC2' ' HJ ' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.402 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 26.6 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.479 -0.563 . . . . 1.0 109.479 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.6 mt -92.38 135.1 34.31 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.283 -0.886 . . . . 1.0 109.357 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.96 162.17 34.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.898 . . . . 1.0 109.547 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -73.05 150.45 42.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.196 -0.94 . . . . 1.0 109.666 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.0 t -80.21 -2.63 45.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.332 -0.855 . . . . 1.0 109.749 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -145.88 152.38 39.38 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.235 -0.915 . . . . 1.0 109.284 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.1 mmt -89.99 -0.68 57.71 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.211 -0.931 . . . . 1.0 109.771 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -96.9 131.17 43.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.205 -0.934 . . . . 1.0 109.059 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.8 mt -139.97 149.94 43.87 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.204 -0.935 . . . . 1.0 109.173 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 54.6 p -131.36 155.35 47.4 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.573 -0.899 . . . . 1.0 108.573 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -146.15 159.59 43.1 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.04 -1.038 . . . . 1.0 110.067 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.415 ' HG2' HH11 ' A' ' 18' ' ' ARG . 36.9 ttt-85 -145.26 133.98 22.24 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.48 -0.763 . . . . 1.0 109.296 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.9 mt -86.59 119.63 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 1.0 108.915 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 69.7 t -69.62 -41.11 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.353 -0.842 . . . . 1.0 109.207 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -164.56 157.87 17.51 Favored 'General case' 0 C--N 1.286 -2.175 0 O-C-N 119.686 -1.884 . . . . 1.0 110.819 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.473 ' HB2' ' CE1' ' A' ' 28' ' ' HIS . 56.7 m-85 -100.41 113.0 25.41 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 106.475 -1.676 . . . . 1.0 106.475 178.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.425 ' C ' ' H ' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -56.87 136.54 79.25 Favored Pre-proline 0 C--N 1.299 -1.588 0 C-N-CA 119.103 -1.039 . . . . 1.0 109.199 -177.938 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -57.48 -7.87 3.4 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 CA-C-N 119.606 0.895 . . . . 1.0 110.31 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.425 ' H ' ' C ' ' A' ' 23' ' ' THR . 68.2 m-20 -58.27 -31.55 67.55 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 120.036 -0.666 . . . . 1.0 109.656 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 78.0 mtm -142.55 163.25 33.35 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.228 -0.92 . . . . 1.0 109.895 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 42.3 p -72.56 161.23 31.05 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.454 -0.778 . . . . 1.0 109.648 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.473 ' CE1' ' HB2' ' A' ' 22' ' ' TYR . 0.4 OUTLIER -61.22 -40.06 92.58 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.274 -0.891 . . . . 1.0 110.045 -179.447 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.3 m -61.1 -42.52 98.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.997 -1.065 . . . . 1.0 110.545 -179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.0 -40.03 87.25 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.077 -1.014 . . . . 1.0 110.297 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 79.7 t -68.12 -43.35 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.122 -0.986 . . . . 1.0 110.555 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.04 -49.31 78.18 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.044 -1.035 . . . . 1.0 110.676 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -61.87 -33.81 74.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.946 -1.097 . . . . 1.0 110.176 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.02 -49.74 76.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.833 -1.167 . . . . 1.0 110.31 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.448 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 49.7 m-85 -67.2 -39.94 86.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.915 -1.116 . . . . 1.0 110.449 -179.335 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -60.02 -40.54 89.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.873 -1.142 . . . . 1.0 109.793 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -60.09 -40.73 90.61 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.918 -1.114 . . . . 1.0 108.763 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.94 -46.99 87.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.49 -0.756 . . . . 1.0 110.254 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -66.57 -39.04 88.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.032 -1.043 . . . . 1.0 109.98 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -60.03 -46.62 88.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.08 -1.012 . . . . 1.0 109.882 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 67.8 t -60.01 -41.46 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.148 -0.97 . . . . 1.0 110.36 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -79.39 -36.8 38.62 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.875 -1.14 . . . . 1.0 110.587 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.1 p -70.0 -18.86 63.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.024 -1.047 . . . . 1.0 109.995 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.04 -39.96 87.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.166 -0.959 . . . . 1.0 110.549 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.4 m -117.96 33.84 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.276 -0.89 . . . . 1.0 110.756 -178.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.7 p -151.4 134.48 8.91 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 120.769 -1.207 . . . . 1.0 109.604 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -73.5 13.14 0.75 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 CA-C-N 119.677 0.92 . . . . 1.0 112.004 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 79.9 mt -68.36 139.78 55.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.061 -1.024 . . . . 1.0 109.865 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -110.5 120.98 44.18 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.83 -0.804 . . . . 1.0 108.83 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -106.28 125.27 50.79 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.334 -0.854 . . . . 1.0 109.509 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.1 m -119.92 129.97 54.59 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.648 -0.658 . . . . 1.0 109.929 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -83.29 130.25 35.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.366 -0.834 . . . . 1.0 109.149 179.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 98.4 mt -101.33 123.21 45.06 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.246 -0.909 . . . . 1.0 109.199 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.439 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 48.8 m170 -60.85 -40.0 91.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.313 -0.867 . . . . 1.0 109.792 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 83.0 m-20 -146.67 169.99 17.89 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.21 -0.931 . . . . 1.0 109.827 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.04 179.1 35.93 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.451 -1.46 . . . . 1.0 109.451 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.5 mt -95.8 134.6 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.234 -1.156 . . . . 1.0 109.377 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.52 159.79 17.21 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.429 -0.794 . . . . 1.0 109.337 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.02 -49.11 78.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.156 -0.965 . . . . 1.0 109.436 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.6 mt -104.84 99.18 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.387 -0.821 . . . . 1.0 109.939 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.1 ptp -100.16 132.83 45.3 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.141 -0.975 . . . . 1.0 109.047 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.448 HG21 ' CZ ' ' A' ' 35' ' ' PHE . 85.5 mt -110.03 130.48 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.588 -0.695 . . . . 1.0 109.534 -179.349 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.3 p -151.2 158.53 44.06 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.128 -0.983 . . . . 1.0 110.245 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -102.84 127.64 49.94 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.212 -1.033 . . . . 1.0 108.212 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -117.73 -166.83 14.04 Favored Glycine 0 N--CA 1.499 2.863 0 N-CA-C 110.018 -1.233 . . . . 1.0 110.018 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.586 HG22 ' N ' ' A' ' 67' ' ' LYS . 83.0 mt -134.3 167.14 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.669 -0.901 . . . . 1.0 108.702 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.586 ' N ' HG22 ' A' ' 66' ' ' ILE . 61.7 tttm -35.52 -77.48 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.806 -0.559 . . . . 1.0 111.188 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.425 ' HG2' ' H ' ' A' ' 68' ' ' GLU . 12.3 pt-20 -70.02 73.52 0.45 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.969 -1.082 . . . . 1.0 110.283 -178.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.512 ' ND1' ' O ' ' A' ' 66' ' ' ILE . 51.8 m80 -59.97 -40.0 87.57 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.201 -0.937 . . . . 1.0 108.997 178.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 139.93 20.01 0.39 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 108.352 -1.899 . . . . 1.0 108.352 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -140.81 168.47 19.71 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.646 -0.914 . . . . 1.0 108.835 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.428 ' O ' ' C ' ' A' ' 73' ' ' TYR . 91.9 m-85 -60.02 -50.23 74.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.049 -1.032 . . . . 1.0 110.56 -179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.428 ' C ' ' O ' ' A' ' 72' ' ' PHE . 76.0 m-85 -35.31 95.73 0.09 OUTLIER Pre-proline 0 N--CA 1.507 2.394 0 O-C-N 121.934 -0.479 . . . . 1.0 110.814 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -92.16 145.57 2.88 Favored 'Trans proline' 0 N--CA 1.488 1.178 0 C-N-CA 120.99 1.127 . . . . 1.0 112.706 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.475 ' CE2' ' OD1' ' A' ' 99' ' ' ASP . 37.4 m-85 -88.75 169.36 11.71 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.94 -1.133 . . . . 1.0 107.94 178.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 79' ' ' SER . 24.2 p-10 -103.27 13.34 34.08 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.054 -1.029 . . . . 1.0 110.569 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 108.89 -151.54 17.09 Favored Glycine 0 N--CA 1.503 3.103 0 N-CA-C 109.223 -1.551 . . . . 1.0 109.223 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.404 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 13.6 Cg_exo -58.58 -64.13 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.552 0 CA-C-N 118.892 1.346 . . . . 1.0 112.737 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.447 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 79.2 p -75.04 159.83 31.25 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.976 -1.078 . . . . 1.0 109.828 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.97 -129.8 8.83 Favored Glycine 0 N--CA 1.502 3.068 0 N-CA-C 109.992 -1.243 . . . . 1.0 109.992 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.441 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 23.0 mt -66.17 104.38 1.16 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.358 -1.084 . . . . 1.0 108.889 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 33.8 mt -80.04 -15.73 56.57 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.991 -1.068 . . . . 1.0 108.727 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 97' ' ' HIS . . . 179.61 170.8 1.05 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.07 -0.715 . . . . 1.0 109.07 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -160.03 153.46 22.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.184 -0.947 . . . . 1.0 109.423 178.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -142.2 158.58 43.58 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.409 -0.807 . . . . 1.0 109.297 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -96.18 153.32 39.1 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 108.287 -1.005 . . . . 1.0 108.287 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.454 ' O ' ' N ' ' A' ' 89' ' ' GLY . 2.9 Cg_exo -49.38 170.02 0.1 OUTLIER 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 120.529 0.819 . . . . 1.0 111.549 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -64.98 58.92 0.29 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.021 1.147 . . . . 1.0 112.08 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -66.75 -172.4 5.06 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.269 -1.532 . . . . 1.0 109.269 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -72.82 -92.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.169 1.246 . . . . 1.0 112.938 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -85.05 -53.61 5.17 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.991 -1.068 . . . . 1.0 111.362 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -68.96 -40.01 79.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.091 -1.006 . . . . 1.0 110.154 -178.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -55.72 169.31 2.43 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.019 -1.232 . . . . 1.0 110.019 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.43 5.76 78.55 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.656 -1.378 . . . . 1.0 109.656 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.7 p-10 -79.03 162.64 25.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.047 -1.267 . . . . 1.0 109.542 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.24 124.43 11.49 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.229 -0.919 . . . . 1.0 109.468 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.415 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 8.9 m170 -111.84 146.35 37.83 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.486 0.66 . . . . 1.0 109.963 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -126.64 148.98 49.76 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.343 -0.984 . . . . 1.0 108.343 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.475 ' OD1' ' CE2' ' A' ' 75' ' ' PHE . 87.8 m-20 -78.57 123.52 27.18 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.862 -1.149 . . . . 1.0 109.367 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -83.08 -9.38 59.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.893 . . . . 1.0 109.257 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -83.08 -13.5 55.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.335 -0.853 . . . . 1.0 108.897 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.404 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 99.1 mt-10 -89.09 166.19 14.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.508 -0.745 . . . . 1.0 109.168 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.7 m -99.12 105.82 17.95 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.225 -0.922 . . . . 1.0 109.342 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -88.04 124.11 33.42 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.557 -0.905 . . . . 1.0 108.557 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.643 HG21 ' HB2' ' A' ' 109' ' ' LYS . 9.0 t -140.2 160.03 40.87 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.232 -0.917 . . . . 1.0 110.115 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 32.2 t -96.63 -10.02 28.0 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.415 -0.958 . . . . 1.0 108.415 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.3 t -91.06 -176.34 4.58 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.681 -0.859 . . . . 1.0 108.681 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.4 t -85.59 77.81 9.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.995 -1.066 . . . . 1.0 109.373 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.643 ' HB2' HG21 ' A' ' 105' ' ' THR . 66.5 mttm -148.44 149.93 32.59 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.372 -0.973 . . . . 1.0 108.372 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.13 -139.71 5.08 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.764 -1.335 . . . . 1.0 109.764 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -101.01 115.58 30.83 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.451 -1.029 . . . . 1.0 108.923 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.444 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 17.4 t-20 -62.69 134.52 56.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.115 -0.99 . . . . 1.0 109.945 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.7 tp -60.03 -46.19 90.34 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.513 -0.742 . . . . 1.0 110.867 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -59.51 -40.04 85.78 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.261 -0.899 . . . . 1.0 110.743 -178.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -58.41 -51.09 71.31 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.686 -1.259 . . . . 1.0 109.337 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 64.6 t -70.04 -40.77 78.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.097 -1.002 . . . . 1.0 110.235 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.93 -49.42 76.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.172 -0.955 . . . . 1.0 109.738 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.97 -39.68 86.5 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.197 -0.939 . . . . 1.0 110.366 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -63.52 -49.85 71.9 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.14 -0.975 . . . . 1.0 111.416 -178.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -60.03 -38.81 83.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.602 -1.311 . . . . 1.0 110.276 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -60.06 -39.95 87.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.698 -1.251 . . . . 1.0 108.493 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.23 -40.27 91.44 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.571 -1.411 . . . . 1.0 109.571 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -66.53 -39.99 88.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.037 -1.272 . . . . 1.0 109.132 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 84.3 p -66.38 -24.44 66.49 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.278 -0.889 . . . . 1.0 109.566 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 92.9 mt -81.78 -1.69 48.15 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.152 -0.967 . . . . 1.0 109.607 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 89.69 9.64 66.14 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 110.645 -0.982 . . . . 1.0 110.645 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 82.6 mt -84.82 147.13 26.98 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.924 -1.339 . . . . 1.0 109.302 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 41.3 t0 -102.2 172.9 6.63 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.462 -0.774 . . . . 1.0 109.49 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.527 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 61.3 m80 -59.05 136.93 58.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.878 . . . . 1.0 109.612 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 47.3 t -98.57 157.01 16.51 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.369 -0.832 . . . . 1.0 109.293 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -99.71 0.01 40.97 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.383 -0.823 . . . . 1.0 109.582 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 9.6 t70 -85.46 129.45 55.2 Favored Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 108.225 -1.028 . . . . 1.0 108.225 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -68.47 -21.07 40.9 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 CA-C-N 120.126 1.081 . . . . 1.0 112.004 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.459 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -87.5 -4.61 80.0 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.443 -1.463 . . . . 1.0 109.443 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.09 145.71 26.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.241 -1.152 . . . . 1.0 109.496 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.454 ' C ' ' H ' ' A' ' 138' ' ' PHE . 84.5 mt -69.95 -34.9 74.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.249 -0.907 . . . . 1.0 109.493 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 96.8 mmm -70.98 18.84 0.06 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.341 -0.85 . . . . 1.0 110.533 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.454 ' H ' ' C ' ' A' ' 136' ' ' LEU . 11.9 t80 -68.73 133.29 90.53 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.902 -1.124 . . . . 1.0 108.096 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -63.43 -13.15 34.43 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 120.782 0.988 . . . . 1.0 113.843 -178.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.7 mt -108.36 139.96 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.036 -1.04 . . . . 1.0 109.884 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.444 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 56.0 t80 -73.63 129.37 37.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.511 -0.743 . . . . 1.0 110.127 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.6 t -138.49 140.12 39.06 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.589 -0.893 . . . . 1.0 108.589 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -79.88 130.0 34.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.036 -1.04 . . . . 1.0 109.537 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 20.6 m -115.81 125.51 52.81 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.705 -0.622 . . . . 1.0 109.639 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.9 100.06 0.22 Allowed Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.068 -2.013 . . . . 1.0 108.068 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -70.14 138.24 51.73 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.292 -1.122 . . . . 1.0 109.955 -178.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.1 m 176.26 -81.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.51 -0.922 . . . . 1.0 108.51 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -112.93 19.87 16.91 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -61.16 137.48 58.23 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 1.0 110.492 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 96.6 mmm -137.53 146.99 44.81 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.336 -0.986 . . . . 1.0 108.336 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.9 mt -47.84 111.38 1.7 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.183 -0.948 . . . . 1.0 109.377 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -54.9 178.24 0.09 OUTLIER 'Trans proline' 0 N--CA 1.494 1.516 0 CA-C-N 120.051 1.054 . . . . 1.0 112.379 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -60.39 -39.96 89.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.4 -0.813 . . . . 1.0 110.065 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -57.27 -47.87 80.34 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.142 -0.974 . . . . 1.0 109.597 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.04 -39.98 75.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.237 -0.914 . . . . 1.0 110.231 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 55.9 t -63.41 -46.95 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.989 -1.07 . . . . 1.0 109.261 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -60.01 -40.04 87.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.16 -0.962 . . . . 1.0 110.208 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -68.8 -56.63 9.05 Favored Glycine 0 N--CA 1.493 2.463 0 O-C-N 121.142 -0.974 . . . . 1.0 111.131 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.49 HG23 ' N ' ' A' ' 160' ' ' GLN . 5.4 tp -61.27 -40.02 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.941 -1.329 . . . . 1.0 109.711 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 164' ' ' GLY . 93.1 mm-40 -64.99 -39.94 94.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 1.0 109.613 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 87.5 p -65.25 -26.76 68.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.185 -0.947 . . . . 1.0 110.051 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.402 ' CD2' ' N ' ' A' ' 7' ' ' THR . 89.5 mt -88.38 -50.59 6.23 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.993 -1.067 . . . . 1.0 110.263 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -94.47 -9.53 35.2 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.027 -1.046 . . . . 1.0 110.422 -179.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.496 2.678 0 N-CA-C 109.509 -1.437 . . . . 1.0 109.509 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 169' ' ' WAY . . . . . 0.767 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.3 m . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.481 -0.562 . . . . 1.0 109.481 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.6 mt -70.15 139.41 52.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 1.0 109.212 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -160.77 159.99 30.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.342 -0.849 . . . . 1.0 109.476 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -71.29 148.77 46.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.007 -1.058 . . . . 1.0 109.278 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.9 t -81.93 0.87 37.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.905 . . . . 1.0 109.766 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -149.97 155.68 40.39 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.017 -1.052 . . . . 1.0 110.054 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.544 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.93 0.01 57.62 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.405 -0.809 . . . . 1.0 109.731 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -95.89 126.95 41.49 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.234 -0.916 . . . . 1.0 108.696 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.8 mt -140.48 151.35 44.76 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.276 -0.89 . . . . 1.0 109.377 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.9 p -130.42 152.1 50.19 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.825 -0.806 . . . . 1.0 108.825 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -145.4 160.04 42.15 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.116 -0.99 . . . . 1.0 109.911 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.716 HH12 ' H ' ' A' ' 58' ' ' ALA . 13.9 ttp-105 -143.4 137.6 28.78 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.294 -0.879 . . . . 1.0 109.793 -179.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 92.0 mt -88.53 119.08 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.219 -0.925 . . . . 1.0 108.837 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.0 t -69.92 -39.98 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 1.0 109.722 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -163.0 150.99 13.67 Favored 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 117.243 -1.783 . . . . 1.0 111.744 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.446 ' HB2' ' CE1' ' A' ' 28' ' ' HIS . 43.2 m-85 -99.79 105.13 16.88 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 104.313 -2.477 . . . . 1.0 104.313 176.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.1 t -58.32 145.74 73.79 Favored Pre-proline 0 C--N 1.294 -1.807 0 O-C-N 121.027 -1.046 . . . . 1.0 110.419 -176.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -60.86 -11.65 18.82 Favored 'Trans proline' 0 N--CA 1.488 1.16 0 C-N-CA 120.961 1.108 . . . . 1.0 111.57 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -56.7 -32.43 65.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.326 -0.859 . . . . 1.0 110.002 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.6 mtm -140.13 160.52 39.75 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.185 -0.947 . . . . 1.0 109.415 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 66.3 p -73.59 162.34 29.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.255 -0.903 . . . . 1.0 109.781 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.446 ' CE1' ' HB2' ' A' ' 22' ' ' TYR . 1.1 m-70 -60.87 -41.75 96.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.213 -0.929 . . . . 1.0 109.98 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.6 m -60.44 -41.88 94.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.083 -1.011 . . . . 1.0 110.183 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.59 -40.03 80.64 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.187 -0.946 . . . . 1.0 110.277 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 69.3 t -68.73 -43.67 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.117 -0.989 . . . . 1.0 110.205 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -59.93 -48.6 81.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.127 -0.983 . . . . 1.0 110.754 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.445 ' HA ' ' HZ2' ' A' ' 36' ' ' LYS . 16.7 ptpt -62.01 -33.45 74.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.765 -1.209 . . . . 1.0 110.118 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.99 -50.84 72.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.919 -1.113 . . . . 1.0 110.215 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.43 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 57.5 m-85 -69.15 -39.78 78.61 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.85 -1.156 . . . . 1.0 110.609 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.445 ' HZ2' ' HA ' ' A' ' 33' ' ' LYS . 9.6 mtmp? -59.93 -41.85 92.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.913 -1.117 . . . . 1.0 109.715 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -60.6 -40.04 90.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.79 -1.194 . . . . 1.0 108.725 178.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.99 -44.06 94.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -0.871 . . . . 1.0 110.059 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -65.58 -40.15 92.43 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.867 -1.146 . . . . 1.0 109.106 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.4 ' O ' ' CG ' ' A' ' 44' ' ' ASP . 48.1 tptt -60.12 -49.65 76.8 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.496 -0.752 . . . . 1.0 110.718 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.8 t -60.18 -43.03 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 120.799 -1.188 . . . . 1.0 110.487 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -76.98 -36.83 56.15 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.801 -1.187 . . . . 1.0 109.996 -178.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.1 p -71.0 -20.73 62.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.058 -1.026 . . . . 1.0 109.882 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.4 ' CG ' ' O ' ' A' ' 40' ' ' LYS . 81.7 m-20 -59.95 -40.12 87.93 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.354 -0.841 . . . . 1.0 110.6 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.5 m -110.04 24.13 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 121.187 -0.945 . . . . 1.0 110.73 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.4 p -150.15 134.09 9.02 Favored Pre-proline 0 N--CA 1.501 2.094 0 O-C-N 120.973 -1.079 . . . . 1.0 109.588 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -74.49 21.91 0.4 Allowed 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 120.794 0.996 . . . . 1.0 112.166 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 79.6 mt -69.74 138.71 53.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.132 -0.98 . . . . 1.0 109.954 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -106.86 120.78 42.95 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -109.9 125.59 52.98 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.44 -0.787 . . . . 1.0 109.547 -179.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 93.8 m -120.05 130.1 54.54 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.641 -0.662 . . . . 1.0 109.735 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.41 ' NH1' ' HG3' ' A' ' 52' ' ' ARG . 39.0 ttm-85 -81.32 130.27 34.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.368 -0.832 . . . . 1.0 109.226 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.1 mt -102.38 126.92 49.55 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.189 -0.944 . . . . 1.0 109.37 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.447 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 43.6 m170 -62.86 -40.12 96.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.368 -0.833 . . . . 1.0 109.666 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 78.7 m-20 -148.52 173.32 13.26 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.354 -0.841 . . . . 1.0 109.799 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.519 ' O ' ' NH1' ' A' ' 18' ' ' ARG . . . 95.85 178.51 36.36 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.411 -1.476 . . . . 1.0 109.411 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.5 mt -95.5 133.79 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.114 -1.227 . . . . 1.0 109.245 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.716 ' H ' HH12 ' A' ' 18' ' ' ARG . . . -110.15 159.04 17.7 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.401 -0.812 . . . . 1.0 109.232 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.06 -49.41 77.75 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.227 -0.921 . . . . 1.0 109.249 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 93.9 mt -106.4 102.13 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.428 -0.795 . . . . 1.0 109.83 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.8 ptp -101.87 134.27 45.32 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.213 -0.93 . . . . 1.0 109.102 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.43 HG21 ' CZ ' ' A' ' 35' ' ' PHE . 84.5 mt -109.94 130.53 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 109.091 -0.707 . . . . 1.0 109.091 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.6 p -151.15 157.03 42.19 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.929 -1.107 . . . . 1.0 110.577 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -105.68 120.08 40.78 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.769 -1.197 . . . . 1.0 107.769 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -111.68 -171.06 18.88 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 110.739 -0.944 . . . . 1.0 110.739 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.566 ' O ' ' C ' ' A' ' 67' ' ' LYS . 96.6 mt -136.33 163.9 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 107.892 -1.151 . . . . 1.0 107.892 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.566 ' C ' ' O ' ' A' ' 66' ' ' ILE . 28.0 tptp -0.29 -91.95 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.874 0 CA-C-O 120.983 0.421 . . . . 1.0 111.757 -179.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -79.01 136.65 37.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.947 -1.096 . . . . 1.0 109.018 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.554 ' CE1' ' OD2' ' A' ' 71' ' ' ASP . 44.3 p-80 -138.48 29.56 2.41 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.995 -1.065 . . . . 1.0 110.543 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.77 22.51 18.07 Favored Glycine 0 N--CA 1.501 2.998 0 O-C-N 121.066 -1.021 . . . . 1.0 111.327 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.554 ' OD2' ' CE1' ' A' ' 69' ' ' HIS . 29.7 p-10 -149.44 173.96 13.0 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.695 -1.473 . . . . 1.0 110.13 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.612 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 2.1 p90 -98.18 29.69 3.43 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.458 -0.776 . . . . 1.0 109.657 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.612 ' CE2' ' CE2' ' A' ' 72' ' ' PHE . 52.0 m-85 -130.02 75.71 79.07 Favored Pre-proline 0 N--CA 1.499 2.018 0 N-CA-C 108.552 -0.907 . . . . 1.0 108.552 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -70.35 168.32 22.68 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 120.788 0.992 . . . . 1.0 112.485 -179.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.552 ' CE2' ' OD1' ' A' ' 99' ' ' ASP . 88.7 m-85 -90.85 172.7 8.43 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.239 -1.023 . . . . 1.0 108.239 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.0 p-10 -100.72 9.71 42.08 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.218 -0.926 . . . . 1.0 111.119 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 118.01 -149.68 18.4 Favored Glycine 0 N--CA 1.506 3.304 0 N-CA-C 109.012 -1.635 . . . . 1.0 109.012 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.439 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 9.6 Cg_exo -60.11 -65.72 0.07 OUTLIER 'Trans proline' 0 N--CA 1.492 1.395 0 CA-C-N 119.157 1.479 . . . . 1.0 112.392 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 90.0 p -76.54 164.74 25.66 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.966 -1.084 . . . . 1.0 110.079 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.38 -130.87 9.67 Favored Glycine 0 N--CA 1.502 3.057 0 N-CA-C 109.998 -1.241 . . . . 1.0 109.998 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.435 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 5.0 mt -68.62 105.43 2.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.509 -0.995 . . . . 1.0 108.624 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 82.1 mt -75.87 -32.6 59.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.091 -1.006 . . . . 1.0 109.535 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -176.44 161.95 2.27 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.929 -0.767 . . . . 1.0 108.929 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -160.24 162.41 33.71 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.154 -0.966 . . . . 1.0 110.084 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 95' ' ' ASP . . . -139.65 157.97 44.9 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.168 -1.049 . . . . 1.0 108.168 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -90.92 152.23 44.22 Favored Pre-proline 0 N--CA 1.497 1.918 0 N-CA-C 108.186 -1.042 . . . . 1.0 108.186 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -54.97 167.95 1.4 Allowed 'Trans proline' 0 N--CA 1.492 1.401 0 CA-C-N 119.437 0.835 . . . . 1.0 111.44 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -49.7 123.76 11.13 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 120.558 0.839 . . . . 1.0 111.84 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 90' ' ' PRO . . . -159.19 -170.93 24.35 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.311 -1.516 . . . . 1.0 109.311 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 89' ' ' GLY . 8.1 Cg_exo -55.49 -148.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.001 1.134 . . . . 1.0 112.693 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -59.56 -39.96 85.75 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.586 -0.696 . . . . 1.0 109.697 -179.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -66.48 -40.01 89.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.073 -1.017 . . . . 1.0 109.732 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.29 168.94 37.27 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.851 -1.3 . . . . 1.0 109.851 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 66.43 8.54 45.91 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.158 -1.177 . . . . 1.0 110.158 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.437 ' O ' ' HB1' ' A' ' 85' ' ' ALA . 42.5 p-10 -81.4 169.03 17.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.998 -1.295 . . . . 1.0 109.78 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.31 116.4 6.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.088 -1.008 . . . . 1.0 109.13 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -105.54 130.52 53.58 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.515 -0.74 . . . . 1.0 109.824 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -112.59 142.6 44.98 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.522 -0.918 . . . . 1.0 108.522 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.552 ' OD1' ' CE2' ' A' ' 75' ' ' PHE . 94.1 m-20 -79.32 124.6 28.55 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.082 -1.011 . . . . 1.0 109.938 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 44.7 t0 -84.08 2.34 39.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.362 -0.836 . . . . 1.0 109.189 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -81.31 -16.06 53.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.345 -0.847 . . . . 1.0 109.952 -179.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.549 ' OE1' ' N ' ' A' ' 102' ' ' GLU . 58.1 mp0 -93.43 170.14 9.83 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.174 -0.954 . . . . 1.0 109.49 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 47.7 m -98.96 105.42 17.56 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.462 -0.94 . . . . 1.0 108.462 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -84.29 127.93 34.27 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.319 -0.863 . . . . 1.0 108.941 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.679 HG21 ' HB2' ' A' ' 109' ' ' LYS . 9.2 t -139.95 159.93 41.05 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.391 -0.818 . . . . 1.0 110.066 -179.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.1 t -93.64 -10.46 34.46 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.923 -1.14 . . . . 1.0 107.923 178.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 81.7 p -92.13 179.08 5.68 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.577 -0.897 . . . . 1.0 108.577 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.3 t -85.34 75.95 10.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.94 -1.1 . . . . 1.0 109.564 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.679 ' HB2' HG21 ' A' ' 105' ' ' THR . 4.0 mmmm -140.02 144.86 37.13 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 107.987 -1.116 . . . . 1.0 107.987 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 49.89 -129.97 27.15 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.119 -1.592 . . . . 1.0 109.119 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -104.97 115.44 30.28 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.318 -1.107 . . . . 1.0 109.309 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.717 HD21 ' N ' ' A' ' 113' ' ' LEU . 0.4 OUTLIER -65.3 131.77 47.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.905 . . . . 1.0 109.581 179.636 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.717 ' N ' HD21 ' A' ' 112' ' ' ASN . 63.1 tp -59.96 -45.09 93.8 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.445 -0.784 . . . . 1.0 111.215 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -59.93 -40.02 87.46 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.046 -1.033 . . . . 1.0 110.69 -178.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -59.34 -52.68 64.59 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.849 -1.157 . . . . 1.0 109.835 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.4 t -69.93 -40.06 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.924 -1.11 . . . . 1.0 109.409 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.74 -52.3 65.52 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.138 -0.976 . . . . 1.0 108.839 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.78 -32.59 67.67 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 120.64 -1.288 . . . . 1.0 109.686 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -66.48 -55.82 13.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.031 -1.043 . . . . 1.0 111.666 -178.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.29 -31.88 70.67 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.487 -1.383 . . . . 1.0 110.131 -179.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -59.8 -41.52 91.41 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.752 -1.218 . . . . 1.0 108.396 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.0 -43.46 98.15 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.364 -1.494 . . . . 1.0 109.364 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -64.5 -39.86 94.57 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.047 -1.267 . . . . 1.0 109.248 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.0 p -67.82 -25.85 65.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.354 -0.841 . . . . 1.0 109.525 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 75.2 mt -81.57 -3.1 52.37 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.234 -0.916 . . . . 1.0 109.94 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.67 9.3 58.83 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 110.534 -1.027 . . . . 1.0 110.534 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.1 mt -85.88 144.59 27.59 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.917 -1.343 . . . . 1.0 109.559 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 28.6 t0 -101.63 173.41 6.44 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.97 -0.752 . . . . 1.0 108.97 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.509 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 75.7 m80 -60.01 134.61 57.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.203 -0.936 . . . . 1.0 109.236 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 47.6 t -96.77 160.24 14.48 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.023 -1.048 . . . . 1.0 109.376 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -99.67 2.17 44.15 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.353 -0.842 . . . . 1.0 109.655 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 9.6 t70 -85.18 129.48 55.67 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.901 . . . . 1.0 108.713 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -68.13 -25.48 37.38 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 CA-C-N 119.984 1.03 . . . . 1.0 112.389 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.437 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -84.9 -3.82 87.62 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.837 -1.305 . . . . 1.0 109.837 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.03 144.84 27.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.35 -1.088 . . . . 1.0 109.663 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 93.8 mt -70.03 -30.68 68.02 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.316 -0.865 . . . . 1.0 109.187 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 98.1 mmm -72.67 15.47 0.19 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.385 -0.822 . . . . 1.0 110.603 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -72.13 137.59 81.77 Favored Pre-proline 0 N--CA 1.5 2.061 0 O-C-N 121.02 -1.05 . . . . 1.0 108.421 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -61.8 -11.92 23.07 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 120.862 1.041 . . . . 1.0 114.29 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 95.9 mt -109.97 139.08 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.443 0 O-C-N 120.655 -1.278 . . . . 1.0 109.744 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -73.55 129.87 38.88 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.582 -0.699 . . . . 1.0 110.08 -179.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 15.2 t -140.1 143.33 36.2 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.482 -0.762 . . . . 1.0 109.139 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -81.21 149.44 29.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.957 -1.089 . . . . 1.0 109.532 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.9 t -140.23 155.5 46.87 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.906 -0.776 . . . . 1.0 108.906 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.45 111.43 3.57 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.465 -1.454 . . . . 1.0 109.465 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -76.78 -1.48 28.36 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.297 -1.119 . . . . 1.0 109.391 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.2 m -60.0 -40.13 88.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.372 -0.83 . . . . 1.0 109.762 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -160.36 67.48 0.35 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.238 -0.914 . . . . 1.0 109.336 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' A' ' 149' ' ' PHE . 39.0 t80 -99.16 125.04 44.63 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.333 -0.855 . . . . 1.0 109.36 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 75.2 mtm -120.24 141.3 50.07 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.843 -0.799 . . . . 1.0 108.843 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 49.0 mt -49.17 129.06 16.22 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.041 -1.037 . . . . 1.0 108.654 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -66.08 176.93 3.4 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 CA-C-N 119.944 1.016 . . . . 1.0 112.798 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.28 -39.78 88.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.623 -0.673 . . . . 1.0 109.588 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -58.06 -49.28 77.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.315 -0.866 . . . . 1.0 109.86 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -70.03 -40.01 75.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.014 -1.054 . . . . 1.0 109.774 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.3 t -60.1 -46.35 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.129 -0.982 . . . . 1.0 109.335 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -60.23 -39.99 88.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.904 -1.123 . . . . 1.0 110.131 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -68.63 -55.28 12.1 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.154 -1.022 . . . . 1.0 111.113 -178.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.477 HG23 ' N ' ' A' ' 160' ' ' GLN . 5.7 tp -61.93 -40.39 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.941 -1.329 . . . . 1.0 109.74 -179.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.477 ' N ' HG23 ' A' ' 159' ' ' ILE . 26.4 mm100 -66.39 -39.93 89.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 1.0 109.648 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 91.9 p -70.17 -22.59 62.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 1.0 110.044 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 86.9 mt -88.1 -50.39 6.42 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.957 -1.089 . . . . 1.0 110.188 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -93.0 -9.78 38.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.96 -1.087 . . . . 1.0 109.697 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.524 0 N-CA-C 109.621 -1.392 . . . . 1.0 109.621 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 169' ' ' WAY . . . . . 0.535 ' CJ ' ' HE3' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.284 -0.636 . . . . 1.0 109.284 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.4 mt -81.92 144.58 30.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.287 -0.883 . . . . 1.0 109.346 179.8 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -160.92 163.03 32.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 1.0 109.242 179.72 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 62.7 m95 -72.42 145.35 47.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -0.923 . . . . 1.0 109.806 -179.435 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 61.1 m -88.84 4.24 48.4 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.33 -0.856 . . . . 1.0 110.235 -179.522 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.452 ' NZ ' ' O ' ' A' ' 14' ' ' ASN . 21.5 pttp -140.76 150.78 43.82 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.123 -0.986 . . . . 1.0 109.394 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.1 mmt -90.03 0.23 57.23 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.394 -0.816 . . . . 1.0 109.798 -179.043 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.452 ' O ' ' NZ ' ' A' ' 12' ' ' LYS . 33.2 m120 -94.89 128.59 41.78 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.2 -0.938 . . . . 1.0 109.349 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.7 mt -141.43 150.01 41.76 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.156 -0.965 . . . . 1.0 108.974 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.8 p -132.66 155.39 48.85 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.565 -0.71 . . . . 1.0 109.145 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -145.69 162.7 36.96 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.045 -1.034 . . . . 1.0 110.119 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.544 ' NE ' ' O ' ' A' ' 56' ' ' GLY . 36.8 ttm-85 -144.25 131.43 20.66 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.629 -0.669 . . . . 1.0 109.44 -179.378 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.5 mt -88.92 114.55 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.074 -1.016 . . . . 1.0 108.624 178.64 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.7 -40.55 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 1.0 109.906 -179.58 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.6 p-10 -165.56 154.46 11.89 Favored 'General case' 0 C--N 1.285 -2.2 0 O-C-N 119.675 -1.89 . . . . 1.0 111.168 -179.154 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -99.95 113.0 25.27 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 105.814 -1.921 . . . . 1.0 105.814 178.081 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 23' ' ' THR . 0.4 OUTLIER -56.45 137.79 75.94 Favored Pre-proline 0 C--N 1.297 -1.707 0 O-C-N 120.957 -1.09 . . . . 1.0 109.201 -177.805 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -56.76 -9.29 3.86 Favored 'Trans proline' 0 N--CA 1.483 0.872 0 CA-C-N 119.503 0.858 . . . . 1.0 110.352 179.528 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.412 ' H ' ' C ' ' A' ' 23' ' ' THR . 98.0 m-20 -57.1 -32.08 65.93 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 120.13 -0.628 . . . . 1.0 110.086 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.8 mtm -140.94 164.36 30.48 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.117 -0.99 . . . . 1.0 109.441 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 75.6 p -71.96 160.69 32.1 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.373 -0.829 . . . . 1.0 109.131 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -60.12 -42.34 94.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.173 -0.954 . . . . 1.0 110.2 -179.105 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.546 ' O ' ' NZ ' ' A' ' 33' ' ' LYS . 73.2 m -60.23 -43.18 96.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.103 -0.998 . . . . 1.0 111.006 -179.163 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.25 -40.89 96.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.083 -1.011 . . . . 1.0 110.802 -178.708 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 63.2 t -67.18 -40.21 84.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.101 -0.999 . . . . 1.0 109.746 -179.624 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -60.02 -50.13 74.94 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.261 -0.899 . . . . 1.0 110.929 -179.259 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.546 ' NZ ' ' O ' ' A' ' 29' ' ' SER . 1.7 ptpp? -63.9 -31.03 72.08 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.04 -1.037 . . . . 1.0 110.015 -179.517 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.9 -49.55 77.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.046 -1.034 . . . . 1.0 109.566 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -67.54 -38.97 84.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.118 -0.989 . . . . 1.0 109.797 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.0 -41.91 93.15 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.982 -1.074 . . . . 1.0 109.429 -179.518 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -60.96 -40.87 95.03 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.911 -1.118 . . . . 1.0 108.693 178.936 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.55 -47.08 85.43 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.369 -0.832 . . . . 1.0 109.743 179.447 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.428 ' CZ ' ' CZ ' ' A' ' 121' ' ' PHE . 48.7 m-85 -67.68 -39.98 84.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.063 -1.023 . . . . 1.0 109.742 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -59.95 -45.58 92.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.163 -0.96 . . . . 1.0 109.618 -179.085 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.5 t -60.01 -45.53 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.328 -0.858 . . . . 1.0 109.913 -179.42 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 76.8 m95 -76.71 -35.23 57.97 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.075 -1.015 . . . . 1.0 109.995 -179.54 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 62.9 p -71.62 -19.6 62.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.075 -1.016 . . . . 1.0 109.873 -179.771 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -60.0 -39.22 85.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.252 -0.905 . . . . 1.0 110.562 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.9 m -110.5 -22.96 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.249 -0.907 . . . . 1.0 110.62 -178.592 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.418 ' C ' ' H ' ' A' ' 48' ' ' LEU . 56.1 p -95.73 130.4 31.84 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 120.888 -1.132 . . . . 1.0 110.108 -179.623 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -72.32 18.48 0.33 Allowed 'Trans proline' 0 N--CA 1.492 1.4 0 CA-C-N 119.873 0.99 . . . . 1.0 111.463 178.621 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.418 ' H ' ' C ' ' A' ' 46' ' ' THR . 77.4 mt -69.3 138.7 54.04 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.207 -0.933 . . . . 1.0 109.602 -179.47 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -109.26 121.88 46.12 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 179.532 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -107.13 128.93 54.83 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.369 -0.832 . . . . 1.0 109.359 -179.269 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 90.2 m -121.88 130.26 53.22 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.524 -0.735 . . . . 1.0 109.961 -179.526 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -80.14 130.05 34.95 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.236 -0.915 . . . . 1.0 109.163 179.656 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.499 ' O ' ' NH1' ' A' ' 18' ' ' ARG . 94.3 mt -102.53 132.42 48.6 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.165 -0.959 . . . . 1.0 109.415 179.331 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.491 ' C ' HH12 ' A' ' 18' ' ' ARG . 23.9 m-70 -68.83 -39.91 79.74 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.662 -0.649 . . . . 1.0 110.206 -179.702 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.484 ' C ' ' NH2' ' A' ' 18' ' ' ARG . 74.1 m-20 -150.09 166.75 28.84 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.115 -0.99 . . . . 1.0 109.992 -179.565 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.544 ' O ' ' NE ' ' A' ' 18' ' ' ARG . . . 99.95 -176.42 28.27 Favored Glycine 0 N--CA 1.498 2.825 0 N-CA-C 109.53 -1.428 . . . . 1.0 109.53 -179.696 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.4 mt -95.5 135.25 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.192 -1.181 . . . . 1.0 109.261 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.04 158.94 18.25 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.436 -0.79 . . . . 1.0 109.284 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -59.99 -49.57 77.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.2 -0.937 . . . . 1.0 109.51 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 92.5 mt -108.35 98.47 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.434 -0.791 . . . . 1.0 109.698 179.634 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.5 ptm -97.96 126.07 43.19 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.487 -0.931 . . . . 1.0 108.487 179.134 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.8 mt -104.84 136.84 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.455 -0.778 . . . . 1.0 110.58 -178.509 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.1 p -153.68 160.03 42.22 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.398 -0.814 . . . . 1.0 109.548 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -102.13 122.28 43.84 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.605 -0.887 . . . . 1.0 108.605 179.486 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 98' ' ' PHE . . . -99.76 -172.76 30.51 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 110.822 -0.911 . . . . 1.0 110.822 -178.677 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.564 HG22 ' N ' ' A' ' 67' ' ' LYS . 73.4 mt -135.7 167.86 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.784 -0.833 . . . . 1.0 109.043 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.564 ' N ' HG22 ' A' ' 66' ' ' ILE . 19.8 tptm -23.88 -77.98 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 CA-C-O 121.128 0.49 . . . . 1.0 111.84 -179.374 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -70.25 149.29 47.6 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.086 -1.009 . . . . 1.0 110.443 -179.235 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.458 ' C ' ' H ' ' A' ' 71' ' ' ASP . 1.5 m80 -138.62 153.05 48.61 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.56 -0.904 . . . . 1.0 108.56 179.607 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.7 40.76 0.98 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.098 -1.601 . . . . 1.0 109.098 179.364 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' A' ' 69' ' ' HIS . 32.9 p-10 -140.14 -178.95 5.7 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.457 -1.025 . . . . 1.0 109.092 -179.791 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -98.26 22.76 9.15 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.291 -0.881 . . . . 1.0 109.734 -179.809 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -129.41 78.33 75.91 Favored Pre-proline 0 N--CA 1.502 2.142 0 O-C-N 121.453 -0.78 . . . . 1.0 109.334 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -73.78 167.01 28.3 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.165 1.243 . . . . 1.0 112.441 -179.596 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.533 ' CE2' ' OD1' ' A' ' 99' ' ' ASP . 40.6 m-85 -93.5 171.08 9.12 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.409 -0.807 . . . . 1.0 109.305 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 79' ' ' SER . 34.5 p-10 -101.05 10.65 40.79 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.352 -0.842 . . . . 1.0 110.474 -179.288 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 114.96 -155.61 16.22 Favored Glycine 0 N--CA 1.504 3.188 0 N-CA-C 109.092 -1.603 . . . . 1.0 109.092 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.424 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 15.8 Cg_exo -56.64 -64.12 0.14 Allowed 'Trans proline' 0 N--CA 1.492 1.403 0 CA-C-N 118.827 1.314 . . . . 1.0 112.308 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.43 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 83.9 p -75.0 159.03 32.26 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.896 -1.128 . . . . 1.0 109.384 179.715 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.03 -129.67 8.22 Favored Glycine 0 N--CA 1.502 3.045 0 N-CA-C 110.218 -1.153 . . . . 1.0 110.218 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.401 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 19.0 mt -70.19 112.72 6.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.351 -1.087 . . . . 1.0 109.406 -179.584 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 38.1 mt -79.22 -24.54 43.02 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.155 -0.966 . . . . 1.0 108.703 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -177.07 170.68 2.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.531 -0.731 . . . . 1.0 109.412 -179.733 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -162.41 163.33 27.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.104 -0.997 . . . . 1.0 109.968 179.676 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -147.2 153.48 39.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.385 -0.822 . . . . 1.0 109.071 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -88.44 152.67 50.07 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.151 -0.968 . . . . 1.0 109.23 -179.607 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -53.5 162.58 3.2 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 CA-C-N 119.214 0.755 . . . . 1.0 111.716 179.583 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -45.09 157.66 0.21 Allowed 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 121.12 1.213 . . . . 1.0 111.942 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -174.57 173.54 46.14 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.728 -1.349 . . . . 1.0 109.728 -179.759 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -49.86 -75.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 120.881 1.054 . . . . 1.0 111.675 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -130.08 -40.81 1.3 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.395 -0.816 . . . . 1.0 109.369 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -63.01 -44.15 96.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.544 -0.722 . . . . 1.0 110.213 -179.377 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -69.51 170.1 43.13 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.467 -1.453 . . . . 1.0 109.467 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 80.08 6.25 89.25 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.05 -1.22 . . . . 1.0 110.05 179.899 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.2 p-10 -80.52 167.59 19.95 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.074 -1.25 . . . . 1.0 109.409 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.08 120.72 7.49 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.019 -1.051 . . . . 1.0 110.014 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -106.06 154.03 21.22 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.58 -0.7 . . . . 1.0 109.633 179.772 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' A' ' 65' ' ' GLY . 28.0 m-85 -129.94 152.01 49.87 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.289 -1.004 . . . . 1.0 108.289 179.177 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.533 ' OD1' ' CE2' ' A' ' 75' ' ' PHE . 86.5 m-20 -78.5 120.81 23.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.913 -1.117 . . . . 1.0 109.987 -179.63 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -84.06 -7.85 59.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.311 -0.868 . . . . 1.0 109.056 179.286 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -82.63 -15.93 50.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.3 -0.875 . . . . 1.0 109.178 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.424 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 97.2 mt-10 -89.88 169.92 10.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.502 -0.749 . . . . 1.0 109.07 -179.727 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 16.9 m -99.23 108.5 21.09 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.26 -0.9 . . . . 1.0 109.286 -179.555 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.491 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 93.7 m95 -91.08 125.14 35.78 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.705 -0.85 . . . . 1.0 108.705 179.505 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.665 HG21 ' HB2' ' A' ' 109' ' ' LYS . 7.3 t -140.16 151.17 45.04 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.376 -0.828 . . . . 1.0 109.885 -179.156 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 55.7 m -90.25 -8.23 51.51 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.074 -1.084 . . . . 1.0 108.074 178.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.1 p -90.65 177.27 6.39 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.625 -0.879 . . . . 1.0 108.625 178.875 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 m -81.09 76.53 8.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.981 -1.074 . . . . 1.0 109.628 -179.853 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.665 ' HB2' HG21 ' A' ' 105' ' ' THR . 98.5 mttt -147.03 149.67 33.57 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.367 -0.833 . . . . 1.0 108.884 179.585 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.31 -135.88 7.38 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.935 -1.266 . . . . 1.0 109.935 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -100.11 118.22 36.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.413 -1.051 . . . . 1.0 109.143 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -66.58 129.09 38.69 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.365 -0.835 . . . . 1.0 110.294 -179.567 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.6 tp -60.02 -40.66 90.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.357 -0.84 . . . . 1.0 109.875 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -59.96 -47.76 84.47 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.416 -0.802 . . . . 1.0 110.587 -178.893 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -58.66 -50.63 73.16 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.854 -1.154 . . . . 1.0 109.761 -179.612 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 77.9 t -69.1 -40.11 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.918 -1.114 . . . . 1.0 109.668 -179.22 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.99 -50.26 74.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.098 -1.001 . . . . 1.0 109.976 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.78 -37.84 80.2 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.564 -1.335 . . . . 1.0 109.521 -179.835 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 67.1 t60 -63.8 -49.98 70.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.316 -0.865 . . . . 1.0 111.624 -178.594 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.84 -38.55 78.97 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.512 -1.367 . . . . 1.0 109.723 -178.735 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.428 ' CZ ' ' CZ ' ' A' ' 39' ' ' PHE . 29.9 m-85 -60.02 -39.86 87.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.92 -1.112 . . . . 1.0 108.535 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.55 -46.83 91.6 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.69 -1.364 . . . . 1.0 109.69 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -63.94 -40.08 95.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.13 -1.217 . . . . 1.0 109.449 179.66 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 91.9 p -68.49 -22.73 64.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.277 -0.89 . . . . 1.0 109.571 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 35.7 mt -81.68 -7.03 59.55 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.103 -0.998 . . . . 1.0 109.472 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 99.54 2.74 56.47 Favored Glycine 0 N--CA 1.499 2.887 0 N-CA-C 110.674 -0.971 . . . . 1.0 110.674 178.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 75.2 mt -85.11 147.23 26.74 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.947 -1.325 . . . . 1.0 109.775 179.653 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 35.5 t0 -102.96 -178.73 3.75 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.86 -0.792 . . . . 1.0 108.86 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.499 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 75.9 m80 -60.1 139.99 57.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.088 -1.008 . . . . 1.0 109.764 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 27.2 t -96.21 162.05 13.69 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.242 -0.912 . . . . 1.0 109.244 179.513 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -101.11 1.92 39.77 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.344 -0.848 . . . . 1.0 109.857 -179.692 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -90.52 114.14 60.14 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.212 -0.93 . . . . 1.0 109.206 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -53.77 -22.75 24.29 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 CA-C-N 120.27 1.132 . . . . 1.0 112.216 -179.796 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -86.8 -7.68 77.78 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.49 -1.044 . . . . 1.0 110.49 -179.306 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.44 149.42 26.67 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.985 -1.303 . . . . 1.0 109.576 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 92.9 mt -70.07 -30.97 68.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.142 -0.974 . . . . 1.0 109.473 179.69 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 98.0 mmm -73.42 13.56 0.44 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.368 -0.833 . . . . 1.0 110.396 -178.952 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -70.37 134.61 86.8 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.964 -1.085 . . . . 1.0 108.114 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -65.35 15.42 0.09 OUTLIER 'Trans proline' 0 N--CA 1.506 2.229 0 C-N-CA 121.065 1.177 . . . . 1.0 115.048 -177.785 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 90.0 mt -133.69 140.49 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 O-C-N 120.73 -1.231 . . . . 1.0 109.609 179.453 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -72.87 130.67 40.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.517 -0.739 . . . . 1.0 110.046 -179.25 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.2 t -143.15 137.63 29.2 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.322 -0.861 . . . . 1.0 109.479 179.777 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -81.41 143.98 31.75 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.081 -1.012 . . . . 1.0 109.18 179.785 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.7 t -139.11 156.53 47.09 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.208 -0.932 . . . . 1.0 110.117 -179.362 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.38 108.87 2.63 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.409 -1.476 . . . . 1.0 109.409 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -77.11 2.8 14.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.325 -1.103 . . . . 1.0 109.44 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 44.2 t -59.97 -45.01 94.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.228 -0.92 . . . . 1.0 110.149 -179.445 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -150.01 29.97 0.72 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.965 -1.084 . . . . 1.0 110.134 -179.536 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -60.44 139.17 57.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.054 -1.029 . . . . 1.0 109.647 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 73.7 mtm -138.55 148.5 44.28 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.353 -0.842 . . . . 1.0 108.762 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.7 mt -53.84 129.68 56.34 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 120.987 -1.071 . . . . 1.0 108.612 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -68.94 175.36 7.52 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 CA-C-N 120.112 1.076 . . . . 1.0 111.715 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.04 -38.78 83.76 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.344 -0.848 . . . . 1.0 109.48 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -55.07 -50.21 69.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.879 . . . . 1.0 110.057 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -70.2 -39.97 74.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.184 -0.947 . . . . 1.0 110.28 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 66.5 t -59.87 -47.02 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.006 -1.059 . . . . 1.0 109.035 -179.467 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -60.53 -40.07 90.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.055 -1.028 . . . . 1.0 110.463 179.772 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -73.82 -52.42 8.16 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.328 -0.939 . . . . 1.0 111.49 -178.465 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.454 HG23 ' N ' ' A' ' 160' ' ' GLN . 8.4 tp -60.49 -39.93 82.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.637 -1.508 . . . . 1.0 109.705 -178.956 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.8 mt-30 -66.37 -38.81 88.42 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.198 -0.939 . . . . 1.0 109.58 179.503 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 96.6 p -60.06 -34.94 74.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.394 -0.816 . . . . 1.0 110.686 -179.021 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 93.3 mt -85.17 -47.59 9.97 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.857 -1.152 . . . . 1.0 111.027 -178.814 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -91.68 -8.46 47.0 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.894 -1.129 . . . . 1.0 110.176 -179.007 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.404 -1.479 . . . . 1.0 109.404 -179.924 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 169' ' ' WAY . . . . . 0.666 ' HC2' ' HJ ' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.2 m . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.6 mt -94.96 129.1 42.16 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.184 -0.948 . . . . 1.0 108.988 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -160.09 163.24 34.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.255 -0.903 . . . . 1.0 109.628 -179.594 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -70.9 144.43 50.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -0.907 . . . . 1.0 109.439 -179.828 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.8 t -95.91 14.25 24.12 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.289 -0.882 . . . . 1.0 109.434 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.51 149.62 37.75 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.236 -0.915 . . . . 1.0 109.438 -179.764 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.3 mmt -91.71 -2.95 56.79 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.33 -0.856 . . . . 1.0 109.731 -179.634 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -101.59 125.63 48.27 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.295 -0.878 . . . . 1.0 109.362 179.767 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.7 mt -140.48 149.35 42.41 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.246 -0.909 . . . . 1.0 109.16 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.1 p -131.77 153.86 49.67 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.875 -0.787 . . . . 1.0 108.875 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -143.11 158.46 43.59 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.145 -0.972 . . . . 1.0 110.385 179.877 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.577 HH12 ' H ' ' A' ' 56' ' ' GLY . 72.1 ttt180 -146.55 134.97 21.94 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.469 -0.769 . . . . 1.0 109.59 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.9 mt -89.89 118.92 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.112 -0.992 . . . . 1.0 108.963 179.008 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.67 -40.58 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.091 -1.006 . . . . 1.0 109.107 -179.801 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -162.11 162.22 28.5 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.667 -1.27 . . . . 1.0 110.26 -179.184 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -103.25 -162.92 0.95 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.521 -1.288 . . . . 1.0 107.521 178.978 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.74 152.04 61.54 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.459 -0.775 . . . . 1.0 109.744 -179.708 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -68.1 -35.99 18.33 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 120.923 1.082 . . . . 1.0 111.512 179.271 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -59.01 -48.6 81.01 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.359 0.599 . . . . 1.0 110.756 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 56.2 mtp -96.29 145.99 25.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.373 -0.829 . . . . 1.0 110.47 -178.435 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.1 p -74.93 160.85 30.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.889 . . . . 1.0 108.783 179.361 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -61.23 -46.2 91.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.219 -0.925 . . . . 1.0 110.777 -179.146 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.8 m -62.2 -40.03 94.74 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.024 -1.047 . . . . 1.0 110.89 -178.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.55 -40.08 88.86 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.106 -0.996 . . . . 1.0 110.947 -179.156 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 71.3 t -68.49 -40.53 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.834 -1.166 . . . . 1.0 110.318 -179.173 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.97 -49.8 76.25 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.042 -1.036 . . . . 1.0 110.564 -179.134 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.19 -32.72 72.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.058 -1.026 . . . . 1.0 110.089 -179.502 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.03 -49.94 75.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.114 -0.991 . . . . 1.0 110.045 -179.447 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -66.4 -37.32 84.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.021 -1.05 . . . . 1.0 110.062 -179.719 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -59.97 -40.56 89.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.974 -1.079 . . . . 1.0 109.533 -179.68 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -61.95 -40.65 96.28 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.949 -1.094 . . . . 1.0 108.88 179.227 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.44 -49.75 76.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.377 -0.827 . . . . 1.0 110.528 -179.285 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.414 ' CZ ' ' CZ ' ' A' ' 121' ' ' PHE . 53.8 m-85 -65.27 -40.53 94.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.985 -1.072 . . . . 1.0 109.962 -179.262 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -59.99 -47.42 85.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.107 -0.995 . . . . 1.0 109.7 -179.579 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 70.8 t -59.99 -40.51 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.339 -0.851 . . . . 1.0 110.426 -179.394 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -79.87 -34.57 39.12 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.911 -1.118 . . . . 1.0 110.202 -179.236 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 94.8 p -72.82 -20.62 61.11 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.966 -1.083 . . . . 1.0 109.916 -179.761 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -59.99 -39.74 86.79 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 1.0 110.342 -179.36 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.4 m -111.81 30.72 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 O-C-N 121.264 -0.897 . . . . 1.0 110.69 -179.474 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.7 p -152.21 137.95 11.4 Favored Pre-proline 0 N--CA 1.502 2.14 0 O-C-N 120.607 -1.308 . . . . 1.0 109.756 179.015 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -74.72 11.83 1.28 Allowed 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 120.746 0.964 . . . . 1.0 112.285 178.686 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 77.9 mt -67.95 137.69 55.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.031 -1.043 . . . . 1.0 109.655 -179.095 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -106.93 120.7 42.74 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.028 -0.73 . . . . 1.0 109.028 179.664 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -108.25 123.33 48.61 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.446 -0.784 . . . . 1.0 109.238 -179.545 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.9 m -120.01 130.03 54.54 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.579 -0.701 . . . . 1.0 109.492 -179.795 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -82.12 132.55 35.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.438 -0.789 . . . . 1.0 109.406 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.3 mt -105.13 128.45 53.38 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.413 -0.804 . . . . 1.0 109.488 179.813 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.417 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 61.7 m170 -68.56 -39.74 80.9 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.481 -0.762 . . . . 1.0 109.347 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 89.4 m-20 -142.84 166.92 23.33 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.294 -0.879 . . . . 1.0 109.328 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.577 ' H ' HH12 ' A' ' 18' ' ' ARG . . . 97.24 172.4 33.91 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.646 -1.381 . . . . 1.0 109.646 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 93.5 mt -95.09 139.23 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.284 -1.127 . . . . 1.0 109.242 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -114.2 164.3 14.07 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.441 -0.787 . . . . 1.0 109.598 -179.634 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -59.94 -47.85 84.09 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.475 -0.935 . . . . 1.0 108.475 179.413 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.3 mt -105.27 133.84 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.697 -0.853 . . . . 1.0 108.697 179.697 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.2 ptm -139.31 129.79 25.71 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.63 -1.294 . . . . 1.0 109.491 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 93.5 mt -102.5 140.2 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.351 0.596 . . . . 1.0 109.958 -179.067 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 81.6 p -151.46 154.75 37.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.318 -0.864 . . . . 1.0 109.623 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -109.18 144.09 37.73 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.048 -0.723 . . . . 1.0 109.048 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.81 -162.82 9.73 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.457 -1.457 . . . . 1.0 109.457 -179.845 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.559 HG22 ' N ' ' A' ' 67' ' ' LYS . 92.6 mt -130.01 164.09 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.583 -0.951 . . . . 1.0 109.247 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.559 ' N ' HG22 ' A' ' 66' ' ' ILE . 49.1 tttm -35.6 -77.91 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 122.052 -0.405 . . . . 1.0 111.609 -179.005 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -69.22 119.32 13.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.84 -1.163 . . . . 1.0 110.043 -178.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.537 ' O ' ' N ' ' A' ' 71' ' ' ASP . 33.0 p-80 -159.99 163.51 34.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.326 -0.859 . . . . 1.0 108.957 179.454 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -51.42 86.44 0.01 OUTLIER Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.52 -1.032 . . . . 1.0 110.52 -179.213 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.537 ' N ' ' O ' ' A' ' 69' ' ' HIS . 51.6 t0 -161.51 147.78 14.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.116 -1.226 . . . . 1.0 109.525 179.385 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.469 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 54.4 p90 -81.84 -14.51 56.19 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.117 -0.989 . . . . 1.0 110.309 -179.863 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.549 ' O ' ' CG ' ' A' ' 73' ' ' TYR . 10.5 p90 -130.64 78.67 73.51 Favored Pre-proline 0 N--CA 1.502 2.165 0 O-C-N 121.302 -0.874 . . . . 1.0 109.484 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -56.7 -177.31 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.098 1.199 . . . . 1.0 112.649 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.554 ' CD2' ' OD2' ' A' ' 99' ' ' ASP . 94.6 m-85 -90.6 175.08 7.18 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.365 -0.834 . . . . 1.0 109.471 -179.872 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -99.56 -1.01 39.33 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.203 -0.935 . . . . 1.0 110.758 -178.981 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.55 -138.04 9.8 Favored Glycine 0 N--CA 1.503 3.114 0 N-CA-C 108.816 -1.714 . . . . 1.0 108.816 -179.729 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.427 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 18.6 Cg_endo -77.67 -58.42 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.376 0 CA-C-N 119.872 1.836 . . . . 1.0 111.932 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 92.2 p -79.42 167.45 20.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.341 -0.849 . . . . 1.0 109.566 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 105.76 -129.33 9.74 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 109.882 -1.287 . . . . 1.0 109.882 179.715 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.43 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 8.3 mt -67.06 105.91 1.8 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.391 -1.064 . . . . 1.0 108.939 -179.781 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.411 HD11 ' CD1' ' A' ' 111' ' ' TYR . 71.9 mt -80.66 -14.25 58.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.114 -0.992 . . . . 1.0 109.027 -179.672 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.93 177.51 0.66 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.468 ' ND1' ' C ' ' A' ' 84' ' ' HIS . 3.2 p80 -161.89 160.61 28.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.101 -1.0 . . . . 1.0 109.508 179.341 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.31 165.02 34.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.884 . . . . 1.0 109.423 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -108.04 151.96 41.54 Favored Pre-proline 0 N--CA 1.498 1.962 0 N-CA-C 108.494 -0.928 . . . . 1.0 108.494 179.576 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -62.52 165.76 14.85 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 120.643 0.895 . . . . 1.0 111.675 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -50.93 129.21 27.13 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 120.85 1.033 . . . . 1.0 111.371 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 90' ' ' PRO . . . -164.68 -169.95 28.97 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.728 -1.349 . . . . 1.0 109.728 -179.658 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.409 ' O ' ' O ' ' A' ' 89' ' ' GLY . 14.1 Cg_exo -57.99 -150.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 121.009 1.139 . . . . 1.0 111.736 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -60.13 -41.52 92.83 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.149 -0.969 . . . . 1.0 109.793 -179.597 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -60.85 -39.99 91.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.107 -0.996 . . . . 1.0 109.241 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.44 169.6 49.52 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.231 -1.547 . . . . 1.0 109.231 179.654 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 67.93 69.9 1.27 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.983 -1.247 . . . . 1.0 109.983 179.773 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 31.6 p-10 -149.41 161.88 41.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.177 -1.19 . . . . 1.0 108.982 179.402 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.95 120.96 8.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.151 -0.968 . . . . 1.0 109.78 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -104.29 139.83 38.73 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.566 -0.709 . . . . 1.0 110.069 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.476 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 25.8 m-85 -119.95 139.93 51.7 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.483 -0.761 . . . . 1.0 108.976 179.081 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.554 ' OD2' ' CD2' ' A' ' 75' ' ' PHE . 99.0 m-20 -79.98 126.19 30.72 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.915 -1.116 . . . . 1.0 109.787 179.907 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 49.1 t0 -87.75 0.94 55.07 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.306 -0.871 . . . . 1.0 109.844 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -81.34 -16.52 52.13 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.934 -1.104 . . . . 1.0 110.246 -179.428 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.545 ' OE1' ' N ' ' A' ' 102' ' ' GLU . 56.6 mp0 -93.02 174.99 6.95 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.183 -0.948 . . . . 1.0 109.445 -179.769 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 27.6 m -99.43 107.49 19.73 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.341 -0.849 . . . . 1.0 109.051 179.921 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -87.32 123.08 31.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 1.0 108.987 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.671 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.1 t -141.75 159.09 42.93 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.335 -0.853 . . . . 1.0 109.931 -179.192 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 44.3 t -96.03 -9.76 30.17 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.288 -1.005 . . . . 1.0 108.288 178.91 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 94.6 p -90.64 178.04 6.18 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.007 -0.738 . . . . 1.0 109.007 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.2 t -78.81 74.01 5.35 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.137 -0.977 . . . . 1.0 109.678 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.671 ' HB2' HG21 ' A' ' 105' ' ' THR . 98.4 mttt -146.66 148.69 32.31 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.463 -0.94 . . . . 1.0 108.463 179.093 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 46.28 -139.91 6.57 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.89 -1.284 . . . . 1.0 109.89 179.927 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.411 ' CD1' HD11 ' A' ' 82' ' ' LEU . 93.1 m-85 -100.0 116.35 31.84 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.323 -1.104 . . . . 1.0 109.173 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.43 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 2.2 t-20 -63.54 133.91 54.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.11 -0.994 . . . . 1.0 109.842 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.3 tp -59.98 -44.03 94.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.464 -0.772 . . . . 1.0 110.436 -179.744 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -60.04 -40.02 87.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.108 -0.995 . . . . 1.0 110.357 -178.733 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -59.48 -51.43 69.93 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.711 -1.243 . . . . 1.0 109.543 -179.702 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.6 t -69.95 -42.63 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.961 -1.087 . . . . 1.0 110.087 -179.174 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.43 -52.15 66.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.933 . . . . 1.0 109.764 -179.331 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.69 -38.09 80.58 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.414 -0.804 . . . . 1.0 110.343 -179.613 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -63.41 -50.1 71.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -0.927 . . . . 1.0 111.2 -178.401 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.476 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 8.2 pt-20 -59.97 -39.79 86.86 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.691 -1.256 . . . . 1.0 110.298 -179.233 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.414 ' CZ ' ' CZ ' ' A' ' 39' ' ' PHE . 30.9 m-85 -60.03 -39.96 87.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.78 -1.2 . . . . 1.0 108.95 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.81 -42.35 94.49 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.648 -1.381 . . . . 1.0 109.648 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -66.01 -39.78 90.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.99 -1.3 . . . . 1.0 109.033 179.394 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 80.6 p -64.56 -23.98 67.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.345 -0.847 . . . . 1.0 109.462 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.2 mt -82.56 -1.84 51.87 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.132 -0.98 . . . . 1.0 109.577 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.05 10.21 64.73 Favored Glycine 0 N--CA 1.497 2.728 0 C-N-CA 120.304 -0.951 . . . . 1.0 110.812 179.191 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.5 mt -85.38 146.97 26.74 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.899 -1.354 . . . . 1.0 109.682 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 12.3 t70 -99.69 172.47 7.25 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.479 -0.763 . . . . 1.0 109.22 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.46 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 66.2 m80 -59.99 139.48 57.4 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.182 -0.949 . . . . 1.0 109.66 -179.534 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 34.1 t -98.76 152.97 19.11 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.346 -0.846 . . . . 1.0 109.407 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -96.67 -0.02 49.05 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.208 -0.933 . . . . 1.0 109.683 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -85.24 130.49 51.64 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.057 -1.027 . . . . 1.0 108.237 179.227 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -68.48 -21.37 40.38 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 CA-C-N 120.121 1.079 . . . . 1.0 112.147 -179.457 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -86.1 -4.83 83.86 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.942 -1.263 . . . . 1.0 109.942 -179.704 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -87.33 145.1 26.47 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.127 -1.219 . . . . 1.0 109.534 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.427 ' C ' ' H ' ' A' ' 138' ' ' PHE . 91.6 mt -70.0 -31.06 68.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.087 -1.008 . . . . 1.0 108.975 179.643 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.3 mmm -73.0 19.14 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.441 -0.787 . . . . 1.0 110.201 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.427 ' H ' ' C ' ' A' ' 136' ' ' LEU . 16.0 t80 -70.0 131.7 88.9 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 120.914 -1.116 . . . . 1.0 108.087 179.866 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -63.9 0.48 2.02 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 121.012 1.142 . . . . 1.0 114.536 -177.864 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 95.7 mt -123.19 139.45 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 120.935 -1.103 . . . . 1.0 109.321 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.43 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 58.8 t80 -73.1 125.03 26.72 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.288 -0.882 . . . . 1.0 109.896 -179.396 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.9 t -138.2 140.05 39.58 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.719 -0.845 . . . . 1.0 108.719 179.388 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -81.25 130.5 35.05 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.081 -1.012 . . . . 1.0 109.921 -179.763 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.7 m -118.91 137.07 53.71 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.97 -0.752 . . . . 1.0 108.97 179.832 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -62.12 103.04 0.53 Allowed Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.121 -1.992 . . . . 1.0 108.121 178.841 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -72.64 114.62 10.97 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.19 -1.182 . . . . 1.0 108.728 -179.241 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.4 p -178.37 109.18 0.05 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.377 -0.972 . . . . 1.0 108.377 -179.694 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 49.99 39.88 19.87 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.046 -1.034 . . . . 1.0 108.752 -179.249 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -88.39 119.18 28.57 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.363 -0.836 . . . . 1.0 109.398 -179.699 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 97.3 mtp -110.17 148.29 32.08 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.343 -0.984 . . . . 1.0 108.343 179.368 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.7 mt -52.46 136.86 41.84 Favored Pre-proline 0 C--N 1.3 -1.552 0 O-C-N 121.158 -0.964 . . . . 1.0 109.214 -179.514 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -68.78 174.23 8.93 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 CA-C-N 119.569 0.882 . . . . 1.0 112.177 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -60.36 -39.99 89.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.498 -0.752 . . . . 1.0 109.951 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -55.09 -49.35 71.91 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.123 -0.986 . . . . 1.0 109.852 -179.347 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.12 -40.01 75.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.244 -0.91 . . . . 1.0 110.214 -179.688 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.8 t -59.99 -46.47 94.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.163 -0.961 . . . . 1.0 109.067 -179.661 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -61.58 -40.01 93.25 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.083 -1.01 . . . . 1.0 110.075 179.71 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.39 -53.38 13.45 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 120.312 -0.947 . . . . 1.0 111.468 -178.483 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.494 HG23 ' N ' ' A' ' 160' ' ' GLN . 6.0 tp -60.73 -39.98 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.835 -1.391 . . . . 1.0 109.778 -178.818 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.544 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.3 mt-30 -66.07 -39.98 90.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.115 -0.991 . . . . 1.0 109.51 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 86.2 p -61.24 -30.37 70.41 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.175 -0.953 . . . . 1.0 110.263 -179.642 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 85.5 mt -86.69 -51.8 5.91 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.001 -1.062 . . . . 1.0 110.656 -179.025 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -91.85 -9.23 44.11 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.067 -1.02 . . . . 1.0 110.312 -178.931 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.511 0 N-CA-C 109.457 -1.457 . . . . 1.0 109.457 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 169' ' ' WAY . . . . . 0.93 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 m . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.415 -0.587 . . . . 1.0 109.415 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.0 mt -86.07 126.38 34.13 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.199 -0.938 . . . . 1.0 109.412 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.9 pttt -162.7 163.35 26.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.284 -0.885 . . . . 1.0 109.301 179.671 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -70.21 149.56 47.36 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.113 -0.992 . . . . 1.0 109.566 -179.51 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 98.3 p -90.03 1.19 56.6 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.29 -0.881 . . . . 1.0 109.757 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -146.92 154.86 41.78 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.074 -1.016 . . . . 1.0 110.039 -179.6 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.549 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.5 0.37 57.35 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.382 -0.824 . . . . 1.0 109.713 -179.81 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -93.93 125.09 38.35 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.152 -0.968 . . . . 1.0 109.203 -179.747 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.5 mt -142.27 150.23 40.6 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.355 -0.841 . . . . 1.0 108.982 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.9 p -130.75 153.12 49.36 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.411 -0.959 . . . . 1.0 108.411 179.643 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -145.11 159.99 42.12 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.059 -1.026 . . . . 1.0 109.902 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.494 ' NH1' ' O ' ' A' ' 56' ' ' GLY . 43.3 ttp180 -144.75 139.18 27.69 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.604 -0.685 . . . . 1.0 109.316 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.8 mm -88.15 118.45 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.266 -1.013 . . . . 1.0 108.266 179.212 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.3 t -69.79 -39.95 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.131 -0.981 . . . . 1.0 108.985 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.678 HD21 ' H ' ' A' ' 64' ' ' PHE . 15.2 p30 -160.71 153.8 21.51 Favored 'General case' 0 C--N 1.287 -2.124 0 O-C-N 120.028 -1.67 . . . . 1.0 110.697 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -97.02 101.28 12.82 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 104.895 -2.261 . . . . 1.0 104.895 177.091 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.559 ' O ' ' N ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -55.33 116.55 11.96 Favored Pre-proline 0 C--N 1.299 -1.598 0 C-N-CA 118.849 -1.141 . . . . 1.0 108.408 -177.588 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -50.23 -1.17 0.04 OUTLIER 'Trans proline' 0 N--CA 1.486 1.055 0 CA-C-N 119.804 0.966 . . . . 1.0 112.447 -179.592 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.559 ' N ' ' O ' ' A' ' 23' ' ' THR . 87.0 m-20 -60.1 -18.5 47.6 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 118.826 -1.149 . . . . 1.0 108.065 178.455 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 76.2 mtm -147.99 163.84 35.61 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.617 -0.883 . . . . 1.0 108.617 179.281 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.0 p -73.23 157.36 37.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.17 -0.956 . . . . 1.0 109.123 179.735 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -60.68 -40.09 90.87 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.293 -0.879 . . . . 1.0 109.964 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 63.6 m -60.29 -41.96 94.46 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.206 -0.934 . . . . 1.0 109.616 -179.405 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.32 -40.15 85.92 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.446 -0.784 . . . . 1.0 110.397 179.737 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 70.7 t -67.4 -44.98 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 1.0 110.708 -179.02 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.87 -48.12 82.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.134 -0.979 . . . . 1.0 110.388 -178.362 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -62.47 -32.86 73.81 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.884 -1.135 . . . . 1.0 110.285 -179.783 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.408 ' CB ' HD23 ' A' ' 113' ' ' LEU . . . -60.01 -49.72 76.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.015 -1.053 . . . . 1.0 110.072 -179.274 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.433 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 53.7 m-85 -68.63 -40.01 80.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.968 -1.083 . . . . 1.0 109.805 -179.648 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.3 mmtt -60.04 -44.87 94.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.019 -1.051 . . . . 1.0 109.642 -179.468 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -60.12 -40.26 89.11 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.149 -0.97 . . . . 1.0 109.219 179.726 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.17 -45.36 93.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.528 -0.732 . . . . 1.0 109.642 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -66.15 -34.66 78.54 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.884 -1.135 . . . . 1.0 109.605 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.7 tptt -59.82 -52.59 64.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.168 -0.957 . . . . 1.0 110.166 -179.665 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.0 m -60.91 -39.86 83.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 O-C-N 120.895 -1.128 . . . . 1.0 110.556 -179.678 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -79.35 -38.34 35.33 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.99 -1.069 . . . . 1.0 110.161 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.3 p -71.68 -22.96 61.58 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.709 -1.244 . . . . 1.0 110.123 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -60.09 -40.02 88.14 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.193 -0.942 . . . . 1.0 111.104 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.6 m -111.42 25.12 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 O-C-N 121.211 -0.931 . . . . 1.0 111.122 -178.309 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.3 p -148.79 133.84 9.27 Favored Pre-proline 0 N--CA 1.501 2.122 0 O-C-N 120.701 -1.249 . . . . 1.0 109.617 179.495 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -72.37 17.49 0.35 Allowed 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 120.696 0.931 . . . . 1.0 111.902 179.335 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 75.3 mt -67.23 137.92 56.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.195 -0.941 . . . . 1.0 109.829 -179.273 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -108.29 121.42 44.87 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.095 -0.706 . . . . 1.0 109.095 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -109.57 127.65 54.64 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.488 -0.758 . . . . 1.0 109.264 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.7 m -119.99 129.95 54.52 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.482 0.658 . . . . 1.0 109.559 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -82.45 131.25 35.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.359 -0.838 . . . . 1.0 109.529 179.85 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.9 mt -105.94 128.85 54.07 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.274 -0.891 . . . . 1.0 109.514 179.639 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.41 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 17.5 m-70 -66.44 -40.08 89.26 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.436 -0.79 . . . . 1.0 109.839 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 68.0 m-20 -150.07 173.12 14.22 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.222 -0.924 . . . . 1.0 109.468 -179.709 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.494 ' O ' ' NH1' ' A' ' 18' ' ' ARG . . . 95.37 178.68 37.03 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.071 -1.612 . . . . 1.0 109.071 -179.723 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.5 mt -93.7 133.62 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.139 -1.213 . . . . 1.0 109.439 -179.679 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.68 158.26 18.26 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.483 -0.76 . . . . 1.0 109.167 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -59.72 -49.41 77.84 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.21 -0.931 . . . . 1.0 109.238 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 90.4 mt -105.77 99.74 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.335 -0.853 . . . . 1.0 109.875 179.562 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.7 ptp -99.21 134.77 41.59 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.146 -0.971 . . . . 1.0 109.145 179.048 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.433 HG21 ' CZ ' ' A' ' 35' ' ' PHE . 85.5 mt -109.93 132.33 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.655 -0.653 . . . . 1.0 109.462 -179.014 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.0 p -151.67 157.74 42.5 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.875 -1.141 . . . . 1.0 110.562 -179.775 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.678 ' H ' HD21 ' A' ' 21' ' ' ASN . 62.0 m-85 -109.62 120.79 43.58 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.55 -0.907 . . . . 1.0 108.55 179.28 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.28 -169.78 23.01 Favored Glycine 0 N--CA 1.499 2.87 0 N-CA-C 110.24 -1.144 . . . . 1.0 110.24 -179.515 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.581 HG22 ' N ' ' A' ' 67' ' ' LYS . 87.4 mt -134.91 165.61 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.644 -0.915 . . . . 1.0 108.836 179.809 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.581 ' N ' HG22 ' A' ' 66' ' ' ILE . 20.7 tptm -9.87 -78.73 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.714 0 C-N-CA 122.91 0.484 . . . . 1.0 112.088 179.857 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.647 ' CD ' ' H ' ' A' ' 68' ' ' GLU . 3.6 pm0 -68.94 140.69 55.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.051 -1.03 . . . . 1.0 109.171 179.792 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -126.93 7.58 6.69 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.3 -0.875 . . . . 1.0 109.657 -178.995 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 70.24 20.73 76.88 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.024 -1.63 . . . . 1.0 109.024 -179.573 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 72' ' ' PHE . 46.6 t0 -149.52 160.12 43.74 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.608 -0.937 . . . . 1.0 108.617 -179.627 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.533 ' O ' ' CD1' ' A' ' 73' ' ' TYR . 1.8 p90 -70.91 -174.14 0.89 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.778 -1.201 . . . . 1.0 109.716 -179.701 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.625 ' O ' ' CG ' ' A' ' 73' ' ' TYR . 3.5 p90 40.29 60.48 7.0 Favored Pre-proline 0 N--CA 1.497 1.903 0 CA-C-O 121.869 0.843 . . . . 1.0 110.106 -178.674 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.409 ' HD3' ' N ' ' A' ' 73' ' ' TYR . 20.4 Cg_endo -74.18 -161.94 0.13 Allowed 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 120.984 1.123 . . . . 1.0 111.875 179.837 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.55 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 83.0 m-85 -87.04 164.09 16.67 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.419 -0.801 . . . . 1.0 109.33 179.661 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.3 p-10 -101.01 3.96 41.97 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.35 -0.844 . . . . 1.0 110.961 -178.955 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 126.32 -151.61 18.03 Favored Glycine 0 N--CA 1.507 3.383 0 N-CA-C 108.911 -1.676 . . . . 1.0 108.911 -179.68 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -60.0 -66.21 0.07 OUTLIER 'Trans proline' 0 N--CA 1.492 1.438 0 CA-C-N 119.116 1.458 . . . . 1.0 112.02 179.617 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 91.7 p -76.82 161.89 28.09 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.183 -0.948 . . . . 1.0 109.525 179.811 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 117.48 -133.21 10.4 Favored Glycine 0 N--CA 1.501 3.002 0 N-CA-C 109.307 -1.517 . . . . 1.0 109.307 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.8 mt -70.16 111.55 5.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.088 -1.242 . . . . 1.0 108.456 179.541 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 38.3 mt -79.33 -17.48 54.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.963 -1.085 . . . . 1.0 108.806 -179.431 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 179.97 175.45 0.8 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.719 -0.845 . . . . 1.0 108.719 179.762 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -166.0 157.7 13.99 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.188 -0.945 . . . . 1.0 109.298 178.86 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -144.93 157.9 43.99 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -96.89 151.29 37.7 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 107.881 -1.155 . . . . 1.0 107.881 179.478 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -61.54 163.52 17.89 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 CA-C-N 119.324 0.794 . . . . 1.0 111.751 -179.32 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -41.1 135.25 2.54 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.113 1.208 . . . . 1.0 112.253 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 90' ' ' PRO . . . -162.61 -169.48 26.06 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 109.2 -1.56 . . . . 1.0 109.2 -179.62 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.435 ' O ' ' O ' ' A' ' 89' ' ' GLY . 18.6 Cg_exo -55.94 -146.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.424 1.416 . . . . 1.0 112.686 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -61.36 -40.3 93.78 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.303 -0.873 . . . . 1.0 111.096 -179.19 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -80.19 -11.98 59.69 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.734 -1.229 . . . . 1.0 110.621 -179.092 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -74.16 168.41 54.32 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.96 -1.656 . . . . 1.0 108.96 179.675 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 65.21 17.54 63.88 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.531 -1.427 . . . . 1.0 109.531 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.4 p-10 -80.02 164.32 23.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.214 -1.168 . . . . 1.0 109.707 -179.64 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.61 124.42 9.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.234 -0.916 . . . . 1.0 109.529 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -112.91 147.59 36.74 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.592 -0.693 . . . . 1.0 109.937 -179.8 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -125.57 149.44 48.34 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 -179.839 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.55 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 84.7 m-20 -78.92 123.23 27.06 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.078 -1.014 . . . . 1.0 109.627 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -84.93 -7.73 59.04 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.233 -0.917 . . . . 1.0 109.275 179.577 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -83.5 -14.01 53.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.401 -0.812 . . . . 1.0 109.186 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -88.73 168.67 12.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.503 -0.748 . . . . 1.0 109.166 -179.579 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 30.9 m -99.94 106.08 17.85 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.209 -0.932 . . . . 1.0 109.214 -179.6 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -87.11 123.38 32.11 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.577 -0.897 . . . . 1.0 108.577 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.637 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.7 t -141.99 156.57 45.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.38 -0.825 . . . . 1.0 109.901 -178.892 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.7 t -96.8 -7.69 33.03 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.594 -0.891 . . . . 1.0 108.594 179.21 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 79.4 p -93.62 173.43 7.69 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.524 -0.735 . . . . 1.0 109.428 179.522 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.0 t -70.72 70.34 0.46 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 1.0 109.617 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.637 ' HB2' HG21 ' A' ' 105' ' ' THR . 44.6 mtpt -146.55 153.8 40.79 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.213 -0.93 . . . . 1.0 109.22 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 109' ' ' LYS . . . 41.89 -139.78 1.95 Allowed Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.037 -1.225 . . . . 1.0 110.037 179.494 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -101.0 119.12 38.28 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.33 -1.1 . . . . 1.0 108.943 179.524 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -63.88 132.19 50.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.177 -0.952 . . . . 1.0 109.796 -179.585 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.408 HD23 ' CB ' ' A' ' 34' ' ' ALA . 58.7 tp -59.88 -39.97 87.08 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.351 -0.843 . . . . 1.0 109.923 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -59.91 -41.05 90.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.218 -0.926 . . . . 1.0 110.261 -179.218 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -58.85 -57.92 10.89 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.829 -1.169 . . . . 1.0 110.294 -179.482 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.7 t -66.3 -41.12 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.402 -0.811 . . . . 1.0 109.964 -178.431 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.84 -51.66 68.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.966 -1.084 . . . . 1.0 109.192 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.548 ' HB1' HD13 ' A' ' 136' ' ' LEU . . . -60.06 -39.49 86.19 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.336 -0.852 . . . . 1.0 110.246 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 76.7 t60 -63.8 -49.86 71.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.894 . . . . 1.0 111.443 -178.194 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -59.95 -37.7 80.3 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.671 -1.268 . . . . 1.0 110.086 -179.046 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -60.15 -39.81 87.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.645 -1.284 . . . . 1.0 108.453 179.302 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -59.06 -40.38 95.51 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.246 -1.542 . . . . 1.0 109.246 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -68.48 -39.99 81.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.043 -1.269 . . . . 1.0 108.832 179.192 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.1 p -65.76 -24.75 67.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.411 -0.806 . . . . 1.0 109.12 179.703 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 65.9 mt -81.86 -4.91 57.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.361 -0.837 . . . . 1.0 109.47 179.851 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 92.22 10.03 61.36 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.659 -0.976 . . . . 1.0 110.659 179.105 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.8 mt -85.21 147.91 26.36 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.871 -1.37 . . . . 1.0 109.671 179.933 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 44.1 t0 -100.63 175.46 5.65 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.476 -0.765 . . . . 1.0 108.97 -179.884 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.515 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 74.0 m80 -59.93 138.89 57.72 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.973 . . . . 1.0 109.72 -179.597 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 46.7 t -97.34 155.66 16.79 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.32 -0.863 . . . . 1.0 109.226 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -99.26 0.21 42.66 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.144 -0.973 . . . . 1.0 109.754 -179.893 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -85.32 130.4 51.82 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.306 -0.871 . . . . 1.0 108.695 179.85 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -68.1 -19.88 44.67 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 CA-C-N 120.136 1.084 . . . . 1.0 112.456 -179.668 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -91.2 -4.63 68.47 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 110.243 -1.143 . . . . 1.0 110.243 -179.558 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.86 145.63 27.1 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.014 -1.286 . . . . 1.0 109.31 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.548 HD13 ' HB1' ' A' ' 118' ' ' ALA . 70.3 mt -66.34 -38.63 88.08 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.911 -1.118 . . . . 1.0 110.01 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 94.5 mmm -69.97 19.84 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.315 -0.866 . . . . 1.0 110.585 -178.529 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.482 ' H ' ' C ' ' A' ' 136' ' ' LEU . 17.3 t80 -70.15 129.59 90.5 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 108.094 -1.076 . . . . 1.0 108.094 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -54.68 -10.98 2.85 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 CA-C-N 119.996 1.034 . . . . 1.0 114.079 -179.061 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.9 mt -113.93 140.63 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.512 0 O-C-N 120.891 -1.13 . . . . 1.0 110.664 -178.867 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.433 ' CD1' ' C ' ' A' ' 141' ' ' TYR . 20.7 t80 -74.7 129.58 37.97 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.513 -0.742 . . . . 1.0 110.069 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.0 t -139.0 142.4 38.32 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.434 -0.792 . . . . 1.0 109.402 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -83.05 152.18 25.48 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.994 -1.066 . . . . 1.0 109.721 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.43 ' H ' ' NZ ' ' A' ' 146' ' ' LYS . 2.7 m -145.66 154.45 42.12 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.399 -0.813 . . . . 1.0 109.863 -179.771 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.92 103.93 1.55 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.312 -1.915 . . . . 1.0 108.312 178.633 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.43 ' NZ ' ' H ' ' A' ' 144' ' ' THR . 37.3 mmtm -77.3 12.49 1.49 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.212 -1.169 . . . . 1.0 110.095 -178.998 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 48.5 t -60.0 -39.96 87.58 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.032 -1.043 . . . . 1.0 108.633 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -160.01 69.81 0.42 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.355 -0.841 . . . . 1.0 109.071 179.053 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -97.7 139.74 33.13 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.308 -0.87 . . . . 1.0 110.498 -179.547 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 97.4 mmm -136.9 149.72 47.8 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.983 -1.118 . . . . 1.0 107.983 178.844 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.9 mt -53.57 131.13 54.84 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.058 -1.026 . . . . 1.0 109.566 -179.134 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -68.49 175.47 6.95 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 CA-C-N 119.835 0.977 . . . . 1.0 112.136 179.638 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -60.08 -39.9 87.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.514 -0.741 . . . . 1.0 110.027 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -57.19 -47.31 81.56 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.221 -0.925 . . . . 1.0 110.067 -179.146 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -69.86 -39.83 76.12 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.188 -0.945 . . . . 1.0 109.435 -179.751 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.28 -45.02 96.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.198 -0.939 . . . . 1.0 109.196 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -60.23 -39.72 87.66 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.926 -1.109 . . . . 1.0 109.748 179.519 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.71 -54.41 10.02 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 120.501 -0.857 . . . . 1.0 111.669 -178.471 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 160' ' ' GLN . 8.4 tp -60.03 -40.18 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.666 -1.491 . . . . 1.0 109.621 -178.728 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.546 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.7 mt-30 -65.54 -39.39 91.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.089 -1.007 . . . . 1.0 109.466 179.217 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 84.7 p -59.13 -30.91 68.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.055 -1.028 . . . . 1.0 110.032 -179.553 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 88.7 mt -86.92 -53.61 4.8 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.938 -1.101 . . . . 1.0 110.725 -179.147 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -91.92 -9.98 41.19 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.91 -1.119 . . . . 1.0 110.933 -178.727 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.597 0 N-CA-C 109.292 -1.523 . . . . 1.0 109.292 -179.633 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 169' ' ' WAY . . . . . 0.943 ' HC2' ' HJ ' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.7 m . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.475 -0.565 . . . . 1.0 109.475 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.0 mt -70.04 138.96 52.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.151 -0.968 . . . . 1.0 108.934 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -162.48 166.52 24.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 1.0 109.867 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -72.19 140.75 48.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.185 -0.947 . . . . 1.0 110.043 -179.398 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.3 t -89.99 0.02 57.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.406 -0.809 . . . . 1.0 109.722 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.538 ' NZ ' ' O ' ' A' ' 14' ' ' ASN . 20.7 pttp -141.98 154.21 44.86 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.185 -0.947 . . . . 1.0 109.622 -179.651 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.4 mmt -90.47 -0.13 57.54 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.363 -0.835 . . . . 1.0 110.203 -178.834 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.538 ' O ' ' NZ ' ' A' ' 12' ' ' LYS . 30.1 m120 -97.02 128.61 44.15 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.224 -0.922 . . . . 1.0 109.151 -179.844 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.4 mt -141.66 149.54 40.76 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.265 -0.897 . . . . 1.0 109.307 -179.824 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.5 p -132.11 154.11 49.8 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.004 -0.739 . . . . 1.0 109.004 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -144.58 159.1 43.35 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.11 -0.994 . . . . 1.0 110.193 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 56' ' ' GLY . 26.3 ttm-85 -145.4 132.11 19.98 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.592 -0.693 . . . . 1.0 109.864 -179.455 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 39.8 mm -87.88 112.72 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.335 -0.987 . . . . 1.0 108.335 178.734 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.5 t -69.95 -40.05 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.101 -0.999 . . . . 1.0 109.443 -179.418 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -162.17 156.97 22.5 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.777 -1.202 . . . . 1.0 110.152 -179.588 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.611 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 54.0 m-85 -96.91 -167.14 1.5 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.169 -1.419 . . . . 1.0 107.169 178.851 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.29 141.58 32.11 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.325 -0.859 . . . . 1.0 110.094 -179.439 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -66.89 -19.1 52.81 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 120.763 0.976 . . . . 1.0 110.365 178.83 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.43 -39.91 85.04 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.553 -0.749 . . . . 1.0 109.949 179.405 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 74.8 mtm -130.04 161.66 30.5 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.419 -0.801 . . . . 1.0 109.484 -179.43 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.0 p -70.79 158.26 36.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -0.911 . . . . 1.0 109.2 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.611 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 1.0 OUTLIER -60.73 -40.76 93.59 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.355 -0.841 . . . . 1.0 110.239 -179.169 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.539 ' O ' ' NZ ' ' A' ' 33' ' ' LYS . 73.8 m -59.94 -41.02 90.94 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.006 -1.059 . . . . 1.0 110.758 -179.455 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -64.61 -40.08 94.86 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.945 -1.097 . . . . 1.0 110.004 -179.629 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.4 t -67.28 -39.96 83.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.222 -0.924 . . . . 1.0 109.83 -179.71 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -60.04 -49.93 75.74 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.098 -1.001 . . . . 1.0 110.647 -178.878 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.539 ' NZ ' ' O ' ' A' ' 29' ' ' SER . 2.1 ptpp? -64.19 -30.34 71.41 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.131 -0.981 . . . . 1.0 109.911 -179.704 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.04 -48.87 79.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.064 -1.022 . . . . 1.0 109.669 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -67.15 -38.38 85.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.075 -1.015 . . . . 1.0 110.02 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -59.95 -42.66 94.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.008 -1.058 . . . . 1.0 109.657 -179.651 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -60.04 -43.71 95.14 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.027 -1.046 . . . . 1.0 109.02 179.355 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.06 -49.71 76.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.463 -0.773 . . . . 1.0 109.868 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -61.97 -39.97 93.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.265 -0.897 . . . . 1.0 109.291 -179.803 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -60.06 -50.0 75.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.212 -0.93 . . . . 1.0 109.197 -179.591 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 70.2 t -59.98 -40.73 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.249 -0.907 . . . . 1.0 109.869 -179.549 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -78.94 -37.77 38.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.026 -1.047 . . . . 1.0 109.861 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.3 p -69.97 -15.32 63.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.267 -0.895 . . . . 1.0 109.829 -179.726 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -59.98 -40.0 87.61 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.136 -0.978 . . . . 1.0 110.091 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.3 m -115.06 -17.71 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.437 -0.789 . . . . 1.0 111.191 -178.483 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.3 p -90.76 124.36 62.47 Favored Pre-proline 0 N--CA 1.501 2.078 0 O-C-N 120.463 -1.398 . . . . 1.0 109.416 179.926 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -73.69 15.47 0.56 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 CA-C-N 120.221 1.115 . . . . 1.0 111.434 178.88 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.5 mt -69.61 140.26 53.71 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.41 -0.806 . . . . 1.0 110.369 -179.299 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -102.33 121.63 42.66 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.798 -0.816 . . . . 1.0 108.798 179.198 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -107.09 125.79 51.52 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.288 -0.882 . . . . 1.0 109.768 -179.204 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.2 m -120.03 129.98 54.5 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.576 -0.702 . . . . 1.0 109.882 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -82.23 131.96 35.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.244 -0.91 . . . . 1.0 109.487 179.752 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.493 ' O ' ' NH1' ' A' ' 18' ' ' ARG . 90.3 mt -106.63 134.0 50.45 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.301 -0.874 . . . . 1.0 109.274 179.502 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.435 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 59.1 m170 -66.23 -39.98 89.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.388 -0.82 . . . . 1.0 109.874 -179.641 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.464 ' O ' ' NH2' ' A' ' 18' ' ' ARG . 69.0 m-20 -154.42 178.84 9.6 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.087 -1.008 . . . . 1.0 109.635 -179.77 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.538 ' O ' ' NE ' ' A' ' 18' ' ' ARG . . . 96.62 -168.26 25.04 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.642 -1.383 . . . . 1.0 109.642 -179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.7 mt -101.4 130.51 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.361 -1.082 . . . . 1.0 109.622 -179.813 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.45 154.73 26.53 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.422 -0.799 . . . . 1.0 109.447 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -60.01 -49.56 77.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.2 -0.938 . . . . 1.0 109.624 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.6 mt -104.11 94.99 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.334 -0.853 . . . . 1.0 109.608 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.3 ptm -100.73 127.39 47.17 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.208 -0.933 . . . . 1.0 109.61 179.754 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 87.2 mt -106.42 137.7 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.52 -0.738 . . . . 1.0 109.657 -179.643 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 66.3 p -152.69 161.92 41.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.224 -0.923 . . . . 1.0 109.71 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -109.97 149.98 29.15 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.531 -0.731 . . . . 1.0 109.329 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -143.71 -161.88 9.11 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.315 -1.514 . . . . 1.0 109.315 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.537 ' O ' ' C ' ' A' ' 67' ' ' LYS . 81.2 mt -130.04 159.98 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.344 -1.092 . . . . 1.0 109.269 -179.942 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.537 ' C ' ' O ' ' A' ' 66' ' ' ILE . 7.5 ttpm? -8.74 -107.47 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 CA-C-N 115.878 -0.601 . . . . 1.0 111.909 -178.112 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -74.95 126.5 31.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.665 -1.272 . . . . 1.0 109.496 179.784 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.463 ' CE1' ' CE1' ' A' ' 75' ' ' PHE . 1.8 m80 -69.77 -40.03 76.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.024 -1.047 . . . . 1.0 109.443 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 175.61 -57.14 0.11 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.394 -1.482 . . . . 1.0 109.394 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 72' ' ' PHE . 45.7 t0 -156.35 153.5 29.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.177 -1.19 . . . . 1.0 109.64 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.51 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 97.7 m-85 57.81 15.38 2.97 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.669 -0.645 . . . . 1.0 110.47 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -143.53 70.0 17.43 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 120.928 -1.107 . . . . 1.0 109.208 178.869 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -86.06 110.64 1.07 Allowed 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 121.458 1.439 . . . . 1.0 113.249 -179.452 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.518 ' CD1' ' O ' ' A' ' 67' ' ' LYS . 32.8 m-85 -87.38 166.08 15.11 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 106.959 -1.497 . . . . 1.0 106.959 177.951 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.7 p-10 -106.09 20.0 19.64 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 120.927 -1.108 . . . . 1.0 110.934 -178.682 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.28 -150.38 18.11 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 109.493 -1.443 . . . . 1.0 109.493 179.608 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.442 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 8.8 Cg_exo -60.67 -62.72 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.524 0 CA-C-N 118.864 1.332 . . . . 1.0 112.896 -179.593 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 83.2 p -74.04 157.61 35.81 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.019 -1.051 . . . . 1.0 110.206 -179.268 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.65 -126.82 7.56 Favored Glycine 0 N--CA 1.502 3.075 0 N-CA-C 110.244 -1.142 . . . . 1.0 110.244 179.605 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.427 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 15.3 mt -69.75 102.73 1.98 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.43 -1.041 . . . . 1.0 109.3 -179.702 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 41.3 mt -75.67 -24.44 56.33 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.881 -1.137 . . . . 1.0 108.57 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.4 172.22 1.2 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.702 -0.851 . . . . 1.0 108.702 -179.963 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.497 ' ND1' ' C ' ' A' ' 84' ' ' HIS . 2.8 p80 -161.61 171.41 18.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.128 -0.983 . . . . 1.0 109.238 178.938 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.41 160.91 43.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.172 -0.955 . . . . 1.0 109.467 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -101.32 154.33 37.27 Favored Pre-proline 0 N--CA 1.496 1.862 0 N-CA-C 108.367 -0.975 . . . . 1.0 108.367 179.687 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.87 168.64 0.76 Allowed 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 120.738 0.959 . . . . 1.0 111.588 179.68 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -55.78 126.21 21.69 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 120.862 1.041 . . . . 1.0 111.441 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.63 125.69 1.38 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.384 -1.886 . . . . 1.0 108.384 -179.778 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -69.6 -29.61 24.35 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 CA-C-N 120.181 1.991 . . . . 1.0 112.022 -179.797 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.45 ' O ' ' CG ' ' A' ' 92' ' ' TYR . 42.5 t30 -61.42 -51.24 69.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.901 . . . . 1.0 109.753 -179.599 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.45 ' CG ' ' O ' ' A' ' 91' ' ' ASN . 86.6 m-85 -157.71 -7.94 0.09 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.098 -1.001 . . . . 1.0 109.543 179.532 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -64.2 168.4 25.23 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.904 -1.279 . . . . 1.0 109.904 -179.635 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.31 4.49 74.06 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.722 -1.351 . . . . 1.0 109.722 179.75 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -80.33 171.98 14.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.053 -1.263 . . . . 1.0 109.66 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.05 124.53 9.64 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.159 -0.963 . . . . 1.0 109.848 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -107.05 131.01 54.57 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.483 -0.761 . . . . 1.0 109.529 179.75 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.494 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 38.4 m-85 -114.28 144.18 43.66 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.504 -0.748 . . . . 1.0 109.028 179.588 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.427 ' OD2' ' O ' ' A' ' 81' ' ' LEU . 91.7 m-20 -78.95 124.23 28.05 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.934 -1.104 . . . . 1.0 109.926 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 55.7 t0 -85.45 -6.77 59.17 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.211 -0.93 . . . . 1.0 109.233 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -81.9 -14.94 55.48 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.097 -1.002 . . . . 1.0 109.329 179.863 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.442 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 94.3 mt-10 -89.23 168.55 12.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.362 -0.836 . . . . 1.0 109.68 -178.943 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 26.3 m -98.51 105.17 17.28 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.199 -0.938 . . . . 1.0 109.494 -179.516 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.422 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 86.5 m95 -88.47 124.24 33.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.379 -0.826 . . . . 1.0 109.059 179.727 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.668 HG21 ' HB2' ' A' ' 109' ' ' LYS . 7.9 t -140.78 153.63 45.92 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.197 -0.939 . . . . 1.0 109.91 -179.476 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 85.0 p -93.2 -5.6 49.65 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.456 -0.942 . . . . 1.0 108.456 179.15 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 46.4 t -94.3 179.71 5.21 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.718 -0.845 . . . . 1.0 108.718 179.305 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.9 m -80.79 75.75 7.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.004 -1.06 . . . . 1.0 109.372 179.862 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.668 ' HB2' HG21 ' A' ' 105' ' ' THR . 68.5 mttm -148.61 151.52 35.16 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.308 -0.87 . . . . 1.0 108.828 179.364 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.53 -138.84 4.83 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.841 -1.304 . . . . 1.0 109.841 179.667 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -100.01 115.92 30.85 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.348 -1.09 . . . . 1.0 108.862 179.604 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -63.61 131.81 49.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.158 -0.964 . . . . 1.0 109.617 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.1 tp -60.0 -43.59 95.08 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.331 -0.856 . . . . 1.0 110.899 -179.484 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -59.91 -41.11 91.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.971 -1.081 . . . . 1.0 110.794 -178.592 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.96 -50.47 73.64 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.809 -1.182 . . . . 1.0 109.603 -179.468 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.1 t -70.01 -41.44 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.051 -1.031 . . . . 1.0 110.09 -179.365 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.45 -51.44 69.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.147 -0.971 . . . . 1.0 109.633 -179.318 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.05 -37.01 78.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.146 -0.971 . . . . 1.0 109.945 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 59.4 t60 -62.36 -49.94 73.55 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.249 -0.907 . . . . 1.0 111.182 -178.784 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.494 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 6.9 pt-20 -59.54 -39.49 84.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.654 -1.278 . . . . 1.0 109.529 -179.38 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -60.07 -39.96 87.87 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.892 -1.13 . . . . 1.0 108.615 179.205 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.36 -47.71 61.61 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.283 -1.527 . . . . 1.0 109.283 179.775 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -66.1 -39.96 90.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.286 -1.126 . . . . 1.0 110.16 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 83.1 p -66.43 -22.19 66.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.131 -0.98 . . . . 1.0 109.897 -179.609 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 79.6 mt -81.9 1.84 33.3 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.134 -0.979 . . . . 1.0 109.948 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.12 4.99 70.96 Favored Glycine 0 N--CA 1.497 2.749 0 O-C-N 121.005 -1.059 . . . . 1.0 110.532 179.167 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.2 mt -86.99 147.85 25.56 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.984 -1.303 . . . . 1.0 109.787 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 37.6 t0 -101.98 172.39 6.95 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.878 -0.786 . . . . 1.0 108.878 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.513 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 59.3 m80 -56.58 132.72 52.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.004 -1.06 . . . . 1.0 109.54 -179.684 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 40.0 t -96.45 157.37 15.93 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.249 -0.907 . . . . 1.0 109.412 179.839 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -99.97 5.06 45.21 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.347 -0.845 . . . . 1.0 109.125 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -86.23 126.5 64.73 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 108.317 -0.994 . . . . 1.0 108.317 179.442 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -68.04 -22.07 42.1 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 CA-C-N 120.253 1.126 . . . . 1.0 112.273 -179.686 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -84.99 -5.69 85.81 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.684 -1.366 . . . . 1.0 109.684 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.15 135.19 33.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.186 -1.185 . . . . 1.0 108.842 179.467 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.466 ' C ' ' H ' ' A' ' 138' ' ' PHE . 89.2 mt -60.7 -40.05 90.79 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.076 -1.015 . . . . 1.0 110.238 -179.442 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 89.6 mtp -69.22 23.92 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.207 -0.933 . . . . 1.0 111.009 -178.425 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.466 ' H ' ' C ' ' A' ' 136' ' ' LEU . 17.3 t80 -69.92 130.33 90.1 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 120.761 -1.212 . . . . 1.0 108.328 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -49.07 -21.82 4.47 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 120.825 1.016 . . . . 1.0 114.392 -178.453 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 90.4 mt -106.37 139.81 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 O-C-N 120.886 -1.134 . . . . 1.0 110.87 -178.576 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -75.0 126.76 31.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.791 -0.568 . . . . 1.0 109.614 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.8 t -138.16 142.31 40.08 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.452 -0.78 . . . . 1.0 109.167 179.388 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -80.41 139.94 36.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.145 -0.972 . . . . 1.0 109.13 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.3 t -139.95 152.09 46.07 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.282 -0.886 . . . . 1.0 109.909 -179.322 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.96 101.1 0.83 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.33 -1.508 . . . . 1.0 109.33 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -76.79 -0.79 25.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.348 -1.09 . . . . 1.0 110.019 -179.718 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 53.9 m -59.97 -40.03 87.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.082 -1.011 . . . . 1.0 109.658 -179.6 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -138.91 21.06 2.65 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.144 -0.973 . . . . 1.0 109.989 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -62.03 139.94 58.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.78 -1.2 . . . . 1.0 109.721 -179.714 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 67.6 mtt -139.64 148.32 42.28 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.386 -0.968 . . . . 1.0 108.386 179.179 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 35.0 mt -54.94 129.78 66.3 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 120.945 -1.097 . . . . 1.0 109.202 -179.407 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -70.82 173.33 12.08 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 CA-C-N 119.863 0.987 . . . . 1.0 112.21 179.749 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -60.17 -39.62 87.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.328 -0.857 . . . . 1.0 109.519 179.403 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -53.06 -47.94 68.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.217 -0.927 . . . . 1.0 109.594 -179.517 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.411 ' O ' HG22 ' A' ' 159' ' ' ILE . 96.9 m-20 -70.33 -40.07 74.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.064 -1.022 . . . . 1.0 110.152 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 78.7 t -60.02 -47.35 92.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.88 -1.137 . . . . 1.0 109.176 -179.784 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -60.06 -39.97 87.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.071 -1.018 . . . . 1.0 110.434 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -73.23 -54.28 7.04 Favored Glycine 0 N--CA 1.496 2.672 0 O-C-N 121.215 -0.928 . . . . 1.0 111.685 -178.213 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.492 HG23 ' N ' ' A' ' 160' ' ' GLN . 4.8 tp -59.98 -39.99 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.953 -1.322 . . . . 1.0 109.691 -178.808 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.571 ' O ' ' N ' ' A' ' 164' ' ' GLY . 93.0 mm-40 -64.94 -38.25 90.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.2 -0.938 . . . . 1.0 109.463 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 60.3 p -61.51 -33.34 73.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.071 -1.018 . . . . 1.0 110.346 -179.359 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.8 mt -84.84 -52.31 6.12 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.959 -1.088 . . . . 1.0 110.536 -179.001 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -91.31 -9.24 45.71 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.104 -0.997 . . . . 1.0 110.483 -178.902 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.496 2.66 0 N-CA-C 109.448 -1.461 . . . . 1.0 109.448 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 169' ' ' WAY . . . . . 0.773 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.46 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 10.6 m . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.297 -0.631 . . . . 1.0 109.297 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.8 mt -66.87 130.25 42.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.841 -1.162 . . . . 1.0 109.162 179.856 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -161.71 161.44 29.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.878 . . . . 1.0 109.785 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -70.15 146.26 50.94 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.325 -0.86 . . . . 1.0 109.518 -179.623 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.9 t -85.94 1.42 50.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.342 -0.849 . . . . 1.0 109.818 -179.54 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -144.17 152.98 41.63 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.153 -0.967 . . . . 1.0 109.607 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.8 mmt -90.24 -0.02 57.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.358 -0.839 . . . . 1.0 109.769 -179.302 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -97.04 130.52 44.34 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.206 -0.933 . . . . 1.0 109.11 179.762 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.2 mt -141.75 148.94 39.8 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.196 -0.94 . . . . 1.0 109.406 -179.814 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.9 p -134.37 155.29 50.53 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.715 -0.846 . . . . 1.0 108.715 179.819 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -146.14 160.05 42.47 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.061 -1.024 . . . . 1.0 110.201 -179.9 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.486 ' NH1' ' N ' ' A' ' 56' ' ' GLY . 71.8 ttt180 -145.5 134.16 22.2 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.562 -0.711 . . . . 1.0 109.556 -179.736 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 32.0 mm -89.0 115.11 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.182 -0.949 . . . . 1.0 108.922 179.026 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.91 -40.58 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.173 -0.954 . . . . 1.0 109.295 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -164.98 160.52 19.15 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.929 -1.107 . . . . 1.0 110.008 -179.507 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.461 ' CD2' ' CG ' ' A' ' 28' ' ' HIS . 47.7 m-85 -101.68 -161.53 0.86 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.894 -1.15 . . . . 1.0 107.894 179.132 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.33 147.59 47.6 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.448 -0.782 . . . . 1.0 110.054 -179.809 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -69.62 -14.99 37.36 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 120.916 1.078 . . . . 1.0 110.267 178.245 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.42 -38.93 81.9 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.083 -0.962 . . . . 1.0 109.965 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 76.0 mtm -139.64 168.4 19.91 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.284 -0.885 . . . . 1.0 109.552 -179.756 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.4 p -73.45 156.61 38.07 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.445 -0.785 . . . . 1.0 109.771 -179.496 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.461 ' CG ' ' CD2' ' A' ' 22' ' ' TYR . 2.2 m-70 -59.99 -40.09 87.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.431 -0.793 . . . . 1.0 110.463 -179.538 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 53.4 m -59.97 -39.96 87.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 1.0 110.202 -178.474 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.39 -39.95 89.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.033 -1.042 . . . . 1.0 109.325 179.574 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 76.6 t -68.7 -40.29 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.266 -0.896 . . . . 1.0 110.348 -179.561 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.96 -49.26 78.4 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.841 -1.162 . . . . 1.0 110.37 -179.186 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -61.34 -32.1 71.98 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.98 -1.075 . . . . 1.0 109.529 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.84 -48.57 81.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.977 -1.077 . . . . 1.0 109.649 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -66.03 -39.78 90.49 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.091 -1.006 . . . . 1.0 109.923 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.97 -40.65 89.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.924 -1.11 . . . . 1.0 109.284 -179.395 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -60.13 -41.78 93.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.034 -1.041 . . . . 1.0 108.927 179.085 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.97 -48.07 83.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.355 -0.841 . . . . 1.0 110.124 -179.683 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -64.89 -39.94 94.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.138 -0.976 . . . . 1.0 109.564 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -59.96 -48.25 82.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.15 -0.969 . . . . 1.0 109.27 -179.65 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.9 t -60.02 -41.53 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.294 -0.879 . . . . 1.0 110.122 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.468 ' O ' HG23 ' A' ' 46' ' ' THR . 76.3 m95 -81.36 -31.5 33.35 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.978 -1.076 . . . . 1.0 109.99 -179.421 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.0 p -70.02 -20.12 63.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.958 -1.089 . . . . 1.0 109.023 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -60.27 -39.96 88.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.404 -0.81 . . . . 1.0 110.263 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.1 m -113.15 -17.35 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 O-C-N 121.219 -0.926 . . . . 1.0 110.49 -179.17 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.478 ' C ' ' H ' ' A' ' 48' ' ' LEU . 44.8 p -94.02 114.41 63.11 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 120.779 -1.2 . . . . 1.0 108.982 179.729 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.76 16.36 0.22 Allowed 'Trans proline' 0 N--CA 1.491 1.327 0 CA-C-N 120.354 1.162 . . . . 1.0 111.237 179.462 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.478 ' H ' ' C ' ' A' ' 46' ' ' THR . 59.2 mt -69.52 142.87 53.59 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.567 -0.708 . . . . 1.0 109.511 -179.718 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -102.07 120.74 40.92 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.779 -0.823 . . . . 1.0 108.779 179.403 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -106.29 128.07 53.71 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.32 -0.863 . . . . 1.0 109.581 -179.438 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.0 m -120.04 130.01 54.5 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.58 -0.7 . . . . 1.0 109.469 179.642 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.8 ttp180 -82.62 129.99 35.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 1.0 109.558 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.4 mt -111.0 116.52 31.33 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.416 -0.802 . . . . 1.0 108.981 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.441 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 91.5 m-70 -74.61 -20.46 59.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.861 . . . . 1.0 110.065 -179.77 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 84.0 m-20 -145.13 160.66 41.08 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.18 -0.95 . . . . 1.0 109.639 -179.482 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.486 ' N ' ' NH1' ' A' ' 18' ' ' ARG . . . 90.02 173.95 45.22 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.677 -1.369 . . . . 1.0 109.677 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 87.2 mt -94.34 139.25 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.135 -1.215 . . . . 1.0 109.135 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.08 159.76 18.87 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.499 -0.75 . . . . 1.0 109.38 -179.739 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -59.94 -49.79 76.29 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.174 -0.954 . . . . 1.0 109.307 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 84.3 mt -103.12 98.88 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.449 -0.782 . . . . 1.0 109.568 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.2 ptm -101.85 129.23 48.03 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.295 -0.878 . . . . 1.0 109.206 179.455 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 86.9 mt -105.25 134.45 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.618 -0.676 . . . . 1.0 109.688 -179.125 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 54.6 p -149.73 153.54 37.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.208 -0.932 . . . . 1.0 109.623 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -103.89 124.02 48.2 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.937 -0.764 . . . . 1.0 108.937 179.904 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -107.13 -167.15 22.18 Favored Glycine 0 N--CA 1.502 3.044 0 N-CA-C 110.531 -1.028 . . . . 1.0 110.531 -179.232 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.571 HG22 ' N ' ' A' ' 67' ' ' LYS . 77.0 mt -137.39 167.4 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.598 -0.943 . . . . 1.0 108.74 179.731 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.571 ' N ' HG22 ' A' ' 66' ' ' ILE . 47.6 tptt -27.6 -78.95 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.292 0 CA-C-O 120.943 0.401 . . . . 1.0 111.248 -179.43 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -75.12 128.9 36.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.926 -1.109 . . . . 1.0 109.701 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -165.21 -21.63 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.14 -0.975 . . . . 1.0 109.304 179.601 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -177.84 135.98 2.89 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.366 -1.494 . . . . 1.0 109.366 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -61.77 -40.02 93.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.329 -1.1 . . . . 1.0 109.809 -179.9 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.491 ' C ' ' CG ' ' A' ' 73' ' ' TYR . 97.4 m-85 -68.95 142.28 54.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.215 -0.928 . . . . 1.0 109.878 -179.423 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.491 ' CG ' ' C ' ' A' ' 72' ' ' PHE . 3.4 p90 41.66 64.31 5.64 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.615 -0.678 . . . . 1.0 110.238 -179.248 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -75.85 157.7 39.12 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.1 1.2 . . . . 1.0 111.984 179.648 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.551 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 73.9 m-85 -90.38 150.28 21.93 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.201 -0.937 . . . . 1.0 108.89 179.51 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.5 p-10 -100.01 10.47 41.24 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.315 -0.866 . . . . 1.0 110.614 -178.884 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 116.73 -152.31 17.92 Favored Glycine 0 N--CA 1.505 3.293 0 N-CA-C 109.432 -1.467 . . . . 1.0 109.432 179.689 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -58.07 -65.77 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.429 0 CA-C-N 118.905 1.352 . . . . 1.0 112.338 -179.768 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 80.7 p -76.27 159.26 30.76 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.232 -0.917 . . . . 1.0 109.878 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.86 -130.87 9.3 Favored Glycine 0 N--CA 1.503 3.148 0 N-CA-C 109.6 -1.4 . . . . 1.0 109.6 179.836 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.402 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 15.2 mt -70.18 105.03 2.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.07 -1.253 . . . . 1.0 109.046 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 40.2 mt -77.43 -18.29 57.35 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.295 -1.002 . . . . 1.0 108.295 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.98 172.49 1.04 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.417 -0.957 . . . . 1.0 108.417 179.846 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.433 ' ND1' ' C ' ' A' ' 84' ' ' HIS . 8.1 p80 -163.09 156.76 19.9 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.988 -1.07 . . . . 1.0 109.744 179.348 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.07 157.8 43.68 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.721 -0.844 . . . . 1.0 108.721 179.836 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -94.84 153.15 40.06 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.059 -1.026 . . . . 1.0 109.057 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.577 ' O ' ' N ' ' A' ' 89' ' ' GLY . 5.3 Cg_endo -59.17 166.43 7.3 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 120.447 0.765 . . . . 1.0 111.01 179.576 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -50.05 77.99 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.252 1.302 . . . . 1.0 112.264 -179.843 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -99.27 -170.52 30.7 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.202 -1.559 . . . . 1.0 109.202 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.409 ' O ' ' O ' ' A' ' 89' ' ' GLY . 12.8 Cg_exo -55.84 -155.36 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.175 1.25 . . . . 1.0 112.622 -179.685 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -60.03 -40.3 88.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.277 -0.889 . . . . 1.0 109.79 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -67.11 -40.01 86.78 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.184 -0.947 . . . . 1.0 109.298 179.812 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.53 169.48 37.18 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.699 -1.36 . . . . 1.0 109.699 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.44 8.55 86.94 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.573 -1.411 . . . . 1.0 109.573 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -79.86 170.01 17.1 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.221 -1.164 . . . . 1.0 109.993 -179.679 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.17 124.49 10.9 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.176 -0.952 . . . . 1.0 110.058 -179.638 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.426 ' ND1' ' CE1' ' A' ' 84' ' ' HIS . 54.1 m170 -108.95 141.64 40.74 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.497 -0.752 . . . . 1.0 110.222 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -124.19 144.09 50.13 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 109.036 -0.728 . . . . 1.0 109.036 179.223 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.551 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 77.4 m-20 -78.96 121.33 24.77 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.967 -1.083 . . . . 1.0 109.677 179.814 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -85.32 -7.19 59.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.337 -0.852 . . . . 1.0 109.004 179.424 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -84.04 -12.53 55.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.452 -0.78 . . . . 1.0 109.395 -179.801 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -89.31 169.95 10.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.45 -0.782 . . . . 1.0 109.766 -178.915 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 18.2 m -98.87 103.86 15.85 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.338 -0.851 . . . . 1.0 109.245 -179.657 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.435 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 89.0 m95 -88.17 127.11 35.43 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.814 -0.809 . . . . 1.0 108.814 179.763 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.668 HG21 ' HB2' ' A' ' 109' ' ' LYS . 5.7 t -143.03 154.13 43.66 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.168 -0.958 . . . . 1.0 109.929 -179.522 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.9 m -94.05 -10.56 33.05 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.208 -0.933 . . . . 1.0 108.597 179.382 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.7 m -91.29 177.67 6.18 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.597 -0.89 . . . . 1.0 108.597 179.355 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.7 t -76.5 80.17 3.2 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.012 -1.055 . . . . 1.0 109.648 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.668 ' HB2' HG21 ' A' ' 105' ' ' THR . 9.5 mtmp? -153.53 150.12 28.38 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.328 -0.857 . . . . 1.0 109.283 179.499 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 43.48 -140.31 2.97 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.046 -1.222 . . . . 1.0 110.046 179.465 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -99.98 111.87 24.16 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.343 -1.093 . . . . 1.0 109.076 179.695 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.417 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 19.6 t-20 -61.55 136.53 58.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.072 -1.017 . . . . 1.0 109.9 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.2 tp -59.97 -44.11 94.67 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.357 -0.839 . . . . 1.0 110.467 179.815 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -59.96 -41.47 91.98 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.08 -1.013 . . . . 1.0 110.889 -178.22 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.99 -50.11 75.01 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.814 -1.179 . . . . 1.0 109.487 -179.395 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 56.3 t -70.0 -41.5 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.06 -1.025 . . . . 1.0 110.307 -179.47 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.33 -52.8 64.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.09 -1.006 . . . . 1.0 110.074 -178.973 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.55 -35.5 74.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.11 -0.994 . . . . 1.0 110.099 -179.728 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -63.93 -50.3 69.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.948 . . . . 1.0 111.254 -178.512 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -60.05 -39.21 85.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.645 -1.285 . . . . 1.0 110.091 -179.297 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -60.04 -39.87 87.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.967 -1.083 . . . . 1.0 108.844 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.68 -44.39 94.05 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.431 -1.468 . . . . 1.0 109.431 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -64.95 -39.99 94.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.19 -1.182 . . . . 1.0 109.494 179.54 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 83.2 p -65.7 -22.9 66.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.228 -0.92 . . . . 1.0 109.523 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 82.2 mt -82.55 -1.2 49.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.241 -0.912 . . . . 1.0 109.283 179.709 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.73 8.71 65.16 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 110.819 -0.912 . . . . 1.0 110.819 178.985 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.4 mt -85.82 146.35 26.8 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.881 -1.364 . . . . 1.0 109.652 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 44.5 t0 -100.41 172.7 6.97 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.484 -0.76 . . . . 1.0 109.199 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.519 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 64.7 m80 -58.86 136.92 57.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.911 . . . . 1.0 109.703 -179.661 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 42.0 t -98.04 155.63 17.03 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.37 -0.831 . . . . 1.0 109.176 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -98.75 1.91 46.48 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.265 -0.897 . . . . 1.0 109.934 179.953 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -85.4 128.5 59.13 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.074 -1.016 . . . . 1.0 108.368 179.336 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -67.8 -17.4 47.15 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 CA-C-N 120.237 1.12 . . . . 1.0 112.519 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -90.32 -5.53 69.75 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.696 -1.361 . . . . 1.0 109.696 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -89.05 140.02 29.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.218 -1.166 . . . . 1.0 109.35 179.726 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.449 ' C ' ' H ' ' A' ' 138' ' ' PHE . 98.3 mt -63.86 -31.99 73.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.139 -0.976 . . . . 1.0 109.83 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 96.0 mmm -71.21 19.43 0.06 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.322 -0.861 . . . . 1.0 110.503 -179.027 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.449 ' H ' ' C ' ' A' ' 136' ' ' LEU . 11.3 t80 -69.31 132.14 89.94 Favored Pre-proline 0 N--CA 1.495 1.775 0 N-CA-C 107.817 -1.179 . . . . 1.0 107.817 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -61.88 -13.74 32.65 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 CA-C-N 119.837 0.977 . . . . 1.0 113.33 -178.346 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.5 mt -108.14 139.28 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.199 -0.938 . . . . 1.0 109.343 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.417 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 33.4 t80 -72.69 129.56 38.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.324 -0.86 . . . . 1.0 109.853 -179.464 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.2 t -140.15 143.74 36.31 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.868 -0.79 . . . . 1.0 108.868 179.762 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -81.01 144.8 31.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.137 -0.977 . . . . 1.0 109.289 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.5 t -140.5 151.94 45.21 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.184 -0.947 . . . . 1.0 109.825 -179.863 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -61.81 103.93 0.65 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.284 -1.126 . . . . 1.0 110.284 -179.478 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.413 ' NZ ' ' CB ' ' A' ' 146' ' ' LYS . 9.1 mtpm? -77.28 -7.94 56.8 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.337 -1.096 . . . . 1.0 109.236 179.638 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 82.5 p -59.97 -40.01 87.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 1.0 109.832 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -154.27 69.63 0.77 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.11 -0.993 . . . . 1.0 109.65 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -100.45 127.1 46.89 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.219 -0.926 . . . . 1.0 109.642 179.66 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 75.5 mtm -121.44 141.46 50.98 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.572 -0.899 . . . . 1.0 108.572 179.203 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.8 mt -52.6 128.47 43.55 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 120.917 -1.115 . . . . 1.0 108.82 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -68.64 175.48 7.08 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 CA-C-N 120.036 1.049 . . . . 1.0 111.903 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -59.97 -40.03 87.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.331 -0.856 . . . . 1.0 109.697 179.798 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -54.56 -49.21 70.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.256 -0.903 . . . . 1.0 110.172 -179.227 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -69.92 -39.97 75.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.993 -1.067 . . . . 1.0 110.026 -179.601 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 60.1 t -60.06 -47.1 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 1.0 109.218 -179.831 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -60.07 -40.01 88.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.125 -0.984 . . . . 1.0 110.203 -179.75 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.12 -55.27 9.39 Favored Glycine 0 N--CA 1.495 2.619 0 O-C-N 121.143 -0.973 . . . . 1.0 111.301 -178.567 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.484 HG23 ' N ' ' A' ' 160' ' ' GLN . 4.8 tp -60.17 -40.09 82.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.946 -1.326 . . . . 1.0 109.734 -178.996 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.533 ' O ' ' N ' ' A' ' 164' ' ' GLY . 26.0 mm100 -64.35 -40.06 95.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.081 -1.012 . . . . 1.0 109.789 179.852 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 94.1 p -62.08 -30.44 71.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.11 -0.994 . . . . 1.0 110.196 -179.537 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.46 ' CD2' ' N ' ' A' ' 7' ' ' THR . 93.1 mt -84.92 -54.24 4.79 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.028 -1.045 . . . . 1.0 110.623 -179.099 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -89.73 -8.85 51.35 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.002 -1.061 . . . . 1.0 110.011 -179.094 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.584 0 N-CA-C 109.513 -1.435 . . . . 1.0 109.513 179.775 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 169' ' ' WAY . . . . . 0.957 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 96.0 m . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.303 0.573 . . . . 1.0 109.513 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.7 mt -70.03 142.98 52.67 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.389 -0.82 . . . . 1.0 109.703 -179.616 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -160.67 160.01 31.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.357 -0.839 . . . . 1.0 109.405 179.776 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 47.6 m95 -75.28 125.39 28.88 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.091 -1.005 . . . . 1.0 109.249 -179.923 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.7 p -73.28 -29.49 62.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.02 -1.05 . . . . 1.0 109.518 179.877 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -92.07 139.08 30.99 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.304 -0.999 . . . . 1.0 108.304 179.405 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.613 ' N ' ' SD ' ' A' ' 13' ' ' MET . 3.5 mmm -90.62 0.07 57.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.251 -0.906 . . . . 1.0 109.828 -178.372 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -98.17 125.86 43.39 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.707 -0.849 . . . . 1.0 108.707 179.46 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.7 mt -138.7 152.25 47.85 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.202 -0.937 . . . . 1.0 109.307 -179.503 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.6 p -132.98 154.16 50.76 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.997 -0.742 . . . . 1.0 108.997 -179.953 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -144.29 159.99 41.75 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.131 -0.981 . . . . 1.0 109.848 -179.656 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.537 ' NE ' ' O ' ' A' ' 56' ' ' GLY . 25.2 ttm-85 -142.17 134.54 27.88 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.397 -0.814 . . . . 1.0 109.585 -179.721 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 87.1 mt -87.92 117.97 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.482 -0.933 . . . . 1.0 108.482 178.73 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.9 t -69.32 -38.8 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.172 -0.955 . . . . 1.0 109.417 -179.32 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -159.19 157.88 31.62 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 122.217 1.008 . . . . 1.0 111.5 179.424 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.488 ' O ' ' O ' ' A' ' 23' ' ' THR . 15.5 m-85 -112.13 77.02 1.01 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 103.678 -2.712 . . . . 1.0 103.678 176.652 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.488 ' O ' ' O ' ' A' ' 22' ' ' TYR . 5.4 t -29.15 150.84 0.03 OUTLIER Pre-proline 0 C--N 1.282 -2.341 0 CA-C-N 115.741 -0.663 . . . . 1.0 112.178 -177.535 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -65.15 -6.55 13.31 Favored 'Trans proline' 0 N--CA 1.5 1.855 0 C-N-CA 121.275 1.317 . . . . 1.0 113.383 -178.56 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -59.15 -37.78 78.14 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 119.509 -0.876 . . . . 1.0 110.285 179.839 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 73.4 mtm -138.75 162.64 34.2 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.142 -0.974 . . . . 1.0 109.591 -179.776 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.4 p -71.45 160.4 32.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.363 -0.836 . . . . 1.0 109.436 -179.663 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -60.01 -40.44 89.26 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.313 -0.867 . . . . 1.0 109.869 -179.178 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.2 m -60.03 -42.48 94.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.136 -0.977 . . . . 1.0 110.501 -179.416 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.09 -40.0 82.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.085 -1.01 . . . . 1.0 110.023 -179.638 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 70.2 t -67.56 -44.84 86.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.164 -0.96 . . . . 1.0 110.288 -179.233 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -59.99 -49.42 77.75 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.139 -0.976 . . . . 1.0 111.13 -178.896 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -60.48 -33.47 72.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.818 -1.176 . . . . 1.0 109.847 -179.537 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.0 -49.97 75.57 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.967 -1.083 . . . . 1.0 109.95 -179.538 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -66.56 -38.81 87.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.912 -1.117 . . . . 1.0 109.894 -179.886 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.97 -42.42 94.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.078 -1.014 . . . . 1.0 109.514 -179.256 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -60.07 -39.96 87.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.133 -0.98 . . . . 1.0 109.137 179.394 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.06 -48.35 82.09 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.31 -0.868 . . . . 1.0 109.851 -179.592 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -66.26 -39.18 89.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 1.0 110.075 -179.747 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -60.01 -48.78 80.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.063 -1.023 . . . . 1.0 109.448 -179.248 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 86.2 t -59.98 -40.04 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.104 -0.997 . . . . 1.0 110.566 -179.376 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -81.47 -33.66 31.85 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.902 -1.124 . . . . 1.0 110.005 -179.555 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 94.3 p -72.05 -21.15 61.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.895 -1.128 . . . . 1.0 109.78 179.89 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.96 -39.98 87.47 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.243 -0.911 . . . . 1.0 110.626 -179.589 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 m -110.98 24.48 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 O-C-N 121.27 -0.894 . . . . 1.0 110.682 -179.118 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.5 p -149.15 135.23 10.05 Favored Pre-proline 0 N--CA 1.5 2.061 0 O-C-N 120.761 -1.212 . . . . 1.0 109.505 179.376 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -73.87 16.39 0.53 Allowed 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 120.693 0.928 . . . . 1.0 111.901 179.083 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 93.9 mt -68.31 139.35 55.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.071 -1.018 . . . . 1.0 109.756 -179.423 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -110.71 120.81 43.62 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.954 -0.758 . . . . 1.0 108.954 -179.961 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -108.38 123.49 48.92 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.393 -0.817 . . . . 1.0 109.466 -179.492 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -120.03 130.01 54.51 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.7 -0.625 . . . . 1.0 109.327 179.885 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -83.95 132.87 34.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.216 -0.927 . . . . 1.0 109.285 179.696 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.521 ' C ' HH12 ' A' ' 18' ' ' ARG . 91.2 mt -102.2 139.73 37.42 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.23 -0.919 . . . . 1.0 108.915 179.67 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.438 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 41.5 m170 -69.52 -40.0 77.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 1.0 110.228 -179.306 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.52 ' O ' ' NH2' ' A' ' 18' ' ' ARG . 70.4 m-20 -153.44 179.68 8.56 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.024 -1.047 . . . . 1.0 109.885 -179.636 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.537 ' O ' ' NE ' ' A' ' 18' ' ' ARG . . . 92.39 -170.84 33.06 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.75 -1.34 . . . . 1.0 109.75 179.928 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.0 mt -97.11 131.36 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.337 -1.096 . . . . 1.0 109.221 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.23 166.11 11.11 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.354 -0.841 . . . . 1.0 109.21 -179.949 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.01 -49.22 78.53 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.128 -0.982 . . . . 1.0 108.915 -179.928 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.5 mt -119.96 114.12 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.676 -0.64 . . . . 1.0 109.389 179.31 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.5 ptp -101.71 138.29 38.89 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.254 -0.904 . . . . 1.0 108.999 179.126 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.6 mt -109.99 131.86 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.359 -0.838 . . . . 1.0 109.794 -179.133 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 71.6 p -150.01 160.68 43.44 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.224 -0.923 . . . . 1.0 109.974 -179.541 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -107.13 122.57 46.75 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.463 -0.773 . . . . 1.0 109.388 179.987 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' A' ' 100' ' ' ASP . . . -96.45 167.67 24.88 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.208 -1.557 . . . . 1.0 109.208 179.6 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.484 ' O ' ' C ' ' A' ' 67' ' ' LYS . 11.3 tt -110.03 179.99 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.277 -1.131 . . . . 1.0 109.671 -179.4 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 66' ' ' ILE . 28.2 tptp -25.58 -76.56 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.243 0 CA-C-O 121.061 0.458 . . . . 1.0 111.799 179.741 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.582 ' O ' ' N ' ' A' ' 70' ' ' GLY . 20.5 pt-20 -60.79 -39.86 90.47 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.094 -1.004 . . . . 1.0 109.848 -178.754 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.553 ' ND1' ' CE1' ' A' ' 75' ' ' PHE . 2.8 t-160 57.42 -77.35 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.164 -0.96 . . . . 1.0 109.764 179.335 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 68' ' ' GLU . . . -138.48 146.84 18.71 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 108.844 -1.702 . . . . 1.0 108.844 179.635 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -66.58 -39.96 88.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -1.165 . . . . 1.0 110.026 -179.846 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -68.53 -38.96 81.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.346 -0.846 . . . . 1.0 110.8 -179.142 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 73' ' ' TYR . 2.1 p90 -129.97 79.29 73.38 Favored Pre-proline 0 N--CA 1.503 2.207 0 O-C-N 121.147 -0.971 . . . . 1.0 110.037 -179.395 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -78.72 147.28 21.76 Favored 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 121.187 1.258 . . . . 1.0 111.873 179.217 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.553 ' CE1' ' ND1' ' A' ' 69' ' ' HIS . 33.1 m-85 -90.29 172.61 8.65 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.242 -0.911 . . . . 1.0 109.162 179.839 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 79' ' ' SER . 32.8 p-10 -99.8 1.81 43.45 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.144 -0.972 . . . . 1.0 111.538 -178.425 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.406 ' O ' ' OE2' ' A' ' 102' ' ' GLU . . . 111.93 -117.91 4.58 Favored Glycine 0 N--CA 1.508 3.463 0 O-C-N 120.93 -1.106 . . . . 1.0 111.144 178.69 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.466 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 28.3 Cg_endo -73.51 -73.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.948 0 CA-C-N 120.015 1.908 . . . . 1.0 113.399 -178.88 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.451 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 99.2 p -78.17 173.89 11.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.949 -1.095 . . . . 1.0 109.475 -179.366 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 106.04 -134.39 12.09 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 110.152 -1.179 . . . . 1.0 110.152 179.64 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.459 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 19.6 mt -71.91 117.73 13.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.592 -0.946 . . . . 1.0 109.843 -179.397 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 66.1 mt -85.09 -22.77 28.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.986 -1.071 . . . . 1.0 109.127 179.343 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.13 174.46 1.05 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.86 -0.793 . . . . 1.0 108.86 -179.741 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.68 163.3 27.02 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.242 -0.911 . . . . 1.0 109.492 179.276 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -153.72 162.27 41.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.391 -0.818 . . . . 1.0 108.885 -179.743 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -106.41 151.11 40.21 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.373 -0.829 . . . . 1.0 108.85 179.754 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.534 ' O ' ' N ' ' A' ' 89' ' ' GLY . 13.5 Cg_endo -66.27 164.48 27.92 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 120.768 0.979 . . . . 1.0 111.785 179.604 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -51.49 81.68 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 121.037 1.158 . . . . 1.0 111.836 179.762 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -99.71 -169.74 30.02 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.84 -1.304 . . . . 1.0 109.84 -179.609 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 89' ' ' GLY . 21.2 Cg_exo -55.22 -143.83 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.758 1.639 . . . . 1.0 113.236 -179.637 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.404 ' OD1' ' N ' ' A' ' 92' ' ' TYR . 34.2 p-10 -62.26 -40.01 94.78 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.377 -0.827 . . . . 1.0 110.594 -179.154 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.404 ' N ' ' OD1' ' A' ' 91' ' ' ASN . 41.5 p90 -80.0 -10.38 59.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.806 -1.184 . . . . 1.0 109.449 179.942 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -76.41 169.25 54.89 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.457 -1.457 . . . . 1.0 109.457 179.894 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 66.69 76.69 0.34 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.869 -1.292 . . . . 1.0 109.869 179.787 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.9 p-10 -150.54 164.25 36.46 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.176 -1.191 . . . . 1.0 109.178 179.633 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.95 129.64 14.1 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.038 -1.039 . . . . 1.0 109.671 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -127.18 132.39 50.49 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.557 -0.714 . . . . 1.0 109.679 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -109.97 156.74 20.07 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.652 -0.655 . . . . 1.0 109.462 -179.798 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.493 ' OD1' ' CD2' ' A' ' 75' ' ' PHE . 90.8 m-20 -80.06 130.14 35.03 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.014 -1.054 . . . . 1.0 109.816 179.455 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.532 ' N ' ' O ' ' A' ' 65' ' ' GLY . 8.3 t70 -87.75 -6.77 58.02 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.274 -0.891 . . . . 1.0 109.491 179.412 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -83.53 -10.22 58.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.237 -0.914 . . . . 1.0 110.08 -179.519 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.466 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 42.0 mm-40 -90.58 173.88 7.82 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.161 -0.962 . . . . 1.0 109.5 -179.171 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 56.2 m -105.26 107.48 18.49 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.458 -0.941 . . . . 1.0 108.458 179.152 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -86.55 121.37 28.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.243 -0.911 . . . . 1.0 109.3 -179.506 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.666 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.6 t -143.12 156.33 44.77 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.538 -0.726 . . . . 1.0 109.605 -179.273 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 29.4 t -95.31 -7.26 39.21 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.332 -0.988 . . . . 1.0 108.332 178.924 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 68.3 m -91.03 179.78 5.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.565 -0.709 . . . . 1.0 109.226 179.624 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 99.4 p -79.82 68.62 5.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.232 -0.917 . . . . 1.0 109.806 -179.858 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.666 ' HB2' HG21 ' A' ' 105' ' ' THR . 98.4 mttt -143.18 149.51 38.11 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.2 -0.937 . . . . 1.0 108.809 179.5 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.51 -144.02 3.34 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.688 -1.365 . . . . 1.0 109.688 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -100.21 117.43 34.43 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.343 -1.092 . . . . 1.0 109.034 179.625 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.449 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 20.2 t-20 -62.26 132.66 53.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.912 . . . . 1.0 109.545 179.998 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.8 tp -59.96 -43.51 95.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.34 -0.85 . . . . 1.0 110.487 -179.498 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -59.97 -41.11 91.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.027 -1.046 . . . . 1.0 110.784 -178.485 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -58.49 -50.78 72.5 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.683 -1.261 . . . . 1.0 109.188 -179.584 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.0 t -70.04 -40.11 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.127 -0.983 . . . . 1.0 109.681 -179.556 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.94 -52.68 64.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.188 -0.945 . . . . 1.0 109.864 -179.341 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.99 -34.84 73.86 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.651 -1.281 . . . . 1.0 109.887 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -65.3 -50.05 67.16 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.264 -0.897 . . . . 1.0 111.617 -178.426 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -60.0 -40.01 87.75 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.63 -1.293 . . . . 1.0 109.408 -178.72 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -59.99 -40.03 87.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.026 -1.046 . . . . 1.0 108.723 179.879 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.31 -46.41 63.73 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.166 -1.573 . . . . 1.0 109.166 179.847 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.402 ' CE1' ' NE2' ' A' ' 129' ' ' HIS . 79.0 m-70 -65.26 -40.02 93.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.229 -1.159 . . . . 1.0 109.611 179.607 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 84.1 p -66.77 -23.95 66.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 1.0 109.998 -179.754 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 78.4 mt -82.26 -2.27 52.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.128 -0.983 . . . . 1.0 110.046 -179.544 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.57 6.24 68.24 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 110.443 -1.063 . . . . 1.0 110.443 179.357 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.3 mt -84.68 149.08 26.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.053 -1.263 . . . . 1.0 109.07 179.501 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 36.1 t0 -103.27 170.35 8.01 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.764 -0.828 . . . . 1.0 108.764 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.51 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 28.0 m170 -58.53 135.16 57.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.012 -1.055 . . . . 1.0 109.356 -179.631 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 41.9 t -98.18 155.29 17.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.382 -0.824 . . . . 1.0 109.106 179.879 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -98.05 5.58 48.55 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.23 -0.919 . . . . 1.0 110.014 -179.512 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -85.88 126.68 65.05 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 108.121 -1.066 . . . . 1.0 108.121 179.275 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -68.45 -8.81 24.14 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 CA-C-N 120.186 1.102 . . . . 1.0 112.011 -179.615 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -96.44 -7.52 58.03 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.509 -1.437 . . . . 1.0 109.509 179.863 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.87 137.05 33.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.133 -1.216 . . . . 1.0 109.412 179.814 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.435 ' C ' ' H ' ' A' ' 138' ' ' PHE . 64.7 mt -60.03 -39.84 87.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.121 -0.987 . . . . 1.0 110.239 179.86 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 89.8 mtp -71.28 25.52 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.275 -0.891 . . . . 1.0 111.417 -178.463 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.435 ' H ' ' C ' ' A' ' 136' ' ' LEU . 16.2 t80 -69.22 136.44 89.08 Favored Pre-proline 0 N--CA 1.498 1.955 0 N-CA-C 107.459 -1.311 . . . . 1.0 107.459 178.787 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -60.65 -14.28 30.48 Favored 'Trans proline' 0 N--CA 1.5 1.902 0 CA-C-N 120.185 1.102 . . . . 1.0 114.196 -178.062 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.3 mt -109.95 139.07 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 O-C-N 121.014 -1.054 . . . . 1.0 109.697 -179.693 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.449 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 34.2 t80 -74.12 125.42 28.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.354 -0.841 . . . . 1.0 110.119 -179.324 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 7.4 t -136.6 142.94 43.34 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.997 -0.742 . . . . 1.0 108.997 179.812 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -80.67 143.29 33.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.932 -1.105 . . . . 1.0 109.746 -179.775 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.4 m -134.71 138.59 44.52 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.531 -0.73 . . . . 1.0 109.838 -179.475 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -68.0 99.91 0.59 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 107.97 -2.052 . . . . 1.0 107.97 178.658 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -74.46 17.09 0.21 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -1.129 . . . . 1.0 110.484 -178.475 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 41.1 t -57.67 -46.57 84.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.905 -1.122 . . . . 1.0 109.31 -179.853 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -147.72 33.99 0.85 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.147 -0.971 . . . . 1.0 109.368 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -63.73 138.03 58.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.2 -0.938 . . . . 1.0 110.953 -179.104 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 74.0 mtm -134.11 148.53 51.0 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.133 -1.062 . . . . 1.0 108.133 178.954 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 70.7 mt -53.3 129.12 51.06 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 120.918 -1.114 . . . . 1.0 108.867 -179.862 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -69.52 177.05 5.8 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 CA-C-N 120.074 1.062 . . . . 1.0 112.019 179.643 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -60.29 -39.95 88.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.868 . . . . 1.0 110.023 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -55.55 -48.94 73.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.245 -0.91 . . . . 1.0 110.054 -179.047 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -70.03 -40.02 75.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.152 -0.967 . . . . 1.0 110.34 -179.63 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 60.3 t -60.03 -48.81 86.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.027 -1.046 . . . . 1.0 109.124 -179.556 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -60.0 -39.98 87.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.128 -0.983 . . . . 1.0 110.44 179.97 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.06 -54.59 7.93 Favored Glycine 0 N--CA 1.493 2.49 0 O-C-N 121.136 -0.978 . . . . 1.0 111.382 -178.35 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.476 HG23 ' N ' ' A' ' 160' ' ' GLN . 7.1 tp -59.98 -40.11 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.937 -1.331 . . . . 1.0 109.618 -179.026 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.546 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.7 mt-30 -66.61 -39.93 88.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 1.0 109.594 179.597 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 83.1 p -61.52 -31.12 71.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.143 -0.973 . . . . 1.0 110.74 -179.308 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 88.6 mt -86.84 -51.36 6.12 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.779 -1.201 . . . . 1.0 110.551 -179.041 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -90.83 -9.16 47.46 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.984 -1.073 . . . . 1.0 109.931 -179.273 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.524 0 N-CA-C 109.489 -1.444 . . . . 1.0 109.489 -179.866 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 169' ' ' WAY . . . . . 0.627 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 84.7 m . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.296 0.57 . . . . 1.0 109.636 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.1 mt -68.01 142.01 56.05 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.255 -0.903 . . . . 1.0 110.04 -179.618 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -160.6 160.2 31.43 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.471 -0.768 . . . . 1.0 109.018 179.598 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -73.45 147.95 43.69 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.13 -0.981 . . . . 1.0 109.463 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.3 p -84.93 0.13 52.28 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.203 -0.936 . . . . 1.0 109.742 -179.636 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -145.77 153.11 40.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.197 -0.939 . . . . 1.0 109.384 -179.877 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.2 mmt -90.02 -0.73 57.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.257 -0.902 . . . . 1.0 109.129 -179.645 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -96.19 128.2 42.88 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.341 -0.85 . . . . 1.0 108.989 -179.994 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.3 mt -140.02 150.17 44.09 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.232 -0.917 . . . . 1.0 109.04 -179.799 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 59.5 p -131.09 156.14 45.73 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.907 -0.775 . . . . 1.0 108.907 179.937 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -146.06 160.06 42.41 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.133 -0.98 . . . . 1.0 110.055 -179.672 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.598 HH12 ' H ' ' A' ' 56' ' ' GLY . 70.5 ttt180 -142.86 135.31 27.57 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.421 -0.8 . . . . 1.0 109.355 -179.939 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.5 mt -87.78 120.0 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.254 -0.904 . . . . 1.0 108.708 179.185 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 67.0 t -67.72 -39.04 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -0.925 . . . . 1.0 108.887 -179.812 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.44 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 22.0 p-10 -160.61 152.9 20.44 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 119.937 -1.727 . . . . 1.0 111.289 179.687 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.644 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 33.3 m-85 -101.28 74.96 1.59 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 106.612 -1.625 . . . . 1.0 106.612 177.118 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.476 ' C ' ' O ' ' A' ' 22' ' ' TYR . 3.9 t -24.54 143.14 0.04 OUTLIER Pre-proline 0 N--CA 1.508 2.433 0 N-CA-C 112.069 0.396 . . . . 1.0 112.069 -177.786 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -62.58 -5.86 7.83 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 121.247 1.298 . . . . 1.0 112.743 -179.285 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -59.48 -36.93 76.94 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.424 -0.797 . . . . 1.0 109.939 179.704 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 78.2 mtm -138.53 161.23 37.58 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.194 -0.941 . . . . 1.0 109.556 -179.772 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.1 p -71.62 160.19 33.11 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.37 -0.831 . . . . 1.0 109.127 -179.878 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.644 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 2.1 m80 -59.96 -40.59 89.58 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.346 -0.846 . . . . 1.0 110.22 -179.083 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 74.9 m -61.28 -40.47 94.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.098 -1.001 . . . . 1.0 110.275 -179.587 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.35 -39.97 77.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.207 -0.933 . . . . 1.0 110.383 -179.478 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 77.2 t -68.29 -43.56 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.139 -0.975 . . . . 1.0 110.134 -179.258 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.01 -49.4 77.82 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.19 -0.944 . . . . 1.0 110.87 -179.063 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -61.47 -32.86 72.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.885 -1.134 . . . . 1.0 110.112 -179.531 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.97 -49.67 76.77 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.906 -1.121 . . . . 1.0 109.713 -179.579 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.419 ' CE1' HD13 ' A' ' 62' ' ' ILE . 53.7 m-85 -66.27 -38.77 88.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.993 -1.067 . . . . 1.0 109.723 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -59.99 -43.37 95.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.045 -1.034 . . . . 1.0 109.795 -179.619 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -60.1 -41.24 92.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.99 -1.069 . . . . 1.0 109.475 179.58 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.29 -46.69 88.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.331 -0.856 . . . . 1.0 110.133 -179.389 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -67.2 -38.58 85.56 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.05 -1.031 . . . . 1.0 110.001 -179.767 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -59.96 -48.84 80.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.097 -1.002 . . . . 1.0 109.839 -179.349 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 79.7 t -60.09 -40.14 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.144 -0.973 . . . . 1.0 110.113 -179.412 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.456 ' CH2' HD22 ' A' ' 151' ' ' LEU . 69.2 m95 -81.35 -36.57 29.49 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.008 -1.058 . . . . 1.0 110.08 -179.413 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.3 p -70.19 -21.54 63.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.032 -1.043 . . . . 1.0 109.891 -179.632 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.07 -39.87 87.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.29 -0.881 . . . . 1.0 110.666 -179.739 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.411 HG23 HG23 ' A' ' 46' ' ' THR . 11.3 m -109.76 24.21 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.28 -0.888 . . . . 1.0 110.471 -178.824 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.411 HG23 HG23 ' A' ' 45' ' ' VAL . 43.3 p -149.83 134.41 9.32 Favored Pre-proline 0 N--CA 1.499 2.003 0 O-C-N 120.92 -1.113 . . . . 1.0 109.54 179.543 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -74.18 17.42 0.51 Allowed 'Trans proline' 0 N--CA 1.493 1.455 0 CA-C-N 119.702 0.929 . . . . 1.0 111.86 178.882 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 72.6 mt -68.53 139.9 55.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.117 -0.989 . . . . 1.0 109.413 -179.608 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -109.99 120.51 42.7 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 179.851 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -109.53 119.79 40.52 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.398 -0.814 . . . . 1.0 109.0 -179.687 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -120.06 130.03 54.49 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.533 -0.73 . . . . 1.0 109.944 -179.84 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -82.25 135.25 35.27 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.253 -0.904 . . . . 1.0 109.104 179.28 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.9 mt -101.3 129.29 47.25 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.161 -0.962 . . . . 1.0 109.483 -179.956 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.445 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 60.1 m170 -61.79 -40.0 93.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.413 -0.804 . . . . 1.0 109.443 179.879 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 77.9 m-20 -148.84 168.88 21.81 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.251 -0.906 . . . . 1.0 109.449 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.598 ' H ' HH12 ' A' ' 18' ' ' ARG . . . 98.72 178.07 32.31 Favored Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.54 -1.424 . . . . 1.0 109.54 -179.956 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.4 mt -95.87 135.06 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.241 -1.152 . . . . 1.0 109.291 179.863 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.02 160.76 16.15 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.492 -0.755 . . . . 1.0 109.155 -179.75 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -60.04 -49.51 77.38 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.17 -0.956 . . . . 1.0 109.306 -179.747 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.8 mt -105.37 103.51 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.356 -0.84 . . . . 1.0 109.978 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.1 ptp -100.43 133.96 44.08 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.188 -0.945 . . . . 1.0 108.766 178.773 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.419 HD13 ' CE1' ' A' ' 35' ' ' PHE . 85.4 mt -110.08 131.37 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.443 -0.785 . . . . 1.0 110.045 -178.56 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.1 p -150.56 160.3 43.89 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.153 -0.967 . . . . 1.0 109.93 -179.702 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -104.8 123.55 47.88 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 179.592 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 98' ' ' PHE . . . -95.55 -175.9 37.11 Favored Glycine 0 N--CA 1.499 2.894 0 N-CA-C 110.544 -1.023 . . . . 1.0 110.544 -179.274 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.52 HG22 ' N ' ' A' ' 67' ' ' LYS . 61.1 mt -131.81 165.72 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.446 -1.031 . . . . 1.0 109.442 -179.967 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.52 ' N ' HG22 ' A' ' 66' ' ' ILE . 20.5 tptm -22.53 -77.74 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.325 0 CA-C-O 121.165 0.507 . . . . 1.0 111.476 -179.825 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.645 ' CD ' ' H ' ' A' ' 68' ' ' GLU . 4.3 pm0 -68.42 138.4 55.28 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.084 -1.01 . . . . 1.0 109.224 -179.849 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -124.46 8.25 8.37 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.348 -0.845 . . . . 1.0 109.153 -179.34 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 70.01 32.83 69.63 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.373 -1.491 . . . . 1.0 109.373 -179.759 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -141.21 163.18 33.66 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.222 -1.164 . . . . 1.0 109.935 -179.671 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -66.23 -21.68 66.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.262 -0.899 . . . . 1.0 110.254 -179.897 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.534 ' CD2' ' O ' ' A' ' 73' ' ' TYR . 12.7 p90 -128.46 74.12 80.11 Favored Pre-proline 0 N--CA 1.504 2.255 0 O-C-N 121.229 -0.919 . . . . 1.0 110.532 -179.664 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -74.65 -152.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 121.195 1.264 . . . . 1.0 110.991 178.847 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.529 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 87.8 m-85 -83.74 162.67 20.59 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.988 -1.07 . . . . 1.0 109.739 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -102.11 16.12 27.03 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.361 -0.837 . . . . 1.0 110.746 -178.86 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 114.93 -157.51 14.94 Favored Glycine 0 N--CA 1.505 3.285 0 N-CA-C 109.55 -1.42 . . . . 1.0 109.55 179.617 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -58.37 -65.75 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.469 0 CA-C-N 118.568 1.184 . . . . 1.0 112.406 -179.742 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 89.7 p -76.03 162.17 28.28 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.181 -0.949 . . . . 1.0 109.65 -179.948 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.17 -129.09 8.29 Favored Glycine 0 N--CA 1.502 3.058 0 N-CA-C 109.836 -1.306 . . . . 1.0 109.836 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.1 mt -69.63 107.58 3.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.323 -1.104 . . . . 1.0 109.077 -179.958 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 56.7 mt -78.47 -26.54 46.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.896 . . . . 1.0 108.924 179.982 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.53 164.46 1.64 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.342 -0.984 . . . . 1.0 108.342 -179.715 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -160.35 162.74 33.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.128 -0.982 . . . . 1.0 109.44 179.493 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 95' ' ' ASP . . . -145.76 160.0 42.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.283 -0.886 . . . . 1.0 109.583 -179.645 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -93.88 152.97 40.99 Favored Pre-proline 0 N--CA 1.492 1.661 0 N-CA-C 107.944 -1.132 . . . . 1.0 107.944 179.433 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.527 ' O ' ' N ' ' A' ' 89' ' ' GLY . 2.4 Cg_endo -56.95 165.79 4.64 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 CA-C-N 119.166 0.738 . . . . 1.0 111.673 179.778 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -55.62 75.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.346 1.364 . . . . 1.0 112.112 -179.564 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -94.43 -173.69 38.55 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.658 -1.777 . . . . 1.0 108.658 179.5 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.502 ' O ' ' O ' ' A' ' 89' ' ' GLY . 25.6 Cg_exo -51.56 -143.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.77 1.647 . . . . 1.0 113.462 -179.986 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.488 ' OD1' ' N ' ' A' ' 92' ' ' TYR . 34.6 p-10 -60.89 -47.64 85.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.653 -1.279 . . . . 1.0 111.163 -178.619 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.488 ' N ' ' OD1' ' A' ' 91' ' ' ASN . 35.4 p90 -68.36 -29.27 67.95 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.664 -1.273 . . . . 1.0 109.838 -179.372 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.434 ' N ' ' CD1' ' A' ' 92' ' ' TYR . . . -64.17 168.71 24.46 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.857 -1.297 . . . . 1.0 109.857 -179.862 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 69.92 17.02 73.1 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.16 -1.176 . . . . 1.0 110.16 179.679 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.442 ' O ' ' HB1' ' A' ' 85' ' ' ALA . 35.7 p-10 -86.81 171.07 11.16 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.092 -1.24 . . . . 1.0 109.756 -179.959 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.14 123.39 8.93 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.391 -0.818 . . . . 1.0 109.574 179.812 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -112.4 128.51 56.33 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.591 -0.693 . . . . 1.0 109.344 179.753 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.506 ' O ' ' N ' ' A' ' 65' ' ' GLY . 22.7 m-85 -107.71 155.85 19.73 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.478 -0.764 . . . . 1.0 109.063 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.529 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 1.3 m-20 -79.05 120.54 23.76 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.625 -1.297 . . . . 1.0 110.081 -179.616 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 65' ' ' GLY . 40.9 t0 -83.1 -11.88 57.58 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.171 -0.956 . . . . 1.0 108.947 179.389 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -83.17 -10.48 58.6 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.289 -0.882 . . . . 1.0 109.292 -179.543 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -92.46 170.05 10.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.395 -0.816 . . . . 1.0 109.155 -179.872 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 31.3 m -100.13 106.01 17.68 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.246 -0.909 . . . . 1.0 109.26 -179.76 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.481 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 94.5 m95 -88.76 123.39 33.13 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.568 -0.901 . . . . 1.0 108.568 179.537 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.69 HG21 ' HB2' ' A' ' 109' ' ' LYS . 10.1 t -140.05 154.84 47.2 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.355 -0.841 . . . . 1.0 109.942 -179.006 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 87.9 p -94.71 -5.51 45.3 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.284 -1.006 . . . . 1.0 108.284 179.011 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 31.4 t -94.47 178.95 5.44 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.709 -0.849 . . . . 1.0 108.709 179.35 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.2 m -80.2 76.84 6.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.962 -1.086 . . . . 1.0 109.599 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.69 ' HB2' HG21 ' A' ' 105' ' ' THR . 68.7 mttm -148.52 149.39 31.54 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.257 -0.902 . . . . 1.0 108.678 179.429 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.22 -136.98 5.31 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.096 -1.202 . . . . 1.0 110.096 179.695 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -100.07 118.6 36.77 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.403 -1.057 . . . . 1.0 109.21 179.689 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.4 ' HB3' HD23 ' A' ' 115' ' ' LEU . 2.6 t-20 -65.09 131.5 46.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.086 -1.009 . . . . 1.0 109.765 179.992 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.5 tp -60.01 -43.11 95.43 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.372 -0.83 . . . . 1.0 110.084 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -60.0 -43.01 95.48 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.27 -0.894 . . . . 1.0 111.214 -178.584 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 115' ' ' LEU . 4.0 mm? -60.03 -50.02 75.37 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.655 -1.278 . . . . 1.0 109.347 -179.182 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 75.5 t -69.95 -40.29 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.099 -1.0 . . . . 1.0 109.95 -179.405 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.12 -50.02 75.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.145 -0.972 . . . . 1.0 109.746 -179.306 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.84 -36.51 77.0 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.739 -1.226 . . . . 1.0 109.631 179.973 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 63.5 t60 -64.99 -49.97 68.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.129 -0.982 . . . . 1.0 111.541 -178.637 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.4 ' C ' ' OE1' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -59.98 -40.02 87.67 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.519 -1.363 . . . . 1.0 109.873 -178.731 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -60.04 -40.05 88.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.928 -1.107 . . . . 1.0 108.35 179.746 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -54.61 -44.13 78.95 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.128 -1.589 . . . . 1.0 109.128 179.717 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -67.29 -39.99 86.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.194 -1.18 . . . . 1.0 109.828 179.66 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.9 p -66.0 -21.7 66.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.928 . . . . 1.0 109.115 179.888 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 76.2 mt -82.52 -0.84 48.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.39 -0.819 . . . . 1.0 110.028 -179.89 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 89.43 7.31 69.62 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.392 -1.083 . . . . 1.0 110.392 179.282 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.5 mt -84.57 150.13 25.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.898 -1.354 . . . . 1.0 110.092 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 10.0 t70 -101.09 171.13 7.81 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.509 -0.744 . . . . 1.0 109.066 179.509 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.526 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 75.2 m80 -59.65 137.38 58.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.088 -1.007 . . . . 1.0 109.555 -179.78 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 38.6 t -98.55 154.28 18.03 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.315 -0.865 . . . . 1.0 109.322 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -100.17 6.75 44.83 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.39 -0.819 . . . . 1.0 109.748 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -86.58 127.97 58.54 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.136 -0.978 . . . . 1.0 108.563 179.617 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -67.99 -20.21 44.93 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 CA-C-N 120.181 1.1 . . . . 1.0 112.169 -179.818 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -88.47 -4.98 76.07 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.621 -1.392 . . . . 1.0 109.621 -179.865 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.16 145.75 26.87 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.269 -1.136 . . . . 1.0 109.707 179.897 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.419 ' C ' ' H ' ' A' ' 138' ' ' PHE . 84.6 mt -70.05 -33.84 72.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.891 . . . . 1.0 109.553 179.887 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 80.3 mtp -74.41 23.36 0.09 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 1.0 110.481 -179.215 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.419 ' H ' ' C ' ' A' ' 136' ' ' LEU . 12.7 t80 -69.62 133.52 88.73 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 107.409 -1.33 . . . . 1.0 107.409 179.305 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -59.25 -9.94 9.51 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 CA-C-N 120.01 1.039 . . . . 1.0 113.785 -177.896 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 95.4 mt -113.9 138.36 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 O-C-N 121.123 -0.985 . . . . 1.0 109.686 -179.919 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -73.37 131.12 41.5 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.461 -0.774 . . . . 1.0 110.068 -179.351 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.1 t -141.97 133.38 26.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.36 -0.838 . . . . 1.0 109.282 179.697 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -80.71 134.41 35.84 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.139 -0.975 . . . . 1.0 109.58 -179.909 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.8 t -130.91 147.34 52.54 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.376 -0.828 . . . . 1.0 109.406 -179.939 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -66.65 102.91 0.81 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.574 -1.411 . . . . 1.0 109.574 -179.729 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 147' ' ' SER . 8.5 mtmp? -71.34 140.68 50.32 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.301 -1.117 . . . . 1.0 109.468 179.934 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.442 ' CB ' ' O ' ' A' ' 146' ' ' LYS . 1.2 t 165.99 -89.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.844 -0.798 . . . . 1.0 108.844 -179.884 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 148' ' ' HIS . . . . . 0.477 ' O ' ' ND1' ' A' ' 148' ' ' HIS . 54.9 t-80 -97.79 15.53 23.44 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.615 -0.883 . . . . 1.0 108.615 179.484 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -60.43 137.36 58.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.583 -0.698 . . . . 1.0 110.005 -179.811 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 97.2 mmm -136.33 149.53 48.44 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.555 -0.905 . . . . 1.0 108.555 179.301 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.456 HD22 ' CH2' ' A' ' 42' ' ' TRP . 24.6 mt -53.18 129.78 50.46 Favored Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 120.981 -1.074 . . . . 1.0 108.63 -179.802 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -66.39 176.25 4.25 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 CA-C-N 120.01 1.039 . . . . 1.0 112.295 -179.813 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.05 -39.91 87.58 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.366 -0.834 . . . . 1.0 109.475 179.799 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -56.15 -49.94 72.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.311 -0.868 . . . . 1.0 109.939 -179.204 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -70.78 -39.99 72.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.071 -1.018 . . . . 1.0 110.308 -179.473 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 63.7 t -60.11 -47.55 91.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.083 -1.01 . . . . 1.0 109.424 -179.634 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -60.48 -40.01 89.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.847 -1.158 . . . . 1.0 110.182 -179.815 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.45 -54.4 10.69 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 120.272 -0.966 . . . . 1.0 111.323 -178.716 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.477 HG23 ' N ' ' A' ' 160' ' ' GLN . 8.4 tp -59.98 -39.98 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.867 -1.372 . . . . 1.0 109.533 -179.075 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.486 ' O ' ' N ' ' A' ' 164' ' ' GLY . 25.4 mm100 -64.63 -39.9 94.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.269 -0.894 . . . . 1.0 109.27 179.48 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 82.5 p -61.8 -29.18 69.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.286 -0.884 . . . . 1.0 110.812 -179.334 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 94.4 mt -86.38 -56.44 3.43 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.801 -1.187 . . . . 1.0 110.819 -179.133 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -89.94 -9.62 48.15 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.004 -1.06 . . . . 1.0 110.445 -178.712 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.497 2.715 0 N-CA-C 109.362 -1.495 . . . . 1.0 109.362 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 169' ' ' WAY . . . . . 0.665 ' HC2' ' HJ ' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.3 m . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.231 0.538 . . . . 1.0 109.563 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.9 mt -98.83 130.14 45.24 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.274 -0.892 . . . . 1.0 109.379 -179.814 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.02 160.0 35.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 1.0 109.463 179.717 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -74.43 149.47 40.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.38 -0.825 . . . . 1.0 109.987 -179.525 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.7 m -89.93 1.77 55.85 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.354 -0.841 . . . . 1.0 110.361 -179.643 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -141.62 153.77 44.97 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.09 -1.006 . . . . 1.0 109.619 -179.701 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.3 mmt -90.15 0.02 57.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.404 -0.81 . . . . 1.0 110.234 -178.889 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -96.84 129.63 44.24 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.127 -0.983 . . . . 1.0 109.687 -179.837 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.1 mt -142.32 146.74 35.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.26 -0.9 . . . . 1.0 109.033 179.744 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 70.0 p -130.1 160.12 34.71 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.625 -0.88 . . . . 1.0 108.625 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -146.42 159.93 42.74 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.088 -1.007 . . . . 1.0 110.381 179.98 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.488 HH11 ' HG2' ' A' ' 18' ' ' ARG . 1.9 tpt180 -145.38 129.83 17.84 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.294 -0.632 . . . . 1.0 109.294 -179.03 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.1 mt -89.38 117.27 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.137 -0.977 . . . . 1.0 108.542 178.742 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.6 t -69.98 -40.7 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.094 -1.003 . . . . 1.0 109.565 -179.608 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -163.74 159.01 20.91 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.697 -1.252 . . . . 1.0 110.276 -179.908 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.471 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 56.7 m-85 -100.55 -160.72 0.82 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.218 -1.401 . . . . 1.0 107.218 178.933 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.16 149.78 74.22 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.226 -0.921 . . . . 1.0 109.91 -179.874 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -69.81 -13.31 34.37 Favored 'Trans proline' 0 N--CA 1.487 1.116 0 C-N-CA 120.611 0.874 . . . . 1.0 109.947 178.399 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -59.78 -38.52 82.12 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.798 -0.637 . . . . 1.0 109.832 -179.555 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 76.8 mtm -137.95 166.12 24.84 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.289 -0.882 . . . . 1.0 109.52 -179.611 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 67.8 p -72.75 160.34 32.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.369 -0.832 . . . . 1.0 109.333 -179.746 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.471 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 3.5 m80 -60.11 -40.04 88.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.262 -0.899 . . . . 1.0 109.89 -179.552 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 74.1 m -60.1 -40.04 88.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.35 -0.844 . . . . 1.0 110.876 -179.244 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -68.1 -40.04 82.7 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.023 -1.048 . . . . 1.0 110.479 -179.167 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.1 t -69.37 -40.32 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.064 -1.022 . . . . 1.0 110.133 -179.329 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.05 -49.01 79.33 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.055 -1.028 . . . . 1.0 110.412 -179.241 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.66 -32.38 72.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.9 -1.125 . . . . 1.0 109.755 -179.776 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.87 -49.36 77.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.002 -1.061 . . . . 1.0 109.536 -179.428 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -66.6 -39.14 88.25 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.13 -0.981 . . . . 1.0 109.856 179.846 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.96 -41.79 92.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.968 -1.082 . . . . 1.0 109.673 -179.321 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -60.1 -42.11 93.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.104 -0.997 . . . . 1.0 109.743 179.374 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.56 -48.07 83.41 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.223 -0.923 . . . . 1.0 110.317 -179.811 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.501 ' CZ ' ' CZ ' ' A' ' 121' ' ' PHE . 49.8 m-85 -64.27 -39.96 95.0 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.104 -0.997 . . . . 1.0 109.572 -179.415 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -59.98 -47.6 85.15 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.504 -0.748 . . . . 1.0 109.454 -179.069 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.2 t -59.94 -40.16 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.008 -1.057 . . . . 1.0 109.81 -179.683 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 71.9 m95 -78.69 -32.56 47.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.193 -0.942 . . . . 1.0 110.014 -179.714 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 85.3 p -71.39 -14.63 62.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.073 -1.017 . . . . 1.0 109.683 179.923 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -59.91 -39.98 87.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.437 -0.79 . . . . 1.0 110.229 -179.679 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.6 m -114.58 -19.72 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.455 -0.778 . . . . 1.0 110.461 -179.001 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.415 ' C ' ' H ' ' A' ' 48' ' ' LEU . 66.4 p -95.25 121.48 62.0 Favored Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 120.757 -1.215 . . . . 1.0 109.405 179.432 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -73.15 20.84 0.34 Allowed 'Trans proline' 0 N--CA 1.493 1.491 0 CA-C-N 120.236 1.12 . . . . 1.0 111.601 179.153 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.415 ' H ' ' C ' ' A' ' 46' ' ' THR . 77.9 mt -68.86 140.03 55.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 1.0 109.525 -179.85 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -103.26 120.58 41.02 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.679 -0.859 . . . . 1.0 108.679 179.704 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -106.36 120.8 42.83 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.426 -0.796 . . . . 1.0 109.77 -179.194 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.8 m -120.06 130.01 54.49 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 121.498 0.666 . . . . 1.0 110.236 179.895 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.411 ' HG2' ' NH1' ' A' ' 52' ' ' ARG . 10.1 tpt180 -82.85 138.61 33.87 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.476 -0.765 . . . . 1.0 109.166 179.288 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 90.0 mt -106.47 129.99 54.34 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.308 -0.87 . . . . 1.0 108.755 179.166 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.425 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 62.3 m170 -60.0 -40.04 87.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.955 -1.091 . . . . 1.0 109.701 -179.427 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 73.4 m-20 -151.08 172.34 15.91 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.274 -0.891 . . . . 1.0 109.464 -179.71 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.97 -179.51 32.63 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.583 -1.407 . . . . 1.0 109.583 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.7 mt -95.62 133.63 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.374 -1.074 . . . . 1.0 109.401 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.96 162.55 14.42 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.477 -0.765 . . . . 1.0 109.095 -179.89 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -59.95 -48.82 80.14 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.207 -0.933 . . . . 1.0 109.091 179.868 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 93.1 mt -109.55 103.38 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.473 -0.767 . . . . 1.0 110.215 179.807 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.3 ptp -102.32 137.31 40.74 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.183 -0.948 . . . . 1.0 109.297 178.788 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 88.4 mt -109.95 130.47 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.575 -0.703 . . . . 1.0 109.743 -179.542 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.8 p -150.31 158.93 44.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.351 -0.843 . . . . 1.0 109.597 -179.615 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -99.97 128.5 46.05 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.434 -0.95 . . . . 1.0 108.434 179.413 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.6 150.6 16.99 Favored Glycine 0 N--CA 1.498 2.804 0 N-CA-C 110.185 -1.166 . . . . 1.0 110.185 -178.979 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.462 ' O ' ' C ' ' A' ' 67' ' ' LYS . 7.1 tt -101.89 -177.31 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.158 -1.053 . . . . 1.0 108.158 179.407 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 66' ' ' ILE . 52.3 tptt -33.94 -93.9 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.951 -0.468 . . . . 1.0 110.671 -179.732 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -77.95 135.34 37.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.982 -1.074 . . . . 1.0 110.038 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.527 ' CD2' ' H ' ' A' ' 71' ' ' ASP . 46.7 p-80 -162.2 -171.08 2.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.11 -0.994 . . . . 1.0 109.937 179.226 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -40.16 -20.24 0.02 OUTLIER Glycine 0 N--CA 1.495 2.621 0 O-C-N 121.566 -0.708 . . . . 1.0 111.85 -178.403 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.527 ' H ' ' CD2' ' A' ' 69' ' ' HIS . 98.0 m-20 -87.84 132.6 34.13 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.54 -1.565 . . . . 1.0 110.249 -179.456 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -60.06 -42.12 93.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.414 -0.804 . . . . 1.0 109.503 179.366 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.522 ' CD2' ' O ' ' A' ' 73' ' ' TYR . 21.6 p90 -90.55 114.28 60.65 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.275 -0.89 . . . . 1.0 109.391 -179.818 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -73.53 -167.96 0.41 Allowed 'Trans proline' 0 N--CA 1.492 1.427 0 CA-C-N 120.114 1.076 . . . . 1.0 112.064 179.888 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.533 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 97.9 m-85 -89.77 169.9 10.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.312 -0.868 . . . . 1.0 108.663 179.43 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -101.27 13.78 34.01 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.155 -0.965 . . . . 1.0 110.209 -179.296 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 117.12 -156.91 15.36 Favored Glycine 0 N--CA 1.502 3.047 0 N-CA-C 108.894 -1.682 . . . . 1.0 108.894 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -58.48 -65.38 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.451 0 CA-C-N 118.633 1.217 . . . . 1.0 112.267 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 90.6 p -76.85 164.18 26.07 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.183 -0.948 . . . . 1.0 109.815 -179.93 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.85 -129.45 8.65 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 109.587 -1.405 . . . . 1.0 109.587 179.88 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.44 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 13.2 mt -68.99 106.48 2.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.435 -1.038 . . . . 1.0 109.09 179.961 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.417 HD23 ' OE2' ' A' ' 102' ' ' GLU . 50.8 mt -78.71 -23.71 45.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.017 -1.052 . . . . 1.0 108.884 179.95 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.11 169.56 1.9 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.709 -0.849 . . . . 1.0 108.709 179.837 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -161.7 161.89 29.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.159 -0.963 . . . . 1.0 109.127 179.304 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.78 157.03 44.67 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.2 -0.938 . . . . 1.0 109.724 -179.355 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -93.63 151.96 40.45 Favored Pre-proline 0 N--CA 1.494 1.726 0 N-CA-C 108.483 -0.932 . . . . 1.0 108.483 179.691 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -42.16 160.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.243 0 C-N-CA 120.663 0.909 . . . . 1.0 111.667 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -66.77 74.66 0.42 Allowed 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 120.645 0.897 . . . . 1.0 111.955 -179.52 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.475 ' H ' ' HA3' ' A' ' 93' ' ' GLY . . . -82.27 167.92 47.79 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.134 -1.586 . . . . 1.0 109.134 179.771 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -71.16 -34.04 10.68 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 121.417 1.411 . . . . 1.0 112.538 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -110.03 -98.2 0.4 Allowed 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.335 -0.853 . . . . 1.0 111.532 -178.52 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -59.98 -40.01 87.64 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.371 -0.831 . . . . 1.0 110.503 -177.861 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.475 ' HA3' ' H ' ' A' ' 89' ' ' GLY . . . -52.57 168.38 0.84 Allowed Glycine 0 N--CA 1.489 2.17 0 C-N-CA 119.461 -1.352 . . . . 1.0 109.917 -179.328 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.41 4.94 76.05 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.539 -1.424 . . . . 1.0 109.539 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -86.4 174.56 8.93 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.214 -1.168 . . . . 1.0 110.116 -179.623 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.35 124.11 9.86 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.408 -0.808 . . . . 1.0 109.32 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -111.38 137.61 48.93 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.605 -0.684 . . . . 1.0 109.942 -179.752 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.526 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 27.3 m-85 -114.38 154.23 28.45 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 109.111 -0.699 . . . . 1.0 109.111 179.638 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.533 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 1.7 m-20 -78.54 123.66 27.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.056 -1.028 . . . . 1.0 109.522 179.759 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 43.7 t0 -83.93 -12.38 55.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.229 -0.92 . . . . 1.0 109.391 179.724 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -84.14 -10.01 58.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.352 -0.842 . . . . 1.0 109.871 -179.818 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.417 ' OE2' HD23 ' A' ' 82' ' ' LEU . 99.3 mt-10 -91.48 169.65 10.6 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.204 -0.935 . . . . 1.0 110.033 -179.241 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 15.9 m -100.05 106.25 17.99 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.432 -0.792 . . . . 1.0 108.917 -179.788 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.418 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 91.1 m95 -89.18 124.45 34.36 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.76 -0.83 . . . . 1.0 108.76 179.813 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.652 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.7 t -140.04 159.29 42.5 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.422 -0.799 . . . . 1.0 109.944 -179.103 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.4 t -96.88 -13.3 22.58 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.332 -0.855 . . . . 1.0 109.011 179.485 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 65.6 m -90.62 179.14 5.9 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.768 -0.827 . . . . 1.0 108.768 179.388 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.2 m -79.43 80.18 5.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.983 -1.073 . . . . 1.0 109.349 -179.893 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.652 ' HB2' HG21 ' A' ' 105' ' ' THR . 68.3 mttm -148.88 149.53 31.42 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.654 -0.869 . . . . 1.0 108.654 179.379 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 109' ' ' LYS . . . 44.36 -137.3 5.33 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.602 -1.399 . . . . 1.0 109.602 179.71 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -99.6 117.66 34.46 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.32 -1.106 . . . . 1.0 109.017 179.304 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -62.25 130.3 44.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.326 -0.858 . . . . 1.0 109.733 -179.738 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.9 tp -59.99 -41.88 93.0 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.321 -0.862 . . . . 1.0 110.211 -179.579 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -59.97 -40.12 87.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.179 -0.951 . . . . 1.0 110.505 -179.319 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.447 HD21 ' CE ' ' A' ' 146' ' ' LYS . 3.6 mm? -59.04 -51.21 71.05 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.746 -1.221 . . . . 1.0 109.883 -179.675 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.8 t -69.96 -40.37 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.131 -0.981 . . . . 1.0 109.961 -178.905 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.22 -52.6 65.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -0.91 . . . . 1.0 109.943 -179.422 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.03 -39.05 84.57 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.095 -1.003 . . . . 1.0 110.157 -179.769 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -64.05 -50.0 70.13 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.408 -0.808 . . . . 1.0 111.428 -178.272 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.526 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 10.5 pt-20 -60.03 -39.5 86.09 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.664 -1.272 . . . . 1.0 110.319 -179.168 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.501 ' CZ ' ' CZ ' ' A' ' 39' ' ' PHE . 29.6 m-85 -60.0 -40.02 87.76 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.716 -1.24 . . . . 1.0 108.574 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.91 -42.07 94.55 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.526 -1.43 . . . . 1.0 109.526 -179.949 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -66.89 -39.99 87.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.068 -1.254 . . . . 1.0 109.228 179.522 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.5 p -66.71 -24.44 66.24 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.328 -0.858 . . . . 1.0 108.856 179.542 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 71.4 mt -81.67 -0.58 43.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.394 -0.816 . . . . 1.0 109.357 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 88.77 6.79 72.17 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 120.349 -0.929 . . . . 1.0 110.782 178.834 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.9 mt -82.74 146.37 29.04 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.782 -1.422 . . . . 1.0 109.644 179.78 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 33.5 t0 -99.33 173.13 6.92 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.926 -0.768 . . . . 1.0 108.926 -179.73 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.493 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 76.4 m80 -59.97 138.45 57.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.175 -0.953 . . . . 1.0 109.807 -179.422 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 33.3 t -97.09 156.51 16.34 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.267 -0.896 . . . . 1.0 109.208 179.739 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -99.86 1.57 43.04 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.318 -0.864 . . . . 1.0 109.663 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -87.03 130.17 49.26 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.18 -0.95 . . . . 1.0 108.913 179.797 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -69.39 -25.35 30.41 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 CA-C-N 120.099 1.071 . . . . 1.0 112.27 -179.622 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -83.58 -4.99 88.81 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.409 -1.476 . . . . 1.0 109.409 -179.805 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.89 145.34 26.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -1.162 . . . . 1.0 109.319 179.567 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.424 ' C ' ' H ' ' A' ' 138' ' ' PHE . 80.5 mt -69.5 -33.13 72.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.294 -0.879 . . . . 1.0 109.723 179.727 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 93.9 mmm -71.8 18.4 0.08 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.152 -0.967 . . . . 1.0 110.687 -179.463 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.424 ' H ' ' C ' ' A' ' 136' ' ' LEU . 13.2 t80 -69.79 133.14 88.51 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.735 -1.228 . . . . 1.0 107.89 179.819 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -62.94 -15.28 46.57 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 CA-C-N 119.905 1.002 . . . . 1.0 113.792 -178.116 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.0 mt -105.91 141.91 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 120.943 -1.098 . . . . 1.0 109.986 -179.392 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -74.95 129.72 38.14 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.397 -0.815 . . . . 1.0 109.691 -179.723 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.6 t -143.13 139.93 30.62 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.348 -0.845 . . . . 1.0 108.853 179.317 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -81.88 143.73 31.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.99 -1.069 . . . . 1.0 109.407 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 m -140.19 150.97 44.83 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.39 -0.819 . . . . 1.0 109.763 -179.314 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.38 112.18 3.65 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 107.717 -2.153 . . . . 1.0 107.717 178.222 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.447 ' CE ' HD21 ' A' ' 115' ' ' LEU . 33.6 mmtm -76.09 4.89 7.59 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.3 -1.118 . . . . 1.0 109.887 -178.607 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 86.8 p -71.79 122.74 21.22 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.181 -0.95 . . . . 1.0 109.119 179.737 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 52.03 40.0 27.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.283 -0.886 . . . . 1.0 110.078 179.848 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -92.5 129.8 38.34 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.927 -1.108 . . . . 1.0 109.74 179.613 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 96.2 mmm -131.45 150.02 52.31 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.499 -0.926 . . . . 1.0 108.499 179.117 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 22.0 mt -50.61 132.13 27.18 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 120.898 -1.126 . . . . 1.0 109.034 -179.515 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -68.53 174.52 8.25 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 CA-C-N 120.0 1.036 . . . . 1.0 111.639 179.364 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -60.04 -39.96 87.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.285 -0.884 . . . . 1.0 109.863 -179.882 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -55.22 -49.77 71.13 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.131 -0.98 . . . . 1.0 109.935 -179.278 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.12 -39.87 75.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.171 -0.956 . . . . 1.0 110.28 -179.349 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 64.4 t -60.08 -45.47 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.003 -1.061 . . . . 1.0 109.03 -179.563 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -60.96 -40.08 91.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.137 -0.977 . . . . 1.0 110.652 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.79 -53.6 9.46 Favored Glycine 0 N--CA 1.497 2.75 0 O-C-N 121.071 -1.018 . . . . 1.0 111.355 -178.518 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.47 HG23 ' N ' ' A' ' 160' ' ' GLN . 7.8 tp -60.05 -40.02 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.94 -1.33 . . . . 1.0 109.637 -178.923 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.5 mt-30 -65.96 -39.6 90.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.091 -1.005 . . . . 1.0 109.716 179.448 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 84.9 p -60.63 -32.19 71.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.09 -1.006 . . . . 1.0 110.688 -179.29 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.4 mt -85.64 -51.51 6.42 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.898 -1.126 . . . . 1.0 110.669 -178.993 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -91.24 -9.12 46.38 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.986 -1.071 . . . . 1.0 110.411 -178.927 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.517 0 N-CA-C 109.475 -1.45 . . . . 1.0 109.475 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 169' ' ' WAY . . . . . 0.856 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.7 m . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.275 0.559 . . . . 1.0 109.581 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.1 mt -94.19 129.41 40.81 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.353 -0.842 . . . . 1.0 109.519 -179.63 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -160.79 162.29 32.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.367 -0.833 . . . . 1.0 109.617 179.847 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -72.14 149.74 44.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.213 -0.929 . . . . 1.0 109.373 -179.759 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 94.5 p -86.99 1.66 52.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.278 -0.889 . . . . 1.0 109.584 -179.743 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -146.25 154.7 42.02 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.236 -0.915 . . . . 1.0 109.605 -179.845 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.56 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -91.61 0.14 57.53 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.377 -0.827 . . . . 1.0 109.957 -179.631 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -95.16 125.79 40.05 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.109 -0.994 . . . . 1.0 109.192 179.768 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.8 mt -140.04 147.75 40.82 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.363 -0.835 . . . . 1.0 109.192 -179.637 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.0 p -131.44 153.54 49.62 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.482 -0.761 . . . . 1.0 109.032 179.97 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -145.46 160.02 42.22 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.123 -0.985 . . . . 1.0 109.96 -179.988 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.423 HH11 ' HG2' ' A' ' 18' ' ' ARG . 35.3 ttt-85 -142.36 133.8 26.49 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.434 -0.791 . . . . 1.0 109.492 -179.504 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.7 mt -86.61 116.47 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.088 -1.008 . . . . 1.0 108.634 178.917 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.9 t -69.94 -41.46 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.346 -0.846 . . . . 1.0 109.965 -179.311 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -164.48 158.98 18.89 Favored 'General case' 0 C--N 1.291 -1.952 0 O-C-N 119.238 -2.163 . . . . 1.0 111.548 -178.228 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -101.79 119.06 38.19 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.631 -1.618 . . . . 1.0 106.631 178.313 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 23' ' ' THR . 0.1 OUTLIER -61.92 138.0 95.51 Favored Pre-proline 0 C--N 1.303 -1.448 0 O-C-N 121.028 -1.045 . . . . 1.0 109.073 -178.327 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -56.46 -6.35 1.47 Allowed 'Trans proline' 0 N--CA 1.484 0.951 0 CA-C-N 119.614 0.898 . . . . 1.0 110.504 179.554 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 23' ' ' THR . 81.9 m-20 -60.01 -38.69 83.4 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 120.075 -0.65 . . . . 1.0 110.444 -179.457 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 76.7 mtm -139.25 171.11 14.76 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.053 -1.029 . . . . 1.0 109.359 -179.376 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 82.0 p -75.28 164.98 25.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.332 -0.855 . . . . 1.0 109.829 -179.334 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -63.98 -43.79 94.67 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.317 -0.864 . . . . 1.0 110.037 -179.559 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 53.3 m -60.18 -40.08 88.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 1.0 110.712 -178.92 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -65.21 -46.78 79.27 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.011 -1.056 . . . . 1.0 110.359 -179.345 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 70.5 t -64.01 -39.92 87.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.471 -0.768 . . . . 1.0 109.48 -179.738 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -55.55 -55.18 34.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.517 -0.739 . . . . 1.0 111.321 -178.774 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.2 pttt -63.6 -32.12 73.49 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.899 -1.125 . . . . 1.0 110.843 -178.678 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.67 -49.99 74.67 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.728 -1.233 . . . . 1.0 109.563 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -67.15 -39.98 86.61 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.066 -1.021 . . . . 1.0 110.454 -179.822 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -59.97 -40.54 89.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.782 -1.199 . . . . 1.0 109.62 -179.581 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -60.42 -40.05 89.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.975 -1.078 . . . . 1.0 109.159 178.885 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.0 -46.3 89.91 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.434 -0.791 . . . . 1.0 109.689 -179.235 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -65.4 -38.91 91.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.136 -0.977 . . . . 1.0 109.466 179.851 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -59.69 -48.16 82.78 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.208 -0.932 . . . . 1.0 110.18 -179.352 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.06 -42.61 90.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.139 -0.976 . . . . 1.0 109.989 -179.61 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -77.8 -38.79 45.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.174 -0.953 . . . . 1.0 110.161 -179.383 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 84.0 p -70.01 -16.77 63.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.096 -1.002 . . . . 1.0 109.997 -179.645 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -59.9 -40.05 87.45 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.072 -1.018 . . . . 1.0 110.412 -179.614 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.6 m -111.81 -19.49 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.406 0 O-C-N 120.991 -1.068 . . . . 1.0 110.815 -179.41 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.0 p -94.52 128.56 39.66 Favored Pre-proline 0 N--CA 1.5 2.041 0 O-C-N 120.761 -1.212 . . . . 1.0 109.392 179.845 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -73.76 16.46 0.51 Allowed 'Trans proline' 0 N--CA 1.494 1.519 0 CA-C-N 120.17 1.096 . . . . 1.0 111.963 179.27 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.2 mt -69.22 140.01 54.53 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.265 -0.897 . . . . 1.0 109.969 -179.667 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -106.65 121.29 44.05 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.764 -0.828 . . . . 1.0 108.764 179.644 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -106.81 126.03 51.77 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.18 -0.95 . . . . 1.0 109.358 -179.777 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.1 m -120.05 130.03 54.5 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.535 -0.728 . . . . 1.0 109.803 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.434 ' HG2' HH11 ' A' ' 52' ' ' ARG . 33.8 ttt-85 -82.41 133.95 35.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.302 -0.874 . . . . 1.0 109.213 179.51 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.8 mt -103.35 130.57 50.67 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.247 -0.908 . . . . 1.0 109.356 179.856 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.443 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 45.5 m170 -63.41 -39.99 95.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.342 -0.849 . . . . 1.0 110.04 -179.599 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 76.6 m-20 -148.94 172.89 13.98 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.116 -0.99 . . . . 1.0 109.93 -179.505 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.43 177.92 39.98 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.595 -1.402 . . . . 1.0 109.595 179.984 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.7 mt -94.03 133.7 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.237 -1.155 . . . . 1.0 109.06 179.96 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.75 163.5 13.21 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.515 -0.741 . . . . 1.0 109.378 -179.424 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -60.01 -49.41 77.77 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.182 -0.948 . . . . 1.0 109.398 -179.77 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.8 mt -107.54 102.97 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.386 -0.821 . . . . 1.0 109.896 179.827 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.5 ptm -103.27 130.7 50.59 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.149 -0.969 . . . . 1.0 109.613 179.471 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.8 mt -105.4 138.01 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.581 -0.699 . . . . 1.0 109.926 -179.289 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 63.8 p -153.69 158.64 41.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.217 -0.927 . . . . 1.0 109.985 179.885 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.81 123.07 48.02 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.477 -0.934 . . . . 1.0 108.477 179.517 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.429 ' O ' ' CB ' ' A' ' 100' ' ' ASP . . . -99.97 175.82 27.76 Favored Glycine 0 N--CA 1.504 3.173 0 O-C-N 121.091 -1.005 . . . . 1.0 111.482 -178.563 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.539 HG22 ' N ' ' A' ' 67' ' ' LYS . 72.3 mt -129.74 164.56 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.612 -0.934 . . . . 1.0 108.769 179.504 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.539 ' N ' HG22 ' A' ' 66' ' ' ILE . 28.1 tptp -9.76 -78.51 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.687 0 CA-C-O 121.066 0.46 . . . . 1.0 112.084 179.968 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -69.35 114.55 7.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.041 -1.037 . . . . 1.0 109.212 179.906 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -99.71 -11.69 20.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.322 -0.861 . . . . 1.0 109.503 -179.471 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 70.0 32.35 69.63 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.477 -1.449 . . . . 1.0 109.477 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 72' ' ' PHE . 33.5 t0 -130.04 170.02 14.54 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.543 -0.975 . . . . 1.0 109.225 -179.709 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.5 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 86.3 m-85 -68.65 -28.95 67.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 1.0 109.855 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -125.35 79.77 66.17 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 121.449 -0.782 . . . . 1.0 109.236 179.954 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -70.09 -164.04 0.12 Allowed 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 120.751 0.967 . . . . 1.0 112.375 -179.539 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.498 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 87.0 m-85 -85.02 156.52 21.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.461 -0.774 . . . . 1.0 109.138 -179.863 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -100.15 0.01 39.72 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.23 -0.919 . . . . 1.0 110.266 -179.054 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 136.22 -155.64 22.56 Favored Glycine 0 N--CA 1.498 2.816 0 N-CA-C 108.475 -1.85 . . . . 1.0 108.475 -179.474 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.444 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 7.4 Cg_exo -62.72 -63.76 0.08 OUTLIER 'Trans proline' 0 C--N 1.313 -1.318 0 CA-C-N 118.697 1.249 . . . . 1.0 111.67 179.414 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 83.3 p -77.11 160.02 29.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.074 -1.016 . . . . 1.0 109.323 179.566 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 117.1 -129.3 8.29 Favored Glycine 0 N--CA 1.502 3.084 0 N-CA-C 109.642 -1.383 . . . . 1.0 109.642 179.882 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.419 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 22.3 mt -69.82 109.68 4.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -1.174 . . . . 1.0 109.24 -179.836 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 46.7 mt -80.74 -19.22 45.47 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.135 -0.978 . . . . 1.0 108.996 -179.919 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.55 171.26 1.25 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.761 -0.829 . . . . 1.0 108.761 179.697 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -162.07 159.41 26.18 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.142 -0.974 . . . . 1.0 109.796 179.331 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.6 166.2 29.98 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.79 -0.819 . . . . 1.0 108.79 -179.593 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -101.5 152.77 38.09 Favored Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.217 -0.927 . . . . 1.0 108.873 -179.987 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.559 ' O ' ' N ' ' A' ' 89' ' ' GLY . 10.4 Cg_endo -63.05 165.13 17.44 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 120.599 0.866 . . . . 1.0 111.615 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -47.84 81.7 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.259 0 C-N-CA 121.191 1.261 . . . . 1.0 112.438 -179.814 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -99.57 -168.56 29.99 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 108.361 -1.896 . . . . 1.0 108.361 179.419 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.432 ' HB2' ' H ' ' A' ' 91' ' ' ASN . 22.2 Cg_endo -72.15 -115.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 CA-C-N 118.304 1.052 . . . . 1.0 111.412 -179.704 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.432 ' H ' ' HB2' ' A' ' 90' ' ' PRO . 90.2 m-20 -74.9 -40.35 60.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.313 -1.492 . . . . 1.0 110.498 -179.584 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -70.01 -39.96 75.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.175 -0.953 . . . . 1.0 110.57 -178.779 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.426 ' HA3' ' H ' ' A' ' 89' ' ' GLY . . . -60.99 168.92 9.5 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.888 -1.149 . . . . 1.0 110.39 -179.317 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.21 4.61 73.9 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.001 -1.24 . . . . 1.0 110.001 179.511 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.5 p-10 -79.27 162.01 25.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.981 -1.305 . . . . 1.0 109.34 -179.892 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.39 126.15 12.64 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.223 -0.923 . . . . 1.0 109.398 -179.72 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -119.25 153.6 34.74 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.535 -0.728 . . . . 1.0 109.863 -179.774 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -131.22 154.4 48.47 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.622 -0.674 . . . . 1.0 109.281 -179.915 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.498 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 1.2 m-20 -79.46 117.98 20.92 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.04 -1.037 . . . . 1.0 108.749 179.022 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.429 ' CB ' ' O ' ' A' ' 65' ' ' GLY . 35.5 t0 -82.86 -10.66 58.73 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.016 -1.053 . . . . 1.0 109.178 -179.996 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -82.97 -11.63 57.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.383 -0.823 . . . . 1.0 109.107 179.756 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.444 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 99.5 mt-10 -89.53 169.96 10.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.439 -0.788 . . . . 1.0 109.101 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 22.2 m -98.89 104.68 16.74 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.204 -0.935 . . . . 1.0 109.104 -179.671 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.476 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 97.0 m95 -87.63 121.61 30.27 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 179.632 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.651 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.9 t -139.74 153.81 47.28 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.348 -0.845 . . . . 1.0 109.748 -179.198 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.4 m -94.32 -9.11 36.97 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.308 -0.997 . . . . 1.0 108.308 179.187 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 61.6 p -90.99 174.35 7.46 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.601 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 23.1 t -74.04 73.88 1.7 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.183 -0.948 . . . . 1.0 109.543 179.984 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.651 ' HB2' HG21 ' A' ' 105' ' ' THR . 98.2 mttt -148.58 152.49 36.87 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.331 -0.855 . . . . 1.0 109.133 179.471 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 109' ' ' LYS . . . 42.01 -139.65 2.07 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.959 -1.256 . . . . 1.0 109.959 179.631 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -100.05 117.37 34.17 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.353 -1.086 . . . . 1.0 108.855 179.226 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.449 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 58.0 t-20 -63.52 131.2 47.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.154 -0.966 . . . . 1.0 109.939 -179.527 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.2 tp -60.07 -45.07 94.09 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.474 -0.766 . . . . 1.0 111.092 -179.519 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -59.89 -41.92 92.67 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.0 -1.062 . . . . 1.0 111.069 -178.407 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 115' ' ' LEU . 4.1 mm? -58.09 -50.68 72.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.677 -1.264 . . . . 1.0 109.245 -179.49 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 67.6 t -70.44 -39.97 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.962 . . . . 1.0 110.219 -179.544 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.35 -51.77 68.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.063 -1.023 . . . . 1.0 109.597 -179.503 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.04 81.45 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.269 -0.894 . . . . 1.0 109.964 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -60.96 -50.14 74.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.338 -0.852 . . . . 1.0 110.766 -178.403 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -60.11 -40.13 88.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.625 -1.297 . . . . 1.0 109.874 -179.65 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -60.03 -40.09 88.17 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 120.966 -1.084 . . . . 1.0 108.437 179.614 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.58 -42.54 84.66 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.178 -1.569 . . . . 1.0 109.178 179.829 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -67.48 -40.0 85.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -1.15 . . . . 1.0 109.369 179.529 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 73.0 p -65.96 -21.58 66.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 1.0 109.625 -179.908 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 84.2 mt -82.54 0.29 43.33 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.156 -0.965 . . . . 1.0 109.697 -179.796 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.47 3.32 72.03 Favored Glycine 0 N--CA 1.497 2.719 0 C-N-CA 120.221 -0.99 . . . . 1.0 110.754 179.048 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.7 mt -84.2 148.12 26.91 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.954 -1.321 . . . . 1.0 109.576 179.979 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 41.0 t0 -101.57 173.82 6.25 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.776 -0.824 . . . . 1.0 108.776 179.801 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.527 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 76.6 m80 -57.14 135.7 56.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.006 -1.059 . . . . 1.0 109.274 -179.749 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 33.4 t -98.76 156.17 16.98 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.392 -0.818 . . . . 1.0 109.405 -179.839 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -99.65 8.38 44.42 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.303 -0.873 . . . . 1.0 109.344 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -87.18 122.18 71.09 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 1.0 108.688 179.657 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -66.76 -12.47 36.09 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 CA-C-N 120.267 1.131 . . . . 1.0 111.825 -179.765 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -95.51 -4.2 60.87 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.91 -1.276 . . . . 1.0 109.91 -179.843 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -87.87 142.27 27.94 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.069 -1.254 . . . . 1.0 109.816 -179.893 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.6 mt -61.47 -40.08 93.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.335 -0.853 . . . . 1.0 109.717 179.859 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 88.5 mtp -71.69 20.99 0.05 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.413 -0.804 . . . . 1.0 111.528 -178.552 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -68.38 132.63 91.36 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 120.498 -1.376 . . . . 1.0 108.067 179.681 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.425 ' O ' ' HD1' ' A' ' 169' ' ' WAY . 13.8 Cg_exo -48.76 -42.96 35.98 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 CA-C-N 119.88 0.993 . . . . 1.0 113.444 -178.798 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 98.4 mt -82.93 143.62 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.038 -1.039 . . . . 1.0 110.815 -178.853 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.449 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 26.2 t80 -77.42 131.33 37.95 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.693 -0.63 . . . . 1.0 109.52 179.738 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 13.3 t -139.66 140.41 36.89 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.291 -0.88 . . . . 1.0 109.274 179.575 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -82.46 140.55 33.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.212 -0.93 . . . . 1.0 108.939 179.639 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.1 t -140.39 151.28 44.82 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.295 -0.878 . . . . 1.0 109.741 -179.384 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.92 107.97 2.35 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.019 -1.633 . . . . 1.0 109.019 179.661 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 21.7 mtmm -78.13 -0.93 30.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -1.12 . . . . 1.0 109.758 -179.262 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 88.8 p -59.97 -38.35 82.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.283 -0.886 . . . . 1.0 110.133 -179.49 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -139.21 21.63 2.59 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.257 -0.902 . . . . 1.0 110.143 -179.308 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -68.26 137.57 54.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.931 -1.106 . . . . 1.0 109.578 -179.836 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 75.4 mtm -138.87 148.91 44.27 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.244 -1.021 . . . . 1.0 108.244 179.265 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 20.8 mt -51.81 124.03 26.37 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 120.796 -1.19 . . . . 1.0 108.436 -179.737 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -66.15 174.65 5.69 Favored 'Trans proline' 0 N--CA 1.49 1.299 0 CA-C-N 120.124 1.08 . . . . 1.0 112.233 -179.47 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -60.12 -39.81 87.55 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.424 -0.797 . . . . 1.0 109.167 179.816 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -56.45 -49.96 73.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 1.0 110.065 -179.413 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.81 -40.11 72.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.038 -1.039 . . . . 1.0 110.226 -179.411 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 79.0 t -61.37 -48.91 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.089 -1.007 . . . . 1.0 109.444 -179.553 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.18 -39.95 88.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.131 -0.981 . . . . 1.0 110.492 -179.792 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.26 -55.12 8.06 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 120.197 -1.001 . . . . 1.0 111.199 -178.632 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.472 HG23 ' N ' ' A' ' 160' ' ' GLN . 7.7 tp -60.14 -40.1 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.917 -1.343 . . . . 1.0 109.676 -179.096 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.544 ' O ' ' N ' ' A' ' 164' ' ' GLY . 27.1 mm100 -65.09 -39.74 93.61 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.225 -0.922 . . . . 1.0 109.402 179.675 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 86.6 p -62.92 -27.21 69.22 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.224 -0.922 . . . . 1.0 110.135 -179.612 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 92.5 mt -86.69 -53.53 4.89 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.912 -1.117 . . . . 1.0 110.437 -179.376 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -91.79 -9.41 43.66 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.07 -1.019 . . . . 1.0 110.051 -179.083 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.582 0 N-CA-C 109.434 -1.466 . . . . 1.0 109.434 -179.878 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 169' ' ' WAY . . . . . 0.85 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 84.3 m . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.3 mt -75.77 148.54 38.41 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.199 -0.938 . . . . 1.0 109.439 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -162.28 161.25 27.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.294 -0.879 . . . . 1.0 109.669 -179.946 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -72.44 149.35 44.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.075 -1.016 . . . . 1.0 109.156 179.662 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.0 p -85.67 -0.9 56.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.258 -0.901 . . . . 1.0 109.815 -179.497 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -150.47 157.32 42.89 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.101 -0.999 . . . . 1.0 109.518 179.843 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.531 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.01 0.54 57.05 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.179 -0.951 . . . . 1.0 109.988 -179.627 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -94.76 128.35 41.4 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.139 -0.976 . . . . 1.0 108.948 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 97.8 mt -141.85 151.16 42.48 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.158 -0.964 . . . . 1.0 109.342 -179.585 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.7 p -132.86 158.61 42.11 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.055 -0.72 . . . . 1.0 109.055 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -146.27 162.66 37.61 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.1 -1.0 . . . . 1.0 109.988 -179.854 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -143.84 133.04 23.05 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.582 -0.699 . . . . 1.0 109.661 -179.622 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 86.0 mt -88.62 111.21 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.382 -0.97 . . . . 1.0 108.382 178.468 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.4 t -69.96 -40.35 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.012 -1.055 . . . . 1.0 109.679 -179.152 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.9 p-10 -162.37 160.99 27.19 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.839 -1.163 . . . . 1.0 110.431 -179.741 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.428 ' CD2' ' CE1' ' A' ' 28' ' ' HIS . 64.6 m-85 -101.75 -168.89 1.61 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.346 -1.353 . . . . 1.0 107.346 178.902 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.79 143.69 35.59 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.426 -0.796 . . . . 1.0 109.281 179.806 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -63.57 -11.93 28.57 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 CA-C-O 122.511 0.963 . . . . 1.0 110.177 179.067 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -60.04 -39.99 87.86 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 114.942 -1.026 . . . . 1.0 110.126 -179.974 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.5 mtm -142.53 168.3 20.05 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.22 -0.925 . . . . 1.0 110.118 -178.936 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.7 p -72.2 160.06 33.05 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.422 -0.799 . . . . 1.0 109.76 -179.791 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.428 ' CE1' ' CD2' ' A' ' 22' ' ' TYR . 2.8 m-70 -60.13 -39.91 87.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.41 -0.807 . . . . 1.0 110.223 -179.589 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 63.2 m -59.91 -40.12 87.75 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.102 -0.999 . . . . 1.0 110.798 -178.674 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -67.32 -39.94 85.9 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.958 -1.089 . . . . 1.0 110.059 -179.698 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.0 t -69.0 -41.15 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.013 -1.054 . . . . 1.0 110.265 -179.29 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.02 -48.29 82.32 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.02 -1.05 . . . . 1.0 110.51 -179.194 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.54 -33.14 72.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.888 -1.132 . . . . 1.0 109.126 179.852 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.98 -49.35 78.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.087 -1.008 . . . . 1.0 109.849 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -67.47 -38.28 84.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.91 -1.119 . . . . 1.0 109.729 179.915 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.411 ' NZ ' ' NH1' ' A' ' 52' ' ' ARG . 63.5 mmtt -59.95 -43.37 95.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.06 -1.025 . . . . 1.0 109.285 -179.522 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -60.34 -40.26 90.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.019 -1.051 . . . . 1.0 108.92 179.376 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.04 -46.87 88.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.486 -0.759 . . . . 1.0 109.927 -179.947 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -65.68 -39.26 91.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.027 -1.046 . . . . 1.0 109.859 -179.711 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -60.04 -46.37 89.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.039 -1.038 . . . . 1.0 109.761 -179.707 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.8 t -60.12 -43.26 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.169 -0.957 . . . . 1.0 110.585 -179.567 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -77.68 -38.03 48.42 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.92 -1.112 . . . . 1.0 110.113 -179.192 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.9 p -70.43 -15.93 62.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.296 -0.877 . . . . 1.0 110.131 -179.385 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -60.02 -40.01 87.81 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.129 -0.982 . . . . 1.0 110.824 -179.636 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.6 m -112.17 -22.68 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.323 -0.861 . . . . 1.0 110.312 -178.685 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.0 p -93.42 130.93 33.87 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 120.943 -1.098 . . . . 1.0 109.595 -179.992 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -74.61 17.48 0.55 Allowed 'Trans proline' 0 N--CA 1.496 1.638 0 CA-C-N 119.91 1.004 . . . . 1.0 112.043 179.233 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.8 mt -68.94 139.85 55.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.114 -0.991 . . . . 1.0 109.838 -179.444 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -106.62 121.21 43.87 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.933 -0.765 . . . . 1.0 108.933 179.417 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -106.86 124.76 50.09 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.281 -0.887 . . . . 1.0 109.727 -179.428 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.2 m -119.96 130.04 54.58 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.626 -0.671 . . . . 1.0 109.891 179.896 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.472 ' CB ' ' NH1' ' A' ' 52' ' ' ARG . 11.6 ttp-105 -82.88 134.84 35.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.268 -0.895 . . . . 1.0 109.556 179.579 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.3 mt -107.43 134.13 50.93 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.266 -0.896 . . . . 1.0 109.299 179.614 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.434 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 59.5 m170 -65.01 -39.9 94.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.438 -0.789 . . . . 1.0 109.46 -179.931 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 72.0 m-20 -151.44 -176.74 5.71 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.281 -0.887 . . . . 1.0 109.486 -179.805 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.21 -179.48 43.74 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.367 -1.493 . . . . 1.0 109.367 -179.662 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 93.3 mt -97.1 130.45 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.296 -1.12 . . . . 1.0 109.474 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.05 160.46 16.42 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.453 -0.779 . . . . 1.0 109.67 -179.605 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.06 -49.1 78.97 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.284 -0.885 . . . . 1.0 109.348 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.9 mt -105.73 97.04 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.467 -0.771 . . . . 1.0 109.729 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.9 ptm -99.2 125.27 44.74 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.083 -1.01 . . . . 1.0 109.173 179.368 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 86.6 mt -102.81 137.52 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.458 -0.776 . . . . 1.0 109.434 -179.451 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.1 p -153.38 153.32 32.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.185 -0.947 . . . . 1.0 109.852 -179.896 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -104.09 121.36 43.05 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.225 -1.028 . . . . 1.0 108.225 179.116 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -108.22 -172.99 21.71 Favored Glycine 0 N--CA 1.5 2.907 0 N-CA-C 110.852 -0.899 . . . . 1.0 110.852 -178.784 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.57 ' O ' ' C ' ' A' ' 67' ' ' LYS . 83.3 mt -134.99 159.91 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.098 -1.075 . . . . 1.0 108.098 179.29 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.57 ' C ' ' O ' ' A' ' 66' ' ' ILE . 28.2 tptp -0.93 -88.52 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.765 0 CA-C-O 121.283 0.563 . . . . 1.0 111.696 -179.597 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 66' ' ' ILE . 21.1 pt-20 -77.78 150.79 34.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.261 -0.9 . . . . 1.0 109.385 179.152 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.418 ' O ' ' C ' ' A' ' 70' ' ' GLY . 33.4 p-80 -161.24 -155.76 0.42 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.975 -1.078 . . . . 1.0 109.812 179.604 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 69' ' ' HIS . . . -39.59 -84.4 0.01 OUTLIER Glycine 0 N--CA 1.498 2.795 0 N-CA-C 110.628 -0.989 . . . . 1.0 110.628 -179.386 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -65.05 147.18 53.95 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.112 -1.228 . . . . 1.0 108.988 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.619 ' CD1' ' N ' ' A' ' 73' ' ' TYR . 51.6 p90 -59.9 -44.79 94.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.202 -0.936 . . . . 1.0 109.836 -179.199 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.619 ' N ' ' CD1' ' A' ' 72' ' ' PHE . 12.3 t80 -42.08 103.54 0.31 Allowed Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.673 -0.642 . . . . 1.0 109.923 -179.851 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -84.26 -174.23 1.78 Allowed 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 120.921 1.081 . . . . 1.0 113.176 -179.381 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.55 ' CE2' ' OD1' ' A' ' 99' ' ' ASP . 89.8 m-85 -90.63 171.21 9.54 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.505 -0.924 . . . . 1.0 108.505 179.217 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 79' ' ' SER . 20.7 p-10 -96.1 9.53 40.57 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.015 -1.053 . . . . 1.0 110.295 -179.091 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 120.88 -154.86 16.35 Favored Glycine 0 N--CA 1.504 3.181 0 N-CA-C 108.934 -1.666 . . . . 1.0 108.934 179.888 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.434 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 3.7 Cg_exo -63.12 -62.41 0.11 Allowed 'Trans proline' 0 N--CA 1.489 1.224 0 CA-C-N 118.962 1.381 . . . . 1.0 111.715 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.419 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 70.9 p -75.63 162.41 28.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.439 -0.788 . . . . 1.0 109.729 179.736 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 111.67 -126.35 7.64 Favored Glycine 0 N--CA 1.501 2.983 0 N-CA-C 109.9 -1.28 . . . . 1.0 109.9 179.71 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.401 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 7.2 mt -69.69 100.39 1.48 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.36 -1.082 . . . . 1.0 109.074 -179.787 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 46.4 mt -73.91 -29.75 62.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.033 -1.042 . . . . 1.0 109.252 -179.702 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -177.32 166.81 2.33 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.086 -1.079 . . . . 1.0 108.086 -179.661 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -163.07 159.91 23.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.753 -1.217 . . . . 1.0 110.033 179.652 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -138.69 160.32 39.94 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.924 -0.769 . . . . 1.0 108.924 179.898 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -97.45 152.06 38.0 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.248 -0.908 . . . . 1.0 109.278 -179.663 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.529 ' O ' ' N ' ' A' ' 89' ' ' GLY . 12.6 Cg_exo -47.08 167.0 0.08 OUTLIER 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 120.437 0.758 . . . . 1.0 111.359 179.976 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -61.61 63.68 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 120.981 1.121 . . . . 1.0 112.416 -179.312 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -64.64 177.72 9.38 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.936 -1.666 . . . . 1.0 108.936 179.433 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -52.72 -82.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 CA-C-N 118.27 1.035 . . . . 1.0 111.675 -179.655 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -112.49 -45.28 3.26 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.19 -0.944 . . . . 1.0 109.293 179.75 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -59.98 -42.19 93.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.321 -0.862 . . . . 1.0 110.2 179.869 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.428 ' HA3' ' H ' ' A' ' 89' ' ' GLY . . . -61.75 169.43 12.01 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.449 -1.06 . . . . 1.0 110.449 -178.996 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.21 4.17 88.79 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 108.929 -1.669 . . . . 1.0 108.929 -179.823 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.442 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 31.5 p-10 -80.55 167.69 19.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.348 -1.089 . . . . 1.0 109.683 179.932 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.96 119.41 6.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.181 -0.949 . . . . 1.0 109.655 179.826 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -103.87 126.02 50.7 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.398 -0.814 . . . . 1.0 109.593 179.975 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.412 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 28.1 m-85 -106.14 145.92 30.88 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.549 -0.719 . . . . 1.0 109.266 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.55 ' OD1' ' CE2' ' A' ' 75' ' ' PHE . 94.7 m-20 -78.24 121.98 25.1 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.979 -1.076 . . . . 1.0 109.145 179.513 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 45.7 t0 -83.18 -10.89 58.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.232 -0.918 . . . . 1.0 109.622 179.976 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -81.91 -10.98 59.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.311 -0.868 . . . . 1.0 109.852 -179.732 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.434 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 98.7 mt-10 -89.15 169.05 11.8 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.185 -0.947 . . . . 1.0 109.614 -179.348 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 54.8 m -98.12 104.73 16.79 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.168 -0.958 . . . . 1.0 109.291 -179.521 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -89.35 120.95 31.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.882 . . . . 1.0 108.908 179.924 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.638 HG21 ' HB2' ' A' ' 109' ' ' LYS . 6.4 t -140.06 150.16 44.03 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.444 -0.785 . . . . 1.0 109.819 -179.046 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 66.3 m -91.64 -8.59 46.74 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.257 -1.016 . . . . 1.0 108.257 179.034 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 83.5 p -90.17 172.14 9.02 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.787 -0.82 . . . . 1.0 108.787 179.364 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.7 t -74.99 77.2 2.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.024 -1.047 . . . . 1.0 109.416 -179.962 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.638 ' HB2' HG21 ' A' ' 105' ' ' THR . 96.4 mttt -148.85 147.52 28.82 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 179.456 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.14 -138.06 4.72 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.981 -1.248 . . . . 1.0 109.981 179.746 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -100.04 115.2 29.18 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.282 -1.128 . . . . 1.0 109.171 179.906 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -63.96 133.95 54.16 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.087 -1.008 . . . . 1.0 109.781 -179.685 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.4 tp -59.95 -45.09 93.74 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.357 -0.84 . . . . 1.0 111.165 -179.6 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -59.94 -40.97 90.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.988 -1.07 . . . . 1.0 110.695 -178.188 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -59.97 -50.2 74.68 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.838 -1.164 . . . . 1.0 109.436 -179.569 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.5 t -70.01 -40.48 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.099 -1.0 . . . . 1.0 110.109 -179.396 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.93 -51.27 70.77 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.115 -0.99 . . . . 1.0 109.6 -179.312 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.99 -36.56 77.45 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.282 -0.886 . . . . 1.0 110.425 -179.97 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -63.34 -49.88 72.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.166 -0.959 . . . . 1.0 110.806 -178.558 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.412 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 7.3 pt-20 -59.87 -39.15 84.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.746 -1.221 . . . . 1.0 109.999 -179.455 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -60.04 -40.05 88.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.788 -1.195 . . . . 1.0 108.829 179.421 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -56.97 -42.9 93.03 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.547 -1.421 . . . . 1.0 109.547 179.988 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -67.23 -39.96 86.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.108 -1.231 . . . . 1.0 109.993 179.801 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 87.3 p -67.1 -22.18 65.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 1.0 109.909 -179.598 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 81.0 mt -80.84 -0.93 41.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.158 -0.964 . . . . 1.0 109.701 -179.853 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.92 6.14 67.49 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 110.414 -1.075 . . . . 1.0 110.414 179.264 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.4 mt -84.91 150.04 25.24 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.987 -1.302 . . . . 1.0 109.654 179.903 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 38.4 t0 -99.95 175.59 5.72 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.593 -0.891 . . . . 1.0 108.593 179.416 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.501 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 72.6 m80 -59.7 139.98 56.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.97 -1.081 . . . . 1.0 109.491 -179.742 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 44.2 t -98.09 148.1 23.88 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.381 -0.825 . . . . 1.0 109.334 -179.808 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -96.9 2.15 51.33 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.266 -0.896 . . . . 1.0 109.733 -179.646 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 8.2 t0 -86.48 128.14 58.13 Favored Pre-proline 0 N--CA 1.491 1.623 0 N-CA-C 107.947 -1.131 . . . . 1.0 107.947 179.296 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -65.39 -19.67 61.44 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 CA-C-N 120.344 1.158 . . . . 1.0 112.305 -179.665 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.426 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -88.09 -6.36 75.36 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.621 -1.392 . . . . 1.0 109.621 -179.929 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.61 135.41 34.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.244 -1.15 . . . . 1.0 109.235 179.787 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.437 ' C ' ' H ' ' A' ' 138' ' ' PHE . 92.2 mt -60.08 -38.92 84.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.108 -0.995 . . . . 1.0 109.685 -179.692 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 71.0 mtp -69.9 21.81 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.384 -0.823 . . . . 1.0 111.349 -178.631 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.437 ' H ' ' C ' ' A' ' 136' ' ' LEU . 16.1 t80 -67.06 134.43 93.78 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 120.726 -1.234 . . . . 1.0 107.848 179.542 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -61.64 -5.5 5.84 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 120.876 1.05 . . . . 1.0 114.215 -177.886 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 89.6 mt -118.05 136.55 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 O-C-N 120.918 -1.114 . . . . 1.0 109.269 179.55 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -72.11 126.55 30.07 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.349 -0.845 . . . . 1.0 109.958 -178.928 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.8 t -139.55 142.19 37.2 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.81 -0.811 . . . . 1.0 108.81 179.79 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -80.77 145.03 31.69 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.002 -1.061 . . . . 1.0 109.545 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.8 t -140.03 156.66 46.51 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.412 -0.805 . . . . 1.0 109.438 -179.605 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.12 104.49 0.97 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.719 -1.352 . . . . 1.0 109.719 -179.859 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -77.1 -0.93 26.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.364 -1.08 . . . . 1.0 109.898 -179.892 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 42.1 t -60.01 -43.09 95.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.084 -1.01 . . . . 1.0 109.353 -179.562 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -156.05 74.31 0.85 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.096 -1.002 . . . . 1.0 109.556 179.545 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -99.13 122.91 42.98 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.297 -0.877 . . . . 1.0 109.166 179.555 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 96.7 mtp -114.57 140.18 48.99 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.021 -0.733 . . . . 1.0 109.021 179.854 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 57.0 mt -50.26 128.82 23.85 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.021 -1.049 . . . . 1.0 108.836 -179.94 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -69.01 176.97 5.52 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 CA-C-N 120.041 1.05 . . . . 1.0 112.335 179.889 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.04 -40.0 87.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.417 -0.802 . . . . 1.0 109.549 179.775 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -55.76 -49.97 71.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.342 -0.849 . . . . 1.0 109.943 -179.385 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -70.72 -40.0 73.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.023 -1.048 . . . . 1.0 110.151 -179.525 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 76.9 t -62.09 -48.58 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.106 -0.997 . . . . 1.0 109.335 -179.67 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -60.82 -39.98 91.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.975 -1.078 . . . . 1.0 110.283 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.68 -53.83 11.3 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 120.228 -0.987 . . . . 1.0 111.393 -178.634 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.454 HG23 ' N ' ' A' ' 160' ' ' GLN . 6.0 tp -60.48 -40.04 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.868 -1.372 . . . . 1.0 109.795 -178.981 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 164' ' ' GLY . 95.1 mt-30 -64.01 -39.86 95.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.192 -0.943 . . . . 1.0 109.156 179.593 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 86.3 p -62.74 -28.58 70.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.885 . . . . 1.0 110.326 -179.805 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 85.4 mt -87.85 -49.95 6.76 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.947 -1.096 . . . . 1.0 110.401 -179.213 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -91.05 -9.52 45.5 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.067 -1.021 . . . . 1.0 110.148 -179.061 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.554 -1.418 . . . . 1.0 109.554 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 169' ' ' WAY . . . . . 0.952 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.1 mt . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 121.417 0.627 . . . . 1.0 109.529 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.05 162.25 34.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.335 -0.853 . . . . 1.0 108.815 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -71.99 149.21 45.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.999 -1.063 . . . . 1.0 109.071 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.0 t -79.41 -4.8 52.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.402 -0.811 . . . . 1.0 110.382 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.2 pttt -150.08 159.15 44.63 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.954 -1.091 . . . . 1.0 109.705 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.536 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.03 0.41 57.13 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.459 -0.776 . . . . 1.0 109.416 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -95.27 126.51 40.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.329 -0.857 . . . . 1.0 108.753 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.3 mt -140.14 152.11 45.82 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.279 -0.888 . . . . 1.0 109.069 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.8 p -130.27 155.29 46.54 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.893 -0.78 . . . . 1.0 108.893 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -145.62 158.72 43.81 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.039 -1.038 . . . . 1.0 109.89 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.603 HH12 ' H ' ' A' ' 56' ' ' GLY . 70.7 ttt180 -144.14 133.73 23.52 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.513 -0.742 . . . . 1.0 109.533 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.4 mt -89.43 117.59 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.091 -1.006 . . . . 1.0 109.125 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 56.6 t -69.94 -41.44 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.171 -0.956 . . . . 1.0 109.414 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.3 p-10 -163.2 162.99 25.71 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.775 -1.203 . . . . 1.0 110.125 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.407 ' HB2' ' CD2' ' A' ' 28' ' ' HIS . 53.0 m-85 -102.12 -167.39 1.4 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.203 -1.406 . . . . 1.0 107.203 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.72 143.08 35.63 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.374 -0.829 . . . . 1.0 109.817 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -66.07 -15.58 49.12 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 120.854 1.036 . . . . 1.0 110.822 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -59.17 -39.6 83.01 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.288 -0.869 . . . . 1.0 109.995 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.5 mtm -136.27 166.06 24.3 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.252 -0.905 . . . . 1.0 109.428 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.7 p -71.77 161.2 31.33 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.515 -0.74 . . . . 1.0 109.648 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.407 ' CD2' ' HB2' ' A' ' 22' ' ' TYR . 49.3 m170 -61.77 -39.91 93.32 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.553 -0.717 . . . . 1.0 109.741 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.7 m -59.9 -40.05 87.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.983 -1.073 . . . . 1.0 110.08 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -64.67 -40.08 94.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.924 -1.11 . . . . 1.0 109.975 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 63.2 t -70.02 -40.4 78.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 120.935 -1.103 . . . . 1.0 110.278 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.98 -52.87 63.56 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.235 -0.916 . . . . 1.0 110.899 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.5 ptmt -64.5 -28.82 69.92 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.196 -0.94 . . . . 1.0 109.992 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.12 -49.67 76.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.874 -1.141 . . . . 1.0 109.413 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -67.77 -38.53 83.53 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.994 -1.067 . . . . 1.0 110.083 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -59.88 -43.08 94.95 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.903 -1.123 . . . . 1.0 109.37 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -61.59 -40.09 93.55 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.058 -1.026 . . . . 1.0 108.781 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.08 -47.17 87.01 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.528 -0.733 . . . . 1.0 109.825 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -63.31 -39.85 95.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.992 -1.068 . . . . 1.0 109.57 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -59.8 -48.96 79.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.087 -1.008 . . . . 1.0 109.859 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.5 t -60.05 -40.41 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.255 -0.903 . . . . 1.0 110.602 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.436 ' CE3' ' CD1' ' A' ' 125' ' ' LEU . 73.5 m95 -79.4 -37.1 38.03 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.949 -1.094 . . . . 1.0 109.424 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.7 p -71.22 -20.0 62.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.104 -0.998 . . . . 1.0 110.029 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -60.65 -39.91 90.1 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.954 -1.091 . . . . 1.0 110.899 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.2 m -111.31 22.78 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.195 -0.941 . . . . 1.0 111.071 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.6 p -146.94 135.36 10.92 Favored Pre-proline 0 N--CA 1.501 2.11 0 O-C-N 120.843 -1.161 . . . . 1.0 109.361 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -74.28 17.57 0.51 Allowed 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 120.733 0.955 . . . . 1.0 111.967 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 78.2 mt -69.33 139.53 54.27 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.253 -0.904 . . . . 1.0 109.915 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -110.79 120.78 43.52 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.865 -0.791 . . . . 1.0 108.865 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -107.6 122.43 46.68 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.413 -0.804 . . . . 1.0 109.647 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -120.18 130.11 54.43 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.663 -0.648 . . . . 1.0 110.068 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -81.83 135.7 35.43 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.27 -0.894 . . . . 1.0 109.348 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.3 mt -104.27 126.23 51.2 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.364 -0.835 . . . . 1.0 109.181 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.41 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 45.8 m-70 -61.61 -40.16 93.83 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.329 -0.857 . . . . 1.0 109.737 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 77.3 m-20 -146.45 167.48 23.53 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.242 -0.911 . . . . 1.0 109.857 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.603 ' H ' HH12 ' A' ' 18' ' ' ARG . . . 98.22 175.73 33.09 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.136 -1.585 . . . . 1.0 109.136 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -93.55 136.81 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.228 -1.16 . . . . 1.0 108.579 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.66 161.08 15.74 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.423 -0.798 . . . . 1.0 109.281 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.02 -49.8 76.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.303 -0.873 . . . . 1.0 109.144 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 88.6 mt -106.64 102.59 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.377 -0.827 . . . . 1.0 109.702 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.1 ptm -102.47 131.49 49.13 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.348 -0.845 . . . . 1.0 109.148 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 88.3 mt -105.92 135.11 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.539 -0.725 . . . . 1.0 109.808 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 64.4 p -152.32 158.88 43.37 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.192 -0.942 . . . . 1.0 109.851 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -104.46 121.23 43.0 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.24 -170.01 23.97 Favored Glycine 0 N--CA 1.501 2.984 0 O-C-N 121.156 -0.965 . . . . 1.0 111.121 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 78.0 mt . . . . . 0 N--CA 1.498 1.937 0 N-CA-C 107.995 -1.113 . . . . 1.0 107.995 179.521 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.53 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 72.2 m-85 . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 109.207 -0.664 . . . . 1.0 109.207 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -100.11 8.04 44.19 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.236 -0.915 . . . . 1.0 110.102 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 127.99 -156.4 20.69 Favored Glycine 0 N--CA 1.504 3.193 0 N-CA-C 108.608 -1.797 . . . . 1.0 108.608 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -60.7 -65.66 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.462 0 CA-C-N 118.855 1.328 . . . . 1.0 111.422 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 87.4 p -76.53 160.03 29.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.059 -1.026 . . . . 1.0 109.436 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.26 -126.87 7.24 Favored Glycine 0 N--CA 1.504 3.203 0 N-CA-C 110.016 -1.234 . . . . 1.0 110.016 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.427 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 28.4 mt -68.71 107.69 3.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.228 -1.16 . . . . 1.0 109.483 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 38.0 mt -79.67 -16.54 55.55 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.017 -1.052 . . . . 1.0 108.209 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.32 175.26 0.94 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.203 -1.036 . . . . 1.0 108.203 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.468 ' CE1' ' ND1' ' A' ' 97' ' ' HIS . 7.5 p80 -161.2 159.99 29.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.994 -1.066 . . . . 1.0 109.479 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.07 160.16 44.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.371 -0.831 . . . . 1.0 108.866 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -106.25 151.45 40.21 Favored Pre-proline 0 N--CA 1.499 1.984 0 N-CA-C 108.766 -0.827 . . . . 1.0 108.766 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -44.81 161.92 0.08 OUTLIER 'Trans proline' 0 N--CA 1.488 1.152 0 C-N-CA 120.694 0.93 . . . . 1.0 111.656 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo . . . . . 0 N--CA 1.494 1.543 0 C-N-CA 121.158 1.239 . . . . 1.0 112.529 -179.477 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.6 p-10 . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 121.191 0.52 . . . . 1.0 109.733 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.49 122.57 8.26 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.289 -0.882 . . . . 1.0 109.533 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.468 ' ND1' ' CE1' ' A' ' 84' ' ' HIS . 60.8 m170 -110.74 148.25 32.7 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.652 -0.655 . . . . 1.0 109.692 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -123.05 156.46 34.82 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.571 -0.706 . . . . 1.0 109.19 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.53 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 1.1 m-20 -81.2 121.35 26.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 1.0 109.633 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -84.67 -12.95 52.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.068 -1.02 . . . . 1.0 109.422 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -82.96 -11.54 58.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.311 -0.868 . . . . 1.0 109.879 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -87.82 173.01 9.21 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.36 -0.838 . . . . 1.0 110.075 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.0 m -99.88 104.85 16.53 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.411 -0.806 . . . . 1.0 108.871 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.523 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 95.9 m95 -88.71 125.28 34.78 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.633 -0.877 . . . . 1.0 108.633 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.658 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.8 t -140.35 150.46 43.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.492 -0.755 . . . . 1.0 109.308 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 75.7 m -92.17 -8.26 46.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.104 -0.998 . . . . 1.0 108.383 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.8 m -91.19 174.84 7.18 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.57 -0.9 . . . . 1.0 108.57 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.485 ' OG ' ' CZ ' ' A' ' 143' ' ' TYR . 4.2 m -78.06 77.59 4.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.835 -1.166 . . . . 1.0 109.429 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.658 ' HB2' HG21 ' A' ' 105' ' ' THR . 99.2 mttt -146.98 149.58 33.44 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.707 -0.849 . . . . 1.0 108.707 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.81 -135.66 6.64 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.793 -1.323 . . . . 1.0 109.793 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -100.6 114.3 27.85 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.323 -1.104 . . . . 1.0 109.136 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -63.94 132.43 50.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.135 -0.978 . . . . 1.0 109.248 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.3 tp -59.8 -41.38 91.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.32 -0.862 . . . . 1.0 110.255 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -59.97 -43.8 94.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.311 -0.868 . . . . 1.0 111.095 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.453 HD21 HG22 ' A' ' 144' ' ' THR . 1.8 mm? -59.42 -50.49 73.74 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.671 -1.268 . . . . 1.0 109.814 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.1 t -66.24 -40.8 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.933 -1.104 . . . . 1.0 109.407 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.32 -51.5 69.67 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.282 -0.887 . . . . 1.0 110.067 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.27 -36.44 73.26 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.383 -1.448 . . . . 1.0 110.181 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.533 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 56.7 t60 -66.77 -47.75 71.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.113 -0.992 . . . . 1.0 111.746 -178.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -59.54 -39.86 85.34 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.624 -1.298 . . . . 1.0 109.515 -178.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -59.87 -39.37 85.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.11 -0.994 . . . . 1.0 108.513 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.95 -43.48 87.78 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.581 -1.408 . . . . 1.0 109.581 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.533 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 78.0 m-70 -64.5 -39.83 94.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.015 -1.286 . . . . 1.0 109.289 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 90.5 p -66.72 -24.12 66.2 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.137 -0.977 . . . . 1.0 110.025 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.436 ' CD1' ' CE3' ' A' ' 42' ' ' TRP . 80.9 mt -81.71 -1.64 47.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.11 -0.994 . . . . 1.0 109.689 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 91.33 9.62 63.1 Favored Glycine 0 N--CA 1.499 2.835 0 C-N-CA 120.243 -0.979 . . . . 1.0 111.01 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.8 mt -86.92 146.18 26.26 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.903 -1.351 . . . . 1.0 109.903 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 36.9 t0 -103.62 172.02 7.04 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.694 -0.854 . . . . 1.0 108.694 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.545 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 35.5 m170 -59.94 134.67 57.26 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.001 -1.062 . . . . 1.0 109.612 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 37.4 t -97.4 164.83 12.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.283 -0.886 . . . . 1.0 109.513 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -99.16 1.88 45.37 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.294 -0.879 . . . . 1.0 109.237 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 17.3 t0 -85.67 125.11 70.11 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.299 -0.875 . . . . 1.0 108.971 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -68.82 -20.53 39.39 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 CA-C-N 120.146 1.088 . . . . 1.0 111.822 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.451 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -86.26 -7.2 80.27 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.739 -1.344 . . . . 1.0 109.739 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.11 148.52 26.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.128 -1.219 . . . . 1.0 109.913 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.8 mt -69.83 -29.03 66.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.348 -0.845 . . . . 1.0 109.461 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.6 mmm -73.93 8.74 1.84 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.572 -0.705 . . . . 1.0 110.81 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -67.37 132.78 93.14 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 120.795 -1.191 . . . . 1.0 108.38 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -60.32 -24.73 78.38 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 120.861 1.041 . . . . 1.0 113.477 -178.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.3 mt -93.49 139.18 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 120.909 -1.119 . . . . 1.0 110.369 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -73.94 131.59 41.59 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.495 0.664 . . . . 1.0 110.05 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.8 t -141.19 140.45 34.02 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.719 -0.613 . . . . 1.0 109.441 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.485 ' CZ ' ' OG ' ' A' ' 108' ' ' SER . 79.3 t80 -80.94 145.07 31.43 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.241 -0.912 . . . . 1.0 109.033 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.453 HG22 HD21 ' A' ' 115' ' ' LEU . 6.8 t -141.01 155.32 46.22 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.342 -0.849 . . . . 1.0 108.918 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -77.8 112.66 3.54 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.258 -1.537 . . . . 1.0 109.258 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -77.79 3.34 14.47 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.239 -1.154 . . . . 1.0 110.034 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.5 ' O ' ' ND1' ' A' ' 148' ' ' HIS . 86.5 p -59.9 -38.38 82.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.077 -1.014 . . . . 1.0 109.679 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . 0.5 ' ND1' ' O ' ' A' ' 147' ' ' SER . 89.3 m-70 -154.08 33.05 0.43 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.09 -1.006 . . . . 1.0 110.078 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -70.85 138.69 50.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.996 -1.065 . . . . 1.0 109.67 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 58.4 mtt -140.02 149.53 43.31 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.225 -1.028 . . . . 1.0 108.225 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.697 ' H ' HD12 ' A' ' 151' ' ' LEU . 6.8 mp -52.25 127.38 38.59 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.87 -1.144 . . . . 1.0 108.833 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -65.1 -179.05 0.92 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 CA-C-N 120.088 1.067 . . . . 1.0 111.875 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -62.59 -40.14 95.96 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.456 -0.777 . . . . 1.0 110.175 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.407 ' C ' ' OD1' ' A' ' 154' ' ' ASP . 52.7 t0 -57.22 -49.71 75.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.964 -1.085 . . . . 1.0 110.138 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -70.44 -40.04 74.0 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.155 -0.966 . . . . 1.0 109.92 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 51.5 t -61.3 -44.74 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.051 -1.031 . . . . 1.0 109.591 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -61.61 -39.05 89.89 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.98 -1.075 . . . . 1.0 109.97 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -69.97 -53.27 15.52 Favored Glycine 0 N--CA 1.494 2.545 0 O-C-N 121.051 -1.03 . . . . 1.0 111.262 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.46 HG23 ' N ' ' A' ' 160' ' ' GLN . 6.3 tp -62.04 -40.54 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.722 -1.457 . . . . 1.0 109.837 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 164' ' ' GLY . 97.6 mt-30 -64.48 -39.79 94.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.01 -1.056 . . . . 1.0 109.757 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 93.2 p -64.75 -26.61 68.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.139 -0.976 . . . . 1.0 110.271 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 92.2 mt -86.39 -54.02 4.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.164 -0.96 . . . . 1.0 110.174 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -91.0 -11.27 39.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.229 -0.919 . . . . 1.0 110.27 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.626 0 N-CA-C 109.386 -1.486 . . . . 1.0 109.386 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.5 mt . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.5 pttt -161.26 162.05 30.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.372 -0.83 . . . . 1.0 109.499 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -70.65 146.53 49.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.205 -0.934 . . . . 1.0 109.419 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.3 m -99.57 17.82 19.49 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.36 -0.837 . . . . 1.0 110.043 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -147.82 147.63 30.03 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.001 -1.062 . . . . 1.0 109.438 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.538 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -91.82 -0.68 57.54 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.347 -0.845 . . . . 1.0 110.087 -179.707 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -99.28 119.9 38.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.264 -0.898 . . . . 1.0 108.589 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.7 mt -140.04 150.38 44.32 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.262 -0.899 . . . . 1.0 109.059 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.1 p -132.11 158.36 41.83 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.566 -0.709 . . . . 1.0 109.27 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -143.43 158.23 43.81 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.266 -0.896 . . . . 1.0 109.759 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.0 ttt-85 -143.14 132.65 23.58 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.483 -0.76 . . . . 1.0 109.796 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.8 mt -88.46 117.31 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.251 -0.906 . . . . 1.0 109.259 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.89 -40.05 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.079 -1.013 . . . . 1.0 108.937 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.712 HD21 ' H ' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -163.01 160.77 24.99 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.099 -1.001 . . . . 1.0 110.065 -179.656 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.639 ' CD1' ' CD2' ' A' ' 28' ' ' HIS . 46.9 m-85 -102.71 -160.39 0.78 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.086 -1.449 . . . . 1.0 107.086 178.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.62 153.76 77.66 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.053 -1.029 . . . . 1.0 110.704 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -74.16 -16.9 22.28 Favored 'Trans proline' 0 N--CA 1.486 1.068 0 C-N-CA 121.089 1.193 . . . . 1.0 110.124 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.46 -39.97 85.37 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.382 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 73.9 mtm -135.86 163.76 29.49 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.305 -0.872 . . . . 1.0 109.519 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.8 p -72.42 159.71 33.54 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.34 -0.85 . . . . 1.0 109.422 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.639 ' CD2' ' CD1' ' A' ' 22' ' ' TYR . 1.1 m80 -61.41 -40.03 92.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.434 -0.791 . . . . 1.0 110.399 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.5 m -60.08 -39.94 87.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.128 -0.982 . . . . 1.0 110.235 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -67.0 -39.98 87.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.136 -0.977 . . . . 1.0 109.871 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.4 t -68.21 -41.46 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.935 . . . . 1.0 110.457 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -60.05 -48.74 80.47 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.978 -1.076 . . . . 1.0 110.582 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -62.61 -32.46 73.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.979 -1.075 . . . . 1.0 109.948 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.07 -47.83 84.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.086 -1.009 . . . . 1.0 109.68 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.4 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 49.2 m-85 -66.04 -39.73 90.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.074 -1.016 . . . . 1.0 109.868 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -60.02 -41.97 93.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.95 -1.094 . . . . 1.0 109.771 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -60.81 -41.93 96.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.966 -1.084 . . . . 1.0 109.201 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.39 -45.4 93.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.458 -0.776 . . . . 1.0 110.276 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -68.13 -38.37 82.12 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.986 -1.071 . . . . 1.0 110.162 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -59.93 -46.65 88.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.032 -1.043 . . . . 1.0 109.404 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.2 t -59.94 -41.0 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.943 . . . . 1.0 109.759 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.404 ' CZ3' HD22 ' A' ' 151' ' ' LEU . 71.9 m95 -79.48 -36.56 38.52 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.983 -1.073 . . . . 1.0 110.293 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.8 p -71.23 -18.74 62.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.974 -1.078 . . . . 1.0 109.843 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.88 -39.66 90.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.188 -0.945 . . . . 1.0 110.847 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.9 m -110.05 23.25 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.28 -0.887 . . . . 1.0 110.836 -178.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.0 p -149.05 137.7 12.01 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 120.861 -1.149 . . . . 1.0 109.377 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -75.25 18.03 0.59 Allowed 'Trans proline' 0 N--CA 1.495 1.598 0 CA-C-N 119.68 0.921 . . . . 1.0 112.102 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.9 mt -68.19 138.39 55.58 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.048 -1.032 . . . . 1.0 109.991 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -110.15 120.35 42.17 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.665 -0.865 . . . . 1.0 108.665 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -108.12 121.32 44.59 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.42 -0.8 . . . . 1.0 109.589 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -120.01 130.03 54.54 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.598 -0.688 . . . . 1.0 109.333 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -82.53 134.7 35.2 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.198 -0.939 . . . . 1.0 109.441 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.4 mt -104.03 131.94 50.78 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.35 -0.844 . . . . 1.0 109.448 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.438 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 91.6 m-70 -65.03 -40.01 94.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.483 -0.761 . . . . 1.0 110.405 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 80.5 m-20 -146.74 170.02 17.86 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.106 -0.996 . . . . 1.0 109.985 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.26 177.51 40.35 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.483 -1.447 . . . . 1.0 109.483 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.5 mt -93.81 136.45 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.212 -1.17 . . . . 1.0 109.105 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -107.83 173.16 6.44 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.404 -0.81 . . . . 1.0 109.415 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -60.04 -49.18 78.66 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.193 -0.942 . . . . 1.0 109.216 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.0 mt -119.99 117.52 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.471 -0.768 . . . . 1.0 109.179 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.8 ptp -100.97 140.0 35.88 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.209 -0.932 . . . . 1.0 109.293 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.4 HG21 ' CZ ' ' A' ' 35' ' ' PHE . 86.4 mt -110.01 130.09 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.622 -0.674 . . . . 1.0 109.802 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 31.0 p -150.51 156.21 40.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.217 -0.927 . . . . 1.0 109.826 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.712 ' H ' HD21 ' A' ' 21' ' ' ASN . 91.5 m-85 -102.76 122.79 45.2 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.292 -1.003 . . . . 1.0 108.292 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.7 -177.28 23.93 Favored Glycine 0 N--CA 1.499 2.891 0 N-CA-C 110.709 -0.956 . . . . 1.0 110.709 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 87.6 mt . . . . . 0 N--CA 1.493 1.708 0 O-C-N 121.71 -0.877 . . . . 1.0 108.813 179.481 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.517 ' CD2' ' OD2' ' A' ' 99' ' ' ASP . 34.0 m-85 . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -99.94 0.04 40.41 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.217 -0.927 . . . . 1.0 110.478 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 128.05 -139.46 11.1 Favored Glycine 0 N--CA 1.502 3.056 0 N-CA-C 108.344 -1.902 . . . . 1.0 108.344 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.448 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 24.9 Cg_endo -79.02 -52.9 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.314 0 CA-C-N 119.917 1.859 . . . . 1.0 112.09 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 91.6 p -79.6 170.49 16.48 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.205 -0.934 . . . . 1.0 110.086 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.82 -122.5 7.6 Favored Glycine 0 N--CA 1.498 2.817 0 N-CA-C 110.488 -1.045 . . . . 1.0 110.488 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.465 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 9.8 mt -67.26 100.48 0.81 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.454 -1.027 . . . . 1.0 109.111 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 64.2 mt -79.06 -20.03 49.87 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.014 -1.054 . . . . 1.0 110.03 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.01 171.99 1.32 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 1.0 109.035 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -162.28 159.14 25.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.012 -1.055 . . . . 1.0 109.896 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.08 156.18 42.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.49 -0.756 . . . . 1.0 109.322 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -103.5 150.94 38.55 Favored Pre-proline 0 N--CA 1.496 1.863 0 N-CA-C 108.39 -0.967 . . . . 1.0 108.39 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.73 166.47 11.85 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 120.924 1.083 . . . . 1.0 111.42 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo . . . . . 0 C--N 1.313 -1.34 0 C-N-CA 120.661 0.907 . . . . 1.0 111.361 -179.897 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 109.602 -0.518 . . . . 1.0 109.602 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.04 122.43 9.05 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.209 -0.932 . . . . 1.0 109.526 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -109.72 155.98 20.86 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.596 -0.69 . . . . 1.0 109.392 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.524 ' CE2' ' OE2' ' A' ' 120' ' ' GLU . 29.1 m-85 -130.23 143.66 50.91 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.197 -1.038 . . . . 1.0 108.197 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.517 ' OD2' ' CD2' ' A' ' 75' ' ' PHE . 93.6 m-20 -80.01 117.06 20.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.725 -1.234 . . . . 1.0 109.576 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 39.1 t0 -81.59 2.74 27.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.386 -0.821 . . . . 1.0 109.559 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -81.2 -17.34 49.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 1.0 110.101 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' A' ' 102' ' ' GLU . 58.0 mp0 -92.86 174.87 7.02 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.018 -1.051 . . . . 1.0 109.605 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 23.3 m -99.14 105.12 17.17 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.529 -0.915 . . . . 1.0 108.529 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -85.21 128.12 34.55 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.347 -0.845 . . . . 1.0 108.73 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.661 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.9 t -142.77 158.33 43.74 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.416 -0.803 . . . . 1.0 109.781 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.6 t -95.56 -9.09 33.28 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.253 -1.017 . . . . 1.0 108.253 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.4 t -92.1 -171.6 2.88 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.888 -0.782 . . . . 1.0 108.888 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.5 t -88.38 77.77 8.07 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.077 -1.014 . . . . 1.0 109.619 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.661 ' HB2' HG21 ' A' ' 105' ' ' THR . 60.4 mttp -149.31 151.39 34.07 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.324 -0.86 . . . . 1.0 108.761 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.48 -137.7 5.29 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.949 -1.26 . . . . 1.0 109.949 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -100.06 118.97 37.55 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.376 -1.073 . . . . 1.0 109.316 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.65 HD21 ' HZ2' ' A' ' 146' ' ' LYS . 23.8 t-20 -65.52 130.11 42.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 1.0 110.059 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 58.6 tp -60.06 -47.11 87.24 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.368 -0.832 . . . . 1.0 111.295 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -59.79 -42.9 94.4 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.083 -1.01 . . . . 1.0 111.843 -177.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 115' ' ' LEU . 4.0 mm? -60.01 -49.99 75.5 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.532 -1.355 . . . . 1.0 109.21 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 65.3 t -66.66 -42.36 89.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.244 -0.91 . . . . 1.0 110.866 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.97 -48.74 79.06 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.081 -1.012 . . . . 1.0 110.325 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.35 -39.17 82.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.947 -1.096 . . . . 1.0 110.294 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.599 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 56.4 t60 -65.27 -52.42 54.41 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.137 -0.977 . . . . 1.0 111.411 -178.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.524 ' OE2' ' CE2' ' A' ' 98' ' ' PHE . 10.1 pt-20 -60.03 -42.3 94.1 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.772 -1.205 . . . . 1.0 110.609 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -60.09 -39.86 87.59 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.729 -1.232 . . . . 1.0 108.814 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -54.82 -42.74 80.1 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.366 -1.494 . . . . 1.0 109.366 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.599 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 90.1 m-70 -65.68 -39.1 90.94 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.125 -1.221 . . . . 1.0 109.134 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.1 p -62.14 -24.97 67.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -0.903 . . . . 1.0 109.892 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 88.8 mt -81.19 -0.08 38.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.057 -1.027 . . . . 1.0 109.792 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 91.89 10.36 61.49 Favored Glycine 0 N--CA 1.498 2.784 0 O-C-N 121.058 -1.026 . . . . 1.0 110.668 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.3 mt -84.71 150.01 25.4 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.931 -1.334 . . . . 1.0 109.462 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 37.1 t0 -100.65 169.99 8.66 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.435 -0.79 . . . . 1.0 109.06 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.526 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 74.8 m80 -59.99 139.74 57.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.153 -0.967 . . . . 1.0 109.545 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 41.2 t -96.25 156.16 16.46 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.27 -0.894 . . . . 1.0 108.913 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -99.13 3.95 46.75 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.127 -0.983 . . . . 1.0 109.574 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -87.07 129.49 51.73 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.089 -1.007 . . . . 1.0 108.726 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -67.9 -27.82 36.61 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 CA-C-N 120.086 1.066 . . . . 1.0 113.022 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -84.86 -2.31 88.58 Favored Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.824 -1.179 . . . . 1.0 110.454 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.83 146.81 26.07 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.022 -1.281 . . . . 1.0 110.015 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 86.5 mt -70.06 -29.96 67.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.221 -0.924 . . . . 1.0 109.677 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.2 mmm -73.6 8.3 1.94 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.183 -0.948 . . . . 1.0 110.171 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -69.41 132.64 89.48 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.096 -1.002 . . . . 1.0 108.595 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -63.41 14.19 0.07 OUTLIER 'Trans proline' 0 N--CA 1.505 2.182 0 C-N-CA 121.152 1.235 . . . . 1.0 115.167 -177.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 76.0 mt -130.78 138.02 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.382 0 O-C-N 120.785 -1.197 . . . . 1.0 109.495 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . 0.42 ' CD1' ' C ' ' A' ' 141' ' ' TYR . 21.5 t80 -73.37 128.3 35.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.444 -0.785 . . . . 1.0 109.957 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 10.0 t -136.56 137.0 39.76 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.579 -0.701 . . . . 1.0 109.197 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -85.11 143.18 29.0 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.17 -0.956 . . . . 1.0 109.265 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.7 t -140.38 151.19 44.77 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.3 -0.875 . . . . 1.0 109.52 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -68.89 109.39 2.87 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.734 -1.746 . . . . 1.0 108.734 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.65 ' HZ2' HD21 ' A' ' 112' ' ' ASN . 85.0 mttt -73.35 126.03 29.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.133 -1.216 . . . . 1.0 109.298 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 10.6 p -176.86 -93.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.307 -0.871 . . . . 1.0 109.111 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -98.81 18.83 16.09 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.664 -0.865 . . . . 1.0 108.664 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -60.15 134.62 57.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.592 -0.693 . . . . 1.0 109.829 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 95.0 mtp -136.96 150.14 47.98 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.732 -0.84 . . . . 1.0 108.732 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.404 HD22 ' CZ3' ' A' ' 42' ' ' TRP . 20.8 mt -48.23 125.87 11.85 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.069 -1.02 . . . . 1.0 108.949 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -62.83 175.62 2.25 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 CA-C-N 120.118 1.078 . . . . 1.0 112.201 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.02 -39.95 87.62 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.311 -0.868 . . . . 1.0 109.553 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.403 ' OD1' ' C ' ' A' ' 154' ' ' ASP . 52.7 t0 -55.89 -50.02 71.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.911 . . . . 1.0 109.739 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -70.07 -39.94 75.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.143 -0.973 . . . . 1.0 110.427 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.3 t -59.97 -46.41 94.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.903 -1.123 . . . . 1.0 109.018 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -60.3 -40.04 89.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.977 -1.077 . . . . 1.0 110.278 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -67.93 -55.89 12.5 Favored Glycine 0 N--CA 1.494 2.526 0 O-C-N 121.12 -0.988 . . . . 1.0 111.152 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.468 HG23 ' N ' ' A' ' 160' ' ' GLN . 5.3 tp -60.44 -39.98 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.909 -1.347 . . . . 1.0 109.523 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.472 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.5 mt-30 -65.28 -39.93 93.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.076 -1.015 . . . . 1.0 109.812 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 85.6 p -60.05 -33.92 72.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.064 -1.023 . . . . 1.0 110.488 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.4 mt -84.83 -56.71 3.44 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.004 -1.06 . . . . 1.0 111.167 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -89.66 -9.0 51.21 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.989 -1.07 . . . . 1.0 110.647 -178.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.497 2.748 0 N-CA-C 109.538 -1.425 . . . . 1.0 109.538 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.2 mt . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.422 0.63 . . . . 1.0 109.343 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.5 pttm -165.12 167.04 18.61 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.37 -0.831 . . . . 1.0 109.442 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -71.88 142.32 49.54 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.182 -0.949 . . . . 1.0 109.188 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.3 t -89.86 4.47 49.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.253 -0.905 . . . . 1.0 109.924 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -145.07 154.1 42.13 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.182 -0.949 . . . . 1.0 109.452 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.1 mmt -90.47 0.51 57.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.287 -0.883 . . . . 1.0 109.684 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -95.73 126.9 41.31 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.218 -0.927 . . . . 1.0 109.554 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.8 mt -143.26 149.16 37.49 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.366 -0.834 . . . . 1.0 108.816 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.0 p -132.78 155.18 49.37 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.424 -0.798 . . . . 1.0 108.851 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.499 ' CD2' ' NH1' ' A' ' 52' ' ' ARG . 34.7 p90 -148.4 160.12 43.34 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.821 -1.174 . . . . 1.0 110.752 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.403 ' NH1' ' HG2' ' A' ' 18' ' ' ARG . 35.0 ttt-85 -145.72 134.77 22.68 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.387 -0.598 . . . . 1.0 109.387 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.745 ' H ' HH22 ' A' ' 52' ' ' ARG . 93.5 mt -89.9 119.1 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 120.792 -1.193 . . . . 1.0 108.684 178.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 56.1 t -69.0 -40.78 81.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.964 -1.085 . . . . 1.0 109.027 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.4 p-10 -162.95 164.12 25.9 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.032 -1.067 . . . . 1.0 110.203 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.516 ' CD2' ' CG ' ' A' ' 28' ' ' HIS . 36.7 m-85 -103.42 -161.08 0.81 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.646 -1.613 . . . . 1.0 106.646 178.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.12 151.84 74.95 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.614 -0.679 . . . . 1.0 110.668 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -70.19 -14.28 34.55 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.056 1.171 . . . . 1.0 110.062 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -59.45 -40.02 85.5 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 115.307 -0.86 . . . . 1.0 110.027 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.6 mtm -140.47 168.07 20.68 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.343 -0.848 . . . . 1.0 109.236 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.4 p -72.79 159.98 32.92 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.401 -0.812 . . . . 1.0 109.207 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.516 ' CG ' ' CD2' ' A' ' 22' ' ' TYR . 51.2 m170 -59.97 -40.0 87.56 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.442 -0.787 . . . . 1.0 110.007 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 61.9 m -60.01 -40.06 87.98 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.165 -0.959 . . . . 1.0 110.488 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.65 -39.96 91.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.96 -1.088 . . . . 1.0 109.838 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.4 t -69.51 -41.38 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.135 -0.978 . . . . 1.0 110.485 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.0 -49.05 79.18 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.989 -1.069 . . . . 1.0 110.495 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -62.17 -32.91 73.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.987 -1.071 . . . . 1.0 109.825 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.98 -50.43 73.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.184 -0.948 . . . . 1.0 110.042 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -65.82 -38.94 90.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.054 -1.029 . . . . 1.0 109.672 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.97 -42.36 93.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.06 -1.025 . . . . 1.0 109.808 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -60.56 -40.59 92.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.942 -1.098 . . . . 1.0 109.234 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.26 -43.1 96.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -0.89 . . . . 1.0 109.99 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -66.07 -40.01 90.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.03 -1.043 . . . . 1.0 109.705 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -59.94 -47.87 84.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -0.934 . . . . 1.0 110.139 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 70.5 t -59.95 -40.04 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.058 -1.026 . . . . 1.0 109.965 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -81.66 -35.31 30.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.895 -1.128 . . . . 1.0 110.182 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.7 p -70.46 -22.82 62.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.92 -1.113 . . . . 1.0 109.414 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -59.96 -40.01 87.58 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.433 -0.792 . . . . 1.0 110.606 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.416 HG23 HG23 ' A' ' 46' ' ' THR . 8.5 m -112.14 25.35 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.372 -0.83 . . . . 1.0 110.729 -178.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.416 HG23 HG23 ' A' ' 45' ' ' VAL . 59.9 p -148.91 131.62 7.95 Favored Pre-proline 0 N--CA 1.501 2.09 0 O-C-N 120.88 -1.137 . . . . 1.0 109.796 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -72.93 20.54 0.33 Allowed 'Trans proline' 0 N--CA 1.495 1.577 0 CA-C-N 119.668 0.917 . . . . 1.0 112.032 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.9 mt -67.97 139.1 56.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.175 -0.953 . . . . 1.0 109.614 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -107.92 120.58 42.7 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.851 -0.796 . . . . 1.0 108.851 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -107.21 127.1 53.22 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.304 -0.873 . . . . 1.0 110.023 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.3 m -120.05 129.98 54.48 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.648 -0.657 . . . . 1.0 109.404 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.745 HH22 ' H ' ' A' ' 19' ' ' ILE . 28.9 tpt180 -84.03 136.5 34.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.247 -0.908 . . . . 1.0 109.833 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.0 mt -110.61 128.71 55.79 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.438 -0.789 . . . . 1.0 109.26 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.44 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 56.6 m170 -69.43 -39.78 77.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.396 -0.815 . . . . 1.0 109.708 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 76.7 m-20 -148.77 168.66 22.33 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.231 -0.918 . . . . 1.0 110.084 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.27 -175.48 29.52 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 109.868 -1.293 . . . . 1.0 109.868 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.7 mt -94.46 133.98 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.313 -1.11 . . . . 1.0 109.021 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.79 163.0 14.66 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.493 -0.754 . . . . 1.0 109.511 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -59.94 -49.25 78.41 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.279 -0.888 . . . . 1.0 109.045 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 95.8 mt -113.64 108.36 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.465 -0.772 . . . . 1.0 109.516 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.6 ptm -103.47 132.44 49.72 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.207 -0.933 . . . . 1.0 109.435 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 90.1 mt -102.34 138.25 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.506 -0.746 . . . . 1.0 109.777 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.8 p -153.63 157.34 39.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.249 -0.907 . . . . 1.0 109.49 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -102.08 125.28 48.73 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.8 -0.815 . . . . 1.0 108.8 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.14 158.04 16.21 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.424 -1.071 . . . . 1.0 110.424 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 9.8 tt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 108.758 -0.83 . . . . 1.0 108.758 179.985 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.537 ' CE2' ' OD1' ' A' ' 99' ' ' ASP . 27.2 m-85 . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 108.366 -0.976 . . . . 1.0 108.366 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 79' ' ' SER . 23.7 p-10 -99.95 10.25 41.61 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.046 -1.034 . . . . 1.0 110.948 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 110.73 -150.5 17.72 Favored Glycine 0 N--CA 1.507 3.395 0 N-CA-C 109.557 -1.417 . . . . 1.0 109.557 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -58.77 -65.81 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.577 0 CA-C-N 118.913 1.357 . . . . 1.0 112.846 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.433 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 78.9 p -75.24 159.16 31.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.095 -1.003 . . . . 1.0 109.693 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.22 -128.59 8.04 Favored Glycine 0 N--CA 1.5 2.944 0 N-CA-C 109.773 -1.331 . . . . 1.0 109.773 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.464 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 14.8 mt -69.4 105.84 2.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.326 -1.102 . . . . 1.0 109.41 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.42 HD23 ' OE2' ' A' ' 102' ' ' GLU . 72.2 mt -78.73 -24.4 44.88 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.127 -0.983 . . . . 1.0 108.738 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.65 169.99 1.31 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.053 -1.091 . . . . 1.0 108.053 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -163.0 161.39 25.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.855 -1.153 . . . . 1.0 110.209 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -145.5 162.31 37.68 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.502 -0.749 . . . . 1.0 109.193 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -103.06 151.92 38.5 Favored Pre-proline 0 N--CA 1.501 2.113 0 O-C-N 121.114 -0.991 . . . . 1.0 109.227 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -49.67 167.15 0.19 Allowed 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 120.784 0.99 . . . . 1.0 112.518 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo . . . . . 0 N--CA 1.494 1.545 0 C-N-CA 121.249 1.299 . . . . 1.0 111.845 179.131 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.2 p-10 . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.139 0.495 . . . . 1.0 109.716 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.87 123.17 10.26 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.279 -0.888 . . . . 1.0 109.27 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 57.5 m170 -112.31 154.8 25.12 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.571 -0.705 . . . . 1.0 109.973 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.519 ' CZ ' ' OE2' ' A' ' 120' ' ' GLU . 38.9 m-85 -133.12 149.79 52.09 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.625 -0.88 . . . . 1.0 108.625 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.537 ' OD1' ' CE2' ' A' ' 75' ' ' PHE . 64.4 m-20 -79.93 123.23 27.59 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.964 -1.085 . . . . 1.0 110.058 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -84.8 -9.72 57.89 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.297 -0.877 . . . . 1.0 109.621 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -84.73 -11.55 55.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.261 -0.899 . . . . 1.0 109.848 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.42 ' OE2' HD23 ' A' ' 82' ' ' LEU . 96.1 mt-10 -90.02 169.94 10.77 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.37 -0.831 . . . . 1.0 110.026 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 16.7 m -100.14 105.19 16.78 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.435 -0.79 . . . . 1.0 109.101 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -89.32 124.29 34.28 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.084 -0.71 . . . . 1.0 109.084 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.686 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.8 t -140.7 154.55 46.4 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.279 -0.888 . . . . 1.0 110.151 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 70.2 m -92.88 -8.01 44.59 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.427 -0.953 . . . . 1.0 108.427 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.4 m -92.63 176.78 6.32 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.9 m -79.72 76.64 6.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.998 -1.064 . . . . 1.0 109.428 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.686 ' HB2' HG21 ' A' ' 105' ' ' THR . 98.2 mttt -147.26 148.66 31.67 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.392 -0.817 . . . . 1.0 108.866 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 46.11 -139.39 6.66 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.747 -1.341 . . . . 1.0 109.747 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -99.7 114.41 27.5 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.251 -1.146 . . . . 1.0 109.21 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -63.69 133.76 54.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.137 -0.977 . . . . 1.0 109.538 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.3 tp -59.99 -44.76 94.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.506 -0.747 . . . . 1.0 110.825 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -59.97 -42.75 94.84 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.005 -1.06 . . . . 1.0 110.561 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -59.61 -50.01 75.54 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.878 -1.139 . . . . 1.0 109.363 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.7 t -69.07 -41.46 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.15 -0.969 . . . . 1.0 109.691 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.63 -50.16 74.85 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.369 -0.832 . . . . 1.0 110.274 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.44 -38.71 81.41 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.865 -1.147 . . . . 1.0 110.218 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.595 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 57.3 t60 -64.02 -50.01 70.17 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.093 -1.004 . . . . 1.0 111.031 -178.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.519 ' OE2' ' CZ ' ' A' ' 98' ' ' PHE . 7.4 pt-20 -59.99 -44.64 94.38 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.698 -1.251 . . . . 1.0 110.048 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -59.99 -40.03 87.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.785 -1.197 . . . . 1.0 108.895 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.29 -43.75 64.85 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.241 -1.543 . . . . 1.0 109.241 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.595 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 87.8 m-70 -66.29 -39.93 89.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.217 -1.166 . . . . 1.0 109.112 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 77.4 p -62.39 -21.41 65.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.898 . . . . 1.0 109.561 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.5 mt -83.0 -3.55 57.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 1.0 109.391 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 92.4 8.14 62.92 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.524 -1.03 . . . . 1.0 110.524 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.3 mt -86.58 146.34 26.39 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.95 -1.324 . . . . 1.0 109.208 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 27.7 t0 -99.47 175.29 5.9 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.476 -0.765 . . . . 1.0 109.576 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.512 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 75.2 m80 -61.15 135.66 57.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 1.0 109.72 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 41.5 t -97.37 156.7 16.34 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.21 -0.931 . . . . 1.0 109.358 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -97.33 0.39 47.9 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.155 -0.965 . . . . 1.0 109.632 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -83.7 130.23 56.46 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.171 -0.955 . . . . 1.0 108.476 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -70.58 -20.69 30.67 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 CA-C-N 120.022 1.044 . . . . 1.0 112.384 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -87.58 -5.05 79.2 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.823 -1.311 . . . . 1.0 109.823 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.73 145.72 26.55 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.173 -1.192 . . . . 1.0 109.267 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 138' ' ' PHE . 95.5 mt -70.67 -30.98 67.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.078 -1.014 . . . . 1.0 109.477 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 98.2 mmm -70.23 14.14 0.13 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.364 -0.835 . . . . 1.0 109.766 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.468 ' H ' ' C ' ' A' ' 136' ' ' LEU . 13.5 t80 -68.89 134.03 90.07 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.071 -1.018 . . . . 1.0 108.297 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -62.67 -18.36 63.6 Favored 'Trans proline' 0 N--CA 1.501 1.957 0 C-N-CA 121.04 1.16 . . . . 1.0 113.985 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.8 mt -102.79 141.43 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 120.834 -1.166 . . . . 1.0 109.691 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -75.58 126.01 30.16 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.331 -0.856 . . . . 1.0 110.221 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 11.0 t -134.73 137.46 43.5 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.426 -0.796 . . . . 1.0 109.268 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -80.1 143.56 33.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.966 -1.084 . . . . 1.0 108.6 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.9 t -139.83 151.73 45.94 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.313 -0.867 . . . . 1.0 109.615 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.55 104.75 1.51 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.374 -1.49 . . . . 1.0 109.374 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -77.9 1.72 19.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.26 -1.141 . . . . 1.0 109.95 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 73.3 m -60.05 -40.1 88.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.193 -0.942 . . . . 1.0 109.652 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -143.41 29.45 1.43 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.246 -0.909 . . . . 1.0 109.468 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -69.7 138.87 53.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.173 -0.955 . . . . 1.0 110.11 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 93.9 mtp -138.79 146.67 41.62 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.544 -0.91 . . . . 1.0 108.544 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 58.1 mt -51.74 129.03 36.29 Favored Pre-proline 0 C--N 1.302 -1.483 0 O-C-N 121.111 -0.993 . . . . 1.0 108.728 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -69.2 178.56 4.11 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 CA-C-N 119.985 1.03 . . . . 1.0 112.266 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -63.11 -39.89 96.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.476 -0.765 . . . . 1.0 110.12 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -55.64 -48.56 74.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.337 -0.852 . . . . 1.0 109.764 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -69.93 -40.03 75.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.97 . . . . 1.0 109.847 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.04 -48.13 89.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.075 -1.016 . . . . 1.0 108.995 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -60.11 -40.02 88.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.191 -0.943 . . . . 1.0 110.261 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.43 -55.0 7.11 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 120.199 -1.001 . . . . 1.0 111.477 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.49 HG23 ' N ' ' A' ' 160' ' ' GLN . 5.3 tp -60.0 -40.14 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.967 -1.313 . . . . 1.0 109.732 -178.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.55 ' O ' ' N ' ' A' ' 164' ' ' GLY . 12.4 mm100 -64.43 -39.34 93.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.209 -0.932 . . . . 1.0 109.316 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 79.9 p -60.95 -34.13 74.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.139 -0.976 . . . . 1.0 110.484 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.2 mt -84.43 -52.79 5.9 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.877 -1.139 . . . . 1.0 110.671 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -90.67 -8.01 51.1 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.046 -1.034 . . . . 1.0 110.541 -178.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.536 0 N-CA-C 109.288 -1.525 . . . . 1.0 109.288 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.3 mt . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.328 -0.619 . . . . 1.0 109.328 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -160.34 159.97 31.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.24 -0.913 . . . . 1.0 109.384 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -76.37 127.24 32.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.148 -0.97 . . . . 1.0 109.259 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.4 p -69.24 -38.48 78.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.038 -1.039 . . . . 1.0 108.933 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.404 ' H ' ' HG2' ' A' ' 12' ' ' LYS . 49.1 pttt -89.47 136.43 33.03 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.932 -1.136 . . . . 1.0 107.932 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.611 ' N ' ' SD ' ' A' ' 13' ' ' MET . 4.8 mmm -90.7 -0.27 57.64 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.065 -1.022 . . . . 1.0 109.872 -178.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -97.98 132.72 43.3 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.997 -1.112 . . . . 1.0 107.997 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.6 mt -139.57 149.92 44.43 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.202 -0.936 . . . . 1.0 109.376 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.7 p -135.67 156.43 48.85 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.661 -0.866 . . . . 1.0 108.661 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -145.86 160.04 42.35 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.137 -0.977 . . . . 1.0 109.958 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.435 ' HE ' ' HA ' ' A' ' 55' ' ' ASP . 37.0 ttt-85 -144.31 134.94 24.84 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.49 -0.756 . . . . 1.0 109.272 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.8 mt -87.54 119.68 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.244 -0.91 . . . . 1.0 108.748 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.5 t -69.17 -39.93 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.239 -0.913 . . . . 1.0 109.345 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -165.01 153.08 11.67 Favored 'General case' 0 C--N 1.29 -1.991 0 O-C-N 120.163 -1.586 . . . . 1.0 110.802 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -100.81 106.52 17.92 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 105.87 -1.9 . . . . 1.0 105.87 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.459 ' C ' ' H ' ' A' ' 25' ' ' ASP . 0.4 OUTLIER -45.45 140.04 4.32 Favored Pre-proline 0 C--N 1.299 -1.612 0 O-C-N 121.487 -0.758 . . . . 1.0 109.591 -177.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -59.22 -3.05 1.51 Allowed 'Trans proline' 0 N--CA 1.487 1.111 0 CA-C-N 119.358 0.807 . . . . 1.0 110.75 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.459 ' H ' ' C ' ' A' ' 23' ' ' THR . 94.3 m-20 -59.73 -36.04 75.79 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.585 -0.524 . . . . 1.0 109.585 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 78.0 mtm -140.0 166.75 23.8 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.219 -0.925 . . . . 1.0 109.801 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.6 p -71.63 160.15 33.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.417 -0.802 . . . . 1.0 109.335 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -60.09 -40.93 91.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.307 -0.871 . . . . 1.0 110.32 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.5 m -60.03 -40.34 88.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.935 -1.103 . . . . 1.0 110.875 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.01 -42.96 89.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.109 -0.994 . . . . 1.0 110.767 -178.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.7 t -65.37 -39.87 86.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 121.248 -0.907 . . . . 1.0 109.598 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -58.1 -54.97 41.0 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.371 -0.831 . . . . 1.0 111.708 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.9 pttt -63.47 -33.68 76.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.607 -1.308 . . . . 1.0 110.723 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.37 -50.78 70.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.637 -1.289 . . . . 1.0 109.666 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.45 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 47.3 m-85 -67.69 -38.81 84.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.842 -1.161 . . . . 1.0 110.401 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -59.89 -40.69 89.58 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.724 -1.235 . . . . 1.0 109.438 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -60.72 -39.94 90.48 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.158 -0.964 . . . . 1.0 108.988 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.09 -47.12 87.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.432 -0.792 . . . . 1.0 109.834 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -65.21 -38.9 91.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.081 -1.012 . . . . 1.0 109.656 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 44.0 tptt -59.95 -47.83 84.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.079 -1.013 . . . . 1.0 109.893 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.5 t -60.07 -40.77 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.28 -0.887 . . . . 1.0 110.79 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -82.32 -35.38 27.96 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.86 -1.15 . . . . 1.0 110.483 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.6 p -70.03 -17.3 63.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.13 -0.981 . . . . 1.0 109.606 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -59.82 -39.98 86.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.261 -0.9 . . . . 1.0 110.868 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.4 m -110.85 -19.46 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 O-C-N 121.147 -0.971 . . . . 1.0 110.487 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.3 p -94.46 129.79 35.66 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 120.843 -1.161 . . . . 1.0 109.709 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -73.01 10.18 1.18 Allowed 'Trans proline' 0 N--CA 1.494 1.553 0 CA-C-N 119.831 0.975 . . . . 1.0 111.953 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.7 mt -67.95 140.61 56.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.215 -0.928 . . . . 1.0 109.822 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -104.47 121.97 44.55 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.933 -0.765 . . . . 1.0 108.933 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -107.69 122.42 46.69 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.293 -0.879 . . . . 1.0 109.699 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.0 m -119.88 129.98 54.64 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.483 -0.76 . . . . 1.0 109.615 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.475 ' CB ' ' NH1' ' A' ' 52' ' ' ARG . 11.1 ttp-105 -85.03 133.66 34.24 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.288 -0.883 . . . . 1.0 109.725 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 86.2 mt -102.52 126.72 49.67 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.269 -0.894 . . . . 1.0 109.353 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.425 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 54.8 m170 -61.41 -39.87 92.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.447 -0.783 . . . . 1.0 109.874 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.435 ' HA ' ' HE ' ' A' ' 18' ' ' ARG . 80.8 m-20 -146.19 171.4 14.99 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.225 -0.922 . . . . 1.0 109.563 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.24 179.87 38.12 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.758 -1.337 . . . . 1.0 109.758 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.5 mt -95.56 136.39 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.313 -1.11 . . . . 1.0 109.262 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.72 163.58 14.39 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.483 -0.761 . . . . 1.0 109.244 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -59.99 -49.77 76.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -0.895 . . . . 1.0 109.472 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.9 mt -108.48 104.17 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.488 -0.757 . . . . 1.0 109.753 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.8 ptp -100.83 135.06 42.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.218 -0.926 . . . . 1.0 109.181 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.45 HG21 ' CZ ' ' A' ' 35' ' ' PHE . 85.5 mt -109.99 131.09 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.624 -0.673 . . . . 1.0 109.711 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.3 p -150.55 156.59 41.7 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.205 -0.935 . . . . 1.0 109.898 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -102.37 120.02 39.79 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.207 -1.035 . . . . 1.0 108.207 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.0 -169.48 23.25 Favored Glycine 0 N--CA 1.499 2.878 0 N-CA-C 110.629 -0.988 . . . . 1.0 110.629 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 93.2 mt . . . . . 0 N--CA 1.495 1.784 0 N-CA-C 108.139 -1.06 . . . . 1.0 108.139 179.613 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.585 ' CD1' ' OD1' ' A' ' 99' ' ' ASP . 90.6 m-85 . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -101.27 0.03 36.58 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.31 -0.869 . . . . 1.0 110.848 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 134.18 -150.27 19.97 Favored Glycine 0 N--CA 1.504 3.18 0 N-CA-C 108.767 -1.733 . . . . 1.0 108.767 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.424 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 2.8 Cg_exo -64.07 -64.1 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.339 0 CA-C-N 119.013 1.406 . . . . 1.0 111.473 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 94.3 p -77.83 160.85 28.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.118 -0.989 . . . . 1.0 109.331 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.98 -129.83 8.71 Favored Glycine 0 N--CA 1.501 3.007 0 N-CA-C 109.101 -1.6 . . . . 1.0 109.101 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.413 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 10.1 mt -69.41 107.5 3.35 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.132 -1.216 . . . . 1.0 108.735 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 55.6 mt -75.16 -25.77 58.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.942 -1.098 . . . . 1.0 109.31 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.92 172.94 1.25 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -164.61 160.01 19.65 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.999 -1.063 . . . . 1.0 109.648 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -142.86 153.77 43.49 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.412 -0.805 . . . . 1.0 108.867 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -89.18 151.92 47.31 Favored Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.047 -1.033 . . . . 1.0 108.683 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -58.64 165.37 8.01 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 120.951 1.101 . . . . 1.0 111.788 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo . . . . . 0 C--N 1.316 -1.175 0 C-N-CA 121.215 1.277 . . . . 1.0 112.384 179.758 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.204 0.526 . . . . 1.0 109.589 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.0 124.1 11.43 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.266 -0.896 . . . . 1.0 109.4 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -112.99 133.81 54.78 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.549 -0.72 . . . . 1.0 110.098 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.499 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 25.5 m-85 -116.15 149.41 39.08 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 109.005 -0.739 . . . . 1.0 109.005 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.585 ' OD1' ' CD1' ' A' ' 75' ' ' PHE . 82.0 m-20 -77.75 123.67 26.99 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.878 -1.138 . . . . 1.0 109.845 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 42.0 t0 -84.29 -11.56 56.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.447 -0.783 . . . . 1.0 109.184 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -82.19 -11.69 58.56 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.35 -0.844 . . . . 1.0 108.951 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.424 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 97.5 mt-10 -90.53 168.54 11.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.466 -0.771 . . . . 1.0 109.3 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 19.5 m -100.34 105.24 16.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.326 -0.859 . . . . 1.0 108.723 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.462 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 94.5 m95 -87.33 120.58 28.77 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.481 -0.762 . . . . 1.0 109.103 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.662 HG21 ' HB2' ' A' ' 109' ' ' LYS . 7.3 t -139.95 150.02 44.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.461 -0.774 . . . . 1.0 109.779 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 52.7 m -92.85 -6.14 49.43 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.214 -0.929 . . . . 1.0 108.534 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.6 t -92.03 175.69 6.78 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.871 -0.789 . . . . 1.0 108.871 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.1 t -75.59 75.29 2.61 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.028 -1.045 . . . . 1.0 109.222 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.662 ' HB2' HG21 ' A' ' 105' ' ' THR . 98.6 mttt -149.4 149.75 31.33 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.574 -0.898 . . . . 1.0 108.574 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 109' ' ' LYS . . . 42.98 -139.17 2.9 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 110.033 -1.227 . . . . 1.0 110.033 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -100.19 118.85 37.37 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.348 -1.089 . . . . 1.0 109.265 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -63.31 129.39 40.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.359 -0.838 . . . . 1.0 109.877 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.5 tp -60.01 -43.27 95.36 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.49 -0.756 . . . . 1.0 110.552 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -59.99 -41.63 92.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.214 -0.929 . . . . 1.0 111.177 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.61 -49.62 76.81 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.769 -1.207 . . . . 1.0 109.226 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 67.7 t -69.94 -41.32 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.301 -0.874 . . . . 1.0 110.712 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.34 -53.25 60.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.998 -1.064 . . . . 1.0 109.778 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.97 -34.43 73.27 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.186 -0.946 . . . . 1.0 109.785 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.633 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 60.0 t60 -63.12 -50.73 69.33 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.228 -0.92 . . . . 1.0 110.783 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.499 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 6.9 pt-20 -60.0 -39.42 85.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.792 -1.192 . . . . 1.0 110.111 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -59.94 -40.01 87.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.904 -1.123 . . . . 1.0 108.798 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.67 -41.92 94.0 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.332 -1.507 . . . . 1.0 109.332 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.633 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 83.9 m-70 -67.32 -39.96 85.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.139 -1.212 . . . . 1.0 109.577 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 95.4 p -68.97 -21.93 64.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.397 -0.814 . . . . 1.0 109.513 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 49.7 mt -82.99 -0.96 51.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 1.0 109.902 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 92.5 6.43 64.25 Favored Glycine 0 N--CA 1.498 2.77 0 C-N-CA 120.221 -0.99 . . . . 1.0 110.852 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.3 mt -85.1 144.86 27.95 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.745 -1.444 . . . . 1.0 109.916 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 44.6 t0 -99.01 172.43 7.41 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.167 -1.049 . . . . 1.0 108.167 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.528 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 74.6 m80 -61.76 132.17 52.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.757 -1.214 . . . . 1.0 109.281 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.7 t -97.35 158.39 15.49 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.253 -0.905 . . . . 1.0 109.135 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -99.92 8.45 44.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.322 -0.861 . . . . 1.0 109.279 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -85.14 125.35 70.46 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.188 -0.945 . . . . 1.0 108.895 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -66.91 -20.94 50.93 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 CA-C-N 120.195 1.105 . . . . 1.0 112.541 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -87.3 -7.14 77.06 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.078 -1.209 . . . . 1.0 110.078 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.87 139.58 31.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.117 -1.225 . . . . 1.0 109.458 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.453 ' C ' ' H ' ' A' ' 138' ' ' PHE . 91.6 mt -62.18 -40.05 94.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.142 -0.974 . . . . 1.0 109.88 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 85.8 mtp -70.5 24.72 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.245 -0.909 . . . . 1.0 111.04 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.453 ' H ' ' C ' ' A' ' 136' ' ' LEU . 23.5 t80 -69.94 129.99 90.41 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 120.766 -1.209 . . . . 1.0 108.331 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -49.55 -19.8 3.6 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 120.954 1.103 . . . . 1.0 114.505 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 90.6 mt -107.78 137.39 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 O-C-N 120.879 -1.138 . . . . 1.0 110.37 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -74.13 128.27 35.1 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.554 -0.716 . . . . 1.0 109.519 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.9 t -139.55 143.4 37.36 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.915 -0.772 . . . . 1.0 108.915 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -81.53 142.85 32.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.108 -0.995 . . . . 1.0 108.885 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.2 t -139.7 150.96 45.49 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.172 -0.955 . . . . 1.0 110.151 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.64 105.13 1.66 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.218 -1.553 . . . . 1.0 109.218 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 21.8 mtmm -75.74 1.9 13.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.379 -1.071 . . . . 1.0 109.834 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 67.9 m -59.92 -40.02 87.44 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.171 -0.955 . . . . 1.0 109.712 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -144.18 27.7 1.41 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.096 -1.003 . . . . 1.0 110.1 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -68.78 137.4 53.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.919 -1.113 . . . . 1.0 109.768 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 67.1 mtt -138.86 147.94 43.06 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.38 -0.825 . . . . 1.0 108.955 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 74.2 mt -51.57 124.84 26.55 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.0 -1.062 . . . . 1.0 108.631 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -67.81 -179.42 2.06 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 CA-C-N 120.102 1.072 . . . . 1.0 112.329 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -61.77 -39.58 92.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.333 -0.854 . . . . 1.0 109.868 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -56.98 -49.55 75.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -0.945 . . . . 1.0 110.01 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -70.09 -39.97 75.23 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.99 -1.069 . . . . 1.0 110.31 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 76.4 t -60.84 -48.36 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.958 -1.089 . . . . 1.0 108.927 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -60.36 -39.98 89.13 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.16 -0.962 . . . . 1.0 110.856 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.77 -53.79 7.91 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 120.06 -1.067 . . . . 1.0 111.121 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.461 HG23 ' N ' ' A' ' 160' ' ' GLN . 9.4 tp -60.56 -40.53 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.016 -1.284 . . . . 1.0 109.837 -178.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.527 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.9 mt-30 -65.81 -38.69 89.63 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.136 -0.977 . . . . 1.0 109.54 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 83.9 p -65.72 -24.98 67.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.119 -0.988 . . . . 1.0 110.666 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 87.8 mt -87.34 -50.72 6.38 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.747 -1.22 . . . . 1.0 110.0 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -93.01 -9.11 41.01 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.04 -1.038 . . . . 1.0 110.048 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.607 0 N-CA-C 109.548 -1.421 . . . . 1.0 109.548 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.6 mt . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 109.173 -0.677 . . . . 1.0 109.173 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -161.24 163.37 31.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.065 -1.022 . . . . 1.0 109.647 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -71.16 146.2 49.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.881 . . . . 1.0 109.543 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 87.8 p -90.06 3.44 53.27 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.4 -0.812 . . . . 1.0 110.148 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -144.7 154.01 42.31 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.065 -1.022 . . . . 1.0 109.51 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.5 mmt -90.46 -0.04 57.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.229 -0.919 . . . . 1.0 109.748 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -96.65 125.49 41.16 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.126 -0.983 . . . . 1.0 109.182 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.0 mt -140.01 152.34 46.19 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.293 -0.88 . . . . 1.0 109.187 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.5 p -133.61 154.29 51.0 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.494 -0.754 . . . . 1.0 109.312 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -145.1 160.0 42.09 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.186 -0.946 . . . . 1.0 109.811 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 44.9 ttt-85 -144.61 131.5 20.27 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.427 -0.796 . . . . 1.0 109.503 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 86.0 mt -86.94 119.98 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.278 -0.889 . . . . 1.0 108.818 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.6 t -69.47 -41.53 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.089 -1.007 . . . . 1.0 109.282 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -165.09 155.02 13.31 Favored 'General case' 0 C--N 1.289 -2.06 0 O-C-N 119.967 -1.708 . . . . 1.0 110.412 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.411 ' O ' ' C ' ' A' ' 23' ' ' THR . 23.9 m-85 -99.4 95.94 7.37 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 105.907 -1.886 . . . . 1.0 105.907 178.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.411 ' C ' ' O ' ' A' ' 22' ' ' TYR . 1.5 t -39.86 142.53 0.66 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.963 -0.461 . . . . 1.0 110.619 -177.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -59.68 -21.48 63.11 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 120.436 0.757 . . . . 1.0 110.994 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -58.4 -14.86 8.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.73 -0.606 . . . . 1.0 109.865 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 78.0 mtp -142.7 150.78 40.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.291 -0.881 . . . . 1.0 109.816 -178.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.1 p -75.52 160.05 30.61 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.476 -0.935 . . . . 1.0 108.476 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.402 ' CD2' ' HB2' ' A' ' 22' ' ' TYR . 27.9 m170 -60.64 -40.1 90.72 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.12 -0.988 . . . . 1.0 109.948 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.9 m -64.82 -42.35 95.04 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.065 -1.022 . . . . 1.0 110.922 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -66.4 -40.11 89.42 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.153 -0.967 . . . . 1.0 111.321 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.4 t -67.91 -42.07 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.969 -1.082 . . . . 1.0 110.535 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -59.94 -49.49 77.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.127 -0.983 . . . . 1.0 110.715 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -64.15 -32.66 74.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.823 -1.173 . . . . 1.0 110.377 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.35 -50.62 73.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.794 -1.191 . . . . 1.0 110.01 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -69.35 -37.51 77.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.043 -1.036 . . . . 1.0 110.218 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -59.95 -42.72 94.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.981 -1.074 . . . . 1.0 109.484 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -61.78 -40.18 94.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.091 -1.006 . . . . 1.0 108.849 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.82 -50.83 71.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.444 -0.785 . . . . 1.0 110.135 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -63.26 -39.95 96.03 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.952 -1.092 . . . . 1.0 109.947 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -60.05 -48.65 80.84 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.062 -1.024 . . . . 1.0 109.841 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 72.0 t -60.03 -41.84 87.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.34 -0.85 . . . . 1.0 110.435 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -78.43 -34.81 47.63 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.958 -1.089 . . . . 1.0 110.23 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 52.4 p -72.33 -20.0 61.55 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.95 -1.094 . . . . 1.0 109.814 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -60.07 -40.02 88.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.496 -0.752 . . . . 1.0 111.417 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.5 m -111.87 22.48 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.241 -0.912 . . . . 1.0 111.131 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 48' ' ' LEU . 18.8 p -146.57 139.45 14.32 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 120.872 -1.142 . . . . 1.0 109.274 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -72.93 17.55 0.39 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 120.675 0.917 . . . . 1.0 111.178 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.411 ' H ' ' C ' ' A' ' 46' ' ' THR . 90.4 mt -67.65 134.12 50.58 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.361 -0.837 . . . . 1.0 110.374 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -108.78 120.53 42.77 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.531 -0.914 . . . . 1.0 108.531 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -108.4 130.34 55.23 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.309 -0.869 . . . . 1.0 109.418 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.5 m -120.03 130.01 54.51 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.571 -0.705 . . . . 1.0 110.147 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -82.83 129.54 35.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.397 -0.814 . . . . 1.0 109.277 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 89.4 mt -108.89 118.62 37.28 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 108.74 -0.837 . . . . 1.0 108.74 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.445 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 72.2 m-70 -70.18 -24.08 63.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.22 -0.925 . . . . 1.0 110.063 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 77.8 m-20 -148.33 162.88 38.63 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.216 -0.928 . . . . 1.0 109.876 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.21 174.9 39.14 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.746 -1.342 . . . . 1.0 109.746 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 87.5 mt -94.25 134.1 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.331 -1.1 . . . . 1.0 109.019 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.98 160.94 15.98 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.446 -0.784 . . . . 1.0 109.122 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.04 -49.34 78.06 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.178 -0.951 . . . . 1.0 109.113 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.9 mt -105.02 99.06 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.427 -0.796 . . . . 1.0 109.818 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.3 ptm -99.28 133.89 42.91 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.115 -0.99 . . . . 1.0 109.084 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.5 mt -106.09 137.4 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.536 -0.728 . . . . 1.0 109.749 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 81.8 p -153.13 155.82 37.46 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.129 -0.982 . . . . 1.0 109.565 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -104.88 123.96 48.63 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.573 -0.704 . . . . 1.0 109.127 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -103.82 -169.9 25.36 Favored Glycine 0 N--CA 1.5 2.949 0 N-CA-C 110.48 -1.048 . . . . 1.0 110.48 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 70.9 mt . . . . . 0 N--CA 1.498 1.934 0 O-C-N 121.57 -0.959 . . . . 1.0 109.037 -179.973 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.549 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 96.7 m-85 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 108.622 -0.881 . . . . 1.0 108.622 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 79' ' ' SER . 22.8 p-10 -96.75 -0.27 48.41 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.992 -1.067 . . . . 1.0 110.829 -178.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.459 ' O ' ' OE2' ' A' ' 102' ' ' GLU . . . 117.44 -120.03 4.64 Favored Glycine 0 N--CA 1.506 3.325 0 N-CA-C 110.338 -1.105 . . . . 1.0 110.338 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.461 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 28.1 Cg_endo -74.29 -73.19 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.803 0 CA-C-N 120.26 2.03 . . . . 1.0 113.04 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.457 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 82.2 p -78.28 -178.9 5.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.925 -1.109 . . . . 1.0 109.806 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.34 -135.43 12.16 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.305 -1.118 . . . . 1.0 110.305 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.7 mt -71.17 111.11 6.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.552 -0.97 . . . . 1.0 110.033 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 55.2 mt -83.63 -17.3 42.02 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.128 -0.982 . . . . 1.0 108.927 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.86 176.0 0.97 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.023 -0.732 . . . . 1.0 109.023 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -161.84 163.37 29.37 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.103 -0.998 . . . . 1.0 109.444 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.34 170.01 19.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.289 -0.882 . . . . 1.0 109.404 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -107.2 154.06 40.71 Favored Pre-proline 0 N--CA 1.498 1.972 0 N-CA-C 108.849 -0.797 . . . . 1.0 108.849 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -60.3 165.6 10.68 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 120.588 0.859 . . . . 1.0 111.558 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo . . . . . 0 N--CA 1.491 1.354 0 C-N-CA 121.149 1.233 . . . . 1.0 112.108 -179.654 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 40.4 p-10 . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 121.387 0.613 . . . . 1.0 109.835 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.24 129.93 15.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.258 -0.901 . . . . 1.0 109.641 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 58.5 m170 -124.9 147.07 49.02 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.614 -0.679 . . . . 1.0 109.252 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -129.72 151.95 49.76 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.528 -0.732 . . . . 1.0 109.469 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.549 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 96.4 m-20 -79.6 120.55 24.09 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.045 -1.035 . . . . 1.0 109.104 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 43.0 t0 -83.54 -4.97 59.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.235 -0.916 . . . . 1.0 109.04 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -82.01 -10.81 59.12 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.412 -0.805 . . . . 1.0 109.075 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.461 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 49.2 mm-40 -90.68 179.1 5.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.385 -0.822 . . . . 1.0 108.991 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 39.0 m -104.93 104.55 14.32 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.445 -0.946 . . . . 1.0 108.445 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.419 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 88.6 m95 -87.95 120.0 28.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.929 . . . . 1.0 109.08 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.678 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.3 t -140.97 151.2 43.97 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.525 -0.734 . . . . 1.0 109.708 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 61.2 m -92.71 -5.64 50.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.104 -0.998 . . . . 1.0 108.546 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 34.0 t -92.93 174.78 7.06 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.6 -0.889 . . . . 1.0 108.6 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.515 ' OG ' ' CZ ' ' A' ' 143' ' ' TYR . 10.6 m -75.85 75.29 2.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.881 -1.137 . . . . 1.0 109.526 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.678 ' HB2' HG21 ' A' ' 105' ' ' THR . 61.3 mttp -147.5 148.84 31.63 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.58 -0.896 . . . . 1.0 108.58 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 109' ' ' LYS . . . 44.53 -139.18 4.65 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.644 -1.382 . . . . 1.0 109.644 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -98.91 118.97 36.88 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.284 -1.127 . . . . 1.0 109.025 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -64.65 130.24 42.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.459 -0.775 . . . . 1.0 110.044 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.3 tp -59.93 -40.45 88.98 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.256 -0.902 . . . . 1.0 110.056 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -59.92 -40.65 89.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 1.0 110.328 -178.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.486 HD21 ' CE ' ' A' ' 146' ' ' LYS . 3.3 mm? -60.04 -55.4 34.39 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.819 -1.176 . . . . 1.0 109.625 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.0 t -67.44 -42.49 87.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.278 -0.889 . . . . 1.0 109.318 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.94 -52.69 64.32 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.173 -0.954 . . . . 1.0 109.101 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.36 82.38 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.816 -1.177 . . . . 1.0 109.801 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.635 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 73.0 t60 -64.01 -49.85 70.82 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.452 -0.78 . . . . 1.0 111.644 -178.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -59.95 -39.5 85.82 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.602 -1.311 . . . . 1.0 109.664 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -59.81 -40.07 87.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.893 -1.129 . . . . 1.0 108.237 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.38 -43.9 84.88 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.808 -1.717 . . . . 1.0 108.808 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.635 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 87.0 m-70 -67.42 -40.05 85.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.224 -1.162 . . . . 1.0 109.546 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 84.2 p -64.71 -24.03 67.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.206 -0.934 . . . . 1.0 109.731 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 84.5 mt -81.15 0.87 34.42 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.182 -0.949 . . . . 1.0 110.005 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 89.76 4.17 73.09 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 120.056 -1.068 . . . . 1.0 110.738 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.8 mt -84.47 149.74 25.75 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.865 -1.374 . . . . 1.0 109.592 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 37.2 t0 -99.78 174.52 6.18 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.615 -0.883 . . . . 1.0 108.615 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.501 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 74.5 m80 -59.33 139.48 56.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.99 -1.069 . . . . 1.0 109.395 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 38.2 t -98.42 152.73 19.19 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.297 -0.877 . . . . 1.0 109.248 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -99.99 5.49 45.14 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.225 -0.922 . . . . 1.0 109.37 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -88.39 126.82 59.09 Favored Pre-proline 0 N--CA 1.493 1.714 0 N-CA-C 108.179 -1.045 . . . . 1.0 108.179 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -67.56 -15.02 44.06 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 CA-C-N 120.273 1.133 . . . . 1.0 111.94 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -90.72 -5.55 68.63 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.357 -1.497 . . . . 1.0 109.357 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.42 142.51 27.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -1.174 . . . . 1.0 108.901 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.497 ' C ' ' H ' ' A' ' 138' ' ' PHE . 74.5 mt -68.5 -36.9 79.55 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.08 -1.013 . . . . 1.0 109.902 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 76.2 mtp -69.92 20.88 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.133 -0.979 . . . . 1.0 110.405 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.497 ' H ' ' C ' ' A' ' 136' ' ' LEU . 14.6 t80 -66.26 135.5 94.95 Favored Pre-proline 0 N--CA 1.493 1.699 0 N-CA-C 107.853 -1.165 . . . . 1.0 107.853 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -62.92 -10.46 20.38 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 120.826 1.018 . . . . 1.0 114.052 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 91.5 mt -111.81 138.28 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.39 0 O-C-N 120.875 -1.14 . . . . 1.0 110.012 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -74.95 125.1 28.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.505 -0.747 . . . . 1.0 110.484 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 10.2 t -138.98 140.14 38.13 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.441 -0.787 . . . . 1.0 109.043 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.515 ' CZ ' ' OG ' ' A' ' 108' ' ' SER . 89.3 t80 -81.79 141.96 33.02 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.889 -1.132 . . . . 1.0 109.949 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.5 m -130.28 138.33 50.43 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.039 -0.726 . . . . 1.0 109.039 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -66.4 101.38 0.62 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.62 -1.792 . . . . 1.0 108.62 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.486 ' CE ' HD21 ' A' ' 115' ' ' LEU . 58.1 mmtt -75.96 129.33 36.74 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.288 -1.125 . . . . 1.0 109.302 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.5 t -179.78 -51.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.592 -0.892 . . . . 1.0 108.592 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -135.99 19.85 3.24 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.557 -0.905 . . . . 1.0 108.557 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -65.17 139.41 58.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.406 -0.808 . . . . 1.0 110.602 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 96.5 mtp -137.62 149.91 47.0 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.324 -0.991 . . . . 1.0 108.324 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.5 mt -51.83 131.44 38.32 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 120.902 -1.124 . . . . 1.0 109.03 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -71.41 177.96 6.12 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 CA-C-N 119.919 1.007 . . . . 1.0 112.083 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -62.12 -39.97 94.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.418 -0.801 . . . . 1.0 110.285 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -55.06 -48.68 73.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.035 -1.041 . . . . 1.0 109.778 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -69.96 -40.0 75.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.119 -0.988 . . . . 1.0 110.186 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.427 HG12 ' NE2' ' A' ' 160' ' ' GLN . 53.5 t -60.45 -47.78 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.968 -1.083 . . . . 1.0 109.302 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -60.61 -40.02 90.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.05 -1.031 . . . . 1.0 110.076 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.17 -52.39 11.25 Favored Glycine 0 N--CA 1.495 2.631 0 O-C-N 121.246 -0.909 . . . . 1.0 111.874 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.47 HG23 ' N ' ' A' ' 160' ' ' GLN . 8.4 tp -59.94 -39.97 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.744 -1.445 . . . . 1.0 109.917 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.547 ' O ' ' N ' ' A' ' 164' ' ' GLY . 32.3 mt-30 -68.36 -35.21 77.38 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.059 -1.026 . . . . 1.0 109.425 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 77.2 p -60.23 -35.06 74.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.131 -0.981 . . . . 1.0 110.344 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 94.5 mt -86.13 -49.61 7.63 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.958 -1.089 . . . . 1.0 110.671 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -90.04 -9.12 49.74 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.137 -0.977 . . . . 1.0 110.328 -178.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.513 0 N-CA-C 109.411 -1.476 . . . . 1.0 109.411 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.8 mt . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.322 0.582 . . . . 1.0 109.439 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -160.09 160.3 32.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.383 -0.823 . . . . 1.0 109.36 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -71.75 148.94 45.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.211 -0.93 . . . . 1.0 109.573 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 90.7 p -90.03 2.26 55.38 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.42 -0.8 . . . . 1.0 109.798 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.516 ' NZ ' ' O ' ' A' ' 14' ' ' ASN . 20.0 pttp -141.74 153.12 44.4 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.179 -0.95 . . . . 1.0 109.501 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.8 mmt -90.11 -0.04 57.4 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.323 -0.861 . . . . 1.0 109.814 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.516 ' O ' ' NZ ' ' A' ' 12' ' ' LYS . 28.1 m120 -96.97 129.25 44.45 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.197 -0.939 . . . . 1.0 109.286 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.7 mt -141.13 152.0 44.36 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.233 -0.917 . . . . 1.0 109.104 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 63.1 p -133.88 152.81 51.99 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.422 -0.799 . . . . 1.0 109.285 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -145.85 157.46 43.91 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.094 -1.004 . . . . 1.0 109.864 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.412 ' HE ' ' HA ' ' A' ' 55' ' ' ASP . 38.0 ttt-85 -144.54 135.26 24.81 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.376 -0.827 . . . . 1.0 109.356 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 86.3 mt -87.67 119.71 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.274 -0.891 . . . . 1.0 108.793 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 63.4 t -69.12 -40.22 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.315 -0.865 . . . . 1.0 109.409 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -162.86 156.63 20.32 Favored 'General case' 0 C--N 1.287 -2.146 0 O-C-N 119.38 -2.075 . . . . 1.0 111.369 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.438 ' CB ' ' CD2' ' A' ' 28' ' ' HIS . 64.4 m-85 -100.72 109.03 21.02 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 106.248 -1.76 . . . . 1.0 106.248 178.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.423 ' H ' HG22 ' A' ' 23' ' ' THR . 1.1 t -54.62 139.13 60.4 Favored Pre-proline 0 C--N 1.294 -1.842 0 O-C-N 121.38 -0.825 . . . . 1.0 109.309 -178.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -57.8 -6.94 2.84 Favored 'Trans proline' 0 N--CA 1.486 1.085 0 CA-C-N 119.443 0.837 . . . . 1.0 111.145 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -60.07 -39.58 86.54 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 119.78 -0.768 . . . . 1.0 110.013 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.5 mtm -137.27 159.58 41.52 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.265 -0.897 . . . . 1.0 109.086 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.488 ' OG1' ' OE1' ' A' ' 30' ' ' GLU . 36.3 p -75.3 167.88 21.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.166 -0.959 . . . . 1.0 109.714 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.438 ' CD2' ' CB ' ' A' ' 22' ' ' TYR . 29.6 m170 -60.05 -40.43 89.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.434 -0.791 . . . . 1.0 111.057 -178.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.3 m -60.1 -46.09 90.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.886 -1.134 . . . . 1.0 110.733 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.576 ' OE1' ' N ' ' A' ' 30' ' ' GLU . 8.9 mp0 -66.75 -41.51 87.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.222 -0.924 . . . . 1.0 110.259 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 72.2 t -67.49 -44.77 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.995 -1.066 . . . . 1.0 110.134 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -60.0 -49.67 76.74 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.236 -0.915 . . . . 1.0 111.178 -178.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -60.94 -33.81 73.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.692 -1.255 . . . . 1.0 109.852 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.03 -50.93 71.79 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.916 -1.115 . . . . 1.0 110.398 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -65.58 -38.43 89.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.925 -1.11 . . . . 1.0 110.387 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.01 -42.17 93.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.898 -1.127 . . . . 1.0 109.543 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.14 -40.06 88.53 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.219 -0.926 . . . . 1.0 109.291 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.94 -46.45 89.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 1.0 110.075 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -66.84 -38.13 85.81 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.091 -1.006 . . . . 1.0 109.791 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -59.68 -48.26 82.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.13 -0.981 . . . . 1.0 109.577 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.1 t -60.01 -43.08 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.136 -0.977 . . . . 1.0 110.122 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -78.14 -35.69 48.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.99 -1.069 . . . . 1.0 110.18 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.0 p -70.38 -22.43 62.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.096 -1.003 . . . . 1.0 109.741 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.03 -40.01 87.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.31 -0.869 . . . . 1.0 110.8 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.439 HG23 HG23 ' A' ' 46' ' ' THR . 17.2 m -111.96 25.37 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.335 -0.853 . . . . 1.0 110.621 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.439 HG23 HG23 ' A' ' 45' ' ' VAL . 58.5 p -150.01 130.09 6.75 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.144 -0.973 . . . . 1.0 109.083 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -73.54 19.63 0.38 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 CA-C-N 119.974 1.026 . . . . 1.0 112.047 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.6 mt -69.41 138.74 53.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.177 -0.952 . . . . 1.0 109.616 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -107.28 120.8 43.13 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.798 -0.816 . . . . 1.0 108.798 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -107.01 127.92 53.89 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.32 -0.862 . . . . 1.0 109.162 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -119.98 129.95 54.53 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.63 -0.669 . . . . 1.0 109.444 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.429 ' HG2' HH11 ' A' ' 52' ' ' ARG . 34.1 ttt-85 -82.74 130.0 35.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.398 -0.814 . . . . 1.0 109.424 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.4 mt -103.98 119.87 39.86 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.367 -0.833 . . . . 1.0 109.168 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.434 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 59.0 m-70 -62.28 -39.96 94.67 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.427 -0.796 . . . . 1.0 110.005 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 87.4 m-20 -143.4 164.0 31.52 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.259 -0.9 . . . . 1.0 109.86 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.76 177.81 33.72 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.726 -1.35 . . . . 1.0 109.726 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.8 mt -93.24 134.77 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.292 -1.122 . . . . 1.0 109.29 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.28 167.46 10.1 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.515 -0.74 . . . . 1.0 109.422 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -59.96 -48.94 79.64 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.31 -0.869 . . . . 1.0 109.031 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.7 mt -115.59 108.66 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.535 -0.728 . . . . 1.0 109.897 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.5 ptp -98.68 138.53 35.72 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.199 -0.938 . . . . 1.0 109.108 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.9 mt -109.96 133.57 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.499 -0.75 . . . . 1.0 109.747 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 77.6 p -150.98 159.29 44.67 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.059 -1.026 . . . . 1.0 110.022 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -110.47 126.55 54.46 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.564 -0.71 . . . . 1.0 109.248 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 100' ' ' ASP . . . -102.38 -170.74 26.96 Favored Glycine 0 N--CA 1.502 3.059 0 N-CA-C 110.786 -0.925 . . . . 1.0 110.786 -179.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 62.1 mt . . . . . 0 N--CA 1.498 1.97 0 O-C-N 121.532 -0.981 . . . . 1.0 109.303 -179.941 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.545 ' CD1' ' OD1' ' A' ' 99' ' ' ASP . 94.3 m-85 . . . . . 0 N--CA 1.494 1.725 0 N-CA-C 108.799 -0.815 . . . . 1.0 108.799 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 79' ' ' SER . 27.2 p-10 -99.58 -4.12 31.79 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.084 -1.01 . . . . 1.0 110.709 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.441 ' O ' ' OE2' ' A' ' 102' ' ' GLU . . . 119.14 -115.32 3.03 Favored Glycine 0 N--CA 1.505 3.287 0 N-CA-C 110.267 -1.133 . . . . 1.0 110.267 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.468 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 29.1 Cg_endo -73.91 -75.11 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.956 0 CA-C-N 120.158 1.979 . . . . 1.0 113.402 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.459 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 88.5 p -76.61 177.88 7.14 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.915 -1.115 . . . . 1.0 110.151 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.11 -136.53 12.73 Favored Glycine 0 N--CA 1.498 2.819 0 N-CA-C 110.683 -0.967 . . . . 1.0 110.683 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.0 mt -71.81 110.41 6.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.375 -1.073 . . . . 1.0 109.763 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 55.4 mt -83.76 -18.3 38.27 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.73 173.96 1.22 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.502 -0.925 . . . . 1.0 108.502 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.497 ' CE1' ' ND1' ' A' ' 97' ' ' HIS . 9.4 p80 -162.29 164.33 27.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.971 -1.081 . . . . 1.0 109.985 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -157.17 160.52 38.84 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.823 -0.806 . . . . 1.0 108.823 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -106.75 151.36 40.48 Favored Pre-proline 0 N--CA 1.501 2.102 0 O-C-N 121.365 -0.834 . . . . 1.0 109.131 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -62.51 165.56 15.26 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 120.987 1.124 . . . . 1.0 112.328 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo . . . . . 0 N--CA 1.489 1.263 0 C-N-CA 121.161 1.241 . . . . 1.0 112.356 179.898 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.386 -0.598 . . . . 1.0 109.386 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.89 119.83 6.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 1.0 109.191 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.497 ' ND1' ' CE1' ' A' ' 84' ' ' HIS . 52.4 m170 -103.85 145.78 29.61 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.539 -0.725 . . . . 1.0 109.994 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -129.68 147.03 51.43 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.447 -0.946 . . . . 1.0 108.447 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.545 ' OD1' ' CD1' ' A' ' 75' ' ' PHE . 98.3 m-20 -80.81 124.28 28.94 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.92 -1.113 . . . . 1.0 109.579 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 65' ' ' GLY . 39.2 t0 -84.24 -6.81 59.45 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.144 -0.973 . . . . 1.0 109.214 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -80.33 -9.91 59.75 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.633 -0.877 . . . . 1.0 108.633 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.468 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 57.5 mm-40 -89.57 173.3 8.4 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.985 -0.746 . . . . 1.0 108.985 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 54.2 m -105.29 107.62 18.7 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -88.58 119.98 29.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.304 -0.872 . . . . 1.0 108.739 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.663 HG21 ' HB2' ' A' ' 109' ' ' LYS . 9.0 t -140.24 157.85 44.94 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.365 -0.835 . . . . 1.0 109.79 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.4 t -95.76 -9.83 30.72 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.223 -0.923 . . . . 1.0 109.053 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 71.3 m -92.46 179.22 5.59 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.368 -0.833 . . . . 1.0 108.975 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.1 t -78.64 77.78 5.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.032 -1.043 . . . . 1.0 109.56 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.663 ' HB2' HG21 ' A' ' 105' ' ' THR . 68.6 mttm -148.76 148.12 29.62 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.266 -0.896 . . . . 1.0 108.821 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.53 -141.3 4.72 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.746 -1.342 . . . . 1.0 109.746 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -100.33 117.02 33.66 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.352 -1.087 . . . . 1.0 108.925 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -62.74 133.85 55.42 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.076 -1.015 . . . . 1.0 109.219 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.9 tp -59.99 -42.82 95.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 1.0 109.823 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -59.86 -40.8 89.87 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.234 -0.916 . . . . 1.0 110.968 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -59.76 -52.12 66.85 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.604 -1.31 . . . . 1.0 109.722 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.3 t -69.91 -40.79 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.059 -1.026 . . . . 1.0 110.049 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.45 -50.15 74.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.153 -0.967 . . . . 1.0 109.547 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.0 -37.3 79.3 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.71 -1.244 . . . . 1.0 110.16 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.592 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 56.9 t60 -63.5 -50.1 70.96 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.219 -0.926 . . . . 1.0 111.315 -178.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.99 -39.03 84.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.748 -1.22 . . . . 1.0 109.858 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -59.99 -40.05 87.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.821 -1.174 . . . . 1.0 108.519 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.45 -46.8 79.51 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.807 -1.317 . . . . 1.0 109.807 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.592 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 86.0 m-70 -65.85 -39.98 91.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.06 -1.259 . . . . 1.0 109.462 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.1 p -64.58 -25.1 67.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.228 -0.92 . . . . 1.0 109.8 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 72.8 mt -80.95 1.98 28.77 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.138 -0.976 . . . . 1.0 109.371 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 87.19 9.51 73.12 Favored Glycine 0 N--CA 1.495 2.629 0 O-C-N 121.2 -0.938 . . . . 1.0 110.834 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.4 mt -84.95 150.02 25.22 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.836 -1.39 . . . . 1.0 109.759 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 39.6 t0 -99.53 171.33 8.0 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.869 -0.789 . . . . 1.0 108.869 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.537 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 71.9 m80 -59.96 139.96 57.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.12 -0.987 . . . . 1.0 109.53 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 44.4 t -97.1 152.4 18.82 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.428 -0.795 . . . . 1.0 109.554 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -99.01 2.22 46.1 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.311 -0.868 . . . . 1.0 109.354 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 9.5 t70 -87.26 130.0 49.44 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.294 -0.879 . . . . 1.0 108.708 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -67.15 -22.22 47.4 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 CA-C-N 120.078 1.064 . . . . 1.0 112.437 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.444 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -86.89 -2.39 84.14 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.817 -1.313 . . . . 1.0 109.817 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.57 143.48 28.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.183 -1.186 . . . . 1.0 109.219 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.436 ' C ' ' H ' ' A' ' 138' ' ' PHE . 84.3 mt -69.26 -38.31 78.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.098 -1.001 . . . . 1.0 109.698 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 81.4 mtp -72.09 20.92 0.06 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 1.0 110.735 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.436 ' H ' ' C ' ' A' ' 136' ' ' LEU . 16.3 t80 -68.11 134.48 91.58 Favored Pre-proline 0 N--CA 1.496 1.857 0 N-CA-C 107.885 -1.154 . . . . 1.0 107.885 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -61.47 -9.46 13.31 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 120.836 1.024 . . . . 1.0 114.227 -177.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 86.4 mt -113.05 134.08 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 O-C-N 120.955 -1.091 . . . . 1.0 109.705 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -72.34 127.24 31.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.467 -0.77 . . . . 1.0 110.402 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 14.1 t -141.29 141.14 33.95 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.582 -0.895 . . . . 1.0 108.582 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -78.95 143.83 35.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.09 -1.007 . . . . 1.0 109.199 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.6 t -138.8 150.78 46.45 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.292 -0.88 . . . . 1.0 109.71 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -66.15 101.59 0.63 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.465 -1.454 . . . . 1.0 109.465 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 20.9 mtmm -76.71 0.34 20.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.423 -1.046 . . . . 1.0 109.768 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 73.6 p -60.06 -39.97 87.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -0.901 . . . . 1.0 109.965 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -147.62 30.69 0.9 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.079 -1.013 . . . . 1.0 109.526 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -65.28 139.61 58.63 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.132 -0.98 . . . . 1.0 109.586 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 68.2 mtt -136.55 145.24 44.8 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.702 -0.851 . . . . 1.0 108.702 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 20.9 mt -52.86 128.86 46.7 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.091 -1.006 . . . . 1.0 108.719 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -70.13 178.69 4.54 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 CA-C-N 120.081 1.065 . . . . 1.0 112.286 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -60.36 -39.95 89.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.432 -0.792 . . . . 1.0 110.096 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -56.14 -49.12 74.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.199 -0.938 . . . . 1.0 109.969 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -70.08 -39.93 75.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.996 -1.065 . . . . 1.0 110.064 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 58.1 t -61.28 -47.43 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.012 -1.055 . . . . 1.0 109.498 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -60.43 -40.09 89.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.048 -1.032 . . . . 1.0 110.45 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.26 -53.72 8.67 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 120.374 -0.917 . . . . 1.0 111.477 -178.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.476 HG23 ' N ' ' A' ' 160' ' ' GLN . 6.8 tp -59.97 -40.06 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.817 -1.402 . . . . 1.0 109.569 -178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.7 mt-30 -66.06 -39.94 90.5 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.101 -1.0 . . . . 1.0 109.202 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 95.1 p -60.53 -28.75 68.66 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.01 -1.056 . . . . 1.0 109.853 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 86.5 mt -89.8 -51.64 5.4 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.047 -1.033 . . . . 1.0 110.643 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -98.04 -22.08 16.45 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.945 -1.097 . . . . 1.0 110.829 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.626 0 N-CA-C 109.692 -1.363 . . . . 1.0 109.692 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.0 mt . . . . . 0 N--CA 1.496 1.841 0 N-CA-C 109.049 -0.723 . . . . 1.0 109.049 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -160.0 160.04 32.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 1.0 109.69 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -72.88 150.0 43.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.304 -0.873 . . . . 1.0 109.304 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.1 t -85.48 1.61 48.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.303 -0.873 . . . . 1.0 110.093 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.521 ' NZ ' ' O ' ' A' ' 14' ' ' ASN . 20.1 pttp -149.14 154.24 38.9 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.162 -0.961 . . . . 1.0 109.635 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.54 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.01 0.39 57.14 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.289 -0.882 . . . . 1.0 109.666 -179.549 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.521 ' O ' ' NZ ' ' A' ' 12' ' ' LYS . 98.5 m-20 -95.51 128.76 42.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.219 -0.926 . . . . 1.0 108.884 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.5 mt -141.31 149.93 41.85 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.186 -0.946 . . . . 1.0 109.253 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 74.3 p -130.9 155.46 46.71 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.03 -0.73 . . . . 1.0 109.03 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -145.86 160.16 42.18 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.146 -0.972 . . . . 1.0 109.835 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.531 HH12 ' H ' ' A' ' 56' ' ' GLY . 73.4 ttt180 -143.36 133.45 24.32 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.537 -0.727 . . . . 1.0 109.583 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 91.8 mt -88.36 117.09 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.189 -0.944 . . . . 1.0 108.663 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.54 -40.12 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.06 -1.025 . . . . 1.0 109.391 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -163.85 160.94 22.82 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.431 -1.418 . . . . 1.0 110.631 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -97.21 -173.33 2.64 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.56 -1.274 . . . . 1.0 107.56 178.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.7 148.4 43.01 Favored Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 121.377 -0.827 . . . . 1.0 110.029 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -67.68 -20.64 46.35 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 120.833 1.022 . . . . 1.0 110.335 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -59.4 -40.12 85.6 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.15 -0.932 . . . . 1.0 110.168 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 78.0 mtm -138.95 159.93 40.95 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.257 -0.902 . . . . 1.0 109.853 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 82.6 p -74.21 160.86 30.58 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.497 0.665 . . . . 1.0 109.417 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.697 ' H ' ' CD2' ' A' ' 28' ' ' HIS . 2.7 p80 -62.47 -35.88 80.72 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.552 -0.718 . . . . 1.0 110.148 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.9 m -60.04 -40.28 88.82 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.845 -1.16 . . . . 1.0 109.61 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -69.94 -40.04 75.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.114 -0.991 . . . . 1.0 109.035 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.0 t -69.13 -41.47 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.314 -0.866 . . . . 1.0 110.258 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.95 -48.13 82.95 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.931 -1.105 . . . . 1.0 110.346 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -63.75 -31.82 73.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.87 -1.144 . . . . 1.0 109.834 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.97 -49.96 75.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.07 -1.019 . . . . 1.0 110.031 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -65.55 -37.89 88.01 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.018 -1.051 . . . . 1.0 109.661 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.07 -41.24 92.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.096 -1.003 . . . . 1.0 109.878 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -60.07 -45.32 93.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.12 -0.987 . . . . 1.0 109.475 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.12 -48.06 83.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.44 -0.787 . . . . 1.0 110.717 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.42 ' CZ ' ' CZ ' ' A' ' 121' ' ' PHE . 49.7 m-85 -64.04 -40.05 95.44 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.956 -1.09 . . . . 1.0 109.529 -179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.6 tptt -59.99 -47.33 86.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.029 -1.045 . . . . 1.0 109.543 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.02 -41.52 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.143 -0.973 . . . . 1.0 110.128 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -78.49 -36.71 44.74 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.012 -1.055 . . . . 1.0 110.376 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 96.1 p -70.91 -20.76 62.46 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.982 -1.074 . . . . 1.0 109.936 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.93 -39.89 87.04 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.252 -0.905 . . . . 1.0 110.558 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.1 m -110.01 23.84 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.201 -0.937 . . . . 1.0 110.944 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.4 p -150.27 139.8 13.42 Favored Pre-proline 0 N--CA 1.502 2.129 0 O-C-N 120.76 -1.213 . . . . 1.0 109.658 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -75.37 15.7 0.79 Allowed 'Trans proline' 0 N--CA 1.497 1.693 0 CA-C-N 119.743 0.944 . . . . 1.0 112.088 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 88.2 mt -67.1 139.92 57.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.079 -1.013 . . . . 1.0 109.71 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -111.81 121.38 44.91 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 109.045 -0.724 . . . . 1.0 109.045 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -107.8 119.01 38.24 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.33 -0.856 . . . . 1.0 109.251 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.1 m -119.95 129.98 54.57 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.64 -0.663 . . . . 1.0 109.946 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.417 ' HG2' HH11 ' A' ' 52' ' ' ARG . 33.6 ttt-85 -82.0 135.13 35.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 1.0 109.241 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.5 mt -102.1 132.0 48.25 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.343 -0.848 . . . . 1.0 109.188 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.447 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 42.0 m170 -63.95 -40.01 95.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -0.84 . . . . 1.0 109.733 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 76.7 m-20 -148.89 169.95 19.39 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.328 -0.857 . . . . 1.0 109.869 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.531 ' H ' HH12 ' A' ' 18' ' ' ARG . . . 95.06 178.52 37.5 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.7 -1.36 . . . . 1.0 109.7 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.4 mt -92.58 139.52 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.292 -1.122 . . . . 1.0 108.961 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.05 170.55 8.08 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.473 -0.767 . . . . 1.0 109.702 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.03 -49.05 79.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.242 -0.911 . . . . 1.0 108.935 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 90.2 mt -119.95 112.97 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.616 -0.678 . . . . 1.0 109.251 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.0 ptm -100.93 135.0 43.07 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.397 -0.814 . . . . 1.0 108.952 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 95.8 mt -104.43 135.17 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.505 -0.747 . . . . 1.0 110.365 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 79.4 p -152.9 159.03 42.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.345 -0.847 . . . . 1.0 109.278 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -102.81 127.71 49.87 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.413 -0.804 . . . . 1.0 109.564 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.89 157.95 17.86 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 109.436 -1.466 . . . . 1.0 109.436 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.9 tt . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.465 -1.021 . . . . 1.0 108.719 179.995 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.538 ' CD1' ' OD2' ' A' ' 99' ' ' ASP . 90.8 m-85 . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 108.604 -0.887 . . . . 1.0 108.604 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.6 p-10 -97.4 0.0 47.06 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.082 -1.011 . . . . 1.0 110.099 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.21 -157.89 22.9 Favored Glycine 0 N--CA 1.5 2.944 0 N-CA-C 108.722 -1.751 . . . . 1.0 108.722 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -59.68 -63.68 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.354 0 CA-C-N 118.655 1.228 . . . . 1.0 111.612 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 88.1 p -77.62 162.34 27.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.428 -0.795 . . . . 1.0 109.485 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.15 -129.95 9.03 Favored Glycine 0 N--CA 1.499 2.894 0 N-CA-C 109.709 -1.356 . . . . 1.0 109.709 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.449 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 10.2 mt -64.99 101.13 0.47 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.222 -1.164 . . . . 1.0 108.66 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 53.5 mt -75.66 -28.36 58.69 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.468 -0.938 . . . . 1.0 108.468 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -177.92 163.94 1.84 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.385 -0.969 . . . . 1.0 108.385 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -160.78 160.41 31.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.907 -1.121 . . . . 1.0 109.97 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -144.11 156.21 44.25 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.705 -0.85 . . . . 1.0 108.705 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -95.51 150.99 38.26 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.149 -0.969 . . . . 1.0 108.807 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -65.5 165.01 24.04 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 120.771 0.981 . . . . 1.0 111.556 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo . . . . . 0 C--N 1.314 -1.238 0 C-N-CA 121.164 1.243 . . . . 1.0 111.792 179.865 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.016 -0.735 . . . . 1.0 109.016 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.65 123.67 10.73 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.083 -1.011 . . . . 1.0 109.61 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -110.08 154.76 22.8 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.589 0.709 . . . . 1.0 110.015 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.486 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 44.9 m-85 -130.58 150.22 51.88 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.538 ' OD2' ' CD1' ' A' ' 75' ' ' PHE . 1.2 m-20 -78.96 122.86 26.68 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.991 -1.068 . . . . 1.0 109.591 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -84.44 -6.84 59.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.142 -0.974 . . . . 1.0 109.379 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -85.98 -14.74 43.7 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.336 -0.853 . . . . 1.0 110.067 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.574 ' OE1' ' N ' ' A' ' 102' ' ' GLU . 0.9 OUTLIER -88.66 169.91 11.27 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.176 -0.953 . . . . 1.0 109.687 -179.113 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.7 m -99.05 102.57 14.32 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.75 -0.833 . . . . 1.0 108.75 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.446 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 93.4 m95 -85.16 121.99 28.7 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.48 -0.762 . . . . 1.0 109.33 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.646 HG21 ' HB2' ' A' ' 109' ' ' LYS . 7.2 t -140.63 150.4 43.52 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.476 -0.765 . . . . 1.0 109.761 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 74.8 m -93.04 -6.2 48.77 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.193 -0.942 . . . . 1.0 108.52 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.1 p -91.3 178.63 5.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.571 -0.706 . . . . 1.0 109.208 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 89.7 p -77.0 70.0 3.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 1.0 109.376 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.646 ' HB2' HG21 ' A' ' 105' ' ' THR . 68.3 mttm -146.22 150.81 36.52 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.192 -0.942 . . . . 1.0 109.484 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 43.56 -137.73 4.18 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.046 -1.221 . . . . 1.0 110.046 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -99.99 115.32 29.42 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.394 -1.063 . . . . 1.0 109.22 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.441 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 19.3 t-20 -63.18 130.63 45.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.212 -0.93 . . . . 1.0 109.873 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.7 tp -59.92 -43.54 94.83 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.402 -0.811 . . . . 1.0 110.832 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -60.07 -42.14 93.9 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.989 -1.07 . . . . 1.0 111.096 -178.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -60.01 -50.05 75.26 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.672 -1.267 . . . . 1.0 109.509 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.5 t -70.03 -41.4 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.078 -1.014 . . . . 1.0 110.006 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.56 -50.52 72.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.227 -0.921 . . . . 1.0 109.891 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.96 -39.78 86.78 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.255 -0.903 . . . . 1.0 110.627 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.627 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 67.9 t60 -63.03 -48.4 78.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.115 -0.991 . . . . 1.0 111.156 -178.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.486 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 7.0 pt-20 -59.89 -39.6 85.91 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.589 -1.319 . . . . 1.0 110.011 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.42 ' CZ ' ' CZ ' ' A' ' 39' ' ' PHE . 32.3 m-85 -60.02 -40.11 88.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.912 -1.117 . . . . 1.0 108.479 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -56.42 -42.55 89.63 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.365 -1.494 . . . . 1.0 109.365 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.627 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 81.9 m-70 -65.53 -40.02 92.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.073 -1.251 . . . . 1.0 109.592 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 80.0 p -67.15 -23.69 65.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.18 -0.95 . . . . 1.0 109.317 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.7 mt -81.96 -0.97 46.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.183 -0.948 . . . . 1.0 109.59 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 92.68 7.94 62.63 Favored Glycine 0 N--CA 1.497 2.735 0 O-C-N 121.149 -0.969 . . . . 1.0 110.933 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.4 mt -86.98 141.98 28.29 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.854 -1.38 . . . . 1.0 109.858 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 10.8 t70 -98.72 174.94 6.16 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.555 -0.715 . . . . 1.0 109.089 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.491 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 76.8 m80 -59.86 139.74 57.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.026 -1.046 . . . . 1.0 109.9 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 30.4 t -98.98 156.46 16.9 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.405 -0.809 . . . . 1.0 109.182 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -97.05 -1.43 45.4 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.229 -0.919 . . . . 1.0 109.016 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -85.43 129.32 55.76 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.079 -1.013 . . . . 1.0 108.976 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -68.69 -20.16 40.72 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 CA-C-N 120.027 1.045 . . . . 1.0 112.372 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -87.3 -7.14 77.05 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.895 -1.282 . . . . 1.0 109.895 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.58 145.7 26.65 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.086 -1.243 . . . . 1.0 109.427 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.418 ' C ' ' H ' ' A' ' 138' ' ' PHE . 96.1 mt -69.97 -29.13 66.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.047 -1.033 . . . . 1.0 109.696 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.1 mmm -72.2 13.49 0.31 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.332 -0.855 . . . . 1.0 110.262 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.418 ' H ' ' C ' ' A' ' 136' ' ' LEU . 12.2 t80 -70.0 131.83 88.83 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.071 -1.018 . . . . 1.0 108.768 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -63.56 -8.56 15.45 Favored 'Trans proline' 0 N--CA 1.501 1.93 0 C-N-CA 120.924 1.083 . . . . 1.0 114.37 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 84.2 mt -109.72 138.6 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 O-C-N 120.936 -1.103 . . . . 1.0 109.317 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . 0.441 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 45.7 t80 -74.38 128.2 34.94 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.357 -0.839 . . . . 1.0 110.7 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.1 t -139.22 138.29 36.73 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.578 -0.702 . . . . 1.0 109.211 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.467 ' CE1' ' NZ ' ' A' ' 146' ' ' LYS . 70.6 t80 -80.83 150.12 29.28 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.975 -1.078 . . . . 1.0 109.352 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.6 t -142.4 158.56 43.57 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.116 -0.99 . . . . 1.0 109.992 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.07 113.91 4.75 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.423 -1.471 . . . . 1.0 109.423 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.467 ' NZ ' ' CE1' ' A' ' 143' ' ' TYR . 62.2 mttp -80.85 3.28 23.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.382 -1.069 . . . . 1.0 110.203 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 27.6 t -58.07 -41.29 83.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.845 -1.159 . . . . 1.0 109.532 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -160.96 68.66 0.34 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.32 -0.862 . . . . 1.0 109.18 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -94.36 120.54 34.75 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.249 -0.907 . . . . 1.0 109.812 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 75.0 mtm -116.62 142.5 46.81 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 22.3 mt -50.4 132.78 25.53 Favored Pre-proline 0 C--N 1.302 -1.498 0 O-C-N 121.043 -1.036 . . . . 1.0 108.914 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -68.87 179.42 3.23 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 CA-C-N 119.865 0.987 . . . . 1.0 112.355 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -62.43 -39.95 94.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.457 -0.777 . . . . 1.0 110.126 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -56.82 -48.62 77.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 1.0 110.071 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -70.11 -39.96 75.18 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.078 -1.014 . . . . 1.0 109.803 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 54.6 t -61.25 -48.08 90.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.18 -0.95 . . . . 1.0 109.162 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -61.05 -40.08 92.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.115 -0.991 . . . . 1.0 110.413 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.25 -53.66 13.24 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 120.243 -0.98 . . . . 1.0 111.253 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.457 HG23 ' N ' ' A' ' 160' ' ' GLN . 5.2 tp -60.36 -40.0 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.889 -1.36 . . . . 1.0 109.749 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.4 mt-30 -64.71 -39.9 94.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.04 -1.038 . . . . 1.0 109.636 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 84.4 p -65.96 -24.4 66.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -0.949 . . . . 1.0 110.2 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 85.6 mt -88.42 -51.5 5.69 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.931 -1.106 . . . . 1.0 110.232 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -90.89 -8.78 48.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.939 -1.1 . . . . 1.0 109.539 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.493 2.448 0 N-CA-C 109.664 -1.375 . . . . 1.0 109.664 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.9 mt . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.526 -0.546 . . . . 1.0 109.526 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -159.86 160.0 33.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 1.0 109.377 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -73.78 150.06 41.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.224 -0.922 . . . . 1.0 109.047 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.3 t -85.62 -0.07 54.06 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.159 -0.963 . . . . 1.0 110.249 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -150.22 159.57 44.34 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.98 -1.075 . . . . 1.0 109.878 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.557 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -91.8 -0.03 57.51 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.385 -0.822 . . . . 1.0 109.689 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -96.22 123.38 39.82 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.215 -0.928 . . . . 1.0 108.995 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.3 mt -140.0 152.29 46.16 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.368 -0.832 . . . . 1.0 108.997 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.6 p -132.89 155.48 48.96 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.492 -0.755 . . . . 1.0 109.103 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -144.69 158.71 43.67 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.231 -0.918 . . . . 1.0 109.648 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.412 HH11 ' HG2' ' A' ' 18' ' ' ARG . 37.2 ttt-85 -142.44 132.28 24.23 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.467 -0.77 . . . . 1.0 109.47 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 93.1 mt -87.05 119.62 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.331 -0.856 . . . . 1.0 109.113 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.4 t -69.84 -40.3 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.175 -0.953 . . . . 1.0 109.495 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.414 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 18.6 p-10 -162.53 154.99 19.19 Favored 'General case' 0 C--N 1.288 -2.076 0 O-C-N 119.718 -1.864 . . . . 1.0 111.028 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.408 ' OH ' ' NH2' ' A' ' 52' ' ' ARG . 44.0 m-85 -99.87 108.85 21.22 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 105.582 -2.007 . . . . 1.0 105.582 177.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 23' ' ' THR . 1.1 t -57.55 139.58 80.97 Favored Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.055 -1.028 . . . . 1.0 109.727 -177.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -59.16 -10.15 9.77 Favored 'Trans proline' 0 N--CA 1.487 1.093 0 CA-C-N 119.246 0.766 . . . . 1.0 110.96 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -57.57 -28.21 63.37 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.848 -0.741 . . . . 1.0 110.078 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 77.4 mtm -143.44 162.48 35.68 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.085 -1.009 . . . . 1.0 109.862 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.2 p -71.81 160.83 31.91 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.309 -0.869 . . . . 1.0 109.205 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -61.41 -40.21 93.58 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.426 -0.796 . . . . 1.0 110.487 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.5 m -61.08 -41.23 96.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.968 -1.083 . . . . 1.0 110.705 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.89 -40.01 91.15 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.15 -0.969 . . . . 1.0 110.623 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 69.5 t -69.73 -42.22 80.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 120.936 -1.102 . . . . 1.0 110.275 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -59.97 -53.87 52.76 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.212 -0.93 . . . . 1.0 110.83 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.3 ptmm? -65.92 -29.83 70.32 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.586 -0.696 . . . . 1.0 110.821 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.04 -49.93 75.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.785 -1.197 . . . . 1.0 109.463 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -66.96 -38.26 85.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.018 -1.051 . . . . 1.0 110.211 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.06 -40.58 89.96 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.913 -1.117 . . . . 1.0 109.559 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.04 -41.41 96.54 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.889 -1.132 . . . . 1.0 108.964 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.99 -46.44 89.45 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.516 -0.74 . . . . 1.0 109.957 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.432 ' CE1' ' CD1' ' A' ' 50' ' ' PHE . 53.3 m-85 -65.15 -39.98 93.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.968 -1.083 . . . . 1.0 109.499 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -60.05 -48.46 81.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.052 -1.03 . . . . 1.0 109.852 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.7 t -60.0 -41.06 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.092 -1.005 . . . . 1.0 110.083 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -78.4 -36.42 45.78 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.92 -1.113 . . . . 1.0 110.135 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 81.7 p -71.78 -18.02 62.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.071 -1.018 . . . . 1.0 109.845 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -60.01 -39.69 86.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.239 -0.913 . . . . 1.0 110.285 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.478 ' O ' ' NE2' ' A' ' 160' ' ' GLN . 21.9 m -111.41 20.97 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.38 -0.825 . . . . 1.0 110.788 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.434 HG23 HG23 ' A' ' 45' ' ' VAL . 22.5 p -148.42 138.22 12.62 Favored Pre-proline 0 N--CA 1.504 2.255 0 O-C-N 120.77 -1.207 . . . . 1.0 109.914 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -73.95 21.23 0.38 Allowed 'Trans proline' 0 N--CA 1.498 1.793 0 C-N-CA 120.962 1.108 . . . . 1.0 112.495 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.3 mt -69.5 136.46 51.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.893 -1.13 . . . . 1.0 110.018 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -107.91 120.0 41.06 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.614 -0.884 . . . . 1.0 108.614 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.432 ' CD1' ' CE1' ' A' ' 39' ' ' PHE . 95.1 m-85 -108.5 125.29 51.63 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.311 -0.868 . . . . 1.0 109.723 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -120.05 130.03 54.5 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.67 -0.644 . . . . 1.0 109.792 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.408 ' NH2' ' OH ' ' A' ' 22' ' ' TYR . 68.6 ttt180 -82.38 130.73 35.17 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.365 -0.835 . . . . 1.0 109.892 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.0 mt -109.64 124.33 50.99 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.421 -0.799 . . . . 1.0 109.083 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.439 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 48.4 m170 -79.27 -19.08 51.44 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.197 -0.94 . . . . 1.0 110.111 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 79.9 m-20 -146.6 160.42 42.19 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.067 -1.02 . . . . 1.0 109.901 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.97 175.3 44.0 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.555 -1.418 . . . . 1.0 109.555 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.2 mt -96.43 136.46 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.212 -1.17 . . . . 1.0 108.965 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.98 160.86 16.43 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.388 -0.82 . . . . 1.0 109.449 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.04 -49.11 78.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.223 -0.923 . . . . 1.0 109.293 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.9 mt -104.32 98.52 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.416 -0.802 . . . . 1.0 109.839 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.4 ptm -100.11 131.69 45.91 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.191 -0.943 . . . . 1.0 109.399 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 92.1 mt -103.02 138.92 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.541 -0.724 . . . . 1.0 110.208 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 82.5 p -153.07 157.74 40.89 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.371 -0.83 . . . . 1.0 109.249 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -106.5 125.68 51.31 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.83 -0.804 . . . . 1.0 108.83 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 98' ' ' PHE . . . -98.11 178.78 32.11 Favored Glycine 0 N--CA 1.499 2.873 0 O-C-N 121.108 -0.995 . . . . 1.0 110.761 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 41.1 mt . . . . . 0 N--CA 1.497 1.917 0 O-C-N 121.672 -0.899 . . . . 1.0 109.018 179.717 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.54 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 99.0 m-85 . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 108.657 -0.868 . . . . 1.0 108.657 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -100.15 5.51 44.82 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.181 -0.949 . . . . 1.0 110.82 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 126.1 -156.23 19.58 Favored Glycine 0 N--CA 1.504 3.169 0 N-CA-C 109.085 -1.606 . . . . 1.0 109.085 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -59.83 -66.48 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 0 CA-C-N 118.697 1.249 . . . . 1.0 112.372 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 80.3 p -75.56 160.06 30.56 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.12 -0.987 . . . . 1.0 109.529 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.37 -130.02 8.9 Favored Glycine 0 N--CA 1.502 3.04 0 N-CA-C 109.67 -1.372 . . . . 1.0 109.67 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.423 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 10.9 mt -68.6 105.37 2.23 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.252 -1.146 . . . . 1.0 109.065 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 39.2 mt -78.7 -16.29 57.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.98 -1.075 . . . . 1.0 108.951 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 97' ' ' HIS . . . -178.83 176.1 0.97 Allowed 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.435 ' ND1' ' C ' ' A' ' 84' ' ' HIS . 7.0 p80 -161.08 162.25 31.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.015 -1.053 . . . . 1.0 109.557 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.63 165.73 31.42 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.223 -0.923 . . . . 1.0 109.651 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -113.66 153.39 45.88 Favored Pre-proline 0 N--CA 1.5 2.033 0 N-CA-C 108.873 -0.788 . . . . 1.0 108.873 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -55.56 169.08 1.28 Allowed 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.023 1.149 . . . . 1.0 112.363 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo . . . . . 0 N--CA 1.494 1.545 0 C-N-CA 121.278 1.318 . . . . 1.0 112.451 -179.754 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.497 -0.557 . . . . 1.0 109.497 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.01 117.02 5.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.299 -0.876 . . . . 1.0 109.421 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.411 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 38.2 m170 -105.64 152.23 23.38 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.491 -0.755 . . . . 1.0 109.821 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.482 ' O ' ' N ' ' A' ' 65' ' ' GLY . 38.2 m-85 -131.81 148.82 52.58 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.774 -0.824 . . . . 1.0 108.774 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.54 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 89.5 m-20 -79.03 122.83 26.68 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.915 -1.116 . . . . 1.0 109.689 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -84.04 -11.78 56.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.355 -0.841 . . . . 1.0 109.077 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -81.6 -12.56 58.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.408 -0.807 . . . . 1.0 109.278 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -89.23 169.1 11.74 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.868 -0.79 . . . . 1.0 108.868 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 39.2 m -99.81 104.41 16.1 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.201 -0.937 . . . . 1.0 109.266 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.47 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 91.3 m95 -87.46 127.11 35.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.336 -0.852 . . . . 1.0 108.915 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.642 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.0 t -143.14 158.15 43.87 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.356 -0.84 . . . . 1.0 109.755 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.2 t -96.98 -10.41 26.31 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.453 -0.943 . . . . 1.0 108.453 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 81.1 p -90.41 -176.4 4.77 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.007 -0.738 . . . . 1.0 109.007 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 m -82.82 76.57 9.65 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.135 -0.978 . . . . 1.0 109.58 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.642 ' HB2' HG21 ' A' ' 105' ' ' THR . 98.0 mttt -149.6 151.12 33.28 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.19 -0.944 . . . . 1.0 108.992 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 43.73 -139.44 3.63 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.992 -1.243 . . . . 1.0 109.992 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -100.08 116.46 32.17 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.359 -1.083 . . . . 1.0 109.161 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.457 HD22 HD23 ' A' ' 115' ' ' LEU . 58.3 t30 -64.56 132.13 48.97 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.899 -1.125 . . . . 1.0 109.785 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.6 tp -59.99 -42.97 95.38 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.352 -0.842 . . . . 1.0 110.552 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -60.01 -40.65 89.96 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.098 -1.001 . . . . 1.0 110.836 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.457 HD23 HD22 ' A' ' 112' ' ' ASN . 2.7 mm? -59.93 -50.77 72.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.765 -1.209 . . . . 1.0 109.25 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.9 t -70.03 -40.15 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.202 -0.936 . . . . 1.0 110.224 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.58 -52.15 66.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.112 -0.993 . . . . 1.0 109.552 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.98 -34.34 73.18 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.246 -0.909 . . . . 1.0 110.078 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -64.3 -50.04 69.41 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.224 -0.922 . . . . 1.0 111.051 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.451 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 7.1 pt-20 -60.01 -39.31 85.36 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.801 -1.187 . . . . 1.0 110.025 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -59.98 -40.0 87.62 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.934 -1.104 . . . . 1.0 108.851 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.32 -46.05 81.12 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.753 -1.739 . . . . 1.0 108.753 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -64.5 -40.0 94.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.335 -1.097 . . . . 1.0 109.413 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.0 p -67.42 -23.57 65.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.361 -0.837 . . . . 1.0 109.67 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 69.9 mt -82.81 -0.3 47.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.227 -0.921 . . . . 1.0 109.927 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 89.12 9.83 67.02 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 110.447 -1.061 . . . . 1.0 110.447 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.9 mt -85.79 150.05 24.84 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.067 -1.255 . . . . 1.0 110.251 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 12.0 t70 -101.0 169.98 8.59 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.833 -0.803 . . . . 1.0 108.833 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.529 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 23.9 m170 -59.34 136.39 57.95 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.997 -1.065 . . . . 1.0 108.961 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 35.8 t -97.93 155.0 17.28 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.312 -0.868 . . . . 1.0 109.63 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -99.87 4.84 45.33 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.275 -0.891 . . . . 1.0 109.621 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -86.11 128.54 57.4 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 108.323 -0.991 . . . . 1.0 108.323 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -67.78 -18.63 47.54 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 CA-C-N 120.208 1.11 . . . . 1.0 111.864 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -88.9 -5.52 73.67 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.574 -1.41 . . . . 1.0 109.574 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.76 135.95 33.9 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.247 -1.149 . . . . 1.0 109.056 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.421 ' C ' ' H ' ' A' ' 138' ' ' PHE . 94.9 mt -60.5 -39.99 89.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.073 -1.017 . . . . 1.0 109.894 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 92.4 mtp -71.16 24.35 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.337 -0.852 . . . . 1.0 111.558 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.421 ' H ' ' C ' ' A' ' 136' ' ' LEU . 15.5 t80 -68.78 132.8 90.6 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 120.811 -1.181 . . . . 1.0 108.013 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -57.98 -8.78 5.04 Favored 'Trans proline' 0 N--CA 1.5 1.892 0 C-N-CA 120.859 1.039 . . . . 1.0 114.353 -177.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.9 mt -114.83 137.34 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 120.971 -1.08 . . . . 1.0 109.155 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -71.64 129.72 39.4 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.26 -0.9 . . . . 1.0 109.943 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 10.1 t -140.12 135.87 32.96 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.423 -0.798 . . . . 1.0 109.011 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -79.52 144.47 33.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.105 -0.997 . . . . 1.0 109.098 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.7 t -140.97 153.25 45.51 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.203 -0.936 . . . . 1.0 109.465 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.17 112.08 3.88 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.445 -1.462 . . . . 1.0 109.445 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.408 ' HE2' HD21 ' A' ' 112' ' ' ASN . 8.7 mtmp? -78.55 7.92 6.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -1.135 . . . . 1.0 109.598 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 73.4 m -59.99 -40.04 87.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 1.0 109.34 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -158.82 68.2 0.45 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 1.0 109.265 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -100.51 124.62 46.28 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.379 -0.826 . . . . 1.0 109.741 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 76.0 mtm -120.61 141.65 50.14 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.487 -0.931 . . . . 1.0 108.487 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.6 mt -48.89 129.36 14.7 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.015 -1.053 . . . . 1.0 108.924 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -68.23 176.69 5.24 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 CA-C-N 119.939 1.014 . . . . 1.0 112.646 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.23 -40.02 88.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.481 -0.762 . . . . 1.0 109.793 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -56.38 -49.41 74.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -0.944 . . . . 1.0 109.691 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -70.03 -40.01 75.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.204 -0.935 . . . . 1.0 110.141 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 62.4 t -59.97 -46.56 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.936 -1.102 . . . . 1.0 109.099 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -60.73 -40.01 90.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.144 -0.973 . . . . 1.0 110.321 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.34 -54.7 10.17 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 120.199 -1.0 . . . . 1.0 111.188 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.48 HG23 ' N ' ' A' ' 160' ' ' GLN . 7.2 tp -61.7 -40.47 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.975 -1.309 . . . . 1.0 109.957 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.527 ' O ' ' N ' ' A' ' 164' ' ' GLY . 92.3 mm-40 -65.28 -39.61 92.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.182 -0.949 . . . . 1.0 109.539 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 78.0 p -64.7 -27.74 69.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.921 . . . . 1.0 110.273 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 94.0 mt -87.0 -53.18 5.02 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.978 -1.077 . . . . 1.0 110.322 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -92.04 -9.25 43.44 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.215 -0.928 . . . . 1.0 110.119 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.496 2.64 0 N-CA-C 109.401 -1.48 . . . . 1.0 109.401 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.0 mt . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.326 -0.62 . . . . 1.0 109.326 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -165.63 163.66 19.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.216 -0.928 . . . . 1.0 110.126 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -70.45 147.01 49.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 1.0 109.443 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.2 t -89.41 2.2 54.8 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.301 -0.874 . . . . 1.0 109.987 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -147.94 155.39 41.52 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.064 -1.023 . . . . 1.0 109.688 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.535 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.55 1.92 56.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.352 -0.843 . . . . 1.0 109.842 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -95.41 120.95 36.53 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.1 -1.0 . . . . 1.0 109.205 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.9 mt -140.28 150.54 44.18 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.372 -0.83 . . . . 1.0 108.9 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 69.1 p -134.26 156.14 48.94 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.885 -0.783 . . . . 1.0 108.885 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -145.12 162.07 37.93 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.063 -1.023 . . . . 1.0 110.142 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.421 HH21 ' HA ' ' A' ' 57' ' ' ILE . 6.8 ttm180 -141.74 131.05 23.58 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.46 -0.775 . . . . 1.0 109.933 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 86.5 mt -86.76 111.16 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.938 -1.134 . . . . 1.0 107.938 178.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 79.6 t -66.56 -40.71 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.088 -1.008 . . . . 1.0 109.371 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' A' ' 21' ' ' ASN . 18.2 p-10 -161.11 150.55 16.84 Favored 'General case' 0 C--N 1.286 -2.178 0 C-N-CA 117.452 -1.699 . . . . 1.0 111.005 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -97.01 107.81 20.42 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 104.676 -2.342 . . . . 1.0 104.676 177.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 23' ' ' THR . 0.6 OUTLIER -55.75 141.51 65.42 Favored Pre-proline 0 C--N 1.299 -1.595 0 O-C-N 121.143 -0.973 . . . . 1.0 110.168 -176.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -61.19 -11.79 20.45 Favored 'Trans proline' 0 N--CA 1.485 1.028 0 CA-C-N 119.061 0.7 . . . . 1.0 110.869 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -56.77 -26.21 56.99 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.774 -0.77 . . . . 1.0 110.092 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 73.1 mtm -144.32 163.11 34.69 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.965 -1.085 . . . . 1.0 109.27 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.1 p -72.69 158.82 34.89 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.377 -0.827 . . . . 1.0 109.138 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -60.21 -41.48 93.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -0.917 . . . . 1.0 110.401 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.1 m -59.84 -40.38 88.33 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.967 -1.083 . . . . 1.0 110.569 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.93 -41.59 86.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.885 -1.134 . . . . 1.0 110.413 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.3 t -67.9 -40.09 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.86 -1.15 . . . . 1.0 109.818 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -57.48 -58.87 6.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.332 -0.855 . . . . 1.0 111.286 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -27.55 69.4 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.248 -0.908 . . . . 1.0 110.203 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.02 -51.47 69.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.961 -1.087 . . . . 1.0 110.223 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -68.79 -37.02 78.98 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.876 -1.14 . . . . 1.0 110.158 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -60.02 -44.95 94.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.945 -1.097 . . . . 1.0 109.398 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.468 ' HB3' ' HZ3' ' A' ' 37' ' ' LYS . 10.4 mtpm? -59.96 -40.07 87.78 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.157 -0.964 . . . . 1.0 109.207 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.03 -46.86 88.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.341 -0.849 . . . . 1.0 110.049 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.418 ' CZ ' ' CZ ' ' A' ' 121' ' ' PHE . 62.5 m-85 -67.51 -38.64 84.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.926 -1.109 . . . . 1.0 109.747 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -60.02 -47.85 84.15 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.269 -0.895 . . . . 1.0 109.644 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.4 t -59.98 -40.61 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.142 -0.974 . . . . 1.0 109.972 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -79.49 -35.16 40.6 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.864 -1.147 . . . . 1.0 109.789 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.3 p -72.49 -20.26 61.4 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.908 -1.12 . . . . 1.0 109.865 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.88 -40.02 87.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.253 -0.905 . . . . 1.0 110.561 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.7 m -111.13 22.25 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.336 -0.852 . . . . 1.0 110.404 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.6 p -149.0 135.85 10.57 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 120.81 -1.181 . . . . 1.0 109.439 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -73.13 20.72 0.34 Allowed 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 120.682 0.921 . . . . 1.0 112.01 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.76 136.39 54.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 1.0 109.563 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -108.82 120.59 42.94 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.668 -0.864 . . . . 1.0 108.668 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -110.45 124.93 52.68 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.458 -0.776 . . . . 1.0 109.946 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.5 m -119.97 130.01 54.57 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.558 -0.713 . . . . 1.0 109.275 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.412 ' HG2' HH11 ' A' ' 52' ' ' ARG . 33.9 ttt-85 -81.28 130.5 35.06 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.201 -0.937 . . . . 1.0 110.003 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 89.8 mt -104.07 130.02 51.75 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.315 -0.866 . . . . 1.0 109.094 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.436 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 50.9 m170 -63.94 -40.1 95.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.307 -0.871 . . . . 1.0 109.823 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 70.7 m-20 -153.46 179.99 8.29 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.063 -1.023 . . . . 1.0 109.769 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.56 -173.05 32.07 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.839 -1.304 . . . . 1.0 109.839 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.421 ' HA ' HH21 ' A' ' 18' ' ' ARG . 90.2 mt -95.02 126.38 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.341 -1.093 . . . . 1.0 109.109 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.16 158.61 19.45 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.391 -0.818 . . . . 1.0 109.264 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -59.96 -49.94 75.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.232 -0.918 . . . . 1.0 109.87 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 92.7 mt -109.11 97.19 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.504 -0.748 . . . . 1.0 109.882 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.6 ptm -96.5 130.06 43.74 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.913 -1.117 . . . . 1.0 109.061 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.3 mt -108.71 133.38 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.609 -0.682 . . . . 1.0 109.788 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 79.3 p -152.31 158.44 42.76 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.144 -0.972 . . . . 1.0 109.854 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -100.18 135.0 42.28 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.464 -0.939 . . . . 1.0 108.464 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -121.83 167.82 14.54 Favored Glycine 0 N--CA 1.498 2.818 0 N-CA-C 110.243 -1.143 . . . . 1.0 110.243 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 108.514 -0.921 . . . . 1.0 108.514 179.378 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.543 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 89.3 m-85 . . . . . 0 N--CA 1.495 1.797 0 N-CA-C 108.908 -0.775 . . . . 1.0 108.908 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -100.05 12.55 36.64 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.156 -0.965 . . . . 1.0 111.03 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 119.79 -146.8 18.06 Favored Glycine 0 N--CA 1.506 3.352 0 N-CA-C 109.03 -1.628 . . . . 1.0 109.03 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.43 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 13.2 Cg_endo -77.91 -51.94 0.07 OUTLIER 'Trans proline' 0 N--CA 1.49 1.31 0 CA-C-N 119.281 1.54 . . . . 1.0 111.762 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 81.3 p -80.4 161.9 24.74 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.243 -0.911 . . . . 1.0 109.69 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 105.52 -126.53 8.65 Favored Glycine 0 N--CA 1.501 2.972 0 N-CA-C 110.189 -1.165 . . . . 1.0 110.189 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.424 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 13.6 mt -67.12 100.13 0.74 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.414 -1.051 . . . . 1.0 109.344 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 31.0 mt -79.2 -19.15 51.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.083 -1.011 . . . . 1.0 108.765 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.99 171.02 1.42 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.684 -0.858 . . . . 1.0 108.684 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.455 ' ND1' ' C ' ' A' ' 84' ' ' HIS . 8.5 p80 -162.32 167.44 23.82 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.238 -0.914 . . . . 1.0 108.797 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.29 159.55 44.36 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.189 -0.944 . . . . 1.0 109.188 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -95.64 151.83 38.76 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 108.016 -1.105 . . . . 1.0 108.016 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -62.49 166.49 13.22 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 120.47 0.78 . . . . 1.0 111.088 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo . . . . . 0 N--CA 1.491 1.337 0 C-N-CA 121.03 1.153 . . . . 1.0 111.792 -179.748 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 121.197 0.522 . . . . 1.0 110.053 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.7 122.93 9.56 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.294 -0.879 . . . . 1.0 109.524 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.448 ' ND1' ' CE1' ' A' ' 84' ' ' HIS . 41.4 m170 -106.7 142.54 36.18 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.534 -0.729 . . . . 1.0 110.179 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.499 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 40.3 m-85 -124.11 138.24 54.46 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 108.801 -0.814 . . . . 1.0 108.801 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.543 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 93.4 m-20 -80.33 123.59 28.13 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.092 -1.005 . . . . 1.0 109.985 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 9.8 t70 -84.31 2.92 38.01 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.194 -0.941 . . . . 1.0 109.667 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -79.8 -18.8 50.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.227 -0.921 . . . . 1.0 109.42 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 102' ' ' GLU . 57.3 mp0 -91.83 169.96 10.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.366 -0.833 . . . . 1.0 109.166 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 11.9 m -98.59 108.16 20.78 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.433 -0.951 . . . . 1.0 108.433 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -85.63 128.32 34.74 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.248 -0.908 . . . . 1.0 108.565 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.643 HG21 ' HB2' ' A' ' 109' ' ' LYS . 7.6 t -143.87 155.96 44.29 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.265 -0.897 . . . . 1.0 110.071 -178.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 83.6 p -94.91 -7.26 40.54 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.323 -0.991 . . . . 1.0 108.323 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 57.9 m -92.65 179.01 5.62 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.645 -0.872 . . . . 1.0 108.645 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.4 m -80.7 76.08 7.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.983 -1.073 . . . . 1.0 109.34 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.643 ' HB2' HG21 ' A' ' 105' ' ' THR . 58.8 mttp -147.85 152.24 37.28 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.735 -0.839 . . . . 1.0 108.735 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 43.27 -140.0 2.89 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.111 -1.195 . . . . 1.0 110.111 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -100.02 114.46 27.78 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.386 -1.067 . . . . 1.0 109.321 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.452 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 57.8 t-20 -62.27 132.11 51.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.093 -1.005 . . . . 1.0 109.26 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.06 -41.45 92.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.28 -0.888 . . . . 1.0 110.289 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -60.02 -43.91 94.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.214 -0.929 . . . . 1.0 111.344 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -57.81 -51.21 70.51 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.845 -1.159 . . . . 1.0 109.65 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 64.3 t -69.72 -40.02 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.108 -0.995 . . . . 1.0 109.691 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.54 -49.96 74.63 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.237 -0.914 . . . . 1.0 109.55 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.8 -38.99 83.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.321 -0.862 . . . . 1.0 110.47 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.603 ' CE1' ' HE2' ' A' ' 123' ' ' HIS . 77.9 t60 -62.46 -49.86 73.74 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.044 -1.035 . . . . 1.0 111.059 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.499 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 7.7 pt-20 -60.03 -39.48 86.03 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.719 -1.238 . . . . 1.0 110.302 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.418 ' CZ ' ' CZ ' ' A' ' 39' ' ' PHE . 30.4 m-85 -60.07 -40.12 88.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.882 -1.136 . . . . 1.0 108.732 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.11 -45.23 94.2 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.276 -1.53 . . . . 1.0 109.276 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.603 ' HE2' ' CE1' ' A' ' 119' ' ' HIS . 84.8 m-70 -65.75 -39.94 91.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.107 -1.231 . . . . 1.0 109.405 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.3 p -62.02 -26.23 68.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.923 . . . . 1.0 109.195 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 84.5 mt -80.61 -4.27 53.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.186 -0.946 . . . . 1.0 109.718 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 92.41 10.09 61.03 Favored Glycine 0 N--CA 1.496 2.684 0 C-N-CA 120.178 -1.01 . . . . 1.0 110.907 178.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.7 mt -82.74 149.9 27.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.83 -1.394 . . . . 1.0 109.165 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 42.6 t0 -101.19 171.65 7.48 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.542 -0.724 . . . . 1.0 109.339 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.54 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 65.7 m80 -59.91 137.18 58.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.13 -0.982 . . . . 1.0 109.71 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 40.3 t -97.35 156.0 16.64 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.405 -0.81 . . . . 1.0 109.171 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -97.45 2.03 49.84 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.172 -0.955 . . . . 1.0 110.006 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 7.5 t70 -85.84 129.98 52.39 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.097 -1.002 . . . . 1.0 108.665 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -68.23 -28.02 34.31 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 CA-C-N 120.106 1.073 . . . . 1.0 112.377 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.475 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -81.97 -1.81 90.39 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.753 -1.339 . . . . 1.0 109.753 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.17 146.16 25.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.304 -1.115 . . . . 1.0 109.754 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.407 ' C ' ' H ' ' A' ' 138' ' ' PHE . 84.2 mt -69.98 -32.97 71.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.333 -0.855 . . . . 1.0 109.428 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 98.1 mmm -71.78 13.33 0.28 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.504 -0.747 . . . . 1.0 110.328 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.407 ' H ' ' C ' ' A' ' 136' ' ' LEU . 13.5 t80 -69.24 135.6 89.06 Favored Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 107.811 -1.181 . . . . 1.0 107.811 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -64.22 -0.42 2.81 Favored 'Trans proline' 0 N--CA 1.5 1.855 0 CA-C-N 119.96 1.021 . . . . 1.0 114.564 -177.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.7 mt -119.69 138.1 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.368 0 O-C-N 120.835 -1.166 . . . . 1.0 109.979 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . 0.452 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 24.3 t80 -72.75 130.22 40.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.692 -0.63 . . . . 1.0 110.012 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.7 t -140.53 139.98 35.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.429 -0.794 . . . . 1.0 109.198 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -82.72 140.72 32.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.972 -1.08 . . . . 1.0 109.52 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.5 t -138.64 155.46 48.28 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.296 -0.878 . . . . 1.0 109.927 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -75.48 109.64 2.84 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.096 -1.602 . . . . 1.0 109.096 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.449 ' HE2' HD21 ' A' ' 112' ' ' ASN . 8.5 mtmp? -78.23 0.29 25.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.284 -1.127 . . . . 1.0 110.033 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 22.9 t -60.01 -40.49 89.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.075 -1.016 . . . . 1.0 109.856 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -139.94 32.21 1.99 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.212 -0.93 . . . . 1.0 109.825 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -79.23 130.15 35.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.001 -1.062 . . . . 1.0 110.151 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 77.8 mtm -133.87 149.35 51.34 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.39 -0.967 . . . . 1.0 108.39 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 62.0 mt -51.58 128.71 34.39 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 120.957 -1.09 . . . . 1.0 108.898 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -69.63 177.47 5.46 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 CA-C-N 120.051 1.054 . . . . 1.0 112.175 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -62.24 -39.97 94.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.46 -0.775 . . . . 1.0 109.878 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -55.9 -48.46 75.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.15 -0.968 . . . . 1.0 109.87 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.04 -39.87 75.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.078 -1.013 . . . . 1.0 110.027 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.23 -47.15 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.123 -0.986 . . . . 1.0 109.341 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -60.34 -40.07 89.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.845 -1.159 . . . . 1.0 110.503 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -69.9 -54.65 11.21 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 120.176 -1.011 . . . . 1.0 111.129 -178.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.456 HG23 ' N ' ' A' ' 160' ' ' GLN . 4.7 tp -60.05 -39.93 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.857 -1.378 . . . . 1.0 109.572 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.456 ' N ' HG23 ' A' ' 159' ' ' ILE . 95.7 mt-30 -64.01 -39.99 95.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.932 -1.105 . . . . 1.0 109.473 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 88.6 p -58.46 -30.16 66.75 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.747 -1.221 . . . . 1.0 108.871 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 92.5 mt -88.87 -69.62 0.7 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.245 -0.909 . . . . 1.0 111.079 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -89.17 -11.59 43.37 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.998 -1.064 . . . . 1.0 111.185 -177.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.72 0 N-CA-C 109.766 -1.334 . . . . 1.0 109.766 179.967 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.9 mt . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.328 -0.619 . . . . 1.0 109.328 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -163.05 162.34 25.8 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 1.0 109.304 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -71.02 147.26 48.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.181 -0.949 . . . . 1.0 109.594 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.2 t -89.98 2.05 55.57 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.402 -0.811 . . . . 1.0 110.35 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -144.83 154.31 42.53 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.001 -1.062 . . . . 1.0 109.99 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.55 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.28 0.21 57.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.305 -0.872 . . . . 1.0 109.72 -179.734 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -94.0 121.99 36.05 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.148 -0.97 . . . . 1.0 109.007 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.2 mt -140.18 151.47 45.27 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.365 -0.834 . . . . 1.0 109.213 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.0 p -133.72 157.33 46.1 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.455 -0.778 . . . . 1.0 109.193 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -145.32 160.24 41.82 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.142 -0.974 . . . . 1.0 109.916 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -140.99 134.01 29.25 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.369 -0.832 . . . . 1.0 110.068 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.7 mm -89.04 111.21 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.011 -1.107 . . . . 1.0 108.011 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.6 t -67.84 -39.74 82.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.126 -0.984 . . . . 1.0 109.121 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.643 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.0 OUTLIER -161.23 150.5 16.56 Favored 'General case' 0 C--N 1.29 -1.992 0 O-C-N 119.294 -2.129 . . . . 1.0 111.466 -179.628 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.63 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 52.4 m-85 -99.94 99.03 9.74 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 106.097 -1.816 . . . . 1.0 106.097 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.1 t -47.67 141.15 7.58 Favored Pre-proline 0 C--N 1.299 -1.615 0 O-C-N 121.515 -0.74 . . . . 1.0 110.769 -177.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.86 -8.12 7.18 Favored 'Trans proline' 0 N--CA 1.488 1.166 0 C-N-CA 120.649 0.899 . . . . 1.0 111.223 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -59.02 -35.5 73.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.461 -0.775 . . . . 1.0 109.821 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 74.0 mtm -139.59 160.99 38.58 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.192 -0.942 . . . . 1.0 109.657 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 55.1 p -70.71 160.37 32.76 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.401 -0.812 . . . . 1.0 109.397 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.63 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 3.8 m80 -60.1 -40.54 89.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.318 -0.864 . . . . 1.0 110.263 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.7 m -59.97 -42.36 93.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.085 -1.009 . . . . 1.0 110.526 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -67.87 -40.36 83.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.242 -0.911 . . . . 1.0 110.393 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 70.9 t -68.97 -43.01 82.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.166 -0.959 . . . . 1.0 110.242 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -60.04 -49.16 78.75 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.138 -0.976 . . . . 1.0 110.824 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -61.35 -33.12 73.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.908 -1.12 . . . . 1.0 110.068 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.0 -49.77 76.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.893 -1.129 . . . . 1.0 109.979 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.497 ' CE1' HD13 ' A' ' 62' ' ' ILE . 53.5 m-85 -67.36 -39.98 85.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.022 -1.049 . . . . 1.0 110.185 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -60.01 -43.22 95.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.951 -1.093 . . . . 1.0 110.089 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.45 -40.18 95.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.06 -1.025 . . . . 1.0 109.676 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.18 -44.45 95.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.263 -0.898 . . . . 1.0 110.196 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -69.58 -38.2 77.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.04 -1.038 . . . . 1.0 109.697 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.415 ' O ' ' CG ' ' A' ' 44' ' ' ASP . 50.4 tptt -60.0 -48.05 83.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.063 -1.023 . . . . 1.0 109.594 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.3 t -59.97 -41.15 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.119 -0.988 . . . . 1.0 109.869 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -78.46 -37.96 42.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.854 -1.154 . . . . 1.0 109.903 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.3 p -71.18 -19.22 62.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.054 -1.029 . . . . 1.0 109.643 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.415 ' CG ' ' O ' ' A' ' 40' ' ' LYS . 95.0 m-20 -60.04 -40.02 87.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.911 . . . . 1.0 110.603 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.9 m -108.63 22.04 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 121.126 -0.984 . . . . 1.0 111.304 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.2 p -149.79 144.82 18.11 Favored Pre-proline 0 N--CA 1.502 2.129 0 O-C-N 120.678 -1.264 . . . . 1.0 109.418 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -75.27 19.56 0.51 Allowed 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 120.615 0.877 . . . . 1.0 111.502 178.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.7 mt -68.99 130.31 42.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.12 -0.988 . . . . 1.0 109.719 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -107.02 120.61 42.55 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.591 -0.892 . . . . 1.0 108.591 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -108.39 125.98 52.35 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.285 -0.884 . . . . 1.0 109.713 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -120.01 129.95 54.5 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.643 -0.661 . . . . 1.0 109.846 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -82.01 130.92 35.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.325 -0.859 . . . . 1.0 109.028 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 89.4 mt -102.84 135.19 44.95 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.284 -0.885 . . . . 1.0 109.021 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.447 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 91.9 m-70 -64.26 -40.4 95.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.243 -0.911 . . . . 1.0 109.905 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 69.3 m-20 -155.69 -173.76 4.67 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.191 -0.943 . . . . 1.0 109.706 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.59 -169.51 35.77 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.05 -1.22 . . . . 1.0 110.05 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 87.6 mt -93.75 129.42 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.414 -1.051 . . . . 1.0 108.978 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.79 164.31 12.69 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.395 -0.816 . . . . 1.0 109.156 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -59.95 -49.64 76.9 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.124 -0.985 . . . . 1.0 109.032 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.2 mt -122.34 112.81 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.916 -0.772 . . . . 1.0 108.916 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.7 ptp -97.96 137.06 37.34 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.996 -1.065 . . . . 1.0 109.238 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.497 HD13 ' CE1' ' A' ' 35' ' ' PHE . 97.5 mt -105.29 133.07 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.279 -0.888 . . . . 1.0 109.687 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 84.2 p -151.84 152.4 32.56 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.235 -0.916 . . . . 1.0 109.761 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.477 ' H ' HD21 ' A' ' 21' ' ' ASN . 55.3 m-85 -106.68 122.67 46.81 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.461 -0.774 . . . . 1.0 109.045 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -97.31 -178.97 34.18 Favored Glycine 0 N--CA 1.497 2.756 0 O-C-N 121.187 -0.946 . . . . 1.0 111.187 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 67.5 mt . . . . . 0 N--CA 1.497 1.922 0 O-C-N 121.793 -0.827 . . . . 1.0 108.843 179.761 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.556 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 99.8 m-85 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 108.946 -0.761 . . . . 1.0 108.946 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 28.2 p-10 -96.53 -0.04 49.44 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.126 -0.984 . . . . 1.0 110.532 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.426 ' O ' ' OE2' ' A' ' 102' ' ' GLU . . . 117.4 -119.45 4.44 Favored Glycine 0 N--CA 1.504 3.225 0 N-CA-C 110.249 -1.141 . . . . 1.0 110.249 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.459 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 28.8 Cg_endo -74.69 -72.45 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.797 0 CA-C-N 120.179 1.989 . . . . 1.0 113.012 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.425 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 81.3 p -74.76 171.49 13.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.034 -1.041 . . . . 1.0 109.839 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 104.02 -135.19 12.29 Favored Glycine 0 N--CA 1.498 2.8 0 N-CA-C 110.231 -1.148 . . . . 1.0 110.231 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.6 mt -68.86 107.32 3.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.388 -1.066 . . . . 1.0 109.692 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 84.2 mt -79.65 -25.54 41.33 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.158 -0.964 . . . . 1.0 108.892 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.54 172.82 1.4 Allowed 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.733 -0.84 . . . . 1.0 108.733 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -162.78 166.23 24.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.79 -1.194 . . . . 1.0 109.982 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -153.34 159.73 42.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.439 -0.788 . . . . 1.0 109.21 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -106.77 151.63 40.58 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.366 -0.834 . . . . 1.0 109.128 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -64.38 165.51 19.79 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 121.045 1.164 . . . . 1.0 111.614 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo . . . . . 0 C--N 1.316 -1.162 0 C-N-CA 120.906 1.071 . . . . 1.0 112.003 -179.847 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.5 p-10 . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 109.235 -0.654 . . . . 1.0 109.235 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -146.31 123.76 11.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.021 -1.05 . . . . 1.0 109.654 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -114.73 153.17 30.78 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.375 -0.602 . . . . 1.0 109.375 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.529 ' CE2' ' OE2' ' A' ' 120' ' ' GLU . 39.5 m-85 -137.69 149.78 46.8 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.609 -0.886 . . . . 1.0 108.609 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.556 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 88.1 m-20 -81.39 121.14 25.86 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.684 -1.26 . . . . 1.0 109.009 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -82.65 -5.45 58.84 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.121 -0.987 . . . . 1.0 109.35 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -81.39 -9.33 59.75 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.347 -0.846 . . . . 1.0 109.209 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.459 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 52.7 mm-40 -89.03 176.05 7.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.334 -0.854 . . . . 1.0 109.422 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 26.0 m -106.96 107.01 17.82 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.475 -0.935 . . . . 1.0 108.475 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -86.88 122.9 31.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.365 -0.834 . . . . 1.0 109.127 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.637 HG21 ' HB2' ' A' ' 109' ' ' LYS . 7.8 t -141.54 150.76 42.54 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.363 -0.835 . . . . 1.0 109.925 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 59.8 p -93.01 -6.91 47.26 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.232 -1.025 . . . . 1.0 108.232 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 81.9 p -92.83 176.67 6.35 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.005 -0.739 . . . . 1.0 109.005 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.6 t -77.68 76.95 4.21 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.198 -0.939 . . . . 1.0 109.484 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.637 ' HB2' HG21 ' A' ' 105' ' ' THR . 62.9 mttp -148.13 146.92 28.98 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.74 -139.92 5.81 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.881 -1.287 . . . . 1.0 109.881 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -100.11 115.19 29.21 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.304 -1.115 . . . . 1.0 109.365 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.408 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 9.7 t-20 -61.76 133.04 55.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.117 -0.989 . . . . 1.0 109.469 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.5 tp -59.99 -42.95 95.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.32 -0.862 . . . . 1.0 110.482 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -59.93 -40.99 90.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.087 -1.008 . . . . 1.0 110.436 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -59.91 -50.69 72.78 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.872 -1.143 . . . . 1.0 110.014 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.5 t -68.36 -45.11 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.172 -0.955 . . . . 1.0 110.448 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.63 -47.43 82.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.308 -0.87 . . . . 1.0 110.018 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.98 -41.0 91.07 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.929 -1.107 . . . . 1.0 110.77 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.612 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 60.8 t60 -65.91 -49.02 69.5 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.055 -1.028 . . . . 1.0 111.78 -178.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.529 ' OE2' ' CE2' ' A' ' 98' ' ' PHE . 9.0 pt-20 -60.02 -42.34 94.12 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.495 -1.378 . . . . 1.0 110.368 -178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -60.05 -40.04 88.08 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.682 -1.261 . . . . 1.0 108.655 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.32 -42.71 64.42 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.161 -1.576 . . . . 1.0 109.161 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.612 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 83.3 m-70 -66.27 -40.0 89.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -1.13 . . . . 1.0 109.136 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 86.2 p -64.58 -21.96 66.84 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.42 -0.8 . . . . 1.0 109.577 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.9 mt -83.51 1.51 41.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.298 -0.877 . . . . 1.0 109.972 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.93 4.88 68.8 Favored Glycine 0 N--CA 1.497 2.705 0 O-C-N 121.068 -1.02 . . . . 1.0 110.701 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.9 mt -85.52 146.14 27.06 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.887 -1.361 . . . . 1.0 109.387 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 30.8 t0 -102.56 174.84 5.72 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.47 -0.769 . . . . 1.0 109.373 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.451 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 66.9 m80 -59.97 137.93 57.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.142 -0.974 . . . . 1.0 109.374 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 34.2 t -98.25 158.07 15.79 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.361 -0.837 . . . . 1.0 109.48 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -95.97 -0.42 50.71 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.225 -0.922 . . . . 1.0 109.663 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -86.08 128.47 57.73 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.108 -0.995 . . . . 1.0 108.935 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -68.41 -19.84 42.83 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 CA-C-N 120.065 1.059 . . . . 1.0 112.5 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -88.38 -5.0 76.38 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.772 -1.331 . . . . 1.0 109.772 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.79 145.62 27.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.33 -1.1 . . . . 1.0 109.664 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.5 mt -70.0 -30.98 68.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.876 . . . . 1.0 109.406 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.7 mmm -71.89 10.67 0.66 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.361 -0.837 . . . . 1.0 110.053 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -70.05 134.14 87.65 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 107.907 -1.146 . . . . 1.0 107.907 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -60.81 -20.36 65.86 Favored 'Trans proline' 0 N--CA 1.502 1.983 0 C-N-CA 120.968 1.112 . . . . 1.0 114.308 -177.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.6 mt -98.22 139.84 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 O-C-N 120.696 -1.253 . . . . 1.0 110.293 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . 0.408 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 28.3 t80 -75.97 132.28 40.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.482 -0.761 . . . . 1.0 109.901 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.4 t -141.5 142.25 33.6 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.26 -0.9 . . . . 1.0 109.412 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -79.41 143.35 35.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.092 -1.005 . . . . 1.0 108.681 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.3 t -139.99 150.01 43.93 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.172 -0.955 . . . . 1.0 109.684 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.19 108.03 2.32 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.617 -1.393 . . . . 1.0 109.617 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.446 ' NZ ' ' CB ' ' A' ' 146' ' ' LYS . 7.8 mtpm? -76.81 0.12 21.86 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.422 -1.046 . . . . 1.0 109.778 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.3 t -60.01 -44.81 94.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.192 -0.943 . . . . 1.0 110.148 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -142.34 29.61 1.6 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.17 -0.956 . . . . 1.0 110.11 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -66.44 138.03 57.27 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.836 -1.165 . . . . 1.0 109.34 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 76.9 mtm -139.54 142.74 37.2 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.356 -0.84 . . . . 1.0 109.124 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 46.9 mt -49.16 110.92 1.69 Allowed Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.151 -0.968 . . . . 1.0 109.164 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -56.01 177.09 0.15 Allowed 'Trans proline' 0 N--CA 1.494 1.555 0 CA-C-N 120.119 1.078 . . . . 1.0 112.887 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -60.02 -39.88 87.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.466 -0.771 . . . . 1.0 109.997 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -56.1 -48.63 75.79 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.174 -0.953 . . . . 1.0 110.029 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -70.05 -40.01 75.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.908 . . . . 1.0 109.904 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.64 -45.66 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.178 -0.951 . . . . 1.0 109.641 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -61.6 -40.12 93.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.993 -1.067 . . . . 1.0 110.448 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.16 -52.32 14.19 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 120.35 -0.928 . . . . 1.0 111.524 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.448 HG23 ' N ' ' A' ' 160' ' ' GLN . 5.0 tp -60.59 -40.04 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.886 -1.361 . . . . 1.0 109.587 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 164' ' ' GLY . 97.4 mt-30 -65.33 -40.01 93.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.099 -1.001 . . . . 1.0 109.725 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 79.3 p -60.86 -32.25 71.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.112 -0.992 . . . . 1.0 110.483 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 89.5 mt -86.23 -51.83 6.03 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.874 -1.141 . . . . 1.0 110.921 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -92.0 -9.38 43.11 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.851 -1.156 . . . . 1.0 110.458 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.632 0 N-CA-C 109.676 -1.37 . . . . 1.0 109.676 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.3 mt . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.217 -0.66 . . . . 1.0 109.217 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -161.69 166.96 25.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 1.0 109.508 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -70.46 140.6 51.99 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.24 -0.912 . . . . 1.0 109.794 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.4 t -88.0 1.79 53.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.407 -0.808 . . . . 1.0 110.249 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -143.01 153.5 43.04 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.075 -1.016 . . . . 1.0 109.59 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.519 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.95 0.89 57.41 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.479 -0.763 . . . . 1.0 109.597 -179.609 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -96.56 121.14 38.06 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.174 -0.954 . . . . 1.0 109.183 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.8 mt -139.97 148.0 41.29 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.3 -0.875 . . . . 1.0 109.169 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.9 p -130.6 153.77 48.56 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -143.4 157.5 44.41 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.184 -0.948 . . . . 1.0 110.074 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.489 HH12 ' H ' ' A' ' 56' ' ' GLY . 71.7 ttt180 -143.18 132.74 23.64 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.555 -0.715 . . . . 1.0 109.333 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 84.7 mt -87.66 118.31 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.063 -1.023 . . . . 1.0 108.581 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.0 t -69.91 -40.02 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.991 -1.068 . . . . 1.0 109.002 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.2 p-10 -160.4 157.0 27.02 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.733 -1.23 . . . . 1.0 110.169 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.592 ' CD1' ' CD2' ' A' ' 28' ' ' HIS . 47.6 m-85 -100.44 -163.01 0.99 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.38 -1.341 . . . . 1.0 107.38 178.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.73 148.26 55.82 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.371 -0.831 . . . . 1.0 110.336 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -70.83 -21.64 28.27 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 120.661 0.907 . . . . 1.0 110.105 177.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -56.67 -36.05 69.13 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 115.725 -0.671 . . . . 1.0 110.707 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.7 mtm -135.04 163.85 28.96 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.299 -0.876 . . . . 1.0 109.469 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.4 p -73.36 159.68 32.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.484 -0.76 . . . . 1.0 109.291 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.592 ' CD2' ' CD1' ' A' ' 22' ' ' TYR . 2.9 m80 -60.79 -40.03 91.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.465 -0.772 . . . . 1.0 110.031 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.3 m -60.09 -40.46 89.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.147 -0.97 . . . . 1.0 110.185 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -67.29 -40.53 86.12 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.146 -0.971 . . . . 1.0 110.395 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.7 t -68.12 -40.41 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.121 -0.987 . . . . 1.0 109.988 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -60.05 -49.64 76.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.05 -1.031 . . . . 1.0 110.534 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -61.98 -31.55 71.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.984 -1.073 . . . . 1.0 109.68 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.07 -50.29 74.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.089 -1.007 . . . . 1.0 109.802 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -67.41 -39.67 85.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.161 -0.962 . . . . 1.0 110.215 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -59.97 -42.88 95.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.978 -1.077 . . . . 1.0 109.494 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -60.34 -39.84 88.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 1.0 109.065 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.86 -46.2 90.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.51 -0.744 . . . . 1.0 110.024 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.4 ' CZ ' ' CZ ' ' A' ' 121' ' ' PHE . 59.1 m-85 -67.04 -39.4 86.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.051 -1.03 . . . . 1.0 109.196 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.404 ' O ' ' CG ' ' A' ' 44' ' ' ASP . 47.3 tptt -60.09 -47.77 84.52 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.372 -0.83 . . . . 1.0 109.737 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.2 t -60.0 -40.03 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.011 -1.055 . . . . 1.0 109.591 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 70.0 m95 -79.61 -37.16 36.79 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.049 -1.032 . . . . 1.0 110.022 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 62.3 p -70.44 -19.78 62.95 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.034 -1.042 . . . . 1.0 109.557 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.404 ' CG ' ' O ' ' A' ' 40' ' ' LYS . 96.1 m-20 -60.09 -38.55 83.26 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.402 -0.811 . . . . 1.0 110.749 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.3 m -112.33 22.57 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.302 -0.873 . . . . 1.0 110.641 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.7 p -149.81 139.77 13.51 Favored Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 120.928 -1.108 . . . . 1.0 109.655 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -76.97 22.17 0.56 Allowed 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 120.829 1.019 . . . . 1.0 112.378 178.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 77.5 mt -69.71 139.96 53.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.919 -1.113 . . . . 1.0 109.75 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -109.71 120.07 41.36 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -109.09 125.64 52.34 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.351 -0.843 . . . . 1.0 109.481 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 93.8 m -120.07 129.93 54.43 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.542 -0.724 . . . . 1.0 109.476 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -82.72 128.24 34.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.332 -0.855 . . . . 1.0 109.496 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.9 mt -105.37 119.27 38.65 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.363 -0.835 . . . . 1.0 108.844 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.448 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 85.6 m-70 -70.03 -25.17 63.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.419 -0.801 . . . . 1.0 109.993 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 78.3 m-20 -147.76 160.18 43.01 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.271 -0.893 . . . . 1.0 109.806 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.489 ' H ' HH12 ' A' ' 18' ' ' ARG . . . 98.54 174.12 32.41 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 109.624 -1.39 . . . . 1.0 109.624 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.4 mt -94.42 133.49 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.349 -1.089 . . . . 1.0 108.977 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.28 159.35 17.5 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.367 -0.833 . . . . 1.0 109.61 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -59.85 -49.8 76.27 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.238 -0.914 . . . . 1.0 109.196 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.3 mt -105.13 100.43 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.539 -0.726 . . . . 1.0 109.666 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.2 ptm -102.79 127.89 49.77 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.323 -0.861 . . . . 1.0 108.993 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.5 mt -102.65 139.45 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.441 -0.787 . . . . 1.0 109.313 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.0 p -151.38 154.94 37.64 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.169 -0.957 . . . . 1.0 109.522 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -104.44 122.67 45.98 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.767 -0.827 . . . . 1.0 108.767 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.27 -169.5 20.5 Favored Glycine 0 N--CA 1.5 2.956 0 N-CA-C 110.197 -1.161 . . . . 1.0 110.197 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.4 mt . . . . . 0 N--CA 1.495 1.804 0 O-C-N 121.501 -1.0 . . . . 1.0 108.824 -179.855 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.534 ' CE2' ' OD1' ' A' ' 99' ' ' ASP . 22.2 m-85 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 108.782 -0.822 . . . . 1.0 108.782 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.5 p-10 -101.08 6.93 43.52 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.234 -0.916 . . . . 1.0 110.841 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 125.4 -145.71 15.83 Favored Glycine 0 N--CA 1.506 3.321 0 N-CA-C 108.938 -1.665 . . . . 1.0 108.938 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.472 ' O ' ' CG ' ' A' ' 102' ' ' GLU . 12.9 Cg_endo -77.43 -56.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.3 0 CA-C-N 119.41 1.605 . . . . 1.0 111.936 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 83.4 p -78.92 170.63 16.38 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.2 -0.938 . . . . 1.0 110.571 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.79 -120.19 6.78 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 110.571 -1.012 . . . . 1.0 110.571 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.418 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 11.0 mt -66.39 100.66 0.66 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.422 -1.046 . . . . 1.0 109.113 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 66.9 mt -81.15 -19.97 42.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.074 -1.016 . . . . 1.0 109.538 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.78 172.27 1.11 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -162.1 159.52 26.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 1.0 109.241 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.03 163.84 35.64 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.322 -0.861 . . . . 1.0 109.358 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -99.72 153.25 37.87 Favored Pre-proline 0 N--CA 1.495 1.794 0 N-CA-C 108.678 -0.86 . . . . 1.0 108.678 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -59.06 167.22 5.95 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 CA-C-N 118.801 0.607 . . . . 1.0 111.338 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo . . . . . 0 C--N 1.312 -1.379 0 C-N-CA 121.031 1.154 . . . . 1.0 111.759 179.915 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.556 -0.535 . . . . 1.0 109.556 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.75 124.69 10.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.245 -0.91 . . . . 1.0 109.184 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 46.3 m170 -112.33 146.22 38.67 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.484 -0.76 . . . . 1.0 110.141 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -125.44 141.49 52.03 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.819 -0.808 . . . . 1.0 108.819 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.534 ' OD1' ' CE2' ' A' ' 75' ' ' PHE . 95.8 m-20 -79.81 121.43 25.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.079 -1.013 . . . . 1.0 109.42 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 47.0 t0 -84.16 1.55 43.81 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.122 -0.986 . . . . 1.0 109.844 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -81.78 -15.18 55.06 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.004 -1.06 . . . . 1.0 110.312 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.567 ' OE1' ' N ' ' A' ' 102' ' ' GLU . 57.4 mp0 -93.15 177.3 6.1 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.114 -0.991 . . . . 1.0 109.911 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 16.6 m -100.17 108.11 20.14 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.724 -0.843 . . . . 1.0 108.724 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -90.18 121.8 32.54 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.796 -0.816 . . . . 1.0 108.796 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.647 HG21 ' HB2' ' A' ' 109' ' ' LYS . 7.5 t -143.2 158.04 43.97 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.178 -0.951 . . . . 1.0 110.285 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.3 t -95.01 -6.99 41.02 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.459 -0.941 . . . . 1.0 108.459 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 109' ' ' LYS . 45.0 t -90.81 170.03 10.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.577 -0.702 . . . . 1.0 109.216 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.6 m -70.67 63.37 0.28 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.145 -0.972 . . . . 1.0 109.152 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.647 ' HB2' HG21 ' A' ' 105' ' ' THR . 67.9 mmtt -140.92 149.88 42.46 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.399 -0.813 . . . . 1.0 109.234 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 46.67 -146.16 3.57 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.477 -1.449 . . . . 1.0 109.477 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -98.61 115.27 28.28 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.33 -1.1 . . . . 1.0 108.836 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.431 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 61.4 t-20 -62.24 133.49 55.24 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.129 -0.982 . . . . 1.0 109.302 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.1 tp -59.95 -43.45 95.01 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.547 -0.721 . . . . 1.0 110.127 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -60.14 -42.41 94.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.345 -0.847 . . . . 1.0 111.274 -179.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -58.15 -52.83 63.93 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.749 -1.22 . . . . 1.0 109.585 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 71.1 t -66.85 -41.09 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.153 -0.967 . . . . 1.0 109.779 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.11 -49.51 76.7 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.253 -0.905 . . . . 1.0 109.71 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.31 -37.91 78.94 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 120.757 -1.214 . . . . 1.0 110.229 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.636 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 68.3 t60 -65.8 -49.24 69.02 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.157 -0.965 . . . . 1.0 111.884 -178.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -59.92 -39.34 85.13 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.534 -1.354 . . . . 1.0 109.609 -178.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.4 ' CZ ' ' CZ ' ' A' ' 39' ' ' PHE . 29.8 m-85 -59.92 -40.09 87.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.877 -1.14 . . . . 1.0 108.894 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.65 -41.28 93.63 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.761 -1.336 . . . . 1.0 109.761 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.636 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 87.4 m-70 -66.52 -38.98 88.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.951 -1.323 . . . . 1.0 108.866 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 87.5 p -67.8 -22.51 65.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 1.0 109.639 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 84.3 mt -83.35 -1.87 54.39 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.122 -0.986 . . . . 1.0 110.09 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.07 5.4 62.44 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.382 -1.087 . . . . 1.0 110.382 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.6 mt -86.86 144.03 27.18 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.899 -1.353 . . . . 1.0 109.491 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 34.6 t0 -102.54 178.2 4.65 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.563 -0.711 . . . . 1.0 109.176 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.489 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 65.0 m80 -59.89 136.96 58.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.078 -1.014 . . . . 1.0 109.497 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 17.5 t -98.88 158.48 15.61 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.344 -0.848 . . . . 1.0 109.381 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -99.49 2.56 45.03 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.258 -0.902 . . . . 1.0 109.054 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -85.66 122.34 73.21 Favored Pre-proline 0 N--CA 1.488 1.452 0 N-CA-C 108.179 -1.045 . . . . 1.0 108.179 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -67.44 -15.01 44.4 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 CA-C-N 120.117 1.078 . . . . 1.0 111.903 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -90.26 -5.98 69.34 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.354 -1.498 . . . . 1.0 109.354 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -87.62 148.84 24.64 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.246 -1.149 . . . . 1.0 109.829 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.494 ' C ' ' H ' ' A' ' 138' ' ' PHE . 86.0 mt -70.08 -36.34 74.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.169 -0.957 . . . . 1.0 109.298 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.0 mmm -68.91 17.24 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.397 -0.814 . . . . 1.0 110.433 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.494 ' H ' ' C ' ' A' ' 136' ' ' LEU . 14.0 t80 -69.99 134.69 87.57 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 107.711 -1.218 . . . . 1.0 107.711 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -60.53 -6.89 6.17 Favored 'Trans proline' 0 N--CA 1.501 1.952 0 CA-C-N 119.833 0.976 . . . . 1.0 114.609 -177.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.85 137.77 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.43 0 O-C-N 121.054 -1.029 . . . . 1.0 109.656 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . 0.431 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 29.4 t80 -73.14 130.72 40.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.611 -0.681 . . . . 1.0 110.014 -178.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.3 t -139.69 139.94 36.72 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.361 -0.837 . . . . 1.0 109.068 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -81.55 141.75 33.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 1.0 109.256 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.9 t -139.96 152.46 46.34 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.27 -0.894 . . . . 1.0 109.977 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.15 108.66 2.56 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.551 -1.42 . . . . 1.0 109.551 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -77.21 1.19 19.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -1.147 . . . . 1.0 109.659 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 33.9 p -59.97 -40.1 87.96 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.32 -0.862 . . . . 1.0 110.011 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -144.02 22.9 1.73 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.063 -1.023 . . . . 1.0 110.41 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -64.97 135.48 55.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.078 -1.014 . . . . 1.0 110.016 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 78.0 mtm -136.4 146.13 46.09 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.086 -1.079 . . . . 1.0 108.086 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 54.5 mt -51.25 129.63 31.94 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 120.862 -1.149 . . . . 1.0 108.595 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -69.16 177.87 4.75 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 CA-C-N 119.994 1.033 . . . . 1.0 112.19 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -61.75 -40.02 93.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.569 -0.707 . . . . 1.0 110.214 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -54.69 -46.13 74.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.166 -0.959 . . . . 1.0 110.189 -178.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -69.0 -39.43 79.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.056 -1.027 . . . . 1.0 109.913 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 58.2 t -60.11 -47.68 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.087 -1.008 . . . . 1.0 108.792 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -61.1 -40.21 92.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.118 -0.989 . . . . 1.0 110.428 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.03 -51.77 13.41 Favored Glycine 0 N--CA 1.495 2.586 0 O-C-N 121.16 -0.962 . . . . 1.0 111.261 -178.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.484 HG23 ' N ' ' A' ' 160' ' ' GLN . 5.1 tp -62.19 -41.29 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.897 -1.355 . . . . 1.0 110.163 -178.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.536 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.2 mt-30 -63.42 -38.97 93.2 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.0 -1.062 . . . . 1.0 109.597 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 79.5 p -60.91 -34.52 74.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.906 . . . . 1.0 110.507 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 95.6 mt -84.13 -48.81 9.47 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.872 -1.142 . . . . 1.0 110.845 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -91.57 -9.81 42.86 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.824 -1.173 . . . . 1.0 110.322 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.493 2.446 0 N-CA-C 109.615 -1.394 . . . . 1.0 109.615 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.0 mt . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 108.859 -0.793 . . . . 1.0 108.859 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.459 ' NZ ' ' O ' ' A' ' 162' ' ' LEU . 0.8 OUTLIER -159.97 160.04 32.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.175 -0.953 . . . . 1.0 109.601 -179.827 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -72.88 134.66 44.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.906 . . . . 1.0 109.436 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.6 t -69.63 -42.06 74.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 1.0 109.515 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -95.09 149.97 20.69 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.245 -0.91 . . . . 1.0 109.661 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.3 mmt -90.7 -0.0 57.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.28 -0.887 . . . . 1.0 109.598 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -96.72 132.28 42.55 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.227 -0.921 . . . . 1.0 109.313 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.5 mt -140.22 149.99 43.57 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.283 -0.885 . . . . 1.0 109.226 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 70.5 p -133.38 157.24 46.04 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.559 -0.904 . . . . 1.0 108.559 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -143.88 162.93 34.83 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.002 -1.061 . . . . 1.0 110.464 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -141.66 127.45 19.24 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 91.1 mt -87.74 118.65 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.273 -0.892 . . . . 1.0 108.935 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.9 t -69.5 -39.97 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.392 -0.818 . . . . 1.0 109.613 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -164.83 152.94 11.93 Favored 'General case' 0 C--N 1.289 -2.023 0 O-C-N 119.927 -1.733 . . . . 1.0 110.964 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.608 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 27.3 m-85 -98.39 109.46 22.21 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 104.436 -2.431 . . . . 1.0 104.436 177.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.474 ' OG1' ' OD2' ' A' ' 25' ' ' ASP . 3.0 t -57.42 143.07 75.3 Favored Pre-proline 0 C--N 1.294 -1.824 0 C-N-CA 119.355 -0.938 . . . . 1.0 110.21 -176.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -60.16 -8.49 8.36 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 C-N-CA 120.436 0.757 . . . . 1.0 111.015 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.474 ' OD2' ' OG1' ' A' ' 23' ' ' THR . 66.1 m-20 -57.47 -32.56 67.09 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 120.054 -0.658 . . . . 1.0 109.597 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 73.5 mtm -140.06 160.88 38.94 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.208 -0.932 . . . . 1.0 109.317 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 76.4 p -71.41 161.06 31.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.315 -0.866 . . . . 1.0 109.244 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.608 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 9.2 m80 -61.1 -41.17 96.18 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.297 -0.877 . . . . 1.0 110.296 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.4 m -60.71 -40.59 92.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.989 -1.069 . . . . 1.0 110.204 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -68.9 -39.99 79.39 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.419 -0.801 . . . . 1.0 110.563 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 79.3 t -69.25 -42.8 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.1 -1.0 . . . . 1.0 110.399 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -59.98 -49.19 78.65 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.095 -1.003 . . . . 1.0 110.47 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -61.4 -33.35 73.54 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.054 -1.029 . . . . 1.0 109.915 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.96 -48.83 80.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.007 -1.058 . . . . 1.0 109.976 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.418 ' CE1' HD13 ' A' ' 62' ' ' ILE . 55.2 m-85 -68.16 -39.96 82.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.892 -1.13 . . . . 1.0 110.217 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -60.05 -43.76 95.16 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.858 -1.151 . . . . 1.0 109.775 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -60.07 -39.98 87.9 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.087 -1.008 . . . . 1.0 110.107 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.01 -46.83 88.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.223 -0.923 . . . . 1.0 109.906 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -67.36 -36.21 80.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.067 -1.021 . . . . 1.0 109.531 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -60.0 -49.67 76.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.072 -1.018 . . . . 1.0 109.875 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.7 t -60.25 -40.35 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.086 -1.009 . . . . 1.0 110.357 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -81.36 -34.9 31.44 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.957 -1.089 . . . . 1.0 110.118 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.5 p -71.06 -16.91 62.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.04 -1.038 . . . . 1.0 109.645 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.96 -40.03 87.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.326 -0.858 . . . . 1.0 110.062 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.5 m -110.05 -22.02 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.369 -0.832 . . . . 1.0 110.562 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.1 p -94.84 127.73 42.12 Favored Pre-proline 0 N--CA 1.499 2.009 0 O-C-N 120.794 -1.191 . . . . 1.0 109.536 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -74.12 15.66 0.6 Allowed 'Trans proline' 0 N--CA 1.492 1.441 0 CA-C-N 120.067 1.06 . . . . 1.0 111.609 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 78.7 mt -68.06 139.99 56.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 1.0 109.555 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -105.28 121.0 42.95 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.773 -0.825 . . . . 1.0 108.773 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -107.0 120.88 43.26 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.383 -0.823 . . . . 1.0 109.748 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.2 m -120.0 130.03 54.55 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.613 -0.679 . . . . 1.0 109.827 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.472 ' CB ' ' NH1' ' A' ' 52' ' ' ARG . 11.6 ttp-105 -83.05 138.01 33.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.309 -0.869 . . . . 1.0 109.711 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.4 mt -103.6 132.58 49.73 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.289 -0.882 . . . . 1.0 109.025 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.446 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 61.2 m170 -60.12 -39.99 88.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.875 . . . . 1.0 109.857 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 71.9 m-20 -153.43 179.8 8.46 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.234 -0.916 . . . . 1.0 109.464 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.73 -178.47 42.52 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.961 -1.256 . . . . 1.0 109.961 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.7 mt -95.58 132.95 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.387 -1.067 . . . . 1.0 109.454 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.41 165.9 11.41 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.006 -0.738 . . . . 1.0 109.006 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -59.99 -49.64 76.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.012 -1.055 . . . . 1.0 109.396 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 92.9 mt -110.13 105.56 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.429 -0.795 . . . . 1.0 109.826 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.9 ptm -102.07 132.75 47.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.231 -0.918 . . . . 1.0 108.893 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.418 HD13 ' CE1' ' A' ' 35' ' ' PHE . 85.9 mt -109.39 133.11 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.61 -0.681 . . . . 1.0 109.63 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 43.6 p -149.99 160.74 43.39 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.222 -0.924 . . . . 1.0 109.926 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -106.71 123.12 47.66 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.557 -0.714 . . . . 1.0 109.15 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.48 -171.58 26.92 Favored Glycine 0 N--CA 1.499 2.879 0 N-CA-C 110.655 -0.978 . . . . 1.0 110.655 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 60.9 mt . . . . . 0 N--CA 1.496 1.87 0 O-C-N 121.656 -0.908 . . . . 1.0 108.669 179.802 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.543 ' CD1' ' OD2' ' A' ' 99' ' ' ASP . 94.0 m-85 . . . . . 0 N--CA 1.494 1.769 0 N-CA-C 108.828 -0.805 . . . . 1.0 108.828 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -99.77 0.89 42.57 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.197 -0.94 . . . . 1.0 110.944 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.51 -148.38 19.36 Favored Glycine 0 N--CA 1.504 3.185 0 N-CA-C 108.876 -1.69 . . . . 1.0 108.876 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.456 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 2.5 Cg_endo -68.65 -63.15 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.302 0 CA-C-N 119.124 1.462 . . . . 1.0 111.273 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 87.7 p -79.14 166.68 21.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.123 -0.986 . . . . 1.0 109.161 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 112.86 -128.62 8.51 Favored Glycine 0 N--CA 1.501 2.976 0 N-CA-C 109.517 -1.433 . . . . 1.0 109.517 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.418 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 20.2 mt -70.43 112.47 6.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.334 -1.098 . . . . 1.0 109.367 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 46.0 mt -83.95 -15.18 48.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.943 -1.098 . . . . 1.0 109.037 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 179.06 172.52 0.82 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.033 -0.728 . . . . 1.0 109.033 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -162.71 158.26 22.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 1.0 109.196 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.33 158.86 44.53 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.178 -0.952 . . . . 1.0 109.437 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -96.48 153.54 38.84 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.173 -0.955 . . . . 1.0 108.849 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -64.84 166.04 19.38 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 120.719 0.946 . . . . 1.0 111.952 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo . . . . . 0 C--N 1.314 -1.286 0 C-N-CA 120.958 1.105 . . . . 1.0 111.691 179.533 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.279 0.562 . . . . 1.0 109.746 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.83 120.83 7.69 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.304 -0.873 . . . . 1.0 109.174 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -108.59 147.9 31.13 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.534 -0.728 . . . . 1.0 110.374 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -124.15 146.37 48.7 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.999 -0.741 . . . . 1.0 108.999 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.543 ' OD2' ' CD1' ' A' ' 75' ' ' PHE . 1.3 m-20 -79.6 123.73 27.88 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.057 -1.027 . . . . 1.0 109.347 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -89.22 -0.02 57.13 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.106 -0.996 . . . . 1.0 110.226 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -81.85 -16.1 51.88 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.074 -1.016 . . . . 1.0 110.08 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.604 ' OE1' ' N ' ' A' ' 102' ' ' GLU . 40.1 mp0 -93.97 173.89 7.43 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.307 -0.87 . . . . 1.0 109.202 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.8 m -99.69 105.42 17.24 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.216 -0.927 . . . . 1.0 108.862 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.496 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 90.2 m95 -85.87 126.06 33.77 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.761 -0.829 . . . . 1.0 108.761 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.699 HG21 ' HB2' ' A' ' 109' ' ' LYS . 7.8 t -141.07 153.61 45.56 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.467 -0.77 . . . . 1.0 109.635 -179.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 52.5 m -90.94 -5.17 55.82 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.198 -1.038 . . . . 1.0 108.198 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.7 t -92.73 177.93 5.95 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.752 -0.833 . . . . 1.0 108.752 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.5 m -80.25 64.29 5.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.027 -1.046 . . . . 1.0 109.998 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.699 ' HB2' HG21 ' A' ' 105' ' ' THR . 69.6 mmtt -139.01 152.38 47.59 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.267 -0.896 . . . . 1.0 108.788 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.8 -139.42 6.2 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.759 -1.336 . . . . 1.0 109.759 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -99.72 113.8 26.5 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.338 -1.095 . . . . 1.0 109.057 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.608 HD22 ' N ' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -62.77 130.68 45.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.148 -0.97 . . . . 1.0 109.76 -179.822 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.608 ' N ' HD22 ' A' ' 112' ' ' ASN . 61.7 tp -60.01 -43.29 95.33 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.48 -0.763 . . . . 1.0 111.022 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -60.01 -39.99 87.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.165 -0.959 . . . . 1.0 110.645 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -59.95 -50.86 72.09 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.811 -1.181 . . . . 1.0 109.874 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 71.0 t -69.98 -40.06 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.931 -1.106 . . . . 1.0 110.196 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.19 -51.97 67.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -0.939 . . . . 1.0 110.089 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.84 -37.97 80.73 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.271 -0.893 . . . . 1.0 110.259 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.627 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 67.8 t60 -64.24 -50.2 68.92 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.182 -0.949 . . . . 1.0 111.267 -178.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -60.07 -37.83 81.07 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.552 -1.342 . . . . 1.0 110.329 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -59.98 -40.05 87.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.766 -1.208 . . . . 1.0 108.255 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.39 -41.83 93.4 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.382 -1.487 . . . . 1.0 109.382 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.627 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 90.0 m-70 -68.74 -39.93 80.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.022 -1.281 . . . . 1.0 109.467 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.4 p -67.2 -33.08 74.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.318 -0.864 . . . . 1.0 109.618 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.486 HD13 HD11 ' A' ' 159' ' ' ILE . 81.6 mt -70.22 -39.68 74.96 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.23 -0.919 . . . . 1.0 109.84 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 135.31 7.59 1.92 Allowed Glycine 0 N--CA 1.5 2.959 0 N-CA-C 110.045 -1.222 . . . . 1.0 110.045 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.1 mt -87.65 141.21 28.78 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.08 -1.247 . . . . 1.0 110.042 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 34.5 t0 -99.15 175.34 5.93 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.88 -0.785 . . . . 1.0 108.88 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.517 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 63.2 m80 -60.05 133.49 56.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.033 -1.042 . . . . 1.0 109.606 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 47.8 t -98.76 158.1 15.85 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.359 -0.838 . . . . 1.0 109.1 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -98.35 3.05 48.58 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.265 -0.897 . . . . 1.0 109.369 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -85.64 129.55 54.47 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.205 -0.934 . . . . 1.0 108.62 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -69.54 -25.45 29.6 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 CA-C-N 120.012 1.04 . . . . 1.0 112.34 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -82.23 -3.86 90.41 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.413 -1.475 . . . . 1.0 109.413 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.15 143.93 26.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.421 -1.047 . . . . 1.0 109.467 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.501 ' C ' ' H ' ' A' ' 138' ' ' PHE . 89.0 mt -70.0 -34.1 72.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.076 -1.015 . . . . 1.0 109.6 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.3 mmm -70.02 18.19 0.05 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.394 -0.817 . . . . 1.0 109.997 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.501 ' H ' ' C ' ' A' ' 136' ' ' LEU . 13.7 t80 -69.5 133.62 88.94 Favored Pre-proline 0 N--CA 1.488 1.446 0 N-CA-C 107.552 -1.277 . . . . 1.0 107.552 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -60.51 -15.91 39.1 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 CA-C-N 119.805 0.966 . . . . 1.0 114.005 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 95.7 mt -106.59 138.82 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 120.988 -1.07 . . . . 1.0 110.083 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -73.75 129.98 39.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.579 -0.701 . . . . 1.0 109.967 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.1 t -141.31 141.96 33.87 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.43 -0.794 . . . . 1.0 109.246 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -79.98 144.5 33.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.013 -1.054 . . . . 1.0 109.381 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.5 t -140.01 150.64 44.68 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.437 -0.789 . . . . 1.0 109.266 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.61 105.11 1.44 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.422 -1.471 . . . . 1.0 109.422 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -73.61 -6.24 45.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.432 -1.04 . . . . 1.0 109.788 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 61.1 m -60.04 -40.09 88.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.257 -0.902 . . . . 1.0 110.819 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -141.75 19.87 2.16 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.036 -1.04 . . . . 1.0 110.4 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -61.03 140.0 57.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.843 -1.16 . . . . 1.0 109.953 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 67.8 mtt -138.47 145.44 40.85 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.661 -0.866 . . . . 1.0 108.661 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 45.5 mt -54.48 129.04 61.63 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.921 -1.112 . . . . 1.0 108.914 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -68.14 177.9 4.04 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 CA-C-N 119.996 1.034 . . . . 1.0 112.166 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -61.13 -39.96 92.02 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.315 -0.866 . . . . 1.0 110.141 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -56.32 -49.94 72.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.162 -0.961 . . . . 1.0 110.091 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -70.62 -40.03 73.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.137 -0.977 . . . . 1.0 110.252 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.452 ' O ' ' OE1' ' A' ' 160' ' ' GLN . 68.1 t -63.85 -50.06 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.963 . . . . 1.0 109.618 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.54 -40.01 89.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.844 -1.16 . . . . 1.0 110.063 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.42 -48.45 30.19 Favored Glycine 0 N--CA 1.493 2.473 0 O-C-N 121.352 -0.842 . . . . 1.0 112.227 -178.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.564 ' CG2' ' NE2' ' A' ' 160' ' ' GLN . 4.7 tp -60.9 -43.29 95.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.609 -1.524 . . . . 1.0 110.464 -177.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.564 ' NE2' ' CG2' ' A' ' 159' ' ' ILE . 5.9 mp0 -67.64 -36.38 80.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.579 -1.325 . . . . 1.0 108.903 179.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 79.4 p -60.75 -27.99 68.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.131 -0.981 . . . . 1.0 109.878 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.459 ' O ' ' NZ ' ' A' ' 9' ' ' LYS . 88.1 mt -85.28 -45.93 11.5 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.02 -1.05 . . . . 1.0 110.381 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -91.36 -9.29 45.39 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.017 -1.052 . . . . 1.0 109.821 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.553 -1.419 . . . . 1.0 109.553 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.0 mt . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.427 0.632 . . . . 1.0 109.54 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -160.76 160.68 31.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.499 -0.75 . . . . 1.0 109.499 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -71.47 148.74 46.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.185 -0.947 . . . . 1.0 109.61 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 91.6 p -88.44 3.39 50.21 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.333 -0.854 . . . . 1.0 109.98 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -145.07 153.24 41.24 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.067 -1.021 . . . . 1.0 109.609 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.6 mmt -90.38 -0.01 57.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.392 -0.818 . . . . 1.0 109.606 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -96.58 131.41 43.24 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.179 -0.951 . . . . 1.0 109.283 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.8 mt -143.95 151.03 39.23 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.117 -0.989 . . . . 1.0 109.399 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 54.5 p -135.71 155.73 49.93 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.475 -0.765 . . . . 1.0 108.937 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -144.27 161.19 39.54 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.146 -0.971 . . . . 1.0 110.383 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.494 HH11 ' HG2' ' A' ' 18' ' ' ARG . 0.8 OUTLIER -139.17 131.08 27.72 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 109.084 -0.709 . . . . 1.0 109.084 -179.384 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.9 mt -89.79 116.49 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.161 -0.962 . . . . 1.0 108.765 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.5 t -68.67 -39.93 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.193 -0.942 . . . . 1.0 109.226 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.403 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 23.8 p-10 -164.7 152.98 12.24 Favored 'General case' 0 C--N 1.288 -2.081 0 O-C-N 120.051 -1.656 . . . . 1.0 110.873 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.624 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 36.7 m-85 -99.94 109.11 21.48 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 104.781 -2.303 . . . . 1.0 104.781 177.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 t -55.87 140.55 68.43 Favored Pre-proline 0 C--N 1.297 -1.712 0 O-C-N 121.124 -0.985 . . . . 1.0 110.111 -176.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.27 -11.04 9.61 Favored 'Trans proline' 0 N--CA 1.485 1.008 0 CA-C-N 119.194 0.748 . . . . 1.0 110.901 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -55.61 -29.88 59.92 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.898 -0.721 . . . . 1.0 110.007 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 73.9 mtm -144.42 162.2 37.09 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.035 -1.041 . . . . 1.0 109.587 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.9 p -72.95 159.89 32.98 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.395 -0.815 . . . . 1.0 109.391 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.624 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 1.9 m80 -60.16 -40.75 90.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.306 -0.871 . . . . 1.0 110.07 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.5 m -60.12 -41.39 92.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.151 -0.968 . . . . 1.0 110.336 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.82 -40.0 79.71 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.205 -0.934 . . . . 1.0 110.321 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 70.9 t -67.59 -43.96 86.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.24 -0.913 . . . . 1.0 110.23 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -59.98 -49.92 75.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.137 -0.977 . . . . 1.0 110.837 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -61.44 -32.73 72.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.928 -1.108 . . . . 1.0 110.22 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.98 -50.07 75.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.984 -1.072 . . . . 1.0 110.006 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -68.11 -37.25 80.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.0 -1.062 . . . . 1.0 110.034 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -60.05 -44.41 94.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.973 -1.08 . . . . 1.0 109.428 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -60.44 -40.03 89.64 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.165 -0.959 . . . . 1.0 109.204 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.1 -45.96 91.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.355 -0.841 . . . . 1.0 110.212 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -69.88 -39.82 76.07 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.009 -1.057 . . . . 1.0 109.746 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -59.89 -47.88 83.98 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.194 -0.941 . . . . 1.0 109.91 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.0 t -60.0 -41.9 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.095 -1.003 . . . . 1.0 109.8 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 63.1 m95 -79.0 -35.6 42.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.038 -1.039 . . . . 1.0 109.874 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.7 p -70.14 -20.35 63.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.808 -1.183 . . . . 1.0 109.217 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -59.97 -40.13 88.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.506 -0.746 . . . . 1.0 110.667 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.7 m -110.8 23.0 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.333 -0.855 . . . . 1.0 110.633 -178.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 28.6 p -149.95 139.63 13.35 Favored Pre-proline 0 N--CA 1.5 2.052 0 O-C-N 120.909 -1.119 . . . . 1.0 109.23 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -75.17 19.35 0.51 Allowed 'Trans proline' 0 N--CA 1.496 1.638 0 CA-C-N 119.664 0.916 . . . . 1.0 111.605 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.0 mt -67.49 138.92 56.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -0.86 . . . . 1.0 109.933 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -112.91 120.8 42.68 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.947 -0.76 . . . . 1.0 108.947 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -109.14 122.24 46.88 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.325 -0.86 . . . . 1.0 109.354 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -119.99 130.07 54.58 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.572 0.701 . . . . 1.0 109.974 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -83.14 132.7 35.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.35 -0.844 . . . . 1.0 109.64 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.2 mt -101.76 132.68 47.36 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.198 -0.939 . . . . 1.0 108.894 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.446 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 43.1 m170 -61.27 -40.05 92.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.088 -1.007 . . . . 1.0 110.061 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 73.8 m-20 -152.31 178.01 9.97 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.19 -0.944 . . . . 1.0 109.546 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.07 -178.58 42.08 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.71 -1.356 . . . . 1.0 109.71 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.3 mt -94.45 134.82 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.393 -1.063 . . . . 1.0 109.115 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.92 174.09 6.03 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.505 -0.747 . . . . 1.0 109.154 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -60.05 -49.09 79.02 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.081 -1.012 . . . . 1.0 108.513 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.8 mt -120.03 118.07 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.544 -0.723 . . . . 1.0 109.42 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.1 ptp -101.63 139.26 37.52 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.164 -0.96 . . . . 1.0 109.153 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 97.0 mt -107.46 133.56 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.393 -0.817 . . . . 1.0 109.927 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 79.7 p -152.45 156.75 40.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.292 -0.88 . . . . 1.0 109.368 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -100.77 125.58 47.26 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.288 -0.883 . . . . 1.0 109.161 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 100' ' ' ASP . . . -93.14 155.31 22.28 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.946 -1.261 . . . . 1.0 109.946 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 9.6 tt . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.444 -1.033 . . . . 1.0 108.77 179.931 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.523 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 77.0 m-85 . . . . . 0 N--CA 1.495 1.791 0 N-CA-C 108.438 -0.949 . . . . 1.0 108.438 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -100.62 9.19 42.82 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.277 -0.889 . . . . 1.0 111.168 -178.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 121.15 -159.94 15.59 Favored Glycine 0 N--CA 1.508 3.459 0 N-CA-C 109.161 -1.575 . . . . 1.0 109.161 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -56.36 -63.97 0.15 Allowed 'Trans proline' 0 N--CA 1.49 1.268 0 CA-C-N 118.771 1.285 . . . . 1.0 111.955 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 96.3 p -76.54 160.45 29.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.496 -0.752 . . . . 1.0 109.578 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.71 -130.8 9.29 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 110.177 -1.169 . . . . 1.0 110.177 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.1 mt -69.49 105.33 2.59 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.424 -1.045 . . . . 1.0 109.242 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.449 HD23 ' OE2' ' A' ' 102' ' ' GLU . 32.2 mt -79.82 -14.76 58.44 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.124 -0.985 . . . . 1.0 109.057 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.57 175.54 0.88 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.056 -0.72 . . . . 1.0 109.056 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.523 ' CE1' ' ND1' ' A' ' 97' ' ' HIS . 21.2 p80 -163.22 160.91 24.57 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.231 -0.918 . . . . 1.0 109.787 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -153.2 167.74 28.31 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.858 -0.793 . . . . 1.0 108.858 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -114.51 153.98 46.61 Favored Pre-proline 0 N--CA 1.499 2.006 0 N-CA-C 108.494 -0.928 . . . . 1.0 108.494 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -69.71 161.42 46.0 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 120.57 0.847 . . . . 1.0 111.503 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo . . . . . 0 C--N 1.313 -1.331 0 C-N-CA 121.068 1.179 . . . . 1.0 112.104 -179.902 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 45.5 p-10 . . . . . 0 N--CA 1.494 1.761 0 N-CA-C 109.236 -0.653 . . . . 1.0 109.236 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.88 123.24 9.01 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.101 -0.999 . . . . 1.0 109.18 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.523 ' ND1' ' CE1' ' A' ' 84' ' ' HIS . 64.9 m170 -117.78 159.98 22.12 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.625 0.726 . . . . 1.0 109.933 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.536 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 47.1 m-85 -137.88 153.46 49.56 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.702 -0.851 . . . . 1.0 108.702 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.523 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 1.5 m-20 -79.39 124.0 28.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.844 -1.16 . . . . 1.0 109.662 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 65' ' ' GLY . 36.5 t0 -84.81 -12.67 53.13 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.473 -0.767 . . . . 1.0 109.416 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -82.26 -11.51 58.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.265 -0.897 . . . . 1.0 109.574 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.449 ' OE2' HD23 ' A' ' 82' ' ' LEU . 98.0 mt-10 -91.63 166.79 12.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.294 -0.879 . . . . 1.0 109.153 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.3 m -98.78 107.42 19.86 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.177 -0.952 . . . . 1.0 109.086 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.454 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 94.1 m95 -88.74 123.65 33.36 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.846 -0.798 . . . . 1.0 108.846 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.679 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.7 t -140.36 153.16 46.3 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.378 -0.826 . . . . 1.0 109.439 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.8 t -92.06 -6.09 51.64 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.205 -1.035 . . . . 1.0 108.205 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 65.1 p -93.16 179.44 5.43 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.713 -0.847 . . . . 1.0 108.713 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.2 m -82.04 77.06 8.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.016 -1.052 . . . . 1.0 109.467 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.679 ' HB2' HG21 ' A' ' 105' ' ' THR . 52.6 mtmt -149.31 150.03 31.86 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.74 -139.85 5.86 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.567 -1.413 . . . . 1.0 109.567 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.418 ' CD1' HD13 ' A' ' 82' ' ' LEU . 95.2 m-85 -100.09 113.77 26.63 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.312 -1.111 . . . . 1.0 108.751 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -62.94 134.11 55.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.113 -0.992 . . . . 1.0 109.34 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.6 tp -59.98 -43.94 94.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.39 -0.819 . . . . 1.0 110.587 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -59.88 -43.22 94.87 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.965 -1.085 . . . . 1.0 110.603 -178.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -58.6 -51.91 67.9 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.74 -1.225 . . . . 1.0 109.644 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.6 t -68.47 -43.97 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.174 -0.954 . . . . 1.0 110.319 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.25 -52.79 63.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.304 -0.873 . . . . 1.0 110.014 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.95 -32.65 71.0 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.937 -1.102 . . . . 1.0 109.882 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.443 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 45.7 t60 -65.68 -52.95 47.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.969 -1.082 . . . . 1.0 110.654 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.536 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 7.7 pt-20 -60.13 -40.97 91.63 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.902 -1.124 . . . . 1.0 110.453 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -60.03 -39.91 87.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.861 -1.149 . . . . 1.0 109.001 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -56.45 -42.8 90.13 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.128 -1.589 . . . . 1.0 109.128 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.443 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 90.6 m-70 -67.44 -39.98 85.43 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.213 -1.169 . . . . 1.0 109.221 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 59.7 p -64.45 -25.01 67.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -0.895 . . . . 1.0 109.923 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.2 mt -80.19 -0.53 36.59 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.13 -0.981 . . . . 1.0 110.049 -179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 91.93 6.8 64.95 Favored Glycine 0 N--CA 1.497 2.744 0 O-C-N 120.997 -1.065 . . . . 1.0 110.562 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.4 mt -84.79 149.46 25.72 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.907 -1.349 . . . . 1.0 109.554 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 42.0 t0 -98.67 171.32 8.19 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.674 -0.861 . . . . 1.0 108.674 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.535 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 62.8 m80 -58.92 136.98 58.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.026 -1.046 . . . . 1.0 109.724 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.0 t -97.36 151.16 20.2 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.542 -0.724 . . . . 1.0 109.246 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -99.86 6.83 45.28 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.255 -0.903 . . . . 1.0 108.907 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -87.31 123.76 69.31 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.057 -1.027 . . . . 1.0 108.396 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -64.2 -17.1 58.47 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 CA-C-N 120.189 1.103 . . . . 1.0 112.168 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -89.98 -6.35 69.58 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.553 -1.419 . . . . 1.0 109.553 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.56 141.49 30.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.221 -1.164 . . . . 1.0 109.25 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.461 ' C ' ' H ' ' A' ' 138' ' ' PHE . 97.0 mt -65.78 -39.74 91.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.15 -0.969 . . . . 1.0 109.6 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 91.1 mtp -70.36 23.35 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.32 -0.862 . . . . 1.0 111.117 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.461 ' H ' ' C ' ' A' ' 136' ' ' LEU . 11.5 t80 -67.26 133.11 93.33 Favored Pre-proline 0 N--CA 1.493 1.692 0 N-CA-C 107.522 -1.288 . . . . 1.0 107.522 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -61.7 -9.79 14.87 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 CA-C-N 119.958 1.021 . . . . 1.0 113.644 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 88.4 mt -113.45 133.28 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.162 -0.961 . . . . 1.0 109.14 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -71.36 128.51 36.1 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.168 -0.957 . . . . 1.0 110.102 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.8 t -141.84 143.59 33.46 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.637 -0.875 . . . . 1.0 108.637 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -81.24 146.03 30.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.079 -1.013 . . . . 1.0 109.766 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.0 t -140.8 157.49 45.32 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.371 -0.831 . . . . 1.0 109.662 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.95 106.47 1.97 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.534 -1.426 . . . . 1.0 109.534 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.458 ' NZ ' ' CB ' ' A' ' 146' ' ' LYS . 8.4 mtpm? -77.43 2.9 14.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -1.15 . . . . 1.0 109.597 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.471 ' O ' ' ND1' ' A' ' 148' ' ' HIS . 34.7 t -59.44 -46.06 89.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 1.0 110.067 -179.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . 0.471 ' ND1' ' O ' ' A' ' 147' ' ' SER . 50.0 m-70 -146.58 30.77 0.99 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.014 -1.054 . . . . 1.0 109.472 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -61.0 136.0 57.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.145 -0.972 . . . . 1.0 109.7 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 65.9 mtt -133.47 144.56 49.53 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.476 -0.765 . . . . 1.0 108.939 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 36.4 mt -51.48 125.77 28.06 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.177 -0.952 . . . . 1.0 108.767 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -67.63 177.52 4.0 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 CA-C-N 120.04 1.05 . . . . 1.0 112.253 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.21 -39.98 88.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.395 -0.816 . . . . 1.0 109.955 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -55.11 -48.34 73.74 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.183 -0.948 . . . . 1.0 109.998 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -69.98 -39.96 75.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.042 -1.037 . . . . 1.0 110.115 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 56.3 t -59.95 -49.13 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.158 -0.964 . . . . 1.0 109.478 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -60.34 -40.11 89.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.878 -1.138 . . . . 1.0 110.468 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.63 -53.28 12.66 Favored Glycine 0 N--CA 1.496 2.638 0 O-C-N 121.046 -1.034 . . . . 1.0 111.512 -178.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.476 HG23 ' N ' ' A' ' 160' ' ' GLN . 6.3 tp -61.19 -40.0 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.97 -1.312 . . . . 1.0 109.617 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 164' ' ' GLY . 97.1 mt-30 -65.49 -39.69 92.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 1.0 109.566 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 83.3 p -60.0 -34.65 73.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 1.0 110.625 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 83.7 mt -87.47 -50.47 6.52 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.843 -1.161 . . . . 1.0 110.884 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -90.62 -9.12 48.16 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.969 -1.082 . . . . 1.0 110.226 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.568 0 N-CA-C 109.512 -1.435 . . . . 1.0 109.512 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.3 mt . . . . . 0 N--CA 1.488 1.436 0 N-CA-C 109.075 -0.713 . . . . 1.0 109.075 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -159.84 159.88 33.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.198 -0.939 . . . . 1.0 109.525 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -71.76 145.54 48.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -0.868 . . . . 1.0 109.193 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.1 t -80.83 -0.86 40.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.413 -0.805 . . . . 1.0 110.369 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -149.27 154.8 39.58 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.067 -1.02 . . . . 1.0 109.574 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.551 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.07 0.03 57.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.34 -0.85 . . . . 1.0 109.723 -179.644 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -97.65 124.76 42.08 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.279 -0.888 . . . . 1.0 108.954 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.4 mt -140.03 150.07 43.96 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.263 -0.898 . . . . 1.0 109.713 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.0 p -130.7 157.3 43.16 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.61 -0.885 . . . . 1.0 108.61 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -144.18 160.05 41.61 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.082 -1.011 . . . . 1.0 110.251 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.462 ' CZ ' ' O ' ' A' ' 54' ' ' HIS . 26.1 tpt180 -143.61 129.4 19.36 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.652 -0.655 . . . . 1.0 109.566 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 86.8 mt -88.11 119.68 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.149 -0.969 . . . . 1.0 109.132 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.6 t -69.48 -40.53 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.169 -0.957 . . . . 1.0 109.259 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.66 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.0 OUTLIER -163.8 165.21 23.2 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.496 -1.378 . . . . 1.0 110.948 -179.126 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -104.22 -172.98 2.2 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.78 -1.193 . . . . 1.0 107.78 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.85 148.81 47.28 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.445 -0.784 . . . . 1.0 109.901 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -64.93 -16.11 53.8 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 120.926 1.084 . . . . 1.0 110.156 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.94 -39.99 87.41 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.348 -0.842 . . . . 1.0 110.471 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.6 mtm -144.21 160.16 41.43 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.128 -0.982 . . . . 1.0 109.663 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 69.3 p -73.48 159.98 32.39 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.393 -0.817 . . . . 1.0 109.373 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.715 ' H ' ' CD2' ' A' ' 28' ' ' HIS . 2.8 p80 -60.95 -31.82 71.36 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.337 -0.852 . . . . 1.0 109.972 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 56.0 m -60.02 -42.11 93.63 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.855 -1.153 . . . . 1.0 109.446 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -69.92 -40.06 75.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.09 -1.006 . . . . 1.0 109.544 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 56.2 t -69.58 -40.07 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.232 -0.917 . . . . 1.0 110.001 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -59.73 -49.92 75.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.088 -1.008 . . . . 1.0 110.107 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -63.25 -31.54 72.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.976 -1.078 . . . . 1.0 109.958 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.01 -49.96 75.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.017 -1.052 . . . . 1.0 110.197 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.424 ' CE1' HD13 ' A' ' 62' ' ' ILE . 52.1 m-85 -67.66 -36.94 81.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.98 -1.075 . . . . 1.0 109.978 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -59.93 -41.07 90.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.987 -1.071 . . . . 1.0 109.721 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -62.2 -40.18 95.21 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.071 -1.018 . . . . 1.0 108.868 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.97 -45.89 91.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.511 -0.743 . . . . 1.0 110.139 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.508 ' CD1' ' CD1' ' A' ' 50' ' ' PHE . 63.4 m-85 -68.4 -40.06 81.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.963 -1.085 . . . . 1.0 110.02 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.402 ' O ' ' CG ' ' A' ' 44' ' ' ASP . 27.4 tptp -60.01 -47.54 85.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.122 -0.987 . . . . 1.0 109.665 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.5 t -60.01 -40.09 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.184 -0.948 . . . . 1.0 110.119 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -81.54 -35.46 30.27 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.876 -1.14 . . . . 1.0 109.985 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.5 p -71.64 -20.1 62.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.905 -1.122 . . . . 1.0 109.725 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.402 ' CG ' ' O ' ' A' ' 40' ' ' LYS . 95.3 m-20 -59.95 -39.89 87.12 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.246 -0.909 . . . . 1.0 111.048 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 m -109.52 20.25 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 O-C-N 121.191 -0.943 . . . . 1.0 110.797 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.3 p -147.93 140.38 14.6 Favored Pre-proline 0 N--CA 1.502 2.128 0 O-C-N 120.83 -1.169 . . . . 1.0 109.221 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -72.83 18.37 0.36 Allowed 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 120.716 0.944 . . . . 1.0 111.999 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 79.0 mt -68.1 137.12 54.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.122 -0.986 . . . . 1.0 109.916 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -111.46 120.75 43.19 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.885 -0.783 . . . . 1.0 108.885 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.508 ' CD1' ' CD1' ' A' ' 39' ' ' PHE . 92.4 m-85 -109.16 123.3 48.99 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.367 -0.833 . . . . 1.0 109.335 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.1 m -119.95 130.02 54.6 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.55 -0.718 . . . . 1.0 109.679 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -82.32 132.35 35.22 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.467 -0.77 . . . . 1.0 109.566 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.4 mt -104.96 131.16 52.83 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.326 -0.859 . . . . 1.0 108.819 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.462 ' O ' ' CZ ' ' A' ' 18' ' ' ARG . 42.2 m170 -61.73 -40.24 94.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.177 -0.952 . . . . 1.0 110.005 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 74.9 m-20 -151.74 176.33 11.5 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.112 -0.992 . . . . 1.0 109.924 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.87 -179.76 35.63 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.858 -1.297 . . . . 1.0 109.858 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 91.3 mt -93.51 130.44 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.366 -1.079 . . . . 1.0 109.583 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.46 164.52 12.62 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.971 -0.752 . . . . 1.0 108.971 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.87 -49.52 77.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.067 -1.021 . . . . 1.0 109.332 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.7 mt -111.81 109.63 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.506 -0.746 . . . . 1.0 109.534 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.5 ptm -106.46 132.0 53.0 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.328 -0.858 . . . . 1.0 109.481 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.424 HD13 ' CE1' ' A' ' 35' ' ' PHE . 86.1 mt -103.22 137.72 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.619 -0.675 . . . . 1.0 109.383 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.2 p -152.08 152.96 33.03 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.07 -1.019 . . . . 1.0 109.755 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.647 ' H ' HD21 ' A' ' 21' ' ' ASN . 93.4 m-85 -100.42 120.27 39.73 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.891 -0.781 . . . . 1.0 108.891 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -103.85 -170.6 25.37 Favored Glycine 0 N--CA 1.5 2.966 0 N-CA-C 110.773 -0.931 . . . . 1.0 110.773 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 74.4 mt . . . . . 0 N--CA 1.497 1.889 0 O-C-N 121.569 -0.959 . . . . 1.0 109.111 179.838 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 . . . . . 0 N--CA 1.495 1.824 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.5 p-10 -101.81 -0.07 34.85 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.331 -0.855 . . . . 1.0 111.127 -178.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 128.04 -149.16 18.04 Favored Glycine 0 N--CA 1.505 3.261 0 N-CA-C 109.381 -1.488 . . . . 1.0 109.381 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.425 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 3.5 Cg_exo -64.39 -64.36 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.501 0 CA-C-N 118.953 1.376 . . . . 1.0 112.114 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 77.0 p -75.9 158.67 31.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.12 -0.987 . . . . 1.0 109.039 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.26 -128.34 8.04 Favored Glycine 0 N--CA 1.501 3.012 0 N-CA-C 109.594 -1.402 . . . . 1.0 109.594 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.425 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 18.4 mt -67.28 106.35 2.02 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.389 -1.065 . . . . 1.0 109.555 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 46.3 mt -75.81 -23.63 55.83 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.919 -1.113 . . . . 1.0 109.063 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -177.68 173.89 1.56 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.635 -0.876 . . . . 1.0 108.635 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.558 ' NE2' ' ND1' ' A' ' 97' ' ' HIS . 0.3 OUTLIER -161.08 165.75 29.18 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.175 -0.953 . . . . 1.0 109.177 179.521 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -155.3 159.15 39.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.388 -0.82 . . . . 1.0 109.162 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -99.05 153.9 37.57 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 121.097 -1.002 . . . . 1.0 108.499 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -62.75 160.39 33.11 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 120.847 1.031 . . . . 1.0 112.396 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo . . . . . 0 N--CA 1.492 1.419 0 C-N-CA 121.806 1.67 . . . . 1.0 113.212 -179.716 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 43.0 p-10 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.218 -0.66 . . . . 1.0 109.218 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.87 121.39 8.53 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.086 -1.009 . . . . 1.0 109.423 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.558 ' ND1' ' NE2' ' A' ' 84' ' ' HIS . 3.4 m170 -109.63 147.25 33.4 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.7 -0.625 . . . . 1.0 109.575 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -121.21 151.73 39.63 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.66 -0.867 . . . . 1.0 108.66 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.425 ' OD2' ' O ' ' A' ' 81' ' ' LEU . 88.7 m-20 -78.67 120.63 23.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.973 -1.079 . . . . 1.0 109.386 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -83.11 -10.44 58.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.318 -0.864 . . . . 1.0 109.334 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -83.08 -10.07 58.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.892 . . . . 1.0 109.471 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 97.8 mt-10 -91.63 168.19 11.67 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.308 -0.87 . . . . 1.0 109.618 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 8.2 m -97.73 106.48 18.79 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.335 -0.853 . . . . 1.0 109.007 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -89.13 121.17 31.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.429 -0.794 . . . . 1.0 108.887 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.607 HG21 ' HB2' ' A' ' 109' ' ' LYS . 6.1 t -140.31 152.55 45.94 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.325 -0.86 . . . . 1.0 110.103 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 69.8 m -95.03 -8.42 36.81 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.774 -0.824 . . . . 1.0 108.774 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 90.3 p -91.89 175.33 6.92 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.467 -0.771 . . . . 1.0 108.957 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.1 t -72.82 71.85 1.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.04 -1.038 . . . . 1.0 109.485 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.607 ' HB2' HG21 ' A' ' 105' ' ' THR . 43.7 mtpt -148.47 154.76 40.3 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.287 -0.883 . . . . 1.0 108.836 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 109' ' ' LYS . . . 40.83 -141.89 0.88 Allowed Glycine 0 N--CA 1.499 2.864 0 N-CA-C 110.473 -1.051 . . . . 1.0 110.473 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -99.53 119.55 38.22 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.336 -1.096 . . . . 1.0 108.962 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -64.08 130.39 43.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.157 -0.965 . . . . 1.0 109.623 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.9 tp -60.0 -43.45 95.17 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.436 -0.79 . . . . 1.0 110.814 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -59.84 -40.22 87.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.103 -0.998 . . . . 1.0 110.774 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -59.28 -51.35 70.32 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.845 -1.16 . . . . 1.0 109.197 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.6 t -69.99 -41.78 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.161 -0.962 . . . . 1.0 109.728 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.1 -51.76 68.36 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.032 -1.043 . . . . 1.0 109.264 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.59 -40.63 88.11 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.428 -0.795 . . . . 1.0 110.662 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.63 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 63.4 t60 -62.54 -49.17 76.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.204 -0.935 . . . . 1.0 111.022 -178.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -59.83 -38.8 83.05 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.619 -1.301 . . . . 1.0 109.701 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -59.85 -40.02 87.16 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.818 -1.176 . . . . 1.0 108.46 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -56.99 -40.44 91.16 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.576 -1.41 . . . . 1.0 109.576 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.63 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 86.7 m-70 -67.36 -40.06 85.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.957 -1.319 . . . . 1.0 109.311 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 86.1 p -66.03 -26.09 67.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.131 -0.981 . . . . 1.0 109.056 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 83.2 mt -80.51 2.55 24.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.365 -0.834 . . . . 1.0 109.552 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 85.14 9.77 79.49 Favored Glycine 0 N--CA 1.494 2.562 0 C-N-CA 120.2 -1.0 . . . . 1.0 110.921 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 77.5 mt -87.05 141.06 28.94 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.712 -1.464 . . . . 1.0 109.673 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 30.8 t0 -98.98 173.01 7.04 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.432 -0.792 . . . . 1.0 109.263 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.507 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 66.9 m80 -60.08 132.69 54.71 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.272 -0.892 . . . . 1.0 109.821 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.6 t -100.26 156.03 17.45 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.812 -0.81 . . . . 1.0 108.812 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -98.28 6.29 47.52 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.1 -1.0 . . . . 1.0 109.514 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -86.16 125.27 68.67 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.15 -0.969 . . . . 1.0 108.476 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -67.26 -19.34 50.33 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 CA-C-N 120.226 1.116 . . . . 1.0 112.57 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -87.21 -8.03 75.78 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.88 -1.288 . . . . 1.0 109.88 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.6 145.65 25.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.04 -1.271 . . . . 1.0 109.443 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.437 ' C ' ' H ' ' A' ' 138' ' ' PHE . 95.0 mt -68.38 -31.19 70.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.23 -0.919 . . . . 1.0 109.39 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 96.4 mmm -71.22 17.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.427 -0.796 . . . . 1.0 110.743 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.437 ' H ' ' C ' ' A' ' 136' ' ' LEU . 12.5 t80 -70.01 130.17 90.12 Favored Pre-proline 0 N--CA 1.494 1.764 0 N-CA-C 107.901 -1.148 . . . . 1.0 107.901 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -68.13 4.96 1.29 Allowed 'Trans proline' 0 N--CA 1.505 2.173 0 C-N-CA 121.041 1.16 . . . . 1.0 114.623 -177.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.6 mt -119.63 134.37 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 O-C-N 120.984 -1.072 . . . . 1.0 108.446 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -71.74 130.8 42.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.022 -1.049 . . . . 1.0 109.666 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 15.0 t -145.11 144.98 31.22 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.56 -0.904 . . . . 1.0 108.56 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -80.8 147.68 30.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.99 -1.069 . . . . 1.0 109.912 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 19.3 m -137.77 145.14 42.04 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.481 -0.762 . . . . 1.0 110.008 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.17 97.16 0.57 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 107.646 -2.181 . . . . 1.0 107.646 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -73.97 5.1 4.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.379 -1.071 . . . . 1.0 109.805 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 70.0 m -60.05 -40.09 88.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.132 -0.98 . . . . 1.0 110.052 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -147.5 39.95 0.99 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.021 -1.05 . . . . 1.0 109.911 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -78.87 130.59 35.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.099 -1.001 . . . . 1.0 110.915 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 97.9 mmm -128.67 145.02 51.27 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.108 -1.071 . . . . 1.0 108.108 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 26.8 mt -50.26 129.43 24.11 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 120.841 -1.162 . . . . 1.0 108.981 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -71.97 179.44 4.85 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 CA-C-N 119.939 1.014 . . . . 1.0 112.084 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -61.42 -40.02 92.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.431 -0.793 . . . . 1.0 110.171 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -57.46 -45.11 85.13 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.185 -0.947 . . . . 1.0 110.353 -178.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -70.0 -39.9 75.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.804 -1.185 . . . . 1.0 109.49 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.5 t -59.75 -45.61 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.094 -1.004 . . . . 1.0 109.379 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -62.09 -40.07 94.59 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.945 -1.097 . . . . 1.0 110.016 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.4 -54.49 8.77 Favored Glycine 0 N--CA 1.494 2.523 0 C-N-CA 120.253 -0.975 . . . . 1.0 111.197 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.474 HG23 ' N ' ' A' ' 160' ' ' GLN . 8.8 tp -60.18 -40.33 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.934 -1.333 . . . . 1.0 109.644 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.553 ' O ' ' N ' ' A' ' 164' ' ' GLY . 92.1 mm-40 -65.15 -39.87 93.6 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.191 -0.943 . . . . 1.0 109.416 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 78.7 p -61.56 -28.62 69.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.085 -1.009 . . . . 1.0 110.279 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.4 mt -87.27 -52.58 5.31 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.94 -1.1 . . . . 1.0 110.477 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -90.81 -10.04 44.24 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.088 -1.007 . . . . 1.0 110.103 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.523 0 N-CA-C 109.348 -1.501 . . . . 1.0 109.348 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.1 mt . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.032 -0.729 . . . . 1.0 109.032 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -159.69 160.05 33.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.214 -0.929 . . . . 1.0 109.339 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -73.41 151.09 41.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.115 -0.991 . . . . 1.0 109.683 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.0 t -87.54 0.5 55.5 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.456 -0.777 . . . . 1.0 109.478 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -144.82 150.91 37.96 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.262 -0.899 . . . . 1.0 109.217 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.9 mmt -90.01 -0.1 57.4 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.357 -0.839 . . . . 1.0 109.952 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -98.2 131.02 44.91 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.266 -0.897 . . . . 1.0 108.896 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.9 mt -139.84 150.51 44.75 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.288 -0.882 . . . . 1.0 109.088 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 48.8 p -133.09 157.65 44.76 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.414 -0.804 . . . . 1.0 109.32 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -146.47 160.23 42.37 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.062 -1.024 . . . . 1.0 110.049 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.407 ' HE ' ' HA ' ' A' ' 55' ' ' ASP . 42.6 ttt-85 -144.32 133.29 22.68 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.381 -0.824 . . . . 1.0 109.429 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 84.9 mt -87.69 117.62 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.198 -0.939 . . . . 1.0 108.961 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.4 t -69.99 -39.97 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.16 -0.963 . . . . 1.0 109.767 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.534 HD21 ' H ' ' A' ' 64' ' ' PHE . 15.7 p30 -162.06 152.13 16.74 Favored 'General case' 0 C--N 1.292 -1.895 0 O-C-N 119.798 -1.814 . . . . 1.0 111.656 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -99.04 105.64 17.79 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 103.924 -2.621 . . . . 1.0 103.924 176.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.64 145.34 50.93 Favored Pre-proline 0 C--N 1.295 -1.8 0 O-C-N 121.127 -0.983 . . . . 1.0 110.532 -175.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -56.1 -14.14 10.95 Favored 'Trans proline' 0 N--CA 1.486 1.078 0 C-N-CA 120.668 0.912 . . . . 1.0 110.865 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -59.79 -39.2 84.16 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.523 -0.871 . . . . 1.0 109.708 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.7 mtm -139.66 156.18 46.98 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.211 -0.931 . . . . 1.0 109.496 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 82.5 p -75.6 163.88 26.88 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.423 -0.798 . . . . 1.0 109.681 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.559 ' H ' ' CD2' ' A' ' 28' ' ' HIS . 6.9 p80 -59.97 -39.03 84.27 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.542 -0.724 . . . . 1.0 110.079 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.4 m -60.02 -45.27 93.34 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.854 -1.154 . . . . 1.0 109.696 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -69.99 -40.2 75.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.136 -0.978 . . . . 1.0 109.846 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 77.6 t -68.48 -44.59 83.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.275 -0.891 . . . . 1.0 109.989 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -59.87 -48.54 81.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.052 -1.03 . . . . 1.0 111.033 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -61.11 -34.65 75.3 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.632 -1.292 . . . . 1.0 110.223 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.2 -48.66 80.81 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.868 -1.145 . . . . 1.0 109.619 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.404 ' CE1' HD13 ' A' ' 62' ' ' ILE . 53.1 m-85 -66.47 -37.81 85.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.074 -1.016 . . . . 1.0 109.523 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.06 -40.82 90.8 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.899 -1.126 . . . . 1.0 109.307 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -60.11 -42.74 95.36 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.941 -1.099 . . . . 1.0 108.27 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.0 -48.47 81.56 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.427 -0.796 . . . . 1.0 109.599 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -65.62 -39.01 91.04 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.01 -1.056 . . . . 1.0 109.852 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -59.4 -47.19 86.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.1 -1.0 . . . . 1.0 109.728 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.4 t -61.37 -41.34 89.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.216 -0.928 . . . . 1.0 110.303 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -77.99 -36.89 48.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.067 -1.021 . . . . 1.0 109.809 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 86.7 p -71.22 -15.5 62.46 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.506 -0.746 . . . . 1.0 109.634 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -59.19 -40.07 84.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.3 -0.875 . . . . 1.0 109.909 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.9 m -112.94 -21.79 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.301 -0.874 . . . . 1.0 110.874 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.1 p -91.4 128.32 47.38 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 120.697 -1.252 . . . . 1.0 110.268 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -75.81 15.67 0.87 Allowed 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 120.855 1.037 . . . . 1.0 111.471 179.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 79.1 mt -69.16 140.62 54.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.335 -0.853 . . . . 1.0 109.55 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -106.11 121.04 43.34 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -106.93 123.18 47.81 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.303 -0.873 . . . . 1.0 109.194 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -120.0 130.24 54.64 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.589 -0.694 . . . . 1.0 109.728 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -82.09 135.85 35.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.185 -0.947 . . . . 1.0 109.073 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 84.7 mt -103.67 129.68 51.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.317 -0.864 . . . . 1.0 108.837 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.43 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 18.5 m170 -61.3 -40.01 92.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 1.0 109.869 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 75.1 m-20 -149.11 169.86 19.73 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.188 -0.945 . . . . 1.0 109.809 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.0 -178.03 34.42 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.726 -1.35 . . . . 1.0 109.726 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.2 mt -93.87 139.13 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.269 -1.136 . . . . 1.0 109.3 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.35 169.23 9.1 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.517 -0.739 . . . . 1.0 109.439 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -59.99 -48.42 81.78 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.27 -0.894 . . . . 1.0 109.147 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.0 mt -119.92 112.34 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.503 -0.748 . . . . 1.0 109.401 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.7 ptm -103.58 133.81 47.98 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.306 -0.871 . . . . 1.0 108.9 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.404 HD13 ' CE1' ' A' ' 35' ' ' PHE . 84.6 mt -107.54 133.83 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.568 -0.707 . . . . 1.0 109.394 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 76.6 p -151.74 157.57 42.19 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.072 -1.017 . . . . 1.0 109.988 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.534 ' H ' HD21 ' A' ' 21' ' ' ASN . 73.7 m-85 -110.02 121.72 45.91 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.823 -0.806 . . . . 1.0 108.823 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -114.24 -167.23 15.93 Favored Glycine 0 N--CA 1.501 2.977 0 N-CA-C 110.289 -1.124 . . . . 1.0 110.289 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 96.9 mt . . . . . 0 N--CA 1.496 1.83 0 O-C-N 121.653 -0.91 . . . . 1.0 108.594 179.271 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.544 ' CD1' ' OD1' ' A' ' 99' ' ' ASP . 96.3 m-85 . . . . . 0 N--CA 1.495 1.782 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.1 p-10 -100.26 0.56 40.51 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.911 -1.118 . . . . 1.0 110.81 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 129.85 -146.15 17.11 Favored Glycine 0 N--CA 1.502 3.091 0 N-CA-C 108.663 -1.775 . . . . 1.0 108.663 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.426 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 5.7 Cg_exo -65.54 -63.4 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.331 0 CA-C-N 119.314 1.557 . . . . 1.0 111.63 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 84.4 p -78.58 161.1 27.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.206 -0.934 . . . . 1.0 110.001 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.47 -133.06 10.85 Favored Glycine 0 N--CA 1.502 3.047 0 N-CA-C 109.916 -1.273 . . . . 1.0 109.916 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.7 mt -65.56 107.92 1.86 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.345 -1.091 . . . . 1.0 108.287 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 50.9 mt -75.65 -29.95 59.28 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.113 -0.992 . . . . 1.0 109.123 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -177.07 168.6 2.4 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -160.63 162.39 32.73 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.18 -0.95 . . . . 1.0 109.6 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' A' ' 95' ' ' ASP . . . -146.25 158.67 43.9 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.256 -0.903 . . . . 1.0 109.511 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -101.78 151.98 38.03 Favored Pre-proline 0 N--CA 1.498 1.963 0 N-CA-C 108.469 -0.937 . . . . 1.0 108.469 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -63.68 165.36 18.46 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 120.535 0.823 . . . . 1.0 111.93 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo . . . . . 0 N--CA 1.489 1.233 0 C-N-CA 121.035 1.157 . . . . 1.0 111.753 179.609 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.4 ' O ' ' HB1' ' A' ' 85' ' ' ALA . 48.7 p-10 . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 109.282 -0.636 . . . . 1.0 109.282 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.15 118.84 7.0 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.225 -0.922 . . . . 1.0 110.126 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -104.12 136.02 44.52 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.505 -0.747 . . . . 1.0 109.845 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.44 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 19.4 m-85 -116.15 142.51 46.72 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.745 -0.835 . . . . 1.0 108.745 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.544 ' OD1' ' CD1' ' A' ' 75' ' ' PHE . 93.4 m-20 -79.22 124.09 28.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.935 -1.103 . . . . 1.0 109.523 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 48.3 t0 -84.32 -0.02 50.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.323 -0.861 . . . . 1.0 109.662 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -79.62 -16.39 55.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.022 -1.049 . . . . 1.0 110.157 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' A' ' 102' ' ' GLU . 56.1 mp0 -93.53 171.17 9.06 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.177 -0.952 . . . . 1.0 109.128 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 13.7 m -99.48 108.57 21.05 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.352 -0.981 . . . . 1.0 108.352 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -85.84 127.57 34.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 1.0 109.368 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.451 ' CG2' ' O ' ' A' ' 109' ' ' LYS . 1.8 t -139.86 153.11 46.95 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.428 -0.795 . . . . 1.0 109.638 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.5 t -98.69 -4.28 34.03 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.418 -0.801 . . . . 1.0 108.972 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 53.1 m -89.65 -116.47 0.06 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.327 -0.858 . . . . 1.0 109.626 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.8 p -141.84 64.58 1.39 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.134 -0.979 . . . . 1.0 110.147 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.451 ' O ' ' CG2' ' A' ' 105' ' ' THR . 98.7 mttt -144.87 155.29 43.38 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.09 -1.006 . . . . 1.0 108.848 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 49.97 -138.62 20.3 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.485 -1.446 . . . . 1.0 109.485 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -99.55 118.96 37.25 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.241 -1.152 . . . . 1.0 109.337 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -62.24 127.48 31.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.296 -0.878 . . . . 1.0 109.927 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.7 tp -59.98 -40.29 88.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.3 -0.875 . . . . 1.0 110.237 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -59.89 -40.96 90.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.237 -0.915 . . . . 1.0 110.233 -178.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.431 HD21 ' HZ1' ' A' ' 146' ' ' LYS . 3.0 mm? -60.76 -51.31 69.88 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.511 -1.368 . . . . 1.0 110.173 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.1 t -68.96 -43.77 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -0.889 . . . . 1.0 110.296 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.5 -52.24 66.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.074 -1.016 . . . . 1.0 109.739 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.23 -39.62 87.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.875 . . . . 1.0 110.374 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.625 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 68.2 t60 -62.04 -50.01 73.73 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.366 -0.834 . . . . 1.0 111.481 -178.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.44 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 9.5 pt-20 -59.6 -39.77 85.26 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.842 -1.161 . . . . 1.0 109.943 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -60.39 -39.8 88.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.955 -1.091 . . . . 1.0 108.738 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.76 -43.29 86.79 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.162 -1.575 . . . . 1.0 109.162 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.625 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 89.2 m-70 -67.53 -39.91 85.04 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.221 -1.164 . . . . 1.0 109.864 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 72.3 p -66.72 -21.61 66.07 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.134 -0.979 . . . . 1.0 109.463 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 77.1 mt -81.67 -0.73 44.01 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.457 -0.777 . . . . 1.0 109.484 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.82 6.96 66.85 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 110.902 -0.879 . . . . 1.0 110.902 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.5 mt -86.84 149.51 24.78 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.815 -1.403 . . . . 1.0 109.733 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 36.3 t0 -100.78 173.9 6.3 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.546 -0.721 . . . . 1.0 109.056 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.482 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 76.3 m80 -58.06 137.78 56.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.079 -1.013 . . . . 1.0 109.069 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 41.1 t -98.35 151.12 20.87 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.383 -0.823 . . . . 1.0 109.719 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -97.65 1.54 48.81 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.329 -0.857 . . . . 1.0 109.487 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -87.04 128.88 54.12 Favored Pre-proline 0 N--CA 1.489 1.487 0 N-CA-C 108.217 -1.031 . . . . 1.0 108.217 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -69.08 -11.04 30.76 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 CA-C-N 120.128 1.081 . . . . 1.0 112.059 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -93.43 -8.87 60.79 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.425 -1.47 . . . . 1.0 109.425 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.54 136.28 33.87 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.4 -1.059 . . . . 1.0 109.195 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.439 ' C ' ' H ' ' A' ' 138' ' ' PHE . 89.8 mt -60.84 -37.15 81.07 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.027 -1.046 . . . . 1.0 109.638 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 72.8 mtp -70.06 21.42 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.473 -0.767 . . . . 1.0 111.361 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.439 ' H ' ' C ' ' A' ' 136' ' ' LEU . 12.1 t80 -67.69 132.68 92.58 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 120.941 -1.099 . . . . 1.0 108.089 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -62.2 -2.07 2.82 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 CA-C-N 119.851 0.982 . . . . 1.0 114.56 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 95.7 mt -118.46 140.61 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.683 0 O-C-N 120.831 -1.168 . . . . 1.0 110.081 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -75.84 126.49 31.11 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.544 -0.723 . . . . 1.0 110.528 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 14.3 t -144.43 141.88 29.93 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.327 -0.858 . . . . 1.0 109.502 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -80.68 149.63 29.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.094 -1.004 . . . . 1.0 109.571 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.558 ' H ' ' NZ ' ' A' ' 146' ' ' LYS . 3.9 m -146.19 162.49 37.9 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.232 -0.918 . . . . 1.0 109.761 -178.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.439 ' N ' ' CG2' ' A' ' 144' ' ' THR . . . -84.88 103.17 2.64 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.134 -1.586 . . . . 1.0 109.134 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.558 ' NZ ' ' H ' ' A' ' 144' ' ' THR . 9.8 mptt -77.7 3.42 14.05 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.206 -1.173 . . . . 1.0 109.74 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 18.5 t -59.97 -47.56 85.3 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.464 -0.772 . . . . 1.0 109.793 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -133.65 19.12 3.89 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.267 -0.896 . . . . 1.0 110.097 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -65.35 139.84 58.61 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.901 -1.124 . . . . 1.0 110.416 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 76.6 mtm -138.04 149.69 46.26 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.284 -1.006 . . . . 1.0 108.284 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.1 mt -53.07 128.63 48.22 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.819 -1.176 . . . . 1.0 108.882 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.37 175.55 5.79 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 CA-C-N 120.201 1.107 . . . . 1.0 112.334 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -60.06 -39.69 86.89 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.529 -0.732 . . . . 1.0 109.968 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -56.65 -48.43 77.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.264 -0.897 . . . . 1.0 110.107 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -70.15 -40.03 75.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.137 -0.977 . . . . 1.0 109.677 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 76.7 t -63.09 -48.47 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.097 -1.002 . . . . 1.0 109.661 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -60.32 -40.24 89.91 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.904 -1.123 . . . . 1.0 110.298 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.67 -54.55 8.38 Favored Glycine 0 N--CA 1.496 2.659 0 O-C-N 121.168 -0.958 . . . . 1.0 111.41 -178.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.454 HG23 ' N ' ' A' ' 160' ' ' GLN . 6.3 tp -60.94 -40.22 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.813 -1.404 . . . . 1.0 109.59 -179.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.2 mm-40 -65.27 -39.71 92.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.16 -0.963 . . . . 1.0 109.434 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 83.9 p -66.68 -26.62 67.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.231 -0.918 . . . . 1.0 110.265 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 84.9 mt -87.0 -50.85 6.38 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.954 -1.091 . . . . 1.0 110.202 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -91.47 -9.19 45.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.104 -0.998 . . . . 1.0 110.286 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.492 2.429 0 N-CA-C 109.549 -1.42 . . . . 1.0 109.549 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.2 mt . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.233 -0.655 . . . . 1.0 109.233 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -160.6 160.4 31.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 1.0 109.016 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -72.25 151.67 42.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.101 -0.999 . . . . 1.0 109.214 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 82.8 p -86.51 1.92 49.82 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.243 -0.91 . . . . 1.0 110.487 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -149.63 154.59 38.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.082 -1.011 . . . . 1.0 109.342 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.504 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.02 0.96 56.83 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.219 -0.925 . . . . 1.0 109.88 -179.529 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -95.85 127.69 42.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.107 -0.996 . . . . 1.0 108.687 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.6 mt -141.36 151.0 43.18 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.154 -0.966 . . . . 1.0 109.256 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.3 p -132.11 155.58 47.87 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.439 -0.788 . . . . 1.0 109.088 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -144.02 159.98 41.66 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.163 -0.96 . . . . 1.0 109.934 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.535 HH12 ' C ' ' A' ' 53' ' ' LEU . 25.2 ttm-85 -145.87 136.09 23.83 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.533 -0.729 . . . . 1.0 109.906 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 87.4 mt -88.81 113.93 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 108.339 -0.985 . . . . 1.0 108.339 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.66 -40.27 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.104 -0.997 . . . . 1.0 109.094 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -161.9 160.98 28.6 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.856 -1.152 . . . . 1.0 110.473 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.557 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 62.8 m-85 -101.95 -168.05 1.49 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.607 -1.257 . . . . 1.0 107.607 179.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.22 149.02 50.83 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.165 -0.959 . . . . 1.0 110.131 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -70.63 -12.03 30.62 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 120.827 1.018 . . . . 1.0 110.148 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -59.62 -39.96 85.99 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 115.334 -0.848 . . . . 1.0 110.531 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.9 mtm -139.99 169.93 16.8 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.163 -0.96 . . . . 1.0 109.634 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 78.8 p -73.15 160.05 32.57 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.137 -0.977 . . . . 1.0 109.472 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.557 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 1.8 m80 -60.16 -39.79 87.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.52 -0.738 . . . . 1.0 110.344 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.1 m -59.97 -39.9 87.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.08 -1.012 . . . . 1.0 109.549 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -62.47 -46.57 87.88 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.099 -1.001 . . . . 1.0 110.31 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.2 t -66.32 -39.92 85.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.401 -0.812 . . . . 1.0 109.804 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -54.44 -57.08 12.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.276 -0.89 . . . . 1.0 111.221 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.8 pttt -62.32 -32.17 72.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.683 -1.261 . . . . 1.0 110.439 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.34 -49.95 70.9 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.887 -1.133 . . . . 1.0 109.687 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -65.17 -39.67 93.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.027 -1.046 . . . . 1.0 109.759 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.15 -40.22 89.12 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.062 -1.024 . . . . 1.0 109.485 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -60.06 -43.45 95.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.979 -1.076 . . . . 1.0 108.845 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.21 -47.33 84.91 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.471 -0.768 . . . . 1.0 110.39 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.429 ' CZ ' ' CZ ' ' A' ' 121' ' ' PHE . 43.0 m-85 -63.32 -40.25 96.79 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.816 -1.178 . . . . 1.0 109.767 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -60.01 -44.43 94.57 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.163 -0.961 . . . . 1.0 110.043 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.8 t -60.11 -41.88 88.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.292 -0.88 . . . . 1.0 110.26 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -79.68 -37.49 35.72 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.157 -0.964 . . . . 1.0 111.162 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.3 p -69.85 -17.58 63.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.889 -1.132 . . . . 1.0 109.664 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.77 -40.14 91.41 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.546 -0.721 . . . . 1.0 110.833 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.8 m -118.65 35.3 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.257 -0.902 . . . . 1.0 110.69 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.6 p -151.12 134.62 9.08 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 120.917 -1.114 . . . . 1.0 109.925 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -73.39 10.64 1.17 Allowed 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 120.809 1.006 . . . . 1.0 111.908 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.0 mt -68.93 136.85 53.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.001 -1.062 . . . . 1.0 110.02 -179.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -107.21 120.76 42.99 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.501 -0.926 . . . . 1.0 108.501 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -108.25 124.57 50.51 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.309 -0.869 . . . . 1.0 109.599 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -120.37 130.02 54.21 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.56 -0.712 . . . . 1.0 110.088 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -81.37 130.03 34.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.235 -0.916 . . . . 1.0 109.288 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.535 ' C ' HH12 ' A' ' 18' ' ' ARG . 85.1 mt -106.04 139.94 39.8 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.391 -0.818 . . . . 1.0 108.942 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.444 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 41.3 m170 -95.33 -14.35 23.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.254 -0.904 . . . . 1.0 109.704 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 77.2 m-20 -149.66 160.28 43.64 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.309 -0.869 . . . . 1.0 109.865 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.535 ' O ' ' NE ' ' A' ' 18' ' ' ARG . . . 88.12 179.6 47.06 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.751 -1.34 . . . . 1.0 109.751 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.6 mt -97.36 139.77 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.322 -1.105 . . . . 1.0 109.514 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.04 155.75 22.3 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.478 -0.763 . . . . 1.0 109.16 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -59.92 -49.83 76.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.113 -0.992 . . . . 1.0 109.257 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.7 mt -103.91 99.85 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.405 -0.809 . . . . 1.0 109.786 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.5 ptp -99.8 138.94 36.18 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.161 -0.962 . . . . 1.0 109.166 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.2 mt -110.19 132.15 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.999 -0.741 . . . . 1.0 108.999 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 71.5 p -149.3 149.91 31.68 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.896 -1.127 . . . . 1.0 109.879 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -101.98 123.45 45.91 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.727 -0.842 . . . . 1.0 108.727 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.73 -165.96 22.51 Favored Glycine 0 N--CA 1.499 2.838 0 N-CA-C 110.107 -1.197 . . . . 1.0 110.107 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 71.8 mt . . . . . 0 N--CA 1.495 1.811 0 O-C-N 121.671 -0.899 . . . . 1.0 108.822 179.895 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.551 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 89.2 m-85 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 108.609 -0.886 . . . . 1.0 108.609 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -105.18 20.01 19.61 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.319 -0.863 . . . . 1.0 110.811 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 112.37 -156.71 15.41 Favored Glycine 0 N--CA 1.504 3.222 0 N-CA-C 109.149 -1.58 . . . . 1.0 109.149 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -57.41 -68.25 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.49 0 CA-C-N 118.657 1.228 . . . . 1.0 112.423 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 84.9 p -76.36 162.86 27.53 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.326 -0.859 . . . . 1.0 109.982 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.78 -129.16 8.37 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 109.734 -1.346 . . . . 1.0 109.734 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.0 mt -69.12 107.71 3.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.44 -1.035 . . . . 1.0 109.123 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 60.1 mt -78.92 -22.4 45.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.894 -1.129 . . . . 1.0 109.016 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -177.49 173.03 1.73 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.755 -0.831 . . . . 1.0 108.755 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.572 ' CE1' ' ND1' ' A' ' 97' ' ' HIS . 19.8 p80 -161.56 162.2 30.11 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.047 -1.033 . . . . 1.0 109.652 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.4 155.13 40.85 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.745 -0.835 . . . . 1.0 108.745 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -93.44 151.67 40.4 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.176 -0.952 . . . . 1.0 108.559 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -50.0 169.38 0.14 Allowed 'Trans proline' 0 N--CA 1.488 1.176 0 CA-C-N 119.189 0.746 . . . . 1.0 111.295 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo . . . . . 0 C--N 1.314 -1.274 0 C-N-CA 120.661 0.908 . . . . 1.0 111.849 179.903 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.244 0.545 . . . . 1.0 109.895 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.08 122.75 10.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.267 -0.896 . . . . 1.0 109.428 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.572 ' ND1' ' CE1' ' A' ' 84' ' ' HIS . 46.1 m170 -105.31 136.36 44.99 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.652 -0.655 . . . . 1.0 109.853 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -120.23 145.0 47.44 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.896 -0.779 . . . . 1.0 108.896 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.551 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 82.9 m-20 -78.56 121.75 25.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.034 -1.041 . . . . 1.0 109.856 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 37.8 t0 -85.63 -7.36 58.88 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.905 -0.776 . . . . 1.0 108.905 179.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -82.39 -12.56 57.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.432 -0.793 . . . . 1.0 109.197 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -91.1 170.56 9.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.378 -0.826 . . . . 1.0 109.291 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.9 m -101.29 105.37 16.45 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.382 -0.824 . . . . 1.0 109.097 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.426 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 88.2 m95 -88.41 123.77 33.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.342 -0.849 . . . . 1.0 109.057 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.669 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.1 t -140.52 157.67 45.14 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.331 -0.856 . . . . 1.0 110.198 -179.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 53.4 m -96.1 -9.18 31.4 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.181 -1.044 . . . . 1.0 108.181 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 72.4 m -92.35 171.58 8.96 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.58 -0.896 . . . . 1.0 108.58 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.6 t -72.09 76.19 0.95 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.07 -1.018 . . . . 1.0 109.928 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.669 ' HB2' HG21 ' A' ' 105' ' ' THR . 64.2 mttp -149.53 150.29 32.06 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.204 -0.935 . . . . 1.0 108.982 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.07 -137.46 4.91 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.702 -1.359 . . . . 1.0 109.702 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -102.68 117.57 34.95 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.436 -1.038 . . . . 1.0 109.405 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.592 HD22 ' NZ ' ' A' ' 146' ' ' LYS . 55.3 t-20 -64.2 130.09 42.52 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.22 -0.925 . . . . 1.0 109.583 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.2 tp -60.13 -40.56 90.19 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.41 -0.806 . . . . 1.0 110.94 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -58.71 -40.13 82.79 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.793 -1.192 . . . . 1.0 110.346 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -58.68 -59.92 4.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.944 -1.097 . . . . 1.0 109.749 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 86.9 t -62.99 -42.13 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.53 -0.732 . . . . 1.0 110.216 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.69 -49.99 75.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.119 -0.988 . . . . 1.0 109.403 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.99 -39.69 86.59 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.918 -1.114 . . . . 1.0 109.803 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.632 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 68.4 t60 -65.08 -48.55 73.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.347 -0.846 . . . . 1.0 111.946 -178.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.506 ' OE2' ' CD1' ' A' ' 121' ' ' PHE . 1.1 pp20? -59.13 -40.05 84.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.535 -1.353 . . . . 1.0 109.281 -178.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.506 ' CD1' ' OE2' ' A' ' 120' ' ' GLU . 28.4 m-85 -60.04 -39.87 87.42 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.857 -1.152 . . . . 1.0 109.175 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.76 -45.36 85.81 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.843 -1.303 . . . . 1.0 109.843 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.632 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 87.6 m-70 -64.89 -40.06 94.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.004 -1.292 . . . . 1.0 109.645 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 82.2 p -63.78 -23.48 67.38 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.251 -0.906 . . . . 1.0 109.421 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.6 mt -84.16 -1.09 54.42 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.046 -1.034 . . . . 1.0 109.876 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.48 10.83 63.18 Favored Glycine 0 N--CA 1.496 2.698 0 C-N-CA 120.025 -1.084 . . . . 1.0 110.747 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 77.9 mt -84.65 144.0 28.87 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.888 -1.36 . . . . 1.0 109.944 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 11.6 t70 -99.15 170.1 8.93 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.302 -0.874 . . . . 1.0 109.029 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.493 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 65.7 m80 -60.0 137.35 58.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.153 -0.967 . . . . 1.0 110.154 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 28.6 t -100.62 154.15 18.82 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -97.98 5.72 48.5 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.096 -1.003 . . . . 1.0 109.911 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -86.98 129.48 51.93 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.066 -1.021 . . . . 1.0 108.66 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -66.4 -24.0 50.38 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 CA-C-N 120.188 1.103 . . . . 1.0 112.406 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -86.15 -5.09 83.47 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.012 -1.235 . . . . 1.0 110.012 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.59 144.48 27.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.933 -1.334 . . . . 1.0 108.731 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.433 ' C ' ' H ' ' A' ' 138' ' ' PHE . 88.4 mt -68.99 -33.22 73.33 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.307 -0.871 . . . . 1.0 109.181 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 96.3 mmm -71.58 19.87 0.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.462 -0.774 . . . . 1.0 110.771 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.433 ' H ' ' C ' ' A' ' 136' ' ' LEU . 12.0 t80 -69.16 132.34 90.1 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 120.826 -1.171 . . . . 1.0 108.532 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -64.53 -3.65 6.92 Favored 'Trans proline' 0 N--CA 1.501 1.926 0 CA-C-N 119.888 0.996 . . . . 1.0 113.936 -178.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.0 mt -118.67 141.11 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 O-C-N 121.012 -1.055 . . . . 1.0 109.104 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . 0.497 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 38.3 t80 -74.73 130.63 39.82 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.489 -0.757 . . . . 1.0 110.252 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.8 t -140.63 142.48 35.0 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.431 -0.951 . . . . 1.0 108.431 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -79.8 144.17 33.77 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.918 -1.114 . . . . 1.0 110.074 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.4 m -130.42 140.03 50.58 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.04 -0.726 . . . . 1.0 109.04 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.41 113.92 3.98 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 107.655 -2.178 . . . . 1.0 107.655 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.592 ' NZ ' HD22 ' A' ' 112' ' ' ASN . 33.0 mmtm -73.25 98.77 2.72 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.063 -1.257 . . . . 1.0 109.297 -178.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.9 m -159.72 104.75 1.58 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.301 -0.875 . . . . 1.0 108.846 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 72.9 m80 50.1 40.57 21.97 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.408 -0.807 . . . . 1.0 109.399 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -85.19 129.96 34.7 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.16 -0.963 . . . . 1.0 109.393 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 66.9 mtt -124.28 149.06 46.93 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.981 -0.748 . . . . 1.0 108.981 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 29.1 mt -51.84 131.54 38.42 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.099 -1.001 . . . . 1.0 108.408 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -66.14 174.41 6.0 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 CA-C-N 119.992 1.033 . . . . 1.0 112.32 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -60.08 -39.65 86.81 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.429 -0.794 . . . . 1.0 110.152 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -57.16 -49.67 75.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.135 -0.978 . . . . 1.0 109.809 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.01 -40.19 75.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.088 -1.008 . . . . 1.0 110.516 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 67.5 t -60.74 -45.72 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.949 -1.094 . . . . 1.0 108.989 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -60.17 -39.92 88.13 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.137 -0.977 . . . . 1.0 110.398 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -69.54 -52.45 21.09 Favored Glycine 0 N--CA 1.494 2.546 0 O-C-N 121.145 -0.972 . . . . 1.0 111.504 -178.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.455 HG23 ' N ' ' A' ' 160' ' ' GLN . 5.3 tp -62.25 -40.01 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.754 -1.439 . . . . 1.0 109.661 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.8 mt-30 -65.01 -38.99 92.74 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.246 -0.909 . . . . 1.0 109.628 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 79.5 p -69.26 -22.25 63.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.174 -0.953 . . . . 1.0 110.174 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 88.8 mt -88.24 -50.68 6.2 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.888 -1.132 . . . . 1.0 110.065 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -93.53 -9.32 38.67 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.034 -1.041 . . . . 1.0 109.67 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.509 0 N-CA-C 109.473 -1.451 . . . . 1.0 109.473 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.4 mt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.582 -0.525 . . . . 1.0 109.582 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.55 ' HB3' ' HZ3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -161.41 159.82 28.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.149 -0.969 . . . . 1.0 109.56 179.502 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -76.23 152.6 36.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 1.0 109.407 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 99.0 p -87.51 0.03 56.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.361 -0.837 . . . . 1.0 109.809 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -148.57 154.59 39.96 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.154 -0.966 . . . . 1.0 109.686 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.567 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.49 -0.03 57.5 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.377 -0.827 . . . . 1.0 110.222 -179.577 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -96.6 122.38 39.46 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.181 -0.949 . . . . 1.0 108.863 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 71.8 mt -138.85 149.08 44.49 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.471 -0.768 . . . . 1.0 108.98 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.3 p -131.67 160.01 36.68 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.703 -0.851 . . . . 1.0 108.703 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -142.89 161.19 38.77 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.13 -0.981 . . . . 1.0 110.435 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -142.63 129.75 20.85 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.137 -0.69 . . . . 1.0 109.137 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.7 mt -88.13 118.25 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.182 -0.949 . . . . 1.0 108.908 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.67 -39.53 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.218 -0.926 . . . . 1.0 109.505 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.46 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 21.4 p-10 -162.47 155.5 19.94 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.212 -1.555 . . . . 1.0 111.366 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.487 ' HB2' ' CD2' ' A' ' 28' ' ' HIS . 19.3 m-85 -104.96 75.73 1.2 Allowed 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 106.358 -1.719 . . . . 1.0 106.358 176.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.482 ' O ' ' O ' ' A' ' 22' ' ' TYR . 3.0 t -23.45 144.71 0.02 OUTLIER Pre-proline 0 N--CA 1.512 2.636 0 C-N-CA 122.83 0.452 . . . . 1.0 111.744 -177.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -63.94 -4.74 7.92 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 121.631 1.554 . . . . 1.0 112.915 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -59.09 -36.84 75.82 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.442 -0.786 . . . . 1.0 109.557 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 76.8 mtm -138.47 164.17 30.08 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.298 -0.876 . . . . 1.0 109.582 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 76.0 p -70.58 160.03 33.25 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.378 -0.826 . . . . 1.0 109.154 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.487 ' CD2' ' HB2' ' A' ' 22' ' ' TYR . 26.2 m170 -60.03 -42.45 94.4 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.291 -0.881 . . . . 1.0 110.206 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.2 m -60.41 -40.6 91.58 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.166 -0.959 . . . . 1.0 110.735 -179.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -65.78 -41.04 92.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.973 -1.079 . . . . 1.0 110.144 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 69.5 t -66.6 -40.0 85.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 121.422 -0.799 . . . . 1.0 109.978 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -59.78 -52.54 65.03 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.404 -0.81 . . . . 1.0 112.144 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.2 pttt -65.13 -32.63 74.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.558 -1.339 . . . . 1.0 110.277 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.57 -51.31 70.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.941 -1.1 . . . . 1.0 110.181 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.437 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 45.0 m-85 -65.87 -37.39 86.03 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.825 -1.172 . . . . 1.0 110.099 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -59.99 -40.55 89.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.942 -1.098 . . . . 1.0 109.67 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -61.55 -40.31 94.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.067 -1.021 . . . . 1.0 109.529 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.08 -46.12 90.64 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.422 -0.799 . . . . 1.0 110.44 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -68.07 -39.67 82.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.01 -1.056 . . . . 1.0 109.86 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.408 ' O ' ' CG ' ' A' ' 44' ' ' ASP . 49.9 tptt -60.02 -47.17 86.94 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.186 -0.946 . . . . 1.0 109.878 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.2 t -60.08 -42.07 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.145 -0.972 . . . . 1.0 110.846 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -79.31 -35.36 41.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.85 -1.156 . . . . 1.0 110.148 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 38.8 p -71.5 -16.26 62.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.098 -1.001 . . . . 1.0 109.62 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.408 ' CG ' ' O ' ' A' ' 40' ' ' LYS . 96.0 m-20 -59.98 -39.59 86.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.339 -0.851 . . . . 1.0 110.314 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.4 m -112.18 -21.85 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.306 -0.871 . . . . 1.0 110.65 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.6 p -93.78 133.05 28.49 Favored Pre-proline 0 N--CA 1.501 2.109 0 O-C-N 120.759 -1.213 . . . . 1.0 109.611 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -75.43 15.95 0.77 Allowed 'Trans proline' 0 N--CA 1.496 1.622 0 CA-C-N 120.204 1.109 . . . . 1.0 112.039 178.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 78.8 mt -68.31 140.02 55.93 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.195 -0.941 . . . . 1.0 109.912 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -108.19 121.73 45.46 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 108.993 -0.743 . . . . 1.0 108.993 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -108.95 124.52 50.81 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.249 -0.907 . . . . 1.0 109.958 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.0 m -119.96 129.95 54.55 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.418 0.628 . . . . 1.0 109.306 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -83.82 137.9 33.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.307 -0.871 . . . . 1.0 110.042 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 77.3 mt -102.79 129.29 49.4 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.703 -0.851 . . . . 1.0 108.703 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.448 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 61.0 m170 -61.67 -40.04 93.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.914 . . . . 1.0 109.428 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 75.0 m-20 -151.0 168.02 25.85 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.379 -0.825 . . . . 1.0 109.249 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.03 -178.64 29.57 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.543 -1.423 . . . . 1.0 109.543 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.0 mt -96.3 132.82 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.353 -1.087 . . . . 1.0 109.76 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.96 164.71 12.34 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.367 -0.833 . . . . 1.0 109.071 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.04 -49.48 77.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.189 -0.944 . . . . 1.0 109.527 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 95.2 mt -107.28 101.85 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.51 -0.743 . . . . 1.0 109.691 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.2 ptp -100.21 135.97 40.82 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.248 -0.908 . . . . 1.0 109.469 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.437 HG21 ' CZ ' ' A' ' 35' ' ' PHE . 85.4 mt -110.0 133.92 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.726 -0.609 . . . . 1.0 109.945 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.2 p -152.47 155.18 37.0 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.017 -1.052 . . . . 1.0 110.274 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -102.68 121.86 43.28 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.499 -0.926 . . . . 1.0 108.499 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.78 -173.45 22.86 Favored Glycine 0 N--CA 1.499 2.894 0 N-CA-C 110.761 -0.935 . . . . 1.0 110.761 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 96.7 mt . . . . . 0 N--CA 1.497 1.91 0 N-CA-C 107.755 -1.202 . . . . 1.0 107.755 179.413 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.561 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 94.4 m-85 . . . . . 0 N--CA 1.494 1.739 0 N-CA-C 109.106 -0.701 . . . . 1.0 109.106 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 79' ' ' SER . 23.2 p-10 -99.72 18.61 17.7 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.132 -0.98 . . . . 1.0 110.61 -178.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 110.21 -151.87 17.4 Favored Glycine 0 N--CA 1.503 3.16 0 N-CA-C 109.337 -1.505 . . . . 1.0 109.337 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.439 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 6.3 Cg_exo -62.16 -63.67 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.563 0 CA-C-N 118.919 1.359 . . . . 1.0 112.408 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.434 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 95.9 p -77.36 162.77 27.0 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.934 -1.104 . . . . 1.0 109.882 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.68 -130.05 9.01 Favored Glycine 0 N--CA 1.502 3.081 0 N-CA-C 110.341 -1.104 . . . . 1.0 110.341 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.429 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 8.9 mt -68.54 108.32 3.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.607 -0.937 . . . . 1.0 108.589 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 74.4 mt -80.67 -17.98 49.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.969 -1.082 . . . . 1.0 109.818 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.64 174.13 1.23 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.427 -0.796 . . . . 1.0 109.194 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.434 ' CE1' ' ND1' ' A' ' 97' ' ' HIS . 11.5 p80 -161.99 159.35 26.36 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.357 -0.84 . . . . 1.0 109.236 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.22 154.6 40.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.154 -0.966 . . . . 1.0 109.368 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -92.15 152.11 42.32 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.096 -1.002 . . . . 1.0 108.418 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -50.01 171.08 0.1 OUTLIER 'Trans proline' 0 N--CA 1.49 1.265 0 CA-C-N 119.139 0.728 . . . . 1.0 111.191 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo . . . . . 0 C--N 1.315 -1.21 0 CA-C-O 121.932 0.722 . . . . 1.0 111.402 -179.693 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.2 p-10 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.446 0.641 . . . . 1.0 109.856 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.0 120.48 7.42 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.434 -0.792 . . . . 1.0 109.02 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.434 ' ND1' ' CE1' ' A' ' 84' ' ' HIS . 48.7 m170 -105.61 139.51 40.1 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.561 -0.712 . . . . 1.0 110.265 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.528 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 29.2 m-85 -120.78 140.97 50.95 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.733 -0.84 . . . . 1.0 108.733 179.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.561 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 93.9 m-20 -78.92 122.94 26.75 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.834 -1.166 . . . . 1.0 109.65 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 34.4 t0 -84.39 1.61 44.42 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.281 -0.887 . . . . 1.0 109.722 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -80.74 -17.95 49.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.124 -0.985 . . . . 1.0 109.57 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' A' ' 102' ' ' GLU . 56.9 mp0 -91.27 172.13 8.75 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.315 -0.865 . . . . 1.0 109.012 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 15.5 m -100.93 107.02 18.41 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.292 -1.003 . . . . 1.0 108.292 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -85.2 127.29 34.23 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.533 -0.914 . . . . 1.0 108.533 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.681 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.9 t -141.8 153.63 44.67 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.343 -0.848 . . . . 1.0 109.979 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 96.6 p -91.88 -5.66 52.88 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.911 -1.144 . . . . 1.0 107.911 178.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 65.2 m -93.1 -176.94 4.32 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.899 -0.778 . . . . 1.0 108.899 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.8 t -85.08 75.51 10.35 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.017 -1.052 . . . . 1.0 109.454 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.681 ' HB2' HG21 ' A' ' 105' ' ' THR . 98.2 mttt -148.67 152.82 37.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.321 -0.862 . . . . 1.0 108.889 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 43.37 -138.72 3.54 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 110.169 -1.172 . . . . 1.0 110.169 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -99.99 117.4 34.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.35 -1.088 . . . . 1.0 109.277 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -64.24 132.6 50.76 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.105 -0.997 . . . . 1.0 109.426 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.3 tp -59.97 -44.1 94.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 1.0 110.309 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -59.98 -40.9 90.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.167 -0.958 . . . . 1.0 111.585 -178.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -59.38 -49.98 75.71 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.443 -1.41 . . . . 1.0 109.415 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 66.0 t -69.97 -40.01 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.136 -0.977 . . . . 1.0 110.047 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.21 -52.8 63.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.089 -1.007 . . . . 1.0 109.807 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.0 -39.54 86.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.824 . . . . 1.0 110.695 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.616 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 69.0 t60 -61.94 -50.03 73.77 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.047 -1.033 . . . . 1.0 111.387 -178.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.528 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 8.2 pt-20 -60.04 -38.57 83.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.608 -1.308 . . . . 1.0 110.113 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -60.03 -40.03 87.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.82 -1.175 . . . . 1.0 108.588 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.79 -43.18 94.74 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.449 -1.46 . . . . 1.0 109.449 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.616 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 90.5 m-70 -65.62 -40.01 92.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.05 -1.265 . . . . 1.0 109.291 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 93.3 p -67.19 -25.39 66.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.179 -0.951 . . . . 1.0 109.438 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 83.2 mt -82.53 -3.0 55.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.22 -0.925 . . . . 1.0 109.791 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 96.94 7.53 57.45 Favored Glycine 0 N--CA 1.5 2.906 0 O-C-N 121.101 -1.0 . . . . 1.0 111.108 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.3 mt -85.25 148.0 26.29 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.698 -1.472 . . . . 1.0 109.693 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 39.7 t0 -102.75 171.49 7.39 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.993 -0.743 . . . . 1.0 108.993 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.536 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 76.9 m80 -59.22 136.26 57.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.012 -1.055 . . . . 1.0 109.106 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 40.3 t -97.38 155.28 16.98 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.237 -0.915 . . . . 1.0 109.541 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -98.61 1.3 46.24 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.351 -0.843 . . . . 1.0 109.75 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -85.4 130.18 52.53 Favored Pre-proline 0 N--CA 1.495 1.79 0 N-CA-C 107.843 -1.169 . . . . 1.0 107.843 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -67.44 -26.18 41.01 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 CA-C-N 120.212 1.111 . . . . 1.0 113.285 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -85.92 -2.75 86.09 Favored Glycine 0 N--CA 1.497 2.709 0 C-N-CA 119.799 -1.191 . . . . 1.0 110.342 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.63 144.42 27.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.047 -1.266 . . . . 1.0 109.146 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.407 ' C ' ' H ' ' A' ' 138' ' ' PHE . 91.5 mt -67.05 -33.46 75.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.177 -0.952 . . . . 1.0 109.813 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 94.8 mmm -69.17 9.61 0.41 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.164 -0.96 . . . . 1.0 110.2 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.407 ' H ' ' C ' ' A' ' 136' ' ' LEU . 13.2 t80 -67.43 135.9 93.18 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 107.738 -1.208 . . . . 1.0 107.738 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -65.13 -31.83 53.79 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 CA-C-N 119.898 0.999 . . . . 1.0 113.818 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 90.6 mt -83.42 140.41 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.481 -1.387 . . . . 1.0 110.119 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -76.07 128.92 36.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.491 -0.756 . . . . 1.0 109.591 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 10.2 t -140.16 142.41 35.95 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.221 -0.924 . . . . 1.0 109.55 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -82.5 144.93 30.08 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.359 -0.838 . . . . 1.0 109.643 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.8 t -140.79 156.09 46.24 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.259 -0.9 . . . . 1.0 110.076 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.0 110.36 3.17 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.92 -1.672 . . . . 1.0 108.92 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -78.63 -3.38 43.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.328 -1.101 . . . . 1.0 109.708 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.0 t -60.04 -41.14 91.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.234 -0.916 . . . . 1.0 110.635 -178.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -143.01 28.89 1.52 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.939 -1.101 . . . . 1.0 110.513 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -68.32 135.65 52.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.754 -1.216 . . . . 1.0 109.071 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 98.7 mtp -138.39 148.2 44.23 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.502 -0.925 . . . . 1.0 108.502 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 88.0 mt -50.83 121.25 14.76 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 120.959 -1.088 . . . . 1.0 108.682 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -66.57 178.55 2.61 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 CA-C-N 120.275 1.134 . . . . 1.0 112.153 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.16 -39.97 88.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.474 -0.766 . . . . 1.0 109.669 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -56.94 -49.2 76.38 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.238 -0.914 . . . . 1.0 109.678 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.68 -40.01 73.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.961 -1.087 . . . . 1.0 110.299 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 72.9 t -62.15 -46.67 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.915 -1.116 . . . . 1.0 109.159 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -60.28 -40.05 89.02 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 1.0 110.212 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.13 -53.77 8.8 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 120.219 -0.991 . . . . 1.0 111.436 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.468 HG23 ' N ' ' A' ' 160' ' ' GLN . 9.9 tp -60.45 -40.31 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.74 -1.447 . . . . 1.0 109.971 -178.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.536 ' O ' ' N ' ' A' ' 164' ' ' GLY . 25.8 mm100 -65.68 -39.6 91.49 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.323 -0.861 . . . . 1.0 109.352 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 79.2 p -63.46 -25.82 68.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.197 -0.94 . . . . 1.0 110.14 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 84.5 mt -86.95 -52.56 5.39 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.959 -1.088 . . . . 1.0 110.456 -179.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -92.7 -9.01 42.31 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.035 -1.041 . . . . 1.0 110.135 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.522 0 N-CA-C 109.502 -1.439 . . . . 1.0 109.502 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.1 mt . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 121.27 0.557 . . . . 1.0 109.575 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.9 pttt -161.96 160.05 27.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 1.0 109.85 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -73.56 147.25 44.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.403 -0.81 . . . . 1.0 109.411 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 99.4 p -89.33 3.1 53.26 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.192 -0.942 . . . . 1.0 110.091 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -143.21 153.61 43.0 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.118 -0.989 . . . . 1.0 109.435 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.1 mmt -90.17 -0.1 57.44 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.399 -0.813 . . . . 1.0 110.219 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -97.27 127.98 43.72 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.111 -0.993 . . . . 1.0 109.632 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.7 mt -142.28 148.65 38.4 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.101 -1.0 . . . . 1.0 109.123 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.4 p -135.28 158.57 44.03 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -145.1 160.99 40.54 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.038 -1.039 . . . . 1.0 110.615 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.51 HH11 ' HG2' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -141.81 131.14 23.59 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 -179.141 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.7 mt -88.14 115.24 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.127 -0.983 . . . . 1.0 108.694 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.08 -41.7 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.122 -0.986 . . . . 1.0 109.537 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.543 HD21 ' H ' ' A' ' 64' ' ' PHE . 1.8 p30 -164.36 160.94 21.36 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.271 -1.518 . . . . 1.0 110.114 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.587 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 51.1 m-85 -102.06 -169.92 1.74 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.157 -1.053 . . . . 1.0 108.157 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.25 147.02 42.1 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.343 -0.848 . . . . 1.0 110.154 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -68.61 -14.42 39.47 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 120.876 1.05 . . . . 1.0 110.912 178.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -59.86 -39.59 85.74 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.601 -0.727 . . . . 1.0 110.186 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 74.3 mtm -137.23 165.26 26.54 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.283 -0.886 . . . . 1.0 109.425 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.7 p -72.51 159.63 33.62 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.289 -0.882 . . . . 1.0 109.406 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.587 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 0.9 OUTLIER -60.16 -39.98 88.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.422 -0.799 . . . . 1.0 110.346 -179.25 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.1 m -59.91 -40.11 87.7 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.151 -0.968 . . . . 1.0 110.266 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -66.0 -40.0 90.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.126 -0.984 . . . . 1.0 110.087 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.6 t -68.8 -40.38 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.209 -0.932 . . . . 1.0 110.272 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.94 -49.91 75.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.031 -1.043 . . . . 1.0 110.197 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -61.7 -32.52 72.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.039 -1.038 . . . . 1.0 110.015 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.89 -48.51 81.4 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.888 -1.133 . . . . 1.0 110.007 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -66.89 -39.04 87.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.94 -1.1 . . . . 1.0 109.815 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -60.04 -42.5 94.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.111 -0.993 . . . . 1.0 109.516 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -60.14 -41.21 92.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.09 -1.006 . . . . 1.0 109.203 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.71 -45.3 94.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.503 -0.748 . . . . 1.0 110.224 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -65.64 -38.55 89.68 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.065 -1.022 . . . . 1.0 109.95 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -59.59 -48.82 80.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.102 -0.999 . . . . 1.0 109.782 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 76.1 t -60.0 -40.36 82.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.163 -0.961 . . . . 1.0 110.556 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -81.18 -36.54 30.03 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.842 -1.161 . . . . 1.0 109.823 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.6 p -70.22 -17.08 63.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.179 -0.951 . . . . 1.0 109.666 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -60.03 -40.04 87.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.938 . . . . 1.0 110.3 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -112.16 -17.61 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.338 -0.851 . . . . 1.0 110.782 -179.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.9 p -94.93 125.5 50.63 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 120.744 -1.223 . . . . 1.0 109.48 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -72.37 16.14 0.39 Allowed 'Trans proline' 0 N--CA 1.495 1.578 0 CA-C-N 120.177 1.099 . . . . 1.0 111.8 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 66.3 mt -69.17 140.01 54.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.297 -0.877 . . . . 1.0 109.934 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -106.32 120.56 42.19 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.79 -0.819 . . . . 1.0 108.79 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -106.75 127.22 53.2 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.273 -0.892 . . . . 1.0 109.42 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.9 m -119.99 129.69 54.4 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -84.04 132.57 34.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.517 -0.739 . . . . 1.0 109.116 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.9 mt -105.4 131.7 52.51 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.175 -0.953 . . . . 1.0 109.171 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.44 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 43.0 m170 -61.02 -40.01 91.94 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.146 -0.971 . . . . 1.0 109.284 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 71.9 m-20 -151.95 180.0 7.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.365 -0.834 . . . . 1.0 109.624 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.67 178.71 39.43 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.364 -1.494 . . . . 1.0 109.364 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.5 mt -96.9 130.28 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.284 -1.127 . . . . 1.0 109.673 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.54 162.67 14.48 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.581 -0.699 . . . . 1.0 109.163 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -59.92 -49.83 76.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.187 -0.945 . . . . 1.0 109.499 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 94.8 mt -104.81 101.24 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.412 -0.805 . . . . 1.0 109.898 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.2 ptp -100.93 132.13 46.48 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.319 -0.863 . . . . 1.0 109.161 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.6 mt -102.5 138.09 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.454 -0.779 . . . . 1.0 109.724 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 81.4 p -151.34 160.02 43.99 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.312 -0.867 . . . . 1.0 109.716 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.543 ' H ' HD21 ' A' ' 21' ' ' ASN . 86.1 m-85 -109.61 125.87 53.02 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.516 -0.74 . . . . 1.0 109.515 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -101.78 -178.26 28.15 Favored Glycine 0 N--CA 1.5 2.921 0 N-CA-C 110.839 -0.904 . . . . 1.0 110.839 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.5 mt . . . . . 0 N--CA 1.498 1.964 0 O-C-N 121.613 -0.933 . . . . 1.0 109.721 179.786 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.536 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 67.8 m-85 . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 109.48 -0.563 . . . . 1.0 109.48 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.6 p-10 -101.0 0.29 37.87 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.454 -0.779 . . . . 1.0 109.994 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 135.19 -155.29 22.01 Favored Glycine 0 N--CA 1.501 2.976 0 N-CA-C 108.707 -1.757 . . . . 1.0 108.707 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.425 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 12.3 Cg_exo -59.41 -68.2 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.39 0 CA-C-N 118.843 1.322 . . . . 1.0 111.776 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 88.1 p -76.0 160.69 29.59 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.311 -0.868 . . . . 1.0 109.203 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.75 -131.09 8.95 Favored Glycine 0 N--CA 1.501 3.031 0 N-CA-C 109.369 -1.493 . . . . 1.0 109.369 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.425 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 24.1 mt -69.81 111.81 5.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.069 -1.254 . . . . 1.0 109.06 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 30.8 mt -82.17 -13.8 56.6 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.237 -0.915 . . . . 1.0 108.625 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 179.39 169.43 1.05 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.999 -0.741 . . . . 1.0 108.999 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.479 ' NE2' ' ND1' ' A' ' 97' ' ' HIS . 3.4 p-80 -162.54 160.88 26.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.077 -1.015 . . . . 1.0 109.572 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -147.48 164.53 33.09 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.193 -0.942 . . . . 1.0 109.577 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -100.8 152.81 37.94 Favored Pre-proline 0 N--CA 1.498 1.966 0 N-CA-C 108.713 -0.847 . . . . 1.0 108.713 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -56.42 169.07 1.78 Allowed 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 120.582 0.855 . . . . 1.0 111.774 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo . . . . . 0 N--CA 1.49 1.314 0 C-N-CA 120.745 0.963 . . . . 1.0 111.608 179.729 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.508 -0.553 . . . . 1.0 109.508 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.87 139.2 23.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.232 -0.917 . . . . 1.0 109.38 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.479 ' ND1' ' NE2' ' A' ' 84' ' ' HIS . 18.0 m170 -130.13 157.71 41.68 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.56 -0.713 . . . . 1.0 109.884 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -136.72 153.81 50.76 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.011 -0.737 . . . . 1.0 109.011 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.536 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 0.6 OUTLIER -79.99 122.09 26.29 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.062 -1.024 . . . . 1.0 109.495 179.842 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -85.28 -11.62 54.32 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.095 -1.003 . . . . 1.0 109.347 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -81.33 -10.68 59.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.873 . . . . 1.0 109.47 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 98.3 mt-10 -90.81 169.98 10.49 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.311 -0.868 . . . . 1.0 109.466 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 22.3 m -98.43 106.23 18.48 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.103 -0.998 . . . . 1.0 109.728 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.427 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 93.5 m95 -89.82 127.48 35.99 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.704 -0.85 . . . . 1.0 108.704 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.674 HG21 ' HB2' ' A' ' 109' ' ' LYS . 9.2 t -143.19 155.65 44.58 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.237 -0.915 . . . . 1.0 109.583 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 60.0 p -94.82 -5.7 44.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.111 -0.993 . . . . 1.0 108.431 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 70.3 m -93.48 179.17 5.47 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.955 -0.757 . . . . 1.0 108.955 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 19.6 m -81.04 77.02 7.98 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.008 -1.058 . . . . 1.0 108.988 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.674 ' HB2' HG21 ' A' ' 105' ' ' THR . 67.9 mttm -149.06 150.19 32.35 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.739 -0.838 . . . . 1.0 108.739 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.21 -138.77 4.48 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.203 -1.159 . . . . 1.0 110.203 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -99.5 116.68 32.21 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.303 -1.116 . . . . 1.0 109.487 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.66 131.42 47.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.156 -0.965 . . . . 1.0 109.246 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.7 tp -59.86 -41.66 91.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 1.0 110.12 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -59.98 -43.0 95.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.133 -0.979 . . . . 1.0 111.106 -178.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 115' ' ' LEU . 3.8 mm? -59.38 -50.17 74.98 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.661 -1.274 . . . . 1.0 109.319 -178.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 95.7 t -70.54 -42.2 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.059 -1.025 . . . . 1.0 109.974 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.13 -50.66 73.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.004 -1.06 . . . . 1.0 110.12 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.09 -36.44 77.4 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.581 -1.325 . . . . 1.0 109.577 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.599 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 72.3 t60 -65.5 -48.71 71.65 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.29 -0.881 . . . . 1.0 111.353 -178.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.67 -39.95 82.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.642 -1.286 . . . . 1.0 109.419 -178.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -60.04 -39.99 87.82 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.945 -1.097 . . . . 1.0 109.077 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.4 -46.51 80.07 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.795 -1.322 . . . . 1.0 109.795 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.599 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 85.9 m-70 -65.37 -39.93 92.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.135 -1.215 . . . . 1.0 109.3 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.8 p -64.64 -23.61 67.31 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.291 -0.88 . . . . 1.0 108.998 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 50.6 mt -82.49 -4.97 58.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 1.0 109.59 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 95.27 5.83 60.36 Favored Glycine 0 N--CA 1.499 2.869 0 O-C-N 121.154 -0.966 . . . . 1.0 111.075 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.2 mt -84.21 150.27 25.58 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.811 -1.405 . . . . 1.0 109.94 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 11.0 t70 -103.16 173.19 6.42 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.558 -0.714 . . . . 1.0 109.477 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.483 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 69.2 m80 -59.97 136.35 57.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.132 -0.98 . . . . 1.0 109.221 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 47.7 t -99.45 156.02 17.25 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.324 -0.86 . . . . 1.0 109.516 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -98.72 2.37 47.0 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.165 -0.959 . . . . 1.0 109.358 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -85.66 128.46 58.75 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 120.955 -1.091 . . . . 1.0 108.409 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -68.44 -17.04 43.95 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 CA-C-N 120.14 1.086 . . . . 1.0 112.094 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -89.32 -7.48 69.65 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.091 -1.203 . . . . 1.0 110.091 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.09 144.99 26.18 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.159 -1.201 . . . . 1.0 109.125 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.482 ' C ' ' H ' ' A' ' 138' ' ' PHE . 96.2 mt -69.71 -31.51 69.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.035 -1.04 . . . . 1.0 109.599 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 94.1 mmm -70.88 19.82 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.178 -0.951 . . . . 1.0 110.372 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.482 ' H ' ' C ' ' A' ' 136' ' ' LEU . 13.5 t80 -69.2 131.86 90.28 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.104 -0.997 . . . . 1.0 108.367 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -62.95 -2.22 3.45 Favored 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 120.831 1.021 . . . . 1.0 114.149 -178.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.0 mt -120.43 136.77 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 O-C-N 120.987 -1.071 . . . . 1.0 109.944 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -71.97 127.73 33.49 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.278 -0.889 . . . . 1.0 110.437 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.413 ' O ' HG23 ' A' ' 142' ' ' THR . 9.7 t -139.83 133.61 30.57 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.436 -0.79 . . . . 1.0 109.346 179.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -82.16 144.89 30.41 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.065 -1.022 . . . . 1.0 108.749 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 2.5 t -141.86 159.98 41.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.101 -0.999 . . . . 1.0 109.473 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.27 105.66 1.7 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.928 -1.669 . . . . 1.0 108.928 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -78.06 9.8 3.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.342 -1.093 . . . . 1.0 109.37 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 59.2 m -59.91 -40.09 87.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.908 . . . . 1.0 109.826 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -150.25 29.92 0.7 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.006 -1.059 . . . . 1.0 109.575 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -61.59 138.78 58.31 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.154 -0.966 . . . . 1.0 109.59 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 66.9 mtt -137.83 145.86 42.78 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.689 -0.856 . . . . 1.0 108.689 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 45.4 mt -52.31 129.32 41.92 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.043 -1.036 . . . . 1.0 108.883 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -70.19 175.74 8.05 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 CA-C-N 119.985 1.03 . . . . 1.0 112.33 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.44 -39.9 89.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.54 -0.725 . . . . 1.0 110.097 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -56.73 -47.55 79.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.081 -1.012 . . . . 1.0 109.593 -179.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.417 ' O ' HG22 ' A' ' 159' ' ' ILE . 97.0 m-20 -70.33 -39.98 74.42 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.101 -1.0 . . . . 1.0 110.121 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 74.2 t -60.81 -47.74 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.028 -1.045 . . . . 1.0 109.098 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -60.26 -39.93 88.53 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.136 -0.977 . . . . 1.0 110.389 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.75 -54.55 7.24 Favored Glycine 0 N--CA 1.495 2.577 0 O-C-N 121.029 -1.044 . . . . 1.0 111.276 -178.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.475 HG23 ' N ' ' A' ' 160' ' ' GLN . 7.1 tp -60.1 -40.02 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.996 -1.297 . . . . 1.0 109.672 -178.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.554 ' O ' ' N ' ' A' ' 164' ' ' GLY . 26.4 mt-30 -65.51 -39.56 91.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.106 -0.996 . . . . 1.0 109.492 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 83.3 p -60.61 -32.0 71.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.214 -0.929 . . . . 1.0 110.688 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 97.4 mt -85.13 -49.97 7.81 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.772 -1.205 . . . . 1.0 110.606 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -91.39 -8.92 46.6 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.023 -1.048 . . . . 1.0 110.173 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.492 2.41 0 N-CA-C 109.563 -1.415 . . . . 1.0 109.563 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.6 mt . . . . . 0 N--CA 1.494 1.74 0 N-CA-C 109.357 -0.608 . . . . 1.0 109.357 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.96 162.17 34.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.898 . . . . 1.0 109.547 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -73.05 150.45 42.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.196 -0.94 . . . . 1.0 109.666 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.0 t -80.21 -2.63 45.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.332 -0.855 . . . . 1.0 109.749 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -145.88 152.38 39.38 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.235 -0.915 . . . . 1.0 109.284 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.1 mmt -89.99 -0.68 57.71 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.211 -0.931 . . . . 1.0 109.771 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -96.9 131.17 43.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.205 -0.934 . . . . 1.0 109.059 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.8 mt -139.97 149.94 43.87 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.204 -0.935 . . . . 1.0 109.173 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 54.6 p -131.36 155.35 47.4 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.573 -0.899 . . . . 1.0 108.573 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -146.15 159.59 43.1 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.04 -1.038 . . . . 1.0 110.067 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.415 ' HG2' HH11 ' A' ' 18' ' ' ARG . 36.9 ttt-85 -145.26 133.98 22.24 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.48 -0.763 . . . . 1.0 109.296 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.9 mt -86.59 119.63 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 1.0 108.915 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 69.7 t -69.62 -41.11 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.353 -0.842 . . . . 1.0 109.207 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -164.56 157.87 17.51 Favored 'General case' 0 C--N 1.286 -2.175 0 O-C-N 119.686 -1.884 . . . . 1.0 110.819 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -100.41 113.0 25.41 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 106.475 -1.676 . . . . 1.0 106.475 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.425 ' C ' ' H ' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -56.87 136.54 79.25 Favored Pre-proline 0 C--N 1.299 -1.588 0 C-N-CA 119.103 -1.039 . . . . 1.0 109.199 -177.938 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -57.48 -7.87 3.4 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 CA-C-N 119.606 0.895 . . . . 1.0 110.31 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.425 ' H ' ' C ' ' A' ' 23' ' ' THR . 68.2 m-20 -58.27 -31.55 67.55 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 120.036 -0.666 . . . . 1.0 109.656 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 78.0 mtm -142.55 163.25 33.35 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.228 -0.92 . . . . 1.0 109.895 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 42.3 p -72.56 161.23 31.05 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.454 -0.778 . . . . 1.0 109.648 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -61.22 -40.06 92.58 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.274 -0.891 . . . . 1.0 110.045 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.3 m -61.1 -42.52 98.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.997 -1.065 . . . . 1.0 110.545 -179.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.0 -40.03 87.25 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.077 -1.014 . . . . 1.0 110.297 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 79.7 t -68.12 -43.35 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.122 -0.986 . . . . 1.0 110.555 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.04 -49.31 78.18 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.044 -1.035 . . . . 1.0 110.676 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -61.87 -33.81 74.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.946 -1.097 . . . . 1.0 110.176 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.02 -49.74 76.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.833 -1.167 . . . . 1.0 110.31 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.448 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 49.7 m-85 -67.2 -39.94 86.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.915 -1.116 . . . . 1.0 110.449 -179.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -60.02 -40.54 89.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.873 -1.142 . . . . 1.0 109.793 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -60.09 -40.73 90.61 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.918 -1.114 . . . . 1.0 108.763 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.94 -46.99 87.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.49 -0.756 . . . . 1.0 110.254 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -66.57 -39.04 88.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.032 -1.043 . . . . 1.0 109.98 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -60.03 -46.62 88.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.08 -1.012 . . . . 1.0 109.882 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 67.8 t -60.01 -41.46 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.148 -0.97 . . . . 1.0 110.36 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -79.39 -36.8 38.62 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.875 -1.14 . . . . 1.0 110.587 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.1 p -70.0 -18.86 63.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.024 -1.047 . . . . 1.0 109.995 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.04 -39.96 87.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.166 -0.959 . . . . 1.0 110.549 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.4 m -117.96 33.84 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.276 -0.89 . . . . 1.0 110.756 -178.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.7 p -151.4 134.48 8.91 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 120.769 -1.207 . . . . 1.0 109.604 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -73.5 13.14 0.75 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 CA-C-N 119.677 0.92 . . . . 1.0 112.004 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 79.9 mt -68.36 139.78 55.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.061 -1.024 . . . . 1.0 109.865 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -110.5 120.98 44.18 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.83 -0.804 . . . . 1.0 108.83 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -106.28 125.27 50.79 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.334 -0.854 . . . . 1.0 109.509 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.1 m -119.92 129.97 54.59 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.648 -0.658 . . . . 1.0 109.929 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -83.29 130.25 35.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.366 -0.834 . . . . 1.0 109.149 179.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 98.4 mt -101.33 123.21 45.06 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.246 -0.909 . . . . 1.0 109.199 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.439 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 48.8 m170 -60.85 -40.0 91.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.313 -0.867 . . . . 1.0 109.792 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 83.0 m-20 -146.67 169.99 17.89 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.21 -0.931 . . . . 1.0 109.827 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.04 179.1 35.93 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.451 -1.46 . . . . 1.0 109.451 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.5 mt -95.8 134.6 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.234 -1.156 . . . . 1.0 109.377 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.52 159.79 17.21 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.429 -0.794 . . . . 1.0 109.337 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.02 -49.11 78.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.156 -0.965 . . . . 1.0 109.436 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.6 mt -104.84 99.18 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.387 -0.821 . . . . 1.0 109.939 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.1 ptp -100.16 132.83 45.3 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.141 -0.975 . . . . 1.0 109.047 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.448 HG21 ' CZ ' ' A' ' 35' ' ' PHE . 85.5 mt -110.03 130.48 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.588 -0.695 . . . . 1.0 109.534 -179.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.3 p -151.2 158.53 44.06 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.128 -0.983 . . . . 1.0 110.245 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -102.84 127.64 49.94 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.212 -1.033 . . . . 1.0 108.212 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -117.73 -166.83 14.04 Favored Glycine 0 N--CA 1.499 2.863 0 N-CA-C 110.018 -1.233 . . . . 1.0 110.018 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 83.0 mt . . . . . 0 N--CA 1.494 1.767 0 O-C-N 121.669 -0.901 . . . . 1.0 108.702 -179.883 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.475 ' CE2' ' OD1' ' A' ' 99' ' ' ASP . 37.4 m-85 . . . . . 0 N--CA 1.493 1.72 0 N-CA-C 107.94 -1.133 . . . . 1.0 107.94 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 79' ' ' SER . 24.2 p-10 -103.27 13.34 34.08 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.054 -1.029 . . . . 1.0 110.569 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 108.89 -151.54 17.09 Favored Glycine 0 N--CA 1.503 3.103 0 N-CA-C 109.223 -1.551 . . . . 1.0 109.223 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.404 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 13.6 Cg_exo -58.58 -64.13 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.552 0 CA-C-N 118.892 1.346 . . . . 1.0 112.737 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.447 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 79.2 p -75.04 159.83 31.25 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.976 -1.078 . . . . 1.0 109.828 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.97 -129.8 8.83 Favored Glycine 0 N--CA 1.502 3.068 0 N-CA-C 109.992 -1.243 . . . . 1.0 109.992 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.441 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 23.0 mt -66.17 104.38 1.16 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.358 -1.084 . . . . 1.0 108.889 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 33.8 mt -80.04 -15.73 56.57 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.991 -1.068 . . . . 1.0 108.727 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 97' ' ' HIS . . . 179.61 170.8 1.05 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.07 -0.715 . . . . 1.0 109.07 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -160.03 153.46 22.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.184 -0.947 . . . . 1.0 109.423 178.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -142.2 158.58 43.58 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.409 -0.807 . . . . 1.0 109.297 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -96.18 153.32 39.1 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 108.287 -1.005 . . . . 1.0 108.287 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -49.38 170.02 0.1 OUTLIER 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 120.529 0.819 . . . . 1.0 111.549 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo . . . . . 0 N--CA 1.493 1.493 0 C-N-CA 121.021 1.147 . . . . 1.0 112.08 -179.296 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.7 p-10 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.542 -0.54 . . . . 1.0 109.542 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.24 124.43 11.49 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.229 -0.919 . . . . 1.0 109.468 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.415 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 8.9 m170 -111.84 146.35 37.83 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.486 0.66 . . . . 1.0 109.963 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -126.64 148.98 49.76 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.343 -0.984 . . . . 1.0 108.343 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.475 ' OD1' ' CE2' ' A' ' 75' ' ' PHE . 87.8 m-20 -78.57 123.52 27.18 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.862 -1.149 . . . . 1.0 109.367 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -83.08 -9.38 59.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.893 . . . . 1.0 109.257 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -83.08 -13.5 55.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.335 -0.853 . . . . 1.0 108.897 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.404 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 99.1 mt-10 -89.09 166.19 14.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.508 -0.745 . . . . 1.0 109.168 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.7 m -99.12 105.82 17.95 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.225 -0.922 . . . . 1.0 109.342 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -88.04 124.11 33.42 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.557 -0.905 . . . . 1.0 108.557 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.643 HG21 ' HB2' ' A' ' 109' ' ' LYS . 9.0 t -140.2 160.03 40.87 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.232 -0.917 . . . . 1.0 110.115 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 32.2 t -96.63 -10.02 28.0 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.415 -0.958 . . . . 1.0 108.415 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.3 t -91.06 -176.34 4.58 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.681 -0.859 . . . . 1.0 108.681 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.4 t -85.59 77.81 9.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.995 -1.066 . . . . 1.0 109.373 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.643 ' HB2' HG21 ' A' ' 105' ' ' THR . 66.5 mttm -148.44 149.93 32.59 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.372 -0.973 . . . . 1.0 108.372 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.13 -139.71 5.08 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.764 -1.335 . . . . 1.0 109.764 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -101.01 115.58 30.83 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.451 -1.029 . . . . 1.0 108.923 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.444 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 17.4 t-20 -62.69 134.52 56.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.115 -0.99 . . . . 1.0 109.945 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.7 tp -60.03 -46.19 90.34 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.513 -0.742 . . . . 1.0 110.867 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -59.51 -40.04 85.78 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.261 -0.899 . . . . 1.0 110.743 -178.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -58.41 -51.09 71.31 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.686 -1.259 . . . . 1.0 109.337 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 64.6 t -70.04 -40.77 78.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.097 -1.002 . . . . 1.0 110.235 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.93 -49.42 76.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.172 -0.955 . . . . 1.0 109.738 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.97 -39.68 86.5 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.197 -0.939 . . . . 1.0 110.366 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.615 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 71.0 t60 -63.52 -49.85 71.9 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.14 -0.975 . . . . 1.0 111.416 -178.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -60.03 -38.81 83.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.602 -1.311 . . . . 1.0 110.276 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -60.06 -39.95 87.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.698 -1.251 . . . . 1.0 108.493 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.23 -40.27 91.44 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.571 -1.411 . . . . 1.0 109.571 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.615 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 78.4 m-70 -66.53 -39.99 88.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.037 -1.272 . . . . 1.0 109.132 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 84.3 p -66.38 -24.44 66.49 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.278 -0.889 . . . . 1.0 109.566 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 92.9 mt -81.78 -1.69 48.15 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.152 -0.967 . . . . 1.0 109.607 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 89.69 9.64 66.14 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 110.645 -0.982 . . . . 1.0 110.645 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 82.6 mt -84.82 147.13 26.98 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.924 -1.339 . . . . 1.0 109.302 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 41.3 t0 -102.2 172.9 6.63 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.462 -0.774 . . . . 1.0 109.49 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.527 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 61.3 m80 -59.05 136.93 58.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.878 . . . . 1.0 109.612 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 47.3 t -98.57 157.01 16.51 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.369 -0.832 . . . . 1.0 109.293 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -99.71 0.01 40.97 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.383 -0.823 . . . . 1.0 109.582 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 9.6 t70 -85.46 129.45 55.2 Favored Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 108.225 -1.028 . . . . 1.0 108.225 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -68.47 -21.07 40.9 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 CA-C-N 120.126 1.081 . . . . 1.0 112.004 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.459 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -87.5 -4.61 80.0 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.443 -1.463 . . . . 1.0 109.443 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.09 145.71 26.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.241 -1.152 . . . . 1.0 109.496 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.454 ' C ' ' H ' ' A' ' 138' ' ' PHE . 84.5 mt -69.95 -34.9 74.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.249 -0.907 . . . . 1.0 109.493 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 96.8 mmm -70.98 18.84 0.06 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.341 -0.85 . . . . 1.0 110.533 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.454 ' H ' ' C ' ' A' ' 136' ' ' LEU . 11.9 t80 -68.73 133.29 90.53 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.902 -1.124 . . . . 1.0 108.096 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -63.43 -13.15 34.43 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 120.782 0.988 . . . . 1.0 113.843 -178.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.7 mt -108.36 139.96 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.036 -1.04 . . . . 1.0 109.884 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . 0.444 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 56.0 t80 -73.63 129.37 37.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.511 -0.743 . . . . 1.0 110.127 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.6 t -138.49 140.12 39.06 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.589 -0.893 . . . . 1.0 108.589 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -79.88 130.0 34.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.036 -1.04 . . . . 1.0 109.537 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 20.6 m -115.81 125.51 52.81 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.705 -0.622 . . . . 1.0 109.639 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.9 100.06 0.22 Allowed Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.068 -2.013 . . . . 1.0 108.068 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -70.14 138.24 51.73 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.292 -1.122 . . . . 1.0 109.955 -178.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.1 m 176.26 -81.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.51 -0.922 . . . . 1.0 108.51 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -112.93 19.87 16.91 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -61.16 137.48 58.23 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 1.0 110.492 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 96.6 mmm -137.53 146.99 44.81 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.336 -0.986 . . . . 1.0 108.336 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.9 mt -47.84 111.38 1.7 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.183 -0.948 . . . . 1.0 109.377 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -54.9 178.24 0.09 OUTLIER 'Trans proline' 0 N--CA 1.494 1.516 0 CA-C-N 120.051 1.054 . . . . 1.0 112.379 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -60.39 -39.96 89.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.4 -0.813 . . . . 1.0 110.065 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -57.27 -47.87 80.34 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.142 -0.974 . . . . 1.0 109.597 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.04 -39.98 75.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.237 -0.914 . . . . 1.0 110.231 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 55.9 t -63.41 -46.95 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.989 -1.07 . . . . 1.0 109.261 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -60.01 -40.04 87.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.16 -0.962 . . . . 1.0 110.208 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -68.8 -56.63 9.05 Favored Glycine 0 N--CA 1.493 2.463 0 O-C-N 121.142 -0.974 . . . . 1.0 111.131 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.49 HG23 ' N ' ' A' ' 160' ' ' GLN . 5.4 tp -61.27 -40.02 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.941 -1.329 . . . . 1.0 109.711 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 164' ' ' GLY . 93.1 mm-40 -64.99 -39.94 94.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 1.0 109.613 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 87.5 p -65.25 -26.76 68.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.185 -0.947 . . . . 1.0 110.051 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 89.5 mt -88.38 -50.59 6.23 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.993 -1.067 . . . . 1.0 110.263 -179.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -94.47 -9.53 35.2 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.027 -1.046 . . . . 1.0 110.422 -179.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.496 2.678 0 N-CA-C 109.509 -1.437 . . . . 1.0 109.509 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.6 mt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.212 -0.662 . . . . 1.0 109.212 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -160.77 159.99 30.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.342 -0.849 . . . . 1.0 109.476 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -71.29 148.77 46.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.007 -1.058 . . . . 1.0 109.278 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.9 t -81.93 0.87 37.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.905 . . . . 1.0 109.766 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -149.97 155.68 40.39 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.017 -1.052 . . . . 1.0 110.054 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.544 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.93 0.01 57.62 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.405 -0.809 . . . . 1.0 109.731 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -95.89 126.95 41.49 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.234 -0.916 . . . . 1.0 108.696 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.8 mt -140.48 151.35 44.76 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.276 -0.89 . . . . 1.0 109.377 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.9 p -130.42 152.1 50.19 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.825 -0.806 . . . . 1.0 108.825 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -145.4 160.04 42.15 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.116 -0.99 . . . . 1.0 109.911 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.716 HH12 ' H ' ' A' ' 58' ' ' ALA . 13.9 ttp-105 -143.4 137.6 28.78 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.294 -0.879 . . . . 1.0 109.793 -179.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 92.0 mt -88.53 119.08 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.219 -0.925 . . . . 1.0 108.837 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.0 t -69.92 -39.98 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 1.0 109.722 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.703 HD21 ' H ' ' A' ' 64' ' ' PHE . 9.7 p30 -163.0 150.99 13.67 Favored 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 117.243 -1.783 . . . . 1.0 111.744 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.427 ' HB2' ' CD2' ' A' ' 28' ' ' HIS . 43.2 m-85 -99.79 105.13 16.88 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 104.313 -2.477 . . . . 1.0 104.313 176.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.1 t -58.32 145.74 73.79 Favored Pre-proline 0 C--N 1.294 -1.807 0 O-C-N 121.027 -1.046 . . . . 1.0 110.419 -176.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -60.86 -11.65 18.82 Favored 'Trans proline' 0 N--CA 1.488 1.16 0 C-N-CA 120.961 1.108 . . . . 1.0 111.57 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -56.7 -32.43 65.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.326 -0.859 . . . . 1.0 110.002 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.6 mtm -140.13 160.52 39.75 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.185 -0.947 . . . . 1.0 109.415 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 66.3 p -73.59 162.34 29.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.255 -0.903 . . . . 1.0 109.781 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.427 ' CD2' ' HB2' ' A' ' 22' ' ' TYR . 30.3 m170 -60.87 -41.75 96.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.213 -0.929 . . . . 1.0 109.98 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.6 m -60.44 -41.88 94.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.083 -1.011 . . . . 1.0 110.183 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.59 -40.03 80.64 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.187 -0.946 . . . . 1.0 110.277 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 69.3 t -68.73 -43.67 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.117 -0.989 . . . . 1.0 110.205 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -59.93 -48.6 81.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.127 -0.983 . . . . 1.0 110.754 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.445 ' HA ' ' HZ2' ' A' ' 36' ' ' LYS . 16.7 ptpt -62.01 -33.45 74.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.765 -1.209 . . . . 1.0 110.118 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.99 -50.84 72.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.919 -1.113 . . . . 1.0 110.215 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.43 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 57.5 m-85 -69.15 -39.78 78.61 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.85 -1.156 . . . . 1.0 110.609 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.445 ' HZ2' ' HA ' ' A' ' 33' ' ' LYS . 9.6 mtmp? -59.93 -41.85 92.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.913 -1.117 . . . . 1.0 109.715 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -60.6 -40.04 90.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.79 -1.194 . . . . 1.0 108.725 178.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.99 -44.06 94.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -0.871 . . . . 1.0 110.059 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -65.58 -40.15 92.43 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.867 -1.146 . . . . 1.0 109.106 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.4 ' O ' ' CG ' ' A' ' 44' ' ' ASP . 48.1 tptt -60.12 -49.65 76.8 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.496 -0.752 . . . . 1.0 110.718 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.8 t -60.18 -43.03 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 120.799 -1.188 . . . . 1.0 110.487 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -76.98 -36.83 56.15 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.801 -1.187 . . . . 1.0 109.996 -178.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.1 p -71.0 -20.73 62.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.058 -1.026 . . . . 1.0 109.882 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.4 ' CG ' ' O ' ' A' ' 40' ' ' LYS . 81.7 m-20 -59.95 -40.12 87.93 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.354 -0.841 . . . . 1.0 110.6 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.446 ' O ' ' NE2' ' A' ' 160' ' ' GLN . 12.5 m -110.04 24.13 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 121.187 -0.945 . . . . 1.0 110.73 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.4 p -150.15 134.09 9.02 Favored Pre-proline 0 N--CA 1.501 2.094 0 O-C-N 120.973 -1.079 . . . . 1.0 109.588 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -74.49 21.91 0.4 Allowed 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 120.794 0.996 . . . . 1.0 112.166 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 79.6 mt -69.74 138.71 53.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.132 -0.98 . . . . 1.0 109.954 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -106.86 120.78 42.95 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -109.9 125.59 52.98 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.44 -0.787 . . . . 1.0 109.547 -179.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 93.8 m -120.05 130.1 54.54 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.641 -0.662 . . . . 1.0 109.735 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.41 ' NH1' ' HG3' ' A' ' 52' ' ' ARG . 39.0 ttm-85 -81.32 130.27 34.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.368 -0.832 . . . . 1.0 109.226 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.1 mt -102.38 126.92 49.55 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.189 -0.944 . . . . 1.0 109.37 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.447 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 43.6 m170 -62.86 -40.12 96.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.368 -0.833 . . . . 1.0 109.666 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 78.7 m-20 -148.52 173.32 13.26 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.354 -0.841 . . . . 1.0 109.799 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.519 ' O ' ' NH1' ' A' ' 18' ' ' ARG . . . 95.85 178.51 36.36 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.411 -1.476 . . . . 1.0 109.411 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.5 mt -95.5 133.79 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.114 -1.227 . . . . 1.0 109.245 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.716 ' H ' HH12 ' A' ' 18' ' ' ARG . . . -110.15 159.04 17.7 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.401 -0.812 . . . . 1.0 109.232 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.06 -49.41 77.75 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.227 -0.921 . . . . 1.0 109.249 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 93.9 mt -106.4 102.13 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.428 -0.795 . . . . 1.0 109.83 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.8 ptp -101.87 134.27 45.32 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.213 -0.93 . . . . 1.0 109.102 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.43 HG21 ' CZ ' ' A' ' 35' ' ' PHE . 84.5 mt -109.94 130.53 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 109.091 -0.707 . . . . 1.0 109.091 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.6 p -151.15 157.03 42.19 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.929 -1.107 . . . . 1.0 110.577 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.703 ' H ' HD21 ' A' ' 21' ' ' ASN . 90.8 m-85 -105.68 120.08 40.78 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.769 -1.197 . . . . 1.0 107.769 178.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -111.68 -171.06 18.88 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 110.739 -0.944 . . . . 1.0 110.739 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.493 1.675 0 N-CA-C 107.892 -1.151 . . . . 1.0 107.892 179.401 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.552 ' CE2' ' OD1' ' A' ' 99' ' ' ASP . 88.7 m-85 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 108.239 -1.023 . . . . 1.0 108.239 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.0 p-10 -100.72 9.71 42.08 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.218 -0.926 . . . . 1.0 111.119 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 118.01 -149.68 18.4 Favored Glycine 0 N--CA 1.506 3.304 0 N-CA-C 109.012 -1.635 . . . . 1.0 109.012 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.439 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 9.6 Cg_exo -60.11 -65.72 0.07 OUTLIER 'Trans proline' 0 N--CA 1.492 1.395 0 CA-C-N 119.157 1.479 . . . . 1.0 112.392 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 90.0 p -76.54 164.74 25.66 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.966 -1.084 . . . . 1.0 110.079 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.38 -130.87 9.67 Favored Glycine 0 N--CA 1.502 3.057 0 N-CA-C 109.998 -1.241 . . . . 1.0 109.998 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.435 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 5.0 mt -68.62 105.43 2.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.509 -0.995 . . . . 1.0 108.624 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 82.1 mt -75.87 -32.6 59.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.091 -1.006 . . . . 1.0 109.535 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -176.44 161.95 2.27 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.929 -0.767 . . . . 1.0 108.929 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -160.24 162.41 33.71 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.154 -0.966 . . . . 1.0 110.084 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 95' ' ' ASP . . . -139.65 157.97 44.9 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.168 -1.049 . . . . 1.0 108.168 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -90.92 152.23 44.22 Favored Pre-proline 0 N--CA 1.497 1.918 0 N-CA-C 108.186 -1.042 . . . . 1.0 108.186 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -54.97 167.95 1.4 Allowed 'Trans proline' 0 N--CA 1.492 1.401 0 CA-C-N 119.437 0.835 . . . . 1.0 111.44 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo . . . . . 0 C--N 1.307 -1.654 0 C-N-CA 120.558 0.839 . . . . 1.0 111.84 -179.861 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.437 ' O ' ' HB1' ' A' ' 85' ' ' ALA . 42.5 p-10 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.31 0.576 . . . . 1.0 109.78 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.31 116.4 6.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.088 -1.008 . . . . 1.0 109.13 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -105.54 130.52 53.58 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.515 -0.74 . . . . 1.0 109.824 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -112.59 142.6 44.98 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.522 -0.918 . . . . 1.0 108.522 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.552 ' OD1' ' CE2' ' A' ' 75' ' ' PHE . 94.1 m-20 -79.32 124.6 28.55 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.082 -1.011 . . . . 1.0 109.938 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 44.7 t0 -84.08 2.34 39.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.362 -0.836 . . . . 1.0 109.189 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -81.31 -16.06 53.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.345 -0.847 . . . . 1.0 109.952 -179.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.549 ' OE1' ' N ' ' A' ' 102' ' ' GLU . 58.1 mp0 -93.43 170.14 9.83 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.174 -0.954 . . . . 1.0 109.49 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 47.7 m -98.96 105.42 17.56 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.462 -0.94 . . . . 1.0 108.462 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -84.29 127.93 34.27 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.319 -0.863 . . . . 1.0 108.941 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.679 HG21 ' HB2' ' A' ' 109' ' ' LYS . 9.2 t -139.95 159.93 41.05 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.391 -0.818 . . . . 1.0 110.066 -179.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.1 t -93.64 -10.46 34.46 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.923 -1.14 . . . . 1.0 107.923 178.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 81.7 p -92.13 179.08 5.68 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.577 -0.897 . . . . 1.0 108.577 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.3 t -85.34 75.95 10.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.94 -1.1 . . . . 1.0 109.564 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.679 ' HB2' HG21 ' A' ' 105' ' ' THR . 4.0 mmmm -140.02 144.86 37.13 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 107.987 -1.116 . . . . 1.0 107.987 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 49.89 -129.97 27.15 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.119 -1.592 . . . . 1.0 109.119 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -104.97 115.44 30.28 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.318 -1.107 . . . . 1.0 109.309 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.736 HD21 ' NZ ' ' A' ' 146' ' ' LYS . 62.2 t-20 -65.3 131.77 47.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.905 . . . . 1.0 109.581 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.1 tp -59.96 -45.09 93.8 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.445 -0.784 . . . . 1.0 111.215 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -59.93 -40.02 87.46 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.046 -1.033 . . . . 1.0 110.69 -178.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -59.34 -52.68 64.59 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.849 -1.157 . . . . 1.0 109.835 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.4 t -69.93 -40.06 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.924 -1.11 . . . . 1.0 109.409 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.74 -52.3 65.52 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.138 -0.976 . . . . 1.0 108.839 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.78 -32.59 67.67 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 120.64 -1.288 . . . . 1.0 109.686 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.548 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 76.4 t60 -66.48 -55.82 13.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.031 -1.043 . . . . 1.0 111.666 -178.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.29 -31.88 70.67 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.487 -1.383 . . . . 1.0 110.131 -179.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -59.8 -41.52 91.41 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.752 -1.218 . . . . 1.0 108.396 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.0 -43.46 98.15 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.364 -1.494 . . . . 1.0 109.364 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.548 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 84.4 m-70 -64.5 -39.86 94.57 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.047 -1.267 . . . . 1.0 109.248 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.0 p -67.82 -25.85 65.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.354 -0.841 . . . . 1.0 109.525 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 75.2 mt -81.57 -3.1 52.37 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.234 -0.916 . . . . 1.0 109.94 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.67 9.3 58.83 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 110.534 -1.027 . . . . 1.0 110.534 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.1 mt -85.88 144.59 27.59 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.917 -1.343 . . . . 1.0 109.559 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 28.6 t0 -101.63 173.41 6.44 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.97 -0.752 . . . . 1.0 108.97 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.509 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 75.7 m80 -60.01 134.61 57.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.203 -0.936 . . . . 1.0 109.236 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 47.6 t -96.77 160.24 14.48 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.023 -1.048 . . . . 1.0 109.376 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -99.67 2.17 44.15 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.353 -0.842 . . . . 1.0 109.655 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 9.6 t70 -85.18 129.48 55.67 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.901 . . . . 1.0 108.713 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -68.13 -25.48 37.38 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 CA-C-N 119.984 1.03 . . . . 1.0 112.389 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.437 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -84.9 -3.82 87.62 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.837 -1.305 . . . . 1.0 109.837 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.03 144.84 27.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.35 -1.088 . . . . 1.0 109.663 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 93.8 mt -70.03 -30.68 68.02 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.316 -0.865 . . . . 1.0 109.187 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 98.1 mmm -72.67 15.47 0.19 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.385 -0.822 . . . . 1.0 110.603 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -72.13 137.59 81.77 Favored Pre-proline 0 N--CA 1.5 2.061 0 O-C-N 121.02 -1.05 . . . . 1.0 108.421 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -61.8 -11.92 23.07 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 120.862 1.041 . . . . 1.0 114.29 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 95.9 mt -109.97 139.08 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.443 0 O-C-N 120.655 -1.278 . . . . 1.0 109.744 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -73.55 129.87 38.88 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.582 -0.699 . . . . 1.0 110.08 -179.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 15.2 t -140.1 143.33 36.2 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.482 -0.762 . . . . 1.0 109.139 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -81.21 149.44 29.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.957 -1.089 . . . . 1.0 109.532 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.9 t -140.23 155.5 46.87 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.906 -0.776 . . . . 1.0 108.906 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.45 111.43 3.57 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.465 -1.454 . . . . 1.0 109.465 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.736 ' NZ ' HD21 ' A' ' 112' ' ' ASN . 49.7 mtmt -76.78 -1.48 28.36 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.297 -1.119 . . . . 1.0 109.391 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.2 m -60.0 -40.13 88.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.372 -0.83 . . . . 1.0 109.762 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -160.36 67.48 0.35 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.238 -0.914 . . . . 1.0 109.336 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' A' ' 149' ' ' PHE . 39.0 t80 -99.16 125.04 44.63 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.333 -0.855 . . . . 1.0 109.36 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 75.2 mtm -120.24 141.3 50.07 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.843 -0.799 . . . . 1.0 108.843 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 49.0 mt -49.17 129.06 16.22 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.041 -1.037 . . . . 1.0 108.654 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -66.08 176.93 3.4 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 CA-C-N 119.944 1.016 . . . . 1.0 112.798 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.28 -39.78 88.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.623 -0.673 . . . . 1.0 109.588 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -58.06 -49.28 77.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.315 -0.866 . . . . 1.0 109.86 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -70.03 -40.01 75.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.014 -1.054 . . . . 1.0 109.774 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.3 t -60.1 -46.35 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.129 -0.982 . . . . 1.0 109.335 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -60.23 -39.99 88.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.904 -1.123 . . . . 1.0 110.131 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -68.63 -55.28 12.1 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.154 -1.022 . . . . 1.0 111.113 -178.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.477 HG23 ' N ' ' A' ' 160' ' ' GLN . 5.7 tp -61.93 -40.39 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.941 -1.329 . . . . 1.0 109.74 -179.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.477 ' N ' HG23 ' A' ' 159' ' ' ILE . 94.2 mm-40 -66.39 -39.93 89.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 1.0 109.648 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 91.9 p -70.17 -22.59 62.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 1.0 110.044 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 86.9 mt -88.1 -50.39 6.42 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.957 -1.089 . . . . 1.0 110.188 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -93.0 -9.78 38.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.96 -1.087 . . . . 1.0 109.697 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.524 0 N-CA-C 109.621 -1.392 . . . . 1.0 109.621 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.4 mt . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.346 -0.612 . . . . 1.0 109.346 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -160.92 163.03 32.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 1.0 109.242 179.72 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 62.7 m95 -72.42 145.35 47.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -0.923 . . . . 1.0 109.806 -179.435 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 61.1 m -88.84 4.24 48.4 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.33 -0.856 . . . . 1.0 110.235 -179.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.452 ' NZ ' ' O ' ' A' ' 14' ' ' ASN . 21.5 pttp -140.76 150.78 43.82 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.123 -0.986 . . . . 1.0 109.394 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.1 mmt -90.03 0.23 57.23 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.394 -0.816 . . . . 1.0 109.798 -179.043 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.452 ' O ' ' NZ ' ' A' ' 12' ' ' LYS . 33.2 m120 -94.89 128.59 41.78 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.2 -0.938 . . . . 1.0 109.349 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.7 mt -141.43 150.01 41.76 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.156 -0.965 . . . . 1.0 108.974 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.8 p -132.66 155.39 48.85 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.565 -0.71 . . . . 1.0 109.145 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -145.69 162.7 36.96 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.045 -1.034 . . . . 1.0 110.119 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.544 ' NE ' ' O ' ' A' ' 56' ' ' GLY . 36.8 ttm-85 -144.25 131.43 20.66 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.629 -0.669 . . . . 1.0 109.44 -179.378 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.5 mt -88.92 114.55 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.074 -1.016 . . . . 1.0 108.624 178.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.7 -40.55 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 1.0 109.906 -179.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.6 p-10 -165.56 154.46 11.89 Favored 'General case' 0 C--N 1.285 -2.2 0 O-C-N 119.675 -1.89 . . . . 1.0 111.168 -179.154 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -99.95 113.0 25.27 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 105.814 -1.921 . . . . 1.0 105.814 178.081 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 23' ' ' THR . 0.4 OUTLIER -56.45 137.79 75.94 Favored Pre-proline 0 C--N 1.297 -1.707 0 O-C-N 120.957 -1.09 . . . . 1.0 109.201 -177.805 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -56.76 -9.29 3.86 Favored 'Trans proline' 0 N--CA 1.483 0.872 0 CA-C-N 119.503 0.858 . . . . 1.0 110.352 179.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.412 ' H ' ' C ' ' A' ' 23' ' ' THR . 98.0 m-20 -57.1 -32.08 65.93 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 120.13 -0.628 . . . . 1.0 110.086 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.8 mtm -140.94 164.36 30.48 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.117 -0.99 . . . . 1.0 109.441 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 75.6 p -71.96 160.69 32.1 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.373 -0.829 . . . . 1.0 109.131 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 24.1 m170 -60.12 -42.34 94.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.173 -0.954 . . . . 1.0 110.2 -179.105 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.546 ' O ' ' NZ ' ' A' ' 33' ' ' LYS . 73.2 m -60.23 -43.18 96.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.103 -0.998 . . . . 1.0 111.006 -179.163 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.25 -40.89 96.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.083 -1.011 . . . . 1.0 110.802 -178.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 63.2 t -67.18 -40.21 84.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.101 -0.999 . . . . 1.0 109.746 -179.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -60.02 -50.13 74.94 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.261 -0.899 . . . . 1.0 110.929 -179.259 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.546 ' NZ ' ' O ' ' A' ' 29' ' ' SER . 1.7 ptpp? -63.9 -31.03 72.08 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.04 -1.037 . . . . 1.0 110.015 -179.517 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.9 -49.55 77.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.046 -1.034 . . . . 1.0 109.566 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -67.54 -38.97 84.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.118 -0.989 . . . . 1.0 109.797 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.0 -41.91 93.15 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.982 -1.074 . . . . 1.0 109.429 -179.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -60.96 -40.87 95.03 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.911 -1.118 . . . . 1.0 108.693 178.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.55 -47.08 85.43 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.369 -0.832 . . . . 1.0 109.743 179.447 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.428 ' CZ ' ' CZ ' ' A' ' 121' ' ' PHE . 48.7 m-85 -67.68 -39.98 84.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.063 -1.023 . . . . 1.0 109.742 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -59.95 -45.58 92.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.163 -0.96 . . . . 1.0 109.618 -179.085 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.5 t -60.01 -45.53 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.328 -0.858 . . . . 1.0 109.913 -179.42 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 76.8 m95 -76.71 -35.23 57.97 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.075 -1.015 . . . . 1.0 109.995 -179.54 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 62.9 p -71.62 -19.6 62.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.075 -1.016 . . . . 1.0 109.873 -179.771 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -60.0 -39.22 85.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.252 -0.905 . . . . 1.0 110.562 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.9 m -110.5 -22.96 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.249 -0.907 . . . . 1.0 110.62 -178.592 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.418 ' C ' ' H ' ' A' ' 48' ' ' LEU . 56.1 p -95.73 130.4 31.84 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 120.888 -1.132 . . . . 1.0 110.108 -179.623 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -72.32 18.48 0.33 Allowed 'Trans proline' 0 N--CA 1.492 1.4 0 CA-C-N 119.873 0.99 . . . . 1.0 111.463 178.621 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.418 ' H ' ' C ' ' A' ' 46' ' ' THR . 77.4 mt -69.3 138.7 54.04 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.207 -0.933 . . . . 1.0 109.602 -179.47 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -109.26 121.88 46.12 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 179.532 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -107.13 128.93 54.83 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.369 -0.832 . . . . 1.0 109.359 -179.269 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 90.2 m -121.88 130.26 53.22 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.524 -0.735 . . . . 1.0 109.961 -179.526 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -80.14 130.05 34.95 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.236 -0.915 . . . . 1.0 109.163 179.656 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.499 ' O ' ' NH1' ' A' ' 18' ' ' ARG . 94.3 mt -102.53 132.42 48.6 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.165 -0.959 . . . . 1.0 109.415 179.331 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.491 ' C ' HH12 ' A' ' 18' ' ' ARG . 23.9 m-70 -68.83 -39.91 79.74 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.662 -0.649 . . . . 1.0 110.206 -179.702 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.484 ' C ' ' NH2' ' A' ' 18' ' ' ARG . 74.1 m-20 -150.09 166.75 28.84 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.115 -0.99 . . . . 1.0 109.992 -179.565 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.544 ' O ' ' NE ' ' A' ' 18' ' ' ARG . . . 99.95 -176.42 28.27 Favored Glycine 0 N--CA 1.498 2.825 0 N-CA-C 109.53 -1.428 . . . . 1.0 109.53 -179.696 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.4 mt -95.5 135.25 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.192 -1.181 . . . . 1.0 109.261 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.04 158.94 18.25 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.436 -0.79 . . . . 1.0 109.284 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -59.99 -49.57 77.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.2 -0.937 . . . . 1.0 109.51 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 92.5 mt -108.35 98.47 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.434 -0.791 . . . . 1.0 109.698 179.634 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.5 ptm -97.96 126.07 43.19 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.487 -0.931 . . . . 1.0 108.487 179.134 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.8 mt -104.84 136.84 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.455 -0.778 . . . . 1.0 110.58 -178.509 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.1 p -153.68 160.03 42.22 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.398 -0.814 . . . . 1.0 109.548 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -102.13 122.28 43.84 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.605 -0.887 . . . . 1.0 108.605 179.486 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 98' ' ' PHE . . . -99.76 -172.76 30.51 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 110.822 -0.911 . . . . 1.0 110.822 -178.677 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 73.4 mt . . . . . 0 N--CA 1.497 1.883 0 O-C-N 121.784 -0.833 . . . . 1.0 109.043 179.935 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.533 ' CE2' ' OD1' ' A' ' 99' ' ' ASP . 40.6 m-85 . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 109.305 -0.628 . . . . 1.0 109.305 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 79' ' ' SER . 34.5 p-10 -101.05 10.65 40.79 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.352 -0.842 . . . . 1.0 110.474 -179.288 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 114.96 -155.61 16.22 Favored Glycine 0 N--CA 1.504 3.188 0 N-CA-C 109.092 -1.603 . . . . 1.0 109.092 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.424 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 15.8 Cg_exo -56.64 -64.12 0.14 Allowed 'Trans proline' 0 N--CA 1.492 1.403 0 CA-C-N 118.827 1.314 . . . . 1.0 112.308 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.43 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 83.9 p -75.0 159.03 32.26 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.896 -1.128 . . . . 1.0 109.384 179.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.03 -129.67 8.22 Favored Glycine 0 N--CA 1.502 3.045 0 N-CA-C 110.218 -1.153 . . . . 1.0 110.218 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.401 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 19.0 mt -70.19 112.72 6.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.351 -1.087 . . . . 1.0 109.406 -179.584 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 38.1 mt -79.22 -24.54 43.02 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.155 -0.966 . . . . 1.0 108.703 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -177.07 170.68 2.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.531 -0.731 . . . . 1.0 109.412 -179.733 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -162.41 163.33 27.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.104 -0.997 . . . . 1.0 109.968 179.676 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -147.2 153.48 39.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.385 -0.822 . . . . 1.0 109.071 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -88.44 152.67 50.07 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.151 -0.968 . . . . 1.0 109.23 -179.607 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -53.5 162.58 3.2 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 CA-C-N 119.214 0.755 . . . . 1.0 111.716 179.583 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo . . . . . 0 N--CA 1.49 1.28 0 C-N-CA 121.12 1.213 . . . . 1.0 111.942 179.68 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.2 p-10 . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 109.409 -0.589 . . . . 1.0 109.409 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.08 120.72 7.49 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.019 -1.051 . . . . 1.0 110.014 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -106.06 154.03 21.22 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.58 -0.7 . . . . 1.0 109.633 179.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' A' ' 65' ' ' GLY . 28.0 m-85 -129.94 152.01 49.87 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.289 -1.004 . . . . 1.0 108.289 179.177 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.533 ' OD1' ' CE2' ' A' ' 75' ' ' PHE . 86.5 m-20 -78.5 120.81 23.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.913 -1.117 . . . . 1.0 109.987 -179.63 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -84.06 -7.85 59.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.311 -0.868 . . . . 1.0 109.056 179.286 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -82.63 -15.93 50.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.3 -0.875 . . . . 1.0 109.178 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.424 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 97.2 mt-10 -89.88 169.92 10.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.502 -0.749 . . . . 1.0 109.07 -179.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 16.9 m -99.23 108.5 21.09 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.26 -0.9 . . . . 1.0 109.286 -179.555 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.491 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 93.7 m95 -91.08 125.14 35.78 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.705 -0.85 . . . . 1.0 108.705 179.505 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.665 HG21 ' HB2' ' A' ' 109' ' ' LYS . 7.3 t -140.16 151.17 45.04 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.376 -0.828 . . . . 1.0 109.885 -179.156 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 55.7 m -90.25 -8.23 51.51 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.074 -1.084 . . . . 1.0 108.074 178.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.1 p -90.65 177.27 6.39 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.625 -0.879 . . . . 1.0 108.625 178.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 m -81.09 76.53 8.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.981 -1.074 . . . . 1.0 109.628 -179.853 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.665 ' HB2' HG21 ' A' ' 105' ' ' THR . 98.5 mttt -147.03 149.67 33.57 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.367 -0.833 . . . . 1.0 108.884 179.585 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.31 -135.88 7.38 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.935 -1.266 . . . . 1.0 109.935 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -100.11 118.22 36.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.413 -1.051 . . . . 1.0 109.143 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -66.58 129.09 38.69 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.365 -0.835 . . . . 1.0 110.294 -179.567 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.6 tp -60.02 -40.66 90.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.357 -0.84 . . . . 1.0 109.875 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -59.96 -47.76 84.47 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.416 -0.802 . . . . 1.0 110.587 -178.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -58.66 -50.63 73.16 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.854 -1.154 . . . . 1.0 109.761 -179.612 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 77.9 t -69.1 -40.11 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.918 -1.114 . . . . 1.0 109.668 -179.22 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.99 -50.26 74.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.098 -1.001 . . . . 1.0 109.976 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.78 -37.84 80.2 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.564 -1.335 . . . . 1.0 109.521 -179.835 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.487 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 67.1 t60 -63.8 -49.98 70.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.316 -0.865 . . . . 1.0 111.624 -178.594 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.84 -38.55 78.97 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.512 -1.367 . . . . 1.0 109.723 -178.735 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.428 ' CZ ' ' CZ ' ' A' ' 39' ' ' PHE . 29.9 m-85 -60.02 -39.86 87.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.92 -1.112 . . . . 1.0 108.535 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.55 -46.83 91.6 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.69 -1.364 . . . . 1.0 109.69 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.487 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 81.8 m-70 -63.94 -40.08 95.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.13 -1.217 . . . . 1.0 109.449 179.66 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 91.9 p -68.49 -22.73 64.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.277 -0.89 . . . . 1.0 109.571 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 35.7 mt -81.68 -7.03 59.55 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.103 -0.998 . . . . 1.0 109.472 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 99.54 2.74 56.47 Favored Glycine 0 N--CA 1.499 2.887 0 N-CA-C 110.674 -0.971 . . . . 1.0 110.674 178.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 75.2 mt -85.11 147.23 26.74 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.947 -1.325 . . . . 1.0 109.775 179.653 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 35.5 t0 -102.96 -178.73 3.75 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.86 -0.792 . . . . 1.0 108.86 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.499 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 75.9 m80 -60.1 139.99 57.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.088 -1.008 . . . . 1.0 109.764 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 27.2 t -96.21 162.05 13.69 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.242 -0.912 . . . . 1.0 109.244 179.513 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -101.11 1.92 39.77 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.344 -0.848 . . . . 1.0 109.857 -179.692 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -90.52 114.14 60.14 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.212 -0.93 . . . . 1.0 109.206 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -53.77 -22.75 24.29 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 CA-C-N 120.27 1.132 . . . . 1.0 112.216 -179.796 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -86.8 -7.68 77.78 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.49 -1.044 . . . . 1.0 110.49 -179.306 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.44 149.42 26.67 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.985 -1.303 . . . . 1.0 109.576 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 92.9 mt -70.07 -30.97 68.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.142 -0.974 . . . . 1.0 109.473 179.69 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 98.0 mmm -73.42 13.56 0.44 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.368 -0.833 . . . . 1.0 110.396 -178.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -70.37 134.61 86.8 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.964 -1.085 . . . . 1.0 108.114 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -65.35 15.42 0.09 OUTLIER 'Trans proline' 0 N--CA 1.506 2.229 0 C-N-CA 121.065 1.177 . . . . 1.0 115.048 -177.785 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 90.0 mt -133.69 140.49 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 O-C-N 120.73 -1.231 . . . . 1.0 109.609 179.453 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -72.87 130.67 40.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.517 -0.739 . . . . 1.0 110.046 -179.25 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.2 t -143.15 137.63 29.2 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.322 -0.861 . . . . 1.0 109.479 179.777 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -81.41 143.98 31.75 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.081 -1.012 . . . . 1.0 109.18 179.785 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.7 t -139.11 156.53 47.09 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.208 -0.932 . . . . 1.0 110.117 -179.362 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.38 108.87 2.63 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.409 -1.476 . . . . 1.0 109.409 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -77.11 2.8 14.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.325 -1.103 . . . . 1.0 109.44 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 44.2 t -59.97 -45.01 94.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.228 -0.92 . . . . 1.0 110.149 -179.445 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -150.01 29.97 0.72 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.965 -1.084 . . . . 1.0 110.134 -179.536 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -60.44 139.17 57.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.054 -1.029 . . . . 1.0 109.647 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 73.7 mtm -138.55 148.5 44.28 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.353 -0.842 . . . . 1.0 108.762 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.7 mt -53.84 129.68 56.34 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 120.987 -1.071 . . . . 1.0 108.612 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -68.94 175.36 7.52 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 CA-C-N 120.112 1.076 . . . . 1.0 111.715 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.04 -38.78 83.76 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.344 -0.848 . . . . 1.0 109.48 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -55.07 -50.21 69.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.879 . . . . 1.0 110.057 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -70.2 -39.97 74.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.184 -0.947 . . . . 1.0 110.28 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 66.5 t -59.87 -47.02 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.006 -1.059 . . . . 1.0 109.035 -179.467 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -60.53 -40.07 90.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.055 -1.028 . . . . 1.0 110.463 179.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -73.82 -52.42 8.16 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.328 -0.939 . . . . 1.0 111.49 -178.465 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.454 HG23 ' N ' ' A' ' 160' ' ' GLN . 8.4 tp -60.49 -39.93 82.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.637 -1.508 . . . . 1.0 109.705 -178.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.8 mt-30 -66.37 -38.81 88.42 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.198 -0.939 . . . . 1.0 109.58 179.503 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 96.6 p -60.06 -34.94 74.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.394 -0.816 . . . . 1.0 110.686 -179.021 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 93.3 mt -85.17 -47.59 9.97 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.857 -1.152 . . . . 1.0 111.027 -178.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -91.68 -8.46 47.0 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.894 -1.129 . . . . 1.0 110.176 -179.007 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.404 -1.479 . . . . 1.0 109.404 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.6 mt . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -160.09 163.24 34.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.255 -0.903 . . . . 1.0 109.628 -179.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -70.9 144.43 50.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -0.907 . . . . 1.0 109.439 -179.828 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.8 t -95.91 14.25 24.12 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.289 -0.882 . . . . 1.0 109.434 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.51 149.62 37.75 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.236 -0.915 . . . . 1.0 109.438 -179.764 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.3 mmt -91.71 -2.95 56.79 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.33 -0.856 . . . . 1.0 109.731 -179.634 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -101.59 125.63 48.27 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.295 -0.878 . . . . 1.0 109.362 179.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.7 mt -140.48 149.35 42.41 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.246 -0.909 . . . . 1.0 109.16 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.1 p -131.77 153.86 49.67 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.875 -0.787 . . . . 1.0 108.875 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -143.11 158.46 43.59 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.145 -0.972 . . . . 1.0 110.385 179.877 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.577 HH12 ' H ' ' A' ' 56' ' ' GLY . 72.1 ttt180 -146.55 134.97 21.94 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.469 -0.769 . . . . 1.0 109.59 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.9 mt -89.89 118.92 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.112 -0.992 . . . . 1.0 108.963 179.008 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.67 -40.58 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.091 -1.006 . . . . 1.0 109.107 -179.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -162.11 162.22 28.5 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.667 -1.27 . . . . 1.0 110.26 -179.184 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -103.25 -162.92 0.95 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.521 -1.288 . . . . 1.0 107.521 178.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.74 152.04 61.54 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.459 -0.775 . . . . 1.0 109.744 -179.708 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -68.1 -35.99 18.33 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 120.923 1.082 . . . . 1.0 111.512 179.271 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -59.01 -48.6 81.01 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.359 0.599 . . . . 1.0 110.756 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 56.2 mtp -96.29 145.99 25.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.373 -0.829 . . . . 1.0 110.47 -178.435 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.1 p -74.93 160.85 30.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.889 . . . . 1.0 108.783 179.361 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -61.23 -46.2 91.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.219 -0.925 . . . . 1.0 110.777 -179.146 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.8 m -62.2 -40.03 94.74 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.024 -1.047 . . . . 1.0 110.89 -178.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.55 -40.08 88.86 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.106 -0.996 . . . . 1.0 110.947 -179.156 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 71.3 t -68.49 -40.53 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.834 -1.166 . . . . 1.0 110.318 -179.173 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.97 -49.8 76.25 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.042 -1.036 . . . . 1.0 110.564 -179.134 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.19 -32.72 72.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.058 -1.026 . . . . 1.0 110.089 -179.502 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.03 -49.94 75.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.114 -0.991 . . . . 1.0 110.045 -179.447 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -66.4 -37.32 84.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.021 -1.05 . . . . 1.0 110.062 -179.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -59.97 -40.56 89.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.974 -1.079 . . . . 1.0 109.533 -179.68 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -61.95 -40.65 96.28 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.949 -1.094 . . . . 1.0 108.88 179.227 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.44 -49.75 76.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.377 -0.827 . . . . 1.0 110.528 -179.285 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.414 ' CZ ' ' CZ ' ' A' ' 121' ' ' PHE . 53.8 m-85 -65.27 -40.53 94.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.985 -1.072 . . . . 1.0 109.962 -179.262 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -59.99 -47.42 85.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.107 -0.995 . . . . 1.0 109.7 -179.579 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 70.8 t -59.99 -40.51 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.339 -0.851 . . . . 1.0 110.426 -179.394 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -79.87 -34.57 39.12 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.911 -1.118 . . . . 1.0 110.202 -179.236 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 94.8 p -72.82 -20.62 61.11 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.966 -1.083 . . . . 1.0 109.916 -179.761 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -59.99 -39.74 86.79 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 1.0 110.342 -179.36 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.4 m -111.81 30.72 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 O-C-N 121.264 -0.897 . . . . 1.0 110.69 -179.474 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.7 p -152.21 137.95 11.4 Favored Pre-proline 0 N--CA 1.502 2.14 0 O-C-N 120.607 -1.308 . . . . 1.0 109.756 179.015 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -74.72 11.83 1.28 Allowed 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 120.746 0.964 . . . . 1.0 112.285 178.686 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 77.9 mt -67.95 137.69 55.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.031 -1.043 . . . . 1.0 109.655 -179.095 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -106.93 120.7 42.74 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.028 -0.73 . . . . 1.0 109.028 179.664 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -108.25 123.33 48.61 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.446 -0.784 . . . . 1.0 109.238 -179.545 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.9 m -120.01 130.03 54.54 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.579 -0.701 . . . . 1.0 109.492 -179.795 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -82.12 132.55 35.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.438 -0.789 . . . . 1.0 109.406 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.3 mt -105.13 128.45 53.38 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.413 -0.804 . . . . 1.0 109.488 179.813 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.417 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 61.7 m170 -68.56 -39.74 80.9 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.481 -0.762 . . . . 1.0 109.347 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 89.4 m-20 -142.84 166.92 23.33 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.294 -0.879 . . . . 1.0 109.328 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.577 ' H ' HH12 ' A' ' 18' ' ' ARG . . . 97.24 172.4 33.91 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.646 -1.381 . . . . 1.0 109.646 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 93.5 mt -95.09 139.23 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.284 -1.127 . . . . 1.0 109.242 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -114.2 164.3 14.07 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.441 -0.787 . . . . 1.0 109.598 -179.634 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -59.94 -47.85 84.09 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.475 -0.935 . . . . 1.0 108.475 179.413 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.3 mt -105.27 133.84 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.697 -0.853 . . . . 1.0 108.697 179.697 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.2 ptm -139.31 129.79 25.71 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.63 -1.294 . . . . 1.0 109.491 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 93.5 mt -102.5 140.2 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.351 0.596 . . . . 1.0 109.958 -179.067 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 81.6 p -151.46 154.75 37.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.318 -0.864 . . . . 1.0 109.623 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -109.18 144.09 37.73 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.048 -0.723 . . . . 1.0 109.048 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.81 -162.82 9.73 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.457 -1.457 . . . . 1.0 109.457 -179.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 92.6 mt . . . . . 0 N--CA 1.497 1.902 0 O-C-N 121.583 -0.951 . . . . 1.0 109.247 -179.933 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.554 ' CD2' ' OD2' ' A' ' 99' ' ' ASP . 94.6 m-85 . . . . . 0 N--CA 1.495 1.787 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -99.56 -1.01 39.33 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.203 -0.935 . . . . 1.0 110.758 -178.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.55 -138.04 9.8 Favored Glycine 0 N--CA 1.503 3.114 0 N-CA-C 108.816 -1.714 . . . . 1.0 108.816 -179.729 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.427 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 18.6 Cg_endo -77.67 -58.42 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.376 0 CA-C-N 119.872 1.836 . . . . 1.0 111.932 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 92.2 p -79.42 167.45 20.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.341 -0.849 . . . . 1.0 109.566 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 105.76 -129.33 9.74 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 109.882 -1.287 . . . . 1.0 109.882 179.715 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.43 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 8.3 mt -67.06 105.91 1.8 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.391 -1.064 . . . . 1.0 108.939 -179.781 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.411 HD11 ' CD1' ' A' ' 111' ' ' TYR . 71.9 mt -80.66 -14.25 58.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.114 -0.992 . . . . 1.0 109.027 -179.672 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.93 177.51 0.66 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.468 ' ND1' ' C ' ' A' ' 84' ' ' HIS . 3.2 p80 -161.89 160.61 28.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.101 -1.0 . . . . 1.0 109.508 179.341 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.31 165.02 34.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.884 . . . . 1.0 109.423 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -108.04 151.96 41.54 Favored Pre-proline 0 N--CA 1.498 1.962 0 N-CA-C 108.494 -0.928 . . . . 1.0 108.494 179.576 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -62.52 165.76 14.85 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 120.643 0.895 . . . . 1.0 111.675 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo . . . . . 0 C--N 1.314 -1.263 0 C-N-CA 120.85 1.033 . . . . 1.0 111.371 179.967 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 31.6 p-10 . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 108.982 -0.747 . . . . 1.0 108.982 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.95 120.96 8.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.151 -0.968 . . . . 1.0 109.78 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -104.29 139.83 38.73 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.566 -0.709 . . . . 1.0 110.069 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.476 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 25.8 m-85 -119.95 139.93 51.7 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.483 -0.761 . . . . 1.0 108.976 179.081 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.554 ' OD2' ' CD2' ' A' ' 75' ' ' PHE . 99.0 m-20 -79.98 126.19 30.72 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.915 -1.116 . . . . 1.0 109.787 179.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 49.1 t0 -87.75 0.94 55.07 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.306 -0.871 . . . . 1.0 109.844 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -81.34 -16.52 52.13 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.934 -1.104 . . . . 1.0 110.246 -179.428 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.545 ' OE1' ' N ' ' A' ' 102' ' ' GLU . 56.6 mp0 -93.02 174.99 6.95 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.183 -0.948 . . . . 1.0 109.445 -179.769 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 27.6 m -99.43 107.49 19.73 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.341 -0.849 . . . . 1.0 109.051 179.921 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -87.32 123.08 31.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 1.0 108.987 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.671 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.1 t -141.75 159.09 42.93 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.335 -0.853 . . . . 1.0 109.931 -179.192 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 44.3 t -96.03 -9.76 30.17 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.288 -1.005 . . . . 1.0 108.288 178.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 94.6 p -90.64 178.04 6.18 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.007 -0.738 . . . . 1.0 109.007 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.2 t -78.81 74.01 5.35 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.137 -0.977 . . . . 1.0 109.678 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.671 ' HB2' HG21 ' A' ' 105' ' ' THR . 98.4 mttt -146.66 148.69 32.31 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.463 -0.94 . . . . 1.0 108.463 179.093 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 46.28 -139.91 6.57 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.89 -1.284 . . . . 1.0 109.89 179.927 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.411 ' CD1' HD11 ' A' ' 82' ' ' LEU . 93.1 m-85 -100.0 116.35 31.84 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.323 -1.104 . . . . 1.0 109.173 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.43 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 2.2 t-20 -63.54 133.91 54.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.11 -0.994 . . . . 1.0 109.842 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.3 tp -59.98 -44.03 94.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.464 -0.772 . . . . 1.0 110.436 -179.744 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -60.04 -40.02 87.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.108 -0.995 . . . . 1.0 110.357 -178.733 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -59.48 -51.43 69.93 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.711 -1.243 . . . . 1.0 109.543 -179.702 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.6 t -69.95 -42.63 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.961 -1.087 . . . . 1.0 110.087 -179.174 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.43 -52.15 66.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.933 . . . . 1.0 109.764 -179.331 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.69 -38.09 80.58 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.414 -0.804 . . . . 1.0 110.343 -179.613 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.621 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 66.7 t60 -63.41 -50.1 71.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -0.927 . . . . 1.0 111.2 -178.401 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.476 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 8.2 pt-20 -59.97 -39.79 86.86 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.691 -1.256 . . . . 1.0 110.298 -179.233 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.414 ' CZ ' ' CZ ' ' A' ' 39' ' ' PHE . 30.9 m-85 -60.03 -39.96 87.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.78 -1.2 . . . . 1.0 108.95 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.81 -42.35 94.49 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.648 -1.381 . . . . 1.0 109.648 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.621 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 88.0 m-70 -66.01 -39.78 90.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.99 -1.3 . . . . 1.0 109.033 179.394 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 80.6 p -64.56 -23.98 67.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.345 -0.847 . . . . 1.0 109.462 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.2 mt -82.56 -1.84 51.87 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.132 -0.98 . . . . 1.0 109.577 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.05 10.21 64.73 Favored Glycine 0 N--CA 1.497 2.728 0 C-N-CA 120.304 -0.951 . . . . 1.0 110.812 179.191 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.5 mt -85.38 146.97 26.74 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.899 -1.354 . . . . 1.0 109.682 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 12.3 t70 -99.69 172.47 7.25 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.479 -0.763 . . . . 1.0 109.22 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.46 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 66.2 m80 -59.99 139.48 57.4 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.182 -0.949 . . . . 1.0 109.66 -179.534 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 34.1 t -98.76 152.97 19.11 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.346 -0.846 . . . . 1.0 109.407 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -96.67 -0.02 49.05 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.208 -0.933 . . . . 1.0 109.683 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -85.24 130.49 51.64 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.057 -1.027 . . . . 1.0 108.237 179.227 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -68.48 -21.37 40.38 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 CA-C-N 120.121 1.079 . . . . 1.0 112.147 -179.457 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -86.1 -4.83 83.86 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.942 -1.263 . . . . 1.0 109.942 -179.704 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -87.33 145.1 26.47 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.127 -1.219 . . . . 1.0 109.534 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.427 ' C ' ' H ' ' A' ' 138' ' ' PHE . 91.6 mt -70.0 -31.06 68.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.087 -1.008 . . . . 1.0 108.975 179.643 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.3 mmm -73.0 19.14 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.441 -0.787 . . . . 1.0 110.201 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.427 ' H ' ' C ' ' A' ' 136' ' ' LEU . 16.0 t80 -70.0 131.7 88.9 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 120.914 -1.116 . . . . 1.0 108.087 179.866 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -63.9 0.48 2.02 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 121.012 1.142 . . . . 1.0 114.536 -177.864 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 95.7 mt -123.19 139.45 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 120.935 -1.103 . . . . 1.0 109.321 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . 0.43 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 58.8 t80 -73.1 125.03 26.72 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.288 -0.882 . . . . 1.0 109.896 -179.396 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.9 t -138.2 140.05 39.58 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.719 -0.845 . . . . 1.0 108.719 179.388 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -81.25 130.5 35.05 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.081 -1.012 . . . . 1.0 109.921 -179.763 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.7 m -118.91 137.07 53.71 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.97 -0.752 . . . . 1.0 108.97 179.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -62.12 103.04 0.53 Allowed Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.121 -1.992 . . . . 1.0 108.121 178.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -72.64 114.62 10.97 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.19 -1.182 . . . . 1.0 108.728 -179.241 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.4 p -178.37 109.18 0.05 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.377 -0.972 . . . . 1.0 108.377 -179.694 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 49.99 39.88 19.87 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.046 -1.034 . . . . 1.0 108.752 -179.249 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -88.39 119.18 28.57 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.363 -0.836 . . . . 1.0 109.398 -179.699 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 97.3 mtp -110.17 148.29 32.08 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.343 -0.984 . . . . 1.0 108.343 179.368 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.7 mt -52.46 136.86 41.84 Favored Pre-proline 0 C--N 1.3 -1.552 0 O-C-N 121.158 -0.964 . . . . 1.0 109.214 -179.514 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -68.78 174.23 8.93 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 CA-C-N 119.569 0.882 . . . . 1.0 112.177 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -60.36 -39.99 89.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.498 -0.752 . . . . 1.0 109.951 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -55.09 -49.35 71.91 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.123 -0.986 . . . . 1.0 109.852 -179.347 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.12 -40.01 75.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.244 -0.91 . . . . 1.0 110.214 -179.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.8 t -59.99 -46.47 94.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.163 -0.961 . . . . 1.0 109.067 -179.661 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -61.58 -40.01 93.25 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.083 -1.01 . . . . 1.0 110.075 179.71 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.39 -53.38 13.45 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 120.312 -0.947 . . . . 1.0 111.468 -178.483 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.494 HG23 ' N ' ' A' ' 160' ' ' GLN . 6.0 tp -60.73 -39.98 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.835 -1.391 . . . . 1.0 109.778 -178.818 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.544 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.3 mt-30 -66.07 -39.98 90.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.115 -0.991 . . . . 1.0 109.51 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 86.2 p -61.24 -30.37 70.41 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.175 -0.953 . . . . 1.0 110.263 -179.642 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 85.5 mt -86.69 -51.8 5.91 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.001 -1.062 . . . . 1.0 110.656 -179.025 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -91.85 -9.23 44.11 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.067 -1.02 . . . . 1.0 110.312 -178.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.511 0 N-CA-C 109.457 -1.457 . . . . 1.0 109.457 -179.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.0 mt . . . . . 0 N--CA 1.494 1.726 0 N-CA-C 109.412 -0.588 . . . . 1.0 109.412 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.9 pttt -162.7 163.35 26.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.284 -0.885 . . . . 1.0 109.301 179.671 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -70.21 149.56 47.36 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.113 -0.992 . . . . 1.0 109.566 -179.51 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 98.3 p -90.03 1.19 56.6 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.29 -0.881 . . . . 1.0 109.757 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -146.92 154.86 41.78 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.074 -1.016 . . . . 1.0 110.039 -179.6 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.549 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.5 0.37 57.35 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.382 -0.824 . . . . 1.0 109.713 -179.81 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -93.93 125.09 38.35 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.152 -0.968 . . . . 1.0 109.203 -179.747 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.5 mt -142.27 150.23 40.6 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.355 -0.841 . . . . 1.0 108.982 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.9 p -130.75 153.12 49.36 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.411 -0.959 . . . . 1.0 108.411 179.643 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -145.11 159.99 42.12 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.059 -1.026 . . . . 1.0 109.902 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.494 ' NH1' ' O ' ' A' ' 56' ' ' GLY . 43.3 ttp180 -144.75 139.18 27.69 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.604 -0.685 . . . . 1.0 109.316 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.8 mm -88.15 118.45 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.266 -1.013 . . . . 1.0 108.266 179.212 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.3 t -69.79 -39.95 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.131 -0.981 . . . . 1.0 108.985 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.678 HD21 ' H ' ' A' ' 64' ' ' PHE . 15.2 p30 -160.71 153.8 21.51 Favored 'General case' 0 C--N 1.287 -2.124 0 O-C-N 120.028 -1.67 . . . . 1.0 110.697 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -97.02 101.28 12.82 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 104.895 -2.261 . . . . 1.0 104.895 177.091 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.559 ' O ' ' N ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -55.33 116.55 11.96 Favored Pre-proline 0 C--N 1.299 -1.598 0 C-N-CA 118.849 -1.141 . . . . 1.0 108.408 -177.588 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -50.23 -1.17 0.04 OUTLIER 'Trans proline' 0 N--CA 1.486 1.055 0 CA-C-N 119.804 0.966 . . . . 1.0 112.447 -179.592 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.559 ' N ' ' O ' ' A' ' 23' ' ' THR . 87.0 m-20 -60.1 -18.5 47.6 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 118.826 -1.149 . . . . 1.0 108.065 178.455 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 76.2 mtm -147.99 163.84 35.61 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.617 -0.883 . . . . 1.0 108.617 179.281 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.0 p -73.23 157.36 37.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.17 -0.956 . . . . 1.0 109.123 179.735 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -60.68 -40.09 90.87 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.293 -0.879 . . . . 1.0 109.964 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 63.6 m -60.29 -41.96 94.46 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.206 -0.934 . . . . 1.0 109.616 -179.405 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.32 -40.15 85.92 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.446 -0.784 . . . . 1.0 110.397 179.737 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 70.7 t -67.4 -44.98 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 1.0 110.708 -179.02 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.87 -48.12 82.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.134 -0.979 . . . . 1.0 110.388 -178.362 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -62.47 -32.86 73.81 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.884 -1.135 . . . . 1.0 110.285 -179.783 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.408 ' CB ' HD23 ' A' ' 113' ' ' LEU . . . -60.01 -49.72 76.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.015 -1.053 . . . . 1.0 110.072 -179.274 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.433 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 53.7 m-85 -68.63 -40.01 80.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.968 -1.083 . . . . 1.0 109.805 -179.648 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.3 mmtt -60.04 -44.87 94.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.019 -1.051 . . . . 1.0 109.642 -179.468 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -60.12 -40.26 89.11 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.149 -0.97 . . . . 1.0 109.219 179.726 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.17 -45.36 93.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.528 -0.732 . . . . 1.0 109.642 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -66.15 -34.66 78.54 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.884 -1.135 . . . . 1.0 109.605 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.7 tptt -59.82 -52.59 64.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.168 -0.957 . . . . 1.0 110.166 -179.665 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.0 m -60.91 -39.86 83.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 O-C-N 120.895 -1.128 . . . . 1.0 110.556 -179.678 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -79.35 -38.34 35.33 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.99 -1.069 . . . . 1.0 110.161 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.3 p -71.68 -22.96 61.58 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.709 -1.244 . . . . 1.0 110.123 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -60.09 -40.02 88.14 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.193 -0.942 . . . . 1.0 111.104 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.6 m -111.42 25.12 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 O-C-N 121.211 -0.931 . . . . 1.0 111.122 -178.309 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.3 p -148.79 133.84 9.27 Favored Pre-proline 0 N--CA 1.501 2.122 0 O-C-N 120.701 -1.249 . . . . 1.0 109.617 179.495 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -72.37 17.49 0.35 Allowed 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 120.696 0.931 . . . . 1.0 111.902 179.335 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 75.3 mt -67.23 137.92 56.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.195 -0.941 . . . . 1.0 109.829 -179.273 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -108.29 121.42 44.87 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.095 -0.706 . . . . 1.0 109.095 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -109.57 127.65 54.64 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.488 -0.758 . . . . 1.0 109.264 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.7 m -119.99 129.95 54.52 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.482 0.658 . . . . 1.0 109.559 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -82.45 131.25 35.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.359 -0.838 . . . . 1.0 109.529 179.85 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.9 mt -105.94 128.85 54.07 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.274 -0.891 . . . . 1.0 109.514 179.639 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.41 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 17.5 m-70 -66.44 -40.08 89.26 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.436 -0.79 . . . . 1.0 109.839 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 68.0 m-20 -150.07 173.12 14.22 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.222 -0.924 . . . . 1.0 109.468 -179.709 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.494 ' O ' ' NH1' ' A' ' 18' ' ' ARG . . . 95.37 178.68 37.03 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.071 -1.612 . . . . 1.0 109.071 -179.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.5 mt -93.7 133.62 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.139 -1.213 . . . . 1.0 109.439 -179.679 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.68 158.26 18.26 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.483 -0.76 . . . . 1.0 109.167 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -59.72 -49.41 77.84 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.21 -0.931 . . . . 1.0 109.238 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 90.4 mt -105.77 99.74 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.335 -0.853 . . . . 1.0 109.875 179.562 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.7 ptp -99.21 134.77 41.59 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.146 -0.971 . . . . 1.0 109.145 179.048 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.433 HG21 ' CZ ' ' A' ' 35' ' ' PHE . 85.5 mt -109.93 132.33 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.655 -0.653 . . . . 1.0 109.462 -179.014 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.0 p -151.67 157.74 42.5 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.875 -1.141 . . . . 1.0 110.562 -179.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.678 ' H ' HD21 ' A' ' 21' ' ' ASN . 62.0 m-85 -109.62 120.79 43.58 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.55 -0.907 . . . . 1.0 108.55 179.28 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.28 -169.78 23.01 Favored Glycine 0 N--CA 1.499 2.87 0 N-CA-C 110.24 -1.144 . . . . 1.0 110.24 -179.515 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 87.4 mt . . . . . 0 N--CA 1.498 1.951 0 O-C-N 121.644 -0.915 . . . . 1.0 108.836 179.809 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.55 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 83.0 m-85 . . . . . 0 N--CA 1.493 1.675 0 N-CA-C 109.33 -0.619 . . . . 1.0 109.33 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.3 p-10 -101.01 3.96 41.97 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.35 -0.844 . . . . 1.0 110.961 -178.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 126.32 -151.61 18.03 Favored Glycine 0 N--CA 1.507 3.383 0 N-CA-C 108.911 -1.676 . . . . 1.0 108.911 -179.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -60.0 -66.21 0.07 OUTLIER 'Trans proline' 0 N--CA 1.492 1.438 0 CA-C-N 119.116 1.458 . . . . 1.0 112.02 179.617 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 91.7 p -76.82 161.89 28.09 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.183 -0.948 . . . . 1.0 109.525 179.811 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 117.48 -133.21 10.4 Favored Glycine 0 N--CA 1.501 3.002 0 N-CA-C 109.307 -1.517 . . . . 1.0 109.307 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.8 mt -70.16 111.55 5.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.088 -1.242 . . . . 1.0 108.456 179.541 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 38.3 mt -79.33 -17.48 54.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.963 -1.085 . . . . 1.0 108.806 -179.431 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 179.97 175.45 0.8 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.719 -0.845 . . . . 1.0 108.719 179.762 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -166.0 157.7 13.99 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.188 -0.945 . . . . 1.0 109.298 178.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -144.93 157.9 43.99 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -96.89 151.29 37.7 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 107.881 -1.155 . . . . 1.0 107.881 179.478 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -61.54 163.52 17.89 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 CA-C-N 119.324 0.794 . . . . 1.0 111.751 -179.32 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo . . . . . 0 C--N 1.314 -1.267 0 C-N-CA 121.113 1.208 . . . . 1.0 112.253 179.917 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.4 p-10 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.272 0.558 . . . . 1.0 109.707 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.61 124.42 9.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.234 -0.916 . . . . 1.0 109.529 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -112.91 147.59 36.74 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.592 -0.693 . . . . 1.0 109.937 -179.8 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -125.57 149.44 48.34 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 -179.839 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.55 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 84.7 m-20 -78.92 123.23 27.06 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.078 -1.014 . . . . 1.0 109.627 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -84.93 -7.73 59.04 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.233 -0.917 . . . . 1.0 109.275 179.577 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -83.5 -14.01 53.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.401 -0.812 . . . . 1.0 109.186 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -88.73 168.67 12.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.503 -0.748 . . . . 1.0 109.166 -179.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 30.9 m -99.94 106.08 17.85 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.209 -0.932 . . . . 1.0 109.214 -179.6 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -87.11 123.38 32.11 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.577 -0.897 . . . . 1.0 108.577 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.637 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.7 t -141.99 156.57 45.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.38 -0.825 . . . . 1.0 109.901 -178.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.7 t -96.8 -7.69 33.03 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.594 -0.891 . . . . 1.0 108.594 179.21 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 79.4 p -93.62 173.43 7.69 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.524 -0.735 . . . . 1.0 109.428 179.522 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.0 t -70.72 70.34 0.46 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 1.0 109.617 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.637 ' HB2' HG21 ' A' ' 105' ' ' THR . 44.6 mtpt -146.55 153.8 40.79 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.213 -0.93 . . . . 1.0 109.22 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 109' ' ' LYS . . . 41.89 -139.78 1.95 Allowed Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.037 -1.225 . . . . 1.0 110.037 179.494 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -101.0 119.12 38.28 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.33 -1.1 . . . . 1.0 108.943 179.524 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -63.88 132.19 50.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.177 -0.952 . . . . 1.0 109.796 -179.585 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.408 HD23 ' CB ' ' A' ' 34' ' ' ALA . 58.7 tp -59.88 -39.97 87.08 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.351 -0.843 . . . . 1.0 109.923 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -59.91 -41.05 90.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.218 -0.926 . . . . 1.0 110.261 -179.218 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -58.85 -57.92 10.89 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.829 -1.169 . . . . 1.0 110.294 -179.482 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.7 t -66.3 -41.12 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.402 -0.811 . . . . 1.0 109.964 -178.431 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.84 -51.66 68.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.966 -1.084 . . . . 1.0 109.192 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.548 ' HB1' HD13 ' A' ' 136' ' ' LEU . . . -60.06 -39.49 86.19 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.336 -0.852 . . . . 1.0 110.246 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.638 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 76.7 t60 -63.8 -49.86 71.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.894 . . . . 1.0 111.443 -178.194 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -59.95 -37.7 80.3 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.671 -1.268 . . . . 1.0 110.086 -179.046 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -60.15 -39.81 87.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.645 -1.284 . . . . 1.0 108.453 179.302 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -59.06 -40.38 95.51 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.246 -1.542 . . . . 1.0 109.246 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.638 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 80.7 m-70 -68.48 -39.99 81.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.043 -1.269 . . . . 1.0 108.832 179.192 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.1 p -65.76 -24.75 67.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.411 -0.806 . . . . 1.0 109.12 179.703 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 65.9 mt -81.86 -4.91 57.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.361 -0.837 . . . . 1.0 109.47 179.851 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 92.22 10.03 61.36 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.659 -0.976 . . . . 1.0 110.659 179.105 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.8 mt -85.21 147.91 26.36 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.871 -1.37 . . . . 1.0 109.671 179.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 44.1 t0 -100.63 175.46 5.65 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.476 -0.765 . . . . 1.0 108.97 -179.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.515 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 74.0 m80 -59.93 138.89 57.72 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.973 . . . . 1.0 109.72 -179.597 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 46.7 t -97.34 155.66 16.79 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.32 -0.863 . . . . 1.0 109.226 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -99.26 0.21 42.66 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.144 -0.973 . . . . 1.0 109.754 -179.893 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -85.32 130.4 51.82 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.306 -0.871 . . . . 1.0 108.695 179.85 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -68.1 -19.88 44.67 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 CA-C-N 120.136 1.084 . . . . 1.0 112.456 -179.668 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -91.2 -4.63 68.47 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 110.243 -1.143 . . . . 1.0 110.243 -179.558 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.86 145.63 27.1 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.014 -1.286 . . . . 1.0 109.31 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.548 HD13 ' HB1' ' A' ' 118' ' ' ALA . 70.3 mt -66.34 -38.63 88.08 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.911 -1.118 . . . . 1.0 110.01 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 94.5 mmm -69.97 19.84 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.315 -0.866 . . . . 1.0 110.585 -178.529 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.482 ' H ' ' C ' ' A' ' 136' ' ' LEU . 17.3 t80 -70.15 129.59 90.5 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 108.094 -1.076 . . . . 1.0 108.094 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -54.68 -10.98 2.85 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 CA-C-N 119.996 1.034 . . . . 1.0 114.079 -179.061 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.9 mt -113.93 140.63 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.512 0 O-C-N 120.891 -1.13 . . . . 1.0 110.664 -178.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . 0.433 ' CD1' ' C ' ' A' ' 141' ' ' TYR . 20.7 t80 -74.7 129.58 37.97 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.513 -0.742 . . . . 1.0 110.069 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.0 t -139.0 142.4 38.32 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.434 -0.792 . . . . 1.0 109.402 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -83.05 152.18 25.48 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.994 -1.066 . . . . 1.0 109.721 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.43 ' H ' ' NZ ' ' A' ' 146' ' ' LYS . 2.7 m -145.66 154.45 42.12 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.399 -0.813 . . . . 1.0 109.863 -179.771 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.92 103.93 1.55 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.312 -1.915 . . . . 1.0 108.312 178.633 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.43 ' NZ ' ' H ' ' A' ' 144' ' ' THR . 37.3 mmtm -77.3 12.49 1.49 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.212 -1.169 . . . . 1.0 110.095 -178.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 48.5 t -60.0 -39.96 87.58 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.032 -1.043 . . . . 1.0 108.633 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -160.01 69.81 0.42 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.355 -0.841 . . . . 1.0 109.071 179.053 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -97.7 139.74 33.13 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.308 -0.87 . . . . 1.0 110.498 -179.547 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 97.4 mmm -136.9 149.72 47.8 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.983 -1.118 . . . . 1.0 107.983 178.844 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.9 mt -53.57 131.13 54.84 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.058 -1.026 . . . . 1.0 109.566 -179.134 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -68.49 175.47 6.95 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 CA-C-N 119.835 0.977 . . . . 1.0 112.136 179.638 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -60.08 -39.9 87.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.514 -0.741 . . . . 1.0 110.027 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -57.19 -47.31 81.56 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.221 -0.925 . . . . 1.0 110.067 -179.146 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -69.86 -39.83 76.12 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.188 -0.945 . . . . 1.0 109.435 -179.751 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.28 -45.02 96.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.198 -0.939 . . . . 1.0 109.196 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -60.23 -39.72 87.66 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.926 -1.109 . . . . 1.0 109.748 179.519 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.71 -54.41 10.02 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 120.501 -0.857 . . . . 1.0 111.669 -178.471 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 160' ' ' GLN . 8.4 tp -60.03 -40.18 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.666 -1.491 . . . . 1.0 109.621 -178.728 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.546 ' O ' ' N ' ' A' ' 164' ' ' GLY . 26.5 mt-30 -65.54 -39.39 91.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.089 -1.007 . . . . 1.0 109.466 179.217 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 84.7 p -59.13 -30.91 68.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.055 -1.028 . . . . 1.0 110.032 -179.553 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 88.7 mt -86.92 -53.61 4.8 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.938 -1.101 . . . . 1.0 110.725 -179.147 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -91.92 -9.98 41.19 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.91 -1.119 . . . . 1.0 110.933 -178.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.597 0 N-CA-C 109.292 -1.523 . . . . 1.0 109.292 -179.633 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.0 mt . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 108.934 -0.765 . . . . 1.0 108.934 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -162.48 166.52 24.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 1.0 109.867 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -72.19 140.75 48.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.185 -0.947 . . . . 1.0 110.043 -179.398 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.3 t -89.99 0.02 57.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.406 -0.809 . . . . 1.0 109.722 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.538 ' NZ ' ' O ' ' A' ' 14' ' ' ASN . 20.7 pttp -141.98 154.21 44.86 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.185 -0.947 . . . . 1.0 109.622 -179.651 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.4 mmt -90.47 -0.13 57.54 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.363 -0.835 . . . . 1.0 110.203 -178.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.538 ' O ' ' NZ ' ' A' ' 12' ' ' LYS . 30.1 m120 -97.02 128.61 44.15 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.224 -0.922 . . . . 1.0 109.151 -179.844 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.4 mt -141.66 149.54 40.76 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.265 -0.897 . . . . 1.0 109.307 -179.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.5 p -132.11 154.11 49.8 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.004 -0.739 . . . . 1.0 109.004 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -144.58 159.1 43.35 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.11 -0.994 . . . . 1.0 110.193 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 56' ' ' GLY . 26.3 ttm-85 -145.4 132.11 19.98 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.592 -0.693 . . . . 1.0 109.864 -179.455 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 39.8 mm -87.88 112.72 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.335 -0.987 . . . . 1.0 108.335 178.734 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.5 t -69.95 -40.05 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.101 -0.999 . . . . 1.0 109.443 -179.418 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -162.17 156.97 22.5 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.777 -1.202 . . . . 1.0 110.152 -179.588 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.611 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 54.0 m-85 -96.91 -167.14 1.5 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.169 -1.419 . . . . 1.0 107.169 178.851 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.29 141.58 32.11 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.325 -0.859 . . . . 1.0 110.094 -179.439 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -66.89 -19.1 52.81 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 120.763 0.976 . . . . 1.0 110.365 178.83 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.43 -39.91 85.04 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.553 -0.749 . . . . 1.0 109.949 179.405 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 74.8 mtm -130.04 161.66 30.5 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.419 -0.801 . . . . 1.0 109.484 -179.43 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.0 p -70.79 158.26 36.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -0.911 . . . . 1.0 109.2 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.611 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 1.0 OUTLIER -60.73 -40.76 93.59 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.355 -0.841 . . . . 1.0 110.239 -179.169 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.539 ' O ' ' NZ ' ' A' ' 33' ' ' LYS . 73.8 m -59.94 -41.02 90.94 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.006 -1.059 . . . . 1.0 110.758 -179.455 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -64.61 -40.08 94.86 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.945 -1.097 . . . . 1.0 110.004 -179.629 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.4 t -67.28 -39.96 83.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.222 -0.924 . . . . 1.0 109.83 -179.71 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -60.04 -49.93 75.74 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.098 -1.001 . . . . 1.0 110.647 -178.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.539 ' NZ ' ' O ' ' A' ' 29' ' ' SER . 2.1 ptpp? -64.19 -30.34 71.41 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.131 -0.981 . . . . 1.0 109.911 -179.704 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.04 -48.87 79.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.064 -1.022 . . . . 1.0 109.669 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -67.15 -38.38 85.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.075 -1.015 . . . . 1.0 110.02 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -59.95 -42.66 94.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.008 -1.058 . . . . 1.0 109.657 -179.651 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -60.04 -43.71 95.14 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.027 -1.046 . . . . 1.0 109.02 179.355 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.06 -49.71 76.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.463 -0.773 . . . . 1.0 109.868 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -61.97 -39.97 93.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.265 -0.897 . . . . 1.0 109.291 -179.803 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -60.06 -50.0 75.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.212 -0.93 . . . . 1.0 109.197 -179.591 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 70.2 t -59.98 -40.73 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.249 -0.907 . . . . 1.0 109.869 -179.549 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -78.94 -37.77 38.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.026 -1.047 . . . . 1.0 109.861 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.3 p -69.97 -15.32 63.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.267 -0.895 . . . . 1.0 109.829 -179.726 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -59.98 -40.0 87.61 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.136 -0.978 . . . . 1.0 110.091 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.3 m -115.06 -17.71 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.437 -0.789 . . . . 1.0 111.191 -178.483 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.3 p -90.76 124.36 62.47 Favored Pre-proline 0 N--CA 1.501 2.078 0 O-C-N 120.463 -1.398 . . . . 1.0 109.416 179.926 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -73.69 15.47 0.56 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 CA-C-N 120.221 1.115 . . . . 1.0 111.434 178.88 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.5 mt -69.61 140.26 53.71 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.41 -0.806 . . . . 1.0 110.369 -179.299 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -102.33 121.63 42.66 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.798 -0.816 . . . . 1.0 108.798 179.198 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -107.09 125.79 51.52 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.288 -0.882 . . . . 1.0 109.768 -179.204 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.2 m -120.03 129.98 54.5 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.576 -0.702 . . . . 1.0 109.882 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -82.23 131.96 35.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.244 -0.91 . . . . 1.0 109.487 179.752 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.493 ' O ' ' NH1' ' A' ' 18' ' ' ARG . 90.3 mt -106.63 134.0 50.45 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.301 -0.874 . . . . 1.0 109.274 179.502 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.435 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 59.1 m170 -66.23 -39.98 89.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.388 -0.82 . . . . 1.0 109.874 -179.641 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.464 ' O ' ' NH2' ' A' ' 18' ' ' ARG . 69.0 m-20 -154.42 178.84 9.6 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.087 -1.008 . . . . 1.0 109.635 -179.77 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.538 ' O ' ' NE ' ' A' ' 18' ' ' ARG . . . 96.62 -168.26 25.04 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.642 -1.383 . . . . 1.0 109.642 -179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.7 mt -101.4 130.51 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.361 -1.082 . . . . 1.0 109.622 -179.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.45 154.73 26.53 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.422 -0.799 . . . . 1.0 109.447 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -60.01 -49.56 77.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.2 -0.938 . . . . 1.0 109.624 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.6 mt -104.11 94.99 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.334 -0.853 . . . . 1.0 109.608 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.3 ptm -100.73 127.39 47.17 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.208 -0.933 . . . . 1.0 109.61 179.754 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 87.2 mt -106.42 137.7 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.52 -0.738 . . . . 1.0 109.657 -179.643 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 66.3 p -152.69 161.92 41.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.224 -0.923 . . . . 1.0 109.71 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -109.97 149.98 29.15 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.531 -0.731 . . . . 1.0 109.329 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -143.71 -161.88 9.11 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.315 -1.514 . . . . 1.0 109.315 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.2 mt . . . . . 0 N--CA 1.498 1.952 0 O-C-N 121.344 -1.092 . . . . 1.0 109.269 -179.942 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 106.959 -1.497 . . . . 1.0 106.959 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.7 p-10 -106.09 20.0 19.64 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 120.927 -1.108 . . . . 1.0 110.934 -178.682 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.28 -150.38 18.11 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 109.493 -1.443 . . . . 1.0 109.493 179.608 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.442 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 8.8 Cg_exo -60.67 -62.72 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.524 0 CA-C-N 118.864 1.332 . . . . 1.0 112.896 -179.593 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 83.2 p -74.04 157.61 35.81 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.019 -1.051 . . . . 1.0 110.206 -179.268 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.65 -126.82 7.56 Favored Glycine 0 N--CA 1.502 3.075 0 N-CA-C 110.244 -1.142 . . . . 1.0 110.244 179.605 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.427 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 15.3 mt -69.75 102.73 1.98 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.43 -1.041 . . . . 1.0 109.3 -179.702 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 41.3 mt -75.67 -24.44 56.33 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.881 -1.137 . . . . 1.0 108.57 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.4 172.22 1.2 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.702 -0.851 . . . . 1.0 108.702 -179.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.497 ' ND1' ' C ' ' A' ' 84' ' ' HIS . 2.8 p80 -161.61 171.41 18.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.128 -0.983 . . . . 1.0 109.238 178.938 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.41 160.91 43.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.172 -0.955 . . . . 1.0 109.467 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -101.32 154.33 37.27 Favored Pre-proline 0 N--CA 1.496 1.862 0 N-CA-C 108.367 -0.975 . . . . 1.0 108.367 179.687 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.87 168.64 0.76 Allowed 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 120.738 0.959 . . . . 1.0 111.588 179.68 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo . . . . . 0 C--N 1.312 -1.383 0 C-N-CA 120.862 1.041 . . . . 1.0 111.441 179.931 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.239 0.542 . . . . 1.0 109.66 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.05 124.53 9.64 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.159 -0.963 . . . . 1.0 109.848 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -107.05 131.01 54.57 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.483 -0.761 . . . . 1.0 109.529 179.75 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.494 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 38.4 m-85 -114.28 144.18 43.66 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.504 -0.748 . . . . 1.0 109.028 179.588 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.427 ' OD2' ' O ' ' A' ' 81' ' ' LEU . 91.7 m-20 -78.95 124.23 28.05 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.934 -1.104 . . . . 1.0 109.926 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 55.7 t0 -85.45 -6.77 59.17 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.211 -0.93 . . . . 1.0 109.233 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -81.9 -14.94 55.48 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.097 -1.002 . . . . 1.0 109.329 179.863 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.442 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 94.3 mt-10 -89.23 168.55 12.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.362 -0.836 . . . . 1.0 109.68 -178.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 26.3 m -98.51 105.17 17.28 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.199 -0.938 . . . . 1.0 109.494 -179.516 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.422 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 86.5 m95 -88.47 124.24 33.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.379 -0.826 . . . . 1.0 109.059 179.727 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.668 HG21 ' HB2' ' A' ' 109' ' ' LYS . 7.9 t -140.78 153.63 45.92 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.197 -0.939 . . . . 1.0 109.91 -179.476 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 85.0 p -93.2 -5.6 49.65 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.456 -0.942 . . . . 1.0 108.456 179.15 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 46.4 t -94.3 179.71 5.21 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.718 -0.845 . . . . 1.0 108.718 179.305 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.9 m -80.79 75.75 7.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.004 -1.06 . . . . 1.0 109.372 179.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.668 ' HB2' HG21 ' A' ' 105' ' ' THR . 68.5 mttm -148.61 151.52 35.16 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.308 -0.87 . . . . 1.0 108.828 179.364 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.53 -138.84 4.83 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.841 -1.304 . . . . 1.0 109.841 179.667 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -100.01 115.92 30.85 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.348 -1.09 . . . . 1.0 108.862 179.604 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -63.61 131.81 49.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.158 -0.964 . . . . 1.0 109.617 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.1 tp -60.0 -43.59 95.08 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.331 -0.856 . . . . 1.0 110.899 -179.484 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -59.91 -41.11 91.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.971 -1.081 . . . . 1.0 110.794 -178.592 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.96 -50.47 73.64 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.809 -1.182 . . . . 1.0 109.603 -179.468 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.1 t -70.01 -41.44 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.051 -1.031 . . . . 1.0 110.09 -179.365 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.45 -51.44 69.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.147 -0.971 . . . . 1.0 109.633 -179.318 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.05 -37.01 78.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.146 -0.971 . . . . 1.0 109.945 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.511 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 59.4 t60 -62.36 -49.94 73.55 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.249 -0.907 . . . . 1.0 111.182 -178.784 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.494 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 6.9 pt-20 -59.54 -39.49 84.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.654 -1.278 . . . . 1.0 109.529 -179.38 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -60.07 -39.96 87.87 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.892 -1.13 . . . . 1.0 108.615 179.205 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.36 -47.71 61.61 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.283 -1.527 . . . . 1.0 109.283 179.775 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.511 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 89.1 m-70 -66.1 -39.96 90.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.286 -1.126 . . . . 1.0 110.16 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 83.1 p -66.43 -22.19 66.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.131 -0.98 . . . . 1.0 109.897 -179.609 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 79.6 mt -81.9 1.84 33.3 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.134 -0.979 . . . . 1.0 109.948 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.12 4.99 70.96 Favored Glycine 0 N--CA 1.497 2.749 0 O-C-N 121.005 -1.059 . . . . 1.0 110.532 179.167 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.2 mt -86.99 147.85 25.56 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.984 -1.303 . . . . 1.0 109.787 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 37.6 t0 -101.98 172.39 6.95 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.878 -0.786 . . . . 1.0 108.878 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.513 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 59.3 m80 -56.58 132.72 52.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.004 -1.06 . . . . 1.0 109.54 -179.684 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 40.0 t -96.45 157.37 15.93 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.249 -0.907 . . . . 1.0 109.412 179.839 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -99.97 5.06 45.21 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.347 -0.845 . . . . 1.0 109.125 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -86.23 126.5 64.73 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 108.317 -0.994 . . . . 1.0 108.317 179.442 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -68.04 -22.07 42.1 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 CA-C-N 120.253 1.126 . . . . 1.0 112.273 -179.686 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -84.99 -5.69 85.81 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.684 -1.366 . . . . 1.0 109.684 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.15 135.19 33.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.186 -1.185 . . . . 1.0 108.842 179.467 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.466 ' C ' ' H ' ' A' ' 138' ' ' PHE . 89.2 mt -60.7 -40.05 90.79 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.076 -1.015 . . . . 1.0 110.238 -179.442 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 89.6 mtp -69.22 23.92 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.207 -0.933 . . . . 1.0 111.009 -178.425 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.466 ' H ' ' C ' ' A' ' 136' ' ' LEU . 17.3 t80 -69.92 130.33 90.1 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 120.761 -1.212 . . . . 1.0 108.328 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -49.07 -21.82 4.47 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 120.825 1.016 . . . . 1.0 114.392 -178.453 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 90.4 mt -106.37 139.81 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 O-C-N 120.886 -1.134 . . . . 1.0 110.87 -178.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -75.0 126.76 31.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.791 -0.568 . . . . 1.0 109.614 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.8 t -138.16 142.31 40.08 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.452 -0.78 . . . . 1.0 109.167 179.388 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -80.41 139.94 36.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.145 -0.972 . . . . 1.0 109.13 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.3 t -139.95 152.09 46.07 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.282 -0.886 . . . . 1.0 109.909 -179.322 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.96 101.1 0.83 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.33 -1.508 . . . . 1.0 109.33 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -76.79 -0.79 25.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.348 -1.09 . . . . 1.0 110.019 -179.718 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 53.9 m -59.97 -40.03 87.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.082 -1.011 . . . . 1.0 109.658 -179.6 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -138.91 21.06 2.65 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.144 -0.973 . . . . 1.0 109.989 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -62.03 139.94 58.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.78 -1.2 . . . . 1.0 109.721 -179.714 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 67.6 mtt -139.64 148.32 42.28 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.386 -0.968 . . . . 1.0 108.386 179.179 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 35.0 mt -54.94 129.78 66.3 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 120.945 -1.097 . . . . 1.0 109.202 -179.407 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -70.82 173.33 12.08 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 CA-C-N 119.863 0.987 . . . . 1.0 112.21 179.749 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -60.17 -39.62 87.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.328 -0.857 . . . . 1.0 109.519 179.403 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -53.06 -47.94 68.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.217 -0.927 . . . . 1.0 109.594 -179.517 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.411 ' O ' HG22 ' A' ' 159' ' ' ILE . 96.9 m-20 -70.33 -40.07 74.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.064 -1.022 . . . . 1.0 110.152 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 78.7 t -60.02 -47.35 92.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.88 -1.137 . . . . 1.0 109.176 -179.784 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -60.06 -39.97 87.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.071 -1.018 . . . . 1.0 110.434 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -73.23 -54.28 7.04 Favored Glycine 0 N--CA 1.496 2.672 0 O-C-N 121.215 -0.928 . . . . 1.0 111.685 -178.213 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.492 HG23 ' N ' ' A' ' 160' ' ' GLN . 4.8 tp -59.98 -39.99 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.953 -1.322 . . . . 1.0 109.691 -178.808 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.571 ' O ' ' N ' ' A' ' 164' ' ' GLY . 93.0 mm-40 -64.94 -38.25 90.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.2 -0.938 . . . . 1.0 109.463 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 60.3 p -61.51 -33.34 73.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.071 -1.018 . . . . 1.0 110.346 -179.359 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.8 mt -84.84 -52.31 6.12 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.959 -1.088 . . . . 1.0 110.536 -179.001 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -91.31 -9.24 45.71 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.104 -0.997 . . . . 1.0 110.483 -178.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.496 2.66 0 N-CA-C 109.448 -1.461 . . . . 1.0 109.448 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.8 mt . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.162 -0.681 . . . . 1.0 109.162 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -161.71 161.44 29.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.878 . . . . 1.0 109.785 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -70.15 146.26 50.94 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.325 -0.86 . . . . 1.0 109.518 -179.623 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.9 t -85.94 1.42 50.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.342 -0.849 . . . . 1.0 109.818 -179.54 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -144.17 152.98 41.63 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.153 -0.967 . . . . 1.0 109.607 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.8 mmt -90.24 -0.02 57.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.358 -0.839 . . . . 1.0 109.769 -179.302 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -97.04 130.52 44.34 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.206 -0.933 . . . . 1.0 109.11 179.762 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.2 mt -141.75 148.94 39.8 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.196 -0.94 . . . . 1.0 109.406 -179.814 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.9 p -134.37 155.29 50.53 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.715 -0.846 . . . . 1.0 108.715 179.819 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -146.14 160.05 42.47 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.061 -1.024 . . . . 1.0 110.201 -179.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.486 ' NH1' ' N ' ' A' ' 56' ' ' GLY . 71.8 ttt180 -145.5 134.16 22.2 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.562 -0.711 . . . . 1.0 109.556 -179.736 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 32.0 mm -89.0 115.11 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.182 -0.949 . . . . 1.0 108.922 179.026 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.91 -40.58 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.173 -0.954 . . . . 1.0 109.295 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -164.98 160.52 19.15 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.929 -1.107 . . . . 1.0 110.008 -179.507 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.461 ' CD2' ' CG ' ' A' ' 28' ' ' HIS . 47.7 m-85 -101.68 -161.53 0.86 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.894 -1.15 . . . . 1.0 107.894 179.132 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.33 147.59 47.6 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.448 -0.782 . . . . 1.0 110.054 -179.809 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -69.62 -14.99 37.36 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 120.916 1.078 . . . . 1.0 110.267 178.245 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.42 -38.93 81.9 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.083 -0.962 . . . . 1.0 109.965 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 76.0 mtm -139.64 168.4 19.91 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.284 -0.885 . . . . 1.0 109.552 -179.756 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.4 p -73.45 156.61 38.07 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.445 -0.785 . . . . 1.0 109.771 -179.496 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.461 ' CG ' ' CD2' ' A' ' 22' ' ' TYR . 41.6 m170 -59.99 -40.09 87.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.431 -0.793 . . . . 1.0 110.463 -179.538 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 53.4 m -59.97 -39.96 87.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 1.0 110.202 -178.474 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.39 -39.95 89.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.033 -1.042 . . . . 1.0 109.325 179.574 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 76.6 t -68.7 -40.29 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.266 -0.896 . . . . 1.0 110.348 -179.561 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.96 -49.26 78.4 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.841 -1.162 . . . . 1.0 110.37 -179.186 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -61.34 -32.1 71.98 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.98 -1.075 . . . . 1.0 109.529 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.84 -48.57 81.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.977 -1.077 . . . . 1.0 109.649 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -66.03 -39.78 90.49 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.091 -1.006 . . . . 1.0 109.923 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.97 -40.65 89.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.924 -1.11 . . . . 1.0 109.284 -179.395 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -60.13 -41.78 93.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.034 -1.041 . . . . 1.0 108.927 179.085 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.97 -48.07 83.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.355 -0.841 . . . . 1.0 110.124 -179.683 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -64.89 -39.94 94.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.138 -0.976 . . . . 1.0 109.564 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -59.96 -48.25 82.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.15 -0.969 . . . . 1.0 109.27 -179.65 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.9 t -60.02 -41.53 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.294 -0.879 . . . . 1.0 110.122 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.468 ' O ' HG23 ' A' ' 46' ' ' THR . 76.3 m95 -81.36 -31.5 33.35 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.978 -1.076 . . . . 1.0 109.99 -179.421 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.0 p -70.02 -20.12 63.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.958 -1.089 . . . . 1.0 109.023 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -60.27 -39.96 88.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.404 -0.81 . . . . 1.0 110.263 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.1 m -113.15 -17.35 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 O-C-N 121.219 -0.926 . . . . 1.0 110.49 -179.17 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.478 ' C ' ' H ' ' A' ' 48' ' ' LEU . 44.8 p -94.02 114.41 63.11 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 120.779 -1.2 . . . . 1.0 108.982 179.729 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.76 16.36 0.22 Allowed 'Trans proline' 0 N--CA 1.491 1.327 0 CA-C-N 120.354 1.162 . . . . 1.0 111.237 179.462 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.478 ' H ' ' C ' ' A' ' 46' ' ' THR . 59.2 mt -69.52 142.87 53.59 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.567 -0.708 . . . . 1.0 109.511 -179.718 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -102.07 120.74 40.92 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.779 -0.823 . . . . 1.0 108.779 179.403 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -106.29 128.07 53.71 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.32 -0.863 . . . . 1.0 109.581 -179.438 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.0 m -120.04 130.01 54.5 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.58 -0.7 . . . . 1.0 109.469 179.642 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.8 ttp180 -82.62 129.99 35.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 1.0 109.558 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.4 mt -111.0 116.52 31.33 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.416 -0.802 . . . . 1.0 108.981 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.441 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 91.5 m-70 -74.61 -20.46 59.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.861 . . . . 1.0 110.065 -179.77 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 84.0 m-20 -145.13 160.66 41.08 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.18 -0.95 . . . . 1.0 109.639 -179.482 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.486 ' N ' ' NH1' ' A' ' 18' ' ' ARG . . . 90.02 173.95 45.22 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.677 -1.369 . . . . 1.0 109.677 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 87.2 mt -94.34 139.25 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.135 -1.215 . . . . 1.0 109.135 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.08 159.76 18.87 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.499 -0.75 . . . . 1.0 109.38 -179.739 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -59.94 -49.79 76.29 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.174 -0.954 . . . . 1.0 109.307 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 84.3 mt -103.12 98.88 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.449 -0.782 . . . . 1.0 109.568 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.2 ptm -101.85 129.23 48.03 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.295 -0.878 . . . . 1.0 109.206 179.455 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 86.9 mt -105.25 134.45 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.618 -0.676 . . . . 1.0 109.688 -179.125 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 54.6 p -149.73 153.54 37.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.208 -0.932 . . . . 1.0 109.623 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -103.89 124.02 48.2 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.937 -0.764 . . . . 1.0 108.937 179.904 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -107.13 -167.15 22.18 Favored Glycine 0 N--CA 1.502 3.044 0 N-CA-C 110.531 -1.028 . . . . 1.0 110.531 -179.232 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 77.0 mt . . . . . 0 N--CA 1.497 1.884 0 O-C-N 121.598 -0.943 . . . . 1.0 108.74 179.731 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.551 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 73.9 m-85 . . . . . 0 N--CA 1.494 1.759 0 N-CA-C 108.89 -0.781 . . . . 1.0 108.89 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.5 p-10 -100.01 10.47 41.24 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.315 -0.866 . . . . 1.0 110.614 -178.884 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 116.73 -152.31 17.92 Favored Glycine 0 N--CA 1.505 3.293 0 N-CA-C 109.432 -1.467 . . . . 1.0 109.432 179.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -58.07 -65.77 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.429 0 CA-C-N 118.905 1.352 . . . . 1.0 112.338 -179.768 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 80.7 p -76.27 159.26 30.76 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.232 -0.917 . . . . 1.0 109.878 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.86 -130.87 9.3 Favored Glycine 0 N--CA 1.503 3.148 0 N-CA-C 109.6 -1.4 . . . . 1.0 109.6 179.836 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.402 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 15.2 mt -70.18 105.03 2.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.07 -1.253 . . . . 1.0 109.046 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 40.2 mt -77.43 -18.29 57.35 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.295 -1.002 . . . . 1.0 108.295 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.98 172.49 1.04 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.417 -0.957 . . . . 1.0 108.417 179.846 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.433 ' ND1' ' C ' ' A' ' 84' ' ' HIS . 8.1 p80 -163.09 156.76 19.9 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.988 -1.07 . . . . 1.0 109.744 179.348 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.07 157.8 43.68 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.721 -0.844 . . . . 1.0 108.721 179.836 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -94.84 153.15 40.06 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.059 -1.026 . . . . 1.0 109.057 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -59.17 166.43 7.3 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 120.447 0.765 . . . . 1.0 111.01 179.576 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo . . . . . 0 N--CA 1.493 1.468 0 C-N-CA 121.252 1.302 . . . . 1.0 112.264 -179.843 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.238 0.542 . . . . 1.0 109.993 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.17 124.49 10.9 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.176 -0.952 . . . . 1.0 110.058 -179.638 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.426 ' ND1' ' CE1' ' A' ' 84' ' ' HIS . 54.1 m170 -108.95 141.64 40.74 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.497 -0.752 . . . . 1.0 110.222 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -124.19 144.09 50.13 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 109.036 -0.728 . . . . 1.0 109.036 179.223 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.551 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 77.4 m-20 -78.96 121.33 24.77 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.967 -1.083 . . . . 1.0 109.677 179.814 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -85.32 -7.19 59.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.337 -0.852 . . . . 1.0 109.004 179.424 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -84.04 -12.53 55.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.452 -0.78 . . . . 1.0 109.395 -179.801 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -89.31 169.95 10.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.45 -0.782 . . . . 1.0 109.766 -178.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 18.2 m -98.87 103.86 15.85 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.338 -0.851 . . . . 1.0 109.245 -179.657 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.435 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 89.0 m95 -88.17 127.11 35.43 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.814 -0.809 . . . . 1.0 108.814 179.763 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.668 HG21 ' HB2' ' A' ' 109' ' ' LYS . 5.7 t -143.03 154.13 43.66 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.168 -0.958 . . . . 1.0 109.929 -179.522 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.9 m -94.05 -10.56 33.05 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.208 -0.933 . . . . 1.0 108.597 179.382 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.7 m -91.29 177.67 6.18 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.597 -0.89 . . . . 1.0 108.597 179.355 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.7 t -76.5 80.17 3.2 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.012 -1.055 . . . . 1.0 109.648 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.668 ' HB2' HG21 ' A' ' 105' ' ' THR . 9.5 mtmp? -153.53 150.12 28.38 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.328 -0.857 . . . . 1.0 109.283 179.499 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 43.48 -140.31 2.97 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.046 -1.222 . . . . 1.0 110.046 179.465 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -99.98 111.87 24.16 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.343 -1.093 . . . . 1.0 109.076 179.695 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.417 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 19.6 t-20 -61.55 136.53 58.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.072 -1.017 . . . . 1.0 109.9 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.2 tp -59.97 -44.11 94.67 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.357 -0.839 . . . . 1.0 110.467 179.815 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -59.96 -41.47 91.98 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.08 -1.013 . . . . 1.0 110.889 -178.22 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.99 -50.11 75.01 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.814 -1.179 . . . . 1.0 109.487 -179.395 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 56.3 t -70.0 -41.5 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.06 -1.025 . . . . 1.0 110.307 -179.47 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.33 -52.8 64.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.09 -1.006 . . . . 1.0 110.074 -178.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.55 -35.5 74.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.11 -0.994 . . . . 1.0 110.099 -179.728 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.597 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 74.1 t60 -63.93 -50.3 69.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.948 . . . . 1.0 111.254 -178.512 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -60.05 -39.21 85.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.645 -1.285 . . . . 1.0 110.091 -179.297 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -60.04 -39.87 87.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.967 -1.083 . . . . 1.0 108.844 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.68 -44.39 94.05 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.431 -1.468 . . . . 1.0 109.431 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.597 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 85.9 m-70 -64.95 -39.99 94.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.19 -1.182 . . . . 1.0 109.494 179.54 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 83.2 p -65.7 -22.9 66.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.228 -0.92 . . . . 1.0 109.523 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 82.2 mt -82.55 -1.2 49.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.241 -0.912 . . . . 1.0 109.283 179.709 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.73 8.71 65.16 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 110.819 -0.912 . . . . 1.0 110.819 178.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.4 mt -85.82 146.35 26.8 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.881 -1.364 . . . . 1.0 109.652 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 44.5 t0 -100.41 172.7 6.97 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.484 -0.76 . . . . 1.0 109.199 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.519 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 64.7 m80 -58.86 136.92 57.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.911 . . . . 1.0 109.703 -179.661 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 42.0 t -98.04 155.63 17.03 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.37 -0.831 . . . . 1.0 109.176 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -98.75 1.91 46.48 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.265 -0.897 . . . . 1.0 109.934 179.953 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -85.4 128.5 59.13 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.074 -1.016 . . . . 1.0 108.368 179.336 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -67.8 -17.4 47.15 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 CA-C-N 120.237 1.12 . . . . 1.0 112.519 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -90.32 -5.53 69.75 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.696 -1.361 . . . . 1.0 109.696 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -89.05 140.02 29.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.218 -1.166 . . . . 1.0 109.35 179.726 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.449 ' C ' ' H ' ' A' ' 138' ' ' PHE . 98.3 mt -63.86 -31.99 73.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.139 -0.976 . . . . 1.0 109.83 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 96.0 mmm -71.21 19.43 0.06 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.322 -0.861 . . . . 1.0 110.503 -179.027 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.449 ' H ' ' C ' ' A' ' 136' ' ' LEU . 11.3 t80 -69.31 132.14 89.94 Favored Pre-proline 0 N--CA 1.495 1.775 0 N-CA-C 107.817 -1.179 . . . . 1.0 107.817 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -61.88 -13.74 32.65 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 CA-C-N 119.837 0.977 . . . . 1.0 113.33 -178.346 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.5 mt -108.14 139.28 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.199 -0.938 . . . . 1.0 109.343 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . 0.417 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 33.4 t80 -72.69 129.56 38.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.324 -0.86 . . . . 1.0 109.853 -179.464 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.2 t -140.15 143.74 36.31 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.868 -0.79 . . . . 1.0 108.868 179.762 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -81.01 144.8 31.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.137 -0.977 . . . . 1.0 109.289 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.5 t -140.5 151.94 45.21 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.184 -0.947 . . . . 1.0 109.825 -179.863 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -61.81 103.93 0.65 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.284 -1.126 . . . . 1.0 110.284 -179.478 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.413 ' NZ ' ' CB ' ' A' ' 146' ' ' LYS . 9.1 mtpm? -77.28 -7.94 56.8 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.337 -1.096 . . . . 1.0 109.236 179.638 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 82.5 p -59.97 -40.01 87.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 1.0 109.832 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -154.27 69.63 0.77 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.11 -0.993 . . . . 1.0 109.65 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -100.45 127.1 46.89 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.219 -0.926 . . . . 1.0 109.642 179.66 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 75.5 mtm -121.44 141.46 50.98 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.572 -0.899 . . . . 1.0 108.572 179.203 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.8 mt -52.6 128.47 43.55 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 120.917 -1.115 . . . . 1.0 108.82 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -68.64 175.48 7.08 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 CA-C-N 120.036 1.049 . . . . 1.0 111.903 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -59.97 -40.03 87.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.331 -0.856 . . . . 1.0 109.697 179.798 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -54.56 -49.21 70.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.256 -0.903 . . . . 1.0 110.172 -179.227 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -69.92 -39.97 75.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.993 -1.067 . . . . 1.0 110.026 -179.601 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 60.1 t -60.06 -47.1 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 1.0 109.218 -179.831 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -60.07 -40.01 88.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.125 -0.984 . . . . 1.0 110.203 -179.75 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.12 -55.27 9.39 Favored Glycine 0 N--CA 1.495 2.619 0 O-C-N 121.143 -0.973 . . . . 1.0 111.301 -178.567 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.484 HG23 ' N ' ' A' ' 160' ' ' GLN . 4.8 tp -60.17 -40.09 82.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.946 -1.326 . . . . 1.0 109.734 -178.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.533 ' O ' ' N ' ' A' ' 164' ' ' GLY . 26.0 mm100 -64.35 -40.06 95.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.081 -1.012 . . . . 1.0 109.789 179.852 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 94.1 p -62.08 -30.44 71.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.11 -0.994 . . . . 1.0 110.196 -179.537 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 93.1 mt -84.92 -54.24 4.79 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.028 -1.045 . . . . 1.0 110.623 -179.099 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -89.73 -8.85 51.35 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.002 -1.061 . . . . 1.0 110.011 -179.094 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.584 0 N-CA-C 109.513 -1.435 . . . . 1.0 109.513 179.775 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.7 mt . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.367 0.603 . . . . 1.0 109.703 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -160.67 160.01 31.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.357 -0.839 . . . . 1.0 109.405 179.776 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 47.6 m95 -75.28 125.39 28.88 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.091 -1.005 . . . . 1.0 109.249 -179.923 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.7 p -73.28 -29.49 62.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.02 -1.05 . . . . 1.0 109.518 179.877 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -92.07 139.08 30.99 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.304 -0.999 . . . . 1.0 108.304 179.405 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.613 ' N ' ' SD ' ' A' ' 13' ' ' MET . 3.5 mmm -90.62 0.07 57.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.251 -0.906 . . . . 1.0 109.828 -178.372 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -98.17 125.86 43.39 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.707 -0.849 . . . . 1.0 108.707 179.46 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.7 mt -138.7 152.25 47.85 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.202 -0.937 . . . . 1.0 109.307 -179.503 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.6 p -132.98 154.16 50.76 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.997 -0.742 . . . . 1.0 108.997 -179.953 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -144.29 159.99 41.75 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.131 -0.981 . . . . 1.0 109.848 -179.656 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.537 ' NE ' ' O ' ' A' ' 56' ' ' GLY . 25.2 ttm-85 -142.17 134.54 27.88 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.397 -0.814 . . . . 1.0 109.585 -179.721 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 87.1 mt -87.92 117.97 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.482 -0.933 . . . . 1.0 108.482 178.73 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.9 t -69.32 -38.8 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.172 -0.955 . . . . 1.0 109.417 -179.32 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -159.19 157.88 31.62 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 122.217 1.008 . . . . 1.0 111.5 179.424 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.509 ' HB2' ' CD2' ' A' ' 28' ' ' HIS . 15.5 m-85 -112.13 77.02 1.01 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 103.678 -2.712 . . . . 1.0 103.678 176.652 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.488 ' O ' ' O ' ' A' ' 22' ' ' TYR . 5.4 t -29.15 150.84 0.03 OUTLIER Pre-proline 0 C--N 1.282 -2.341 0 CA-C-N 115.741 -0.663 . . . . 1.0 112.178 -177.535 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -65.15 -6.55 13.31 Favored 'Trans proline' 0 N--CA 1.5 1.855 0 C-N-CA 121.275 1.317 . . . . 1.0 113.383 -178.56 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -59.15 -37.78 78.14 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 119.509 -0.876 . . . . 1.0 110.285 179.839 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 73.4 mtm -138.75 162.64 34.2 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.142 -0.974 . . . . 1.0 109.591 -179.776 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.4 p -71.45 160.4 32.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.363 -0.836 . . . . 1.0 109.436 -179.663 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.509 ' CD2' ' HB2' ' A' ' 22' ' ' TYR . 23.4 m170 -60.01 -40.44 89.26 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.313 -0.867 . . . . 1.0 109.869 -179.178 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.2 m -60.03 -42.48 94.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.136 -0.977 . . . . 1.0 110.501 -179.416 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.09 -40.0 82.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.085 -1.01 . . . . 1.0 110.023 -179.638 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 70.2 t -67.56 -44.84 86.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.164 -0.96 . . . . 1.0 110.288 -179.233 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -59.99 -49.42 77.75 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.139 -0.976 . . . . 1.0 111.13 -178.896 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -60.48 -33.47 72.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.818 -1.176 . . . . 1.0 109.847 -179.537 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.0 -49.97 75.57 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.967 -1.083 . . . . 1.0 109.95 -179.538 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -66.56 -38.81 87.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.912 -1.117 . . . . 1.0 109.894 -179.886 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.97 -42.42 94.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.078 -1.014 . . . . 1.0 109.514 -179.256 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -60.07 -39.96 87.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.133 -0.98 . . . . 1.0 109.137 179.394 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.06 -48.35 82.09 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.31 -0.868 . . . . 1.0 109.851 -179.592 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -66.26 -39.18 89.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 1.0 110.075 -179.747 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -60.01 -48.78 80.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.063 -1.023 . . . . 1.0 109.448 -179.248 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 86.2 t -59.98 -40.04 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.104 -0.997 . . . . 1.0 110.566 -179.376 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -81.47 -33.66 31.85 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.902 -1.124 . . . . 1.0 110.005 -179.555 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 94.3 p -72.05 -21.15 61.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.895 -1.128 . . . . 1.0 109.78 179.89 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.96 -39.98 87.47 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.243 -0.911 . . . . 1.0 110.626 -179.589 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 m -110.98 24.48 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 O-C-N 121.27 -0.894 . . . . 1.0 110.682 -179.118 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.5 p -149.15 135.23 10.05 Favored Pre-proline 0 N--CA 1.5 2.061 0 O-C-N 120.761 -1.212 . . . . 1.0 109.505 179.376 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -73.87 16.39 0.53 Allowed 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 120.693 0.928 . . . . 1.0 111.901 179.083 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 93.9 mt -68.31 139.35 55.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.071 -1.018 . . . . 1.0 109.756 -179.423 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -110.71 120.81 43.62 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.954 -0.758 . . . . 1.0 108.954 -179.961 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -108.38 123.49 48.92 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.393 -0.817 . . . . 1.0 109.466 -179.492 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -120.03 130.01 54.51 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.7 -0.625 . . . . 1.0 109.327 179.885 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -83.95 132.87 34.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.216 -0.927 . . . . 1.0 109.285 179.696 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.521 ' C ' HH12 ' A' ' 18' ' ' ARG . 91.2 mt -102.2 139.73 37.42 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.23 -0.919 . . . . 1.0 108.915 179.67 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.438 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 41.5 m170 -69.52 -40.0 77.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 1.0 110.228 -179.306 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.52 ' O ' ' NH2' ' A' ' 18' ' ' ARG . 70.4 m-20 -153.44 179.68 8.56 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.024 -1.047 . . . . 1.0 109.885 -179.636 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.537 ' O ' ' NE ' ' A' ' 18' ' ' ARG . . . 92.39 -170.84 33.06 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.75 -1.34 . . . . 1.0 109.75 179.928 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.0 mt -97.11 131.36 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.337 -1.096 . . . . 1.0 109.221 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.23 166.11 11.11 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.354 -0.841 . . . . 1.0 109.21 -179.949 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.01 -49.22 78.53 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.128 -0.982 . . . . 1.0 108.915 -179.928 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.5 mt -119.96 114.12 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.676 -0.64 . . . . 1.0 109.389 179.31 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.5 ptp -101.71 138.29 38.89 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.254 -0.904 . . . . 1.0 108.999 179.126 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.6 mt -109.99 131.86 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.359 -0.838 . . . . 1.0 109.794 -179.133 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 71.6 p -150.01 160.68 43.44 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.224 -0.923 . . . . 1.0 109.974 -179.541 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -107.13 122.57 46.75 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.463 -0.773 . . . . 1.0 109.388 179.987 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' A' ' 100' ' ' ASP . . . -96.45 167.67 24.88 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.208 -1.557 . . . . 1.0 109.208 179.6 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 11.3 tt . . . . . 0 N--CA 1.496 1.838 0 O-C-N 121.277 -1.131 . . . . 1.0 109.671 -179.4 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.493 ' CD2' ' OD1' ' A' ' 99' ' ' ASP . 33.1 m-85 . . . . . 0 N--CA 1.497 1.909 0 N-CA-C 109.162 -0.681 . . . . 1.0 109.162 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 79' ' ' SER . 32.8 p-10 -99.8 1.81 43.45 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.144 -0.972 . . . . 1.0 111.538 -178.425 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.406 ' O ' ' OE2' ' A' ' 102' ' ' GLU . . . 111.93 -117.91 4.58 Favored Glycine 0 N--CA 1.508 3.463 0 O-C-N 120.93 -1.106 . . . . 1.0 111.144 178.69 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.466 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 28.3 Cg_endo -73.51 -73.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.948 0 CA-C-N 120.015 1.908 . . . . 1.0 113.399 -178.88 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.451 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 99.2 p -78.17 173.89 11.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.949 -1.095 . . . . 1.0 109.475 -179.366 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 106.04 -134.39 12.09 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 110.152 -1.179 . . . . 1.0 110.152 179.64 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.459 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 19.6 mt -71.91 117.73 13.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.592 -0.946 . . . . 1.0 109.843 -179.397 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 66.1 mt -85.09 -22.77 28.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.986 -1.071 . . . . 1.0 109.127 179.343 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.13 174.46 1.05 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.86 -0.793 . . . . 1.0 108.86 -179.741 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.68 163.3 27.02 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.242 -0.911 . . . . 1.0 109.492 179.276 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -153.72 162.27 41.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.391 -0.818 . . . . 1.0 108.885 -179.743 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -106.41 151.11 40.21 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.373 -0.829 . . . . 1.0 108.85 179.754 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -66.27 164.48 27.92 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 120.768 0.979 . . . . 1.0 111.785 179.604 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.49 1.279 0 C-N-CA 121.037 1.158 . . . . 1.0 111.836 179.762 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.9 p-10 . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 109.178 -0.675 . . . . 1.0 109.178 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.95 129.64 14.1 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.038 -1.039 . . . . 1.0 109.671 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -127.18 132.39 50.49 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.557 -0.714 . . . . 1.0 109.679 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -109.97 156.74 20.07 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.652 -0.655 . . . . 1.0 109.462 -179.798 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.493 ' OD1' ' CD2' ' A' ' 75' ' ' PHE . 90.8 m-20 -80.06 130.14 35.03 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.014 -1.054 . . . . 1.0 109.816 179.455 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.532 ' N ' ' O ' ' A' ' 65' ' ' GLY . 8.3 t70 -87.75 -6.77 58.02 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.274 -0.891 . . . . 1.0 109.491 179.412 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -83.53 -10.22 58.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.237 -0.914 . . . . 1.0 110.08 -179.519 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.466 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 42.0 mm-40 -90.58 173.88 7.82 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.161 -0.962 . . . . 1.0 109.5 -179.171 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 56.2 m -105.26 107.48 18.49 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.458 -0.941 . . . . 1.0 108.458 179.152 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -86.55 121.37 28.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.243 -0.911 . . . . 1.0 109.3 -179.506 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.666 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.6 t -143.12 156.33 44.77 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.538 -0.726 . . . . 1.0 109.605 -179.273 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 29.4 t -95.31 -7.26 39.21 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.332 -0.988 . . . . 1.0 108.332 178.924 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 68.3 m -91.03 179.78 5.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.565 -0.709 . . . . 1.0 109.226 179.624 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 99.4 p -79.82 68.62 5.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.232 -0.917 . . . . 1.0 109.806 -179.858 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.666 ' HB2' HG21 ' A' ' 105' ' ' THR . 98.4 mttt -143.18 149.51 38.11 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.2 -0.937 . . . . 1.0 108.809 179.5 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.51 -144.02 3.34 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.688 -1.365 . . . . 1.0 109.688 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -100.21 117.43 34.43 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.343 -1.092 . . . . 1.0 109.034 179.625 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.449 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 20.2 t-20 -62.26 132.66 53.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.912 . . . . 1.0 109.545 179.998 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.8 tp -59.96 -43.51 95.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.34 -0.85 . . . . 1.0 110.487 -179.498 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -59.97 -41.11 91.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.027 -1.046 . . . . 1.0 110.784 -178.485 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -58.49 -50.78 72.5 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.683 -1.261 . . . . 1.0 109.188 -179.584 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.0 t -70.04 -40.11 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.127 -0.983 . . . . 1.0 109.681 -179.556 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.94 -52.68 64.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.188 -0.945 . . . . 1.0 109.864 -179.341 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.99 -34.84 73.86 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.651 -1.281 . . . . 1.0 109.887 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -65.3 -50.05 67.16 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.264 -0.897 . . . . 1.0 111.617 -178.426 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -60.0 -40.01 87.75 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.63 -1.293 . . . . 1.0 109.408 -178.72 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -59.99 -40.03 87.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.026 -1.046 . . . . 1.0 108.723 179.879 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.31 -46.41 63.73 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.166 -1.573 . . . . 1.0 109.166 179.847 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.41 ' NE2' ' NE2' ' A' ' 129' ' ' HIS . 79.0 m-70 -65.26 -40.02 93.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.229 -1.159 . . . . 1.0 109.611 179.607 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 84.1 p -66.77 -23.95 66.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 1.0 109.998 -179.754 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 78.4 mt -82.26 -2.27 52.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.128 -0.983 . . . . 1.0 110.046 -179.544 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.57 6.24 68.24 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 110.443 -1.063 . . . . 1.0 110.443 179.357 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.3 mt -84.68 149.08 26.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.053 -1.263 . . . . 1.0 109.07 179.501 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 36.1 t0 -103.27 170.35 8.01 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.764 -0.828 . . . . 1.0 108.764 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.51 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 28.0 m170 -58.53 135.16 57.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.012 -1.055 . . . . 1.0 109.356 -179.631 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 41.9 t -98.18 155.29 17.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.382 -0.824 . . . . 1.0 109.106 179.879 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -98.05 5.58 48.55 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.23 -0.919 . . . . 1.0 110.014 -179.512 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -85.88 126.68 65.05 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 108.121 -1.066 . . . . 1.0 108.121 179.275 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -68.45 -8.81 24.14 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 CA-C-N 120.186 1.102 . . . . 1.0 112.011 -179.615 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -96.44 -7.52 58.03 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.509 -1.437 . . . . 1.0 109.509 179.863 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.87 137.05 33.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.133 -1.216 . . . . 1.0 109.412 179.814 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.435 ' C ' ' H ' ' A' ' 138' ' ' PHE . 64.7 mt -60.03 -39.84 87.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.121 -0.987 . . . . 1.0 110.239 179.86 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 89.8 mtp -71.28 25.52 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.275 -0.891 . . . . 1.0 111.417 -178.463 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.435 ' H ' ' C ' ' A' ' 136' ' ' LEU . 16.2 t80 -69.22 136.44 89.08 Favored Pre-proline 0 N--CA 1.498 1.955 0 N-CA-C 107.459 -1.311 . . . . 1.0 107.459 178.787 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -60.65 -14.28 30.48 Favored 'Trans proline' 0 N--CA 1.5 1.902 0 CA-C-N 120.185 1.102 . . . . 1.0 114.196 -178.062 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.3 mt -109.95 139.07 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 O-C-N 121.014 -1.054 . . . . 1.0 109.697 -179.693 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . 0.449 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 34.2 t80 -74.12 125.42 28.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.354 -0.841 . . . . 1.0 110.119 -179.324 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 7.4 t -136.6 142.94 43.34 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.997 -0.742 . . . . 1.0 108.997 179.812 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -80.67 143.29 33.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.932 -1.105 . . . . 1.0 109.746 -179.775 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.4 m -134.71 138.59 44.52 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.531 -0.73 . . . . 1.0 109.838 -179.475 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -68.0 99.91 0.59 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 107.97 -2.052 . . . . 1.0 107.97 178.658 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -74.46 17.09 0.21 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -1.129 . . . . 1.0 110.484 -178.475 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 41.1 t -57.67 -46.57 84.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.905 -1.122 . . . . 1.0 109.31 -179.853 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -147.72 33.99 0.85 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.147 -0.971 . . . . 1.0 109.368 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -63.73 138.03 58.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.2 -0.938 . . . . 1.0 110.953 -179.104 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 74.0 mtm -134.11 148.53 51.0 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.133 -1.062 . . . . 1.0 108.133 178.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 70.7 mt -53.3 129.12 51.06 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 120.918 -1.114 . . . . 1.0 108.867 -179.862 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -69.52 177.05 5.8 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 CA-C-N 120.074 1.062 . . . . 1.0 112.019 179.643 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -60.29 -39.95 88.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.868 . . . . 1.0 110.023 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -55.55 -48.94 73.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.245 -0.91 . . . . 1.0 110.054 -179.047 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -70.03 -40.02 75.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.152 -0.967 . . . . 1.0 110.34 -179.63 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 60.3 t -60.03 -48.81 86.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.027 -1.046 . . . . 1.0 109.124 -179.556 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -60.0 -39.98 87.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.128 -0.983 . . . . 1.0 110.44 179.97 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.06 -54.59 7.93 Favored Glycine 0 N--CA 1.493 2.49 0 O-C-N 121.136 -0.978 . . . . 1.0 111.382 -178.35 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.476 HG23 ' N ' ' A' ' 160' ' ' GLN . 7.1 tp -59.98 -40.11 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.937 -1.331 . . . . 1.0 109.618 -179.026 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.546 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.7 mt-30 -66.61 -39.93 88.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 1.0 109.594 179.597 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 83.1 p -61.52 -31.12 71.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.143 -0.973 . . . . 1.0 110.74 -179.308 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 88.6 mt -86.84 -51.36 6.12 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.779 -1.201 . . . . 1.0 110.551 -179.041 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -90.83 -9.16 47.46 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.984 -1.073 . . . . 1.0 109.931 -179.273 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.524 0 N-CA-C 109.489 -1.444 . . . . 1.0 109.489 -179.866 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.1 mt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.565 0.697 . . . . 1.0 110.04 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -160.6 160.2 31.43 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.471 -0.768 . . . . 1.0 109.018 179.598 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -73.45 147.95 43.69 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.13 -0.981 . . . . 1.0 109.463 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.3 p -84.93 0.13 52.28 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.203 -0.936 . . . . 1.0 109.742 -179.636 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -145.77 153.11 40.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.197 -0.939 . . . . 1.0 109.384 -179.877 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.2 mmt -90.02 -0.73 57.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.257 -0.902 . . . . 1.0 109.129 -179.645 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -96.19 128.2 42.88 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.341 -0.85 . . . . 1.0 108.989 -179.994 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.3 mt -140.02 150.17 44.09 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.232 -0.917 . . . . 1.0 109.04 -179.799 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 59.5 p -131.09 156.14 45.73 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.907 -0.775 . . . . 1.0 108.907 179.937 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -146.06 160.06 42.41 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.133 -0.98 . . . . 1.0 110.055 -179.672 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.598 HH12 ' H ' ' A' ' 56' ' ' GLY . 70.5 ttt180 -142.86 135.31 27.57 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.421 -0.8 . . . . 1.0 109.355 -179.939 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.5 mt -87.78 120.0 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.254 -0.904 . . . . 1.0 108.708 179.185 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 67.0 t -67.72 -39.04 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -0.925 . . . . 1.0 108.887 -179.812 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.44 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 22.0 p-10 -160.61 152.9 20.44 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 119.937 -1.727 . . . . 1.0 111.289 179.687 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.644 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 33.3 m-85 -101.28 74.96 1.59 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 106.612 -1.625 . . . . 1.0 106.612 177.118 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.476 ' C ' ' O ' ' A' ' 22' ' ' TYR . 3.9 t -24.54 143.14 0.04 OUTLIER Pre-proline 0 N--CA 1.508 2.433 0 N-CA-C 112.069 0.396 . . . . 1.0 112.069 -177.786 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -62.58 -5.86 7.83 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 121.247 1.298 . . . . 1.0 112.743 -179.285 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -59.48 -36.93 76.94 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.424 -0.797 . . . . 1.0 109.939 179.704 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 78.2 mtm -138.53 161.23 37.58 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.194 -0.941 . . . . 1.0 109.556 -179.772 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.1 p -71.62 160.19 33.11 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.37 -0.831 . . . . 1.0 109.127 -179.878 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.644 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 2.1 m80 -59.96 -40.59 89.58 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.346 -0.846 . . . . 1.0 110.22 -179.083 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 74.9 m -61.28 -40.47 94.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.098 -1.001 . . . . 1.0 110.275 -179.587 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.35 -39.97 77.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.207 -0.933 . . . . 1.0 110.383 -179.478 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 77.2 t -68.29 -43.56 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.139 -0.975 . . . . 1.0 110.134 -179.258 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.01 -49.4 77.82 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.19 -0.944 . . . . 1.0 110.87 -179.063 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -61.47 -32.86 72.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.885 -1.134 . . . . 1.0 110.112 -179.531 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.97 -49.67 76.77 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.906 -1.121 . . . . 1.0 109.713 -179.579 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.419 ' CE1' HD13 ' A' ' 62' ' ' ILE . 53.7 m-85 -66.27 -38.77 88.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.993 -1.067 . . . . 1.0 109.723 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -59.99 -43.37 95.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.045 -1.034 . . . . 1.0 109.795 -179.619 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -60.1 -41.24 92.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.99 -1.069 . . . . 1.0 109.475 179.58 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.29 -46.69 88.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.331 -0.856 . . . . 1.0 110.133 -179.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -67.2 -38.58 85.56 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.05 -1.031 . . . . 1.0 110.001 -179.767 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -59.96 -48.84 80.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.097 -1.002 . . . . 1.0 109.839 -179.349 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 79.7 t -60.09 -40.14 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.144 -0.973 . . . . 1.0 110.113 -179.412 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.456 ' CH2' HD22 ' A' ' 151' ' ' LEU . 69.2 m95 -81.35 -36.57 29.49 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.008 -1.058 . . . . 1.0 110.08 -179.413 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.3 p -70.19 -21.54 63.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.032 -1.043 . . . . 1.0 109.891 -179.632 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.07 -39.87 87.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.29 -0.881 . . . . 1.0 110.666 -179.739 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.463 ' O ' ' NE2' ' A' ' 160' ' ' GLN . 11.3 m -109.76 24.21 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.28 -0.888 . . . . 1.0 110.471 -178.824 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.411 HG23 HG23 ' A' ' 45' ' ' VAL . 43.3 p -149.83 134.41 9.32 Favored Pre-proline 0 N--CA 1.499 2.003 0 O-C-N 120.92 -1.113 . . . . 1.0 109.54 179.543 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -74.18 17.42 0.51 Allowed 'Trans proline' 0 N--CA 1.493 1.455 0 CA-C-N 119.702 0.929 . . . . 1.0 111.86 178.882 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 72.6 mt -68.53 139.9 55.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.117 -0.989 . . . . 1.0 109.413 -179.608 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -109.99 120.51 42.7 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 179.851 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -109.53 119.79 40.52 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.398 -0.814 . . . . 1.0 109.0 -179.687 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -120.06 130.03 54.49 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.533 -0.73 . . . . 1.0 109.944 -179.84 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -82.25 135.25 35.27 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.253 -0.904 . . . . 1.0 109.104 179.28 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.9 mt -101.3 129.29 47.25 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.161 -0.962 . . . . 1.0 109.483 -179.956 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.445 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 60.1 m170 -61.79 -40.0 93.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.413 -0.804 . . . . 1.0 109.443 179.879 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 77.9 m-20 -148.84 168.88 21.81 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.251 -0.906 . . . . 1.0 109.449 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.598 ' H ' HH12 ' A' ' 18' ' ' ARG . . . 98.72 178.07 32.31 Favored Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.54 -1.424 . . . . 1.0 109.54 -179.956 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.4 mt -95.87 135.06 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.241 -1.152 . . . . 1.0 109.291 179.863 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.02 160.76 16.15 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.492 -0.755 . . . . 1.0 109.155 -179.75 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -60.04 -49.51 77.38 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.17 -0.956 . . . . 1.0 109.306 -179.747 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.8 mt -105.37 103.51 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.356 -0.84 . . . . 1.0 109.978 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.1 ptp -100.43 133.96 44.08 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.188 -0.945 . . . . 1.0 108.766 178.773 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.419 HD13 ' CE1' ' A' ' 35' ' ' PHE . 85.4 mt -110.08 131.37 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.443 -0.785 . . . . 1.0 110.045 -178.56 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.1 p -150.56 160.3 43.89 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.153 -0.967 . . . . 1.0 109.93 -179.702 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -104.8 123.55 47.88 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 179.592 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 98' ' ' PHE . . . -95.55 -175.9 37.11 Favored Glycine 0 N--CA 1.499 2.894 0 N-CA-C 110.544 -1.023 . . . . 1.0 110.544 -179.274 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.1 mt . . . . . 0 N--CA 1.501 2.083 0 O-C-N 121.446 -1.031 . . . . 1.0 109.442 -179.967 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.529 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 87.8 m-85 . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 121.274 0.559 . . . . 1.0 109.739 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -102.11 16.12 27.03 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.361 -0.837 . . . . 1.0 110.746 -178.86 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 114.93 -157.51 14.94 Favored Glycine 0 N--CA 1.505 3.285 0 N-CA-C 109.55 -1.42 . . . . 1.0 109.55 179.617 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -58.37 -65.75 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.469 0 CA-C-N 118.568 1.184 . . . . 1.0 112.406 -179.742 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 89.7 p -76.03 162.17 28.28 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.181 -0.949 . . . . 1.0 109.65 -179.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.17 -129.09 8.29 Favored Glycine 0 N--CA 1.502 3.058 0 N-CA-C 109.836 -1.306 . . . . 1.0 109.836 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.1 mt -69.63 107.58 3.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.323 -1.104 . . . . 1.0 109.077 -179.958 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 56.7 mt -78.47 -26.54 46.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.896 . . . . 1.0 108.924 179.982 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.53 164.46 1.64 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.342 -0.984 . . . . 1.0 108.342 -179.715 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -160.35 162.74 33.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.128 -0.982 . . . . 1.0 109.44 179.493 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 95' ' ' ASP . . . -145.76 160.0 42.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.283 -0.886 . . . . 1.0 109.583 -179.645 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -93.88 152.97 40.99 Favored Pre-proline 0 N--CA 1.492 1.661 0 N-CA-C 107.944 -1.132 . . . . 1.0 107.944 179.433 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -56.95 165.79 4.64 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 CA-C-N 119.166 0.738 . . . . 1.0 111.673 179.778 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo . . . . . 0 N--CA 1.493 1.488 0 C-N-CA 121.346 1.364 . . . . 1.0 112.112 -179.564 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.442 ' O ' ' HB1' ' A' ' 85' ' ' ALA . 35.7 p-10 . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 121.281 0.562 . . . . 1.0 109.756 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.14 123.39 8.93 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.391 -0.818 . . . . 1.0 109.574 179.812 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -112.4 128.51 56.33 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.591 -0.693 . . . . 1.0 109.344 179.753 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.506 ' O ' ' N ' ' A' ' 65' ' ' GLY . 22.7 m-85 -107.71 155.85 19.73 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.478 -0.764 . . . . 1.0 109.063 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.529 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 1.3 m-20 -79.05 120.54 23.76 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.625 -1.297 . . . . 1.0 110.081 -179.616 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 65' ' ' GLY . 40.9 t0 -83.1 -11.88 57.58 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.171 -0.956 . . . . 1.0 108.947 179.389 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -83.17 -10.48 58.6 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.289 -0.882 . . . . 1.0 109.292 -179.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -92.46 170.05 10.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.395 -0.816 . . . . 1.0 109.155 -179.872 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 31.3 m -100.13 106.01 17.68 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.246 -0.909 . . . . 1.0 109.26 -179.76 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.481 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 94.5 m95 -88.76 123.39 33.13 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.568 -0.901 . . . . 1.0 108.568 179.537 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.69 HG21 ' HB2' ' A' ' 109' ' ' LYS . 10.1 t -140.05 154.84 47.2 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.355 -0.841 . . . . 1.0 109.942 -179.006 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 87.9 p -94.71 -5.51 45.3 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.284 -1.006 . . . . 1.0 108.284 179.011 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 31.4 t -94.47 178.95 5.44 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.709 -0.849 . . . . 1.0 108.709 179.35 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.2 m -80.2 76.84 6.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.962 -1.086 . . . . 1.0 109.599 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.69 ' HB2' HG21 ' A' ' 105' ' ' THR . 68.7 mttm -148.52 149.39 31.54 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.257 -0.902 . . . . 1.0 108.678 179.429 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.22 -136.98 5.31 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.096 -1.202 . . . . 1.0 110.096 179.695 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -100.07 118.6 36.77 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.403 -1.057 . . . . 1.0 109.21 179.689 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.4 ' HB3' HD23 ' A' ' 115' ' ' LEU . 2.6 t-20 -65.09 131.5 46.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.086 -1.009 . . . . 1.0 109.765 179.992 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.5 tp -60.01 -43.11 95.43 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.372 -0.83 . . . . 1.0 110.084 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -60.0 -43.01 95.48 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.27 -0.894 . . . . 1.0 111.214 -178.584 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 115' ' ' LEU . 4.0 mm? -60.03 -50.02 75.37 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.655 -1.278 . . . . 1.0 109.347 -179.182 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 75.5 t -69.95 -40.29 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.099 -1.0 . . . . 1.0 109.95 -179.405 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.12 -50.02 75.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.145 -0.972 . . . . 1.0 109.746 -179.306 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.84 -36.51 77.0 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.739 -1.226 . . . . 1.0 109.631 179.973 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.632 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 63.5 t60 -64.99 -49.97 68.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.129 -0.982 . . . . 1.0 111.541 -178.637 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.4 ' C ' ' OE1' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -59.98 -40.02 87.67 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.519 -1.363 . . . . 1.0 109.873 -178.731 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -60.04 -40.05 88.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.928 -1.107 . . . . 1.0 108.35 179.746 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -54.61 -44.13 78.95 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.128 -1.589 . . . . 1.0 109.128 179.717 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.632 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 85.9 m-70 -67.29 -39.99 86.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.194 -1.18 . . . . 1.0 109.828 179.66 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.9 p -66.0 -21.7 66.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.928 . . . . 1.0 109.115 179.888 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 76.2 mt -82.52 -0.84 48.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.39 -0.819 . . . . 1.0 110.028 -179.89 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 89.43 7.31 69.62 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.392 -1.083 . . . . 1.0 110.392 179.282 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.5 mt -84.57 150.13 25.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.898 -1.354 . . . . 1.0 110.092 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 10.0 t70 -101.09 171.13 7.81 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.509 -0.744 . . . . 1.0 109.066 179.509 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.526 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 75.2 m80 -59.65 137.38 58.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.088 -1.007 . . . . 1.0 109.555 -179.78 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 38.6 t -98.55 154.28 18.03 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.315 -0.865 . . . . 1.0 109.322 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -100.17 6.75 44.83 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.39 -0.819 . . . . 1.0 109.748 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -86.58 127.97 58.54 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.136 -0.978 . . . . 1.0 108.563 179.617 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -67.99 -20.21 44.93 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 CA-C-N 120.181 1.1 . . . . 1.0 112.169 -179.818 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -88.47 -4.98 76.07 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.621 -1.392 . . . . 1.0 109.621 -179.865 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.16 145.75 26.87 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.269 -1.136 . . . . 1.0 109.707 179.897 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.419 ' C ' ' H ' ' A' ' 138' ' ' PHE . 84.6 mt -70.05 -33.84 72.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.891 . . . . 1.0 109.553 179.887 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 80.3 mtp -74.41 23.36 0.09 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 1.0 110.481 -179.215 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.419 ' H ' ' C ' ' A' ' 136' ' ' LEU . 12.7 t80 -69.62 133.52 88.73 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 107.409 -1.33 . . . . 1.0 107.409 179.305 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -59.25 -9.94 9.51 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 CA-C-N 120.01 1.039 . . . . 1.0 113.785 -177.896 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 95.4 mt -113.9 138.36 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 O-C-N 121.123 -0.985 . . . . 1.0 109.686 -179.919 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -73.37 131.12 41.5 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.461 -0.774 . . . . 1.0 110.068 -179.351 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.1 t -141.97 133.38 26.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.36 -0.838 . . . . 1.0 109.282 179.697 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -80.71 134.41 35.84 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.139 -0.975 . . . . 1.0 109.58 -179.909 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.8 t -130.91 147.34 52.54 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.376 -0.828 . . . . 1.0 109.406 -179.939 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -66.65 102.91 0.81 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.574 -1.411 . . . . 1.0 109.574 -179.729 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 147' ' ' SER . 8.5 mtmp? -71.34 140.68 50.32 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.301 -1.117 . . . . 1.0 109.468 179.934 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.442 ' CB ' ' O ' ' A' ' 146' ' ' LYS . 1.2 t 165.99 -89.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.844 -0.798 . . . . 1.0 108.844 -179.884 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . 0.477 ' O ' ' ND1' ' A' ' 148' ' ' HIS . 54.9 t-80 -97.79 15.53 23.44 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.615 -0.883 . . . . 1.0 108.615 179.484 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -60.43 137.36 58.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.583 -0.698 . . . . 1.0 110.005 -179.811 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 97.2 mmm -136.33 149.53 48.44 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.555 -0.905 . . . . 1.0 108.555 179.301 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.456 HD22 ' CH2' ' A' ' 42' ' ' TRP . 24.6 mt -53.18 129.78 50.46 Favored Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 120.981 -1.074 . . . . 1.0 108.63 -179.802 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -66.39 176.25 4.25 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 CA-C-N 120.01 1.039 . . . . 1.0 112.295 -179.813 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.05 -39.91 87.58 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.366 -0.834 . . . . 1.0 109.475 179.799 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -56.15 -49.94 72.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.311 -0.868 . . . . 1.0 109.939 -179.204 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -70.78 -39.99 72.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.071 -1.018 . . . . 1.0 110.308 -179.473 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 63.7 t -60.11 -47.55 91.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.083 -1.01 . . . . 1.0 109.424 -179.634 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -60.48 -40.01 89.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.847 -1.158 . . . . 1.0 110.182 -179.815 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.45 -54.4 10.69 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 120.272 -0.966 . . . . 1.0 111.323 -178.716 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.477 HG23 ' N ' ' A' ' 160' ' ' GLN . 8.4 tp -59.98 -39.98 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.867 -1.372 . . . . 1.0 109.533 -179.075 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.486 ' O ' ' N ' ' A' ' 164' ' ' GLY . 91.9 mm-40 -64.63 -39.9 94.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.269 -0.894 . . . . 1.0 109.27 179.48 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 82.5 p -61.8 -29.18 69.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.286 -0.884 . . . . 1.0 110.812 -179.334 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 94.4 mt -86.38 -56.44 3.43 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.801 -1.187 . . . . 1.0 110.819 -179.133 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -89.94 -9.62 48.15 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.004 -1.06 . . . . 1.0 110.445 -178.712 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.497 2.715 0 N-CA-C 109.362 -1.495 . . . . 1.0 109.362 -179.995 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.9 mt . . . . . 0 N--CA 1.495 1.785 0 N-CA-C 109.379 -0.6 . . . . 1.0 109.379 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.02 160.0 35.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 1.0 109.463 179.717 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -74.43 149.47 40.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.38 -0.825 . . . . 1.0 109.987 -179.525 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.7 m -89.93 1.77 55.85 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.354 -0.841 . . . . 1.0 110.361 -179.643 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -141.62 153.77 44.97 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.09 -1.006 . . . . 1.0 109.619 -179.701 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.3 mmt -90.15 0.02 57.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.404 -0.81 . . . . 1.0 110.234 -178.889 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -96.84 129.63 44.24 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.127 -0.983 . . . . 1.0 109.687 -179.837 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.1 mt -142.32 146.74 35.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.26 -0.9 . . . . 1.0 109.033 179.744 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 70.0 p -130.1 160.12 34.71 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.625 -0.88 . . . . 1.0 108.625 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -146.42 159.93 42.74 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.088 -1.007 . . . . 1.0 110.381 179.98 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.488 HH11 ' HG2' ' A' ' 18' ' ' ARG . 1.9 tpt180 -145.38 129.83 17.84 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.294 -0.632 . . . . 1.0 109.294 -179.03 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.1 mt -89.38 117.27 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.137 -0.977 . . . . 1.0 108.542 178.742 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.6 t -69.98 -40.7 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.094 -1.003 . . . . 1.0 109.565 -179.608 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -163.74 159.01 20.91 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.697 -1.252 . . . . 1.0 110.276 -179.908 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.471 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 56.7 m-85 -100.55 -160.72 0.82 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.218 -1.401 . . . . 1.0 107.218 178.933 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.16 149.78 74.22 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.226 -0.921 . . . . 1.0 109.91 -179.874 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -69.81 -13.31 34.37 Favored 'Trans proline' 0 N--CA 1.487 1.116 0 C-N-CA 120.611 0.874 . . . . 1.0 109.947 178.399 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -59.78 -38.52 82.12 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.798 -0.637 . . . . 1.0 109.832 -179.555 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 76.8 mtm -137.95 166.12 24.84 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.289 -0.882 . . . . 1.0 109.52 -179.611 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 67.8 p -72.75 160.34 32.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.369 -0.832 . . . . 1.0 109.333 -179.746 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.471 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 3.5 m80 -60.11 -40.04 88.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.262 -0.899 . . . . 1.0 109.89 -179.552 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 74.1 m -60.1 -40.04 88.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.35 -0.844 . . . . 1.0 110.876 -179.244 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -68.1 -40.04 82.7 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.023 -1.048 . . . . 1.0 110.479 -179.167 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.1 t -69.37 -40.32 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.064 -1.022 . . . . 1.0 110.133 -179.329 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.05 -49.01 79.33 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.055 -1.028 . . . . 1.0 110.412 -179.241 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.66 -32.38 72.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.9 -1.125 . . . . 1.0 109.755 -179.776 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.87 -49.36 77.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.002 -1.061 . . . . 1.0 109.536 -179.428 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -66.6 -39.14 88.25 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.13 -0.981 . . . . 1.0 109.856 179.846 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.96 -41.79 92.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.968 -1.082 . . . . 1.0 109.673 -179.321 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -60.1 -42.11 93.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.104 -0.997 . . . . 1.0 109.743 179.374 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.56 -48.07 83.41 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.223 -0.923 . . . . 1.0 110.317 -179.811 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.501 ' CZ ' ' CZ ' ' A' ' 121' ' ' PHE . 49.8 m-85 -64.27 -39.96 95.0 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.104 -0.997 . . . . 1.0 109.572 -179.415 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -59.98 -47.6 85.15 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.504 -0.748 . . . . 1.0 109.454 -179.069 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.2 t -59.94 -40.16 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.008 -1.057 . . . . 1.0 109.81 -179.683 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 71.9 m95 -78.69 -32.56 47.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.193 -0.942 . . . . 1.0 110.014 -179.714 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 85.3 p -71.39 -14.63 62.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.073 -1.017 . . . . 1.0 109.683 179.923 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -59.91 -39.98 87.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.437 -0.79 . . . . 1.0 110.229 -179.679 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.6 m -114.58 -19.72 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.455 -0.778 . . . . 1.0 110.461 -179.001 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.415 ' C ' ' H ' ' A' ' 48' ' ' LEU . 66.4 p -95.25 121.48 62.0 Favored Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 120.757 -1.215 . . . . 1.0 109.405 179.432 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -73.15 20.84 0.34 Allowed 'Trans proline' 0 N--CA 1.493 1.491 0 CA-C-N 120.236 1.12 . . . . 1.0 111.601 179.153 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.415 ' H ' ' C ' ' A' ' 46' ' ' THR . 77.9 mt -68.86 140.03 55.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 1.0 109.525 -179.85 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -103.26 120.58 41.02 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.679 -0.859 . . . . 1.0 108.679 179.704 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -106.36 120.8 42.83 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.426 -0.796 . . . . 1.0 109.77 -179.194 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.8 m -120.06 130.01 54.49 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 121.498 0.666 . . . . 1.0 110.236 179.895 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.411 ' HG2' ' NH1' ' A' ' 52' ' ' ARG . 10.1 tpt180 -82.85 138.61 33.87 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.476 -0.765 . . . . 1.0 109.166 179.288 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 90.0 mt -106.47 129.99 54.34 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.308 -0.87 . . . . 1.0 108.755 179.166 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.425 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 62.3 m170 -60.0 -40.04 87.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.955 -1.091 . . . . 1.0 109.701 -179.427 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 73.4 m-20 -151.08 172.34 15.91 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.274 -0.891 . . . . 1.0 109.464 -179.71 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.97 -179.51 32.63 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.583 -1.407 . . . . 1.0 109.583 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.7 mt -95.62 133.63 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.374 -1.074 . . . . 1.0 109.401 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.96 162.55 14.42 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.477 -0.765 . . . . 1.0 109.095 -179.89 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -59.95 -48.82 80.14 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.207 -0.933 . . . . 1.0 109.091 179.868 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 93.1 mt -109.55 103.38 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.473 -0.767 . . . . 1.0 110.215 179.807 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.3 ptp -102.32 137.31 40.74 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.183 -0.948 . . . . 1.0 109.297 178.788 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 88.4 mt -109.95 130.47 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.575 -0.703 . . . . 1.0 109.743 -179.542 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.8 p -150.31 158.93 44.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.351 -0.843 . . . . 1.0 109.597 -179.615 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -99.97 128.5 46.05 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.434 -0.95 . . . . 1.0 108.434 179.413 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.6 150.6 16.99 Favored Glycine 0 N--CA 1.498 2.804 0 N-CA-C 110.185 -1.166 . . . . 1.0 110.185 -178.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 7.1 tt . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 108.158 -1.053 . . . . 1.0 108.158 179.407 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.533 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 97.9 m-85 . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 108.663 -0.865 . . . . 1.0 108.663 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -101.27 13.78 34.01 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.155 -0.965 . . . . 1.0 110.209 -179.296 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 117.12 -156.91 15.36 Favored Glycine 0 N--CA 1.502 3.047 0 N-CA-C 108.894 -1.682 . . . . 1.0 108.894 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -58.48 -65.38 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.451 0 CA-C-N 118.633 1.217 . . . . 1.0 112.267 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 90.6 p -76.85 164.18 26.07 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.183 -0.948 . . . . 1.0 109.815 -179.93 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.85 -129.45 8.65 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 109.587 -1.405 . . . . 1.0 109.587 179.88 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.44 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 13.2 mt -68.99 106.48 2.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.435 -1.038 . . . . 1.0 109.09 179.961 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.417 HD23 ' OE2' ' A' ' 102' ' ' GLU . 50.8 mt -78.71 -23.71 45.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.017 -1.052 . . . . 1.0 108.884 179.95 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.11 169.56 1.9 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.709 -0.849 . . . . 1.0 108.709 179.837 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -161.7 161.89 29.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.159 -0.963 . . . . 1.0 109.127 179.304 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.78 157.03 44.67 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.2 -0.938 . . . . 1.0 109.724 -179.355 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -93.63 151.96 40.45 Favored Pre-proline 0 N--CA 1.494 1.726 0 N-CA-C 108.483 -0.932 . . . . 1.0 108.483 179.691 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -42.16 160.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.243 0 C-N-CA 120.663 0.909 . . . . 1.0 111.667 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo . . . . . 0 N--CA 1.49 1.276 0 C-N-CA 120.645 0.897 . . . . 1.0 111.955 -179.52 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 121.428 0.632 . . . . 1.0 110.116 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.35 124.11 9.86 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.408 -0.808 . . . . 1.0 109.32 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -111.38 137.61 48.93 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.605 -0.684 . . . . 1.0 109.942 -179.752 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.526 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 27.3 m-85 -114.38 154.23 28.45 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 109.111 -0.699 . . . . 1.0 109.111 179.638 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.533 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 1.7 m-20 -78.54 123.66 27.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.056 -1.028 . . . . 1.0 109.522 179.759 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 43.7 t0 -83.93 -12.38 55.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.229 -0.92 . . . . 1.0 109.391 179.724 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -84.14 -10.01 58.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.352 -0.842 . . . . 1.0 109.871 -179.818 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.417 ' OE2' HD23 ' A' ' 82' ' ' LEU . 99.3 mt-10 -91.48 169.65 10.6 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.204 -0.935 . . . . 1.0 110.033 -179.241 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 15.9 m -100.05 106.25 17.99 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.432 -0.792 . . . . 1.0 108.917 -179.788 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.418 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 91.1 m95 -89.18 124.45 34.36 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.76 -0.83 . . . . 1.0 108.76 179.813 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.652 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.7 t -140.04 159.29 42.5 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.422 -0.799 . . . . 1.0 109.944 -179.103 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.4 t -96.88 -13.3 22.58 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.332 -0.855 . . . . 1.0 109.011 179.485 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 65.6 m -90.62 179.14 5.9 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.768 -0.827 . . . . 1.0 108.768 179.388 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.2 m -79.43 80.18 5.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.983 -1.073 . . . . 1.0 109.349 -179.893 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.652 ' HB2' HG21 ' A' ' 105' ' ' THR . 68.3 mttm -148.88 149.53 31.42 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.654 -0.869 . . . . 1.0 108.654 179.379 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 109' ' ' LYS . . . 44.36 -137.3 5.33 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.602 -1.399 . . . . 1.0 109.602 179.71 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -99.6 117.66 34.46 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.32 -1.106 . . . . 1.0 109.017 179.304 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -62.25 130.3 44.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.326 -0.858 . . . . 1.0 109.733 -179.738 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.9 tp -59.99 -41.88 93.0 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.321 -0.862 . . . . 1.0 110.211 -179.579 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -59.97 -40.12 87.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.179 -0.951 . . . . 1.0 110.505 -179.319 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.447 HD21 ' CE ' ' A' ' 146' ' ' LYS . 3.6 mm? -59.04 -51.21 71.05 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.746 -1.221 . . . . 1.0 109.883 -179.675 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.8 t -69.96 -40.37 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.131 -0.981 . . . . 1.0 109.961 -178.905 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.22 -52.6 65.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -0.91 . . . . 1.0 109.943 -179.422 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.03 -39.05 84.57 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.095 -1.003 . . . . 1.0 110.157 -179.769 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.624 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 70.3 t60 -64.05 -50.0 70.13 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.408 -0.808 . . . . 1.0 111.428 -178.272 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.526 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 10.5 pt-20 -60.03 -39.5 86.09 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.664 -1.272 . . . . 1.0 110.319 -179.168 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.501 ' CZ ' ' CZ ' ' A' ' 39' ' ' PHE . 29.6 m-85 -60.0 -40.02 87.76 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.716 -1.24 . . . . 1.0 108.574 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.91 -42.07 94.55 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.526 -1.43 . . . . 1.0 109.526 -179.949 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.624 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 84.6 m-70 -66.89 -39.99 87.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.068 -1.254 . . . . 1.0 109.228 179.522 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.5 p -66.71 -24.44 66.24 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.328 -0.858 . . . . 1.0 108.856 179.542 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 71.4 mt -81.67 -0.58 43.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.394 -0.816 . . . . 1.0 109.357 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 88.77 6.79 72.17 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 120.349 -0.929 . . . . 1.0 110.782 178.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.9 mt -82.74 146.37 29.04 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.782 -1.422 . . . . 1.0 109.644 179.78 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 33.5 t0 -99.33 173.13 6.92 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.926 -0.768 . . . . 1.0 108.926 -179.73 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.493 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 76.4 m80 -59.97 138.45 57.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.175 -0.953 . . . . 1.0 109.807 -179.422 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 33.3 t -97.09 156.51 16.34 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.267 -0.896 . . . . 1.0 109.208 179.739 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -99.86 1.57 43.04 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.318 -0.864 . . . . 1.0 109.663 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -87.03 130.17 49.26 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.18 -0.95 . . . . 1.0 108.913 179.797 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -69.39 -25.35 30.41 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 CA-C-N 120.099 1.071 . . . . 1.0 112.27 -179.622 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -83.58 -4.99 88.81 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.409 -1.476 . . . . 1.0 109.409 -179.805 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.89 145.34 26.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -1.162 . . . . 1.0 109.319 179.567 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.424 ' C ' ' H ' ' A' ' 138' ' ' PHE . 80.5 mt -69.5 -33.13 72.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.294 -0.879 . . . . 1.0 109.723 179.727 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 93.9 mmm -71.8 18.4 0.08 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.152 -0.967 . . . . 1.0 110.687 -179.463 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.424 ' H ' ' C ' ' A' ' 136' ' ' LEU . 13.2 t80 -69.79 133.14 88.51 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.735 -1.228 . . . . 1.0 107.89 179.819 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -62.94 -15.28 46.57 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 CA-C-N 119.905 1.002 . . . . 1.0 113.792 -178.116 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.0 mt -105.91 141.91 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 120.943 -1.098 . . . . 1.0 109.986 -179.392 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -74.95 129.72 38.14 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.397 -0.815 . . . . 1.0 109.691 -179.723 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.6 t -143.13 139.93 30.62 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.348 -0.845 . . . . 1.0 108.853 179.317 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -81.88 143.73 31.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.99 -1.069 . . . . 1.0 109.407 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 m -140.19 150.97 44.83 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.39 -0.819 . . . . 1.0 109.763 -179.314 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.38 112.18 3.65 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 107.717 -2.153 . . . . 1.0 107.717 178.222 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.447 ' CE ' HD21 ' A' ' 115' ' ' LEU . 33.6 mmtm -76.09 4.89 7.59 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.3 -1.118 . . . . 1.0 109.887 -178.607 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 86.8 p -71.79 122.74 21.22 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.181 -0.95 . . . . 1.0 109.119 179.737 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 52.03 40.0 27.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.283 -0.886 . . . . 1.0 110.078 179.848 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -92.5 129.8 38.34 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.927 -1.108 . . . . 1.0 109.74 179.613 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 96.2 mmm -131.45 150.02 52.31 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.499 -0.926 . . . . 1.0 108.499 179.117 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 22.0 mt -50.61 132.13 27.18 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 120.898 -1.126 . . . . 1.0 109.034 -179.515 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -68.53 174.52 8.25 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 CA-C-N 120.0 1.036 . . . . 1.0 111.639 179.364 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -60.04 -39.96 87.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.285 -0.884 . . . . 1.0 109.863 -179.882 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -55.22 -49.77 71.13 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.131 -0.98 . . . . 1.0 109.935 -179.278 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.12 -39.87 75.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.171 -0.956 . . . . 1.0 110.28 -179.349 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 64.4 t -60.08 -45.47 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.003 -1.061 . . . . 1.0 109.03 -179.563 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -60.96 -40.08 91.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.137 -0.977 . . . . 1.0 110.652 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.79 -53.6 9.46 Favored Glycine 0 N--CA 1.497 2.75 0 O-C-N 121.071 -1.018 . . . . 1.0 111.355 -178.518 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.47 HG23 ' N ' ' A' ' 160' ' ' GLN . 7.8 tp -60.05 -40.02 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.94 -1.33 . . . . 1.0 109.637 -178.923 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.5 mt-30 -65.96 -39.6 90.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.091 -1.005 . . . . 1.0 109.716 179.448 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 84.9 p -60.63 -32.19 71.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.09 -1.006 . . . . 1.0 110.688 -179.29 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.4 mt -85.64 -51.51 6.42 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.898 -1.126 . . . . 1.0 110.669 -178.993 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -91.24 -9.12 46.38 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.986 -1.071 . . . . 1.0 110.411 -178.927 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.517 0 N-CA-C 109.475 -1.45 . . . . 1.0 109.475 -179.947 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.1 mt . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 121.381 0.61 . . . . 1.0 109.519 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -160.79 162.29 32.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.367 -0.833 . . . . 1.0 109.617 179.847 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -72.14 149.74 44.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.213 -0.929 . . . . 1.0 109.373 -179.759 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 94.5 p -86.99 1.66 52.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.278 -0.889 . . . . 1.0 109.584 -179.743 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -146.25 154.7 42.02 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.236 -0.915 . . . . 1.0 109.605 -179.845 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.56 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -91.61 0.14 57.53 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.377 -0.827 . . . . 1.0 109.957 -179.631 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -95.16 125.79 40.05 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.109 -0.994 . . . . 1.0 109.192 179.768 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.8 mt -140.04 147.75 40.82 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.363 -0.835 . . . . 1.0 109.192 -179.637 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.0 p -131.44 153.54 49.62 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.482 -0.761 . . . . 1.0 109.032 179.97 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -145.46 160.02 42.22 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.123 -0.985 . . . . 1.0 109.96 -179.988 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.423 HH11 ' HG2' ' A' ' 18' ' ' ARG . 35.3 ttt-85 -142.36 133.8 26.49 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.434 -0.791 . . . . 1.0 109.492 -179.504 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.7 mt -86.61 116.47 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.088 -1.008 . . . . 1.0 108.634 178.917 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.9 t -69.94 -41.46 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.346 -0.846 . . . . 1.0 109.965 -179.311 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -164.48 158.98 18.89 Favored 'General case' 0 C--N 1.291 -1.952 0 O-C-N 119.238 -2.163 . . . . 1.0 111.548 -178.228 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -101.79 119.06 38.19 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.631 -1.618 . . . . 1.0 106.631 178.313 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 23' ' ' THR . 0.1 OUTLIER -61.92 138.0 95.51 Favored Pre-proline 0 C--N 1.303 -1.448 0 O-C-N 121.028 -1.045 . . . . 1.0 109.073 -178.327 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -56.46 -6.35 1.47 Allowed 'Trans proline' 0 N--CA 1.484 0.951 0 CA-C-N 119.614 0.898 . . . . 1.0 110.504 179.554 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 23' ' ' THR . 81.9 m-20 -60.01 -38.69 83.4 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 120.075 -0.65 . . . . 1.0 110.444 -179.457 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 76.7 mtm -139.25 171.11 14.76 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.053 -1.029 . . . . 1.0 109.359 -179.376 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 82.0 p -75.28 164.98 25.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.332 -0.855 . . . . 1.0 109.829 -179.334 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 25.9 m170 -63.98 -43.79 94.67 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.317 -0.864 . . . . 1.0 110.037 -179.559 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 53.3 m -60.18 -40.08 88.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 1.0 110.712 -178.92 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -65.21 -46.78 79.27 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.011 -1.056 . . . . 1.0 110.359 -179.345 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 70.5 t -64.01 -39.92 87.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.471 -0.768 . . . . 1.0 109.48 -179.738 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -55.55 -55.18 34.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.517 -0.739 . . . . 1.0 111.321 -178.774 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.2 pttt -63.6 -32.12 73.49 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.899 -1.125 . . . . 1.0 110.843 -178.678 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.67 -49.99 74.67 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.728 -1.233 . . . . 1.0 109.563 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -67.15 -39.98 86.61 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.066 -1.021 . . . . 1.0 110.454 -179.822 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -59.97 -40.54 89.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.782 -1.199 . . . . 1.0 109.62 -179.581 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -60.42 -40.05 89.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.975 -1.078 . . . . 1.0 109.159 178.885 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.0 -46.3 89.91 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.434 -0.791 . . . . 1.0 109.689 -179.235 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -65.4 -38.91 91.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.136 -0.977 . . . . 1.0 109.466 179.851 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -59.69 -48.16 82.78 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.208 -0.932 . . . . 1.0 110.18 -179.352 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.06 -42.61 90.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.139 -0.976 . . . . 1.0 109.989 -179.61 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -77.8 -38.79 45.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.174 -0.953 . . . . 1.0 110.161 -179.383 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 84.0 p -70.01 -16.77 63.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.096 -1.002 . . . . 1.0 109.997 -179.645 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -59.9 -40.05 87.45 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.072 -1.018 . . . . 1.0 110.412 -179.614 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.6 m -111.81 -19.49 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.406 0 O-C-N 120.991 -1.068 . . . . 1.0 110.815 -179.41 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.0 p -94.52 128.56 39.66 Favored Pre-proline 0 N--CA 1.5 2.041 0 O-C-N 120.761 -1.212 . . . . 1.0 109.392 179.845 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -73.76 16.46 0.51 Allowed 'Trans proline' 0 N--CA 1.494 1.519 0 CA-C-N 120.17 1.096 . . . . 1.0 111.963 179.27 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.2 mt -69.22 140.01 54.53 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.265 -0.897 . . . . 1.0 109.969 -179.667 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -106.65 121.29 44.05 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.764 -0.828 . . . . 1.0 108.764 179.644 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -106.81 126.03 51.77 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.18 -0.95 . . . . 1.0 109.358 -179.777 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.1 m -120.05 130.03 54.5 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.535 -0.728 . . . . 1.0 109.803 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.434 ' HG2' HH11 ' A' ' 52' ' ' ARG . 33.8 ttt-85 -82.41 133.95 35.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.302 -0.874 . . . . 1.0 109.213 179.51 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.8 mt -103.35 130.57 50.67 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.247 -0.908 . . . . 1.0 109.356 179.856 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.443 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 45.5 m170 -63.41 -39.99 95.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.342 -0.849 . . . . 1.0 110.04 -179.599 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 76.6 m-20 -148.94 172.89 13.98 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.116 -0.99 . . . . 1.0 109.93 -179.505 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.43 177.92 39.98 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.595 -1.402 . . . . 1.0 109.595 179.984 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.7 mt -94.03 133.7 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.237 -1.155 . . . . 1.0 109.06 179.96 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.75 163.5 13.21 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.515 -0.741 . . . . 1.0 109.378 -179.424 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -60.01 -49.41 77.77 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.182 -0.948 . . . . 1.0 109.398 -179.77 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.8 mt -107.54 102.97 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.386 -0.821 . . . . 1.0 109.896 179.827 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.5 ptm -103.27 130.7 50.59 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.149 -0.969 . . . . 1.0 109.613 179.471 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.8 mt -105.4 138.01 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.581 -0.699 . . . . 1.0 109.926 -179.289 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 63.8 p -153.69 158.64 41.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.217 -0.927 . . . . 1.0 109.985 179.885 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.81 123.07 48.02 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.477 -0.934 . . . . 1.0 108.477 179.517 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.429 ' O ' ' CB ' ' A' ' 100' ' ' ASP . . . -99.97 175.82 27.76 Favored Glycine 0 N--CA 1.504 3.173 0 O-C-N 121.091 -1.005 . . . . 1.0 111.482 -178.563 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 72.3 mt . . . . . 0 N--CA 1.5 2.034 0 O-C-N 121.612 -0.934 . . . . 1.0 108.769 179.504 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.498 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 87.0 m-85 . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -100.15 0.01 39.72 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.23 -0.919 . . . . 1.0 110.266 -179.054 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 136.22 -155.64 22.56 Favored Glycine 0 N--CA 1.498 2.816 0 N-CA-C 108.475 -1.85 . . . . 1.0 108.475 -179.474 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.444 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 7.4 Cg_exo -62.72 -63.76 0.08 OUTLIER 'Trans proline' 0 C--N 1.313 -1.318 0 CA-C-N 118.697 1.249 . . . . 1.0 111.67 179.414 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 83.3 p -77.11 160.02 29.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.074 -1.016 . . . . 1.0 109.323 179.566 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 117.1 -129.3 8.29 Favored Glycine 0 N--CA 1.502 3.084 0 N-CA-C 109.642 -1.383 . . . . 1.0 109.642 179.882 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.419 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 22.3 mt -69.82 109.68 4.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -1.174 . . . . 1.0 109.24 -179.836 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 46.7 mt -80.74 -19.22 45.47 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.135 -0.978 . . . . 1.0 108.996 -179.919 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.55 171.26 1.25 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.761 -0.829 . . . . 1.0 108.761 179.697 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -162.07 159.41 26.18 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.142 -0.974 . . . . 1.0 109.796 179.331 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.6 166.2 29.98 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.79 -0.819 . . . . 1.0 108.79 -179.593 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -101.5 152.77 38.09 Favored Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.217 -0.927 . . . . 1.0 108.873 -179.987 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -63.05 165.13 17.44 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 120.599 0.866 . . . . 1.0 111.615 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo . . . . . 0 N--CA 1.489 1.259 0 C-N-CA 121.191 1.261 . . . . 1.0 112.438 -179.814 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.5 p-10 . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.39 126.15 12.64 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.223 -0.923 . . . . 1.0 109.398 -179.72 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -119.25 153.6 34.74 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.535 -0.728 . . . . 1.0 109.863 -179.774 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -131.22 154.4 48.47 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.622 -0.674 . . . . 1.0 109.281 -179.915 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.498 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 1.2 m-20 -79.46 117.98 20.92 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.04 -1.037 . . . . 1.0 108.749 179.022 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.429 ' CB ' ' O ' ' A' ' 65' ' ' GLY . 35.5 t0 -82.86 -10.66 58.73 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.016 -1.053 . . . . 1.0 109.178 -179.996 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -82.97 -11.63 57.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.383 -0.823 . . . . 1.0 109.107 179.756 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.444 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 99.5 mt-10 -89.53 169.96 10.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.439 -0.788 . . . . 1.0 109.101 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 22.2 m -98.89 104.68 16.74 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.204 -0.935 . . . . 1.0 109.104 -179.671 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.476 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 97.0 m95 -87.63 121.61 30.27 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 179.632 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.651 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.9 t -139.74 153.81 47.28 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.348 -0.845 . . . . 1.0 109.748 -179.198 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.4 m -94.32 -9.11 36.97 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.308 -0.997 . . . . 1.0 108.308 179.187 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 61.6 p -90.99 174.35 7.46 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.601 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 23.1 t -74.04 73.88 1.7 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.183 -0.948 . . . . 1.0 109.543 179.984 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.651 ' HB2' HG21 ' A' ' 105' ' ' THR . 98.2 mttt -148.58 152.49 36.87 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.331 -0.855 . . . . 1.0 109.133 179.471 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 109' ' ' LYS . . . 42.01 -139.65 2.07 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.959 -1.256 . . . . 1.0 109.959 179.631 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -100.05 117.37 34.17 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.353 -1.086 . . . . 1.0 108.855 179.226 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.449 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 58.0 t-20 -63.52 131.2 47.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.154 -0.966 . . . . 1.0 109.939 -179.527 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.2 tp -60.07 -45.07 94.09 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.474 -0.766 . . . . 1.0 111.092 -179.519 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -59.89 -41.92 92.67 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.0 -1.062 . . . . 1.0 111.069 -178.407 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 115' ' ' LEU . 4.1 mm? -58.09 -50.68 72.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.677 -1.264 . . . . 1.0 109.245 -179.49 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 67.6 t -70.44 -39.97 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.962 . . . . 1.0 110.219 -179.544 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.35 -51.77 68.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.063 -1.023 . . . . 1.0 109.597 -179.503 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.04 81.45 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.269 -0.894 . . . . 1.0 109.964 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.601 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 56.2 t60 -60.96 -50.14 74.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.338 -0.852 . . . . 1.0 110.766 -178.403 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -60.11 -40.13 88.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.625 -1.297 . . . . 1.0 109.874 -179.65 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -60.03 -40.09 88.17 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 120.966 -1.084 . . . . 1.0 108.437 179.614 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.58 -42.54 84.66 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.178 -1.569 . . . . 1.0 109.178 179.829 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.601 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 89.2 m-70 -67.48 -40.0 85.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -1.15 . . . . 1.0 109.369 179.529 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 73.0 p -65.96 -21.58 66.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 1.0 109.625 -179.908 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 84.2 mt -82.54 0.29 43.33 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.156 -0.965 . . . . 1.0 109.697 -179.796 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.47 3.32 72.03 Favored Glycine 0 N--CA 1.497 2.719 0 C-N-CA 120.221 -0.99 . . . . 1.0 110.754 179.048 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.7 mt -84.2 148.12 26.91 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.954 -1.321 . . . . 1.0 109.576 179.979 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 41.0 t0 -101.57 173.82 6.25 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.776 -0.824 . . . . 1.0 108.776 179.801 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.527 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 76.6 m80 -57.14 135.7 56.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.006 -1.059 . . . . 1.0 109.274 -179.749 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 33.4 t -98.76 156.17 16.98 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.392 -0.818 . . . . 1.0 109.405 -179.839 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -99.65 8.38 44.42 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.303 -0.873 . . . . 1.0 109.344 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -87.18 122.18 71.09 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 1.0 108.688 179.657 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -66.76 -12.47 36.09 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 CA-C-N 120.267 1.131 . . . . 1.0 111.825 -179.765 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -95.51 -4.2 60.87 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.91 -1.276 . . . . 1.0 109.91 -179.843 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -87.87 142.27 27.94 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.069 -1.254 . . . . 1.0 109.816 -179.893 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.6 mt -61.47 -40.08 93.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.335 -0.853 . . . . 1.0 109.717 179.859 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 88.5 mtp -71.69 20.99 0.05 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.413 -0.804 . . . . 1.0 111.528 -178.552 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -68.38 132.63 91.36 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 120.498 -1.376 . . . . 1.0 108.067 179.681 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -48.76 -42.96 35.98 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 CA-C-N 119.88 0.993 . . . . 1.0 113.444 -178.798 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 98.4 mt -82.93 143.62 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.038 -1.039 . . . . 1.0 110.815 -178.853 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . 0.449 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 26.2 t80 -77.42 131.33 37.95 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.693 -0.63 . . . . 1.0 109.52 179.738 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 13.3 t -139.66 140.41 36.89 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.291 -0.88 . . . . 1.0 109.274 179.575 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -82.46 140.55 33.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.212 -0.93 . . . . 1.0 108.939 179.639 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.1 t -140.39 151.28 44.82 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.295 -0.878 . . . . 1.0 109.741 -179.384 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.92 107.97 2.35 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.019 -1.633 . . . . 1.0 109.019 179.661 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 21.7 mtmm -78.13 -0.93 30.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -1.12 . . . . 1.0 109.758 -179.262 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 88.8 p -59.97 -38.35 82.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.283 -0.886 . . . . 1.0 110.133 -179.49 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -139.21 21.63 2.59 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.257 -0.902 . . . . 1.0 110.143 -179.308 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -68.26 137.57 54.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.931 -1.106 . . . . 1.0 109.578 -179.836 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 75.4 mtm -138.87 148.91 44.27 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.244 -1.021 . . . . 1.0 108.244 179.265 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 20.8 mt -51.81 124.03 26.37 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 120.796 -1.19 . . . . 1.0 108.436 -179.737 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -66.15 174.65 5.69 Favored 'Trans proline' 0 N--CA 1.49 1.299 0 CA-C-N 120.124 1.08 . . . . 1.0 112.233 -179.47 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -60.12 -39.81 87.55 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.424 -0.797 . . . . 1.0 109.167 179.816 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -56.45 -49.96 73.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 1.0 110.065 -179.413 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.81 -40.11 72.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.038 -1.039 . . . . 1.0 110.226 -179.411 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 79.0 t -61.37 -48.91 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.089 -1.007 . . . . 1.0 109.444 -179.553 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.18 -39.95 88.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.131 -0.981 . . . . 1.0 110.492 -179.792 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.26 -55.12 8.06 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 120.197 -1.001 . . . . 1.0 111.199 -178.632 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.472 HG23 ' N ' ' A' ' 160' ' ' GLN . 7.7 tp -60.14 -40.1 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.917 -1.343 . . . . 1.0 109.676 -179.096 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.544 ' O ' ' N ' ' A' ' 164' ' ' GLY . 27.1 mm100 -65.09 -39.74 93.61 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.225 -0.922 . . . . 1.0 109.402 179.675 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 86.6 p -62.92 -27.21 69.22 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.224 -0.922 . . . . 1.0 110.135 -179.612 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 92.5 mt -86.69 -53.53 4.89 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.912 -1.117 . . . . 1.0 110.437 -179.376 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -91.79 -9.41 43.66 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.07 -1.019 . . . . 1.0 110.051 -179.083 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.582 0 N-CA-C 109.434 -1.466 . . . . 1.0 109.434 -179.878 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.3 mt . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 109.439 -0.578 . . . . 1.0 109.439 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -162.28 161.25 27.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.294 -0.879 . . . . 1.0 109.669 -179.946 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -72.44 149.35 44.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.075 -1.016 . . . . 1.0 109.156 179.662 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.0 p -85.67 -0.9 56.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.258 -0.901 . . . . 1.0 109.815 -179.497 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -150.47 157.32 42.89 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.101 -0.999 . . . . 1.0 109.518 179.843 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.531 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.01 0.54 57.05 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.179 -0.951 . . . . 1.0 109.988 -179.627 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -94.76 128.35 41.4 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.139 -0.976 . . . . 1.0 108.948 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 97.8 mt -141.85 151.16 42.48 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.158 -0.964 . . . . 1.0 109.342 -179.585 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.7 p -132.86 158.61 42.11 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.055 -0.72 . . . . 1.0 109.055 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -146.27 162.66 37.61 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.1 -1.0 . . . . 1.0 109.988 -179.854 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -143.84 133.04 23.05 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.582 -0.699 . . . . 1.0 109.661 -179.622 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 86.0 mt -88.62 111.21 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.382 -0.97 . . . . 1.0 108.382 178.468 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.4 t -69.96 -40.35 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.012 -1.055 . . . . 1.0 109.679 -179.152 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.9 p-10 -162.37 160.99 27.19 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.839 -1.163 . . . . 1.0 110.431 -179.741 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.511 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 64.6 m-85 -101.75 -168.89 1.61 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.346 -1.353 . . . . 1.0 107.346 178.902 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.79 143.69 35.59 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.426 -0.796 . . . . 1.0 109.281 179.806 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -63.57 -11.93 28.57 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 CA-C-O 122.511 0.963 . . . . 1.0 110.177 179.067 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -60.04 -39.99 87.86 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 114.942 -1.026 . . . . 1.0 110.126 -179.974 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.5 mtm -142.53 168.3 20.05 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.22 -0.925 . . . . 1.0 110.118 -178.936 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.7 p -72.2 160.06 33.05 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.422 -0.799 . . . . 1.0 109.76 -179.791 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.511 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 54.5 m170 -60.13 -39.91 87.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.41 -0.807 . . . . 1.0 110.223 -179.589 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 63.2 m -59.91 -40.12 87.75 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.102 -0.999 . . . . 1.0 110.798 -178.674 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -67.32 -39.94 85.9 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.958 -1.089 . . . . 1.0 110.059 -179.698 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.0 t -69.0 -41.15 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.013 -1.054 . . . . 1.0 110.265 -179.29 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.02 -48.29 82.32 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.02 -1.05 . . . . 1.0 110.51 -179.194 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.54 -33.14 72.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.888 -1.132 . . . . 1.0 109.126 179.852 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.98 -49.35 78.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.087 -1.008 . . . . 1.0 109.849 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -67.47 -38.28 84.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.91 -1.119 . . . . 1.0 109.729 179.915 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.411 ' NZ ' ' NH1' ' A' ' 52' ' ' ARG . 63.5 mmtt -59.95 -43.37 95.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.06 -1.025 . . . . 1.0 109.285 -179.522 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -60.34 -40.26 90.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.019 -1.051 . . . . 1.0 108.92 179.376 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.04 -46.87 88.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.486 -0.759 . . . . 1.0 109.927 -179.947 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -65.68 -39.26 91.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.027 -1.046 . . . . 1.0 109.859 -179.711 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -60.04 -46.37 89.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.039 -1.038 . . . . 1.0 109.761 -179.707 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.8 t -60.12 -43.26 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.169 -0.957 . . . . 1.0 110.585 -179.567 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -77.68 -38.03 48.42 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.92 -1.112 . . . . 1.0 110.113 -179.192 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.9 p -70.43 -15.93 62.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.296 -0.877 . . . . 1.0 110.131 -179.385 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -60.02 -40.01 87.81 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.129 -0.982 . . . . 1.0 110.824 -179.636 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.6 m -112.17 -22.68 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.323 -0.861 . . . . 1.0 110.312 -178.685 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.0 p -93.42 130.93 33.87 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 120.943 -1.098 . . . . 1.0 109.595 -179.992 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -74.61 17.48 0.55 Allowed 'Trans proline' 0 N--CA 1.496 1.638 0 CA-C-N 119.91 1.004 . . . . 1.0 112.043 179.233 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.8 mt -68.94 139.85 55.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.114 -0.991 . . . . 1.0 109.838 -179.444 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -106.62 121.21 43.87 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.933 -0.765 . . . . 1.0 108.933 179.417 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -106.86 124.76 50.09 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.281 -0.887 . . . . 1.0 109.727 -179.428 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.2 m -119.96 130.04 54.58 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.626 -0.671 . . . . 1.0 109.891 179.896 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.472 ' CB ' ' NH1' ' A' ' 52' ' ' ARG . 11.6 ttp-105 -82.88 134.84 35.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.268 -0.895 . . . . 1.0 109.556 179.579 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.3 mt -107.43 134.13 50.93 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.266 -0.896 . . . . 1.0 109.299 179.614 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.434 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 59.5 m170 -65.01 -39.9 94.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.438 -0.789 . . . . 1.0 109.46 -179.931 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 72.0 m-20 -151.44 -176.74 5.71 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.281 -0.887 . . . . 1.0 109.486 -179.805 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.21 -179.48 43.74 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.367 -1.493 . . . . 1.0 109.367 -179.662 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 93.3 mt -97.1 130.45 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.296 -1.12 . . . . 1.0 109.474 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.05 160.46 16.42 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.453 -0.779 . . . . 1.0 109.67 -179.605 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.06 -49.1 78.97 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.284 -0.885 . . . . 1.0 109.348 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.9 mt -105.73 97.04 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.467 -0.771 . . . . 1.0 109.729 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.9 ptm -99.2 125.27 44.74 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.083 -1.01 . . . . 1.0 109.173 179.368 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 86.6 mt -102.81 137.52 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.458 -0.776 . . . . 1.0 109.434 -179.451 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.1 p -153.38 153.32 32.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.185 -0.947 . . . . 1.0 109.852 -179.896 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -104.09 121.36 43.05 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.225 -1.028 . . . . 1.0 108.225 179.116 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -108.22 -172.99 21.71 Favored Glycine 0 N--CA 1.5 2.907 0 N-CA-C 110.852 -0.899 . . . . 1.0 110.852 -178.784 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 83.3 mt . . . . . 0 N--CA 1.493 1.708 0 N-CA-C 108.098 -1.075 . . . . 1.0 108.098 179.29 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.55 ' CE2' ' OD1' ' A' ' 99' ' ' ASP . 89.8 m-85 . . . . . 0 N--CA 1.496 1.853 0 N-CA-C 108.505 -0.924 . . . . 1.0 108.505 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 79' ' ' SER . 20.7 p-10 -96.1 9.53 40.57 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.015 -1.053 . . . . 1.0 110.295 -179.091 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 120.88 -154.86 16.35 Favored Glycine 0 N--CA 1.504 3.181 0 N-CA-C 108.934 -1.666 . . . . 1.0 108.934 179.888 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.434 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 3.7 Cg_exo -63.12 -62.41 0.11 Allowed 'Trans proline' 0 N--CA 1.489 1.224 0 CA-C-N 118.962 1.381 . . . . 1.0 111.715 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.419 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 70.9 p -75.63 162.41 28.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.439 -0.788 . . . . 1.0 109.729 179.736 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 111.67 -126.35 7.64 Favored Glycine 0 N--CA 1.501 2.983 0 N-CA-C 109.9 -1.28 . . . . 1.0 109.9 179.71 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.401 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 7.2 mt -69.69 100.39 1.48 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.36 -1.082 . . . . 1.0 109.074 -179.787 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 46.4 mt -73.91 -29.75 62.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.033 -1.042 . . . . 1.0 109.252 -179.702 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -177.32 166.81 2.33 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.086 -1.079 . . . . 1.0 108.086 -179.661 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -163.07 159.91 23.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.753 -1.217 . . . . 1.0 110.033 179.652 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -138.69 160.32 39.94 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.924 -0.769 . . . . 1.0 108.924 179.898 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -97.45 152.06 38.0 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.248 -0.908 . . . . 1.0 109.278 -179.663 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -47.08 167.0 0.08 OUTLIER 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 120.437 0.758 . . . . 1.0 111.359 179.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo . . . . . 0 N--CA 1.494 1.536 0 C-N-CA 120.981 1.121 . . . . 1.0 112.416 -179.312 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.442 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 31.5 p-10 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.683 -0.488 . . . . 1.0 109.683 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.96 119.41 6.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.181 -0.949 . . . . 1.0 109.655 179.826 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -103.87 126.02 50.7 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.398 -0.814 . . . . 1.0 109.593 179.975 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.412 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 28.1 m-85 -106.14 145.92 30.88 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.549 -0.719 . . . . 1.0 109.266 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.55 ' OD1' ' CE2' ' A' ' 75' ' ' PHE . 94.7 m-20 -78.24 121.98 25.1 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.979 -1.076 . . . . 1.0 109.145 179.513 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 45.7 t0 -83.18 -10.89 58.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.232 -0.918 . . . . 1.0 109.622 179.976 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -81.91 -10.98 59.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.311 -0.868 . . . . 1.0 109.852 -179.732 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.434 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 98.7 mt-10 -89.15 169.05 11.8 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.185 -0.947 . . . . 1.0 109.614 -179.348 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 54.8 m -98.12 104.73 16.79 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.168 -0.958 . . . . 1.0 109.291 -179.521 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -89.35 120.95 31.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.882 . . . . 1.0 108.908 179.924 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.638 HG21 ' HB2' ' A' ' 109' ' ' LYS . 6.4 t -140.06 150.16 44.03 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.444 -0.785 . . . . 1.0 109.819 -179.046 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 66.3 m -91.64 -8.59 46.74 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.257 -1.016 . . . . 1.0 108.257 179.034 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 83.5 p -90.17 172.14 9.02 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.787 -0.82 . . . . 1.0 108.787 179.364 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.7 t -74.99 77.2 2.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.024 -1.047 . . . . 1.0 109.416 -179.962 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.638 ' HB2' HG21 ' A' ' 105' ' ' THR . 96.4 mttt -148.85 147.52 28.82 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 179.456 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.14 -138.06 4.72 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.981 -1.248 . . . . 1.0 109.981 179.746 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -100.04 115.2 29.18 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.282 -1.128 . . . . 1.0 109.171 179.906 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -63.96 133.95 54.16 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.087 -1.008 . . . . 1.0 109.781 -179.685 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.4 tp -59.95 -45.09 93.74 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.357 -0.84 . . . . 1.0 111.165 -179.6 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -59.94 -40.97 90.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.988 -1.07 . . . . 1.0 110.695 -178.188 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -59.97 -50.2 74.68 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.838 -1.164 . . . . 1.0 109.436 -179.569 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.5 t -70.01 -40.48 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.099 -1.0 . . . . 1.0 110.109 -179.396 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.93 -51.27 70.77 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.115 -0.99 . . . . 1.0 109.6 -179.312 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.99 -36.56 77.45 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.282 -0.886 . . . . 1.0 110.425 -179.97 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.607 ' NE2' ' NE2' ' A' ' 123' ' ' HIS . 63.6 t60 -63.34 -49.88 72.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.166 -0.959 . . . . 1.0 110.806 -178.558 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.412 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 7.3 pt-20 -59.87 -39.15 84.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.746 -1.221 . . . . 1.0 109.999 -179.455 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -60.04 -40.05 88.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.788 -1.195 . . . . 1.0 108.829 179.421 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -56.97 -42.9 93.03 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.547 -1.421 . . . . 1.0 109.547 179.988 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.607 ' NE2' ' NE2' ' A' ' 119' ' ' HIS . 87.8 m-70 -67.23 -39.96 86.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.108 -1.231 . . . . 1.0 109.993 179.801 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 87.3 p -67.1 -22.18 65.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 1.0 109.909 -179.598 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 81.0 mt -80.84 -0.93 41.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.158 -0.964 . . . . 1.0 109.701 -179.853 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.92 6.14 67.49 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 110.414 -1.075 . . . . 1.0 110.414 179.264 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.4 mt -84.91 150.04 25.24 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.987 -1.302 . . . . 1.0 109.654 179.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 38.4 t0 -99.95 175.59 5.72 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.593 -0.891 . . . . 1.0 108.593 179.416 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.501 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 72.6 m80 -59.7 139.98 56.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.97 -1.081 . . . . 1.0 109.491 -179.742 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 44.2 t -98.09 148.1 23.88 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.381 -0.825 . . . . 1.0 109.334 -179.808 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -96.9 2.15 51.33 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.266 -0.896 . . . . 1.0 109.733 -179.646 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 8.2 t0 -86.48 128.14 58.13 Favored Pre-proline 0 N--CA 1.491 1.623 0 N-CA-C 107.947 -1.131 . . . . 1.0 107.947 179.296 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -65.39 -19.67 61.44 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 CA-C-N 120.344 1.158 . . . . 1.0 112.305 -179.665 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.426 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -88.09 -6.36 75.36 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.621 -1.392 . . . . 1.0 109.621 -179.929 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.61 135.41 34.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.244 -1.15 . . . . 1.0 109.235 179.787 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.437 ' C ' ' H ' ' A' ' 138' ' ' PHE . 92.2 mt -60.08 -38.92 84.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.108 -0.995 . . . . 1.0 109.685 -179.692 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 71.0 mtp -69.9 21.81 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.384 -0.823 . . . . 1.0 111.349 -178.631 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.437 ' H ' ' C ' ' A' ' 136' ' ' LEU . 16.1 t80 -67.06 134.43 93.78 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 120.726 -1.234 . . . . 1.0 107.848 179.542 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -61.64 -5.5 5.84 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 120.876 1.05 . . . . 1.0 114.215 -177.886 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 89.6 mt -118.05 136.55 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 O-C-N 120.918 -1.114 . . . . 1.0 109.269 179.55 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -72.11 126.55 30.07 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.349 -0.845 . . . . 1.0 109.958 -178.928 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.8 t -139.55 142.19 37.2 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.81 -0.811 . . . . 1.0 108.81 179.79 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -80.77 145.03 31.69 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.002 -1.061 . . . . 1.0 109.545 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.8 t -140.03 156.66 46.51 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.412 -0.805 . . . . 1.0 109.438 -179.605 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.12 104.49 0.97 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.719 -1.352 . . . . 1.0 109.719 -179.859 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -77.1 -0.93 26.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.364 -1.08 . . . . 1.0 109.898 -179.892 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 42.1 t -60.01 -43.09 95.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.084 -1.01 . . . . 1.0 109.353 -179.562 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -156.05 74.31 0.85 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.096 -1.002 . . . . 1.0 109.556 179.545 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -99.13 122.91 42.98 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.297 -0.877 . . . . 1.0 109.166 179.555 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 96.7 mtp -114.57 140.18 48.99 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.021 -0.733 . . . . 1.0 109.021 179.854 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 57.0 mt -50.26 128.82 23.85 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.021 -1.049 . . . . 1.0 108.836 -179.94 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -69.01 176.97 5.52 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 CA-C-N 120.041 1.05 . . . . 1.0 112.335 179.889 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.04 -40.0 87.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.417 -0.802 . . . . 1.0 109.549 179.775 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -55.76 -49.97 71.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.342 -0.849 . . . . 1.0 109.943 -179.385 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -70.72 -40.0 73.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.023 -1.048 . . . . 1.0 110.151 -179.525 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 76.9 t -62.09 -48.58 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.106 -0.997 . . . . 1.0 109.335 -179.67 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -60.82 -39.98 91.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.975 -1.078 . . . . 1.0 110.283 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.68 -53.83 11.3 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 120.228 -0.987 . . . . 1.0 111.393 -178.634 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.454 HG23 ' N ' ' A' ' 160' ' ' GLN . 6.0 tp -60.48 -40.04 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.868 -1.372 . . . . 1.0 109.795 -178.981 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 164' ' ' GLY . 95.1 mt-30 -64.01 -39.86 95.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.192 -0.943 . . . . 1.0 109.156 179.593 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 86.3 p -62.74 -28.58 70.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.885 . . . . 1.0 110.326 -179.805 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 85.4 mt -87.85 -49.95 6.76 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.947 -1.096 . . . . 1.0 110.401 -179.213 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -91.05 -9.52 45.5 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.067 -1.021 . . . . 1.0 110.148 -179.061 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.554 -1.418 . . . . 1.0 109.554 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.494 -0.558 . . . . 1.0 109.494 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.1 mt -94.41 128.33 40.88 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.19 -0.944 . . . . 1.0 109.529 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.05 162.25 34.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.335 -0.853 . . . . 1.0 108.815 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -71.99 149.21 45.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.999 -1.063 . . . . 1.0 109.071 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.0 t -79.41 -4.8 52.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.402 -0.811 . . . . 1.0 110.382 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.2 pttt -150.08 159.15 44.63 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.954 -1.091 . . . . 1.0 109.705 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.536 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.03 0.41 57.13 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.459 -0.776 . . . . 1.0 109.416 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -95.27 126.51 40.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.329 -0.857 . . . . 1.0 108.753 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.3 mt -140.14 152.11 45.82 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.279 -0.888 . . . . 1.0 109.069 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.8 p -130.27 155.29 46.54 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.893 -0.78 . . . . 1.0 108.893 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -145.62 158.72 43.81 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.039 -1.038 . . . . 1.0 109.89 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.603 HH12 ' H ' ' A' ' 56' ' ' GLY . 70.7 ttt180 -144.14 133.73 23.52 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.513 -0.742 . . . . 1.0 109.533 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.4 mt -89.43 117.59 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.091 -1.006 . . . . 1.0 109.125 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 56.6 t -69.94 -41.44 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.171 -0.956 . . . . 1.0 109.414 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.3 p-10 -163.2 162.99 25.71 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.775 -1.203 . . . . 1.0 110.125 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.407 ' HB2' ' CD2' ' A' ' 28' ' ' HIS . 53.0 m-85 -102.12 -167.39 1.4 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.203 -1.406 . . . . 1.0 107.203 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.72 143.08 35.63 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.374 -0.829 . . . . 1.0 109.817 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -66.07 -15.58 49.12 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 120.854 1.036 . . . . 1.0 110.822 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -59.17 -39.6 83.01 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.288 -0.869 . . . . 1.0 109.995 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.5 mtm -136.27 166.06 24.3 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.252 -0.905 . . . . 1.0 109.428 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.7 p -71.77 161.2 31.33 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.515 -0.74 . . . . 1.0 109.648 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.407 ' CD2' ' HB2' ' A' ' 22' ' ' TYR . 49.3 m170 -61.77 -39.91 93.32 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.553 -0.717 . . . . 1.0 109.741 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.7 m -59.9 -40.05 87.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.983 -1.073 . . . . 1.0 110.08 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -64.67 -40.08 94.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.924 -1.11 . . . . 1.0 109.975 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 63.2 t -70.02 -40.4 78.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 120.935 -1.103 . . . . 1.0 110.278 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.98 -52.87 63.56 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.235 -0.916 . . . . 1.0 110.899 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.5 ptmt -64.5 -28.82 69.92 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.196 -0.94 . . . . 1.0 109.992 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.12 -49.67 76.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.874 -1.141 . . . . 1.0 109.413 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -67.77 -38.53 83.53 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.994 -1.067 . . . . 1.0 110.083 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -59.88 -43.08 94.95 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.903 -1.123 . . . . 1.0 109.37 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -61.59 -40.09 93.55 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.058 -1.026 . . . . 1.0 108.781 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.08 -47.17 87.01 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.528 -0.733 . . . . 1.0 109.825 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -63.31 -39.85 95.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.992 -1.068 . . . . 1.0 109.57 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -59.8 -48.96 79.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.087 -1.008 . . . . 1.0 109.859 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.5 t -60.05 -40.41 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.255 -0.903 . . . . 1.0 110.602 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.436 ' CE3' ' CD1' ' A' ' 125' ' ' LEU . 73.5 m95 -79.4 -37.1 38.03 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.949 -1.094 . . . . 1.0 109.424 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.7 p -71.22 -20.0 62.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.104 -0.998 . . . . 1.0 110.029 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -60.65 -39.91 90.1 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.954 -1.091 . . . . 1.0 110.899 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.2 m -111.31 22.78 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.195 -0.941 . . . . 1.0 111.071 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.6 p -146.94 135.36 10.92 Favored Pre-proline 0 N--CA 1.501 2.11 0 O-C-N 120.843 -1.161 . . . . 1.0 109.361 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -74.28 17.57 0.51 Allowed 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 120.733 0.955 . . . . 1.0 111.967 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 78.2 mt -69.33 139.53 54.27 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.253 -0.904 . . . . 1.0 109.915 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -110.79 120.78 43.52 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.865 -0.791 . . . . 1.0 108.865 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -107.6 122.43 46.68 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.413 -0.804 . . . . 1.0 109.647 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -120.18 130.11 54.43 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.663 -0.648 . . . . 1.0 110.068 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -81.83 135.7 35.43 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.27 -0.894 . . . . 1.0 109.348 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.3 mt -104.27 126.23 51.2 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.364 -0.835 . . . . 1.0 109.181 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.41 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 45.8 m-70 -61.61 -40.16 93.83 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.329 -0.857 . . . . 1.0 109.737 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 77.3 m-20 -146.45 167.48 23.53 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.242 -0.911 . . . . 1.0 109.857 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.603 ' H ' HH12 ' A' ' 18' ' ' ARG . . . 98.22 175.73 33.09 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.136 -1.585 . . . . 1.0 109.136 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -93.55 136.81 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.228 -1.16 . . . . 1.0 108.579 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.66 161.08 15.74 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.423 -0.798 . . . . 1.0 109.281 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.02 -49.8 76.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.303 -0.873 . . . . 1.0 109.144 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 88.6 mt -106.64 102.59 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.377 -0.827 . . . . 1.0 109.702 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.1 ptm -102.47 131.49 49.13 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.348 -0.845 . . . . 1.0 109.148 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 88.3 mt -105.92 135.11 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.539 -0.725 . . . . 1.0 109.808 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 64.4 p -152.32 158.88 43.37 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.192 -0.942 . . . . 1.0 109.851 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -104.46 121.23 43.0 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.24 -170.01 23.97 Favored Glycine 0 N--CA 1.501 2.984 0 O-C-N 121.156 -0.965 . . . . 1.0 111.121 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.609 HG22 ' N ' ' A' ' 67' ' ' LYS . 78.0 mt -136.62 170.76 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 107.995 -1.113 . . . . 1.0 107.995 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.609 ' N ' HG22 ' A' ' 66' ' ' ILE . 21.6 tptm -29.92 -94.86 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 O-C-N 121.718 -0.614 . . . . 1.0 111.014 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -79.27 128.93 33.93 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.616 -1.302 . . . . 1.0 110.173 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.536 ' NE2' ' OD2' ' A' ' 71' ' ' ASP . 54.4 p-80 -153.01 9.87 0.45 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.072 -1.018 . . . . 1.0 109.813 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.403 ' O ' ' OD1' ' A' ' 71' ' ' ASP . . . 108.93 48.9 0.81 Allowed Glycine 0 N--CA 1.501 3.006 0 O-C-N 121.352 -0.843 . . . . 1.0 111.507 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.536 ' OD2' ' NE2' ' A' ' 69' ' ' HIS . 85.2 m-20 -139.95 150.49 44.57 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.828 -1.396 . . . . 1.0 109.154 178.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -65.79 -37.41 86.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.314 -0.866 . . . . 1.0 109.353 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 73' ' ' TYR . 3.0 p90 -130.5 77.45 75.89 Favored Pre-proline 0 N--CA 1.5 2.036 0 N-CA-C 108.79 -0.818 . . . . 1.0 108.79 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -60.98 -148.16 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 121.005 1.137 . . . . 1.0 112.751 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.53 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 72.2 m-85 -84.55 157.69 21.18 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.632 -0.668 . . . . 1.0 109.207 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -100.11 8.04 44.19 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.236 -0.915 . . . . 1.0 110.102 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 127.99 -156.4 20.69 Favored Glycine 0 N--CA 1.504 3.193 0 N-CA-C 108.608 -1.797 . . . . 1.0 108.608 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -60.7 -65.66 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.462 0 CA-C-N 118.855 1.328 . . . . 1.0 111.422 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 87.4 p -76.53 160.03 29.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.059 -1.026 . . . . 1.0 109.436 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.26 -126.87 7.24 Favored Glycine 0 N--CA 1.504 3.203 0 N-CA-C 110.016 -1.234 . . . . 1.0 110.016 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.427 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 28.4 mt -68.71 107.69 3.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.228 -1.16 . . . . 1.0 109.483 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 38.0 mt -79.67 -16.54 55.55 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.017 -1.052 . . . . 1.0 108.209 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.32 175.26 0.94 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.203 -1.036 . . . . 1.0 108.203 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.468 ' CE1' ' ND1' ' A' ' 97' ' ' HIS . 7.5 p80 -161.2 159.99 29.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.994 -1.066 . . . . 1.0 109.479 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.07 160.16 44.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.371 -0.831 . . . . 1.0 108.866 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -106.25 151.45 40.21 Favored Pre-proline 0 N--CA 1.499 1.984 0 N-CA-C 108.766 -0.827 . . . . 1.0 108.766 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -44.81 161.92 0.08 OUTLIER 'Trans proline' 0 N--CA 1.488 1.152 0 C-N-CA 120.694 0.93 . . . . 1.0 111.656 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -66.24 151.76 82.72 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.158 1.239 . . . . 1.0 112.529 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -177.02 153.1 13.03 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.282 -1.527 . . . . 1.0 109.282 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -70.7 37.44 0.29 Allowed 'Trans proline' 0 N--CA 1.493 1.48 0 CA-C-N 118.661 1.23 . . . . 1.0 112.055 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -158.54 -130.13 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.981 -1.074 . . . . 1.0 110.566 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.409 ' O ' ' O ' ' A' ' 93' ' ' GLY . 68.3 m-85 -61.08 -38.8 87.54 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.543 -0.723 . . . . 1.0 110.355 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 92' ' ' TYR . . . -45.1 168.82 0.02 OUTLIER Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.244 -1.143 . . . . 1.0 110.244 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 71.13 4.8 57.14 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.046 -1.222 . . . . 1.0 110.046 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.6 p-10 -81.11 170.95 15.53 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.021 -1.281 . . . . 1.0 109.733 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.49 122.57 8.26 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.289 -0.882 . . . . 1.0 109.533 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.468 ' ND1' ' CE1' ' A' ' 84' ' ' HIS . 60.8 m170 -110.74 148.25 32.7 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.652 -0.655 . . . . 1.0 109.692 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -123.05 156.46 34.82 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.571 -0.706 . . . . 1.0 109.19 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.53 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 1.1 m-20 -81.2 121.35 26.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 1.0 109.633 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -84.67 -12.95 52.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.068 -1.02 . . . . 1.0 109.422 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -82.96 -11.54 58.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.311 -0.868 . . . . 1.0 109.879 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -87.82 173.01 9.21 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.36 -0.838 . . . . 1.0 110.075 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.0 m -99.88 104.85 16.53 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.411 -0.806 . . . . 1.0 108.871 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.523 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 95.9 m95 -88.71 125.28 34.78 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.633 -0.877 . . . . 1.0 108.633 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.658 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.8 t -140.35 150.46 43.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.492 -0.755 . . . . 1.0 109.308 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 75.7 m -92.17 -8.26 46.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.104 -0.998 . . . . 1.0 108.383 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.8 m -91.19 174.84 7.18 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.57 -0.9 . . . . 1.0 108.57 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.485 ' OG ' ' CZ ' ' A' ' 143' ' ' TYR . 4.2 m -78.06 77.59 4.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.835 -1.166 . . . . 1.0 109.429 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.658 ' HB2' HG21 ' A' ' 105' ' ' THR . 99.2 mttt -146.98 149.58 33.44 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.707 -0.849 . . . . 1.0 108.707 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.81 -135.66 6.64 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.793 -1.323 . . . . 1.0 109.793 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -100.6 114.3 27.85 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.323 -1.104 . . . . 1.0 109.136 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -63.94 132.43 50.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.135 -0.978 . . . . 1.0 109.248 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.3 tp -59.8 -41.38 91.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.32 -0.862 . . . . 1.0 110.255 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -59.97 -43.8 94.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.311 -0.868 . . . . 1.0 111.095 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.453 HD21 HG22 ' A' ' 144' ' ' THR . 1.8 mm? -59.42 -50.49 73.74 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.671 -1.268 . . . . 1.0 109.814 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.1 t -66.24 -40.8 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.933 -1.104 . . . . 1.0 109.407 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.32 -51.5 69.67 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.282 -0.887 . . . . 1.0 110.067 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.27 -36.44 73.26 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.383 -1.448 . . . . 1.0 110.181 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -66.77 -47.75 71.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.113 -0.992 . . . . 1.0 111.746 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -59.54 -39.86 85.34 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.624 -1.298 . . . . 1.0 109.515 -178.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -59.87 -39.37 85.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.11 -0.994 . . . . 1.0 108.513 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.95 -43.48 87.78 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.581 -1.408 . . . . 1.0 109.581 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -64.5 -39.83 94.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.015 -1.286 . . . . 1.0 109.289 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 90.5 p -66.72 -24.12 66.2 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.137 -0.977 . . . . 1.0 110.025 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.436 ' CD1' ' CE3' ' A' ' 42' ' ' TRP . 80.9 mt -81.71 -1.64 47.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.11 -0.994 . . . . 1.0 109.689 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 91.33 9.62 63.1 Favored Glycine 0 N--CA 1.499 2.835 0 C-N-CA 120.243 -0.979 . . . . 1.0 111.01 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.8 mt -86.92 146.18 26.26 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.903 -1.351 . . . . 1.0 109.903 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 36.9 t0 -103.62 172.02 7.04 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.694 -0.854 . . . . 1.0 108.694 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.545 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 35.5 m170 -59.94 134.67 57.26 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.001 -1.062 . . . . 1.0 109.612 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 37.4 t -97.4 164.83 12.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.283 -0.886 . . . . 1.0 109.513 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -99.16 1.88 45.37 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.294 -0.879 . . . . 1.0 109.237 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 17.3 t0 -85.67 125.11 70.11 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.299 -0.875 . . . . 1.0 108.971 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -68.82 -20.53 39.39 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 CA-C-N 120.146 1.088 . . . . 1.0 111.822 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.451 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -86.26 -7.2 80.27 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.739 -1.344 . . . . 1.0 109.739 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.11 148.52 26.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.128 -1.219 . . . . 1.0 109.913 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.8 mt -69.83 -29.03 66.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.348 -0.845 . . . . 1.0 109.461 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.6 mmm -73.93 8.74 1.84 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.572 -0.705 . . . . 1.0 110.81 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -67.37 132.78 93.14 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 120.795 -1.191 . . . . 1.0 108.38 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -60.32 -24.73 78.38 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 120.861 1.041 . . . . 1.0 113.477 -178.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.3 mt -93.49 139.18 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 120.909 -1.119 . . . . 1.0 110.369 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -73.94 131.59 41.59 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.495 0.664 . . . . 1.0 110.05 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.8 t -141.19 140.45 34.02 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.719 -0.613 . . . . 1.0 109.441 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.485 ' CZ ' ' OG ' ' A' ' 108' ' ' SER . 79.3 t80 -80.94 145.07 31.43 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.241 -0.912 . . . . 1.0 109.033 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.453 HG22 HD21 ' A' ' 115' ' ' LEU . 6.8 t -141.01 155.32 46.22 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.342 -0.849 . . . . 1.0 108.918 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -77.8 112.66 3.54 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.258 -1.537 . . . . 1.0 109.258 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -77.79 3.34 14.47 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.239 -1.154 . . . . 1.0 110.034 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.5 ' O ' ' ND1' ' A' ' 148' ' ' HIS . 86.5 p -59.9 -38.38 82.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.077 -1.014 . . . . 1.0 109.679 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . 0.5 ' ND1' ' O ' ' A' ' 147' ' ' SER . 89.3 m-70 -154.08 33.05 0.43 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.09 -1.006 . . . . 1.0 110.078 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -70.85 138.69 50.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.996 -1.065 . . . . 1.0 109.67 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 58.4 mtt -140.02 149.53 43.31 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.225 -1.028 . . . . 1.0 108.225 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.697 ' H ' HD12 ' A' ' 151' ' ' LEU . 6.8 mp -52.25 127.38 38.59 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.87 -1.144 . . . . 1.0 108.833 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -65.1 -179.05 0.92 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 CA-C-N 120.088 1.067 . . . . 1.0 111.875 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -62.59 -40.14 95.96 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.456 -0.777 . . . . 1.0 110.175 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.407 ' C ' ' OD1' ' A' ' 154' ' ' ASP . 52.7 t0 -57.22 -49.71 75.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.964 -1.085 . . . . 1.0 110.138 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -70.44 -40.04 74.0 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.155 -0.966 . . . . 1.0 109.92 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 51.5 t -61.3 -44.74 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.051 -1.031 . . . . 1.0 109.591 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -61.61 -39.05 89.89 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.98 -1.075 . . . . 1.0 109.97 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -69.97 -53.27 15.52 Favored Glycine 0 N--CA 1.494 2.545 0 O-C-N 121.051 -1.03 . . . . 1.0 111.262 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.46 HG23 ' N ' ' A' ' 160' ' ' GLN . 6.3 tp -62.04 -40.54 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.722 -1.457 . . . . 1.0 109.837 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 164' ' ' GLY . 97.6 mt-30 -64.48 -39.79 94.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.01 -1.056 . . . . 1.0 109.757 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 93.2 p -64.75 -26.61 68.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.139 -0.976 . . . . 1.0 110.271 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 92.2 mt -86.39 -54.02 4.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.164 -0.96 . . . . 1.0 110.174 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -91.0 -11.27 39.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.229 -0.919 . . . . 1.0 110.27 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.626 0 N-CA-C 109.386 -1.486 . . . . 1.0 109.386 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' WAY . . . . . 0.65 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.7 m . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.419 -0.585 . . . . 1.0 109.419 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.5 mt -67.62 139.85 56.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.132 -0.98 . . . . 1.0 109.316 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.5 pttt -161.26 162.05 30.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.372 -0.83 . . . . 1.0 109.499 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -70.65 146.53 49.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.205 -0.934 . . . . 1.0 109.419 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.3 m -99.57 17.82 19.49 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.36 -0.837 . . . . 1.0 110.043 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -147.82 147.63 30.03 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.001 -1.062 . . . . 1.0 109.438 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.538 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -91.82 -0.68 57.54 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.347 -0.845 . . . . 1.0 110.087 -179.707 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -99.28 119.9 38.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.264 -0.898 . . . . 1.0 108.589 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.7 mt -140.04 150.38 44.32 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.262 -0.899 . . . . 1.0 109.059 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.1 p -132.11 158.36 41.83 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.566 -0.709 . . . . 1.0 109.27 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -143.43 158.23 43.81 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.266 -0.896 . . . . 1.0 109.759 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.0 ttt-85 -143.14 132.65 23.58 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.483 -0.76 . . . . 1.0 109.796 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.8 mt -88.46 117.31 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.251 -0.906 . . . . 1.0 109.259 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.89 -40.05 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.079 -1.013 . . . . 1.0 108.937 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.712 HD21 ' H ' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -163.01 160.77 24.99 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.099 -1.001 . . . . 1.0 110.065 -179.656 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.639 ' CD1' ' CD2' ' A' ' 28' ' ' HIS . 46.9 m-85 -102.71 -160.39 0.78 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.086 -1.449 . . . . 1.0 107.086 178.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.62 153.76 77.66 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.053 -1.029 . . . . 1.0 110.704 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -74.16 -16.9 22.28 Favored 'Trans proline' 0 N--CA 1.486 1.068 0 C-N-CA 121.089 1.193 . . . . 1.0 110.124 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.46 -39.97 85.37 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.382 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 73.9 mtm -135.86 163.76 29.49 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.305 -0.872 . . . . 1.0 109.519 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.8 p -72.42 159.71 33.54 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.34 -0.85 . . . . 1.0 109.422 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.639 ' CD2' ' CD1' ' A' ' 22' ' ' TYR . 1.1 m80 -61.41 -40.03 92.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.434 -0.791 . . . . 1.0 110.399 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.5 m -60.08 -39.94 87.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.128 -0.982 . . . . 1.0 110.235 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -67.0 -39.98 87.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.136 -0.977 . . . . 1.0 109.871 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.4 t -68.21 -41.46 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.935 . . . . 1.0 110.457 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -60.05 -48.74 80.47 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.978 -1.076 . . . . 1.0 110.582 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -62.61 -32.46 73.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.979 -1.075 . . . . 1.0 109.948 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.07 -47.83 84.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.086 -1.009 . . . . 1.0 109.68 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.4 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 49.2 m-85 -66.04 -39.73 90.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.074 -1.016 . . . . 1.0 109.868 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -60.02 -41.97 93.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.95 -1.094 . . . . 1.0 109.771 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -60.81 -41.93 96.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.966 -1.084 . . . . 1.0 109.201 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.39 -45.4 93.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.458 -0.776 . . . . 1.0 110.276 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -68.13 -38.37 82.12 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.986 -1.071 . . . . 1.0 110.162 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -59.93 -46.65 88.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.032 -1.043 . . . . 1.0 109.404 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.2 t -59.94 -41.0 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.943 . . . . 1.0 109.759 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.404 ' CZ3' HD22 ' A' ' 151' ' ' LEU . 71.9 m95 -79.48 -36.56 38.52 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.983 -1.073 . . . . 1.0 110.293 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.8 p -71.23 -18.74 62.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.974 -1.078 . . . . 1.0 109.843 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.88 -39.66 90.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.188 -0.945 . . . . 1.0 110.847 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.9 m -110.05 23.25 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.28 -0.887 . . . . 1.0 110.836 -178.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.0 p -149.05 137.7 12.01 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 120.861 -1.149 . . . . 1.0 109.377 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -75.25 18.03 0.59 Allowed 'Trans proline' 0 N--CA 1.495 1.598 0 CA-C-N 119.68 0.921 . . . . 1.0 112.102 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.9 mt -68.19 138.39 55.58 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.048 -1.032 . . . . 1.0 109.991 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -110.15 120.35 42.17 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.665 -0.865 . . . . 1.0 108.665 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -108.12 121.32 44.59 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.42 -0.8 . . . . 1.0 109.589 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -120.01 130.03 54.54 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.598 -0.688 . . . . 1.0 109.333 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -82.53 134.7 35.2 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.198 -0.939 . . . . 1.0 109.441 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.4 mt -104.03 131.94 50.78 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.35 -0.844 . . . . 1.0 109.448 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.438 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 91.6 m-70 -65.03 -40.01 94.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.483 -0.761 . . . . 1.0 110.405 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 80.5 m-20 -146.74 170.02 17.86 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.106 -0.996 . . . . 1.0 109.985 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.26 177.51 40.35 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.483 -1.447 . . . . 1.0 109.483 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.5 mt -93.81 136.45 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.212 -1.17 . . . . 1.0 109.105 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -107.83 173.16 6.44 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.404 -0.81 . . . . 1.0 109.415 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -60.04 -49.18 78.66 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.193 -0.942 . . . . 1.0 109.216 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.0 mt -119.99 117.52 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.471 -0.768 . . . . 1.0 109.179 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.8 ptp -100.97 140.0 35.88 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.209 -0.932 . . . . 1.0 109.293 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.4 HG21 ' CZ ' ' A' ' 35' ' ' PHE . 86.4 mt -110.01 130.09 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.622 -0.674 . . . . 1.0 109.802 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 31.0 p -150.51 156.21 40.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.217 -0.927 . . . . 1.0 109.826 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.712 ' H ' HD21 ' A' ' 21' ' ' ASN . 91.5 m-85 -102.76 122.79 45.2 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.292 -1.003 . . . . 1.0 108.292 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.7 -177.28 23.93 Favored Glycine 0 N--CA 1.499 2.891 0 N-CA-C 110.709 -0.956 . . . . 1.0 110.709 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.568 HG22 ' N ' ' A' ' 67' ' ' LYS . 87.6 mt -136.62 164.63 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.71 -0.877 . . . . 1.0 108.813 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.568 ' N ' HG22 ' A' ' 66' ' ' ILE . 20.1 tptm -15.04 -78.97 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.504 0 N-CA-C 112.377 0.51 . . . . 1.0 112.377 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -72.37 144.84 48.08 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.114 -0.991 . . . . 1.0 110.862 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.3 m80 -134.45 173.03 12.09 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 108.269 -1.011 . . . . 1.0 108.269 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.02 -42.86 98.57 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.057 -1.617 . . . . 1.0 109.057 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -80.19 161.38 25.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.287 -1.125 . . . . 1.0 108.855 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -90.32 97.84 11.42 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.985 -1.072 . . . . 1.0 109.764 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.558 ' O ' ' CG ' ' A' ' 73' ' ' TYR . 10.1 p90 -172.3 51.27 0.13 Allowed Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 108.797 -0.816 . . . . 1.0 108.797 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.515 ' CD ' ' N ' ' A' ' 73' ' ' TYR . 13.4 Cg_exo -41.61 160.91 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.159 0 C-N-CA 121.361 1.374 . . . . 1.0 113.083 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.517 ' CD2' ' OD2' ' A' ' 99' ' ' ASP . 34.0 m-85 -88.82 -176.16 5.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.706 -0.621 . . . . 1.0 109.507 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -99.94 0.04 40.41 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.217 -0.927 . . . . 1.0 110.478 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 128.05 -139.46 11.1 Favored Glycine 0 N--CA 1.502 3.056 0 N-CA-C 108.344 -1.902 . . . . 1.0 108.344 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.448 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 24.9 Cg_endo -79.02 -52.9 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.314 0 CA-C-N 119.917 1.859 . . . . 1.0 112.09 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 91.6 p -79.6 170.49 16.48 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.205 -0.934 . . . . 1.0 110.086 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.82 -122.5 7.6 Favored Glycine 0 N--CA 1.498 2.817 0 N-CA-C 110.488 -1.045 . . . . 1.0 110.488 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.465 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 9.8 mt -67.26 100.48 0.81 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.454 -1.027 . . . . 1.0 109.111 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 64.2 mt -79.06 -20.03 49.87 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.014 -1.054 . . . . 1.0 110.03 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.01 171.99 1.32 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 1.0 109.035 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.528 ' CE1' ' OH ' ' A' ' 73' ' ' TYR . 6.4 p80 -162.28 159.14 25.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.012 -1.055 . . . . 1.0 109.896 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.08 156.18 42.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.49 -0.756 . . . . 1.0 109.322 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -103.5 150.94 38.55 Favored Pre-proline 0 N--CA 1.496 1.863 0 N-CA-C 108.39 -0.967 . . . . 1.0 108.39 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.73 166.47 11.85 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 120.924 1.083 . . . . 1.0 111.42 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -55.52 139.71 82.58 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 120.661 0.907 . . . . 1.0 111.361 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -160.28 -172.02 26.96 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 109.384 -1.486 . . . . 1.0 109.384 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.44 -76.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.114 1.209 . . . . 1.0 112.189 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -119.96 -49.78 2.3 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.439 -0.788 . . . . 1.0 110.23 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.469 ' CD1' ' N ' ' A' ' 93' ' ' GLY . 40.4 p90 -62.76 -39.92 95.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.956 -1.09 . . . . 1.0 110.097 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.469 ' N ' ' CD1' ' A' ' 92' ' ' TYR . . . -69.32 168.1 45.91 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.909 -1.276 . . . . 1.0 109.909 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 71.87 64.26 2.74 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.906 -1.278 . . . . 1.0 109.906 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -153.41 160.89 42.72 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.234 -1.157 . . . . 1.0 109.602 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.04 122.43 9.05 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.209 -0.932 . . . . 1.0 109.526 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -109.72 155.98 20.86 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.596 -0.69 . . . . 1.0 109.392 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.524 ' CE2' ' OE2' ' A' ' 120' ' ' GLU . 29.1 m-85 -130.23 143.66 50.91 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.197 -1.038 . . . . 1.0 108.197 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.517 ' OD2' ' CD2' ' A' ' 75' ' ' PHE . 93.6 m-20 -80.01 117.06 20.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.725 -1.234 . . . . 1.0 109.576 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 39.1 t0 -81.59 2.74 27.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.386 -0.821 . . . . 1.0 109.559 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -81.2 -17.34 49.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 1.0 110.101 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' A' ' 102' ' ' GLU . 58.0 mp0 -92.86 174.87 7.02 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.018 -1.051 . . . . 1.0 109.605 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 23.3 m -99.14 105.12 17.17 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.529 -0.915 . . . . 1.0 108.529 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -85.21 128.12 34.55 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.347 -0.845 . . . . 1.0 108.73 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.661 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.9 t -142.77 158.33 43.74 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.416 -0.803 . . . . 1.0 109.781 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.6 t -95.56 -9.09 33.28 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.253 -1.017 . . . . 1.0 108.253 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.4 t -92.1 -171.6 2.88 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.888 -0.782 . . . . 1.0 108.888 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.5 t -88.38 77.77 8.07 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.077 -1.014 . . . . 1.0 109.619 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.661 ' HB2' HG21 ' A' ' 105' ' ' THR . 60.4 mttp -149.31 151.39 34.07 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.324 -0.86 . . . . 1.0 108.761 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.48 -137.7 5.29 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.949 -1.26 . . . . 1.0 109.949 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -100.06 118.97 37.55 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.376 -1.073 . . . . 1.0 109.316 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.65 HD21 ' HZ2' ' A' ' 146' ' ' LYS . 23.8 t-20 -65.52 130.11 42.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 1.0 110.059 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 58.6 tp -60.06 -47.11 87.24 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.368 -0.832 . . . . 1.0 111.295 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -59.79 -42.9 94.4 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.083 -1.01 . . . . 1.0 111.843 -177.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 115' ' ' LEU . 4.0 mm? -60.01 -49.99 75.5 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.532 -1.355 . . . . 1.0 109.21 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 65.3 t -66.66 -42.36 89.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.244 -0.91 . . . . 1.0 110.866 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.97 -48.74 79.06 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.081 -1.012 . . . . 1.0 110.325 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.35 -39.17 82.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.947 -1.096 . . . . 1.0 110.294 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.441 ' CE1' ' HE2' ' A' ' 123' ' ' HIS . 56.4 t60 -65.27 -52.42 54.41 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.137 -0.977 . . . . 1.0 111.411 -178.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.524 ' OE2' ' CE2' ' A' ' 98' ' ' PHE . 10.1 pt-20 -60.03 -42.3 94.1 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.772 -1.205 . . . . 1.0 110.609 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -60.09 -39.86 87.59 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.729 -1.232 . . . . 1.0 108.814 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -54.82 -42.74 80.1 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.366 -1.494 . . . . 1.0 109.366 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.441 ' HE2' ' CE1' ' A' ' 119' ' ' HIS . 90.1 m-70 -65.68 -39.1 90.94 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.125 -1.221 . . . . 1.0 109.134 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.1 p -62.14 -24.97 67.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -0.903 . . . . 1.0 109.892 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 88.8 mt -81.19 -0.08 38.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.057 -1.027 . . . . 1.0 109.792 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 91.89 10.36 61.49 Favored Glycine 0 N--CA 1.498 2.784 0 O-C-N 121.058 -1.026 . . . . 1.0 110.668 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.3 mt -84.71 150.01 25.4 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.931 -1.334 . . . . 1.0 109.462 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 37.1 t0 -100.65 169.99 8.66 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.435 -0.79 . . . . 1.0 109.06 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.526 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 74.8 m80 -59.99 139.74 57.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.153 -0.967 . . . . 1.0 109.545 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 41.2 t -96.25 156.16 16.46 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.27 -0.894 . . . . 1.0 108.913 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -99.13 3.95 46.75 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.127 -0.983 . . . . 1.0 109.574 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -87.07 129.49 51.73 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.089 -1.007 . . . . 1.0 108.726 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -67.9 -27.82 36.61 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 CA-C-N 120.086 1.066 . . . . 1.0 113.022 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -84.86 -2.31 88.58 Favored Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.824 -1.179 . . . . 1.0 110.454 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.83 146.81 26.07 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.022 -1.281 . . . . 1.0 110.015 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 86.5 mt -70.06 -29.96 67.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.221 -0.924 . . . . 1.0 109.677 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.2 mmm -73.6 8.3 1.94 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.183 -0.948 . . . . 1.0 110.171 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -69.41 132.64 89.48 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.096 -1.002 . . . . 1.0 108.595 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -63.41 14.19 0.07 OUTLIER 'Trans proline' 0 N--CA 1.505 2.182 0 C-N-CA 121.152 1.235 . . . . 1.0 115.167 -177.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 76.0 mt -130.78 138.02 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.382 0 O-C-N 120.785 -1.197 . . . . 1.0 109.495 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.42 ' CD1' ' C ' ' A' ' 141' ' ' TYR . 21.5 t80 -73.37 128.3 35.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.444 -0.785 . . . . 1.0 109.957 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 10.0 t -136.56 137.0 39.76 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.579 -0.701 . . . . 1.0 109.197 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -85.11 143.18 29.0 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.17 -0.956 . . . . 1.0 109.265 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.7 t -140.38 151.19 44.77 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.3 -0.875 . . . . 1.0 109.52 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -68.89 109.39 2.87 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.734 -1.746 . . . . 1.0 108.734 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.65 ' HZ2' HD21 ' A' ' 112' ' ' ASN . 85.0 mttt -73.35 126.03 29.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.133 -1.216 . . . . 1.0 109.298 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 10.6 p -176.86 -93.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.307 -0.871 . . . . 1.0 109.111 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -98.81 18.83 16.09 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.664 -0.865 . . . . 1.0 108.664 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -60.15 134.62 57.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.592 -0.693 . . . . 1.0 109.829 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 95.0 mtp -136.96 150.14 47.98 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.732 -0.84 . . . . 1.0 108.732 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.404 HD22 ' CZ3' ' A' ' 42' ' ' TRP . 20.8 mt -48.23 125.87 11.85 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.069 -1.02 . . . . 1.0 108.949 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -62.83 175.62 2.25 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 CA-C-N 120.118 1.078 . . . . 1.0 112.201 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.02 -39.95 87.62 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.311 -0.868 . . . . 1.0 109.553 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.403 ' OD1' ' C ' ' A' ' 154' ' ' ASP . 52.7 t0 -55.89 -50.02 71.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.911 . . . . 1.0 109.739 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -70.07 -39.94 75.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.143 -0.973 . . . . 1.0 110.427 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.3 t -59.97 -46.41 94.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.903 -1.123 . . . . 1.0 109.018 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -60.3 -40.04 89.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.977 -1.077 . . . . 1.0 110.278 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -67.93 -55.89 12.5 Favored Glycine 0 N--CA 1.494 2.526 0 O-C-N 121.12 -0.988 . . . . 1.0 111.152 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.468 HG23 ' N ' ' A' ' 160' ' ' GLN . 5.3 tp -60.44 -39.98 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.909 -1.347 . . . . 1.0 109.523 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.472 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.5 mt-30 -65.28 -39.93 93.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.076 -1.015 . . . . 1.0 109.812 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 85.6 p -60.05 -33.92 72.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.064 -1.023 . . . . 1.0 110.488 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.4 mt -84.83 -56.71 3.44 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.004 -1.06 . . . . 1.0 111.167 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -89.66 -9.0 51.21 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.989 -1.07 . . . . 1.0 110.647 -178.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.497 2.748 0 N-CA-C 109.538 -1.425 . . . . 1.0 109.538 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' WAY . . . . . 0.803 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 90.5 m . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.413 -0.588 . . . . 1.0 109.413 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.2 mt -68.1 139.28 56.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 1.0 109.343 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.5 pttm -165.12 167.04 18.61 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.37 -0.831 . . . . 1.0 109.442 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -71.88 142.32 49.54 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.182 -0.949 . . . . 1.0 109.188 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.3 t -89.86 4.47 49.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.253 -0.905 . . . . 1.0 109.924 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -145.07 154.1 42.13 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.182 -0.949 . . . . 1.0 109.452 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.1 mmt -90.47 0.51 57.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.287 -0.883 . . . . 1.0 109.684 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -95.73 126.9 41.31 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.218 -0.927 . . . . 1.0 109.554 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.8 mt -143.26 149.16 37.49 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.366 -0.834 . . . . 1.0 108.816 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.0 p -132.78 155.18 49.37 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.424 -0.798 . . . . 1.0 108.851 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.499 ' CD2' ' NH1' ' A' ' 52' ' ' ARG . 34.7 p90 -148.4 160.12 43.34 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.821 -1.174 . . . . 1.0 110.752 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.403 ' NH1' ' HG2' ' A' ' 18' ' ' ARG . 35.0 ttt-85 -145.72 134.77 22.68 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.387 -0.598 . . . . 1.0 109.387 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.745 ' H ' HH22 ' A' ' 52' ' ' ARG . 93.5 mt -89.9 119.1 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 120.792 -1.193 . . . . 1.0 108.684 178.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 56.1 t -69.0 -40.78 81.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.964 -1.085 . . . . 1.0 109.027 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.4 p-10 -162.95 164.12 25.9 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.032 -1.067 . . . . 1.0 110.203 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.516 ' CD2' ' CG ' ' A' ' 28' ' ' HIS . 36.7 m-85 -103.42 -161.08 0.81 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.646 -1.613 . . . . 1.0 106.646 178.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.12 151.84 74.95 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.614 -0.679 . . . . 1.0 110.668 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -70.19 -14.28 34.55 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.056 1.171 . . . . 1.0 110.062 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -59.45 -40.02 85.5 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 115.307 -0.86 . . . . 1.0 110.027 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.6 mtm -140.47 168.07 20.68 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.343 -0.848 . . . . 1.0 109.236 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.4 p -72.79 159.98 32.92 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.401 -0.812 . . . . 1.0 109.207 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.516 ' CG ' ' CD2' ' A' ' 22' ' ' TYR . 51.2 m170 -59.97 -40.0 87.56 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.442 -0.787 . . . . 1.0 110.007 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 61.9 m -60.01 -40.06 87.98 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.165 -0.959 . . . . 1.0 110.488 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.65 -39.96 91.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.96 -1.088 . . . . 1.0 109.838 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.4 t -69.51 -41.38 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.135 -0.978 . . . . 1.0 110.485 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.0 -49.05 79.18 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.989 -1.069 . . . . 1.0 110.495 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -62.17 -32.91 73.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.987 -1.071 . . . . 1.0 109.825 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.98 -50.43 73.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.184 -0.948 . . . . 1.0 110.042 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -65.82 -38.94 90.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.054 -1.029 . . . . 1.0 109.672 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.97 -42.36 93.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.06 -1.025 . . . . 1.0 109.808 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -60.56 -40.59 92.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.942 -1.098 . . . . 1.0 109.234 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.26 -43.1 96.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -0.89 . . . . 1.0 109.99 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -66.07 -40.01 90.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.03 -1.043 . . . . 1.0 109.705 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -59.94 -47.87 84.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -0.934 . . . . 1.0 110.139 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 70.5 t -59.95 -40.04 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.058 -1.026 . . . . 1.0 109.965 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -81.66 -35.31 30.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.895 -1.128 . . . . 1.0 110.182 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.7 p -70.46 -22.82 62.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.92 -1.113 . . . . 1.0 109.414 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -59.96 -40.01 87.58 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.433 -0.792 . . . . 1.0 110.606 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.416 HG23 HG23 ' A' ' 46' ' ' THR . 8.5 m -112.14 25.35 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.372 -0.83 . . . . 1.0 110.729 -178.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.416 HG23 HG23 ' A' ' 45' ' ' VAL . 59.9 p -148.91 131.62 7.95 Favored Pre-proline 0 N--CA 1.501 2.09 0 O-C-N 120.88 -1.137 . . . . 1.0 109.796 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -72.93 20.54 0.33 Allowed 'Trans proline' 0 N--CA 1.495 1.577 0 CA-C-N 119.668 0.917 . . . . 1.0 112.032 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.9 mt -67.97 139.1 56.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.175 -0.953 . . . . 1.0 109.614 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -107.92 120.58 42.7 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.851 -0.796 . . . . 1.0 108.851 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -107.21 127.1 53.22 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.304 -0.873 . . . . 1.0 110.023 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.3 m -120.05 129.98 54.48 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.648 -0.657 . . . . 1.0 109.404 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.745 HH22 ' H ' ' A' ' 19' ' ' ILE . 28.9 tpt180 -84.03 136.5 34.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.247 -0.908 . . . . 1.0 109.833 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.0 mt -110.61 128.71 55.79 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.438 -0.789 . . . . 1.0 109.26 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.44 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 56.6 m170 -69.43 -39.78 77.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.396 -0.815 . . . . 1.0 109.708 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 76.7 m-20 -148.77 168.66 22.33 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.231 -0.918 . . . . 1.0 110.084 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.27 -175.48 29.52 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 109.868 -1.293 . . . . 1.0 109.868 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.7 mt -94.46 133.98 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.313 -1.11 . . . . 1.0 109.021 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.79 163.0 14.66 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.493 -0.754 . . . . 1.0 109.511 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -59.94 -49.25 78.41 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.279 -0.888 . . . . 1.0 109.045 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.418 HG23 ' O ' ' A' ' 94' ' ' GLY . 95.8 mt -113.64 108.36 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.465 -0.772 . . . . 1.0 109.516 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.6 ptm -103.47 132.44 49.72 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.207 -0.933 . . . . 1.0 109.435 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 90.1 mt -102.34 138.25 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.506 -0.746 . . . . 1.0 109.777 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.8 p -153.63 157.34 39.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.249 -0.907 . . . . 1.0 109.49 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -102.08 125.28 48.73 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.8 -0.815 . . . . 1.0 108.8 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.14 158.04 16.21 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.424 -1.071 . . . . 1.0 110.424 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.414 HG12 ' H ' ' A' ' 67' ' ' LYS . 9.8 tt -109.8 -178.03 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.758 -0.83 . . . . 1.0 108.758 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.414 ' H ' HG12 ' A' ' 66' ' ' ILE . 22.0 tptm -38.52 -78.76 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.748 -0.595 . . . . 1.0 110.221 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -73.09 126.28 29.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.119 -0.988 . . . . 1.0 110.058 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.45 ' CE1' ' CE1' ' A' ' 75' ' ' PHE . 0.9 OUTLIER -100.09 -2.51 34.07 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.225 -0.922 . . . . 1.0 108.873 179.829 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.96 7.19 88.72 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.651 -1.78 . . . . 1.0 108.651 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.401 ' C ' ' H ' ' A' ' 73' ' ' TYR . 96.0 m-20 -131.51 170.02 15.29 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.676 -0.897 . . . . 1.0 108.929 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.411 ' CE2' ' CZ ' ' A' ' 73' ' ' TYR . 24.3 p90 -73.64 43.65 0.15 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.108 -0.995 . . . . 1.0 109.742 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.411 ' CZ ' ' CE2' ' A' ' 72' ' ' PHE . 55.0 m-85 -132.48 74.75 74.97 Favored Pre-proline 0 N--CA 1.501 2.106 0 O-C-N 121.458 -0.776 . . . . 1.0 109.164 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -80.16 146.3 17.8 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.395 1.397 . . . . 1.0 112.391 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.537 ' CE2' ' OD1' ' A' ' 99' ' ' ASP . 27.2 m-85 -93.14 169.41 10.43 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.366 -0.976 . . . . 1.0 108.366 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 79' ' ' SER . 23.7 p-10 -99.95 10.25 41.61 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.046 -1.034 . . . . 1.0 110.948 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 110.73 -150.5 17.72 Favored Glycine 0 N--CA 1.507 3.395 0 N-CA-C 109.557 -1.417 . . . . 1.0 109.557 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -58.77 -65.81 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.577 0 CA-C-N 118.913 1.357 . . . . 1.0 112.846 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.433 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 78.9 p -75.24 159.16 31.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.095 -1.003 . . . . 1.0 109.693 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.22 -128.59 8.04 Favored Glycine 0 N--CA 1.5 2.944 0 N-CA-C 109.773 -1.331 . . . . 1.0 109.773 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.464 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 14.8 mt -69.4 105.84 2.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.326 -1.102 . . . . 1.0 109.41 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.42 HD23 ' OE2' ' A' ' 102' ' ' GLU . 72.2 mt -78.73 -24.4 44.88 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.127 -0.983 . . . . 1.0 108.738 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.65 169.99 1.31 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.053 -1.091 . . . . 1.0 108.053 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -163.0 161.39 25.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.855 -1.153 . . . . 1.0 110.209 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -145.5 162.31 37.68 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.502 -0.749 . . . . 1.0 109.193 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -103.06 151.92 38.5 Favored Pre-proline 0 N--CA 1.501 2.113 0 O-C-N 121.114 -0.991 . . . . 1.0 109.227 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.442 ' O ' ' N ' ' A' ' 89' ' ' GLY . 7.4 Cg_exo -49.67 167.15 0.19 Allowed 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 120.784 0.99 . . . . 1.0 112.518 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -61.61 73.83 0.09 OUTLIER 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.249 1.299 . . . . 1.0 111.845 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -89.76 -168.4 43.11 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 108.852 -1.699 . . . . 1.0 108.852 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 89' ' ' GLY . 17.0 Cg_exo -56.04 -147.41 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 121.215 1.277 . . . . 1.0 112.713 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -60.34 -40.0 89.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.292 -0.88 . . . . 1.0 110.172 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -70.04 -38.58 75.89 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.072 -1.018 . . . . 1.0 109.462 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -59.37 169.52 6.37 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.669 -1.372 . . . . 1.0 109.669 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.418 ' O ' HG23 ' A' ' 60' ' ' ILE . . . 73.42 16.11 78.92 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.206 -1.158 . . . . 1.0 110.206 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.2 p-10 -79.93 166.26 21.8 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.967 -1.314 . . . . 1.0 109.716 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.87 123.17 10.26 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.279 -0.888 . . . . 1.0 109.27 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 57.5 m170 -112.31 154.8 25.12 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.571 -0.705 . . . . 1.0 109.973 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.519 ' CZ ' ' OE2' ' A' ' 120' ' ' GLU . 38.9 m-85 -133.12 149.79 52.09 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.625 -0.88 . . . . 1.0 108.625 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.537 ' OD1' ' CE2' ' A' ' 75' ' ' PHE . 64.4 m-20 -79.93 123.23 27.59 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.964 -1.085 . . . . 1.0 110.058 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -84.8 -9.72 57.89 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.297 -0.877 . . . . 1.0 109.621 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -84.73 -11.55 55.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.261 -0.899 . . . . 1.0 109.848 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.42 ' OE2' HD23 ' A' ' 82' ' ' LEU . 96.1 mt-10 -90.02 169.94 10.77 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.37 -0.831 . . . . 1.0 110.026 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 16.7 m -100.14 105.19 16.78 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.435 -0.79 . . . . 1.0 109.101 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -89.32 124.29 34.28 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.084 -0.71 . . . . 1.0 109.084 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.686 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.8 t -140.7 154.55 46.4 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.279 -0.888 . . . . 1.0 110.151 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 70.2 m -92.88 -8.01 44.59 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.427 -0.953 . . . . 1.0 108.427 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.4 m -92.63 176.78 6.32 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.9 m -79.72 76.64 6.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.998 -1.064 . . . . 1.0 109.428 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.686 ' HB2' HG21 ' A' ' 105' ' ' THR . 98.2 mttt -147.26 148.66 31.67 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.392 -0.817 . . . . 1.0 108.866 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 46.11 -139.39 6.66 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.747 -1.341 . . . . 1.0 109.747 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -99.7 114.41 27.5 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.251 -1.146 . . . . 1.0 109.21 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -63.69 133.76 54.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.137 -0.977 . . . . 1.0 109.538 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.3 tp -59.99 -44.76 94.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.506 -0.747 . . . . 1.0 110.825 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -59.97 -42.75 94.84 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.005 -1.06 . . . . 1.0 110.561 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -59.61 -50.01 75.54 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.878 -1.139 . . . . 1.0 109.363 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.7 t -69.07 -41.46 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.15 -0.969 . . . . 1.0 109.691 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.63 -50.16 74.85 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.369 -0.832 . . . . 1.0 110.274 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.44 -38.71 81.41 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.865 -1.147 . . . . 1.0 110.218 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -64.02 -50.01 70.17 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.093 -1.004 . . . . 1.0 111.031 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.519 ' OE2' ' CZ ' ' A' ' 98' ' ' PHE . 7.4 pt-20 -59.99 -44.64 94.38 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.698 -1.251 . . . . 1.0 110.048 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -59.99 -40.03 87.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.785 -1.197 . . . . 1.0 108.895 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.29 -43.75 64.85 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.241 -1.543 . . . . 1.0 109.241 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -66.29 -39.93 89.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.217 -1.166 . . . . 1.0 109.112 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 77.4 p -62.39 -21.41 65.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.898 . . . . 1.0 109.561 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.5 mt -83.0 -3.55 57.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 1.0 109.391 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 92.4 8.14 62.92 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.524 -1.03 . . . . 1.0 110.524 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.3 mt -86.58 146.34 26.39 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.95 -1.324 . . . . 1.0 109.208 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 27.7 t0 -99.47 175.29 5.9 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.476 -0.765 . . . . 1.0 109.576 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.512 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 75.2 m80 -61.15 135.66 57.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 1.0 109.72 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 41.5 t -97.37 156.7 16.34 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.21 -0.931 . . . . 1.0 109.358 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -97.33 0.39 47.9 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.155 -0.965 . . . . 1.0 109.632 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -83.7 130.23 56.46 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.171 -0.955 . . . . 1.0 108.476 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -70.58 -20.69 30.67 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 CA-C-N 120.022 1.044 . . . . 1.0 112.384 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -87.58 -5.05 79.2 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.823 -1.311 . . . . 1.0 109.823 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.73 145.72 26.55 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.173 -1.192 . . . . 1.0 109.267 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 138' ' ' PHE . 95.5 mt -70.67 -30.98 67.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.078 -1.014 . . . . 1.0 109.477 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 98.2 mmm -70.23 14.14 0.13 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.364 -0.835 . . . . 1.0 109.766 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.468 ' H ' ' C ' ' A' ' 136' ' ' LEU . 13.5 t80 -68.89 134.03 90.07 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.071 -1.018 . . . . 1.0 108.297 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -62.67 -18.36 63.6 Favored 'Trans proline' 0 N--CA 1.501 1.957 0 C-N-CA 121.04 1.16 . . . . 1.0 113.985 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.8 mt -102.79 141.43 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 120.834 -1.166 . . . . 1.0 109.691 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -75.58 126.01 30.16 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.331 -0.856 . . . . 1.0 110.221 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 11.0 t -134.73 137.46 43.5 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.426 -0.796 . . . . 1.0 109.268 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -80.1 143.56 33.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.966 -1.084 . . . . 1.0 108.6 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.9 t -139.83 151.73 45.94 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.313 -0.867 . . . . 1.0 109.615 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.55 104.75 1.51 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.374 -1.49 . . . . 1.0 109.374 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -77.9 1.72 19.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.26 -1.141 . . . . 1.0 109.95 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 73.3 m -60.05 -40.1 88.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.193 -0.942 . . . . 1.0 109.652 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -143.41 29.45 1.43 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.246 -0.909 . . . . 1.0 109.468 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -69.7 138.87 53.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.173 -0.955 . . . . 1.0 110.11 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 93.9 mtp -138.79 146.67 41.62 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.544 -0.91 . . . . 1.0 108.544 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 58.1 mt -51.74 129.03 36.29 Favored Pre-proline 0 C--N 1.302 -1.483 0 O-C-N 121.111 -0.993 . . . . 1.0 108.728 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -69.2 178.56 4.11 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 CA-C-N 119.985 1.03 . . . . 1.0 112.266 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -63.11 -39.89 96.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.476 -0.765 . . . . 1.0 110.12 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -55.64 -48.56 74.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.337 -0.852 . . . . 1.0 109.764 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -69.93 -40.03 75.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.97 . . . . 1.0 109.847 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.04 -48.13 89.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.075 -1.016 . . . . 1.0 108.995 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -60.11 -40.02 88.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.191 -0.943 . . . . 1.0 110.261 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.43 -55.0 7.11 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 120.199 -1.001 . . . . 1.0 111.477 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.49 HG23 ' N ' ' A' ' 160' ' ' GLN . 5.3 tp -60.0 -40.14 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.967 -1.313 . . . . 1.0 109.732 -178.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.55 ' O ' ' N ' ' A' ' 164' ' ' GLY . 12.4 mm100 -64.43 -39.34 93.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.209 -0.932 . . . . 1.0 109.316 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 79.9 p -60.95 -34.13 74.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.139 -0.976 . . . . 1.0 110.484 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.2 mt -84.43 -52.79 5.9 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.877 -1.139 . . . . 1.0 110.671 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -90.67 -8.01 51.1 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.046 -1.034 . . . . 1.0 110.541 -178.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.536 0 N-CA-C 109.288 -1.525 . . . . 1.0 109.288 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' WAY . . . . . 0.946 ' HC2' ' HJ ' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.3 m . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.369 -0.604 . . . . 1.0 109.369 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.3 mt -60.68 139.99 57.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.92 -1.112 . . . . 1.0 109.328 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -160.34 159.97 31.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.24 -0.913 . . . . 1.0 109.384 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -76.37 127.24 32.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.148 -0.97 . . . . 1.0 109.259 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.4 p -69.24 -38.48 78.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.038 -1.039 . . . . 1.0 108.933 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.404 ' H ' ' HG2' ' A' ' 12' ' ' LYS . 49.1 pttt -89.47 136.43 33.03 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.932 -1.136 . . . . 1.0 107.932 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.611 ' N ' ' SD ' ' A' ' 13' ' ' MET . 4.8 mmm -90.7 -0.27 57.64 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.065 -1.022 . . . . 1.0 109.872 -178.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -97.98 132.72 43.3 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.997 -1.112 . . . . 1.0 107.997 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.6 mt -139.57 149.92 44.43 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.202 -0.936 . . . . 1.0 109.376 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.7 p -135.67 156.43 48.85 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.661 -0.866 . . . . 1.0 108.661 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -145.86 160.04 42.35 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.137 -0.977 . . . . 1.0 109.958 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.435 ' HE ' ' HA ' ' A' ' 55' ' ' ASP . 37.0 ttt-85 -144.31 134.94 24.84 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.49 -0.756 . . . . 1.0 109.272 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.8 mt -87.54 119.68 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.244 -0.91 . . . . 1.0 108.748 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.5 t -69.17 -39.93 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.239 -0.913 . . . . 1.0 109.345 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -165.01 153.08 11.67 Favored 'General case' 0 C--N 1.29 -1.991 0 O-C-N 120.163 -1.586 . . . . 1.0 110.802 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -100.81 106.52 17.92 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 105.87 -1.9 . . . . 1.0 105.87 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.459 ' C ' ' H ' ' A' ' 25' ' ' ASP . 0.4 OUTLIER -45.45 140.04 4.32 Favored Pre-proline 0 C--N 1.299 -1.612 0 O-C-N 121.487 -0.758 . . . . 1.0 109.591 -177.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -59.22 -3.05 1.51 Allowed 'Trans proline' 0 N--CA 1.487 1.111 0 CA-C-N 119.358 0.807 . . . . 1.0 110.75 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.459 ' H ' ' C ' ' A' ' 23' ' ' THR . 94.3 m-20 -59.73 -36.04 75.79 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.585 -0.524 . . . . 1.0 109.585 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 78.0 mtm -140.0 166.75 23.8 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.219 -0.925 . . . . 1.0 109.801 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.6 p -71.63 160.15 33.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.417 -0.802 . . . . 1.0 109.335 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -60.09 -40.93 91.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.307 -0.871 . . . . 1.0 110.32 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.5 m -60.03 -40.34 88.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.935 -1.103 . . . . 1.0 110.875 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.01 -42.96 89.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.109 -0.994 . . . . 1.0 110.767 -178.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.7 t -65.37 -39.87 86.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 121.248 -0.907 . . . . 1.0 109.598 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -58.1 -54.97 41.0 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.371 -0.831 . . . . 1.0 111.708 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.9 pttt -63.47 -33.68 76.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.607 -1.308 . . . . 1.0 110.723 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.37 -50.78 70.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.637 -1.289 . . . . 1.0 109.666 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.45 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 47.3 m-85 -67.69 -38.81 84.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.842 -1.161 . . . . 1.0 110.401 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -59.89 -40.69 89.58 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.724 -1.235 . . . . 1.0 109.438 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -60.72 -39.94 90.48 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.158 -0.964 . . . . 1.0 108.988 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.09 -47.12 87.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.432 -0.792 . . . . 1.0 109.834 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -65.21 -38.9 91.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.081 -1.012 . . . . 1.0 109.656 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 44.0 tptt -59.95 -47.83 84.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.079 -1.013 . . . . 1.0 109.893 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.5 t -60.07 -40.77 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.28 -0.887 . . . . 1.0 110.79 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -82.32 -35.38 27.96 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.86 -1.15 . . . . 1.0 110.483 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.6 p -70.03 -17.3 63.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.13 -0.981 . . . . 1.0 109.606 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -59.82 -39.98 86.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.261 -0.9 . . . . 1.0 110.868 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.4 m -110.85 -19.46 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 O-C-N 121.147 -0.971 . . . . 1.0 110.487 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.3 p -94.46 129.79 35.66 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 120.843 -1.161 . . . . 1.0 109.709 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -73.01 10.18 1.18 Allowed 'Trans proline' 0 N--CA 1.494 1.553 0 CA-C-N 119.831 0.975 . . . . 1.0 111.953 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.7 mt -67.95 140.61 56.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.215 -0.928 . . . . 1.0 109.822 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -104.47 121.97 44.55 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.933 -0.765 . . . . 1.0 108.933 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -107.69 122.42 46.69 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.293 -0.879 . . . . 1.0 109.699 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.0 m -119.88 129.98 54.64 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.483 -0.76 . . . . 1.0 109.615 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.475 ' CB ' ' NH1' ' A' ' 52' ' ' ARG . 11.1 ttp-105 -85.03 133.66 34.24 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.288 -0.883 . . . . 1.0 109.725 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 86.2 mt -102.52 126.72 49.67 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.269 -0.894 . . . . 1.0 109.353 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.425 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 54.8 m170 -61.41 -39.87 92.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.447 -0.783 . . . . 1.0 109.874 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.435 ' HA ' ' HE ' ' A' ' 18' ' ' ARG . 80.8 m-20 -146.19 171.4 14.99 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.225 -0.922 . . . . 1.0 109.563 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.24 179.87 38.12 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.758 -1.337 . . . . 1.0 109.758 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.5 mt -95.56 136.39 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.313 -1.11 . . . . 1.0 109.262 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.72 163.58 14.39 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.483 -0.761 . . . . 1.0 109.244 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -59.99 -49.77 76.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -0.895 . . . . 1.0 109.472 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.9 mt -108.48 104.17 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.488 -0.757 . . . . 1.0 109.753 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.8 ptp -100.83 135.06 42.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.218 -0.926 . . . . 1.0 109.181 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.45 HG21 ' CZ ' ' A' ' 35' ' ' PHE . 85.5 mt -109.99 131.09 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.624 -0.673 . . . . 1.0 109.711 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.3 p -150.55 156.59 41.7 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.205 -0.935 . . . . 1.0 109.898 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -102.37 120.02 39.79 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.207 -1.035 . . . . 1.0 108.207 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.0 -169.48 23.25 Favored Glycine 0 N--CA 1.499 2.878 0 N-CA-C 110.629 -0.988 . . . . 1.0 110.629 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.603 HG22 ' N ' ' A' ' 67' ' ' LYS . 93.2 mt -134.39 168.99 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.139 -1.06 . . . . 1.0 108.139 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.603 ' N ' HG22 ' A' ' 66' ' ' ILE . 52.1 tptt -17.96 -98.01 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.649 0 CA-C-O 120.884 0.373 . . . . 1.0 111.455 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.632 ' CD ' ' H ' ' A' ' 68' ' ' GLU . 3.9 pm0 -74.26 139.49 44.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.817 -1.177 . . . . 1.0 109.973 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.497 ' CD2' ' OD2' ' A' ' 71' ' ' ASP . 44.2 p-80 -152.89 33.27 0.48 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.887 -1.133 . . . . 1.0 109.936 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.71 21.97 62.78 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 120.227 -0.987 . . . . 1.0 110.721 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.497 ' OD2' ' CD2' ' A' ' 69' ' ' HIS . 97.8 m-20 -129.98 145.53 51.64 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.216 -1.167 . . . . 1.0 109.545 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -74.02 156.14 37.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.368 -0.833 . . . . 1.0 109.332 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 49.96 60.03 15.77 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.139 -0.976 . . . . 1.0 109.354 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -60.28 -152.67 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 120.891 1.061 . . . . 1.0 111.987 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.585 ' CD1' ' OD1' ' A' ' 99' ' ' ASP . 90.6 m-85 -86.55 166.0 15.77 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.162 -0.961 . . . . 1.0 109.2 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -101.27 0.03 36.58 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.31 -0.869 . . . . 1.0 110.848 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 134.18 -150.27 19.97 Favored Glycine 0 N--CA 1.504 3.18 0 N-CA-C 108.767 -1.733 . . . . 1.0 108.767 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.424 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 2.8 Cg_exo -64.07 -64.1 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.339 0 CA-C-N 119.013 1.406 . . . . 1.0 111.473 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 94.3 p -77.83 160.85 28.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.118 -0.989 . . . . 1.0 109.331 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.98 -129.83 8.71 Favored Glycine 0 N--CA 1.501 3.007 0 N-CA-C 109.101 -1.6 . . . . 1.0 109.101 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.413 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 10.1 mt -69.41 107.5 3.35 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.132 -1.216 . . . . 1.0 108.735 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 55.6 mt -75.16 -25.77 58.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.942 -1.098 . . . . 1.0 109.31 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.92 172.94 1.25 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -164.61 160.01 19.65 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.999 -1.063 . . . . 1.0 109.648 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -142.86 153.77 43.49 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.412 -0.805 . . . . 1.0 108.867 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -89.18 151.92 47.31 Favored Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.047 -1.033 . . . . 1.0 108.683 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -58.64 165.37 8.01 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 120.951 1.101 . . . . 1.0 111.788 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -42.84 136.38 4.72 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 C-N-CA 121.215 1.277 . . . . 1.0 112.384 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -175.78 -169.35 37.3 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.212 -1.555 . . . . 1.0 109.212 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -61.44 -153.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 121.124 1.216 . . . . 1.0 112.038 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -60.08 -41.6 92.8 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.018 -1.051 . . . . 1.0 109.421 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -60.14 -43.42 95.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.153 -0.967 . . . . 1.0 109.69 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -78.1 168.26 53.92 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.28 -1.128 . . . . 1.0 110.28 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 72.5 7.03 67.57 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.343 -1.503 . . . . 1.0 109.343 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 -80.95 172.47 13.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.331 -1.099 . . . . 1.0 109.589 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.0 124.1 11.43 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.266 -0.896 . . . . 1.0 109.4 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -112.99 133.81 54.78 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.549 -0.72 . . . . 1.0 110.098 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.499 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 25.5 m-85 -116.15 149.41 39.08 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 109.005 -0.739 . . . . 1.0 109.005 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.585 ' OD1' ' CD1' ' A' ' 75' ' ' PHE . 82.0 m-20 -77.75 123.67 26.99 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.878 -1.138 . . . . 1.0 109.845 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 42.0 t0 -84.29 -11.56 56.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.447 -0.783 . . . . 1.0 109.184 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -82.19 -11.69 58.56 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.35 -0.844 . . . . 1.0 108.951 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.424 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 97.5 mt-10 -90.53 168.54 11.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.466 -0.771 . . . . 1.0 109.3 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 19.5 m -100.34 105.24 16.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.326 -0.859 . . . . 1.0 108.723 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.462 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 94.5 m95 -87.33 120.58 28.77 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.481 -0.762 . . . . 1.0 109.103 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.662 HG21 ' HB2' ' A' ' 109' ' ' LYS . 7.3 t -139.95 150.02 44.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.461 -0.774 . . . . 1.0 109.779 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 52.7 m -92.85 -6.14 49.43 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.214 -0.929 . . . . 1.0 108.534 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.6 t -92.03 175.69 6.78 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.871 -0.789 . . . . 1.0 108.871 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.1 t -75.59 75.29 2.61 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.028 -1.045 . . . . 1.0 109.222 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.662 ' HB2' HG21 ' A' ' 105' ' ' THR . 98.6 mttt -149.4 149.75 31.33 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.574 -0.898 . . . . 1.0 108.574 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 109' ' ' LYS . . . 42.98 -139.17 2.9 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 110.033 -1.227 . . . . 1.0 110.033 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -100.19 118.85 37.37 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.348 -1.089 . . . . 1.0 109.265 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -63.31 129.39 40.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.359 -0.838 . . . . 1.0 109.877 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.5 tp -60.01 -43.27 95.36 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.49 -0.756 . . . . 1.0 110.552 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -59.99 -41.63 92.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.214 -0.929 . . . . 1.0 111.177 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.61 -49.62 76.81 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.769 -1.207 . . . . 1.0 109.226 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 67.7 t -69.94 -41.32 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.301 -0.874 . . . . 1.0 110.712 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.34 -53.25 60.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.998 -1.064 . . . . 1.0 109.778 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.97 -34.43 73.27 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.186 -0.946 . . . . 1.0 109.785 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 60.0 t60 -63.12 -50.73 69.33 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.228 -0.92 . . . . 1.0 110.783 -178.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.499 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 6.9 pt-20 -60.0 -39.42 85.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.792 -1.192 . . . . 1.0 110.111 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -59.94 -40.01 87.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.904 -1.123 . . . . 1.0 108.798 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.67 -41.92 94.0 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.332 -1.507 . . . . 1.0 109.332 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -67.32 -39.96 85.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.139 -1.212 . . . . 1.0 109.577 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 95.4 p -68.97 -21.93 64.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.397 -0.814 . . . . 1.0 109.513 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 49.7 mt -82.99 -0.96 51.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 1.0 109.902 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 92.5 6.43 64.25 Favored Glycine 0 N--CA 1.498 2.77 0 C-N-CA 120.221 -0.99 . . . . 1.0 110.852 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.3 mt -85.1 144.86 27.95 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.745 -1.444 . . . . 1.0 109.916 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 44.6 t0 -99.01 172.43 7.41 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.167 -1.049 . . . . 1.0 108.167 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.528 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 74.6 m80 -61.76 132.17 52.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.757 -1.214 . . . . 1.0 109.281 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.7 t -97.35 158.39 15.49 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.253 -0.905 . . . . 1.0 109.135 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -99.92 8.45 44.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.322 -0.861 . . . . 1.0 109.279 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -85.14 125.35 70.46 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.188 -0.945 . . . . 1.0 108.895 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -66.91 -20.94 50.93 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 CA-C-N 120.195 1.105 . . . . 1.0 112.541 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -87.3 -7.14 77.06 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.078 -1.209 . . . . 1.0 110.078 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.87 139.58 31.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.117 -1.225 . . . . 1.0 109.458 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.453 ' C ' ' H ' ' A' ' 138' ' ' PHE . 91.6 mt -62.18 -40.05 94.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.142 -0.974 . . . . 1.0 109.88 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 85.8 mtp -70.5 24.72 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.245 -0.909 . . . . 1.0 111.04 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.453 ' H ' ' C ' ' A' ' 136' ' ' LEU . 23.5 t80 -69.94 129.99 90.41 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 120.766 -1.209 . . . . 1.0 108.331 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -49.55 -19.8 3.6 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 120.954 1.103 . . . . 1.0 114.505 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 90.6 mt -107.78 137.39 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 O-C-N 120.879 -1.138 . . . . 1.0 110.37 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -74.13 128.27 35.1 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.554 -0.716 . . . . 1.0 109.519 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.9 t -139.55 143.4 37.36 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.915 -0.772 . . . . 1.0 108.915 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -81.53 142.85 32.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.108 -0.995 . . . . 1.0 108.885 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.2 t -139.7 150.96 45.49 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.172 -0.955 . . . . 1.0 110.151 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.64 105.13 1.66 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.218 -1.553 . . . . 1.0 109.218 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 21.8 mtmm -75.74 1.9 13.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.379 -1.071 . . . . 1.0 109.834 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 67.9 m -59.92 -40.02 87.44 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.171 -0.955 . . . . 1.0 109.712 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -144.18 27.7 1.41 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.096 -1.003 . . . . 1.0 110.1 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -68.78 137.4 53.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.919 -1.113 . . . . 1.0 109.768 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 67.1 mtt -138.86 147.94 43.06 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.38 -0.825 . . . . 1.0 108.955 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 74.2 mt -51.57 124.84 26.55 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.0 -1.062 . . . . 1.0 108.631 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -67.81 -179.42 2.06 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 CA-C-N 120.102 1.072 . . . . 1.0 112.329 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -61.77 -39.58 92.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.333 -0.854 . . . . 1.0 109.868 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -56.98 -49.55 75.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -0.945 . . . . 1.0 110.01 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -70.09 -39.97 75.23 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.99 -1.069 . . . . 1.0 110.31 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 76.4 t -60.84 -48.36 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.958 -1.089 . . . . 1.0 108.927 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -60.36 -39.98 89.13 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.16 -0.962 . . . . 1.0 110.856 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.77 -53.79 7.91 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 120.06 -1.067 . . . . 1.0 111.121 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.461 HG23 ' N ' ' A' ' 160' ' ' GLN . 9.4 tp -60.56 -40.53 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.016 -1.284 . . . . 1.0 109.837 -178.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.527 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.9 mt-30 -65.81 -38.69 89.63 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.136 -0.977 . . . . 1.0 109.54 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 83.9 p -65.72 -24.98 67.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.119 -0.988 . . . . 1.0 110.666 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 87.8 mt -87.34 -50.72 6.38 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.747 -1.22 . . . . 1.0 110.0 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -93.01 -9.11 41.01 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.04 -1.038 . . . . 1.0 110.048 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.607 0 N-CA-C 109.548 -1.421 . . . . 1.0 109.548 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' WAY . . . . . 0.961 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.2 m . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.6 mt -87.41 139.94 30.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.239 -0.913 . . . . 1.0 109.173 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -161.24 163.37 31.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.065 -1.022 . . . . 1.0 109.647 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -71.16 146.2 49.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.881 . . . . 1.0 109.543 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 87.8 p -90.06 3.44 53.27 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.4 -0.812 . . . . 1.0 110.148 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -144.7 154.01 42.31 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.065 -1.022 . . . . 1.0 109.51 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.5 mmt -90.46 -0.04 57.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.229 -0.919 . . . . 1.0 109.748 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -96.65 125.49 41.16 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.126 -0.983 . . . . 1.0 109.182 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.0 mt -140.01 152.34 46.19 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.293 -0.88 . . . . 1.0 109.187 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.5 p -133.61 154.29 51.0 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.494 -0.754 . . . . 1.0 109.312 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -145.1 160.0 42.09 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.186 -0.946 . . . . 1.0 109.811 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 44.9 ttt-85 -144.61 131.5 20.27 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.427 -0.796 . . . . 1.0 109.503 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 86.0 mt -86.94 119.98 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.278 -0.889 . . . . 1.0 108.818 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.6 t -69.47 -41.53 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.089 -1.007 . . . . 1.0 109.282 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -165.09 155.02 13.31 Favored 'General case' 0 C--N 1.289 -2.06 0 O-C-N 119.967 -1.708 . . . . 1.0 110.412 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.411 ' O ' ' C ' ' A' ' 23' ' ' THR . 23.9 m-85 -99.4 95.94 7.37 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 105.907 -1.886 . . . . 1.0 105.907 178.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.411 ' C ' ' O ' ' A' ' 22' ' ' TYR . 1.5 t -39.86 142.53 0.66 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.963 -0.461 . . . . 1.0 110.619 -177.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -59.68 -21.48 63.11 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 120.436 0.757 . . . . 1.0 110.994 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -58.4 -14.86 8.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.73 -0.606 . . . . 1.0 109.865 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 78.0 mtp -142.7 150.78 40.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.291 -0.881 . . . . 1.0 109.816 -178.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.1 p -75.52 160.05 30.61 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.476 -0.935 . . . . 1.0 108.476 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.402 ' CD2' ' HB2' ' A' ' 22' ' ' TYR . 27.9 m170 -60.64 -40.1 90.72 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.12 -0.988 . . . . 1.0 109.948 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.9 m -64.82 -42.35 95.04 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.065 -1.022 . . . . 1.0 110.922 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -66.4 -40.11 89.42 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.153 -0.967 . . . . 1.0 111.321 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.4 t -67.91 -42.07 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.969 -1.082 . . . . 1.0 110.535 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -59.94 -49.49 77.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.127 -0.983 . . . . 1.0 110.715 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -64.15 -32.66 74.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.823 -1.173 . . . . 1.0 110.377 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.35 -50.62 73.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.794 -1.191 . . . . 1.0 110.01 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -69.35 -37.51 77.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.043 -1.036 . . . . 1.0 110.218 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -59.95 -42.72 94.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.981 -1.074 . . . . 1.0 109.484 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -61.78 -40.18 94.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.091 -1.006 . . . . 1.0 108.849 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.82 -50.83 71.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.444 -0.785 . . . . 1.0 110.135 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -63.26 -39.95 96.03 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.952 -1.092 . . . . 1.0 109.947 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -60.05 -48.65 80.84 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.062 -1.024 . . . . 1.0 109.841 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 72.0 t -60.03 -41.84 87.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.34 -0.85 . . . . 1.0 110.435 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -78.43 -34.81 47.63 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.958 -1.089 . . . . 1.0 110.23 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 52.4 p -72.33 -20.0 61.55 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.95 -1.094 . . . . 1.0 109.814 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -60.07 -40.02 88.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.496 -0.752 . . . . 1.0 111.417 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.5 m -111.87 22.48 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.241 -0.912 . . . . 1.0 111.131 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 48' ' ' LEU . 18.8 p -146.57 139.45 14.32 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 120.872 -1.142 . . . . 1.0 109.274 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -72.93 17.55 0.39 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 120.675 0.917 . . . . 1.0 111.178 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.411 ' H ' ' C ' ' A' ' 46' ' ' THR . 90.4 mt -67.65 134.12 50.58 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.361 -0.837 . . . . 1.0 110.374 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -108.78 120.53 42.77 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.531 -0.914 . . . . 1.0 108.531 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -108.4 130.34 55.23 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.309 -0.869 . . . . 1.0 109.418 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.5 m -120.03 130.01 54.51 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.571 -0.705 . . . . 1.0 110.147 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -82.83 129.54 35.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.397 -0.814 . . . . 1.0 109.277 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 89.4 mt -108.89 118.62 37.28 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 108.74 -0.837 . . . . 1.0 108.74 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.445 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 72.2 m-70 -70.18 -24.08 63.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.22 -0.925 . . . . 1.0 110.063 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 77.8 m-20 -148.33 162.88 38.63 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.216 -0.928 . . . . 1.0 109.876 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.21 174.9 39.14 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.746 -1.342 . . . . 1.0 109.746 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 87.5 mt -94.25 134.1 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.331 -1.1 . . . . 1.0 109.019 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.98 160.94 15.98 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.446 -0.784 . . . . 1.0 109.122 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.04 -49.34 78.06 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.178 -0.951 . . . . 1.0 109.113 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.9 mt -105.02 99.06 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.427 -0.796 . . . . 1.0 109.818 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.3 ptm -99.28 133.89 42.91 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.115 -0.99 . . . . 1.0 109.084 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.5 mt -106.09 137.4 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.536 -0.728 . . . . 1.0 109.749 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 81.8 p -153.13 155.82 37.46 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.129 -0.982 . . . . 1.0 109.565 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -104.88 123.96 48.63 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.573 -0.704 . . . . 1.0 109.127 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -103.82 -169.9 25.36 Favored Glycine 0 N--CA 1.5 2.949 0 N-CA-C 110.48 -1.048 . . . . 1.0 110.48 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.555 HG22 ' N ' ' A' ' 67' ' ' LYS . 70.9 mt -136.3 167.28 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.57 -0.959 . . . . 1.0 109.037 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.555 ' N ' HG22 ' A' ' 66' ' ' ILE . 20.7 tptm -21.45 -76.48 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.481 0 CA-C-O 121.185 0.517 . . . . 1.0 111.708 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.637 ' CD ' ' H ' ' A' ' 68' ' ' GLU . 4.3 pm0 -66.08 146.05 55.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -0.913 . . . . 1.0 109.733 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -128.52 151.18 49.72 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.935 -0.765 . . . . 1.0 108.935 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.92 -44.42 97.16 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.264 -1.535 . . . . 1.0 109.264 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 73' ' ' TYR . 92.3 m-20 -80.01 159.4 26.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.22 -1.165 . . . . 1.0 109.194 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -69.75 52.57 0.11 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.142 -0.974 . . . . 1.0 109.059 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.45 ' N ' ' O ' ' A' ' 71' ' ' ASP . 57.2 t80 -139.95 70.54 35.73 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.37 -0.831 . . . . 1.0 108.859 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -78.45 161.44 28.39 Favored 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 121.439 1.426 . . . . 1.0 112.657 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.549 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 96.7 m-85 -88.75 170.31 10.89 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.622 -0.881 . . . . 1.0 108.622 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 79' ' ' SER . 22.8 p-10 -96.75 -0.27 48.41 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.992 -1.067 . . . . 1.0 110.829 -178.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.459 ' O ' ' OE2' ' A' ' 102' ' ' GLU . . . 117.44 -120.03 4.64 Favored Glycine 0 N--CA 1.506 3.325 0 N-CA-C 110.338 -1.105 . . . . 1.0 110.338 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.461 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 28.1 Cg_endo -74.29 -73.19 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.803 0 CA-C-N 120.26 2.03 . . . . 1.0 113.04 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.457 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 82.2 p -78.28 -178.9 5.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.925 -1.109 . . . . 1.0 109.806 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.34 -135.43 12.16 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.305 -1.118 . . . . 1.0 110.305 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.7 mt -71.17 111.11 6.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.552 -0.97 . . . . 1.0 110.033 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 55.2 mt -83.63 -17.3 42.02 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.128 -0.982 . . . . 1.0 108.927 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.86 176.0 0.97 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.023 -0.732 . . . . 1.0 109.023 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -161.84 163.37 29.37 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.103 -0.998 . . . . 1.0 109.444 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.34 170.01 19.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.289 -0.882 . . . . 1.0 109.404 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -107.2 154.06 40.71 Favored Pre-proline 0 N--CA 1.498 1.972 0 N-CA-C 108.849 -0.797 . . . . 1.0 108.849 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' A' ' 89' ' ' GLY . 8.8 Cg_endo -60.3 165.6 10.68 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 120.588 0.859 . . . . 1.0 111.558 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -56.29 77.55 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.149 1.233 . . . . 1.0 112.108 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -99.93 -168.25 29.51 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 108.812 -1.715 . . . . 1.0 108.812 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 89' ' ' GLY . 14.3 Cg_exo -57.47 -145.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 121.044 1.163 . . . . 1.0 112.276 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -64.24 -40.01 95.13 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.201 -0.937 . . . . 1.0 109.423 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -67.27 -39.89 86.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.367 -0.833 . . . . 1.0 109.787 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.32 171.82 42.67 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.94 -1.264 . . . . 1.0 109.94 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 71.71 15.03 75.55 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.976 -1.65 . . . . 1.0 108.976 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 40.4 p-10 -79.66 171.6 14.92 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.499 -1.0 . . . . 1.0 109.835 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.24 129.93 15.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.258 -0.901 . . . . 1.0 109.641 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 58.5 m170 -124.9 147.07 49.02 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.614 -0.679 . . . . 1.0 109.252 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -129.72 151.95 49.76 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.528 -0.732 . . . . 1.0 109.469 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.549 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 96.4 m-20 -79.6 120.55 24.09 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.045 -1.035 . . . . 1.0 109.104 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 43.0 t0 -83.54 -4.97 59.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.235 -0.916 . . . . 1.0 109.04 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -82.01 -10.81 59.12 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.412 -0.805 . . . . 1.0 109.075 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.461 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 49.2 mm-40 -90.68 179.1 5.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.385 -0.822 . . . . 1.0 108.991 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 39.0 m -104.93 104.55 14.32 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.445 -0.946 . . . . 1.0 108.445 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.419 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 88.6 m95 -87.95 120.0 28.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.929 . . . . 1.0 109.08 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.678 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.3 t -140.97 151.2 43.97 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.525 -0.734 . . . . 1.0 109.708 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 61.2 m -92.71 -5.64 50.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.104 -0.998 . . . . 1.0 108.546 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 34.0 t -92.93 174.78 7.06 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.6 -0.889 . . . . 1.0 108.6 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.515 ' OG ' ' CZ ' ' A' ' 143' ' ' TYR . 10.6 m -75.85 75.29 2.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.881 -1.137 . . . . 1.0 109.526 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.678 ' HB2' HG21 ' A' ' 105' ' ' THR . 61.3 mttp -147.5 148.84 31.63 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.58 -0.896 . . . . 1.0 108.58 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 109' ' ' LYS . . . 44.53 -139.18 4.65 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.644 -1.382 . . . . 1.0 109.644 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -98.91 118.97 36.88 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.284 -1.127 . . . . 1.0 109.025 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -64.65 130.24 42.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.459 -0.775 . . . . 1.0 110.044 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.3 tp -59.93 -40.45 88.98 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.256 -0.902 . . . . 1.0 110.056 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -59.92 -40.65 89.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 1.0 110.328 -178.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.486 HD21 ' CE ' ' A' ' 146' ' ' LYS . 3.3 mm? -60.04 -55.4 34.39 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.819 -1.176 . . . . 1.0 109.625 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.0 t -67.44 -42.49 87.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.278 -0.889 . . . . 1.0 109.318 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.94 -52.69 64.32 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.173 -0.954 . . . . 1.0 109.101 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.36 82.38 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.816 -1.177 . . . . 1.0 109.801 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 73.0 t60 -64.01 -49.85 70.82 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.452 -0.78 . . . . 1.0 111.644 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -59.95 -39.5 85.82 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.602 -1.311 . . . . 1.0 109.664 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -59.81 -40.07 87.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.893 -1.129 . . . . 1.0 108.237 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.38 -43.9 84.88 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.808 -1.717 . . . . 1.0 108.808 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -67.42 -40.05 85.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.224 -1.162 . . . . 1.0 109.546 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 84.2 p -64.71 -24.03 67.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.206 -0.934 . . . . 1.0 109.731 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 84.5 mt -81.15 0.87 34.42 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.182 -0.949 . . . . 1.0 110.005 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 89.76 4.17 73.09 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 120.056 -1.068 . . . . 1.0 110.738 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.8 mt -84.47 149.74 25.75 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.865 -1.374 . . . . 1.0 109.592 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 37.2 t0 -99.78 174.52 6.18 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.615 -0.883 . . . . 1.0 108.615 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.501 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 74.5 m80 -59.33 139.48 56.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.99 -1.069 . . . . 1.0 109.395 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 38.2 t -98.42 152.73 19.19 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.297 -0.877 . . . . 1.0 109.248 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -99.99 5.49 45.14 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.225 -0.922 . . . . 1.0 109.37 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -88.39 126.82 59.09 Favored Pre-proline 0 N--CA 1.493 1.714 0 N-CA-C 108.179 -1.045 . . . . 1.0 108.179 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -67.56 -15.02 44.06 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 CA-C-N 120.273 1.133 . . . . 1.0 111.94 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -90.72 -5.55 68.63 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.357 -1.497 . . . . 1.0 109.357 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.42 142.51 27.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -1.174 . . . . 1.0 108.901 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.497 ' C ' ' H ' ' A' ' 138' ' ' PHE . 74.5 mt -68.5 -36.9 79.55 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.08 -1.013 . . . . 1.0 109.902 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 76.2 mtp -69.92 20.88 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.133 -0.979 . . . . 1.0 110.405 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.497 ' H ' ' C ' ' A' ' 136' ' ' LEU . 14.6 t80 -66.26 135.5 94.95 Favored Pre-proline 0 N--CA 1.493 1.699 0 N-CA-C 107.853 -1.165 . . . . 1.0 107.853 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -62.92 -10.46 20.38 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 120.826 1.018 . . . . 1.0 114.052 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 91.5 mt -111.81 138.28 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.39 0 O-C-N 120.875 -1.14 . . . . 1.0 110.012 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -74.95 125.1 28.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.505 -0.747 . . . . 1.0 110.484 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 10.2 t -138.98 140.14 38.13 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.441 -0.787 . . . . 1.0 109.043 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.515 ' CZ ' ' OG ' ' A' ' 108' ' ' SER . 89.3 t80 -81.79 141.96 33.02 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.889 -1.132 . . . . 1.0 109.949 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.5 m -130.28 138.33 50.43 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.039 -0.726 . . . . 1.0 109.039 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -66.4 101.38 0.62 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.62 -1.792 . . . . 1.0 108.62 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.486 ' CE ' HD21 ' A' ' 115' ' ' LEU . 58.1 mmtt -75.96 129.33 36.74 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.288 -1.125 . . . . 1.0 109.302 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.5 t -179.78 -51.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.592 -0.892 . . . . 1.0 108.592 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -135.99 19.85 3.24 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.557 -0.905 . . . . 1.0 108.557 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -65.17 139.41 58.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.406 -0.808 . . . . 1.0 110.602 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 96.5 mtp -137.62 149.91 47.0 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.324 -0.991 . . . . 1.0 108.324 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.5 mt -51.83 131.44 38.32 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 120.902 -1.124 . . . . 1.0 109.03 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -71.41 177.96 6.12 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 CA-C-N 119.919 1.007 . . . . 1.0 112.083 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -62.12 -39.97 94.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.418 -0.801 . . . . 1.0 110.285 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -55.06 -48.68 73.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.035 -1.041 . . . . 1.0 109.778 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -69.96 -40.0 75.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.119 -0.988 . . . . 1.0 110.186 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.427 HG12 ' NE2' ' A' ' 160' ' ' GLN . 53.5 t -60.45 -47.78 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.968 -1.083 . . . . 1.0 109.302 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -60.61 -40.02 90.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.05 -1.031 . . . . 1.0 110.076 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.17 -52.39 11.25 Favored Glycine 0 N--CA 1.495 2.631 0 O-C-N 121.246 -0.909 . . . . 1.0 111.874 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.47 HG23 ' N ' ' A' ' 160' ' ' GLN . 8.4 tp -59.94 -39.97 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.744 -1.445 . . . . 1.0 109.917 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.547 ' O ' ' N ' ' A' ' 164' ' ' GLY . 32.3 mt-30 -68.36 -35.21 77.38 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.059 -1.026 . . . . 1.0 109.425 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 77.2 p -60.23 -35.06 74.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.131 -0.981 . . . . 1.0 110.344 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 94.5 mt -86.13 -49.61 7.63 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.958 -1.089 . . . . 1.0 110.671 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -90.04 -9.12 49.74 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.137 -0.977 . . . . 1.0 110.328 -178.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.513 0 N-CA-C 109.411 -1.476 . . . . 1.0 109.411 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' WAY . . . . . 0.862 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.6 m . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.373 -0.603 . . . . 1.0 109.373 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.8 mt -70.58 142.48 51.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.293 -0.879 . . . . 1.0 109.439 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -160.09 160.3 32.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.383 -0.823 . . . . 1.0 109.36 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -71.75 148.94 45.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.211 -0.93 . . . . 1.0 109.573 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 90.7 p -90.03 2.26 55.38 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.42 -0.8 . . . . 1.0 109.798 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.516 ' NZ ' ' O ' ' A' ' 14' ' ' ASN . 20.0 pttp -141.74 153.12 44.4 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.179 -0.95 . . . . 1.0 109.501 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.8 mmt -90.11 -0.04 57.4 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.323 -0.861 . . . . 1.0 109.814 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.516 ' O ' ' NZ ' ' A' ' 12' ' ' LYS . 28.1 m120 -96.97 129.25 44.45 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.197 -0.939 . . . . 1.0 109.286 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.7 mt -141.13 152.0 44.36 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.233 -0.917 . . . . 1.0 109.104 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 63.1 p -133.88 152.81 51.99 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.422 -0.799 . . . . 1.0 109.285 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -145.85 157.46 43.91 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.094 -1.004 . . . . 1.0 109.864 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.412 ' HE ' ' HA ' ' A' ' 55' ' ' ASP . 38.0 ttt-85 -144.54 135.26 24.81 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.376 -0.827 . . . . 1.0 109.356 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 86.3 mt -87.67 119.71 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.274 -0.891 . . . . 1.0 108.793 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 63.4 t -69.12 -40.22 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.315 -0.865 . . . . 1.0 109.409 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -162.86 156.63 20.32 Favored 'General case' 0 C--N 1.287 -2.146 0 O-C-N 119.38 -2.075 . . . . 1.0 111.369 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.438 ' CB ' ' CD2' ' A' ' 28' ' ' HIS . 64.4 m-85 -100.72 109.03 21.02 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 106.248 -1.76 . . . . 1.0 106.248 178.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.423 ' H ' HG22 ' A' ' 23' ' ' THR . 1.1 t -54.62 139.13 60.4 Favored Pre-proline 0 C--N 1.294 -1.842 0 O-C-N 121.38 -0.825 . . . . 1.0 109.309 -178.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -57.8 -6.94 2.84 Favored 'Trans proline' 0 N--CA 1.486 1.085 0 CA-C-N 119.443 0.837 . . . . 1.0 111.145 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -60.07 -39.58 86.54 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 119.78 -0.768 . . . . 1.0 110.013 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.5 mtm -137.27 159.58 41.52 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.265 -0.897 . . . . 1.0 109.086 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.488 ' OG1' ' OE1' ' A' ' 30' ' ' GLU . 36.3 p -75.3 167.88 21.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.166 -0.959 . . . . 1.0 109.714 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.438 ' CD2' ' CB ' ' A' ' 22' ' ' TYR . 29.6 m170 -60.05 -40.43 89.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.434 -0.791 . . . . 1.0 111.057 -178.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.3 m -60.1 -46.09 90.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.886 -1.134 . . . . 1.0 110.733 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.576 ' OE1' ' N ' ' A' ' 30' ' ' GLU . 8.9 mp0 -66.75 -41.51 87.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.222 -0.924 . . . . 1.0 110.259 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 72.2 t -67.49 -44.77 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.995 -1.066 . . . . 1.0 110.134 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -60.0 -49.67 76.74 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.236 -0.915 . . . . 1.0 111.178 -178.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -60.94 -33.81 73.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.692 -1.255 . . . . 1.0 109.852 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.03 -50.93 71.79 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.916 -1.115 . . . . 1.0 110.398 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -65.58 -38.43 89.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.925 -1.11 . . . . 1.0 110.387 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.01 -42.17 93.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.898 -1.127 . . . . 1.0 109.543 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.14 -40.06 88.53 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.219 -0.926 . . . . 1.0 109.291 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.94 -46.45 89.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 1.0 110.075 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -66.84 -38.13 85.81 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.091 -1.006 . . . . 1.0 109.791 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -59.68 -48.26 82.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.13 -0.981 . . . . 1.0 109.577 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.1 t -60.01 -43.08 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.136 -0.977 . . . . 1.0 110.122 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -78.14 -35.69 48.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.99 -1.069 . . . . 1.0 110.18 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.0 p -70.38 -22.43 62.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.096 -1.003 . . . . 1.0 109.741 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.03 -40.01 87.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.31 -0.869 . . . . 1.0 110.8 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.439 HG23 HG23 ' A' ' 46' ' ' THR . 17.2 m -111.96 25.37 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.335 -0.853 . . . . 1.0 110.621 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.439 HG23 HG23 ' A' ' 45' ' ' VAL . 58.5 p -150.01 130.09 6.75 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.144 -0.973 . . . . 1.0 109.083 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -73.54 19.63 0.38 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 CA-C-N 119.974 1.026 . . . . 1.0 112.047 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.6 mt -69.41 138.74 53.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.177 -0.952 . . . . 1.0 109.616 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -107.28 120.8 43.13 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.798 -0.816 . . . . 1.0 108.798 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -107.01 127.92 53.89 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.32 -0.862 . . . . 1.0 109.162 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -119.98 129.95 54.53 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.63 -0.669 . . . . 1.0 109.444 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.429 ' HG2' HH11 ' A' ' 52' ' ' ARG . 34.1 ttt-85 -82.74 130.0 35.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.398 -0.814 . . . . 1.0 109.424 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.4 mt -103.98 119.87 39.86 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.367 -0.833 . . . . 1.0 109.168 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.434 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 59.0 m-70 -62.28 -39.96 94.67 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.427 -0.796 . . . . 1.0 110.005 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 87.4 m-20 -143.4 164.0 31.52 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.259 -0.9 . . . . 1.0 109.86 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.76 177.81 33.72 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.726 -1.35 . . . . 1.0 109.726 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.8 mt -93.24 134.77 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.292 -1.122 . . . . 1.0 109.29 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.28 167.46 10.1 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.515 -0.74 . . . . 1.0 109.422 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -59.96 -48.94 79.64 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.31 -0.869 . . . . 1.0 109.031 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.7 mt -115.59 108.66 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.535 -0.728 . . . . 1.0 109.897 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.5 ptp -98.68 138.53 35.72 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.199 -0.938 . . . . 1.0 109.108 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.9 mt -109.96 133.57 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.499 -0.75 . . . . 1.0 109.747 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 77.6 p -150.98 159.29 44.67 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.059 -1.026 . . . . 1.0 110.022 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -110.47 126.55 54.46 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.564 -0.71 . . . . 1.0 109.248 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 100' ' ' ASP . . . -102.38 -170.74 26.96 Favored Glycine 0 N--CA 1.502 3.059 0 N-CA-C 110.786 -0.925 . . . . 1.0 110.786 -179.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.554 HG22 ' N ' ' A' ' 67' ' ' LYS . 62.1 mt -137.57 167.21 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.532 -0.981 . . . . 1.0 109.303 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.554 ' N ' HG22 ' A' ' 66' ' ' ILE . 48.3 tptt -22.34 -77.82 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.462 0 CA-C-O 120.961 0.41 . . . . 1.0 111.631 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -67.65 139.12 56.79 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.945 -1.097 . . . . 1.0 108.824 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -127.81 2.67 6.04 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.447 -0.783 . . . . 1.0 109.454 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.19 8.67 87.67 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.557 -1.417 . . . . 1.0 109.557 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -110.02 161.58 15.38 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.512 -0.993 . . . . 1.0 109.29 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -70.04 -15.48 63.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.252 -0.905 . . . . 1.0 109.212 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -138.93 75.12 36.28 Favored Pre-proline 0 N--CA 1.496 1.875 0 O-C-N 121.448 -0.782 . . . . 1.0 109.437 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -74.12 -151.55 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 121.261 1.308 . . . . 1.0 111.839 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.545 ' CD1' ' OD1' ' A' ' 99' ' ' ASP . 94.3 m-85 -85.17 166.93 16.18 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.2 -0.937 . . . . 1.0 108.799 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 79' ' ' SER . 27.2 p-10 -99.58 -4.12 31.79 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.084 -1.01 . . . . 1.0 110.709 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.441 ' O ' ' OE2' ' A' ' 102' ' ' GLU . . . 119.14 -115.32 3.03 Favored Glycine 0 N--CA 1.505 3.287 0 N-CA-C 110.267 -1.133 . . . . 1.0 110.267 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.468 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 29.1 Cg_endo -73.91 -75.11 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.956 0 CA-C-N 120.158 1.979 . . . . 1.0 113.402 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.459 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 88.5 p -76.61 177.88 7.14 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.915 -1.115 . . . . 1.0 110.151 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.11 -136.53 12.73 Favored Glycine 0 N--CA 1.498 2.819 0 N-CA-C 110.683 -0.967 . . . . 1.0 110.683 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.0 mt -71.81 110.41 6.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.375 -1.073 . . . . 1.0 109.763 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 55.4 mt -83.76 -18.3 38.27 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.73 173.96 1.22 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.502 -0.925 . . . . 1.0 108.502 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.497 ' CE1' ' ND1' ' A' ' 97' ' ' HIS . 9.4 p80 -162.29 164.33 27.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.971 -1.081 . . . . 1.0 109.985 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -157.17 160.52 38.84 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.823 -0.806 . . . . 1.0 108.823 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -106.75 151.36 40.48 Favored Pre-proline 0 N--CA 1.501 2.102 0 O-C-N 121.365 -0.834 . . . . 1.0 109.131 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.526 ' O ' ' N ' ' A' ' 89' ' ' GLY . 10.0 Cg_endo -62.51 165.56 15.26 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 120.987 1.124 . . . . 1.0 112.328 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -47.48 84.02 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.161 1.241 . . . . 1.0 112.356 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -96.47 -174.53 35.56 Favored Glycine 0 N--CA 1.498 2.792 0 N-CA-C 109.137 -1.585 . . . . 1.0 109.137 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -76.55 -95.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 121.372 1.381 . . . . 1.0 112.814 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -79.14 -57.28 3.81 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.035 -1.041 . . . . 1.0 111.062 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -69.88 -21.83 63.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.174 -0.954 . . . . 1.0 110.161 -178.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -61.36 169.03 10.94 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.269 -1.532 . . . . 1.0 109.269 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 68.98 72.99 0.76 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.929 -1.268 . . . . 1.0 109.929 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -158.85 159.84 35.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.213 -1.169 . . . . 1.0 109.386 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.89 119.83 6.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 1.0 109.191 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.497 ' ND1' ' CE1' ' A' ' 84' ' ' HIS . 52.4 m170 -103.85 145.78 29.61 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.539 -0.725 . . . . 1.0 109.994 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -129.68 147.03 51.43 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.447 -0.946 . . . . 1.0 108.447 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.545 ' OD1' ' CD1' ' A' ' 75' ' ' PHE . 98.3 m-20 -80.81 124.28 28.94 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.92 -1.113 . . . . 1.0 109.579 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 65' ' ' GLY . 39.2 t0 -84.24 -6.81 59.45 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.144 -0.973 . . . . 1.0 109.214 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -80.33 -9.91 59.75 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.633 -0.877 . . . . 1.0 108.633 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.468 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 57.5 mm-40 -89.57 173.3 8.4 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.985 -0.746 . . . . 1.0 108.985 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 54.2 m -105.29 107.62 18.7 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -88.58 119.98 29.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.304 -0.872 . . . . 1.0 108.739 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.663 HG21 ' HB2' ' A' ' 109' ' ' LYS . 9.0 t -140.24 157.85 44.94 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.365 -0.835 . . . . 1.0 109.79 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.4 t -95.76 -9.83 30.72 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.223 -0.923 . . . . 1.0 109.053 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 71.3 m -92.46 179.22 5.59 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.368 -0.833 . . . . 1.0 108.975 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.1 t -78.64 77.78 5.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.032 -1.043 . . . . 1.0 109.56 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.663 ' HB2' HG21 ' A' ' 105' ' ' THR . 68.6 mttm -148.76 148.12 29.62 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.266 -0.896 . . . . 1.0 108.821 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.53 -141.3 4.72 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.746 -1.342 . . . . 1.0 109.746 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -100.33 117.02 33.66 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.352 -1.087 . . . . 1.0 108.925 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -62.74 133.85 55.42 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.076 -1.015 . . . . 1.0 109.219 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.9 tp -59.99 -42.82 95.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 1.0 109.823 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -59.86 -40.8 89.87 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.234 -0.916 . . . . 1.0 110.968 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -59.76 -52.12 66.85 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.604 -1.31 . . . . 1.0 109.722 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.3 t -69.91 -40.79 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.059 -1.026 . . . . 1.0 110.049 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.45 -50.15 74.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.153 -0.967 . . . . 1.0 109.547 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.0 -37.3 79.3 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.71 -1.244 . . . . 1.0 110.16 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 56.9 t60 -63.5 -50.1 70.96 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.219 -0.926 . . . . 1.0 111.315 -178.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.99 -39.03 84.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.748 -1.22 . . . . 1.0 109.858 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -59.99 -40.05 87.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.821 -1.174 . . . . 1.0 108.519 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.45 -46.8 79.51 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.807 -1.317 . . . . 1.0 109.807 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -65.85 -39.98 91.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.06 -1.259 . . . . 1.0 109.462 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.1 p -64.58 -25.1 67.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.228 -0.92 . . . . 1.0 109.8 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 72.8 mt -80.95 1.98 28.77 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.138 -0.976 . . . . 1.0 109.371 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 87.19 9.51 73.12 Favored Glycine 0 N--CA 1.495 2.629 0 O-C-N 121.2 -0.938 . . . . 1.0 110.834 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.4 mt -84.95 150.02 25.22 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.836 -1.39 . . . . 1.0 109.759 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 39.6 t0 -99.53 171.33 8.0 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.869 -0.789 . . . . 1.0 108.869 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.537 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 71.9 m80 -59.96 139.96 57.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.12 -0.987 . . . . 1.0 109.53 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 44.4 t -97.1 152.4 18.82 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.428 -0.795 . . . . 1.0 109.554 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -99.01 2.22 46.1 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.311 -0.868 . . . . 1.0 109.354 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 9.5 t70 -87.26 130.0 49.44 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.294 -0.879 . . . . 1.0 108.708 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -67.15 -22.22 47.4 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 CA-C-N 120.078 1.064 . . . . 1.0 112.437 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.444 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -86.89 -2.39 84.14 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.817 -1.313 . . . . 1.0 109.817 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.57 143.48 28.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.183 -1.186 . . . . 1.0 109.219 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.436 ' C ' ' H ' ' A' ' 138' ' ' PHE . 84.3 mt -69.26 -38.31 78.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.098 -1.001 . . . . 1.0 109.698 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 81.4 mtp -72.09 20.92 0.06 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 1.0 110.735 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.436 ' H ' ' C ' ' A' ' 136' ' ' LEU . 16.3 t80 -68.11 134.48 91.58 Favored Pre-proline 0 N--CA 1.496 1.857 0 N-CA-C 107.885 -1.154 . . . . 1.0 107.885 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -61.47 -9.46 13.31 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 120.836 1.024 . . . . 1.0 114.227 -177.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 86.4 mt -113.05 134.08 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 O-C-N 120.955 -1.091 . . . . 1.0 109.705 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -72.34 127.24 31.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.467 -0.77 . . . . 1.0 110.402 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 14.1 t -141.29 141.14 33.95 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.582 -0.895 . . . . 1.0 108.582 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -78.95 143.83 35.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.09 -1.007 . . . . 1.0 109.199 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.6 t -138.8 150.78 46.45 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.292 -0.88 . . . . 1.0 109.71 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -66.15 101.59 0.63 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.465 -1.454 . . . . 1.0 109.465 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 20.9 mtmm -76.71 0.34 20.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.423 -1.046 . . . . 1.0 109.768 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 73.6 p -60.06 -39.97 87.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -0.901 . . . . 1.0 109.965 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -147.62 30.69 0.9 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.079 -1.013 . . . . 1.0 109.526 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -65.28 139.61 58.63 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.132 -0.98 . . . . 1.0 109.586 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 68.2 mtt -136.55 145.24 44.8 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.702 -0.851 . . . . 1.0 108.702 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 20.9 mt -52.86 128.86 46.7 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.091 -1.006 . . . . 1.0 108.719 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -70.13 178.69 4.54 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 CA-C-N 120.081 1.065 . . . . 1.0 112.286 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -60.36 -39.95 89.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.432 -0.792 . . . . 1.0 110.096 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -56.14 -49.12 74.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.199 -0.938 . . . . 1.0 109.969 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -70.08 -39.93 75.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.996 -1.065 . . . . 1.0 110.064 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 58.1 t -61.28 -47.43 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.012 -1.055 . . . . 1.0 109.498 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -60.43 -40.09 89.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.048 -1.032 . . . . 1.0 110.45 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.26 -53.72 8.67 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 120.374 -0.917 . . . . 1.0 111.477 -178.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.476 HG23 ' N ' ' A' ' 160' ' ' GLN . 6.8 tp -59.97 -40.06 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.817 -1.402 . . . . 1.0 109.569 -178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.7 mt-30 -66.06 -39.94 90.5 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.101 -1.0 . . . . 1.0 109.202 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 95.1 p -60.53 -28.75 68.66 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.01 -1.056 . . . . 1.0 109.853 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 86.5 mt -89.8 -51.64 5.4 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.047 -1.033 . . . . 1.0 110.643 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -98.04 -22.08 16.45 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.945 -1.097 . . . . 1.0 110.829 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.626 0 N-CA-C 109.692 -1.363 . . . . 1.0 109.692 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' WAY . . . . . 0.925 ' HC2' ' HJ ' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.0 mt -96.92 131.77 43.37 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.215 -0.928 . . . . 1.0 109.049 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -160.0 160.04 32.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 1.0 109.69 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -72.88 150.0 43.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.304 -0.873 . . . . 1.0 109.304 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.1 t -85.48 1.61 48.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.303 -0.873 . . . . 1.0 110.093 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.521 ' NZ ' ' O ' ' A' ' 14' ' ' ASN . 20.1 pttp -149.14 154.24 38.9 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.162 -0.961 . . . . 1.0 109.635 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.54 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.01 0.39 57.14 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.289 -0.882 . . . . 1.0 109.666 -179.549 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.521 ' O ' ' NZ ' ' A' ' 12' ' ' LYS . 98.5 m-20 -95.51 128.76 42.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.219 -0.926 . . . . 1.0 108.884 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.5 mt -141.31 149.93 41.85 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.186 -0.946 . . . . 1.0 109.253 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 74.3 p -130.9 155.46 46.71 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.03 -0.73 . . . . 1.0 109.03 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -145.86 160.16 42.18 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.146 -0.972 . . . . 1.0 109.835 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.531 HH12 ' H ' ' A' ' 56' ' ' GLY . 73.4 ttt180 -143.36 133.45 24.32 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.537 -0.727 . . . . 1.0 109.583 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 91.8 mt -88.36 117.09 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.189 -0.944 . . . . 1.0 108.663 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.54 -40.12 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.06 -1.025 . . . . 1.0 109.391 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -163.85 160.94 22.82 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.431 -1.418 . . . . 1.0 110.631 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -97.21 -173.33 2.64 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.56 -1.274 . . . . 1.0 107.56 178.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.7 148.4 43.01 Favored Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 121.377 -0.827 . . . . 1.0 110.029 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -67.68 -20.64 46.35 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 120.833 1.022 . . . . 1.0 110.335 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -59.4 -40.12 85.6 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.15 -0.932 . . . . 1.0 110.168 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 78.0 mtm -138.95 159.93 40.95 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.257 -0.902 . . . . 1.0 109.853 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 82.6 p -74.21 160.86 30.58 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.497 0.665 . . . . 1.0 109.417 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.697 ' H ' ' CD2' ' A' ' 28' ' ' HIS . 2.7 p80 -62.47 -35.88 80.72 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.552 -0.718 . . . . 1.0 110.148 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.9 m -60.04 -40.28 88.82 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.845 -1.16 . . . . 1.0 109.61 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -69.94 -40.04 75.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.114 -0.991 . . . . 1.0 109.035 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.0 t -69.13 -41.47 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.314 -0.866 . . . . 1.0 110.258 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.95 -48.13 82.95 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.931 -1.105 . . . . 1.0 110.346 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -63.75 -31.82 73.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.87 -1.144 . . . . 1.0 109.834 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.97 -49.96 75.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.07 -1.019 . . . . 1.0 110.031 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -65.55 -37.89 88.01 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.018 -1.051 . . . . 1.0 109.661 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.07 -41.24 92.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.096 -1.003 . . . . 1.0 109.878 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -60.07 -45.32 93.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.12 -0.987 . . . . 1.0 109.475 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.12 -48.06 83.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.44 -0.787 . . . . 1.0 110.717 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.42 ' CZ ' ' CZ ' ' A' ' 121' ' ' PHE . 49.7 m-85 -64.04 -40.05 95.44 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.956 -1.09 . . . . 1.0 109.529 -179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.6 tptt -59.99 -47.33 86.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.029 -1.045 . . . . 1.0 109.543 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.02 -41.52 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.143 -0.973 . . . . 1.0 110.128 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -78.49 -36.71 44.74 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.012 -1.055 . . . . 1.0 110.376 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 96.1 p -70.91 -20.76 62.46 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.982 -1.074 . . . . 1.0 109.936 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.93 -39.89 87.04 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.252 -0.905 . . . . 1.0 110.558 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.1 m -110.01 23.84 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.201 -0.937 . . . . 1.0 110.944 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.4 p -150.27 139.8 13.42 Favored Pre-proline 0 N--CA 1.502 2.129 0 O-C-N 120.76 -1.213 . . . . 1.0 109.658 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -75.37 15.7 0.79 Allowed 'Trans proline' 0 N--CA 1.497 1.693 0 CA-C-N 119.743 0.944 . . . . 1.0 112.088 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 88.2 mt -67.1 139.92 57.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.079 -1.013 . . . . 1.0 109.71 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -111.81 121.38 44.91 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 109.045 -0.724 . . . . 1.0 109.045 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -107.8 119.01 38.24 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.33 -0.856 . . . . 1.0 109.251 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.1 m -119.95 129.98 54.57 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.64 -0.663 . . . . 1.0 109.946 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.417 ' HG2' HH11 ' A' ' 52' ' ' ARG . 33.6 ttt-85 -82.0 135.13 35.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 1.0 109.241 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.5 mt -102.1 132.0 48.25 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.343 -0.848 . . . . 1.0 109.188 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.447 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 42.0 m170 -63.95 -40.01 95.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -0.84 . . . . 1.0 109.733 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 76.7 m-20 -148.89 169.95 19.39 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.328 -0.857 . . . . 1.0 109.869 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.531 ' H ' HH12 ' A' ' 18' ' ' ARG . . . 95.06 178.52 37.5 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.7 -1.36 . . . . 1.0 109.7 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.4 mt -92.58 139.52 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.292 -1.122 . . . . 1.0 108.961 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.05 170.55 8.08 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.473 -0.767 . . . . 1.0 109.702 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.03 -49.05 79.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.242 -0.911 . . . . 1.0 108.935 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 90.2 mt -119.95 112.97 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.616 -0.678 . . . . 1.0 109.251 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.0 ptm -100.93 135.0 43.07 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.397 -0.814 . . . . 1.0 108.952 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 95.8 mt -104.43 135.17 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.505 -0.747 . . . . 1.0 110.365 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 79.4 p -152.9 159.03 42.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.345 -0.847 . . . . 1.0 109.278 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -102.81 127.71 49.87 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.413 -0.804 . . . . 1.0 109.564 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.89 157.95 17.86 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 109.436 -1.466 . . . . 1.0 109.436 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.421 ' O ' ' C ' ' A' ' 67' ' ' LYS . 6.9 tt -104.53 -178.71 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.465 -1.021 . . . . 1.0 108.719 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 66' ' ' ILE . 28.1 tptp -38.33 -77.99 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.819 -0.551 . . . . 1.0 110.585 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.663 ' CD ' ' H ' ' A' ' 68' ' ' GLU . 1.0 OUTLIER -72.2 119.98 17.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.317 -0.864 . . . . 1.0 110.749 -179.013 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.621 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 3.5 m80 -69.94 -47.81 60.89 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.098 -1.002 . . . . 1.0 108.673 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.05 -12.67 63.5 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.69 -1.364 . . . . 1.0 109.69 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -122.46 -15.6 7.55 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.474 -1.015 . . . . 1.0 110.542 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.504 ' CZ ' ' CE1' ' A' ' 69' ' ' HIS . 55.6 p90 -169.9 -169.99 0.95 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.694 -1.253 . . . . 1.0 110.537 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -42.68 120.94 2.71 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.644 -0.66 . . . . 1.0 109.848 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.442 ' HA ' ' HD1' ' A' ' 69' ' ' HIS . 38.3 Cg_endo -76.96 -172.33 1.4 Allowed 'Trans proline' 0 N--CA 1.495 1.585 0 CA-C-N 119.868 0.989 . . . . 1.0 112.927 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.621 ' CE2' ' NE2' ' A' ' 69' ' ' HIS . 90.8 m-85 -87.71 168.01 13.36 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.604 -0.887 . . . . 1.0 108.604 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.6 p-10 -97.4 0.0 47.06 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.082 -1.011 . . . . 1.0 110.099 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.21 -157.89 22.9 Favored Glycine 0 N--CA 1.5 2.944 0 N-CA-C 108.722 -1.751 . . . . 1.0 108.722 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -59.68 -63.68 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.354 0 CA-C-N 118.655 1.228 . . . . 1.0 111.612 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 88.1 p -77.62 162.34 27.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.428 -0.795 . . . . 1.0 109.485 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.15 -129.95 9.03 Favored Glycine 0 N--CA 1.499 2.894 0 N-CA-C 109.709 -1.356 . . . . 1.0 109.709 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.449 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 10.2 mt -64.99 101.13 0.47 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.222 -1.164 . . . . 1.0 108.66 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 53.5 mt -75.66 -28.36 58.69 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.468 -0.938 . . . . 1.0 108.468 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -177.92 163.94 1.84 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.385 -0.969 . . . . 1.0 108.385 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -160.78 160.41 31.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.907 -1.121 . . . . 1.0 109.97 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -144.11 156.21 44.25 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.705 -0.85 . . . . 1.0 108.705 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -95.51 150.99 38.26 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.149 -0.969 . . . . 1.0 108.807 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -65.5 165.01 24.04 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 120.771 0.981 . . . . 1.0 111.556 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -42.34 136.22 4.07 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.164 1.243 . . . . 1.0 111.792 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 90' ' ' PRO . . . -172.39 -173.91 39.35 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.492 -1.337 . . . . 1.0 110.108 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 89' ' ' GLY . 6.0 Cg_exo -57.94 -148.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 120.913 1.075 . . . . 1.0 111.9 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -61.2 -39.92 92.01 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.355 -0.84 . . . . 1.0 109.865 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -65.36 -40.09 93.15 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.008 -1.057 . . . . 1.0 109.982 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.63 177.46 37.33 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.404 -1.478 . . . . 1.0 109.404 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 62.76 72.16 0.71 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.507 -1.437 . . . . 1.0 109.507 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -157.67 160.78 38.34 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.395 -1.062 . . . . 1.0 109.016 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.65 123.67 10.73 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.083 -1.011 . . . . 1.0 109.61 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -110.08 154.76 22.8 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.589 0.709 . . . . 1.0 110.015 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.486 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 44.9 m-85 -130.58 150.22 51.88 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.538 ' OD2' ' CD1' ' A' ' 75' ' ' PHE . 1.2 m-20 -78.96 122.86 26.68 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.991 -1.068 . . . . 1.0 109.591 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -84.44 -6.84 59.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.142 -0.974 . . . . 1.0 109.379 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -85.98 -14.74 43.7 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.336 -0.853 . . . . 1.0 110.067 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.574 ' OE1' ' N ' ' A' ' 102' ' ' GLU . 0.9 OUTLIER -88.66 169.91 11.27 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.176 -0.953 . . . . 1.0 109.687 -179.113 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.7 m -99.05 102.57 14.32 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.75 -0.833 . . . . 1.0 108.75 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.446 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 93.4 m95 -85.16 121.99 28.7 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.48 -0.762 . . . . 1.0 109.33 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.646 HG21 ' HB2' ' A' ' 109' ' ' LYS . 7.2 t -140.63 150.4 43.52 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.476 -0.765 . . . . 1.0 109.761 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 74.8 m -93.04 -6.2 48.77 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.193 -0.942 . . . . 1.0 108.52 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.1 p -91.3 178.63 5.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.571 -0.706 . . . . 1.0 109.208 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 89.7 p -77.0 70.0 3.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 1.0 109.376 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.646 ' HB2' HG21 ' A' ' 105' ' ' THR . 68.3 mttm -146.22 150.81 36.52 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.192 -0.942 . . . . 1.0 109.484 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 43.56 -137.73 4.18 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.046 -1.221 . . . . 1.0 110.046 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -99.99 115.32 29.42 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.394 -1.063 . . . . 1.0 109.22 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.441 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 19.3 t-20 -63.18 130.63 45.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.212 -0.93 . . . . 1.0 109.873 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.7 tp -59.92 -43.54 94.83 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.402 -0.811 . . . . 1.0 110.832 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -60.07 -42.14 93.9 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.989 -1.07 . . . . 1.0 111.096 -178.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -60.01 -50.05 75.26 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.672 -1.267 . . . . 1.0 109.509 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.5 t -70.03 -41.4 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.078 -1.014 . . . . 1.0 110.006 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.56 -50.52 72.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.227 -0.921 . . . . 1.0 109.891 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.96 -39.78 86.78 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.255 -0.903 . . . . 1.0 110.627 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -63.03 -48.4 78.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.115 -0.991 . . . . 1.0 111.156 -178.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.486 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 7.0 pt-20 -59.89 -39.6 85.91 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.589 -1.319 . . . . 1.0 110.011 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.42 ' CZ ' ' CZ ' ' A' ' 39' ' ' PHE . 32.3 m-85 -60.02 -40.11 88.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.912 -1.117 . . . . 1.0 108.479 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -56.42 -42.55 89.63 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.365 -1.494 . . . . 1.0 109.365 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -65.53 -40.02 92.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.073 -1.251 . . . . 1.0 109.592 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 80.0 p -67.15 -23.69 65.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.18 -0.95 . . . . 1.0 109.317 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.7 mt -81.96 -0.97 46.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.183 -0.948 . . . . 1.0 109.59 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 92.68 7.94 62.63 Favored Glycine 0 N--CA 1.497 2.735 0 O-C-N 121.149 -0.969 . . . . 1.0 110.933 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.4 mt -86.98 141.98 28.29 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.854 -1.38 . . . . 1.0 109.858 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 10.8 t70 -98.72 174.94 6.16 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.555 -0.715 . . . . 1.0 109.089 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.491 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 76.8 m80 -59.86 139.74 57.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.026 -1.046 . . . . 1.0 109.9 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 30.4 t -98.98 156.46 16.9 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.405 -0.809 . . . . 1.0 109.182 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -97.05 -1.43 45.4 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.229 -0.919 . . . . 1.0 109.016 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -85.43 129.32 55.76 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.079 -1.013 . . . . 1.0 108.976 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -68.69 -20.16 40.72 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 CA-C-N 120.027 1.045 . . . . 1.0 112.372 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -87.3 -7.14 77.05 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.895 -1.282 . . . . 1.0 109.895 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.58 145.7 26.65 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.086 -1.243 . . . . 1.0 109.427 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.418 ' C ' ' H ' ' A' ' 138' ' ' PHE . 96.1 mt -69.97 -29.13 66.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.047 -1.033 . . . . 1.0 109.696 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.1 mmm -72.2 13.49 0.31 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.332 -0.855 . . . . 1.0 110.262 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.418 ' H ' ' C ' ' A' ' 136' ' ' LEU . 12.2 t80 -70.0 131.83 88.83 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.071 -1.018 . . . . 1.0 108.768 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -63.56 -8.56 15.45 Favored 'Trans proline' 0 N--CA 1.501 1.93 0 C-N-CA 120.924 1.083 . . . . 1.0 114.37 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 84.2 mt -109.72 138.6 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 O-C-N 120.936 -1.103 . . . . 1.0 109.317 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.441 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 45.7 t80 -74.38 128.2 34.94 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.357 -0.839 . . . . 1.0 110.7 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.1 t -139.22 138.29 36.73 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.578 -0.702 . . . . 1.0 109.211 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.467 ' CE1' ' NZ ' ' A' ' 146' ' ' LYS . 70.6 t80 -80.83 150.12 29.28 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.975 -1.078 . . . . 1.0 109.352 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.6 t -142.4 158.56 43.57 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.116 -0.99 . . . . 1.0 109.992 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.07 113.91 4.75 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.423 -1.471 . . . . 1.0 109.423 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.467 ' NZ ' ' CE1' ' A' ' 143' ' ' TYR . 62.2 mttp -80.85 3.28 23.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.382 -1.069 . . . . 1.0 110.203 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 27.6 t -58.07 -41.29 83.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.845 -1.159 . . . . 1.0 109.532 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -160.96 68.66 0.34 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.32 -0.862 . . . . 1.0 109.18 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -94.36 120.54 34.75 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.249 -0.907 . . . . 1.0 109.812 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 75.0 mtm -116.62 142.5 46.81 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 22.3 mt -50.4 132.78 25.53 Favored Pre-proline 0 C--N 1.302 -1.498 0 O-C-N 121.043 -1.036 . . . . 1.0 108.914 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -68.87 179.42 3.23 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 CA-C-N 119.865 0.987 . . . . 1.0 112.355 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -62.43 -39.95 94.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.457 -0.777 . . . . 1.0 110.126 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -56.82 -48.62 77.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 1.0 110.071 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -70.11 -39.96 75.18 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.078 -1.014 . . . . 1.0 109.803 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 54.6 t -61.25 -48.08 90.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.18 -0.95 . . . . 1.0 109.162 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -61.05 -40.08 92.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.115 -0.991 . . . . 1.0 110.413 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.25 -53.66 13.24 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 120.243 -0.98 . . . . 1.0 111.253 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.457 HG23 ' N ' ' A' ' 160' ' ' GLN . 5.2 tp -60.36 -40.0 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.889 -1.36 . . . . 1.0 109.749 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.4 mt-30 -64.71 -39.9 94.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.04 -1.038 . . . . 1.0 109.636 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 84.4 p -65.96 -24.4 66.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -0.949 . . . . 1.0 110.2 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 85.6 mt -88.42 -51.5 5.69 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.931 -1.106 . . . . 1.0 110.232 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -90.89 -8.78 48.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.939 -1.1 . . . . 1.0 109.539 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.493 2.448 0 N-CA-C 109.664 -1.375 . . . . 1.0 109.664 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' WAY . . . . . 0.55 ' HC2' ' HJ ' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 87.6 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.9 mt -70.09 144.24 52.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.896 . . . . 1.0 109.526 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -159.86 160.0 33.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 1.0 109.377 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -73.78 150.06 41.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.224 -0.922 . . . . 1.0 109.047 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.3 t -85.62 -0.07 54.06 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.159 -0.963 . . . . 1.0 110.249 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -150.22 159.57 44.34 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.98 -1.075 . . . . 1.0 109.878 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.557 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -91.8 -0.03 57.51 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.385 -0.822 . . . . 1.0 109.689 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -96.22 123.38 39.82 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.215 -0.928 . . . . 1.0 108.995 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.3 mt -140.0 152.29 46.16 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.368 -0.832 . . . . 1.0 108.997 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.6 p -132.89 155.48 48.96 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.492 -0.755 . . . . 1.0 109.103 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -144.69 158.71 43.67 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.231 -0.918 . . . . 1.0 109.648 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.412 HH11 ' HG2' ' A' ' 18' ' ' ARG . 37.2 ttt-85 -142.44 132.28 24.23 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.467 -0.77 . . . . 1.0 109.47 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 93.1 mt -87.05 119.62 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.331 -0.856 . . . . 1.0 109.113 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.4 t -69.84 -40.3 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.175 -0.953 . . . . 1.0 109.495 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.414 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 18.6 p-10 -162.53 154.99 19.19 Favored 'General case' 0 C--N 1.288 -2.076 0 O-C-N 119.718 -1.864 . . . . 1.0 111.028 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.408 ' OH ' ' NH2' ' A' ' 52' ' ' ARG . 44.0 m-85 -99.87 108.85 21.22 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 105.582 -2.007 . . . . 1.0 105.582 177.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 23' ' ' THR . 1.1 t -57.55 139.58 80.97 Favored Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.055 -1.028 . . . . 1.0 109.727 -177.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -59.16 -10.15 9.77 Favored 'Trans proline' 0 N--CA 1.487 1.093 0 CA-C-N 119.246 0.766 . . . . 1.0 110.96 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -57.57 -28.21 63.37 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.848 -0.741 . . . . 1.0 110.078 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 77.4 mtm -143.44 162.48 35.68 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.085 -1.009 . . . . 1.0 109.862 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.2 p -71.81 160.83 31.91 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.309 -0.869 . . . . 1.0 109.205 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -61.41 -40.21 93.58 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.426 -0.796 . . . . 1.0 110.487 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.5 m -61.08 -41.23 96.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.968 -1.083 . . . . 1.0 110.705 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.89 -40.01 91.15 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.15 -0.969 . . . . 1.0 110.623 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 69.5 t -69.73 -42.22 80.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 120.936 -1.102 . . . . 1.0 110.275 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -59.97 -53.87 52.76 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.212 -0.93 . . . . 1.0 110.83 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.3 ptmm? -65.92 -29.83 70.32 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.586 -0.696 . . . . 1.0 110.821 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.04 -49.93 75.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.785 -1.197 . . . . 1.0 109.463 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -66.96 -38.26 85.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.018 -1.051 . . . . 1.0 110.211 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.06 -40.58 89.96 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.913 -1.117 . . . . 1.0 109.559 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.04 -41.41 96.54 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.889 -1.132 . . . . 1.0 108.964 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.99 -46.44 89.45 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.516 -0.74 . . . . 1.0 109.957 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.432 ' CE1' ' CD1' ' A' ' 50' ' ' PHE . 53.3 m-85 -65.15 -39.98 93.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.968 -1.083 . . . . 1.0 109.499 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -60.05 -48.46 81.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.052 -1.03 . . . . 1.0 109.852 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.7 t -60.0 -41.06 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.092 -1.005 . . . . 1.0 110.083 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -78.4 -36.42 45.78 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.92 -1.113 . . . . 1.0 110.135 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 81.7 p -71.78 -18.02 62.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.071 -1.018 . . . . 1.0 109.845 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -60.01 -39.69 86.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.239 -0.913 . . . . 1.0 110.285 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.478 ' O ' ' NE2' ' A' ' 160' ' ' GLN . 21.9 m -111.41 20.97 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.38 -0.825 . . . . 1.0 110.788 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.434 HG23 HG23 ' A' ' 45' ' ' VAL . 22.5 p -148.42 138.22 12.62 Favored Pre-proline 0 N--CA 1.504 2.255 0 O-C-N 120.77 -1.207 . . . . 1.0 109.914 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -73.95 21.23 0.38 Allowed 'Trans proline' 0 N--CA 1.498 1.793 0 C-N-CA 120.962 1.108 . . . . 1.0 112.495 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.3 mt -69.5 136.46 51.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.893 -1.13 . . . . 1.0 110.018 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -107.91 120.0 41.06 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.614 -0.884 . . . . 1.0 108.614 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.432 ' CD1' ' CE1' ' A' ' 39' ' ' PHE . 95.1 m-85 -108.5 125.29 51.63 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.311 -0.868 . . . . 1.0 109.723 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -120.05 130.03 54.5 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.67 -0.644 . . . . 1.0 109.792 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.408 ' NH2' ' OH ' ' A' ' 22' ' ' TYR . 68.6 ttt180 -82.38 130.73 35.17 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.365 -0.835 . . . . 1.0 109.892 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.0 mt -109.64 124.33 50.99 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.421 -0.799 . . . . 1.0 109.083 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.439 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 48.4 m170 -79.27 -19.08 51.44 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.197 -0.94 . . . . 1.0 110.111 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 79.9 m-20 -146.6 160.42 42.19 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.067 -1.02 . . . . 1.0 109.901 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.97 175.3 44.0 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.555 -1.418 . . . . 1.0 109.555 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.2 mt -96.43 136.46 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.212 -1.17 . . . . 1.0 108.965 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.98 160.86 16.43 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.388 -0.82 . . . . 1.0 109.449 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.04 -49.11 78.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.223 -0.923 . . . . 1.0 109.293 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.9 mt -104.32 98.52 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.416 -0.802 . . . . 1.0 109.839 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.4 ptm -100.11 131.69 45.91 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.191 -0.943 . . . . 1.0 109.399 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 92.1 mt -103.02 138.92 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.541 -0.724 . . . . 1.0 110.208 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 82.5 p -153.07 157.74 40.89 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.371 -0.83 . . . . 1.0 109.249 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -106.5 125.68 51.31 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.83 -0.804 . . . . 1.0 108.83 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 98' ' ' PHE . . . -98.11 178.78 32.11 Favored Glycine 0 N--CA 1.499 2.873 0 O-C-N 121.108 -0.995 . . . . 1.0 110.761 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.497 ' CG2' ' N ' ' A' ' 67' ' ' LYS . 41.1 mt -134.79 165.73 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.672 -0.899 . . . . 1.0 109.018 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.497 ' N ' ' CG2' ' A' ' 66' ' ' ILE . 47.2 tptt -30.47 -76.46 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 121.058 0.456 . . . . 1.0 111.486 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -66.36 56.57 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.255 -0.903 . . . . 1.0 110.311 -178.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 67' ' ' LYS . 45.3 t-80 -60.07 -42.03 93.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.503 -0.748 . . . . 1.0 109.783 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.31 -162.49 53.52 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.108 -1.197 . . . . 1.0 110.108 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 72' ' ' PHE . 50.4 t0 54.81 -128.02 2.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.391 -1.064 . . . . 1.0 109.293 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.403 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 96.6 m-85 -54.34 -178.74 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.254 -0.904 . . . . 1.0 108.884 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -52.6 130.91 45.78 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 120.988 -1.07 . . . . 1.0 108.68 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -71.12 -175.86 1.64 Allowed 'Trans proline' 0 N--CA 1.494 1.547 0 CA-C-N 119.885 0.995 . . . . 1.0 112.334 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.54 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 99.0 m-85 -86.72 166.67 15.11 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.657 -0.868 . . . . 1.0 108.657 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -100.15 5.51 44.82 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.181 -0.949 . . . . 1.0 110.82 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 126.1 -156.23 19.58 Favored Glycine 0 N--CA 1.504 3.169 0 N-CA-C 109.085 -1.606 . . . . 1.0 109.085 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -59.83 -66.48 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 0 CA-C-N 118.697 1.249 . . . . 1.0 112.372 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 80.3 p -75.56 160.06 30.56 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.12 -0.987 . . . . 1.0 109.529 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.37 -130.02 8.9 Favored Glycine 0 N--CA 1.502 3.04 0 N-CA-C 109.67 -1.372 . . . . 1.0 109.67 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.423 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 10.9 mt -68.6 105.37 2.23 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.252 -1.146 . . . . 1.0 109.065 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 39.2 mt -78.7 -16.29 57.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.98 -1.075 . . . . 1.0 108.951 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 97' ' ' HIS . . . -178.83 176.1 0.97 Allowed 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.435 ' ND1' ' C ' ' A' ' 84' ' ' HIS . 7.0 p80 -161.08 162.25 31.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.015 -1.053 . . . . 1.0 109.557 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.63 165.73 31.42 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.223 -0.923 . . . . 1.0 109.651 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -113.66 153.39 45.88 Favored Pre-proline 0 N--CA 1.5 2.033 0 N-CA-C 108.873 -0.788 . . . . 1.0 108.873 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.475 ' O ' ' N ' ' A' ' 89' ' ' GLY . 1.9 Cg_endo -55.56 169.08 1.28 Allowed 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.023 1.149 . . . . 1.0 112.363 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -62.12 66.12 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.278 1.318 . . . . 1.0 112.451 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -70.18 167.01 49.77 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.968 -1.653 . . . . 1.0 108.968 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -43.03 -60.34 0.78 Allowed 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.25 1.3 . . . . 1.0 112.151 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.499 ' OD1' ' CD2' ' A' ' 92' ' ' TYR . 34.8 p-10 -141.72 -33.47 0.5 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.314 -0.866 . . . . 1.0 109.356 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.499 ' CD2' ' OD1' ' A' ' 91' ' ' ASN . 84.9 m-85 -69.79 -40.03 76.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.247 -0.908 . . . . 1.0 109.492 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.421 ' HA3' ' H ' ' A' ' 89' ' ' GLY . . . -71.49 174.62 41.65 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.252 -1.139 . . . . 1.0 110.252 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.94 5.91 89.33 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.289 -1.524 . . . . 1.0 109.289 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -79.26 169.2 18.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.327 -1.102 . . . . 1.0 109.497 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.01 117.02 5.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.299 -0.876 . . . . 1.0 109.421 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.411 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 38.2 m170 -105.64 152.23 23.38 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.491 -0.755 . . . . 1.0 109.821 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.482 ' O ' ' N ' ' A' ' 65' ' ' GLY . 38.2 m-85 -131.81 148.82 52.58 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.774 -0.824 . . . . 1.0 108.774 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.54 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 89.5 m-20 -79.03 122.83 26.68 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.915 -1.116 . . . . 1.0 109.689 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -84.04 -11.78 56.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.355 -0.841 . . . . 1.0 109.077 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -81.6 -12.56 58.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.408 -0.807 . . . . 1.0 109.278 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -89.23 169.1 11.74 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.868 -0.79 . . . . 1.0 108.868 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 39.2 m -99.81 104.41 16.1 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.201 -0.937 . . . . 1.0 109.266 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.47 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 91.3 m95 -87.46 127.11 35.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.336 -0.852 . . . . 1.0 108.915 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.642 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.0 t -143.14 158.15 43.87 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.356 -0.84 . . . . 1.0 109.755 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.2 t -96.98 -10.41 26.31 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.453 -0.943 . . . . 1.0 108.453 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 81.1 p -90.41 -176.4 4.77 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.007 -0.738 . . . . 1.0 109.007 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 m -82.82 76.57 9.65 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.135 -0.978 . . . . 1.0 109.58 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.642 ' HB2' HG21 ' A' ' 105' ' ' THR . 98.0 mttt -149.6 151.12 33.28 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.19 -0.944 . . . . 1.0 108.992 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 43.73 -139.44 3.63 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.992 -1.243 . . . . 1.0 109.992 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -100.08 116.46 32.17 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.359 -1.083 . . . . 1.0 109.161 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.457 HD22 HD23 ' A' ' 115' ' ' LEU . 58.3 t30 -64.56 132.13 48.97 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.899 -1.125 . . . . 1.0 109.785 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.6 tp -59.99 -42.97 95.38 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.352 -0.842 . . . . 1.0 110.552 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -60.01 -40.65 89.96 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.098 -1.001 . . . . 1.0 110.836 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.457 HD23 HD22 ' A' ' 112' ' ' ASN . 2.7 mm? -59.93 -50.77 72.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.765 -1.209 . . . . 1.0 109.25 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.9 t -70.03 -40.15 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.202 -0.936 . . . . 1.0 110.224 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.58 -52.15 66.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.112 -0.993 . . . . 1.0 109.552 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.98 -34.34 73.18 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.246 -0.909 . . . . 1.0 110.078 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -64.3 -50.04 69.41 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.224 -0.922 . . . . 1.0 111.051 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.451 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 7.1 pt-20 -60.01 -39.31 85.36 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.801 -1.187 . . . . 1.0 110.025 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -59.98 -40.0 87.62 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.934 -1.104 . . . . 1.0 108.851 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.32 -46.05 81.12 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.753 -1.739 . . . . 1.0 108.753 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -64.5 -40.0 94.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.335 -1.097 . . . . 1.0 109.413 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.0 p -67.42 -23.57 65.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.361 -0.837 . . . . 1.0 109.67 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 69.9 mt -82.81 -0.3 47.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.227 -0.921 . . . . 1.0 109.927 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 89.12 9.83 67.02 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 110.447 -1.061 . . . . 1.0 110.447 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.9 mt -85.79 150.05 24.84 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.067 -1.255 . . . . 1.0 110.251 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 12.0 t70 -101.0 169.98 8.59 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.833 -0.803 . . . . 1.0 108.833 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.529 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 23.9 m170 -59.34 136.39 57.95 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.997 -1.065 . . . . 1.0 108.961 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 35.8 t -97.93 155.0 17.28 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.312 -0.868 . . . . 1.0 109.63 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -99.87 4.84 45.33 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.275 -0.891 . . . . 1.0 109.621 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -86.11 128.54 57.4 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 108.323 -0.991 . . . . 1.0 108.323 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -67.78 -18.63 47.54 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 CA-C-N 120.208 1.11 . . . . 1.0 111.864 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -88.9 -5.52 73.67 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.574 -1.41 . . . . 1.0 109.574 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.76 135.95 33.9 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.247 -1.149 . . . . 1.0 109.056 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.421 ' C ' ' H ' ' A' ' 138' ' ' PHE . 94.9 mt -60.5 -39.99 89.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.073 -1.017 . . . . 1.0 109.894 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 92.4 mtp -71.16 24.35 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.337 -0.852 . . . . 1.0 111.558 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.421 ' H ' ' C ' ' A' ' 136' ' ' LEU . 15.5 t80 -68.78 132.8 90.6 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 120.811 -1.181 . . . . 1.0 108.013 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -57.98 -8.78 5.04 Favored 'Trans proline' 0 N--CA 1.5 1.892 0 C-N-CA 120.859 1.039 . . . . 1.0 114.353 -177.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.9 mt -114.83 137.34 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 120.971 -1.08 . . . . 1.0 109.155 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -71.64 129.72 39.4 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.26 -0.9 . . . . 1.0 109.943 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 10.1 t -140.12 135.87 32.96 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.423 -0.798 . . . . 1.0 109.011 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -79.52 144.47 33.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.105 -0.997 . . . . 1.0 109.098 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.7 t -140.97 153.25 45.51 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.203 -0.936 . . . . 1.0 109.465 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.17 112.08 3.88 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.445 -1.462 . . . . 1.0 109.445 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.408 ' HE2' HD21 ' A' ' 112' ' ' ASN . 8.7 mtmp? -78.55 7.92 6.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -1.135 . . . . 1.0 109.598 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 73.4 m -59.99 -40.04 87.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 1.0 109.34 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -158.82 68.2 0.45 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 1.0 109.265 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -100.51 124.62 46.28 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.379 -0.826 . . . . 1.0 109.741 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 76.0 mtm -120.61 141.65 50.14 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.487 -0.931 . . . . 1.0 108.487 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.6 mt -48.89 129.36 14.7 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.015 -1.053 . . . . 1.0 108.924 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -68.23 176.69 5.24 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 CA-C-N 119.939 1.014 . . . . 1.0 112.646 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.23 -40.02 88.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.481 -0.762 . . . . 1.0 109.793 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -56.38 -49.41 74.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -0.944 . . . . 1.0 109.691 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -70.03 -40.01 75.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.204 -0.935 . . . . 1.0 110.141 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 62.4 t -59.97 -46.56 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.936 -1.102 . . . . 1.0 109.099 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -60.73 -40.01 90.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.144 -0.973 . . . . 1.0 110.321 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.34 -54.7 10.17 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 120.199 -1.0 . . . . 1.0 111.188 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.48 HG23 ' N ' ' A' ' 160' ' ' GLN . 7.2 tp -61.7 -40.47 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.975 -1.309 . . . . 1.0 109.957 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.527 ' O ' ' N ' ' A' ' 164' ' ' GLY . 92.3 mm-40 -65.28 -39.61 92.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.182 -0.949 . . . . 1.0 109.539 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 78.0 p -64.7 -27.74 69.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.921 . . . . 1.0 110.273 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 94.0 mt -87.0 -53.18 5.02 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.978 -1.077 . . . . 1.0 110.322 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -92.04 -9.25 43.44 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.215 -0.928 . . . . 1.0 110.119 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.496 2.64 0 N-CA-C 109.401 -1.48 . . . . 1.0 109.401 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' WAY . . . . . 0.822 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.8 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.446 -0.575 . . . . 1.0 109.446 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.0 mt -78.09 124.66 28.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.299 -0.876 . . . . 1.0 109.326 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -165.63 163.66 19.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.216 -0.928 . . . . 1.0 110.126 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -70.45 147.01 49.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 1.0 109.443 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.2 t -89.41 2.2 54.8 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.301 -0.874 . . . . 1.0 109.987 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -147.94 155.39 41.52 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.064 -1.023 . . . . 1.0 109.688 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.535 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.55 1.92 56.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.352 -0.843 . . . . 1.0 109.842 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -95.41 120.95 36.53 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.1 -1.0 . . . . 1.0 109.205 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.9 mt -140.28 150.54 44.18 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.372 -0.83 . . . . 1.0 108.9 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 69.1 p -134.26 156.14 48.94 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.885 -0.783 . . . . 1.0 108.885 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -145.12 162.07 37.93 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.063 -1.023 . . . . 1.0 110.142 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.421 HH21 ' HA ' ' A' ' 57' ' ' ILE . 6.8 ttm180 -141.74 131.05 23.58 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.46 -0.775 . . . . 1.0 109.933 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 86.5 mt -86.76 111.16 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.938 -1.134 . . . . 1.0 107.938 178.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 79.6 t -66.56 -40.71 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.088 -1.008 . . . . 1.0 109.371 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' A' ' 21' ' ' ASN . 18.2 p-10 -161.11 150.55 16.84 Favored 'General case' 0 C--N 1.286 -2.178 0 C-N-CA 117.452 -1.699 . . . . 1.0 111.005 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -97.01 107.81 20.42 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 104.676 -2.342 . . . . 1.0 104.676 177.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 23' ' ' THR . 0.6 OUTLIER -55.75 141.51 65.42 Favored Pre-proline 0 C--N 1.299 -1.595 0 O-C-N 121.143 -0.973 . . . . 1.0 110.168 -176.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -61.19 -11.79 20.45 Favored 'Trans proline' 0 N--CA 1.485 1.028 0 CA-C-N 119.061 0.7 . . . . 1.0 110.869 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -56.77 -26.21 56.99 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.774 -0.77 . . . . 1.0 110.092 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 73.1 mtm -144.32 163.11 34.69 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.965 -1.085 . . . . 1.0 109.27 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.1 p -72.69 158.82 34.89 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.377 -0.827 . . . . 1.0 109.138 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -60.21 -41.48 93.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -0.917 . . . . 1.0 110.401 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.1 m -59.84 -40.38 88.33 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.967 -1.083 . . . . 1.0 110.569 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.93 -41.59 86.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.885 -1.134 . . . . 1.0 110.413 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.3 t -67.9 -40.09 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.86 -1.15 . . . . 1.0 109.818 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -57.48 -58.87 6.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.332 -0.855 . . . . 1.0 111.286 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -27.55 69.4 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.248 -0.908 . . . . 1.0 110.203 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.02 -51.47 69.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.961 -1.087 . . . . 1.0 110.223 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -68.79 -37.02 78.98 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.876 -1.14 . . . . 1.0 110.158 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -60.02 -44.95 94.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.945 -1.097 . . . . 1.0 109.398 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.468 ' HB3' ' HZ3' ' A' ' 37' ' ' LYS . 10.4 mtpm? -59.96 -40.07 87.78 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.157 -0.964 . . . . 1.0 109.207 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.03 -46.86 88.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.341 -0.849 . . . . 1.0 110.049 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.418 ' CZ ' ' CZ ' ' A' ' 121' ' ' PHE . 62.5 m-85 -67.51 -38.64 84.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.926 -1.109 . . . . 1.0 109.747 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -60.02 -47.85 84.15 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.269 -0.895 . . . . 1.0 109.644 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.4 t -59.98 -40.61 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.142 -0.974 . . . . 1.0 109.972 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -79.49 -35.16 40.6 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.864 -1.147 . . . . 1.0 109.789 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.3 p -72.49 -20.26 61.4 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.908 -1.12 . . . . 1.0 109.865 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.88 -40.02 87.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.253 -0.905 . . . . 1.0 110.561 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.7 m -111.13 22.25 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.336 -0.852 . . . . 1.0 110.404 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.6 p -149.0 135.85 10.57 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 120.81 -1.181 . . . . 1.0 109.439 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -73.13 20.72 0.34 Allowed 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 120.682 0.921 . . . . 1.0 112.01 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.76 136.39 54.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 1.0 109.563 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -108.82 120.59 42.94 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.668 -0.864 . . . . 1.0 108.668 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -110.45 124.93 52.68 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.458 -0.776 . . . . 1.0 109.946 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.5 m -119.97 130.01 54.57 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.558 -0.713 . . . . 1.0 109.275 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.412 ' HG2' HH11 ' A' ' 52' ' ' ARG . 33.9 ttt-85 -81.28 130.5 35.06 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.201 -0.937 . . . . 1.0 110.003 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 89.8 mt -104.07 130.02 51.75 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.315 -0.866 . . . . 1.0 109.094 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.436 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 50.9 m170 -63.94 -40.1 95.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.307 -0.871 . . . . 1.0 109.823 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 70.7 m-20 -153.46 179.99 8.29 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.063 -1.023 . . . . 1.0 109.769 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.56 -173.05 32.07 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.839 -1.304 . . . . 1.0 109.839 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.421 ' HA ' HH21 ' A' ' 18' ' ' ARG . 90.2 mt -95.02 126.38 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.341 -1.093 . . . . 1.0 109.109 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.16 158.61 19.45 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.391 -0.818 . . . . 1.0 109.264 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -59.96 -49.94 75.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.232 -0.918 . . . . 1.0 109.87 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 92.7 mt -109.11 97.19 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.504 -0.748 . . . . 1.0 109.882 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.6 ptm -96.5 130.06 43.74 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.913 -1.117 . . . . 1.0 109.061 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.3 mt -108.71 133.38 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.609 -0.682 . . . . 1.0 109.788 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 79.3 p -152.31 158.44 42.76 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.144 -0.972 . . . . 1.0 109.854 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -100.18 135.0 42.28 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.464 -0.939 . . . . 1.0 108.464 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -121.83 167.82 14.54 Favored Glycine 0 N--CA 1.498 2.818 0 N-CA-C 110.243 -1.143 . . . . 1.0 110.243 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.547 ' O ' ' C ' ' A' ' 67' ' ' LYS . 96.5 mt -130.0 159.98 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.514 -0.921 . . . . 1.0 108.514 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.547 ' C ' ' O ' ' A' ' 66' ' ' ILE . 52.3 tptt -1.38 -93.19 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.748 0 C-N-CA 123.067 0.547 . . . . 1.0 111.89 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -78.97 136.19 37.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.107 -0.996 . . . . 1.0 109.348 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 36.6 p-80 -159.99 -171.3 3.18 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.94 -1.1 . . . . 1.0 110.323 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -39.96 -60.02 1.96 Allowed Glycine 0 N--CA 1.496 2.661 0 O-C-N 121.557 -0.714 . . . . 1.0 111.556 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -60.04 142.47 53.95 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.893 -1.357 . . . . 1.0 109.954 -179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -70.05 -19.51 63.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.36 -0.837 . . . . 1.0 110.119 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -90.7 112.89 55.72 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 121.3 -0.875 . . . . 1.0 109.439 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -77.43 178.47 7.58 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 CA-C-N 120.116 1.077 . . . . 1.0 112.546 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.543 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 89.3 m-85 -91.0 173.07 8.15 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.417 -0.802 . . . . 1.0 108.908 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -100.05 12.55 36.64 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.156 -0.965 . . . . 1.0 111.03 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 119.79 -146.8 18.06 Favored Glycine 0 N--CA 1.506 3.352 0 N-CA-C 109.03 -1.628 . . . . 1.0 109.03 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.43 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 13.2 Cg_endo -77.91 -51.94 0.07 OUTLIER 'Trans proline' 0 N--CA 1.49 1.31 0 CA-C-N 119.281 1.54 . . . . 1.0 111.762 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 81.3 p -80.4 161.9 24.74 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.243 -0.911 . . . . 1.0 109.69 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 105.52 -126.53 8.65 Favored Glycine 0 N--CA 1.501 2.972 0 N-CA-C 110.189 -1.165 . . . . 1.0 110.189 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.424 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 13.6 mt -67.12 100.13 0.74 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.414 -1.051 . . . . 1.0 109.344 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 31.0 mt -79.2 -19.15 51.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.083 -1.011 . . . . 1.0 108.765 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.99 171.02 1.42 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.684 -0.858 . . . . 1.0 108.684 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.455 ' ND1' ' C ' ' A' ' 84' ' ' HIS . 8.5 p80 -162.32 167.44 23.82 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.238 -0.914 . . . . 1.0 108.797 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.29 159.55 44.36 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.189 -0.944 . . . . 1.0 109.188 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -95.64 151.83 38.76 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 108.016 -1.105 . . . . 1.0 108.016 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.566 ' O ' ' N ' ' A' ' 89' ' ' GLY . 8.3 Cg_endo -62.49 166.49 13.22 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 120.47 0.78 . . . . 1.0 111.088 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -52.35 78.53 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 121.03 1.153 . . . . 1.0 111.792 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -101.06 -167.29 28.05 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.496 -1.441 . . . . 1.0 109.496 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 89' ' ' GLY . 14.8 Cg_exo -56.97 -148.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 121.148 1.232 . . . . 1.0 111.855 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -59.98 -39.94 87.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.995 -1.066 . . . . 1.0 109.819 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -66.71 -40.07 88.28 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.101 -0.999 . . . . 1.0 110.358 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -62.18 168.49 15.49 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.813 -1.315 . . . . 1.0 109.813 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.35 6.74 86.7 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.908 -1.277 . . . . 1.0 109.908 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -80.3 170.04 16.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.146 -1.208 . . . . 1.0 110.053 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.7 122.93 9.56 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.294 -0.879 . . . . 1.0 109.524 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.448 ' ND1' ' CE1' ' A' ' 84' ' ' HIS . 41.4 m170 -106.7 142.54 36.18 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.534 -0.729 . . . . 1.0 110.179 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.499 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 40.3 m-85 -124.11 138.24 54.46 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 108.801 -0.814 . . . . 1.0 108.801 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.543 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 93.4 m-20 -80.33 123.59 28.13 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.092 -1.005 . . . . 1.0 109.985 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 9.8 t70 -84.31 2.92 38.01 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.194 -0.941 . . . . 1.0 109.667 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -79.8 -18.8 50.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.227 -0.921 . . . . 1.0 109.42 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 102' ' ' GLU . 57.3 mp0 -91.83 169.96 10.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.366 -0.833 . . . . 1.0 109.166 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 11.9 m -98.59 108.16 20.78 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.433 -0.951 . . . . 1.0 108.433 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -85.63 128.32 34.74 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.248 -0.908 . . . . 1.0 108.565 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.643 HG21 ' HB2' ' A' ' 109' ' ' LYS . 7.6 t -143.87 155.96 44.29 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.265 -0.897 . . . . 1.0 110.071 -178.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 83.6 p -94.91 -7.26 40.54 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.323 -0.991 . . . . 1.0 108.323 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 57.9 m -92.65 179.01 5.62 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.645 -0.872 . . . . 1.0 108.645 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.4 m -80.7 76.08 7.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.983 -1.073 . . . . 1.0 109.34 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.643 ' HB2' HG21 ' A' ' 105' ' ' THR . 58.8 mttp -147.85 152.24 37.28 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.735 -0.839 . . . . 1.0 108.735 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 43.27 -140.0 2.89 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.111 -1.195 . . . . 1.0 110.111 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -100.02 114.46 27.78 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.386 -1.067 . . . . 1.0 109.321 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.452 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 57.8 t-20 -62.27 132.11 51.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.093 -1.005 . . . . 1.0 109.26 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.06 -41.45 92.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.28 -0.888 . . . . 1.0 110.289 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -60.02 -43.91 94.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.214 -0.929 . . . . 1.0 111.344 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -57.81 -51.21 70.51 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.845 -1.159 . . . . 1.0 109.65 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 64.3 t -69.72 -40.02 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.108 -0.995 . . . . 1.0 109.691 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.54 -49.96 74.63 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.237 -0.914 . . . . 1.0 109.55 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.8 -38.99 83.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.321 -0.862 . . . . 1.0 110.47 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -62.46 -49.86 73.74 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.044 -1.035 . . . . 1.0 111.059 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.499 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 7.7 pt-20 -60.03 -39.48 86.03 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.719 -1.238 . . . . 1.0 110.302 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.418 ' CZ ' ' CZ ' ' A' ' 39' ' ' PHE . 30.4 m-85 -60.07 -40.12 88.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.882 -1.136 . . . . 1.0 108.732 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.11 -45.23 94.2 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.276 -1.53 . . . . 1.0 109.276 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -65.75 -39.94 91.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.107 -1.231 . . . . 1.0 109.405 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.3 p -62.02 -26.23 68.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.923 . . . . 1.0 109.195 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 84.5 mt -80.61 -4.27 53.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.186 -0.946 . . . . 1.0 109.718 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 92.41 10.09 61.03 Favored Glycine 0 N--CA 1.496 2.684 0 C-N-CA 120.178 -1.01 . . . . 1.0 110.907 178.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.7 mt -82.74 149.9 27.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.83 -1.394 . . . . 1.0 109.165 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 42.6 t0 -101.19 171.65 7.48 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.542 -0.724 . . . . 1.0 109.339 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.54 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 65.7 m80 -59.91 137.18 58.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.13 -0.982 . . . . 1.0 109.71 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 40.3 t -97.35 156.0 16.64 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.405 -0.81 . . . . 1.0 109.171 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -97.45 2.03 49.84 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.172 -0.955 . . . . 1.0 110.006 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 7.5 t70 -85.84 129.98 52.39 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.097 -1.002 . . . . 1.0 108.665 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -68.23 -28.02 34.31 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 CA-C-N 120.106 1.073 . . . . 1.0 112.377 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.475 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -81.97 -1.81 90.39 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.753 -1.339 . . . . 1.0 109.753 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.17 146.16 25.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.304 -1.115 . . . . 1.0 109.754 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.407 ' C ' ' H ' ' A' ' 138' ' ' PHE . 84.2 mt -69.98 -32.97 71.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.333 -0.855 . . . . 1.0 109.428 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 98.1 mmm -71.78 13.33 0.28 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.504 -0.747 . . . . 1.0 110.328 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.407 ' H ' ' C ' ' A' ' 136' ' ' LEU . 13.5 t80 -69.24 135.6 89.06 Favored Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 107.811 -1.181 . . . . 1.0 107.811 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -64.22 -0.42 2.81 Favored 'Trans proline' 0 N--CA 1.5 1.855 0 CA-C-N 119.96 1.021 . . . . 1.0 114.564 -177.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.7 mt -119.69 138.1 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.368 0 O-C-N 120.835 -1.166 . . . . 1.0 109.979 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.452 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 24.3 t80 -72.75 130.22 40.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.692 -0.63 . . . . 1.0 110.012 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.7 t -140.53 139.98 35.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.429 -0.794 . . . . 1.0 109.198 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -82.72 140.72 32.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.972 -1.08 . . . . 1.0 109.52 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.5 t -138.64 155.46 48.28 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.296 -0.878 . . . . 1.0 109.927 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -75.48 109.64 2.84 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.096 -1.602 . . . . 1.0 109.096 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.449 ' HE2' HD21 ' A' ' 112' ' ' ASN . 8.5 mtmp? -78.23 0.29 25.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.284 -1.127 . . . . 1.0 110.033 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 22.9 t -60.01 -40.49 89.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.075 -1.016 . . . . 1.0 109.856 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -139.94 32.21 1.99 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.212 -0.93 . . . . 1.0 109.825 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -79.23 130.15 35.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.001 -1.062 . . . . 1.0 110.151 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 77.8 mtm -133.87 149.35 51.34 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.39 -0.967 . . . . 1.0 108.39 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 62.0 mt -51.58 128.71 34.39 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 120.957 -1.09 . . . . 1.0 108.898 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -69.63 177.47 5.46 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 CA-C-N 120.051 1.054 . . . . 1.0 112.175 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -62.24 -39.97 94.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.46 -0.775 . . . . 1.0 109.878 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -55.9 -48.46 75.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.15 -0.968 . . . . 1.0 109.87 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.04 -39.87 75.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.078 -1.013 . . . . 1.0 110.027 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.23 -47.15 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.123 -0.986 . . . . 1.0 109.341 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -60.34 -40.07 89.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.845 -1.159 . . . . 1.0 110.503 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -69.9 -54.65 11.21 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 120.176 -1.011 . . . . 1.0 111.129 -178.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.456 HG23 ' N ' ' A' ' 160' ' ' GLN . 4.7 tp -60.05 -39.93 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.857 -1.378 . . . . 1.0 109.572 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.456 ' N ' HG23 ' A' ' 159' ' ' ILE . 95.7 mt-30 -64.01 -39.99 95.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.932 -1.105 . . . . 1.0 109.473 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 88.6 p -58.46 -30.16 66.75 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.747 -1.221 . . . . 1.0 108.871 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 92.5 mt -88.87 -69.62 0.7 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.245 -0.909 . . . . 1.0 111.079 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -89.17 -11.59 43.37 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.998 -1.064 . . . . 1.0 111.185 -177.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.72 0 N-CA-C 109.766 -1.334 . . . . 1.0 109.766 179.967 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' WAY . . . . . 0.878 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.2 m . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.445 -0.576 . . . . 1.0 109.445 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.9 mt -82.64 133.34 35.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.201 -0.937 . . . . 1.0 109.328 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -163.05 162.34 25.8 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 1.0 109.304 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -71.02 147.26 48.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.181 -0.949 . . . . 1.0 109.594 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.2 t -89.98 2.05 55.57 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.402 -0.811 . . . . 1.0 110.35 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -144.83 154.31 42.53 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.001 -1.062 . . . . 1.0 109.99 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.55 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.28 0.21 57.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.305 -0.872 . . . . 1.0 109.72 -179.734 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -94.0 121.99 36.05 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.148 -0.97 . . . . 1.0 109.007 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.2 mt -140.18 151.47 45.27 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.365 -0.834 . . . . 1.0 109.213 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.0 p -133.72 157.33 46.1 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.455 -0.778 . . . . 1.0 109.193 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -145.32 160.24 41.82 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.142 -0.974 . . . . 1.0 109.916 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -140.99 134.01 29.25 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.369 -0.832 . . . . 1.0 110.068 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.7 mm -89.04 111.21 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.011 -1.107 . . . . 1.0 108.011 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.6 t -67.84 -39.74 82.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.126 -0.984 . . . . 1.0 109.121 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.643 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.0 OUTLIER -161.23 150.5 16.56 Favored 'General case' 0 C--N 1.29 -1.992 0 O-C-N 119.294 -2.129 . . . . 1.0 111.466 -179.628 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.63 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 52.4 m-85 -99.94 99.03 9.74 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 106.097 -1.816 . . . . 1.0 106.097 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.1 t -47.67 141.15 7.58 Favored Pre-proline 0 C--N 1.299 -1.615 0 O-C-N 121.515 -0.74 . . . . 1.0 110.769 -177.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.86 -8.12 7.18 Favored 'Trans proline' 0 N--CA 1.488 1.166 0 C-N-CA 120.649 0.899 . . . . 1.0 111.223 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -59.02 -35.5 73.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.461 -0.775 . . . . 1.0 109.821 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 74.0 mtm -139.59 160.99 38.58 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.192 -0.942 . . . . 1.0 109.657 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 55.1 p -70.71 160.37 32.76 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.401 -0.812 . . . . 1.0 109.397 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.63 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 3.8 m80 -60.1 -40.54 89.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.318 -0.864 . . . . 1.0 110.263 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.7 m -59.97 -42.36 93.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.085 -1.009 . . . . 1.0 110.526 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -67.87 -40.36 83.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.242 -0.911 . . . . 1.0 110.393 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 70.9 t -68.97 -43.01 82.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.166 -0.959 . . . . 1.0 110.242 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -60.04 -49.16 78.75 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.138 -0.976 . . . . 1.0 110.824 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -61.35 -33.12 73.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.908 -1.12 . . . . 1.0 110.068 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.0 -49.77 76.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.893 -1.129 . . . . 1.0 109.979 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.497 ' CE1' HD13 ' A' ' 62' ' ' ILE . 53.5 m-85 -67.36 -39.98 85.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.022 -1.049 . . . . 1.0 110.185 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -60.01 -43.22 95.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.951 -1.093 . . . . 1.0 110.089 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.45 -40.18 95.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.06 -1.025 . . . . 1.0 109.676 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.18 -44.45 95.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.263 -0.898 . . . . 1.0 110.196 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -69.58 -38.2 77.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.04 -1.038 . . . . 1.0 109.697 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.415 ' O ' ' CG ' ' A' ' 44' ' ' ASP . 50.4 tptt -60.0 -48.05 83.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.063 -1.023 . . . . 1.0 109.594 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.3 t -59.97 -41.15 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.119 -0.988 . . . . 1.0 109.869 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -78.46 -37.96 42.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.854 -1.154 . . . . 1.0 109.903 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.3 p -71.18 -19.22 62.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.054 -1.029 . . . . 1.0 109.643 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.415 ' CG ' ' O ' ' A' ' 40' ' ' LYS . 95.0 m-20 -60.04 -40.02 87.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.911 . . . . 1.0 110.603 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.9 m -108.63 22.04 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 121.126 -0.984 . . . . 1.0 111.304 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.2 p -149.79 144.82 18.11 Favored Pre-proline 0 N--CA 1.502 2.129 0 O-C-N 120.678 -1.264 . . . . 1.0 109.418 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -75.27 19.56 0.51 Allowed 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 120.615 0.877 . . . . 1.0 111.502 178.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.7 mt -68.99 130.31 42.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.12 -0.988 . . . . 1.0 109.719 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -107.02 120.61 42.55 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.591 -0.892 . . . . 1.0 108.591 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -108.39 125.98 52.35 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.285 -0.884 . . . . 1.0 109.713 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -120.01 129.95 54.5 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.643 -0.661 . . . . 1.0 109.846 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -82.01 130.92 35.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.325 -0.859 . . . . 1.0 109.028 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 89.4 mt -102.84 135.19 44.95 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.284 -0.885 . . . . 1.0 109.021 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.447 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 91.9 m-70 -64.26 -40.4 95.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.243 -0.911 . . . . 1.0 109.905 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 69.3 m-20 -155.69 -173.76 4.67 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.191 -0.943 . . . . 1.0 109.706 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.59 -169.51 35.77 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.05 -1.22 . . . . 1.0 110.05 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 87.6 mt -93.75 129.42 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.414 -1.051 . . . . 1.0 108.978 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.79 164.31 12.69 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.395 -0.816 . . . . 1.0 109.156 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -59.95 -49.64 76.9 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.124 -0.985 . . . . 1.0 109.032 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.2 mt -122.34 112.81 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.916 -0.772 . . . . 1.0 108.916 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.7 ptp -97.96 137.06 37.34 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.996 -1.065 . . . . 1.0 109.238 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.497 HD13 ' CE1' ' A' ' 35' ' ' PHE . 97.5 mt -105.29 133.07 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.279 -0.888 . . . . 1.0 109.687 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 84.2 p -151.84 152.4 32.56 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.235 -0.916 . . . . 1.0 109.761 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.477 ' H ' HD21 ' A' ' 21' ' ' ASN . 55.3 m-85 -106.68 122.67 46.81 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.461 -0.774 . . . . 1.0 109.045 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -97.31 -178.97 34.18 Favored Glycine 0 N--CA 1.497 2.756 0 O-C-N 121.187 -0.946 . . . . 1.0 111.187 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.532 HG22 ' N ' ' A' ' 67' ' ' LYS . 67.5 mt -134.16 165.32 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.793 -0.827 . . . . 1.0 108.843 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.532 ' N ' HG22 ' A' ' 66' ' ' ILE . 20.0 tptm -9.3 -77.41 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.594 0 C-N-CA 123.035 0.534 . . . . 1.0 112.265 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.407 ' HG2' ' H ' ' A' ' 68' ' ' GLU . 9.4 pt-20 -64.62 94.15 0.12 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.075 -1.016 . . . . 1.0 109.506 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -60.01 -40.06 87.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.515 -0.74 . . . . 1.0 109.598 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.76 1.66 67.82 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.231 -1.548 . . . . 1.0 109.231 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.541 ' C ' ' H ' ' A' ' 73' ' ' TYR . 95.9 m-20 -129.04 170.02 13.99 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.665 -0.903 . . . . 1.0 108.586 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.617 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 6.4 p90 -71.0 25.33 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.007 -1.058 . . . . 1.0 109.895 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.617 ' CE2' ' CE2' ' A' ' 72' ' ' PHE . 42.4 m-85 -129.09 77.11 78.34 Favored Pre-proline 0 N--CA 1.499 1.981 0 N-CA-C 108.439 -0.949 . . . . 1.0 108.439 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -75.78 143.58 26.85 Favored 'Trans proline' 0 N--CA 1.488 1.2 0 C-N-CA 120.947 1.098 . . . . 1.0 112.468 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.556 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 99.8 m-85 -85.51 158.91 20.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.465 -0.772 . . . . 1.0 108.946 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 28.2 p-10 -96.53 -0.04 49.44 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.126 -0.984 . . . . 1.0 110.532 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.426 ' O ' ' OE2' ' A' ' 102' ' ' GLU . . . 117.4 -119.45 4.44 Favored Glycine 0 N--CA 1.504 3.225 0 N-CA-C 110.249 -1.141 . . . . 1.0 110.249 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.459 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 28.8 Cg_endo -74.69 -72.45 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.797 0 CA-C-N 120.179 1.989 . . . . 1.0 113.012 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.425 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 81.3 p -74.76 171.49 13.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.034 -1.041 . . . . 1.0 109.839 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 104.02 -135.19 12.29 Favored Glycine 0 N--CA 1.498 2.8 0 N-CA-C 110.231 -1.148 . . . . 1.0 110.231 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.6 mt -68.86 107.32 3.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.388 -1.066 . . . . 1.0 109.692 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 84.2 mt -79.65 -25.54 41.33 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.158 -0.964 . . . . 1.0 108.892 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.54 172.82 1.4 Allowed 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.733 -0.84 . . . . 1.0 108.733 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -162.78 166.23 24.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.79 -1.194 . . . . 1.0 109.982 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -153.34 159.73 42.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.439 -0.788 . . . . 1.0 109.21 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -106.77 151.63 40.58 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.366 -0.834 . . . . 1.0 109.128 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -64.38 165.51 19.79 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 121.045 1.164 . . . . 1.0 111.614 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -46.09 124.25 7.24 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 120.906 1.071 . . . . 1.0 112.003 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 90' ' ' PRO . . . -167.01 -169.66 30.89 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.347 -1.501 . . . . 1.0 109.347 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.405 ' O ' ' O ' ' A' ' 89' ' ' GLY . 13.0 Cg_exo -57.1 -151.55 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 121.133 1.222 . . . . 1.0 112.32 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -60.11 -40.71 90.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.348 -0.845 . . . . 1.0 110.007 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -68.2 -40.0 82.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.905 . . . . 1.0 109.159 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -80.05 169.92 53.37 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.914 -1.675 . . . . 1.0 108.914 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 58.67 65.43 3.5 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.47 -1.452 . . . . 1.0 109.47 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.5 p-10 -149.97 170.78 18.03 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.284 -1.127 . . . . 1.0 109.235 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -146.31 123.76 11.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.021 -1.05 . . . . 1.0 109.654 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -114.73 153.17 30.78 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.375 -0.602 . . . . 1.0 109.375 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.529 ' CE2' ' OE2' ' A' ' 120' ' ' GLU . 39.5 m-85 -137.69 149.78 46.8 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.609 -0.886 . . . . 1.0 108.609 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.556 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 88.1 m-20 -81.39 121.14 25.86 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.684 -1.26 . . . . 1.0 109.009 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -82.65 -5.45 58.84 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.121 -0.987 . . . . 1.0 109.35 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -81.39 -9.33 59.75 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.347 -0.846 . . . . 1.0 109.209 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.459 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 52.7 mm-40 -89.03 176.05 7.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.334 -0.854 . . . . 1.0 109.422 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 26.0 m -106.96 107.01 17.82 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.475 -0.935 . . . . 1.0 108.475 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -86.88 122.9 31.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.365 -0.834 . . . . 1.0 109.127 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.637 HG21 ' HB2' ' A' ' 109' ' ' LYS . 7.8 t -141.54 150.76 42.54 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.363 -0.835 . . . . 1.0 109.925 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 59.8 p -93.01 -6.91 47.26 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.232 -1.025 . . . . 1.0 108.232 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 81.9 p -92.83 176.67 6.35 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.005 -0.739 . . . . 1.0 109.005 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.6 t -77.68 76.95 4.21 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.198 -0.939 . . . . 1.0 109.484 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.637 ' HB2' HG21 ' A' ' 105' ' ' THR . 62.9 mttp -148.13 146.92 28.98 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.74 -139.92 5.81 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.881 -1.287 . . . . 1.0 109.881 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -100.11 115.19 29.21 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.304 -1.115 . . . . 1.0 109.365 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.408 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 9.7 t-20 -61.76 133.04 55.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.117 -0.989 . . . . 1.0 109.469 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.5 tp -59.99 -42.95 95.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.32 -0.862 . . . . 1.0 110.482 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -59.93 -40.99 90.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.087 -1.008 . . . . 1.0 110.436 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -59.91 -50.69 72.78 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.872 -1.143 . . . . 1.0 110.014 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.5 t -68.36 -45.11 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.172 -0.955 . . . . 1.0 110.448 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.63 -47.43 82.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.308 -0.87 . . . . 1.0 110.018 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.98 -41.0 91.07 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.929 -1.107 . . . . 1.0 110.77 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 60.8 t60 -65.91 -49.02 69.5 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.055 -1.028 . . . . 1.0 111.78 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.529 ' OE2' ' CE2' ' A' ' 98' ' ' PHE . 9.0 pt-20 -60.02 -42.34 94.12 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.495 -1.378 . . . . 1.0 110.368 -178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -60.05 -40.04 88.08 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.682 -1.261 . . . . 1.0 108.655 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.32 -42.71 64.42 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.161 -1.576 . . . . 1.0 109.161 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -66.27 -40.0 89.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -1.13 . . . . 1.0 109.136 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 86.2 p -64.58 -21.96 66.84 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.42 -0.8 . . . . 1.0 109.577 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.9 mt -83.51 1.51 41.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.298 -0.877 . . . . 1.0 109.972 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.93 4.88 68.8 Favored Glycine 0 N--CA 1.497 2.705 0 O-C-N 121.068 -1.02 . . . . 1.0 110.701 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.9 mt -85.52 146.14 27.06 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.887 -1.361 . . . . 1.0 109.387 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 30.8 t0 -102.56 174.84 5.72 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.47 -0.769 . . . . 1.0 109.373 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.451 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 66.9 m80 -59.97 137.93 57.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.142 -0.974 . . . . 1.0 109.374 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 34.2 t -98.25 158.07 15.79 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.361 -0.837 . . . . 1.0 109.48 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -95.97 -0.42 50.71 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.225 -0.922 . . . . 1.0 109.663 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -86.08 128.47 57.73 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.108 -0.995 . . . . 1.0 108.935 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -68.41 -19.84 42.83 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 CA-C-N 120.065 1.059 . . . . 1.0 112.5 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -88.38 -5.0 76.38 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.772 -1.331 . . . . 1.0 109.772 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.79 145.62 27.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.33 -1.1 . . . . 1.0 109.664 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.5 mt -70.0 -30.98 68.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.876 . . . . 1.0 109.406 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.7 mmm -71.89 10.67 0.66 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.361 -0.837 . . . . 1.0 110.053 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -70.05 134.14 87.65 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 107.907 -1.146 . . . . 1.0 107.907 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -60.81 -20.36 65.86 Favored 'Trans proline' 0 N--CA 1.502 1.983 0 C-N-CA 120.968 1.112 . . . . 1.0 114.308 -177.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.6 mt -98.22 139.84 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 O-C-N 120.696 -1.253 . . . . 1.0 110.293 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.408 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 28.3 t80 -75.97 132.28 40.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.482 -0.761 . . . . 1.0 109.901 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.4 t -141.5 142.25 33.6 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.26 -0.9 . . . . 1.0 109.412 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -79.41 143.35 35.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.092 -1.005 . . . . 1.0 108.681 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.3 t -139.99 150.01 43.93 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.172 -0.955 . . . . 1.0 109.684 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.19 108.03 2.32 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.617 -1.393 . . . . 1.0 109.617 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.446 ' NZ ' ' CB ' ' A' ' 146' ' ' LYS . 7.8 mtpm? -76.81 0.12 21.86 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.422 -1.046 . . . . 1.0 109.778 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.3 t -60.01 -44.81 94.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.192 -0.943 . . . . 1.0 110.148 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -142.34 29.61 1.6 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.17 -0.956 . . . . 1.0 110.11 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -66.44 138.03 57.27 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.836 -1.165 . . . . 1.0 109.34 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 76.9 mtm -139.54 142.74 37.2 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.356 -0.84 . . . . 1.0 109.124 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 46.9 mt -49.16 110.92 1.69 Allowed Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.151 -0.968 . . . . 1.0 109.164 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -56.01 177.09 0.15 Allowed 'Trans proline' 0 N--CA 1.494 1.555 0 CA-C-N 120.119 1.078 . . . . 1.0 112.887 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -60.02 -39.88 87.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.466 -0.771 . . . . 1.0 109.997 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -56.1 -48.63 75.79 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.174 -0.953 . . . . 1.0 110.029 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -70.05 -40.01 75.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.908 . . . . 1.0 109.904 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.64 -45.66 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.178 -0.951 . . . . 1.0 109.641 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -61.6 -40.12 93.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.993 -1.067 . . . . 1.0 110.448 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.16 -52.32 14.19 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 120.35 -0.928 . . . . 1.0 111.524 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.448 HG23 ' N ' ' A' ' 160' ' ' GLN . 5.0 tp -60.59 -40.04 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.886 -1.361 . . . . 1.0 109.587 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 164' ' ' GLY . 97.4 mt-30 -65.33 -40.01 93.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.099 -1.001 . . . . 1.0 109.725 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 79.3 p -60.86 -32.25 71.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.112 -0.992 . . . . 1.0 110.483 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 89.5 mt -86.23 -51.83 6.03 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.874 -1.141 . . . . 1.0 110.921 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -92.0 -9.38 43.11 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.851 -1.156 . . . . 1.0 110.458 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.632 0 N-CA-C 109.676 -1.37 . . . . 1.0 109.676 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' WAY . . . . . 0.507 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 79.1 m . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.3 mt -69.27 140.35 54.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.149 -0.97 . . . . 1.0 109.217 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -161.69 166.96 25.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 1.0 109.508 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -70.46 140.6 51.99 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.24 -0.912 . . . . 1.0 109.794 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.4 t -88.0 1.79 53.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.407 -0.808 . . . . 1.0 110.249 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -143.01 153.5 43.04 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.075 -1.016 . . . . 1.0 109.59 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.519 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.95 0.89 57.41 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.479 -0.763 . . . . 1.0 109.597 -179.609 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -96.56 121.14 38.06 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.174 -0.954 . . . . 1.0 109.183 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.8 mt -139.97 148.0 41.29 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.3 -0.875 . . . . 1.0 109.169 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.9 p -130.6 153.77 48.56 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -143.4 157.5 44.41 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.184 -0.948 . . . . 1.0 110.074 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.489 HH12 ' H ' ' A' ' 56' ' ' GLY . 71.7 ttt180 -143.18 132.74 23.64 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.555 -0.715 . . . . 1.0 109.333 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 84.7 mt -87.66 118.31 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.063 -1.023 . . . . 1.0 108.581 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.0 t -69.91 -40.02 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.991 -1.068 . . . . 1.0 109.002 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.2 p-10 -160.4 157.0 27.02 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.733 -1.23 . . . . 1.0 110.169 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.592 ' CD1' ' CD2' ' A' ' 28' ' ' HIS . 47.6 m-85 -100.44 -163.01 0.99 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.38 -1.341 . . . . 1.0 107.38 178.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.73 148.26 55.82 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.371 -0.831 . . . . 1.0 110.336 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -70.83 -21.64 28.27 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 120.661 0.907 . . . . 1.0 110.105 177.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -56.67 -36.05 69.13 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 115.725 -0.671 . . . . 1.0 110.707 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.7 mtm -135.04 163.85 28.96 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.299 -0.876 . . . . 1.0 109.469 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.4 p -73.36 159.68 32.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.484 -0.76 . . . . 1.0 109.291 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.592 ' CD2' ' CD1' ' A' ' 22' ' ' TYR . 2.9 m80 -60.79 -40.03 91.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.465 -0.772 . . . . 1.0 110.031 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.3 m -60.09 -40.46 89.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.147 -0.97 . . . . 1.0 110.185 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -67.29 -40.53 86.12 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.146 -0.971 . . . . 1.0 110.395 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.7 t -68.12 -40.41 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.121 -0.987 . . . . 1.0 109.988 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -60.05 -49.64 76.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.05 -1.031 . . . . 1.0 110.534 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -61.98 -31.55 71.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.984 -1.073 . . . . 1.0 109.68 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.07 -50.29 74.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.089 -1.007 . . . . 1.0 109.802 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -67.41 -39.67 85.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.161 -0.962 . . . . 1.0 110.215 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -59.97 -42.88 95.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.978 -1.077 . . . . 1.0 109.494 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -60.34 -39.84 88.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 1.0 109.065 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.86 -46.2 90.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.51 -0.744 . . . . 1.0 110.024 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.4 ' CZ ' ' CZ ' ' A' ' 121' ' ' PHE . 59.1 m-85 -67.04 -39.4 86.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.051 -1.03 . . . . 1.0 109.196 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.404 ' O ' ' CG ' ' A' ' 44' ' ' ASP . 47.3 tptt -60.09 -47.77 84.52 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.372 -0.83 . . . . 1.0 109.737 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.2 t -60.0 -40.03 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.011 -1.055 . . . . 1.0 109.591 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 70.0 m95 -79.61 -37.16 36.79 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.049 -1.032 . . . . 1.0 110.022 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 62.3 p -70.44 -19.78 62.95 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.034 -1.042 . . . . 1.0 109.557 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.404 ' CG ' ' O ' ' A' ' 40' ' ' LYS . 96.1 m-20 -60.09 -38.55 83.26 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.402 -0.811 . . . . 1.0 110.749 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.3 m -112.33 22.57 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.302 -0.873 . . . . 1.0 110.641 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.7 p -149.81 139.77 13.51 Favored Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 120.928 -1.108 . . . . 1.0 109.655 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -76.97 22.17 0.56 Allowed 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 120.829 1.019 . . . . 1.0 112.378 178.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 77.5 mt -69.71 139.96 53.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.919 -1.113 . . . . 1.0 109.75 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -109.71 120.07 41.36 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -109.09 125.64 52.34 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.351 -0.843 . . . . 1.0 109.481 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 93.8 m -120.07 129.93 54.43 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.542 -0.724 . . . . 1.0 109.476 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -82.72 128.24 34.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.332 -0.855 . . . . 1.0 109.496 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.9 mt -105.37 119.27 38.65 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.363 -0.835 . . . . 1.0 108.844 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.448 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 85.6 m-70 -70.03 -25.17 63.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.419 -0.801 . . . . 1.0 109.993 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 78.3 m-20 -147.76 160.18 43.01 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.271 -0.893 . . . . 1.0 109.806 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.489 ' H ' HH12 ' A' ' 18' ' ' ARG . . . 98.54 174.12 32.41 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 109.624 -1.39 . . . . 1.0 109.624 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.4 mt -94.42 133.49 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.349 -1.089 . . . . 1.0 108.977 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.28 159.35 17.5 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.367 -0.833 . . . . 1.0 109.61 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -59.85 -49.8 76.27 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.238 -0.914 . . . . 1.0 109.196 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.3 mt -105.13 100.43 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.539 -0.726 . . . . 1.0 109.666 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.2 ptm -102.79 127.89 49.77 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.323 -0.861 . . . . 1.0 108.993 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.5 mt -102.65 139.45 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.441 -0.787 . . . . 1.0 109.313 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.0 p -151.38 154.94 37.64 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.169 -0.957 . . . . 1.0 109.522 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -104.44 122.67 45.98 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.767 -0.827 . . . . 1.0 108.767 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.27 -169.5 20.5 Favored Glycine 0 N--CA 1.5 2.956 0 N-CA-C 110.197 -1.161 . . . . 1.0 110.197 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.591 HG22 ' N ' ' A' ' 67' ' ' LYS . 81.4 mt -138.51 167.76 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.501 -1.0 . . . . 1.0 108.824 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.591 ' N ' HG22 ' A' ' 66' ' ' ILE . 21.0 tptm -22.04 -78.4 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.443 0 CA-C-O 121.061 0.458 . . . . 1.0 111.782 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.632 ' CD ' ' H ' ' A' ' 68' ' ' GLU . 1.0 OUTLIER -73.02 121.88 20.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.067 -1.021 . . . . 1.0 110.102 -179.421 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -100.5 -19.91 15.98 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.389 -0.967 . . . . 1.0 108.389 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.19 -4.87 84.57 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.075 -1.61 . . . . 1.0 109.075 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -119.76 -116.96 0.32 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.707 -0.878 . . . . 1.0 109.35 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -51.76 169.96 0.06 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.233 -0.917 . . . . 1.0 110.063 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -51.7 146.72 12.95 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 108.875 -0.787 . . . . 1.0 108.875 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -57.15 -171.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 120.676 0.917 . . . . 1.0 112.11 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.534 ' CE2' ' OD1' ' A' ' 99' ' ' ASP . 22.2 m-85 -90.05 -173.37 3.83 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.782 -0.822 . . . . 1.0 108.782 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.5 p-10 -101.08 6.93 43.52 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.234 -0.916 . . . . 1.0 110.841 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 125.4 -145.71 15.83 Favored Glycine 0 N--CA 1.506 3.321 0 N-CA-C 108.938 -1.665 . . . . 1.0 108.938 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.472 ' O ' ' CG ' ' A' ' 102' ' ' GLU . 12.9 Cg_endo -77.43 -56.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.3 0 CA-C-N 119.41 1.605 . . . . 1.0 111.936 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 83.4 p -78.92 170.63 16.38 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.2 -0.938 . . . . 1.0 110.571 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.79 -120.19 6.78 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 110.571 -1.012 . . . . 1.0 110.571 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.418 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 11.0 mt -66.39 100.66 0.66 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.422 -1.046 . . . . 1.0 109.113 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 66.9 mt -81.15 -19.97 42.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.074 -1.016 . . . . 1.0 109.538 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.78 172.27 1.11 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -162.1 159.52 26.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 1.0 109.241 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.03 163.84 35.64 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.322 -0.861 . . . . 1.0 109.358 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -99.72 153.25 37.87 Favored Pre-proline 0 N--CA 1.495 1.794 0 N-CA-C 108.678 -0.86 . . . . 1.0 108.678 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -59.06 167.22 5.95 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 CA-C-N 118.801 0.607 . . . . 1.0 111.338 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -46.56 132.4 16.21 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.031 1.154 . . . . 1.0 111.759 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -173.13 -172.28 38.55 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.473 -1.451 . . . . 1.0 109.473 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -57.04 -155.72 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 121.342 1.361 . . . . 1.0 112.191 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -60.01 -40.66 90.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.207 -0.933 . . . . 1.0 109.415 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -59.91 -48.02 83.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.438 -0.789 . . . . 1.0 109.248 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -76.73 169.0 54.92 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.841 -1.304 . . . . 1.0 109.841 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 72.71 6.65 67.44 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.341 -1.503 . . . . 1.0 109.341 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -80.0 167.95 19.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.063 -1.257 . . . . 1.0 109.556 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.75 124.69 10.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.245 -0.91 . . . . 1.0 109.184 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 46.3 m170 -112.33 146.22 38.67 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.484 -0.76 . . . . 1.0 110.141 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -125.44 141.49 52.03 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.819 -0.808 . . . . 1.0 108.819 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.534 ' OD1' ' CE2' ' A' ' 75' ' ' PHE . 95.8 m-20 -79.81 121.43 25.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.079 -1.013 . . . . 1.0 109.42 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 47.0 t0 -84.16 1.55 43.81 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.122 -0.986 . . . . 1.0 109.844 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -81.78 -15.18 55.06 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.004 -1.06 . . . . 1.0 110.312 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.567 ' OE1' ' N ' ' A' ' 102' ' ' GLU . 57.4 mp0 -93.15 177.3 6.1 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.114 -0.991 . . . . 1.0 109.911 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 16.6 m -100.17 108.11 20.14 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.724 -0.843 . . . . 1.0 108.724 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -90.18 121.8 32.54 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.796 -0.816 . . . . 1.0 108.796 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.647 HG21 ' HB2' ' A' ' 109' ' ' LYS . 7.5 t -143.2 158.04 43.97 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.178 -0.951 . . . . 1.0 110.285 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.3 t -95.01 -6.99 41.02 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.459 -0.941 . . . . 1.0 108.459 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 109' ' ' LYS . 45.0 t -90.81 170.03 10.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.577 -0.702 . . . . 1.0 109.216 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.6 m -70.67 63.37 0.28 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.145 -0.972 . . . . 1.0 109.152 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.647 ' HB2' HG21 ' A' ' 105' ' ' THR . 67.9 mmtt -140.92 149.88 42.46 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.399 -0.813 . . . . 1.0 109.234 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 46.67 -146.16 3.57 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.477 -1.449 . . . . 1.0 109.477 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -98.61 115.27 28.28 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.33 -1.1 . . . . 1.0 108.836 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.431 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 61.4 t-20 -62.24 133.49 55.24 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.129 -0.982 . . . . 1.0 109.302 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.1 tp -59.95 -43.45 95.01 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.547 -0.721 . . . . 1.0 110.127 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -60.14 -42.41 94.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.345 -0.847 . . . . 1.0 111.274 -179.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -58.15 -52.83 63.93 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.749 -1.22 . . . . 1.0 109.585 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 71.1 t -66.85 -41.09 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.153 -0.967 . . . . 1.0 109.779 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.11 -49.51 76.7 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.253 -0.905 . . . . 1.0 109.71 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.31 -37.91 78.94 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 120.757 -1.214 . . . . 1.0 110.229 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -65.8 -49.24 69.02 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.157 -0.965 . . . . 1.0 111.884 -178.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -59.92 -39.34 85.13 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.534 -1.354 . . . . 1.0 109.609 -178.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.4 ' CZ ' ' CZ ' ' A' ' 39' ' ' PHE . 29.8 m-85 -59.92 -40.09 87.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.877 -1.14 . . . . 1.0 108.894 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.65 -41.28 93.63 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.761 -1.336 . . . . 1.0 109.761 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -66.52 -38.98 88.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.951 -1.323 . . . . 1.0 108.866 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 87.5 p -67.8 -22.51 65.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 1.0 109.639 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 84.3 mt -83.35 -1.87 54.39 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.122 -0.986 . . . . 1.0 110.09 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.07 5.4 62.44 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.382 -1.087 . . . . 1.0 110.382 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.6 mt -86.86 144.03 27.18 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.899 -1.353 . . . . 1.0 109.491 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 34.6 t0 -102.54 178.2 4.65 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.563 -0.711 . . . . 1.0 109.176 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.489 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 65.0 m80 -59.89 136.96 58.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.078 -1.014 . . . . 1.0 109.497 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 17.5 t -98.88 158.48 15.61 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.344 -0.848 . . . . 1.0 109.381 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -99.49 2.56 45.03 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.258 -0.902 . . . . 1.0 109.054 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -85.66 122.34 73.21 Favored Pre-proline 0 N--CA 1.488 1.452 0 N-CA-C 108.179 -1.045 . . . . 1.0 108.179 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -67.44 -15.01 44.4 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 CA-C-N 120.117 1.078 . . . . 1.0 111.903 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -90.26 -5.98 69.34 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.354 -1.498 . . . . 1.0 109.354 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -87.62 148.84 24.64 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.246 -1.149 . . . . 1.0 109.829 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.494 ' C ' ' H ' ' A' ' 138' ' ' PHE . 86.0 mt -70.08 -36.34 74.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.169 -0.957 . . . . 1.0 109.298 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.0 mmm -68.91 17.24 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.397 -0.814 . . . . 1.0 110.433 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.494 ' H ' ' C ' ' A' ' 136' ' ' LEU . 14.0 t80 -69.99 134.69 87.57 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 107.711 -1.218 . . . . 1.0 107.711 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -60.53 -6.89 6.17 Favored 'Trans proline' 0 N--CA 1.501 1.952 0 CA-C-N 119.833 0.976 . . . . 1.0 114.609 -177.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.85 137.77 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.43 0 O-C-N 121.054 -1.029 . . . . 1.0 109.656 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.431 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 29.4 t80 -73.14 130.72 40.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.611 -0.681 . . . . 1.0 110.014 -178.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.3 t -139.69 139.94 36.72 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.361 -0.837 . . . . 1.0 109.068 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -81.55 141.75 33.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 1.0 109.256 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.9 t -139.96 152.46 46.34 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.27 -0.894 . . . . 1.0 109.977 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.15 108.66 2.56 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.551 -1.42 . . . . 1.0 109.551 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -77.21 1.19 19.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -1.147 . . . . 1.0 109.659 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 33.9 p -59.97 -40.1 87.96 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.32 -0.862 . . . . 1.0 110.011 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -144.02 22.9 1.73 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.063 -1.023 . . . . 1.0 110.41 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -64.97 135.48 55.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.078 -1.014 . . . . 1.0 110.016 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 78.0 mtm -136.4 146.13 46.09 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.086 -1.079 . . . . 1.0 108.086 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 54.5 mt -51.25 129.63 31.94 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 120.862 -1.149 . . . . 1.0 108.595 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -69.16 177.87 4.75 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 CA-C-N 119.994 1.033 . . . . 1.0 112.19 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -61.75 -40.02 93.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.569 -0.707 . . . . 1.0 110.214 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -54.69 -46.13 74.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.166 -0.959 . . . . 1.0 110.189 -178.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -69.0 -39.43 79.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.056 -1.027 . . . . 1.0 109.913 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 58.2 t -60.11 -47.68 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.087 -1.008 . . . . 1.0 108.792 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -61.1 -40.21 92.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.118 -0.989 . . . . 1.0 110.428 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.03 -51.77 13.41 Favored Glycine 0 N--CA 1.495 2.586 0 O-C-N 121.16 -0.962 . . . . 1.0 111.261 -178.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.484 HG23 ' N ' ' A' ' 160' ' ' GLN . 5.1 tp -62.19 -41.29 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.897 -1.355 . . . . 1.0 110.163 -178.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.536 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.2 mt-30 -63.42 -38.97 93.2 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.0 -1.062 . . . . 1.0 109.597 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 79.5 p -60.91 -34.52 74.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.906 . . . . 1.0 110.507 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 95.6 mt -84.13 -48.81 9.47 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.872 -1.142 . . . . 1.0 110.845 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -91.57 -9.81 42.86 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.824 -1.173 . . . . 1.0 110.322 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.493 2.446 0 N-CA-C 109.615 -1.394 . . . . 1.0 109.615 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' WAY . . . . . 0.999 ' HC2' ' HJ ' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.5 m . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.0 mt -92.22 136.47 33.16 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.264 -0.898 . . . . 1.0 108.859 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.459 ' NZ ' ' O ' ' A' ' 162' ' ' LEU . 0.8 OUTLIER -159.97 160.04 32.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.175 -0.953 . . . . 1.0 109.601 -179.827 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -72.88 134.66 44.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.906 . . . . 1.0 109.436 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.6 t -69.63 -42.06 74.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 1.0 109.515 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -95.09 149.97 20.69 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.245 -0.91 . . . . 1.0 109.661 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.3 mmt -90.7 -0.0 57.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.28 -0.887 . . . . 1.0 109.598 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -96.72 132.28 42.55 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.227 -0.921 . . . . 1.0 109.313 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.5 mt -140.22 149.99 43.57 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.283 -0.885 . . . . 1.0 109.226 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 70.5 p -133.38 157.24 46.04 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.559 -0.904 . . . . 1.0 108.559 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -143.88 162.93 34.83 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.002 -1.061 . . . . 1.0 110.464 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -141.66 127.45 19.24 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 91.1 mt -87.74 118.65 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.273 -0.892 . . . . 1.0 108.935 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.9 t -69.5 -39.97 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.392 -0.818 . . . . 1.0 109.613 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -164.83 152.94 11.93 Favored 'General case' 0 C--N 1.289 -2.023 0 O-C-N 119.927 -1.733 . . . . 1.0 110.964 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.608 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 27.3 m-85 -98.39 109.46 22.21 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 104.436 -2.431 . . . . 1.0 104.436 177.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.474 ' OG1' ' OD2' ' A' ' 25' ' ' ASP . 3.0 t -57.42 143.07 75.3 Favored Pre-proline 0 C--N 1.294 -1.824 0 C-N-CA 119.355 -0.938 . . . . 1.0 110.21 -176.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -60.16 -8.49 8.36 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 C-N-CA 120.436 0.757 . . . . 1.0 111.015 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.474 ' OD2' ' OG1' ' A' ' 23' ' ' THR . 66.1 m-20 -57.47 -32.56 67.09 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 120.054 -0.658 . . . . 1.0 109.597 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 73.5 mtm -140.06 160.88 38.94 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.208 -0.932 . . . . 1.0 109.317 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 76.4 p -71.41 161.06 31.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.315 -0.866 . . . . 1.0 109.244 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.608 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 9.2 m80 -61.1 -41.17 96.18 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.297 -0.877 . . . . 1.0 110.296 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.4 m -60.71 -40.59 92.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.989 -1.069 . . . . 1.0 110.204 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -68.9 -39.99 79.39 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.419 -0.801 . . . . 1.0 110.563 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 79.3 t -69.25 -42.8 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.1 -1.0 . . . . 1.0 110.399 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -59.98 -49.19 78.65 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.095 -1.003 . . . . 1.0 110.47 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -61.4 -33.35 73.54 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.054 -1.029 . . . . 1.0 109.915 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.96 -48.83 80.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.007 -1.058 . . . . 1.0 109.976 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.418 ' CE1' HD13 ' A' ' 62' ' ' ILE . 55.2 m-85 -68.16 -39.96 82.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.892 -1.13 . . . . 1.0 110.217 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -60.05 -43.76 95.16 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.858 -1.151 . . . . 1.0 109.775 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -60.07 -39.98 87.9 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.087 -1.008 . . . . 1.0 110.107 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.01 -46.83 88.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.223 -0.923 . . . . 1.0 109.906 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -67.36 -36.21 80.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.067 -1.021 . . . . 1.0 109.531 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -60.0 -49.67 76.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.072 -1.018 . . . . 1.0 109.875 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.7 t -60.25 -40.35 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.086 -1.009 . . . . 1.0 110.357 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -81.36 -34.9 31.44 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.957 -1.089 . . . . 1.0 110.118 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.5 p -71.06 -16.91 62.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.04 -1.038 . . . . 1.0 109.645 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.96 -40.03 87.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.326 -0.858 . . . . 1.0 110.062 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.5 m -110.05 -22.02 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.369 -0.832 . . . . 1.0 110.562 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.1 p -94.84 127.73 42.12 Favored Pre-proline 0 N--CA 1.499 2.009 0 O-C-N 120.794 -1.191 . . . . 1.0 109.536 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -74.12 15.66 0.6 Allowed 'Trans proline' 0 N--CA 1.492 1.441 0 CA-C-N 120.067 1.06 . . . . 1.0 111.609 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 78.7 mt -68.06 139.99 56.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 1.0 109.555 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -105.28 121.0 42.95 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.773 -0.825 . . . . 1.0 108.773 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -107.0 120.88 43.26 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.383 -0.823 . . . . 1.0 109.748 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.2 m -120.0 130.03 54.55 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.613 -0.679 . . . . 1.0 109.827 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.472 ' CB ' ' NH1' ' A' ' 52' ' ' ARG . 11.6 ttp-105 -83.05 138.01 33.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.309 -0.869 . . . . 1.0 109.711 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.4 mt -103.6 132.58 49.73 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.289 -0.882 . . . . 1.0 109.025 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.446 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 61.2 m170 -60.12 -39.99 88.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.875 . . . . 1.0 109.857 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 71.9 m-20 -153.43 179.8 8.46 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.234 -0.916 . . . . 1.0 109.464 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.73 -178.47 42.52 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.961 -1.256 . . . . 1.0 109.961 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.7 mt -95.58 132.95 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.387 -1.067 . . . . 1.0 109.454 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.41 165.9 11.41 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.006 -0.738 . . . . 1.0 109.006 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -59.99 -49.64 76.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.012 -1.055 . . . . 1.0 109.396 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 92.9 mt -110.13 105.56 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.429 -0.795 . . . . 1.0 109.826 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.9 ptm -102.07 132.75 47.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.231 -0.918 . . . . 1.0 108.893 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.418 HD13 ' CE1' ' A' ' 35' ' ' PHE . 85.9 mt -109.39 133.11 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.61 -0.681 . . . . 1.0 109.63 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 43.6 p -149.99 160.74 43.39 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.222 -0.924 . . . . 1.0 109.926 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -106.71 123.12 47.66 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.557 -0.714 . . . . 1.0 109.15 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.48 -171.58 26.92 Favored Glycine 0 N--CA 1.499 2.879 0 N-CA-C 110.655 -0.978 . . . . 1.0 110.655 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.546 HG22 ' N ' ' A' ' 67' ' ' LYS . 60.9 mt -136.72 167.68 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.656 -0.908 . . . . 1.0 108.669 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.546 ' N ' HG22 ' A' ' 66' ' ' ILE . 50.0 tptt -21.73 -79.0 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.459 0 CA-C-O 121.099 0.476 . . . . 1.0 111.783 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.407 ' HG2' ' H ' ' A' ' 68' ' ' GLU . 15.2 pt-20 -73.14 126.6 30.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.149 -0.97 . . . . 1.0 109.794 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.618 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 1.3 m170 -77.88 -20.6 52.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.065 -1.022 . . . . 1.0 108.598 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.84 -9.19 75.18 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.412 -1.875 . . . . 1.0 108.412 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -119.96 -88.98 0.61 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.836 -0.803 . . . . 1.0 109.106 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -155.74 162.23 40.56 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.219 -0.926 . . . . 1.0 109.661 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 52.5 t80 54.03 68.99 2.38 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.326 -0.859 . . . . 1.0 109.874 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -79.22 -170.55 1.03 Allowed 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.561 1.508 . . . . 1.0 112.147 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.618 ' CE2' ' NE2' ' A' ' 69' ' ' HIS . 94.0 m-85 -89.23 170.38 10.64 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.28 -0.888 . . . . 1.0 108.828 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.466 ' C ' ' NZ ' ' A' ' 67' ' ' LYS . 31.8 p-10 -99.77 0.89 42.57 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.197 -0.94 . . . . 1.0 110.944 -178.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.51 -148.38 19.36 Favored Glycine 0 N--CA 1.504 3.185 0 N-CA-C 108.876 -1.69 . . . . 1.0 108.876 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.456 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 2.5 Cg_endo -68.65 -63.15 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.302 0 CA-C-N 119.124 1.462 . . . . 1.0 111.273 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 87.7 p -79.14 166.68 21.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.123 -0.986 . . . . 1.0 109.161 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 112.86 -128.62 8.51 Favored Glycine 0 N--CA 1.501 2.976 0 N-CA-C 109.517 -1.433 . . . . 1.0 109.517 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.418 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 20.2 mt -70.43 112.47 6.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.334 -1.098 . . . . 1.0 109.367 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 46.0 mt -83.95 -15.18 48.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.943 -1.098 . . . . 1.0 109.037 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 179.06 172.52 0.82 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.033 -0.728 . . . . 1.0 109.033 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -162.71 158.26 22.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 1.0 109.196 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.33 158.86 44.53 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.178 -0.952 . . . . 1.0 109.437 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -96.48 153.54 38.84 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.173 -0.955 . . . . 1.0 108.849 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -64.84 166.04 19.38 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 120.719 0.946 . . . . 1.0 111.952 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -44.97 120.03 2.71 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 120.958 1.105 . . . . 1.0 111.691 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 90' ' ' PRO . . . -158.44 -166.86 18.39 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.164 -1.575 . . . . 1.0 109.164 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.451 ' O ' ' O ' ' A' ' 89' ' ' GLY . 16.6 Cg_exo -54.28 -157.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 120.972 1.115 . . . . 1.0 112.535 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -59.96 -40.03 87.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.213 -0.929 . . . . 1.0 110.265 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -63.79 -40.02 95.65 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.18 -0.95 . . . . 1.0 109.409 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -68.69 169.26 41.93 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.748 -1.341 . . . . 1.0 109.748 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 72.17 6.62 65.21 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.889 -1.285 . . . . 1.0 109.889 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -80.07 169.07 18.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.097 -1.237 . . . . 1.0 109.746 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.83 120.83 7.69 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.304 -0.873 . . . . 1.0 109.174 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -108.59 147.9 31.13 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.534 -0.728 . . . . 1.0 110.374 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -124.15 146.37 48.7 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.999 -0.741 . . . . 1.0 108.999 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.543 ' OD2' ' CD1' ' A' ' 75' ' ' PHE . 1.3 m-20 -79.6 123.73 27.88 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.057 -1.027 . . . . 1.0 109.347 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -89.22 -0.02 57.13 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.106 -0.996 . . . . 1.0 110.226 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -81.85 -16.1 51.88 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.074 -1.016 . . . . 1.0 110.08 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.604 ' OE1' ' N ' ' A' ' 102' ' ' GLU . 40.1 mp0 -93.97 173.89 7.43 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.307 -0.87 . . . . 1.0 109.202 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.8 m -99.69 105.42 17.24 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.216 -0.927 . . . . 1.0 108.862 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.496 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 90.2 m95 -85.87 126.06 33.77 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.761 -0.829 . . . . 1.0 108.761 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.699 HG21 ' HB2' ' A' ' 109' ' ' LYS . 7.8 t -141.07 153.61 45.56 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.467 -0.77 . . . . 1.0 109.635 -179.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 52.5 m -90.94 -5.17 55.82 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.198 -1.038 . . . . 1.0 108.198 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.7 t -92.73 177.93 5.95 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.752 -0.833 . . . . 1.0 108.752 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.5 m -80.25 64.29 5.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.027 -1.046 . . . . 1.0 109.998 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.699 ' HB2' HG21 ' A' ' 105' ' ' THR . 69.6 mmtt -139.01 152.38 47.59 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.267 -0.896 . . . . 1.0 108.788 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.8 -139.42 6.2 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.759 -1.336 . . . . 1.0 109.759 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -99.72 113.8 26.5 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.338 -1.095 . . . . 1.0 109.057 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.608 HD22 ' N ' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -62.77 130.68 45.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.148 -0.97 . . . . 1.0 109.76 -179.822 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.608 ' N ' HD22 ' A' ' 112' ' ' ASN . 61.7 tp -60.01 -43.29 95.33 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.48 -0.763 . . . . 1.0 111.022 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -60.01 -39.99 87.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.165 -0.959 . . . . 1.0 110.645 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -59.95 -50.86 72.09 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.811 -1.181 . . . . 1.0 109.874 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 71.0 t -69.98 -40.06 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.931 -1.106 . . . . 1.0 110.196 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.19 -51.97 67.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -0.939 . . . . 1.0 110.089 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.84 -37.97 80.73 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.271 -0.893 . . . . 1.0 110.259 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -64.24 -50.2 68.92 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.182 -0.949 . . . . 1.0 111.267 -178.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -60.07 -37.83 81.07 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.552 -1.342 . . . . 1.0 110.329 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -59.98 -40.05 87.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.766 -1.208 . . . . 1.0 108.255 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.39 -41.83 93.4 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.382 -1.487 . . . . 1.0 109.382 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -68.74 -39.93 80.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.022 -1.281 . . . . 1.0 109.467 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.4 p -67.2 -33.08 74.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.318 -0.864 . . . . 1.0 109.618 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.486 HD13 HD11 ' A' ' 159' ' ' ILE . 81.6 mt -70.22 -39.68 74.96 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.23 -0.919 . . . . 1.0 109.84 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 135.31 7.59 1.92 Allowed Glycine 0 N--CA 1.5 2.959 0 N-CA-C 110.045 -1.222 . . . . 1.0 110.045 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.1 mt -87.65 141.21 28.78 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.08 -1.247 . . . . 1.0 110.042 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 34.5 t0 -99.15 175.34 5.93 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.88 -0.785 . . . . 1.0 108.88 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.517 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 63.2 m80 -60.05 133.49 56.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.033 -1.042 . . . . 1.0 109.606 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 47.8 t -98.76 158.1 15.85 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.359 -0.838 . . . . 1.0 109.1 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -98.35 3.05 48.58 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.265 -0.897 . . . . 1.0 109.369 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -85.64 129.55 54.47 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.205 -0.934 . . . . 1.0 108.62 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -69.54 -25.45 29.6 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 CA-C-N 120.012 1.04 . . . . 1.0 112.34 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -82.23 -3.86 90.41 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.413 -1.475 . . . . 1.0 109.413 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.15 143.93 26.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.421 -1.047 . . . . 1.0 109.467 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.501 ' C ' ' H ' ' A' ' 138' ' ' PHE . 89.0 mt -70.0 -34.1 72.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.076 -1.015 . . . . 1.0 109.6 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.3 mmm -70.02 18.19 0.05 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.394 -0.817 . . . . 1.0 109.997 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.501 ' H ' ' C ' ' A' ' 136' ' ' LEU . 13.7 t80 -69.5 133.62 88.94 Favored Pre-proline 0 N--CA 1.488 1.446 0 N-CA-C 107.552 -1.277 . . . . 1.0 107.552 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -60.51 -15.91 39.1 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 CA-C-N 119.805 0.966 . . . . 1.0 114.005 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 95.7 mt -106.59 138.82 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 120.988 -1.07 . . . . 1.0 110.083 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -73.75 129.98 39.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.579 -0.701 . . . . 1.0 109.967 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.1 t -141.31 141.96 33.87 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.43 -0.794 . . . . 1.0 109.246 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -79.98 144.5 33.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.013 -1.054 . . . . 1.0 109.381 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.5 t -140.01 150.64 44.68 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.437 -0.789 . . . . 1.0 109.266 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.61 105.11 1.44 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.422 -1.471 . . . . 1.0 109.422 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -73.61 -6.24 45.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.432 -1.04 . . . . 1.0 109.788 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 61.1 m -60.04 -40.09 88.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.257 -0.902 . . . . 1.0 110.819 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -141.75 19.87 2.16 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.036 -1.04 . . . . 1.0 110.4 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -61.03 140.0 57.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.843 -1.16 . . . . 1.0 109.953 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 67.8 mtt -138.47 145.44 40.85 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.661 -0.866 . . . . 1.0 108.661 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 45.5 mt -54.48 129.04 61.63 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.921 -1.112 . . . . 1.0 108.914 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -68.14 177.9 4.04 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 CA-C-N 119.996 1.034 . . . . 1.0 112.166 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -61.13 -39.96 92.02 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.315 -0.866 . . . . 1.0 110.141 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -56.32 -49.94 72.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.162 -0.961 . . . . 1.0 110.091 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -70.62 -40.03 73.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.137 -0.977 . . . . 1.0 110.252 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.452 ' O ' ' OE1' ' A' ' 160' ' ' GLN . 68.1 t -63.85 -50.06 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.963 . . . . 1.0 109.618 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.54 -40.01 89.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.844 -1.16 . . . . 1.0 110.063 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.42 -48.45 30.19 Favored Glycine 0 N--CA 1.493 2.473 0 O-C-N 121.352 -0.842 . . . . 1.0 112.227 -178.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.564 ' CG2' ' NE2' ' A' ' 160' ' ' GLN . 4.7 tp -60.9 -43.29 95.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.609 -1.524 . . . . 1.0 110.464 -177.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.564 ' NE2' ' CG2' ' A' ' 159' ' ' ILE . 5.9 mp0 -67.64 -36.38 80.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.579 -1.325 . . . . 1.0 108.903 179.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 79.4 p -60.75 -27.99 68.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.131 -0.981 . . . . 1.0 109.878 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.459 ' O ' ' NZ ' ' A' ' 9' ' ' LYS . 88.1 mt -85.28 -45.93 11.5 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.02 -1.05 . . . . 1.0 110.381 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -91.36 -9.29 45.39 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.017 -1.052 . . . . 1.0 109.821 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.553 -1.419 . . . . 1.0 109.553 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' WAY . . . . . 0.539 ' HC2' ' HJ ' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 87.4 m . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.0 mt -85.54 129.98 34.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.239 -0.913 . . . . 1.0 109.54 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -160.76 160.68 31.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.499 -0.75 . . . . 1.0 109.499 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -71.47 148.74 46.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.185 -0.947 . . . . 1.0 109.61 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 91.6 p -88.44 3.39 50.21 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.333 -0.854 . . . . 1.0 109.98 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -145.07 153.24 41.24 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.067 -1.021 . . . . 1.0 109.609 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.6 mmt -90.38 -0.01 57.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.392 -0.818 . . . . 1.0 109.606 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -96.58 131.41 43.24 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.179 -0.951 . . . . 1.0 109.283 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.8 mt -143.95 151.03 39.23 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.117 -0.989 . . . . 1.0 109.399 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 54.5 p -135.71 155.73 49.93 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.475 -0.765 . . . . 1.0 108.937 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -144.27 161.19 39.54 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.146 -0.971 . . . . 1.0 110.383 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.494 HH11 ' HG2' ' A' ' 18' ' ' ARG . 0.8 OUTLIER -139.17 131.08 27.72 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 109.084 -0.709 . . . . 1.0 109.084 -179.384 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.9 mt -89.79 116.49 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.161 -0.962 . . . . 1.0 108.765 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.5 t -68.67 -39.93 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.193 -0.942 . . . . 1.0 109.226 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.403 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 23.8 p-10 -164.7 152.98 12.24 Favored 'General case' 0 C--N 1.288 -2.081 0 O-C-N 120.051 -1.656 . . . . 1.0 110.873 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.624 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 36.7 m-85 -99.94 109.11 21.48 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 104.781 -2.303 . . . . 1.0 104.781 177.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 t -55.87 140.55 68.43 Favored Pre-proline 0 C--N 1.297 -1.712 0 O-C-N 121.124 -0.985 . . . . 1.0 110.111 -176.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.27 -11.04 9.61 Favored 'Trans proline' 0 N--CA 1.485 1.008 0 CA-C-N 119.194 0.748 . . . . 1.0 110.901 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -55.61 -29.88 59.92 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.898 -0.721 . . . . 1.0 110.007 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 73.9 mtm -144.42 162.2 37.09 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.035 -1.041 . . . . 1.0 109.587 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.9 p -72.95 159.89 32.98 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.395 -0.815 . . . . 1.0 109.391 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.624 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 1.9 m80 -60.16 -40.75 90.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.306 -0.871 . . . . 1.0 110.07 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.5 m -60.12 -41.39 92.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.151 -0.968 . . . . 1.0 110.336 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.82 -40.0 79.71 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.205 -0.934 . . . . 1.0 110.321 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 70.9 t -67.59 -43.96 86.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.24 -0.913 . . . . 1.0 110.23 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -59.98 -49.92 75.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.137 -0.977 . . . . 1.0 110.837 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -61.44 -32.73 72.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.928 -1.108 . . . . 1.0 110.22 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.98 -50.07 75.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.984 -1.072 . . . . 1.0 110.006 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -68.11 -37.25 80.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.0 -1.062 . . . . 1.0 110.034 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -60.05 -44.41 94.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.973 -1.08 . . . . 1.0 109.428 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -60.44 -40.03 89.64 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.165 -0.959 . . . . 1.0 109.204 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.1 -45.96 91.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.355 -0.841 . . . . 1.0 110.212 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -69.88 -39.82 76.07 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.009 -1.057 . . . . 1.0 109.746 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -59.89 -47.88 83.98 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.194 -0.941 . . . . 1.0 109.91 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.0 t -60.0 -41.9 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.095 -1.003 . . . . 1.0 109.8 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 63.1 m95 -79.0 -35.6 42.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.038 -1.039 . . . . 1.0 109.874 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.7 p -70.14 -20.35 63.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.808 -1.183 . . . . 1.0 109.217 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -59.97 -40.13 88.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.506 -0.746 . . . . 1.0 110.667 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.7 m -110.8 23.0 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.333 -0.855 . . . . 1.0 110.633 -178.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 28.6 p -149.95 139.63 13.35 Favored Pre-proline 0 N--CA 1.5 2.052 0 O-C-N 120.909 -1.119 . . . . 1.0 109.23 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -75.17 19.35 0.51 Allowed 'Trans proline' 0 N--CA 1.496 1.638 0 CA-C-N 119.664 0.916 . . . . 1.0 111.605 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.0 mt -67.49 138.92 56.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -0.86 . . . . 1.0 109.933 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -112.91 120.8 42.68 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.947 -0.76 . . . . 1.0 108.947 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -109.14 122.24 46.88 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.325 -0.86 . . . . 1.0 109.354 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -119.99 130.07 54.58 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.572 0.701 . . . . 1.0 109.974 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -83.14 132.7 35.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.35 -0.844 . . . . 1.0 109.64 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.2 mt -101.76 132.68 47.36 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.198 -0.939 . . . . 1.0 108.894 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.446 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 43.1 m170 -61.27 -40.05 92.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.088 -1.007 . . . . 1.0 110.061 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 73.8 m-20 -152.31 178.01 9.97 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.19 -0.944 . . . . 1.0 109.546 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.07 -178.58 42.08 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.71 -1.356 . . . . 1.0 109.71 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.3 mt -94.45 134.82 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.393 -1.063 . . . . 1.0 109.115 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.92 174.09 6.03 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.505 -0.747 . . . . 1.0 109.154 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -60.05 -49.09 79.02 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.081 -1.012 . . . . 1.0 108.513 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.8 mt -120.03 118.07 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.544 -0.723 . . . . 1.0 109.42 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.1 ptp -101.63 139.26 37.52 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.164 -0.96 . . . . 1.0 109.153 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 97.0 mt -107.46 133.56 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.393 -0.817 . . . . 1.0 109.927 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 79.7 p -152.45 156.75 40.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.292 -0.88 . . . . 1.0 109.368 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -100.77 125.58 47.26 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.288 -0.883 . . . . 1.0 109.161 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 100' ' ' ASP . . . -93.14 155.31 22.28 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.946 -1.261 . . . . 1.0 109.946 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.446 ' O ' ' C ' ' A' ' 67' ' ' LYS . 9.6 tt -108.71 -178.62 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.444 -1.033 . . . . 1.0 108.77 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 66' ' ' ILE . 52.7 tptt -36.11 -77.96 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.93 -0.481 . . . . 1.0 110.404 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -68.25 121.33 16.01 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.908 -1.12 . . . . 1.0 108.863 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.48 ' O ' ' O ' ' A' ' 70' ' ' GLY . 5.5 t-80 -165.46 127.01 1.99 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.408 -0.807 . . . . 1.0 109.254 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 69' ' ' HIS . . . 48.49 99.6 0.01 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.731 -1.348 . . . . 1.0 109.731 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.04 -39.85 87.38 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.956 -1.32 . . . . 1.0 109.742 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -61.33 -38.97 88.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.129 -0.982 . . . . 1.0 109.757 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -129.95 79.01 73.97 Favored Pre-proline 0 N--CA 1.503 2.211 0 O-C-N 121.368 -0.833 . . . . 1.0 109.541 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -83.7 165.5 13.81 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 121.551 1.501 . . . . 1.0 112.456 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.523 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 77.0 m-85 -87.25 155.32 20.13 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.438 -0.949 . . . . 1.0 108.438 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -100.62 9.19 42.82 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.277 -0.889 . . . . 1.0 111.168 -178.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 121.15 -159.94 15.59 Favored Glycine 0 N--CA 1.508 3.459 0 N-CA-C 109.161 -1.575 . . . . 1.0 109.161 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -56.36 -63.97 0.15 Allowed 'Trans proline' 0 N--CA 1.49 1.268 0 CA-C-N 118.771 1.285 . . . . 1.0 111.955 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 96.3 p -76.54 160.45 29.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.496 -0.752 . . . . 1.0 109.578 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.71 -130.8 9.29 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 110.177 -1.169 . . . . 1.0 110.177 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.1 mt -69.49 105.33 2.59 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.424 -1.045 . . . . 1.0 109.242 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.449 HD23 ' OE2' ' A' ' 102' ' ' GLU . 32.2 mt -79.82 -14.76 58.44 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.124 -0.985 . . . . 1.0 109.057 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.57 175.54 0.88 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.056 -0.72 . . . . 1.0 109.056 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.51 ' CE1' ' ND1' ' A' ' 97' ' ' HIS . 21.2 p80 -163.22 160.91 24.57 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.231 -0.918 . . . . 1.0 109.787 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -153.2 167.74 28.31 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.858 -0.793 . . . . 1.0 108.858 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -114.51 153.98 46.61 Favored Pre-proline 0 N--CA 1.499 2.006 0 N-CA-C 108.494 -0.928 . . . . 1.0 108.494 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -69.71 161.42 46.0 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 120.57 0.847 . . . . 1.0 111.503 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -43.74 128.02 6.56 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.068 1.179 . . . . 1.0 112.104 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -171.87 -170.78 36.23 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.649 -1.38 . . . . 1.0 109.649 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -60.26 -144.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.192 1.261 . . . . 1.0 111.558 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -61.31 -40.01 92.61 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.987 -1.071 . . . . 1.0 109.394 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -62.04 -43.65 98.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.078 -1.014 . . . . 1.0 109.486 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -78.94 168.76 53.72 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.387 -1.485 . . . . 1.0 109.387 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 68.68 68.71 1.57 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.65 -1.38 . . . . 1.0 109.65 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 45.5 p-10 -152.49 160.78 43.22 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.179 -1.189 . . . . 1.0 109.236 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.88 123.24 9.01 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.101 -0.999 . . . . 1.0 109.18 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.51 ' ND1' ' CE1' ' A' ' 84' ' ' HIS . 64.9 m170 -117.78 159.98 22.12 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.625 0.726 . . . . 1.0 109.933 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.536 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 47.1 m-85 -137.88 153.46 49.56 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.702 -0.851 . . . . 1.0 108.702 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.523 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 1.5 m-20 -79.39 124.0 28.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.844 -1.16 . . . . 1.0 109.662 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 65' ' ' GLY . 36.5 t0 -84.81 -12.67 53.13 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.473 -0.767 . . . . 1.0 109.416 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -82.26 -11.51 58.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.265 -0.897 . . . . 1.0 109.574 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.449 ' OE2' HD23 ' A' ' 82' ' ' LEU . 98.0 mt-10 -91.63 166.79 12.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.294 -0.879 . . . . 1.0 109.153 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.3 m -98.78 107.42 19.86 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.177 -0.952 . . . . 1.0 109.086 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.454 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 94.1 m95 -88.74 123.65 33.36 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.846 -0.798 . . . . 1.0 108.846 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.679 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.7 t -140.36 153.16 46.3 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.378 -0.826 . . . . 1.0 109.439 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.8 t -92.06 -6.09 51.64 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.205 -1.035 . . . . 1.0 108.205 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 65.1 p -93.16 179.44 5.43 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.713 -0.847 . . . . 1.0 108.713 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.2 m -82.04 77.06 8.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.016 -1.052 . . . . 1.0 109.467 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.679 ' HB2' HG21 ' A' ' 105' ' ' THR . 52.6 mtmt -149.31 150.03 31.86 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.74 -139.85 5.86 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.567 -1.413 . . . . 1.0 109.567 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.418 ' CD1' HD13 ' A' ' 82' ' ' LEU . 95.2 m-85 -100.09 113.77 26.63 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.312 -1.111 . . . . 1.0 108.751 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -62.94 134.11 55.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.113 -0.992 . . . . 1.0 109.34 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.6 tp -59.98 -43.94 94.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.39 -0.819 . . . . 1.0 110.587 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -59.88 -43.22 94.87 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.965 -1.085 . . . . 1.0 110.603 -178.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -58.6 -51.91 67.9 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.74 -1.225 . . . . 1.0 109.644 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.6 t -68.47 -43.97 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.174 -0.954 . . . . 1.0 110.319 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.25 -52.79 63.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.304 -0.873 . . . . 1.0 110.014 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.95 -32.65 71.0 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.937 -1.102 . . . . 1.0 109.882 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 45.7 t60 -65.68 -52.95 47.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.969 -1.082 . . . . 1.0 110.654 -179.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.536 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 7.7 pt-20 -60.13 -40.97 91.63 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.902 -1.124 . . . . 1.0 110.453 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -60.03 -39.91 87.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.861 -1.149 . . . . 1.0 109.001 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -56.45 -42.8 90.13 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.128 -1.589 . . . . 1.0 109.128 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -67.44 -39.98 85.43 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.213 -1.169 . . . . 1.0 109.221 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 59.7 p -64.45 -25.01 67.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -0.895 . . . . 1.0 109.923 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.2 mt -80.19 -0.53 36.59 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.13 -0.981 . . . . 1.0 110.049 -179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 91.93 6.8 64.95 Favored Glycine 0 N--CA 1.497 2.744 0 O-C-N 120.997 -1.065 . . . . 1.0 110.562 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.4 mt -84.79 149.46 25.72 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.907 -1.349 . . . . 1.0 109.554 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 42.0 t0 -98.67 171.32 8.19 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.674 -0.861 . . . . 1.0 108.674 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.535 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 62.8 m80 -58.92 136.98 58.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.026 -1.046 . . . . 1.0 109.724 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.0 t -97.36 151.16 20.2 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.542 -0.724 . . . . 1.0 109.246 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -99.86 6.83 45.28 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.255 -0.903 . . . . 1.0 108.907 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -87.31 123.76 69.31 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.057 -1.027 . . . . 1.0 108.396 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -64.2 -17.1 58.47 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 CA-C-N 120.189 1.103 . . . . 1.0 112.168 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -89.98 -6.35 69.58 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.553 -1.419 . . . . 1.0 109.553 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.56 141.49 30.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.221 -1.164 . . . . 1.0 109.25 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.461 ' C ' ' H ' ' A' ' 138' ' ' PHE . 97.0 mt -65.78 -39.74 91.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.15 -0.969 . . . . 1.0 109.6 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 91.1 mtp -70.36 23.35 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.32 -0.862 . . . . 1.0 111.117 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.461 ' H ' ' C ' ' A' ' 136' ' ' LEU . 11.5 t80 -67.26 133.11 93.33 Favored Pre-proline 0 N--CA 1.493 1.692 0 N-CA-C 107.522 -1.288 . . . . 1.0 107.522 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -61.7 -9.79 14.87 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 CA-C-N 119.958 1.021 . . . . 1.0 113.644 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 88.4 mt -113.45 133.28 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.162 -0.961 . . . . 1.0 109.14 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -71.36 128.51 36.1 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.168 -0.957 . . . . 1.0 110.102 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.8 t -141.84 143.59 33.46 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.637 -0.875 . . . . 1.0 108.637 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -81.24 146.03 30.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.079 -1.013 . . . . 1.0 109.766 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.0 t -140.8 157.49 45.32 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.371 -0.831 . . . . 1.0 109.662 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.95 106.47 1.97 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.534 -1.426 . . . . 1.0 109.534 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.458 ' NZ ' ' CB ' ' A' ' 146' ' ' LYS . 8.4 mtpm? -77.43 2.9 14.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -1.15 . . . . 1.0 109.597 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.471 ' O ' ' ND1' ' A' ' 148' ' ' HIS . 34.7 t -59.44 -46.06 89.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 1.0 110.067 -179.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . 0.471 ' ND1' ' O ' ' A' ' 147' ' ' SER . 50.0 m-70 -146.58 30.77 0.99 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.014 -1.054 . . . . 1.0 109.472 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -61.0 136.0 57.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.145 -0.972 . . . . 1.0 109.7 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 65.9 mtt -133.47 144.56 49.53 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.476 -0.765 . . . . 1.0 108.939 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 36.4 mt -51.48 125.77 28.06 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.177 -0.952 . . . . 1.0 108.767 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -67.63 177.52 4.0 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 CA-C-N 120.04 1.05 . . . . 1.0 112.253 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.21 -39.98 88.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.395 -0.816 . . . . 1.0 109.955 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -55.11 -48.34 73.74 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.183 -0.948 . . . . 1.0 109.998 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -69.98 -39.96 75.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.042 -1.037 . . . . 1.0 110.115 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 56.3 t -59.95 -49.13 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.158 -0.964 . . . . 1.0 109.478 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -60.34 -40.11 89.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.878 -1.138 . . . . 1.0 110.468 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.63 -53.28 12.66 Favored Glycine 0 N--CA 1.496 2.638 0 O-C-N 121.046 -1.034 . . . . 1.0 111.512 -178.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.476 HG23 ' N ' ' A' ' 160' ' ' GLN . 6.3 tp -61.19 -40.0 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.97 -1.312 . . . . 1.0 109.617 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 164' ' ' GLY . 97.1 mt-30 -65.49 -39.69 92.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 1.0 109.566 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 83.3 p -60.0 -34.65 73.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 1.0 110.625 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 83.7 mt -87.47 -50.47 6.52 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.843 -1.161 . . . . 1.0 110.884 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -90.62 -9.12 48.16 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.969 -1.082 . . . . 1.0 110.226 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.568 0 N-CA-C 109.512 -1.435 . . . . 1.0 109.512 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' WAY . . . . . 0.978 ' HC2' ' HJ ' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.0 m . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.484 -0.561 . . . . 1.0 109.484 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.3 mt -73.52 144.73 46.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.178 -0.951 . . . . 1.0 109.075 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -159.84 159.88 33.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.198 -0.939 . . . . 1.0 109.525 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -71.76 145.54 48.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -0.868 . . . . 1.0 109.193 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.1 t -80.83 -0.86 40.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.413 -0.805 . . . . 1.0 110.369 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -149.27 154.8 39.58 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.067 -1.02 . . . . 1.0 109.574 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.551 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.07 0.03 57.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.34 -0.85 . . . . 1.0 109.723 -179.644 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -97.65 124.76 42.08 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.279 -0.888 . . . . 1.0 108.954 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.4 mt -140.03 150.07 43.96 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.263 -0.898 . . . . 1.0 109.713 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.0 p -130.7 157.3 43.16 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.61 -0.885 . . . . 1.0 108.61 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -144.18 160.05 41.61 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.082 -1.011 . . . . 1.0 110.251 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.462 ' CZ ' ' O ' ' A' ' 54' ' ' HIS . 26.1 tpt180 -143.61 129.4 19.36 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.652 -0.655 . . . . 1.0 109.566 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 86.8 mt -88.11 119.68 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.149 -0.969 . . . . 1.0 109.132 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.6 t -69.48 -40.53 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.169 -0.957 . . . . 1.0 109.259 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.66 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.0 OUTLIER -163.8 165.21 23.2 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.496 -1.378 . . . . 1.0 110.948 -179.126 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -104.22 -172.98 2.2 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.78 -1.193 . . . . 1.0 107.78 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.85 148.81 47.28 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.445 -0.784 . . . . 1.0 109.901 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -64.93 -16.11 53.8 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 120.926 1.084 . . . . 1.0 110.156 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.94 -39.99 87.41 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.348 -0.842 . . . . 1.0 110.471 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.6 mtm -144.21 160.16 41.43 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.128 -0.982 . . . . 1.0 109.663 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 69.3 p -73.48 159.98 32.39 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.393 -0.817 . . . . 1.0 109.373 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.715 ' H ' ' CD2' ' A' ' 28' ' ' HIS . 2.8 p80 -60.95 -31.82 71.36 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.337 -0.852 . . . . 1.0 109.972 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 56.0 m -60.02 -42.11 93.63 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.855 -1.153 . . . . 1.0 109.446 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -69.92 -40.06 75.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.09 -1.006 . . . . 1.0 109.544 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 56.2 t -69.58 -40.07 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.232 -0.917 . . . . 1.0 110.001 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -59.73 -49.92 75.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.088 -1.008 . . . . 1.0 110.107 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -63.25 -31.54 72.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.976 -1.078 . . . . 1.0 109.958 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.01 -49.96 75.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.017 -1.052 . . . . 1.0 110.197 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.424 ' CE1' HD13 ' A' ' 62' ' ' ILE . 52.1 m-85 -67.66 -36.94 81.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.98 -1.075 . . . . 1.0 109.978 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -59.93 -41.07 90.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.987 -1.071 . . . . 1.0 109.721 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -62.2 -40.18 95.21 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.071 -1.018 . . . . 1.0 108.868 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.97 -45.89 91.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.511 -0.743 . . . . 1.0 110.139 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.508 ' CD1' ' CD1' ' A' ' 50' ' ' PHE . 63.4 m-85 -68.4 -40.06 81.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.963 -1.085 . . . . 1.0 110.02 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.402 ' O ' ' CG ' ' A' ' 44' ' ' ASP . 27.4 tptp -60.01 -47.54 85.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.122 -0.987 . . . . 1.0 109.665 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.5 t -60.01 -40.09 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.184 -0.948 . . . . 1.0 110.119 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -81.54 -35.46 30.27 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.876 -1.14 . . . . 1.0 109.985 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.5 p -71.64 -20.1 62.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.905 -1.122 . . . . 1.0 109.725 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.402 ' CG ' ' O ' ' A' ' 40' ' ' LYS . 95.3 m-20 -59.95 -39.89 87.12 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.246 -0.909 . . . . 1.0 111.048 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 m -109.52 20.25 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 O-C-N 121.191 -0.943 . . . . 1.0 110.797 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.3 p -147.93 140.38 14.6 Favored Pre-proline 0 N--CA 1.502 2.128 0 O-C-N 120.83 -1.169 . . . . 1.0 109.221 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -72.83 18.37 0.36 Allowed 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 120.716 0.944 . . . . 1.0 111.999 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 79.0 mt -68.1 137.12 54.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.122 -0.986 . . . . 1.0 109.916 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -111.46 120.75 43.19 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.885 -0.783 . . . . 1.0 108.885 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.508 ' CD1' ' CD1' ' A' ' 39' ' ' PHE . 92.4 m-85 -109.16 123.3 48.99 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.367 -0.833 . . . . 1.0 109.335 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.1 m -119.95 130.02 54.6 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.55 -0.718 . . . . 1.0 109.679 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -82.32 132.35 35.22 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.467 -0.77 . . . . 1.0 109.566 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.4 mt -104.96 131.16 52.83 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.326 -0.859 . . . . 1.0 108.819 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.462 ' O ' ' CZ ' ' A' ' 18' ' ' ARG . 42.2 m170 -61.73 -40.24 94.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.177 -0.952 . . . . 1.0 110.005 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 74.9 m-20 -151.74 176.33 11.5 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.112 -0.992 . . . . 1.0 109.924 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.87 -179.76 35.63 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.858 -1.297 . . . . 1.0 109.858 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 91.3 mt -93.51 130.44 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.366 -1.079 . . . . 1.0 109.583 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.46 164.52 12.62 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.971 -0.752 . . . . 1.0 108.971 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.87 -49.52 77.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.067 -1.021 . . . . 1.0 109.332 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.7 mt -111.81 109.63 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.506 -0.746 . . . . 1.0 109.534 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.5 ptm -106.46 132.0 53.0 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.328 -0.858 . . . . 1.0 109.481 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.424 HD13 ' CE1' ' A' ' 35' ' ' PHE . 86.1 mt -103.22 137.72 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.619 -0.675 . . . . 1.0 109.383 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.2 p -152.08 152.96 33.03 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.07 -1.019 . . . . 1.0 109.755 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.647 ' H ' HD21 ' A' ' 21' ' ' ASN . 93.4 m-85 -100.42 120.27 39.73 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.891 -0.781 . . . . 1.0 108.891 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -103.85 -170.6 25.37 Favored Glycine 0 N--CA 1.5 2.966 0 N-CA-C 110.773 -0.931 . . . . 1.0 110.773 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.528 HG22 ' N ' ' A' ' 67' ' ' LYS . 74.4 mt -137.16 165.37 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.569 -0.959 . . . . 1.0 109.111 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.528 ' N ' HG22 ' A' ' 66' ' ' ILE . 27.2 tptp -27.94 -80.55 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 120.99 0.424 . . . . 1.0 111.387 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.619 ' CD ' ' H ' ' A' ' 68' ' ' GLU . 0.9 OUTLIER -77.17 95.72 4.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.929 -1.107 . . . . 1.0 109.91 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.509 ' ND1' ' O ' ' A' ' 66' ' ' ILE . 6.1 p-80 -157.94 4.98 0.12 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.059 -1.026 . . . . 1.0 109.644 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -156.26 89.01 0.12 Allowed Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.122 -1.591 . . . . 1.0 109.122 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -60.05 -43.95 95.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.139 -1.213 . . . . 1.0 109.547 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -60.39 -39.96 89.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.148 -0.97 . . . . 1.0 109.012 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -128.75 79.98 73.47 Favored Pre-proline 0 N--CA 1.5 2.045 0 N-CA-C 109.075 -0.713 . . . . 1.0 109.075 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -76.55 149.77 30.94 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 C-N-CA 121.044 1.163 . . . . 1.0 112.085 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -94.84 168.41 10.82 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.249 -0.907 . . . . 1.0 109.609 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.5 p-10 -101.81 -0.07 34.85 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.331 -0.855 . . . . 1.0 111.127 -178.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 128.04 -149.16 18.04 Favored Glycine 0 N--CA 1.505 3.261 0 N-CA-C 109.381 -1.488 . . . . 1.0 109.381 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.425 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 3.5 Cg_exo -64.39 -64.36 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.501 0 CA-C-N 118.953 1.376 . . . . 1.0 112.114 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 77.0 p -75.9 158.67 31.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.12 -0.987 . . . . 1.0 109.039 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.26 -128.34 8.04 Favored Glycine 0 N--CA 1.501 3.012 0 N-CA-C 109.594 -1.402 . . . . 1.0 109.594 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.425 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 18.4 mt -67.28 106.35 2.02 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.389 -1.065 . . . . 1.0 109.555 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 46.3 mt -75.81 -23.63 55.83 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.919 -1.113 . . . . 1.0 109.063 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -177.68 173.89 1.56 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.635 -0.876 . . . . 1.0 108.635 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -161.08 165.75 29.18 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.175 -0.953 . . . . 1.0 109.177 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -155.3 159.15 39.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.388 -0.82 . . . . 1.0 109.162 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -99.05 153.9 37.57 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 121.097 -1.002 . . . . 1.0 108.499 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -62.75 160.39 33.11 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 120.847 1.031 . . . . 1.0 112.396 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -41.01 121.21 1.25 Allowed 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 121.806 1.67 . . . . 1.0 113.212 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.98 -169.23 26.11 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.816 -1.314 . . . . 1.0 109.816 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -58.94 -151.98 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.118 1.212 . . . . 1.0 111.622 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -60.33 -41.58 93.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.798 -1.189 . . . . 1.0 109.432 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -60.16 -41.49 92.88 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.296 -0.877 . . . . 1.0 109.858 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -80.02 169.09 52.74 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.32 -1.112 . . . . 1.0 110.32 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 70.19 5.08 52.66 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.985 -1.246 . . . . 1.0 109.985 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 43.0 p-10 -80.65 160.25 25.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.103 -1.234 . . . . 1.0 109.218 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.87 121.39 8.53 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.086 -1.009 . . . . 1.0 109.423 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -109.63 147.25 33.4 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.7 -0.625 . . . . 1.0 109.575 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -121.21 151.73 39.63 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.66 -0.867 . . . . 1.0 108.66 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.425 ' OD2' ' O ' ' A' ' 81' ' ' LEU . 88.7 m-20 -78.67 120.63 23.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.973 -1.079 . . . . 1.0 109.386 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -83.11 -10.44 58.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.318 -0.864 . . . . 1.0 109.334 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -83.08 -10.07 58.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.892 . . . . 1.0 109.471 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 97.8 mt-10 -91.63 168.19 11.67 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.308 -0.87 . . . . 1.0 109.618 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 8.2 m -97.73 106.48 18.79 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.335 -0.853 . . . . 1.0 109.007 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -89.13 121.17 31.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.429 -0.794 . . . . 1.0 108.887 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.607 HG21 ' HB2' ' A' ' 109' ' ' LYS . 6.1 t -140.31 152.55 45.94 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.325 -0.86 . . . . 1.0 110.103 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 69.8 m -95.03 -8.42 36.81 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.774 -0.824 . . . . 1.0 108.774 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 90.3 p -91.89 175.33 6.92 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.467 -0.771 . . . . 1.0 108.957 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.1 t -72.82 71.85 1.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.04 -1.038 . . . . 1.0 109.485 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.607 ' HB2' HG21 ' A' ' 105' ' ' THR . 43.7 mtpt -148.47 154.76 40.3 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.287 -0.883 . . . . 1.0 108.836 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 109' ' ' LYS . . . 40.83 -141.89 0.88 Allowed Glycine 0 N--CA 1.499 2.864 0 N-CA-C 110.473 -1.051 . . . . 1.0 110.473 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -99.53 119.55 38.22 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.336 -1.096 . . . . 1.0 108.962 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -64.08 130.39 43.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.157 -0.965 . . . . 1.0 109.623 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.9 tp -60.0 -43.45 95.17 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.436 -0.79 . . . . 1.0 110.814 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -59.84 -40.22 87.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.103 -0.998 . . . . 1.0 110.774 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -59.28 -51.35 70.32 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.845 -1.16 . . . . 1.0 109.197 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.6 t -69.99 -41.78 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.161 -0.962 . . . . 1.0 109.728 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.1 -51.76 68.36 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.032 -1.043 . . . . 1.0 109.264 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.59 -40.63 88.11 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.428 -0.795 . . . . 1.0 110.662 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -62.54 -49.17 76.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.204 -0.935 . . . . 1.0 111.022 -178.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -59.83 -38.8 83.05 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.619 -1.301 . . . . 1.0 109.701 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -59.85 -40.02 87.16 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.818 -1.176 . . . . 1.0 108.46 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -56.99 -40.44 91.16 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.576 -1.41 . . . . 1.0 109.576 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -67.36 -40.06 85.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.957 -1.319 . . . . 1.0 109.311 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 86.1 p -66.03 -26.09 67.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.131 -0.981 . . . . 1.0 109.056 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 83.2 mt -80.51 2.55 24.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.365 -0.834 . . . . 1.0 109.552 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 85.14 9.77 79.49 Favored Glycine 0 N--CA 1.494 2.562 0 C-N-CA 120.2 -1.0 . . . . 1.0 110.921 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 77.5 mt -87.05 141.06 28.94 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.712 -1.464 . . . . 1.0 109.673 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 30.8 t0 -98.98 173.01 7.04 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.432 -0.792 . . . . 1.0 109.263 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.507 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 66.9 m80 -60.08 132.69 54.71 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.272 -0.892 . . . . 1.0 109.821 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.6 t -100.26 156.03 17.45 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.812 -0.81 . . . . 1.0 108.812 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -98.28 6.29 47.52 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.1 -1.0 . . . . 1.0 109.514 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -86.16 125.27 68.67 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.15 -0.969 . . . . 1.0 108.476 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -67.26 -19.34 50.33 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 CA-C-N 120.226 1.116 . . . . 1.0 112.57 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -87.21 -8.03 75.78 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.88 -1.288 . . . . 1.0 109.88 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.6 145.65 25.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.04 -1.271 . . . . 1.0 109.443 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.437 ' C ' ' H ' ' A' ' 138' ' ' PHE . 95.0 mt -68.38 -31.19 70.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.23 -0.919 . . . . 1.0 109.39 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 96.4 mmm -71.22 17.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.427 -0.796 . . . . 1.0 110.743 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.437 ' H ' ' C ' ' A' ' 136' ' ' LEU . 12.5 t80 -70.01 130.17 90.12 Favored Pre-proline 0 N--CA 1.494 1.764 0 N-CA-C 107.901 -1.148 . . . . 1.0 107.901 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -68.13 4.96 1.29 Allowed 'Trans proline' 0 N--CA 1.505 2.173 0 C-N-CA 121.041 1.16 . . . . 1.0 114.623 -177.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.6 mt -119.63 134.37 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 O-C-N 120.984 -1.072 . . . . 1.0 108.446 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -71.74 130.8 42.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.022 -1.049 . . . . 1.0 109.666 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 15.0 t -145.11 144.98 31.22 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.56 -0.904 . . . . 1.0 108.56 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -80.8 147.68 30.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.99 -1.069 . . . . 1.0 109.912 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 19.3 m -137.77 145.14 42.04 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.481 -0.762 . . . . 1.0 110.008 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.17 97.16 0.57 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 107.646 -2.181 . . . . 1.0 107.646 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -73.97 5.1 4.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.379 -1.071 . . . . 1.0 109.805 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 70.0 m -60.05 -40.09 88.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.132 -0.98 . . . . 1.0 110.052 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -147.5 39.95 0.99 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.021 -1.05 . . . . 1.0 109.911 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -78.87 130.59 35.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.099 -1.001 . . . . 1.0 110.915 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 97.9 mmm -128.67 145.02 51.27 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.108 -1.071 . . . . 1.0 108.108 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 26.8 mt -50.26 129.43 24.11 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 120.841 -1.162 . . . . 1.0 108.981 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -71.97 179.44 4.85 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 CA-C-N 119.939 1.014 . . . . 1.0 112.084 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -61.42 -40.02 92.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.431 -0.793 . . . . 1.0 110.171 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -57.46 -45.11 85.13 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.185 -0.947 . . . . 1.0 110.353 -178.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -70.0 -39.9 75.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.804 -1.185 . . . . 1.0 109.49 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.5 t -59.75 -45.61 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.094 -1.004 . . . . 1.0 109.379 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -62.09 -40.07 94.59 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.945 -1.097 . . . . 1.0 110.016 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.4 -54.49 8.77 Favored Glycine 0 N--CA 1.494 2.523 0 C-N-CA 120.253 -0.975 . . . . 1.0 111.197 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.474 HG23 ' N ' ' A' ' 160' ' ' GLN . 8.8 tp -60.18 -40.33 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.934 -1.333 . . . . 1.0 109.644 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.553 ' O ' ' N ' ' A' ' 164' ' ' GLY . 92.1 mm-40 -65.15 -39.87 93.6 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.191 -0.943 . . . . 1.0 109.416 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 78.7 p -61.56 -28.62 69.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.085 -1.009 . . . . 1.0 110.279 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.4 mt -87.27 -52.58 5.31 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.94 -1.1 . . . . 1.0 110.477 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -90.81 -10.04 44.24 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.088 -1.007 . . . . 1.0 110.103 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.523 0 N-CA-C 109.348 -1.501 . . . . 1.0 109.348 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' WAY . . . . . 0.897 ' HC2' ' HJ ' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.18 -0.674 . . . . 1.0 109.18 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.1 mt -74.83 150.01 39.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.438 -0.789 . . . . 1.0 109.032 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -159.69 160.05 33.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.214 -0.929 . . . . 1.0 109.339 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -73.41 151.09 41.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.115 -0.991 . . . . 1.0 109.683 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.0 t -87.54 0.5 55.5 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.456 -0.777 . . . . 1.0 109.478 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -144.82 150.91 37.96 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.262 -0.899 . . . . 1.0 109.217 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.9 mmt -90.01 -0.1 57.4 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.357 -0.839 . . . . 1.0 109.952 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -98.2 131.02 44.91 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.266 -0.897 . . . . 1.0 108.896 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.9 mt -139.84 150.51 44.75 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.288 -0.882 . . . . 1.0 109.088 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 48.8 p -133.09 157.65 44.76 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.414 -0.804 . . . . 1.0 109.32 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -146.47 160.23 42.37 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.062 -1.024 . . . . 1.0 110.049 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.407 ' HE ' ' HA ' ' A' ' 55' ' ' ASP . 42.6 ttt-85 -144.32 133.29 22.68 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.381 -0.824 . . . . 1.0 109.429 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 84.9 mt -87.69 117.62 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.198 -0.939 . . . . 1.0 108.961 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.4 t -69.99 -39.97 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.16 -0.963 . . . . 1.0 109.767 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.534 HD21 ' H ' ' A' ' 64' ' ' PHE . 15.7 p30 -162.06 152.13 16.74 Favored 'General case' 0 C--N 1.292 -1.895 0 O-C-N 119.798 -1.814 . . . . 1.0 111.656 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -99.04 105.64 17.79 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 103.924 -2.621 . . . . 1.0 103.924 176.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.64 145.34 50.93 Favored Pre-proline 0 C--N 1.295 -1.8 0 O-C-N 121.127 -0.983 . . . . 1.0 110.532 -175.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -56.1 -14.14 10.95 Favored 'Trans proline' 0 N--CA 1.486 1.078 0 C-N-CA 120.668 0.912 . . . . 1.0 110.865 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -59.79 -39.2 84.16 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.523 -0.871 . . . . 1.0 109.708 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.7 mtm -139.66 156.18 46.98 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.211 -0.931 . . . . 1.0 109.496 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 82.5 p -75.6 163.88 26.88 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.423 -0.798 . . . . 1.0 109.681 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.559 ' H ' ' CD2' ' A' ' 28' ' ' HIS . 6.9 p80 -59.97 -39.03 84.27 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.542 -0.724 . . . . 1.0 110.079 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.4 m -60.02 -45.27 93.34 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.854 -1.154 . . . . 1.0 109.696 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -69.99 -40.2 75.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.136 -0.978 . . . . 1.0 109.846 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 77.6 t -68.48 -44.59 83.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.275 -0.891 . . . . 1.0 109.989 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -59.87 -48.54 81.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.052 -1.03 . . . . 1.0 111.033 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -61.11 -34.65 75.3 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.632 -1.292 . . . . 1.0 110.223 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.2 -48.66 80.81 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.868 -1.145 . . . . 1.0 109.619 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.404 ' CE1' HD13 ' A' ' 62' ' ' ILE . 53.1 m-85 -66.47 -37.81 85.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.074 -1.016 . . . . 1.0 109.523 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.06 -40.82 90.8 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.899 -1.126 . . . . 1.0 109.307 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -60.11 -42.74 95.36 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.941 -1.099 . . . . 1.0 108.27 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.0 -48.47 81.56 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.427 -0.796 . . . . 1.0 109.599 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -65.62 -39.01 91.04 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.01 -1.056 . . . . 1.0 109.852 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -59.4 -47.19 86.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.1 -1.0 . . . . 1.0 109.728 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.4 t -61.37 -41.34 89.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.216 -0.928 . . . . 1.0 110.303 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -77.99 -36.89 48.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.067 -1.021 . . . . 1.0 109.809 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 86.7 p -71.22 -15.5 62.46 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.506 -0.746 . . . . 1.0 109.634 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -59.19 -40.07 84.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.3 -0.875 . . . . 1.0 109.909 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.9 m -112.94 -21.79 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.301 -0.874 . . . . 1.0 110.874 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.1 p -91.4 128.32 47.38 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 120.697 -1.252 . . . . 1.0 110.268 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -75.81 15.67 0.87 Allowed 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 120.855 1.037 . . . . 1.0 111.471 179.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 79.1 mt -69.16 140.62 54.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.335 -0.853 . . . . 1.0 109.55 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -106.11 121.04 43.34 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -106.93 123.18 47.81 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.303 -0.873 . . . . 1.0 109.194 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -120.0 130.24 54.64 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.589 -0.694 . . . . 1.0 109.728 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -82.09 135.85 35.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.185 -0.947 . . . . 1.0 109.073 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 84.7 mt -103.67 129.68 51.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.317 -0.864 . . . . 1.0 108.837 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.43 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 18.5 m170 -61.3 -40.01 92.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 1.0 109.869 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 75.1 m-20 -149.11 169.86 19.73 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.188 -0.945 . . . . 1.0 109.809 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.0 -178.03 34.42 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.726 -1.35 . . . . 1.0 109.726 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.2 mt -93.87 139.13 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.269 -1.136 . . . . 1.0 109.3 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.35 169.23 9.1 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.517 -0.739 . . . . 1.0 109.439 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -59.99 -48.42 81.78 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.27 -0.894 . . . . 1.0 109.147 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.0 mt -119.92 112.34 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.503 -0.748 . . . . 1.0 109.401 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.7 ptm -103.58 133.81 47.98 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.306 -0.871 . . . . 1.0 108.9 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.404 HD13 ' CE1' ' A' ' 35' ' ' PHE . 84.6 mt -107.54 133.83 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.568 -0.707 . . . . 1.0 109.394 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 76.6 p -151.74 157.57 42.19 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.072 -1.017 . . . . 1.0 109.988 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.534 ' H ' HD21 ' A' ' 21' ' ' ASN . 73.7 m-85 -110.02 121.72 45.91 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.823 -0.806 . . . . 1.0 108.823 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -114.24 -167.23 15.93 Favored Glycine 0 N--CA 1.501 2.977 0 N-CA-C 110.289 -1.124 . . . . 1.0 110.289 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.563 ' O ' ' C ' ' A' ' 67' ' ' LYS . 96.9 mt -134.95 159.07 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.653 -0.91 . . . . 1.0 108.594 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.563 ' C ' ' O ' ' A' ' 66' ' ' ILE . 50.0 tptt -1.18 -93.24 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.757 0 C-N-CA 123.004 0.522 . . . . 1.0 111.806 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -80.41 130.63 35.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.927 -1.108 . . . . 1.0 109.854 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.541 ' NE2' ' OD2' ' A' ' 71' ' ' ASP . 35.1 p-80 -139.95 24.85 2.35 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.064 -1.022 . . . . 1.0 109.622 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.415 ' O ' ' OD1' ' A' ' 71' ' ' ASP . . . 82.98 44.49 7.1 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 120.218 -0.991 . . . . 1.0 110.942 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.541 ' OD2' ' NE2' ' A' ' 69' ' ' HIS . 88.2 m-20 -139.17 150.31 45.45 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.157 -1.202 . . . . 1.0 109.197 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.445 ' CD1' ' O ' ' A' ' 72' ' ' PHE . 60.1 t80 -69.15 -16.53 63.67 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.342 -0.848 . . . . 1.0 110.125 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -121.83 81.45 41.83 Favored Pre-proline 0 N--CA 1.505 2.316 0 O-C-N 121.303 -0.873 . . . . 1.0 110.06 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.36 179.98 2.19 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 120.671 0.914 . . . . 1.0 112.175 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.544 ' CD1' ' OD1' ' A' ' 99' ' ' ASP . 96.3 m-85 -89.49 170.44 10.51 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.366 -0.834 . . . . 1.0 108.894 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.1 p-10 -100.26 0.56 40.51 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.911 -1.118 . . . . 1.0 110.81 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 129.85 -146.15 17.11 Favored Glycine 0 N--CA 1.502 3.091 0 N-CA-C 108.663 -1.775 . . . . 1.0 108.663 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.426 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 5.7 Cg_exo -65.54 -63.4 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.331 0 CA-C-N 119.314 1.557 . . . . 1.0 111.63 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 84.4 p -78.58 161.1 27.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.206 -0.934 . . . . 1.0 110.001 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.47 -133.06 10.85 Favored Glycine 0 N--CA 1.502 3.047 0 N-CA-C 109.916 -1.273 . . . . 1.0 109.916 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.7 mt -65.56 107.92 1.86 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.345 -1.091 . . . . 1.0 108.287 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 50.9 mt -75.65 -29.95 59.28 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.113 -0.992 . . . . 1.0 109.123 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -177.07 168.6 2.4 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -160.63 162.39 32.73 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.18 -0.95 . . . . 1.0 109.6 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' A' ' 95' ' ' ASP . . . -146.25 158.67 43.9 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.256 -0.903 . . . . 1.0 109.511 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -101.78 151.98 38.03 Favored Pre-proline 0 N--CA 1.498 1.963 0 N-CA-C 108.469 -0.937 . . . . 1.0 108.469 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -63.68 165.36 18.46 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 120.535 0.823 . . . . 1.0 111.93 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -47.27 122.35 6.4 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 121.035 1.157 . . . . 1.0 111.753 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 90' ' ' PRO . . . -160.76 -170.74 25.77 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.778 -1.329 . . . . 1.0 109.778 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 89' ' ' GLY . 28.1 Cg_exo -54.53 -144.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.56 1.507 . . . . 1.0 113.311 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -61.26 -42.2 98.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.464 -0.772 . . . . 1.0 110.698 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -73.43 -27.76 61.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.9 -1.125 . . . . 1.0 110.168 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.63 171.03 50.38 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.278 -1.529 . . . . 1.0 109.278 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 55.14 71.1 0.77 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.704 -1.358 . . . . 1.0 109.704 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.4 ' O ' ' HB1' ' A' ' 85' ' ' ALA . 48.7 p-10 -153.74 162.34 41.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.349 -1.089 . . . . 1.0 109.282 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.15 118.84 7.0 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.225 -0.922 . . . . 1.0 110.126 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -104.12 136.02 44.52 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.505 -0.747 . . . . 1.0 109.845 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.44 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 19.4 m-85 -116.15 142.51 46.72 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.745 -0.835 . . . . 1.0 108.745 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.544 ' OD1' ' CD1' ' A' ' 75' ' ' PHE . 93.4 m-20 -79.22 124.09 28.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.935 -1.103 . . . . 1.0 109.523 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 48.3 t0 -84.32 -0.02 50.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.323 -0.861 . . . . 1.0 109.662 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -79.62 -16.39 55.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.022 -1.049 . . . . 1.0 110.157 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' A' ' 102' ' ' GLU . 56.1 mp0 -93.53 171.17 9.06 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.177 -0.952 . . . . 1.0 109.128 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 13.7 m -99.48 108.57 21.05 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.352 -0.981 . . . . 1.0 108.352 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -85.84 127.57 34.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 1.0 109.368 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.451 ' CG2' ' O ' ' A' ' 109' ' ' LYS . 1.8 t -139.86 153.11 46.95 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.428 -0.795 . . . . 1.0 109.638 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.5 t -98.69 -4.28 34.03 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.418 -0.801 . . . . 1.0 108.972 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 53.1 m -89.65 -116.47 0.06 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.327 -0.858 . . . . 1.0 109.626 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.8 p -141.84 64.58 1.39 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.134 -0.979 . . . . 1.0 110.147 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.451 ' O ' ' CG2' ' A' ' 105' ' ' THR . 98.7 mttt -144.87 155.29 43.38 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.09 -1.006 . . . . 1.0 108.848 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 49.97 -138.62 20.3 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.485 -1.446 . . . . 1.0 109.485 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -99.55 118.96 37.25 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.241 -1.152 . . . . 1.0 109.337 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -62.24 127.48 31.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.296 -0.878 . . . . 1.0 109.927 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.7 tp -59.98 -40.29 88.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.3 -0.875 . . . . 1.0 110.237 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -59.89 -40.96 90.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.237 -0.915 . . . . 1.0 110.233 -178.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.431 HD21 ' HZ1' ' A' ' 146' ' ' LYS . 3.0 mm? -60.76 -51.31 69.88 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.511 -1.368 . . . . 1.0 110.173 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.1 t -68.96 -43.77 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -0.889 . . . . 1.0 110.296 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.5 -52.24 66.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.074 -1.016 . . . . 1.0 109.739 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.23 -39.62 87.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.875 . . . . 1.0 110.374 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -62.04 -50.01 73.73 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.366 -0.834 . . . . 1.0 111.481 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.44 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 9.5 pt-20 -59.6 -39.77 85.26 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.842 -1.161 . . . . 1.0 109.943 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -60.39 -39.8 88.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.955 -1.091 . . . . 1.0 108.738 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.76 -43.29 86.79 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.162 -1.575 . . . . 1.0 109.162 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -67.53 -39.91 85.04 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.221 -1.164 . . . . 1.0 109.864 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 72.3 p -66.72 -21.61 66.07 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.134 -0.979 . . . . 1.0 109.463 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 77.1 mt -81.67 -0.73 44.01 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.457 -0.777 . . . . 1.0 109.484 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.82 6.96 66.85 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 110.902 -0.879 . . . . 1.0 110.902 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.5 mt -86.84 149.51 24.78 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.815 -1.403 . . . . 1.0 109.733 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 36.3 t0 -100.78 173.9 6.3 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.546 -0.721 . . . . 1.0 109.056 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.482 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 76.3 m80 -58.06 137.78 56.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.079 -1.013 . . . . 1.0 109.069 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 41.1 t -98.35 151.12 20.87 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.383 -0.823 . . . . 1.0 109.719 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -97.65 1.54 48.81 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.329 -0.857 . . . . 1.0 109.487 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -87.04 128.88 54.12 Favored Pre-proline 0 N--CA 1.489 1.487 0 N-CA-C 108.217 -1.031 . . . . 1.0 108.217 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -69.08 -11.04 30.76 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 CA-C-N 120.128 1.081 . . . . 1.0 112.059 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -93.43 -8.87 60.79 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.425 -1.47 . . . . 1.0 109.425 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.54 136.28 33.87 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.4 -1.059 . . . . 1.0 109.195 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.439 ' C ' ' H ' ' A' ' 138' ' ' PHE . 89.8 mt -60.84 -37.15 81.07 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.027 -1.046 . . . . 1.0 109.638 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 72.8 mtp -70.06 21.42 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.473 -0.767 . . . . 1.0 111.361 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.439 ' H ' ' C ' ' A' ' 136' ' ' LEU . 12.1 t80 -67.69 132.68 92.58 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 120.941 -1.099 . . . . 1.0 108.089 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -62.2 -2.07 2.82 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 CA-C-N 119.851 0.982 . . . . 1.0 114.56 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 95.7 mt -118.46 140.61 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.683 0 O-C-N 120.831 -1.168 . . . . 1.0 110.081 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -75.84 126.49 31.11 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.544 -0.723 . . . . 1.0 110.528 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 14.3 t -144.43 141.88 29.93 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.327 -0.858 . . . . 1.0 109.502 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -80.68 149.63 29.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.094 -1.004 . . . . 1.0 109.571 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.558 ' H ' ' NZ ' ' A' ' 146' ' ' LYS . 3.9 m -146.19 162.49 37.9 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.232 -0.918 . . . . 1.0 109.761 -178.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.439 ' N ' ' CG2' ' A' ' 144' ' ' THR . . . -84.88 103.17 2.64 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.134 -1.586 . . . . 1.0 109.134 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.558 ' NZ ' ' H ' ' A' ' 144' ' ' THR . 9.8 mptt -77.7 3.42 14.05 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.206 -1.173 . . . . 1.0 109.74 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 18.5 t -59.97 -47.56 85.3 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.464 -0.772 . . . . 1.0 109.793 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -133.65 19.12 3.89 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.267 -0.896 . . . . 1.0 110.097 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -65.35 139.84 58.61 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.901 -1.124 . . . . 1.0 110.416 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 76.6 mtm -138.04 149.69 46.26 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.284 -1.006 . . . . 1.0 108.284 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.1 mt -53.07 128.63 48.22 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.819 -1.176 . . . . 1.0 108.882 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.37 175.55 5.79 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 CA-C-N 120.201 1.107 . . . . 1.0 112.334 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -60.06 -39.69 86.89 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.529 -0.732 . . . . 1.0 109.968 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -56.65 -48.43 77.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.264 -0.897 . . . . 1.0 110.107 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -70.15 -40.03 75.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.137 -0.977 . . . . 1.0 109.677 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 76.7 t -63.09 -48.47 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.097 -1.002 . . . . 1.0 109.661 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -60.32 -40.24 89.91 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.904 -1.123 . . . . 1.0 110.298 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.67 -54.55 8.38 Favored Glycine 0 N--CA 1.496 2.659 0 O-C-N 121.168 -0.958 . . . . 1.0 111.41 -178.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.454 HG23 ' N ' ' A' ' 160' ' ' GLN . 6.3 tp -60.94 -40.22 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.813 -1.404 . . . . 1.0 109.59 -179.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.2 mm-40 -65.27 -39.71 92.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.16 -0.963 . . . . 1.0 109.434 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 83.9 p -66.68 -26.62 67.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.231 -0.918 . . . . 1.0 110.265 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 84.9 mt -87.0 -50.85 6.38 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.954 -1.091 . . . . 1.0 110.202 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -91.47 -9.19 45.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.104 -0.998 . . . . 1.0 110.286 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.492 2.429 0 N-CA-C 109.549 -1.42 . . . . 1.0 109.549 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' WAY . . . . . 0.512 ' CJ ' ' HE3' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.6 m . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.549 -0.537 . . . . 1.0 109.549 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.2 mt -67.19 140.11 57.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.91 . . . . 1.0 109.233 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -160.6 160.4 31.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 1.0 109.016 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -72.25 151.67 42.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.101 -0.999 . . . . 1.0 109.214 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 82.8 p -86.51 1.92 49.82 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.243 -0.91 . . . . 1.0 110.487 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -149.63 154.59 38.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.082 -1.011 . . . . 1.0 109.342 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.504 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.02 0.96 56.83 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.219 -0.925 . . . . 1.0 109.88 -179.529 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -95.85 127.69 42.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.107 -0.996 . . . . 1.0 108.687 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.6 mt -141.36 151.0 43.18 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.154 -0.966 . . . . 1.0 109.256 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.3 p -132.11 155.58 47.87 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.439 -0.788 . . . . 1.0 109.088 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -144.02 159.98 41.66 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.163 -0.96 . . . . 1.0 109.934 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.535 HH12 ' C ' ' A' ' 53' ' ' LEU . 25.2 ttm-85 -145.87 136.09 23.83 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.533 -0.729 . . . . 1.0 109.906 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 87.4 mt -88.81 113.93 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 108.339 -0.985 . . . . 1.0 108.339 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.66 -40.27 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.104 -0.997 . . . . 1.0 109.094 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -161.9 160.98 28.6 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.856 -1.152 . . . . 1.0 110.473 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.557 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 62.8 m-85 -101.95 -168.05 1.49 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.607 -1.257 . . . . 1.0 107.607 179.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.22 149.02 50.83 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.165 -0.959 . . . . 1.0 110.131 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -70.63 -12.03 30.62 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 120.827 1.018 . . . . 1.0 110.148 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -59.62 -39.96 85.99 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 115.334 -0.848 . . . . 1.0 110.531 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.9 mtm -139.99 169.93 16.8 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.163 -0.96 . . . . 1.0 109.634 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 78.8 p -73.15 160.05 32.57 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.137 -0.977 . . . . 1.0 109.472 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.557 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 1.8 m80 -60.16 -39.79 87.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.52 -0.738 . . . . 1.0 110.344 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.1 m -59.97 -39.9 87.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.08 -1.012 . . . . 1.0 109.549 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -62.47 -46.57 87.88 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.099 -1.001 . . . . 1.0 110.31 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.2 t -66.32 -39.92 85.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.401 -0.812 . . . . 1.0 109.804 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -54.44 -57.08 12.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.276 -0.89 . . . . 1.0 111.221 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.8 pttt -62.32 -32.17 72.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.683 -1.261 . . . . 1.0 110.439 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.34 -49.95 70.9 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.887 -1.133 . . . . 1.0 109.687 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -65.17 -39.67 93.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.027 -1.046 . . . . 1.0 109.759 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.15 -40.22 89.12 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.062 -1.024 . . . . 1.0 109.485 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -60.06 -43.45 95.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.979 -1.076 . . . . 1.0 108.845 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.21 -47.33 84.91 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.471 -0.768 . . . . 1.0 110.39 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.429 ' CZ ' ' CZ ' ' A' ' 121' ' ' PHE . 43.0 m-85 -63.32 -40.25 96.79 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.816 -1.178 . . . . 1.0 109.767 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -60.01 -44.43 94.57 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.163 -0.961 . . . . 1.0 110.043 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.8 t -60.11 -41.88 88.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.292 -0.88 . . . . 1.0 110.26 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -79.68 -37.49 35.72 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.157 -0.964 . . . . 1.0 111.162 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.3 p -69.85 -17.58 63.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.889 -1.132 . . . . 1.0 109.664 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.77 -40.14 91.41 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.546 -0.721 . . . . 1.0 110.833 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.8 m -118.65 35.3 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.257 -0.902 . . . . 1.0 110.69 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.6 p -151.12 134.62 9.08 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 120.917 -1.114 . . . . 1.0 109.925 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -73.39 10.64 1.17 Allowed 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 120.809 1.006 . . . . 1.0 111.908 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.0 mt -68.93 136.85 53.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.001 -1.062 . . . . 1.0 110.02 -179.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -107.21 120.76 42.99 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.501 -0.926 . . . . 1.0 108.501 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -108.25 124.57 50.51 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.309 -0.869 . . . . 1.0 109.599 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -120.37 130.02 54.21 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.56 -0.712 . . . . 1.0 110.088 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -81.37 130.03 34.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.235 -0.916 . . . . 1.0 109.288 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.535 ' C ' HH12 ' A' ' 18' ' ' ARG . 85.1 mt -106.04 139.94 39.8 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.391 -0.818 . . . . 1.0 108.942 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.444 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 41.3 m170 -95.33 -14.35 23.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.254 -0.904 . . . . 1.0 109.704 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 77.2 m-20 -149.66 160.28 43.64 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.309 -0.869 . . . . 1.0 109.865 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.535 ' O ' ' NE ' ' A' ' 18' ' ' ARG . . . 88.12 179.6 47.06 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.751 -1.34 . . . . 1.0 109.751 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.6 mt -97.36 139.77 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.322 -1.105 . . . . 1.0 109.514 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.04 155.75 22.3 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.478 -0.763 . . . . 1.0 109.16 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -59.92 -49.83 76.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.113 -0.992 . . . . 1.0 109.257 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.7 mt -103.91 99.85 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.405 -0.809 . . . . 1.0 109.786 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.5 ptp -99.8 138.94 36.18 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.161 -0.962 . . . . 1.0 109.166 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.2 mt -110.19 132.15 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.999 -0.741 . . . . 1.0 108.999 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 71.5 p -149.3 149.91 31.68 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.896 -1.127 . . . . 1.0 109.879 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -101.98 123.45 45.91 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.727 -0.842 . . . . 1.0 108.727 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.73 -165.96 22.51 Favored Glycine 0 N--CA 1.499 2.838 0 N-CA-C 110.107 -1.197 . . . . 1.0 110.107 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.531 HG22 ' N ' ' A' ' 67' ' ' LYS . 71.8 mt -133.17 166.47 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.671 -0.899 . . . . 1.0 108.822 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.531 ' N ' HG22 ' A' ' 66' ' ' ILE . 19.9 tptm -28.8 -82.47 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 CA-C-O 120.999 0.428 . . . . 1.0 111.539 -179.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.406 ' HG2' ' H ' ' A' ' 68' ' ' GLU . 15.7 pt-20 -76.64 128.87 35.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.927 -1.108 . . . . 1.0 110.125 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.611 ' CE1' ' CE2' ' A' ' 75' ' ' PHE . 51.5 p-80 -160.0 169.19 23.96 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.291 -0.88 . . . . 1.0 108.96 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -57.51 94.66 0.04 OUTLIER Glycine 0 N--CA 1.492 2.378 0 C-N-CA 120.031 -1.08 . . . . 1.0 110.44 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.484 ' OD1' ' CD1' ' A' ' 73' ' ' TYR . 55.9 t0 -171.38 140.29 1.41 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.239 -1.154 . . . . 1.0 109.304 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.513 ' CZ ' ' CD1' ' A' ' 73' ' ' TYR . 54.0 p90 -70.44 -19.98 62.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.037 -1.039 . . . . 1.0 109.71 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.559 ' O ' ' CG ' ' A' ' 73' ' ' TYR . 8.0 p90 -129.91 76.82 77.69 Favored Pre-proline 0 N--CA 1.501 2.117 0 O-C-N 121.408 -0.808 . . . . 1.0 109.142 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -53.67 -170.02 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 120.957 1.105 . . . . 1.0 112.56 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.611 ' CE2' ' CE1' ' A' ' 69' ' ' HIS . 89.2 m-85 -87.17 168.09 13.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 1.0 108.609 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -105.18 20.01 19.61 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.319 -0.863 . . . . 1.0 110.811 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 112.37 -156.71 15.41 Favored Glycine 0 N--CA 1.504 3.222 0 N-CA-C 109.149 -1.58 . . . . 1.0 109.149 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -57.41 -68.25 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.49 0 CA-C-N 118.657 1.228 . . . . 1.0 112.423 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 84.9 p -76.36 162.86 27.53 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.326 -0.859 . . . . 1.0 109.982 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.78 -129.16 8.37 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 109.734 -1.346 . . . . 1.0 109.734 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.0 mt -69.12 107.71 3.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.44 -1.035 . . . . 1.0 109.123 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 60.1 mt -78.92 -22.4 45.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.894 -1.129 . . . . 1.0 109.016 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -177.49 173.03 1.73 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.755 -0.831 . . . . 1.0 108.755 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.571 ' CE1' ' ND1' ' A' ' 97' ' ' HIS . 19.8 p80 -161.56 162.2 30.11 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.047 -1.033 . . . . 1.0 109.652 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.4 155.13 40.85 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.745 -0.835 . . . . 1.0 108.745 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -93.44 151.67 40.4 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.176 -0.952 . . . . 1.0 108.559 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.491 ' O ' ' N ' ' A' ' 89' ' ' GLY . 2.8 Cg_exo -50.0 169.38 0.14 Allowed 'Trans proline' 0 N--CA 1.488 1.176 0 CA-C-N 119.189 0.746 . . . . 1.0 111.295 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.69 75.37 0.06 OUTLIER 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 120.661 0.908 . . . . 1.0 111.849 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -93.01 -174.0 40.85 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.241 -1.544 . . . . 1.0 109.241 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 89' ' ' GLY . 14.3 Cg_exo -54.91 -144.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 121.452 1.435 . . . . 1.0 113.089 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -60.02 -39.88 87.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.478 -0.764 . . . . 1.0 109.551 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -68.35 -39.7 81.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.274 -0.891 . . . . 1.0 109.947 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -68.07 169.87 38.49 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.567 -1.013 . . . . 1.0 110.567 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.73 6.75 87.19 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.346 -1.501 . . . . 1.0 109.346 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -80.19 170.01 17.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.215 -1.167 . . . . 1.0 109.895 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.08 122.75 10.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.267 -0.896 . . . . 1.0 109.428 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.571 ' ND1' ' CE1' ' A' ' 84' ' ' HIS . 46.1 m170 -105.31 136.36 44.99 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.652 -0.655 . . . . 1.0 109.853 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -120.23 145.0 47.44 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.896 -0.779 . . . . 1.0 108.896 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.551 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 82.9 m-20 -78.56 121.75 25.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.034 -1.041 . . . . 1.0 109.856 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 37.8 t0 -85.63 -7.36 58.88 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.905 -0.776 . . . . 1.0 108.905 179.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -82.39 -12.56 57.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.432 -0.793 . . . . 1.0 109.197 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -91.1 170.56 9.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.378 -0.826 . . . . 1.0 109.291 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.9 m -101.29 105.37 16.45 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.382 -0.824 . . . . 1.0 109.097 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.426 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 88.2 m95 -88.41 123.77 33.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.342 -0.849 . . . . 1.0 109.057 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.669 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.1 t -140.52 157.67 45.14 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.331 -0.856 . . . . 1.0 110.198 -179.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 53.4 m -96.1 -9.18 31.4 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.181 -1.044 . . . . 1.0 108.181 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 72.4 m -92.35 171.58 8.96 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.58 -0.896 . . . . 1.0 108.58 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.6 t -72.09 76.19 0.95 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.07 -1.018 . . . . 1.0 109.928 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.669 ' HB2' HG21 ' A' ' 105' ' ' THR . 64.2 mttp -149.53 150.29 32.06 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.204 -0.935 . . . . 1.0 108.982 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.07 -137.46 4.91 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.702 -1.359 . . . . 1.0 109.702 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -102.68 117.57 34.95 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.436 -1.038 . . . . 1.0 109.405 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.592 HD22 ' NZ ' ' A' ' 146' ' ' LYS . 55.3 t-20 -64.2 130.09 42.52 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.22 -0.925 . . . . 1.0 109.583 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.2 tp -60.13 -40.56 90.19 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.41 -0.806 . . . . 1.0 110.94 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -58.71 -40.13 82.79 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.793 -1.192 . . . . 1.0 110.346 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -58.68 -59.92 4.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.944 -1.097 . . . . 1.0 109.749 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 86.9 t -62.99 -42.13 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.53 -0.732 . . . . 1.0 110.216 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.69 -49.99 75.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.119 -0.988 . . . . 1.0 109.403 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.99 -39.69 86.59 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.918 -1.114 . . . . 1.0 109.803 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.518 ' CD2' ' HB1' ' A' ' 169' ' ' WAY . 68.4 t60 -65.08 -48.55 73.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.347 -0.846 . . . . 1.0 111.946 -178.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.506 ' OE2' ' CD1' ' A' ' 121' ' ' PHE . 1.1 pp20? -59.13 -40.05 84.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.535 -1.353 . . . . 1.0 109.281 -178.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.506 ' CD1' ' OE2' ' A' ' 120' ' ' GLU . 28.4 m-85 -60.04 -39.87 87.42 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.857 -1.152 . . . . 1.0 109.175 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.76 -45.36 85.81 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.843 -1.303 . . . . 1.0 109.843 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -64.89 -40.06 94.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.004 -1.292 . . . . 1.0 109.645 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 82.2 p -63.78 -23.48 67.38 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.251 -0.906 . . . . 1.0 109.421 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.6 mt -84.16 -1.09 54.42 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.046 -1.034 . . . . 1.0 109.876 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.48 10.83 63.18 Favored Glycine 0 N--CA 1.496 2.698 0 C-N-CA 120.025 -1.084 . . . . 1.0 110.747 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 77.9 mt -84.65 144.0 28.87 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.888 -1.36 . . . . 1.0 109.944 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 11.6 t70 -99.15 170.1 8.93 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.302 -0.874 . . . . 1.0 109.029 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.493 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 65.7 m80 -60.0 137.35 58.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.153 -0.967 . . . . 1.0 110.154 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 28.6 t -100.62 154.15 18.82 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -97.98 5.72 48.5 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.096 -1.003 . . . . 1.0 109.911 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -86.98 129.48 51.93 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.066 -1.021 . . . . 1.0 108.66 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -66.4 -24.0 50.38 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 CA-C-N 120.188 1.103 . . . . 1.0 112.406 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -86.15 -5.09 83.47 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.012 -1.235 . . . . 1.0 110.012 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.59 144.48 27.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.933 -1.334 . . . . 1.0 108.731 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.433 ' C ' ' H ' ' A' ' 138' ' ' PHE . 88.4 mt -68.99 -33.22 73.33 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.307 -0.871 . . . . 1.0 109.181 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 96.3 mmm -71.58 19.87 0.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.462 -0.774 . . . . 1.0 110.771 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.433 ' H ' ' C ' ' A' ' 136' ' ' LEU . 12.0 t80 -69.16 132.34 90.1 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 120.826 -1.171 . . . . 1.0 108.532 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -64.53 -3.65 6.92 Favored 'Trans proline' 0 N--CA 1.501 1.926 0 CA-C-N 119.888 0.996 . . . . 1.0 113.936 -178.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.0 mt -118.67 141.11 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 O-C-N 121.012 -1.055 . . . . 1.0 109.104 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.497 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 38.3 t80 -74.73 130.63 39.82 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.489 -0.757 . . . . 1.0 110.252 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.8 t -140.63 142.48 35.0 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.431 -0.951 . . . . 1.0 108.431 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -79.8 144.17 33.77 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.918 -1.114 . . . . 1.0 110.074 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.4 m -130.42 140.03 50.58 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.04 -0.726 . . . . 1.0 109.04 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.41 113.92 3.98 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 107.655 -2.178 . . . . 1.0 107.655 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.592 ' NZ ' HD22 ' A' ' 112' ' ' ASN . 33.0 mmtm -73.25 98.77 2.72 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.063 -1.257 . . . . 1.0 109.297 -178.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.9 m -159.72 104.75 1.58 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.301 -0.875 . . . . 1.0 108.846 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 72.9 m80 50.1 40.57 21.97 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.408 -0.807 . . . . 1.0 109.399 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -85.19 129.96 34.7 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.16 -0.963 . . . . 1.0 109.393 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 66.9 mtt -124.28 149.06 46.93 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.981 -0.748 . . . . 1.0 108.981 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 29.1 mt -51.84 131.54 38.42 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.099 -1.001 . . . . 1.0 108.408 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -66.14 174.41 6.0 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 CA-C-N 119.992 1.033 . . . . 1.0 112.32 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -60.08 -39.65 86.81 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.429 -0.794 . . . . 1.0 110.152 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -57.16 -49.67 75.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.135 -0.978 . . . . 1.0 109.809 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.01 -40.19 75.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.088 -1.008 . . . . 1.0 110.516 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 67.5 t -60.74 -45.72 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.949 -1.094 . . . . 1.0 108.989 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -60.17 -39.92 88.13 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.137 -0.977 . . . . 1.0 110.398 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -69.54 -52.45 21.09 Favored Glycine 0 N--CA 1.494 2.546 0 O-C-N 121.145 -0.972 . . . . 1.0 111.504 -178.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.455 HG23 ' N ' ' A' ' 160' ' ' GLN . 5.3 tp -62.25 -40.01 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.754 -1.439 . . . . 1.0 109.661 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.8 mt-30 -65.01 -38.99 92.74 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.246 -0.909 . . . . 1.0 109.628 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 79.5 p -69.26 -22.25 63.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.174 -0.953 . . . . 1.0 110.174 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 88.8 mt -88.24 -50.68 6.2 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.888 -1.132 . . . . 1.0 110.065 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -93.53 -9.32 38.67 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.034 -1.041 . . . . 1.0 109.67 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.509 0 N-CA-C 109.473 -1.451 . . . . 1.0 109.473 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' WAY . . . . . 0.518 ' HB1' ' CD2' ' A' ' 119' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.8 m . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.237 0.542 . . . . 1.0 109.614 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.4 mt -76.55 138.36 40.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.252 -0.905 . . . . 1.0 109.582 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.55 ' HB3' ' HZ3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -161.41 159.82 28.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.149 -0.969 . . . . 1.0 109.56 179.502 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -76.23 152.6 36.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 1.0 109.407 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 99.0 p -87.51 0.03 56.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.361 -0.837 . . . . 1.0 109.809 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -148.57 154.59 39.96 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.154 -0.966 . . . . 1.0 109.686 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.567 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.49 -0.03 57.5 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.377 -0.827 . . . . 1.0 110.222 -179.577 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -96.6 122.38 39.46 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.181 -0.949 . . . . 1.0 108.863 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 71.8 mt -138.85 149.08 44.49 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.471 -0.768 . . . . 1.0 108.98 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.3 p -131.67 160.01 36.68 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.703 -0.851 . . . . 1.0 108.703 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -142.89 161.19 38.77 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.13 -0.981 . . . . 1.0 110.435 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -142.63 129.75 20.85 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.137 -0.69 . . . . 1.0 109.137 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.7 mt -88.13 118.25 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.182 -0.949 . . . . 1.0 108.908 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.67 -39.53 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.218 -0.926 . . . . 1.0 109.505 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.46 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 21.4 p-10 -162.47 155.5 19.94 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.212 -1.555 . . . . 1.0 111.366 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.487 ' HB2' ' CD2' ' A' ' 28' ' ' HIS . 19.3 m-85 -104.96 75.73 1.2 Allowed 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 106.358 -1.719 . . . . 1.0 106.358 176.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.482 ' O ' ' O ' ' A' ' 22' ' ' TYR . 3.0 t -23.45 144.71 0.02 OUTLIER Pre-proline 0 N--CA 1.512 2.636 0 C-N-CA 122.83 0.452 . . . . 1.0 111.744 -177.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -63.94 -4.74 7.92 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 121.631 1.554 . . . . 1.0 112.915 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -59.09 -36.84 75.82 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.442 -0.786 . . . . 1.0 109.557 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 76.8 mtm -138.47 164.17 30.08 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.298 -0.876 . . . . 1.0 109.582 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 76.0 p -70.58 160.03 33.25 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.378 -0.826 . . . . 1.0 109.154 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.487 ' CD2' ' HB2' ' A' ' 22' ' ' TYR . 26.2 m170 -60.03 -42.45 94.4 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.291 -0.881 . . . . 1.0 110.206 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.2 m -60.41 -40.6 91.58 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.166 -0.959 . . . . 1.0 110.735 -179.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -65.78 -41.04 92.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.973 -1.079 . . . . 1.0 110.144 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 69.5 t -66.6 -40.0 85.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 121.422 -0.799 . . . . 1.0 109.978 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -59.78 -52.54 65.03 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.404 -0.81 . . . . 1.0 112.144 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.2 pttt -65.13 -32.63 74.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.558 -1.339 . . . . 1.0 110.277 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.57 -51.31 70.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.941 -1.1 . . . . 1.0 110.181 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.437 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 45.0 m-85 -65.87 -37.39 86.03 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.825 -1.172 . . . . 1.0 110.099 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -59.99 -40.55 89.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.942 -1.098 . . . . 1.0 109.67 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -61.55 -40.31 94.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.067 -1.021 . . . . 1.0 109.529 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.08 -46.12 90.64 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.422 -0.799 . . . . 1.0 110.44 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -68.07 -39.67 82.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.01 -1.056 . . . . 1.0 109.86 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.408 ' O ' ' CG ' ' A' ' 44' ' ' ASP . 49.9 tptt -60.02 -47.17 86.94 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.186 -0.946 . . . . 1.0 109.878 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.2 t -60.08 -42.07 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.145 -0.972 . . . . 1.0 110.846 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -79.31 -35.36 41.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.85 -1.156 . . . . 1.0 110.148 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 38.8 p -71.5 -16.26 62.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.098 -1.001 . . . . 1.0 109.62 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.408 ' CG ' ' O ' ' A' ' 40' ' ' LYS . 96.0 m-20 -59.98 -39.59 86.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.339 -0.851 . . . . 1.0 110.314 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.4 m -112.18 -21.85 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.306 -0.871 . . . . 1.0 110.65 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.6 p -93.78 133.05 28.49 Favored Pre-proline 0 N--CA 1.501 2.109 0 O-C-N 120.759 -1.213 . . . . 1.0 109.611 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -75.43 15.95 0.77 Allowed 'Trans proline' 0 N--CA 1.496 1.622 0 CA-C-N 120.204 1.109 . . . . 1.0 112.039 178.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 78.8 mt -68.31 140.02 55.93 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.195 -0.941 . . . . 1.0 109.912 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -108.19 121.73 45.46 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 108.993 -0.743 . . . . 1.0 108.993 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -108.95 124.52 50.81 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.249 -0.907 . . . . 1.0 109.958 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.0 m -119.96 129.95 54.55 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.418 0.628 . . . . 1.0 109.306 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -83.82 137.9 33.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.307 -0.871 . . . . 1.0 110.042 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 77.3 mt -102.79 129.29 49.4 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.703 -0.851 . . . . 1.0 108.703 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.448 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 61.0 m170 -61.67 -40.04 93.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.914 . . . . 1.0 109.428 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 75.0 m-20 -151.0 168.02 25.85 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.379 -0.825 . . . . 1.0 109.249 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.03 -178.64 29.57 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.543 -1.423 . . . . 1.0 109.543 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.0 mt -96.3 132.82 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.353 -1.087 . . . . 1.0 109.76 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.96 164.71 12.34 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.367 -0.833 . . . . 1.0 109.071 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.04 -49.48 77.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.189 -0.944 . . . . 1.0 109.527 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 95.2 mt -107.28 101.85 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.51 -0.743 . . . . 1.0 109.691 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.2 ptp -100.21 135.97 40.82 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.248 -0.908 . . . . 1.0 109.469 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.437 HG21 ' CZ ' ' A' ' 35' ' ' PHE . 85.4 mt -110.0 133.92 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.726 -0.609 . . . . 1.0 109.945 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.2 p -152.47 155.18 37.0 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.017 -1.052 . . . . 1.0 110.274 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -102.68 121.86 43.28 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.499 -0.926 . . . . 1.0 108.499 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.78 -173.45 22.86 Favored Glycine 0 N--CA 1.499 2.894 0 N-CA-C 110.761 -0.935 . . . . 1.0 110.761 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.678 HG22 ' N ' ' A' ' 67' ' ' LYS . 96.7 mt -136.38 175.53 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 107.755 -1.202 . . . . 1.0 107.755 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.678 ' N ' HG22 ' A' ' 66' ' ' ILE . 50.8 tptt -28.94 -89.22 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.818 -0.551 . . . . 1.0 110.75 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -76.79 127.99 33.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.934 -1.104 . . . . 1.0 109.464 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.467 ' CE1' ' OD2' ' A' ' 71' ' ' ASP . 32.0 p-80 -145.19 24.67 1.43 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.921 -1.112 . . . . 1.0 109.737 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.03 50.26 3.75 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 110.139 -1.185 . . . . 1.0 110.139 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.467 ' OD2' ' CE1' ' A' ' 69' ' ' HIS . 21.8 p-10 -148.18 161.34 41.66 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.145 -1.209 . . . . 1.0 109.262 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -91.25 -2.37 57.46 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.145 -0.972 . . . . 1.0 110.235 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.535 ' CD2' ' O ' ' A' ' 73' ' ' TYR . 10.7 p90 -134.33 72.27 70.99 Favored Pre-proline 0 N--CA 1.5 2.073 0 O-C-N 121.318 -0.864 . . . . 1.0 109.189 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -57.45 -171.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.036 1.157 . . . . 1.0 112.504 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.561 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 94.4 m-85 -91.1 171.74 9.04 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.29 -0.881 . . . . 1.0 109.106 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 79' ' ' SER . 23.2 p-10 -99.72 18.61 17.7 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.132 -0.98 . . . . 1.0 110.61 -178.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 110.21 -151.87 17.4 Favored Glycine 0 N--CA 1.503 3.16 0 N-CA-C 109.337 -1.505 . . . . 1.0 109.337 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.439 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 6.3 Cg_exo -62.16 -63.67 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.563 0 CA-C-N 118.919 1.359 . . . . 1.0 112.408 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.434 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 95.9 p -77.36 162.77 27.0 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.934 -1.104 . . . . 1.0 109.882 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.68 -130.05 9.01 Favored Glycine 0 N--CA 1.502 3.081 0 N-CA-C 110.341 -1.104 . . . . 1.0 110.341 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.429 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 8.9 mt -68.54 108.32 3.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.607 -0.937 . . . . 1.0 108.589 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 74.4 mt -80.67 -17.98 49.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.969 -1.082 . . . . 1.0 109.818 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.64 174.13 1.23 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.427 -0.796 . . . . 1.0 109.194 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.424 ' CE1' ' ND1' ' A' ' 97' ' ' HIS . 11.5 p80 -161.99 159.35 26.36 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.357 -0.84 . . . . 1.0 109.236 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.22 154.6 40.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.154 -0.966 . . . . 1.0 109.368 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -92.15 152.11 42.32 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.096 -1.002 . . . . 1.0 108.418 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.442 ' O ' ' N ' ' A' ' 89' ' ' GLY . 5.3 Cg_exo -50.01 171.08 0.1 OUTLIER 'Trans proline' 0 N--CA 1.49 1.265 0 CA-C-N 119.139 0.728 . . . . 1.0 111.191 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -63.59 75.88 0.14 Allowed 'Trans proline' 0 C--N 1.315 -1.21 0 CA-C-O 121.932 0.722 . . . . 1.0 111.402 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -88.97 -172.36 46.21 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.837 -1.705 . . . . 1.0 108.837 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 89' ' ' GLY . 14.0 Cg_exo -56.06 -152.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.031 1.154 . . . . 1.0 111.91 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.437 ' H ' ' ND2' ' A' ' 91' ' ' ASN . 3.5 p30 -61.06 -40.28 93.07 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.144 -0.973 . . . . 1.0 109.311 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -60.65 -45.5 93.85 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.22 -0.925 . . . . 1.0 109.272 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -69.11 177.5 28.29 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.537 -1.025 . . . . 1.0 110.537 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.46 13.56 83.41 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.603 -1.399 . . . . 1.0 109.603 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.2 p-10 -80.83 173.81 12.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.109 -1.23 . . . . 1.0 109.856 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.0 120.48 7.42 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.434 -0.792 . . . . 1.0 109.02 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.424 ' ND1' ' CE1' ' A' ' 84' ' ' HIS . 48.7 m170 -105.61 139.51 40.1 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.561 -0.712 . . . . 1.0 110.265 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.528 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 29.2 m-85 -120.78 140.97 50.95 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.733 -0.84 . . . . 1.0 108.733 179.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.561 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 93.9 m-20 -78.92 122.94 26.75 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.834 -1.166 . . . . 1.0 109.65 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 34.4 t0 -84.39 1.61 44.42 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.281 -0.887 . . . . 1.0 109.722 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -80.74 -17.95 49.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.124 -0.985 . . . . 1.0 109.57 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' A' ' 102' ' ' GLU . 56.9 mp0 -91.27 172.13 8.75 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.315 -0.865 . . . . 1.0 109.012 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 15.5 m -100.93 107.02 18.41 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.292 -1.003 . . . . 1.0 108.292 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -85.2 127.29 34.23 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.533 -0.914 . . . . 1.0 108.533 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.681 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.9 t -141.8 153.63 44.67 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.343 -0.848 . . . . 1.0 109.979 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 96.6 p -91.88 -5.66 52.88 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.911 -1.144 . . . . 1.0 107.911 178.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 65.2 m -93.1 -176.94 4.32 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.899 -0.778 . . . . 1.0 108.899 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.8 t -85.08 75.51 10.35 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.017 -1.052 . . . . 1.0 109.454 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.681 ' HB2' HG21 ' A' ' 105' ' ' THR . 98.2 mttt -148.67 152.82 37.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.321 -0.862 . . . . 1.0 108.889 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 43.37 -138.72 3.54 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 110.169 -1.172 . . . . 1.0 110.169 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -99.99 117.4 34.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.35 -1.088 . . . . 1.0 109.277 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -64.24 132.6 50.76 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.105 -0.997 . . . . 1.0 109.426 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.3 tp -59.97 -44.1 94.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 1.0 110.309 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -59.98 -40.9 90.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.167 -0.958 . . . . 1.0 111.585 -178.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -59.38 -49.98 75.71 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.443 -1.41 . . . . 1.0 109.415 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 66.0 t -69.97 -40.01 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.136 -0.977 . . . . 1.0 110.047 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.21 -52.8 63.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.089 -1.007 . . . . 1.0 109.807 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.0 -39.54 86.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.824 . . . . 1.0 110.695 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.437 ' CE1' ' HE2' ' A' ' 123' ' ' HIS . 69.0 t60 -61.94 -50.03 73.77 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.047 -1.033 . . . . 1.0 111.387 -178.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.528 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 8.2 pt-20 -60.04 -38.57 83.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.608 -1.308 . . . . 1.0 110.113 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -60.03 -40.03 87.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.82 -1.175 . . . . 1.0 108.588 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.79 -43.18 94.74 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.449 -1.46 . . . . 1.0 109.449 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.437 ' HE2' ' CE1' ' A' ' 119' ' ' HIS . 90.5 m-70 -65.62 -40.01 92.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.05 -1.265 . . . . 1.0 109.291 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 93.3 p -67.19 -25.39 66.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.179 -0.951 . . . . 1.0 109.438 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 83.2 mt -82.53 -3.0 55.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.22 -0.925 . . . . 1.0 109.791 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 96.94 7.53 57.45 Favored Glycine 0 N--CA 1.5 2.906 0 O-C-N 121.101 -1.0 . . . . 1.0 111.108 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.3 mt -85.25 148.0 26.29 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.698 -1.472 . . . . 1.0 109.693 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 39.7 t0 -102.75 171.49 7.39 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.993 -0.743 . . . . 1.0 108.993 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.536 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 76.9 m80 -59.22 136.26 57.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.012 -1.055 . . . . 1.0 109.106 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 40.3 t -97.38 155.28 16.98 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.237 -0.915 . . . . 1.0 109.541 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -98.61 1.3 46.24 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.351 -0.843 . . . . 1.0 109.75 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -85.4 130.18 52.53 Favored Pre-proline 0 N--CA 1.495 1.79 0 N-CA-C 107.843 -1.169 . . . . 1.0 107.843 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -67.44 -26.18 41.01 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 CA-C-N 120.212 1.111 . . . . 1.0 113.285 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -85.92 -2.75 86.09 Favored Glycine 0 N--CA 1.497 2.709 0 C-N-CA 119.799 -1.191 . . . . 1.0 110.342 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.63 144.42 27.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.047 -1.266 . . . . 1.0 109.146 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.407 ' C ' ' H ' ' A' ' 138' ' ' PHE . 91.5 mt -67.05 -33.46 75.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.177 -0.952 . . . . 1.0 109.813 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 94.8 mmm -69.17 9.61 0.41 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.164 -0.96 . . . . 1.0 110.2 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.407 ' H ' ' C ' ' A' ' 136' ' ' LEU . 13.2 t80 -67.43 135.9 93.18 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 107.738 -1.208 . . . . 1.0 107.738 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -65.13 -31.83 53.79 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 CA-C-N 119.898 0.999 . . . . 1.0 113.818 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 90.6 mt -83.42 140.41 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.481 -1.387 . . . . 1.0 110.119 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -76.07 128.92 36.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.491 -0.756 . . . . 1.0 109.591 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 10.2 t -140.16 142.41 35.95 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.221 -0.924 . . . . 1.0 109.55 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -82.5 144.93 30.08 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.359 -0.838 . . . . 1.0 109.643 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.8 t -140.79 156.09 46.24 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.259 -0.9 . . . . 1.0 110.076 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.0 110.36 3.17 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.92 -1.672 . . . . 1.0 108.92 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -78.63 -3.38 43.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.328 -1.101 . . . . 1.0 109.708 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.0 t -60.04 -41.14 91.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.234 -0.916 . . . . 1.0 110.635 -178.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -143.01 28.89 1.52 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.939 -1.101 . . . . 1.0 110.513 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -68.32 135.65 52.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.754 -1.216 . . . . 1.0 109.071 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 98.7 mtp -138.39 148.2 44.23 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.502 -0.925 . . . . 1.0 108.502 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 88.0 mt -50.83 121.25 14.76 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 120.959 -1.088 . . . . 1.0 108.682 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -66.57 178.55 2.61 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 CA-C-N 120.275 1.134 . . . . 1.0 112.153 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.16 -39.97 88.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.474 -0.766 . . . . 1.0 109.669 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -56.94 -49.2 76.38 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.238 -0.914 . . . . 1.0 109.678 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.68 -40.01 73.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.961 -1.087 . . . . 1.0 110.299 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 72.9 t -62.15 -46.67 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.915 -1.116 . . . . 1.0 109.159 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -60.28 -40.05 89.02 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.009 . . . . 1.0 110.212 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.13 -53.77 8.8 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 120.219 -0.991 . . . . 1.0 111.436 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.468 HG23 ' N ' ' A' ' 160' ' ' GLN . 9.9 tp -60.45 -40.31 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.74 -1.447 . . . . 1.0 109.971 -178.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.536 ' O ' ' N ' ' A' ' 164' ' ' GLY . 25.8 mm100 -65.68 -39.6 91.49 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.323 -0.861 . . . . 1.0 109.352 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 79.2 p -63.46 -25.82 68.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.197 -0.94 . . . . 1.0 110.14 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 84.5 mt -86.95 -52.56 5.39 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.959 -1.088 . . . . 1.0 110.456 -179.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -92.7 -9.01 42.31 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.035 -1.041 . . . . 1.0 110.135 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.522 0 N-CA-C 109.502 -1.439 . . . . 1.0 109.502 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' WAY . . . . . 0.867 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.9 m . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.284 0.564 . . . . 1.0 109.494 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.1 mt -95.57 125.13 39.95 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.219 -0.926 . . . . 1.0 109.575 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.9 pttt -161.96 160.05 27.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 1.0 109.85 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -73.56 147.25 44.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.403 -0.81 . . . . 1.0 109.411 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 99.4 p -89.33 3.1 53.26 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.192 -0.942 . . . . 1.0 110.091 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -143.21 153.61 43.0 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.118 -0.989 . . . . 1.0 109.435 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.1 mmt -90.17 -0.1 57.44 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.399 -0.813 . . . . 1.0 110.219 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -97.27 127.98 43.72 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.111 -0.993 . . . . 1.0 109.632 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.7 mt -142.28 148.65 38.4 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.101 -1.0 . . . . 1.0 109.123 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.4 p -135.28 158.57 44.03 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -145.1 160.99 40.54 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.038 -1.039 . . . . 1.0 110.615 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.51 HH11 ' HG2' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -141.81 131.14 23.59 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 -179.141 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.7 mt -88.14 115.24 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.127 -0.983 . . . . 1.0 108.694 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.08 -41.7 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.122 -0.986 . . . . 1.0 109.537 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.543 HD21 ' H ' ' A' ' 64' ' ' PHE . 1.8 p30 -164.36 160.94 21.36 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.271 -1.518 . . . . 1.0 110.114 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.587 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 51.1 m-85 -102.06 -169.92 1.74 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.157 -1.053 . . . . 1.0 108.157 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.25 147.02 42.1 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.343 -0.848 . . . . 1.0 110.154 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -68.61 -14.42 39.47 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 120.876 1.05 . . . . 1.0 110.912 178.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -59.86 -39.59 85.74 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.601 -0.727 . . . . 1.0 110.186 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 74.3 mtm -137.23 165.26 26.54 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.283 -0.886 . . . . 1.0 109.425 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.7 p -72.51 159.63 33.62 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.289 -0.882 . . . . 1.0 109.406 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.587 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 0.9 OUTLIER -60.16 -39.98 88.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.422 -0.799 . . . . 1.0 110.346 -179.25 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.1 m -59.91 -40.11 87.7 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.151 -0.968 . . . . 1.0 110.266 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -66.0 -40.0 90.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.126 -0.984 . . . . 1.0 110.087 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.6 t -68.8 -40.38 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.209 -0.932 . . . . 1.0 110.272 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.94 -49.91 75.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.031 -1.043 . . . . 1.0 110.197 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -61.7 -32.52 72.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.039 -1.038 . . . . 1.0 110.015 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.89 -48.51 81.4 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.888 -1.133 . . . . 1.0 110.007 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -66.89 -39.04 87.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.94 -1.1 . . . . 1.0 109.815 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -60.04 -42.5 94.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.111 -0.993 . . . . 1.0 109.516 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -60.14 -41.21 92.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.09 -1.006 . . . . 1.0 109.203 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.71 -45.3 94.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.503 -0.748 . . . . 1.0 110.224 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -65.64 -38.55 89.68 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.065 -1.022 . . . . 1.0 109.95 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -59.59 -48.82 80.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.102 -0.999 . . . . 1.0 109.782 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 76.1 t -60.0 -40.36 82.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.163 -0.961 . . . . 1.0 110.556 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -81.18 -36.54 30.03 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.842 -1.161 . . . . 1.0 109.823 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.6 p -70.22 -17.08 63.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.179 -0.951 . . . . 1.0 109.666 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -60.03 -40.04 87.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.938 . . . . 1.0 110.3 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -112.16 -17.61 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.338 -0.851 . . . . 1.0 110.782 -179.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.9 p -94.93 125.5 50.63 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 120.744 -1.223 . . . . 1.0 109.48 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -72.37 16.14 0.39 Allowed 'Trans proline' 0 N--CA 1.495 1.578 0 CA-C-N 120.177 1.099 . . . . 1.0 111.8 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 66.3 mt -69.17 140.01 54.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.297 -0.877 . . . . 1.0 109.934 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -106.32 120.56 42.19 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.79 -0.819 . . . . 1.0 108.79 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -106.75 127.22 53.2 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.273 -0.892 . . . . 1.0 109.42 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.9 m -119.99 129.69 54.4 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -84.04 132.57 34.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.517 -0.739 . . . . 1.0 109.116 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.9 mt -105.4 131.7 52.51 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.175 -0.953 . . . . 1.0 109.171 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.44 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 43.0 m170 -61.02 -40.01 91.94 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.146 -0.971 . . . . 1.0 109.284 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 71.9 m-20 -151.95 180.0 7.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.365 -0.834 . . . . 1.0 109.624 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.67 178.71 39.43 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.364 -1.494 . . . . 1.0 109.364 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.5 mt -96.9 130.28 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.284 -1.127 . . . . 1.0 109.673 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.54 162.67 14.48 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.581 -0.699 . . . . 1.0 109.163 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -59.92 -49.83 76.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.187 -0.945 . . . . 1.0 109.499 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 94.8 mt -104.81 101.24 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.412 -0.805 . . . . 1.0 109.898 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.2 ptp -100.93 132.13 46.48 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.319 -0.863 . . . . 1.0 109.161 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.6 mt -102.5 138.09 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.454 -0.779 . . . . 1.0 109.724 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 81.4 p -151.34 160.02 43.99 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.312 -0.867 . . . . 1.0 109.716 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.543 ' H ' HD21 ' A' ' 21' ' ' ASN . 86.1 m-85 -109.61 125.87 53.02 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.516 -0.74 . . . . 1.0 109.515 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -101.78 -178.26 28.15 Favored Glycine 0 N--CA 1.5 2.921 0 N-CA-C 110.839 -0.904 . . . . 1.0 110.839 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.525 HG22 ' N ' ' A' ' 67' ' ' LYS . 61.5 mt -136.82 163.72 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.613 -0.933 . . . . 1.0 109.721 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.525 ' N ' HG22 ' A' ' 66' ' ' ILE . 46.8 tptt -11.33 -76.37 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.314 0 N-CA-C 113.332 0.864 . . . . 1.0 113.332 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.421 ' H ' ' HG2' ' A' ' 68' ' ' GLU . 12.1 pt-20 -59.88 -49.98 75.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.057 -1.027 . . . . 1.0 110.834 -177.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.565 ' O ' ' N ' ' A' ' 71' ' ' ASP . 42.3 t-80 45.1 51.37 8.99 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.81 -1.181 . . . . 1.0 109.677 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 69' ' ' HIS . . . -28.6 84.32 0.0 OUTLIER Glycine 0 N--CA 1.505 3.266 0 CA-C-O 121.292 0.385 . . . . 1.0 112.188 -178.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 69' ' ' HIS . 64.7 m-20 -160.72 176.99 10.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.521 -0.987 . . . . 1.0 109.449 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -70.03 137.34 51.23 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.271 -0.893 . . . . 1.0 109.107 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 8.3 t80 44.73 69.47 2.49 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 121.283 -0.886 . . . . 1.0 109.777 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -66.6 -158.3 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.104 1.203 . . . . 1.0 112.503 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.536 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 67.8 m-85 -85.33 157.77 20.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.514 -0.741 . . . . 1.0 109.48 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.6 p-10 -101.0 0.29 37.87 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.454 -0.779 . . . . 1.0 109.994 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 135.19 -155.29 22.01 Favored Glycine 0 N--CA 1.501 2.976 0 N-CA-C 108.707 -1.757 . . . . 1.0 108.707 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.425 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 12.3 Cg_exo -59.41 -68.2 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.39 0 CA-C-N 118.843 1.322 . . . . 1.0 111.776 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 88.1 p -76.0 160.69 29.59 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.311 -0.868 . . . . 1.0 109.203 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.75 -131.09 8.95 Favored Glycine 0 N--CA 1.501 3.031 0 N-CA-C 109.369 -1.493 . . . . 1.0 109.369 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.425 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 24.1 mt -69.81 111.81 5.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.069 -1.254 . . . . 1.0 109.06 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 30.8 mt -82.17 -13.8 56.6 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.237 -0.915 . . . . 1.0 108.625 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 179.39 169.43 1.05 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.999 -0.741 . . . . 1.0 108.999 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.801 ' CD2' ' HD1' ' A' ' 97' ' ' HIS . 3.4 p-80 -162.54 160.88 26.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.077 -1.015 . . . . 1.0 109.572 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -147.48 164.53 33.09 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.193 -0.942 . . . . 1.0 109.577 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -100.8 152.81 37.94 Favored Pre-proline 0 N--CA 1.498 1.966 0 N-CA-C 108.713 -0.847 . . . . 1.0 108.713 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.472 ' O ' ' N ' ' A' ' 89' ' ' GLY . 1.0 OUTLIER -56.42 169.07 1.78 Allowed 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 120.582 0.855 . . . . 1.0 111.774 179.876 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -62.7 71.77 0.12 Allowed 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 120.745 0.963 . . . . 1.0 111.608 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -78.39 177.24 53.79 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.334 -1.506 . . . . 1.0 109.334 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -48.05 -75.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 120.991 1.127 . . . . 1.0 112.121 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -121.04 -49.66 2.18 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.419 -0.801 . . . . 1.0 109.766 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -60.29 -39.99 88.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.316 -0.865 . . . . 1.0 110.225 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.447 ' HA3' ' H ' ' A' ' 89' ' ' GLY . . . -65.06 170.44 25.35 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.839 -1.304 . . . . 1.0 109.839 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 80.11 4.26 89.7 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.616 -1.394 . . . . 1.0 109.616 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -80.64 170.17 16.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.113 -1.227 . . . . 1.0 109.508 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.87 139.2 23.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.232 -0.917 . . . . 1.0 109.38 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.801 ' HD1' ' CD2' ' A' ' 84' ' ' HIS . 18.0 m170 -130.13 157.71 41.68 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.56 -0.713 . . . . 1.0 109.884 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -136.72 153.81 50.76 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.011 -0.737 . . . . 1.0 109.011 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.536 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 0.6 OUTLIER -79.99 122.09 26.29 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.062 -1.024 . . . . 1.0 109.495 179.842 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -85.28 -11.62 54.32 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.095 -1.003 . . . . 1.0 109.347 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -81.33 -10.68 59.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.873 . . . . 1.0 109.47 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 98.3 mt-10 -90.81 169.98 10.49 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.311 -0.868 . . . . 1.0 109.466 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 22.3 m -98.43 106.23 18.48 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.103 -0.998 . . . . 1.0 109.728 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.427 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 93.5 m95 -89.82 127.48 35.99 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.704 -0.85 . . . . 1.0 108.704 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.674 HG21 ' HB2' ' A' ' 109' ' ' LYS . 9.2 t -143.19 155.65 44.58 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.237 -0.915 . . . . 1.0 109.583 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 60.0 p -94.82 -5.7 44.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.111 -0.993 . . . . 1.0 108.431 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 70.3 m -93.48 179.17 5.47 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.955 -0.757 . . . . 1.0 108.955 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 19.6 m -81.04 77.02 7.98 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.008 -1.058 . . . . 1.0 108.988 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.674 ' HB2' HG21 ' A' ' 105' ' ' THR . 67.9 mttm -149.06 150.19 32.35 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.739 -0.838 . . . . 1.0 108.739 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.21 -138.77 4.48 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.203 -1.159 . . . . 1.0 110.203 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -99.5 116.68 32.21 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.303 -1.116 . . . . 1.0 109.487 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.66 131.42 47.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.156 -0.965 . . . . 1.0 109.246 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.7 tp -59.86 -41.66 91.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 1.0 110.12 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -59.98 -43.0 95.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.133 -0.979 . . . . 1.0 111.106 -178.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 115' ' ' LEU . 3.8 mm? -59.38 -50.17 74.98 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.661 -1.274 . . . . 1.0 109.319 -178.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 95.7 t -70.54 -42.2 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.059 -1.025 . . . . 1.0 109.974 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.13 -50.66 73.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.004 -1.06 . . . . 1.0 110.12 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.09 -36.44 77.4 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.581 -1.325 . . . . 1.0 109.577 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -65.5 -48.71 71.65 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.29 -0.881 . . . . 1.0 111.353 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.67 -39.95 82.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.642 -1.286 . . . . 1.0 109.419 -178.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -60.04 -39.99 87.82 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.945 -1.097 . . . . 1.0 109.077 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.4 -46.51 80.07 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.795 -1.322 . . . . 1.0 109.795 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -65.37 -39.93 92.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.135 -1.215 . . . . 1.0 109.3 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.8 p -64.64 -23.61 67.31 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.291 -0.88 . . . . 1.0 108.998 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 50.6 mt -82.49 -4.97 58.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 1.0 109.59 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 95.27 5.83 60.36 Favored Glycine 0 N--CA 1.499 2.869 0 O-C-N 121.154 -0.966 . . . . 1.0 111.075 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.2 mt -84.21 150.27 25.58 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.811 -1.405 . . . . 1.0 109.94 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 11.0 t70 -103.16 173.19 6.42 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.558 -0.714 . . . . 1.0 109.477 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.483 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 69.2 m80 -59.97 136.35 57.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.132 -0.98 . . . . 1.0 109.221 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 47.7 t -99.45 156.02 17.25 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.324 -0.86 . . . . 1.0 109.516 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -98.72 2.37 47.0 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.165 -0.959 . . . . 1.0 109.358 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -85.66 128.46 58.75 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 120.955 -1.091 . . . . 1.0 108.409 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -68.44 -17.04 43.95 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 CA-C-N 120.14 1.086 . . . . 1.0 112.094 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -89.32 -7.48 69.65 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.091 -1.203 . . . . 1.0 110.091 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.09 144.99 26.18 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.159 -1.201 . . . . 1.0 109.125 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.482 ' C ' ' H ' ' A' ' 138' ' ' PHE . 96.2 mt -69.71 -31.51 69.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.035 -1.04 . . . . 1.0 109.599 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 94.1 mmm -70.88 19.82 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.178 -0.951 . . . . 1.0 110.372 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.482 ' H ' ' C ' ' A' ' 136' ' ' LEU . 13.5 t80 -69.2 131.86 90.28 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.104 -0.997 . . . . 1.0 108.367 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -62.95 -2.22 3.45 Favored 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 120.831 1.021 . . . . 1.0 114.149 -178.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.0 mt -120.43 136.77 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 O-C-N 120.987 -1.071 . . . . 1.0 109.944 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -71.97 127.73 33.49 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.278 -0.889 . . . . 1.0 110.437 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.413 ' O ' HG23 ' A' ' 142' ' ' THR . 9.7 t -139.83 133.61 30.57 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.436 -0.79 . . . . 1.0 109.346 179.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -82.16 144.89 30.41 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.065 -1.022 . . . . 1.0 108.749 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 2.5 t -141.86 159.98 41.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.101 -0.999 . . . . 1.0 109.473 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.27 105.66 1.7 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.928 -1.669 . . . . 1.0 108.928 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -78.06 9.8 3.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.342 -1.093 . . . . 1.0 109.37 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 59.2 m -59.91 -40.09 87.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.908 . . . . 1.0 109.826 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -150.25 29.92 0.7 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.006 -1.059 . . . . 1.0 109.575 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -61.59 138.78 58.31 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.154 -0.966 . . . . 1.0 109.59 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 66.9 mtt -137.83 145.86 42.78 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.689 -0.856 . . . . 1.0 108.689 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 45.4 mt -52.31 129.32 41.92 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.043 -1.036 . . . . 1.0 108.883 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -70.19 175.74 8.05 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 CA-C-N 119.985 1.03 . . . . 1.0 112.33 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.44 -39.9 89.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.54 -0.725 . . . . 1.0 110.097 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -56.73 -47.55 79.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.081 -1.012 . . . . 1.0 109.593 -179.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.417 ' O ' HG22 ' A' ' 159' ' ' ILE . 97.0 m-20 -70.33 -39.98 74.42 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.101 -1.0 . . . . 1.0 110.121 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 74.2 t -60.81 -47.74 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.028 -1.045 . . . . 1.0 109.098 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -60.26 -39.93 88.53 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.136 -0.977 . . . . 1.0 110.389 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.75 -54.55 7.24 Favored Glycine 0 N--CA 1.495 2.577 0 O-C-N 121.029 -1.044 . . . . 1.0 111.276 -178.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.475 HG23 ' N ' ' A' ' 160' ' ' GLN . 7.1 tp -60.1 -40.02 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.996 -1.297 . . . . 1.0 109.672 -178.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.554 ' O ' ' N ' ' A' ' 164' ' ' GLY . 26.4 mt-30 -65.51 -39.56 91.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.106 -0.996 . . . . 1.0 109.492 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 83.3 p -60.61 -32.0 71.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.214 -0.929 . . . . 1.0 110.688 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 97.4 mt -85.13 -49.97 7.81 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.772 -1.205 . . . . 1.0 110.606 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -91.39 -8.92 46.6 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.023 -1.048 . . . . 1.0 110.173 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.492 2.41 0 N-CA-C 109.563 -1.415 . . . . 1.0 109.563 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' WAY . . . . . 0.895 ' HC2' ' HJ ' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.402 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 26.6 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.479 -0.563 . . . . 1.0 109.479 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.6 mt -92.38 135.1 34.31 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.283 -0.886 . . . . 1.0 109.357 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.96 162.17 34.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.898 . . . . 1.0 109.547 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -73.05 150.45 42.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.196 -0.94 . . . . 1.0 109.666 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.0 t -80.21 -2.63 45.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.332 -0.855 . . . . 1.0 109.749 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -145.88 152.38 39.38 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.235 -0.915 . . . . 1.0 109.284 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.1 mmt -89.99 -0.68 57.71 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.211 -0.931 . . . . 1.0 109.771 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -96.9 131.17 43.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.205 -0.934 . . . . 1.0 109.059 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.8 mt -139.97 149.94 43.87 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.204 -0.935 . . . . 1.0 109.173 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 54.6 p -131.36 155.35 47.4 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.573 -0.899 . . . . 1.0 108.573 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -146.15 159.59 43.1 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.04 -1.038 . . . . 1.0 110.067 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.415 ' HG2' HH11 ' A' ' 18' ' ' ARG . 36.9 ttt-85 -145.26 133.98 22.24 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.48 -0.763 . . . . 1.0 109.296 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.9 mt -86.59 119.63 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 1.0 108.915 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 69.7 t -69.62 -41.11 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.353 -0.842 . . . . 1.0 109.207 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -164.56 157.87 17.51 Favored 'General case' 0 C--N 1.286 -2.175 0 O-C-N 119.686 -1.884 . . . . 1.0 110.819 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -100.41 113.0 25.41 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 106.475 -1.676 . . . . 1.0 106.475 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.425 ' C ' ' H ' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -56.87 136.54 79.25 Favored Pre-proline 0 C--N 1.299 -1.588 0 C-N-CA 119.103 -1.039 . . . . 1.0 109.199 -177.938 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -57.48 -7.87 3.4 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 CA-C-N 119.606 0.895 . . . . 1.0 110.31 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.425 ' H ' ' C ' ' A' ' 23' ' ' THR . 68.2 m-20 -58.27 -31.55 67.55 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 120.036 -0.666 . . . . 1.0 109.656 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 78.0 mtm -142.55 163.25 33.35 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.228 -0.92 . . . . 1.0 109.895 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 42.3 p -72.56 161.23 31.05 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.454 -0.778 . . . . 1.0 109.648 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -61.22 -40.06 92.58 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.274 -0.891 . . . . 1.0 110.045 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.3 m -61.1 -42.52 98.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.997 -1.065 . . . . 1.0 110.545 -179.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.0 -40.03 87.25 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.077 -1.014 . . . . 1.0 110.297 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 79.7 t -68.12 -43.35 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.122 -0.986 . . . . 1.0 110.555 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.04 -49.31 78.18 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.044 -1.035 . . . . 1.0 110.676 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -61.87 -33.81 74.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.946 -1.097 . . . . 1.0 110.176 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.02 -49.74 76.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.833 -1.167 . . . . 1.0 110.31 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.448 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 49.7 m-85 -67.2 -39.94 86.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.915 -1.116 . . . . 1.0 110.449 -179.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -60.02 -40.54 89.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.873 -1.142 . . . . 1.0 109.793 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -60.09 -40.73 90.61 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.918 -1.114 . . . . 1.0 108.763 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.94 -46.99 87.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.49 -0.756 . . . . 1.0 110.254 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -66.57 -39.04 88.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.032 -1.043 . . . . 1.0 109.98 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -60.03 -46.62 88.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.08 -1.012 . . . . 1.0 109.882 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 67.8 t -60.01 -41.46 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.148 -0.97 . . . . 1.0 110.36 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -79.39 -36.8 38.62 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.875 -1.14 . . . . 1.0 110.587 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.1 p -70.0 -18.86 63.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.024 -1.047 . . . . 1.0 109.995 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.04 -39.96 87.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.166 -0.959 . . . . 1.0 110.549 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.4 m -117.96 33.84 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.276 -0.89 . . . . 1.0 110.756 -178.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.7 p -151.4 134.48 8.91 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 120.769 -1.207 . . . . 1.0 109.604 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -73.5 13.14 0.75 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 CA-C-N 119.677 0.92 . . . . 1.0 112.004 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 79.9 mt -68.36 139.78 55.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.061 -1.024 . . . . 1.0 109.865 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -110.5 120.98 44.18 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.83 -0.804 . . . . 1.0 108.83 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -106.28 125.27 50.79 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.334 -0.854 . . . . 1.0 109.509 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.1 m -119.92 129.97 54.59 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.648 -0.658 . . . . 1.0 109.929 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -83.29 130.25 35.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.366 -0.834 . . . . 1.0 109.149 179.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 98.4 mt -101.33 123.21 45.06 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.246 -0.909 . . . . 1.0 109.199 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.439 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 48.8 m170 -60.85 -40.0 91.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.313 -0.867 . . . . 1.0 109.792 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 83.0 m-20 -146.67 169.99 17.89 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.21 -0.931 . . . . 1.0 109.827 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.04 179.1 35.93 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.451 -1.46 . . . . 1.0 109.451 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.5 mt -95.8 134.6 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.234 -1.156 . . . . 1.0 109.377 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.52 159.79 17.21 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.429 -0.794 . . . . 1.0 109.337 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.02 -49.11 78.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.156 -0.965 . . . . 1.0 109.436 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.6 mt -104.84 99.18 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.387 -0.821 . . . . 1.0 109.939 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.1 ptp -100.16 132.83 45.3 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.141 -0.975 . . . . 1.0 109.047 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.448 HG21 ' CZ ' ' A' ' 35' ' ' PHE . 85.5 mt -110.03 130.48 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.588 -0.695 . . . . 1.0 109.534 -179.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.3 p -151.2 158.53 44.06 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.128 -0.983 . . . . 1.0 110.245 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -102.84 127.64 49.94 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.212 -1.033 . . . . 1.0 108.212 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -117.73 -166.83 14.04 Favored Glycine 0 N--CA 1.499 2.863 0 N-CA-C 110.018 -1.233 . . . . 1.0 110.018 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.586 HG22 ' N ' ' A' ' 67' ' ' LYS . 83.0 mt -134.3 167.14 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.669 -0.901 . . . . 1.0 108.702 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.586 ' N ' HG22 ' A' ' 66' ' ' ILE . 61.7 tttm -35.52 -77.48 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.806 -0.559 . . . . 1.0 111.188 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.425 ' HG2' ' H ' ' A' ' 68' ' ' GLU . 12.3 pt-20 -70.02 73.52 0.45 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.969 -1.082 . . . . 1.0 110.283 -178.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.512 ' ND1' ' O ' ' A' ' 66' ' ' ILE . 51.8 m80 -59.97 -40.0 87.57 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.201 -0.937 . . . . 1.0 108.997 178.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 139.93 20.01 0.39 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 108.352 -1.899 . . . . 1.0 108.352 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -140.81 168.47 19.71 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.646 -0.914 . . . . 1.0 108.835 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.428 ' O ' ' C ' ' A' ' 73' ' ' TYR . 91.9 m-85 -60.02 -50.23 74.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.049 -1.032 . . . . 1.0 110.56 -179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.428 ' C ' ' O ' ' A' ' 72' ' ' PHE . 76.0 m-85 -35.31 95.73 0.09 OUTLIER Pre-proline 0 N--CA 1.507 2.394 0 O-C-N 121.934 -0.479 . . . . 1.0 110.814 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -92.16 145.57 2.88 Favored 'Trans proline' 0 N--CA 1.488 1.178 0 C-N-CA 120.99 1.127 . . . . 1.0 112.706 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.475 ' CE2' ' OD1' ' A' ' 99' ' ' ASP . 37.4 m-85 -88.75 169.36 11.71 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.94 -1.133 . . . . 1.0 107.94 178.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 79' ' ' SER . 24.2 p-10 -103.27 13.34 34.08 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.054 -1.029 . . . . 1.0 110.569 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 108.89 -151.54 17.09 Favored Glycine 0 N--CA 1.503 3.103 0 N-CA-C 109.223 -1.551 . . . . 1.0 109.223 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.404 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 13.6 Cg_exo -58.58 -64.13 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.552 0 CA-C-N 118.892 1.346 . . . . 1.0 112.737 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.447 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 79.2 p -75.04 159.83 31.25 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.976 -1.078 . . . . 1.0 109.828 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.97 -129.8 8.83 Favored Glycine 0 N--CA 1.502 3.068 0 N-CA-C 109.992 -1.243 . . . . 1.0 109.992 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.441 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 23.0 mt -66.17 104.38 1.16 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.358 -1.084 . . . . 1.0 108.889 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 33.8 mt -80.04 -15.73 56.57 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.991 -1.068 . . . . 1.0 108.727 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 97' ' ' HIS . . . 179.61 170.8 1.05 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.07 -0.715 . . . . 1.0 109.07 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -160.03 153.46 22.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.184 -0.947 . . . . 1.0 109.423 178.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -142.2 158.58 43.58 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.409 -0.807 . . . . 1.0 109.297 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -96.18 153.32 39.1 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 108.287 -1.005 . . . . 1.0 108.287 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.454 ' O ' ' N ' ' A' ' 89' ' ' GLY . 2.9 Cg_exo -49.38 170.02 0.1 OUTLIER 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 120.529 0.819 . . . . 1.0 111.549 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -64.98 58.92 0.29 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.021 1.147 . . . . 1.0 112.08 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -66.75 -172.4 5.06 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.269 -1.532 . . . . 1.0 109.269 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -72.82 -92.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.169 1.246 . . . . 1.0 112.938 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -85.05 -53.61 5.17 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.991 -1.068 . . . . 1.0 111.362 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -68.96 -40.01 79.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.091 -1.006 . . . . 1.0 110.154 -178.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -55.72 169.31 2.43 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.019 -1.232 . . . . 1.0 110.019 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.43 5.76 78.55 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.656 -1.378 . . . . 1.0 109.656 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.7 p-10 -79.03 162.64 25.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.047 -1.267 . . . . 1.0 109.542 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.24 124.43 11.49 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.229 -0.919 . . . . 1.0 109.468 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.415 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 8.9 m170 -111.84 146.35 37.83 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.486 0.66 . . . . 1.0 109.963 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -126.64 148.98 49.76 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.343 -0.984 . . . . 1.0 108.343 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.475 ' OD1' ' CE2' ' A' ' 75' ' ' PHE . 87.8 m-20 -78.57 123.52 27.18 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.862 -1.149 . . . . 1.0 109.367 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -83.08 -9.38 59.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.893 . . . . 1.0 109.257 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -83.08 -13.5 55.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.335 -0.853 . . . . 1.0 108.897 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.404 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 99.1 mt-10 -89.09 166.19 14.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.508 -0.745 . . . . 1.0 109.168 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.7 m -99.12 105.82 17.95 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.225 -0.922 . . . . 1.0 109.342 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -88.04 124.11 33.42 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.557 -0.905 . . . . 1.0 108.557 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.643 HG21 ' HB2' ' A' ' 109' ' ' LYS . 9.0 t -140.2 160.03 40.87 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.232 -0.917 . . . . 1.0 110.115 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 32.2 t -96.63 -10.02 28.0 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.415 -0.958 . . . . 1.0 108.415 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.3 t -91.06 -176.34 4.58 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.681 -0.859 . . . . 1.0 108.681 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.4 t -85.59 77.81 9.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.995 -1.066 . . . . 1.0 109.373 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.643 ' HB2' HG21 ' A' ' 105' ' ' THR . 66.5 mttm -148.44 149.93 32.59 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.372 -0.973 . . . . 1.0 108.372 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.13 -139.71 5.08 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.764 -1.335 . . . . 1.0 109.764 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -101.01 115.58 30.83 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.451 -1.029 . . . . 1.0 108.923 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.444 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 17.4 t-20 -62.69 134.52 56.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.115 -0.99 . . . . 1.0 109.945 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.7 tp -60.03 -46.19 90.34 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.513 -0.742 . . . . 1.0 110.867 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -59.51 -40.04 85.78 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.261 -0.899 . . . . 1.0 110.743 -178.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -58.41 -51.09 71.31 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.686 -1.259 . . . . 1.0 109.337 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 64.6 t -70.04 -40.77 78.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.097 -1.002 . . . . 1.0 110.235 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.93 -49.42 76.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.172 -0.955 . . . . 1.0 109.738 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.97 -39.68 86.5 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.197 -0.939 . . . . 1.0 110.366 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -63.52 -49.85 71.9 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.14 -0.975 . . . . 1.0 111.416 -178.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -60.03 -38.81 83.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.602 -1.311 . . . . 1.0 110.276 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -60.06 -39.95 87.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.698 -1.251 . . . . 1.0 108.493 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.23 -40.27 91.44 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.571 -1.411 . . . . 1.0 109.571 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -66.53 -39.99 88.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.037 -1.272 . . . . 1.0 109.132 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 84.3 p -66.38 -24.44 66.49 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.278 -0.889 . . . . 1.0 109.566 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 92.9 mt -81.78 -1.69 48.15 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.152 -0.967 . . . . 1.0 109.607 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 89.69 9.64 66.14 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 110.645 -0.982 . . . . 1.0 110.645 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 82.6 mt -84.82 147.13 26.98 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.924 -1.339 . . . . 1.0 109.302 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 41.3 t0 -102.2 172.9 6.63 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.462 -0.774 . . . . 1.0 109.49 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.527 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 61.3 m80 -59.05 136.93 58.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.878 . . . . 1.0 109.612 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 47.3 t -98.57 157.01 16.51 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.369 -0.832 . . . . 1.0 109.293 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -99.71 0.01 40.97 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.383 -0.823 . . . . 1.0 109.582 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 9.6 t70 -85.46 129.45 55.2 Favored Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 108.225 -1.028 . . . . 1.0 108.225 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -68.47 -21.07 40.9 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 CA-C-N 120.126 1.081 . . . . 1.0 112.004 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.459 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -87.5 -4.61 80.0 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.443 -1.463 . . . . 1.0 109.443 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.09 145.71 26.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.241 -1.152 . . . . 1.0 109.496 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.454 ' C ' ' H ' ' A' ' 138' ' ' PHE . 84.5 mt -69.95 -34.9 74.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.249 -0.907 . . . . 1.0 109.493 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 96.8 mmm -70.98 18.84 0.06 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.341 -0.85 . . . . 1.0 110.533 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.454 ' H ' ' C ' ' A' ' 136' ' ' LEU . 11.9 t80 -68.73 133.29 90.53 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.902 -1.124 . . . . 1.0 108.096 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -63.43 -13.15 34.43 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 120.782 0.988 . . . . 1.0 113.843 -178.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.7 mt -108.36 139.96 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.036 -1.04 . . . . 1.0 109.884 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.444 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 56.0 t80 -73.63 129.37 37.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.511 -0.743 . . . . 1.0 110.127 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.6 t -138.49 140.12 39.06 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.589 -0.893 . . . . 1.0 108.589 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -79.88 130.0 34.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.036 -1.04 . . . . 1.0 109.537 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 20.6 m -115.81 125.51 52.81 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.705 -0.622 . . . . 1.0 109.639 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.9 100.06 0.22 Allowed Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.068 -2.013 . . . . 1.0 108.068 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -70.14 138.24 51.73 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.292 -1.122 . . . . 1.0 109.955 -178.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.1 m 176.26 -81.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.51 -0.922 . . . . 1.0 108.51 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -112.93 19.87 16.91 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -61.16 137.48 58.23 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 1.0 110.492 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 96.6 mmm -137.53 146.99 44.81 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.336 -0.986 . . . . 1.0 108.336 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.9 mt -47.84 111.38 1.7 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.183 -0.948 . . . . 1.0 109.377 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -54.9 178.24 0.09 OUTLIER 'Trans proline' 0 N--CA 1.494 1.516 0 CA-C-N 120.051 1.054 . . . . 1.0 112.379 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -60.39 -39.96 89.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.4 -0.813 . . . . 1.0 110.065 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -57.27 -47.87 80.34 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.142 -0.974 . . . . 1.0 109.597 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.04 -39.98 75.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.237 -0.914 . . . . 1.0 110.231 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 55.9 t -63.41 -46.95 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.989 -1.07 . . . . 1.0 109.261 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -60.01 -40.04 87.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.16 -0.962 . . . . 1.0 110.208 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -68.8 -56.63 9.05 Favored Glycine 0 N--CA 1.493 2.463 0 O-C-N 121.142 -0.974 . . . . 1.0 111.131 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.49 HG23 ' N ' ' A' ' 160' ' ' GLN . 5.4 tp -61.27 -40.02 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.941 -1.329 . . . . 1.0 109.711 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 164' ' ' GLY . 93.1 mm-40 -64.99 -39.94 94.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 1.0 109.613 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 87.5 p -65.25 -26.76 68.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.185 -0.947 . . . . 1.0 110.051 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.402 ' CD2' ' N ' ' A' ' 7' ' ' THR . 89.5 mt -88.38 -50.59 6.23 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.993 -1.067 . . . . 1.0 110.263 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -94.47 -9.53 35.2 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.027 -1.046 . . . . 1.0 110.422 -179.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.496 2.678 0 N-CA-C 109.509 -1.437 . . . . 1.0 109.509 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' WAY . . . . . 0.767 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.3 m . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.481 -0.562 . . . . 1.0 109.481 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.6 mt -70.15 139.41 52.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 1.0 109.212 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -160.77 159.99 30.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.342 -0.849 . . . . 1.0 109.476 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -71.29 148.77 46.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.007 -1.058 . . . . 1.0 109.278 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.9 t -81.93 0.87 37.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.905 . . . . 1.0 109.766 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -149.97 155.68 40.39 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.017 -1.052 . . . . 1.0 110.054 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.544 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.93 0.01 57.62 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.405 -0.809 . . . . 1.0 109.731 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -95.89 126.95 41.49 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.234 -0.916 . . . . 1.0 108.696 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.8 mt -140.48 151.35 44.76 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.276 -0.89 . . . . 1.0 109.377 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.9 p -130.42 152.1 50.19 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.825 -0.806 . . . . 1.0 108.825 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -145.4 160.04 42.15 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.116 -0.99 . . . . 1.0 109.911 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.716 HH12 ' H ' ' A' ' 58' ' ' ALA . 13.9 ttp-105 -143.4 137.6 28.78 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.294 -0.879 . . . . 1.0 109.793 -179.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 92.0 mt -88.53 119.08 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.219 -0.925 . . . . 1.0 108.837 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.0 t -69.92 -39.98 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 1.0 109.722 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.703 HD21 ' H ' ' A' ' 64' ' ' PHE . 9.7 p30 -163.0 150.99 13.67 Favored 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 117.243 -1.783 . . . . 1.0 111.744 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.427 ' HB2' ' CD2' ' A' ' 28' ' ' HIS . 43.2 m-85 -99.79 105.13 16.88 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 104.313 -2.477 . . . . 1.0 104.313 176.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.1 t -58.32 145.74 73.79 Favored Pre-proline 0 C--N 1.294 -1.807 0 O-C-N 121.027 -1.046 . . . . 1.0 110.419 -176.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -60.86 -11.65 18.82 Favored 'Trans proline' 0 N--CA 1.488 1.16 0 C-N-CA 120.961 1.108 . . . . 1.0 111.57 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -56.7 -32.43 65.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.326 -0.859 . . . . 1.0 110.002 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.6 mtm -140.13 160.52 39.75 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.185 -0.947 . . . . 1.0 109.415 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 66.3 p -73.59 162.34 29.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.255 -0.903 . . . . 1.0 109.781 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.427 ' CD2' ' HB2' ' A' ' 22' ' ' TYR . 30.3 m170 -60.87 -41.75 96.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.213 -0.929 . . . . 1.0 109.98 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.6 m -60.44 -41.88 94.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.083 -1.011 . . . . 1.0 110.183 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.59 -40.03 80.64 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.187 -0.946 . . . . 1.0 110.277 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 69.3 t -68.73 -43.67 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.117 -0.989 . . . . 1.0 110.205 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -59.93 -48.6 81.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.127 -0.983 . . . . 1.0 110.754 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.445 ' HA ' ' HZ2' ' A' ' 36' ' ' LYS . 16.7 ptpt -62.01 -33.45 74.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.765 -1.209 . . . . 1.0 110.118 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.99 -50.84 72.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.919 -1.113 . . . . 1.0 110.215 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.43 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 57.5 m-85 -69.15 -39.78 78.61 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.85 -1.156 . . . . 1.0 110.609 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.445 ' HZ2' ' HA ' ' A' ' 33' ' ' LYS . 9.6 mtmp? -59.93 -41.85 92.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.913 -1.117 . . . . 1.0 109.715 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -60.6 -40.04 90.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.79 -1.194 . . . . 1.0 108.725 178.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.99 -44.06 94.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -0.871 . . . . 1.0 110.059 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -65.58 -40.15 92.43 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.867 -1.146 . . . . 1.0 109.106 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.4 ' O ' ' CG ' ' A' ' 44' ' ' ASP . 48.1 tptt -60.12 -49.65 76.8 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.496 -0.752 . . . . 1.0 110.718 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.8 t -60.18 -43.03 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 120.799 -1.188 . . . . 1.0 110.487 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -76.98 -36.83 56.15 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.801 -1.187 . . . . 1.0 109.996 -178.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.1 p -71.0 -20.73 62.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.058 -1.026 . . . . 1.0 109.882 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.4 ' CG ' ' O ' ' A' ' 40' ' ' LYS . 81.7 m-20 -59.95 -40.12 87.93 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.354 -0.841 . . . . 1.0 110.6 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.446 ' O ' ' NE2' ' A' ' 160' ' ' GLN . 12.5 m -110.04 24.13 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 121.187 -0.945 . . . . 1.0 110.73 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.4 p -150.15 134.09 9.02 Favored Pre-proline 0 N--CA 1.501 2.094 0 O-C-N 120.973 -1.079 . . . . 1.0 109.588 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -74.49 21.91 0.4 Allowed 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 120.794 0.996 . . . . 1.0 112.166 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 79.6 mt -69.74 138.71 53.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.132 -0.98 . . . . 1.0 109.954 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -106.86 120.78 42.95 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -109.9 125.59 52.98 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.44 -0.787 . . . . 1.0 109.547 -179.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 93.8 m -120.05 130.1 54.54 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.641 -0.662 . . . . 1.0 109.735 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.41 ' NH1' ' HG3' ' A' ' 52' ' ' ARG . 39.0 ttm-85 -81.32 130.27 34.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.368 -0.832 . . . . 1.0 109.226 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.1 mt -102.38 126.92 49.55 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.189 -0.944 . . . . 1.0 109.37 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.447 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 43.6 m170 -62.86 -40.12 96.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.368 -0.833 . . . . 1.0 109.666 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 78.7 m-20 -148.52 173.32 13.26 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.354 -0.841 . . . . 1.0 109.799 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.519 ' O ' ' NH1' ' A' ' 18' ' ' ARG . . . 95.85 178.51 36.36 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.411 -1.476 . . . . 1.0 109.411 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.5 mt -95.5 133.79 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.114 -1.227 . . . . 1.0 109.245 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.716 ' H ' HH12 ' A' ' 18' ' ' ARG . . . -110.15 159.04 17.7 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.401 -0.812 . . . . 1.0 109.232 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.06 -49.41 77.75 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.227 -0.921 . . . . 1.0 109.249 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 93.9 mt -106.4 102.13 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.428 -0.795 . . . . 1.0 109.83 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.8 ptp -101.87 134.27 45.32 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.213 -0.93 . . . . 1.0 109.102 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.43 HG21 ' CZ ' ' A' ' 35' ' ' PHE . 84.5 mt -109.94 130.53 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 109.091 -0.707 . . . . 1.0 109.091 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.6 p -151.15 157.03 42.19 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.929 -1.107 . . . . 1.0 110.577 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.703 ' H ' HD21 ' A' ' 21' ' ' ASN . 90.8 m-85 -105.68 120.08 40.78 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.769 -1.197 . . . . 1.0 107.769 178.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -111.68 -171.06 18.88 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 110.739 -0.944 . . . . 1.0 110.739 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.566 ' O ' ' C ' ' A' ' 67' ' ' LYS . 96.6 mt -136.33 163.9 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 107.892 -1.151 . . . . 1.0 107.892 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.566 ' C ' ' O ' ' A' ' 66' ' ' ILE . 28.0 tptp -0.29 -91.95 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.874 0 CA-C-O 120.983 0.421 . . . . 1.0 111.757 -179.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -79.01 136.65 37.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.947 -1.096 . . . . 1.0 109.018 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.554 ' CE1' ' OD2' ' A' ' 71' ' ' ASP . 44.3 p-80 -138.48 29.56 2.41 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.995 -1.065 . . . . 1.0 110.543 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.77 22.51 18.07 Favored Glycine 0 N--CA 1.501 2.998 0 O-C-N 121.066 -1.021 . . . . 1.0 111.327 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.554 ' OD2' ' CE1' ' A' ' 69' ' ' HIS . 29.7 p-10 -149.44 173.96 13.0 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.695 -1.473 . . . . 1.0 110.13 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.612 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 2.1 p90 -98.18 29.69 3.43 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.458 -0.776 . . . . 1.0 109.657 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.612 ' CE2' ' CE2' ' A' ' 72' ' ' PHE . 52.0 m-85 -130.02 75.71 79.07 Favored Pre-proline 0 N--CA 1.499 2.018 0 N-CA-C 108.552 -0.907 . . . . 1.0 108.552 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -70.35 168.32 22.68 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 120.788 0.992 . . . . 1.0 112.485 -179.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.552 ' CE2' ' OD1' ' A' ' 99' ' ' ASP . 88.7 m-85 -90.85 172.7 8.43 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.239 -1.023 . . . . 1.0 108.239 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.0 p-10 -100.72 9.71 42.08 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.218 -0.926 . . . . 1.0 111.119 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 118.01 -149.68 18.4 Favored Glycine 0 N--CA 1.506 3.304 0 N-CA-C 109.012 -1.635 . . . . 1.0 109.012 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.439 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 9.6 Cg_exo -60.11 -65.72 0.07 OUTLIER 'Trans proline' 0 N--CA 1.492 1.395 0 CA-C-N 119.157 1.479 . . . . 1.0 112.392 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 90.0 p -76.54 164.74 25.66 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.966 -1.084 . . . . 1.0 110.079 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.38 -130.87 9.67 Favored Glycine 0 N--CA 1.502 3.057 0 N-CA-C 109.998 -1.241 . . . . 1.0 109.998 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.435 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 5.0 mt -68.62 105.43 2.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.509 -0.995 . . . . 1.0 108.624 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 82.1 mt -75.87 -32.6 59.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.091 -1.006 . . . . 1.0 109.535 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -176.44 161.95 2.27 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.929 -0.767 . . . . 1.0 108.929 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -160.24 162.41 33.71 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.154 -0.966 . . . . 1.0 110.084 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 95' ' ' ASP . . . -139.65 157.97 44.9 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.168 -1.049 . . . . 1.0 108.168 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -90.92 152.23 44.22 Favored Pre-proline 0 N--CA 1.497 1.918 0 N-CA-C 108.186 -1.042 . . . . 1.0 108.186 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -54.97 167.95 1.4 Allowed 'Trans proline' 0 N--CA 1.492 1.401 0 CA-C-N 119.437 0.835 . . . . 1.0 111.44 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -49.7 123.76 11.13 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 120.558 0.839 . . . . 1.0 111.84 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 90' ' ' PRO . . . -159.19 -170.93 24.35 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.311 -1.516 . . . . 1.0 109.311 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 89' ' ' GLY . 8.1 Cg_exo -55.49 -148.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.001 1.134 . . . . 1.0 112.693 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -59.56 -39.96 85.75 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.586 -0.696 . . . . 1.0 109.697 -179.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -66.48 -40.01 89.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.073 -1.017 . . . . 1.0 109.732 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.29 168.94 37.27 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.851 -1.3 . . . . 1.0 109.851 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 66.43 8.54 45.91 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.158 -1.177 . . . . 1.0 110.158 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.437 ' O ' ' HB1' ' A' ' 85' ' ' ALA . 42.5 p-10 -81.4 169.03 17.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.998 -1.295 . . . . 1.0 109.78 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.31 116.4 6.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.088 -1.008 . . . . 1.0 109.13 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -105.54 130.52 53.58 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.515 -0.74 . . . . 1.0 109.824 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -112.59 142.6 44.98 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.522 -0.918 . . . . 1.0 108.522 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.552 ' OD1' ' CE2' ' A' ' 75' ' ' PHE . 94.1 m-20 -79.32 124.6 28.55 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.082 -1.011 . . . . 1.0 109.938 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 44.7 t0 -84.08 2.34 39.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.362 -0.836 . . . . 1.0 109.189 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -81.31 -16.06 53.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.345 -0.847 . . . . 1.0 109.952 -179.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.549 ' OE1' ' N ' ' A' ' 102' ' ' GLU . 58.1 mp0 -93.43 170.14 9.83 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.174 -0.954 . . . . 1.0 109.49 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 47.7 m -98.96 105.42 17.56 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.462 -0.94 . . . . 1.0 108.462 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -84.29 127.93 34.27 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.319 -0.863 . . . . 1.0 108.941 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.679 HG21 ' HB2' ' A' ' 109' ' ' LYS . 9.2 t -139.95 159.93 41.05 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.391 -0.818 . . . . 1.0 110.066 -179.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.1 t -93.64 -10.46 34.46 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.923 -1.14 . . . . 1.0 107.923 178.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 81.7 p -92.13 179.08 5.68 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.577 -0.897 . . . . 1.0 108.577 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.3 t -85.34 75.95 10.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.94 -1.1 . . . . 1.0 109.564 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.679 ' HB2' HG21 ' A' ' 105' ' ' THR . 4.0 mmmm -140.02 144.86 37.13 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 107.987 -1.116 . . . . 1.0 107.987 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 49.89 -129.97 27.15 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.119 -1.592 . . . . 1.0 109.119 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -104.97 115.44 30.28 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.318 -1.107 . . . . 1.0 109.309 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.736 HD21 ' NZ ' ' A' ' 146' ' ' LYS . 62.2 t-20 -65.3 131.77 47.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.905 . . . . 1.0 109.581 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.1 tp -59.96 -45.09 93.8 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.445 -0.784 . . . . 1.0 111.215 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -59.93 -40.02 87.46 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.046 -1.033 . . . . 1.0 110.69 -178.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -59.34 -52.68 64.59 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.849 -1.157 . . . . 1.0 109.835 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.4 t -69.93 -40.06 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.924 -1.11 . . . . 1.0 109.409 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.74 -52.3 65.52 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.138 -0.976 . . . . 1.0 108.839 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.78 -32.59 67.67 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 120.64 -1.288 . . . . 1.0 109.686 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -66.48 -55.82 13.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.031 -1.043 . . . . 1.0 111.666 -178.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.29 -31.88 70.67 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.487 -1.383 . . . . 1.0 110.131 -179.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -59.8 -41.52 91.41 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.752 -1.218 . . . . 1.0 108.396 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.0 -43.46 98.15 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.364 -1.494 . . . . 1.0 109.364 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -64.5 -39.86 94.57 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.047 -1.267 . . . . 1.0 109.248 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.0 p -67.82 -25.85 65.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.354 -0.841 . . . . 1.0 109.525 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 75.2 mt -81.57 -3.1 52.37 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.234 -0.916 . . . . 1.0 109.94 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.67 9.3 58.83 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 110.534 -1.027 . . . . 1.0 110.534 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.1 mt -85.88 144.59 27.59 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.917 -1.343 . . . . 1.0 109.559 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 28.6 t0 -101.63 173.41 6.44 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.97 -0.752 . . . . 1.0 108.97 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.509 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 75.7 m80 -60.01 134.61 57.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.203 -0.936 . . . . 1.0 109.236 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 47.6 t -96.77 160.24 14.48 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.023 -1.048 . . . . 1.0 109.376 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -99.67 2.17 44.15 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.353 -0.842 . . . . 1.0 109.655 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 9.6 t70 -85.18 129.48 55.67 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.901 . . . . 1.0 108.713 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -68.13 -25.48 37.38 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 CA-C-N 119.984 1.03 . . . . 1.0 112.389 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.437 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -84.9 -3.82 87.62 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.837 -1.305 . . . . 1.0 109.837 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.03 144.84 27.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.35 -1.088 . . . . 1.0 109.663 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 93.8 mt -70.03 -30.68 68.02 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.316 -0.865 . . . . 1.0 109.187 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 98.1 mmm -72.67 15.47 0.19 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.385 -0.822 . . . . 1.0 110.603 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -72.13 137.59 81.77 Favored Pre-proline 0 N--CA 1.5 2.061 0 O-C-N 121.02 -1.05 . . . . 1.0 108.421 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -61.8 -11.92 23.07 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 120.862 1.041 . . . . 1.0 114.29 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 95.9 mt -109.97 139.08 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.443 0 O-C-N 120.655 -1.278 . . . . 1.0 109.744 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -73.55 129.87 38.88 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.582 -0.699 . . . . 1.0 110.08 -179.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 15.2 t -140.1 143.33 36.2 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.482 -0.762 . . . . 1.0 109.139 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -81.21 149.44 29.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.957 -1.089 . . . . 1.0 109.532 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.9 t -140.23 155.5 46.87 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.906 -0.776 . . . . 1.0 108.906 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.45 111.43 3.57 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.465 -1.454 . . . . 1.0 109.465 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.736 ' NZ ' HD21 ' A' ' 112' ' ' ASN . 49.7 mtmt -76.78 -1.48 28.36 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.297 -1.119 . . . . 1.0 109.391 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.2 m -60.0 -40.13 88.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.372 -0.83 . . . . 1.0 109.762 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -160.36 67.48 0.35 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.238 -0.914 . . . . 1.0 109.336 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' A' ' 149' ' ' PHE . 39.0 t80 -99.16 125.04 44.63 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.333 -0.855 . . . . 1.0 109.36 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 75.2 mtm -120.24 141.3 50.07 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.843 -0.799 . . . . 1.0 108.843 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 49.0 mt -49.17 129.06 16.22 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.041 -1.037 . . . . 1.0 108.654 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -66.08 176.93 3.4 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 CA-C-N 119.944 1.016 . . . . 1.0 112.798 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.28 -39.78 88.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.623 -0.673 . . . . 1.0 109.588 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -58.06 -49.28 77.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.315 -0.866 . . . . 1.0 109.86 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -70.03 -40.01 75.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.014 -1.054 . . . . 1.0 109.774 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.3 t -60.1 -46.35 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.129 -0.982 . . . . 1.0 109.335 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -60.23 -39.99 88.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.904 -1.123 . . . . 1.0 110.131 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -68.63 -55.28 12.1 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.154 -1.022 . . . . 1.0 111.113 -178.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.477 HG23 ' N ' ' A' ' 160' ' ' GLN . 5.7 tp -61.93 -40.39 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.941 -1.329 . . . . 1.0 109.74 -179.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.477 ' N ' HG23 ' A' ' 159' ' ' ILE . 94.2 mm-40 -66.39 -39.93 89.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 1.0 109.648 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 91.9 p -70.17 -22.59 62.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 1.0 110.044 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 86.9 mt -88.1 -50.39 6.42 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.957 -1.089 . . . . 1.0 110.188 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -93.0 -9.78 38.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.96 -1.087 . . . . 1.0 109.697 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.524 0 N-CA-C 109.621 -1.392 . . . . 1.0 109.621 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' WAY . . . . . 0.535 ' CJ ' ' HE3' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.284 -0.636 . . . . 1.0 109.284 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.4 mt -81.92 144.58 30.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.287 -0.883 . . . . 1.0 109.346 179.8 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -160.92 163.03 32.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 1.0 109.242 179.72 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 62.7 m95 -72.42 145.35 47.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -0.923 . . . . 1.0 109.806 -179.435 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 61.1 m -88.84 4.24 48.4 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.33 -0.856 . . . . 1.0 110.235 -179.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.452 ' NZ ' ' O ' ' A' ' 14' ' ' ASN . 21.5 pttp -140.76 150.78 43.82 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.123 -0.986 . . . . 1.0 109.394 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.1 mmt -90.03 0.23 57.23 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.394 -0.816 . . . . 1.0 109.798 -179.043 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.452 ' O ' ' NZ ' ' A' ' 12' ' ' LYS . 33.2 m120 -94.89 128.59 41.78 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.2 -0.938 . . . . 1.0 109.349 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.7 mt -141.43 150.01 41.76 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.156 -0.965 . . . . 1.0 108.974 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.8 p -132.66 155.39 48.85 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.565 -0.71 . . . . 1.0 109.145 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -145.69 162.7 36.96 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.045 -1.034 . . . . 1.0 110.119 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.544 ' NE ' ' O ' ' A' ' 56' ' ' GLY . 36.8 ttm-85 -144.25 131.43 20.66 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.629 -0.669 . . . . 1.0 109.44 -179.378 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.5 mt -88.92 114.55 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.074 -1.016 . . . . 1.0 108.624 178.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.7 -40.55 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 1.0 109.906 -179.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.6 p-10 -165.56 154.46 11.89 Favored 'General case' 0 C--N 1.285 -2.2 0 O-C-N 119.675 -1.89 . . . . 1.0 111.168 -179.154 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -99.95 113.0 25.27 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 105.814 -1.921 . . . . 1.0 105.814 178.081 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 23' ' ' THR . 0.4 OUTLIER -56.45 137.79 75.94 Favored Pre-proline 0 C--N 1.297 -1.707 0 O-C-N 120.957 -1.09 . . . . 1.0 109.201 -177.805 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -56.76 -9.29 3.86 Favored 'Trans proline' 0 N--CA 1.483 0.872 0 CA-C-N 119.503 0.858 . . . . 1.0 110.352 179.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.412 ' H ' ' C ' ' A' ' 23' ' ' THR . 98.0 m-20 -57.1 -32.08 65.93 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 120.13 -0.628 . . . . 1.0 110.086 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.8 mtm -140.94 164.36 30.48 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.117 -0.99 . . . . 1.0 109.441 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 75.6 p -71.96 160.69 32.1 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.373 -0.829 . . . . 1.0 109.131 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 24.1 m170 -60.12 -42.34 94.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.173 -0.954 . . . . 1.0 110.2 -179.105 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.546 ' O ' ' NZ ' ' A' ' 33' ' ' LYS . 73.2 m -60.23 -43.18 96.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.103 -0.998 . . . . 1.0 111.006 -179.163 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.25 -40.89 96.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.083 -1.011 . . . . 1.0 110.802 -178.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 63.2 t -67.18 -40.21 84.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.101 -0.999 . . . . 1.0 109.746 -179.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -60.02 -50.13 74.94 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.261 -0.899 . . . . 1.0 110.929 -179.259 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.546 ' NZ ' ' O ' ' A' ' 29' ' ' SER . 1.7 ptpp? -63.9 -31.03 72.08 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.04 -1.037 . . . . 1.0 110.015 -179.517 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.9 -49.55 77.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.046 -1.034 . . . . 1.0 109.566 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -67.54 -38.97 84.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.118 -0.989 . . . . 1.0 109.797 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.0 -41.91 93.15 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.982 -1.074 . . . . 1.0 109.429 -179.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -60.96 -40.87 95.03 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.911 -1.118 . . . . 1.0 108.693 178.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.55 -47.08 85.43 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.369 -0.832 . . . . 1.0 109.743 179.447 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.428 ' CZ ' ' CZ ' ' A' ' 121' ' ' PHE . 48.7 m-85 -67.68 -39.98 84.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.063 -1.023 . . . . 1.0 109.742 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -59.95 -45.58 92.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.163 -0.96 . . . . 1.0 109.618 -179.085 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.5 t -60.01 -45.53 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.328 -0.858 . . . . 1.0 109.913 -179.42 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 76.8 m95 -76.71 -35.23 57.97 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.075 -1.015 . . . . 1.0 109.995 -179.54 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 62.9 p -71.62 -19.6 62.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.075 -1.016 . . . . 1.0 109.873 -179.771 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -60.0 -39.22 85.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.252 -0.905 . . . . 1.0 110.562 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.9 m -110.5 -22.96 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.249 -0.907 . . . . 1.0 110.62 -178.592 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.418 ' C ' ' H ' ' A' ' 48' ' ' LEU . 56.1 p -95.73 130.4 31.84 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 120.888 -1.132 . . . . 1.0 110.108 -179.623 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -72.32 18.48 0.33 Allowed 'Trans proline' 0 N--CA 1.492 1.4 0 CA-C-N 119.873 0.99 . . . . 1.0 111.463 178.621 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.418 ' H ' ' C ' ' A' ' 46' ' ' THR . 77.4 mt -69.3 138.7 54.04 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.207 -0.933 . . . . 1.0 109.602 -179.47 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -109.26 121.88 46.12 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 179.532 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -107.13 128.93 54.83 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.369 -0.832 . . . . 1.0 109.359 -179.269 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 90.2 m -121.88 130.26 53.22 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.524 -0.735 . . . . 1.0 109.961 -179.526 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -80.14 130.05 34.95 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.236 -0.915 . . . . 1.0 109.163 179.656 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.499 ' O ' ' NH1' ' A' ' 18' ' ' ARG . 94.3 mt -102.53 132.42 48.6 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.165 -0.959 . . . . 1.0 109.415 179.331 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.491 ' C ' HH12 ' A' ' 18' ' ' ARG . 23.9 m-70 -68.83 -39.91 79.74 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.662 -0.649 . . . . 1.0 110.206 -179.702 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.484 ' C ' ' NH2' ' A' ' 18' ' ' ARG . 74.1 m-20 -150.09 166.75 28.84 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.115 -0.99 . . . . 1.0 109.992 -179.565 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.544 ' O ' ' NE ' ' A' ' 18' ' ' ARG . . . 99.95 -176.42 28.27 Favored Glycine 0 N--CA 1.498 2.825 0 N-CA-C 109.53 -1.428 . . . . 1.0 109.53 -179.696 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.4 mt -95.5 135.25 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.192 -1.181 . . . . 1.0 109.261 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.04 158.94 18.25 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.436 -0.79 . . . . 1.0 109.284 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -59.99 -49.57 77.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.2 -0.937 . . . . 1.0 109.51 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 92.5 mt -108.35 98.47 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.434 -0.791 . . . . 1.0 109.698 179.634 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.5 ptm -97.96 126.07 43.19 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.487 -0.931 . . . . 1.0 108.487 179.134 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.8 mt -104.84 136.84 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.455 -0.778 . . . . 1.0 110.58 -178.509 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.1 p -153.68 160.03 42.22 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.398 -0.814 . . . . 1.0 109.548 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -102.13 122.28 43.84 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.605 -0.887 . . . . 1.0 108.605 179.486 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 98' ' ' PHE . . . -99.76 -172.76 30.51 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 110.822 -0.911 . . . . 1.0 110.822 -178.677 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.564 HG22 ' N ' ' A' ' 67' ' ' LYS . 73.4 mt -135.7 167.86 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.784 -0.833 . . . . 1.0 109.043 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.564 ' N ' HG22 ' A' ' 66' ' ' ILE . 19.8 tptm -23.88 -77.98 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 CA-C-O 121.128 0.49 . . . . 1.0 111.84 -179.374 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -70.25 149.29 47.6 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.086 -1.009 . . . . 1.0 110.443 -179.235 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.458 ' C ' ' H ' ' A' ' 71' ' ' ASP . 1.5 m80 -138.62 153.05 48.61 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.56 -0.904 . . . . 1.0 108.56 179.607 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.7 40.76 0.98 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.098 -1.601 . . . . 1.0 109.098 179.364 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' A' ' 69' ' ' HIS . 32.9 p-10 -140.14 -178.95 5.7 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.457 -1.025 . . . . 1.0 109.092 -179.791 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -98.26 22.76 9.15 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.291 -0.881 . . . . 1.0 109.734 -179.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -129.41 78.33 75.91 Favored Pre-proline 0 N--CA 1.502 2.142 0 O-C-N 121.453 -0.78 . . . . 1.0 109.334 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -73.78 167.01 28.3 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.165 1.243 . . . . 1.0 112.441 -179.596 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.533 ' CE2' ' OD1' ' A' ' 99' ' ' ASP . 40.6 m-85 -93.5 171.08 9.12 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.409 -0.807 . . . . 1.0 109.305 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 79' ' ' SER . 34.5 p-10 -101.05 10.65 40.79 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.352 -0.842 . . . . 1.0 110.474 -179.288 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 114.96 -155.61 16.22 Favored Glycine 0 N--CA 1.504 3.188 0 N-CA-C 109.092 -1.603 . . . . 1.0 109.092 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.424 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 15.8 Cg_exo -56.64 -64.12 0.14 Allowed 'Trans proline' 0 N--CA 1.492 1.403 0 CA-C-N 118.827 1.314 . . . . 1.0 112.308 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.43 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 83.9 p -75.0 159.03 32.26 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.896 -1.128 . . . . 1.0 109.384 179.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.03 -129.67 8.22 Favored Glycine 0 N--CA 1.502 3.045 0 N-CA-C 110.218 -1.153 . . . . 1.0 110.218 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.401 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 19.0 mt -70.19 112.72 6.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.351 -1.087 . . . . 1.0 109.406 -179.584 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 38.1 mt -79.22 -24.54 43.02 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.155 -0.966 . . . . 1.0 108.703 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -177.07 170.68 2.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.531 -0.731 . . . . 1.0 109.412 -179.733 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -162.41 163.33 27.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.104 -0.997 . . . . 1.0 109.968 179.676 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -147.2 153.48 39.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.385 -0.822 . . . . 1.0 109.071 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -88.44 152.67 50.07 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.151 -0.968 . . . . 1.0 109.23 -179.607 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -53.5 162.58 3.2 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 CA-C-N 119.214 0.755 . . . . 1.0 111.716 179.583 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -45.09 157.66 0.21 Allowed 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 121.12 1.213 . . . . 1.0 111.942 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -174.57 173.54 46.14 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.728 -1.349 . . . . 1.0 109.728 -179.759 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -49.86 -75.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 120.881 1.054 . . . . 1.0 111.675 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -130.08 -40.81 1.3 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.395 -0.816 . . . . 1.0 109.369 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -63.01 -44.15 96.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.544 -0.722 . . . . 1.0 110.213 -179.377 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -69.51 170.1 43.13 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.467 -1.453 . . . . 1.0 109.467 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 80.08 6.25 89.25 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.05 -1.22 . . . . 1.0 110.05 179.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.2 p-10 -80.52 167.59 19.95 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.074 -1.25 . . . . 1.0 109.409 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.08 120.72 7.49 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.019 -1.051 . . . . 1.0 110.014 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -106.06 154.03 21.22 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.58 -0.7 . . . . 1.0 109.633 179.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' A' ' 65' ' ' GLY . 28.0 m-85 -129.94 152.01 49.87 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.289 -1.004 . . . . 1.0 108.289 179.177 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.533 ' OD1' ' CE2' ' A' ' 75' ' ' PHE . 86.5 m-20 -78.5 120.81 23.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.913 -1.117 . . . . 1.0 109.987 -179.63 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -84.06 -7.85 59.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.311 -0.868 . . . . 1.0 109.056 179.286 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -82.63 -15.93 50.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.3 -0.875 . . . . 1.0 109.178 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.424 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 97.2 mt-10 -89.88 169.92 10.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.502 -0.749 . . . . 1.0 109.07 -179.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 16.9 m -99.23 108.5 21.09 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.26 -0.9 . . . . 1.0 109.286 -179.555 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.491 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 93.7 m95 -91.08 125.14 35.78 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.705 -0.85 . . . . 1.0 108.705 179.505 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.665 HG21 ' HB2' ' A' ' 109' ' ' LYS . 7.3 t -140.16 151.17 45.04 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.376 -0.828 . . . . 1.0 109.885 -179.156 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 55.7 m -90.25 -8.23 51.51 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.074 -1.084 . . . . 1.0 108.074 178.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.1 p -90.65 177.27 6.39 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.625 -0.879 . . . . 1.0 108.625 178.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 m -81.09 76.53 8.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.981 -1.074 . . . . 1.0 109.628 -179.853 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.665 ' HB2' HG21 ' A' ' 105' ' ' THR . 98.5 mttt -147.03 149.67 33.57 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.367 -0.833 . . . . 1.0 108.884 179.585 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.31 -135.88 7.38 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.935 -1.266 . . . . 1.0 109.935 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -100.11 118.22 36.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.413 -1.051 . . . . 1.0 109.143 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -66.58 129.09 38.69 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.365 -0.835 . . . . 1.0 110.294 -179.567 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.6 tp -60.02 -40.66 90.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.357 -0.84 . . . . 1.0 109.875 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -59.96 -47.76 84.47 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.416 -0.802 . . . . 1.0 110.587 -178.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -58.66 -50.63 73.16 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.854 -1.154 . . . . 1.0 109.761 -179.612 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 77.9 t -69.1 -40.11 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.918 -1.114 . . . . 1.0 109.668 -179.22 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.99 -50.26 74.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.098 -1.001 . . . . 1.0 109.976 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.78 -37.84 80.2 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.564 -1.335 . . . . 1.0 109.521 -179.835 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 67.1 t60 -63.8 -49.98 70.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.316 -0.865 . . . . 1.0 111.624 -178.594 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.84 -38.55 78.97 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.512 -1.367 . . . . 1.0 109.723 -178.735 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.428 ' CZ ' ' CZ ' ' A' ' 39' ' ' PHE . 29.9 m-85 -60.02 -39.86 87.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.92 -1.112 . . . . 1.0 108.535 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.55 -46.83 91.6 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.69 -1.364 . . . . 1.0 109.69 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -63.94 -40.08 95.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.13 -1.217 . . . . 1.0 109.449 179.66 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 91.9 p -68.49 -22.73 64.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.277 -0.89 . . . . 1.0 109.571 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 35.7 mt -81.68 -7.03 59.55 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.103 -0.998 . . . . 1.0 109.472 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 99.54 2.74 56.47 Favored Glycine 0 N--CA 1.499 2.887 0 N-CA-C 110.674 -0.971 . . . . 1.0 110.674 178.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 75.2 mt -85.11 147.23 26.74 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.947 -1.325 . . . . 1.0 109.775 179.653 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 35.5 t0 -102.96 -178.73 3.75 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.86 -0.792 . . . . 1.0 108.86 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.499 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 75.9 m80 -60.1 139.99 57.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.088 -1.008 . . . . 1.0 109.764 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 27.2 t -96.21 162.05 13.69 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.242 -0.912 . . . . 1.0 109.244 179.513 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -101.11 1.92 39.77 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.344 -0.848 . . . . 1.0 109.857 -179.692 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -90.52 114.14 60.14 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.212 -0.93 . . . . 1.0 109.206 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -53.77 -22.75 24.29 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 CA-C-N 120.27 1.132 . . . . 1.0 112.216 -179.796 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -86.8 -7.68 77.78 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.49 -1.044 . . . . 1.0 110.49 -179.306 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.44 149.42 26.67 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.985 -1.303 . . . . 1.0 109.576 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 92.9 mt -70.07 -30.97 68.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.142 -0.974 . . . . 1.0 109.473 179.69 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 98.0 mmm -73.42 13.56 0.44 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.368 -0.833 . . . . 1.0 110.396 -178.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -70.37 134.61 86.8 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.964 -1.085 . . . . 1.0 108.114 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -65.35 15.42 0.09 OUTLIER 'Trans proline' 0 N--CA 1.506 2.229 0 C-N-CA 121.065 1.177 . . . . 1.0 115.048 -177.785 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 90.0 mt -133.69 140.49 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 O-C-N 120.73 -1.231 . . . . 1.0 109.609 179.453 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -72.87 130.67 40.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.517 -0.739 . . . . 1.0 110.046 -179.25 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.2 t -143.15 137.63 29.2 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.322 -0.861 . . . . 1.0 109.479 179.777 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -81.41 143.98 31.75 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.081 -1.012 . . . . 1.0 109.18 179.785 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.7 t -139.11 156.53 47.09 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.208 -0.932 . . . . 1.0 110.117 -179.362 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.38 108.87 2.63 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.409 -1.476 . . . . 1.0 109.409 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -77.11 2.8 14.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.325 -1.103 . . . . 1.0 109.44 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 44.2 t -59.97 -45.01 94.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.228 -0.92 . . . . 1.0 110.149 -179.445 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -150.01 29.97 0.72 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.965 -1.084 . . . . 1.0 110.134 -179.536 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -60.44 139.17 57.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.054 -1.029 . . . . 1.0 109.647 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 73.7 mtm -138.55 148.5 44.28 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.353 -0.842 . . . . 1.0 108.762 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.7 mt -53.84 129.68 56.34 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 120.987 -1.071 . . . . 1.0 108.612 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -68.94 175.36 7.52 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 CA-C-N 120.112 1.076 . . . . 1.0 111.715 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.04 -38.78 83.76 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.344 -0.848 . . . . 1.0 109.48 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -55.07 -50.21 69.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.879 . . . . 1.0 110.057 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -70.2 -39.97 74.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.184 -0.947 . . . . 1.0 110.28 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 66.5 t -59.87 -47.02 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.006 -1.059 . . . . 1.0 109.035 -179.467 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -60.53 -40.07 90.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.055 -1.028 . . . . 1.0 110.463 179.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -73.82 -52.42 8.16 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.328 -0.939 . . . . 1.0 111.49 -178.465 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.454 HG23 ' N ' ' A' ' 160' ' ' GLN . 8.4 tp -60.49 -39.93 82.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.637 -1.508 . . . . 1.0 109.705 -178.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.8 mt-30 -66.37 -38.81 88.42 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.198 -0.939 . . . . 1.0 109.58 179.503 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 96.6 p -60.06 -34.94 74.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.394 -0.816 . . . . 1.0 110.686 -179.021 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 93.3 mt -85.17 -47.59 9.97 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.857 -1.152 . . . . 1.0 111.027 -178.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -91.68 -8.46 47.0 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.894 -1.129 . . . . 1.0 110.176 -179.007 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.404 -1.479 . . . . 1.0 109.404 -179.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 169' ' ' WAY . . . . . 0.666 ' HC2' ' HJ ' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.2 m . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.6 mt -94.96 129.1 42.16 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.184 -0.948 . . . . 1.0 108.988 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -160.09 163.24 34.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.255 -0.903 . . . . 1.0 109.628 -179.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -70.9 144.43 50.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -0.907 . . . . 1.0 109.439 -179.828 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.8 t -95.91 14.25 24.12 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.289 -0.882 . . . . 1.0 109.434 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.51 149.62 37.75 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.236 -0.915 . . . . 1.0 109.438 -179.764 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.3 mmt -91.71 -2.95 56.79 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.33 -0.856 . . . . 1.0 109.731 -179.634 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -101.59 125.63 48.27 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.295 -0.878 . . . . 1.0 109.362 179.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.7 mt -140.48 149.35 42.41 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.246 -0.909 . . . . 1.0 109.16 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.1 p -131.77 153.86 49.67 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.875 -0.787 . . . . 1.0 108.875 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -143.11 158.46 43.59 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.145 -0.972 . . . . 1.0 110.385 179.877 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.577 HH12 ' H ' ' A' ' 56' ' ' GLY . 72.1 ttt180 -146.55 134.97 21.94 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.469 -0.769 . . . . 1.0 109.59 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.9 mt -89.89 118.92 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.112 -0.992 . . . . 1.0 108.963 179.008 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.67 -40.58 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.091 -1.006 . . . . 1.0 109.107 -179.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -162.11 162.22 28.5 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.667 -1.27 . . . . 1.0 110.26 -179.184 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -103.25 -162.92 0.95 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.521 -1.288 . . . . 1.0 107.521 178.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.74 152.04 61.54 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.459 -0.775 . . . . 1.0 109.744 -179.708 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -68.1 -35.99 18.33 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 120.923 1.082 . . . . 1.0 111.512 179.271 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -59.01 -48.6 81.01 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.359 0.599 . . . . 1.0 110.756 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 56.2 mtp -96.29 145.99 25.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.373 -0.829 . . . . 1.0 110.47 -178.435 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.1 p -74.93 160.85 30.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.889 . . . . 1.0 108.783 179.361 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -61.23 -46.2 91.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.219 -0.925 . . . . 1.0 110.777 -179.146 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.8 m -62.2 -40.03 94.74 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.024 -1.047 . . . . 1.0 110.89 -178.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.55 -40.08 88.86 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.106 -0.996 . . . . 1.0 110.947 -179.156 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 71.3 t -68.49 -40.53 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.834 -1.166 . . . . 1.0 110.318 -179.173 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.97 -49.8 76.25 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.042 -1.036 . . . . 1.0 110.564 -179.134 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.19 -32.72 72.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.058 -1.026 . . . . 1.0 110.089 -179.502 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.03 -49.94 75.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.114 -0.991 . . . . 1.0 110.045 -179.447 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -66.4 -37.32 84.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.021 -1.05 . . . . 1.0 110.062 -179.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -59.97 -40.56 89.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.974 -1.079 . . . . 1.0 109.533 -179.68 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -61.95 -40.65 96.28 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.949 -1.094 . . . . 1.0 108.88 179.227 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.44 -49.75 76.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.377 -0.827 . . . . 1.0 110.528 -179.285 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.414 ' CZ ' ' CZ ' ' A' ' 121' ' ' PHE . 53.8 m-85 -65.27 -40.53 94.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.985 -1.072 . . . . 1.0 109.962 -179.262 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -59.99 -47.42 85.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.107 -0.995 . . . . 1.0 109.7 -179.579 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 70.8 t -59.99 -40.51 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.339 -0.851 . . . . 1.0 110.426 -179.394 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -79.87 -34.57 39.12 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.911 -1.118 . . . . 1.0 110.202 -179.236 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 94.8 p -72.82 -20.62 61.11 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.966 -1.083 . . . . 1.0 109.916 -179.761 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -59.99 -39.74 86.79 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 1.0 110.342 -179.36 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.4 m -111.81 30.72 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 O-C-N 121.264 -0.897 . . . . 1.0 110.69 -179.474 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.7 p -152.21 137.95 11.4 Favored Pre-proline 0 N--CA 1.502 2.14 0 O-C-N 120.607 -1.308 . . . . 1.0 109.756 179.015 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -74.72 11.83 1.28 Allowed 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 120.746 0.964 . . . . 1.0 112.285 178.686 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 77.9 mt -67.95 137.69 55.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.031 -1.043 . . . . 1.0 109.655 -179.095 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -106.93 120.7 42.74 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.028 -0.73 . . . . 1.0 109.028 179.664 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -108.25 123.33 48.61 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.446 -0.784 . . . . 1.0 109.238 -179.545 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.9 m -120.01 130.03 54.54 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.579 -0.701 . . . . 1.0 109.492 -179.795 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -82.12 132.55 35.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.438 -0.789 . . . . 1.0 109.406 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.3 mt -105.13 128.45 53.38 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.413 -0.804 . . . . 1.0 109.488 179.813 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.417 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 61.7 m170 -68.56 -39.74 80.9 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.481 -0.762 . . . . 1.0 109.347 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 89.4 m-20 -142.84 166.92 23.33 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.294 -0.879 . . . . 1.0 109.328 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.577 ' H ' HH12 ' A' ' 18' ' ' ARG . . . 97.24 172.4 33.91 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.646 -1.381 . . . . 1.0 109.646 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.419 HG21 HD21 ' A' ' 91' ' ' ASN . 93.5 mt -95.09 139.23 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.284 -1.127 . . . . 1.0 109.242 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -114.2 164.3 14.07 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.441 -0.787 . . . . 1.0 109.598 -179.634 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -59.94 -47.85 84.09 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.475 -0.935 . . . . 1.0 108.475 179.413 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.3 mt -105.27 133.84 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.697 -0.853 . . . . 1.0 108.697 179.697 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.2 ptm -139.31 129.79 25.71 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.63 -1.294 . . . . 1.0 109.491 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 93.5 mt -102.5 140.2 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.351 0.596 . . . . 1.0 109.958 -179.067 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 81.6 p -151.46 154.75 37.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.318 -0.864 . . . . 1.0 109.623 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -109.18 144.09 37.73 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.048 -0.723 . . . . 1.0 109.048 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.81 -162.82 9.73 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.457 -1.457 . . . . 1.0 109.457 -179.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.559 HG22 ' N ' ' A' ' 67' ' ' LYS . 92.6 mt -130.01 164.09 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.583 -0.951 . . . . 1.0 109.247 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.559 ' N ' HG22 ' A' ' 66' ' ' ILE . 49.1 tttm -35.6 -77.91 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 122.052 -0.405 . . . . 1.0 111.609 -179.005 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -69.22 119.32 13.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.84 -1.163 . . . . 1.0 110.043 -178.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.537 ' O ' ' N ' ' A' ' 71' ' ' ASP . 33.0 p-80 -159.99 163.51 34.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.326 -0.859 . . . . 1.0 108.957 179.454 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -51.42 86.44 0.01 OUTLIER Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.52 -1.032 . . . . 1.0 110.52 -179.213 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.537 ' N ' ' O ' ' A' ' 69' ' ' HIS . 51.6 t0 -161.51 147.78 14.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.116 -1.226 . . . . 1.0 109.525 179.385 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.469 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 54.4 p90 -81.84 -14.51 56.19 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.117 -0.989 . . . . 1.0 110.309 -179.863 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.549 ' O ' ' CG ' ' A' ' 73' ' ' TYR . 10.5 p90 -130.64 78.67 73.51 Favored Pre-proline 0 N--CA 1.502 2.165 0 O-C-N 121.302 -0.874 . . . . 1.0 109.484 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -56.7 -177.31 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.098 1.199 . . . . 1.0 112.649 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.554 ' CD2' ' OD2' ' A' ' 99' ' ' ASP . 94.6 m-85 -90.6 175.08 7.18 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.365 -0.834 . . . . 1.0 109.471 -179.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -99.56 -1.01 39.33 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.203 -0.935 . . . . 1.0 110.758 -178.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.55 -138.04 9.8 Favored Glycine 0 N--CA 1.503 3.114 0 N-CA-C 108.816 -1.714 . . . . 1.0 108.816 -179.729 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.427 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 18.6 Cg_endo -77.67 -58.42 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.376 0 CA-C-N 119.872 1.836 . . . . 1.0 111.932 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 92.2 p -79.42 167.45 20.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.341 -0.849 . . . . 1.0 109.566 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 105.76 -129.33 9.74 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 109.882 -1.287 . . . . 1.0 109.882 179.715 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.43 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 8.3 mt -67.06 105.91 1.8 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.391 -1.064 . . . . 1.0 108.939 -179.781 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.411 HD11 ' CD1' ' A' ' 111' ' ' TYR . 71.9 mt -80.66 -14.25 58.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.114 -0.992 . . . . 1.0 109.027 -179.672 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.93 177.51 0.66 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.468 ' ND1' ' C ' ' A' ' 84' ' ' HIS . 3.2 p80 -161.89 160.61 28.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.101 -1.0 . . . . 1.0 109.508 179.341 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.31 165.02 34.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.884 . . . . 1.0 109.423 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -108.04 151.96 41.54 Favored Pre-proline 0 N--CA 1.498 1.962 0 N-CA-C 108.494 -0.928 . . . . 1.0 108.494 179.576 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -62.52 165.76 14.85 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 120.643 0.895 . . . . 1.0 111.675 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -50.93 129.21 27.13 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 120.85 1.033 . . . . 1.0 111.371 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 90' ' ' PRO . . . -164.68 -169.95 28.97 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.728 -1.349 . . . . 1.0 109.728 -179.658 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.409 ' O ' ' O ' ' A' ' 89' ' ' GLY . 14.1 Cg_exo -57.99 -150.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 121.009 1.139 . . . . 1.0 111.736 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.419 HD21 HG21 ' A' ' 57' ' ' ILE . 26.1 t-20 -60.13 -41.52 92.83 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.149 -0.969 . . . . 1.0 109.793 -179.597 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -60.85 -39.99 91.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.107 -0.996 . . . . 1.0 109.241 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.44 169.6 49.52 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.231 -1.547 . . . . 1.0 109.231 179.654 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 67.93 69.9 1.27 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.983 -1.247 . . . . 1.0 109.983 179.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 31.6 p-10 -149.41 161.88 41.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.177 -1.19 . . . . 1.0 108.982 179.402 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.95 120.96 8.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.151 -0.968 . . . . 1.0 109.78 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -104.29 139.83 38.73 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.566 -0.709 . . . . 1.0 110.069 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.476 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 25.8 m-85 -119.95 139.93 51.7 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.483 -0.761 . . . . 1.0 108.976 179.081 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.554 ' OD2' ' CD2' ' A' ' 75' ' ' PHE . 99.0 m-20 -79.98 126.19 30.72 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.915 -1.116 . . . . 1.0 109.787 179.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 49.1 t0 -87.75 0.94 55.07 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.306 -0.871 . . . . 1.0 109.844 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -81.34 -16.52 52.13 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.934 -1.104 . . . . 1.0 110.246 -179.428 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.545 ' OE1' ' N ' ' A' ' 102' ' ' GLU . 56.6 mp0 -93.02 174.99 6.95 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.183 -0.948 . . . . 1.0 109.445 -179.769 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 27.6 m -99.43 107.49 19.73 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.341 -0.849 . . . . 1.0 109.051 179.921 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -87.32 123.08 31.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 1.0 108.987 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.671 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.1 t -141.75 159.09 42.93 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.335 -0.853 . . . . 1.0 109.931 -179.192 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 44.3 t -96.03 -9.76 30.17 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.288 -1.005 . . . . 1.0 108.288 178.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 94.6 p -90.64 178.04 6.18 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.007 -0.738 . . . . 1.0 109.007 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.2 t -78.81 74.01 5.35 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.137 -0.977 . . . . 1.0 109.678 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.671 ' HB2' HG21 ' A' ' 105' ' ' THR . 98.4 mttt -146.66 148.69 32.31 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.463 -0.94 . . . . 1.0 108.463 179.093 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 46.28 -139.91 6.57 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.89 -1.284 . . . . 1.0 109.89 179.927 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.411 ' CD1' HD11 ' A' ' 82' ' ' LEU . 93.1 m-85 -100.0 116.35 31.84 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.323 -1.104 . . . . 1.0 109.173 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.43 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 2.2 t-20 -63.54 133.91 54.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.11 -0.994 . . . . 1.0 109.842 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.3 tp -59.98 -44.03 94.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.464 -0.772 . . . . 1.0 110.436 -179.744 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -60.04 -40.02 87.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.108 -0.995 . . . . 1.0 110.357 -178.733 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -59.48 -51.43 69.93 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.711 -1.243 . . . . 1.0 109.543 -179.702 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.6 t -69.95 -42.63 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.961 -1.087 . . . . 1.0 110.087 -179.174 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.43 -52.15 66.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.933 . . . . 1.0 109.764 -179.331 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.69 -38.09 80.58 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.414 -0.804 . . . . 1.0 110.343 -179.613 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -63.41 -50.1 71.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -0.927 . . . . 1.0 111.2 -178.401 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.476 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 8.2 pt-20 -59.97 -39.79 86.86 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.691 -1.256 . . . . 1.0 110.298 -179.233 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.414 ' CZ ' ' CZ ' ' A' ' 39' ' ' PHE . 30.9 m-85 -60.03 -39.96 87.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.78 -1.2 . . . . 1.0 108.95 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.81 -42.35 94.49 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.648 -1.381 . . . . 1.0 109.648 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -66.01 -39.78 90.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.99 -1.3 . . . . 1.0 109.033 179.394 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 80.6 p -64.56 -23.98 67.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.345 -0.847 . . . . 1.0 109.462 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.2 mt -82.56 -1.84 51.87 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.132 -0.98 . . . . 1.0 109.577 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.05 10.21 64.73 Favored Glycine 0 N--CA 1.497 2.728 0 C-N-CA 120.304 -0.951 . . . . 1.0 110.812 179.191 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.5 mt -85.38 146.97 26.74 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.899 -1.354 . . . . 1.0 109.682 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 12.3 t70 -99.69 172.47 7.25 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.479 -0.763 . . . . 1.0 109.22 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.46 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 66.2 m80 -59.99 139.48 57.4 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.182 -0.949 . . . . 1.0 109.66 -179.534 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 34.1 t -98.76 152.97 19.11 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.346 -0.846 . . . . 1.0 109.407 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -96.67 -0.02 49.05 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.208 -0.933 . . . . 1.0 109.683 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -85.24 130.49 51.64 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.057 -1.027 . . . . 1.0 108.237 179.227 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -68.48 -21.37 40.38 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 CA-C-N 120.121 1.079 . . . . 1.0 112.147 -179.457 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -86.1 -4.83 83.86 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.942 -1.263 . . . . 1.0 109.942 -179.704 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -87.33 145.1 26.47 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.127 -1.219 . . . . 1.0 109.534 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.427 ' C ' ' H ' ' A' ' 138' ' ' PHE . 91.6 mt -70.0 -31.06 68.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.087 -1.008 . . . . 1.0 108.975 179.643 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.3 mmm -73.0 19.14 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.441 -0.787 . . . . 1.0 110.201 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.427 ' H ' ' C ' ' A' ' 136' ' ' LEU . 16.0 t80 -70.0 131.7 88.9 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 120.914 -1.116 . . . . 1.0 108.087 179.866 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -63.9 0.48 2.02 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 121.012 1.142 . . . . 1.0 114.536 -177.864 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 95.7 mt -123.19 139.45 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 120.935 -1.103 . . . . 1.0 109.321 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.43 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 58.8 t80 -73.1 125.03 26.72 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.288 -0.882 . . . . 1.0 109.896 -179.396 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.9 t -138.2 140.05 39.58 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.719 -0.845 . . . . 1.0 108.719 179.388 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -81.25 130.5 35.05 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.081 -1.012 . . . . 1.0 109.921 -179.763 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.7 m -118.91 137.07 53.71 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.97 -0.752 . . . . 1.0 108.97 179.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -62.12 103.04 0.53 Allowed Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.121 -1.992 . . . . 1.0 108.121 178.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -72.64 114.62 10.97 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.19 -1.182 . . . . 1.0 108.728 -179.241 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.4 p -178.37 109.18 0.05 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.377 -0.972 . . . . 1.0 108.377 -179.694 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 49.99 39.88 19.87 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.046 -1.034 . . . . 1.0 108.752 -179.249 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -88.39 119.18 28.57 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.363 -0.836 . . . . 1.0 109.398 -179.699 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 97.3 mtp -110.17 148.29 32.08 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.343 -0.984 . . . . 1.0 108.343 179.368 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.7 mt -52.46 136.86 41.84 Favored Pre-proline 0 C--N 1.3 -1.552 0 O-C-N 121.158 -0.964 . . . . 1.0 109.214 -179.514 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -68.78 174.23 8.93 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 CA-C-N 119.569 0.882 . . . . 1.0 112.177 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -60.36 -39.99 89.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.498 -0.752 . . . . 1.0 109.951 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -55.09 -49.35 71.91 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.123 -0.986 . . . . 1.0 109.852 -179.347 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.12 -40.01 75.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.244 -0.91 . . . . 1.0 110.214 -179.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.8 t -59.99 -46.47 94.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.163 -0.961 . . . . 1.0 109.067 -179.661 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -61.58 -40.01 93.25 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.083 -1.01 . . . . 1.0 110.075 179.71 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.39 -53.38 13.45 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 120.312 -0.947 . . . . 1.0 111.468 -178.483 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.494 HG23 ' N ' ' A' ' 160' ' ' GLN . 6.0 tp -60.73 -39.98 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.835 -1.391 . . . . 1.0 109.778 -178.818 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.544 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.3 mt-30 -66.07 -39.98 90.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.115 -0.991 . . . . 1.0 109.51 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 86.2 p -61.24 -30.37 70.41 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.175 -0.953 . . . . 1.0 110.263 -179.642 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 85.5 mt -86.69 -51.8 5.91 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.001 -1.062 . . . . 1.0 110.656 -179.025 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -91.85 -9.23 44.11 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.067 -1.02 . . . . 1.0 110.312 -178.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.511 0 N-CA-C 109.457 -1.457 . . . . 1.0 109.457 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 169' ' ' WAY . . . . . 0.93 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 m . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.415 -0.587 . . . . 1.0 109.415 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.0 mt -86.07 126.38 34.13 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.199 -0.938 . . . . 1.0 109.412 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.9 pttt -162.7 163.35 26.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.284 -0.885 . . . . 1.0 109.301 179.671 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -70.21 149.56 47.36 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.113 -0.992 . . . . 1.0 109.566 -179.51 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 98.3 p -90.03 1.19 56.6 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.29 -0.881 . . . . 1.0 109.757 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -146.92 154.86 41.78 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.074 -1.016 . . . . 1.0 110.039 -179.6 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.549 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.5 0.37 57.35 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.382 -0.824 . . . . 1.0 109.713 -179.81 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -93.93 125.09 38.35 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.152 -0.968 . . . . 1.0 109.203 -179.747 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.5 mt -142.27 150.23 40.6 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.355 -0.841 . . . . 1.0 108.982 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.9 p -130.75 153.12 49.36 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.411 -0.959 . . . . 1.0 108.411 179.643 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -145.11 159.99 42.12 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.059 -1.026 . . . . 1.0 109.902 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.494 ' NH1' ' O ' ' A' ' 56' ' ' GLY . 43.3 ttp180 -144.75 139.18 27.69 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.604 -0.685 . . . . 1.0 109.316 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.8 mm -88.15 118.45 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.266 -1.013 . . . . 1.0 108.266 179.212 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.3 t -69.79 -39.95 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.131 -0.981 . . . . 1.0 108.985 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.678 HD21 ' H ' ' A' ' 64' ' ' PHE . 15.2 p30 -160.71 153.8 21.51 Favored 'General case' 0 C--N 1.287 -2.124 0 O-C-N 120.028 -1.67 . . . . 1.0 110.697 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -97.02 101.28 12.82 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 104.895 -2.261 . . . . 1.0 104.895 177.091 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.559 ' O ' ' N ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -55.33 116.55 11.96 Favored Pre-proline 0 C--N 1.299 -1.598 0 C-N-CA 118.849 -1.141 . . . . 1.0 108.408 -177.588 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -50.23 -1.17 0.04 OUTLIER 'Trans proline' 0 N--CA 1.486 1.055 0 CA-C-N 119.804 0.966 . . . . 1.0 112.447 -179.592 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.559 ' N ' ' O ' ' A' ' 23' ' ' THR . 87.0 m-20 -60.1 -18.5 47.6 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 118.826 -1.149 . . . . 1.0 108.065 178.455 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 76.2 mtm -147.99 163.84 35.61 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.617 -0.883 . . . . 1.0 108.617 179.281 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.0 p -73.23 157.36 37.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.17 -0.956 . . . . 1.0 109.123 179.735 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -60.68 -40.09 90.87 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.293 -0.879 . . . . 1.0 109.964 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 63.6 m -60.29 -41.96 94.46 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.206 -0.934 . . . . 1.0 109.616 -179.405 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.32 -40.15 85.92 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.446 -0.784 . . . . 1.0 110.397 179.737 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 70.7 t -67.4 -44.98 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 1.0 110.708 -179.02 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.87 -48.12 82.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.134 -0.979 . . . . 1.0 110.388 -178.362 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -62.47 -32.86 73.81 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.884 -1.135 . . . . 1.0 110.285 -179.783 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.408 ' CB ' HD23 ' A' ' 113' ' ' LEU . . . -60.01 -49.72 76.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.015 -1.053 . . . . 1.0 110.072 -179.274 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.433 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 53.7 m-85 -68.63 -40.01 80.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.968 -1.083 . . . . 1.0 109.805 -179.648 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.3 mmtt -60.04 -44.87 94.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.019 -1.051 . . . . 1.0 109.642 -179.468 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -60.12 -40.26 89.11 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.149 -0.97 . . . . 1.0 109.219 179.726 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.17 -45.36 93.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.528 -0.732 . . . . 1.0 109.642 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -66.15 -34.66 78.54 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.884 -1.135 . . . . 1.0 109.605 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.7 tptt -59.82 -52.59 64.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.168 -0.957 . . . . 1.0 110.166 -179.665 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.0 m -60.91 -39.86 83.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 O-C-N 120.895 -1.128 . . . . 1.0 110.556 -179.678 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -79.35 -38.34 35.33 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.99 -1.069 . . . . 1.0 110.161 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.3 p -71.68 -22.96 61.58 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.709 -1.244 . . . . 1.0 110.123 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -60.09 -40.02 88.14 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.193 -0.942 . . . . 1.0 111.104 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.6 m -111.42 25.12 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 O-C-N 121.211 -0.931 . . . . 1.0 111.122 -178.309 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.3 p -148.79 133.84 9.27 Favored Pre-proline 0 N--CA 1.501 2.122 0 O-C-N 120.701 -1.249 . . . . 1.0 109.617 179.495 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -72.37 17.49 0.35 Allowed 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 120.696 0.931 . . . . 1.0 111.902 179.335 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 75.3 mt -67.23 137.92 56.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.195 -0.941 . . . . 1.0 109.829 -179.273 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -108.29 121.42 44.87 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.095 -0.706 . . . . 1.0 109.095 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -109.57 127.65 54.64 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.488 -0.758 . . . . 1.0 109.264 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.7 m -119.99 129.95 54.52 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.482 0.658 . . . . 1.0 109.559 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -82.45 131.25 35.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.359 -0.838 . . . . 1.0 109.529 179.85 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.9 mt -105.94 128.85 54.07 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.274 -0.891 . . . . 1.0 109.514 179.639 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.41 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 17.5 m-70 -66.44 -40.08 89.26 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.436 -0.79 . . . . 1.0 109.839 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 68.0 m-20 -150.07 173.12 14.22 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.222 -0.924 . . . . 1.0 109.468 -179.709 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.494 ' O ' ' NH1' ' A' ' 18' ' ' ARG . . . 95.37 178.68 37.03 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.071 -1.612 . . . . 1.0 109.071 -179.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.5 mt -93.7 133.62 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.139 -1.213 . . . . 1.0 109.439 -179.679 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.68 158.26 18.26 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.483 -0.76 . . . . 1.0 109.167 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -59.72 -49.41 77.84 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.21 -0.931 . . . . 1.0 109.238 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 90.4 mt -105.77 99.74 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.335 -0.853 . . . . 1.0 109.875 179.562 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.7 ptp -99.21 134.77 41.59 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.146 -0.971 . . . . 1.0 109.145 179.048 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.433 HG21 ' CZ ' ' A' ' 35' ' ' PHE . 85.5 mt -109.93 132.33 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.655 -0.653 . . . . 1.0 109.462 -179.014 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.0 p -151.67 157.74 42.5 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.875 -1.141 . . . . 1.0 110.562 -179.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.678 ' H ' HD21 ' A' ' 21' ' ' ASN . 62.0 m-85 -109.62 120.79 43.58 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.55 -0.907 . . . . 1.0 108.55 179.28 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.28 -169.78 23.01 Favored Glycine 0 N--CA 1.499 2.87 0 N-CA-C 110.24 -1.144 . . . . 1.0 110.24 -179.515 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.581 HG22 ' N ' ' A' ' 67' ' ' LYS . 87.4 mt -134.91 165.61 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.644 -0.915 . . . . 1.0 108.836 179.809 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.581 ' N ' HG22 ' A' ' 66' ' ' ILE . 20.7 tptm -9.87 -78.73 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.714 0 C-N-CA 122.91 0.484 . . . . 1.0 112.088 179.857 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.647 ' CD ' ' H ' ' A' ' 68' ' ' GLU . 3.6 pm0 -68.94 140.69 55.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.051 -1.03 . . . . 1.0 109.171 179.792 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -126.93 7.58 6.69 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.3 -0.875 . . . . 1.0 109.657 -178.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 70.24 20.73 76.88 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.024 -1.63 . . . . 1.0 109.024 -179.573 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 72' ' ' PHE . 46.6 t0 -149.52 160.12 43.74 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.608 -0.937 . . . . 1.0 108.617 -179.627 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.533 ' O ' ' CD1' ' A' ' 73' ' ' TYR . 1.8 p90 -70.91 -174.14 0.89 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.778 -1.201 . . . . 1.0 109.716 -179.701 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.625 ' O ' ' CG ' ' A' ' 73' ' ' TYR . 3.5 p90 40.29 60.48 7.0 Favored Pre-proline 0 N--CA 1.497 1.903 0 CA-C-O 121.869 0.843 . . . . 1.0 110.106 -178.674 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.409 ' HD3' ' N ' ' A' ' 73' ' ' TYR . 20.4 Cg_endo -74.18 -161.94 0.13 Allowed 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 120.984 1.123 . . . . 1.0 111.875 179.837 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.55 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 83.0 m-85 -87.04 164.09 16.67 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.419 -0.801 . . . . 1.0 109.33 179.661 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.3 p-10 -101.01 3.96 41.97 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.35 -0.844 . . . . 1.0 110.961 -178.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 126.32 -151.61 18.03 Favored Glycine 0 N--CA 1.507 3.383 0 N-CA-C 108.911 -1.676 . . . . 1.0 108.911 -179.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -60.0 -66.21 0.07 OUTLIER 'Trans proline' 0 N--CA 1.492 1.438 0 CA-C-N 119.116 1.458 . . . . 1.0 112.02 179.617 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 91.7 p -76.82 161.89 28.09 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.183 -0.948 . . . . 1.0 109.525 179.811 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 117.48 -133.21 10.4 Favored Glycine 0 N--CA 1.501 3.002 0 N-CA-C 109.307 -1.517 . . . . 1.0 109.307 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.8 mt -70.16 111.55 5.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.088 -1.242 . . . . 1.0 108.456 179.541 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 38.3 mt -79.33 -17.48 54.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.963 -1.085 . . . . 1.0 108.806 -179.431 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 179.97 175.45 0.8 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.719 -0.845 . . . . 1.0 108.719 179.762 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -166.0 157.7 13.99 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.188 -0.945 . . . . 1.0 109.298 178.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -144.93 157.9 43.99 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -96.89 151.29 37.7 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 107.881 -1.155 . . . . 1.0 107.881 179.478 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -61.54 163.52 17.89 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 CA-C-N 119.324 0.794 . . . . 1.0 111.751 -179.32 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -41.1 135.25 2.54 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.113 1.208 . . . . 1.0 112.253 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 90' ' ' PRO . . . -162.61 -169.48 26.06 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 109.2 -1.56 . . . . 1.0 109.2 -179.62 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.435 ' O ' ' O ' ' A' ' 89' ' ' GLY . 18.6 Cg_exo -55.94 -146.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.424 1.416 . . . . 1.0 112.686 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -61.36 -40.3 93.78 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.303 -0.873 . . . . 1.0 111.096 -179.19 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -80.19 -11.98 59.69 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.734 -1.229 . . . . 1.0 110.621 -179.092 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -74.16 168.41 54.32 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.96 -1.656 . . . . 1.0 108.96 179.675 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 65.21 17.54 63.88 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.531 -1.427 . . . . 1.0 109.531 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.4 p-10 -80.02 164.32 23.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.214 -1.168 . . . . 1.0 109.707 -179.64 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.61 124.42 9.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.234 -0.916 . . . . 1.0 109.529 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -112.91 147.59 36.74 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.592 -0.693 . . . . 1.0 109.937 -179.8 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -125.57 149.44 48.34 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 -179.839 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.55 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 84.7 m-20 -78.92 123.23 27.06 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.078 -1.014 . . . . 1.0 109.627 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -84.93 -7.73 59.04 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.233 -0.917 . . . . 1.0 109.275 179.577 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -83.5 -14.01 53.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.401 -0.812 . . . . 1.0 109.186 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -88.73 168.67 12.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.503 -0.748 . . . . 1.0 109.166 -179.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 30.9 m -99.94 106.08 17.85 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.209 -0.932 . . . . 1.0 109.214 -179.6 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -87.11 123.38 32.11 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.577 -0.897 . . . . 1.0 108.577 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.637 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.7 t -141.99 156.57 45.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.38 -0.825 . . . . 1.0 109.901 -178.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.7 t -96.8 -7.69 33.03 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.594 -0.891 . . . . 1.0 108.594 179.21 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 79.4 p -93.62 173.43 7.69 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.524 -0.735 . . . . 1.0 109.428 179.522 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.0 t -70.72 70.34 0.46 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 1.0 109.617 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.637 ' HB2' HG21 ' A' ' 105' ' ' THR . 44.6 mtpt -146.55 153.8 40.79 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.213 -0.93 . . . . 1.0 109.22 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 109' ' ' LYS . . . 41.89 -139.78 1.95 Allowed Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.037 -1.225 . . . . 1.0 110.037 179.494 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -101.0 119.12 38.28 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.33 -1.1 . . . . 1.0 108.943 179.524 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -63.88 132.19 50.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.177 -0.952 . . . . 1.0 109.796 -179.585 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.408 HD23 ' CB ' ' A' ' 34' ' ' ALA . 58.7 tp -59.88 -39.97 87.08 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.351 -0.843 . . . . 1.0 109.923 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -59.91 -41.05 90.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.218 -0.926 . . . . 1.0 110.261 -179.218 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -58.85 -57.92 10.89 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.829 -1.169 . . . . 1.0 110.294 -179.482 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.7 t -66.3 -41.12 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.402 -0.811 . . . . 1.0 109.964 -178.431 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.84 -51.66 68.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.966 -1.084 . . . . 1.0 109.192 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.548 ' HB1' HD13 ' A' ' 136' ' ' LEU . . . -60.06 -39.49 86.19 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.336 -0.852 . . . . 1.0 110.246 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 76.7 t60 -63.8 -49.86 71.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.894 . . . . 1.0 111.443 -178.194 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -59.95 -37.7 80.3 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.671 -1.268 . . . . 1.0 110.086 -179.046 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -60.15 -39.81 87.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.645 -1.284 . . . . 1.0 108.453 179.302 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -59.06 -40.38 95.51 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.246 -1.542 . . . . 1.0 109.246 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -68.48 -39.99 81.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.043 -1.269 . . . . 1.0 108.832 179.192 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.1 p -65.76 -24.75 67.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.411 -0.806 . . . . 1.0 109.12 179.703 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 65.9 mt -81.86 -4.91 57.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.361 -0.837 . . . . 1.0 109.47 179.851 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 92.22 10.03 61.36 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.659 -0.976 . . . . 1.0 110.659 179.105 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.8 mt -85.21 147.91 26.36 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.871 -1.37 . . . . 1.0 109.671 179.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 44.1 t0 -100.63 175.46 5.65 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.476 -0.765 . . . . 1.0 108.97 -179.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.515 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 74.0 m80 -59.93 138.89 57.72 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.973 . . . . 1.0 109.72 -179.597 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 46.7 t -97.34 155.66 16.79 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.32 -0.863 . . . . 1.0 109.226 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -99.26 0.21 42.66 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.144 -0.973 . . . . 1.0 109.754 -179.893 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -85.32 130.4 51.82 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.306 -0.871 . . . . 1.0 108.695 179.85 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -68.1 -19.88 44.67 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 CA-C-N 120.136 1.084 . . . . 1.0 112.456 -179.668 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -91.2 -4.63 68.47 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 110.243 -1.143 . . . . 1.0 110.243 -179.558 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.86 145.63 27.1 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.014 -1.286 . . . . 1.0 109.31 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.548 HD13 ' HB1' ' A' ' 118' ' ' ALA . 70.3 mt -66.34 -38.63 88.08 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.911 -1.118 . . . . 1.0 110.01 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 94.5 mmm -69.97 19.84 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.315 -0.866 . . . . 1.0 110.585 -178.529 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.482 ' H ' ' C ' ' A' ' 136' ' ' LEU . 17.3 t80 -70.15 129.59 90.5 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 108.094 -1.076 . . . . 1.0 108.094 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -54.68 -10.98 2.85 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 CA-C-N 119.996 1.034 . . . . 1.0 114.079 -179.061 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.9 mt -113.93 140.63 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.512 0 O-C-N 120.891 -1.13 . . . . 1.0 110.664 -178.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.433 ' CD1' ' C ' ' A' ' 141' ' ' TYR . 20.7 t80 -74.7 129.58 37.97 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.513 -0.742 . . . . 1.0 110.069 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.0 t -139.0 142.4 38.32 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.434 -0.792 . . . . 1.0 109.402 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -83.05 152.18 25.48 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.994 -1.066 . . . . 1.0 109.721 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.43 ' H ' ' NZ ' ' A' ' 146' ' ' LYS . 2.7 m -145.66 154.45 42.12 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.399 -0.813 . . . . 1.0 109.863 -179.771 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.92 103.93 1.55 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.312 -1.915 . . . . 1.0 108.312 178.633 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.43 ' NZ ' ' H ' ' A' ' 144' ' ' THR . 37.3 mmtm -77.3 12.49 1.49 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.212 -1.169 . . . . 1.0 110.095 -178.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 48.5 t -60.0 -39.96 87.58 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.032 -1.043 . . . . 1.0 108.633 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -160.01 69.81 0.42 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.355 -0.841 . . . . 1.0 109.071 179.053 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -97.7 139.74 33.13 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.308 -0.87 . . . . 1.0 110.498 -179.547 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 97.4 mmm -136.9 149.72 47.8 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.983 -1.118 . . . . 1.0 107.983 178.844 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.9 mt -53.57 131.13 54.84 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.058 -1.026 . . . . 1.0 109.566 -179.134 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -68.49 175.47 6.95 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 CA-C-N 119.835 0.977 . . . . 1.0 112.136 179.638 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -60.08 -39.9 87.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.514 -0.741 . . . . 1.0 110.027 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -57.19 -47.31 81.56 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.221 -0.925 . . . . 1.0 110.067 -179.146 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -69.86 -39.83 76.12 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.188 -0.945 . . . . 1.0 109.435 -179.751 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.28 -45.02 96.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.198 -0.939 . . . . 1.0 109.196 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -60.23 -39.72 87.66 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.926 -1.109 . . . . 1.0 109.748 179.519 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.71 -54.41 10.02 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 120.501 -0.857 . . . . 1.0 111.669 -178.471 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 160' ' ' GLN . 8.4 tp -60.03 -40.18 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.666 -1.491 . . . . 1.0 109.621 -178.728 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.546 ' O ' ' N ' ' A' ' 164' ' ' GLY . 26.5 mt-30 -65.54 -39.39 91.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.089 -1.007 . . . . 1.0 109.466 179.217 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 84.7 p -59.13 -30.91 68.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.055 -1.028 . . . . 1.0 110.032 -179.553 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 88.7 mt -86.92 -53.61 4.8 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.938 -1.101 . . . . 1.0 110.725 -179.147 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -91.92 -9.98 41.19 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.91 -1.119 . . . . 1.0 110.933 -178.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.597 0 N-CA-C 109.292 -1.523 . . . . 1.0 109.292 -179.633 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 169' ' ' WAY . . . . . 0.943 ' HC2' ' HJ ' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.7 m . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.475 -0.565 . . . . 1.0 109.475 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.0 mt -70.04 138.96 52.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.151 -0.968 . . . . 1.0 108.934 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -162.48 166.52 24.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 1.0 109.867 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -72.19 140.75 48.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.185 -0.947 . . . . 1.0 110.043 -179.398 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.3 t -89.99 0.02 57.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.406 -0.809 . . . . 1.0 109.722 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.538 ' NZ ' ' O ' ' A' ' 14' ' ' ASN . 20.7 pttp -141.98 154.21 44.86 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.185 -0.947 . . . . 1.0 109.622 -179.651 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.4 mmt -90.47 -0.13 57.54 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.363 -0.835 . . . . 1.0 110.203 -178.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.538 ' O ' ' NZ ' ' A' ' 12' ' ' LYS . 30.1 m120 -97.02 128.61 44.15 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.224 -0.922 . . . . 1.0 109.151 -179.844 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.4 mt -141.66 149.54 40.76 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.265 -0.897 . . . . 1.0 109.307 -179.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.5 p -132.11 154.11 49.8 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.004 -0.739 . . . . 1.0 109.004 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -144.58 159.1 43.35 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.11 -0.994 . . . . 1.0 110.193 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 56' ' ' GLY . 26.3 ttm-85 -145.4 132.11 19.98 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.592 -0.693 . . . . 1.0 109.864 -179.455 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 39.8 mm -87.88 112.72 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.335 -0.987 . . . . 1.0 108.335 178.734 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.5 t -69.95 -40.05 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.101 -0.999 . . . . 1.0 109.443 -179.418 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -162.17 156.97 22.5 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.777 -1.202 . . . . 1.0 110.152 -179.588 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.611 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 54.0 m-85 -96.91 -167.14 1.5 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.169 -1.419 . . . . 1.0 107.169 178.851 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.29 141.58 32.11 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.325 -0.859 . . . . 1.0 110.094 -179.439 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -66.89 -19.1 52.81 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 120.763 0.976 . . . . 1.0 110.365 178.83 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.43 -39.91 85.04 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.553 -0.749 . . . . 1.0 109.949 179.405 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 74.8 mtm -130.04 161.66 30.5 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.419 -0.801 . . . . 1.0 109.484 -179.43 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.0 p -70.79 158.26 36.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -0.911 . . . . 1.0 109.2 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.611 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 1.0 OUTLIER -60.73 -40.76 93.59 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.355 -0.841 . . . . 1.0 110.239 -179.169 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.539 ' O ' ' NZ ' ' A' ' 33' ' ' LYS . 73.8 m -59.94 -41.02 90.94 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.006 -1.059 . . . . 1.0 110.758 -179.455 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -64.61 -40.08 94.86 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.945 -1.097 . . . . 1.0 110.004 -179.629 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.4 t -67.28 -39.96 83.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.222 -0.924 . . . . 1.0 109.83 -179.71 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -60.04 -49.93 75.74 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.098 -1.001 . . . . 1.0 110.647 -178.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.539 ' NZ ' ' O ' ' A' ' 29' ' ' SER . 2.1 ptpp? -64.19 -30.34 71.41 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.131 -0.981 . . . . 1.0 109.911 -179.704 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.04 -48.87 79.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.064 -1.022 . . . . 1.0 109.669 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -67.15 -38.38 85.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.075 -1.015 . . . . 1.0 110.02 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -59.95 -42.66 94.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.008 -1.058 . . . . 1.0 109.657 -179.651 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -60.04 -43.71 95.14 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.027 -1.046 . . . . 1.0 109.02 179.355 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.06 -49.71 76.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.463 -0.773 . . . . 1.0 109.868 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -61.97 -39.97 93.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.265 -0.897 . . . . 1.0 109.291 -179.803 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -60.06 -50.0 75.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.212 -0.93 . . . . 1.0 109.197 -179.591 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 70.2 t -59.98 -40.73 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.249 -0.907 . . . . 1.0 109.869 -179.549 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -78.94 -37.77 38.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.026 -1.047 . . . . 1.0 109.861 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.3 p -69.97 -15.32 63.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.267 -0.895 . . . . 1.0 109.829 -179.726 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -59.98 -40.0 87.61 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.136 -0.978 . . . . 1.0 110.091 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.3 m -115.06 -17.71 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.437 -0.789 . . . . 1.0 111.191 -178.483 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.3 p -90.76 124.36 62.47 Favored Pre-proline 0 N--CA 1.501 2.078 0 O-C-N 120.463 -1.398 . . . . 1.0 109.416 179.926 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -73.69 15.47 0.56 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 CA-C-N 120.221 1.115 . . . . 1.0 111.434 178.88 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.5 mt -69.61 140.26 53.71 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.41 -0.806 . . . . 1.0 110.369 -179.299 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -102.33 121.63 42.66 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.798 -0.816 . . . . 1.0 108.798 179.198 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -107.09 125.79 51.52 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.288 -0.882 . . . . 1.0 109.768 -179.204 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.2 m -120.03 129.98 54.5 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.576 -0.702 . . . . 1.0 109.882 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -82.23 131.96 35.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.244 -0.91 . . . . 1.0 109.487 179.752 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.493 ' O ' ' NH1' ' A' ' 18' ' ' ARG . 90.3 mt -106.63 134.0 50.45 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.301 -0.874 . . . . 1.0 109.274 179.502 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.435 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 59.1 m170 -66.23 -39.98 89.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.388 -0.82 . . . . 1.0 109.874 -179.641 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.464 ' O ' ' NH2' ' A' ' 18' ' ' ARG . 69.0 m-20 -154.42 178.84 9.6 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.087 -1.008 . . . . 1.0 109.635 -179.77 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.538 ' O ' ' NE ' ' A' ' 18' ' ' ARG . . . 96.62 -168.26 25.04 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.642 -1.383 . . . . 1.0 109.642 -179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.7 mt -101.4 130.51 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.361 -1.082 . . . . 1.0 109.622 -179.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.45 154.73 26.53 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.422 -0.799 . . . . 1.0 109.447 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -60.01 -49.56 77.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.2 -0.938 . . . . 1.0 109.624 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.6 mt -104.11 94.99 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.334 -0.853 . . . . 1.0 109.608 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.3 ptm -100.73 127.39 47.17 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.208 -0.933 . . . . 1.0 109.61 179.754 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 87.2 mt -106.42 137.7 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.52 -0.738 . . . . 1.0 109.657 -179.643 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 66.3 p -152.69 161.92 41.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.224 -0.923 . . . . 1.0 109.71 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -109.97 149.98 29.15 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.531 -0.731 . . . . 1.0 109.329 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -143.71 -161.88 9.11 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.315 -1.514 . . . . 1.0 109.315 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.537 ' O ' ' C ' ' A' ' 67' ' ' LYS . 81.2 mt -130.04 159.98 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.344 -1.092 . . . . 1.0 109.269 -179.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.537 ' C ' ' O ' ' A' ' 66' ' ' ILE . 7.5 ttpm? -8.74 -107.47 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 CA-C-N 115.878 -0.601 . . . . 1.0 111.909 -178.112 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -74.95 126.5 31.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.665 -1.272 . . . . 1.0 109.496 179.784 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.463 ' CE1' ' CE1' ' A' ' 75' ' ' PHE . 1.8 m80 -69.77 -40.03 76.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.024 -1.047 . . . . 1.0 109.443 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 175.61 -57.14 0.11 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.394 -1.482 . . . . 1.0 109.394 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 72' ' ' PHE . 45.7 t0 -156.35 153.5 29.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.177 -1.19 . . . . 1.0 109.64 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.51 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 97.7 m-85 57.81 15.38 2.97 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.669 -0.645 . . . . 1.0 110.47 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -143.53 70.0 17.43 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 120.928 -1.107 . . . . 1.0 109.208 178.869 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -86.06 110.64 1.07 Allowed 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 121.458 1.439 . . . . 1.0 113.249 -179.452 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.518 ' CD1' ' O ' ' A' ' 67' ' ' LYS . 32.8 m-85 -87.38 166.08 15.11 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 106.959 -1.497 . . . . 1.0 106.959 177.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.7 p-10 -106.09 20.0 19.64 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 120.927 -1.108 . . . . 1.0 110.934 -178.682 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.28 -150.38 18.11 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 109.493 -1.443 . . . . 1.0 109.493 179.608 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.442 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 8.8 Cg_exo -60.67 -62.72 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.524 0 CA-C-N 118.864 1.332 . . . . 1.0 112.896 -179.593 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 83.2 p -74.04 157.61 35.81 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.019 -1.051 . . . . 1.0 110.206 -179.268 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.65 -126.82 7.56 Favored Glycine 0 N--CA 1.502 3.075 0 N-CA-C 110.244 -1.142 . . . . 1.0 110.244 179.605 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.427 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 15.3 mt -69.75 102.73 1.98 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.43 -1.041 . . . . 1.0 109.3 -179.702 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 41.3 mt -75.67 -24.44 56.33 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.881 -1.137 . . . . 1.0 108.57 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.4 172.22 1.2 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.702 -0.851 . . . . 1.0 108.702 -179.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.497 ' ND1' ' C ' ' A' ' 84' ' ' HIS . 2.8 p80 -161.61 171.41 18.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.128 -0.983 . . . . 1.0 109.238 178.938 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.41 160.91 43.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.172 -0.955 . . . . 1.0 109.467 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -101.32 154.33 37.27 Favored Pre-proline 0 N--CA 1.496 1.862 0 N-CA-C 108.367 -0.975 . . . . 1.0 108.367 179.687 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.87 168.64 0.76 Allowed 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 120.738 0.959 . . . . 1.0 111.588 179.68 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -55.78 126.21 21.69 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 120.862 1.041 . . . . 1.0 111.441 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.63 125.69 1.38 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.384 -1.886 . . . . 1.0 108.384 -179.778 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -69.6 -29.61 24.35 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 CA-C-N 120.181 1.991 . . . . 1.0 112.022 -179.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.45 ' O ' ' CG ' ' A' ' 92' ' ' TYR . 42.5 t30 -61.42 -51.24 69.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.901 . . . . 1.0 109.753 -179.599 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.45 ' CG ' ' O ' ' A' ' 91' ' ' ASN . 86.6 m-85 -157.71 -7.94 0.09 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.098 -1.001 . . . . 1.0 109.543 179.532 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -64.2 168.4 25.23 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.904 -1.279 . . . . 1.0 109.904 -179.635 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.31 4.49 74.06 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.722 -1.351 . . . . 1.0 109.722 179.75 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -80.33 171.98 14.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.053 -1.263 . . . . 1.0 109.66 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.05 124.53 9.64 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.159 -0.963 . . . . 1.0 109.848 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -107.05 131.01 54.57 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.483 -0.761 . . . . 1.0 109.529 179.75 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.494 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 38.4 m-85 -114.28 144.18 43.66 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.504 -0.748 . . . . 1.0 109.028 179.588 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.427 ' OD2' ' O ' ' A' ' 81' ' ' LEU . 91.7 m-20 -78.95 124.23 28.05 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.934 -1.104 . . . . 1.0 109.926 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 55.7 t0 -85.45 -6.77 59.17 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.211 -0.93 . . . . 1.0 109.233 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -81.9 -14.94 55.48 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.097 -1.002 . . . . 1.0 109.329 179.863 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.442 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 94.3 mt-10 -89.23 168.55 12.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.362 -0.836 . . . . 1.0 109.68 -178.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 26.3 m -98.51 105.17 17.28 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.199 -0.938 . . . . 1.0 109.494 -179.516 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.422 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 86.5 m95 -88.47 124.24 33.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.379 -0.826 . . . . 1.0 109.059 179.727 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.668 HG21 ' HB2' ' A' ' 109' ' ' LYS . 7.9 t -140.78 153.63 45.92 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.197 -0.939 . . . . 1.0 109.91 -179.476 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 85.0 p -93.2 -5.6 49.65 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.456 -0.942 . . . . 1.0 108.456 179.15 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 46.4 t -94.3 179.71 5.21 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.718 -0.845 . . . . 1.0 108.718 179.305 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.9 m -80.79 75.75 7.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.004 -1.06 . . . . 1.0 109.372 179.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.668 ' HB2' HG21 ' A' ' 105' ' ' THR . 68.5 mttm -148.61 151.52 35.16 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.308 -0.87 . . . . 1.0 108.828 179.364 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.53 -138.84 4.83 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.841 -1.304 . . . . 1.0 109.841 179.667 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -100.01 115.92 30.85 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.348 -1.09 . . . . 1.0 108.862 179.604 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -63.61 131.81 49.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.158 -0.964 . . . . 1.0 109.617 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.1 tp -60.0 -43.59 95.08 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.331 -0.856 . . . . 1.0 110.899 -179.484 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -59.91 -41.11 91.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.971 -1.081 . . . . 1.0 110.794 -178.592 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.96 -50.47 73.64 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.809 -1.182 . . . . 1.0 109.603 -179.468 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.1 t -70.01 -41.44 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.051 -1.031 . . . . 1.0 110.09 -179.365 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.45 -51.44 69.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.147 -0.971 . . . . 1.0 109.633 -179.318 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.05 -37.01 78.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.146 -0.971 . . . . 1.0 109.945 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 59.4 t60 -62.36 -49.94 73.55 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.249 -0.907 . . . . 1.0 111.182 -178.784 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.494 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 6.9 pt-20 -59.54 -39.49 84.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.654 -1.278 . . . . 1.0 109.529 -179.38 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -60.07 -39.96 87.87 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.892 -1.13 . . . . 1.0 108.615 179.205 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.36 -47.71 61.61 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.283 -1.527 . . . . 1.0 109.283 179.775 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -66.1 -39.96 90.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.286 -1.126 . . . . 1.0 110.16 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 83.1 p -66.43 -22.19 66.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.131 -0.98 . . . . 1.0 109.897 -179.609 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 79.6 mt -81.9 1.84 33.3 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.134 -0.979 . . . . 1.0 109.948 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.12 4.99 70.96 Favored Glycine 0 N--CA 1.497 2.749 0 O-C-N 121.005 -1.059 . . . . 1.0 110.532 179.167 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.2 mt -86.99 147.85 25.56 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.984 -1.303 . . . . 1.0 109.787 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 37.6 t0 -101.98 172.39 6.95 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.878 -0.786 . . . . 1.0 108.878 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.513 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 59.3 m80 -56.58 132.72 52.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.004 -1.06 . . . . 1.0 109.54 -179.684 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 40.0 t -96.45 157.37 15.93 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.249 -0.907 . . . . 1.0 109.412 179.839 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -99.97 5.06 45.21 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.347 -0.845 . . . . 1.0 109.125 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -86.23 126.5 64.73 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 108.317 -0.994 . . . . 1.0 108.317 179.442 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -68.04 -22.07 42.1 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 CA-C-N 120.253 1.126 . . . . 1.0 112.273 -179.686 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -84.99 -5.69 85.81 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.684 -1.366 . . . . 1.0 109.684 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.15 135.19 33.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.186 -1.185 . . . . 1.0 108.842 179.467 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.466 ' C ' ' H ' ' A' ' 138' ' ' PHE . 89.2 mt -60.7 -40.05 90.79 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.076 -1.015 . . . . 1.0 110.238 -179.442 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 89.6 mtp -69.22 23.92 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.207 -0.933 . . . . 1.0 111.009 -178.425 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.466 ' H ' ' C ' ' A' ' 136' ' ' LEU . 17.3 t80 -69.92 130.33 90.1 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 120.761 -1.212 . . . . 1.0 108.328 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -49.07 -21.82 4.47 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 120.825 1.016 . . . . 1.0 114.392 -178.453 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 90.4 mt -106.37 139.81 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 O-C-N 120.886 -1.134 . . . . 1.0 110.87 -178.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -75.0 126.76 31.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.791 -0.568 . . . . 1.0 109.614 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.8 t -138.16 142.31 40.08 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.452 -0.78 . . . . 1.0 109.167 179.388 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -80.41 139.94 36.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.145 -0.972 . . . . 1.0 109.13 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.3 t -139.95 152.09 46.07 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.282 -0.886 . . . . 1.0 109.909 -179.322 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.96 101.1 0.83 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.33 -1.508 . . . . 1.0 109.33 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -76.79 -0.79 25.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.348 -1.09 . . . . 1.0 110.019 -179.718 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 53.9 m -59.97 -40.03 87.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.082 -1.011 . . . . 1.0 109.658 -179.6 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -138.91 21.06 2.65 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.144 -0.973 . . . . 1.0 109.989 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -62.03 139.94 58.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.78 -1.2 . . . . 1.0 109.721 -179.714 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 67.6 mtt -139.64 148.32 42.28 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.386 -0.968 . . . . 1.0 108.386 179.179 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 35.0 mt -54.94 129.78 66.3 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 120.945 -1.097 . . . . 1.0 109.202 -179.407 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -70.82 173.33 12.08 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 CA-C-N 119.863 0.987 . . . . 1.0 112.21 179.749 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -60.17 -39.62 87.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.328 -0.857 . . . . 1.0 109.519 179.403 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -53.06 -47.94 68.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.217 -0.927 . . . . 1.0 109.594 -179.517 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.411 ' O ' HG22 ' A' ' 159' ' ' ILE . 96.9 m-20 -70.33 -40.07 74.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.064 -1.022 . . . . 1.0 110.152 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 78.7 t -60.02 -47.35 92.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.88 -1.137 . . . . 1.0 109.176 -179.784 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -60.06 -39.97 87.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.071 -1.018 . . . . 1.0 110.434 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -73.23 -54.28 7.04 Favored Glycine 0 N--CA 1.496 2.672 0 O-C-N 121.215 -0.928 . . . . 1.0 111.685 -178.213 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.492 HG23 ' N ' ' A' ' 160' ' ' GLN . 4.8 tp -59.98 -39.99 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.953 -1.322 . . . . 1.0 109.691 -178.808 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.571 ' O ' ' N ' ' A' ' 164' ' ' GLY . 93.0 mm-40 -64.94 -38.25 90.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.2 -0.938 . . . . 1.0 109.463 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 60.3 p -61.51 -33.34 73.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.071 -1.018 . . . . 1.0 110.346 -179.359 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.8 mt -84.84 -52.31 6.12 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.959 -1.088 . . . . 1.0 110.536 -179.001 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -91.31 -9.24 45.71 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.104 -0.997 . . . . 1.0 110.483 -178.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.496 2.66 0 N-CA-C 109.448 -1.461 . . . . 1.0 109.448 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 169' ' ' WAY . . . . . 0.773 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.46 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 10.6 m . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.297 -0.631 . . . . 1.0 109.297 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.8 mt -66.87 130.25 42.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.841 -1.162 . . . . 1.0 109.162 179.856 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -161.71 161.44 29.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.878 . . . . 1.0 109.785 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -70.15 146.26 50.94 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.325 -0.86 . . . . 1.0 109.518 -179.623 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.9 t -85.94 1.42 50.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.342 -0.849 . . . . 1.0 109.818 -179.54 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -144.17 152.98 41.63 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.153 -0.967 . . . . 1.0 109.607 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.8 mmt -90.24 -0.02 57.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.358 -0.839 . . . . 1.0 109.769 -179.302 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -97.04 130.52 44.34 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.206 -0.933 . . . . 1.0 109.11 179.762 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.2 mt -141.75 148.94 39.8 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.196 -0.94 . . . . 1.0 109.406 -179.814 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.9 p -134.37 155.29 50.53 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.715 -0.846 . . . . 1.0 108.715 179.819 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -146.14 160.05 42.47 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.061 -1.024 . . . . 1.0 110.201 -179.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.486 ' NH1' ' N ' ' A' ' 56' ' ' GLY . 71.8 ttt180 -145.5 134.16 22.2 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.562 -0.711 . . . . 1.0 109.556 -179.736 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 32.0 mm -89.0 115.11 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.182 -0.949 . . . . 1.0 108.922 179.026 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.91 -40.58 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.173 -0.954 . . . . 1.0 109.295 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -164.98 160.52 19.15 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.929 -1.107 . . . . 1.0 110.008 -179.507 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.461 ' CD2' ' CG ' ' A' ' 28' ' ' HIS . 47.7 m-85 -101.68 -161.53 0.86 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.894 -1.15 . . . . 1.0 107.894 179.132 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.33 147.59 47.6 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.448 -0.782 . . . . 1.0 110.054 -179.809 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -69.62 -14.99 37.36 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 120.916 1.078 . . . . 1.0 110.267 178.245 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.42 -38.93 81.9 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.083 -0.962 . . . . 1.0 109.965 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 76.0 mtm -139.64 168.4 19.91 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.284 -0.885 . . . . 1.0 109.552 -179.756 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.4 p -73.45 156.61 38.07 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.445 -0.785 . . . . 1.0 109.771 -179.496 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.461 ' CG ' ' CD2' ' A' ' 22' ' ' TYR . 41.6 m170 -59.99 -40.09 87.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.431 -0.793 . . . . 1.0 110.463 -179.538 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 53.4 m -59.97 -39.96 87.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 1.0 110.202 -178.474 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.39 -39.95 89.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.033 -1.042 . . . . 1.0 109.325 179.574 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 76.6 t -68.7 -40.29 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.266 -0.896 . . . . 1.0 110.348 -179.561 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.96 -49.26 78.4 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.841 -1.162 . . . . 1.0 110.37 -179.186 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -61.34 -32.1 71.98 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.98 -1.075 . . . . 1.0 109.529 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.84 -48.57 81.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.977 -1.077 . . . . 1.0 109.649 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -66.03 -39.78 90.49 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.091 -1.006 . . . . 1.0 109.923 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.97 -40.65 89.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.924 -1.11 . . . . 1.0 109.284 -179.395 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -60.13 -41.78 93.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.034 -1.041 . . . . 1.0 108.927 179.085 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.97 -48.07 83.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.355 -0.841 . . . . 1.0 110.124 -179.683 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -64.89 -39.94 94.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.138 -0.976 . . . . 1.0 109.564 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -59.96 -48.25 82.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.15 -0.969 . . . . 1.0 109.27 -179.65 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.9 t -60.02 -41.53 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.294 -0.879 . . . . 1.0 110.122 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.468 ' O ' HG23 ' A' ' 46' ' ' THR . 76.3 m95 -81.36 -31.5 33.35 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.978 -1.076 . . . . 1.0 109.99 -179.421 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.0 p -70.02 -20.12 63.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.958 -1.089 . . . . 1.0 109.023 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -60.27 -39.96 88.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.404 -0.81 . . . . 1.0 110.263 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.1 m -113.15 -17.35 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 O-C-N 121.219 -0.926 . . . . 1.0 110.49 -179.17 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.478 ' C ' ' H ' ' A' ' 48' ' ' LEU . 44.8 p -94.02 114.41 63.11 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 120.779 -1.2 . . . . 1.0 108.982 179.729 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.76 16.36 0.22 Allowed 'Trans proline' 0 N--CA 1.491 1.327 0 CA-C-N 120.354 1.162 . . . . 1.0 111.237 179.462 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.478 ' H ' ' C ' ' A' ' 46' ' ' THR . 59.2 mt -69.52 142.87 53.59 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.567 -0.708 . . . . 1.0 109.511 -179.718 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -102.07 120.74 40.92 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.779 -0.823 . . . . 1.0 108.779 179.403 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -106.29 128.07 53.71 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.32 -0.863 . . . . 1.0 109.581 -179.438 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.0 m -120.04 130.01 54.5 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.58 -0.7 . . . . 1.0 109.469 179.642 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.8 ttp180 -82.62 129.99 35.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 1.0 109.558 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.4 mt -111.0 116.52 31.33 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.416 -0.802 . . . . 1.0 108.981 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.441 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 91.5 m-70 -74.61 -20.46 59.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.861 . . . . 1.0 110.065 -179.77 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 84.0 m-20 -145.13 160.66 41.08 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.18 -0.95 . . . . 1.0 109.639 -179.482 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.486 ' N ' ' NH1' ' A' ' 18' ' ' ARG . . . 90.02 173.95 45.22 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.677 -1.369 . . . . 1.0 109.677 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 87.2 mt -94.34 139.25 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.135 -1.215 . . . . 1.0 109.135 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.08 159.76 18.87 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.499 -0.75 . . . . 1.0 109.38 -179.739 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -59.94 -49.79 76.29 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.174 -0.954 . . . . 1.0 109.307 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 84.3 mt -103.12 98.88 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.449 -0.782 . . . . 1.0 109.568 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.2 ptm -101.85 129.23 48.03 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.295 -0.878 . . . . 1.0 109.206 179.455 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 86.9 mt -105.25 134.45 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.618 -0.676 . . . . 1.0 109.688 -179.125 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 54.6 p -149.73 153.54 37.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.208 -0.932 . . . . 1.0 109.623 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -103.89 124.02 48.2 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.937 -0.764 . . . . 1.0 108.937 179.904 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -107.13 -167.15 22.18 Favored Glycine 0 N--CA 1.502 3.044 0 N-CA-C 110.531 -1.028 . . . . 1.0 110.531 -179.232 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.571 HG22 ' N ' ' A' ' 67' ' ' LYS . 77.0 mt -137.39 167.4 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.598 -0.943 . . . . 1.0 108.74 179.731 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.571 ' N ' HG22 ' A' ' 66' ' ' ILE . 47.6 tptt -27.6 -78.95 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.292 0 CA-C-O 120.943 0.401 . . . . 1.0 111.248 -179.43 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -75.12 128.9 36.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.926 -1.109 . . . . 1.0 109.701 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -165.21 -21.63 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.14 -0.975 . . . . 1.0 109.304 179.601 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -177.84 135.98 2.89 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.366 -1.494 . . . . 1.0 109.366 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -61.77 -40.02 93.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.329 -1.1 . . . . 1.0 109.809 -179.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.491 ' C ' ' CG ' ' A' ' 73' ' ' TYR . 97.4 m-85 -68.95 142.28 54.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.215 -0.928 . . . . 1.0 109.878 -179.423 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.491 ' CG ' ' C ' ' A' ' 72' ' ' PHE . 3.4 p90 41.66 64.31 5.64 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.615 -0.678 . . . . 1.0 110.238 -179.248 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -75.85 157.7 39.12 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.1 1.2 . . . . 1.0 111.984 179.648 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.551 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 73.9 m-85 -90.38 150.28 21.93 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.201 -0.937 . . . . 1.0 108.89 179.51 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.5 p-10 -100.01 10.47 41.24 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.315 -0.866 . . . . 1.0 110.614 -178.884 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 116.73 -152.31 17.92 Favored Glycine 0 N--CA 1.505 3.293 0 N-CA-C 109.432 -1.467 . . . . 1.0 109.432 179.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -58.07 -65.77 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.429 0 CA-C-N 118.905 1.352 . . . . 1.0 112.338 -179.768 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 80.7 p -76.27 159.26 30.76 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.232 -0.917 . . . . 1.0 109.878 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.86 -130.87 9.3 Favored Glycine 0 N--CA 1.503 3.148 0 N-CA-C 109.6 -1.4 . . . . 1.0 109.6 179.836 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.402 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 15.2 mt -70.18 105.03 2.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.07 -1.253 . . . . 1.0 109.046 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 40.2 mt -77.43 -18.29 57.35 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.295 -1.002 . . . . 1.0 108.295 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.98 172.49 1.04 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.417 -0.957 . . . . 1.0 108.417 179.846 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.433 ' ND1' ' C ' ' A' ' 84' ' ' HIS . 8.1 p80 -163.09 156.76 19.9 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.988 -1.07 . . . . 1.0 109.744 179.348 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.07 157.8 43.68 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.721 -0.844 . . . . 1.0 108.721 179.836 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -94.84 153.15 40.06 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.059 -1.026 . . . . 1.0 109.057 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.577 ' O ' ' N ' ' A' ' 89' ' ' GLY . 5.3 Cg_endo -59.17 166.43 7.3 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 120.447 0.765 . . . . 1.0 111.01 179.576 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -50.05 77.99 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.252 1.302 . . . . 1.0 112.264 -179.843 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -99.27 -170.52 30.7 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.202 -1.559 . . . . 1.0 109.202 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.409 ' O ' ' O ' ' A' ' 89' ' ' GLY . 12.8 Cg_exo -55.84 -155.36 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.175 1.25 . . . . 1.0 112.622 -179.685 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -60.03 -40.3 88.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.277 -0.889 . . . . 1.0 109.79 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -67.11 -40.01 86.78 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.184 -0.947 . . . . 1.0 109.298 179.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.53 169.48 37.18 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.699 -1.36 . . . . 1.0 109.699 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.44 8.55 86.94 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.573 -1.411 . . . . 1.0 109.573 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -79.86 170.01 17.1 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.221 -1.164 . . . . 1.0 109.993 -179.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.17 124.49 10.9 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.176 -0.952 . . . . 1.0 110.058 -179.638 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.426 ' ND1' ' CE1' ' A' ' 84' ' ' HIS . 54.1 m170 -108.95 141.64 40.74 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.497 -0.752 . . . . 1.0 110.222 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -124.19 144.09 50.13 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 109.036 -0.728 . . . . 1.0 109.036 179.223 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.551 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 77.4 m-20 -78.96 121.33 24.77 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.967 -1.083 . . . . 1.0 109.677 179.814 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -85.32 -7.19 59.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.337 -0.852 . . . . 1.0 109.004 179.424 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -84.04 -12.53 55.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.452 -0.78 . . . . 1.0 109.395 -179.801 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -89.31 169.95 10.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.45 -0.782 . . . . 1.0 109.766 -178.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 18.2 m -98.87 103.86 15.85 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.338 -0.851 . . . . 1.0 109.245 -179.657 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.435 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 89.0 m95 -88.17 127.11 35.43 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.814 -0.809 . . . . 1.0 108.814 179.763 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.668 HG21 ' HB2' ' A' ' 109' ' ' LYS . 5.7 t -143.03 154.13 43.66 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.168 -0.958 . . . . 1.0 109.929 -179.522 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.9 m -94.05 -10.56 33.05 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.208 -0.933 . . . . 1.0 108.597 179.382 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.7 m -91.29 177.67 6.18 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.597 -0.89 . . . . 1.0 108.597 179.355 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.7 t -76.5 80.17 3.2 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.012 -1.055 . . . . 1.0 109.648 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.668 ' HB2' HG21 ' A' ' 105' ' ' THR . 9.5 mtmp? -153.53 150.12 28.38 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.328 -0.857 . . . . 1.0 109.283 179.499 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 43.48 -140.31 2.97 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.046 -1.222 . . . . 1.0 110.046 179.465 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -99.98 111.87 24.16 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.343 -1.093 . . . . 1.0 109.076 179.695 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.417 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 19.6 t-20 -61.55 136.53 58.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.072 -1.017 . . . . 1.0 109.9 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.2 tp -59.97 -44.11 94.67 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.357 -0.839 . . . . 1.0 110.467 179.815 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -59.96 -41.47 91.98 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.08 -1.013 . . . . 1.0 110.889 -178.22 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.99 -50.11 75.01 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.814 -1.179 . . . . 1.0 109.487 -179.395 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 56.3 t -70.0 -41.5 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.06 -1.025 . . . . 1.0 110.307 -179.47 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.33 -52.8 64.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.09 -1.006 . . . . 1.0 110.074 -178.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.55 -35.5 74.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.11 -0.994 . . . . 1.0 110.099 -179.728 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -63.93 -50.3 69.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.948 . . . . 1.0 111.254 -178.512 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -60.05 -39.21 85.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.645 -1.285 . . . . 1.0 110.091 -179.297 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -60.04 -39.87 87.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.967 -1.083 . . . . 1.0 108.844 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.68 -44.39 94.05 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.431 -1.468 . . . . 1.0 109.431 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -64.95 -39.99 94.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.19 -1.182 . . . . 1.0 109.494 179.54 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 83.2 p -65.7 -22.9 66.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.228 -0.92 . . . . 1.0 109.523 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 82.2 mt -82.55 -1.2 49.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.241 -0.912 . . . . 1.0 109.283 179.709 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.73 8.71 65.16 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 110.819 -0.912 . . . . 1.0 110.819 178.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.4 mt -85.82 146.35 26.8 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.881 -1.364 . . . . 1.0 109.652 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 44.5 t0 -100.41 172.7 6.97 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.484 -0.76 . . . . 1.0 109.199 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.519 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 64.7 m80 -58.86 136.92 57.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.911 . . . . 1.0 109.703 -179.661 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 42.0 t -98.04 155.63 17.03 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.37 -0.831 . . . . 1.0 109.176 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -98.75 1.91 46.48 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.265 -0.897 . . . . 1.0 109.934 179.953 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -85.4 128.5 59.13 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.074 -1.016 . . . . 1.0 108.368 179.336 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -67.8 -17.4 47.15 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 CA-C-N 120.237 1.12 . . . . 1.0 112.519 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -90.32 -5.53 69.75 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.696 -1.361 . . . . 1.0 109.696 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -89.05 140.02 29.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.218 -1.166 . . . . 1.0 109.35 179.726 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.449 ' C ' ' H ' ' A' ' 138' ' ' PHE . 98.3 mt -63.86 -31.99 73.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.139 -0.976 . . . . 1.0 109.83 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 96.0 mmm -71.21 19.43 0.06 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.322 -0.861 . . . . 1.0 110.503 -179.027 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.449 ' H ' ' C ' ' A' ' 136' ' ' LEU . 11.3 t80 -69.31 132.14 89.94 Favored Pre-proline 0 N--CA 1.495 1.775 0 N-CA-C 107.817 -1.179 . . . . 1.0 107.817 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -61.88 -13.74 32.65 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 CA-C-N 119.837 0.977 . . . . 1.0 113.33 -178.346 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.5 mt -108.14 139.28 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.199 -0.938 . . . . 1.0 109.343 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.417 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 33.4 t80 -72.69 129.56 38.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.324 -0.86 . . . . 1.0 109.853 -179.464 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.2 t -140.15 143.74 36.31 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.868 -0.79 . . . . 1.0 108.868 179.762 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -81.01 144.8 31.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.137 -0.977 . . . . 1.0 109.289 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.5 t -140.5 151.94 45.21 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.184 -0.947 . . . . 1.0 109.825 -179.863 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -61.81 103.93 0.65 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.284 -1.126 . . . . 1.0 110.284 -179.478 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.413 ' NZ ' ' CB ' ' A' ' 146' ' ' LYS . 9.1 mtpm? -77.28 -7.94 56.8 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.337 -1.096 . . . . 1.0 109.236 179.638 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 82.5 p -59.97 -40.01 87.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 1.0 109.832 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -154.27 69.63 0.77 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.11 -0.993 . . . . 1.0 109.65 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -100.45 127.1 46.89 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.219 -0.926 . . . . 1.0 109.642 179.66 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 75.5 mtm -121.44 141.46 50.98 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.572 -0.899 . . . . 1.0 108.572 179.203 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.8 mt -52.6 128.47 43.55 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 120.917 -1.115 . . . . 1.0 108.82 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -68.64 175.48 7.08 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 CA-C-N 120.036 1.049 . . . . 1.0 111.903 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -59.97 -40.03 87.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.331 -0.856 . . . . 1.0 109.697 179.798 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -54.56 -49.21 70.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.256 -0.903 . . . . 1.0 110.172 -179.227 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -69.92 -39.97 75.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.993 -1.067 . . . . 1.0 110.026 -179.601 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 60.1 t -60.06 -47.1 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 1.0 109.218 -179.831 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -60.07 -40.01 88.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.125 -0.984 . . . . 1.0 110.203 -179.75 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.12 -55.27 9.39 Favored Glycine 0 N--CA 1.495 2.619 0 O-C-N 121.143 -0.973 . . . . 1.0 111.301 -178.567 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.484 HG23 ' N ' ' A' ' 160' ' ' GLN . 4.8 tp -60.17 -40.09 82.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.946 -1.326 . . . . 1.0 109.734 -178.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.533 ' O ' ' N ' ' A' ' 164' ' ' GLY . 26.0 mm100 -64.35 -40.06 95.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.081 -1.012 . . . . 1.0 109.789 179.852 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 94.1 p -62.08 -30.44 71.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.11 -0.994 . . . . 1.0 110.196 -179.537 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.46 ' CD2' ' N ' ' A' ' 7' ' ' THR . 93.1 mt -84.92 -54.24 4.79 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.028 -1.045 . . . . 1.0 110.623 -179.099 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -89.73 -8.85 51.35 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.002 -1.061 . . . . 1.0 110.011 -179.094 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.584 0 N-CA-C 109.513 -1.435 . . . . 1.0 109.513 179.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 169' ' ' WAY . . . . . 0.957 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 96.0 m . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.303 0.573 . . . . 1.0 109.513 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.7 mt -70.03 142.98 52.67 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.389 -0.82 . . . . 1.0 109.703 -179.616 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -160.67 160.01 31.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.357 -0.839 . . . . 1.0 109.405 179.776 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 47.6 m95 -75.28 125.39 28.88 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.091 -1.005 . . . . 1.0 109.249 -179.923 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.7 p -73.28 -29.49 62.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.02 -1.05 . . . . 1.0 109.518 179.877 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -92.07 139.08 30.99 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.304 -0.999 . . . . 1.0 108.304 179.405 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.613 ' N ' ' SD ' ' A' ' 13' ' ' MET . 3.5 mmm -90.62 0.07 57.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.251 -0.906 . . . . 1.0 109.828 -178.372 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -98.17 125.86 43.39 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.707 -0.849 . . . . 1.0 108.707 179.46 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.7 mt -138.7 152.25 47.85 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.202 -0.937 . . . . 1.0 109.307 -179.503 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.6 p -132.98 154.16 50.76 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.997 -0.742 . . . . 1.0 108.997 -179.953 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -144.29 159.99 41.75 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.131 -0.981 . . . . 1.0 109.848 -179.656 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.537 ' NE ' ' O ' ' A' ' 56' ' ' GLY . 25.2 ttm-85 -142.17 134.54 27.88 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.397 -0.814 . . . . 1.0 109.585 -179.721 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 87.1 mt -87.92 117.97 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.482 -0.933 . . . . 1.0 108.482 178.73 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.9 t -69.32 -38.8 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.172 -0.955 . . . . 1.0 109.417 -179.32 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -159.19 157.88 31.62 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 122.217 1.008 . . . . 1.0 111.5 179.424 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.509 ' HB2' ' CD2' ' A' ' 28' ' ' HIS . 15.5 m-85 -112.13 77.02 1.01 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 103.678 -2.712 . . . . 1.0 103.678 176.652 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.488 ' O ' ' O ' ' A' ' 22' ' ' TYR . 5.4 t -29.15 150.84 0.03 OUTLIER Pre-proline 0 C--N 1.282 -2.341 0 CA-C-N 115.741 -0.663 . . . . 1.0 112.178 -177.535 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -65.15 -6.55 13.31 Favored 'Trans proline' 0 N--CA 1.5 1.855 0 C-N-CA 121.275 1.317 . . . . 1.0 113.383 -178.56 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -59.15 -37.78 78.14 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 119.509 -0.876 . . . . 1.0 110.285 179.839 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 73.4 mtm -138.75 162.64 34.2 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.142 -0.974 . . . . 1.0 109.591 -179.776 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.4 p -71.45 160.4 32.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.363 -0.836 . . . . 1.0 109.436 -179.663 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.509 ' CD2' ' HB2' ' A' ' 22' ' ' TYR . 23.4 m170 -60.01 -40.44 89.26 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.313 -0.867 . . . . 1.0 109.869 -179.178 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.2 m -60.03 -42.48 94.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.136 -0.977 . . . . 1.0 110.501 -179.416 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.09 -40.0 82.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.085 -1.01 . . . . 1.0 110.023 -179.638 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 70.2 t -67.56 -44.84 86.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.164 -0.96 . . . . 1.0 110.288 -179.233 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -59.99 -49.42 77.75 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.139 -0.976 . . . . 1.0 111.13 -178.896 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -60.48 -33.47 72.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.818 -1.176 . . . . 1.0 109.847 -179.537 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.0 -49.97 75.57 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.967 -1.083 . . . . 1.0 109.95 -179.538 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -66.56 -38.81 87.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.912 -1.117 . . . . 1.0 109.894 -179.886 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.97 -42.42 94.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.078 -1.014 . . . . 1.0 109.514 -179.256 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -60.07 -39.96 87.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.133 -0.98 . . . . 1.0 109.137 179.394 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.06 -48.35 82.09 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.31 -0.868 . . . . 1.0 109.851 -179.592 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -66.26 -39.18 89.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 1.0 110.075 -179.747 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -60.01 -48.78 80.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.063 -1.023 . . . . 1.0 109.448 -179.248 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 86.2 t -59.98 -40.04 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.104 -0.997 . . . . 1.0 110.566 -179.376 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -81.47 -33.66 31.85 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.902 -1.124 . . . . 1.0 110.005 -179.555 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 94.3 p -72.05 -21.15 61.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.895 -1.128 . . . . 1.0 109.78 179.89 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.96 -39.98 87.47 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.243 -0.911 . . . . 1.0 110.626 -179.589 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 m -110.98 24.48 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 O-C-N 121.27 -0.894 . . . . 1.0 110.682 -179.118 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.5 p -149.15 135.23 10.05 Favored Pre-proline 0 N--CA 1.5 2.061 0 O-C-N 120.761 -1.212 . . . . 1.0 109.505 179.376 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -73.87 16.39 0.53 Allowed 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 120.693 0.928 . . . . 1.0 111.901 179.083 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 93.9 mt -68.31 139.35 55.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.071 -1.018 . . . . 1.0 109.756 -179.423 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -110.71 120.81 43.62 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.954 -0.758 . . . . 1.0 108.954 -179.961 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -108.38 123.49 48.92 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.393 -0.817 . . . . 1.0 109.466 -179.492 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.4 m -120.03 130.01 54.51 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.7 -0.625 . . . . 1.0 109.327 179.885 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -83.95 132.87 34.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.216 -0.927 . . . . 1.0 109.285 179.696 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.521 ' C ' HH12 ' A' ' 18' ' ' ARG . 91.2 mt -102.2 139.73 37.42 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.23 -0.919 . . . . 1.0 108.915 179.67 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.438 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 41.5 m170 -69.52 -40.0 77.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 1.0 110.228 -179.306 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.52 ' O ' ' NH2' ' A' ' 18' ' ' ARG . 70.4 m-20 -153.44 179.68 8.56 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.024 -1.047 . . . . 1.0 109.885 -179.636 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.537 ' O ' ' NE ' ' A' ' 18' ' ' ARG . . . 92.39 -170.84 33.06 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.75 -1.34 . . . . 1.0 109.75 179.928 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.0 mt -97.11 131.36 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.337 -1.096 . . . . 1.0 109.221 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.23 166.11 11.11 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.354 -0.841 . . . . 1.0 109.21 -179.949 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.01 -49.22 78.53 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.128 -0.982 . . . . 1.0 108.915 -179.928 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.5 mt -119.96 114.12 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.676 -0.64 . . . . 1.0 109.389 179.31 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.5 ptp -101.71 138.29 38.89 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.254 -0.904 . . . . 1.0 108.999 179.126 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.6 mt -109.99 131.86 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.359 -0.838 . . . . 1.0 109.794 -179.133 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 71.6 p -150.01 160.68 43.44 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.224 -0.923 . . . . 1.0 109.974 -179.541 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -107.13 122.57 46.75 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.463 -0.773 . . . . 1.0 109.388 179.987 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' A' ' 100' ' ' ASP . . . -96.45 167.67 24.88 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.208 -1.557 . . . . 1.0 109.208 179.6 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.484 ' O ' ' C ' ' A' ' 67' ' ' LYS . 11.3 tt -110.03 179.99 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.277 -1.131 . . . . 1.0 109.671 -179.4 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 66' ' ' ILE . 28.2 tptp -25.58 -76.56 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.243 0 CA-C-O 121.061 0.458 . . . . 1.0 111.799 179.741 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.582 ' O ' ' N ' ' A' ' 70' ' ' GLY . 20.5 pt-20 -60.79 -39.86 90.47 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.094 -1.004 . . . . 1.0 109.848 -178.754 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.553 ' ND1' ' CE1' ' A' ' 75' ' ' PHE . 2.8 t-160 57.42 -77.35 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.164 -0.96 . . . . 1.0 109.764 179.335 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 68' ' ' GLU . . . -138.48 146.84 18.71 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 108.844 -1.702 . . . . 1.0 108.844 179.635 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -66.58 -39.96 88.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -1.165 . . . . 1.0 110.026 -179.846 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -68.53 -38.96 81.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.346 -0.846 . . . . 1.0 110.8 -179.142 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 73' ' ' TYR . 2.1 p90 -129.97 79.29 73.38 Favored Pre-proline 0 N--CA 1.503 2.207 0 O-C-N 121.147 -0.971 . . . . 1.0 110.037 -179.395 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -78.72 147.28 21.76 Favored 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 121.187 1.258 . . . . 1.0 111.873 179.217 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.553 ' CE1' ' ND1' ' A' ' 69' ' ' HIS . 33.1 m-85 -90.29 172.61 8.65 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.242 -0.911 . . . . 1.0 109.162 179.839 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 79' ' ' SER . 32.8 p-10 -99.8 1.81 43.45 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.144 -0.972 . . . . 1.0 111.538 -178.425 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.406 ' O ' ' OE2' ' A' ' 102' ' ' GLU . . . 111.93 -117.91 4.58 Favored Glycine 0 N--CA 1.508 3.463 0 O-C-N 120.93 -1.106 . . . . 1.0 111.144 178.69 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.466 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 28.3 Cg_endo -73.51 -73.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.948 0 CA-C-N 120.015 1.908 . . . . 1.0 113.399 -178.88 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.451 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 99.2 p -78.17 173.89 11.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.949 -1.095 . . . . 1.0 109.475 -179.366 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 106.04 -134.39 12.09 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 110.152 -1.179 . . . . 1.0 110.152 179.64 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.459 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 19.6 mt -71.91 117.73 13.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.592 -0.946 . . . . 1.0 109.843 -179.397 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 66.1 mt -85.09 -22.77 28.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.986 -1.071 . . . . 1.0 109.127 179.343 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.13 174.46 1.05 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.86 -0.793 . . . . 1.0 108.86 -179.741 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.68 163.3 27.02 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.242 -0.911 . . . . 1.0 109.492 179.276 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -153.72 162.27 41.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.391 -0.818 . . . . 1.0 108.885 -179.743 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -106.41 151.11 40.21 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.373 -0.829 . . . . 1.0 108.85 179.754 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.534 ' O ' ' N ' ' A' ' 89' ' ' GLY . 13.5 Cg_endo -66.27 164.48 27.92 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 120.768 0.979 . . . . 1.0 111.785 179.604 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -51.49 81.68 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 121.037 1.158 . . . . 1.0 111.836 179.762 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -99.71 -169.74 30.02 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.84 -1.304 . . . . 1.0 109.84 -179.609 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 89' ' ' GLY . 21.2 Cg_exo -55.22 -143.83 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.758 1.639 . . . . 1.0 113.236 -179.637 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.404 ' OD1' ' N ' ' A' ' 92' ' ' TYR . 34.2 p-10 -62.26 -40.01 94.78 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.377 -0.827 . . . . 1.0 110.594 -179.154 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.404 ' N ' ' OD1' ' A' ' 91' ' ' ASN . 41.5 p90 -80.0 -10.38 59.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.806 -1.184 . . . . 1.0 109.449 179.942 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -76.41 169.25 54.89 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.457 -1.457 . . . . 1.0 109.457 179.894 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 66.69 76.69 0.34 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.869 -1.292 . . . . 1.0 109.869 179.787 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.9 p-10 -150.54 164.25 36.46 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.176 -1.191 . . . . 1.0 109.178 179.633 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.95 129.64 14.1 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.038 -1.039 . . . . 1.0 109.671 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -127.18 132.39 50.49 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.557 -0.714 . . . . 1.0 109.679 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -109.97 156.74 20.07 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.652 -0.655 . . . . 1.0 109.462 -179.798 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.493 ' OD1' ' CD2' ' A' ' 75' ' ' PHE . 90.8 m-20 -80.06 130.14 35.03 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.014 -1.054 . . . . 1.0 109.816 179.455 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.532 ' N ' ' O ' ' A' ' 65' ' ' GLY . 8.3 t70 -87.75 -6.77 58.02 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.274 -0.891 . . . . 1.0 109.491 179.412 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -83.53 -10.22 58.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.237 -0.914 . . . . 1.0 110.08 -179.519 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.466 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 42.0 mm-40 -90.58 173.88 7.82 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.161 -0.962 . . . . 1.0 109.5 -179.171 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 56.2 m -105.26 107.48 18.49 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.458 -0.941 . . . . 1.0 108.458 179.152 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -86.55 121.37 28.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.243 -0.911 . . . . 1.0 109.3 -179.506 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.666 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.6 t -143.12 156.33 44.77 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.538 -0.726 . . . . 1.0 109.605 -179.273 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 29.4 t -95.31 -7.26 39.21 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.332 -0.988 . . . . 1.0 108.332 178.924 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 68.3 m -91.03 179.78 5.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.565 -0.709 . . . . 1.0 109.226 179.624 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 99.4 p -79.82 68.62 5.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.232 -0.917 . . . . 1.0 109.806 -179.858 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.666 ' HB2' HG21 ' A' ' 105' ' ' THR . 98.4 mttt -143.18 149.51 38.11 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.2 -0.937 . . . . 1.0 108.809 179.5 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.51 -144.02 3.34 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.688 -1.365 . . . . 1.0 109.688 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -100.21 117.43 34.43 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.343 -1.092 . . . . 1.0 109.034 179.625 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.449 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 20.2 t-20 -62.26 132.66 53.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.912 . . . . 1.0 109.545 179.998 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.8 tp -59.96 -43.51 95.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.34 -0.85 . . . . 1.0 110.487 -179.498 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -59.97 -41.11 91.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.027 -1.046 . . . . 1.0 110.784 -178.485 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -58.49 -50.78 72.5 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.683 -1.261 . . . . 1.0 109.188 -179.584 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.0 t -70.04 -40.11 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.127 -0.983 . . . . 1.0 109.681 -179.556 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.94 -52.68 64.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.188 -0.945 . . . . 1.0 109.864 -179.341 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.99 -34.84 73.86 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.651 -1.281 . . . . 1.0 109.887 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -65.3 -50.05 67.16 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.264 -0.897 . . . . 1.0 111.617 -178.426 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -60.0 -40.01 87.75 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.63 -1.293 . . . . 1.0 109.408 -178.72 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -59.99 -40.03 87.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.026 -1.046 . . . . 1.0 108.723 179.879 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.31 -46.41 63.73 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.166 -1.573 . . . . 1.0 109.166 179.847 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.402 ' CE1' ' NE2' ' A' ' 129' ' ' HIS . 79.0 m-70 -65.26 -40.02 93.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.229 -1.159 . . . . 1.0 109.611 179.607 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 84.1 p -66.77 -23.95 66.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 1.0 109.998 -179.754 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 78.4 mt -82.26 -2.27 52.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.128 -0.983 . . . . 1.0 110.046 -179.544 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.57 6.24 68.24 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 110.443 -1.063 . . . . 1.0 110.443 179.357 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.3 mt -84.68 149.08 26.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.053 -1.263 . . . . 1.0 109.07 179.501 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 36.1 t0 -103.27 170.35 8.01 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.764 -0.828 . . . . 1.0 108.764 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.51 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 28.0 m170 -58.53 135.16 57.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.012 -1.055 . . . . 1.0 109.356 -179.631 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 41.9 t -98.18 155.29 17.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.382 -0.824 . . . . 1.0 109.106 179.879 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -98.05 5.58 48.55 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.23 -0.919 . . . . 1.0 110.014 -179.512 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -85.88 126.68 65.05 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 108.121 -1.066 . . . . 1.0 108.121 179.275 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -68.45 -8.81 24.14 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 CA-C-N 120.186 1.102 . . . . 1.0 112.011 -179.615 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -96.44 -7.52 58.03 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.509 -1.437 . . . . 1.0 109.509 179.863 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.87 137.05 33.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.133 -1.216 . . . . 1.0 109.412 179.814 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.435 ' C ' ' H ' ' A' ' 138' ' ' PHE . 64.7 mt -60.03 -39.84 87.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.121 -0.987 . . . . 1.0 110.239 179.86 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 89.8 mtp -71.28 25.52 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.275 -0.891 . . . . 1.0 111.417 -178.463 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.435 ' H ' ' C ' ' A' ' 136' ' ' LEU . 16.2 t80 -69.22 136.44 89.08 Favored Pre-proline 0 N--CA 1.498 1.955 0 N-CA-C 107.459 -1.311 . . . . 1.0 107.459 178.787 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -60.65 -14.28 30.48 Favored 'Trans proline' 0 N--CA 1.5 1.902 0 CA-C-N 120.185 1.102 . . . . 1.0 114.196 -178.062 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.3 mt -109.95 139.07 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 O-C-N 121.014 -1.054 . . . . 1.0 109.697 -179.693 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.449 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 34.2 t80 -74.12 125.42 28.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.354 -0.841 . . . . 1.0 110.119 -179.324 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 7.4 t -136.6 142.94 43.34 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.997 -0.742 . . . . 1.0 108.997 179.812 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -80.67 143.29 33.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.932 -1.105 . . . . 1.0 109.746 -179.775 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.4 m -134.71 138.59 44.52 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.531 -0.73 . . . . 1.0 109.838 -179.475 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -68.0 99.91 0.59 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 107.97 -2.052 . . . . 1.0 107.97 178.658 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -74.46 17.09 0.21 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -1.129 . . . . 1.0 110.484 -178.475 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 41.1 t -57.67 -46.57 84.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.905 -1.122 . . . . 1.0 109.31 -179.853 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -147.72 33.99 0.85 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.147 -0.971 . . . . 1.0 109.368 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -63.73 138.03 58.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.2 -0.938 . . . . 1.0 110.953 -179.104 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 74.0 mtm -134.11 148.53 51.0 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.133 -1.062 . . . . 1.0 108.133 178.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 70.7 mt -53.3 129.12 51.06 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 120.918 -1.114 . . . . 1.0 108.867 -179.862 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -69.52 177.05 5.8 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 CA-C-N 120.074 1.062 . . . . 1.0 112.019 179.643 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -60.29 -39.95 88.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.868 . . . . 1.0 110.023 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -55.55 -48.94 73.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.245 -0.91 . . . . 1.0 110.054 -179.047 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -70.03 -40.02 75.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.152 -0.967 . . . . 1.0 110.34 -179.63 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 60.3 t -60.03 -48.81 86.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.027 -1.046 . . . . 1.0 109.124 -179.556 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -60.0 -39.98 87.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.128 -0.983 . . . . 1.0 110.44 179.97 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.06 -54.59 7.93 Favored Glycine 0 N--CA 1.493 2.49 0 O-C-N 121.136 -0.978 . . . . 1.0 111.382 -178.35 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.476 HG23 ' N ' ' A' ' 160' ' ' GLN . 7.1 tp -59.98 -40.11 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.937 -1.331 . . . . 1.0 109.618 -179.026 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.546 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.7 mt-30 -66.61 -39.93 88.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 1.0 109.594 179.597 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 83.1 p -61.52 -31.12 71.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.143 -0.973 . . . . 1.0 110.74 -179.308 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 88.6 mt -86.84 -51.36 6.12 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.779 -1.201 . . . . 1.0 110.551 -179.041 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -90.83 -9.16 47.46 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.984 -1.073 . . . . 1.0 109.931 -179.273 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.524 0 N-CA-C 109.489 -1.444 . . . . 1.0 109.489 -179.866 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 169' ' ' WAY . . . . . 0.627 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 84.7 m . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.296 0.57 . . . . 1.0 109.636 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.1 mt -68.01 142.01 56.05 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.255 -0.903 . . . . 1.0 110.04 -179.618 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -160.6 160.2 31.43 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.471 -0.768 . . . . 1.0 109.018 179.598 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -73.45 147.95 43.69 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.13 -0.981 . . . . 1.0 109.463 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.3 p -84.93 0.13 52.28 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.203 -0.936 . . . . 1.0 109.742 -179.636 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -145.77 153.11 40.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.197 -0.939 . . . . 1.0 109.384 -179.877 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.2 mmt -90.02 -0.73 57.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.257 -0.902 . . . . 1.0 109.129 -179.645 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -96.19 128.2 42.88 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.341 -0.85 . . . . 1.0 108.989 -179.994 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.3 mt -140.02 150.17 44.09 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.232 -0.917 . . . . 1.0 109.04 -179.799 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 59.5 p -131.09 156.14 45.73 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.907 -0.775 . . . . 1.0 108.907 179.937 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -146.06 160.06 42.41 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.133 -0.98 . . . . 1.0 110.055 -179.672 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.598 HH12 ' H ' ' A' ' 56' ' ' GLY . 70.5 ttt180 -142.86 135.31 27.57 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.421 -0.8 . . . . 1.0 109.355 -179.939 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 85.5 mt -87.78 120.0 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.254 -0.904 . . . . 1.0 108.708 179.185 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 67.0 t -67.72 -39.04 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -0.925 . . . . 1.0 108.887 -179.812 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.44 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 22.0 p-10 -160.61 152.9 20.44 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 119.937 -1.727 . . . . 1.0 111.289 179.687 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.644 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 33.3 m-85 -101.28 74.96 1.59 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 106.612 -1.625 . . . . 1.0 106.612 177.118 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.476 ' C ' ' O ' ' A' ' 22' ' ' TYR . 3.9 t -24.54 143.14 0.04 OUTLIER Pre-proline 0 N--CA 1.508 2.433 0 N-CA-C 112.069 0.396 . . . . 1.0 112.069 -177.786 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -62.58 -5.86 7.83 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 121.247 1.298 . . . . 1.0 112.743 -179.285 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -59.48 -36.93 76.94 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.424 -0.797 . . . . 1.0 109.939 179.704 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 78.2 mtm -138.53 161.23 37.58 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.194 -0.941 . . . . 1.0 109.556 -179.772 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.1 p -71.62 160.19 33.11 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.37 -0.831 . . . . 1.0 109.127 -179.878 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.644 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 2.1 m80 -59.96 -40.59 89.58 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.346 -0.846 . . . . 1.0 110.22 -179.083 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 74.9 m -61.28 -40.47 94.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.098 -1.001 . . . . 1.0 110.275 -179.587 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.35 -39.97 77.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.207 -0.933 . . . . 1.0 110.383 -179.478 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 77.2 t -68.29 -43.56 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.139 -0.975 . . . . 1.0 110.134 -179.258 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.01 -49.4 77.82 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.19 -0.944 . . . . 1.0 110.87 -179.063 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -61.47 -32.86 72.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.885 -1.134 . . . . 1.0 110.112 -179.531 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.97 -49.67 76.77 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.906 -1.121 . . . . 1.0 109.713 -179.579 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.419 ' CE1' HD13 ' A' ' 62' ' ' ILE . 53.7 m-85 -66.27 -38.77 88.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.993 -1.067 . . . . 1.0 109.723 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -59.99 -43.37 95.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.045 -1.034 . . . . 1.0 109.795 -179.619 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -60.1 -41.24 92.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.99 -1.069 . . . . 1.0 109.475 179.58 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.29 -46.69 88.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.331 -0.856 . . . . 1.0 110.133 -179.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -67.2 -38.58 85.56 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.05 -1.031 . . . . 1.0 110.001 -179.767 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -59.96 -48.84 80.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.097 -1.002 . . . . 1.0 109.839 -179.349 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 79.7 t -60.09 -40.14 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.144 -0.973 . . . . 1.0 110.113 -179.412 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.456 ' CH2' HD22 ' A' ' 151' ' ' LEU . 69.2 m95 -81.35 -36.57 29.49 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.008 -1.058 . . . . 1.0 110.08 -179.413 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.3 p -70.19 -21.54 63.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.032 -1.043 . . . . 1.0 109.891 -179.632 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.07 -39.87 87.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.29 -0.881 . . . . 1.0 110.666 -179.739 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.463 ' O ' ' NE2' ' A' ' 160' ' ' GLN . 11.3 m -109.76 24.21 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.28 -0.888 . . . . 1.0 110.471 -178.824 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.411 HG23 HG23 ' A' ' 45' ' ' VAL . 43.3 p -149.83 134.41 9.32 Favored Pre-proline 0 N--CA 1.499 2.003 0 O-C-N 120.92 -1.113 . . . . 1.0 109.54 179.543 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -74.18 17.42 0.51 Allowed 'Trans proline' 0 N--CA 1.493 1.455 0 CA-C-N 119.702 0.929 . . . . 1.0 111.86 178.882 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 72.6 mt -68.53 139.9 55.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.117 -0.989 . . . . 1.0 109.413 -179.608 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -109.99 120.51 42.7 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 179.851 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -109.53 119.79 40.52 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.398 -0.814 . . . . 1.0 109.0 -179.687 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.3 m -120.06 130.03 54.49 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.533 -0.73 . . . . 1.0 109.944 -179.84 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -82.25 135.25 35.27 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.253 -0.904 . . . . 1.0 109.104 179.28 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.9 mt -101.3 129.29 47.25 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.161 -0.962 . . . . 1.0 109.483 -179.956 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.445 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 60.1 m170 -61.79 -40.0 93.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.413 -0.804 . . . . 1.0 109.443 179.879 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 77.9 m-20 -148.84 168.88 21.81 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.251 -0.906 . . . . 1.0 109.449 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.598 ' H ' HH12 ' A' ' 18' ' ' ARG . . . 98.72 178.07 32.31 Favored Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.54 -1.424 . . . . 1.0 109.54 -179.956 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.4 mt -95.87 135.06 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.241 -1.152 . . . . 1.0 109.291 179.863 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.02 160.76 16.15 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.492 -0.755 . . . . 1.0 109.155 -179.75 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -60.04 -49.51 77.38 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.17 -0.956 . . . . 1.0 109.306 -179.747 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.8 mt -105.37 103.51 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.356 -0.84 . . . . 1.0 109.978 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.1 ptp -100.43 133.96 44.08 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.188 -0.945 . . . . 1.0 108.766 178.773 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.419 HD13 ' CE1' ' A' ' 35' ' ' PHE . 85.4 mt -110.08 131.37 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.443 -0.785 . . . . 1.0 110.045 -178.56 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.1 p -150.56 160.3 43.89 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.153 -0.967 . . . . 1.0 109.93 -179.702 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -104.8 123.55 47.88 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 179.592 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 98' ' ' PHE . . . -95.55 -175.9 37.11 Favored Glycine 0 N--CA 1.499 2.894 0 N-CA-C 110.544 -1.023 . . . . 1.0 110.544 -179.274 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.52 HG22 ' N ' ' A' ' 67' ' ' LYS . 61.1 mt -131.81 165.72 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.446 -1.031 . . . . 1.0 109.442 -179.967 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.52 ' N ' HG22 ' A' ' 66' ' ' ILE . 20.5 tptm -22.53 -77.74 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.325 0 CA-C-O 121.165 0.507 . . . . 1.0 111.476 -179.825 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.645 ' CD ' ' H ' ' A' ' 68' ' ' GLU . 4.3 pm0 -68.42 138.4 55.28 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.084 -1.01 . . . . 1.0 109.224 -179.849 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -124.46 8.25 8.37 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.348 -0.845 . . . . 1.0 109.153 -179.34 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 70.01 32.83 69.63 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.373 -1.491 . . . . 1.0 109.373 -179.759 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -141.21 163.18 33.66 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.222 -1.164 . . . . 1.0 109.935 -179.671 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -66.23 -21.68 66.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.262 -0.899 . . . . 1.0 110.254 -179.897 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.534 ' CD2' ' O ' ' A' ' 73' ' ' TYR . 12.7 p90 -128.46 74.12 80.11 Favored Pre-proline 0 N--CA 1.504 2.255 0 O-C-N 121.229 -0.919 . . . . 1.0 110.532 -179.664 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -74.65 -152.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 121.195 1.264 . . . . 1.0 110.991 178.847 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.529 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 87.8 m-85 -83.74 162.67 20.59 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.988 -1.07 . . . . 1.0 109.739 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -102.11 16.12 27.03 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.361 -0.837 . . . . 1.0 110.746 -178.86 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 114.93 -157.51 14.94 Favored Glycine 0 N--CA 1.505 3.285 0 N-CA-C 109.55 -1.42 . . . . 1.0 109.55 179.617 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -58.37 -65.75 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.469 0 CA-C-N 118.568 1.184 . . . . 1.0 112.406 -179.742 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 89.7 p -76.03 162.17 28.28 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.181 -0.949 . . . . 1.0 109.65 -179.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.17 -129.09 8.29 Favored Glycine 0 N--CA 1.502 3.058 0 N-CA-C 109.836 -1.306 . . . . 1.0 109.836 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.1 mt -69.63 107.58 3.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.323 -1.104 . . . . 1.0 109.077 -179.958 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 56.7 mt -78.47 -26.54 46.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.896 . . . . 1.0 108.924 179.982 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.53 164.46 1.64 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.342 -0.984 . . . . 1.0 108.342 -179.715 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -160.35 162.74 33.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.128 -0.982 . . . . 1.0 109.44 179.493 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 95' ' ' ASP . . . -145.76 160.0 42.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.283 -0.886 . . . . 1.0 109.583 -179.645 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -93.88 152.97 40.99 Favored Pre-proline 0 N--CA 1.492 1.661 0 N-CA-C 107.944 -1.132 . . . . 1.0 107.944 179.433 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.527 ' O ' ' N ' ' A' ' 89' ' ' GLY . 2.4 Cg_endo -56.95 165.79 4.64 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 CA-C-N 119.166 0.738 . . . . 1.0 111.673 179.778 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -55.62 75.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.346 1.364 . . . . 1.0 112.112 -179.564 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -94.43 -173.69 38.55 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.658 -1.777 . . . . 1.0 108.658 179.5 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.502 ' O ' ' O ' ' A' ' 89' ' ' GLY . 25.6 Cg_exo -51.56 -143.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.77 1.647 . . . . 1.0 113.462 -179.986 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.488 ' OD1' ' N ' ' A' ' 92' ' ' TYR . 34.6 p-10 -60.89 -47.64 85.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.653 -1.279 . . . . 1.0 111.163 -178.619 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.488 ' N ' ' OD1' ' A' ' 91' ' ' ASN . 35.4 p90 -68.36 -29.27 67.95 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.664 -1.273 . . . . 1.0 109.838 -179.372 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.434 ' N ' ' CD1' ' A' ' 92' ' ' TYR . . . -64.17 168.71 24.46 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.857 -1.297 . . . . 1.0 109.857 -179.862 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 69.92 17.02 73.1 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.16 -1.176 . . . . 1.0 110.16 179.679 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.442 ' O ' ' HB1' ' A' ' 85' ' ' ALA . 35.7 p-10 -86.81 171.07 11.16 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.092 -1.24 . . . . 1.0 109.756 -179.959 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.14 123.39 8.93 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.391 -0.818 . . . . 1.0 109.574 179.812 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -112.4 128.51 56.33 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.591 -0.693 . . . . 1.0 109.344 179.753 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.506 ' O ' ' N ' ' A' ' 65' ' ' GLY . 22.7 m-85 -107.71 155.85 19.73 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.478 -0.764 . . . . 1.0 109.063 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.529 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 1.3 m-20 -79.05 120.54 23.76 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.625 -1.297 . . . . 1.0 110.081 -179.616 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 65' ' ' GLY . 40.9 t0 -83.1 -11.88 57.58 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.171 -0.956 . . . . 1.0 108.947 179.389 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -83.17 -10.48 58.6 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.289 -0.882 . . . . 1.0 109.292 -179.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -92.46 170.05 10.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.395 -0.816 . . . . 1.0 109.155 -179.872 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 31.3 m -100.13 106.01 17.68 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.246 -0.909 . . . . 1.0 109.26 -179.76 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.481 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 94.5 m95 -88.76 123.39 33.13 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.568 -0.901 . . . . 1.0 108.568 179.537 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.69 HG21 ' HB2' ' A' ' 109' ' ' LYS . 10.1 t -140.05 154.84 47.2 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.355 -0.841 . . . . 1.0 109.942 -179.006 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 87.9 p -94.71 -5.51 45.3 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.284 -1.006 . . . . 1.0 108.284 179.011 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 31.4 t -94.47 178.95 5.44 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.709 -0.849 . . . . 1.0 108.709 179.35 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.2 m -80.2 76.84 6.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.962 -1.086 . . . . 1.0 109.599 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.69 ' HB2' HG21 ' A' ' 105' ' ' THR . 68.7 mttm -148.52 149.39 31.54 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.257 -0.902 . . . . 1.0 108.678 179.429 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.22 -136.98 5.31 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.096 -1.202 . . . . 1.0 110.096 179.695 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -100.07 118.6 36.77 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.403 -1.057 . . . . 1.0 109.21 179.689 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.4 ' HB3' HD23 ' A' ' 115' ' ' LEU . 2.6 t-20 -65.09 131.5 46.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.086 -1.009 . . . . 1.0 109.765 179.992 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.5 tp -60.01 -43.11 95.43 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.372 -0.83 . . . . 1.0 110.084 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -60.0 -43.01 95.48 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.27 -0.894 . . . . 1.0 111.214 -178.584 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 115' ' ' LEU . 4.0 mm? -60.03 -50.02 75.37 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.655 -1.278 . . . . 1.0 109.347 -179.182 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 75.5 t -69.95 -40.29 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.099 -1.0 . . . . 1.0 109.95 -179.405 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.12 -50.02 75.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.145 -0.972 . . . . 1.0 109.746 -179.306 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.84 -36.51 77.0 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.739 -1.226 . . . . 1.0 109.631 179.973 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 63.5 t60 -64.99 -49.97 68.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.129 -0.982 . . . . 1.0 111.541 -178.637 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.4 ' C ' ' OE1' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -59.98 -40.02 87.67 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.519 -1.363 . . . . 1.0 109.873 -178.731 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -60.04 -40.05 88.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.928 -1.107 . . . . 1.0 108.35 179.746 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -54.61 -44.13 78.95 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.128 -1.589 . . . . 1.0 109.128 179.717 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -67.29 -39.99 86.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.194 -1.18 . . . . 1.0 109.828 179.66 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.9 p -66.0 -21.7 66.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.928 . . . . 1.0 109.115 179.888 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 76.2 mt -82.52 -0.84 48.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.39 -0.819 . . . . 1.0 110.028 -179.89 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 89.43 7.31 69.62 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.392 -1.083 . . . . 1.0 110.392 179.282 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.5 mt -84.57 150.13 25.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.898 -1.354 . . . . 1.0 110.092 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 10.0 t70 -101.09 171.13 7.81 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.509 -0.744 . . . . 1.0 109.066 179.509 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.526 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 75.2 m80 -59.65 137.38 58.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.088 -1.007 . . . . 1.0 109.555 -179.78 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 38.6 t -98.55 154.28 18.03 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.315 -0.865 . . . . 1.0 109.322 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -100.17 6.75 44.83 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.39 -0.819 . . . . 1.0 109.748 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -86.58 127.97 58.54 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.136 -0.978 . . . . 1.0 108.563 179.617 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -67.99 -20.21 44.93 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 CA-C-N 120.181 1.1 . . . . 1.0 112.169 -179.818 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -88.47 -4.98 76.07 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.621 -1.392 . . . . 1.0 109.621 -179.865 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.16 145.75 26.87 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.269 -1.136 . . . . 1.0 109.707 179.897 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.419 ' C ' ' H ' ' A' ' 138' ' ' PHE . 84.6 mt -70.05 -33.84 72.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.891 . . . . 1.0 109.553 179.887 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 80.3 mtp -74.41 23.36 0.09 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 1.0 110.481 -179.215 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.419 ' H ' ' C ' ' A' ' 136' ' ' LEU . 12.7 t80 -69.62 133.52 88.73 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 107.409 -1.33 . . . . 1.0 107.409 179.305 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -59.25 -9.94 9.51 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 CA-C-N 120.01 1.039 . . . . 1.0 113.785 -177.896 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 95.4 mt -113.9 138.36 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 O-C-N 121.123 -0.985 . . . . 1.0 109.686 -179.919 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -73.37 131.12 41.5 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.461 -0.774 . . . . 1.0 110.068 -179.351 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.1 t -141.97 133.38 26.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.36 -0.838 . . . . 1.0 109.282 179.697 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -80.71 134.41 35.84 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.139 -0.975 . . . . 1.0 109.58 -179.909 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.8 t -130.91 147.34 52.54 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.376 -0.828 . . . . 1.0 109.406 -179.939 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -66.65 102.91 0.81 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.574 -1.411 . . . . 1.0 109.574 -179.729 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 147' ' ' SER . 8.5 mtmp? -71.34 140.68 50.32 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.301 -1.117 . . . . 1.0 109.468 179.934 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.442 ' CB ' ' O ' ' A' ' 146' ' ' LYS . 1.2 t 165.99 -89.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.844 -0.798 . . . . 1.0 108.844 -179.884 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . 0.477 ' O ' ' ND1' ' A' ' 148' ' ' HIS . 54.9 t-80 -97.79 15.53 23.44 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.615 -0.883 . . . . 1.0 108.615 179.484 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -60.43 137.36 58.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.583 -0.698 . . . . 1.0 110.005 -179.811 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 97.2 mmm -136.33 149.53 48.44 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.555 -0.905 . . . . 1.0 108.555 179.301 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.456 HD22 ' CH2' ' A' ' 42' ' ' TRP . 24.6 mt -53.18 129.78 50.46 Favored Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 120.981 -1.074 . . . . 1.0 108.63 -179.802 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -66.39 176.25 4.25 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 CA-C-N 120.01 1.039 . . . . 1.0 112.295 -179.813 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.05 -39.91 87.58 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.366 -0.834 . . . . 1.0 109.475 179.799 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -56.15 -49.94 72.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.311 -0.868 . . . . 1.0 109.939 -179.204 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -70.78 -39.99 72.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.071 -1.018 . . . . 1.0 110.308 -179.473 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 63.7 t -60.11 -47.55 91.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.083 -1.01 . . . . 1.0 109.424 -179.634 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -60.48 -40.01 89.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.847 -1.158 . . . . 1.0 110.182 -179.815 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.45 -54.4 10.69 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 120.272 -0.966 . . . . 1.0 111.323 -178.716 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.477 HG23 ' N ' ' A' ' 160' ' ' GLN . 8.4 tp -59.98 -39.98 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.867 -1.372 . . . . 1.0 109.533 -179.075 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.486 ' O ' ' N ' ' A' ' 164' ' ' GLY . 91.9 mm-40 -64.63 -39.9 94.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.269 -0.894 . . . . 1.0 109.27 179.48 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 82.5 p -61.8 -29.18 69.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.286 -0.884 . . . . 1.0 110.812 -179.334 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 94.4 mt -86.38 -56.44 3.43 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.801 -1.187 . . . . 1.0 110.819 -179.133 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -89.94 -9.62 48.15 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.004 -1.06 . . . . 1.0 110.445 -178.712 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.497 2.715 0 N-CA-C 109.362 -1.495 . . . . 1.0 109.362 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 169' ' ' WAY . . . . . 0.665 ' HC2' ' HJ ' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.3 m . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.231 0.538 . . . . 1.0 109.563 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.9 mt -98.83 130.14 45.24 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.274 -0.892 . . . . 1.0 109.379 -179.814 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.02 160.0 35.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 1.0 109.463 179.717 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -74.43 149.47 40.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.38 -0.825 . . . . 1.0 109.987 -179.525 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.7 m -89.93 1.77 55.85 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.354 -0.841 . . . . 1.0 110.361 -179.643 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -141.62 153.77 44.97 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.09 -1.006 . . . . 1.0 109.619 -179.701 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.3 mmt -90.15 0.02 57.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.404 -0.81 . . . . 1.0 110.234 -178.889 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -96.84 129.63 44.24 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.127 -0.983 . . . . 1.0 109.687 -179.837 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.1 mt -142.32 146.74 35.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.26 -0.9 . . . . 1.0 109.033 179.744 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 70.0 p -130.1 160.12 34.71 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.625 -0.88 . . . . 1.0 108.625 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -146.42 159.93 42.74 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.088 -1.007 . . . . 1.0 110.381 179.98 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.488 HH11 ' HG2' ' A' ' 18' ' ' ARG . 1.9 tpt180 -145.38 129.83 17.84 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.294 -0.632 . . . . 1.0 109.294 -179.03 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.1 mt -89.38 117.27 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.137 -0.977 . . . . 1.0 108.542 178.742 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.6 t -69.98 -40.7 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.094 -1.003 . . . . 1.0 109.565 -179.608 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -163.74 159.01 20.91 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.697 -1.252 . . . . 1.0 110.276 -179.908 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.471 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 56.7 m-85 -100.55 -160.72 0.82 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.218 -1.401 . . . . 1.0 107.218 178.933 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.16 149.78 74.22 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.226 -0.921 . . . . 1.0 109.91 -179.874 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -69.81 -13.31 34.37 Favored 'Trans proline' 0 N--CA 1.487 1.116 0 C-N-CA 120.611 0.874 . . . . 1.0 109.947 178.399 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -59.78 -38.52 82.12 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.798 -0.637 . . . . 1.0 109.832 -179.555 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 76.8 mtm -137.95 166.12 24.84 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.289 -0.882 . . . . 1.0 109.52 -179.611 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 67.8 p -72.75 160.34 32.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.369 -0.832 . . . . 1.0 109.333 -179.746 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.471 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 3.5 m80 -60.11 -40.04 88.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.262 -0.899 . . . . 1.0 109.89 -179.552 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 74.1 m -60.1 -40.04 88.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.35 -0.844 . . . . 1.0 110.876 -179.244 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -68.1 -40.04 82.7 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.023 -1.048 . . . . 1.0 110.479 -179.167 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.1 t -69.37 -40.32 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.064 -1.022 . . . . 1.0 110.133 -179.329 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.05 -49.01 79.33 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.055 -1.028 . . . . 1.0 110.412 -179.241 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.66 -32.38 72.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.9 -1.125 . . . . 1.0 109.755 -179.776 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.87 -49.36 77.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.002 -1.061 . . . . 1.0 109.536 -179.428 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -66.6 -39.14 88.25 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.13 -0.981 . . . . 1.0 109.856 179.846 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.96 -41.79 92.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.968 -1.082 . . . . 1.0 109.673 -179.321 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -60.1 -42.11 93.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.104 -0.997 . . . . 1.0 109.743 179.374 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.56 -48.07 83.41 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.223 -0.923 . . . . 1.0 110.317 -179.811 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.501 ' CZ ' ' CZ ' ' A' ' 121' ' ' PHE . 49.8 m-85 -64.27 -39.96 95.0 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.104 -0.997 . . . . 1.0 109.572 -179.415 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -59.98 -47.6 85.15 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.504 -0.748 . . . . 1.0 109.454 -179.069 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.2 t -59.94 -40.16 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.008 -1.057 . . . . 1.0 109.81 -179.683 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 71.9 m95 -78.69 -32.56 47.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.193 -0.942 . . . . 1.0 110.014 -179.714 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 85.3 p -71.39 -14.63 62.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.073 -1.017 . . . . 1.0 109.683 179.923 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -59.91 -39.98 87.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.437 -0.79 . . . . 1.0 110.229 -179.679 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.6 m -114.58 -19.72 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.455 -0.778 . . . . 1.0 110.461 -179.001 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.415 ' C ' ' H ' ' A' ' 48' ' ' LEU . 66.4 p -95.25 121.48 62.0 Favored Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 120.757 -1.215 . . . . 1.0 109.405 179.432 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -73.15 20.84 0.34 Allowed 'Trans proline' 0 N--CA 1.493 1.491 0 CA-C-N 120.236 1.12 . . . . 1.0 111.601 179.153 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.415 ' H ' ' C ' ' A' ' 46' ' ' THR . 77.9 mt -68.86 140.03 55.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 1.0 109.525 -179.85 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -103.26 120.58 41.02 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.679 -0.859 . . . . 1.0 108.679 179.704 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -106.36 120.8 42.83 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.426 -0.796 . . . . 1.0 109.77 -179.194 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.8 m -120.06 130.01 54.49 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 121.498 0.666 . . . . 1.0 110.236 179.895 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.411 ' HG2' ' NH1' ' A' ' 52' ' ' ARG . 10.1 tpt180 -82.85 138.61 33.87 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.476 -0.765 . . . . 1.0 109.166 179.288 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 90.0 mt -106.47 129.99 54.34 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.308 -0.87 . . . . 1.0 108.755 179.166 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.425 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 62.3 m170 -60.0 -40.04 87.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.955 -1.091 . . . . 1.0 109.701 -179.427 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 73.4 m-20 -151.08 172.34 15.91 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.274 -0.891 . . . . 1.0 109.464 -179.71 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.97 -179.51 32.63 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.583 -1.407 . . . . 1.0 109.583 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.7 mt -95.62 133.63 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.374 -1.074 . . . . 1.0 109.401 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.96 162.55 14.42 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.477 -0.765 . . . . 1.0 109.095 -179.89 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -59.95 -48.82 80.14 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.207 -0.933 . . . . 1.0 109.091 179.868 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 93.1 mt -109.55 103.38 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.473 -0.767 . . . . 1.0 110.215 179.807 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.3 ptp -102.32 137.31 40.74 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.183 -0.948 . . . . 1.0 109.297 178.788 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 88.4 mt -109.95 130.47 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.575 -0.703 . . . . 1.0 109.743 -179.542 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.8 p -150.31 158.93 44.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.351 -0.843 . . . . 1.0 109.597 -179.615 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -99.97 128.5 46.05 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.434 -0.95 . . . . 1.0 108.434 179.413 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.6 150.6 16.99 Favored Glycine 0 N--CA 1.498 2.804 0 N-CA-C 110.185 -1.166 . . . . 1.0 110.185 -178.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.462 ' O ' ' C ' ' A' ' 67' ' ' LYS . 7.1 tt -101.89 -177.31 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.158 -1.053 . . . . 1.0 108.158 179.407 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 66' ' ' ILE . 52.3 tptt -33.94 -93.9 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.951 -0.468 . . . . 1.0 110.671 -179.732 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -77.95 135.34 37.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.982 -1.074 . . . . 1.0 110.038 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.527 ' CD2' ' H ' ' A' ' 71' ' ' ASP . 46.7 p-80 -162.2 -171.08 2.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.11 -0.994 . . . . 1.0 109.937 179.226 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -40.16 -20.24 0.02 OUTLIER Glycine 0 N--CA 1.495 2.621 0 O-C-N 121.566 -0.708 . . . . 1.0 111.85 -178.403 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.527 ' H ' ' CD2' ' A' ' 69' ' ' HIS . 98.0 m-20 -87.84 132.6 34.13 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.54 -1.565 . . . . 1.0 110.249 -179.456 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -60.06 -42.12 93.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.414 -0.804 . . . . 1.0 109.503 179.366 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.522 ' CD2' ' O ' ' A' ' 73' ' ' TYR . 21.6 p90 -90.55 114.28 60.65 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.275 -0.89 . . . . 1.0 109.391 -179.818 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -73.53 -167.96 0.41 Allowed 'Trans proline' 0 N--CA 1.492 1.427 0 CA-C-N 120.114 1.076 . . . . 1.0 112.064 179.888 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.533 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 97.9 m-85 -89.77 169.9 10.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.312 -0.868 . . . . 1.0 108.663 179.43 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -101.27 13.78 34.01 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.155 -0.965 . . . . 1.0 110.209 -179.296 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 117.12 -156.91 15.36 Favored Glycine 0 N--CA 1.502 3.047 0 N-CA-C 108.894 -1.682 . . . . 1.0 108.894 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -58.48 -65.38 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.451 0 CA-C-N 118.633 1.217 . . . . 1.0 112.267 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 90.6 p -76.85 164.18 26.07 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.183 -0.948 . . . . 1.0 109.815 -179.93 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.85 -129.45 8.65 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 109.587 -1.405 . . . . 1.0 109.587 179.88 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.44 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 13.2 mt -68.99 106.48 2.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.435 -1.038 . . . . 1.0 109.09 179.961 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.417 HD23 ' OE2' ' A' ' 102' ' ' GLU . 50.8 mt -78.71 -23.71 45.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.017 -1.052 . . . . 1.0 108.884 179.95 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.11 169.56 1.9 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.709 -0.849 . . . . 1.0 108.709 179.837 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -161.7 161.89 29.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.159 -0.963 . . . . 1.0 109.127 179.304 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.78 157.03 44.67 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.2 -0.938 . . . . 1.0 109.724 -179.355 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -93.63 151.96 40.45 Favored Pre-proline 0 N--CA 1.494 1.726 0 N-CA-C 108.483 -0.932 . . . . 1.0 108.483 179.691 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -42.16 160.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.243 0 C-N-CA 120.663 0.909 . . . . 1.0 111.667 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -66.77 74.66 0.42 Allowed 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 120.645 0.897 . . . . 1.0 111.955 -179.52 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.475 ' H ' ' HA3' ' A' ' 93' ' ' GLY . . . -82.27 167.92 47.79 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.134 -1.586 . . . . 1.0 109.134 179.771 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -71.16 -34.04 10.68 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 121.417 1.411 . . . . 1.0 112.538 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -110.03 -98.2 0.4 Allowed 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.335 -0.853 . . . . 1.0 111.532 -178.52 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -59.98 -40.01 87.64 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.371 -0.831 . . . . 1.0 110.503 -177.861 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.475 ' HA3' ' H ' ' A' ' 89' ' ' GLY . . . -52.57 168.38 0.84 Allowed Glycine 0 N--CA 1.489 2.17 0 C-N-CA 119.461 -1.352 . . . . 1.0 109.917 -179.328 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.41 4.94 76.05 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.539 -1.424 . . . . 1.0 109.539 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -86.4 174.56 8.93 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.214 -1.168 . . . . 1.0 110.116 -179.623 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.35 124.11 9.86 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.408 -0.808 . . . . 1.0 109.32 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -111.38 137.61 48.93 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.605 -0.684 . . . . 1.0 109.942 -179.752 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.526 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 27.3 m-85 -114.38 154.23 28.45 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 109.111 -0.699 . . . . 1.0 109.111 179.638 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.533 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 1.7 m-20 -78.54 123.66 27.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.056 -1.028 . . . . 1.0 109.522 179.759 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 43.7 t0 -83.93 -12.38 55.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.229 -0.92 . . . . 1.0 109.391 179.724 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -84.14 -10.01 58.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.352 -0.842 . . . . 1.0 109.871 -179.818 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.417 ' OE2' HD23 ' A' ' 82' ' ' LEU . 99.3 mt-10 -91.48 169.65 10.6 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.204 -0.935 . . . . 1.0 110.033 -179.241 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 15.9 m -100.05 106.25 17.99 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.432 -0.792 . . . . 1.0 108.917 -179.788 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.418 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 91.1 m95 -89.18 124.45 34.36 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.76 -0.83 . . . . 1.0 108.76 179.813 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.652 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.7 t -140.04 159.29 42.5 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.422 -0.799 . . . . 1.0 109.944 -179.103 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.4 t -96.88 -13.3 22.58 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.332 -0.855 . . . . 1.0 109.011 179.485 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 65.6 m -90.62 179.14 5.9 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.768 -0.827 . . . . 1.0 108.768 179.388 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.2 m -79.43 80.18 5.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.983 -1.073 . . . . 1.0 109.349 -179.893 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.652 ' HB2' HG21 ' A' ' 105' ' ' THR . 68.3 mttm -148.88 149.53 31.42 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.654 -0.869 . . . . 1.0 108.654 179.379 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 109' ' ' LYS . . . 44.36 -137.3 5.33 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.602 -1.399 . . . . 1.0 109.602 179.71 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -99.6 117.66 34.46 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.32 -1.106 . . . . 1.0 109.017 179.304 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -62.25 130.3 44.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.326 -0.858 . . . . 1.0 109.733 -179.738 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.9 tp -59.99 -41.88 93.0 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.321 -0.862 . . . . 1.0 110.211 -179.579 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -59.97 -40.12 87.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.179 -0.951 . . . . 1.0 110.505 -179.319 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.447 HD21 ' CE ' ' A' ' 146' ' ' LYS . 3.6 mm? -59.04 -51.21 71.05 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.746 -1.221 . . . . 1.0 109.883 -179.675 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.8 t -69.96 -40.37 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.131 -0.981 . . . . 1.0 109.961 -178.905 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.22 -52.6 65.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -0.91 . . . . 1.0 109.943 -179.422 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.03 -39.05 84.57 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.095 -1.003 . . . . 1.0 110.157 -179.769 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -64.05 -50.0 70.13 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.408 -0.808 . . . . 1.0 111.428 -178.272 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.526 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 10.5 pt-20 -60.03 -39.5 86.09 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.664 -1.272 . . . . 1.0 110.319 -179.168 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.501 ' CZ ' ' CZ ' ' A' ' 39' ' ' PHE . 29.6 m-85 -60.0 -40.02 87.76 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.716 -1.24 . . . . 1.0 108.574 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.91 -42.07 94.55 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.526 -1.43 . . . . 1.0 109.526 -179.949 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -66.89 -39.99 87.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.068 -1.254 . . . . 1.0 109.228 179.522 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.5 p -66.71 -24.44 66.24 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.328 -0.858 . . . . 1.0 108.856 179.542 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 71.4 mt -81.67 -0.58 43.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.394 -0.816 . . . . 1.0 109.357 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 88.77 6.79 72.17 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 120.349 -0.929 . . . . 1.0 110.782 178.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.9 mt -82.74 146.37 29.04 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.782 -1.422 . . . . 1.0 109.644 179.78 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 33.5 t0 -99.33 173.13 6.92 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.926 -0.768 . . . . 1.0 108.926 -179.73 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.493 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 76.4 m80 -59.97 138.45 57.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.175 -0.953 . . . . 1.0 109.807 -179.422 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 33.3 t -97.09 156.51 16.34 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.267 -0.896 . . . . 1.0 109.208 179.739 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -99.86 1.57 43.04 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.318 -0.864 . . . . 1.0 109.663 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -87.03 130.17 49.26 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.18 -0.95 . . . . 1.0 108.913 179.797 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -69.39 -25.35 30.41 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 CA-C-N 120.099 1.071 . . . . 1.0 112.27 -179.622 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -83.58 -4.99 88.81 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.409 -1.476 . . . . 1.0 109.409 -179.805 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.89 145.34 26.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -1.162 . . . . 1.0 109.319 179.567 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.424 ' C ' ' H ' ' A' ' 138' ' ' PHE . 80.5 mt -69.5 -33.13 72.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.294 -0.879 . . . . 1.0 109.723 179.727 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 93.9 mmm -71.8 18.4 0.08 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.152 -0.967 . . . . 1.0 110.687 -179.463 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.424 ' H ' ' C ' ' A' ' 136' ' ' LEU . 13.2 t80 -69.79 133.14 88.51 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.735 -1.228 . . . . 1.0 107.89 179.819 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -62.94 -15.28 46.57 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 CA-C-N 119.905 1.002 . . . . 1.0 113.792 -178.116 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.0 mt -105.91 141.91 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 120.943 -1.098 . . . . 1.0 109.986 -179.392 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -74.95 129.72 38.14 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.397 -0.815 . . . . 1.0 109.691 -179.723 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.6 t -143.13 139.93 30.62 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.348 -0.845 . . . . 1.0 108.853 179.317 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -81.88 143.73 31.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.99 -1.069 . . . . 1.0 109.407 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 m -140.19 150.97 44.83 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.39 -0.819 . . . . 1.0 109.763 -179.314 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.38 112.18 3.65 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 107.717 -2.153 . . . . 1.0 107.717 178.222 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.447 ' CE ' HD21 ' A' ' 115' ' ' LEU . 33.6 mmtm -76.09 4.89 7.59 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.3 -1.118 . . . . 1.0 109.887 -178.607 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 86.8 p -71.79 122.74 21.22 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.181 -0.95 . . . . 1.0 109.119 179.737 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 52.03 40.0 27.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.283 -0.886 . . . . 1.0 110.078 179.848 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -92.5 129.8 38.34 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.927 -1.108 . . . . 1.0 109.74 179.613 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 96.2 mmm -131.45 150.02 52.31 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.499 -0.926 . . . . 1.0 108.499 179.117 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 22.0 mt -50.61 132.13 27.18 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 120.898 -1.126 . . . . 1.0 109.034 -179.515 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -68.53 174.52 8.25 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 CA-C-N 120.0 1.036 . . . . 1.0 111.639 179.364 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -60.04 -39.96 87.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.285 -0.884 . . . . 1.0 109.863 -179.882 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -55.22 -49.77 71.13 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.131 -0.98 . . . . 1.0 109.935 -179.278 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.12 -39.87 75.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.171 -0.956 . . . . 1.0 110.28 -179.349 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 64.4 t -60.08 -45.47 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.003 -1.061 . . . . 1.0 109.03 -179.563 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -60.96 -40.08 91.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.137 -0.977 . . . . 1.0 110.652 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.79 -53.6 9.46 Favored Glycine 0 N--CA 1.497 2.75 0 O-C-N 121.071 -1.018 . . . . 1.0 111.355 -178.518 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.47 HG23 ' N ' ' A' ' 160' ' ' GLN . 7.8 tp -60.05 -40.02 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.94 -1.33 . . . . 1.0 109.637 -178.923 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.5 mt-30 -65.96 -39.6 90.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.091 -1.005 . . . . 1.0 109.716 179.448 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 84.9 p -60.63 -32.19 71.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.09 -1.006 . . . . 1.0 110.688 -179.29 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.4 mt -85.64 -51.51 6.42 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.898 -1.126 . . . . 1.0 110.669 -178.993 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -91.24 -9.12 46.38 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.986 -1.071 . . . . 1.0 110.411 -178.927 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.494 2.517 0 N-CA-C 109.475 -1.45 . . . . 1.0 109.475 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 169' ' ' WAY . . . . . 0.856 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.7 m . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.275 0.559 . . . . 1.0 109.581 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.1 mt -94.19 129.41 40.81 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.353 -0.842 . . . . 1.0 109.519 -179.63 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -160.79 162.29 32.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.367 -0.833 . . . . 1.0 109.617 179.847 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -72.14 149.74 44.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.213 -0.929 . . . . 1.0 109.373 -179.759 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 94.5 p -86.99 1.66 52.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.278 -0.889 . . . . 1.0 109.584 -179.743 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -146.25 154.7 42.02 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.236 -0.915 . . . . 1.0 109.605 -179.845 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.56 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -91.61 0.14 57.53 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.377 -0.827 . . . . 1.0 109.957 -179.631 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -95.16 125.79 40.05 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.109 -0.994 . . . . 1.0 109.192 179.768 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.8 mt -140.04 147.75 40.82 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.363 -0.835 . . . . 1.0 109.192 -179.637 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.0 p -131.44 153.54 49.62 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.482 -0.761 . . . . 1.0 109.032 179.97 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -145.46 160.02 42.22 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.123 -0.985 . . . . 1.0 109.96 -179.988 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.423 HH11 ' HG2' ' A' ' 18' ' ' ARG . 35.3 ttt-85 -142.36 133.8 26.49 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.434 -0.791 . . . . 1.0 109.492 -179.504 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.7 mt -86.61 116.47 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.088 -1.008 . . . . 1.0 108.634 178.917 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.9 t -69.94 -41.46 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.346 -0.846 . . . . 1.0 109.965 -179.311 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -164.48 158.98 18.89 Favored 'General case' 0 C--N 1.291 -1.952 0 O-C-N 119.238 -2.163 . . . . 1.0 111.548 -178.228 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -101.79 119.06 38.19 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.631 -1.618 . . . . 1.0 106.631 178.313 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 23' ' ' THR . 0.1 OUTLIER -61.92 138.0 95.51 Favored Pre-proline 0 C--N 1.303 -1.448 0 O-C-N 121.028 -1.045 . . . . 1.0 109.073 -178.327 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -56.46 -6.35 1.47 Allowed 'Trans proline' 0 N--CA 1.484 0.951 0 CA-C-N 119.614 0.898 . . . . 1.0 110.504 179.554 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 23' ' ' THR . 81.9 m-20 -60.01 -38.69 83.4 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 120.075 -0.65 . . . . 1.0 110.444 -179.457 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 76.7 mtm -139.25 171.11 14.76 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.053 -1.029 . . . . 1.0 109.359 -179.376 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 82.0 p -75.28 164.98 25.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.332 -0.855 . . . . 1.0 109.829 -179.334 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 25.9 m170 -63.98 -43.79 94.67 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.317 -0.864 . . . . 1.0 110.037 -179.559 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 53.3 m -60.18 -40.08 88.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 1.0 110.712 -178.92 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -65.21 -46.78 79.27 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.011 -1.056 . . . . 1.0 110.359 -179.345 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 70.5 t -64.01 -39.92 87.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.471 -0.768 . . . . 1.0 109.48 -179.738 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -55.55 -55.18 34.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.517 -0.739 . . . . 1.0 111.321 -178.774 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.2 pttt -63.6 -32.12 73.49 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.899 -1.125 . . . . 1.0 110.843 -178.678 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.67 -49.99 74.67 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.728 -1.233 . . . . 1.0 109.563 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -67.15 -39.98 86.61 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.066 -1.021 . . . . 1.0 110.454 -179.822 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -59.97 -40.54 89.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.782 -1.199 . . . . 1.0 109.62 -179.581 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -60.42 -40.05 89.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.975 -1.078 . . . . 1.0 109.159 178.885 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.0 -46.3 89.91 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.434 -0.791 . . . . 1.0 109.689 -179.235 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -65.4 -38.91 91.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.136 -0.977 . . . . 1.0 109.466 179.851 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -59.69 -48.16 82.78 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.208 -0.932 . . . . 1.0 110.18 -179.352 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.06 -42.61 90.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.139 -0.976 . . . . 1.0 109.989 -179.61 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -77.8 -38.79 45.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.174 -0.953 . . . . 1.0 110.161 -179.383 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 84.0 p -70.01 -16.77 63.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.096 -1.002 . . . . 1.0 109.997 -179.645 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -59.9 -40.05 87.45 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.072 -1.018 . . . . 1.0 110.412 -179.614 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.6 m -111.81 -19.49 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.406 0 O-C-N 120.991 -1.068 . . . . 1.0 110.815 -179.41 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.0 p -94.52 128.56 39.66 Favored Pre-proline 0 N--CA 1.5 2.041 0 O-C-N 120.761 -1.212 . . . . 1.0 109.392 179.845 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -73.76 16.46 0.51 Allowed 'Trans proline' 0 N--CA 1.494 1.519 0 CA-C-N 120.17 1.096 . . . . 1.0 111.963 179.27 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.2 mt -69.22 140.01 54.53 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.265 -0.897 . . . . 1.0 109.969 -179.667 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -106.65 121.29 44.05 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.764 -0.828 . . . . 1.0 108.764 179.644 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -106.81 126.03 51.77 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.18 -0.95 . . . . 1.0 109.358 -179.777 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.1 m -120.05 130.03 54.5 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.535 -0.728 . . . . 1.0 109.803 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.434 ' HG2' HH11 ' A' ' 52' ' ' ARG . 33.8 ttt-85 -82.41 133.95 35.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.302 -0.874 . . . . 1.0 109.213 179.51 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.8 mt -103.35 130.57 50.67 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.247 -0.908 . . . . 1.0 109.356 179.856 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.443 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 45.5 m170 -63.41 -39.99 95.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.342 -0.849 . . . . 1.0 110.04 -179.599 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 76.6 m-20 -148.94 172.89 13.98 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.116 -0.99 . . . . 1.0 109.93 -179.505 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.43 177.92 39.98 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.595 -1.402 . . . . 1.0 109.595 179.984 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.7 mt -94.03 133.7 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.237 -1.155 . . . . 1.0 109.06 179.96 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.75 163.5 13.21 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.515 -0.741 . . . . 1.0 109.378 -179.424 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -60.01 -49.41 77.77 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.182 -0.948 . . . . 1.0 109.398 -179.77 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.8 mt -107.54 102.97 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.386 -0.821 . . . . 1.0 109.896 179.827 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.5 ptm -103.27 130.7 50.59 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.149 -0.969 . . . . 1.0 109.613 179.471 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.8 mt -105.4 138.01 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.581 -0.699 . . . . 1.0 109.926 -179.289 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 63.8 p -153.69 158.64 41.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.217 -0.927 . . . . 1.0 109.985 179.885 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.81 123.07 48.02 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.477 -0.934 . . . . 1.0 108.477 179.517 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.429 ' O ' ' CB ' ' A' ' 100' ' ' ASP . . . -99.97 175.82 27.76 Favored Glycine 0 N--CA 1.504 3.173 0 O-C-N 121.091 -1.005 . . . . 1.0 111.482 -178.563 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.539 HG22 ' N ' ' A' ' 67' ' ' LYS . 72.3 mt -129.74 164.56 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.612 -0.934 . . . . 1.0 108.769 179.504 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.539 ' N ' HG22 ' A' ' 66' ' ' ILE . 28.1 tptp -9.76 -78.51 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.687 0 CA-C-O 121.066 0.46 . . . . 1.0 112.084 179.968 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -69.35 114.55 7.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.041 -1.037 . . . . 1.0 109.212 179.906 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -99.71 -11.69 20.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.322 -0.861 . . . . 1.0 109.503 -179.471 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 70.0 32.35 69.63 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.477 -1.449 . . . . 1.0 109.477 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 72' ' ' PHE . 33.5 t0 -130.04 170.02 14.54 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.543 -0.975 . . . . 1.0 109.225 -179.709 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.5 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 86.3 m-85 -68.65 -28.95 67.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 1.0 109.855 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -125.35 79.77 66.17 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 121.449 -0.782 . . . . 1.0 109.236 179.954 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -70.09 -164.04 0.12 Allowed 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 120.751 0.967 . . . . 1.0 112.375 -179.539 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.498 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 87.0 m-85 -85.02 156.52 21.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.461 -0.774 . . . . 1.0 109.138 -179.863 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -100.15 0.01 39.72 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.23 -0.919 . . . . 1.0 110.266 -179.054 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 136.22 -155.64 22.56 Favored Glycine 0 N--CA 1.498 2.816 0 N-CA-C 108.475 -1.85 . . . . 1.0 108.475 -179.474 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.444 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 7.4 Cg_exo -62.72 -63.76 0.08 OUTLIER 'Trans proline' 0 C--N 1.313 -1.318 0 CA-C-N 118.697 1.249 . . . . 1.0 111.67 179.414 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 83.3 p -77.11 160.02 29.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.074 -1.016 . . . . 1.0 109.323 179.566 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 117.1 -129.3 8.29 Favored Glycine 0 N--CA 1.502 3.084 0 N-CA-C 109.642 -1.383 . . . . 1.0 109.642 179.882 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.419 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 22.3 mt -69.82 109.68 4.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -1.174 . . . . 1.0 109.24 -179.836 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 46.7 mt -80.74 -19.22 45.47 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.135 -0.978 . . . . 1.0 108.996 -179.919 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -179.55 171.26 1.25 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.761 -0.829 . . . . 1.0 108.761 179.697 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -162.07 159.41 26.18 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.142 -0.974 . . . . 1.0 109.796 179.331 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.6 166.2 29.98 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.79 -0.819 . . . . 1.0 108.79 -179.593 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -101.5 152.77 38.09 Favored Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.217 -0.927 . . . . 1.0 108.873 -179.987 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.559 ' O ' ' N ' ' A' ' 89' ' ' GLY . 10.4 Cg_endo -63.05 165.13 17.44 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 120.599 0.866 . . . . 1.0 111.615 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -47.84 81.7 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.259 0 C-N-CA 121.191 1.261 . . . . 1.0 112.438 -179.814 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -99.57 -168.56 29.99 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 108.361 -1.896 . . . . 1.0 108.361 179.419 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.432 ' HB2' ' H ' ' A' ' 91' ' ' ASN . 22.2 Cg_endo -72.15 -115.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 CA-C-N 118.304 1.052 . . . . 1.0 111.412 -179.704 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.432 ' H ' ' HB2' ' A' ' 90' ' ' PRO . 20.2 m120 -74.9 -40.35 60.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.313 -1.492 . . . . 1.0 110.498 -179.584 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -70.01 -39.96 75.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.175 -0.953 . . . . 1.0 110.57 -178.779 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.426 ' HA3' ' H ' ' A' ' 89' ' ' GLY . . . -60.99 168.92 9.5 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.888 -1.149 . . . . 1.0 110.39 -179.317 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.21 4.61 73.9 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.001 -1.24 . . . . 1.0 110.001 179.511 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.5 p-10 -79.27 162.01 25.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.981 -1.305 . . . . 1.0 109.34 -179.892 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.39 126.15 12.64 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.223 -0.923 . . . . 1.0 109.398 -179.72 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -119.25 153.6 34.74 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.535 -0.728 . . . . 1.0 109.863 -179.774 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -131.22 154.4 48.47 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.622 -0.674 . . . . 1.0 109.281 -179.915 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.498 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 1.2 m-20 -79.46 117.98 20.92 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.04 -1.037 . . . . 1.0 108.749 179.022 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.429 ' CB ' ' O ' ' A' ' 65' ' ' GLY . 35.5 t0 -82.86 -10.66 58.73 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.016 -1.053 . . . . 1.0 109.178 -179.996 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -82.97 -11.63 57.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.383 -0.823 . . . . 1.0 109.107 179.756 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.444 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 99.5 mt-10 -89.53 169.96 10.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.439 -0.788 . . . . 1.0 109.101 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 22.2 m -98.89 104.68 16.74 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.204 -0.935 . . . . 1.0 109.104 -179.671 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.476 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 97.0 m95 -87.63 121.61 30.27 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 179.632 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.651 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.9 t -139.74 153.81 47.28 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.348 -0.845 . . . . 1.0 109.748 -179.198 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.4 m -94.32 -9.11 36.97 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.308 -0.997 . . . . 1.0 108.308 179.187 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 61.6 p -90.99 174.35 7.46 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.601 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 23.1 t -74.04 73.88 1.7 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.183 -0.948 . . . . 1.0 109.543 179.984 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.651 ' HB2' HG21 ' A' ' 105' ' ' THR . 98.2 mttt -148.58 152.49 36.87 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.331 -0.855 . . . . 1.0 109.133 179.471 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 109' ' ' LYS . . . 42.01 -139.65 2.07 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.959 -1.256 . . . . 1.0 109.959 179.631 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -100.05 117.37 34.17 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.353 -1.086 . . . . 1.0 108.855 179.226 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.449 ' N ' ' OH ' ' A' ' 141' ' ' TYR . 58.0 t-20 -63.52 131.2 47.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.154 -0.966 . . . . 1.0 109.939 -179.527 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.2 tp -60.07 -45.07 94.09 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.474 -0.766 . . . . 1.0 111.092 -179.519 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -59.89 -41.92 92.67 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.0 -1.062 . . . . 1.0 111.069 -178.407 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 115' ' ' LEU . 4.1 mm? -58.09 -50.68 72.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.677 -1.264 . . . . 1.0 109.245 -179.49 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 67.6 t -70.44 -39.97 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.962 . . . . 1.0 110.219 -179.544 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.35 -51.77 68.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.063 -1.023 . . . . 1.0 109.597 -179.503 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.04 81.45 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.269 -0.894 . . . . 1.0 109.964 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -60.96 -50.14 74.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.338 -0.852 . . . . 1.0 110.766 -178.403 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -60.11 -40.13 88.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.625 -1.297 . . . . 1.0 109.874 -179.65 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -60.03 -40.09 88.17 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 120.966 -1.084 . . . . 1.0 108.437 179.614 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.58 -42.54 84.66 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.178 -1.569 . . . . 1.0 109.178 179.829 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -67.48 -40.0 85.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -1.15 . . . . 1.0 109.369 179.529 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 73.0 p -65.96 -21.58 66.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 1.0 109.625 -179.908 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 84.2 mt -82.54 0.29 43.33 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.156 -0.965 . . . . 1.0 109.697 -179.796 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.47 3.32 72.03 Favored Glycine 0 N--CA 1.497 2.719 0 C-N-CA 120.221 -0.99 . . . . 1.0 110.754 179.048 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.7 mt -84.2 148.12 26.91 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.954 -1.321 . . . . 1.0 109.576 179.979 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 41.0 t0 -101.57 173.82 6.25 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.776 -0.824 . . . . 1.0 108.776 179.801 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.527 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 76.6 m80 -57.14 135.7 56.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.006 -1.059 . . . . 1.0 109.274 -179.749 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 33.4 t -98.76 156.17 16.98 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.392 -0.818 . . . . 1.0 109.405 -179.839 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -99.65 8.38 44.42 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.303 -0.873 . . . . 1.0 109.344 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -87.18 122.18 71.09 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 1.0 108.688 179.657 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -66.76 -12.47 36.09 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 CA-C-N 120.267 1.131 . . . . 1.0 111.825 -179.765 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -95.51 -4.2 60.87 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.91 -1.276 . . . . 1.0 109.91 -179.843 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -87.87 142.27 27.94 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.069 -1.254 . . . . 1.0 109.816 -179.893 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.6 mt -61.47 -40.08 93.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.335 -0.853 . . . . 1.0 109.717 179.859 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 88.5 mtp -71.69 20.99 0.05 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.413 -0.804 . . . . 1.0 111.528 -178.552 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -68.38 132.63 91.36 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 120.498 -1.376 . . . . 1.0 108.067 179.681 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.425 ' O ' ' HD1' ' A' ' 169' ' ' WAY . 13.8 Cg_exo -48.76 -42.96 35.98 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 CA-C-N 119.88 0.993 . . . . 1.0 113.444 -178.798 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 98.4 mt -82.93 143.62 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.038 -1.039 . . . . 1.0 110.815 -178.853 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.449 ' OH ' ' N ' ' A' ' 112' ' ' ASN . 26.2 t80 -77.42 131.33 37.95 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.693 -0.63 . . . . 1.0 109.52 179.738 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 13.3 t -139.66 140.41 36.89 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.291 -0.88 . . . . 1.0 109.274 179.575 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -82.46 140.55 33.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.212 -0.93 . . . . 1.0 108.939 179.639 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.1 t -140.39 151.28 44.82 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.295 -0.878 . . . . 1.0 109.741 -179.384 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.92 107.97 2.35 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.019 -1.633 . . . . 1.0 109.019 179.661 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 21.7 mtmm -78.13 -0.93 30.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -1.12 . . . . 1.0 109.758 -179.262 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 88.8 p -59.97 -38.35 82.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.283 -0.886 . . . . 1.0 110.133 -179.49 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -139.21 21.63 2.59 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.257 -0.902 . . . . 1.0 110.143 -179.308 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -68.26 137.57 54.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.931 -1.106 . . . . 1.0 109.578 -179.836 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 75.4 mtm -138.87 148.91 44.27 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.244 -1.021 . . . . 1.0 108.244 179.265 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 20.8 mt -51.81 124.03 26.37 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 120.796 -1.19 . . . . 1.0 108.436 -179.737 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -66.15 174.65 5.69 Favored 'Trans proline' 0 N--CA 1.49 1.299 0 CA-C-N 120.124 1.08 . . . . 1.0 112.233 -179.47 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -60.12 -39.81 87.55 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.424 -0.797 . . . . 1.0 109.167 179.816 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -56.45 -49.96 73.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 1.0 110.065 -179.413 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.81 -40.11 72.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.038 -1.039 . . . . 1.0 110.226 -179.411 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 79.0 t -61.37 -48.91 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.089 -1.007 . . . . 1.0 109.444 -179.553 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.18 -39.95 88.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.131 -0.981 . . . . 1.0 110.492 -179.792 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.26 -55.12 8.06 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 120.197 -1.001 . . . . 1.0 111.199 -178.632 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.472 HG23 ' N ' ' A' ' 160' ' ' GLN . 7.7 tp -60.14 -40.1 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.917 -1.343 . . . . 1.0 109.676 -179.096 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.544 ' O ' ' N ' ' A' ' 164' ' ' GLY . 27.1 mm100 -65.09 -39.74 93.61 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.225 -0.922 . . . . 1.0 109.402 179.675 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 86.6 p -62.92 -27.21 69.22 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.224 -0.922 . . . . 1.0 110.135 -179.612 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 92.5 mt -86.69 -53.53 4.89 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.912 -1.117 . . . . 1.0 110.437 -179.376 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -91.79 -9.41 43.66 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.07 -1.019 . . . . 1.0 110.051 -179.083 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.495 2.582 0 N-CA-C 109.434 -1.466 . . . . 1.0 109.434 -179.878 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 169' ' ' WAY . . . . . 0.85 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 84.3 m . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.3 mt -75.77 148.54 38.41 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.199 -0.938 . . . . 1.0 109.439 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -162.28 161.25 27.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.294 -0.879 . . . . 1.0 109.669 -179.946 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -72.44 149.35 44.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.075 -1.016 . . . . 1.0 109.156 179.662 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.0 p -85.67 -0.9 56.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.258 -0.901 . . . . 1.0 109.815 -179.497 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -150.47 157.32 42.89 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.101 -0.999 . . . . 1.0 109.518 179.843 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.531 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.01 0.54 57.05 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.179 -0.951 . . . . 1.0 109.988 -179.627 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -94.76 128.35 41.4 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.139 -0.976 . . . . 1.0 108.948 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 97.8 mt -141.85 151.16 42.48 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.158 -0.964 . . . . 1.0 109.342 -179.585 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.7 p -132.86 158.61 42.11 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.055 -0.72 . . . . 1.0 109.055 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -146.27 162.66 37.61 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.1 -1.0 . . . . 1.0 109.988 -179.854 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -143.84 133.04 23.05 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.582 -0.699 . . . . 1.0 109.661 -179.622 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 86.0 mt -88.62 111.21 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.382 -0.97 . . . . 1.0 108.382 178.468 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.4 t -69.96 -40.35 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.012 -1.055 . . . . 1.0 109.679 -179.152 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.9 p-10 -162.37 160.99 27.19 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.839 -1.163 . . . . 1.0 110.431 -179.741 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.511 ' CD2' ' CD2' ' A' ' 28' ' ' HIS . 64.6 m-85 -101.75 -168.89 1.61 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.346 -1.353 . . . . 1.0 107.346 178.902 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.79 143.69 35.59 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.426 -0.796 . . . . 1.0 109.281 179.806 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -63.57 -11.93 28.57 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 CA-C-O 122.511 0.963 . . . . 1.0 110.177 179.067 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -60.04 -39.99 87.86 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 114.942 -1.026 . . . . 1.0 110.126 -179.974 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.5 mtm -142.53 168.3 20.05 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.22 -0.925 . . . . 1.0 110.118 -178.936 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.7 p -72.2 160.06 33.05 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.422 -0.799 . . . . 1.0 109.76 -179.791 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.511 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 54.5 m170 -60.13 -39.91 87.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.41 -0.807 . . . . 1.0 110.223 -179.589 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 63.2 m -59.91 -40.12 87.75 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.102 -0.999 . . . . 1.0 110.798 -178.674 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -67.32 -39.94 85.9 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.958 -1.089 . . . . 1.0 110.059 -179.698 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.0 t -69.0 -41.15 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.013 -1.054 . . . . 1.0 110.265 -179.29 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.02 -48.29 82.32 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.02 -1.05 . . . . 1.0 110.51 -179.194 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.54 -33.14 72.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.888 -1.132 . . . . 1.0 109.126 179.852 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.98 -49.35 78.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.087 -1.008 . . . . 1.0 109.849 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -67.47 -38.28 84.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.91 -1.119 . . . . 1.0 109.729 179.915 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.411 ' NZ ' ' NH1' ' A' ' 52' ' ' ARG . 63.5 mmtt -59.95 -43.37 95.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.06 -1.025 . . . . 1.0 109.285 -179.522 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -60.34 -40.26 90.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.019 -1.051 . . . . 1.0 108.92 179.376 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.04 -46.87 88.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.486 -0.759 . . . . 1.0 109.927 -179.947 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -65.68 -39.26 91.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.027 -1.046 . . . . 1.0 109.859 -179.711 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -60.04 -46.37 89.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.039 -1.038 . . . . 1.0 109.761 -179.707 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.8 t -60.12 -43.26 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.169 -0.957 . . . . 1.0 110.585 -179.567 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -77.68 -38.03 48.42 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.92 -1.112 . . . . 1.0 110.113 -179.192 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.9 p -70.43 -15.93 62.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.296 -0.877 . . . . 1.0 110.131 -179.385 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -60.02 -40.01 87.81 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.129 -0.982 . . . . 1.0 110.824 -179.636 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.6 m -112.17 -22.68 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.323 -0.861 . . . . 1.0 110.312 -178.685 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.0 p -93.42 130.93 33.87 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 120.943 -1.098 . . . . 1.0 109.595 -179.992 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -74.61 17.48 0.55 Allowed 'Trans proline' 0 N--CA 1.496 1.638 0 CA-C-N 119.91 1.004 . . . . 1.0 112.043 179.233 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.8 mt -68.94 139.85 55.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.114 -0.991 . . . . 1.0 109.838 -179.444 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -106.62 121.21 43.87 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.933 -0.765 . . . . 1.0 108.933 179.417 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -106.86 124.76 50.09 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.281 -0.887 . . . . 1.0 109.727 -179.428 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.2 m -119.96 130.04 54.58 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.626 -0.671 . . . . 1.0 109.891 179.896 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.472 ' CB ' ' NH1' ' A' ' 52' ' ' ARG . 11.6 ttp-105 -82.88 134.84 35.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.268 -0.895 . . . . 1.0 109.556 179.579 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.3 mt -107.43 134.13 50.93 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.266 -0.896 . . . . 1.0 109.299 179.614 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.434 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 59.5 m170 -65.01 -39.9 94.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.438 -0.789 . . . . 1.0 109.46 -179.931 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 72.0 m-20 -151.44 -176.74 5.71 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.281 -0.887 . . . . 1.0 109.486 -179.805 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.21 -179.48 43.74 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.367 -1.493 . . . . 1.0 109.367 -179.662 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 93.3 mt -97.1 130.45 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.296 -1.12 . . . . 1.0 109.474 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.05 160.46 16.42 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.453 -0.779 . . . . 1.0 109.67 -179.605 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.06 -49.1 78.97 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.284 -0.885 . . . . 1.0 109.348 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.9 mt -105.73 97.04 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.467 -0.771 . . . . 1.0 109.729 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.9 ptm -99.2 125.27 44.74 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.083 -1.01 . . . . 1.0 109.173 179.368 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 86.6 mt -102.81 137.52 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.458 -0.776 . . . . 1.0 109.434 -179.451 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.1 p -153.38 153.32 32.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.185 -0.947 . . . . 1.0 109.852 -179.896 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -104.09 121.36 43.05 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.225 -1.028 . . . . 1.0 108.225 179.116 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -108.22 -172.99 21.71 Favored Glycine 0 N--CA 1.5 2.907 0 N-CA-C 110.852 -0.899 . . . . 1.0 110.852 -178.784 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.57 ' O ' ' C ' ' A' ' 67' ' ' LYS . 83.3 mt -134.99 159.91 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.098 -1.075 . . . . 1.0 108.098 179.29 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.57 ' C ' ' O ' ' A' ' 66' ' ' ILE . 28.2 tptp -0.93 -88.52 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.765 0 CA-C-O 121.283 0.563 . . . . 1.0 111.696 -179.597 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 66' ' ' ILE . 21.1 pt-20 -77.78 150.79 34.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.261 -0.9 . . . . 1.0 109.385 179.152 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.418 ' O ' ' C ' ' A' ' 70' ' ' GLY . 33.4 p-80 -161.24 -155.76 0.42 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.975 -1.078 . . . . 1.0 109.812 179.604 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 69' ' ' HIS . . . -39.59 -84.4 0.01 OUTLIER Glycine 0 N--CA 1.498 2.795 0 N-CA-C 110.628 -0.989 . . . . 1.0 110.628 -179.386 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -65.05 147.18 53.95 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.112 -1.228 . . . . 1.0 108.988 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.619 ' CD1' ' N ' ' A' ' 73' ' ' TYR . 51.6 p90 -59.9 -44.79 94.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.202 -0.936 . . . . 1.0 109.836 -179.199 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.619 ' N ' ' CD1' ' A' ' 72' ' ' PHE . 12.3 t80 -42.08 103.54 0.31 Allowed Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.673 -0.642 . . . . 1.0 109.923 -179.851 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -84.26 -174.23 1.78 Allowed 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 120.921 1.081 . . . . 1.0 113.176 -179.381 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.55 ' CE2' ' OD1' ' A' ' 99' ' ' ASP . 89.8 m-85 -90.63 171.21 9.54 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.505 -0.924 . . . . 1.0 108.505 179.217 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 79' ' ' SER . 20.7 p-10 -96.1 9.53 40.57 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.015 -1.053 . . . . 1.0 110.295 -179.091 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 120.88 -154.86 16.35 Favored Glycine 0 N--CA 1.504 3.181 0 N-CA-C 108.934 -1.666 . . . . 1.0 108.934 179.888 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.434 ' O ' ' OE2' ' A' ' 102' ' ' GLU . 3.7 Cg_exo -63.12 -62.41 0.11 Allowed 'Trans proline' 0 N--CA 1.489 1.224 0 CA-C-N 118.962 1.381 . . . . 1.0 111.715 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.419 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 70.9 p -75.63 162.41 28.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.439 -0.788 . . . . 1.0 109.729 179.736 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 111.67 -126.35 7.64 Favored Glycine 0 N--CA 1.501 2.983 0 N-CA-C 109.9 -1.28 . . . . 1.0 109.9 179.71 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.401 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 7.2 mt -69.69 100.39 1.48 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.36 -1.082 . . . . 1.0 109.074 -179.787 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 46.4 mt -73.91 -29.75 62.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.033 -1.042 . . . . 1.0 109.252 -179.702 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -177.32 166.81 2.33 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.086 -1.079 . . . . 1.0 108.086 -179.661 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -163.07 159.91 23.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.753 -1.217 . . . . 1.0 110.033 179.652 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -138.69 160.32 39.94 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.924 -0.769 . . . . 1.0 108.924 179.898 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -97.45 152.06 38.0 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.248 -0.908 . . . . 1.0 109.278 -179.663 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.529 ' O ' ' N ' ' A' ' 89' ' ' GLY . 12.6 Cg_exo -47.08 167.0 0.08 OUTLIER 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 120.437 0.758 . . . . 1.0 111.359 179.976 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -61.61 63.68 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 120.981 1.121 . . . . 1.0 112.416 -179.312 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 87' ' ' PRO . . . -64.64 177.72 9.38 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.936 -1.666 . . . . 1.0 108.936 179.433 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -52.72 -82.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 CA-C-N 118.27 1.035 . . . . 1.0 111.675 -179.655 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -112.49 -45.28 3.26 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.19 -0.944 . . . . 1.0 109.293 179.75 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -59.98 -42.19 93.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.321 -0.862 . . . . 1.0 110.2 179.869 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.428 ' HA3' ' H ' ' A' ' 89' ' ' GLY . . . -61.75 169.43 12.01 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.449 -1.06 . . . . 1.0 110.449 -178.996 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.21 4.17 88.79 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 108.929 -1.669 . . . . 1.0 108.929 -179.823 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.442 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 31.5 p-10 -80.55 167.69 19.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.348 -1.089 . . . . 1.0 109.683 179.932 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.96 119.41 6.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.181 -0.949 . . . . 1.0 109.655 179.826 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -103.87 126.02 50.7 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.398 -0.814 . . . . 1.0 109.593 179.975 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.412 ' CZ ' ' OE1' ' A' ' 120' ' ' GLU . 28.1 m-85 -106.14 145.92 30.88 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.549 -0.719 . . . . 1.0 109.266 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.55 ' OD1' ' CE2' ' A' ' 75' ' ' PHE . 94.7 m-20 -78.24 121.98 25.1 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.979 -1.076 . . . . 1.0 109.145 179.513 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 45.7 t0 -83.18 -10.89 58.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.232 -0.918 . . . . 1.0 109.622 179.976 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -81.91 -10.98 59.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.311 -0.868 . . . . 1.0 109.852 -179.732 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.434 ' OE2' ' O ' ' A' ' 78' ' ' PRO . 98.7 mt-10 -89.15 169.05 11.8 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.185 -0.947 . . . . 1.0 109.614 -179.348 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 54.8 m -98.12 104.73 16.79 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.168 -0.958 . . . . 1.0 109.291 -179.521 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -89.35 120.95 31.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.882 . . . . 1.0 108.908 179.924 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.638 HG21 ' HB2' ' A' ' 109' ' ' LYS . 6.4 t -140.06 150.16 44.03 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.444 -0.785 . . . . 1.0 109.819 -179.046 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 66.3 m -91.64 -8.59 46.74 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.257 -1.016 . . . . 1.0 108.257 179.034 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 83.5 p -90.17 172.14 9.02 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.787 -0.82 . . . . 1.0 108.787 179.364 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.7 t -74.99 77.2 2.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.024 -1.047 . . . . 1.0 109.416 -179.962 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.638 ' HB2' HG21 ' A' ' 105' ' ' THR . 96.4 mttt -148.85 147.52 28.82 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 179.456 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.14 -138.06 4.72 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.981 -1.248 . . . . 1.0 109.981 179.746 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -100.04 115.2 29.18 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.282 -1.128 . . . . 1.0 109.171 179.906 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -63.96 133.95 54.16 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.087 -1.008 . . . . 1.0 109.781 -179.685 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.4 tp -59.95 -45.09 93.74 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.357 -0.84 . . . . 1.0 111.165 -179.6 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -59.94 -40.97 90.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.988 -1.07 . . . . 1.0 110.695 -178.188 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -59.97 -50.2 74.68 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.838 -1.164 . . . . 1.0 109.436 -179.569 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.5 t -70.01 -40.48 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.099 -1.0 . . . . 1.0 110.109 -179.396 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.93 -51.27 70.77 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.115 -0.99 . . . . 1.0 109.6 -179.312 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.99 -36.56 77.45 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.282 -0.886 . . . . 1.0 110.425 -179.97 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -63.34 -49.88 72.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.166 -0.959 . . . . 1.0 110.806 -178.558 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.412 ' OE1' ' CZ ' ' A' ' 98' ' ' PHE . 7.3 pt-20 -59.87 -39.15 84.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.746 -1.221 . . . . 1.0 109.999 -179.455 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -60.04 -40.05 88.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.788 -1.195 . . . . 1.0 108.829 179.421 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -56.97 -42.9 93.03 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.547 -1.421 . . . . 1.0 109.547 179.988 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -67.23 -39.96 86.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.108 -1.231 . . . . 1.0 109.993 179.801 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 87.3 p -67.1 -22.18 65.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 1.0 109.909 -179.598 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 81.0 mt -80.84 -0.93 41.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.158 -0.964 . . . . 1.0 109.701 -179.853 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.92 6.14 67.49 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 110.414 -1.075 . . . . 1.0 110.414 179.264 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.4 mt -84.91 150.04 25.24 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.987 -1.302 . . . . 1.0 109.654 179.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 38.4 t0 -99.95 175.59 5.72 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.593 -0.891 . . . . 1.0 108.593 179.416 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.501 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 72.6 m80 -59.7 139.98 56.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.97 -1.081 . . . . 1.0 109.491 -179.742 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 44.2 t -98.09 148.1 23.88 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.381 -0.825 . . . . 1.0 109.334 -179.808 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -96.9 2.15 51.33 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.266 -0.896 . . . . 1.0 109.733 -179.646 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 8.2 t0 -86.48 128.14 58.13 Favored Pre-proline 0 N--CA 1.491 1.623 0 N-CA-C 107.947 -1.131 . . . . 1.0 107.947 179.296 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -65.39 -19.67 61.44 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 CA-C-N 120.344 1.158 . . . . 1.0 112.305 -179.665 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.426 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -88.09 -6.36 75.36 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.621 -1.392 . . . . 1.0 109.621 -179.929 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.61 135.41 34.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.244 -1.15 . . . . 1.0 109.235 179.787 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.437 ' C ' ' H ' ' A' ' 138' ' ' PHE . 92.2 mt -60.08 -38.92 84.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.108 -0.995 . . . . 1.0 109.685 -179.692 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 71.0 mtp -69.9 21.81 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.384 -0.823 . . . . 1.0 111.349 -178.631 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.437 ' H ' ' C ' ' A' ' 136' ' ' LEU . 16.1 t80 -67.06 134.43 93.78 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 120.726 -1.234 . . . . 1.0 107.848 179.542 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -61.64 -5.5 5.84 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 120.876 1.05 . . . . 1.0 114.215 -177.886 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 89.6 mt -118.05 136.55 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 O-C-N 120.918 -1.114 . . . . 1.0 109.269 179.55 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -72.11 126.55 30.07 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.349 -0.845 . . . . 1.0 109.958 -178.928 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.8 t -139.55 142.19 37.2 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.81 -0.811 . . . . 1.0 108.81 179.79 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -80.77 145.03 31.69 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.002 -1.061 . . . . 1.0 109.545 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.8 t -140.03 156.66 46.51 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.412 -0.805 . . . . 1.0 109.438 -179.605 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.12 104.49 0.97 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.719 -1.352 . . . . 1.0 109.719 -179.859 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -77.1 -0.93 26.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.364 -1.08 . . . . 1.0 109.898 -179.892 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 42.1 t -60.01 -43.09 95.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.084 -1.01 . . . . 1.0 109.353 -179.562 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -156.05 74.31 0.85 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.096 -1.002 . . . . 1.0 109.556 179.545 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -99.13 122.91 42.98 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.297 -0.877 . . . . 1.0 109.166 179.555 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 96.7 mtp -114.57 140.18 48.99 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.021 -0.733 . . . . 1.0 109.021 179.854 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 57.0 mt -50.26 128.82 23.85 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.021 -1.049 . . . . 1.0 108.836 -179.94 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -69.01 176.97 5.52 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 CA-C-N 120.041 1.05 . . . . 1.0 112.335 179.889 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.04 -40.0 87.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.417 -0.802 . . . . 1.0 109.549 179.775 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -55.76 -49.97 71.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.342 -0.849 . . . . 1.0 109.943 -179.385 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -70.72 -40.0 73.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.023 -1.048 . . . . 1.0 110.151 -179.525 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 76.9 t -62.09 -48.58 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.106 -0.997 . . . . 1.0 109.335 -179.67 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -60.82 -39.98 91.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.975 -1.078 . . . . 1.0 110.283 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -70.68 -53.83 11.3 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 120.228 -0.987 . . . . 1.0 111.393 -178.634 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.454 HG23 ' N ' ' A' ' 160' ' ' GLN . 6.0 tp -60.48 -40.04 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.868 -1.372 . . . . 1.0 109.795 -178.981 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 164' ' ' GLY . 95.1 mt-30 -64.01 -39.86 95.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.192 -0.943 . . . . 1.0 109.156 179.593 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 86.3 p -62.74 -28.58 70.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.885 . . . . 1.0 110.326 -179.805 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 85.4 mt -87.85 -49.95 6.76 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.947 -1.096 . . . . 1.0 110.401 -179.213 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -91.05 -9.52 45.5 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.067 -1.021 . . . . 1.0 110.148 -179.061 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.554 -1.418 . . . . 1.0 109.554 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 169' ' ' WAY . . . . . 0.952 ' HI ' ' HC2' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_